PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cai, G; Wu, D; Wang, Z; Xu, Z; Wong, KB; Ng, CF; Chan, FL; Yu, S				Cai, G.; Wu, D.; Wang, Z.; Xu, Z.; Wong, K-B; Ng, C-F; Chan, F. L.; Yu, S.			Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial-mesenchymal transition and remodeling of actin cytoskeleton organization	ONCOGENE			English	Article							MOLECULAR CHARACTERIZATION; THERAPEUTIC TARGET; CELL INVASION; EXPRESSION; RECEPTOR; GROWTH; PROGRESSION; UNC-33; FAMILY; DIHYDROPYRIMIDINASE	The cancer cells can acquire migration and invasion capacities during the metastasis process through the developmental regulatory program epithelial-mesenchymal-transition (EMT), and through its reverse process mesenchymal-epithelial transition cancer cells can recolonize at distant metastatic sites. Among the multifaceted effects exerted by this program, reorganization of actin cytoskeleton is the key mechanical drive for the invasive properties gained by cancer cells. Collapsin response mediator protein-1 (CRMP1) is a cytosolic phosphoprotein and originally characterized as the mediator of semaphorin 3A signaling involved in axon differentiation during neural development. Here we report that CRMP1 can act as a suppressor of tumorigenicity and metastasis in prostate cancer cells. We demonstrated that CRMP1 exhibited a decreased expression pattern in high-grade prostate cancer tissues and many prostate cancer cell lines, and its downregulation in cancer cells was attributed to histone deacetylation and direct repression of its gene by the EMT regulator Snail. Functional analyses revealed that CRMP1 suppressed EMT in prostate cancer cells, as its knockdown could trigger EMT and enhance in vitro invasion capacity, whereas its overexpression could inhibit EMT and suppress both in vitro invasion and in vivo metastasis capacities of prostate cancer cells. Moreover, CRMP1 overexpression could significantly confer resistance to EMT induced by Snail or transforming growth factor-beta 1 in prostatic epithelial cells and prostate cancer cells. Finally, we demonstrated that CRMP1 could associate with actin and WAVE1, an activator of actin nucleation complex Arp2/3, and also its knockdown could stabilize F-actin and trigger the formation of stress fibers in prostate cancer cells. Together, our study shows that CRMP1 acts an EMT and metastasis suppressor in prostate cancer cells via its regulation of actin polymerization and also suggests that targeting the CRMP1-actin signaling in actin organization could be a potential strategy for management of prostate cancer metastasis.	[Cai, G.; Wu, D.; Wang, Z.; Xu, Z.; Chan, F. L.; Yu, S.] Chinese Univ Hong Kong, Sch Biomed Sci, Kwee Seong Integrated Biomed Sci Bldg, Shatin, Hong Kong, Peoples R China; [Wong, K-B] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Ng, C-F] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, FL; Yu, S (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Kwee Seong Integrated Biomed Sci Bldg, Shatin, Hong Kong, Peoples R China.	franky-chan@cuhk.edu.hk; yushan771@hotmail.com	Chi-fai, NG/AAV-8270-2021; Wong, Kam-Bo/AAU-9364-2021; Ng, Chi-Fai/E-5134-2011; Wong, Kam-Bo/G-4258-2013; Chan, Franky L./M-1043-2018	Wong, Kam-Bo/0000-0002-6984-5373; Ng, Chi-Fai/0000-0002-1723-9646; Wong, Kam-Bo/0000-0002-6984-5373; Chan, Franky L./0000-0003-0567-2052; Wang, Zhu/0000-0002-5457-3731; Wu, Dinglan/0000-0002-5057-9626	earmarked research grant from the Research Grants Council of Hong Kong [CUHK4411-/06M]; research grant from the National Natural Science Foundation of China	earmarked research grant from the Research Grants Council of Hong Kong; research grant from the National Natural Science Foundation of China	We thank Dr Isaiah Fidler for providing the PC-3M and PC-3M-LN4 cell lines, Dr Andrew ML Chan for the A549 cell line, Dr Cheng-Chung Wu for the pGL3-CRMP1-Luc and Dr Alexander Staruschenko for the pcDNA3.1-His-WASF1. This work was supported by an earmarked research grant from the Research Grants Council of Hong Kong (project no. CUHK4411-/06M) and a research grant from the National Natural Science Foundation of China.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Byk T, 1996, J NEUROSCI, V16, P688; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Cheung CP, 2005, J CLIN ENDOCR METAB, V90, P1830, DOI 10.1210/jc.2004-1421; Chu JH, 2009, PROSTATE, V69, P428, DOI 10.1002/pros.20897; Fukada M, 2000, J BIOL CHEM, V275, P37957, DOI 10.1074/jbc.M003277200; Gao M, 2008, BIOCHEM BIOPH RES CO, V376, P283, DOI 10.1016/j.bbrc.2008.08.144; Gao X, 2010, ONCOGENE, V29, P4555, DOI 10.1038/onc.2010.213; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; Hiroshima Y, 2013, ANN SURG ONCOL, V20, pS369, DOI 10.1245/s10434-012-2491-3; Hu Y, 2002, J BIOL CHEM, V277, P44462, DOI 10.1074/jbc.M205784200; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Leung T, 2002, FEBS LETT, V532, P445, DOI 10.1016/S0014-5793(02)03736-5; Lui K, 2006, PROSTATE, V66, P1600, DOI 10.1002/pros.20429; Meyronet D, 2008, AM J SURG PATHOL, V32, P1699, DOI 10.1097/PAS.0b013e31817dc37c; MINTURN JE, 1995, J NEUROSCI, V15, P6757; Oliemuller E, 2013, INT J CANCER, V132, P1986, DOI 10.1002/ijc.27881; Pan SH, 2011, J CLIN INVEST, V121, P3189, DOI 10.1172/JCI42975; Pan SH, 2010, LUNG CANCER, V67, P93, DOI 10.1016/j.lungcan.2009.03.006; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Smith BN, 2012, CELL ADHES MIGR, V6, P433, DOI 10.4161/cam.21687; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wang LH, 1997, J NEUROCHEM, V69, P2261; Wu CC, 2008, MOL CANCER THER, V7, P1365, DOI 10.1158/1535-7163.MCT-08-0091; Wu DL, 2015, J PATHOL, V236, P103, DOI 10.1002/path.4505; Yamashita N, 2012, MOL NEUROBIOL, V45, P234, DOI 10.1007/s12035-012-8242-4; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yu S, 2008, ONCOGENE, V27, P3313, DOI 10.1038/sj.onc.1210986; Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855; Yu S, 2014, J PATHOL, V234, P514, DOI 10.1002/path.4413; Yu S, 2009, BIOCHEM BIOPH RES CO, V382, P756, DOI 10.1016/j.bbrc.2009.03.110	40	32	32	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 26	2017	36	4					546	558		10.1038/onc.2016.227	http://dx.doi.org/10.1038/onc.2016.227			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8II	27321179	Green Published, hybrid			2022-12-26	WOS:000394166700011
J	Chung, HJ; Park, JE; Lee, NS; Kim, H; Jang, CY				Chung, Hee Jin; Park, Ji Eun; Lee, Nam Soo; Kim, Hongtae; Jang, Chang-Young			Phosphorylation of Astrin Regulates Its Kinetochore Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; cell division; cyclin-dependent kinase (Cdk); kinetochore; phosphorylation; mitosis	SPINDLE-ASSOCIATED PROTEIN; POLO-BOX DOMAIN; MITOTIC-SPINDLE; MICROTUBULE ATTACHMENTS; CHROMOSOME ALIGNMENT; MITOSIS; CENTROSOME; CELLS; CAPTURE; COMPLEX	The error-free segregation of chromosomes, which requires the precisely timed search and capture of chromosomes by spindles during early mitotic and meiotic cell division, is responsible for genomic stability and is achieved by the spindle assembly checkpoint in the metaphase-anaphase transition. Mitotic kinases orchestrate M phase events, such as the reorganization of cell architecture and kinetochore (KT) composition with the exquisite phosphorylation of mitotic regulators, to ensure timely and temporal progression. However, the molecular mechanisms underlying the changes of KT composition for stable spindle attachment during mitosis are poorly understood. Here, we show that the sequential action of the kinase Cdk1 and the phosphatase Cdc14A control spindle attachment to KTs. During prophase, the mitotic spindle protein Spag5/Astrin is transported into centrosomes by Kinastrin and phosphorylated at Ser-135 and Ser-249 by Cdk1, which, in prometaphase, is loaded onto the spindle and targeted to KTs. We also demonstrate that Cdc14A dephosphorylates Astrin, and therefore the overexpression of Cdc14A sequesters Astrin in the centrosome and results in aberrant chromosome alignment. Mechanistically, Plk1 acts as an upstream kinase for Astrin phosphorylation by Cdk1 and targeting phospho-Astrin to KTs, leading to the recruitment of outer KT components, such as Cenp-E, and the stable attachment of spindles to KTs. These comprehensive findings reveal a regulatory circuit for protein targeting to KTs that controls the KT composition change of stable spindle attachment and chromosome integrity.	[Kim, Hongtae] Sungkyunkwan Univ, Ctr Neurosci Imaging Res, Inst Basic Sci, Suwon 440746, South Korea; [Chung, Hee Jin; Lee, Nam Soo; Kim, Hongtae] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Park, Ji Eun; Jang, Chang-Young] Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Seoul 04310, South Korea	Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sookmyung Women's University	Kim, H (corresponding author), Sungkyunkwan Univ, Ctr Neurosci Imaging Res, Inst Basic Sci, Suwon 440746, South Korea.; Kim, H (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea.; Jang, CY (corresponding author), Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Seoul 04310, South Korea.	khtcat@skku.edu; cyjang@sookmyung.ac.kr			Institute for Basic Science Grant [IBS-R015-D1]; National Research Foundation of Korea - Korea government [NRF-2015R1A2A2A01003975, 2011-0030074]	Institute for Basic Science Grant; National Research Foundation of Korea - Korea government(National Research Foundation of KoreaKorean Government)	This work was supported by Institute for Basic Science Grant IBS-R015-D1 and National Research Foundation of Korea grants NRF-2015R1A2A2A01003975 and 2011-0030074 funded by the Korea government. The authors declare that they have no conflicts of interest with the contents of this article.	Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026; Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Amin MA, 2014, J CELL SCI, V127, P2818, DOI 10.1242/jcs.150755; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Cheng TS, 2008, J BIOL CHEM, V283, P2454, DOI 10.1074/jbc.M706794200; Cheng TS, 2007, EXP CELL RES, V313, P1710, DOI 10.1016/j.yexcr.2007.02.023; Chiu SC, 2014, AM J PHYSIOL-CELL PH, V307, pC466, DOI 10.1152/ajpcell.00164.2014; Cho HJ, 2010, MOL CELLS, V30, P355, DOI 10.1007/s10059-010-0134-8; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Dunsch AK, 2011, J CELL BIOL, V192, P959, DOI 10.1083/jcb.201008023; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Gruber J, 2002, J CELL SCI, V115, P4053, DOI 10.1242/jcs.00088; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Loffler H, 2011, CANCER RES, V71, P2129, DOI 10.1158/0008-5472.CAN-10-2684; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; Maia ARR, 2012, J CELL BIOL, V199, P285, DOI 10.1083/jcb.201203091; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; McEwen BF, 1998, CHROMOSOMA, V107, P366, DOI 10.1007/s004120050320; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Suzuki A, 2011, J CELL BIOL, V193, P125, DOI 10.1083/jcb.201012050; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Tanaka K, 2012, J BIOCHEM, V152, P415, DOI 10.1093/jb/mvs109; Tanaka TU, 2005, NAT REV MOL CELL BIO, V6, P929, DOI 10.1038/nrm1764; Tavernier N, 2015, J CELL BIOL, V208, P661, DOI 10.1083/jcb.201408064; Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163; Thompson SL, 2011, CHROMOSOME RES, V19, P433, DOI 10.1007/s10577-010-9179-y; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738	43	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17579	17592		10.1074/jbc.M115.712745	http://dx.doi.org/10.1074/jbc.M115.712745			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27325694	hybrid, Green Published			2022-12-26	WOS:000383241300010
J	Yao, YF; Shi, Q; Chen, B; Wang, QS; Li, XD; Li, L; Huang, YH; Ji, JG; Shen, PP				Yao, Yongfang; Shi, Qian; Chen, Bing; Wang, Qingsong; Li, Xinda; Li, Long; Huang, Yahong; Ji, Jianguo; Shen, Pingping			Identification of Caspase-6 as a New Regulator of Alternatively Activated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; cytokine; immunology; macrophage; toll-like receptor (TLR); tumor immunology	TUMOR-ASSOCIATED MACROPHAGES; SUPPRESSOR-CELLS; CANCER; ANGIOGENESIS; POLARIZATION; DISTINCT; PLASTICITY; MONOCYTES; DIFFERENTIATION; DEGENERATION	Alternatively activated macrophages (AAMs) play essential roles in the promotion of tissue remodeling, vasculogenesis, and tumor progression; however, the detailed mechanisms underlying the activation of AAMs remain largely unknown. Here, by using quantitative proteomic analysis, we identified 62 proteins that were up-regulated in IL-4-induced macrophages. Among these, Caspase-6 was increased significantly. Caspase-6 is important in the apoptotic signaling pathway; however, its role in non-apoptosis is also reported. Here, we first examined the non-apoptotic role of Caspase-6 in the alternative activation of macrophages after administration of IL-4, 4T1 tumor conditional medium, or co-culture with 4T1 cells. Both treatments promoted alternative activation of RAW264.7 cells and primary macrophages, whereas disruption of caspase-6 expression and activity could markedly suppress the biomarker levels of AAMs. Overexpression of Caspase-6 could significantly promote the activation of AAMs. Importantly, we further present evidence that caspase-6 could regulate breast cancer cell invasion by modulating MMP-2 and MMP-9 expression in 4T1 tumor-associated macrophages, as ablation of protein levels or activity of caspase-6 suppressed tumor cell invasion in vitro. In conclusion, the observed results markedly expanded our views of the dynamic changes in protein composition during alternative activation of macrophages, and they revealed a critical new role of caspase-6 in regulating this cellular biological process, which suggested that caspase-6 might be a key nod molecule to regulate immunological steady-state and be a therapeutic candidate for tumor immunotherapy.	[Yao, Yongfang; Li, Xinda; Li, Long; Huang, Yahong; Shen, Pingping] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Jiangsu, Peoples R China; [Yao, Yongfang; Li, Xinda; Li, Long; Huang, Yahong; Shen, Pingping] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210023, Jiangsu, Peoples R China; [Shi, Qian] Univ Texas Hlth Sci Ctr San Antonio, Div Nephrol, Dept Med, San Antonio, TX 78229 USA; [Chen, Bing] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Hematol, Nanjing 210008, Peoples R China; [Wang, Qingsong; Ji, Jianguo] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Nanjing University; Nanjing University; University of Texas System; University of Texas Health San Antonio; Nanjing University; Peking University	Shen, PP (corresponding author), Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Jiangsu, Peoples R China.; Shen, PP (corresponding author), Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210023, Jiangsu, Peoples R China.; Ji, JG (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.; Ji, JG (corresponding author), Peking Univ, Inst Syst Biomed, Sch Basic Med Sci, Beijing 100191, Peoples R China.	jijg@pku.edu.cn; ppshen1812@gmail.com			National Natural Science Foundation of China [81473220, 81273527, 81421091]; National Key Research and Development Program [2016YFA0500301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program	This work was supported by National Natural Science Foundation of China Projects 81473220, 81273527, and 81421091 and by National Key Research and Development Program no. 2016YFA0500301. The authors declare that they have no conflicts of interest with the contents of this article.	ABRAMSON SL, 1990, J IMMUNOL, V144, P625; Bingle L, 2006, BRIT J CANCER, V94, P101, DOI 10.1038/sj.bjc.6602901; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Clear AJ, 2010, BLOOD, V115, P5053, DOI 10.1182/blood-2009-11-253260; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Farina AR, 2014, CANCERS, V6, P240, DOI 10.3390/cancers6010240; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gal A, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-402; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Kalhori V, 2015, MOL CELL ENDOCRINOL, V404, P113, DOI 10.1016/j.mce.2015.01.037; Kobayashi H, 2011, J IMMUNOL, V186, P403, DOI 10.4049/jimmunol.1001906; Kodumudi KN, 2010, CLIN CANCER RES, V16, P4583, DOI 10.1158/1078-0432.CCR-10-0733; Laoui D, 2011, INT J DEV BIOL, V55, P861, DOI 10.1387/ijdb.113371dl; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; MANTOVANI A, 1979, J NATL CANCER I, V63, P61; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn; Obeid E, 2013, INT J ONCOL, V43, P5, DOI 10.3892/ijo.2013.1938; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian XS, 2011, J BIOL CHEM, V286, P2111, DOI 10.1074/jbc.M110.154971; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Rust C, 2009, J BIOL CHEM, V284, P2908, DOI 10.1074/jbc.M804585200; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Squadrito ML, 2011, MOL ASPECTS MED, V32, P123, DOI 10.1016/j.mam.2011.04.005; Uribe V, 2012, HUM MOL GENET, V21, P1954, DOI 10.1093/hmg/dds005; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang T, 2012, PIGM CELL MELANOMA R, V25, P493, DOI 10.1111/j.1755-148X.2012.01005.x; Watanabe C, 2008, J IMMUNOL, V181, P6810, DOI 10.4049/jimmunol.181.10.6810; Wong BKY, 2015, NEUROBIOL DIS, V76, P24, DOI 10.1016/j.nbd.2014.12.030; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343	67	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17450	17466		10.1074/jbc.M116.717868	http://dx.doi.org/10.1074/jbc.M116.717868			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27325699	hybrid, Green Published			2022-12-26	WOS:000382643800043
J	Chang, YC; Tung, HJ; Hsu, SW; Chen, LS; Kung, PT; Huang, KH; Chiou, SJ; Tsai, WC				Chang, Yu-Chia; Tung, Ho-Jui; Hsu, Shang-Wei; Chen, Lei-Shin; Kung, Pei-Tseng; Huang, Kuang-Hua; Chiou, Shang-Jyh; Tsai, Wen-Chen			Use of Seasonal Influenza Vaccination and Its Associated Factors among Elderly People with Disabilities in Taiwan: A Population-Based Study	PLOS ONE			English	Article							PREVENTIVE SERVICES; HEALTH; ADULTS; BARRIERS; CARE; DETERMINANTS; EXPERIENCE; RECEIPT; PROGRAM; LEVEL	Background Influenza immunization among elderly people with disabilities is a critical public health concern; however, few studies have examined the factors associated with vaccination rates in non-Western societies. Methods By linking the National Disability Registration System and health service claims dataset from the National Health Insurance program, this population-based study investigated the seasonal influenza vaccination rate among elderly people with disabilities in Taiwan (N = 283,172) in 2008. A multivariate logistic regression analysis was conducted to adjust for covariates. Results Nationally, only 32.7% of Taiwanese elderly people with disabilities received influenza vaccination. The strongest predictor for getting vaccinated among older Taiwanese people with disabilities was their experience of receiving an influenza vaccination in the previous year (adjusted odds ratio [AOR] = 6.80, 95% confidence interval [CI]: 6.67-6.93). Frequent OPD use (AOR = 1.85, 95% CI: 1.81-1.89) and undergoing health examinations in the previous year (AOR = 1.66, 95% CI: 1.62-1.69) also showed a moderate and significant association with receiving an influenza vaccination. Conclusions Although free influenza vaccination has been provided in Taiwan since 2001, influenza immunization rates among elderly people with disabilities remain low. Policy initiatives are required to address the identified factors for improving influenza immunization rates among elderly people with disabilities.	[Chang, Yu-Chia; Tung, Ho-Jui; Hsu, Shang-Wei; Kung, Pei-Tseng] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Chang, Yu-Chia; Hsu, Shang-Wei] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Lei-Shin] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA; [Huang, Kuang-Hua; Tsai, Wen-Chen] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Chiou, Shang-Jyh] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan	Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Texas A&M University System; Texas A&M University College Station; China Medical University Taiwan; National Taipei University of Nursing & Health Science (NTUNHS)	Tsai, WC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.	wtsai@mail.cmu.edu.tw	TUNG, HO-JUI/AAD-6851-2020; Tsai, Wen-Chen/O-3095-2015	Tsai, Wen-Chen/0000-0002-9684-0789	National Science Council [NSC 102-2410-H-468-019, NSC 103-2918-I-468 -003]; China Medical University [CMU 100-ASIA-10]; Asia University, Taiwan, ROC	National Science Council(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Asia University, Taiwan, ROC	This study was supported by the grants NSC 102-2410-H-468-019- and NSC 103-2918-I-468 -003- from the National Science Council, and the grant CMU 100-ASIA-10 from China Medical University and Asia University, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Centers for Disease Control and Prevention, PEOPLE AT HIGH RISK; Centers for Disease Control and Prevention, WHAT YOU SHOULD KNOW; Chan L, 1999, ARCH PHYS MED REHAB, V80, P642, DOI 10.1016/S0003-9993(99)90166-1; Chen CH, 2011, THE ASSESSMENT OF IN; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; Damiani G, 2007, PREV MED, V45, P373, DOI 10.1016/j.ypmed.2007.07.007; Diab ME, 2004, ARCH PHYS MED REHAB, V85, P749, DOI 10.1016/j.apmr.2003.06.028; Endrich MM, 2009, VACCINE, V27, P4018, DOI 10.1016/j.vaccine.2009.04.029; Evans MR, 2003, VACCINE, V21, P2421, DOI 10.1016/S0264-410X(03)00059-8; Henning-Smith C, 2013, MED CARE, V51, P1015, DOI 10.1097/MLR.0b013e3182a95d65; Iezzoni LI, 2000, AM J PUBLIC HEALTH, V90, P955, DOI 10.2105/AJPH.90.6.955; Iezzoni LI, 2011, DISABIL HEALTH J, V4, P238, DOI 10.1016/j.dhjo.2011.06.001; Kamal Khalid M, 2003, J Am Pharm Assoc (2003), V43, P403, DOI 10.1331/154434503321831120; Kohlhammer Y, 2007, PUBLIC HEALTH, V121, P742, DOI 10.1016/j.puhe.2007.02.011; Kroll T, 2006, HEALTH SOC CARE COMM, V14, P284, DOI 10.1111/j.1365-2524.2006.00613.x; Lai HT, 2014, RES DEV DISABIL, V35, P2231, DOI 10.1016/j.ridd.2014.05.014; Lee JE, 2014, DISABIL REHABIL, V36, P1728, DOI 10.3109/09638288.2013.867368; Lin YY, 2016, GERONTOLOGIST, V56, P176, DOI 10.1093/geront/gnv107; McGuire LC, 2007, PREVENTING CHRONIC D, V4; Ministry of Health and Welfare, THE DISABLED POPULAT; Ministry of the Interior, 2012, STATISTICAL REPORT O; Nagata JM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-388; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nowalk MP, 2004, J AM GERIATR SOC, V52, P25, DOI 10.1111/j.1532-5415.2004.52006.x; O'Reilly D, 2002, AGE AGEING, V31, P385, DOI 10.1093/ageing/31.5.385; Partnership for Prevention, 2007, PARTNERSHIP FOR PREV; Patrick DL, 1997, AM J HEALTH PROMOT, V11, P257, DOI 10.4278/0890-1171-11.4.257; Rosenbach M L, 1995, Health Care Financ Rev, V17, P147; Skinner CS, 2015, HEALTH BEHAVIOR THEO; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Tabbarah M, 2005, J AM GERIATR SOC, V53, P1354, DOI 10.1111/j.1532-5415.2005.53424.x; U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics, 2012, HEALTHY PEOPLE 2010; Wang ST, 2005, VACCINE, V23, P1973, DOI 10.1016/j.vaccine.2004.10.011; Ward L, 2008, J CLIN NURS, V17, P5, DOI 10.1111/j.1365-2702.2006.01861.x; Wei WH, 2006, WOMEN HEALTH ISS, V16, P286, DOI 10.1016/j.whi.2006.09.002; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organization, INFL SEAS; Yang CL., 2013, TAIWAN EPIDEMIOL B, V29, P252; Yen CF, 2012, RES DEV DISABIL, V33, P704, DOI 10.1016/j.ridd.2011.11.011	41	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158075	10.1371/journal.pone.0158075	http://dx.doi.org/10.1371/journal.pone.0158075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP3JL	27336627	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200106
J	Khan, MNI; Hijbeek, R; Berger, U; Koedam, N; Grueters, U; Islam, SMZ; Hasan, MA; Dahdouh-Guebas, F				Khan, Md Nabiul Islam; Hijbeek, Renske; Berger, Uta; Koedam, Nico; Grueters, Uwe; Islam, S. M. Zahirul; Hasan, Md Asadul; Dahdouh-Guebas, Farid			An Evaluation of the Plant Density Estimator the Point-Centred Quarter Method (PCQM) Using Monte Carlo Simulation	PLOS ONE			English	Article							FIELD DATA SETS; PROTOCOL; OPTIMIZATION; PARAMETERS; PATTERNS; FORESTS	Background In the Point-Centred Quarter Method (PCQM), the mean distance of the first nearest plants in each quadrant of a number of random sample points is converted to plant density. It is a quick method for plant density estimation. In recent publications the estimator equations of simple PCQM (PCQM1) and higher order ones (PCQM2 and PCQM3, which uses the distance of the second and third nearest plants, respectively) show discrepancy. This study attempts to review PCQM estimators in order to find the most accurate equation form. We tested the accuracy of different PCQM equations using Monte Carlo Simulations in simulated (having 'random', 'aggregated' and 'regular' spatial patterns) plant populations and empirical ones. Principal Findings PCQM requires at least 50 sample points to ensure a desired level of accuracy. PCQM with a corrected estimator is more accurate than with a previously published estimator. The published PCQM versions (PCQM1, PCQM2 and PCQM3) show significant differences in accuracy of density estimation, i.e. the higher order PCQM provides higher accuracy. However, the corrected PCQM versions show no significant differences among them as tested in various spatial patterns except in plant assemblages with a strong repulsion (plant competition). If N is number of sample points and R is distance, the corrected estimator of PCQM1 is 4 (4N - 1)/(pi Sigma R-2) but not 12N/(pi Sigma R-2), of PCQM2 is 4(8N - 1)/(pi Sigma R-2) but not 28N/(pi Sigma R-2) and of PCQM3 is 4(12N - 1)/(pi Sigma R-2) but not 44N/(pi Sigma R-2) as published. Significance If the spatial pattern of a plant association is random, PCQM1 with a corrected equation estimator and over 50 sample points would be sufficient to provide accurate density estimation. PCQM using just the nearest tree in each quadrant is therefore sufficient, which facilitates sampling of trees, particularly in areas with just a few hundred trees per hectare. PCQM3 provides the best density estimations for all types of plant assemblages including the repulsion process. Since in practice, the spatial pattern of a plant association remains unknown before starting a vegetation survey, for field applications the use of PCQM3 along with the corrected estimator is recommended. However, for sparse plant populations, where the use of PCQM3 may pose practical limitations, the PCQM2 or PCQM1 would be applied. During application of PCQM in the field, care should be taken to summarize the distance data based on 'the inverse summation of squared distances' but not 'the summation of inverse squared distances' as erroneously published.	[Khan, Md Nabiul Islam; Dahdouh-Guebas, Farid] Univ Libre Bruxelles, Fac Sci, Dept Biol Organismes, Lab Syst Ecol & Resource Management, Brussels, Belgium; [Khan, Md Nabiul Islam; Berger, Uta; Grueters, Uwe] Tech Univ Dresden, Inst Forest Growth & Forest Comp Sci, Tharandt, Germany; [Khan, Md Nabiul Islam; Islam, S. M. Zahirul; Hasan, Md Asadul] Khulna Univ, Forestry & Wood Technol Discipline, Khulna, Bangladesh; [Hijbeek, Renske; Koedam, Nico; Dahdouh-Guebas, Farid] Vrije Univ Brussel, Fac Sci & Bioengn Sci, Biodivers & Ecol Res Unit, Brussels, Belgium; [Hijbeek, Renske] Wageningen Univ & Res Ctr, Plant Prod Syst, Wageningen, Netherlands	Universite Libre de Bruxelles; Technische Universitat Dresden; Khulna University; Vrije Universiteit Brussel; Wageningen University & Research	Khan, MNI (corresponding author), Univ Libre Bruxelles, Fac Sci, Dept Biol Organismes, Lab Syst Ecol & Resource Management, Brussels, Belgium.; Khan, MNI (corresponding author), Tech Univ Dresden, Inst Forest Growth & Forest Comp Sci, Tharandt, Germany.; Khan, MNI (corresponding author), Khulna Univ, Forestry & Wood Technol Discipline, Khulna, Bangladesh.	mkhan@ulb.ac.be	Khan, Md Nabiul Islam Islam/AAW-7861-2021; Khan, Nabiul Islam/K-3799-2015	Khan, Md Nabiul Islam Islam/0000-0002-1536-8954; DAHDOUH-GUEBAS, Farid/0000-0002-5906-8996	National Science Foundation (FNRS), Belgium [1765914]; Khulna University, Bangladesh	National Science Foundation (FNRS), Belgium(Fonds de la Recherche Scientifique - FNRS); Khulna University, Bangladesh	The study was undertaken as part of the project 'Ecological functionality and stability of mangrove ecosystems: a modelling approach' under the grant type 'Mandat d' Impulsion Scientifique' (MIS ID 1765914) of the National Science Foundation (FNRS), Belgium. This study was also funded by Khulna University, Bangladesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; BEASOM SL, 1975, J RANGE MANAGE, V28, P142, DOI 10.2307/3897447; Berger U, 1999, ECOL MODEL, V115, P119, DOI 10.1016/S0304-3800(98)00187-2; Cintron G., 1984, MANGROVE ECOSYSTEM R, P1; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; COTTAM G, 1956, ECOLOGY, V37, P451, DOI 10.2307/1930167; COTTAM G, 1953, ECOLOGY, V34, P741, DOI 10.2307/1931337; Dahdouh-Guebas F, 2004, MAR ECOL PROG SER, V272, P77, DOI 10.3354/meps272077; Dahdouh-Guebas F, 2006, FOREST ECOL MANAG, V228, P1, DOI 10.1016/j.foreco.2005.10.076; Engeman RA, 2005, ENVIRONMETRICS, V16, P767, DOI 10.1002/env.736; ENGEMAN RM, 1994, ECOLOGY, V75, P1769, DOI 10.2307/1939636; Engeman RM, 1998, ECOLOGY, V79, P1425, DOI 10.1890/0012-9658(1998)079[1425:OOVATS]2.0.CO;2; Giraudoux P., 2012, PGIRMESS DATA ANAL E; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hijbeek R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067201; Kumarathunge DP, 2011, APPL ECOL ENV RES, V9, P425, DOI 10.15666/aeer/0904_425431; Lenth R., 2019, Journal of Statistical Software, V60, P1; Magnussen S, 2008, EUR J FOREST RES, V127, P213, DOI 10.1007/s10342-007-0197-z; MAGNUSSEN S, 1995, FOREST ECOL MANAG, V78, P71, DOI 10.1016/0378-1127(95)03596-1; Magnussen S, 2012, EUR J FOREST RES, V131, P1513, DOI 10.1007/s10342-012-0619-4; Neukermans G, 2007, SPATIAL SCI, V52, P75; Nielson RM, 2004, ENVIRONMETRICS, V15, P119, DOI 10.1002/env.627; Picard N, 2005, FOREST SCI, V51, P7; POLLARD JH, 1971, BIOMETRICS, V27, P991, DOI 10.2307/2528833; R Core Team, 2013, R LANG ENV STAT COMP; Satyanarayana B, 2010, BOT MAR, V53, P79, DOI 10.1515/BOT.2010.006; Sheil D, 2003, J TROP FOR SCI, V15, P117; White Neil A., 2008, BMC Ecology, V8, P6, DOI 10.1186/1472-6785-8-6; Zurell D, 2010, OIKOS, V119, P622, DOI 10.1111/j.1600-0706.2009.18284.x	30	5	6	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157985	10.1371/journal.pone.0157985	http://dx.doi.org/10.1371/journal.pone.0157985			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336390	Green Submitted, Green Published, gold			2022-12-26	WOS:000378389200081
J	Montgomery, MC; Oldenburg, CE; Nunn, AS; Mena, L; Anderson, P; Liegler, T; Mayer, KH; Patel, R; Almonte, A; Chan, PA				Montgomery, Madeline C.; Oldenburg, Catherine E.; Nunn, Amy S.; Mena, Leandro; Anderson, Peter; Liegler, Teri; Mayer, Kenneth H.; Patel, Rupa; Almonte, Alexi; Chan, Philip A.			Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting	PLOS ONE			English	Article							DRUG-RESISTANCE; AFRICAN WOMEN; INFECTION; MEN	Background The HIV epidemic in the United States (US) disproportionately affects gay, bisexual, and other men who have sex with men (MSM). Pre-exposure prophylaxis (PrEP) using co-formulated tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) has demonstrated high efficacy in reducing HIV incidence among MSM. However, low adherence was reported in major efficacy trials and may present a substantial barrier to successful PrEP implementation. Rates of adherence to PrEP in "real-world" clinical settings in the US remain largely unknown. Methods We reviewed demographic and clinical data for the first 50 patients to enroll in a clinical PrEP program in Providence, Rhode Island. We analyzed self-reported drug adherence as well as drug concentrations in dried blood spots (DBS) from patients who attended either a three-or six-month follow-up appointment. We further assessed drug concentrations and the resistance profile of a single patient who seroconverted while taking PrEP. Results Of the first 50 patients to be prescribed PrEP, 62% attended a follow-up appointment at three months and 38% at six months. Of those who attended an appointment at either time point (70%, n = 35), 92% and 95% reported taking +/- 4 doses/week at three and six months, respectively. Drug concentrations were performed on a random sample of 20 of the 35 patients who attended a follow-up appointment. TDF levels consistent with +/- 4 doses/week were found in 90% of these patients. There was a significant correlation between self-reported adherence and drug concentrations (r = 0.49, p = 0.02). One patient who had been prescribed PrEP seroconverted at his three-month follow-up visit. The patient's drug concentrations were consistent with daily dosing. Population sequencing and ultrasensitive allele-specific PCR detected the M184V mutation, but no other TDF- or FTC-associated mutations, including those present as minor variants. Conclusion In this clinical PrEP program, adherence was high, and self-reported drug adherence accurately reflected drug concentrations as measured by DBS.	[Montgomery, Madeline C.; Almonte, Alexi; Chan, Philip A.] Brown Univ, Div Infect Dis, Providence, RI 02912 USA; [Oldenburg, Catherine E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Nunn, Amy S.] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA; [Mena, Leandro] Univ Mississippi, Div Infect Dis, Jackson, MS 39216 USA; [Anderson, Peter] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA; [Liegler, Teri] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA; [Mayer, Kenneth H.] Harvard Univ, Sch Med, Boston, MA USA; [Patel, Rupa] Washington Univ, Div Infect Dis, St Louis, MO USA	Brown University; Harvard University; Harvard T.H. Chan School of Public Health; Brown University; University of Mississippi; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Francisco; Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Washington University (WUSTL)	Chan, PA (corresponding author), Brown Univ, Div Infect Dis, Providence, RI 02912 USA.	pchan@lifespan.org		Montgomery, Madeline/0000-0002-4528-1964; Chan, Philip/0000-0003-0964-5895	Gilead Sciences, Inc.; National Institute of Allergy and Infectious Diseases [1K23AI096923]; National Institute on Drug Abuse [T32DA013911]; National Institute of Mental Health [R25MH083620]; Lifespan/Tufts/Brown Center for AIDS Research [P30AI042853]; University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research [P30AI027763]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853, P30AI027763, K23AI096923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH083620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	Gilead Sciences, Inc.(Gilead Sciences); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lifespan/Tufts/Brown Center for AIDS Research; University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was supported by a PrEP research grant from Gilead Sciences, Inc. [www.gilead.com]. PAC is supported by the National Institute of Allergy and Infectious Diseases (1K23AI096923; [www.niaid.nih.gov]). CEO is supported by the National Institute on Drug Abuse (T32DA013911; [www.drugabuse.gov]) and the National Institute of Mental Health (R25MH083620; [www.nimh.nih.gov]). Additional support was provided by the Lifespan/Tufts/Brown Center for AIDS Research (P30AI042853; [www.ltbcfar.org]) and the University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (P30AI027763; [cfar.ucsf.edu]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by a PrEP research grant from Gilead Sciences, Inc. PAC is supported by the National Institute of Allergy and Infectious Diseases (1K23AI096923). CEO is supported by the National Institute on Drug Abuse (T32DA013911) and the National Institute of Mental Health (R25MH083620). Additional support was provided by the Lifespan/Tufts/Brown Center for AIDS Research (P30AI042853) and the University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (P30AI027763).	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; [Anonymous], 2014, PREEXP PROPH PREV HI; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Castillo-Mancilla JR, 2013, AIDS RES HUM RETROV, V29, P384, DOI [10.1089/aid.2012.0089, 10.1089/AID.2012.0089]; Centers for Disease Control and Prevention, 2015, HIV SURVEILL REP, V25; Cohen MS, 2012, CURR OPIN HIV AIDS, V7, P99, DOI 10.1097/COH.0b013e32834f5cf2; Cohen SE, 2014, C RETR OPP INF MAR B; Corneli AL, 2014, JAIDS-J ACQ IMM DEF, V66, P324, DOI 10.1097/QAI.0000000000000158; Daar ES, 2008, CURR OPIN HIV AIDS, V3, P10, DOI 10.1097/COH.0b013e3282f2e295; Gandhi M, 2015, J INFECT DIS, V212, P1402, DOI 10.1093/infdis/jiv239; Grant RM, 2015, AIDS, V29, P331, DOI 10.1097/QAD.0000000000000556; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hurt CB, 2011, CLIN INFECT DIS, V53, P1265, DOI 10.1093/cid/cir684; Knox DCT, 2016, C RETR OPP INF 2016; Liegler T, 2014, J INFECT DIS, V210, P1217, DOI 10.1093/infdis/jiu233; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; Liu AY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083736, 10.1371/journal.pone.0095291]; Lu M, 2008, AIDS BEHAV, V12, P86, DOI 10.1007/s10461-007-9261-4; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Spinner CD, 2016, INFECTION, V44, P151, DOI 10.1007/s15010-015-0850-2; Stadler J, 2016, MED ANTHROPOL, V35, P503, DOI 10.1080/01459740.2015.1116528; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Weis JF, 2016, AIDS, V30, P31, DOI 10.1097/QAD.0000000000000915	27	54	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157742	10.1371/journal.pone.0157742	http://dx.doi.org/10.1371/journal.pone.0157742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333000	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212800047
J	Caravelli, F; Staniczenko, PPA				Caravelli, Francesco; Staniczenko, Phillip P. A.			Bounds on Transient Instability for Complex Ecosystems	PLOS ONE			English	Article							ECOLOGICAL-SYSTEMS; INTERACTION STRENGTHS; CRITICAL TRANSITIONS; TIPPING POINT; STABILITY; DYNAMICS; REACTIVITY; PSEUDOSPECTRA; RESILIENCE; DIVERSITY	Stability is a desirable property of complex ecosystems. If a community of interacting species is at a stable equilibrium point then it is able to withstand small perturbations to component species' abundances without suffering adverse effects. In ecology, the Jacobian matrix evaluated at an equilibrium point is known as the community matrix, which describes the population dynamics of interacting species. A system's asymptotic short-and long-term behaviour can be determined from eigenvalues derived from the community matrix. Here we use results from the theory of pseudospectra to describe intermediate, transient dynamics. We first recover the established result that the transition from stable to unstable dynamics includes a region of 'transient instability', where the effect of a small perturbation to species' abundances-to the population vector-is amplified before ultimately decaying. Then we show that the shift from stability to transient instability can be affected by uncertainty in, or small changes to, entries in the community matrix, and determine lower and upper bounds to the maximum amplitude of perturbations to the population vector. Of five different types of community matrix, we find that amplification is least severe when predator-prey interactions dominate. This analysis is relevant to other systems whose dynamics can be expressed in terms of the Jacobian matrix.	[Caravelli, Francesco] Invenia Labs, 27 Parkside Pl, Cambridge CB1 1HQ, England; [Caravelli, Francesco] London Inst Math Sci, 35a South St, London W1K 2XF, England; [Caravelli, Francesco] UCL, Dept Comp Sci, Gower St, London WC1E 6BT, England; [Staniczenko, Phillip P. A.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Staniczenko, Phillip P. A.] Natl Socioenvironm Synth Ctr SESYNC, Annapolis, MD 21401 USA	University of London; University College London; University System of Maryland; University of Maryland College Park	Caravelli, F (corresponding author), Invenia Labs, 27 Parkside Pl, Cambridge CB1 1HQ, England.; Caravelli, F (corresponding author), London Inst Math Sci, 35a South St, London W1K 2XF, England.; Caravelli, F (corresponding author), UCL, Dept Comp Sci, Gower St, London WC1E 6BT, England.	fc@lims.ac.uk	Caravelli, Francesco/H-3947-2019	Caravelli, Francesco/0000-0001-7964-3030	Invenia Labs Limited; AXA Research Fellowship; British Ecological Society grant [4785/5824]; Direct For Biological Sciences [1639145, 1052875] Funding Source: National Science Foundation	Invenia Labs Limited; AXA Research Fellowship(AXA Research Fund); British Ecological Society grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	FC was supported by Invenia Labs Limited. PPAS was supported by an AXA Research Fellowship and British Ecological Society grant 4785/5824. The funder provided support in the form of salary for author FC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Allesina S, 2015, POPUL ECOL, V57, P63, DOI 10.1007/s10144-014-0471-0; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Barabas G, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0218; Caravelli F, 2015, BOUNDS TRANSIENT INS; Caswell H, 2005, J DIFFER EQU APPL, V11, P295, DOI 10.1080/10236190412331335382; Chen X, 2001, P ROY SOC B-BIOL SCI, V268, P869, DOI 10.1098/rspb.2001.1596; Dai L, 2013, NATURE, V496, P355, DOI 10.1038/nature12071; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; Donohue I, 2013, ECOL LETT, V16, P421, DOI 10.1111/ele.12086; Embree M, 2005, SPECTRA AND PSEUDOSP; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; KREISS HO, 1968, MATH COMPUT, V22, P703, DOI 10.2307/2004572; Kressner D, 2014, SIAM J MATRIX ANAL A, V35, P292, DOI 10.1137/120869432; LEVEQUE RJ, 1984, BIT, V24, P584, DOI 10.1007/BF01934916; LEVINS RICHARD, 1968; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; MCNAUGHTON SJ, 1978, NATURE, V274, P251, DOI 10.1038/274251a0; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Nelson DR, 1998, PHYS REV E, V58, P1383, DOI 10.1103/PhysRevE.58.1383; Neubert MG, 1997, ECOLOGY, V78, P653, DOI 10.1890/0012-9658(1997)078[0653:ATRFMT]2.0.CO;2; Neubert MG, 2004, ECOL MODEL, V179, P29, DOI 10.1016/j.ecolmodel.2004.05.001; Neubert MG, 2009, ECOLOGY, V90, P2683, DOI 10.1890/08-2014.1; Neutel AM, 2014, ECOL LETT, V17, P651, DOI 10.1111/ele.12266; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Rohr RP, 2014, SCIENCE, V345, P416, DOI 10.1126/science.1253497; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Snyder RE, 2010, THEOR POPUL BIOL, V77, P243, DOI 10.1016/j.tpb.2010.03.004; Tang S, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00021; Tang S, 2014, ECOL LETT, V17, P1094, DOI 10.1111/ele.12312; Trefethen L. N., 1997, NUMERICAL LINEAR ALG, V50; Trefethen LN, 1997, SIAM REV, V39, P383, DOI 10.1137/S0036144595295284; Trefethen LN, 1984, AM MATH MONTHLY, V91, P371; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; Verdy A, 2008, B MATH BIOL, V70, P1634, DOI 10.1007/s11538-008-9312-7; Wright TG, 2001, SIAM J SCI COMPUT, V23, P591, DOI 10.1137/S1064827500373012; YODZIS P, 1981, NATURE, V289, P674, DOI 10.1038/289674a0	39	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157876	10.1371/journal.pone.0157876	http://dx.doi.org/10.1371/journal.pone.0157876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327511	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212400055
J	Rafiq, MK; Bachmann, RT; Rafiq, MT; Shang, ZH; Joseph, S; Long, RJ				Rafiq, Muhammad Khalid; Bachmann, Robert Thomas; Rafiq, Muhammad Tariq; Shang, Zhanhuan; Joseph, Stephen; Long, Ruijun			Influence of Pyrolysis Temperature on Physico-Chemical Properties of Corn Stover (Zea mays L.) Biochar and Feasibility for Carbon Capture and Energy Balance	PLOS ONE			English	Article							POTENTIAL USE; GASIFICATION; RESIDUE; PERTINENT; CELLULOSE; VALUES; CHINA; FIELD	This study examined the influence of pyrolysis temperature on biochar characteristics and evaluated its suitability for carbon capture and energy production. Biochar was produced from corn stover using slow pyrolysis at 300, 400 and 500 degrees C and 2 hrs holding time. The experimental biochars were characterized by elemental analysis, BET, FTIR, TGA/DTA, NMR (C-13). Higher heating value (HHV) of feedstock and biochars was measured using bomb calorimeter. Results show that carbon content of corn stover biochar increased from 45.5% to 64.5%, with increasing pyrolysis temperatures. A decrease in H:C and O:C ratios as well as volatile matter, coupled with increase in the concentration of aromatic carbon in the biochar as determined by FTIR and NMR (C-13) demonstrates a higher biochar carbon stability at 500 degrees C. It was estimated that corn stover pyrolysed at 500 degrees C could provide of 10.12 MJ/kg thermal energy. Pyrolysis is therefore a potential technology with its carbon-negative, energy positive and soil amendment benefits thus creating win- win scenario.	[Rafiq, Muhammad Khalid; Shang, Zhanhuan; Long, Ruijun] Lanzhou Univ, Coll Pastoral Agr Sci & Technol Agr, 222 Tianshui South Rd, Lanzhou 730000, Peoples R China; [Rafiq, Muhammad Khalid] Pakistan Agr Res Council, Directorate Range Mgt & Forestry, Islamabad 44000, Pakistan; [Bachmann, Robert Thomas] Univ Kuala Lumpur UniKL, MICET, Lot 1988, Alor Gajah 78000, Melaka, Malaysia; [Rafiq, Muhammad Tariq] Int Islamic Univ, Dept Environm Sci, Islamabad 44000, Pakistan; [Rafiq, Muhammad Khalid; Shang, Zhanhuan; Long, Ruijun] Lanzhou Univ, State Key Lab Grassland Agroecosyst, Int Ctr Tibetan Plateau Ecosyst Management, Sch Life Sci, Lanzhou 730000, Peoples R China; [Joseph, Stephen] Univ New S Wales, Sch Mat Sci & Engn, Sydney, NSW 2052, Australia	Lanzhou University; National Agricultural Research Council - Pakistan; International Islamic University, Pakistan; Lanzhou University; University of New South Wales Sydney	Long, RJ (corresponding author), Lanzhou Univ, Coll Pastoral Agr Sci & Technol Agr, 222 Tianshui South Rd, Lanzhou 730000, Peoples R China.; Long, RJ (corresponding author), Lanzhou Univ, State Key Lab Grassland Agroecosyst, Int Ctr Tibetan Plateau Ecosyst Management, Sch Life Sci, Lanzhou 730000, Peoples R China.	longrj@lzu.edu.cn	Bachmann, Robert Thomas/B-8801-2009	Bachmann, Robert Thomas/0000-0001-7636-5338	Chinese Ministry of Science and Technology Project [2012BAC01B02-3]; National Natural Science Foundation of China [411714]	Chinese Ministry of Science and Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This experiment was financially assisted under Chinese Ministry of Science and Technology Project No. 2012BAC01B02-3 and National Natural Science Foundation of China, grant no. 411714. ZS.; This experiment was financially assisted under Chinese Ministry of Science and Technology Project No. 2012BAC01B02-3 and National Natural Science Foundation of China, grant no. 411714.	Ahmedna M, 1997, J SCI FOOD AGR, V75, P117, DOI [10.1002/(SICI)1097-0010(199709)75:1<117::AID-JSFA850>3.3.CO;2-D, 10.1002/(SICI)1097-0010(199709)75:1&lt;117::AID-JSFA850&gt;3.0.CO;2-M]; Antal MJ, 2003, IND ENG CHEM RES, V42, P1619, DOI 10.1021/ie0207919; Brewer CE, 2011, BIOENERG RES, V4, P312, DOI 10.1007/s12155-011-9133-7; Brewer CE, 2009, ENVIRON PROG SUSTAIN, V28, P386, DOI 10.1002/ep.10378; Bustin RM, 1999, INT J COAL GEOL, V38, P237, DOI 10.1016/S0166-5162(98)00025-1; Cao GL, 2008, J ENVIRON SCI, V20, P50, DOI 10.1016/S1001-0742(08)60007-8; Cao XD, 2010, BIORESOURCE TECHNOL, V101, P5222, DOI 10.1016/j.biortech.2010.02.052; Capunitan JA, 2012, FUEL, V95, P563, DOI 10.1016/j.fuel.2011.12.029; Cheah S, 2014, ENVIRON SCI TECHNOL, V48, P8474, DOI 10.1021/es500073r; Chen BL, 2008, ENVIRON SCI TECHNOL, V42, P5137, DOI 10.1021/es8002684; Chen YQ, 2012, BIORESOURCE TECHNOL, V107, P411, DOI 10.1016/j.biortech.2011.10.074; Chun Y, 2004, ENVIRON SCI TECHNOL, V38, P4649, DOI 10.1021/es035034w; Clare A, 2015, GLOBAL CHANGE BIOL B; Dai ZM, 2013, J SOIL SEDIMENT, V13, P989, DOI 10.1007/s11368-013-0698-y; Demirbas A, 1997, FUEL, V76, P431, DOI 10.1016/S0016-2361(97)85520-2; Demirbas A, 2004, J ANAL APPL PYROL, V72, P243, DOI 10.1016/j.jaap.2004.07.003; El Bassam N, 1998, RENEW ENERG, V15, P205, DOI 10.1016/S0960-1481(98)00157-8; Enders A, 2012, BIORESOURCE TECHNOL, V114, P644, DOI 10.1016/j.biortech.2012.03.022; Ertas M, 2010, J ANAL APPL PYROL, V88, P22, DOI 10.1016/j.jaap.2010.02.006; Feng L, 2013, BIORESOURCES, V8, P2487; Fernandes MB, 2003, CHEMOSPHERE, V51, P785, DOI 10.1016/S0045-6535(03)00098-5; Fuertes AB, 2010, AUST J SOIL RES, V48, P618, DOI 10.1071/SR10010; Gaunt JL, 2008, ENVIRON SCI TECHNOL, V42, P4152, DOI 10.1021/es071361i; Gronli M, 1999, IND ENG CHEM RES, V38, P2238, DOI 10.1021/ie980601n; Guerena D, 2013, PLANT SOIL, V365, P239, DOI 10.1007/s11104-012-1383-4; Hale SE, 2013, CHEMOSPHERE, V91, P1612, DOI 10.1016/j.chemosphere.2012.12.057; International Flame Research Foundation (IFRF), 2011, IFRF ONL COMB HDB; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Kim KH, 2012, BIORESOURCE TECHNOL, V118, P158, DOI 10.1016/j.biortech.2012.04.094; Kumar A, 2008, BIOMASS BIOENERG, V32, P460, DOI 10.1016/j.biombioe.2007.11.004; Kung CC, 2015, ECOL INDIC, V51, P139, DOI 10.1016/j.ecolind.2014.06.043; Lee JW, 2010, ENVIRON SCI TECHNOL, V44, P7970, DOI 10.1021/es101337x; Lee JW, 2010, ENERG ENVIRON SCI, V3, P1695, DOI 10.1039/c004561f; Lehmann J., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P403, DOI 10.1007/s11027-005-9006-5; Liu H, 2008, RENEW SUST ENERG REV, V12, P1402, DOI 10.1016/j.rser.2007.01.011; Mullen CA, 2010, BIOMASS BIOENERG, V34, P67, DOI 10.1016/j.biombioe.2009.09.012; National Bureau of Statistics of China, 2013, CHIN CIT STAT YB 201; Nsamba H.K., 2015, J SUSTAINABLE BIOENE, V5, P10, DOI 10.4236/jsbs.2015.51002; Parikh J, 2007, FUEL, V86, P1710, DOI 10.1016/j.fuel.2006.12.029; Pereira RC, 2014, ANIM FEED SCI TECH, V196, P22, DOI 10.1016/j.anifeedsci.2014.06.019; Peterson SC, 2014, IND CROP PROD, V53, P228, DOI 10.1016/j.indcrop.2013.12.028; Pretty J, 2010, INT J AGR SUSTAIN, V8, P219, DOI 10.3763/ijas.2010.0534; Qiu J, 2009, NATURE, V462, P550, DOI 10.1038/462550a; Rajkovich S, 2012, BIOL FERT SOILS, V48, P271, DOI 10.1007/s00374-011-0624-7; Rayment G., 1992, AUSTRALIAN LABORATOR; Roberts KG, 2010, ENVIRON SCI TECHNOL, V44, P827, DOI 10.1021/es902266r; Smith J.M., 1981, CHEM ENG KINETICS; Spokas K. A., 2009, Annals of Environmental Science, V3, P179; Spokas KA, 2011, CHEMOSPHERE, V85, P869, DOI 10.1016/j.chemosphere.2011.06.108; Thangalazhy-Gopakumar S, 2010, BIORESOURCE TECHNOL, V101, P8389, DOI 10.1016/j.biortech.2010.05.040; Tsai WT, 2012, CHEMOSPHERE, V89, P198, DOI 10.1016/j.chemosphere.2012.05.085; Uzoma KC, 2011, SOIL USE MANAGE, V27, P205, DOI 10.1111/j.1475-2743.2011.00340.x; Vargas-Moreno JM, 2012, RENEW SUST ENERG REV, V16, P3065, DOI 10.1016/j.rser.2012.02.054; Woolf D., 2008, BLACK SOIL GREEN RIC, P1; Yang HP, 2007, FUEL, V86, P1781, DOI 10.1016/j.fuel.2006.12.013; Yuan JH, 2011, BIORESOURCE TECHNOL, V102, P3488, DOI 10.1016/j.biortech.2010.11.018; Zheng MX, 2009, BIORESOURCE TECHNOL, V100, P5140, DOI 10.1016/j.biortech.2009.05.045; Zhou XP, 2011, BIOMASS BIOENERG, V35, P1, DOI 10.1016/j.biombioe.2010.08.006	58	132	138	8	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0156894	10.1371/journal.pone.0156894	http://dx.doi.org/10.1371/journal.pone.0156894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327870	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212400010
J	Fernandez, D; Flores-Santibanez, F; Neira, J; Osorio-Barrios, F; Tejon, G; Nunez, S; Hidalgo, Y; Fuenzalida, MJ; Meza, D; Ureta, G; Lladser, A; Pacheco, R; Acuna-Castillo, C; Guixe, V; Quintana, FJ; Bono, MR; Rosemblatt, M; Sauma, D				Fernandez, Dominique; Flores-Santibanez, Felipe; Neira, Jocelyn; Osorio-Barrios, Francisco; Tejon, Gabriela; Nunez, Sarah; Hidalgo, Yessia; Jose Fuenzalida, Maria; Meza, Daniel; Ureta, Gonzalo; Lladser, Alvaro; Pacheco, Rodrigo; Acuna-Castillo, Claudio; Guixe, Victoria; Quintana, Francisco J.; Rosa Bono, Maria; Rosemblatt, Mario; Sauma, Daniela			Purinergic Signaling as a Regulator of Th17 Cell Plasticity	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PATHOGENIC T(H)17 CELLS; CYTOKINE GM-CSF; T-CELLS; CROHNS-DISEASE; ADENOSINE GENERATION; IMMUNE SUPPRESSION; ADAPTIVE IMMUNITY; TYPE-1 CELLS; TGF-BETA	T helper type 17 (Th17) lymphocytes, characterized by the production of interleukin-17 and other pro-inflammatory cytokines, are present in intestinal lamina propria and have been described as important players driving intestinal inflammation. Recent evidence, supporting the notion of a functional and phenotypic instability of Th17 cells, has shown that Th17 differentiate into type 1 regulatory (Tr1) T cells during the resolution of intestinal inflammation. Moreover, it has been suggested that the expression of CD39 ectonucleotidase endows Th17 cells with immunosuppressive properties. However, the exact role of CD39 ectonucleotidase in Th17 cells has not been studied in the context of intestinal inflammation. Here we show that Th17 cells expressing CD39 ectonucleotidase can hydrolyze ATP and survive to ATP-induced cell death. Moreover, in vitro-generated Th17 cells expressing the CD39 ectonucleotidase produce IL-10 and are less pathogenic than CD39 negative Th17 cells in a model of experimental colitis in Rag(-/-) mice. Remarkably, we show that CD39 activity regulates the conversion of Th17 cells to IL-10-producing cells in vitro, which is abrogated in the presence of ATP and the CD39-specific inhibitor ARL67156. All these data suggest that CD39 expression by Th17 cells allows the depletion of ATP and is crucial for IL-10 production and survival during the resolution of intestinal inflammation.	[Fernandez, Dominique; Flores-Santibanez, Felipe; Tejon, Gabriela; Nunez, Sarah; Hidalgo, Yessia; Jose Fuenzalida, Maria; Meza, Daniel; Guixe, Victoria; Rosa Bono, Maria; Rosemblatt, Mario; Sauma, Daniela] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Neira, Jocelyn; Pacheco, Rodrigo; Rosemblatt, Mario] Univ Andres Bello, Fac Ciencias Biol, Santiago, Chile; [Neira, Jocelyn; Osorio-Barrios, Francisco; Ureta, Gonzalo; Lladser, Alvaro; Pacheco, Rodrigo; Rosemblatt, Mario] Fdn Ciencia & Vida, Santiago, Chile; [Acuna-Castillo, Claudio] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago, Chile; [Acuna-Castillo, Claudio] Univ Santiago Chile, Fac Quim & Biol, CBA, Santiago, Chile; [Quintana, Francisco J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Universidad de Chile; Universidad Andres Bello; Universidad de Santiago de Chile; Universidad de Santiago de Chile; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sauma, D (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile.	dsauma@u.uchile.cl	Sauma, Daniela/D-8387-2013; Quintana, Francisco Javier/AAB-6915-2020; Acuña-Castillo, Claudio/AAI-7090-2021	Sauma, Daniela/0000-0001-8622-3245; Acuña-Castillo, Claudio/0000-0003-3607-6077; Nunez, Sarah/0000-0001-8102-8010; Flores, Felipe/0000-0002-6916-3962; Pacheco, Rodrigo/0000-0001-8057-9806; Fernandez, Dominique/0000-0002-9960-3455; Osorio-Barrios, Francisco/0000-0002-6853-7846	FONDECYT [1140431, 11121478]; PAI [79110009];  [FONDEQUIP/EQM114137];  [CONICYT PFB-16]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); PAI; ; 	This work was supported by FONDECYT 1140431 (MRB), FONDECYT 11121478 (DS), PAI 79110009 (MRB, DS), FONDEQUIP/EQM114137 (MRB) and CONICYT PFB-16 (MR).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Annunziato F, 2010, EUR J IMMUNOL, V40, P3312, DOI 10.1002/eji.201041145; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Beavis PA, 2012, TRENDS IMMUNOL, V33, P231, DOI 10.1016/j.it.2012.02.009; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Feng T, 2011, J IMMUNOL, V186, P6313, DOI 10.4049/jimmunol.1001454; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gocke AR, 2007, J IMMUNOL, V178, P1341, DOI 10.4049/jimmunol.178.3.1341; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Holtta V, 2008, INFLAMM BOWEL DIS, V14, P1175, DOI 10.1002/ibd.20475; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Nielsen OH, 2003, SCAND J GASTROENTERO, V38, P180, DOI 10.1080/00365520310000672; Nunez S, 2013, IMMUNOLOGY, V139, P61, DOI 10.1111/imm.12055; Nurieva R, 2009, J IMMUNOL, V182, P2565, DOI 10.4049/jimmunol.0803931; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Quintana FJ, 2013, PHARMACOL REV, V65, P1148, DOI 10.1124/pr.113.007823; Regateiro FS, 2013, CLIN EXP IMMUNOL, V171, P1, DOI 10.1111/j.1365-2249.2012.04623.x; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Seiderer J, 2008, INFLAMM BOWEL DIS, V14, P437, DOI 10.1002/ibd.20339; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123	46	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157889	10.1371/journal.pone.0157889	http://dx.doi.org/10.1371/journal.pone.0157889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322617	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212000051
J	Torrente, A; Lukk, M; Xue, V; Parkinson, H; Rung, J; Brazma, A				Torrente, Aurora; Lukk, Margus; Xue, Vincent; Parkinson, Helen; Rung, Johan; Brazma, Alvis			Identification of Cancer Related Genes Using a Comprehensive Map of Human Gene Expression	PLOS ONE			English	Article							MIXED-EFFECTS MODEL; RESOURCE; ATLAS	Rapid accumulation and availability of gene expression datasets in public repositories have enabled large-scale meta-analyses of combined data. The richness of cross-experiment data has provided new biological insights, including identification of new cancer genes. In this study, we compiled a human gene expression dataset from similar to 40,000 publicly available Affymetrix HG-U133Plus2 arrays. After strict quality control and data normalisation the data was quantified in an expression matrix of similar to 20,000 genes and similar to 28,000 samples. To enable different ways of sample grouping, existing annotations where subjected to systematic ontology assisted categorisation and manual curation. Groups like normal tissues, neoplasmic tissues, cell lines, homoeotic cells and incompletely differentiated cells were created. Unsupervised analysis of the data confirmed global structure of expression consistent with earlier analysis but with more details revealed due to increased resolution. A suitable mixed-effects linear model was used to further investigate gene expression in solid tissue tumours, and to compare these with the respective healthy solid tissues. The analysis identified 1,285 genes with systematic expression change in cancer. The list is significantly enriched with known cancer genes from large, public, peer-reviewed databases, whereas the remaining ones are proposed as new cancer gene candidates. The compiled dataset is publicly available in the ArrayExpress Archive. It contains the most diverse collection of biological samples, making it the largest systematically annotated gene expression dataset of its kind in the public domain.	[Torrente, Aurora] Univ Carlos III Madrid, Inst Gregorio Millan, Madrid, Spain; [Torrente, Aurora; Parkinson, Helen; Brazma, Alvis] EBI, EMBL, Hinxton, England; [Lukk, Margus] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Xue, Vincent] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Rung, Johan] Dept Immunol Genet & Pathol, Clin Sequencing Facil, Sci Life Lab, Uppsala, Sweden	Universidad Carlos III de Madrid; European Molecular Biology Laboratory (EMBL); Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Massachusetts Institute of Technology (MIT)	Torrente, A (corresponding author), Univ Carlos III Madrid, Inst Gregorio Millan, Madrid, Spain.; Torrente, A (corresponding author), EBI, EMBL, Hinxton, England.	etorrent@est-econ.uc3m.es	Torrente, Aurora/L-4950-2014; Torrente, Aurora/AAT-1593-2020	Torrente, Aurora/0000-0001-9183-8367; Torrente, Aurora/0000-0001-9183-8367; Rung, Johan/0000-0001-5875-8429; Lukk, Margus/0000-0002-0701-5358; Parkinson, Helen/0000-0003-3035-4195; Brazma, Alvis/0000-0001-5988-7409	EurocanPlatform grant of FP7 frameworks from the European Commission; Ramon Areces Foundation	EurocanPlatform grant of FP7 frameworks from the European Commission; Ramon Areces Foundation	AB received funding from the EurocanPlatform grant of FP7 frameworks from the European Commission. AT was partially supported by the Ramon Areces Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bock-Axelsen J, 2007, P NATL ACAD SCI USA, V104, P13122, DOI 10.1073/pnas.0705824104; Chen JJ, 2004, BIOINFORMATICS, V20, P1436, DOI 10.1093/bioinformatics/bth118; Churchill GA, 2004, BIOTECHNIQUES, V37, P173, DOI 10.2144/04372TE01; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Hatzis C, 2011, JNCI-J NATL CANCER I, V103, P1871, DOI 10.1093/jnci/djr438; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Huret JL, 2013, NUCLEIC ACIDS RES, V41, pD920, DOI 10.1093/nar/gks1082; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Liang YL, 2005, BIOINFORMATICS, V21, P3009, DOI 10.1093/bioinformatics/bti465; Luan YH, 2003, BIOINFORMATICS, V19, P474, DOI 10.1093/bioinformatics/btg014; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Malone J, 2010, BIOINFORMATICS, V26, P1112, DOI 10.1093/bioinformatics/btq099; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Schmid PR, 2012, P NATL ACAD SCI USA, V109, P5594, DOI 10.1073/pnas.1118792109; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thilakarathne Pushpike J, 2013, Int J Bioinform Res Appl, V9, P71, DOI 10.1504/IJBRA.2013.050654; Wang L, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1484; Yu TW, 2008, FRONT BIOSCI-LANDMRK, V13, P2714, DOI 10.2741/2878; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102	32	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157484	10.1371/journal.pone.0157484	http://dx.doi.org/10.1371/journal.pone.0157484			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322383	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212000018
J	Cui, Y; Zhang, Y; Chang, QL; Xian, JF; Hou, ZJ; Li, DM				Cui, Ying; Zhang, Yue; Chang, Qinglin; Xian, Junfang; Hou, Zhijia; Li, Dongmei			Digital Evaluation of Orbital Cyst Associated with Microphthalmos: Characteristics and Their Relationship with Orbital Volume	PLOS ONE			English	Article							CONGENITAL EYE MALFORMATIONS; BILATERAL MICROPHTHALMOS; DESCRIPTIVE EPIDEMIOLOGY; ANOPHTHALMIA; EXPANSION; FEATURES; EXCISION	Purpose To study the characteristics of orbital cyst associated with microphthalmos in a group of Chinese patients, and to analyze the relationship between orbital cyst and orbital volume. Design Cross-sectional comparative study. Participants 120 patients who were diagnosed as unilateral clinical blind microphthalmos, in which 20 patients had orbital cyst in the affected eye. Method Participants had computed tomography (CT) scan. CT images were analyzed with a computer-aided software. Main Outcome Measures Volume and position of orbital cyst, microphthalmic to contralateral ratio (MCR) of orbital volume, height and depth and orbital rim displacement. Results 38.1% of the cysts located anterior to or at the equator of the globe, 75% of which located infratemporally and all of which were outside the muscle cone. Most (84.6%) of the posterior cysts were inside the muscle cone. The anterior cysts were larger than the posterior cysts (p = 0.005). MCR of orbital volume (p<0.001), height (p = 0.004) and width (p = 0.043) were significantly higher in patients with orbital cyst than controls. For patients with orbital cyst, larger cyst-plus-globe volume of the affected eye was associated with higher MCR of orbital volume (r = 0.630, p = 0.003). Patients with large cyst-plus-globe volume had higher MCR of orbital volume (p = 0.002), height (p = 0.014), width (p = 0.005) and depth (p = 0.002) and less displacement in inferior (p = 0.004) orbital rim, compared with patients with small cyst-plus-globe volume, but the differences between patients with small cyst-plus-globe volume and patients without cyst were not significant. Conclusions Microphthalmic eyes with large cyst-plus-globe volume showed better similarity with the contralateral eyes, comparing with microphthalmic eyes without orbital cyst or with small cyst-plus-globe volume. It suggested that the existence of orbital cysts (especially large cysts) in microphthalmic eyes might play a positive role in the orbital development.	[Cui, Ying; Zhang, Yue; Hou, Zhijia; Li, Dongmei] Capital Med Univ, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Cui, Ying; Zhang, Yue; Hou, Zhijia; Li, Dongmei] Capital Med Univ, Beijing Tongren Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Cui, Ying; Zhang, Yue; Hou, Zhijia; Li, Dongmei] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Chang, Qinglin; Xian, Junfang] Capital Med Univ, Beijing Tongren Hosp, Dept Med Imaging Ctr, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Li, DM (corresponding author), Capital Med Univ, Beijing Tongren Eye Ctr, Beijing, Peoples R China.; Li, DM (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Ophthalmol, Beijing, Peoples R China.; Li, DM (corresponding author), Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China.	ldmlily@x263.net			Beijing Municipal Science & Technology Commission [Z131107002213002]	Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by the Beijing Municipal Science & Technology Commission (No. Z131107002213002) to Dr. Dongmei Li, http://www.bjkw.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P. K., 1993, Indian Journal of Ophthalmology, V41, P177; Andersen ST, 2004, ACTA OPHTHALMOL SCAN, V82, P490, DOI 10.1111/j.1600-0420.2004.00281.x; Bacskulin A, 2000, GRAEF ARCH CLIN EXP, V238, P24, DOI 10.1007/s004170050004; BRIGGS RM, 1968, PLAST RECONSTR SURG, V41, P376, DOI 10.1097/00006534-196804000-00019; Callahan Michael J, 2011, Pediatr Radiol, V41 Suppl 2, P488, DOI 10.1007/s00247-011-2099-y; Chaudhry IA, 2004, OPHTHAL PLAST RECONS, V20, P452, DOI 10.1097/01.IOP.0000143716.12643.98; Demirci H, 2003, EYE, V17, P273, DOI 10.1038/sj.eye.6700318; Dolk H, 1998, BRIT MED J, V317, P905, DOI 10.1136/bmj.317.7163.905; Duke-Elder S, 1963, SYSTEM OPHTHALMOLOGY, V3, P483; Forrester MB, 2006, BIRTH DEFECTS RES A, V76, P187, DOI 10.1002/bdra.20237; Gossman MD, 1999, OPHTHALMOLOGY, V106, P2005; Gundlach KKH, 2005, PLAST RECONSTR SURG, V116, P1214, DOI 10.1097/01.prs.0000181653.38200.eb; Harlan G C, 1902, Trans Am Ophthalmol Soc, V9, P474; Hou ZJ, 2012, J AAPOS, V16, P458, DOI 10.1016/j.jaapos.2012.07.002; Kallen B, 2005, EUR J EPIDEMIOL, V20, P345, DOI 10.1007/s10654-004-6880-1; Kallen B, 1996, INT J EPIDEMIOL, V25, P1009, DOI 10.1093/ije/25.5.1009; LIEB W, 1990, BRIT J OPHTHALMOL, V74, P59, DOI 10.1136/bjo.74.1.59; McLean CJ, 2003, BRIT J OPHTHALMOL, V87, P860, DOI 10.1136/bjo.87.7.860; Ozturker C, 2015, OPHTHAL PLAST RECONS, V31, pE150, DOI 10.1097/IOP.0000000000000185; Polito E, 1995, OPHTHALMIC PLAST REC, V11, P288, DOI 10.1097/00002341-199512000-00013; Skalicky SE, 2013, JAMA OPHTHALMOL, V131, P1517, DOI 10.1001/jamaophthalmol.2013.5305; Stoll C, 1997, ANN GENET-PARIS, V40, P122; STOLL C, 1992, OPHTHALMIC PAED GEN, V13, P179, DOI 10.3109/13816819209046487; Tse DT, 2007, AM J OPHTHALMOL, V143, P317, DOI 10.1016/j.ajo.2006.10.028; Tse DT, 2011, AM J OPHTHALMOL, V151, P470, DOI 10.1016/j.ajo.2010.09.009; Tucker S, 1996, EYE, V10, P310, DOI 10.1038/eye.1996.65; WARBURG M, 1993, J MED GENET, V30, P664, DOI 10.1136/jmg.30.8.664; Wiwatwongwana D, 2009, OPHTHAL PLAST RECONS, V25, P241, DOI 10.1097/IOP.0b013e3181a30377; WRIGHT DC, 1987, J COMPUT ASSIST TOMO, V11, P727, DOI 10.1097/00004728-198707000-00038; Yang GJ, 2012, AM J OPHTHALMOL, V154, P601, DOI 10.1016/j.ajo.2012.03.025; ZEITER HJ, 1963, AM J OPHTHALMOL, V55, P910, DOI 10.1016/0002-9394(63)90368-4	31	7	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157819	10.1371/journal.pone.0157819	http://dx.doi.org/10.1371/journal.pone.0157819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315369	Green Submitted, Green Published, gold			2022-12-26	WOS:000378030000056
J	Schabort, DTWP; Letebele, PK; Steyn, L; Kilian, SG; du Preez, JC				Schabort, Du Toit W. P.; Letebele, Precious K.; Steyn, Laurinda; Kilian, Stephanus G.; du Preez, James C.			Differential RNA-seq, Multi-Network Analysis and Metabolic Regulation Analysis of Kluyveromyces marxianus Reveals a Compartmentalised Response to Xylose	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; SEQUENCE; PATHWAY; ETHANOL	We investigated the transcriptomic response of a new strain of the yeast Kluyveromyces marxianus, in glucose and xylose media using RNA-seq. The data were explored in a number of innovative ways using a variety of networks types, pathway maps, enrichment statistics, reporter metabolites and a flux simulation model, revealing different aspects of the genome-scale response in an integrative systems biology manner. The importance of the subcellular localisation in the transcriptomic response is emphasised here, revealing new insights. As was previously reported by others using a rich medium, we show that peroxisomal fatty acid catabolism was dramatically up-regulated in a defined xylose mineral medium without fatty acids, along with mechanisms to activate fatty acids and transfer products of beta-oxidation to the mitochondria. Notably, we observed a strong up-regulation of the 2-methylcitrate pathway, supporting capacity for odd-chain fatty acid catabolism. Next we asked which pathways would respond to the additional requirement for NADPH for xylose utilisation, and rationalised the unexpected results using simulations with Flux Balance Analysis. On a fundamental level, we investigated the contribution of the hierarchical and metabolic regulation levels to the regulation of metabolic fluxes. Metabolic regulation analysis suggested that genetic level regulation plays a major role in regulating metabolic fluxes in adaptation to xylose, even for the high capacity reactions, which is unexpected. In addition, isozyme switching may play an important role in re-routing of metabolic fluxes in subcellular compartments in K. marxianus.	[Schabort, Du Toit W. P.; Letebele, Precious K.; Steyn, Laurinda; Kilian, Stephanus G.; du Preez, James C.] Univ Free State, Dept Microbial Biochem & Food Biotechnol, Bloemfontein, South Africa	University of the Free State	Schabort, DTWP (corresponding author), Univ Free State, Dept Microbial Biochem & Food Biotechnol, Bloemfontein, South Africa.	SchabortDWP@ufs.ac.za	Steyn, Laurinda/AAC-7834-2019		National Research Foundation of South Africa (ZA), CSPG - Thuthuka (PhD Track) [TTK20110831000026600, 80657]	National Research Foundation of South Africa (ZA), CSPG - Thuthuka (PhD Track)	This work was supported by the National Research Foundation of South Africa (ZA), CSPG - Thuthuka (PhD Track) (http://www.nrf.ac.za/), Reference: TTK20110831000026600, UID: 80657, awarded to Mr. WPD Schabort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Alff-Tuomala S, 2016, APPL MICROBIOL BIOT, V100, P969, DOI 10.1007/s00253-015-7038-7; Barupal DK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-99; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buermans HPJ, 2014, BBA-MOL BASIS DIS, V1842, P1932, DOI 10.1016/j.bbadis.2014.06.015; Canelas AB, 2011, METAB ENG, V13, P294, DOI 10.1016/j.ymben.2011.02.005; Chi ZM, 2009, APPL MICROBIOL BIOT, V82, P211, DOI 10.1007/s00253-008-1827-1; Covert MW, 2001, TRENDS BIOCHEM SCI, V26, P179, DOI 10.1016/S0968-0004(00)01754-0; Dias O, 2014, BIOTECHNOL J, V9, P776, DOI 10.1002/biot.201300242; DUPREEZ JC, 1983, BIOTECHNOL LETT, V5, P357, DOI 10.1007/BF01141138; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036; Gao JQ, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0295-y; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Groeneveld P, 2009, FEBS J, V276, P254, DOI 10.1111/j.1742-4658.2008.06778.x; Guaragnella N, 2003, J BIOL CHEM, V278, P45882, DOI 10.1074/jbc.M309301200; Gurvitz A, 1997, J BIOL CHEM, V272, P22140, DOI 10.1074/jbc.272.35.22140; Harcus D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080733; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kim WH, 2003, J BIOCHEM MOL BIOL, V36, P442; Lertwattanasakul N, 2007, BIOSCI BIOTECH BIOCH, V71, P1170, DOI 10.1271/bbb.60622; Lertwattanasakul N, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0227-x; Lertwattanasakul N, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-20; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Lucau-Danila A, 2003, J BIOL CHEM, V278, P52641, DOI 10.1074/jbc.M309580200; Luttik MAH, 2000, J BACTERIOL, V182, P7007, DOI 10.1128/JB.182.24.7007-7013.2000; Maciejewski H, 2014, BRIEF BIOINFORM, V15, P504, DOI 10.1093/bib/bbt002; Oliveira AP, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-17; Orencio-Trejo M, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-8; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; PRONK JT, 1994, MICROBIOL-UK, V140, P717, DOI 10.1099/00221287-140-4-717; Rocha SN, 2011, ANTON LEEUW INT J G, V100, P619, DOI 10.1007/s10482-011-9617-7; Runquist D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-49; Schilling CH, 1999, BIOTECHNOL PROGR, V15, P288, DOI 10.1021/bp9900357; Tang J, 2011, CURR GENOMICS, V12, P391, DOI 10.2174/138920211797248619; ter Kuile BH, 2001, FEBS LETT, V500, P169, DOI 10.1016/S0014-5793(01)02613-8; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001	42	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0156242	10.1371/journal.pone.0156242	http://dx.doi.org/10.1371/journal.pone.0156242			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315089	Green Published, gold			2022-12-26	WOS:000378030000002
J	Zhao, LQ; Winklhofer, S; Jiang, R; Wang, XL; He, W				Zhao, Liqin; Winklhofer, Sebastian; Jiang, Rong; Wang, Xinlian; He, Wen			Dual Energy CT (DECT) Monochromatic Imaging: Added Value of Adaptive Statistical Iterative Reconstructions (ASIR) in Portal Venography	PLOS ONE			English	Article							SPECTRAL CT; DOSE REDUCTION; QUALITY; ENHANCEMENT; ALGORITHM	Objective To investigate the effect of the adaptive statistical iterative reconstructions (ASIR) on image quality in portal venography by dual energy CT (DECT) imaging. Materials and Methods DECT scans of 45 cirrhotic patients obtained in the portal venous phase were analyzed. Monochromatic images at 70keV were reconstructed with the following 4 ASIR percentages: 0%, 30%, 50%, and 70%. The image noise (IN) (standard deviation, SD) of portal vein (PV), the contrast-to-noise-ratio (CNR), and the subjective score for the sharpness of PV boundaries, and the diagnostic acceptability (DA) were obtained. The IN, CNR, and the subjective scores were compared among the four ASIR groups. Results The IN (in HU) of PV (10.05 +/- 3.14, 9.23 +/- 3.05, 8.44 +/- 2.95 and 7.83 +/- 2.90) decreased and CNR values of PV (8.04 +/- 3.32, 8.95 +/- 3.63, 9.80 +/- 4.12 and 10.74 +/- 4.73) increased with the increase in ASIR percentage (0%, 30%, 50%, and 70%, respectively), and were statistically different for the 4 ASIR groups (p<0.05). The subjective scores showed that the sharpness of portal vein boundaries (3.13 +/- 0.59, 2.82 +/- 0.44, 2.73 +/- 0.54 and 2.07 +/- 0.54) decreased with higher ASIR percentages (p<0.05). The subjective diagnostic acceptability was highest at 30% ASIR (p<0.05). Conclusions 30% ASIR addition in DECT portal venography could improve the 70 keV monochromatic image quality.	[Zhao, Liqin; Jiang, Rong; Wang, Xinlian; He, Wen] Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing, Peoples R China; [Winklhofer, Sebastian] Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland	Capital Medical University; University of Zurich; University Zurich Hospital	Zhao, LQ (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing, Peoples R China.	zhaolq0129@163.com	Winklhofer, Sebastian/AAB-8987-2022	Zhao, Li-qin/0000-0002-1274-5179	National Natural Science Foundation of China [81201092]; Beijing Health System High Level Health Technical Personnel Training Plan [2013-3-068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Health System High Level Health Technical Personnel Training Plan	This article is supported by a grant from the National Natural Science Foundation of China (No. 81201092) (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list) and the Beijing Health System High Level Health Technical Personnel Training Plan (No. 2013-3-068) (http://www.bjwsrc.org/hhrnew/index.php?a=show&c=index&catid=30&id=1094&m=content). Both of the roles of the two funders were in data collection and analysis.	Botsikas D, 2014, EUR J RADIOL, V83, P1746, DOI 10.1016/j.ejrad.2014.06.017; Brook OR, 2012, RADIOLOGY, V263, P696, DOI 10.1148/radiol.12111170; Chen TW, 2010, ABDOM IMAGING, V35, P1, DOI 10.1007/s00261-009-9506-y; Fleischmann D, 2009, RADIOL CLIN N AM, V47, P13, DOI 10.1016/j.rcl.2008.10.009; Flicek KT, 2010, AM J ROENTGENOL, V195, P126, DOI 10.2214/AJR.09.3855; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; He JZ, 2014, ACAD RADIOL, V21, P364, DOI 10.1016/j.acra.2013.11.004; Kim DH, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/434609; Kiyosue H, 2013, RADIOGRAPHICS, V33, P87, DOI 10.1148/rg.331125037; Li JH, 2010, J COMPUT ASSIST TOMO, V34, P874, DOI 10.1097/RCT.0b013e3181ed2f72; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; Morgan DE, 2014, ABDOM IMAGING, V39, P108, DOI 10.1007/s00261-013-0033-5; Pinho DF, 2013, EUR RADIOL, V23, P351, DOI 10.1007/s00330-012-2624-x; Prakash P, 2010, J COMPUT ASSIST TOMO, V34, P40, DOI 10.1097/RCT.0b013e3181b26c67; Rampado O, 2012, EUR J RADIOL, V81, P3172, DOI 10.1016/j.ejrad.2012.06.017; Sagara Y, 2010, AM J ROENTGENOL, V195, P713, DOI 10.2214/AJR.09.2989; Scheske JA, 2013, RADIOLOGY, V268, P702, DOI 10.1148/radiol.13121901; Silva AC, 2010, AM J ROENTGENOL, V194, P191, DOI 10.2214/AJR.09.2953; Simons D, 2014, EUR RADIOL, V24, P930, DOI 10.1007/s00330-013-3087-4; Vohra Sandeep, 2014, Indian J Radiol Imaging, V24, P350, DOI 10.4103/0971-3026.143897; Zhao LQ, 2012, EUR J RADIOL, V81, P1677, DOI 10.1016/j.ejrad.2011.02.063; Zheng SW, 2014, EUR J RADIOL, V83, P1216, DOI 10.1016/j.ejrad.2014.02.003	22	3	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0156830	10.1371/journal.pone.0156830	http://dx.doi.org/10.1371/journal.pone.0156830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315158	Green Accepted, gold, Green Published			2022-12-26	WOS:000378030000004
J	Hu, LF; Chen, GS; Kong, QX; Gao, LP; Chen, X; Ye, Y; Li, JB				Hu, Li-Fen; Chen, Guo-Sheng; Kong, Qin-Xiang; Gao, Li-Ping; Chen, Xi; Ye, Ying; Li, Jia-Bin			Increase in the Prevalence of Resistance Determinants to Trimethoprim/Sulfamethoxazole in Clinical Stenotrophomonas maltophilia Isolates in China	PLOS ONE			English	Article							CLASS-1 INTEGRONS; PCR	Aims This study was carried to reveal the genetic mechanisms of trimethoprim/sulfamethoxazole (SXT) resistance. Methods Among 300 clinical Stenotrophomonas maltophilia isolates from China, resistance determinants such as sul and dfrA genes, integrons and transposase were examined using PCR, DNA sequencing and thermal asymmetric interlaced PCR (TAIL-PCR). Data were analyzed using SPSS 20.0. Results Of the 300 isolates, 116 (38.7%) were resistant to SXT. An alarming trend of increased resistance to SXT were found over the 10-year period. The positive rates of sul and class 1 integrase (intl1) increased gradually with the development of SXT resistance over the 10-year period. Multiple logistic regression analyses indicated that the genes of qacE Delta 1-sul1 (81% vs 46.2%, p = 0.000), sul2 (50.9% vs 9.8%, p = 0.000), intl1 (83.6% vs 65.8%, p = 0.000), dfrA12 (25% vs 3.3%, p = 0.000), dfrA17 (15.5% vs 3.8%, p = 0.000) and dfrA27 (4.3% vs 1.6%, p = 0.01) were more prevalent in SXT-resistant isolates than SXT-susceptible isolates except dfrA1(p = 0.83) and dfrA5(p = 0.18). Sequencing data revealed 12 types of resistance gene cassettes (aar-3-dfrA27, dfrA12-aadA2, dfrA17-aadA5, cmlA1, aacA4, aadA5, arr-3-aacA4, aadA1, aadB-aadA4, aacA4-catB8-aadA1, aadB-aac(60)-II-bla(CARB-8) and aac(60)-II-bla(CARB-8)) located in the class 1 integron in 163 isolates (87% SXT-resistant vs 33.7% SXT-susceptible isolates, p = 0.000). A novel finding was the aar-3-dfrA27 (KC748137) gene cassette. The gene of sul2 linked to transposase in 50 SXT-resistant and 7 SXT-susceptible isolates was detected by TAIL-PCR. Conclusions The findings demonstrated a higher prevalence of sul, dfrA, intl1 and resistance gene cassettes in class 1 integron in SXT-resistant clinical S. maltophilia isolates in China. The sul1 and dfrA genes located in integrons and the sul2 linked to transposase may imply wide and rapid dissemination of resistance gene in bacteria.	[Hu, Li-Fen; Chen, Guo-Sheng; Kong, Qin-Xiang; Gao, Li-Ping; Chen, Xi; Ye, Ying; Li, Jia-Bin] Anhui Med Univ, Affiliated Hosp 1, Dept Infect Dis, Hefei, Anhui, Peoples R China; [Hu, Li-Fen; Ye, Ying; Li, Jia-Bin] Anhui Ctr Surveillance Bacterial Resistance, Hefei, Anhui, Peoples R China; [Li, Jia-Bin] Anhui Med Univ, Chaohu Affiliated Hosp, Dept Infect Dis, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Ye, Y; Li, JB (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Infect Dis, Hefei, Anhui, Peoples R China.; Ye, Y; Li, JB (corresponding author), Anhui Ctr Surveillance Bacterial Resistance, Hefei, Anhui, Peoples R China.; Li, JB (corresponding author), Anhui Med Univ, Chaohu Affiliated Hosp, Dept Infect Dis, Hefei, Anhui, Peoples R China.	yeying2@139.com; lijiabin948@vip.sohu.com	li, jiabin/AHD-4645-2022		Natural Science Foundation of China [81101313, 81172737]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (No. 81101313, Li-Fen Hu, https://isis.nsfc.gov.cn), and by Natural Science Foundation of China (No. 81172737, Jia-Bin Li, https://isis.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbolla R, 2004, ANTIMICROB AGENTS CH, V48, P666, DOI 10.1128/AAC.48.2.666-669.2004; Brooke JS, 2014, EXPERT REV ANTI-INFE, V12, P1, DOI 10.1586/14787210.2014.864553; Chang JS, 2013, CLIN OPHTHALMOL, V7, P771, DOI 10.2147/OPTH.S39608; Chang LL, 2007, J ANTIMICROB CHEMOTH, V59, P1038, DOI 10.1093/jac/dkm034; Cho SY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0801-7; Church D, 2013, SCAND J INFECT DIS, V45, P265, DOI 10.3109/00365548.2012.732240; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA, V33, P68; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Farrell DJ, 2010, ANTIMICROB AGENTS CH, V54, P2735, DOI 10.1128/AAC.01774-09; Gaze WH, 2005, ANTIMICROB AGENTS CH, V49, P1802, DOI 10.1128/AAC.49.5.1802-1807.2005; Goldstein C, 2001, ANTIMICROB AGENTS CH, V45, P723, DOI 10.1128/AAC.45.3.723-726.2001; Hu LF, 2011, INT J ANTIMICROB AG, V37, P230, DOI 10.1016/j.ijantimicag.2010.10.025; Kaur P, 2015, MICROB DRUG RESIST, V21, P380, DOI 10.1089/mdr.2014.0176; Lee MF, 2011, ANTIMICROB AGENTS CH, V55, P943, DOI 10.1128/AAC.00988-10; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Trinh Q, 2014, ANAL BIOCHEM, V466, P24, DOI 10.1016/j.ab.2014.07.022; Toleman MA, 2007, EMERG INFECT DIS, V13, P559, DOI 10.3201/eid1304.061378; White PA, 2001, ANTIMICROB AGENTS CH, V45, P2658, DOI 10.1128/AAC.45.9.2658-2661.2001; Wu H, 2012, J MICROBIOL IMMUNOL, V45, P120, DOI 10.1016/j.jmii.2011.09.028	20	25	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157693	10.1371/journal.pone.0157693	http://dx.doi.org/10.1371/journal.pone.0157693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310255	gold, Green Submitted, Green Published			2022-12-26	WOS:000378029800124
J	Mutt, E; Sowdhamini, R				Mutt, Eshita; Sowdhamini, Ramanathan			Molecular Dynamics Simulations and Structural Analysis to Decipher Functional Impact of a Twenty Residue Insert in the Ternary Complex of Mus musculus TdT Isoform	PLOS ONE			English	Article							DNA-POLYMERASE MU; TRANSFER-RNA SYNTHETASE; HUMAN POL-MU; TERMINAL DEOXYNUCLEOTIDYLTRANSFERASE; STRUCTURE NETWORK; HIGH-THROUGHPUT; DOMAIN; PROTEINS; CONSEQUENCES; TRANSITIONS	Insertions/deletions are common evolutionary tools employed to alter the structural and functional repertoire of protein domains. An insert situated proximal to the active site or ligand binding site frequently impacts protein function; however, the effect of distal indels on protein activity and/or stability are often not studied. In this paper, we have investigated a distal insert, which influences the function and stability of a unique DNA polymerase, called terminal deoxynucleotidyl transferase (TdT). TdT (EC: 2.7.7.31) is a monomeric 58 kDa protein belonging to family X of eukaryotic DNA polymerases and known for its role in V(D)J recombination as well as in non-homologous end-joining (NHEJ) pathways. Two murine isoforms of TdT, with a length difference of twenty residues and having different biochemical properties, have been studied. All-atom molecular dynamics simulations at different temperatures and interaction network analyses were performed on the short and long-length isoforms. We observed conformational changes in the regions distal to the insert position (thumb subdomain) in the longer isoform, which indirectly affects the activity and stability of the enzyme through a mediating loop (Loop1). A structural rationale could be provided to explain the reduced polymerization rate as well as increased thermosensitivity of the longer isoform caused by peripherally located length variations within a DNA polymerase. These observations increase our understanding of the roles of length variants in introducing functional diversity in protein families in general.	[Mutt, Eshita; Sowdhamini, Ramanathan] Natl Ctr Biol Sci TIFR, GKVK Campus,Bellary Rd, Bangalore 560065, Karnataka, India; [Mutt, Eshita] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Sowdhamini, R (corresponding author), Natl Ctr Biol Sci TIFR, GKVK Campus,Bellary Rd, Bangalore 560065, Karnataka, India.	mini@ncbs.res.in		Mutt, Eshita/0000-0003-3225-4761	Department of Biotechnology Grant, India	Department of Biotechnology Grant, India	Department of Biotechnology Grant, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; [Anonymous], PYMOL MOL GRAPH SYST; Barkho S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003188; Beard WA, 2003, STRUCTURE, V11, P489, DOI 10.1016/S0969-2126(03)00051-0; Beard WA, 2000, MUTAT RES-DNA REPAIR, V460, P231, DOI 10.1016/S0921-8777(00)00029-X; Boule JB, 2000, J BIOL CHEM, V275, P28984, DOI 10.1074/jbc.M005544200; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Delarue M, 2002, EMBO J, V21, P427, DOI 10.1093/emboj/21.3.427; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731; DOYEN N, 1993, NUCLEIC ACIDS RES, V21, P1187, DOI 10.1093/nar/21.5.1187; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Esteban V, 2013, DNA REPAIR, V12, P824, DOI 10.1016/j.dnarep.2013.07.007; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P15711, DOI 10.1073/pnas.0704459104; Ghosh A, 2007, BIOPHYS J, V92, P2523, DOI 10.1529/biophysj.106.099903; Gouge J, 2013, J MOL BIOL, V425, P4334, DOI 10.1016/j.jmb.2013.07.009; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; JORGENSEN WL, 1983, J AM CHEM SOC, V105, P1407, DOI 10.1021/ja00344a001; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Martin MJ, 2014, NUCLEIC ACIDS RES, V42, P7923, DOI 10.1093/nar/gku475; Juarez R, 2006, NUCLEIC ACIDS RES, V34, P4572, DOI 10.1093/nar/gkl457; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; Li YL, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003074; Li YL, 2010, BIOPHYS J, V99, P3463, DOI 10.1016/j.bpj.2010.09.056; Liberles DA, 2012, PROTEIN SCI, V21, P769, DOI 10.1002/pro.2071; Liu RJ, 2011, BIOCHEM J, V440, P217, DOI 10.1042/BJ20111177; Mejia E, DNA REPAIR AMST, V18, P1; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Moon AF, 2014, NAT STRUCT MOL BIOL, V21, P253, DOI 10.1038/nsmb.2766; Mutt E, 2014, NUCLEIC ACIDS RES, V42, pD246, DOI 10.1093/nar/gkt1014; Pandya C, 2013, P NATL ACAD SCI USA, V110, pE3381, DOI 10.1073/pnas.1305519110; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pellegrini-Calace M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000440; Pugalenthi G, 2006, NUCLEIC ACIDS RES, V34, pW231, DOI 10.1093/nar/gkl314; Repasky JAE, 2004, J IMMUNOL, V172, P5478, DOI 10.4049/jimmunol.172.9.5478; Romain F, 2009, NUCLEIC ACIDS RES, V37, P4642, DOI 10.1093/nar/gkp460; Sandhya S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004981; Schlick T, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1287-7; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Vijayabaskar MS, 2011, OPEN BIOINFORMA J, P5; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yamtich J, 2010, BBA-PROTEINS PROTEOM, V1804, P1136, DOI 10.1016/j.bbapap.2009.07.008; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	53	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157286	10.1371/journal.pone.0157286	http://dx.doi.org/10.1371/journal.pone.0157286			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311013	gold, Green Published, Green Submitted			2022-12-26	WOS:000378029800051
J	Maalcke, WJ; Reimann, J; de Vries, S; Butt, JN; Dietl, A; Kip, N; Mersdorf, U; Barends, TRM; Jetten, MSM; Keltjens, JT; Kartal, B				Maalcke, Wouter J.; Reimann, Joachim; de Vries, Simon; Butt, Julea N.; Dietl, Andreas; Kip, Nardy; Mersdorf, Ulrike; Barends, Thomas R. M.; Jetten, Mike S. M.; Keltjens, Jan T.; Kartal, Boran			Characterization of Anammox Hydrazine Dehydrogenase, a Key N-2-producing Enzyme in the Global Nitrogen Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electron paramagnetic resonance (EPR); enzyme kinetics; enzyme purification; nitrogen metabolism; reactive nitrogen species (RNS); anaerobic ammonium oxidation; hydrazine; octaheme proteins	ANAEROBIC AMMONIUM OXIDATION; HYDROXYLAMINE OXIDOREDUCTASE; CYTOCHROME-C; NITROSOMONAS-EUROPAEA; MULTIHEME PROTEIN; OXIDIZING ENZYME; EPR SIGNALS; HEME; MECHANISM; SEDIMENTATION	Anaerobic ammonium-oxidizing (anammox) bacteria derive their energy for growth from the oxidation of ammonium with nitrite as the electron acceptor. N-2, the end product of this metabolism, is produced from the oxidation of the intermediate, hydrazine (N2H4). Previously, we identified N-2-producing hydrazine dehydrogenase (KsHDH) from the anammox organism Kuenenia stuttgartiensis as the gene product of kustc0694 and determined some of its catalytic properties. In the genome of K. stuttgartiensis, kustc0694 is one of 10 paralogs related to octaheme hydroxylamine (NH2OH) oxidoreductase (HAO). Here, we characterized KsHDH as a covalently cross-linked homotrimeric octaheme protein as found for HAO and HAO-related hydroxylamine-oxidizing enzyme kustc1061 from K. stuttgartiensis. Interestingly, the HDH trimers formed octamers in solution, each octamer harboring an amazing 192 c-type heme moieties. Whereas HAO and kustc1061 are capable of hydrazine oxidation as well, KsHDH was highly specific for this activity. To understand this specificity, we performed detailed amino acid sequence analyses and investigated the catalytic and spectroscopic (electronic absorbance, EPR) properties of KsHDH in comparison with the well defined HAO and kustc1061. We conclude that HDH specificity is most likely derived from structural changes around the catalytic heme 4 (P-460) and of the electron-wiring circuit comprising seven His/His-ligated c-type hemes in each subunit. These nuances make HDH a globally prominent N-2-producing enzyme, next to nitrous oxide (N2O) reductase from denitrifying microorganisms.	[Maalcke, Wouter J.; Reimann, Joachim; Kip, Nardy; Jetten, Mike S. M.; Keltjens, Jan T.; Kartal, Boran] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Microbiol, NL-6525 AJ Nijmegen, Netherlands; [de Vries, Simon; Jetten, Mike S. M.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands; [Butt, Julea N.] Univ East Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Butt, Julea N.] Univ East Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Mersdorf, Ulrike; Barends, Thomas R. M.] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany; [Maalcke, Wouter J.] Dr Heinekamp Benelux, Vlasstr 12, NL-5561 AJ Riethoven, Netherlands; [Kip, Nardy] HAN Univ Appl Sci, Inst Appl Sci, Laan van Scheut 2, NL-6525 EM Nijmegen, Netherlands	Radboud University Nijmegen; Delft University of Technology; University of East Anglia; University of East Anglia; Max Planck Society	Kartal, B (corresponding author), Max Planck Inst Marine Microbiol, Microbial Physiol Grp, Celsiusstr 1, D-28359 Bremen, Germany.	bkartal@mpi-bremen.de	Butt, Julea/E-2133-2011; Jetten, Mike/B-8834-2011; Keltjens, Jan/M-3002-2013; Kartal, Boran/ABD-5400-2021	Butt, Julea/0000-0002-9624-5226; Jetten, Mike/0000-0002-4691-7039; Kartal, Boran/0000-0003-4199-952X	Netherlands Organization for Scientific Research (NWO) VENI Grant [863.11.003]; Netherlands Organization for Scientific Research (NWO) Darwin Grant [142.16.1201]; ALW-NWO Open Programme Grant [822.02.005]; Dutch Government "Zwaartekrachtsubsidie" (Gravitation Grant) to the Soehngen Institute for Anaerobic Microbiology (SIAM) [024 002 002]; European Research Council [ERC 232937, ERC 339880, ERC 640422]; Max-Planck Society	Netherlands Organization for Scientific Research (NWO) VENI Grant(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO) Darwin Grant(Netherlands Organization for Scientific Research (NWO)); ALW-NWO Open Programme Grant; Dutch Government "Zwaartekrachtsubsidie" (Gravitation Grant) to the Soehngen Institute for Anaerobic Microbiology (SIAM); European Research Council(European Research Council (ERC)European Commission); Max-Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by Netherlands Organization for Scientific Research (NWO) VENI Grant 863.11.003 (to B. K.), Darwin Grant 142.16.1201 (to W. J. M.), and ALW-NWO Open Programme Grant 822.02.005 (to J. R.); by the Dutch Government "Zwaartekrachtsubsidie" (Gravitation Grant) to the Soehngen Institute for Anaerobic Microbiology (SIAM 024 002 002) (to M. S. M. J.); by European Research Council advanced Grants ERC 232937 (to M. S. M. J.), ERC 339880 (to M. S. M. J.), and ERC 640422 (to B. K.); and by the Max-Planck Society (to T. R. M. B., U. M., and A. D.). The authors declare that they have no conflicts of interest with the contents of this paper.	Arciero DM, 1998, BIOCHEMISTRY-US, V37, P523, DOI 10.1021/bi972187l; Attia AAA, 2014, J PHYS CHEM B, V118, P12140, DOI 10.1021/jp507023a; Bencini A., 1990, ELECT PARAMAGNETIC R; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Cedervall P, 2013, BIOCHEMISTRY-US, V52, P6211, DOI 10.1021/bi400960w; de Almeida NM, 2015, J BACTERIOL, V197, P2432, DOI 10.1128/JB.00186-15; Devol AH, 2015, ANNU REV MAR SCI, V7, P403, DOI 10.1146/annurev-marine-010213-135040; DEVRIES S, 1979, BIOCHIM BIOPHYS ACTA, V546, P334; Dietl A, 2015, NATURE, V527, P404, DOI 10.1038/nature15517; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Farhoud MH, 2005, MOL CELL PROTEOMICS, V4, P1653, DOI 10.1074/mcp.M500171-MCP200; Fernandez ML, 2008, J INORG BIOCHEM, V102, P1523, DOI 10.1016/j.jinorgbio.2008.01.032; Hendrich MP, 2001, J AM CHEM SOC, V123, P2997, DOI 10.1021/ja002982d; Hooper AB, 1997, ANTON LEEUW INT J G, V71, P59, DOI 10.1023/A:1000133919203; HOOPER AB, 1965, J BIOL CHEM, V240, P4044; Igarashi N, 1997, NAT STRUCT BIOL, V4, P276, DOI 10.1038/nsb0497-276; Kartal B, 2010, SCIENCE, V328, P702, DOI 10.1126/science.1185941; Kartal B, 2013, FEMS MICROBIOL REV, V37, P428, DOI 10.1111/1574-6976.12014; Kartal B, 2012, ADV MICROB PHYSIOL, V60, P211, DOI 10.1016/B978-0-12-398264-3.00003-6; Kartal B, 2011, NATURE, V479, P127, DOI 10.1038/nature10453; Kleingardner JG, 2015, ACCOUNTS CHEM RES, V48, P1845, DOI 10.1021/acs.accounts.5b00106; Klotz MG, 2008, ENVIRON MICROBIOL, V10, P3150, DOI 10.1111/j.1462-2920.2008.01733.x; Kostera J, 2010, BIOCHEMISTRY-US, V49, P8546, DOI 10.1021/bi1006783; Kurnikov IV, 2005, BIOCHEMISTRY-US, V44, P1856, DOI 10.1021/bi048060v; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Maalcke WJ, 2014, J BIOL CHEM, V289, P1228, DOI 10.1074/jbc.M113.525147; Schalk J, 2000, BIOCHEMISTRY-US, V39, P5405, DOI 10.1021/bi992721k; Shimamura M, 2008, J BIOSCI BIOENG, V105, P243, DOI 10.1263/jbb.105.243; Shimamura M, 2007, APPL ENVIRON MICROB, V73, P1065, DOI 10.1128/AEM.01978-06; TERRY KR, 1981, BIOCHEMISTRY-US, V20, P7026, DOI 10.1021/bi00527a039; vandeGraaf AA, 1997, MICROBIOL-SGM, V143, P2415, DOI 10.1099/00221287-143-7-2415; VONWACHENFELDT C, 1994, FEBS LETT, V340, P109, DOI 10.1016/0014-5793(94)80182-7; YONETANI T, 1965, J BIOL CHEM, V240, P4509	34	67	72	16	129	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17077	17092		10.1074/jbc.M116.735530	http://dx.doi.org/10.1074/jbc.M116.735530			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27317665	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000382643800014
J	Runnsjo, A; Dabkowska, AP; Sparr, E; Kocherbitov, V; Arnebrant, T; Engblom, J				Runnsjo, Anna; Dabkowska, Aleksandra P.; Sparr, Emma; Kocherbitov, Vitaly; Arnebrant, Thomas; Engblom, Johan			Diffusion through Pig Gastric Mucin: Effect of Relative Humidity	PLOS ONE			English	Article							HUMAN CERVICAL-MUCUS; SATURATED SALT-SOLUTIONS; PHYSICAL-CHARACTERIZATION; GASTROINTESTINAL MUCUS; GLASS-TRANSITION; CYSTIC-FIBROSIS; WATER SORPTION; SKIN; TRANSPORT; PH	Mucus covers the epithelium found in all intestinal tracts, where it serves as an important protecting barrier, and pharmaceutical drugs administrated by the oral, rectal, vaginal, ocular, or nasal route need to penetrate the mucus in order to reach their targets. Furthermore, the diffusion in mucus as well as the viscosity of mucus in the eyes, nose and throat can change depending on the relative humidity of the surrounding air. In this study we have investigated how diffusion through gels of mucin, the main protein in mucus, is affected by changes in ambient relative humidity (i.e. water activity). Already a small decrease in water activity was found to give rise to a significant decrease in penetration rate through the mucin gel of the antibacterial drug metronidazole. We also show that a decrease in water activity leads to decreased diffusion rate in the mucin gel for the fluorophore fluorescein. This study shows that it is possible to alter transport rates of molecules through mucus by changing the water activity in the gel. It furthermore illustrates the importance of considering effects of the water activity in the mucosa during development of potential pharmaceuticals.	[Runnsjo, Anna; Kocherbitov, Vitaly; Arnebrant, Thomas; Engblom, Johan] Malmo Univ, Fac Hlth & Soc, Biomed Sci, Malmo, Sweden; [Runnsjo, Anna; Kocherbitov, Vitaly; Arnebrant, Thomas; Engblom, Johan] Malmo Univ, Biofilms Res Ctr Biointerfaces, Malmo, Sweden; [Dabkowska, Aleksandra P.; Sparr, Emma] Lund Univ, Div Phys Chem, Lund, Sweden	Malmo University; Malmo University; Lund University	Runnsjo, A (corresponding author), Malmo Univ, Fac Hlth & Soc, Biomed Sci, Malmo, Sweden.; Runnsjo, A (corresponding author), Malmo Univ, Biofilms Res Ctr Biointerfaces, Malmo, Sweden.	anna.runnsjo@mah.se	Kocherbitov, Vitaly/N-1792-2017	Kocherbitov, Vitaly/0000-0002-9852-5440; Sparr, Emma/0000-0001-8343-9657	Knowledge Foundation (KK-stiftelsen, Sweden) [2010/0234]; Gustaf Th. Ohlsson Foundation (Sweden); Biofilms - Research Center for Biointerfaces at Malmo University (Sweden); Swedish Foundation for Strategic Research [F06-0047]; Swedish Research Council [2012-3932]; Linnaeus Center of Excellence "Organizing molecular matter"; Knut and Alice Wallenberg's foundation	Knowledge Foundation (KK-stiftelsen, Sweden); Gustaf Th. Ohlsson Foundation (Sweden); Biofilms - Research Center for Biointerfaces at Malmo University (Sweden); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Linnaeus Center of Excellence "Organizing molecular matter"; Knut and Alice Wallenberg's foundation(Knut & Alice Wallenberg Foundation)	This study was conducted with financial support from the following sources: Knowledge Foundation (KK-stiftelsen, Sweden, www.kks.se), grant 2010/0234 "Mucoadhesion - A prerequisite or a constraint in nasal drug delivery" (AR, VK, TA, JE); Gustaf Th. Ohlsson Foundation (Sweden) (AR, VK, TA, JE); Biofilms - Research Center for Biointerfaces at Malmo University (Sweden, https://www.mah.se/brcb) (AR, VK, TA, JE); Swedish Foundation for Strategic Research (www.stratresearch.se), grant number F06-0047 (AD, ES); and Swedish Research Council (www.vr.se), grant number 2012-3932, and the Linnaeus Center of Excellence "Organizing molecular matter" (AD, ES). Knut and Alice Wallenberg's foundation (www.wallenberg.com/kaw) funded the acquisition of the FCS equipment and the confocal microscope. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001; Bjorklund S, 2010, J CONTROL RELEASE, V143, P191, DOI 10.1016/j.jconrel.2010.01.005; BRONAUGH RL, 1986, J PHARM SCI, V75, P1094, DOI 10.1002/jps.2600751115; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Celli JP, 2007, BIOMACROMOLECULES, V8, P1580, DOI 10.1021/bm0609691; CLOWES HM, 1994, TOXICOL IN VITRO, V8, P827, DOI 10.1016/0887-2333(94)90078-7; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Crater JS, 2010, MACROMOL BIOSCI, V10, P1473, DOI 10.1002/mabi.201000137; Culbertson CT, 2002, TALANTA, V56, P365, DOI 10.1016/S0039-9140(01)00602-6; EHLICH D, 1990, MACROMOLECULES, V23, P1600, DOI 10.1021/ma00208a008; Elson EL, 2011, BIOPHYS J, V101, P2855, DOI 10.1016/j.bpj.2011.11.012; Evans D. F., 1999, COLLOIDAL DOMAIN PHY; Georgiades P, 2014, BIOPOLYMERS, V101, P366, DOI 10.1002/bip.22372; Hill DB, 2014, PLOS ONE; Jonsson P, 2008, BIOPHYS J, V95, P5334, DOI 10.1529/biophysj.108.134874; Kapusta P., 2010, ABSOLUTE DIFFUSION C, V1, P1, DOI DOI 10.1209/0295-5075/83/46001; Kirch J, 2012, P NATL ACAD SCI USA, V109, P18355, DOI 10.1073/pnas.1214066109; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; KocevarNared J, 1997, BIOMATERIALS, V18, P677, DOI 10.1016/S0142-9612(96)00180-9; Lafitte G, 2007, J PHARM SCI-US, V96, P258, DOI 10.1002/jps.20749; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Larhed AW, 1998, PHARMACEUT RES, V15, P66, DOI 10.1023/A:1011948703571; Larhed AW, 1997, J PHARM SCI-US, V86, P660, DOI 10.1021/js960503w; Lieleg O, 2010, BIOPHYS J, V98, P1782, DOI 10.1016/j.bpj.2010.01.012; Loren N, 2015, Q REV BIOPHYS, V48, P323, DOI 10.1017/S0033583515000013; Maleki A, 2008, CARBOHYD RES, V343, P328, DOI 10.1016/j.carres.2007.10.005; Matsui H, 2006, P NATL ACAD SCI USA, V103, P18131, DOI 10.1073/pnas.0606428103; Mehrotra R, 1998, BIOCHEM J, V334, P415, DOI 10.1042/bj3340415; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Pollio ML, 1996, FOOD SCI TECHNOL-LEB, V29, P376; Prestin S, 2012, HEAD NECK-J SCI SPEC, V34, P1777, DOI 10.1002/hed.22007; Raynal BDE, 2002, BIOCHEM J, V362, P289, DOI 10.1042/0264-6021:3620289; ROCKLAND LB, 1960, ANAL CHEM, V32, P1375, DOI 10.1021/ac60166a055; Rusu L, 2010, MACROMOL BIOSCI, V10, P1465, DOI 10.1002/mabi.201000033; SALTZMAN WM, 1994, BIOPHYS J, V66, P508, DOI 10.1016/S0006-3495(94)80802-1; Sheehan JK, 2000, BIOCHEM J, V347, P37, DOI 10.1042/0264-6021:3470037; Sigurdsson HH, 2013, INT J PHARM; Smart JD, 2005, ADV DRUG DELIVER REV, V57, P1556, DOI 10.1016/j.addr.2005.07.001; SQUIER CA, 1985, J INVEST DERMATOL, V84, P176, DOI 10.1111/1523-1747.ep12264711; Sunwoo Yujin, 2006, Journal of Physiological Anthropology and Applied Human Science, V25, P7, DOI 10.2114/jpa2.25.7; Tang XX, 2016, J CLIN INVEST, V126, P879, DOI 10.1172/JCI83922; Thornton David J, 2004, Proc Am Thorac Soc, V1, P54, DOI 10.1513/pats.2306016; Wahlgren M, EFFECT GRADIEN UNPUB; YUDIN AI, 1989, BIOL REPROD, V40, P661, DOI 10.1095/biolreprod40.3.661; Znamenskaya Y, 2012, J PHYS CHEM B; Znamenskaya Y, 2013, J PHYS CHEM B, V117, P2554, DOI 10.1021/jp311968b	47	6	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157596	10.1371/journal.pone.0157596	http://dx.doi.org/10.1371/journal.pone.0157596			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336158	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200024
J	Baker, D; Barrett, S; Beale, CM; Crawford, TJ; Ellis, S; Gullett, T; Mayhew, PJ; Parsons, MS; Relf, P; Robertson, P; Small, J; Wainwright, D				Baker, David; Barrett, Sinead; Beale, Colin M.; Crawford, Terry J.; Ellis, Sam; Gullett, Tallulah; Mayhew, Peter J.; Parsons, Mark S.; Relf, Penny; Robertson, Paul; Small, Julian; Wainwright, Dave			Decline of a Rare Moth at Its Last Known English Site: Causes and Lessons for Conservation	PLOS ONE			English	Article							BRITISH BUTTERFLIES; RESPONSES; CLIMATE; HEATHLAND; METAPOPULATION	The conditions required by rare species are often only approximately known. Monitoring such species over time can help refine management of their protected areas. We report population trends of a rare moth, the Dark Bordered Beauty Epione vespertaria (Linnaeus, 1767) (Lepidoptera: Geometridae) at its last known English site on a protected lowland heath, and those of its host-plant, Salix repens (L.) (Malpighiales: Salicaceae). Between 2007 and 2014, adult moth density reduced by an average of 30-35% annually over the monitored area, and its range over the monitored area contracted in concert. By comparing data from before this decline (2005) with data taken in 2013, we show that the density of host-plants over the monitored area reduced three-fold overall, and ten-fold in the areas of highest host-plant density. In addition, plants were significantly smaller in 2013. In 2005, moth larvae tended to be found on plants that were significantly larger than average at the time. By 2013, far fewer plants were of an equivalent size. This suggests that the rapid decline of the moth population coincides with, and is likely driven by, changes in the hostplant population. Why the host-plant population has changed remains less certain, but fire, frost damage and grazing damage have probably contributed. It is likely that a reduction in grazing pressure in parts of the site would aid host-plant recovery, although grazing remains an important site management activity. Our work confirms the value of constant monitoring of rare or priority insect species, of the risks posed to species with few populations even when their populations are large, of the potential conflict between bespoke management for species and generic management of habitats, and hence the value of refining our knowledge of rare species' requirements so that their needs can be incorporated into the management of protected areas.	[Baker, David; Crawford, Terry J.; Relf, Penny] Yorkshire Naturalists Union, Yorkshire Naturalists Union Lepidoptera Grp, York, N Yorkshire, England; [Baker, David; Relf, Penny] Butterfly Conservat, Yorkshire Branch, York, N Yorkshire, England; [Barrett, Sinead; Beale, Colin M.; Crawford, Terry J.; Gullett, Tallulah; Mayhew, Peter J.; Robertson, Paul] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Ellis, Sam; Parsons, Mark S.; Wainwright, Dave] Butterfly Conservat, Wareham, Dorset, England; [Small, Julian] Nat England, York, N Yorkshire, England	University of York - UK	Mayhew, PJ (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	peter.mayhew@york.ac.uk	; Mayhew, Peter John/I-6363-2012	Beale, Colin Michael/0000-0002-2960-5666; Mayhew, Peter John/0000-0002-7346-6560	Natural England grant [ECM108]; Royal Society for the Protection of Birds Biodiversity Grant; First TransPennine Express; Forestry Commission Green Grant	Natural England grant; Royal Society for the Protection of Birds Biodiversity Grant; First TransPennine Express; Forestry Commission Green Grant	This work was supported by a Natural England grant (https://www.gov.uk/government/organisations/natural-england), S41 - Action for Moths, current ref. ECM108 to MSP; a Royal Society for the Protection of Birds Biodiversity Grant to MSP; a First TransPennine Express and Forestry Commission Green Grant (http://www.tpexpress.co.uk/mediafile/1480/4001-transpennine-network-green-grants-proof-2.pdf) to DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, CONV BIOL DIV; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baker D, 2012, ARGUS, V65, P6; Baker David, 2012, Naturalist (Sheffield), V137, P11; BAKKER JP, 1983, J APPL ECOL, V20, P541, DOI 10.2307/2403525; Betzholtz PE, 2007, J INSECT CONSERV, V11, P343, DOI 10.1007/s10841-006-9048-3; Biodiversity Reporting and Information Group, 2007, REP SPEC HAB REV REP; Bivand R, 2014, RGDAL BINDINGS GEOSP; Bivand R.S., 2014, MAPTOOLS TOOLS READI; Bratton JH, 1991, BRIT RED DATA BOOKS; City of York Council, 2013, CIT YORK BIOD ACT PL; Clements Rob, 2001, British Birds, V94, P402; Crawford TJ, 2012, ARGUS, V65, P12; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; English Nature, 2002, LOWL HEALTHL CULT EN; Farrell L, 1983, BRIT RED DATA BOOKS; Fox J., 2018, R COMPANION APPL REG, VThird; Fox R, 2011, STATE UKS BUTTERFLIE; Fox R, 2013, STATE BRITAIN LARGER; Fox R, 2014, J APPL ECOL, V51, P949, DOI 10.1111/1365-2664.12256; Fox R, 2013, INSECT CONSERV DIVER, V6, P5, DOI 10.1111/j.1752-4598.2012.00186.x; Frost HM, 2013, ARGUS, P69; Frost HM, 2012, ARGUS, P66; Frost HM, 2011, ARGUS, P63; Frost HM, 2014, ARGUS, P72; Graham B, 2014, THESIS; Grant SA, 1996, J APPL ECOL, V33, P1267, DOI 10.2307/2404769; Gutierrez D, 1999, OECOLOGIA, V121, P506, DOI 10.1007/s004420050957; Hijmans RJ, 2015, **DATA OBJECT**, DOI DOI 10.HTTPS://CRAN.R-PROJECT.ORG/WEB/PACKAGES/RASTER/INDEX.HTML; Hochkirch A, 2007, BIODIVERS CONSERV, V16, P3597, DOI 10.1007/s10531-006-9123-9; Lawton J.H., 2010, MAKING SPACE NATURE; Li J, 2011, ECOL INFORM, V6, P228, DOI 10.1016/j.ecoinf.2010.12.003; Lin YC, 2007, BIODIVERS CONSERV, V16, P1337, DOI 10.1007/s10531-005-6231-x; Marren P, 1997, ROTHSCHILDS RESERVES; Martin D., 2013, NATURAL ENGLAND REV; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Natural England, 2014, SIT IMPR PLAN STRENS; Nature English, 2005, GRAZ MAN LOWL HEATHL; Nature English, 2004, REPT GUID DEV; New T.R., 2013, LEPIDOPTERA CONSERVA; Newton AC, 2009, BIOL CONSERV, V142, P935, DOI 10.1016/j.biocon.2008.10.018; PARROTT J, 2009, ASPEN SCOTLAND BIODI; Pywell RF, 2011, BIOL CONSERV, V144, P1602, DOI 10.1016/j.biocon.2011.02.010; RAVENSCROFT NOM, 1994, J APPL ECOL, V31, P613, DOI 10.2307/2404152; Resh V. H., 2009, ENCY INSECTS; Robertson P, 2006, S0602 BUTT CONS; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; RUTHERFORD C I, 1971, Naturalist (Rotherham), V918, P93; Schirmel J, 2014, J INSECT CONSERV, V18, P111, DOI 10.1007/s10841-014-9619-7; Shirt D, 1987, BRIT RED DATA BOOKS; Sparks TH, 2006, EUR J ENTOMOL, V103, P379, DOI 10.14411/eje.2006.051; Stokes KE, 2004, J VEG SCI, V15, P505, DOI 10.1111/j.1654-1103.2004.tb02289.x; Tams TJ, 2014, VASCULUM, V99, P33; Taylor K, 2001, J ECOL, V89, P126, DOI 10.1046/j.1365-2745.2001.00534.x; Thomas JA, 2011, J INSECT CONSERV, V15, P241, DOI 10.1007/s10841-010-9341-z; Thomas JA, 1999, FUNCT ECOL, V13, P55, DOI 10.1046/j.1365-2435.1999.00008.x; UK Biodiversity Group, 1999, TRANCH 2 ACT PLANS I; UK Biodiversity Steering Group, 1995, BIOD UK STEER GROUP, V2; van den Berg LJL, 2001, BIOL CONSERV, V101, P217, DOI 10.1016/S0006-3207(01)00069-6; Vu V. Q., 2011, GGBIPLOT GGPLOT2 BAS; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Webb JR, 2010, NATURAL ENGLAND REPO; Webb N., 1986, HEALTHLANDS NEW NATU; Wickham H., 2015, DEVTOOLS TOOLS MAKE; Wigglesworth T, DARK BORDERED BEAUTY; Williams J.M., 2006, COMMON STANDARDS MON	66	1	1	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157423	10.1371/journal.pone.0157423	http://dx.doi.org/10.1371/journal.pone.0157423			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333285	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000378212800029
J	Ma, HS; Yuan, Y; Zhao, L; Ye, Z; Xu, JD; Li, M; Jiang, ZY; Jiang, YF				Ma, Hongshuang; Yuan, Yi; Zhao, Ling; Ye, Zhuang; Xu, Jiandong; Li, Man; Jiang, Zhenyu; Jiang, Yanfang			Association of gamma delta T Cell Compartment Size to Disease Activity and Response to Therapy in SLE	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; IFN-GAMMA; PERIPHERAL-BLOOD; INTERFERON-GAMMA; TUMOR; RECEPTOR; SKIN	Objective Although gamma delta T cells are widely recognized as pivotal elements in immune-mediated diseases, their role in the pathogenesis of SLE and therapeutic outcome remains under explored. The current study aims to characterize the gamma delta T cell compartment in SLE and correlate its status to disease severity and response to therapy. Methods Human peripheral blood-derived gamma delta T cells were isolated from 14 healthy volunteers and 22 SLE patients (before and after 4 and 12 weeks following the onset of glucocorticoids (GC), mycophenolatemofetil (MMF) orhydroxychloroquine (HCQ) treatment). The gamma delta T cells were characterized using flow cytometry. In addition, serum concentration of IFN-gamma, TNF-alpha, IL-2, IL-4, IL-6, IL-10 and IL-17A was determined by cytometric bead array (CBA). Results The SLEDAI scores dropped significantly following therapy in a subset of patients (responders-R) but not in some (non-responders-NR). Peripheral blood gamma delta T cells in general, and gamma 9+delta T cells and TNF-alpha/IL-17-secreting CD4(-)CD8(-)gamma delta T cell subsets in particular, were decreased in SLE compared to healthy controls. The numbers of the gamma delta T cell subsets reached levels similar to those of healthy controls following therapy in R but not in NR. Serum IL-6, IL-10 and IL-17 but not IFN-gamma and TNF-alpha were significantly increased in SLE compared to the healthy controls and exhibited differential changes following therapy. In addition, inverse correlation was observed between SLEDAI scores and gamma delta T cell compartments, especially with TNF-alpha(+)gamma delta T cells, TNF-alpha(+)gamma 9+delta T cells and IL17(+)CD4(-)CD8(-)gamma delta T cells subsets. Differential correlation patterns were also observed between serum cytokine levels and various gamma delta T cell compartments. Conclusions A strong association exists between gamma delta T cell compartments and SLE pathogenesis, disease severity and response to therapy.	[Ma, Hongshuang; Yuan, Yi; Zhao, Ling; Ye, Zhuang; Jiang, Zhenyu] Jilin Univ, Hosp 1, Dept Rheumatol, Changchun 130021, Peoples R China; [Li, Man; Jiang, Yanfang] Jilin Univ, Hosp 1, Genet Diag Ctr, Changchun 130021, Peoples R China; [Jiang, Yanfang] Jilin Univ, Hosp 1, Key Lab Zoonosis Res, Minist Educ, Changchun 130032, Peoples R China; [Jiang, Yanfang] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China; [Xu, Jiandong] Westbury Christian Sch, 10420 Hillcroft, Houston, TX 77096 USA	Jilin University; Jilin University; Jilin University	Jiang, ZY (corresponding author), Jilin Univ, Hosp 1, Dept Rheumatol, Changchun 130021, Peoples R China.; Jiang, YF (corresponding author), Jilin Univ, Hosp 1, Genet Diag Ctr, Changchun 130021, Peoples R China.; Jiang, YF (corresponding author), Jilin Univ, Hosp 1, Key Lab Zoonosis Res, Minist Educ, Changchun 130032, Peoples R China.; Jiang, YF (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China.	jlujzy@aliyun.com; yanfangjiang@hotmail.com						Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; DEUSCH K, 1991, EUR J IMMUNOL, V21, P1053, DOI 10.1002/eji.1830210429; Dolff S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3100; Edwards SC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00455; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; GERLI R, 1991, J RHEUMATOL, V18, P1504; Harigai M, 2008, J IMMUNOL, V181, P2211, DOI 10.4049/jimmunol.181.3.2211; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Holtmeier Wolfgang, 2005, V86, P151, DOI 10.1159/000086659; Hua F, 2013, IMMUNOL RES, V56, P172, DOI 10.1007/s12026-013-8390-2; Koenig KF, 2012, CYTOKINE, V60, P410, DOI 10.1016/j.cyto.2012.07.004; Laggner U, 2011, J IMMUNOL, V187, P2783, DOI 10.4049/jimmunol.1100804; Li Li, 2010, Zhonghua Jie He He Hu Xi Za Zhi, V33, P775; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Lu ZM, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/405395; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Moser B, 2006, TRENDS IMMUNOL, V27, P112, DOI 10.1016/j.it.2006.01.002; Narazaki H, 2003, IMMUNOL LETT, V86, P113, DOI 10.1016/S0165-2478(02)00292-4; Rajadhyaksha Anjali G, 2013, J Assoc Physicians India, V61, P262; Riccieri V, 2000, LUPUS, V9, P333, DOI 10.1191/096120300678828460; Robak E, 2001, MEDIAT INFLAMM, V10, P179, DOI 10.1080/09629350120080300; Sekigawa I, 2004, LUPUS, V13, P217, DOI 10.1191/0961203304lu1012ed; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Su DL, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/985753; TAN EM, 1989, ADV IMMUNOL, V44, P93, DOI 10.1016/S0065-2776(08)60641-0; Viallard JF, 1999, CLIN EXP IMMUNOL, V115, P189; VOLCPLATZER B, 1993, J INVEST DERMATOL, V100, pS84, DOI 10.1111/1523-1747.ep12356084; Wakita D, 2010, EUR J IMMUNOL, V40, P1927, DOI 10.1002/eji.200940157; Wang T, 2003, J IMMUNOL, V171, P2524, DOI 10.4049/jimmunol.171.5.2524; Willis R, 2012, LUPUS, V21, P830, DOI 10.1177/0961203312437270; Wozniacka A, 2006, LUPUS, V15, P268, DOI 10.1191/0961203306lu2299oa; Wu Y, 2009, J IMMUNOL, V183, P5622, DOI 10.4049/jimmunol.0901772	33	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157772	10.1371/journal.pone.0157772	http://dx.doi.org/10.1371/journal.pone.0157772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333282	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212800049
J	Tang, Z; Wang, JW; Zhang, H; Sun, L; Tang, FR; Deng, QL; Yu, JM				Tang, Zheng; Wang, Jiwei; Zhang, Hao; Sun, Li; Tang, Furong; Deng, Qinglong; Yu, Jinming			Associations between Diabetes and Quality of Life among Breast Cancer Survivors	PLOS ONE			English	Article							CONSENSUS REPORT; ELDERLY-WOMEN; MELLITUS; OUTCOMES; INSULIN; RISK; CHEMOTHERAPY; METAANALYSIS; PROGNOSIS; MORTALITY	Objective We aimed to investigate the associations between diabetes and quality of life (QOL) among breast cancer survivors. Methods A cross-sectional survey was conducted at 34 Cancer Recovery Clubs across China from May 2014 to January 2015. Quality of life was measured by the Quality of Life Question-naire-Core 30 (EORTC QLQ-C30) and the Quality of Life Questionnaire-Breast Cancer Module 23 (QLQ-BR23, simplified Chinese version). Information on social-demography, diagnosis and treatment of tumors, and diabetes mellitus were collected by self-reported questionnaires. Univariate analyses of covariance (ANCOVA) was performed to assess the difference in QOL between patients with or without diabetes mellitus, and multiple linear regression models were used to examine the associations after controlling for confounders. Results Diabetes, both of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) significantly reduced QOL. This effect of diabetes on QOL is independent of tumor size, regional lymph node metastasis, distant metastasis and tumor stage index (TNM). After adjusting for different social-demography, diagnosis and treatment of the tumor, the tumor's stage and other chronic comorbidities, breast cancer survivors with diabetes got significantly lower scores in functional dimensions (including physical, role, emotional and social functionings measured by EORTC QLQ-C30; body image (BRBI) and future perspective (BRFU) measured by QLQ-BR23, as well as economic difficulties than those without diabetes (P-adjusted<0.05). Diabetic patients also obtained higher scores in symptom dimensions, including fatigue, nausea and vomiting, pain, dyspnoea, insomnia, constipation and diarrhoea measured by EORTC QLQ-C30; side effects, breast symptoms and upset by hair loss measured by QLQ-BR23 (P-adjusted<0.05). Compared to patients with T1DM, those with T2D Mare likely to suffer more by loss of functioning. Conclusions Diabetes was associated with the decreased QOL for breast cancer survivors.	[Tang, Zheng; Wang, Jiwei; Sun, Li; Tang, Furong; Deng, Qinglong; Yu, Jinming] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Inst Clin Epidemiol,Minist Educ, 130 Dong An Rd, Shanghai 200032, Peoples R China; [Tang, Zheng; Yu, Jinming] Fudan Univ, Collaborat Innovat Ctr Social Risks Governance Hl, Shanghai 200032, Peoples R China; [Zhang, Hao] Fudan Univ, Shanghai Med Coll, Zhongshan Hosp, Div Nephrol, 180 Feng Lin Rd, Shanghai 200032, Peoples R China; [Zhang, Hao] Shanghai Key Lab Kidney & Blood Purificat, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Yu, JM (corresponding author), Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Inst Clin Epidemiol,Minist Educ, 130 Dong An Rd, Shanghai 200032, Peoples R China.; Yu, JM (corresponding author), Fudan Univ, Collaborat Innovat Ctr Social Risks Governance Hl, Shanghai 200032, Peoples R China.	jmy@fudan.edu.cn			National Social Science Foundation of China [13CSH076]; Shanghai Municipal Commission of Health and Family Planning [20134068]	National Social Science Foundation of China; Shanghai Municipal Commission of Health and Family Planning	This study was supported by grants from the National Social Science Foundation of China (Award Number 13CSH076). Shanghai Municipal Commission of Health and Family Planning (Award Number 20134068).	Bao PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117419; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Chen WW, 2012, ONCOLOGIST, V17, P485, DOI 10.1634/theoncologist.2011-0412; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Romero-Figueroa MD, 2013, CLIN BREAST CANCER, V13, P482, DOI 10.1016/j.clbc.2013.08.001; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Epplein M, 2011, J CLIN ONCOL, V29, P406, DOI 10.1200/JCO.2010.30.6951; Erickson K, 2011, J CLIN ONCOL, V29, P54, DOI 10.1200/JCO.2010.29.3183; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Hardefeldt Prue J, 2012, Endocr Relat Cancer, V19, P793, DOI 10.1530/ERC-12-0242; Hernandez AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099317; Hsieh MC, 2012, EXP DIABETES RES, DOI 10.1155/2012/413782; Jia XQ, 2015, DIABETES TECHNOL THE, V17, P248, DOI 10.1089/dia.2014.0226; Jiralerspong S, 2013, ANN ONCOL, V24, P2506, DOI 10.1093/annonc/mdt224; Joshi S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/390863; Joung KH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/920618; Krajcik RA, 2002, CANCER EPIDEM BIOMAR, V11, P1566; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Lawlor DA, 2004, CANCER CAUSE CONTROL, V15, P267, DOI 10.1023/B:CACO.0000024225.14618.a8; Li LY, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0242-4; Lipscombe LL, 2015, BREAST CANCER RES TR, V150, P613, DOI 10.1007/s10549-015-3323-5; Luo J, 2015, BRIT J CANCER, V113, P827, DOI 10.1038/bjc.2015.249; Mohammadzadeh G, 2013, INT J ENDOCRINOL MET, V11, P3, DOI 10.5812/ijem.6535; Organization W. H, 2009, 2008 2013 ACT PLAN G; Peairs KS, 2011, J CLIN ONCOL, V29, P40, DOI 10.1200/JCO.2009.27.3011; Richardson LC, 2005, NAT CLIN PRACT ONCOL, V2, P48, DOI 10.1038/ncponc0062; Schrauder MG, 2011, J CANCER RES CLIN, V137, P975, DOI 10.1007/s00432-010-0960-2; Srokowski TP, 2009, J CLIN ONCOL, V27, P2170, DOI 10.1200/JCO.2008.17.5935; Tseng CH, 2009, DIABETOLOGIA, V52, P240, DOI 10.1007/s00125-008-1204-8; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Wolf I, 2005, LANCET ONCOL, V6, P103, DOI 10.1016/S1470-2045(05)01736-5; Xu H, 2015, ONCOLOGIST, V20, P1236, DOI 10.1634/theoncologist.2015-0096; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	34	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157791	10.1371/journal.pone.0157791	http://dx.doi.org/10.1371/journal.pone.0157791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333326	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212800051
J	Yoon, S; Kim, ED; Song, MS; Han, SJ; Park, TK; Choi, KS; Choi, YK; Seo, KY				Yoon, Sangchul; Kim, Eun-Do; Song, Min-Suk; Han, Soo Jung; Park, Tae Kwann; Choi, Kyoung Sub; Choi, Young-Ki; Seo, Kyoung Yul			Eyedrop Vaccination Induced Systemic and Mucosal Immunity against Influenza Virus in Ferrets	PLOS ONE			English	Article							MELITENSIS REV-1 VACCINE; CENTRAL-NERVOUS-SYSTEM; PROTECTIVE IMMUNITY; ANIMAL-MODELS; H5N1 VIRUS; TRANSMISSION; INFECTION; RESPONSES; EFFICACY; DISEASE	We investigated eyedrop vaccination (EDV) in pre-clinical development for immunological protection against influenza and for potential side effects involving ocular inflammation and the central nervous system (CNS). Live attenuated influenza EDV, CA07 (H1N1), PZ-4 (H1N2) and Uruguay (H3N2), induced both systemic and mucosal virus-specific antibody responses in ferrets. In addition, EDV resulted in a clinically significant protection against viral challenge, and suppression of viral replication in nasal secretion and lung tissue. Regarding safety, we found that administered EDV flow through the tear duct to reach the base of nasal cavity, and thus do not contact the olfactory bulb. All analyses for potential adverse effects due to EDV, including histological and functional examinations, did not reveal significant side effects. On the basis of these findings, we propose that EDV as effective, while being a safe administration route with minimum local side effects, CNS invasion, or visual function disturbance.	[Yoon, Sangchul; Kim, Eun-Do; Han, Soo Jung; Seo, Kyoung Yul] Yonsei Univ, Coll Med, Inst Vis Res, Dept Ophthalmol,Severance Hosp, Seoul 03722, South Korea; [Kim, Eun-Do] Yonsei Univ, Brain Korea Project Med Sci 21, Seoul 03722, South Korea; [Park, Tae Kwann] Soonchunhyang Univ, Bucheon Hosp, Coll Med, Dept Ophthalmol, Gyeonggi Do 14584, South Korea; [Song, Min-Suk; Choi, Young-Ki] Chungbuk Natl Univ, Coll Med, Cheongju 28644, South Korea; [Song, Min-Suk; Choi, Young-Ki] Chungbuk Natl Univ, Med Res Inst, Cheongju 28644, South Korea; [Choi, Kyoung Sub] Natl Hlth Insurance Corp Ilsan Hosp, Dept Ophthalmol, Gyounggi Do 10444, South Korea; [Yoon, Sangchul] Natl Med Ctr, Dept Ophthalmol, Seoul 04564, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Soonchunhyang University; Chungbuk National University; Chungbuk National University; National Medical Center - Korea	Seo, KY (corresponding author), Yonsei Univ, Coll Med, Inst Vis Res, Dept Ophthalmol,Severance Hosp, Seoul 03722, South Korea.	seoky@yuhs.ac	Seo, Kyoung Yul/I-5484-2019	Seo, Kyoung Yul/0000-0002-9855-1980	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [NRF-2013M3A9D5072551]; TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea) [A103001]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning; TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea)	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013M3A9D5072551) and TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea; grant no.: A103001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013M3A9D5072551).	Belser JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002569; Belshe Robert, 2004, Expert Rev Vaccines, V3, P643, DOI 10.1586/14760584.3.6.643; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Cai QY, 2007, INVEST RADIOL, V42, P797, DOI 10.1097/RLI.0b013e31811ecdcd; Chentoufi AA, 2010, CLIN VACCINE IMMUNOL, V17, P342, DOI 10.1128/CVI.00347-09; Dal Monte O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103677; Djupesland PG, 2014, THER DELIV, V5, P709, DOI [10.4155/tde.14.41, 10.4155/TDE.14.41]; FENSTERBANK R, 1985, ANN RECH VET, V16, P351; Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; JACKSON CA, 1985, LAB ANIM SCI, V35, P211; JAYAWARDANE GWL, 1995, VET MICROBIOL, V46, P69, DOI 10.1016/0378-1135(95)00073-J; Kim ED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137608; Kim EH, 2015, SCI REP-UK, V5, DOI 10.1038/srep15940; Kim JK, 2008, J VIROL, V82, P11374, DOI 10.1128/JVI.01176-08; Kumlin U, 2008, INFLUENZA OTHER RESP, V2, P147, DOI 10.1111/j.1750-2659.2008.00051.x; Lee JH, 2009, J VIROL, V83, P4205, DOI [10.1128/JVI.02403-08, 10.1128/JVI.02403-09]; Nagatake T, 2009, J EXP MED, V206, P2351, DOI 10.1084/jem.20091436; Okada K, 2011, ADV OTO-RHINO-LARYNG, V72, P31, DOI 10.1159/000324591; Pascua PNQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008431; Paulsen F, 1998, ANAT EMBRYOL, V198, P1, DOI 10.1007/s004290050160; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHULMAN JL, 1968, AM J PUBLIC HEALTH N, V58, P2092, DOI 10.2105/AJPH.58.11.2092; Seo KY, 2010, J IMMUNOL, V185, P3610, DOI 10.4049/jimmunol.1000680; Silin DS, 2007, EXPERT OPIN DRUG DEL, V4, P323, DOI 10.1517/17425247.4.4.323; Song MS, 2010, J CLIN MICROBIOL, V48, P3204, DOI 10.1128/JCM.00053-10; Steven P, 2009, OPHTHAL RES, V42, P2, DOI 10.1159/000219678; Tsubota K, 1998, PROG RETIN EYE RES, V17, P565, DOI 10.1016/S1350-9462(98)00004-4; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; Webster R., 2002, WORLD HLTH ORG MANUA; Yamada M, 2012, ACTA NEUROPATHOL, V124, P505, DOI 10.1007/s00401-012-1010-8; Yuki Y, 2003, REV MED VIROL, V13, P293, DOI 10.1002/rmv.398; Zhu H, 2005, CURR EYE RES, V30, P841, DOI 10.1080/02713680591004077; ZUNDEL E, 1992, ANN RECH VET, V23, P177	34	1	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157634	10.1371/journal.pone.0157634	http://dx.doi.org/10.1371/journal.pone.0157634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333331	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212800040
J	Waghmare, I; Kango-Singh, M				Waghmare, Indrayani; Kango-Singh, Madhuri			Loss of Cell Adhesion Increases Tumorigenic Potential of Polarity Deficient Scribble Mutant Cells	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; TUMOR SUPPRESSORS; ONCOGENIC RAS; BETA-CATENIN; ADHERENS JUNCTIONS; POSITIVE REGULATOR; EPITHELIAL-CELLS; HIPPO PATHWAY; CANCER; APOPTOSIS	Epithelial polarity genes are important for maintaining tissue architecture, and regulating growth. The Drosophila neoplastic tumor suppressor gene scribble (scrib) belongs to the basolateral polarity complex. Loss of scrib results in disruption of its growth regulatory functions, and downregulation or mislocalization of Scrib is correlated to tumor growth. Somatic scribble mutant cells (scrib-) surrounded by wild-type cells undergo apoptosis, which can be prevented by introduction of secondary mutations that provide a growth advantage. Using genetic tools in Drosophila, we analyzed the phenotypic effects of loss of scrib in different growth promoting backgrounds. We investigated if a central mechanism that regulates cell adhesion governs the growth and invasive potential of scrib mutant cells. Here we show that increased proliferation, and survival abilities of scribcells in different genetic backgrounds affect their differentiation, and intercellular adhesion. Further, loss of scrib is sufficient to cause reduced cell survival, activation of the JNK pathway and a mild reduction of cell adhesion. Our data show that for scrib cells to induce aggressive tumor growth characterized by loss of differentiation, cell adhesion, increased proliferation and invasion, cooperative interactions that derail signaling pathways play an essential role in the mechanisms leading to tumorigenesis. Thus, our study provides new insights on the effects of loss of scrib and the modification of these effects via cooperative interactions that enhance the overall tumorigenic potential of scrib deficient cells.	[Waghmare, Indrayani; Kango-Singh, Madhuri] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Kango-Singh, Madhuri] Univ Dayton, Ctr Tissue Regenerat & Engn Dayton TREND, Dayton, OH 45469 USA; [Kango-Singh, Madhuri] Univ Dayton, Premed Programs, Dayton, OH 45469 USA; [Kango-Singh, Madhuri] Univ Dayton, SupraMol Appl Res & Technol Ctr SMART, Dayton, OH 45469 USA	University of Dayton; University of Dayton; University of Dayton; University of Dayton	Kango-Singh, M (corresponding author), Univ Dayton, Dept Biol, Dayton, OH 45469 USA.; Kango-Singh, M (corresponding author), Univ Dayton, Ctr Tissue Regenerat & Engn Dayton TREND, Dayton, OH 45469 USA.; Kango-Singh, M (corresponding author), Univ Dayton, Premed Programs, Dayton, OH 45469 USA.; Kango-Singh, M (corresponding author), Univ Dayton, SupraMol Appl Res & Technol Ctr SMART, Dayton, OH 45469 USA.	mkangosingh1@udayton.edu		Kango-Singh, Madhuri/0000-0003-2447-6997	Start Up research support	Start Up research support	This work was funded by Start Up research support to MK-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Baker NE, 2001, SEMIN CELL DEV BIOL, V12, P499, DOI 10.1006/scdb.2001.0274; Beaucher M, 2007, DEV BIOL, V303, P625, DOI 10.1016/j.ydbio.2006.12.001; Bergstralh DT, 2015, NAT CELL BIOL, V17, P1497, DOI 10.1038/ncb3248; Bergstralh DT, 2012, ESSAYS BIOCHEM, V53, P129, DOI [10.1042/BSE0530129, 10.1042/bse0530129]; Betz A, 2008, P NATL ACAD SCI USA, V105, P13805, DOI 10.1073/pnas.0806291105; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Chen CL, 2012, P NATL ACAD SCI USA, V109, P484, DOI 10.1073/pnas.1113882109; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Cordero JB, 2010, DEV CELL, V18, P999, DOI 10.1016/j.devcel.2010.05.014; Doggett K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-57; Ellenbroek SIJ, 2012, SEMIN CANCER BIOL, V22, P208, DOI 10.1016/j.semcancer.2012.02.012; Enomoto M, 2015, DEV BIOL, V403, P162, DOI 10.1016/j.ydbio.2015.05.001; Enomoto M, 2011, J GENET GENOMICS, V38, P461, DOI 10.1016/j.jgg.2011.09.005; Flores-Benitez D, 2016, CURR OPIN CELL BIOL, V42, P13, DOI 10.1016/j.ceb.2016.03.018; Gibson MC, 2003, CURR OPIN CELL BIOL, V15, P747, DOI 10.1016/j.ceb.2003.10.008; Glasheen BM, 2010, DEV BIOL, V344, P772, DOI 10.1016/j.ydbio.2010.05.504; Goehring NW, 2013, TRENDS CELL BIOL, V23, P72, DOI 10.1016/j.tcb.2012.10.009; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; HAY BA, 1994, DEVELOPMENT, V120, P2121; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Igaki T, 2002, J BIOL CHEM, V277, P23103, DOI 10.1074/jbc.C200222200; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Igaki T, 2009, APOPTOSIS, V14, P1021, DOI 10.1007/s10495-009-0361-7; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Jemc JC, 2012, DEV BIOL, V367, P114, DOI 10.1016/j.ydbio.2012.04.027; Jogi A, 2012, UPSALA J MED SCI, V117, P217, DOI 10.3109/03009734.2012.659294; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kango-Singh M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-216; Karim FD, 1998, DEVELOPMENT, V125, P1; Kessler T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-15; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; McEwen DG, 2000, CURR BIOL, V10, pR562, DOI 10.1016/S0960-9822(00)00611-4; McEwen DG, 2000, DEVELOPMENT, V127, P3607; McLachlan RW, 2007, J MOL MED-JMM, V85, P545, DOI 10.1007/s00109-007-0198-x; MECHLER BM, 1985, EMBO J, V4, P1551, DOI 10.1002/j.1460-2075.1985.tb03816.x; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Nakajima Y, 2013, NATURE, V500, P359, DOI 10.1038/nature12335; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Parisi F, 2011, CELL ADHES MIGR, V5, P366, DOI 10.4161/cam.5.4.17524; Parsons LM, 2010, FLY, V4, P288, DOI 10.4161/fly.4.4.13116; PEIFER M, 1993, J CELL SCI, V105, P993; PEIFER M, 1993, SCIENCE, V262, P1667, DOI 10.1126/science.8259511; Perl AK, 1999, NAT MED, V5, P286, DOI 10.1038/6502; Pottier C, 2015, EXPERT REV ANTICANC, V15, P943, DOI 10.1586/14737140.2015.1059279; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Ragkousi K, 2014, J CELL BIOL, V207, P181, DOI 10.1083/jcb.201408044; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Rodriguez A, 2002, EMBO J, V21, P2189, DOI 10.1093/emboj/21.9.2189; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; SHIBATA K, 1990, EUR J BIOCHEM, V192, P87, DOI 10.1111/j.1432-1033.1990.tb19199.x; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Su TT, 1998, GENE DEV, V12, P1495, DOI 10.1101/gad.12.10.1495; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Szafranski P, 2004, DEVELOPMENT, V131, P2023, DOI 10.1242/dev.01097; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Tamori Y, 2011, J GENET GENOMICS, V38, P483, DOI 10.1016/j.jgg.2011.09.006; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Verghese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047173; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; West JJ, 2016, TRAFFIC, V17, P1233, DOI 10.1111/tra.12407; Wirtz-Peitz F, 2009, CURR OPIN GENET DEV, V19, P350, DOI 10.1016/j.gde.2009.04.011; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; WOLFF T, 1991, DEVELOPMENT, V113, P841; Wyllie A H, 1980, Int Rev Cytol, V68, P251; XU TA, 1995, DEVELOPMENT, V121, P1053; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	91	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0158081	10.1371/journal.pone.0158081	http://dx.doi.org/10.1371/journal.pone.0158081			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327956	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212400070
J	Croijmans, I; Majid, A				Croijmans, Ilja; Majid, Asifa			Not All Flavor Expertise Is Equal: The Language of Wine and Coffee Experts	PLOS ONE			English	Article							ODOR IDENTIFICATION; OLFACTORY PERFORMANCE; TASTE; PERCEPTION; DISCRIMINATION; MEMORY; RECOGNITION; CONSUMERS; JAPANESE; NOVICE	People in Western cultures are poor at naming smells and flavors. However, for wine and coffee experts, describing smells and flavors is part of their daily routine. So are experts better than lay people at conveying smells and flavors in language? If smells and flavors are more easily linguistically expressed by experts, or more "codable", then experts should be better than novices at describing smells and flavors. If experts are indeed better, we can also ask how general this advantage is: do experts show higher codability only for smells and flavors they are expert in (i.e., wine experts for wine and coffee experts for coffee) or is their linguistic dexterity more general? To address these questions, wine experts, coffee experts, and novices were asked to describe the smell and flavor of wines, coffees, everyday odors, and basic tastes. The resulting descriptions were compared on a number of measures. We found expertise endows a modest advantage in smell and flavor naming. Wine experts showed more consistency in how they described wine smells and flavors than coffee experts, and novices; but coffee experts were not more consistent for coffee descriptions. Neither expert group was any more accurate at identifying everyday smells or tastes. Interestingly, both wine and coffee experts tended to use more source-based terms (e.g., vanilla) in descriptions of their own area of expertise whereas novices tended to use more evaluative terms (e.g., nice). However, the overall linguistic strategies for both groups were en par. To conclude, experts only have a limited, domain-specific advantage when communicating about smells and flavors. The ability to communicate about smells and flavors is a matter not only of perceptual training, but specific linguistic training too.	[Croijmans, Ilja; Majid, Asifa] Radboud Univ Nijmegen, Ctr Language Studies, NL-6525 ED Nijmegen, Netherlands; [Croijmans, Ilja] Int Max Planck Res Sch Language Sci, Nijmegen, Netherlands; [Majid, Asifa] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Majid, Asifa] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society; Radboud University Nijmegen; Max Planck Society	Croijmans, I (corresponding author), Radboud Univ Nijmegen, Ctr Language Studies, NL-6525 ED Nijmegen, Netherlands.; Croijmans, I (corresponding author), Int Max Planck Res Sch Language Sci, Nijmegen, Netherlands.	i.croijmans@let.ru.nl	Majid, Asifa/A-7906-2008	Majid, Asifa/0000-0003-0132-216X; Croijmans, Ilja/0000-0001-9812-0040	Netherlands Organisation for Scientific Research [277-70-011]; Netherlands Organization for Scientific Research: NWO VICI grant "Human olfaction at the intersection of language, culture and biology"	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research: NWO VICI grant "Human olfaction at the intersection of language, culture and biology"(Netherlands Organization for Scientific Research (NWO))	Funding was provided by Netherlands Organisation for Scientific Research, grant number 277-70-011, http://www.nwo.nl/en/research-and-results/research-projects/i/81/8281.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by The Netherlands Organization for Scientific Research: NWO VICI grant "Human olfaction at the intersection of language, culture and biology". Special thanks go to Michiel Buijs, Rose van Asten, Liesbeth Sleijster, Josje de Valk and Nina Krijnen for help with the study.	[Anonymous], 2013, FELLS STATS; Bende M, 1997, PHYSIOL BEHAV, V62, P1065, DOI 10.1016/S0031-9384(97)00251-5; BROWN RW, 1954, J ABNORM SOC PSYCH, V49, P454, DOI 10.1037/h0057814; Burenhult N, 2011, SENSES SOC, V6, P19, DOI 10.2752/174589311X12893982233597; Caballero R, 2007, J PRAGMATICS, V39, P2095, DOI 10.1016/j.pragma.2007.07.005; Caballero R, 2010, HUM COGN PROCESS, V26, P265; Cain WS, 1998, CHEM SENSES, V23, P309, DOI 10.1093/chemse/23.3.309; CAIN WS, 1979, SCIENCE, V203, P467, DOI 10.1126/science.760202; Chollet S, 2001, J SENS STUD, V16, P601, DOI 10.1111/j.1745-459X.2001.tb00323.x; Chollet S, 2000, ANN PSYCHOL, V100, P11; Classen Constance, 1999, INT REV EDUC, V45, P269, DOI DOI 10.1023/A:1003894610869; Davidoff J, 1999, NATURE, V398, P203, DOI 10.1038/18335; ENGEN T, 1987, AM SCI, V75, P497; Gawel R, 1997, J SENS STUD, V12, P267, DOI 10.1111/j.1745-459X.1997.tb00067.x; Gilad Y, 2003, MOL BIOL EVOL, V20, P307, DOI 10.1093/molbev/msg013; Gluck M., 2003, NEW MEDIA LANGUAGE, P107; Grosch W., 2008, COFFEE RECENT DEV, P68; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Herdenstam Anders P. F., 2009, Journal of Wine Research, V20, P53, DOI 10.1080/09571260902978543; Horverak O, 2009, MARKET SCI, V28, P573, DOI 10.1287/mksc.1090.0489; Hughson AL, 2001, AUST J PSYCHOL, V53, P103, DOI 10.1080/00049530108255130; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Husson F, FACTOMINER EXPLORATO; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kellman PJ, 2013, PSYCHOL LEARN MOTIV, V58, P117, DOI 10.1016/B978-0-12-407237-4.00004-9; LAWLESS H, 1977, J EXP PSYCHOL-HUM L, V3, P52, DOI 10.1037/0278-7393.3.1.52; LAWLESS HT, 1984, J FOOD SCI, V49, P120, DOI 10.1111/j.1365-2621.1984.tb13686.x; LEHRER A, 1975, LANGUAGE, V51, P901, DOI 10.2307/412700; Lehrer A., 1983, WINE CONVERSATION; Lev-Ari S, 2016, COGNITIVE SCI, V40, P2050, DOI 10.1111/cogs.12317; Levinson SC, 2014, MIND LANG, V29, P407, DOI 10.1111/mila.12057; Majid A, 2015, TRENDS COGN SCI, V19, P629, DOI 10.1016/j.tics.2015.06.009; Majid A, 2014, COGNITION, V130, P266, DOI 10.1016/j.cognition.2013.11.004; Mayers CS, 1904, BRIT J PSYCHOL, V1, P117; MCAULIFFE WK, 1974, PERCEPT PSYCHOPHYS, V16, P242, DOI 10.3758/BF03203936; Melcher JM, 1996, J MEM LANG, V35, P231, DOI 10.1006/jmla.1996.0013; Menashe I, 2003, NAT GENET, V34, P143, DOI 10.1038/ng1160; Mitterer H, 2009, J EXP PSYCHOL LEARN, V35, P1557, DOI 10.1037/a0017019; Morton AL, 1975, RETHINKING SYMBOLISM, P172; Olofsson JK, 2015, TRENDS COGN SCI, V19, P314, DOI 10.1016/j.tics.2015.04.007; OMAHONY M, 1979, CHEM SENS FLAV, V4, P301, DOI 10.1093/chemse/4.4.301; OMAHONY M, 1986, BRIT J PSYCHOL, V77, P161, DOI 10.1111/j.2044-8295.1986.tb01991.x; Pages J, 2005, FOOD QUAL PREFER, V16, P642, DOI 10.1016/j.foodqual.2005.01.006; Paradis C, 2013, METAPHOR SYMBOL, V28, P22, DOI 10.1080/10926488.2013.742838; Parr WV, 2004, FOOD QUAL PREFER, V15, P411, DOI 10.1016/j.foodqual.2003.07.002; Parr WV, 2002, CHEM SENSES, V27, P747, DOI 10.1093/chemse/27.8.747; Prescott J, 1998, FOOD QUAL PREFER, V9, P393, DOI 10.1016/S0950-3293(98)00021-4; Quandt RE, 2007, J WINE ECON, V2, P129, DOI 10.1017/S1931436100000389; Regier T, 2009, TRENDS COGN SCI, V13, P439, DOI 10.1016/j.tics.2009.07.001; ROBINSON JO, 1970, BRIT J PSYCHOL, V61, P375, DOI 10.1111/j.2044-8295.1970.tb01254.x; Roque LS, 2015, COGN LINGUIST, V26, P31, DOI 10.1515/cog-2014-0089; Royet J.-P., 2013, FRONT PSYCHOL, V4, DOI [10.3389/fpsyg.2013.00928, DOI 10.3389/FPSYG.2013.00928]; Sezille C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00012; SHIBAMOTO T, 1991, 14 INT C COFF SCI, P107; Silverstein M, 2004, CURR ANTHROPOL, V45, P621, DOI 10.1086/423971; Silverstein M, 2006, ANNU REV ANTHROPOL, V35, P481, DOI 10.1146/annurev.anthro.35.081705.123327; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Small DM, 2005, EXP BRAIN RES, V166, P345, DOI 10.1007/s00221-005-2376-9; Smeets MAM, 2008, CHEM SENSES, V33, P725, DOI 10.1093/chemse/bjn038; Smith B. C., 2007, QUESTIONS TASTE PHIL, P41; SOLOMON GEA, 1990, AM J PSYCHOL, V103, P495, DOI 10.2307/1423321; Solomon GEA, 1997, J LEARN SCI, V6, P41, DOI 10.1207/s15327809jls0601_3; Sorokowska A, 2015, SCI TOTAL ENVIRON, V506, P196, DOI 10.1016/j.scitotenv.2014.11.027; Sorokowska A, 2014, CHEMOSENS PERCEPT, V7, P85, DOI 10.1007/s12078-014-9169-0; Sorokowska A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069203; Spence C, 2015, CELL, V161, P24, DOI 10.1016/j.cell.2015.03.007; Suarez Toste E., 2007, METAPHORIK DE, V12, P53; Tempere S, 2016, AUST J GRAPE WINE R, V22, P190, DOI 10.1111/ajgw.12192; Winawer J, 2007, P NATL ACAD SCI USA, V104, P7780, DOI 10.1073/pnas.0701644104; Wipf B., 2010, THESIS; Yeshurun Y, 2010, ANNU REV PSYCHOL, V61, P219, DOI 10.1146/annurev.psych.60.110707.163639; Zucco GM, 2011, PERCEPTION, V40, P598, DOI 10.1068/p6972	73	59	61	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0155845	10.1371/journal.pone.0155845	http://dx.doi.org/10.1371/journal.pone.0155845			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DP0WR	27322035	Green Published, gold, Green Accepted			2022-12-26	WOS:000378212000004
J	Mazor, Y; Yang, CN; Borrok, MJ; Ayriss, J; Aherne, K; Wu, H; Dall'Acqua, WF				Mazor, Yariv; Yang, Chunning; Borrok, M. Jack; Ayriss, Joanne; Aherne, Karen; Wu, Herren; Dall'Acqua, William F.			Enhancement of Immune Effector Functions by Modulating IgG's Intrinsic Affinity for Target Antigen	PLOS ONE			English	Article							FC-GAMMA RECEPTORS; CELL-MEDIATED CYTOTOXICITY; REGULATORY T-CELLS; MONOCLONAL-ANTIBODIES; IN-VIVO; THERAPEUTIC ANTIBODIES; EXPRESSION LEVELS; BREAST-CANCER; EFFICACY; POLYMORPHISMS	Antibody-mediated immune effector functions play an essential role in the anti-tumor efficacy of many therapeutic mAbs. While much of the effort to improve effector potency has focused on augmenting the interaction between the antibody-Fc and activating Fc-receptors expressed on immune cells, the role of antibody binding interactions with the target antigen remains poorly understood. We show that antibody intrinsic affinity to the target antigen clearly influences the extent and efficiency of Fc-mediated effector mechanisms, and report the pivotal role of antibody binding valence on the ability to regulate effector functions. More particularly, we used an array of affinity modulated variants of three different mAbs, anti-CD4, anti-EGFR and anti-HER2 against a panel of target cell lines expressing disparate levels of the target antigen. We found that at saturating antibody concentrations, IgG variants with moderate intrinsic affinities, similar to those generated by the natural humoral immune response, promoted superior effector functions compared to higher affinity antibodies. We hypothesize that at saturating concentrations, effector function correlates most directly with the amount of Fc bound to the cell surface. Thus, high affinity antibodies exhibiting slow offrates are more likely to interact bivalently with the target cell, occupying two antigen sites with a single Fc. In contrast, antibodies with faster off-rates are likely to dissociate each binding arm more rapidly, resulting in a higher likelihood of monovalent binding. Monovalent binding may in turn increase target cell opsonization and lead to improved recruitment of effector cells. This unpredicted relationship between target affinity and effector function potency suggests a careful examination of antibody design and engineering for the development of next-generation immunotherapeutics.	[Mazor, Yariv; Yang, Chunning; Borrok, M. Jack; Ayriss, Joanne; Wu, Herren; Dall'Acqua, William F.] MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD USA; [Aherne, Karen] MedImmune, Dept Biopharmaceut Dev, Gaithersburg, MD USA; [Ayriss, Joanne] Pfizer, Dept Global Biotherapeut, Cambridge, MA USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune; Pfizer	Mazor, Y; Dall'Acqua, WF (corresponding author), MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD USA.	mazory@medimmune.com; dallacquaw@medimmune.com			MedImmune	MedImmune(AstraZenecaMedimmune)	This study received funding from MedImmune. MedImmune provided support in the form of salaries for authors [YM, CY, MJB, JA, KA, HW, WFDA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Battella S, 2016, J LEUKOCYTE BIOL, V99, P87, DOI 10.1189/jlb.5VMR0415-141R; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Boero S, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0680-0; Borrok MJ, 2015, MABS-AUSTIN, V7, P743, DOI 10.1080/19420862.2015.1047570; Brandsma AM, 2015, IMMUNOL REV, V268, P74, DOI 10.1111/imr.12332; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Bulliard Y, 2014, IMMUNOL CELL BIOL, V92, P475, DOI 10.1038/icb.2014.26; Bulliard Y, 2013, J EXP MED, V210, P1685, DOI 10.1084/jem.20130573; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Chester C, 2015, CURR OPIN IMMUNOL, V33, P1, DOI 10.1016/j.coi.2014.12.010; de Bono JS, 2004, ANN ONCOL, V15, P1825, DOI 10.1093/annonc/mdh472; Desjarlais JR, 2011, EXP CELL RES, V317, P1278, DOI 10.1016/j.yexcr.2011.03.018; DiLillo DJ, 2015, CELL, V161, P1035, DOI 10.1016/j.cell.2015.04.016; Dimasi N, 2009, J MOL BIOL, V393, P672, DOI 10.1016/j.jmb.2009.08.032; Dunbar J, 2014, NUCLEIC ACIDS RES, V42, pD1140, DOI 10.1093/nar/gkt1043; Gerdes CA, 2013, CLIN CANCER RES, V19, P1126, DOI 10.1158/1078-0432.CCR-12-0989; Hilchey SP, 2009, BLOOD, V113, P3809, DOI 10.1182/blood-2008-10-185280; Iannello A, 2005, CANCER METAST REV, V24, P487, DOI 10.1007/s10555-005-6192-2; Jung ST, 2013, ACS CHEM BIOL, V8, P368, DOI 10.1021/cb300455f; Kellner C, 2014, METHODS, V65, P105, DOI 10.1016/j.ymeth.2013.06.036; Mazor Y, 2015, MABS-AUSTIN, V7, P461, DOI 10.1080/19420862.2015.1022695; Mazor Y, 2015, MABS-AUSTIN, V7, P377, DOI 10.1080/19420862.2015.1007816; Moore GL, 2010, MABS-AUSTIN, V2, P181, DOI 10.4161/mabs.2.2.11158; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Park S, 2010, CANCER CELL, V18, P160, DOI 10.1016/j.ccr.2010.06.014; Satoh M, 2006, EXPERT OPIN BIOL TH, V6, P1161, DOI 10.1517/14712598.6.11.1161; Schier R, 1996, J MOL BIOL, V263, P551, DOI 10.1006/jmbi.1996.0598; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shuptrine CW, 2012, SEMIN CANCER BIOL, V22, P3, DOI 10.1016/j.semcancer.2011.12.009; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Smyth MJ, 2014, IMMUNOL CELL BIOL, V92, P473, DOI 10.1038/icb.2014.33; Stavenhagen JB, 2007, CANCER RES, V67, P8882, DOI 10.1158/0008-5472.CAN-07-0696; Tang Y, 2007, J IMMUNOL, V179, P2815, DOI 10.4049/jimmunol.179.5.2815; Taylor C, 2007, CLIN CANCER RES, V13, P5133, DOI 10.1158/1078-0432.CCR-07-0507; Thurber GM, 2011, MOL IMAGING BIOL, V13, P623, DOI 10.1007/s11307-010-0397-7; Thurber GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024696; Tuntland T, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00174; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Wang W, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00368; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Zhang W, 2007, J CLIN ONCOL, V25, P3712, DOI 10.1200/JCO.2006.08.8021	46	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157788	10.1371/journal.pone.0157788	http://dx.doi.org/10.1371/journal.pone.0157788			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322177	gold, Green Submitted, Green Published			2022-12-26	WOS:000378212000045
J	He, Y; Schmidt, MA; Erwin, C; Guo, J; Sun, R; Pendarvis, K; Warner, BW; Herman, EM				He, Yonghua; Schmidt, Monica A.; Erwin, Christopher; Guo, Jun; Sun, Raphael; Pendarvis, Ken; Warner, Brad W.; Herman, Eliot M.			Transgenic Soybean Production of Bioactive Human Epidermal Growth Factor (EGF)	PLOS ONE			English	Article							SMALL-BOWEL RESECTION; NEONATAL NECROTIZING ENTEROCOLITIS; BIRTH-WEIGHT INFANTS; HUMAN-MILK; FACTOR RECEPTOR; PHARMACEUTICAL PROTEINS; INTESTINAL ADAPTATION; PROTEASE INHIBITOR; TYROSINE KINASE; ENHANCED LEVELS	Necrotizing enterocolitis (NEC) is a devastating condition of premature infants that results from the gut microbiome invading immature intestinal tissues. This results in a life-threatening disease that is frequently treated with the surgical removal of diseased and dead tissues. Epidermal growth factor (EGF), typically found in bodily fluids, such as amniotic fluid, salvia and mother's breast milk, is an intestinotrophic growth factor and may reduce the onset of NEC in premature infants. We have produced human EGF in soybean seeds to levels biologically relevant and demonstrated its comparable activity to commercially available EGF. Transgenic soybean seeds expressing a seed-specific codon optimized gene encoding of the human EGF protein with an added ER signal tag at the N' terminal were produced. Seven independent lines were grown to homozygous and found to accumulate a range of 6.7 +/- 3.1 to 129.0 +/- 36.7 mu g EGF/g of dry soybean seed. Proteomic and immunoblot analysis indicates that the inserted EGF is the same as the human EGF protein. Phosphorylation and immunohistochemical assays on the EGF receptor in HeLa cells indicate the EGF protein produced in soybean seed is bioactive and comparable to commercially available human EGF. This work demonstrates the feasibility of using soybean seeds as a biofactory to produce therapeutic agents in a soymilk delivery platform.	[He, Yonghua; Schmidt, Monica A.; Herman, Eliot M.] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Erwin, Christopher; Guo, Jun; Sun, Raphael; Warner, Brad W.] St Louis Childrens Hosp, St Louis, MO 63178 USA; [Erwin, Christopher; Guo, Jun; Sun, Raphael; Warner, Brad W.] Washington Univ, Sch Med, St Louis, MO 63178 USA; [Pendarvis, Ken] Univ Arizona, Sch Anim & Comparat Biomed Sci, Tucson, AZ USA	University of Arizona; St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); University of Arizona	Herman, EM (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ USA.	emherman@email.arizona.edu		Herman, Eliot/0000-0001-9398-0316; Guo, Jun/0000-0003-4255-7715	NIH, University Research Strategic Alliance Program [R21 DK094065]; Washington University in St. Louis; Children's Surgical Sciences Research Institute - St. Louis Children's Hospital Foundation	NIH, University Research Strategic Alliance Program; Washington University in St. Louis; Children's Surgical Sciences Research Institute - St. Louis Children's Hospital Foundation	This research was supported by NIH# R21 DK094065 (BWW, PI; EMH and MAS coPIs), University Research Strategic Alliance Program; Washington University in St. Louis, and the Children's Surgical Sciences Research Institute - St. Louis Children's Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderberth I, 2009, ACTA PAEDIATR, V98, P229, DOI [10.1111/j.1651-2227.2008.01060.x, DOI 10.1111/J.1651-2227.2008.01060.X]; Arakawa T, 1998, NAT BIOTECHNOL, V16, P292, DOI 10.1038/4381; Arntzen C, 2015, PLANT BIOTECHNOL J, V13, P1013, DOI 10.1111/pbi.12460; Avraham T, 2005, PLANT BIOTECHNOL J, V3, P71, DOI 10.1111/j.1467-7652.2004.00102.x; Bost K, 2011, SOYBEAN - MOLECULAR ASPECTS OF BREEDING, P3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpenter G, 1980, Birth Defects Orig Artic Ser, V16, P61; CHAET MS, 1994, J PEDIATR SURG, V29, P1035, DOI 10.1016/0022-3468(94)90274-7; Cilieborg MS, 2012, EARLY HUM DEV, V88, pS41, DOI 10.1016/j.earlhumdev.2011.12.027; CLARE JJ, 1991, GENE, V105, P205, DOI 10.1016/0378-1119(91)90152-2; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; COHEN S, 1975, P NATL ACAD SCI USA, V72, P1317, DOI 10.1073/pnas.72.4.1317; Collins J B, 1995, Semin Pediatr Surg, V4, P60; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; CroisyDelcey M, 1997, BIOMED PHARMACOTHER, V51, P286, DOI 10.1016/S0753-3322(97)83545-7; Cunha NB, 2010, GENET MOL RES, V9, P1163, DOI 10.4238/vol9-2gmr849; Cunha NB, 2011, TRANSGENIC RES, V20, P811, DOI 10.1007/s11248-010-9460-z; Ding SH, 2006, BIOTECHNOL LETT, V28, P869, DOI 10.1007/s10529-006-9018-6; Dinkins RD, 2001, IN VITRO CELL DEV-PL, V37, P742; Dvorak B, 2003, PEDIATR RES, V54, P15, DOI 10.1203/01.PDR.0000065729.74325.71; Dvorak B, 2002, AM J PHYSIOL-GASTR L, V282, pG156, DOI 10.1152/ajpgi.00196.2001; Erwin CR, 1999, AM J PHYSIOL-GASTR L, V277, pG533, DOI 10.1152/ajpgi.1999.277.3.G533; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; GEORGENASCIMENTO C, 1988, BIOCHEMISTRY-US, V27, P797, DOI 10.1021/bi00402a046; Guo J, 2009, J BIOL CHEM, V284, P134, DOI 10.1074/jbc.M806133200; Herman E.M., 2015, RECENT ADV GENE EXPR, P193, DOI [10.1007/978-1-4939-2202-4_5, DOI 10.1007/978-1-4939-2202-4_5]; Hofmann GE, 1990, ACTA OBSTET GYN SCAN, V69, P217, DOI 10.3109/00016349009028683; Howard JA, 2005, CROP SCI, V45, P468, DOI 10.2135/cropsci2005.0468; Karunanandaa B, 2005, METAB ENG, V7, P384, DOI 10.1016/j.ymben.2005.05.005; KASSELBERG AG, 1985, J HISTOCHEM CYTOCHEM, V33, P315, DOI 10.1177/33.4.3884705; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kim WS, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00633; Kim WS, 2012, PLANTA, V235, P13, DOI 10.1007/s00425-011-1487-8; Kinney AJ, 2001, PLANT CELL, V13, P1165, DOI 10.1105/tpc.13.5.1165; KLIEGMAN RM, 1981, AM J DIS CHILD, V135, P608, DOI 10.1001/archpedi.1981.02130310014006; Kong QX, 2001, P NATL ACAD SCI USA, V98, P11539, DOI 10.1073/pnas.191617598; KONTUREK SJ, 1992, SCAND J GASTROENTERO, V27, P649, DOI 10.3109/00365529209000134; Leite A, 2000, MOL BREEDING, V6, P47, DOI 10.1023/A:1009648532210; Lin AHY, 2011, PHARMACOL RES, V63, P181, DOI 10.1016/j.phrs.2010.11.007; Livingstone D, 2007, PLANT MOL BIOL, V64, P397, DOI 10.1007/s11103-007-9163-x; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Madkour, 2009, ARAB J BIOTECH, V12, P291; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Martin JA, 2010, NATL VITAL STAT REP, V61, P1; Meinzen-Derr J, 2009, J PERINATOL, V29, P57, DOI 10.1038/jp.2008.117; Messing B, 1999, GASTROENTEROLOGY, V117, P1043, DOI 10.1016/S0016-5085(99)70388-4; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Moravec T, 2007, VACCINE, V25, P1647, DOI 10.1016/j.vaccine.2006.11.010; Nakamura H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020034; Neu J, 1996, PEDIATR CLIN N AM, V43, P409, DOI 10.1016/S0031-3955(05)70413-2; O'Brien DP, 2002, J SURG RES, V105, P25, DOI 10.1006/jsre.2002.6440; Philip R, 2001, PLANT SCI, V161, P323, DOI 10.1016/S0168-9452(01)00420-4; Piller KJ, 2005, PLANTA, V222, P6, DOI 10.1007/s00425-004-1445-9; Pogrebnyak N, 2005, P NATL ACAD SCI USA, V102, P9062, DOI 10.1073/pnas.0503760102; Schmidt MA, 2005, PLANT CELL REP, V24, P383, DOI 10.1007/s00299-005-0950-z; Schmidt MA, 2008, PLANT BIOTECHNOL J, V6, P832, DOI 10.1111/j.1467-7652.2008.00364.x; Schmidt MA, 2015, PLANT BIOTECHNOL J, V13, P590, DOI 10.1111/pbi.12286; Schmidt MA, 2011, PLANT PHYSIOL, V156, P330, DOI 10.1104/pp.111.173807; Schmidt MA, 2008, MOL PLANT, V1, P910, DOI 10.1093/mp/ssn049; Shi JR, 2007, NAT BIOTECHNOL, V25, P930, DOI 10.1038/nbt1322; Shin CE, 1998, J SURG RES, V77, P11, DOI 10.1006/jsre.1998.5336; Sisk PM, 2007, J PERINATOL, V27, P428, DOI 10.1038/sj.jp.7211758; Spencer AU, 2008, AM J CLIN NUTR, V88, P1552, DOI 10.3945/ajcn.2008.26007; Stoger E, 2005, CURR OPIN BIOTECH, V16, P167, DOI 10.1016/j.copbio.2005.01.005; Tacket CO, 2004, VACCINE, V22, P4385, DOI 10.1016/j.vaccine.2004.01.073; Underwood MA, 2013, PEDIATR CLIN N AM, V60, P189, DOI 10.1016/j.pcl.2012.09.008; Venegas-Caleron M, 2010, PROG LIPID RES, V49, P108, DOI 10.1016/j.plipres.2009.10.001; Vitale A, 2005, MOL INTERV, V5, P216, DOI 10.1124/mi.5.4.5; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang J, 2004, MOL CELL ENDOCRINOL, V219, P171, DOI 10.1016/j.mce.2003.12.018; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; WARNER BW, 1993, PEDIATR CLIN N AM, V40, P1335; Yang EB, 1996, BIOCHEM BIOPH RES CO, V224, P309, DOI 10.1006/bbrc.1996.1026	74	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157034	10.1371/journal.pone.0157034	http://dx.doi.org/10.1371/journal.pone.0157034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314851	Green Published, gold, Green Submitted			2022-12-26	WOS:000378030000009
J	Liew, KJ; Ramli, A; Majid, AA				Liew, Khang Jie; Ramli, Ahmad; Majid, Ahmad Abd.			Point Set Denoising Using Bootstrap-Based Radial Basis Function	PLOS ONE			English	Article								This paper examines the application of a bootstrap test error estimation of radial basis functions, specifically thin-plate spline fitting, in surface smoothing. The presence of noisy data is a common issue of the point set model that is generated from 3D scanning devices, and hence, point set denoising is one of the main concerns in point set modelling. Bootstrap test error estimation, which is applied when searching for the smoothing parameters of radial basis functions, is revisited. The main contribution of this paper is a smoothing algorithm that relies on a bootstrap-based radial basis function. The proposed method incorporates a k-nearest neighbour search and then projects the point set to the approximated thin-plate spline surface. Therefore, the denoising process is achieved, and the features are well preserved. A comparison of the proposed method with other smoothing methods is also carried out in this study.	[Liew, Khang Jie; Ramli, Ahmad; Majid, Ahmad Abd.] Univ Sains Malaysia, Sch Math Sci, Minden 11800, Penang, Malaysia	Universiti Sains Malaysia	Liew, KJ (corresponding author), Univ Sains Malaysia, Sch Math Sci, Minden 11800, Penang, Malaysia.	kenji_liewkj@yahoo.com.my	Liew, Khang Jie/AAC-9581-2020; Ramli, Ahmad Lutfi Amri/X-8854-2018; Liew, PhD, Khang Jie/GXW-1829-2022	Liew, Khang Jie/0000-0002-3993-4359; Ramli, Ahmad Lutfi Amri/0000-0003-0853-3920; 	USM [304/PMATHS/6312136]; FRGS [203/PMATHS/6711433]	USM; FRGS	This research is supported by the USM short term grant no. 304/PMATHS/6312136 and FRGS grant no. 203/PMATHS/6711433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa M, 2003, IEEE T VIS COMPUT GR, V9, P3, DOI 10.1109/TVCG.2003.1175093; Amenta N, 2004, ACM T GRAPHIC, V23, P264, DOI 10.1145/1015706.1015713; [Anonymous], 2008, P 5 EUR IEEE VGTC C; Bennink HE, 2007, IFMBE PROC, V15, P28; Bremer P.-T., 2005, Point-Based Graphics 2005 (IEEE Cat. No. 05EX1159), P47, DOI 10.1109/PBG.2005.194063; Carr JC, 2001, COMP GRAPH, P67, DOI 10.1145/383259.383266; Duchon J., 1977, LECT NOTES MATH; Fleishman S, 2003, ACM T GRAPHIC, V22, P950, DOI 10.1145/882262.882368; FRANKE R, 1982, MATH COMPUT, V38, P181, DOI 10.2307/2007474; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Guennebaud G, 2008, COMPUT GRAPH FORUM, V27, P653, DOI 10.1111/j.1467-8659.2008.01163.x; Guennebaud G, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239474; HARDY RL, 1971, J GEOPHYS RES, V76, P1905, DOI 10.1029/JB076i008p01905; LANCASTER P, 1981, MATH COMPUT, V37, P141, DOI 10.1090/S0025-5718-1981-0616367-1; Levin D, 1998, MATH COMPUT, V67, P1517, DOI 10.1090/S0025-5718-98-00974-0; Liew KJ, 2016, COMPUTATION IN PRESS, DOI [10.1007/s40314-016-0332-x, DOI 10.1007/S40314-016-0332-X]; Lipman Y, 2007, ACM T GRAPHIC, V26, DOI [10.1145/1276377.1276405, 10.1145/1239451.1239473]; Pauly M, 2001, COMP GRAPH, P379, DOI 10.1145/383259.383301; Qin H., 2014, LECT NOTES COMPUTER; Qin HX, 2008, VISUAL COMPUT, V24, P1067, DOI 10.1007/s00371-007-0206-8; Ramli A, 2012, BOOTSTRAP BASED SURF; Ramli A., 2009, VMV, P101; Schall O., 2005, Point-Based Graphics 2005 (IEEE Cat. No. 05EX1159), P71, DOI 10.1109/PBG.2005.194067; Schall O., 2007, P 2007 ACM S SOL PHY, P217; Scheidegger CE, 2005, EUR S GEOM PROC; Wahba G., 1990, SPLINE MODELS OBSERV	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0156724	10.1371/journal.pone.0156724	http://dx.doi.org/10.1371/journal.pone.0156724			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315105	Green Published, gold, Green Submitted			2022-12-26	WOS:000378030000003
J	Richard, V; Lamberto, G; Lu, TW; Cappozzo, A; Dumas, R				Richard, Vincent; Lamberto, Giuliano; Lu, Tung-Wu; Cappozzo, Aurelio; Dumas, Raphael			Knee Kinematics Estimation Using Multi-Body Optimisation Embedding a Knee Joint Stiffness Matrix: A Feasibility Study	PLOS ONE			English	Article							TISSUE ARTIFACT ASSESSMENT; BONE-POSE ESTIMATION; TIBIO-FEMORAL JOINT; GLOBAL OPTIMIZATION; ROBOTIC TECHNOLOGY; CRUCIATE LIGAMENT; COORDINATE SYSTEM; MODEL; CONSTRAINTS; MOVEMENT	The use of multi-body optimisation (MBO) to estimate joint kinematics from stereophoto-grammetric data while compensating for soft tissue artefact is still open to debate. Presently used joint models embedded in MBO, such as mechanical linkages, constitute a considerable simplification of joint function, preventing a detailed understanding of it. The present study proposes a knee joint model where femur and tibia are represented as rigid bodies connected through an elastic element the behaviour of which is described by a single stiffness matrix. The deformation energy, computed from the stiffness matrix and joint angles and displacements, is minimised within the MBO. Implemented as a "soft" constraint using a penalty-based method, this elastic joint description challenges the strictness of "hard" constraints. In this study, estimates of knee kinematics obtained using MBO embedding four different knee joint models (i.e., no constraints, spherical joint, parallel mechanism, and elastic joint) were compared against reference kinematics measured using bi-planar fluoroscopy on two healthy subjects ascending stairs. Bland-Altman analysis and sensitivity analysis investigating the influence of variations in the stiffness matrix terms on the estimated kinematics substantiate the conclusions. The difference between the reference knee joint angles and displacements and the corresponding estimates obtained using MBO embedding the stiffness matrix showed an average bias and standard deviation for kinematics of 0.9 +/- 3.2 degrees and 1.6 +/- 2.3 mm. These values were lower than when no joint constraints (1.1 +/- 3.8 degrees, 2.4 +/- 4.1 mm) or a parallel mechanism (7.7 +/- 3.6 degrees, 1.6 +/- 1.7 mm) were used and were comparable to the values obtained with a spherical joint (1.0 +/- 3.2 degrees, 1.3 +/- 1.9 mm). The study demonstrated the feasibility of substituting an elastic joint for more classic joint constraints in MBO.	[Richard, Vincent; Dumas, Raphael] Univ Lyon 1, IFSTTAR, UMR T9406, LBMC, F-69622 Lyon, France; [Richard, Vincent; Cappozzo, Aurelio] Univ Roma Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Lamberto, Giuliano] Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England; [Lamberto, Giuliano] INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England; [Lu, Tung-Wu] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Lu, Tung-Wu] Natl Taiwan Univ, Dept Orthopaed Surg, Taipei 10764, Taiwan	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Universite Gustave-Eiffel; Foro Italico University of Rome; University of Sheffield; National Taiwan University; National Taiwan University	Dumas, R (corresponding author), Univ Lyon 1, IFSTTAR, UMR T9406, LBMC, F-69622 Lyon, France.	raphael.dumas@ifsttar.fr	Dumas, Raphael/H-2281-2018	Dumas, Raphael/0000-0002-0368-8248; Lamberto, Giuliano/0000-0001-7038-2655; Richard, Vincent/0000-0002-5907-6160	Mediterranean Office for Youth [2011/026/01]	Mediterranean Office for Youth	The travel fund granted (grant no 2011/026/01) to VR by the Mediterranean Office for Youth (organisation no longer active) is gratefully acknowledged. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MS, 2010, COMPUT METHOD BIOMEC, V13, P171, DOI 10.1080/10255840903067080; Andersen MS, 2009, COMPUT METHOD BIOMEC, V12, P371, DOI 10.1080/10255840802459412; Andersen MS, 2010, J BIOMECH, V43, P268, DOI 10.1016/j.jbiomech.2009.08.034; Bergamini E, 2011, GAIT POSTURE, V33, P706, DOI 10.1016/j.gaitpost.2011.03.006; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bolsterlee B, 2014, MED BIOL ENG COMPUT, V52, P283, DOI 10.1007/s11517-013-1065-2; Bonci T, 2015, J BIOMECH, V48, P4166, DOI 10.1016/j.jbiomech.2015.10.031; Caplan N, 2014, THE JOURNAL OF BONE, V58, P137, DOI [10.1007/978-1-4471-5451-8_33, DOI 10.1007/978-1-4471-5451-8_33]; Charbonnier C, 2014, ORTHOP TRAUMATOL-SUR, V100, P715, DOI 10.1016/j.otsr.2014.06.015; Clement J, 2014, COMPUT METHOD BIOMEC, V17, P76, DOI 10.1080/10255842.2014.931141; Clement J, 2015, J BIOMECH, V48, P3796, DOI 10.1016/j.jbiomech.2015.09.040; DEJALON JG, 1994, NATO ADV SCI INST SE, V268, P285; Dumas R, 2007, MED BIOL ENG COMPUT, V45, P315, DOI 10.1007/s11517-006-0156-8; Dumas R, 2012, Comput Methods Biomech Biomed Engin, V15 Suppl 1, P183; Duprey S, 2010, J BIOMECH, V43, P2858, DOI 10.1016/j.jbiomech.2010.06.010; El Habachi A, 2015, MED BIOL ENG COMPUT, V53, P655, DOI 10.1007/s11517-015-1269-8; Fox RJ, 1998, AM J SPORT MED, V26, P395, DOI 10.1177/03635465980260030901; Freeman MAR, 2005, J BIOMECH, V38, P197, DOI 10.1016/j.jbiomech.2004.02.006; Fujie H, 2004, J BIOMECH ENG-T ASME, V126, P54, DOI 10.1115/1.1644567; Garling EH, 2007, J BIOMECH, V40, pS18, DOI 10.1016/j.jbiomech.2007.03.003; Gasparutto X, 2015, J BIOMECH, V48, P1141, DOI 10.1016/j.jbiomech.2015.01.010; Hagemeister N, 2011, COMPUT METHOD BIOMEC, V14, P755, DOI 10.1080/10255842.2010.493887; Hsieh HJ, 2015, BIOMED ENG IN PRESS; Kanamori A, 2000, ARTHROSCOPY, V16, P633, DOI 10.1053/jars.2000.7682; Koell P, 2010, COMPUT METHOD BIOMEC, V13, P79, DOI 10.1080/10255842.2010.493731; Krouwer JS, 2008, STAT MED, V27, P778, DOI 10.1002/sim.3086; Lamberto G, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4033480; LATASH ML, 1993, HUM MOVEMENT SCI, V12, P653, DOI 10.1016/0167-9457(93)90010-M; Lenhart RL, 2015, ANN BIOMED ENG, V43, P2675, DOI 10.1007/s10439-015-1326-3; Li K, 2012, J BIOMECH, V45, P2719, DOI 10.1016/j.jbiomech.2012.08.007; LOCH DA, 1992, J BIOMECH, V25, P81, DOI 10.1016/0021-9290(92)90247-X; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Marin F, 2010, CLIN BIOMECH, V25, P389, DOI 10.1016/j.clinbiomech.2010.02.004; Marouane H, 2015, COMPUT METHOD BIOMEC, V18, P339, DOI 10.1080/10255842.2013.795555; Martelli S, 2015, COMPUT METHOD BIOMEC, V18, P1555, DOI 10.1080/10255842.2014.930134; McLaughlin P, 2013, J BIOMECH, V46, P2757, DOI 10.1016/j.jbiomech.2013.08.015; Moniz-Pereira V, 2014, J APPL BIOMECH, V30, P446, DOI 10.1123/jab.2013-0105; Sandholm A, 2011, VISUAL COMPUT, V27, P161, DOI 10.1007/s00371-010-0538-7; Scheys L, 2011, GAIT POSTURE, V33, P158, DOI 10.1016/j.gaitpost.2010.11.003; Sholukha V, 2006, J BIOMECH, V39, P2087, DOI 10.1016/j.jbiomech.2005.06.014; Stagni R, 2009, GAIT POSTURE, V29, P119, DOI 10.1016/j.gaitpost.2008.07.008; Tsai TY, 2011, J BIOMECH, V44, P1182, DOI 10.1016/j.jbiomech.2011.01.009; Valente G, 2015, J BIOMECH, V48, P4198, DOI 10.1016/j.jbiomech.2015.09.042; Valente G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112625; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	47	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157010	10.1371/journal.pone.0157010	http://dx.doi.org/10.1371/journal.pone.0157010			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314586	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000378030000007
J	Basa, RCB; Davies, V; Li, XX; Murali, B; Shah, J; Yang, B; Li, S; Khan, MW; Tian, MX; Tejada, R; Hassan, A; Washington, A; Mukherjee, B; Carethers, JM; McGuire, KL				Basa, Ranor C. B.; Davies, Vince; Li, Xiaoxiao; Murali, Bhavya; Shah, Jinel; Yang, Bing; Li, Shi; Khan, Mohammad W.; Tian, Mengxi; Tejada, Ruth; Hassan, Avan; Washington, Allen, Jr.; Mukherjee, Bhramar; Carethers, John M.; McGuire, Kathleen L.			Decreased Anti-Tumor Cytotoxic Immunity among Microsatellite-Stable Colon Cancers from African Americans	PLOS ONE			English	Article							HUMAN COLORECTAL-CANCER; ADAPTIVE IMMUNITY; PROGNOSTIC-FACTOR; DIETARY PATTERNS; PROSTATE-CANCER; T-CELLS; INSTABILITY; EXPRESSION; IMMUNOSURVEILLANCE; SUPPRESSION	Colorectal cancer is a leading cause of cancer related deaths in the U.S., with African-Americans having higher incidence and mortality rates than Caucasian-Americans. Recent studies have demonstrated that anti-tumor cytotoxic T lymphocytes provide protection to patients with colon cancer while patients deficient in these responses have significantly worse prognosis. To determine if differences in cytotoxic immunity might play a role in racial disparities in colorectal cancer 258 microsatellite-stable colon tumors were examined for infiltrating immune biomarkers via immunohistochemistry. Descriptive summary statistics were calculated using two-sample Wilcoxon rank sum tests, while linear regression models with log-transformed data were used to assess differences in race and Pearson and Spearman correlations were used to correlate different biomarkers. The association between different biomarkers was also assessed using linear regression after adjusting for covariates. No significant differences were observed in CD8(+) (p = 0.83), CD57(+) (p = 0.55), and IL-17-expressing (p = 0.63) cell numbers within the tumor samples tested. When infiltration of granzyme B+ cells was analyzed, however, a significant difference was observed, with African Americans having lower infiltration of cells expressing this cytotoxic marker than Caucasians (p<0.01). Analysis of infiltrating granzyme B+ cells at the invasive borders of the tumor revealed an even greater difference by race (p<0.001). Taken together, the data presented suggest differences in anti-tumor immune cytotoxicity may be a contributing factor in the racial disparities observed in colorectal cancer.	[Basa, Ranor C. B.; Davies, Vince; Li, Xiaoxiao; Murali, Bhavya; Shah, Jinel; Yang, Bing; Khan, Mohammad W.; Tian, Mengxi; Tejada, Ruth; Hassan, Avan; Washington, Allen, Jr.; McGuire, Kathleen L.] San Diego State Univ, Dept Biol, Inst Mol Biol, San Diego, CA 92182 USA; [Li, Shi; Mukherjee, Bhramar] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Carethers, John M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	California State University System; San Diego State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	McGuire, KL (corresponding author), San Diego State Univ, Dept Biol, Inst Mol Biol, San Diego, CA 92182 USA.	kmcguire@mail.sdsu.edu		Basa, Ranor/0000-0001-8412-8770; Washington, Allen/0000-0002-5382-6899	National Cancer Institute [U54CA132384, U54CA132379, U01CA162147, CA156608]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK067287]; National Science Foundation; CSU LSAMP Senior Alliance [HRD-0802628]; National Institute of General Medical Sciences; Minority Access to Research Career [T34GM08303]; NATIONAL CANCER INSTITUTE [U54CA132379, R01CA206010, U01CA162147, U54CA132384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008303] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation(National Science Foundation (NSF)); CSU LSAMP Senior Alliance; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Minority Access to Research Career; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Cancer Institute, www.cancer.gov, U54CA132384, U54CA132379, U01CA162147 (JMC KLM), CA156608 (BM); National Institute of Diabetes and Digestive and Kidney Diseases R01DK067287 (JMC); National Science Foundation, http://www.nsf.gov/, CSU LSAMP Senior Alliance (RT AH) funded by Grant HRD-0802628; and National Institute of General Medical Sciences, https://www.nigms.nih.gov/Pages/default.aspx, Minority Access to Research Career funding (AW) grant T34GM08303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2005, AM J GASTROENTEROL, V100, P515, DOI 10.1111/j.1572-0241.2005.41829.x; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; Carethers JM, 2005, NAT CLIN PRACT GASTR, V2, P352, DOI 10.1038/ncpgasthep0241; Carethers JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100461; Chaput N, 2013, BRIT J CANCER, V109, P1013, DOI 10.1038/bjc.2013.362; Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107; Chiba T, 2004, BRIT J CANCER, V91, P1711, DOI 10.1038/sj.bjc.6602201; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; de la Cruz-Merino L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/174149; Diaz LA, 2015, NEW ENGL J MED, V373, P1979, DOI 10.1056/NEJMc1510353; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Fridman WH, 2011, CURR TOP MICROBIOL, V344, P1, DOI 10.1007/82_2010_46; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Grizzi F, 2013, WORLD J GASTROENTERO, V19, P174, DOI 10.3748/wjg.v19.i2.174; Jovov B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030168; Kinseth MA, 2014, INT J CANCER, V134, P81, DOI 10.1002/ijc.28326; LANIER LL, 1983, J IMMUNOL, V131, P1789; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Maniati E, 2010, ONCOGENE, V29, P5653, DOI 10.1038/onc.2010.367; Menon AG, 2004, LAB INVEST, V84, P493, DOI 10.1038/labinvest.3700055; Michael-Robinson JM, 2001, GUT, V48, P360, DOI 10.1136/gut.48.3.360; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Naito Y, 1998, CANCER RES, V58, P3491; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2008, J LEUKOCYTE BIOL, V84, P981, DOI 10.1189/jlb.1107773; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Satia JA, 2009, NUTR CANCER, V61, P179, DOI 10.1080/01635580802419806; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Susanto O, 2012, TISSUE ANTIGENS, V80, P477, DOI 10.1111/tan.12014; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Williams CD, 2009, CANCER EPIDEM BIOMAR, V18, P1552, DOI 10.1158/1055-9965.EPI-08-1146; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	37	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156660	10.1371/journal.pone.0156660	http://dx.doi.org/10.1371/journal.pone.0156660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310868	gold, Green Submitted, Green Published			2022-12-26	WOS:000378029800011
J	Hinojosa, IA; Green, BS; Gardner, C; Hesse, J; Stanley, JA; Jeffs, AG				Hinojosa, Ivan A.; Green, Bridget S.; Gardner, Caleb; Hesse, Jan; Stanley, Jenni A.; Jeffs, Andrew G.			Reef Sound as an Orientation Cue for Shoreward Migration by Pueruli of the Rock Lobster, Jasus edwardsii	PLOS ONE			English	Article							SPINY LOBSTER; NEW-ZEALAND; UNDERWATER SOUND; PANULIRUS-ARGUS; POPULATION CONNECTIVITY; ANTENNAL RECEPTORS; SWIMMING BEHAVIOR; FISH LARVAE; IN-SITU; SETTLEMENT	The post-larval or puerulus stage of spiny, or rock, lobsters (Palinuridae) swim many kilometres from open oceans into coastal waters where they subsequently settle. The orientation cues used by the puerulus for this migration are unclear, but are presumed to be critical to finding a place to settle. Understanding this process may help explain the biological processes of dispersal and settlement, and be useful for developing realistic dispersal models. In this study, we examined the use of reef sound as an orientation cue by the puerulus stage of the southern rock lobster, Jasus edwardsii. Experiments were conducted using in situ binary choice chambers together with replayed recording of underwater reef sound. The experiment was conducted in a sandy lagoon under varying wind conditions. A significant proportion of puerulus (69%) swam towards the reef sound in calm wind conditions. However, in windy conditions (> 25 m s(-1)) the orientation behaviour appeared to be less consistent with the inclusion of these results, reducing the overall proportion of pueruli that swam towards the reef sound (59.3%). These results resolve previous speculation that underwater reef sound is used as an orientation cue in the shoreward migration of the puerulus of spiny lobsters, and suggest that sea surface winds may moderate the ability of migrating pueruli to use this cue to locate coastal reef habitat to settle. Underwater sound may increase the chance of successful settlement and survival of this valuable species.	[Hinojosa, Ivan A.; Green, Bridget S.; Gardner, Caleb] Univ Tasmania, Inst Marine & Antarct Studies, Taroona, Tasmania 7053, Australia; [Hinojosa, Ivan A.] Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Coquimbo, Chile; [Hinojosa, Ivan A.] Millennium Nucl Ecol & Sustainable Management Oce, Coquimbo, Chile; [Hesse, Jan; Stanley, Jenni A.; Jeffs, Andrew G.] Univ Auckland, Inst Marine Sci, Leigh Marine Lab, POB 349, Warkworth, New Zealand	University of Tasmania; Universidad Catolica del Norte; University of Auckland	Hinojosa, IA (corresponding author), Univ Tasmania, Inst Marine & Antarct Studies, Taroona, Tasmania 7053, Australia.; Hinojosa, IA (corresponding author), Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Coquimbo, Chile.; Hinojosa, IA (corresponding author), Millennium Nucl Ecol & Sustainable Management Oce, Coquimbo, Chile.	Ivan.Hinojosa@utas.edu.au	Hinojosa, Ivan/P-1572-2016; Hinojosa, Ivan A./AAQ-7445-2020; Hinojosa, Ivan/ABC-8915-2021; Jeffs, Andrew G/D-9474-2012; Gardner, Caleb/I-7086-2013	Hinojosa, Ivan/0000-0002-9752-4374; Hinojosa, Ivan/0000-0002-9752-4374; Jeffs, Andrew/0000-0002-8504-1949; Gardner, Caleb/0000-0003-0324-4337	PhD scholarship BECAS-Chile programme; Australian Research Council [LP120200164]; ANZ Trustees programme "Holsworth Wildlife Research Endowment"; Australian Research Council's Industrial Transformation Research Hub funding scheme [IH 120100032]; Chilean Millennium Initiative grant [NC120030]	PhD scholarship BECAS-Chile programme; Australian Research Council(Australian Research Council); ANZ Trustees programme "Holsworth Wildlife Research Endowment"; Australian Research Council's Industrial Transformation Research Hub funding scheme(Australian Research Council); Chilean Millennium Initiative grant	Funding for this research has been provided by the PhD scholarship BECAS-Chile programme to I.A.H., the Australian Research Council Linkage project (project no. LP120200164) from B.S.G. and C.G., the ANZ Trustees programme "Holsworth Wildlife Research Endowment", the Australian Research Council's Industrial Transformation Research Hub funding scheme (project number IH 120100032) to A.J., and the Chilean Millennium Initiative grant (NC120030) to I.A.H.	Bates AE, 2014, NAT CLIM CHANGE, V4, P62, DOI 10.1038/NCLIMATE2062; Booth JD, 2000, MAR ECOL PROG SER, V200, P241, DOI 10.3354/meps200241; BOOTH JD, 1986, NEW ZEAL J MAR FRESH, V20, P291, DOI 10.1080/00288330.1986.9516150; Booth JD, 2001, MAR FRESHWATER RES, V52, P1055, DOI 10.1071/MF01089; BOOTH JD, 1989, NEW ZEAL J MAR FRESH, V23, P43, DOI 10.1080/00288330.1989.9516339; BOOTH JD, 1994, CRUSTACEANA, V66, P271, DOI 10.1163/156854094X00035; Booth JD, 2009, FISH RES, V95, P161, DOI 10.1016/j.fishres.2008.08.009; Bradford RW, 2015, MAR FRESHWATER RES, V66, P213, DOI 10.1071/MF14065; Cato DH, 2002, ACOUST AUST, V30, P1; Chiswell SM, 1999, MAR ECOL PROG SER, V183, P227, DOI 10.3354/meps183227; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; Fiksen O, 2007, MAR ECOL PROG SER, V347, P195, DOI 10.3354/meps06978; Fitzgibbon QP, 2014, FISH FISH, V15, P312, DOI 10.1111/faf.12018; Gardner C, 2001, MAR FRESHWATER RES, V52, P1271, DOI 10.1071/MF01032; Goldstein JS, 2009, LIMNOL OCEANOGR, V54, P1669, DOI 10.4319/lo.2009.54.5.1669; Green BS, 2009, MAR BIOL, V156, P1941, DOI 10.1007/s00227-009-1226-x; Harrell F, RMS REGRESSION MODEL; HAYAKAWA Y, 1990, NIPPON SUISAN GAKK, V56, P1703; Hayakawa Y, 2002, FISHERIES SCI, V68, P393, DOI 10.2331/fishsci.68.sup1_393; Hinojosa IA, 2015, ICES J MAR SCI, V72, P59, DOI 10.1093/icesjms/fsu199; Hobday AJ, 2014, REV FISH BIOL FISHER, V24, P415, DOI 10.1007/s11160-013-9326-6; Igulu MM, 2013, MAR ECOL PROG SER, V493, P243, DOI 10.3354/meps10542; Jeffs A, 2003, MAR FRESHWATER RES, V54, P841, DOI 10.1071/MF03007; Jeffs A, 1997, MAR FRESHWATER RES, V48, P681, DOI 10.1071/MF97047; Jeffs AG, 2005, NEW ZEAL J MAR FRESH, V39, P605, DOI 10.1080/00288330.2005.9517339; Jeffs AG, 2001, MAR FRESHWATER RES, V52, P1211, DOI 10.1071/MF01182; Jeffs AG, 2000, CRUSTACEANA, V73, P847, DOI 10.1163/156854000504859; Jeffs AG, 1999, COMP BIOCHEM PHYS A, V123, P351, DOI 10.1016/S1095-6433(99)00073-2; Jeffs AG, 2013, LOBSTERS: BIOLOGY, MANAGEMENT, AQUACULTURE AND FISHERIES, 2ND EDITION, P259; Kingsford MJ, 2002, B MAR SCI, V70, P309; KNUDSEN VO, 1948, J MAR RES, V7, P410; Kough AS, 2014, MAR ECOL PROG SER, V504, P207, DOI 10.3354/meps10748; Kough AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064970; Kroodsma DE, 2001, ANIM BEHAV, V61, P1029, DOI 10.1006/anbe.2000.1676; Leis JM, 2002, MAR ECOL PROG SER, V232, P259, DOI 10.3354/meps232259; Linnane A, 2010, FISH OCEANOGR, V19, P290, DOI 10.1111/j.1365-2419.2010.00544.x; MACMILLAN DL, 1992, MAR BEHAV PHYSIOL, V19, P211, DOI 10.1080/10236249209378809; Mann DA, 2007, MAR ECOL PROG SER, V338, P307, DOI 10.3354/meps338307; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; Nedelec SL, 2015, MAR ECOL PROG SER, V524, P125, DOI 10.3354/meps11175; PHILLIPS BF, 1978, MAR BIOL, V45, P347, DOI 10.1007/BF00391821; PHILLIPS BF, 1987, J CRUSTACEAN BIOL, V7, P122, DOI 10.2307/1548631; Phillips BF, 2009, REV FISH BIOL FISHER, V19, P193, DOI 10.1007/s11160-008-9099-5; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Quinn GP, 2002, EXPERIMENTAL DESIGN; R Development Core Team, 2008, R A LANGUAGE AND ENV; Radford CA, 2014, MAR ECOL PROG SER, V505, P19, DOI 10.3354/meps10782; Radford CA, 2011, CORAL REEFS, V30, P295, DOI 10.1007/s00338-010-0710-6; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; Radford C.A., 2008, BIOACOUSTICS, V17, P87, DOI [10.1080/09524622.2008.9753776, DOI 10.1080/09524622.2008.9753776]; Radford C, 2008, MAR ECOL PROG SER, V362, P37, DOI 10.3354/meps07444; Radford CA, 2008, OECOLOGIA, V156, P921, DOI 10.1007/s00442-008-1041-y; Radford CA, 2007, B MAR SCI, V80, P369; Radford CA, 2011, MAR ECOL PROG SER, V438, P167, DOI 10.3354/meps09312; Shears NT, 2008, ECOL APPL, V18, P1860, DOI 10.1890/07-1776.1; Simpson SD, 2008, ANIM BEHAV, V75, P1861, DOI 10.1016/j.anbehav.2007.11.004; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Staaterman E, 2014, ICES J MAR SCI, V71, P918, DOI 10.1093/icesjms/fst103; Staaterman E, 2012, J THEOR BIOL, V304, P188, DOI 10.1016/j.jtbi.2012.03.016; Stanley JA, 2015, OECOLOGIA, V178, P685, DOI 10.1007/s00442-015-3251-4; Stanley JA, 2012, P ROY SOC B-BIOL SCI, V279, P3622, DOI 10.1098/rspb.2012.0697; Stanley JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028572; Stanley JA, 2010, BEHAV ECOL, V21, P113, DOI 10.1093/beheco/arp159; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010660; Weiss HM, 2006, MAR TECHNOL SOC J, V40, P86, DOI 10.4031/002533206787353213; Wilkin JL., 2011, LIMNOLOGY OCEANOGRAP, V1, P163, DOI [10.1215/21573698-1504363, DOI 10.1215/21573698-1504363]	68	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157862	10.1371/journal.pone.0157862	http://dx.doi.org/10.1371/journal.pone.0157862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310676	gold, Green Published, Green Submitted			2022-12-26	WOS:000378029800140
J	Lamadrid-Figueroa, H; Montoya, A; Fritz, J; Olvera, M; Torres, LM; Lozano, R				Lamadrid-Figueroa, Hector; Montoya, Alejandra; Fritz, Jimena; Olvera, Marisela; Torres, Luis M.; Lozano, Rafael			Towards an Inclusive and Evidence-Based Definition of the Maternal Mortality Ratio: An Analysis of the Distribution of Time after Delivery of Maternal Deaths in Mexico, 2010-2013	PLOS ONE			English	Article								Progress towards the Millennium Development Goal No. 5 was measured by an indicator that excluded women who died due to pregnancy and childbirth after 42 days from the date of delivery. These women suffered from what are defined as late deaths and sequelae-related deaths (O96 and O97 respectively, according to the International Classification of Diseases, 10th revision). Such deaths end up not being part of the numerator in the calculation of the Maternal Mortality Ratio (MMR), the indicator that governments and international agencies use for reporting. The issue is not trivial since these deaths account for a sizeable fraction of all maternal deaths in the world and show an upward trend over time in many countries. The aim of this study was to analyze empirical data on maternal deaths that occurred between 2010 and 2013 in Mexico, linking databases of the Deliberate Search and Reclassification of Maternal Deaths (BIRMM) and the Birth Information Subsystem (SINAC) of the Ministry of Health. Data were analyzed by negative binomial regression, survival analysis and multiple cause analysis. While the reported MMR decreased by 5% per year between 2010 and 2013, the MMR due to late and sequelae-related deaths doubled from 3.5 to 7 per 100,000 live-births in 2013 (p < 0.01). A survival analysis of all maternal deaths revealed nothing particular around the 42 day threshold, other than the exclusion of 18% of women who died due to childbirth in 2013. The multiple cause analysis showed a strong association between the excluded deaths and obstetric causes. It is suggested to review the construction of the MMR to make it a more inclusive and dignified measurement of maternal mortality by including all deaths due to pregnancy and childbirth into the Maternal Death definition.	[Lamadrid-Figueroa, Hector; Montoya, Alejandra; Fritz, Jimena; Olvera, Marisela; Lozano, Rafael] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Lozano, Rafael] Inst Hlth Metr & Evaluat, Seattle, WA USA	Instituto Nacional de Salud Publica; Institute for Health Metrics & Evaluation	Lozano, R (corresponding author), Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.; Lozano, R (corresponding author), Inst Hlth Metr & Evaluat, Seattle, WA USA.	rafael.lozano@insp.mx	Lamadrid-Figueroa, Hector/ABD-5416-2021; Lozano, Rafael/T-5352-2018	Lamadrid-Figueroa, Hector/0000-0001-8775-8399; Lozano, Rafael/0000-0002-7356-8823; Fritz, Jimena/0000-0002-4157-5981				Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Belotti F, 2010, STATA J, V10, P458, DOI 10.1177/1536867X1001000310; Center for Disease Control and Prevention, REPR HLTH PREGN REL; Direccion General de Informacion In Salud Subsecretaria de Integracion y Desarrollo del Sector Salud Secretaria de Salud/Centro Mexicano para la Clasificacion de Enfermedades y Centro Colaborador para la Familia de Clasificaciones Internacionales de la OMS In Mexico (CEMECE), 2010, SUBS INT DES SECT SA; Fukuda-Parr S, 2010, SHOULD MDG IMPLEMENT, P63; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Hogan MC, 2016, B WORLD HEALTH ORGAN, V94, P362, DOI 10.2471/BLT.15.163360; Hoj L, 2003, BJOG-INT J OBSTET GY, V110, P995, DOI 10.1016/S1470-0328(03)03907-7; Horon IL, 2011, PUBLIC HEALTH REP, V126, P195, DOI 10.1177/003335491112600210; ISRAEL RA, 1986, AM J EPIDEMIOL, V124, P161, DOI 10.1093/oxfordjournals.aje.a114375; Johnson S, 2014, MATERNAL DEATHS SERI, V4; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Lewis G, 2011, BJOG S1, V118; Lu MC, 2015, MATERN CHILD HLTH J, V19, P1435, DOI 10.1007/s10995-015-1665-6; Torres LM, 2014, SALUD PUBLICA MEXICO, V56, P333; National Collaborating Centre for Women's and Children's Health (UK), 2010, HYP PREGN MAN HYP DI, P4; Pattinson R., 2011, 10 CEP HLTH NAT COMM; Redelings MD, 2007, AM J EPIDEMIOL, V166, P104, DOI 10.1093/aje/kwm037; Saucedo M, 2013, OBSTET GYNECOL, V122, P752, DOI 10.1097/AOG.0b013e31829fc38c; Secretaria de Salud, 2012, SUBS INT DES SECT SA; Sharma BR, 2009, J FORENSIC LEG MED, V16, P233, DOI 10.1016/j.jflm.2008.12.005; Storeng KT, 2012, B WORLD HEALTH ORGAN, V90, P418, DOI 10.2471/BLT.11.094011; UN, 2015, MILLENNIUM DEV GOALS; United Nations, 2003, DEV GROUP IND MON MI; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 2004, INT STAT CLASS DIS R, V2; Yamin AE, 2014, J HUMAN DEV CAPABILI, V15	28	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157495	10.1371/journal.pone.0157495	http://dx.doi.org/10.1371/journal.pone.0157495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310260	Green Submitted, Green Published, gold			2022-12-26	WOS:000378029800085
J	Mameli, G; Arru, G; Caggiu, E; Niegowska, M; Leoni, S; Madeddu, G; Babudieri, S; Sechi, GP; Sechi, LA				Mameli, Giuseppe; Arru, Giannina; Caggiu, Elisa; Niegowska, Magdalena; Leoni, Stefania; Madeddu, Giordano; Babudieri, Sergio; Sechi, Gian Pietro; Sechi, Leonardo A.			Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS PATIENTS; EPSTEIN-BARR-VIRUS; MESSENGER-RNAS; UP-REGULATION; MICRORNA; DIFFERENTIATION; MIRNA; PATHOGENESIS; MIR-326	MicroRNAs fine-tune the regulation of Th1/Th17 lymphocyte subsets in multiple sclerosis. We investigated the expression of miRNAs (previously associated with mycobacterial and viral infections) in MS patients and healthy donors (HD) following 6 months natalizumab therapy. In addition, Th1/Th17 cytokines and the presence of anti-EBNA1/VCA IgG in MS patients with different pattern of miRNA expression have been evaluated. MiR-155, miR-26a, miR-132, miR-146a and Th1/Th17 cytokines expression was detected by RT-real time PCR; moreover anti-EBNA1 and VCA IgG titres were measured by ELISA. We observed an up-regulation of miR-155 (p value = 0.009) and miR-132 (p value = 0.04) in MS patients compared to HD. In MS patients, IL-17a (p = 0.037), IFN gamma (p = 0.012) and TNF alpha (p = 0.015) but not IL-6 were over-expressed compared to HD. Two different miRNAs patterns associated to the expression of different cytokines were observed in the MS cohort. Moreover, a down-regulation of miR-155 and miR-26a was seen in MS patients during and after natalizumab therapy. MS patients that over-expressed miR-155 showed a higher EBNA1 IgG titer than MS patients with high levels of miR-26a. In conclusions the expression of particular miRNAs modulates the pro-inflammatory cytokine expression and the humoral response against EBV and this expression is natalizumab regulated.	[Mameli, Giuseppe; Caggiu, Elisa; Niegowska, Magdalena; Sechi, Leonardo A.] Univ Sassari, Dept Med Sci, I-07100 Sassari, Italy; [Arru, Giannina; Leoni, Stefania; Madeddu, Giordano; Babudieri, Sergio; Sechi, Gian Pietro] Univ Sassari, Dept Expt Med, I-07100 Sassari, Italy	University of Sassari; University of Sassari	Sechi, LA (corresponding author), Univ Sassari, Dept Med Sci, I-07100 Sassari, Italy.	sechila@uniss.it	MADEDDU, Giordano/AAP-4342-2020; Sechi, Leonardo Antonio/Y-3109-2018	MADEDDU, Giordano/0000-0001-6099-2273; BABUDIERI, SERGIO/0000-0001-7291-8687; mameli, giuseppe/0000-0002-0286-5433	Sardinian Region [LR7 2010 CRP 25160]; FISM [2013/R/15]	Sardinian Region(Regione Sardegna); FISM(Fondazione Italiana Sclerosi Multipla (FISM))	This work was supported by the Sardinian Region Grant LR7 2010 CRP 25160, FISM (grant number Cod. 2013/R/15).	Arru G, 2015, J NEUROL SCI, V357, P106, DOI 10.1016/j.jns.2015.07.007; Castellazzi M, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/901312; Cossu D, 2015, MULT SCLER J, V21, P984, DOI 10.1177/1352458514557304; Devier DJ, 2015, FRONT MOL NEUROSCI, V8, DOI [10.3389/fnmol.2015.00005, 10.3389/fnmo1.2015.00005]; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Figueredo DD, 2015, BLOOD CELL MOL DIS, V54, P364, DOI 10.1016/j.bcmd.2015.01.004; Gandhi R, 2015, MULT SCLER J, V21, P1095, DOI 10.1177/1352458515578771; Ha JS, 2015, ANN CLIN LAB SCI, V45, P308; Honardoost MA, 2015, GENE, V572, P153, DOI 10.1016/j.gene.2015.08.043; Honardoost MA, 2014, GENE, V544, P128, DOI 10.1016/j.gene.2014.04.069; Ingwersen J, 2015, ANN CLIN TRANSL NEUR, V2, P43, DOI 10.1002/acn3.152; Khan D, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00236; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Ma XT, 2014, INT J MED SCI, V11, P810, DOI 10.7150/ijms.8647; Mameli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044991; Martinez NE, 2015, BRAIN BEHAV IMMUN, V43, P86, DOI 10.1016/j.bbi.2014.07.008; Meira M, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/897249; Miyazaki Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105421; Moore CS, 2013, ANN NEUROL, V74, P709, DOI 10.1002/ana.23967; Motawi TMK, 2016, GENE, V590, P210, DOI 10.1016/j.gene.2016.01.042; Munoz-Culla M, 2014, MULT SCLER J, V20, P1851, DOI 10.1177/1352458514534513; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Otenio CCM, 2012, GENET MOL RES, V11, P4468, DOI 10.4238/2012.September.20.3; Oussaief L, 2015, J VIROL, V89, P12178, DOI 10.1128/JVI.01757-15; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ransohoff RM, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.14; Rice J, 2015, SURGERY, V158, P1345, DOI 10.1016/j.surg.2015.04.025; Shi Y, 2010, SCAND J IMMUNOL, V72, P250, DOI 10.1111/j.1365-3083.2010.02425.x; Waschbisch A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024604; Yoon C, 2015, TUMOUR BIOL; Zhang J, MICRORNA 155 MODULAT; Zhang J, 2014, J NEUROIMMUNOL, V266, P56, DOI 10.1016/j.jneuroim.2013.09.019; Zhou X, 2009, GENETICA, V137, P159, DOI 10.1007/s10709-009-9378-7; Zhu XW, 2014, EUR ARCH OTO-RHINO-L, V271, P1939, DOI 10.1007/s00405-013-2818-0	36	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157153	10.1371/journal.pone.0157153	http://dx.doi.org/10.1371/journal.pone.0157153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310932	gold, Green Submitted, Green Published			2022-12-26	WOS:000378029800037
J	Muneer, S; Ko, CH; Wei, H; Chen, YZ; Jeong, BR				Muneer, Sowbiya; Ko, Chung Ho; Wei, Hao; Chen, Yuze; Jeong, Byoung Ryong			Physiological and Proteomic Investigations to Study the Response of Tomato Graft Unions under Temperature Stress	PLOS ONE			English	Article							HEAT-STRESS; ARABIDOPSIS-THALIANA; OXIDATIVE STRESS; SALT STRESS; TOLERANCE; PROTEINS; ROOTSTOCKS; PLANTS; CELLS; ACCUMULATION	Background Grafting is an established practice for asexual propagation in horticultural and agricultural crops. The study on graft unions has become of interest for horticulturists using proteomic and genomic techniques to observe transfer of genetic material and signal transduction pathways from root to shoot and shoot to root. Another reason to study the graft unions was potentially to observe resistance against abiotic stresses. Using physiological and proteomic analyses, we investigated graft unions (rootstock and scions) of tomato genotypes exposed to standard-normal (23/23 and 25/18 degrees C day/night) and high-low temperatures (30/15 degrees C day/night). Results Graft unions had varied responses to the diverse temperatures. High-low temperature, but not standard-normal temperature, induced the production of reactive oxygen species (ROS) in the form of H2O2 and O-2(-1) in rootstock and scions. However, the expression of many cell protection molecules was also induced, including antioxidant enzymes and their immunoblots, which also show an increase in their activities such as superoxide dismutase (SOD), catalase (CAT), and ascorbate peroxidase (APX). The graft interfaces thus actively defend against stress by modifying their physiological and proteomic responses to establish a new cellular homeostasis. As a result, many proteins for cellular defense were regulated in graft unions under diverse temperature, in addition to the regulation of photosynthetic proteins, ion binding/transport proteins, and protein synthesis. Moreover, biomass, hardness, and vascular transport activity were evaluated to investigate the basic connectivity between rootstock and scions. Conclusions Our study provides physiological evidence of the grafted plants' response to diverse temperature. Most notably, our study provides novel insight into the mechanisms used to adapt the diverse temperature in graft unions (rootstock/scion).	[Muneer, Sowbiya; Ko, Chung Ho; Wei, Hao; Chen, Yuze; Jeong, Byoung Ryong] Gyeongsang Natl Univ, Div Appl Life Sci Plus BK21, Jinju 660701, South Korea; [Jeong, Byoung Ryong] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea; [Jeong, Byoung Ryong] Gyeongsang Natl Univ, Life Sci Res Inst, Jinju 660701, South Korea; [Ko, Chung Ho] Korea Natl Arboretum, Useful Plant Resource Ctr, 21-4 Dudam Gil, Yangpyeong Gun 12519, Gyeonggi Do, South Korea; [Chen, Yuze] Solar Energy Base, Qingdao 266234, Shandong, Peoples R China	Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Korea National Arboretum	Jeong, BR (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci Plus BK21, Jinju 660701, South Korea.; Jeong, BR (corresponding author), Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea.; Jeong, BR (corresponding author), Gyeongsang Natl Univ, Life Sci Res Inst, Jinju 660701, South Korea.	brjeong@gnu.ac.kr	Muneer, Sowbiya/S-5382-2019; Jeong, Byoung Ryong/D-7667-2014; Wei, Hao/AAD-4222-2019	Jeong, Byoung Ryong/0000-0002-4146-7278; Muneer, Sowbiya/0000-0003-0230-772X	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture Forestry and Fisheries [312034-04]; BK21 program, Ministry of Education, Korea	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture Forestry and Fisheries(Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, & Fisheries (iPET), Republic of Korea); BK21 program, Ministry of Education, Korea(Ministry of Education (MOE), Republic of Korea)	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture Forestry and Fisheries (Project No. 312034-04). SM, CHK, HW and YC were supported by a scholarship from BK21 program, Ministry of Education, Korea.	Aebi H, 1984, Methods Enzymol, V105, P121; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bai XG, 2011, J PROTEOME RES, V10, P4349, DOI 10.1021/pr200333f; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; Beltran-Pena E, 2002, PHYSIOL PLANTARUM, V115, P291, DOI 10.1034/j.1399-3054.2002.1150216.x; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Cookson SJ, 2014, J EXP BOT, V65, P2473, DOI 10.1093/jxb/eru145; Cookson SJ, 2013, J EXP BOT, V64, P2997, DOI 10.1093/jxb/ert144; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Ercolano MR, 2012, PLANT CELL REP, V31, P973, DOI 10.1007/s00299-012-1234-z; Estan MT, 2005, J EXP BOT, V56, P703, DOI 10.1093/jxb/eri027; Fernandez-Garcia N, 2004, ANN BOT-LONDON, V93, P53, DOI 10.1093/aob/mch014; Flaishman MA, 2008, J PLANT GROWTH REGUL, V27, P231, DOI 10.1007/s00344-008-9050-y; Flanagan LB, 2005, AGR FOREST METEOROL, V130, P237, DOI 10.1016/j.agrformet.2005.04.002; Fuentes I, 2014, NATURE, V511, P232, DOI 10.1038/nature13291; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; Herald VL, 2003, FEBS LETT, V537, P96, DOI 10.1016/S0014-5793(03)00101-7; Howarth CJ., 2005, ABIOTIC STRESSES PLA, P277, DOI DOI 10.1201/9781482293609-18; Irisarri P, 2015, J PLANT PHYSIOL, V176, P25, DOI 10.1016/j.jplph.2014.10.015; Kim KY, 2004, J EXP BOT, V55, P1153, DOI 10.1093/jxb/erh125; Kim M, 2001, SCIENCE, V293, P287, DOI 10.1126/science.1059805; KOLLMANN R, 1985, PROTOPLASMA, V124, P224, DOI 10.1007/BF01290774; Kumari A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124438; Lee DG, 2007, PROTEOMICS, V7, P3369, DOI 10.1002/pmic.200700266; Li W, 2011, J PLANT PHYSIOL, V168, P1743, DOI 10.1016/j.jplph.2011.03.018; Li WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082725; Li X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107605; Liu TX, 2013, ACTA PHYSIOL PLANT, V35, P501, DOI 10.1007/s11738-012-1092-x; Liu YW, 2014, IJC HEART VASC, V5, P1, DOI 10.1016/j.ijcha.2014.10.016; Majoul T, 2004, PROTEOMICS, V4, P505, DOI 10.1002/pmic.200300570; Milien M, 2012, SCI HORTIC-AMSTERDAM, V144, P130, DOI 10.1016/j.scienta.2012.06.045; Molassiotis AN, 2005, PLANT GROWTH REGUL, V46, P69, DOI 10.1007/s10725-005-6396-z; Muneer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120899; Muneer S, 2012, PLANT GROWTH REGUL, V68, P421, DOI 10.1007/s10725-012-9731-1; Muneer S, 2012, PLANT OMICS, V5, P167; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; Neilson KA, 2010, PROTEOMICS, V10, P828, DOI 10.1002/pmic.200900538; Olmstead MA, 2006, J AM SOC HORTIC SCI, V131, P577, DOI 10.21273/JASHS.131.5.577; Prassinos C, 2009, TREE PHYSIOL, V29, P927, DOI 10.1093/treephys/tpp027; Rivard CL, 2008, HORTSCIENCE, V43, P2104, DOI 10.21273/HORTSCI.43.7.2104; Rivero RM, 2001, PLANT SCI, V160, P315, DOI 10.1016/S0168-9452(00)00395-2; Rocco M, 2006, PROTEOMICS, V6, P3781, DOI 10.1002/pmic.200600128; Rodriguez M., 2005, BIOTECNOL APL, V22, P1, DOI DOI 10.1007/S00284-005-4515-8; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Shabala S, 2010, PLANT J, V61, P839, DOI 10.1111/j.1365-313X.2009.04110.x; Siguenza C, 2005, J NEMATOL, V37, P276; SOUMELIDOU K, 1994, ANN BOT-LONDON, V74, P605, DOI 10.1006/anbo.1994.1161; Stegemann S, 2009, SCIENCE, V324, P649, DOI 10.1126/science.1170397; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Vitale A, 2014, PLANT PHYSIOL BIOCH, V83, P207, DOI 10.1016/j.plaphy.2014.08.006; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wang H, 2006, J EXP BOT, V57, P827, DOI 10.1093/jxb/erj066; Xing WW, 2015, PLANT PHYSIOL BIOCH, V87, P124, DOI 10.1016/j.plaphy.2014.12.011; Yin H, 2012, J EXP BOT, V63, P4219, DOI 10.1093/jxb/ers109; Yuan K, 2011, AFR J BIOTECHNOL, V10, P14816, DOI 10.5897/AJB11.1844; Zhao FG, 2007, PLANT PHYSIOL, V145, P1061, DOI 10.1104/pp.107.105882; Zheng BS, 2010, TREE PHYSIOL, V30, P297, DOI 10.1093/treephys/tpp102; Zhou YH, 2009, J PLANT RES, V122, P529, DOI 10.1007/s10265-009-0247-3; Zhu YH, 2013, INT J MOL SCI, V14, P20614, DOI 10.3390/ijms141020614	60	24	26	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157439	10.1371/journal.pone.0157439	http://dx.doi.org/10.1371/journal.pone.0157439			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310261	gold, Green Submitted, Green Published			2022-12-26	WOS:000378029800072
J	Peralta, DR; Adler, C; Corbalan, NS; Garcia, ECP; Pomares, MF; Vincent, PA				Peralta, Daiana R.; Adler, Conrado; Corbalan, Natalia S.; Paz Garcia, Enrique Carlos; Fernanda Pomares, Maria; Vincent, Paula A.			Enterobactin as Part of the Oxidative Stress Response Repertoire	PLOS ONE			English	Article							ESCHERICHIA-COLI; SMALL RNA; IRON-METABOLISM; CATECHOLATE SIDEROPHORES; BACTERIAL SIDEROPHORES; AZOTOBACTER-VINELANDII; PEROXIDE STRESS; E. COLI; PROMOTER; GENES	Microorganisms produce siderophores to facilitate iron uptake and even though this trait has been extensively studied, there is growing evidence suggesting that siderophores may have other physiological roles aside from iron acquisition. In support of this notion, we previously linked the archetypal siderophore enterobactin with oxidative stress alleviation. To further characterize this association, we studied the sensitivity of Escherichia coli strains lacking different components of the enterobactin system to the classical oxidative stressors hydrogen peroxide and paraquat. We observed that strains impaired in enterobactin production, uptake and hydrolysis were more susceptible to the oxidative damage caused by both compounds than the wild-type strain. In addition, meanwhile iron supplementation had little impact on the sensitivity, the reducing agent ascorbic acid alleviated the oxidative stress and therefore significantly decreased the sensitivity to the stressors. This indicated that the enterobactin-mediated protection is independent of its ability to scavenge iron. Furthermore, enterobactin supplementation conferred resistance to the entE mutant but did not have any protective effect on the fepG and fes mutants. Thus, we inferred that only after enterobactin is hydrolysed by Fes in the cell cytoplasm and iron is released, the free hydroxyl groups are available for radical stabilization. This hypothesis was validated testing the ability of enterobactin to scavenge radicals in vitro. Given the strong connection between enterobactin and oxidative stress, we studied the transcription of the entE gene and the concomitant production of the siderophore in response to such kind of stress. Interestingly, we observed that meanwhile iron represses the expression and production of the siderophore, hydrogen peroxide and paraquat favour these events even if iron is present. Our results support the involvement of enterobactin as part of the oxidative stress response and highlight the existence of a novel regulation mechanism for enterobactin biosynthesis.	[Fernanda Pomares, Maria; Vincent, Paula A.] CONICET UNT, Inst Super Invest Biol INSIBIO, UNT Chacabuco 461,T4000ILI San Miguel Tucuman, San Miguel De Tucuman, Argentina; Inst Quim Biol Dr Bernabe Bloj, Fac Bioquim quim & Farmacia, UNT Chacabuco 461,T4000ILI San Miguel Tucuman, San Miguel De Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Pomares, MF; Vincent, PA (corresponding author), CONICET UNT, Inst Super Invest Biol INSIBIO, UNT Chacabuco 461,T4000ILI San Miguel Tucuman, San Miguel De Tucuman, Argentina.	fpomares@fbqf.unt.edu.ar; pvincent@fbqf.unt.edu.ar		Corbalan, Natalia/0000-0002-3588-3099	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1939, 2222, 2991]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 0972]; CONICET	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was funded by grants PICT 1939, 2222 and 2991 from the Agencia Nacional de Promocion Cientifica y Tecnologica, PIP 0972 from the Consejo Nacional de Investigaciones Cientificas y Tecnicas. DRP was recipient of a fellowship from CONICET. ECPG is CONICET CPA. CA, NSC, MFP and PAV are Career Investigators from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard MES, 2013, BIOCHEM J, V454, P543, DOI 10.1042/BJ20121771; Adler C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084734; Adler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046754; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Arnow LE, 1937, J BIOL CHEM, V118, P531; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; BRICKMAN TJ, 1992, J BIOL CHEM, V267, P12350; BRICKMAN TJ, 1990, J MOL BIOL, V212, P669, DOI 10.1016/0022-2836(90)90229-F; Christoffersen CA, 2001, J BACTERIOL, V183, P2059, DOI 10.1128/JB.183.6.2059-2070.2001; COFFMAN TJ, 1990, J CLIN INVEST, V86, P1030, DOI 10.1172/JCI114805; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Cornish AS, 1998, MICROBIOL-UK, V144, P1747, DOI 10.1099/00221287-144-7-1747; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eisendle M, 2006, EUKARYOT CELL, V5, P1596, DOI 10.1128/EC.00057-06; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Furrer JL, 2002, MOL MICROBIOL, V44, P1225, DOI 10.1046/j.1365-2958.2002.02885.x; Gerstle K, 2012, RNA BIOL, V9, P458, DOI 10.4161/rna.19065; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; HUNT MD, 1994, J BACTERIOL, V176, P3944, DOI 10.1128/JB.176.13.3944-3955.1994; Johnstone TC, 2015, DALTON T, V44, P6320, DOI 10.1039/c4dt03559c; Kim J, 2015, APPL MICROBIOL BIOT, V99, P10611, DOI 10.1007/s00253-015-6914-5; Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020777; Ma L, 2012, J BACTERIOL, V194, P6748, DOI 10.1128/JB.01574-12; Manchado M, 2000, J BACTERIOL, V182, P6842, DOI 10.1128/JB.182.23.6842-6844.2000; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Miller J.H., 1992, SHORT COURSE BACTERI, P150; OBRIEN IG, 1971, BIOCHIM BIOPHYS ACTA, V237, P537, DOI 10.1016/0304-4165(71)90274-1; Paauw A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008240; Povie G, 2010, CHEM COMMUN, V46, P803, DOI 10.1039/b917004a; Prevost K, 2007, MOL MICROBIOL, V64, P1260, DOI 10.1111/j.1365-2958.2007.05733.x; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Reeder BJ, 2005, CHEM RES TOXICOL, V18, P1004, DOI 10.1021/tx049660y; Saka K, 2005, DNA RES, V12, P63, DOI 10.1093/dnares/12.1.63; Salvail H, 2013, EMBO J, V32, P2764, DOI 10.1038/emboj.2013.205; Salvail H, 2010, P NATL ACAD SCI USA, V107, P15223, DOI 10.1073/pnas.1007805107; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Singh V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8113; Soballe B, 2000, MICROBIOL-SGM, V146, P787, DOI 10.1099/00221287-146-4-787; Tindale AE, 2000, MICROBIOL-SGM, V146, P1617, DOI 10.1099/00221287-146-7-1617; Troxell B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00059; WINKELMANN G, 1994, BIOMETALS, V7, P149; Zhou YN, 1998, J BACTERIOL, V180, P1154, DOI 10.1128/JB.180.5.1154-1158.1998	47	56	56	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157799	10.1371/journal.pone.0157799	http://dx.doi.org/10.1371/journal.pone.0157799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310257	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800137
J	Santos, V; Hirshfield, I				Santos, Victor; Hirshfield, Irvin			The Physiological and Molecular Characterization of a Small Colony Variant of Escherichia coli and Its Phenotypic Rescue	PLOS ONE			English	Article							CYCLOPROPANE FATTY-ACIDS; STAPHYLOCOCCUS-AUREUS; RESISTANCE; PERSISTENT; RECOVERY; O-2	Small colony variants (SCVs) can be defined as a naturally occurring sub-population of bacteria characterized by their reduced colony size and distinct biochemical properties. SCVs of Staphylococcus aureus have been studied extensively over the past two decades due to their role in recurrent human infections. However, little work has been done on SCVs of Escherichia coli, and this work has focused on the physiology and morphology that define these colonies of E. coli, such as small size and slow growth. E. coli strain JW0623, has a null lipA mutation in the lipoic acid synthase gene (lipA), and is a lipoic acid auxotroph. When the mutant was grown in LB medium to log phase, it showed remarkable resistance to acid (pH 3), hydrogen peroxide, heat and osmotic stress compared to its parent BW25113. Using RT-PCR and real time RT-PCR, the expression of certain genes was compared in the two strains in an attempt to create a molecular profile of Escherichia coli SCVs. These include genes involved in glycolysis, TCA cycle, electron transport, iron acquisition, biofilm formation and cyclopropane fatty acid synthesis. It was also demonstrated that the addition of 5 mu g/ml of lipoic acid to LB medium allows for the phenotypic rescue of the mutant; reversing its slow growth, its resistance characteristics, and elevated gene expression. These results indicate that the mutation in lipA leads to an E. coli SCV that resembles an electron transport defective SCV of S. aureus These strains are typically auxotrophs, and are phenotypically rescued by adding the missing metabolite to rich medium. There are global shifts in gene expression which are reversible and depend on whether the auxotrophic molecule is absent or present. Looking at the E. coli SCV from an evolutionary point of view, it becomes evident that its path to survival is to express genes that confer stress resistance.	[Santos, Victor; Hirshfield, Irvin] St Johns Univ, Dept Biol Sci, Queens, NY USA	Saint John's University	Santos, V (corresponding author), St Johns Univ, Dept Biol Sci, Queens, NY USA.	santosv@stjohns.edu	Santos, Victor Santana/B-8738-2014	Santos, Victor Santana/0000-0003-0194-7397	St. John's University	St. John's University	The authors received no specific funding for this work. Some funds supplied by St. John's University.; We wish to thank Paramita Basu, Anthony Paratore, David Matatov, Raymond Ochs, and Adam Constantine for their assistance. Finally, we thank St. John's University for financial support of this research.	Abdallah M, 2014, ARCH MICROBIOL, V196, P453, DOI 10.1007/s00203-014-0983-1; ACAR JF, 1978, J CLIN MICROBIOL, V8, P142; Becker S, 1996, J BACTERIOL, V178, P4515, DOI 10.1128/jb.178.15.4515-4521.1996; Brown JL, 1997, INT J FOOD MICROBIOL, V37, P163, DOI 10.1016/S0168-1605(97)00068-8; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Chatterjee I, 2005, J BACTERIOL, V187, P4488, DOI 10.1128/JB.187.13.4488-4496.2005; Chatterjee I, 2007, J BACTERIOL, V189, P2936, DOI 10.1128/JB.01444-06; Chen YY, 2016, INT J FOOD MICROBIOL, V222, P16, DOI 10.1016/j.ijfoodmicro.2016.01.017; CLOWES RC, 1955, J GEN MICROBIOL, V13, P461, DOI 10.1099/00221287-13-3-461; COLWELL CA, 1946, J BACTERIOL, V52, P417, DOI 10.1128/JB.52.4.417-422.1946; Grogan DW, 1997, MICROBIOL MOL BIOL R, V61, P429, DOI 10.1128/.61.4.429-441.1997; HIRSCH HM, 1961, J BACTERIOL, V81, P448, DOI 10.1128/JB.81.3.448-458.1961; Kipp F, 2003, J NEUROL NEUROSUR PS, V74, P1000, DOI 10.1136/jnnp.74.7.1000; Kohler C, 2003, J BACTERIOL, V185, P6928, DOI 10.1128/JB.185.23.6928-6937.2003; Kohler C, 2008, J BACTERIOL, V190, P6351, DOI 10.1128/JB.00505-08; Kriegeskorte A, FRONT CELL INFECT MI, DOI [10.3389/fclimb2014.00141, DOI 10.3389/FCLIMB2014.00141]; PROCTOR RA, 1995, CLIN INFECT DIS, V20, P95, DOI 10.1093/clinids/20.1.95; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Proctor RA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00099; Roggenkamp A, 1998, J CLIN MICROBIOL, V36, P2530, DOI 10.1128/JCM.36.9.2530-2534.1998; Sendi P, 2010, J CLIN MICROBIOL, V48, P1720, DOI 10.1128/JCM.01562-09; Spalding MD, 2010, MICROBIOL MOL BIOL R, V74, P200, DOI 10.1128/MMBR.00008-10; Unden G, 2002, J MOL MICROB BIOTECH, V4, P263; von Eiff C, 2008, INT J ANTIMICROB AG, V31, P507, DOI 10.1016/j.ijantimicag.2007.10.026; WEED LL, 1954, J BACTERIOL, V67, P27, DOI 10.1128/JB.67.1.27-33.1954; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	26	10	10	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157578	10.1371/journal.pone.0157578	http://dx.doi.org/10.1371/journal.pone.0157578			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310825	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800102
J	Greiner, AL; Mamuchishvili, N; Kakutia, N; Stauffer, K; Geleishvili, M; Chitadze, N; Chikviladze, T; Zakhashvili, K; Morgan, J; Salyer, SJ				Greiner, Ashley L.; Mamuchishvili, Nana; Kakutia, Natia; Stauffer, Kendra; Geleishvili, Marika; Chitadze, Nazibrola; Chikviladze, Tamar; Zakhashvili, Khatuna; Morgan, Juliette; Salyer, Stephanie J.			Crimean-Congo Hemorrhagic Fever Knowledge, Attitudes, Practices, Risk Factors, and Seroprevalence in Rural Georgian Villages with Known Transmission in 2014	PLOS ONE			English	Article							COUNTRY; VIRUS	In 2014 the highest annual case count of Crimean-Congo hemorrhagic fever (CCHF) was detected in Georgia since surveillance began in 2009. CCHF is a high-fatality hemorrhagic syndrome transmitted by infected ticks and animal blood. In response to this immediate public health threat, we assessed CCHF risk factors, seroprevalence, and CCHF-related knowledge, attitudes, and practices in the 12 rural villages reporting a 2014 CCHF case, to inform CCHF prevention and control measures. Households were randomly selected for interviewing and serum sample collection. Data were weighted by non-response and gender; percentages reflect weighting. Among 618 respondents, median age was 54.8 years (IQR: 26.5, range: 18.6-101.4); 215 (48.8%) were male. Most (91.5%) participants reported >= 1 CCHF high-risk activity. Of 389 participants with tick exposure, 286 (46.7%) participants handled ticks bare-handed; 65/216 (29.7%) knew the risk. Of 605 respondents, 355 (57.9%) reported animal blood exposure; 32/281 (12.7%) knew the risk. Of 612 responding, 184 (28.8%) knew protective measures against CCHF and tick exposures, but only 54.3% employed the measures. Of 435 serum samples collected, 12 were anti-CCHF IgG positive, indicating a weighted 3.0% seroprevalence. Most (66.7%) seropositive subjects reported tick exposure. In these villages, CCHF risk factors are prevalent, while CCHF-related knowledge and preventive practices are limited; these findings are critical to informing public health interventions to effectively control and prevent ongoing CCHF transmission. Additionally, CCHF seroprevalence is higher than previously detected (0.03%), highlighting the importance of this disease in the South Caucuses and in supporting ongoing regional investigations.	[Greiner, Ashley L.] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Greiner, Ashley L.; Salyer, Stephanie J.] US Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global Hlth Protect, Atlanta, GA USA; [Mamuchishvili, Nana; Kakutia, Natia; Chitadze, Nazibrola; Chikviladze, Tamar; Zakhashvili, Khatuna] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Stauffer, Kendra; Geleishvili, Marika; Morgan, Juliette] US Ctr Dis Control & Prevent, Ctr Global Hlth, South Caucasus Country Off, Tbilisi, Georgia; [Chitadze, Nazibrola; Chikviladze, Tamar] RG Lugar Ctr Publ Hlth Res, Tbilisi, Georgia	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; National Center for Disease Control & Public Health - Georgia	Greiner, AL (corresponding author), US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.; Greiner, AL (corresponding author), US Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global Hlth Protect, Atlanta, GA USA.	agreiner@cdc.gov		Salyer, Stephanie/0000-0001-7679-2006	United States Centers for Disease Control and Prevention	United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Research was funded by the United States Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriamandimby SF, 2011, J CLIN VIROL, V52, P370, DOI 10.1016/j.jcv.2011.08.008; Appannanavar SB, 2011, J GLOB INFECT DIS, V3, P285, DOI 10.4103/0974-777X.83537; Centers for Disease Control and Prevention, 2014, CRIM CONG HEM FEV; Central Intelligence Agency, 2014, WORLD FACTB GEORG; Ergonul O, 2006, CLIN MICROBIOL INFEC, V12, P551, DOI 10.1111/j.1469-0691.2006.01445.x; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; European Centre for Disease Prevention and Control, 2014, HYAL MARG EP TRANSM; Gergova I, 2014, JPN J INFECT DIS, V67, P397, DOI 10.7883/yoken.67.397; Gergova I, 2013, J VECTOR DIS, V50, P265; GOLDFARB LG, 1980, AM J TROP MED HYG, V29, P260, DOI 10.4269/ajtmh.1980.29.260; Greiner AL, 2015, MMWR-MORBID MORTAL W, V64, P228; Kish L, 1965, SURVEY SAMPLING; Knust B, 2012, EMERG INFECT DIS, V18, P643, DOI 10.3201/eid1804.111503; Kuchuloria T, 2014, AM J TROP MED HYG, V91, P246, DOI 10.4269/ajtmh.13-0460; National Institute of Allergy and Infecitous Diseases [NIAID], 2014, NIAID BIOD RES; Sargianou M, 2013, INT J INFECT DIS, V17, pE1160, DOI 10.1016/j.ijid.2013.07.015; Sharifi-Mood Batool, 2014, Int J High Risk Behav Addict, V3, pe11520, DOI 10.5812/ijhrba.11520; Taylor Jr TH, 2010, EMERG INFECT DIS; Vanhomwegen J, 2012, EMERG INFECT DIS, V18, P1958, DOI 10.3201/eid1812.120710; World Health Organization, 2013, CRIM CONG HAEM FEV W; Yilmaz GR, 2009, INT J INFECT DIS, V13, P380, DOI 10.1016/j.ijid.2008.07.021; Zakhashvili K, 2010, EMERG INFECT DIS, V16, P1326, DOI [10.3201/eid1608.100181, 10.3201/eid1608.100097]	22	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158049	10.1371/journal.pone.0158049	http://dx.doi.org/10.1371/journal.pone.0158049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336731	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200097
J	Clafshenkel, WP; Murata, H; Andersen, J; Creeger, Y; Koepsel, RR; Russell, AJ				Clafshenkel, William P.; Murata, Hironobu; Andersen, Jill; Creeger, Yehuda; Koepsel, Richard R.; Russell, Alan J.			The Effect of Covalently-Attached ATRP-Synthesized Polymers on Membrane Stability and Cytoprotection in Human Erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELLS; IN-VIVO; POLY(ETHYLENE GLYCOL); OXIDATIVE STRESS; CONFORMATIONAL-CHANGES; DRUG-DELIVERY; MECHANISM; BINDING; SURFACE; BIOTIN	Erythrocytes have been described as advantageous drug delivery vehicles. In order to ensure an adequate circulation half-life, erythrocytes may benefit from protective enhancements that maintain membrane integrity and neutralize oxidative damage of membrane proteins that otherwise facilitate their premature clearance from circulation. Surface modification of erythrocytes using rationally designed polymers, synthesized via atom-transfer radical polymerization (ATRP), may further expand the field of membrane-engineered red blood cells. This study describes the fate of ATRP-synthesized polymers that were covalently attached to human erythrocytes as well as the effect of membrane engineering on cell stability under physiological and oxidative conditions in vitro. The biocompatible, membrane-reactive polymers were homogenously retained on the periphery of modified erythrocytes for at least 24 hours. Membrane engineering stabilized the erythrocyte membrane and effectively neutralized oxidative species, even in the absence of free-radical scavenger-containing polymers. The targeted functionalization of Band 3 protein by NHS-pDMAA-Cy3 polymers stabilized its monomeric form preventing aggregation in the presence of the crosslinking reagent, bis(sulfosuccinimidyl)suberate (BS3). A free radical scavenging polymer, NHS-pDMAA-TEMPO, provided additional protection of surface modified erythrocytes in an in vitro model of oxidative stress. Preserving or augmenting cytoprotective mechanisms that extend circulation half-life is an important consideration for the use of red blood cells for drug delivery in various pathologies, as they are likely to encounter areas of imbalanced oxidative stress as they circuit the vascular system.	[Clafshenkel, William P.; Murata, Hironobu; Andersen, Jill; Koepsel, Richard R.; Russell, Alan J.] Carnegie Mellon Univ, Inst Complex Engn Syst, Pittsburgh, PA 15213 USA; [Creeger, Yehuda] Carnegie Mellon Univ, Mol Biosensor & Imaging Ctr, Pittsburgh, PA 15213 USA; [Clafshenkel, William P.] Univ Laval, CHU Quebec, Res Ctr, Ctr LOEX, Quebec City, PQ, Canada	Carnegie Mellon University; Carnegie Mellon University; Laval University	Russell, AJ (corresponding author), Carnegie Mellon Univ, Inst Complex Engn Syst, Pittsburgh, PA 15213 USA.	alanrussell@cmu.edu		Koepsel, Richard/0000-0002-6780-4914	Institute for Transfusion Medicine, Blood Science Foundation; Institute of Transfusion Medicine (ITxM, Pittsburgh, PA)	Institute for Transfusion Medicine, Blood Science Foundation; Institute of Transfusion Medicine (ITxM, Pittsburgh, PA)	The Institute for Transfusion Medicine, Blood Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge financial support from the Institute of Transfusion Medicine (ITxM, Pittsburgh, PA). We also gratefully acknowledge the Central Blood Bank (Pittsburgh, PA) for their supply of healthy erythrocytes.	ARBELOA FL, 1989, J LUMIN, V44, P105, DOI 10.1016/0022-2313(89)90027-6; Armstrong JK, 1997, AM J HEMATOL, V56, P26, DOI 10.1002/(SICI)1096-8652(199709)56:1<26::AID-AJH5>3.3.CO;2-D; Azim-Zadeh O, 2007, J BIOL CHEM, V282, P21609, DOI 10.1074/jbc.M610921200; Buehler PW, 2007, J PHARMACOL EXP THER, V323, P49, DOI 10.1124/jpet.107.126409; Chapanian R, 2012, BIOMATERIALS, V33, P3047, DOI 10.1016/j.biomaterials.2011.12.053; Cummings C, 2013, BIOMATERIALS, V34, P7437, DOI 10.1016/j.biomaterials.2013.06.027; D'Souza S, 2014, BIOMATERIALS, V35, P9447, DOI 10.1016/j.biomaterials.2014.07.041; de Back DZ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00009; Debbasch C, 2002, INVEST OPHTH VIS SCI, V43, P3409; Eaton SR, 2005, BIOMEDICAL EPR A; Eggleton CD, 1998, PHYS FLUIDS, V10, P1834, DOI 10.1063/1.869703; Fisher T C, 2000, Immunohematology, V16, P37; Franco RS, 2013, AM J HEMATOL, V88, P44, DOI 10.1002/ajh.23344; GIMSA J, 1995, MOL MEMBR BIOL, V12, P247, DOI 10.3109/09687689509072424; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; Hashemi-Najafabadi S, 2006, BIOCONJUGATE CHEM, V17, P1288, DOI 10.1021/bc060057w; Janvier F, 2013, J MECH BEHAV BIOMED, V18, P100, DOI 10.1016/j.jmbbm.2012.11.008; Kagan VE, 2000, FEBS LETT, V477, P1, DOI 10.1016/S0014-5793(00)01707-5; Kiefer CR, 2000, CURR OPIN HEMATOL, V7, P113, DOI 10.1097/00062752-200003000-00007; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Kurauchi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113403; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai JY, 2015, BIOMACROMOLECULES, V16, P2950, DOI 10.1021/acs.biomac.5b00854; Lang E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/513518; Lee WY, 2012, METALLOMICS, V4, P188, DOI 10.1039/c1mt00147g; Lele BS, 2004, BIOMACROMOLECULES, V5, P1947, DOI 10.1021/bm049728o; Likhtenshtein G.I., 2008, BIOMEDICINE MAT SCI; Lim HWG, 2002, P NATL ACAD SCI USA, V99, P16766, DOI 10.1073/pnas.202617299; Lutz HU, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00387; MAGNANI M, 1994, BIOTECHNOL APPL BIOC, V20, P335, DOI 10.1111/j.1470-8744.1994.tb00321.x; Marczak A, 2007, INT J PHARMACEUT, V335, P154, DOI 10.1016/j.ijpharm.2006.11.023; Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Mohanty JG, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00084; Mukthavaram R, 2014, J CONTROL RELEASE, V183, P146, DOI 10.1016/j.jconrel.2014.03.038; Murad KT, 1999, BLOOD, V93, P2121, DOI 10.1182/blood.V93.6.2121.406a30_2121_2127; Muzykantov VR, 2010, EXPERT OPIN DRUG DEL, V7, P403, DOI 10.1517/17425241003610633; MUZYKANTOV VR, 1993, J IMMUNOL METHODS, V158, P183, DOI 10.1016/0022-1759(93)90212-P; Ohta H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017137; Pandey KB, 2011, BIOMED PAP, V155, P131, DOI 10.5507/bp.2011.027; Pantaleo A, 2009, BIOCHEM J, V418, P359, DOI 10.1042/BJ20081557; Pattison DI, 2012, FREE RADICAL BIO MED, V53, P1664, DOI 10.1016/j.freeradbiomed.2012.08.578; Pendyala Gowri, 2008, J Indian Soc Periodontol, V12, P79, DOI 10.4103/0972-124X.44100; PORAICU D, 1983, RESUSCITATION, V10, P305, DOI 10.1016/0300-9572(83)90032-1; Samuni A, 2002, J AM CHEM SOC, V124, P8719, DOI 10.1021/ja017587h; Schubert R, 2004, HUM MOL GENET, V13, P1793, DOI 10.1093/hmg/ddh189; Scott MD, 1997, P NATL ACAD SCI USA, V94, P7566, DOI 10.1073/pnas.94.14.7566; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Siems WG, 2000, CLIN NEPHROL, V53, pS9; Sivilotti Marco L A, 2004, Toxicol Rev, V23, P169; Stennett EMS, 2014, CHEM SOC REV, V43, P1057, DOI 10.1039/c3cs60211g; Strassberger V, 2010, PROTEOMICS, V10, P3544, DOI 10.1002/pmic.201000308; Su XL, 2014, ARTIF CELL NANOMED B, V42, P222, DOI 10.3109/21691401.2013.834907; Suy S, 1998, J BIOL CHEM, V273, P17871, DOI 10.1074/jbc.273.28.17871; Szweda-Lewandowska Z, 2003, FREE RADICAL RES, V37, P1137, DOI 10.1080/10715760310001604152; Teramura Y, 2008, BIOMATERIALS, V29, P1345, DOI 10.1016/j.biomaterials.2007.11.048; Van Dort HM, 1998, J BIOL CHEM, V273, P14819, DOI 10.1074/jbc.273.24.14819; Villa CH, 2015, THER DELIV, V6, P795, DOI [10.4155/TDE.15.34, 10.4155/tde.15.34]; Vissers MCM, 1998, BIOCHEM J, V330, P131; Vittori D, 2012, ERYTHROCYTE PROGRAMM; Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240; Won DI, 2009, CYTOM PART B-CLIN CY, V76B, P135, DOI 10.1002/cyto.b.20448; Wong P, 1999, J THEOR BIOL, V196, P343, DOI 10.1006/jtbi.1998.0845; Xu HY, 2006, BIOMATERIALS, V27, P3125, DOI 10.1016/j.biomaterials.2006.01.012; Yin JJ, 2009, BIOMATERIALS, V30, P611, DOI 10.1016/j.biomaterials.2008.09.061	65	6	6	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157641	10.1371/journal.pone.0157641	http://dx.doi.org/10.1371/journal.pone.0157641			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27331401	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212800041
J	Sver, L; Bielen, A; Krizan, J; Guzvica, G				Sver, Lidija; Bielen, Ana; Krizan, Josip; Guzvica, Goran			Camera Traps on Wildlife Crossing Structures as a Tool in Gray Wolf (Canis lupus) Management - Five-Years Monitoring of Wolf Abundance Trends in Croatia	PLOS ONE			English	Article							NATIONAL-PARK; LARGE MAMMALS; POPULATION; CARNIVORES; DENSITY; FOREST; FINLAND	The conservation of gray wolf (Canis lupus) and its coexistence with humans presents a challenge and requires continuous monitoring and management efforts. One of the noninvasive methods that produces high-quality wolf monitoring datasets is camera trapping. We present a novel monitoring approach where camera traps are positioned on wildlife crossing structures that channel the animals, thereby increasing trapping success and increasing the cost-efficiency of the method. In this way we have followed abundance trends of five wolf packs whose home ranges are intersected by a motorway which spans throughout the wolf distribution range in Croatia. During the five-year monitoring of six green bridges we have recorded 28 250 camera-events, 132 with wolves. Four viaducts were monitored for two years, recording 4914 camera-events, 185 with wolves. We have detected a negative abundance trend of the monitored Croatian wolf packs since 2011, especially severe in the northern part of the study area. Further, we have pinpointed the legal cull as probable major negative influence on the wolf pack abundance trends (linear regression, r(2) > 0.75, P < 0.05). Using the same approach we did not find evidence for a negative impact of wolves on the prey populations, both wild ungulates and livestock. We encourage strict protection of wolf in Croatia until there is more data proving population stability. In conclusion, quantitative methods, such as the one presented here, should be used as much as possible when assessing wolf abundance trends.	[Sver, Lidija; Bielen, Ana] Univ Zagreb, Dept Biochem Engn, Fac Food Technol & Biotechnol, Zagreb 41000, Croatia; [Krizan, Josip] Gekom Ltd, Geophys & Ecol Modeling, Zagreb, Croatia; [Guzvica, Goran] Oikon Ltd, Dept Biomonitoring & Nat Protect, Inst Appl Ecol, Zagreb, Croatia; [Guzvica, Goran] Geonatura Ltd, Large Carnivore Monitoring Grp, Zagreb, Croatia	University of Zagreb	Guzvica, G (corresponding author), Oikon Ltd, Dept Biomonitoring & Nat Protect, Inst Appl Ecol, Zagreb, Croatia.; Guzvica, G (corresponding author), Geonatura Ltd, Large Carnivore Monitoring Grp, Zagreb, Croatia.	gguzvica@geonatura.hr	Križan, Josip/AAV-7899-2021	Križan, Josip/0000-0002-4557-3537; Bielen, Ana/0000-0002-4486-6688	Croatian Highways Company (Zagreb, Croatia); OIKON Ltd., Institute of Applied Ecology (Zagreb, Croatia) [ZIN2/08]	Croatian Highways Company (Zagreb, Croatia); OIKON Ltd., Institute of Applied Ecology (Zagreb, Croatia)	Funding was provided to GG by Croatian Highways Company (Zagreb, Croatia) (http://hac.hr/en) - Project "Monitoring of water, air, noise, permeability of motorway for wildlife, forest ecosystems, soil and ichthyofauna" and OIKON Ltd., Institute of Applied Ecology (Zagreb, Croatia) (http://www.oikon.hr/) - Project "Anthropogenic impacts on terrestrial macrofauna with emphasis on protected species in the Republic of Croatia" (ZIN2/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; Ausband DE, 2014, J WILDLIFE MANAGE, V78, P335, DOI 10.1002/jwmg.654; Barea-Azcon JM, 2007, BIODIVERS CONSERV, V16, P1213, DOI 10.1007/s10531-006-9114-x; Boitani L, 2015, KEY ACTIONS FOR LARG; Can OE, 2009, ORYX, V43, P427, DOI 10.1017/S0030605308000628; Chapron G, 2003, CR BIOL, V326, P575, DOI 10.1016/S1631-0691(03)00148-3; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Cinque S, 2015, WILDLIFE BIOL, V21, P157, DOI 10.2981/wlb.00098; Clevenger AP, 2003, LONG TERM YEAR ROUND, P293; Corlatti L, 2009, CONSERV BIOL, V23, P548, DOI 10.1111/j.1523-1739.2008.01162.x; Creel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012918; Frkovic A, 1992, WOLVES IN EUROPE STA, P66; Galaverni M, 2012, EUR J WILDLIFE RES, V58, P47, DOI 10.1007/s10344-011-0539-5; Gomercic T, 2010, ZOOL STUD, V49, P816; Guzvica G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106194; Jeremic J, 2013, IZVJESCE O STANJU PO; Jeremic J, 2015, IZVJESCE O STANJU PO; Jeremic J, 2011, IZVJESCE O STANJU PO; Jeremic J, 2012, IZVJESCE O STANJU PO; Jeremic J, 2014, IZVJESCE O STANJU PO; Kaczensky P, 2013, REPORT TO THE EU COM; Kelly MJ, 2008, NORTHEAST NAT, V15, P249, DOI 10.1656/1092-6194(2008)15[249:CTOCTS]2.0.CO;2; Kojola I, 2004, J ZOOL, V263, P229, DOI 10.1017/S0952836904005084; Kojola I, 2014, WILDLIFE BIOL, V20, P279, DOI 10.2981/wlb.00042; Kusak J, 2005, EUR J WILDLIFE RES, V51, P254, DOI 10.1007/s10344-005-0111-2; Kusak J, 2002, THESIS; Kusak J, 2009, EUR J WILDLIFE RES, V55, P7, DOI 10.1007/s10344-008-0208-5; Linnell J, 2005, REPORT ON THE CONSER; Lyra-Jorge MC, 2008, EUR J WILDLIFE RES, V54, P739, DOI 10.1007/s10344-008-0205-8; Majic A, 2010, BIOL CONSERV, V143, P255, DOI 10.1016/j.biocon.2009.09.010; Mech LD, 1995, A TEN YEAR HISTORY O, P329; Okovic P, 2009, IZVJESCE O STANJU PO; Okovic P, 2010, IZVJESCE O STANJU PO; Ott R. Lyman, 1993, AN INTRODUCTION TO S; Randi E, 2011, MAMMAL REV, V41, P99, DOI 10.1111/j.1365-2907.2010.00176.x; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; Smietana W, 1997, ACTA THERIOL, V42, P241; Strbenac A, 2005, PLAN UPRAVLJANJA VUK; Strbenac A, 2010, PLAN UPRAVLJANJA VUK; Swann DE, 2004, WILDLIFE SOC B, V32, P357, DOI 10.2193/0091-7648(2004)32[357:ICFDWA]2.0.CO;2; Trolle M, 2007, BIODIVERS CONSERV, V16, P1197, DOI 10.1007/s10531-006-9105-y; Webb NF, 2011, CAN J ZOOL, V89, P744, DOI [10.1139/Z11-043, 10.1139/z11-043]; Weingarth K, 2012, ANIM BIODIV CONSERV, V35, P197	44	4	4	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0156748	10.1371/journal.pone.0156748	http://dx.doi.org/10.1371/journal.pone.0156748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327498	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400007
J	Ahn, JH; Yang, JH; Yu, CW; Kim, JS; Lee, HJ; Choi, RK; Kim, TH; Jang, HJ; Choi, YJ; Roh, YM; Shim, WH; Bin Song, Y; Hahn, JY; Choi, JH; Lee, SH; Gwon, HC; Choi, SH				Ahn, Jong-Hwa; Yang, Jeong Hoon; Yu, Cheol Woong; Kim, Je Sang; Lee, Hyun Jong; Choi, Rak Kyeong; Kim, Tae Hoon; Jang, Ho Joon; Choi, Young Jin; Roh, Young Moo; Shim, Won-Heum; Bin Song, Young; Hahn, Joo-Yong; Choi, Jin-Ho; Lee, Sang Hoon; Gwon, Hyeon-Cheol; Choi, Seung-Hyuk			First-Generation Versus Second-Generation Drug-Eluting Stents in Coronary Chronic Total Occlusions: Two-Year Results of a Multicenter Registry	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CONSENSUS DOCUMENT; FOLLOW-UP; PERCUTANEOUS RECANALIZATION; BALLOON ANGIOPLASTY; SIROLIMUS; EVEROLIMUS; ARTERIES; OUTCOMES; INTERVENTION	Background Limited data are available regarding the long-term clinical outcomes of second-generation drug-eluting stents (DES) versus first-generation DES in patients with coronary chronic total occlusion (CTO) who undergo percutaneous coronary intervention (PCI). The aim of this study was to compare the clinical outcomes of second-generation DES with those of first-generation DES for the treatment of CTO. Methods and Results Between March 2003 and February 2012, 1,006 consecutive patients with CTO who underwent successful PCI using either first-generation DES (n = 557) or second-generation DES (n = 449) were enrolled in a multicenter, observational registry. Propensity-score matching was also performed. The primary outcome was cardiac death over a 2-year follow-up period. No significant differences were observed between the two groups regarding the incidence of cardiac death (first-generation DES versus second-generation DES; 2.5% vs 2.0%; hazard ratio [HR]: 0.86; 95% confidence interval [CI]: 0.37 to 1.98; p = 0.72) or major adverse cardiac events (MACE, 11.8% vs 11.4%; HR: 1.00; 95% CI: 0.67 to 1.50; p = 0.99). After propensity score matching, the incidences of cardiac death (HR: 0.86; 95% CI: 0.35 to 2.06; p = 0.86) and MACE (HR: 0.93; 95% CI: 0.63 to 1.37; p = 0.71) were still similar in both groups. Furthermore, no significant differences were observed between sirolimus-eluting, paclitaxel-eluting, zotarolimus-eluting, and everolimus-eluting stents regarding the incidence of cardiac death or MACE. Conclusion This study shows that the efficacy of second-generation DES is comparable to that of first-generation DES for treatment of CTO over 2 years of follow-up.	[Ahn, Jong-Hwa] Gyeongsang Natl Univ, Sch Med, Dept Med, Div Cardiol, Chang Won, South Korea; [Ahn, Jong-Hwa] Gyeongsang Natl Univ, Changwon Hosp, Chang Won, South Korea; [Ahn, Jong-Hwa; Yang, Jeong Hoon; Bin Song, Young; Hahn, Joo-Yong; Choi, Jin-Ho; Lee, Sang Hoon; Gwon, Hyeon-Cheol; Choi, Seung-Hyuk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Cardiac & Vasc Ctr, Seoul, South Korea; [Yang, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea; [Yu, Cheol Woong] Korea Univ, Med Ctr, Anam Hosp, Div Cardiol,Dept Med,Cardiovasc Ctr, Seoul, South Korea; [Kim, Je Sang; Lee, Hyun Jong; Choi, Rak Kyeong; Kim, Tae Hoon; Jang, Ho Joon; Choi, Young Jin; Roh, Young Moo; Shim, Won-Heum] Sejong Gen Hosp, Dept Internal Med, Div Cardiol, Bucheon, South Korea	Gyeongsang National University; Gyeongsang National University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Korea University Medicine (KU Medicine); Sejong General Hospital	Choi, SH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Cardiac & Vasc Ctr, Seoul, South Korea.	sh1214.choi@samsung.com	Kim, Tae-Hoon/AAG-3292-2021; Hahn, Joo-Yong/AAU-7250-2020	Hahn, Joo-Yong/0000-0002-4412-377X; Kim, Tae-Hoon/0000-0002-4032-1285				Agostoni P, 2006, AM HEART J, V151, P682, DOI 10.1016/j.ahj.2005.05.001; Alazzoni Ashraf, 2012, Thrombosis, V2012, P126369, DOI 10.1155/2012/126369; Almalla M, 2012, INT J CARDIOL, V157, P451, DOI 10.1016/j.ijcard.2012.04.020; Applegate RJ, 2011, AM J CARDIOL, V107, P833, DOI 10.1016/j.amjcard.2010.10.069; Buller CE, 1999, CIRCULATION, V100, P236, DOI 10.1161/01.CIR.100.3.236; Burzotta F, 2011, JACC-CARDIOVASC INTE, V4, P327, DOI 10.1016/j.jcin.2010.12.005; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; de Waha A, 2011, CIRC-CARDIOVASC INTE, V4, P371, DOI 10.1161/CIRCINTERVENTIONS.111.963256; Eisenstein EL, 2009, JACC-CARDIOVASC INTE, V2, P1199, DOI 10.1016/j.jcin.2009.10.009; Ge L, 2005, EUR HEART J, V26, P1056, DOI 10.1093/eurheartj/ehi191; Godino C, 2013, INT J CARDIOL, V168, P1402, DOI 10.1016/j.ijcard.2012.12.044; Jensen LO, 2012, CIRCULATION, V125, P1246, DOI 10.1161/CIRCULATIONAHA.111.063644; Kimura T, 2012, CIRCULATION, V126, P1225, DOI 10.1161/CIRCULATIONAHA.112.104059; KINOSHITA I, 1995, J AM COLL CARDIOL, V26, P409, DOI 10.1016/0735-1097(95)80015-9; Kirtane AJ, 2013, JACC-CARDIOVASC INTE, V6, P325, DOI 10.1016/j.jcin.2012.12.123; Lanka V, 2014, J INVASIVE CARDIOL, V26, P304; Lansky AJ, 2002, J AM COLL CARDIOL, V39, P274, DOI 10.1016/S0735-1097(01)01745-4; Machado C, 2014, CORONARY ARTERY DIS, V25, P208, DOI 10.1097/MCA.0000000000000078; Maeng M, 2014, LANCET, V383, P2047, DOI 10.1016/S0140-6736(14)60405-0; Moreno R, 2013, CIRC-CARDIOVASC INTE, V6, P21, DOI 10.1161/CIRCINTERVENTIONS.112.000076; Nakamura S, 2005, AM J CARDIOL, V95, P161, DOI 10.1016/j.amjcard.2004.08.088; Olivari Z, 2003, J AM COLL CARDIOL, V41, P1672, DOI 10.1016/S0735-1097(03)00312-7; Park DW, 2010, J AM COLL CARDIOL, V56, P1187, DOI 10.1016/j.jacc.2010.03.086; Park HJ, 2012, CIRC J, V76, P868, DOI 10.1253/circj.CJ-11-1021; Raber L, 2012, CIRCULATION, V125, P1110, DOI 10.1161/CIRCULATIONAHA.111.058560; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Sianos G, 2012, EUROINTERVENTION, V8, P139, DOI 10.4244/EIJV8I1A21; Smits PC, 2011, J AM COLL CARDIOL, V58, P11, DOI 10.1016/j.jacc.2011.02.023; Stone GW, 2011, J AM COLL CARDIOL, V58, P19, DOI 10.1016/j.jacc.2011.02.022; Stone GW, 2005, CIRCULATION, V112, P2364, DOI 10.1161/CIRCULATIONAHA.104.481283; Stone GW, 2005, CIRCULATION, V112, P2530, DOI 10.1161/CIRCULATIONAHA.105.583716; Suttorp MJ, 2006, CIRCULATION, V114, P921, DOI 10.1161/CIRCULATIONAHA.106.613588; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Valenti R, 2013, J AM COLL CARDIOL, V61, P545, DOI 10.1016/j.jacc.2012.10.036; Werner GS, 2004, J AM COLL CARDIOL, V44, P2301, DOI 10.1016/j.jacc.2004.09.040	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157549	10.1371/journal.pone.0157549	http://dx.doi.org/10.1371/journal.pone.0157549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314589	gold, Green Published, Green Submitted			2022-12-26	WOS:000378030000033
J	Schinkel, SCB; Carrasco-Medina, L; Cooper, CL; Crawley, AM				Schinkel, Stephanie C. Burke; Carrasco-Medina, Lorna; Cooper, Curtis L.; Crawley, Angela M.			Generalized Liver- and Blood-Derived CD8(+) T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INTERLEUKIN-7 RECEPTOR EXPRESSION; PERIPHERAL-BLOOD; CD127 EXPRESSION; ANTIRETROVIRAL THERAPY; IMMUNE DYSFUNCTION; HCV INFECTION; HIV-INFECTION; VIRAL PERSISTENCE; MONONUCLEAR-CELLS	Generalized CD8(+) T-cell impairment in chronic hepatitis C virus (HCV) infection and the contribution of liver-infiltrating CD8(+) T-cells to the immunopathogenesis of this infection remain poorly understood. It is hypothesized that this impairment is partially due to reduced CD8(+) T-cell activity in response to cytokines such as IL-7, particularly within the liver. To investigate this, the phenotype and cytokine responsiveness of blood-and liver-derived CD8(+) T-cells from healthy controls and individuals with HCV infection were compared. In blood, IL-7 receptor alpha (CD127) expression on bulk CD8(+) T-cells in HCV infection was no different than controls yet was lower on central memory T-cells, and there were fewer naive cells. IL-7-induced signalling through phosphorylated STAT5 was lower in HCV infection than in controls, and differed between CD8(+) T-cell subsets. Production of Bcl-2 following IL7 stimulation was also lower in HCV infection and inversely related to the degree of liver fibrosis. In liver-derived CD8(+) T-cells, STAT5 activation could not be increased with cytokine stimulation and basal Bcl-2 levels of liver-derived CD8(+) T-cells were lower than bloodderived counterparts in HCV infection. Therefore, generalized CD8(+) T-cell impairment in HCV infection is characterized, in part, by impaired IL-7-mediated signalling and survival, independent of CD127 expression. This impairment is more pronounced in the liver and may be associated with an increased potential for apoptosis. This generalized CD8(+) T-cell impairment represents an important immune dysfunction in chronic HCV infection that may alter patient health.	[Schinkel, Stephanie C. Burke; Crawley, Angela M.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Schinkel, Stephanie C. Burke; Carrasco-Medina, Lorna; Cooper, Curtis L.; Crawley, Angela M.] Ottawa Hosp, Res Inst, Chron Dis Program, Ottawa, ON, Canada; [Cooper, Curtis L.] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Cooper, Curtis L.] Ottawa Hosp Gen Campus, Div Infect Dis, Ottawa, ON, Canada; [Crawley, Angela M.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Carleton University	Crawley, AM (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Crawley, AM (corresponding author), Ottawa Hosp, Res Inst, Chron Dis Program, Ottawa, ON, Canada.; Crawley, AM (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	acrawley@ohri.ca	Cooper, Curtis/M-9320-2019	Crawley, Angela/0000-0002-7453-7922	Ontario Graduate Scholarship; Queen Elizabeth II Graduate Scholarship in Science and Technology; Canadian Institutes of Health Research; Ontario HIV Treatment Network (OHTN); OHTN; Canadian Foundation for AIDS Research; J.P. Bickell Foundation	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Queen Elizabeth II Graduate Scholarship in Science and Technology; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network (OHTN); OHTN; Canadian Foundation for AIDS Research; J.P. Bickell Foundation	S.B.S. was the recipient of the Ontario Graduate Scholarship and the Queen Elizabeth II Graduate Scholarship in Science and Technology. A.M.C. is the recipient of a New Investigator salary award from the Canadian Institutes of Health Research, and a Junior Investigator Development Award from the Ontario HIV Treatment Network (OHTN). This research was funded by the OHTN, Canadian Foundation for AIDS Research and the J.P. Bickell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hakeem MS, 2014, GASTROENTEROLOGY, V147, P870, DOI 10.1053/j.gastro.2014.07.005; Abel M, 2006, HEPATOLOGY, V44, P1607, DOI 10.1002/hep.21438; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barrett L, 2011, J VIRAL HEPATITIS, V18, P170, DOI 10.1111/j.1365-2893.2010.01293.x; Barrett L, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-28; Bazdar DA, 2009, J INFECT DIS, V199, P1019, DOI 10.1086/597210; Bengsch B, 2007, J VIROL, V81, P945, DOI 10.1128/JVI.01354-06; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bertolino P, 2002, IMMUNOL CELL BIOL, V80, P84, DOI 10.1046/j.0818-9641.2001.01048.x; Bonnel AR, 2011, CLIN GASTROENTEROL H, V9, P727, DOI 10.1016/j.cgh.2011.02.031; Borzio M, 2001, DIGEST LIVER DIS, V33, P41, DOI 10.1016/S1590-8658(01)80134-1; Boutboul F, 2005, AIDS, V19, P1981, DOI 10.1097/01.aids.0000191919.24185.46; Chen M, 2005, J IMMUNOL, V175, P1047, DOI 10.4049/jimmunol.175.2.1047; Colle JH, 2006, JAIDS-J ACQ IMM DEF, V42, P277, DOI 10.1097/01.qai.0000214823.11034.4e; Colle JH, 2006, CLIN EXP IMMUNOL, V143, P398, DOI 10.1111/j.1365-2249.2006.03022.x; Collins AS, 2014, J LEUKOCYTE BIOL, V96, P255, DOI 10.1189/jlb.2A1211-608RRRR; Colombat M, 2002, HUM PATHOL, V33, P1170, DOI 10.1053/hupa.2002.129414; Crawley AM, 2014, J LEUKOCYTE BIOL, V95, P117, DOI 10.1189/jlb.0313122; Crawley AM, 2010, J IMMUNOL, V184, P4679, DOI 10.4049/jimmunol.0903758; Faller EM, 2006, JAIDS-J ACQ IMM DEF, V43, P257, DOI 10.1097/01.qai.0000230319.78288.f4; Solari NEF, 2012, J CLIN IMMUNOL, V32, P611, DOI 10.1007/s10875-011-9635-2; Feuth T, 2014, EUR J CLIN MICROBIOL, V33, P1113, DOI 10.1007/s10096-014-2053-7; Gillespie GMA, 2000, J VIROL, V74, P8140, DOI 10.1128/JVI.74.17.8140-8150.2000; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Golden-Mason L, 2006, HEPATOLOGY, V44, P1098, DOI 10.1002/hep.21365; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Graham CS, 2005, AIDS, V19, P767, DOI 10.1097/01.aids.0000168970.80551.3d; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Hartling HJ, 2013, SCAND J IMMUNOL, V78, P378, DOI 10.1111/sji.12096; Hofmeister R, 1999, CYTOKINE GROWTH F R, V10, P41, DOI 10.1016/S1359-6101(98)00025-2; Holz LE, 2012, J HEPATOL, V57, P830, DOI 10.1016/j.jhep.2012.05.015; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; Huang LR, 2013, NAT IMMUNOL, V14, P574, DOI 10.1038/ni.2573; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Jin X, 2000, J INFECT DIS, V181, P165, DOI 10.1086/315201; Jo J, 2009, GASTROENTEROLOGY, V136, P1391, DOI 10.1053/j.gastro.2008.12.034; Juffroy O, 2010, J VIROL, V84, P96, DOI 10.1128/JVI.01475-09; Kimura MY, 2013, NAT IMMUNOL, V14, P143, DOI 10.1038/ni.2494; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Kroy DC, 2014, GASTROENTEROLOGY, V146, P550, DOI 10.1053/j.gastro.2013.10.022; Larrea E, 2014, GUT, V63, P665, DOI 10.1136/gutjnl-2012-304377; Larrubia JR, 2013, J VIRAL HEPATITIS, V20, P85, DOI 10.1111/j.1365-2893.2012.01618.x; Li Y, 2005, J INFECT DIS, V192, P1093, DOI 10.1086/432957; Looney RJ, 1999, CLIN IMMUNOL, V90, P213, DOI 10.1006/clim.1998.4638; Lucas M, 2004, J IMMUNOL, V172, P1744, DOI 10.4049/jimmunol.172.3.1744; MacPherson PA, 2001, J ACQ IMMUN DEF SYND, V28, P454, DOI 10.1097/00042560-200112150-00008; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Marquez M, 2009, CLIN EXP IMMUNOL, V158, P219, DOI 10.1111/j.1365-2249.2009.04005.x; Martinez-Sierra C, 2003, CLIN INFECT DIS, V36, P491, DOI 10.1086/367643; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Meyer-Olson D, 2004, J EXP MED, V200, P307, DOI 10.1084/jem.20040638; Mohsen AH, 2003, GUT, V52, P1035, DOI 10.1136/gut.52.7.1035; Moss P, 2004, HUM IMMUNOL, V65, P456, DOI 10.1016/j.humimm.2004.02.014; Nascimbeni Michelina, 2004, Methods Mol Med, V96, P65; NOURIARIA KT, 1986, J HEPATOL, V2, P195, DOI 10.1016/S0168-8278(86)80078-2; O'Connor AM, 2010, IMMUNOLOGY, V131, P525, DOI 10.1111/j.1365-2567.2010.03325.x; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sasson SC, 2006, J INFECT DIS, V193, P505, DOI 10.1086/499309; Sheahan TP, 2013, GASTROENTEROLOGY, V145, P1199, DOI 10.1053/j.gastro.2013.10.035; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Singhal S, 2000, TRANSPLANTATION, V69, P2251, DOI 10.1097/00007890-200006150-00006; Sipeki N, 2014, WORLD J GASTROENTERO, V20, P2564, DOI 10.3748/wjg.v20.i10.2564; SMYTH MJ, 1991, CELL IMMUNOL, V138, P390, DOI 10.1016/0008-8749(91)90163-6; Sommershof A, 2009, BRAIN BEHAV IMMUN, V23, P1117, DOI 10.1016/j.bbi.2009.07.003; Spangenberg HC, 2005, HEPATOLOGY, V42, P828, DOI 10.1002/hep.20856; Swainson L, 2007, BLOOD, V109, P1034, DOI 10.1182/blood-2006-06-027912; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Tokita D, 2008, J HEPATOL, V49, P1008, DOI 10.1016/j.jhep.2008.07.028; Tripathi P, 2010, J IMMUNOL, V185, P2116, DOI 10.4049/jimmunol.1000842; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Vali B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003454; Valiante NM, 2000, IMMUNOL REV, V174, P77, DOI 10.1034/j.1600-0528.2002.017417.x; Valva P, 2014, CLIN MICROBIOL INFEC, V20, pO998, DOI 10.1111/1469-0691.12728; Vranjkovic A, 2012, AIDS RES HUM RETROV, V28, P295, DOI 10.1089/aid.2011.0003; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Yao ZQ, 2008, IMMUNOLOGY, V125, P197, DOI 10.1111/j.1365-2567.2008.02829.x; Zhao BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077008	79	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157055	10.1371/journal.pone.0157055	http://dx.doi.org/10.1371/journal.pone.0157055			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315061	gold, Green Submitted, Green Published			2022-12-26	WOS:000378030000011
J	Hiebert, CW; Kolmer, JA; McCartney, CA; Briggs, J; Fetch, T; Bariana, H; Choulet, F; Rouse, MN; Spielmeyer, W				Hiebert, Colin W.; Kolmer, James A.; McCartney, Curt A.; Briggs, Jordan; Fetch, Tom; Bariana, Harbans; Choulet, Frederic; Rouse, Matthew N.; Spielmeyer, Wolfgang			Major Gene for Field Stem Rust Resistance Co-Locates with Resistance Gene Sr12 in 'Thatcher' Wheat	PLOS ONE			English	Article							ADULT-PLANT RESISTANCE; RAPID METHOD; RACE TTKS; MARKERS; LEAF; ASSOCIATION; CANTHATCH; VIRULENCE; LR34; ARM	Stem rust, caused by Puccinia graminis (Pgt), is a damaging disease of wheat that can be controlled by utilizing effective stem rust resistance genes. ` Thatcher' wheat carries complex resistance to stem rust that is enhanced in the presence of the resistance gene Lr34. The purpose of this study was to examine APR in ` Thatcher' and look for genetic interactions with Lr34. A RIL population was tested for stem rust resistance in field nurseries in Canada, USA, and Kenya. BSA was used to find SNP markers associated with reduced stem rust severity. A major QTL was identified on chromosome 3BL near the centromere in all environments. Seedling testing showed that Sr12 mapped to the same region as the QTL for APR. The SNP markers were physically mapped and the region carrying the resistance was searched for sequences with homology to members of the NB-LRR resistance gene family. SNP marker from one NB-LRR-like sequence, NB-LRR3 co-segregated with Sr12. Two additional populations, including one that lacked Lr34, were tested in field nurseries. NB-LRR3 mapped near the maximum LOD for reduction in stem rust severity in both populations. Lines from a population that segregated for Sr12 and Lr34 were tested for seedling Pgt biomass and infection type, as well as APR to field stem rust which showed an interaction between the genes. We concluded that Sr12, or a gene closely linked to Sr12, was responsible for ` Thatcher'-derived APR in several environments and this resistance was enhanced in the presence of Lr34.	[Hiebert, Colin W.; McCartney, Curt A.] Agr & Agri Food Canada, Cereal Res Ctr, Morden, MB, Canada; [Kolmer, James A.; Briggs, Jordan; Rouse, Matthew N.] Univ Minnesota, Dept Plant Pathol, St Paul, MN USA; [Kolmer, James A.; Rouse, Matthew N.] USDA ARS, Cereal Dis Lab, St Paul, MN USA; [Fetch, Tom] Agr & Agri Food Canada, Brandon Res Ctr, Brandon, MB, Canada; [Bariana, Harbans] Univ Sydney, Plant Breeding Inst, Cobbitty, NSW, Australia; [Choulet, Frederic] INRA UMR1095 Genet Divers & Ecophysiol Cereals, Clermont Ferrand, France; [Spielmeyer, Wolfgang] CSIRO, Agr & Food, Canberra, ACT, Australia	Agriculture & Agri Food Canada; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); Agriculture & Agri Food Canada; University of Sydney; INRAE; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Spielmeyer, W (corresponding author), CSIRO, Agr & Food, Canberra, ACT, Australia.	Wolfgang.Spielmeyer@csiro.au	Rouse, Matthew N/G-5474-2011; Spielmeyer, Wolfgang/M-3254-2018	Spielmeyer, Wolfgang/0000-0002-5115-7820; Choulet, Frederic/0000-0003-1788-7288	USDA-ARS Appropriated Project [5062-21220-021-00]; USDA-ARS National Plant Disease Recovery System; Durable Rust Resistance in Wheat project; Saskatchewan Agriculture Development Fund [20080009]; Agriculture and Agri-Food Canada Growing Forward; Genome Canada; Saskatchewan Ministry of Agriculture,; Western Grain Research Foundation; ARS [ARS-0423040] Funding Source: Federal RePORTER	USDA-ARS Appropriated Project; USDA-ARS National Plant Disease Recovery System; Durable Rust Resistance in Wheat project; Saskatchewan Agriculture Development Fund; Agriculture and Agri-Food Canada Growing Forward(Agriculture & Agri Food Canada); Genome Canada(Genome Canada); Saskatchewan Ministry of Agriculture,; Western Grain Research Foundation; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors thank USDA-ARS Appropriated Project 5062-21220-021-00, USDA-ARS National Plant Disease Recovery System, the Durable Rust Resistance in Wheat project (MNR), Saskatchewan Agriculture Development Fund project #20080009 (CAM), Agriculture and Agri-Food Canada Growing Forward (CWH, TF, CAM), and as part of CTAG, a Genome Prairie project funded by Genome Canada, Saskatchewan Ministry of Agriculture, and Western Grain Research Foundation (CAM) for financial support. This project was also supported through a grant CIM/2007/084 provided by Australian Centre of International Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Mira Popovic, Ghassan Mardli, Tobi Malasiuk, Elaine Martineau, Taye Zegeye, Alison Morgan, Jessica Hyles, and Shideh Mojerlou for excellent technical assistance. The authors thank USDA-ARS Appropriated Project 5062-21220-021-00, USDA-ARS National Plant Disease Recovery System, the Durable Rust Resistance in Wheat project (MNR), Saskatchewan Agriculture Development Fund project #20080009 (CAM), Agriculture and Agri-Food Canada Growing Forward (CWH, TF, CAM), and as part of CTAG, a Genome Prairie project funded by Genome Canada, Saskatchewan Ministry of Agriculture, and Western Grain Research Foundation (CAM) for financial support. This project was also supported through a grant CIM/2007/084 provided by Australian Centre of International Agricultural Research. We also thank Dr Sridhar Bhavani for providing access to stem rust nursery at Njoro, Kenya.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Ayliffe M, 2013, MOL PLANT MICROBE IN, V26, P658, DOI 10.1094/MPMI-12-12-0291-R; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; DYCK PL, 1991, CROP SCI, V31, P309, DOI 10.2135/cropsci1991.0011183X003100020016x; DYCK PL, 1993, GENOME, V36, P289, DOI 10.1139/g93-040; DYCK PL, 1987, GENOME, V29, P467, DOI 10.1139/g87-081; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Green G. J., 1975, Canadian Plant Disease Survey, V55, P85; Hayes HK, 1936, MINN AGR EXP STN TEC, P325; Hiebert CW, 2011, THEOR APPL GENET, V122, P143, DOI 10.1007/s00122-010-1430-6; HUGHES GR, 1991, CAN J PLANT SCI, V71, P1165, DOI 10.4141/cjps91-162; Jin Y, 2008, PLANT DIS, V92, P923, DOI 10.1094/PDIS-92-6-0923; Jin Y, 2007, PLANT DIS, V91, P1096, DOI 10.1094/PDIS-91-9-1096; Jin Y, 2009, PLANT DIS, V93, P367, DOI 10.1094/PDIS-93-4-0367; Kerber ER, 1999, PHYTOPATHOLOGY, V89, P518, DOI 10.1094/PHYTO.1999.89.6.518; KERBER ER, 1991, GENOME, V34, P935, DOI 10.1139/g91-144; KERBER ER, 1980, CAN J BOT, V58, P1347, DOI 10.1139/b80-166; Knott DR, 2000, CAN J PLANT SCI, V80, P53, DOI 10.4141/P99-016; Kolmer JA, 2011, CROP SCI, V51, P526, DOI 10.2135/cropsci2010.06.0381; Lagudah ES, 2009, THEOR APPL GENET, V119, P889, DOI 10.1007/s00122-009-1097-z; Liu JQ, 1998, PHYTOPATHOLOGY, V88, P171, DOI 10.1094/PHYTO.1998.88.2.171; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; Luig NH., 1983, ADV PLANT BREEDING, V11; McCallum BD, 2008, CAN J PLANT SCI, V88, P649, DOI 10.4141/CJPS07159; MCINTOSH R A, 1980, Cereal Research Communications, V8, P321; Meng L, 2015, CROP J, V3, P269, DOI 10.1016/j.cj.2015.01.001; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; NAZARENO NRX, 1981, PHYTOPATHOLOGY, V71, P181, DOI 10.1094/Phyto-71-181; Pallotta M.A., 2003, P 10 INT WHEAT GEN S, P789; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; PETURSON BJORN, 1958, CANADIAN JOUR PLANT SCI, V38, P16; Pretorius Z. A., 2000, Plant Disease, V84, P203, DOI 10.1094/PDIS.2000.84.2.203B; Roder MS, 1998, GENETICS, V149, P2007; Rouse MN, 2014, THEOR APPL GENET, V127, P1549, DOI 10.1007/s00122-014-2319-6; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; SINGH RP, 1992, PHYTOPATHOLOGY, V82, P835, DOI 10.1094/Phyto-82-835; SINGH RP, 1993, PLANT DIS, V77, P1103, DOI 10.1094/PD-77-1103; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Song QJ, 2005, THEOR APPL GENET, V110, P550, DOI 10.1007/s00122-004-1871-x; Sourdille Pierre, 2004, Functional & Integrative Genomics, V4, P12, DOI 10.1007/s10142-004-0106-1; Spielmeyer W, 2005, THEOR APPL GENET, V111, P731, DOI 10.1007/s00122-005-2058-9; STAKMAN E. C., 1962, Identification of physiologic races of Puccinia graminis var. tritici.; Thomas J, 1997, GENOME, V40, P552, DOI 10.1139/g97-072; TOWNLEYSMITH TF, 1993, CAN J PLANT SCI, V73, P1095, DOI 10.4141/cjps93-146; Tsilo TJ, 2007, CROP SCI, V47, P2013, DOI 10.2135/cropsci2007.02.0087; Vanegas CDG, 2008, EUPHYTICA, V159, P391, DOI 10.1007/s10681-007-9541-0	48	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157029	10.1371/journal.pone.0157029	http://dx.doi.org/10.1371/journal.pone.0157029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309724	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800029
J	Vernaz, N; Girardin, F; Goossens, N; Brugger, U; Riguzzi, M; Perrier, A; Negro, F				Vernaz, Nathalie; Girardin, Francois; Goossens, Nicolas; Brugger, Urs; Riguzzi, Marco; Perrier, Arnaud; Negro, Francesco			Drug Pricing Evolution in Hepatitis C	PLOS ONE			English	Article							GENOTYPE 1 INFECTION; SUSTAINED VIROLOGICAL RESPONSE; TREATMENT-NAIVE PATIENTS; INTERFERON-ALPHA 2A; COST-EFFECTIVENESS; PLUS RIBAVIRIN; DOUBLE-BLIND; CHRONIC HCV; INITIAL TREATMENT; VIRUS TREATMENT	Objective We aimed to determine the association between the stepwise increase in the sustained viral response (SVR) and Swiss and United States (US) market prices of drug regimens for treatment-naive, genotype 1 chronic hepatitis C virus (HCV) infection in the last 25 years. We identified the following five steps in the development of HCV treatment regimens: 1) interferon (IFN)-alpha monotherapy in the early '90s, 2) IFN-alpha in combination with ribavirin (RBV), 3) pegylated (peg) IFN-alpha in combination with RBV, 4) the first direct acting antivirals (DAAs) (telaprevir and boceprevir) in combination with pegIFN-alpha and RBV, and 5) newer DAA-based regimens, such as sofosbuvir (which is or is not combined with ledipasvir) and fixed-dose combination of ritonavir-boosted paritaprevir and ombitasvir in combination with dasabuvir. Design We performed a linear regression and mean cost analysis to test for an association between SVRs and HCV regimen prices. We conducted a sensitivity analysis using US prices at the time of US drug licensing. We selected randomized clinical trials of drugs approved for use in Switzerland from 1997 to July 2015 including treatment-naive patients with HCV genotype 1 infection. Results We identified a statistically significant positive relationship between the proportion of patients achieving SVRs and the costs of HCV regimens in Switzerland ( with a bivariate ordinary least square regression yielding an R2 measure of 0.96) and the US ( R2 = 0.95). The incremental cost per additional percentage of SVR was 597.14 USD in Switzerland and 1,063.81 USD in the US. Conclusion The pricing of drugs for HCV regimens follows a value-based model, which has a stable ratio of costs per achieved SVR over 25 years. Health care systems are struggling with the high resource use of these new agents despite their obvious long-term advantages for the overall health of the population. Therefore, the pharmaceutical industry, health care payers and other stakeholders are challenged with finding new drug pricing schemes to treat the entire population infected with HCV.	[Vernaz, Nathalie; Girardin, Francois; Perrier, Arnaud] Univ Geneva, Univ Hosp Geneva, Med Direct, Geneva, Switzerland; [Vernaz, Nathalie] Univ Hosp Geneva, Finance Direct, Geneva, Switzerland; [Girardin, Francois] Univ Geneva, Univ Hosp Geneva, Div Clin Pharmacol & Toxicol, Geneva, Switzerland; [Goossens, Nicolas] Univ Geneva, Univ Hosp Geneva, Div Gastroenterol, Geneva, Switzerland; [Goossens, Nicolas] Univ Geneva, Univ Hosp Geneva, Div Hepatol, Geneva, Switzerland; [Brugger, Urs; Riguzzi, Marco] Zurich Univ Appl Sci, Winterthur Inst Hlth Econ, Winterthur, Switzerland; [Perrier, Arnaud] Univ Geneva, Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Negro, Francesco] Univ Hosp Geneva, Div Gastroenterol, Geneva, Switzerland; [Negro, Francesco] Univ Hosp Geneva, Div Hepatol & Clin Pathol, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; Zurich University of Applied Sciences; University of Geneva; University of Geneva; University of Geneva	Vernaz, N (corresponding author), Univ Geneva, Univ Hosp Geneva, Med Direct, Geneva, Switzerland.; Vernaz, N (corresponding author), Univ Hosp Geneva, Finance Direct, Geneva, Switzerland.	nathalie.vernaz@hcuge.ch	Girardin, Francois/F-5443-2017; Negro, Francesco/E-2183-2012	Girardin, Francois/0000-0002-0842-927X; Vernaz, Nathalie/0000-0002-1371-5510				Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Andrieux-Meyer I, 2015, LANCET GLOB HEALTH, V3, pE676, DOI 10.1016/S2214-109X(15)00156-4; [Anonymous], 2015, REUTERS         0630; [Anonymous], 2014, 25 YEARS PROGR HEP C; Bach PB, 2015, NEW ENGL J MED, V373, P1797, DOI 10.1056/NEJMp1512750; Bichoupan K, 2014, HEPATOLOGY, V60, P1187, DOI 10.1002/hep.27340; Brunetto MR, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3363; Buti M, 2014, GASTROENTEROLOGY, V146, P744, DOI 10.1053/j.gastro.2013.11.047; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Ezekiel J., 2015, NY TIMES; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Girardin F, 2015, Rev Med Suisse, V11, P1610; Jacobson IM, 2014, LANCET, V384, P403, DOI 10.1016/S0140-6736(14)60494-3; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kamal-Yanni M, 2015, LANCET GLOB HEALTH, V3, pE73, DOI 10.1016/S2214-109X(14)70365-1; Kmietowicz Z, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3222; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371; Mailankody S, 2015, JAMA ONCOL, V1, P539, DOI 10.1001/jamaoncol.2015.0373; Manns M, 2014, LANCET, V384, P414, DOI 10.1016/S0140-6736(14)60538-9; Manns MP, 2007, NAT REV DRUG DISCOV, V6, P991, DOI 10.1038/nrd2411; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marinho RT, 2013, WORLD J GASTROENTERO, V19, P6703, DOI 10.3748/wjg.v19.i40.6703; McCarthy M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5989; McCarthy M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2055; Messori A, 2014, ALIMENT PHARM THER, V40, P217, DOI 10.1111/apt.12823; Morisco F, 2013, WORLD J GASTROENTERO, V19, P2793, DOI 10.3748/wjg.v19.i18.2793; Mullhaupt B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125214; Muller KR, 2011, ISPOR GLOBAL HLTH CA; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Najafzadeh M, 2015, ANN INTERN MED, V162, P407, DOI 10.7326/M14-1152; Neumann PJ, 2011, HEALTH AFFAIR, V30, P2329, DOI 10.1377/hlthaff.2010.1147; Paris V, 2007, PHARM PRICING REIMBU, P27; Pfeil AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126984; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2686; Silva MO, 2013, J HEPATOL, V59, P31, DOI 10.1016/j.jhep.2013.02.018; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; van de Ven N, 2015, HEPATOLOGY, V61, P1174, DOI 10.1002/hep.27641; van de Vooren K, 2015, EUR J HEALTH ECON, V16, P341, DOI 10.1007/s10198-014-0653-x; van de Vooren KV, 2014, APPL HEALTH ECON HEA, V12, P33, DOI 10.1007/s40258-013-0064-7; Vernaz N, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001460; Zoulim F, 2015, GUT, V64, P1824, DOI 10.1136/gutjnl-2015-310421	46	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157098	10.1371/journal.pone.0157098	http://dx.doi.org/10.1371/journal.pone.0157098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310294	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800033
J	Doudican, NA; Orlow, SJ				Doudican, N. A.; Orlow, S. J.			Inhibition of the CRAF/prohibitin interaction reverses CRAF-dependent resistance to vemurafenib	ONCOGENE			English	Article							BRAF V600E MUTATION; RAF INHIBITION; B-RAF; MELANOMA; PROHIBITIN; CELLS; SURVIVAL; PATHWAY; MEK; ACTIVATION	Activating BRAF mutations promote constitutive activation of the mitogen-activated protein kinase (MAPK) signaling pathway and are common in a variety of human malignancies, including melanoma and colon cancer. Several small molecule BRAF inhibitors such as vemurafenib have been developed and demonstrate remarkable clinical efficacy. However, resistance typically emerges in most melanoma patients. Studies have demonstrated that reactivation of MAPK signaling via CRAF overexpression and dysregulation is a mechanism for vemurafenib resistance in melanoma. Prohibitins (PHBs) are highly conserved proteins that are thought to control the cell cycle, senescence and tumor suppression. PHB1 is essential for CRAF-mediated ERK1/2 activation through direct binding to CRAF. We developed a CRAF-mediated model of vemurafenib resistance in melanoma cells to assess the importance of the interaction between CRAF and PHB1 in resistance to BRAF-targeting agents. We demonstrate that CRAF overexpression renders melanoma cells resistant to BRAF-targeting agents. Moreover, treatment with the natural compound rocaglamide A disrupts the interaction between PHB and CRAF in melanoma cells, thus reducing MEK1/2 and ERK1/2 signaling, inhibiting melanoma cell growth and inducing apoptosis. The efficacy of these compounds was also demonstrated in a human melanoma xenograft model. Taken together, these data suggest that PHB1 may serve as a novel, druggable target in CRAF-mediated vemurafenib resistance.	[Doudican, N. A.; Orlow, S. J.] NYU, Sch Med, Ronald O Perelman Dept Dermatol, 522 First Ave,Smilow 401, New York, NY 10016 USA; [Orlow, S. J.] NYU, Sch Med, Dept Cell Biol, New York, NY USA	New York University; New York University	Orlow, SJ (corresponding author), NYU, Sch Med, Ronald O Perelman Dept Dermatol, 522 First Ave,Smilow 401, New York, NY 10016 USA.	seth.orlow@nyumc.org		Orlow, Seth/0000-0003-2548-7380	Orbuch & Brand Pilot Grant Program for Cancers of the Skin; Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center [P30CA016087]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER	Orbuch & Brand Pilot Grant Program for Cancers of the Skin; Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the NYUMC Immunohistochemistry Core for their help with the immunohistochemistry experiments. This study was supported by the Orbuch & Brand Pilot Grant Program for Cancers of the Skin. The NYUMC Immunohistochemistry Core performed the immunohistochemistry experiments outlined in this manuscript. This shared resource is partially supported by the Cancer Center Support Grant, P30CA016087, at the Laura and Isaac Perlmutter Cancer Center.	Al-Obeidi FA, 2000, ONCOGENE, V19, P5690, DOI 10.1038/sj.onc.1203926; ASAMOTO M, 1994, CANCER LETT, V83, P201, DOI 10.1016/0304-3835(94)90320-4; Barras David, 2015, Biomark Cancer, V7, P9, DOI 10.4137/BIC.S25248; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Choi J, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12197; Chowdhury Indrajit, 2012, Front Biosci (Elite Ed), V4, P690; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Doudican N, 2008, MOL CANCER RES, V6, P1308, DOI 10.1158/1541-7786.MCR-07-2159; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hossen MN, 2010, J CONTROL RELEASE, V147, P261, DOI 10.1016/j.jconrel.2010.07.100; Jakob JA, 2012, CANCER-AM CANCER SOC, V118, P4014, DOI 10.1002/cncr.26724; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johansson CH, 2014, PHARMACOL THERAPEUT, V142, P176, DOI 10.1016/j.pharmthera.2013.11.011; Katona TM, 2007, AM J SURG PATHOL, V31, P1029, DOI 10.1097/PAS.0b013e31802b3488; Li DD, 2015, FRONT BIOSCI-LANDMRK, V20, P1068, DOI 10.2741/4359; Luan Z, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-38; Mao ML, 2013, CLIN CANCER RES, V19, P657, DOI 10.1158/1078-0432.CCR-11-1446; Martin-Liberal J, 2015, FUTURE ONCOL, V11, P579, DOI 10.2217/fon.14.252; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Peng YT, 2015, APOPTOSIS, V20, P1135, DOI 10.1007/s10495-015-1143-z; Polier G, 2012, CHEM BIOL, V19, P1093, DOI 10.1016/j.chembiol.2012.07.012; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Robert C, 2011, CURR OPIN ONCOL, V23, P177, DOI 10.1097/CCO.0b013e3283436e8c; Ross JA, 2008, J BIOL CHEM, V283, P4699, DOI 10.1074/jbc.M708232200; Smalley KSM, 2008, MOL CANCER THER, V7, P2876, DOI 10.1158/1535-7163.MCT-08-0431; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Spagnolo F, 2015, ONCOTARGETS THER, V8, P157, DOI 10.2147/OTT.S39096; Sripathi SR, 2011, BIOCHEMISTRY-US, V50, P8342, DOI 10.1021/bi2008933; Su F, 2012, CANCER RES, V72, P969, DOI 10.1158/0008-5472.CAN-11-1875; Sullivan RJ, 2013, ONCOGENE, V32, P2373, DOI 10.1038/onc.2012.345; Tan YH, 2008, PATHOLOGY, V40, P295, DOI 10.1080/00313020801911512; Tu NN, 2015, J THORAC ONCOL, V10, P1396, DOI 10.1097/JTO.0000000000000644; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Yancovitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029336; Zhou TB, 2013, J RECEPT SIG TRANSD, V33, P28, DOI 10.3109/10799893.2012.752006; Zhu JY, 2007, INT J CANCER, V121, P1839, DOI 10.1002/ijc.22883	45	25	26	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 19	2017	36	3					423	428		10.1038/onc.2016.214	http://dx.doi.org/10.1038/onc.2016.214			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IB	27321184				2022-12-26	WOS:000394166000011
J	Bao, HY; Li, FD; Wang, CY; Wang, N; Jiang, YY; Tang, YJ; Wu, JH; Shi, YY				Bao, Hongyu; Li, Fudong; Wang, Chongyuan; Wang, Na; Jiang, Yiyang; Tang, Yajun; Wu, Jihui; Shi, Yunyu			Structural Basis for the Specific Recognition of RhoA by the Dual GTPase-activating Protein ARAP3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURITE OUTGROWTH; RHOGAP; ARF; FAMILY; P190RHOGAP; REGULATORS; MIGRATION; ADHESION; REVEALS; COMPLEX	ARAP3 (Arf-GAP with Rho-GAP domain, ANK repeat, and PH domain-containing protein 3) is unique for its dual specificity GAPs (GTPase-activating protein) activity for Arf6 (ADP-ribosylation factor 6) and RhoA (Ras homolog gene family member A) regulated by phosphatidylinositol 3,4,5-trisphosphate and a small GTPase Rap1-GTP and is involved in regulation of cell shape and adhesion. However, the molecular interface between the ARAP3-RhoGAP domain and RhoA is unknown, as is the substrates specificity of the RhoGAP domain. In this study, we solved the crystal structure of RhoA in complex with the RhoGAP domain of ARAP3. The structure of the complex presented a clear interface between the RhoGAP domain and RhoA. By analyzing the crystal structure and in combination with in vitro GTPase activity assays and isothermal titration calorimetry experiments, we identified the crucial residues affecting RhoGAP activity and substrates specificity among RhoA, Rac1 (Ras-related C3 botulinum toxin substrate 1), and Cdc42 (cell division control protein 42 homolog).	[Wu, Jihui; Shi, Yunyu] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Collaborat Innovat Ctr Chem Life Sci, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, JH; Shi, YY (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Collaborat Innovat Ctr Chem Life Sci, Hefei 230027, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Shi, Yunyu/B-3240-2009	Shi, Yunyu/0000-0002-1348-4759; Jihui, Wu/0000-0002-4339-0518; Bao, Hongyu/0000-0002-6563-1626	National Basic Research Program of China 973 Program [2012CB917201]; Chinese National Natural Science Foundation [31330018, 31170693]; Hefei Center for Physical Science and Technology Grant [2012FXZY002]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010101]	National Basic Research Program of China 973 Program(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Hefei Center for Physical Science and Technology Grant; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China 973 Program Grant 2012CB917201; Chinese National Natural Science Foundation Grants 31330018 and 31170693; Hefei Center for Physical Science and Technology Grant 2012FXZY002; and Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB08010101. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BARFOD ET, 1993, J BIOL CHEM, V268, P26059; Bryan BA, 2005, CELL MOL LIFE SCI, V62, P1547, DOI 10.1007/s00018-005-5029-z; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Craig HE, 2010, CELL SIGNAL, V22, P257, DOI 10.1016/j.cellsig.2009.09.025; Csepanyi-Komi R, 2012, MOL CELL ENDOCRINOL, V353, P10, DOI 10.1016/j.mce.2011.11.005; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DeLano W, 2002, PYMOL 0 99; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gambardella L, 2011, BLOOD, V118, P1087, DOI 10.1182/blood-2010-10-312959; Gambardella L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001026; Graham DL, 2002, CHEM BIOL, V9, P375, DOI 10.1016/S1074-5521(02)00112-6; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ismail SA, 2010, CELL, V141, P812, DOI 10.1016/j.cell.2010.03.051; Jeon CY, 2012, J NEUROCHEM, V120, P684, DOI 10.1111/j.1471-4159.2011.07564.x; Jeon CY, 2010, J CELL PHYSIOL, V224, P786, DOI 10.1002/jcp.22184; Jeon CY, 2010, EXP MOL MED, V42, P335, DOI 10.3858/emm.2010.42.5.035; Kong RR, 2015, J CLIN INVEST, V125, P4407, DOI 10.1172/JCI81673; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krugmann S, 2006, J CELL SCI, V119, P425, DOI 10.1242/jcs.02755; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Levay M, 2009, BIOCHEMISTRY-US, V48, P8615, DOI 10.1021/bi900667y; Ligeti E, 2004, J BIOL CHEM, V279, P5055, DOI 10.1074/jbc.C300547200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Moon MY, 2013, J CELL PHYSIOL, V228, P2119, DOI 10.1002/jcp.24383; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Riching KM, 2015, INT J BIOCHEM CELL B, V59, P111, DOI 10.1016/j.biocel.2014.11.007; Ridley AJ, 2013, J MICROSC-OXFORD, V251, P242, DOI 10.1111/jmi.12025; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; vanLeeuwen HC, 1997, EMBO J, V16, P2043, DOI 10.1093/emboj/16.8.2043; Wang L, 2005, P NATL ACAD SCI USA, V102, P13484, DOI 10.1073/pnas.0504420102; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Yagi R, 2011, ONCOGENE, V30, P1413, DOI 10.1038/onc.2010.522; Yamada T, 2005, J BIOL CHEM, V280, P33026, DOI 10.1074/jbc.M504587200; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999	44	7	7	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16709	16719		10.1074/jbc.M116.736140	http://dx.doi.org/10.1074/jbc.M116.736140			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27311713	Green Published, hybrid			2022-12-26	WOS:000380826700028
J	Sen, A; Hongpaisan, J; Wang, DS; Nelson, TJ; Alkon, DL				Sen, Abhik; Hongpaisan, Jarin; Wang, Desheng; Nelson, Thomas J.; Alkon, Daniel L.			Protein Kinase C epsilon (PKC epsilon) Promotes Synaptogenesis through Membrane Accumulation of the Postsynaptic Density Protein PSD-95	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; UP-REGULATION; NEUROTROPHIC FACTOR; STRUCTURAL BASIS; SYNAPTIC LOSS; MEMORY; ACTIVATION; PHOSPHORYLATION; TRANSLOCATION; EXPRESSION	Protein kinase C epsilon (PKC epsilon) promotes synaptic maturation and synaptogenesis via activation of synaptic growth factors such as BDNF, NGF, and IGF. However, many of the detailed mechanisms by which PKC epsilon induces synaptogenesis are not fully understood. Accumulation of PSD-95 to the postsynaptic density (PSD) is known to lead to synaptic maturation and strengthening of excitatory synapses. Here we investigated the relationship between PKC epsilon and PSD-95. We show that the PKC epsilon activators dicyclopropanated linoleic acid methyl ester and bryostatin 1 induce phosphorylation of PSD-95 at the serine 295 residue, increase the levels of PSD-95, and enhance its membrane localization. Elimination of the serine 295 residue in PSD-95 abolished PKC epsilon-induced membrane accumulation. Knockdown of either PKC epsilon or JNK1 prevented PKC epsilon activator-mediated membrane accumulation of PSD-95. PKC epsilon directly phosphorylated PSD-95 and JNK1 in vitro. Inhibiting PKC epsilon, JNK, or calcium/calmodulin-dependent kinase II activity prevented the effects of PKC epsilon activators on PSD-95 phosphorylation. Increase in membrane accumulation of PKC epsilon and phosphorylated PSD-95 (p-PSD-95(S295)) coincided with an increased number of synapses and increased amplitudes of excitatory post-synaptic potentials (EPSPs) in adult rat hippocampal slices. Knockdown of PKC epsilon also reduced the synthesis of PSD-95 and the presynaptic protein synaptophysin by 30 and 44%, respectively. Prolonged activation of PKC epsilon increased synapse number by 2-fold, increased presynaptic vesicle density, and greatly increased PSD-95 clustering. These results indicate that PKC epsilon promotes synaptogenesis by activating PSD-95 phosphorylation directly through JNK1 and calcium/calmodulin-dependent kinase II and also by inducing expression of PSD-95 and synaptophysin.	[Sen, Abhik; Hongpaisan, Jarin; Wang, Desheng; Nelson, Thomas J.; Alkon, Daniel L.] Blanchette Rockefeller Neurosci Inst, 8 Med Ctr Dr, Morgantown, WV 26505 USA		Sen, A (corresponding author), Blanchette Rockefeller Neurosci Inst, 8 Med Ctr Dr, Morgantown, WV 26505 USA.	asen@brni.org	Sen, Abhik/L-2067-2017	Sen, Abhik/0000-0003-4048-0566				AKERS RF, 1986, SCIENCE, V231, P587, DOI 10.1126/science.3003904; Akita Y, 2002, J BIOCHEM, V132, P847, DOI 10.1093/oxfordjournals.jbchem.a003296; ALKON DL, 1988, SCIENCE, V239, P998, DOI 10.1126/science.2830669; Alkon DL, 2005, P NATL ACAD SCI USA, V102, P16432, DOI 10.1073/pnas.0508001102; BANK B, 1988, P NATL ACAD SCI USA, V85, P1988, DOI 10.1073/pnas.85.6.1988; Barker AJ, 2008, J NEUROSCI, V28, P8150, DOI 10.1523/JNEUROSCI.1744-08.2008; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bell KFS, 2011, CURR OPIN NEUROBIOL, V21, P299, DOI 10.1016/j.conb.2011.01.002; Boersma MCH, 2011, J NEUROSCI, V31, P5414, DOI 10.1523/JNEUROSCI.2456-10.2011; Brooks IM, 2011, J BIOL CHEM, V286, P6697, DOI 10.1074/jbc.M110.183558; Caino MC, 2011, J BIOL CHEM, V286, P11254, DOI 10.1074/jbc.M110.194332; Chen Yuan, 2011, Front Med, V5, P70, DOI 10.1007/s11684-011-0119-9; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Coffey ET, 1997, NEUROSCI LETT, V227, P177, DOI 10.1016/S0304-3940(97)00335-2; Comalada N, 2003, AM J PHYSIOL-CELL PH, V285, pC1235, DOI 10.1152/ajpcell.00228.2003; De Roo M, 2008, CEREB CORTEX, V18, P151, DOI 10.1093/cercor/bhm041; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fagerstrom S, 1996, CELL GROWTH DIFFER, V7, P775; Farias GG, 2009, J BIOL CHEM, V284, P15857, DOI 10.1074/jbc.M808986200; Ferrari LF, 2013, J NEUROSCI, V33, P11002, DOI 10.1523/JNEUROSCI.1785-13.2013; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gomes AR, 2007, TRAFFIC, V8, P259, DOI 10.1111/j.1600-0854.2006.00521.x; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; Hongpaisan J, 2007, P NATL ACAD SCI USA, V104, P19571, DOI 10.1073/pnas.0709311104; Hongpaisan J, 2013, NEUROBIOL DIS, V55, P44, DOI 10.1016/j.nbd.2013.03.012; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; Hurd C, 2002, ONCOGENE, V21, P2154, DOI 10.1038/sj.onc.1205290; Ippolito Dominic M, 2010, J Vis Exp, DOI 10.3791/2270; Kajiya M, 2009, J CELL PHYSIOL, V221, P696, DOI 10.1002/jcp.21909; Kanno T, 2006, J LIPID RES, V47, P1146, DOI 10.1194/jlr.M500329-JLR200; Kellner Yves, 2014, Front Synaptic Neurosci, V6, P5, DOI 10.3389/fnsyn.2014.00005; Khan TK, 2015, J ALZHEIMERS DIS, V43, P491, DOI 10.3233/JAD-141221; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim H, 2013, PROG NEURO-PSYCHOPH, V41, P36, DOI 10.1016/j.pnpbp.2012.11.004; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Kortmansky J, 2003, CANCER INVEST, V21, P924, DOI 10.1081/CNV-120025095; Lang WH, 2004, CELL SIGNAL, V16, P457, DOI 10.1016/j.cellsig.2003.09.002; Li YK, 1996, J BIOL CHEM, V271, P27025, DOI 10.1074/jbc.271.43.27025; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Lim CS, 2012, HIPPOCAMPUS, V22, P2303, DOI 10.1002/hipo.22048; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; Nelson TJ, 2015, BRAIN RES, V1621, P239, DOI 10.1016/j.brainres.2014.11.054; Nelson TJ, 2014, J CHROMATOGR B, V944, P55, DOI 10.1016/j.jchromb.2013.11.020; Nelson TJ, 2009, J BIOL CHEM, V284, P34514, DOI 10.1074/jbc.M109.016683; NELSON TJ, 1990, SCIENCE, V247, P1479, DOI 10.1126/science.2108498; OLDS JL, 1989, SCIENCE, V245, P866, DOI 10.1126/science.2772638; Pascale A, 2004, P NATL ACAD SCI USA, V101, P1217, DOI 10.1073/pnas.0307674100; Prekeris R, 1998, J BIOL CHEM, V273, P26790, DOI 10.1074/jbc.273.41.26790; Prekeris R, 1996, J CELL BIOL, V132, P77, DOI 10.1083/jcb.132.1.77; Sen A, 2015, J NEUROSCI, V35, P7538, DOI 10.1523/JNEUROSCI.0260-15.2015; Sen A, 2012, J BIOL CHEM, V287, P15947, DOI 10.1074/jbc.M111.312710; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Stein V, 2003, J NEUROSCI, V23, P5503; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sun MK, 2008, P NATL ACAD SCI USA, V105, P13620, DOI 10.1073/pnas.0805952105; Sun MK, 2015, TRENDS PHARMACOL SCI, V36, P384, DOI 10.1016/j.tips.2015.04.004; Sun MK, 2014, J PHARMACOL EXP THER, V349, P393, DOI 10.1124/jpet.114.214098; Sun MK, 2009, ARCH PHARM, V342, P689, DOI 10.1002/ardp.200900050; Tokuda K, 2013, NEUROSCI LETT, V537, P40, DOI 10.1016/j.neulet.2013.01.018; WAXHAM MN, 1993, BIOCHEMISTRY-US, V32, P2923, DOI 10.1021/bi00062a024; Yan JZ, 2011, J BIOL CHEM, V286, P25187, DOI 10.1074/jbc.M110.192708; Yang HH, 2011, EUR J NEUROSCI, V33, P1647, DOI 10.1111/j.1460-9568.2011.07661.x; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; Zeidman R, 1999, J CELL BIOL, V145, P713, DOI 10.1083/jcb.145.4.713	71	18	18	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16462	16476		10.1074/jbc.M116.730440	http://dx.doi.org/10.1074/jbc.M116.730440			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27330081	Green Published, hybrid			2022-12-26	WOS:000380826700005
J	Dajkovic, A; Hinde, E; MacKichan, C; Carballido-Lopez, R				Dajkovic, Alex; Hinde, Elizabeth; MacKichan, Calum; Carballido-Lopez, Rut			Dynamic Organization of SecA and SecY Secretion Complexes in the B-subtilis Membrane	PLOS ONE			English	Article							PAIR CORRELATION-ANALYSIS; COLI PLASMA-MEMBRANE; PROTEIN TRANSLOCATION; ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM; SIGNAL SEQUENCE; MOLECULAR-FLOW; BINDING; BACTERIA; MACHINERY	In prokaryotes, about one third of cellular proteins are translocated across the plasma membrane or inserted into it by concerted action of the cytoplasmic ATPase SecA and the universally conserved SecYEG heterotrimeric polypeptide-translocating pore. Secretion complexes have been reported to localize in specific subcellular sites in Bacillus subtilis. In this work, we used a combination of total internal reflection microscopy, scanning fluorescence correlation spectroscopy, and pair correlation function to study the localization and dynamics of SecA and SecY in growing Bacillus subtilis cells. Both SecA and SecY localized in transient and dynamic foci in the cytoplasmic membrane, which displayed no higher-level organization in helices. Foci of SecA and SecY were in constant flux with freely diffusing SecA and SecY molecules. Scanning FCS confirmed the existence of populations of cellular SecA and SecY molecules with a wide range of diffusion coefficients. Diffusion of SecY as an uncomplexed molecular species was short-lived and only local while SecY complexed with its protein partners traversed distances of over half a micrometer in the cell.	[Dajkovic, Alex; MacKichan, Calum; Carballido-Lopez, Rut] Univ Paris Saclay, INRA, Micalis Inst, AgroParisTech, F-78350 Jouy En Josas, France; [Hinde, Elizabeth] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of New South Wales Sydney	Dajkovic, A (corresponding author), Univ Paris Saclay, INRA, Micalis Inst, AgroParisTech, F-78350 Jouy En Josas, France.	adajkovic@jouy.inra.fr	LOPEZ, RUT CARBALLIDO/G-2283-2015	LOPEZ, RUT CARBALLIDO/0000-0001-9383-8811; Hinde, Elizabeth/0000-0001-8317-1152	CEU [PITN-GA-2008-215524]; Human Frontier Science Program Organization [HFSP-RGY0067/2009-C]; European Research Council [ERC-StG 311231]; Fondation pour la Recherche Medicale [FDT20111223619]	CEU; Human Frontier Science Program Organization(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the CEU through project PITN-GA-2008-215524 (TranSys), by a young investigator grant from the Human Frontier Science Program Organization (HFSP-RGY0067/2009-C to R.C-L.), a starting grant from the European Research Council (ERC-StG 311231 to R.C-L.) and a fellowship from the Fondation pour la Recherche Medicale (grant FDT20111223619 to C. M.).; The authors thank the MIMA2 imaging facility for the use of their confocal microscope and Pierre Adenot and Renaud Fleurot for technical help. Arnaud Chastanet, Cyrillle Billaudau, and Benoit Tesson are thanked for their critical reading of the manuscript. This work was supported by the CEU through project PITN-GA-2008-215524 (TranSys), by a young investigator grant from the Human Frontier Science Program Organization (HFSP-RGY0067/2009-C to R.C-L.), a starting grant from the European Research Council (ERC-StG 311231 to R.C-L.) and a fellowship from the Fondation pour la Recherche Medicale (grant FDT20111223619 to C. M.)	Bauer BW, 2014, CELL, V157, P1416, DOI 10.1016/j.cell.2014.03.063; Beckwith J, 2013, RES MICROBIOL, V164, P497, DOI 10.1016/j.resmic.2013.03.007; Brandon LD, 2003, MOL MICROBIOL, V50, P45, DOI 10.1046/j.1365-2958.2003.03674.x; Campo N, 2004, MOL MICROBIOL, V53, P1583, DOI 10.1111/j.1365-2958.2004.04278.x; Carballido-Lopez R, 2006, DEV CELL, V11, P399, DOI 10.1016/j.devcel.2006.07.017; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; Digman MA, 2009, BIOPHYS J, V97, P665, DOI 10.1016/j.bpj.2009.04.048; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Driessen AJM, 2001, NAT STRUCT BIOL, V8, P492, DOI 10.1038/88549; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Fekkes P, 1998, MOL MICROBIOL, V29, P1179, DOI 10.1046/j.1365-2958.1998.00997.x; Gold VAM, 2010, P NATL ACAD SCI USA, V107, P10044, DOI 10.1073/pnas.0914680107; Gregory JA, 2008, GENE DEV, V22, P3475, DOI 10.1101/gad.1732408; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; Hinde E, 2011, BIOPHYS J, V100, P1829, DOI 10.1016/j.bpj.2011.02.024; Hinde E, 2010, P NATL ACAD SCI USA, V107, P16560, DOI 10.1073/pnas.1006731107; Kedrov A, 2013, BIOCHEMISTRY-US, V52, P6740, DOI 10.1021/bi400913x; Kumar M, 2010, BIOPHYS J, V98, P552, DOI 10.1016/j.bpj.2009.11.002; Liang FC, 2009, MOL BIOL CELL, V20, P4256, DOI 10.1091/mbc.E09-01-0075; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Petrasek Z, 2010, METHOD ENZYMOL, V472, P317, DOI 10.1016/S0076-6879(10)72005-X; Rapoport TA, 2008, FEBS J, V275, P4471, DOI 10.1111/j.1742-4658.2008.06588.x; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rosch J, 2004, SCIENCE, V304, P1513, DOI 10.1126/science.1097404; Rosch JW, 2005, MOL MICROBIOL, V58, P959, DOI 10.1111/j.1365-2958.2005.04887.x; Shiomi D, 2006, MOL MICROBIOL, V60, P894, DOI 10.1111/j.1365-2958.2006.05145.x; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Tsui HCT, 2011, MBIO, V2, DOI 10.1128/mBio.00202-11; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218	33	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157899	10.1371/journal.pone.0157899	http://dx.doi.org/10.1371/journal.pone.0157899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336478	Green Published, gold			2022-12-26	WOS:000378389200061
J	Oh, JJ; Lee, JK; Kim, K; Byun, SS; Lee, SE; Hong, SK				Oh, Jong Jin; Lee, Jung Keun; Kim, Kwangmo; Byun, Seok-Soo; Lee, Sang Eun; Hong, Sung Kyu			Comparison of the Width of Peritumoral Surgical Margin in Open and Robotic Partial Nephrectomy: A Propensity Score Matched Analysis	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; NEPHRON-SPARING SURGERY; LAPAROSCOPIC PARTIAL NEPHRECTOMY; ASSISTED PARTIAL NEPHRECTOMY; RESECTION MARGIN; LEARNING-CURVE; OUTCOMES; IMPACT; CRYOABLATION; EXPERIENCE	Background To compare the surgical margin status after open partial nephrectomy (OPN) and robotic partial nephrectomy (RPN) performed in patients with T1a renal cell carcinoma (RCC). Methods This was a propensity score-matched study including 702 patients with cT1a RCC treated with partial nephrectomy (PN) between May 2003 and July 2015. Perioperative parameters, including surgical margin width after PN, were compared between two surgical methods. After determining propensity score for tumor size and location, the width of peritumoral surgical margin was investigated. Multivariate logistic analysis to predict peritumoral surgical margin less than 1mm was analyzed. Results The mean width of peritumoral surgical margin was 2.61 +/- 2.15 mm in OPN group (n = 385), significantly wider than the 2.29 +/- 2.00 mm of RPN group (n = 317) (p = 0.042). The multivariate analysis showed surgical methods was significant factors to narrow surgical margin less than 1mm (p = 0.031). After propensity score matching, the surgical margin width was significantly longer in OPN (2.67 +/- 2.14 mm) group than RPN (2.25 +/- 2.03 mm) group (p = 0.016). A positive resection margin occurred in 7 (1.8%) patients in the OPN group and 4 (1.3%) in the RPN group. During the median follow-up of 48.3 months, two patients who underwent OPN had tumor bed recurrence. Conclusions RPN may result in a narrower peritumoral surgical margin than OPN. Further investigation on the potential impact of such a phenomenon should be performed in a larger-scale study.	[Oh, Jong Jin; Lee, Jung Keun; Kim, Kwangmo; Byun, Seok-Soo; Lee, Sang Eun; Hong, Sung Kyu] Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea	Seoul National University (SNU)	Hong, SK (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea.	skhong@snubh.org		Hong, Sung Kyu/0000-0002-8344-6774				Ani I, 2013, BJU INT, V111, pE300, DOI 10.1111/j.1464-410X.2012.11675.x; Aron M, 2008, BJU INT, V102, P86, DOI 10.1111/j.1464-410X.2008.07580.x; Carini M, 2007, EUR UROL, V51, P12, DOI 10.1016/j.eururo.2006.09.003; Castilla EA, 2002, UROLOGY, V60, P993, DOI 10.1016/S0090-4295(02)01983-0; Chen XS, 2012, UROLOGY, V79, P836, DOI 10.1016/j.urology.2011.11.023; Ellison JS, 2012, J UROLOGY, V188, P45, DOI 10.1016/j.juro.2012.02.2570; Finley DS, 2005, J UROLOGY, V173, P1477, DOI 10.1097/01.ju.0000154165.12738.7f; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Georgiades C, 2013, CARDIOVASC INTER RAD, V36, P783, DOI 10.1007/s00270-012-0470-5; Guillotreau J, 2012, EUR UROL, V61, P899, DOI 10.1016/j.eururo.2012.01.007; Jang HJ, 2014, KOREAN J UROL, V55, P808, DOI 10.4111/kju.2014.55.12.808; Khalifeh A, 2013, J UROLOGY, V190, P1674, DOI 10.1016/j.juro.2013.05.110; Krane LS, 2013, BJU INT, V112, P207, DOI 10.1111/bju.12160; Kwon EO, 2007, BJU INT, V99, P286, DOI 10.1111/j.1464-410X.2006.06623.x; Li QL, 2003, EUR UROL, V44, P448, DOI 10.1016/S0302-2838(03)00310-5; Li QL, 2008, UROLOGY, V71, P924, DOI 10.1016/j.urology.2007.11.078; Lifshitz DA, 2010, UROLOGY, V75, P282, DOI 10.1016/j.urology.2009.07.1351; Ljungberg B, 2007, EUR UROL, V51, P1502, DOI 10.1016/j.eururo.2007.03.035; Marszalek M, 2012, EUR UROL, V61, P757, DOI 10.1016/j.eururo.2011.11.028; Mellon MJ, 2013, INT UROL NEPHROL, V45, P381, DOI 10.1007/s11255-013-0392-4; Minervini A, 2009, EUR UROL, V55, P1410, DOI 10.1016/j.eururo.2008.07.038; Pearson J, 2015, KOREAN J UROL, V56, P607, DOI 10.4111/kju.2015.56.9.607; Porpiglia F, 2013, BJU INT, V112, P1125, DOI 10.1111/bju.12317; Satkunasivam R, 2015, EUR UROL; Shi M, 2007, ANN SURG, V245, P36, DOI 10.1097/01.sla.0000231758.07868.71; Sutherland SE, 2002, J UROLOGY, V167, P61, DOI 10.1016/S0022-5347(05)65383-9; Tabayoyong W, 2015, J UROL; Thompson JE, 2014, EUR UROL, V65, P521, DOI 10.1016/j.eururo.2013.10.030; Uzzo RG, 2001, J UROLOGY, V166, P6, DOI 10.1016/S0022-5347(05)66066-1; Vittori G, 2014, WORLD J UROL, V32, P287, DOI 10.1007/s00345-013-1136-x; Williamson TJ, 2016, BJU INT, V117, P555, DOI 10.1111/bju.13384; Zucchi A, 2003, J UROLOGY, V169, P905, DOI 10.1097/01.ju.0000046779.58281.c4	32	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158027	10.1371/journal.pone.0158027	http://dx.doi.org/10.1371/journal.pone.0158027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336438	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200093
J	George, JC; Stimmelmayr, R; Suydam, R; Usip, S; Givens, G; Sformo, T; Thewissen, JGM				George, John C.; Stimmelmayr, Raphaela; Suydam, Robert; Usip, Sharon; Givens, Geof; Sformo, Todd; Thewissen, J. G. M.			Severe Bone Loss as Part of the Life History Strategy of Bowhead Whales	PLOS ONE			English	Article							BALAENA-MYSTICETUS; EUBALAENA-GLACIALIS; GROWTH; BALEEN; AGE; MOVEMENTS	The evolution of baleen constituted a major evolutionary change that made it possible for baleen whales to reach enormous body sizes while filter feeding on tiny organisms and migrating over tremendous distances. Bowhead whales (Balaena mysticetus) live in the Arctic where the annual cycle of increasing and decreasing ice cover affects their habitat, prey, and migration. During the nursing period, bowheads grow rapidly; but between weaning and approximately year 5, bowhead whales display sustained baleen and head growth while limiting growth in the rest of their bodies. During this period, they withdraw resources from the skeleton, in particular the ribs, which may lose 40% of bone mass. Such dramatic changes in bones of immature mammals are rare, although fossil cetaceans between 40 and 50 million years ago show an array of rib specializations that include bone loss and are usually interpreted as related to buoyancy control.	[George, John C.; Stimmelmayr, Raphaela; Suydam, Robert; Sformo, Todd] North Slope Borough, Dept Wildlife Management, Barrow, AK 99723 USA; [Usip, Sharon; Thewissen, J. G. M.] Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA; [Givens, Geof] Givens Stat Solut LLC, Ft Collins, CO USA	Northeast Ohio Medical University (NEOMED)	George, JC (corresponding author), North Slope Borough, Dept Wildlife Management, Barrow, AK 99723 USA.	Craig.George@north-slope.org		Sformo, Todd/0000-0003-4833-2007	North Slope Borough; NEOMED; Givens Statistical Solutions LLC; North Slope Borough/Shell baseline studies program; Coastal Impact Assistance Program	North Slope Borough; NEOMED; Givens Statistical Solutions LLC; North Slope Borough/Shell baseline studies program; Coastal Impact Assistance Program	North Slope Borough funded collection of samples, maintenance of database, and analysis. NEOMED funded analysis of data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Givens Statistical Solutions LLC provided support in the form of salaries for author GG but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; We thank the captains of Barrow, Alaska, and the Alaska Eskimo Whaling Commission for allowing us to examine their whales and collect of samples. The database on which Fig 3 is based was compiled over four decades by the Department of Wildlife Management, North Slope Borough. We thank all of those involved, especially Director Taqulik Hepa and Deputy Director Harry Brower Jr., for having the vision to proceed with this. We thank Andy Von Duyke for help in collecting rib samples and for discussions concerning antler growth. We also benefitted from discussions with Mary Nerini, Sue Lubetkin, and Judith Zeh. We dedicate this paper to Dr. Thomas F. Albert and the Inupiat hunters who first alerted JCG to the dense bones in yearling bowheads. Funding was provided by the North Slope Borough/Shell baseline studies program and the Coastal Impact Assistance Program administered by the U.S. Fish and Wildlife Service. Our samples were collected in Barrow, Alaska under NOAA-NMFS permit No. 17350-00.	Amson E, 2015, J MAMM EVOL, V22, P473, DOI 10.1007/s10914-014-9280-7; [Anonymous], 2014, R LANG ENV STAT COMP; Armfield BA, 2011, MAR MAMMAL SCI, V27, P819, DOI 10.1111/j.1748-7692.2010.00445.x; BAILEY ALFRED M., 1926, JOUR MAMMALOGY, V7, P9, DOI 10.2307/1373588; BANKS WJ, 1968, ANAT REC, V162, P387, DOI 10.1002/ar.1091620401; Baxter BJ, ANAT REC, V256, P235; Best PB, 1996, MAR BIOL, V124, P483, DOI 10.1007/BF00351030; Bockstoce JR., 1986, WHALES ICE MEN HIST; Braham HW, 1980, MAR FISH REV, P70; Brown RD, 1978, AM J VET RES, V39, P113; Bruni Vincenzina, 2006, Pediatr Endocrinol Rev, V3 Suppl 1, P219; Cooper LN, 2012, HIST BIOL, V24, P279, DOI 10.1080/08912963.2011.624184; Cowan RL, 1969, P SOC EXP BIOL MED, V129, P733; de Buffrenil V., 1990, Journal of Vertebrate Paleontology, V10, P455; de Ricqles Armand, 2001, P289; Fortune SME, 2012, J MAMMAL, V93, P1342, DOI 10.1644/11-MAMM-A-297.1; George JC, 1999, CAN J ZOOL, V77, P571, DOI 10.1139/cjz-77-4-571; George JC, 2009, THESIS; Gray NM, 2007, ANAT REC, V290, P638, DOI 10.1002/ar.20533; Grosse E., 1992, STAT MODELS S; Houssaye A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118409; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Jones ML, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P503; Kawamura A., 1974, Scientific Rep Whales Res Inst Tokyo, VNo. 26, P25; Koski William R., 1993, Society for Marine Mammalogy Special Publication, V2, P239; Lambertsen RH, 2005, J MAMMAL, V86, P342, DOI 10.1644/BER-123.1; Lubetkin SC, 2008, CAN J ZOOL, V86, P525, DOI 10.1139/Z08-028; Lubetkin SC, 2012, CAN J ZOOL, V90, P915, DOI 10.1139/Z2012-057; Mate BR, 2000, CAN J ZOOL, V78, P1168, DOI 10.1139/cjz-78-7-1168; Miller CA, 2011, MAR ECOL PROG SER, V438, P267, DOI 10.3354/meps09174; Miller SC, 1995, BONE, V17, P117; Moore Sue E., 1993, Society for Marine Mammalogy Special Publication, V2, P313; NERINI MK, 1984, J ZOOL, V204, P443, DOI 10.1111/j.1469-7998.1984.tb02381.x; Papanek PE, 2003, J ORTHOP SPORT PHYS, V33, P594, DOI 10.2519/jospt.2003.33.10.594; RICE DW, 1971, AM SOC MAMM SPEC PUB, V3, P1; Schell Donald M., 1993, Society for Marine Mammalogy Special Publication, V2, P491; Szewciw LJ, 2010, P ROY SOC B-BIOL SCI, V277, P2597, DOI 10.1098/rspb.2010.0399; TAYLOR MA, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P151; Thewissen JGM, EMERGENCE WHALES EVO, P353; Uhen M. D., 2003, U MICHIGAN PAPERS PA, V34, P1; Wiffen J, 1995, GEOBIOS-LYON, V28, P625, DOI 10.1016/S0016-6995(95)80216-9	41	23	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0156753	10.1371/journal.pone.0156753	http://dx.doi.org/10.1371/journal.pone.0156753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333180	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212800015
J	Roberts, EM; Todd, CN; Aanen, DK; Nobre, T; Hilbert-Wolf, HL; O'Connor, PM; Tapanila, L; Mtelela, C; Stevens, NJ				Roberts, Eric M.; Todd, Christopher N.; Aanen, Duur K.; Nobre, Tania; Hilbert-Wolf, Hannah L.; O'Connor, Patrick M.; Tapanila, Leif; Mtelela, Cassy; Stevens, Nancy J.			Oligocene Termite Nests with In Situ Fungus Gardens from the Rukwa Rift Basin, Tanzania, Support a Paleogene African Origin for Insect Agriculture	PLOS ONE			English	Article							RED SANDSTONE GROUP; GROWING TERMITES; WESTERN BRANCH; TRACE FOSSILS; EVOLUTION; MIOCENE; DECOMPOSITION; ICHNOFOSSILS; ENVIRONMENTS; ECOSYSTEMS	Based on molecular dating, the origin of insect agriculture is hypothesized to have taken place independently in three clades of fungus-farming insects: the termites, ants or ambrosia beetles during the Paleogene (66-24 Ma). Yet, definitive fossil evidence of fungus-growing behavior has been elusive, with no unequivocal records prior to the late Miocene (7-10 Ma). Here we report fossil evidence of insect agriculture in the form of fossil fungus gardens, preserved within 25 Ma termite nests from southwestern Tanzania. Using these well-dated fossil fungus gardens, we have recalibrated molecular divergence estimates for the origins of termite agriculture to around 31 Ma, lending support to hypotheses suggesting an African Paleogene origin for termite-fungus symbiosis; perhaps coinciding with rift initiation and changes in the African landscape.	[Roberts, Eric M.; Todd, Christopher N.; Hilbert-Wolf, Hannah L.; Mtelela, Cassy] James Cook Univ, Dept Earth & Oceans, Townsville, Qld 4811, Australia; [Aanen, Duur K.] Wageningen Univ, Genet Lab, Droevendaalsesteeg 1,Bldg 107, NL-6708 PB Wageningen, Netherlands; [Nobre, Tania] Univ Evora, Inst Mediterranean Agr & Environm Sci ICAAM, Nucleo Mitra, Ap 94, P-7002554 Evora, Portugal; [O'Connor, Patrick M.; Stevens, Nancy J.] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [O'Connor, Patrick M.; Stevens, Nancy J.] Ohio Univ, Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA; [Tapanila, Leif] Idaho State Univ, Dept Geosci, Pocatello, ID 83209 USA; [Tapanila, Leif] Idaho State Univ, Idaho Museum Nat Hist, Pocatello, ID 83209 USA; [Mtelela, Cassy] Univ Dar Es Salaam, Dept Geol, POB 35052, Dar Es Salaam, Tanzania	James Cook University; Wageningen University & Research; University of Evora; University System of Ohio; Ohio University; University System of Ohio; Ohio University; Idaho; Idaho State University; Idaho; Idaho State University; University of Dar es Salaam	Roberts, EM (corresponding author), James Cook Univ, Dept Earth & Oceans, Townsville, Qld 4811, Australia.	eric.roberts@jcu.edu.au	OConnor, Patrick M/I-9383-2012; Hilbert-Wolf, Hannah/J-5893-2014; Nobre, Tania/C-9925-2012; Stevens, Nancy J/E-6928-2013	OConnor, Patrick M/0000-0002-6762-3806; Hilbert-Wolf, Hannah/0000-0002-4419-2337; Nobre, Tania/0000-0002-1855-7451; Mtelela, Cassy/0000-0002-4573-7909; Todd, Christopher/0000-0003-1502-6097	US National Science Foundation (NSF) [EAR_0617561, EAR_ 0854218, EAR 0933619]; National Geographic Society (CRE); Ohio University; James Cook University; Marie Curie fellowship [321725]; Portuguese Foundation for Science and Technology [SFRH/BCC/52187/2013]; Directorate For Geosciences [1349825] Funding Source: National Science Foundation	US National Science Foundation (NSF)(National Science Foundation (NSF)); National Geographic Society (CRE)(National Geographic Society); Ohio University; James Cook University; Marie Curie fellowship(European Commission); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the US National Science Foundation (NSF EAR_0617561, EAR_ 0854218, EAR 0933619), National Geographic Society (CRE), and funding from Ohio University and James Cook University. TN was supported by a Marie Curie fellowship (FP7-PEOPLE-2012-CIG Project Reference 321725) and by the Portuguese Foundation for Science and Technology (SFRH/BCC/52187/2013).	Aanen DK, 2005, CURR BIOL, V15, P851, DOI 10.1016/j.cub.2005.03.043; Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; Ashour A, 2012, J AFR EARTH SCI, V65, P72, DOI 10.1016/j.jafrearsci.2012.02.004; Bonachela JA, 2015, SCIENCE, V347, P651, DOI 10.1126/science.1261487; Bordy EM, 2005, PALAIOS, V20, P308, DOI 10.2110/palo.2005.p05-R01; Bordy EM, 2004, PALAIOS, V19, P68, DOI 10.1669/0883-1351(2004)019<0068:AEJTII>2.0.CO;2; Bourguignon T, 2015, MOL BIOL EVOL, V32, P406, DOI 10.1093/molbev/msu308; BOWN TM, 1982, PALAEOGEOGR PALAEOCL, V40, P255, DOI 10.1016/0031-0182(82)90031-1; Bown TM, 1993, PROGR ANN M GEOL SOC, V25, P58; BUXTON RD, 1981, OECOLOGIA, V51, P379, DOI 10.1007/BF00540909; COATON W G H, 1975, Cimbebasia Series A, V3, P95; COLLINS NM, 1981, OECOLOGIA, V51, P389, DOI 10.1007/BF00540911; Darlington JPEC, 2005, INSECT SOC, V52, P408, DOI 10.1007/s00040-005-0830-0; Delvaux D, 1998, J AFR EARTH SCI, V26, P397, DOI 10.1016/S0899-5362(98)00023-2; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duringer P, 2007, PALAEOGEOGR PALAEOCL, V251, P323, DOI 10.1016/j.palaeo.2007.03.029; Duringer P, 2006, NATURWISSENSCHAFTEN, V93, P610, DOI 10.1007/s00114-006-0149-3; EBINGER CJ, 1989, GEOL SOC AM BULL, V101, P885, DOI 10.1130/0016-7606(1989)101<0885:TDOTWB>2.3.CO;2; Farrell BD, 2001, EVOLUTION, V55, P2011, DOI 10.1111/j.0014-3820.2001.tb01318.x; Feldmann RM, 2007, NEUES JAHRB GEOL P-A, V244, P71, DOI 10.1127/0077-7749/2007/0244-0071; Genise JF, 2000, PALAIOS, V15, P49, DOI 10.2307/3515591; Genise JF, 2004, GEOL SOC SPEC PUBL, V228, P419, DOI 10.1144/GSL.SP.2004.228.01.19; Genise Jorge F., 1994, Ichnos, V3, P155; Genise JF, 2013, PALAEOGEOGR PALAEOCL, V386, P349, DOI 10.1016/j.palaeo.2013.06.004; Grantham DR, 1958, QUARTER DEGREE SHEET; Hasiotis ST, 2003, PALAEOGEOGR PALAEOCL, V192, P259, DOI 10.1016/S0031-0182(02)00689-2; Hasiotis Stephen T., 1995, Ichnos, V4, P119; Jordal BH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-133; McCartney JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090415; Miller W.R., 2000, Ichnos, V7, P195; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Nobre T, 2011, MOL ECOL, V20, P2619, DOI 10.1111/j.1365-294X.2011.05090.x; O'Connor PM, 2010, NATURE, V466, P748, DOI 10.1038/nature09061; O'Connor PM, 2006, J AFR EARTH SCI, V44, P277, DOI 10.1016/j.jafrearsci.2005.11.022; Poulsen M, 2014, P NATL ACAD SCI USA, V111, P14500, DOI 10.1073/pnas.1319718111; Pringle RM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000377; Roberts EM, 2012, NAT GEOSCI, V5, P289, DOI [10.1038/ngeo1432, 10.1038/NGEO1432]; Roberts EM, 2004, CRETACEOUS RES, V25, P749, DOI 10.1016/j.cretres.2004.06.007; Roberts EM, 2010, J AFR EARTH SCI, V57, P179, DOI 10.1016/j.jafrearsci.2009.09.002; Rouland-Lefevre C, 2000, SYMBIOSIS FUNGI, P289; Sands W.A., 1987, P409; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Schuster M, 2000, CR ACAD SCI II A, V331, P15, DOI 10.1016/S1251-8050(00)01377-X; Smith RMH, 1998, PALAIOS, V13, P547, DOI 10.2307/3515346; Stevens NJ, 2008, DEV PRIMATOL-PROG PR, P159, DOI 10.1007/978-0-387-73896-3_12; Stevens NJ, 2013, NATURE, V497, P611, DOI 10.1038/nature12161; Stevens NJ, 2009, J VERTEBR PALEONTOL, V29, P972, DOI 10.1671/039.029.0302; Stevens NJ, 2009, J VERTEBR PALEONTOL, V29, P631, DOI 10.1671/039.029.0219; Stevens NJ, 2005, J VERTEBR PALEONTOL, V25, P986, DOI 10.1671/0272-4634(2005)025[0986:AAPHFT]2.0.CO;2; Stevens NJ, 2006, J PALEONTOL, V80, P407, DOI 10.1666/0022-3360(2006)080[0407:MRPFTP]2.0.CO;2; Tapanila L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031668; Uys V., 2002, PLANT PROTECTION RES, V15	53	34	35	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0156847	10.1371/journal.pone.0156847	http://dx.doi.org/10.1371/journal.pone.0156847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333288	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000378212800017
J	Cartolano, M; Huettel, B; Hartwig, B; Reinhardt, R; Schneeberger, K				Cartolano, Maria; Huettel, Bruno; Hartwig, Benjamin; Reinhardt, Richard; Schneeberger, Korbinian			cDNA Library Enrichment of Full Length Transcripts for SMRT Long Read Sequencing	PLOS ONE			English	Article							RNA-SEQ; RECONSTRUCTION	The utility of genome assemblies does not only rely on the quality of the assembled genome sequence, but also on the quality of the gene annotations. The Pacific Biosciences Iso-Seq technology is a powerful support for accurate eukaryotic gene model annotation as it allows for direct readout of full-length cDNA sequences without the need for noisy short read-based transcript assembly. We propose the implementation of the TeloPrime Full Length cDNA Amplification kit to the Pacific Biosciences Iso-Seq technology in order to enrich for genuine full-length transcripts in the cDNA libraries. We provide evidence that TeloPrime outperforms the commonly used SMARTer PCR cDNA Synthesis Kit in identifying transcription start and end sites in Arabidopsis thaliana. Furthermore, we show that TeloPrime-based Pacific Biosciences Iso-Seq can be successfully applied to the polyploid genome of bread wheat (Triticum aestivum) not only to efficiently annotate gene models, but also to identify novel transcription sites, gene homeologs, splicing isoforms and previously unidentified gene loci.	[Cartolano, Maria; Hartwig, Benjamin; Schneeberger, Korbinian] Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany; [Huettel, Bruno; Reinhardt, Richard] Max Planck Inst Plant Breeding Res, Max Planck Genome Ctr Cologne, Cologne, Germany; [Cartolano, Maria] Ctr Mol Med Cologne, Dept Translat Genom, Computat Canc Genom, Cologne, Germany	Max Planck Society; Max Planck Society; University of Cologne	Schneeberger, K (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany.	schneeberger@mpipz.mpg.de	, 周一珉/AAQ-9453-2020; Schneeberger, Korbinian/U-6329-2019	Schneeberger, Korbinian/0000-0002-5512-0443; Reinhardt, Richard/0000-0001-9376-2132; Cartolano, Maria/0000-0001-9830-988X	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Max Planck Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogdanov Ekaterina A, 2010, Curr Protoc Mol Biol, VChapter 5, DOI 10.1002/0471142727.mb0512s90; Borrill P, 2015, NEW PHYTOL, V208, P1008, DOI 10.1111/nph.13533; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Chapman JA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0582-8; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Cold Spring Harbor Protocols, 2006, COLD SPRING HARBOR P; Gordon SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132628; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Minoche AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0729-7; Nussbaumer T, 2013, NUCLEIC ACIDS RES, V41, pD1144, DOI 10.1093/nar/gks1153; Rawat V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137391; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; Sorrells ME, 2011, GENOME, V54, P875, DOI [10.1139/G11-054, 10.1139/g11-054]; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Thomas S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094650; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Westbrook CJ, 2015, HUM IMMUNOL, V76, P891, DOI 10.1016/j.humimm.2015.03.022; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xu ZC, 2015, PLANT J, V82, P951, DOI 10.1111/tpj.12865; Zhang W, 2014, GENE, V533, P541, DOI 10.1016/j.gene.2013.10.009	26	30	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157779	10.1371/journal.pone.0157779	http://dx.doi.org/10.1371/journal.pone.0157779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327613	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212400044
J	Kitamura, K; Kakishima, S; Uehara, T; Morita, S; Tainaka, KI; Yoshimura, J				Kitamura, Koshi; Kakishima, Satoshi; Uehara, Takashi; Morita, Satoru; Tainaka, Kei-Ichi; Yoshimura, Jin			The Effects of Rainfall on the Population Dynamics of an Endangered Aquatic Plant, Schoenoplectus gemmifer (Cyperaceae)	PLOS ONE			English	Article							SIZE-DEPENDENT GROWTH; REPRODUCTION; MACROPHYTES; STRATEGIES; HABITATS; IMPACTS; LIGHT; FLOOD	The conservation of aquatic plants in river ecosystems should consider the wash-out (away) problem resulting from severe rainfall. The aquatic plant Schoenoplectus gemmifer is an endangered species endemic to Japan. Our previous study reported that the population size of S. gemmifer in Hamamatsu city, Japan, had decreased by one-tenth because many individuals had been washed out by a series of heavy rains in 2004. However, there is insufficient information on the ecological nature of this endangered aquatic plant for adequate conservation. In this paper, we report the population dynamics of one population in Hamamatsu city from 2004 to 2012 in relation to rainfall. We surveyed the number and growing location of all living individuals in the population 300 times during the study period. To examine the temporal changes of individual plants, we also counted the number of culms for 38 individuals in four observations among 300 records. Decreases and increases in the population size of this plant were associated with washing out and the settlement of gemmae (vegetative propagation), respectively. The major cause of the reduction in the population size was an increase in the number of washed-out individuals and not the decreased settlement of gemmae. The wash-out rates for small and large individuals were not significantly different. Small individuals having a stream form with linear leaves resisted flooding, and large individuals were often partially torn off by flooding events. Modification of river basins to reduce the flow velocity may be effective for the conservation of S. gemmifer.	[Kitamura, Koshi; Kakishima, Satoshi; Uehara, Takashi; Tainaka, Kei-Ichi; Yoshimura, Jin] Shizuoka Univ, Grad Sch Sci & Technol, Hamamatsu, Shizuoka 4328011, Japan; [Morita, Satoru] Shizuoka Univ, Dept Math & Syst Engn, Hamamatsu, Shizuoka, Japan; [Yoshimura, Jin] Chiba Univ, Marine Biosyst Res Ctr, Chiba, Japan; [Yoshimura, Jin] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA	Shizuoka University; Shizuoka University; Chiba University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Kakishima, S (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Hamamatsu, Shizuoka 4328011, Japan.	kakishim@gmail.com	Morita, Satoru/W-7768-2018	Morita, Satoru/0000-0001-5219-6218; Kakishima, Satoshi/0000-0001-6000-3068	Asahi Glass Foundation; Japan Society for Promotion of Science [13J03600, 26840126, 26400388, 20500204, 24500273, 15K00334, 22255004, 22370010, 26257405, 15H04420]	Asahi Glass Foundation; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Asahi Glass Foundation [http://www.af-info.or.jp/en/about/] (to SK) and Grants-in-Aid from the Japan Society for Promotion of Science [http://www.jsps.go.jp/english/] (nos. 13J03600 and 26840126 to SK, no. 26400388 to SM, nos. 20500204, 24500273 and 15K00334 to KT, and nos. 22255004, 22370010, 26257405 and 15H04420 to JY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGSPURGER CK, 1984, J ECOL, V72, P777, DOI 10.2307/2259531; Bednarek AT, 2001, ENVIRON MANAGE, V27, P803, DOI 10.1007/s002670010189; Blom CWPM, 1996, TRENDS ECOL EVOL, V11, P290, DOI 10.1016/0169-5347(96)10034-3; Bornette G, 2011, AQUAT SCI, V73, P1, DOI 10.1007/s00027-010-0162-7; BROCK TCM, 1989, AQUAT BOT, V35, P153, DOI 10.1016/0304-3770(89)90102-2; Cao T, 2007, MAR FRESHWATER RES, V58, P581, DOI 10.1071/MF06090; CHAMBERS PA, 1991, ECOL APPL, V1, P249, DOI 10.2307/1941754; D'Abrosca B, 2006, J CHEM ECOL, V32, P81, DOI 10.1007/s10886-006-9354-y; DALE HM, 1986, HYDROBIOLOGIA, V133, P73, DOI 10.1007/BF00010804; Dupuis L, 2006, ECOL RES, V21, P489, DOI 10.1007/s11284-006-0147-0; Egertson CJ, 2004, HYDROBIOLOGIA, V524, P145, DOI 10.1023/B:HYDR.0000036129.40386.ce; Hukusima T, 1997, ECOL RES, V12, P27, DOI 10.1007/BF02523607; Ishii J, 2004, LIMNOLOGY, V5, P1, DOI 10.1007/s10201-003-0108-z; Jacquemyn H, 2010, J ECOL, V98, P1204, DOI 10.1111/j.1365-2745.2010.01697.x; Japan Meteorological Agency, 2012, WEATH OBS; Kada Y, 2006, INT J JPN SOCIOL, V15, P40, DOI 10.1111/j.1475-6781.2006.00084.x; KAUTSKY L, 1988, OIKOS, V53, P126, DOI 10.2307/3565672; Kitamura K, 2009, ECOL RES, V24, P533, DOI 10.1007/s11284-008-0526-9; Kozlowski G, 2009, HYDROBIOLOGIA, V635, P181, DOI 10.1007/s10750-009-9910-x; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; Mitsui Y, 2011, EVOLUTION, V65, P335, DOI 10.1111/j.1558-5646.2010.01129.x; Naito K, 1995, J PLANT RES, V108, P477, DOI 10.1007/BF02344237; Pimm SL, 2001, WORLD ACCORDING PIMM; Preston C.D., 2001, AQUATIC PLANTS BRITA; Puijalon S, 2008, NEW PHYTOL, V177, P907, DOI 10.1111/j.1469-8137.2007.02314.x; R Core Team, 2012, R LANG ENV STAT COMP; Robert A., 2003, RIVER PROCESSES INTR; Rosenzweig M.L., 2003, WIN WIN ECOLOGY; Sato Chiyoshi, 2004, Journal of Japanese Botany, V79, P23; SCHMITT J, 1987, J ECOL, V75, P651, DOI 10.2307/2260197; Smith M, 2005, ECOL APPL, V15, P1036, DOI 10.1890/04-0434; Smith SG, 2005, MAGNOLIOPHYTA COMMEL, V23, P40; Tardif J, 1999, ECOL MONOGR, V69, P107, DOI 10.1890/0012-9615(1999)069[0107:PDOFNI]2.0.CO;2; Thomaz SM, 2007, HYDROBIOLOGIA, V579, P1, DOI 10.1007/s10750-006-0285-y; van Steenis C.G.G.J., 1981, RHEOPHYTES WORLD; Wesselingh RA, 1997, ECOLOGY, V78, P2118, DOI 10.1890/0012-9658(1997)078[2118:TSFFID]2.0.CO;2	37	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157773	10.1371/journal.pone.0157773	http://dx.doi.org/10.1371/journal.pone.0157773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327439	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212400042
J	Lin, CN; Liao, YS; Chen, WC; Wang, YS; Lee, LW				Lin, Chia-Ni; Liao, Yu-San; Chen, Wen-Chang; Wang, Yue-Sheng; Lee, Li-Wen			Use of Myometrium as an Internal Reference for Endometrial and Cervical Cancer on Multiphase Contrast-Enhanced MRI	PLOS ONE			English	Article							RECTAL-CANCER; DYNAMIC MR; CARCINOMA; INVASION; STAGE; MANAGEMENT; PATHOLOGY; SYSTEM; TRACER	Background Myometrial smooth muscle is normally within the field of view for the gynecological imaging. This study aimed to investigate the use of normal myometrium as an internal reference for endometrial and cervical cancer during multiphase contrast-enhanced magnetic resonance imaging (MCE-MRI) and to explore whether this information regarding tumor enhancement relative to the myometrium could be used to discriminate between endometrial and cervical cancer. Methods MRI images, before and after contrast enhancement, were analyzed in newly diagnosed cervical (n = 18) and endometrial cancer (n = 19) patients. Signal intensities (SIs) from tumor tissue and non-neoplastic myometrium were measured using imaging software. Results The relative signal for cervical cancer was approximately 30% higher than that of endometrial cancer after contrast administration. The area under receiver operating characteristic curve for SI, relative signal enhancement, and tumor to myometrium contrast ratio (as used to discriminate between cervical cancer and endometrial cancer) was 0.7807, 0.7456 and 0.7895, respectively. There was no difference in SI of the normal myometrium between endometrial and cervical cancer patients prior to and after contrast administration. Using non-tumorous myometrium as an internal reference, the tumor to myometrium contrast ratio was significantly higher in tumor tissue from cervical cancer compared with that from endometrial cancer at 25 s post contrast enhancement (p = 0.0016), with an optimal sensitivity of 72.22% and specificity of 84.21%. Conclusion With SI normalized to baseline or normal myometrium, tumor tissue from cervical cancer patients showed significant hyperintensity compared with that of tumor tissue from endometrial cancer patients after contrast enhancement, yielding acceptable performance. The use of the myometrium as an internal reference may provide an alternative method to analyze MCE-MRI data.	[Lin, Chia-Ni; Liao, Yu-San; Chen, Wen-Chang; Wang, Yue-Sheng; Lee, Li-Wen] Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi, Taiwan; [Liao, Yu-San] Natl Chung Cheng Univ, Dept Chem & Biochem, Chiayi 621, Taiwan; [Chen, Wen-Chang] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan; [Lee, Li-Wen] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi Campus, Chiayi, Taiwan	Chang Gung Memorial Hospital; National Chung Cheng University; Central Taiwan University Science & Technology; Chang Gung University of Science & Technology	Lee, LW (corresponding author), Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi, Taiwan.; Lee, LW (corresponding author), Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi Campus, Chiayi, Taiwan.	m4572@cgmh.org.tw	Lee, Li-Wen/AAY-3542-2021	Lee, Li-Wen/0000-0001-8019-1772	Chang Gung memorial hospital [CMRPG6E0062]	Chang Gung memorial hospital(Chang Gung Memorial Hospital)	This study was funded by Chang Gung memorial hospital (grant number: CMRPG6E0062) to CNL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; Alberda WJ, 2013, INT J COLORECTAL DIS, V28, P573, DOI 10.1007/s00384-012-1576-6; Balleyguier C, 2011, EUR RADIOL, V21, P1102, DOI 10.1007/s00330-010-1998-x; Beckmann CR, 2010, OBSTET GYNECOLOGY; Beddy P, 2012, RADIOGRAPHICS, V32, P241, DOI 10.1148/rg.321115045; Bourgioti C, 2015, ABDOM IMAGING, V40, P2529, DOI 10.1007/s00261-015-0399-7; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chen BB, 2014, WORLD J GASTROENTERO, V20, P3125, DOI 10.3748/wjg.v20.i12.3125; Dogan D, 2013, ABDOM IMAGING, V38, P388, DOI 10.1007/s00261-012-9915-1; Huynh TN, 2011, J COMPUT ASSIST TOMO, V35, P459, DOI 10.1097/RCT.0b013e31822227c3; Intven M, 2015, J MAGN RESON IMAGING, V41, P1646, DOI 10.1002/jmri.24718; Khalifa F, 2014, MED PHYS, V41, DOI 10.1118/1.4898202; Kinkel K, 2009, EUR RADIOL, V19, P1565, DOI 10.1007/s00330-009-1309-6; Leach MO, 2012, EUR RADIOL, V22, P1451, DOI 10.1007/s00330-012-2446-x; MARSH M, 1956, OBSTET GYNECOL, V7, P444; McCluggage WG, 2012, J CLIN PATHOL, V65, P293, DOI 10.1136/jclinpath-2011-200352; Mittal K, 2008, ARCH PATHOL LAB MED, V132, P402, DOI 10.1043/1543-2165(2008)132[402:AOITGP]2.0.CO;2; Richart R M, 1973, Pathol Annu, V8, P301; Sala E, 2007, AM J ROENTGENOL, V188, P1577, DOI 10.2214/AJR.06.1196; Sala E, 2013, RADIOLOGY, V266, P717, DOI 10.1148/radiol.12120315; Seki H, 1997, AM J ROENTGENOL, V168, P1579, DOI 10.2214/ajr.168.6.9168730; Seki H, 1997, CLIN RADIOL, V52, P18, DOI 10.1016/S0009-9260(97)80300-5; Song DS, 2012, CLIN MOL HEPATOL, V18, P258, DOI 10.3350/cmh.2012.18.3.258; Thomassin-Naggara I, 2008, J MAGN RESON IMAGING, V28, P111, DOI 10.1002/jmri.21377; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Tomao F, 2014, ONCOTARGETS THER, V7, DOI 10.2147/OTT.S68286; Verma S, 2012, AM J ROENTGENOL, V198, P1277, DOI 10.2214/AJR.12.8510; Wright JD, 2012, LANCET, V379, P1352, DOI 10.1016/S0140-6736(12)60442-5; YAMASHITA Y, 1993, RADIOLOGY, V186, P495, DOI 10.1148/radiology.186.2.8421757; Zahra MA, 2007, LANCET ONCOL, V8, P63, DOI 10.1016/S1470-2045(06)71012-9	31	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157820	10.1371/journal.pone.0157820	http://dx.doi.org/10.1371/journal.pone.0157820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27326456	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212400048
J	Mehrabian, M; Brethour, D; Williams, D; Wang, HS; Arnould, H; Schneider, B; Schmitt-Ulms, G				Mehrabian, Mohadeseh; Brethour, Dylan; Williams, Declan; Wang, Hansen; Arnould, Helene; Schneider, Benoit; Schmitt-Ulms, Gerold			Prion Protein Deficiency Causes Diverse Proteome Shifts in Cell Models That Escape Detection in Brain Tissue	PLOS ONE			English	Article							C-KINASE SUBSTRATE; CROSS-LINKING; MICE LACKING; MARCKS; TRANSITION; ADHESION; ABUNDANT; FAMILY; GAP-43; BASP1	A popular method for studying the function of a given protein is to generate and characterize a suitable model deficient for its expression. For the prion protein (PrP), best known for its role in several invariably fatal neurodegenerative diseases, a natural choice, therefore, would be to undertake such studies with brain samples. We recently documented the surprising observation that PrP deficiency caused a loss or enhancement of NCAM1 polysialylation, dependent on the cell model used. To identify possible causes for this disparity, we set out to systematically investigate the consequence of PrP deficiency on the global proteome in brain tissue and in four distinct cell models. Here we report that PrP deficiency causes robust but surprisingly divergent changes to the global proteomes of cell models but has no discernible impact on the global brain proteome. Amongst >1,500 proteins whose levels were compared in wild-type and PrP-deficient models, members of the MARCKS protein family exhibited pronounced, yet cell model-dependent changes to their steady-state levels. Follow-up experiments revealed that PrP collaborates with members of the MARCKS protein family in its control of NCAM1 polysialylation. We conclude that the physiological function of PrP may be masked in analyses of complex brain samples but its celltype specific influence on a lipid raft-based NCAM1-related cell biology comes to the fore in investigations of specific cell types.	[Mehrabian, Mohadeseh; Brethour, Dylan; Williams, Declan; Wang, Hansen; Schmitt-Ulms, Gerold] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Mehrabian, Mohadeseh; Brethour, Dylan; Williams, Declan; Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med, Toronto, ON, Canada; [Mehrabian, Mohadeseh; Brethour, Dylan; Williams, Declan; Schmitt-Ulms, Gerold] Univ Toronto, Dept Pathobiol, Toronto, ON, Canada; [Arnould, Helene; Schneider, Benoit] French Inst Hlth & Med Res INSERM, Paris, France; [Arnould, Helene; Schneider, Benoit] Univ Paris 05, Paris, France	University of Toronto; University of Toronto; University of Toronto; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Schmitt-Ulms, G (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.; Schmitt-Ulms, G (corresponding author), Univ Toronto, Dept Lab Med, Toronto, ON, Canada.; Schmitt-Ulms, G (corresponding author), Univ Toronto, Dept Pathobiol, Toronto, ON, Canada.	g.schmittulms@utoronto.ca	wang, hansen/I-2510-2019; Schneider, Benoit/AAF-3850-2019	wang, hansen/0000-0003-4414-3372; ARNOULD, Helene/0000-0002-7750-5803; Williams, Declan/0000-0002-6754-1624; Schneider, Benoit/0000-0002-1377-2670	Canadian Institute for Health Research (CIHR); Canadian Foundation for Innovation; Garfield Weston family; Rosiak family; Irwin family	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Garfield Weston family; Rosiak family; Irwin family	Work on this project was supported by an operating grant of the Canadian Institute for Health Research (CIHR) and an infrastructure grant from the Canadian Foundation for Innovation. The authors are most grateful to the Rosiak and Irwin families for their generous support. GS further received support from the Garfield Weston family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are most grateful to the Rosiak and Irwin families for their generous support. GS further received support from the Garfield Weston family.	Bjorkblom B, 2012, MOL CELL BIOL, V32, P3513, DOI 10.1128/MCB.00713-12; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Chen JM, 1996, P NATL ACAD SCI USA, V93, P6275, DOI 10.1073/pnas.93.13.6275; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Crecelius AC, 2008, NEUROREPORT, V19, P1027, DOI 10.1097/WNR.0b013e3283046157; Dayon Loic, 2012, Methods Mol Biol, V893, P115, DOI 10.1007/978-1-61779-885-6_9; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Ehsani S, 2012, J MOL BIOL, V422, P556, DOI 10.1016/j.jmb.2012.06.003; Ehsani S, 2011, PROG NEUROBIOL, V93, P405, DOI 10.1016/j.pneurobio.2010.12.001; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Finlayson AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007833; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; Hartness ME, 2001, EUR J NEUROSCI, V13, P925, DOI 10.1046/j.0953-816x.2001.01466.x; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Liang JJ, 2012, J BIOL CHEM, V287, P16510, DOI 10.1074/jbc.M112.360891; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Loubet D, 2012, FASEB J, V26, P678, DOI 10.1096/fj.11-185579; Lundgren DH, 2010, EXPERT REV PROTEOMIC, V7, P39, DOI 10.1586/EPR.09.69; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Mehrabian M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133741; Mehrabian M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114594; Mosevitsky MI, 1997, BIOCHIMIE, V79, P373, DOI 10.1016/S0300-9084(97)80032-6; Mosevitsky MI, 2005, INT REV CYTOL, V245, P245, DOI 10.1016/S0074-7696(05)45007-X; Ostroumova OS, 2011, FEBS J, V278, P461, DOI 10.1111/j.1742-4658.2010.07967.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Schmitt-Ulms G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007208; Solomon IH, 2012, PRION, V6, P40, DOI 10.4161/pri.6.1.18627; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; Theis T, 2013, J BIOL CHEM, V288, P6726, DOI 10.1074/jbc.M112.444034; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Watt NT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2135; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Wiederkehr A, 1997, EXP CELL RES, V236, P103, DOI 10.1006/excr.1997.3709; Wu M, 1996, P NATL ACAD SCI USA, V93, P2110, DOI 10.1073/pnas.93.5.2110; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Young R, 2009, FEBS LETT, V583, P3296, DOI 10.1016/j.febslet.2009.09.027	45	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0156779	10.1371/journal.pone.0156779	http://dx.doi.org/10.1371/journal.pone.0156779			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327609	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212400008
J	Lin, HV; Efanov, AM; Fang, XK; Beavers, LS; Wang, XS; Wang, JR; Valcarcel, ICG; Ma, TW				Lin, Hua V.; Efanov, Alexander M.; Fang, Xiankang; Beavers, Lisa S.; Wang, Xuesong; Wang, Jingru; Valcarcel, Isabel C. Gonzalez; Ma, Tianwei			GPR142 Controls Tryptophan-Induced Insulin and Incretin Hormone Secretion to Improve Glucose Metabolism	PLOS ONE			English	Article							GASTRIC INHIBITORY POLYPEPTIDE; PROTEIN-COUPLED RECEPTORS; CALCIUM-SENSING RECEPTOR; GLUCAGON; CHOLECYSTOKININ; STIMULATION; AGONISTS; RELEASE; TAK-875; MICE	GPR142, a putative amino acid receptor, is expressed in pancreatic islets and the gastrointestinal tract, but the ligand affinity and physiological role of this receptor remain obscure. In this study, we show that in addition to L-Tryptophan, GPR142 signaling is also activated by L-Phenylalanine but not by other naturally occurring amino acids. Furthermore, we show that Tryptophan and a synthetic GPR142 agonist increase insulin and incretin hormones and improve glucose disposal in mice in a GPR142-dependent manner. In contrast, Phenylalanine improves in vivo glucose disposal independently of GPR142. Noteworthy, refeeding-induced elevations in insulin and glucose-dependent insulinotropic polypeptide are blunted in Gpr142 null mice. In conclusion, these findings demonstrate GPR142 is a Tryptophan receptor critically required for insulin and incretin hormone regulation and suggest GPR142 agonists may be effective therapies that leverage amino acid sensing pathways for the treatment of type 2 diabetes.	[Lin, Hua V.; Fang, Xiankang; Wang, Xuesong; Wang, Jingru; Ma, Tianwei] Eli Lilly & Co, LCRDC, Shanghai, Peoples R China; [Efanov, Alexander M.; Beavers, Lisa S.; Valcarcel, Isabel C. Gonzalez] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly	Lin, HV (corresponding author), Eli Lilly & Co, LCRDC, Shanghai, Peoples R China.	lin_hua@lilly.com	Efanov, Alexander/R-3630-2019	Efanov, Alexander/0000-0002-8630-1503; Fang, Xiankang/0000-0001-6275-9280; Lin, Hua/0000-0001-5001-5567	Eli Lilly Co.	Eli Lilly Co.(Eli Lilly)	Eli Lilly & Co. provided support in the form of salaries for authors (HVL, AME, XF, LSB, XW, JW, ICGV, TM) and funding for research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of each author are articulated in the 'author contributions' section.	Amisten S, 2013, PHARMACOL THERAPEUT, V139, P359, DOI 10.1016/j.pharmthera.2013.05.004; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Christensen M, 2011, DIABETES, V60, P3103, DOI 10.2337/db11-0979; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Diakogiannaki E, 2013, DIABETOLOGIA, V56, P2688, DOI 10.1007/s00125-013-3037-3; Engelstoft MS, 2013, MOL METAB, V2, P376, DOI 10.1016/j.molmet.2013.08.006; FLOYD JC, 1966, J CLIN INVEST, V45, P1487, DOI 10.1172/JCI105456; Gamble JM, 2015, DIABETES OBES METAB, V17, P649, DOI 10.1111/dom.12465; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; Holst JJ, 2011, DIABETES OBES METAB, V13, P89, DOI 10.1111/j.1463-1326.2011.01452.x; Jakubowicz D, 2014, DIABETOLOGIA, V57, P1807, DOI 10.1007/s00125-014-3305-x; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Kaku K, 2015, DIABETES OBES METAB, V17, P675, DOI 10.1111/dom.12467; Lan H, 2008, DIABETES, V57, P2999, DOI 10.2337/db08-0596; Liou AP, 2011, AM J PHYSIOL-GASTR L, V300, pG538, DOI 10.1152/ajpgi.00342.2010; Lizarzaburu M, 2012, BIOORG MED CHEM LETT, V22, P5942, DOI 10.1016/j.bmcl.2012.07.063; Mace OJ, 2012, J PHYSIOL-LONDON, V590, P2917, DOI 10.1113/jphysiol.2011.223800; Matsuda-Nagasumi K, 2013, DIABETES OBES METAB, V15, P538, DOI 10.1111/dom.12065; Matsuo A, 2005, BIOCHEM BIOPH RES CO, V331, P363, DOI 10.1016/j.bbrc.2005.03.174; Muramatsu M, 2014, AM J PHYSIOL-GASTR L, V306, pC1099, DOI 10.1152/ajpgi.00155.2014; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Ogawa Y., 2008, International patent, Patent No. [WO 2008/045484 A1, 2008045484]; Pais R, 2016, PEPTIDES, V77, P9, DOI 10.1016/j.peptides.2015.07.019; PONTER AA, 1994, J NUTR, V124, P259, DOI 10.1093/jn/124.2.259; Psichas A, 2015, J CLIN INVEST, V125, P908, DOI 10.1172/JCI76309; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; REIMERS J, 1988, DIABETOLOGIA, V31, P271; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Sommer CA, 2014, MOL ENDOCRINOL, V28, P1855, DOI 10.1210/me.2014-1194; THOMAS FB, 1978, GASTROENTEROLOGY, V74, P1261; THOMAS FB, 1976, GASTROENTEROLOGY, V70, P523; Toda N, 2013, ACS MED CHEM LETT, V4, P790, DOI 10.1021/ml400186z; Trinquet E, 2011, EXPERT OPIN DRUG DIS, V6, P981, DOI 10.1517/17460441.2011.608658; TSIOLAKIS D, 1984, HORM METAB RES, V16, P226, DOI 10.1055/s-2007-1014752; Tsujihata Y, 2011, J PHARMACOL EXP THER, V339, P228, DOI 10.1124/jpet.111.183772; Vilsboll T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7771; Wang JR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154452; Wang Y, 2011, AM J PHYSIOL-GASTR L, V300, pG528, DOI 10.1152/ajpgi.00387.2010; Yonezawa T, 2013, CURR MED CHEM, V20, P3855	39	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157298	10.1371/journal.pone.0157298	http://dx.doi.org/10.1371/journal.pone.0157298			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322810	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212000013
J	Durnas, B; Wnorowska, U; Pogoda, K; Deptula, P; Watek, M; Piktel, E; Gluszek, S; Gu, XB; Savage, PB; Niemirowicz, K; Bucki, R				Durnas, Bonita; Wnorowska, Urszula; Pogoda, Katarzyna; Deptula, Piotr; Watek, Marzena; Piktel, Ewelina; Gluszek, Stanislaw; Gu, Xiaobo; Savage, Paul B.; Niemirowicz, Katarzyna; Bucki, Robert			Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites	PLOS ONE			English	Article							RESISTANT ACINETOBACTER-BAUMANNII; CATIONIC STEROID ANTIBIOTICS; PSEUDOMONAS-AERUGINOSA; EXTRACELLULAR DNA; ANTIFUNGAL SUSCEPTIBILITY; ANTIBACTERIAL ACTIVITY; OMIGANAN PENTAHYDROCHLORIDE; ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-AUREUS; BACTERICIDAL ACTIVITY	Fungal infections, especially those caused by antibiotic resistant pathogens, have become a serious public health problem due to the growing number of immunocompromised patients, including those subjected to anticancer treatment or suffering from HIV infection. In this study we assessed fungicidal activity of the ceragenins CSA-13, CSA-131 and CSA-192 against four fluconazole resistant Candida strains. We found that ceragenins activity against planktonic Candida cells was higher than activity of human LL-37 peptide and synthetic cationic peptide omiganan. Compared to LL-37 peptide, ceragenins in the presence of DNase I demonstrated an increased ability to kill DNA-induced Candida biofilm. Microscopy studies show that treatment with LL-37 or ceragenins causes Candida cells to undergo extensive surface changes indicating surface membrane damage. This conclusion was substantiated by observation of rapid incorporation of FITC-labeled CSA-13, CSA-131 or LL-37 peptide into the more lipophilic environment of the Candida membrane. In addition to activity against Candida spp., ceragenins CSA-131 and CSA-192 display strong fungicidal activity against sixteen clinical isolates including Cryptococcus neoformans and Aspergillus fumigatus. These results indicate the potential of ceragenins for future development as new fungicidal agents.	[Durnas, Bonita; Bucki, Robert] Jan Kochanowski Univ Humanities & Sci, Fac Hlth Sci, Dept Physiol Pathophysiol & Immunol Infect, Kielce, Poland; [Durnas, Bonita; Watek, Marzena] Holy Cross Oncol Ctr Kielce, Artwinskiego 3, Kielce, Poland; [Wnorowska, Urszula; Deptula, Piotr; Piktel, Ewelina; Niemirowicz, Katarzyna; Bucki, Robert] Med Univ Bialystok, Dept Microbiol & Nanobiomed Engn, Mickiewicza 2C, Bialystok, Poland; [Pogoda, Katarzyna] Polish Acad Sci, Inst Nucl Phys, Radzikowskiego 152, Krakow, Poland; [Gluszek, Stanislaw] Jan Kochanowski Univ Humanities & Sci, Fac Hlth Sci, Kielce, Poland; [Gu, Xiaobo; Savage, Paul B.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Jan Kochanowski University; Medical University of Bialystok; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; Jan Kochanowski University; Brigham Young University	Bucki, R (corresponding author), Jan Kochanowski Univ Humanities & Sci, Fac Hlth Sci, Dept Physiol Pathophysiol & Immunol Infect, Kielce, Poland.; Bucki, R (corresponding author), Med Univ Bialystok, Dept Microbiol & Nanobiomed Engn, Mickiewicza 2C, Bialystok, Poland.	buckirobert@gmail.com	Niemirowicz, Katarzyna/T-5011-2018; Piktel, Ewelina/S-8311-2018; Deptuła, Piotr/T-1176-2018; Savage, Paul B/HGB-3414-2022; Wnorowska, Urszula/S-8312-2018; Durnaś, Bonita/AAU-1826-2021; Stanisław, Gluszek/S-3303-2019; Savage, Paul B/E-1448-2011; Pogoda, Katarzyna/AAD-2057-2020; Wątek, Marzena/AAA-8789-2020	Niemirowicz, Katarzyna/0000-0002-3311-7147; Piktel, Ewelina/0000-0002-4531-7277; Deptuła, Piotr/0000-0003-3553-3774; Savage, Paul B/0000-0002-4642-6109; Wnorowska, Urszula/0000-0002-0410-3475; Durnaś, Bonita/0000-0003-1940-5799; Stanisław, Gluszek/0000-0001-7752-0459; Savage, Paul B/0000-0002-4642-6109; Pogoda, Katarzyna/0000-0001-6994-3435; Wątek, Marzena/0000-0002-3996-200X; Bucki, Robert/0000-0001-7664-9226	RPOWP [UDA-RPPD.01.01.00-20-001/15-00]; National Science Centre, Poland [UMO-2012/07/B/NZ6/03504, UMO-2014/15/D/NZ6/02665]; National Institutes of Health, United States of America [NHHSN2722011000181]	RPOWP; National Science Centre, Poland(National Science Centre, Poland); National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was conducted with the use of equipment purchased by Medical University of Bialystok as part of the RPOWP 2007-2013 funding, Priority I, Axis 1.1, contract No. UDA-RPPD.01.01.00-20-001/15-00 dated 26.06.2015 [http://www.nauka.gov.pl/]) and financially supported by grants from: the National Science Centre, Poland (UMO-2012/07/B/NZ6/03504 to R. Bucki and UMO-2014/15/D/NZ6/02665 to K. Niemirowicz [https://www.ncn.gov.pl/]), and National Institutes of Health, United States of America (NHHSN2722011000181 to P. B. Savage [http://www.nih.gov/]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki W, 2013, PHARMACEUTICALS-BASE, V6, P1055, DOI 10.3390/ph6081055; Baranska-Rybak W, 2006, J ANTIMICROB CHEMOTH, V57, P260, DOI 10.1093/jac/dki460; Bassetti M, 2013, J CLIN MICROBIOL, V51, P4167, DOI 10.1128/JCM.01998-13; Benincasa M, 2006, J ANTIMICROB CHEMOTH, V58, P950, DOI 10.1093/jac/dkl382; Bitar D, 2014, EMERG INFECT DIS, V20, P1149, DOI 10.3201/eid2007.140087; Bucki R, 2008, J ANTIMICROB CHEMOTH, V62, P329, DOI 10.1093/jac/dkn176; Bucki R, 2006, ANTIMICROB AGENTS CH, V50, P2932, DOI 10.1128/AAC.00134-06; Bucki R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0457-x; Bucki R, 2010, ARCH IMMUNOL THER EX, V58, P15, DOI 10.1007/s00005-009-0057-2; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Chen L, 2011, INT J ORAL SCI, V3, P66, DOI 10.4248/IJOS11022; Chin JN, 2008, J ANTIMICROB CHEMOTH, V61, P365, DOI 10.1093/jac/dkm457; Chin JN, 2007, ANTIMICROB AGENTS CH, V51, P1268, DOI 10.1128/AAC.01325-06; Choi JH, 2013, J BIOMED NANOTECHNOL, V9, P291, DOI 10.1166/jbn.2013.1542; CLSI, 2008, M27A3 CLSI; Dawson MJ, 2012, CURR OPIN PHARMACOL, V12, P545, DOI 10.1016/j.coph.2012.06.006; den Hertog AL, 2005, BIOCHEM J, V388, P689, DOI 10.1042/BJ20042099; Ding B, 2002, J MED CHEM, V45, P663, DOI 10.1021/jm0105070; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Epand RF, 2007, BBA-BIOMEMBRANES, V1768, P2500, DOI 10.1016/j.bbamem.2007.05.023; Epand RF, 2010, ANTIMICROB AGENTS CH, V54, P3708, DOI 10.1128/AAC.00380-10; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fritsche TR, 2008, ANTIMICROB AGENTS CH, V52, P1187, DOI 10.1128/AAC.01475-07; Ganguly S, 2011, CURR OPIN MICROBIOL, V14, P380, DOI 10.1016/j.mib.2011.06.001; Garcia-Quintanilla M, 2014, ANTIMICROB AGENTS CH, V58, P2972, DOI 10.1128/AAC.02642-13; Guembe M, 2014, ANTIMICROB AGENTS CH, V58, P5581, DOI 10.1128/AAC.02738-14; Haisma EM, 2014, ANTIMICROB AGENTS CH, V58, P4411, DOI 10.1128/AAC.02554-14; Herriott MM, 2011, TRENDS MICROBIOL, V19, P557, DOI 10.1016/j.tim.2011.07.004; Howell MD, 2009, J INVEST DERMATOL, V129, P2668, DOI 10.1038/jid.2009.120; Isaacson Richard E, 2003, Curr Opin Investig Drugs, V4, P999; Jones EA, 2013, J INNATE IMMUN, V5, P24, DOI 10.1159/000339961; Kim KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028176; Lara D, 2010, J PARASITOL, V96, P638, DOI 10.1645/GE-2329.1; Leszczynska K, 2011, J APPL MICROBIOL, V110, P229, DOI 10.1111/j.1365-2672.2010.04874.x; Leszczynska K, 2013, J ANTIMICROB CHEMOTH, V68, P610, DOI 10.1093/jac/dks434; Lv YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115448, 10.1371/journal.pone.0086364]; Lyon GM, 2010, J CLIN MICROBIOL, V48, P1270, DOI 10.1128/JCM.02363-09; Martins M, 2010, MYCOPATHOLOGIA, V169, P323, DOI 10.1007/s11046-009-9264-y; Mathe L, 2013, CURR GENET, V59, P251, DOI 10.1007/s00294-013-0400-3; Moncla Bernard J, 2011, Adv Biosci Biotechnol, V2, P404; Montagna MT, 2014, J MED MICROBIOL, V63, P1638, DOI 10.1099/jmm.0.075507-0; Niemirowicz K, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0093-5; Orasch C, 2014, CLIN MICROBIOL INFEC, V20, P698, DOI 10.1111/1469-0691.12440; Ordonez SR, 2014, ANTIMICROB AGENTS CH, V58, P2240, DOI 10.1128/AAC.01670-13; Parks QM, 2009, J MED MICROBIOL, V58, P492, DOI 10.1099/jmm.0.005728-0; Polke M, 2015, ADV APPL MICROBIOL, V91, P139, DOI 10.1016/bs.aambs.2014.12.002; Ramage Gordon, 2001, Revista Iberoamericana de Micologia, V18, P163; Rapala-Kozik M, 2015, INFECT IMMUN, V83, P2518, DOI 10.1128/IAI.00023-15; Sader HS, 2004, ANTIMICROB AGENTS CH, V48, P3112, DOI 10.1128/AAC.48.8.3112-3118.2004; Sapaar B, 2014, J APPL MICROBIOL, V116, P1531, DOI 10.1111/jam.12483; Savage PB, 2002, FEMS MICROBIOL LETT, V217, P1; Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x; Singh Shweta, 2015, Infez Med, V23, P211; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; Taff HT, 2013, FUTURE MICROBIOL, V8, P1325, DOI 10.2217/fmb.13.101; Tetz GV, 2009, ANTIMICROB AGENTS CH, V53, P1204, DOI 10.1128/AAC.00471-08; Tetz VV, 2010, DNA CELL BIOL, V29, P399, DOI 10.1089/dna.2009.1011; Tsai PW, 2014, J MICROBIOL, V52, P581, DOI 10.1007/s12275-014-3630-2; Vila-Farres X, 2015, INT J ANTIMICROB AG, V46, P568, DOI 10.1016/j.ijantimicag.2015.08.003; Wnorowska U, 2015, ANTIMICROB AGENTS CH, V59, P3808, DOI 10.1128/AAC.00421-15; Wong CS, 2013, SENSORS-BASEL, V13, P12943, DOI 10.3390/s131012943; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2	63	52	52	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157242	10.1371/journal.pone.0157242	http://dx.doi.org/10.1371/journal.pone.0157242			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315208	Green Submitted, Green Published, gold			2022-12-26	WOS:000378030000014
J	Rijks, JM; Saucedo, B; Spitzen-van der Sluijs, A; Wilkie, GS; van Asten, AJAM; van den Broek, J; Boonyarittichaikij, R; Stege, M; van der Sterren, F; Martel, A; Pasmans, F; Hughes, J; Grone, A; van Beurden, SJ; Kik, MJL				Rijks, Jolianne M.; Saucedo, Bernardo; Spitzen-van der Sluijs, Annemarieke; Wilkie, Gavin S.; van Asten, Alphons J. A. M.; van den Broek, Jan; Boonyarittichaikij, Roschong; Stege, Marisca; van der Sterren, Fleur; Martel, An; Pasmans, Frank; Hughes, Joseph; Grone, Andrea; van Beurden, Steven J.; Kik, Marja J. L.			Investigation of Amphibian Mortality Events in Wildlife Reveals an On-Going Ranavirus Epidemic in the North of the Netherlands	PLOS ONE			English	Article							PELOPHYLAX KL. ESCULENTUS; MAJOR CAPSID PROTEIN; MOLECULAR CHARACTERIZATION; DISEASE; IRIDOVIRUS; MODELS; FISH	In the four years following the first detection of ranavirus (genus Ranavirus, family Iridoviridae) infection in Dutch wildlife in 2010, amphibian mortality events were investigated nationwide to detect, characterize and map ranaviruses in amphibians over time, and to establish the affected host species and the clinico-pathological presentation of the disease in these hosts. The ultimate goal was to obtain more insight into ranavirus disease emergence and ecological risk. In total 155 dead amphibians from 52 sites were submitted between 2011 and 2014, and examined using histopathology, immunohistochemistry, virus isolation and molecular genetic characterization. Ranavirus-associated amphibian mortality events occurred at 18 sites (35%), initially only in proximity of the 2010 index site. Specimens belonging to approximately half of the native amphibian species were infected, including the threatened Pelobates fuscus (spadefoot toad). Clustered massive outbreaks involving dead adult specimens and ranavirus genomic identity indicated that one common midwife toad virus (CMTV)-like ranavirus strain is emerging in provinces in the north of the Netherlands. Modelling based on the spatiotemporal pattern of spread showed a high probability that this emerging virus will continue to be detected at new sites (the discrete reproductive power of this outbreak is 0.35). Phylogenetically distinct CMTV-like ranaviruses were found in the south of the Netherlands more recently. In addition to showing that CMTV-like ranaviruses threaten wild amphibian populations not only in Spain but also in the Netherlands, the current spread and risk of establishment reiterate that understanding the underlying causes of CMTV-like ranavirus emergence requires international attention.	[Rijks, Jolianne M.; Saucedo, Bernardo; van Asten, Alphons J. A. M.; Grone, Andrea; Kik, Marja J. L.] Univ Utrecht, Dutch Wildlife Hlth Ctr, Utrecht, Netherlands; [Saucedo, Bernardo; van Asten, Alphons J. A. M.; Stege, Marisca; Grone, Andrea; van Beurden, Steven J.; Kik, Marja J. L.] Univ Utrecht, Dept Pathobiol, Utrecht, Netherlands; [Spitzen-van der Sluijs, Annemarieke; van der Sterren, Fleur] Reptile Amphibian & Fish Conservat Netherlands, Nijmegen, Netherlands; [Wilkie, Gavin S.; Hughes, Joseph] Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland; [van den Broek, Jan] Univ Utrecht, Dept Farm Anim Hlth, Utrecht, Netherlands; [Boonyarittichaikij, Roschong; Martel, An; Pasmans, Frank] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium	Utrecht University; Utrecht University; University of Glasgow; Utrecht University; Ghent University	Rijks, JM (corresponding author), Univ Utrecht, Dutch Wildlife Hlth Ctr, Utrecht, Netherlands.	j.m.rijks@uu.nl	Spitzen, Annemarieke/AAV-3970-2021; Pasmans, Frank/D-3667-2014; Hughes, Joseph/B-7711-2009; Spitzen, Annemarieke/B-3453-2012	Hughes, Joseph/0000-0003-2556-2563; Spitzen, Annemarieke/0000-0003-2008-9375	Dutch Ministry of Economic Affairs [140008149/2011, 1400006202/2010, 1400008946/2011, 1300011172/2012, 1300014843/2013, 1300017645/2014]; Netherlands Food and Consumer Safety Authority [60000784/2012]; Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT) [245756/359573]; United Kingdom Medical Research Council [MC_UU_12014/3]; Medical Research Council [MC_UU_12014/12, G0801822] Funding Source: researchfish; MRC [MC_UU_12014/12, G0801822] Funding Source: UKRI	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Food and Consumer Safety Authority; Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding provided by Grants 140008149/2011, and 1400006202/2010, 1400008946/2011, 1300011172/2012, 1300014843/2013, 1300017645/2014 from the Dutch Ministry of Economic Affairs: JMR, ASvdS, AJAMvA, MS, FvdS, AG, SJvB, MJLK. Grant 60000784/2012 from the Netherlands Food and Consumer Safety Authority: JMR, ASvdS, AG, MJLK. Grant 245756/359573 from the Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT): BS. Grant MC_UU_12014/3 from the United Kingdom Medical Research Council: GSW, JH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel E, 2009, DIS AQUAT ORGAN, V85, P7, DOI 10.3354/dao02060; Balseiro A, 2009, DIS AQUAT ORGAN, V84, P95, DOI 10.3354/dao02032; Bayley AE, 2013, DIS AQUAT ORGAN, V103, P171, DOI 10.3354/dao02574; Bollinger TK, 1999, J WILDLIFE DIS, V35, P413, DOI 10.7589/0090-3558-35.3.413; Chen ZY, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-101; Creemers R. C. M., 2009, AMFIBIEEN REPTIELEN; FIJAN N, 1991, Veterinarski Arhiv, V61, P151; Gray MJ, 2009, DIS AQUAT ORGAN, V87, P243, DOI 10.3354/dao02138; Grayfer L, 2012, VIRUSES-BASEL, V4, P1075, DOI 10.3390/v4071075; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; Holopainen R, 2009, DIS AQUAT ORGAN, V85, P81, DOI 10.3354/dao02074; Jancovich JK, 2005, MOL ECOL, V14, P213, DOI 10.1111/j.1365-294X.2004.02387.x; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keawcharoen J, 2011, EMERG INFECT DIS, V17, P1016, DOI [10.3201/eid1705.100880, 10.3201/eid/1706.100880]; Kik M, 2011, VET J, V190, P284, DOI 10.1016/j.tvjl.2011.08.031; Kock RA, 2010, REV SCI TECH OIE, V29, P329, DOI 10.20506/rst.29.2.1980; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Li W, 2014, VET MICROBIOL, V172, P129, DOI 10.1016/j.vetmic.2014.05.009; Maniero GD, 2006, DEV COMP IMMUNOL, V30, P649, DOI 10.1016/j.dci.2005.09.007; Mao JH, 1997, VIROLOGY, V229, P212, DOI 10.1006/viro.1996.8435; Mavian C, 2012, J VIROL, V86, P3617, DOI 10.1128/JVI.07108-11; North AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127037; Price SJ, 2014, CURR BIOL, V24, P2586, DOI 10.1016/j.cub.2014.09.028; R Core Team, 2021, R LANGUAGE ENV STAT; Rijks JM, 600007842013 NVWA DU; Schloegel LM, 2010, DIS AQUAT ORGAN, V92, P101, DOI 10.3354/dao02140; Sharifian-Fard M, 2011, EMERG INFECT DIS, V17, P2371, DOI 10.3201/eid1712.110236; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Spitzen-van der Sluijs A, J WILDL DIS IN PRESS; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stohr AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118633; Stohr AC, 2013, VET J, V197, P238, DOI 10.1016/j.tvjl.2013.02.014; Storfer A, 2007, ECOL LETT, V10, P1075, DOI 10.1111/j.1461-0248.2007.01102.x; Tompkins DM, 2015, TRENDS PARASITOL, V31, P149, DOI 10.1016/j.pt.2015.01.007; van Beurden SJ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01293-14; van den Broek J, 2007, BIOSTATISTICS, V8, P453, DOI 10.1093/biostatistics/kxl023; van den Broek J, 2009, ANN APPL STAT, V3, P1505, DOI 10.1214/09-AOAS270; Wang N, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01032-13	38	20	20	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157473	10.1371/journal.pone.0157473	http://dx.doi.org/10.1371/journal.pone.0157473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315226	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000378030000028
J	Chen, ZW; Feng, K; Grover, CE; Li, PB; Liu, F; Wang, YM; Xu, Q; Shang, MZ; Zhou, ZL; Cai, XY; Wang, XX; Wendel, JF; Wang, KB; Hua, JP				Chen, Zhiwen; Feng, Kun; Grover, Corrinne E.; Li, Pengbo; Liu, Fang; Wang, Yumei; Xu, Qin; Shang, Mingzhao; Zhou, Zhongli; Cai, Xiaoyan; Wang, Xingxing; Wendel, Jonathan F.; Wang, Kunbo; Hua, Jinping			Chloroplast DNA Structural Variation, Phylogeny, and Age of Divergence among Diploid Cotton Species	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENOME SEQUENCE; EVOLUTIONARY HISTORY; MAXIMUM-LIKELIHOOD; GOSSYPIUM-HIRSUTUM; PROVIDES INSIGHTS; GENUS GOSSYPIUM; NUCLEOTIDE; CHARACTERS; ORGANIZATION	The cotton genus (Gossypium spp.) contains 8 monophyletic diploid genome groups (A, B, C, D, E, F, G, K) and a single allotetraploid clade (AD). To gain insight into the phylogeny of Gossypium and molecular evolution of the chloroplast genome in this group, we performed a comparative analysis of 19 Gossypium chloroplast genomes, six reported here for the first time. Nucleotide distance in non-coding regions was about three times that of coding regions. As expected, distances were smaller within than among genome groups. Phylogenetic topologies based on nucleotide and indel data support for the resolution of the 8 genome groups into 6 clades. Phylogenetic analysis of indel distribution among the 19 genomes demonstrates contrasting evolutionary dynamics in different clades, with a parallel genome downsizing in two genome groups and a biased accumulation of insertions in the clade containing the cultivated cottons leading to large (for Gossypium) chloroplast genomes. Divergence time estimates derived from the cpDNA sequence suggest that the major diploid clades had diverged approximately 10 to 11 million years ago. The complete nucleotide sequences of 6 cpDNA genomes are provided, offering a resource for cytonuclear studies in Gossypium.	[Chen, Zhiwen; Li, Pengbo; Wang, Yumei; Xu, Qin; Hua, Jinping] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Minist Educ, Key Lab Crop Heterosis & Utilizat,Dept Plant Gene, Beijing 100193, Peoples R China; [Feng, Kun; Liu, Fang; Shang, Mingzhao; Zhou, Zhongli; Cai, Xiaoyan; Wang, Xingxing; Wang, Kunbo] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China; [Grover, Corrinne E.; Wendel, Jonathan F.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Iowa State University	Hua, JP (corresponding author), China Agr Univ, Beijing Key Lab Crop Genet Improvement, Minist Educ, Key Lab Crop Heterosis & Utilizat,Dept Plant Gene, Beijing 100193, Peoples R China.; Wang, KB (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China.; Wendel, JF (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	jfw@iastate.edu; wkbcri@163.com; jinping_hua@cau.edu.cn	Grover, Corrinne E/K-3194-2019; Hua, Jinping/L-3221-2019	Grover, Corrinne E/0000-0003-3878-5459; Chen, Zhiwen/0000-0002-0268-5942	National Natural Science Foundation of China [31171591]; central level, scientific research institutes for basic R & D special fund business [SJA0901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); central level, scientific research institutes for basic R & D special fund business	This work was supported by grants in part from the National Natural Science Foundation of China (31171591) to J. Hua and from the central level, scientific research institutes for basic R & D special fund business (SJA0901) to K. Wang.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Brouard JS, 2010, GENOME BIOL EVOL, V2, P240, DOI 10.1093/gbe/evq014; Carbonell-Caballero J, 2015, MOL BIOL EVOL, V32, P2015, DOI 10.1093/molbev/msv082; Carvalho MR, 2011, AM J BOT, V98, P1337, DOI 10.3732/ajb.1000539; Civan P, 2014, GENOME BIOL EVOL, V6, P897, DOI 10.1093/gbe/evu061; Cong J, 2015, SCI REP-UK, V5, DOI [10.1038/srep10007, 10.1038/srep14139]; Cronn R, 2004, NEW PHYTOL, V161, P133, DOI [10.1111/j.1469-8137.2004.00947.x, 10.1046/j.1469-8137.2003.00947.x]; Cronn RC, 2002, AM J BOT, V89, P707, DOI 10.3732/ajb.89.4.707; Earl D, 2014, GENOME RES, V24, P2077, DOI 10.1101/gr.174920.114; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fu YB, 2010, GENET RESOUR CROP EV, V57, P667, DOI 10.1007/s10722-009-9502-7; GIELLY L, 1994, MOL BIOL EVOL, V11, P769; GONG XS, 1991, CHINESE SCI BULL, V36, P1633; Grover CE, 2015, GENET RESOUR CROP EV, V62, P103, DOI 10.1007/s10722-014-0138-x; Grover CE, 2008, MOL BIOL EVOL, V25, P1415, DOI 10.1093/molbev/msn085; Grover CE, 2007, PLANT J, V50, P995, DOI 10.1111/j.1365-313X.2007.03102.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamilton MB, 2003, MOL BIOL EVOL, V20, P1710, DOI 10.1093/molbev/msg190; Handy SM, 2011, J AGR FOOD CHEM, V59, P10995, DOI 10.1021/jf203215v; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Ibrahim RIH, 2006, GENES GENET SYST, V81, P311, DOI 10.1266/ggs.81.311; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lee SB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-61; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li PB, 2014, GENET RESOUR CROP EV, V61, P107, DOI 10.1007/s10722-013-0018-9; Liu GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069476; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luan PT, 2013, MOL PHYLOGENET EVOL, V66, P748, DOI 10.1016/j.ympev.2012.10.023; Machado Moara, 2011, Investig Genet, V2, P3, DOI 10.1186/2041-2223-2-3; Santorum JM, 2014, BIOINFORMATICS, V30, P1310, DOI 10.1093/bioinformatics/btu032; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; Martin G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067350; Muller K, 2006, MOL PHYLOGENET EVOL, V38, P667, DOI 10.1016/j.ympev.2005.07.011; Muller K, 2005, PLANT SYST EVOL, V250, P39, DOI 10.1007/s00606-004-0224-1; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Muloko-Ntoutoume N, 2000, MOL ECOL, V9, P359, DOI 10.1046/j.1365-294X.2000.00859.x; Njuguna W, 2013, MOL PHYLOGENET EVOL, V66, P17, DOI 10.1016/j.ympev.2012.08.026; Oddou-Muratorio S, 2001, EVOLUTION, V55, P1123, DOI 10.1111/j.0014-3820.2001.tb00632.x; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Nguyen PAT, 2015, PLANTA, V242, P223, DOI 10.1007/s00425-015-2303-7; Randle CP, 2005, AM J BOT, V92, P1575, DOI 10.3732/ajb.92.9.1575; Rodman James E., 1994, Australian Systematic Botany, V7, P57, DOI 10.1071/SB9940057; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Simmons MP, 2001, SYST BIOL, V50, P454, DOI 10.1080/106351501300318049; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Walker JF, 2014, AM J BOT, V101, P722, DOI 10.3732/ajb.1400049; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang Z, 2015, BMC GENOMICS, V16, DOI [10.1186/s12864-015-1988-0, 10.1186/s12864-015-1216-y]; WENDEL JF, 1992, SYST BOT, V17, P115, DOI 10.2307/2419069; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1991, EVOLUTION, V45, P694, DOI 10.1111/j.1558-5646.1991.tb04339.x; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Wendel JF, 2015, MONOGRAPH A IN PRESS; Wendel JF, 2010, PHYSIOLOGY OF COTTON, P1, DOI 10.1007/978-90-481-3195-2_1; Wu ZH, 2014, BIG DATA RES, V1, P1, DOI 10.1016/j.bdr.2014.08.0022214; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037128; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]; Yuan DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17662; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207	73	29	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157183	10.1371/journal.pone.0157183	http://dx.doi.org/10.1371/journal.pone.0157183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309527	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800041
J	Farshadpour, F; Taherkhani, R; Tajbakhsh, S; Tangestani, MG; Hajiani, G; Sharifi, N; Taherkhani, S; Nejadbolkheyr, A				Farshadpour, Fatemeh; Taherkhani, Reza; Tajbakhsh, Saeed; Tangestani, Marziyeh Gholizadeh; Hajiani, Gholamreza; Sharifi, Nasrin; Taherkhani, Sakineh; Nejadbolkheyr, Abdolreza			Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; B-VIRUS; SYPHILIS INFECTIONS; RISK; SEROPREVALENCE; EPIDEMIOLOGY; HIV; METAANALYSIS; EXPERIENCE	Background Blood transfusion is considered a potential risk factor for transmission of life-threatening viral infections, including HIV, HCV and HBV infections. This study was performed to find out the prevalence and trends of these infections among blood donors in Southern Iran. Methods The blood donor data recorded in twelve regional blood transfusion centers from 2004 to 2014 were analyzed in an anonymous way with respect to the results of serological screening for HBV, HCV, and HIV infections. Overall, 293454 donors were screened for viral infections. Results Most of the donors were male, married, aged between 20-40 years, educated, and regular donors. The overall seroprevalence rates of HBV, HCV and HIV were 0.15%, 0.1% and 0.004%, respectively. The highest seroprevalence was found for HBV, followed by HCV and HIV. These infections were more prevalent in male, low educated and first time donors. The highest HCV seroprevalence was observed among donors aged 20 to 40 years, while HBV seroprevalence increased with age. The seroprevalence rates of HBV and HCV from 2004 to 2014 showed significant decreasing trends from 0.460% to 0.060% (P < 0.001) and 0.329% to 0.045% (P < 0.001), respectively. Whereas HIV infection had a slight but not significant decline from 0.0173% in 2004 to 0.0028% in 2014 (P = 0.087). Conclusions The decreasing trends of transfusion-transmissible viral infections in blood donations indicate that the attempts of IBTO were successful in improving the safety of the blood supply, since the prevalence rates of viral infections have been reduced to very low levels in blood donations over the years. However, still more effective techniques such as polymerase chain reaction (PCR) are needed to guarantee blood safety.	[Farshadpour, Fatemeh; Taherkhani, Reza; Tajbakhsh, Saeed; Tangestani, Marziyeh Gholizadeh] Bushehr Univ Med Sci, Sch Med, Dept Microbiol & Parasitol, Bushehr, Iran; [Farshadpour, Fatemeh; Taherkhani, Reza; Tajbakhsh, Saeed] Bushehr Univ Med Sci, Persian Gulf Trop Med Res Ctr, Bushehr, Iran; [Hajiani, Gholamreza; Nejadbolkheyr, Abdolreza] Bushehr Blood Transfus Org, Bushehr, Iran; [Sharifi, Nasrin] Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan, Iran; [Taherkhani, Sakineh] Shahroud Univ Med Sci, Sch Nursing & Midwifery, Reprod Hlth & Midwifery Dept, Shahroud, Iran	Shahroud University Medical Sciences	Taherkhani, R (corresponding author), Bushehr Univ Med Sci, Sch Med, Dept Microbiol & Parasitol, Bushehr, Iran.; Taherkhani, R (corresponding author), Bushehr Univ Med Sci, Persian Gulf Trop Med Res Ctr, Bushehr, Iran.	taherkhanireza2005@yahoo.com	Sharifi, Nasrin/AAW-2843-2021; farshadpour, fatemeh/B-3392-2018; Taherkhani, Reza/B-3384-2018; Tajbakhsh, Saeed/B-2859-2018; Sharifi, Nasrin/G-7661-2017; Taherkhani, Sakineh/P-3990-2018	Sharifi, Nasrin/0000-0002-2879-5883; farshadpour, fatemeh/0000-0002-8317-9573; Taherkhani, Reza/0000-0001-6499-0531; Sharifi, Nasrin/0000-0002-2879-5883; Taherkhani, Sakineh/0000-0003-3161-0963; Tajbakhsh, Saeed/0000-0001-6023-3939	Deputy Research and Affairs of Bushehr University of Medical Sciences, Bushehr, Iran [5919]	Deputy Research and Affairs of Bushehr University of Medical Sciences, Bushehr, Iran	This study was supported by the Deputy Research and Affairs of Bushehr University of Medical Sciences, Bushehr, Iran (grant no. 5919). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekeye AM, 2013, ASIAN J MED SCI, V5, P101, DOI 10.19026/ajms.5.5362; Al-Gani F.A., 2011, INT J BIOL MED RES, V2, P912; Alizadeh S., 2014, Asian Journal of Biological Sciences, V7, P35; Amiri FB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151946; Bozorgi SH, 2012, TRANSFUS APHER SCI, V47, P145, DOI 10.1016/j.transci.2012.06.023; Dhruva GA, 2012, ONLINE J HLTH ALLIED, V11, P5; Elbjeirami W, 2015, J BLOOD DISORD TRANS, V6; Farshadpour F, 2010, INDIAN J MED MICROBI, V28, P54, DOI 10.4103/0255-0857.58731; FARZADEGAN H, 1979, VOX SANG, V37, P182, DOI 10.1111/j.1423-0410.1979.tb02289.x; Fessehaye N, 2011, PAN AFR MED J, V9; Flichman DM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-218; Gonzalez M, 2005, TRANSFUSION, V45, P1670, DOI 10.1111/j.1537-2995.2005.00576.x; Irani-Hakime N, 2006, AM J INFECT CONTROL, V34, P241, DOI 10.1016/j.ajic.2005.06.009; Kafi-Abad SA, 2009, TRANSFUSION MED, V19, P189, DOI 10.1111/j.1365-3148.2009.00935.x; Kafi-Abad SA, 2009, TRANSFUSION, V49, P2214, DOI 10.1111/j.1537-2995.2009.02245.x; Khan AJ, 2000, B WORLD HEALTH ORGAN, V78, P956; Khedmat H, 2009, HEPAT MON, V9, P24; Khodabandehloo M, 2013, J RES MED SCI, V18, P674; Lama JR, 2010, AM J TROP MED HYG, V83, P194, DOI 10.4269/ajtmh.2010.10-0003; Li CQ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-176; Mohammadali F, 2014, ARCH IRAN MED, V17, P613, DOI 0141709/AIM.006; Mohamoud YA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-288; Mudholkar VG, 2014, INT J MED APPL SCI, V3, P82; Nwankwo E, 2012, TURK J MED SCI, V42, P337, DOI 10.3906/sag-1009-1176; Nwokeukwu HI., 2014, HEMATOL LEUKEMIA, V2, P4, DOI [10.7243/2052-434X-2-4, DOI 10.7243/2052-434X-2-4]; O'Brien SF, 2008, TRANSFUSION, V48, P2323, DOI 10.1111/j.1537-2995.2008.01845.x; Pallavi P, 2011, INDIAN J HEMATOL BLO, V27, P1, DOI 10.1007/s12288-010-0047-x; Polizzotto MN, 2008, TRANSFUSION, V48, P55, DOI 10.1111/j.1537-2995.2007.01482.x; Poorolajal J, 2009, J RES MED SCI, V14, P249; Sethi B, 2014, INTERNET J MED UPDAT, V9, P10; Shrestha AC, 2009, J INFECT DEV COUNTR, V3, P794, DOI 10.3855/jidc.311; Song Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094528; Sube K. L. L., 2014, South Sudan Medical Journal, V7, P76; Sultan F, 2007, INT J INFECT DIS, V11, P407, DOI 10.1016/j.ijid.2006.10.004; Taherkhani R, 2015, WORLD J GASTROENTERO, V21, P10790, DOI 10.3748/wjg.v21.i38.10790; Tessema B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-111; Tserenpuntsag B, 2008, J INFECT DEV COUNTR, V2, P73, DOI 10.3855/jidc.326; WHO, BLOOD SAF AV WHO FAC; Ymele FF, 2012, J BLOOD TRANSFUS, V2012, DOI DOI 10.1155/2012/458372; Zulfikar Ahmed, 2012, Medica Innovatica, V1, P24	40	44	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157615	10.1371/journal.pone.0157615	http://dx.doi.org/10.1371/journal.pone.0157615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309959	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000378029800108
J	Lehmann, BD; Jovanovic, B; Chen, X; Estrada, MV; Johnson, KN; Shyr, Y; Moses, HL; Sanders, ME; Pietenpol, JA				Lehmann, Brian D.; Jovanovic, Bojana; Chen, Xi; Estrada, Monica V.; Johnson, Kimberly N.; Shyr, Yu; Moses, Harold L.; Sanders, Melinda E.; Pietenpol, Jennifer A.			Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; PATHOLOGICAL COMPLETE RESPONSE; PROGNOSTIC VALUE; SURVIVAL; IDENTIFICATION; IXABEPILONE; EXPRESSION; PACLITAXEL; WOMEN; RATES	Triple-negative breast cancer (TNBC) is a heterogeneous disease that can be classified into distinct molecular subtypes by gene expression profiling. Considered a difficult-to-treat cancer, a fraction of TNBC patients benefit significantly from neoadjuvant chemotherapy and have far better overall survival. Outside of BRCA1/2 mutation status, biomarkers do not exist to identify patients most likely to respond to current chemotherapy; and, to date, no FDA-approved targeted therapies are available for TNBC patients. Previously, we developed an approach to identify six molecular subtypes TNBC (TNBCtype), with each subtype displaying unique ontologies and differential response to standard-of-care chemotherapy. Given the complexity of the varying histological landscape of tumor specimens, we used histopathological quantification and laser-capture microdissection to determine that transcripts in the previously described immunomodulatory (IM) and mesenchymal stem-like (MSL) subtypes were contributed from infiltrating lymphocytes and tumor-associated stromal cells, respectively. Therefore, we refined TNBC molecular subtypes from six (TNBCtype) into four (TNBCtype-4) tumor-specific subtypes (BL1, BL2, M and LAR) and demonstrate differences in diagnosis age, grade, local and distant disease progression and histopathology. Using five publicly available, neoadjuvant chemotherapy breast cancer gene expression datasets, we retrospectively evaluated chemotherapy response of over 300 TNBC patients from pretreatment biopsies subtyped using either the intrinsic (PAM50) or TNBCtype approaches. Combined analysis of TNBC patients demonstrated that TNBC subtypes significantly differ in response to similar neoadjuvant chemotherapy with 41% of BL1 patients achieving a pathological complete response compared to 18% for BL2 and 29% for LAR with 95% confidence intervals (CIs; [33, 51], [9, 28], [17, 41], respectively). Collectively, we provide pre-clinical data that could inform clinical trials designed to test the hypothesis that improved outcomes can be achieved for TNBC patients, if selection and combination of existing chemotherapies is directed by knowledge of molecular TNBC subtypes.	[Lehmann, Brian D.; Johnson, Kimberly N.; Pietenpol, Jennifer A.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Jovanovic, Bojana] Harvard Univ, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; [Chen, Xi] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Div Biostat, Miami, FL 33136 USA; [Chen, Xi] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Estrada, Monica V.] Vanderbilt Univ, Breast Canc Res Program, Dept Med, 221 Kirkland Hall, Nashville, TN 37235 USA; [Shyr, Yu] Vanderbilt Univ, Dept Biostat, Div Canc Biostat, Ctr Quantitat Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Moses, Harold L.; Pietenpol, Jennifer A.] Vanderbilt Univ, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Sanders, Melinda E.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Harvard University; Dana-Farber Cancer Institute; University of Miami; University of Miami; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Lehmann, BD; Pietenpol, JA (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.; Pietenpol, JA (corresponding author), Vanderbilt Univ, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	brian.d.lehmann@vanderbilt.edu; j.pietenpol@vanderbilt.edu	Lehmann, Brian D./H-8464-2019	Lehmann, Brian D./0000-0003-0407-5248; Estrada, Monica Valeria/0000-0001-9846-8223	NCI/NCI grants [CA105436, CA068485, CA085492, CA102162]; Komen for the Cure Foundation grants [SAC110030, CCR13262005]; Vanderbilt-Ingram Cancer Center [P30 CA068485]; Vanderbilt Vision Center [P30 EY08126]; NIH/NCRR [G20 RR030956]; Specialized Program of Research Excellence in Breast Cancer [CA098131]; NATIONAL CANCER INSTITUTE [R01CA085492, R01CA105436, P30CA068485, P50CA098131, R01CA102162] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR030956] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER	NCI/NCI grants; Komen for the Cure Foundation grants; Vanderbilt-Ingram Cancer Center; Vanderbilt Vision Center; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Specialized Program of Research Excellence in Breast Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by: NCI/NCI grants CA105436 (JAP), CA068485 (JAP), CA085492 (HLM) and CA102162 (HLM); and Komen for the Cure Foundation grants SAC110030 (JAP) and CCR13262005 (BDL). The authors would like to thank Vanderbilt Technologies for Advanced Genomics (VANTAGE) and the Translational Pathology Shared Resources supported by the Vanderbilt-Ingram Cancer Center (P30 CA068485), the Vanderbilt Vision Center (P30 EY08126) and NIH/NCRR (G20 RR030956). Grant support for the histopathological analyses was provided by CA098131 (Specialized Program of Research Excellence in Breast Cancer).; We thank members of the Pietenpol lab and Robert Seitz for critical review of the manuscript. This research was supported by: NCI/NCI grants CA105436 (JAP), CA068485 (JAP), CA085492 (HLM) and CA102162 (HLM); and Komen for the Cure Foundation grants SAC110030 (JAP) and CCR13262005 (BDL). We would like to thank Vanderbilt Technologies for Advanced Genomics (VANTAGE) and the Translational Pathology Shared Resources supported by the Vanderbilt-Ingram Cancer Center (P30 CA068485), the Vanderbilt Vision Center (P30 EY08126) and NIH/NCRR (G20 RR030956). Grant support for the histopathological analyses was provided by CA098131 (Specialized Program of Research Excellence in Breast Cancer).	Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; Allred DC, 1998, MODERN PATHOL, V11, P155; Amirikia KC, 2011, CANCER-AM CANCER SOC, V117, P2747, DOI 10.1002/cncr.25862; [Anonymous], 2015, CANCER DISCOV, V5, P570, DOI 10.1158/2159-8290.CD-NB2015-059; [Anonymous], 2015, CANCER DISCOV, V5, P100, DOI 10.1158/2159-8290.CD-NB2014-184; Asano Y, 2016, BRIT J CANCER, V114, P14, DOI 10.1038/bjc.2015.434; Burstein MD, 2015, CLIN CANCER RES, V21, P1688, DOI 10.1158/1078-0432.CCR-14-0432; Byrski T, 2010, J CLIN ONCOL, V28, P375, DOI 10.1200/JCO.2008.20.7019; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen X, 2012, CANCER INFORM, V11, P147, DOI 10.4137/CIN.S9983; Denkert C, 2015, J CLIN ONCOL, V33, P983, DOI 10.1200/JCO.2014.58.1967; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Esserman LJ, 2012, BREAST CANCER RES TR, V132, P1049, DOI 10.1007/s10549-011-1895-2; Gluck S, 2012, BREAST CANCER RES TR, V132, P781, DOI 10.1007/s10549-011-1412-7; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Horak CE, 2013, CLIN CANCER RES, V19, P1587, DOI 10.1158/1078-0432.CCR-12-1359; Ibrahim EM, 2014, BREAST CANCER RES TR, V148, P467, DOI 10.1007/s10549-014-3185-2; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lehmann BD, 2014, J PATHOL, V232, P142, DOI 10.1002/path.4280; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Miyake T, 2012, CANCER SCI, V103, P913, DOI 10.1111/j.1349-7006.2012.02231.x; Rahim F, 2014, BONE MARROW RES, DOI 10.1155/2014/405920; Ring BZ, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2198-0; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Saura C, 2013, ONCOLOGIST, V18, P787, DOI 10.1634/theoncologist.2013-0075; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Timms KM, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0475-x; Tutt A, 2014, SAN ANTONIO BREAST C, V2014, pS3	35	617	642	9	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157368	10.1371/journal.pone.0157368	http://dx.doi.org/10.1371/journal.pone.0157368			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310713	gold, Green Published, Green Submitted			2022-12-26	WOS:000378029800062
J	Mascret, N; Ibanez-Gijon, J; Brejard, V; Buekers, M; Casanova, R; Marqueste, T; Montagne, G; Rao, G; Roux, Y; Cury, F				Mascret, Nicolas; Ibanez-Gijon, Jorge; Brejard, Vincent; Buekers, Martinus; Casanova, Remy; Marqueste, Tanguy; Montagne, Gilles; Rao, Guillaume; Roux, Yannick; Cury, Francois			The Influence of the 'Trier Social Stress Test' on Free Throw Performance in Basketball: An Interdisciplinary Study	PLOS ONE			English	Article							PSYCHOLOGICAL RESPONSES; PSYCHOSOCIAL STRESS; SALIVARY CORTISOL; MOVEMENT VARIABILITY; SPORT PERFORMANCE; TESTOSTERONE; ANXIETY; COMPETITION; KINEMATICS; LEVEL	The aim of the present study was to explore the relationship between stress and sport performance in a controlled setting. The experimental protocol used to induce stress in a basketball free throw was the Trier Social Stress Test (TSST) and its control condition (Placebo-TSST). Participants (n = 19), novice basketball players but trained sportspersons, were exposed to two counterbalanced conditions in a crossover design. They were equipped with sensors to measure movement execution, while salivary cortisol and psychological state were also measured. The task consisted of two sequences of 40 free throws, one before either the TSST or Placebo-TSST and one after. Physiological and psychological measures evidenced that the TSST induced significant stress responses, whereas the Placebo-TSST did not. Shooting performance remained stable after the TSST but decreased after the Placebo-TSST. We found no effect of the TSST or Placebo-TSST on movement execution. A multivariate model of free throw performance demonstrated that timing, smoothness and explosiveness of the movements are more relevant to account for beginner's behavior than stress-related physiological and psychological states. We conclude that the TSST is a suitable protocol to induce stress responses in sport context, even though the effects on beginners' free throw performance and execution are small and complex.	[Mascret, Nicolas; Ibanez-Gijon, Jorge; Buekers, Martinus; Casanova, Remy; Marqueste, Tanguy; Montagne, Gilles; Rao, Guillaume; Roux, Yannick; Cury, Francois] Aix Marseille Univ, CNRS, ISM, Inst Movement Sci, Marseille, France; [Brejard, Vincent] Aix Marseille Univ, LPCLS EA 3278, F-13621 Aix En Provence, France; [Buekers, Martinus] Katholieke Univ Leuven, Dept Kinesiol, Tervuursevest 101, B-3001 Heverlee, Belgium; [Cury, Francois] Univ Toulon & Var, Toulon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; KU Leuven; Universite de Toulon	Mascret, N (corresponding author), Aix Marseille Univ, CNRS, ISM, Inst Movement Sci, Marseille, France.	nicolas.mascret@univ-amu.fr	Marqueste, Tanguy/AAM-9751-2021; Casanova, Remy/GSO-3393-2022; casanova, remy/U-3603-2017; Bréjard, Vincent/ABB-7970-2021; Ibáñez-Gijón, Jorge/D-6882-2019; Montagne, Gilles/T-6322-2017; casanova, rémy/AGK-6933-2022	Marqueste, Tanguy/0000-0002-2620-1551; casanova, remy/0000-0002-7101-8043; Bréjard, Vincent/0000-0003-1344-0489; Ibáñez-Gijón, Jorge/0000-0001-6897-6980; Montagne, Gilles/0000-0003-2184-2736; casanova, rémy/0000-0002-7101-8043	A*MIDEX project [ANR-11-IDEX-0001-02]; "Investissements d'avenir" French Government Program	A*MIDEX project(French National Research Agency (ANR)); "Investissements d'avenir" French Government Program(French National Research Agency (ANR))	This work has been carried out thanks to the support of the A*MIDEX project (no ANR-11-IDEX-0001-02), funded by the "Investissements d'avenir" French Government Program, managed by the French National Research Agency. NM JIG MB RC TM GM GR YR and FC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2014, NEUROSCI BIOBEHAV R, V38, P94, DOI 10.1016/j.neubiorev.2013.11.005; [Anonymous], 2014, R LANG ENV STAT COMP; Bartlett R, 2008, ROUTLEDGE HDB BIOMEC, P285; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Buchanan TW, 2014, BIOL PSYCHOL, V97, P60, DOI 10.1016/j.biopsycho.2014.02.005; Buekers M, 2016, QUEST; Button C, 2003, RES Q EXERCISE SPORT, V74, P257, DOI 10.1080/02701367.2003.10609090; Crewther BT, 2010, J SPORT MED PHYS FIT, V50, P85; Diamond David M, 2005, Nonlinearity Biol Toxicol Med, V3, P1, DOI 10.2201/nonlin.003.01.001; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Doan BK, 2007, INT J SPORTS MED, V28, P470, DOI 10.1055/s-2006-924557; Filaire E, 2009, PSYCHONEUROENDOCRINO, V34, P150, DOI 10.1016/j.psyneuen.2008.08.022; Giles GE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113618; GILOVICH T, 1985, COGNITIVE PSYCHOL, V17, P295, DOI 10.1016/0010-0285(85)90010-6; Gooding A, 2009, J CLIN SPORT PSYCHOL, V3, P303, DOI 10.1123/jcsp.3.4.303; HARDY L, 1991, BRIT J PSYCHOL, V82, P163, DOI 10.1111/j.2044-8295.1991.tb02391.x; Het S, 2009, PSYCHONEUROENDOCRINO, V34, P1075, DOI 10.1016/j.psyneuen.2009.02.008; Higuchi T, 2002, HUM MOVEMENT SCI, V21, P831, DOI 10.1016/S0167-9457(02)00174-4; Hill D., 2010, INT REV SPORT EXER P, V3, P24, DOI [DOI 10.1080/17509840903301199, 10.1080/17509840903301199]; Hogan N, 2009, J MOTOR BEHAV, V41, P529, DOI 10.3200/35-09-004-RC; JONES G, 1991, PSYCHOLOGIST, V4, P152; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Klaperski S, 2013, PSYCHOL SPORT EXERC, V14, P266, DOI 10.1016/j.psychsport.2012.11.003; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Kudielka B. M., 2007, SOC NEUROSCI-UK, P56, DOI DOI 10.1007/978-1-4614-6852-3; Laborde S, 2014, PERS INDIV DIFFER, V57, P43, DOI 10.1016/j.paid.2013.09.013; Lautenbach F., 2016, PERFORMANCE PSYCHOL, P315, DOI [10.1016/B978-0-12-803377-7.00019-3, DOI 10.1016/B978-0-12-803377-7.00019-3, DOI 10.1016/B978-0-12-803377-7.00019]; Lautenbach F, 2014, PSYCHONEUROENDOCRINO, V42, P218, DOI 10.1016/j.psyneuen.2014.01.011; Lesage FX, 2012, INT J OCCUP MED ENV, V25, P178, DOI 10.2478/S13382-012-0024-8; Luethi M, 2008, FRONT BEHAV NEUROSCI, V2, P1; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; McEwen BS, 2005, J PSYCHIATR NEUROSCI, V30, P315; Mellalieu SD, 2009, J SPORT SCI, V27, P729, DOI 10.1080/02640410902889834; Mullineaux DR, 2010, J SPORT SCI, V28, P1017, DOI 10.1080/02640414.2010.487872; Otten M, 2009, J SPORT EXERCISE PSY, V31, P583, DOI 10.1123/jsep.31.5.583; PASSELERGUE P, 1995, INT J SPORTS MED, V16, P298, DOI 10.1055/s-2007-973009; Quesada AA, 2012, PSYCHONEUROENDOCRINO, V37, P125, DOI 10.1016/j.psyneuen.2011.05.013; Rimmele U, 2007, PSYCHONEUROENDOCRINO, V32, P627, DOI 10.1016/j.psyneuen.2007.04.005; Rimmele U, 2009, PSYCHONEUROENDOCRINO, V34, P190, DOI 10.1016/j.psyneuen.2008.08.023; Rohleder N, 2007, PERS SOC PSYCHOL B, V33, P69, DOI 10.1177/0146167206293986; Salama-Younes M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-22; Salvador A, 2003, PSYCHONEUROENDOCRINO, V28, P364, DOI 10.1016/S0306-4530(02)00028-8; Salvador A, 2009, NEUROSCI BIOBEHAV R, V33, P160, DOI 10.1016/j.neubiorev.2008.09.005; Selye H., 1974, STRESS DISTRESS; Selye H, 1956, J BONE JOINT SURG; Smith D., 2012, SPORT EXERCISE PSYCH, V8, P3; Spielberger C.D., 1993, INVENTAIRE ANXIETE E; Strahler K, 2010, PSYCHOL SPORT EXERC, V11, P148, DOI 10.1016/j.psychsport.2009.10.003; Suay F, 2012, ROUT RES SPORT EXERC, P43; Szabo S, 2012, STRESS, V15, P472, DOI 10.3109/10253890.2012.710919; Tanaka Y, 2010, RES Q EXERCISE SPORT, V81, P416; Wada M, 2001, NEUROSCI LETT, V302, P157, DOI 10.1016/S0304-3940(01)01662-7; Wagner H, 2012, HUM MOVEMENT SCI, V31, P78, DOI 10.1016/j.humov.2011.05.005; Whitehead R, 1996, J SPORT SCI, V14, P393, DOI 10.1080/02640419608727726; Williams AM, 2002, J SPORT EXERCISE PSY, V24, P438, DOI 10.1123/jsep.24.4.438; Woodman T, 2003, J SPORT SCI, V21, P443, DOI 10.1080/0264041031000101809	56	13	16	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157215	10.1371/journal.pone.0157215	http://dx.doi.org/10.1371/journal.pone.0157215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27309715	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800042
J	Tan, RYY; Markus, HS				Tan, Rhea Yan Ying; Markus, Hugh Stephen			CADASIL: Migraine, Encephalopathy, Stroke and Their Inter-Relationships	PLOS ONE			English	Article							PREVALENCE; ACETAZOLAMIDE; SPECTRUM; AURA	Background Migraine is common in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) but its treatment responses are not well described, and its relationship to stroke risk unknown. Encephalopathy is a less common presentation; it has been suggested it is related to migraine. We characterised migraine patterns and treatment responses in CADASIL, and examined associations between migraine and both stroke risk and encephalopathy. Methods 300 symptomatic CADASIL patients were prospectively recruited from a national referral clinic over a nineteen year period, from 1996 to 2015. Data was collected using a standardised questionnaire. Migraine was classified according to the International Classification of Headache Disorders, 3rd edition (beta version). A cross-sectional analysis was carried out on the data collected. Results Migraine was present in 226 (75.3%), and the presenting feature in 203 (67.7%). It was usually accompanied by aura (89.8%). Patients showed variable responses to a variety of drugs for migraine. Of 24 given triptans, 45.5% had consistent or partial responses. None had complications following triptans. Thirty-three (11.0%) patients experienced encephalopathy lasting on average 8.1 +/- 3.4 days. Patients with migraine with aura had higher odds of encephalopathy (OR = 5.4; 95% CI 1.6-28.4; p = 0.002). Patients with confusional aura had higher odds of encephalopathy than those with other aura types (OR = 2.5, 95% CI = 1.0-5.8, p = 0.04). There was also no increase in risk of encephalopathy with sex or age at onset of migraine. Migraineurs had a lower stroke risk than non-migraineurs (HR = 0.46, 95% CI 0.3-0.6, p = 2.1x10(-6)). Conclusions Migraine with aura is a prominent feature of CADASIL. Treatment responses are similar to those seen in the general migraine population and no complications were observed with triptans. Migraine with aura was associated with increased risk of encephalopathy suggesting they may share pathophysiological mechanisms. There was no increased stroke risk associated with migraine, but risk appeared to be reduced although this finding needs confirming.	[Tan, Rhea Yan Ying; Markus, Hugh Stephen] Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge, England	University of Cambridge	Tan, RYY (corresponding author), Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge, England.	yyrt2@medschl.cam.ac.uk			Agency for Science, Technology and Research Singapore (MBBS-PhD scholarship); NIHR Senior Investigator award; Cambridge Universities Trust NIHR Comprehensive Biomedical Research Centre; National Institute for Health Research [NF-SI-0512-10019] Funding Source: researchfish	Agency for Science, Technology and Research Singapore (MBBS-PhD scholarship); NIHR Senior Investigator award; Cambridge Universities Trust NIHR Comprehensive Biomedical Research Centre; National Institute for Health Research(National Institute for Health Research (NIHR))	RYYT is supported by the Agency for Science, Technology and Research Singapore (MBBS-PhD scholarship, https://www.a-star.edu.sg/Awards-Scholarship/Scholarships-Attachments/For-Undergraduate-Studies/National-Science-Scholarship-MBBS-PhD.aspx). HSM is supported by an NIHR Senior Investigator award (http://www.nihr.ac.uk/our-faculty/senior-investigators.htm). His work is supported by the Cambridge Universities Trust NIHR Comprehensive Biomedical Research Centre (http://www.cambridge-brc.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Samii P, 2010, STROKE, V41, P630, DOI 10.1161/STROKEAHA.109.568402; Becker C, 2008, CEPHALALGIA, V28, P57, DOI 10.1111/j.1468-2982.2007.01469.x; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bousser MG, 2005, LANCET NEUROL, V4, P533, DOI 10.1016/S1474-4422(05)70164-2; Brennan KC, 2007, J NEUROPHYSIOL, V97, P4143, DOI 10.1152/jn.00028.2007; CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; Choi JC, 2014, CEPHALALGIA, V34, P22, DOI 10.1177/0333102413497598; Desmond DW, 1999, STROKE, V30, P1230, DOI 10.1161/01.STR.30.6.1230; Dichgans M, 1998, ANN NEUROL, V44, P731, DOI 10.1002/ana.410440506; Donnini I, 2012, J HEADACHE PAIN, V13, P299, DOI 10.1007/s10194-012-0426-9; Eikermann-Haerter K, 2014, HEADACHE, V54, P1146, DOI 10.1111/head.12386; Etminan M, 2005, BMJ-BRIT MED J, V330, P63, DOI 10.1136/bmj.38302.504063.8F; Fan Yuan, 2012, Neurol Clin Pract, V2, P359; Forteza AM, 2001, NEUROLOGY, V57, P2144, DOI 10.1212/WNL.57.11.2144; Guey S, 2016, CEPHALALGIA, V36, P1038, DOI 10.1177/0333102415620909; Gunda B, 2012, STROKE, V43, P137, DOI 10.1161/STROKEAHA.111.631028; Hall GC, 2004, NEUROLOGY, V62, P563, DOI 10.1212/01.WNL.0000110312.36809.7F; Kruit MC, 2010, CEPHALALGIA, V30, P129, DOI 10.1111/j.1468-2982.2009.01904.x; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Liem MK, 2010, CEPHALALGIA, V30, P1284, DOI 10.1177/0333102410370870; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Liu XQ, 2009, ACTA PHARMACOL SIN, V30, P1071, DOI 10.1038/aps.2009.105; Martikainen MH, 2012, J HEADACHE PAIN, V13, P95, DOI 10.1007/s10194-011-0400-y; MHRA, 2013, MED INF PROD DET; Roine S, 2005, NEUROLOGY, V64, P1441, DOI 10.1212/01.WNL.0000158655.71323.8A; Sathe S, 2009, HEADACHE, V49, P590, DOI 10.1111/j.1526-4610.2009.01363.x; Schon F, 2003, J NEUROL NEUROSUR PS, V74, P249, DOI 10.1136/jnnp.74.2.249; Spector JT, 2010, AM J MED, V123, P612, DOI 10.1016/j.amjmed.2009.12.021; Stewart WF, 2008, CEPHALALGIA, V28, P1170, DOI 10.1111/j.1468-2982.2008.01666.x; Tfelt-Hansen P, 2006, CEPHALALGIA, V26, P1265, DOI 10.1111/j.1468-2982.2006.01194.x; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; Vahedi K, 2004, ARCH NEUROL-CHICAGO, V61, P1237, DOI 10.1001/archneur.61.8.1237; Weller M, 1998, NEUROLOGY, V50, P1505, DOI 10.1212/WNL.50.5.1505; Wenzel RG, 2003, PHARMACOTHERAPY, V23, P494, DOI 10.1592/phco.23.4.494.32124; Zivadinov R, 2001, HEADACHE, V41, P805, DOI 10.1046/j.1526-4610.2001.01147.x	35	43	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157613	10.1371/journal.pone.0157613	http://dx.doi.org/10.1371/journal.pone.0157613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309730	gold, Green Published, Green Submitted			2022-12-26	WOS:000378029800107
J	Kim, HJ; Jeong, MY; Parnell, TJ; Babst, M; Phillips, JD; Winge, DR				Kim, Hyung J.; Jeong, Mi-Young; Parnell, Timothy J.; Babst, Markus; Phillips, John D.; Winge, Dennis R.			The Plasma Membrane Protein Nce102 Implicated in Eisosome Formation Rescues a Heme Defect in Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; heme; membrane transport; mitochondria; mitochondrial metabolism; Nce102; eisosomes; ferrochelatase	SACCHAROMYCES-CEREVISIAE; FERRICHROME TRANSPORTER; YEAST; PATHWAY; GENE; BIOSYNTHESIS; MACROPHAGES; ENDOCYTOSIS; ACTIVATION; DEFICIENT	The cellular transport of the cofactor heme and its biosynthetic intermediates such as protoporphyrin IX is a complex and highly coordinated process. To investigate the molecular details of this trafficking pathway, we created a synthetic lesion in the heme biosynthetic pathway by deleting the gene HEM15 encoding the enzyme ferrochelatase in S. cerevisiae and performed a genetic suppressor screen. Cells lacking Hem15 are respiratory-defective because of an inefficient heme delivery to the mitochondria. Thus, the biogenesis of mitochondrial cytochromes is negatively affected. The suppressor screen resulted in the isolation of respiratory-competent colonies containing two distinct missense mutations in Nce102, a protein that localizes to plasma membrane invaginations designated as eisosomes. The presence of the Nce102 mutant alleles enabled formation of the mitochondrial respiratory complexes and respiratory growth in hem15 cells cultured in supplemental hemin. Respiratory function in hem15 cells can also be restored by the presence of a heterologous plasma membrane heme permease (HRG-4), but the mode of suppression mediated by the Nce102 mutant is more efficient. Attenuation of the endocytic pathway through deletion of the gene END3 impaired the Nce102-mediated rescue, suggesting that the Nce102 mutants lead to suppression through the yeast endocytic pathway.	[Kim, Hyung J.; Jeong, Mi-Young; Phillips, John D.; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Kim, Hyung J.; Jeong, Mi-Young; Phillips, John D.; Winge, Dennis R.] Univ Utah, Dept Biochem, Hlth Sci Ctr, Salt Lake City, UT 84132 USA; [Parnell, Timothy J.] Huntsman Canc Inst, Bioinformat Shared Resources, Salt Lake City, UT 84132 USA; [Babst, Markus] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Babst, Markus] Univ Utah, Ctr Cell & Genom Sci, Salt Lake City, UT 84112 USA; [Kim, Hyung J.] Univ Washington, Div Phys Sci, Bothell, WA 98011 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Bothell	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA.; Winge, DR (corresponding author), Univ Utah, Dept Biochem, Hlth Sci Ctr, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu		Parnell, Timothy/0000-0002-3632-3691	National Institutes of Health [GM110755]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090257, U54DK110858, R01DK020503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM110755 (to D. R. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Barros MH, 2001, FEBS LETT, V492, P133, DOI 10.1016/S0014-5793(01)02249-9; BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023, DOI 10.1091/mbc.5.9.1023; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Cleves AE, 1996, J CELL BIOL, V133, P1017, DOI 10.1083/jcb.133.5.1017; Desmyter L, 2007, BIOGERONTOLOGY, V8, P527, DOI 10.1007/s10522-007-9095-5; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Douglas LM, 2013, MBIO, V4, DOI 10.1128/mBio.00723-13; Douglas LM, 2011, MEMBRANES, V1, P394, DOI 10.3390/membranes1040394; Frohlich F, 2009, J CELL BIOL, V185, P1227, DOI 10.1083/jcb.200811081; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; GOLLUB EG, 1977, J BIOL CHEM, V252, P2846; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; Keener JM, 2013, TRAFFIC, V14, P412, DOI 10.1111/tra.12039; Kim Y, 2005, EMBO J, V24, P952, DOI 10.1038/sj.emboj.7600579; Kim Y, 2002, EMBO J, V21, P3632, DOI 10.1093/emboj/cdf382; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luo GZ, 2008, J BIOL CHEM, V283, P10433, DOI 10.1074/jbc.M709972200; O'Callaghan KM, 2010, J BIOL CHEM, V285, P381, DOI 10.1074/jbc.M109.063248; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soto IC, 2012, CELL METAB, V16, P801, DOI 10.1016/j.cmet.2012.10.018; Storbeck S, 2010, ARCHAEA, V2010, DOI 10.1155/2010/175050; THORSNESS M, 1989, MOL CELL BIOL, V9, P5702, DOI 10.1128/MCB.9.12.5702; White C, 2013, CELL METAB, V17, P261, DOI 10.1016/j.cmet.2013.01.005; Xu HB, 2014, CELL PHYSIOL BIOCHEM, V34, P1835, DOI 10.1159/000366383; Yuan XJ, 2012, J BIOL CHEM, V287, P4914, DOI 10.1074/jbc.M111.326785; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	39	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17417	17426		10.1074/jbc.M116.727743	http://dx.doi.org/10.1074/jbc.M116.727743			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27317660	Green Published, hybrid			2022-12-26	WOS:000382643800040
J	Alvarez-Carreno, C; Becerra, A; Lazcano, A				Alvarez-Carreno, Claudia; Becerra, Arturo; Lazcano, Antonio			Molecular Evolution of the Oxygen-Binding Hemerythrin Domain	PLOS ONE			English	Article							ATMOSPHERIC OXYGEN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; F-BOX; PROTEIN; O-2; ACCURATE; STATE; RISE	Background The evolution of oxygenic photosynthesis during Precambrian times entailed the diversification of strategies minimizing reactive oxygen species-associated damage. Four families of oxygen-carrier proteins (hemoglobin, hemerythrin and the two non-homologous families of arthropodan and molluscan hemocyanins) are known to have evolved independently the capacity to bind oxygen reversibly, providing cells with strategies to cope with the evolutionary pressure of oxygen accumulation. Oxygen-binding hemerythrin was first studied in marine invertebrates but further research has made it clear that it is present in the three domains of life, strongly suggesting that its origin predated the emergence of eukaryotes. Results Oxygen-binding hemerythrins are a monophyletic sub-group of the hemerythrin/HHE (histidine, histidine, glutamic acid) cation-binding domain. Oxygen-binding hemerythrin homologs were unambiguously identified in 367/2236 bacterial, 21/150 archaeal and 4/135 eukaryotic genomes. Overall, oxygen-binding hemerythrin homologues were found in the same proportion as single-domain and as long protein sequences. The associated functions of protein domains in long hemerythrin sequences can be classified in three major groups: signal transduction, phosphorelay response regulation, and protein binding. This suggests that in many organisms the reversible oxygen-binding capacity was incorporated in signaling pathways. A maximum-likelihood tree of oxygen-binding hemerythrin homologues revealed a complex evolutionary history in which lateral gene transfer, duplications and gene losses appear to have played an important role. Conclusions Hemerythrin is an ancient protein domain with a complex evolutionary history. The distinctive iron-binding coordination site of oxygen-binding hemerythrins evolved first in prokaryotes, very likely prior to the divergence of Firmicutes and Proteobacteria, and spread into many bacterial, archaeal and eukaryotic species. The later evolution of the oxygen-binding hemerythrin domain in both prokaryotes and eukaryotes led to a wide variety of functions, ranging from protection against oxidative damage in anaerobic and microaerophilic organisms, to oxygen supplying to particular enzymes and pathways in aerobic and facultative species.	[Alvarez-Carreno, Claudia; Becerra, Arturo; Lazcano, Antonio] Univ Nacl Autonoma Mexico, Fac Ciencias, Apdo Postal 70-407,Cd Univ, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Lazcano, A (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Apdo Postal 70-407,Cd Univ, Mexico City 04510, DF, Mexico.	alar@ciencias.unam.mx	Becerra, Arturo/J-8364-2015; Becerra, Arturo/U-2875-2019	Becerra, Arturo/0000-0002-7076-0342; Alvarez Carreno, Claudia/0000-0002-1827-8946; Lazcano, Antonio/0000-0001-7365-8557	CONACYT [290175]; DGAPA-PAPIIT [IN223916]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	Claudia Alvarez is a doctoral student in the Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM), and received fellowship 290175 from CONACYT.r Claudia Alvarez is a doctoral student in the Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM), and received fellowship 290175 from CONACYT. We are indebted to J. Peter Gogarten for insightful discussions and to Luis Montano, Sara Islas and Ricardo Hernandez for their help with the manuscript. Support from DGAPA-PAPIIT(IN223916) is gratefully acknowledged.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bailly X, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-244; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Chen KH-C, 2015, J INORG BIOCHEM, P15; Chow ED, 2007, CURR GENET, V52, P137, DOI 10.1007/s00294-007-0147-9; Cook SF, 1928, J GEN PHYSIOL, V11, P339, DOI 10.1085/jgp.11.4.339; Delaye L, 2007, J MOL EVOL, V64, P15, DOI 10.1007/s00239-005-0281-2; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Farmer CS, 2001, J BIOL INORG CHEM, V6, P418, DOI 10.1007/s007750100218; French CE, 2008, FEMS MICROBIOL LETT, V279, P131, DOI 10.1111/j.1574-6968.2007.01011.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hendrickson W.A., 1985, P1; Isaza CE, 2006, BIOCHEMISTRY-US, V45, P9023, DOI 10.1021/bi0607812; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karlsen OA, 2005, FEBS J, V272, P2428, DOI 10.1111/j.1742-4658.2005.04663.x; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kendall JJ, 2014, ENVIRON MICROBIOL, V16, P1105, DOI 10.1111/1462-2920.12341; Kurtz DM, 1999, ESSAYS BIOCHEM, V34, P85, DOI 10.1042/bse0340085; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16130; Martin-Duran JM, 2013, GENOME BIOL EVOL, V5, P1435, DOI 10.1093/gbe/evt102; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Okamoto Y, 2013, INORG CHEM, V52, P13014, DOI 10.1021/ic401632x; Onoda A, 2011, INORG CHEM, V50, P4892, DOI 10.1021/ic2001267; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Planavsky NJ, 2014, SCIENCE, V346, P635, DOI 10.1126/science.1258410; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950; Rouault TA, 2009, SCIENCE, V326, P676, DOI 10.1126/science.1181938; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Shu C, 2012, CHEMBIOCHEM, V13, P788, DOI 10.1002/cbic.201200043; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stueken EE, 2015, GEOLOGY, V43, P259, DOI 10.1130/G36218.1; Tang J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00670; Terwilliger NB, 1998, J EXP BIOL, V201, P1085; Thompson JW, 2012, J BIOL CHEM, V287, P7357, DOI 10.1074/jbc.M111.308684; Vanin S, 2006, J MOL EVOL, V62, P32, DOI 10.1007/s00239-004-0296-0; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Xiong JJ, 2000, BIOCHEMISTRY-US, V39, P5117, DOI 10.1021/bi992796o; Yeats C, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-3	44	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157904	10.1371/journal.pone.0157904	http://dx.doi.org/10.1371/journal.pone.0157904			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336621	gold, Green Published, Green Submitted			2022-12-26	WOS:000378389200062
J	Boudarham, J; Hameau, S; Zory, R; Hardy, A; Bensmail, D; Roche, N				Boudarham, Julien; Hameau, Sophie; Zory, Raphael; Hardy, Alexandre; Bensmail, Djamel; Roche, Nicolas			Coactivation of Lower Limb Muscles during Gait in Patients with Multiple Sclerosis	PLOS ONE			English	Article							CEREBRAL-PALSY; OLDER-ADULTS; SPASTICITY; WALKING; VARIABILITY; IMPAIRMENT; DISABILITY; BALANCE; PEOPLE; STROKE	Background Coactivation of agonist and antagonist lower limb muscles during gait stiffens joints and ensures stability. In patients with multiple sclerosis, coactivation of lower limb muscles might be a compensatory mechanism to cope with impairments of balance and gait. Objective The aim of this study was to assess coactivation of agonist and antagonist muscles at the knee and ankle joints during gait in patients with multiple sclerosis, and to evaluate the relationship between muscle coactivation and disability, gait performance, dynamic ankle strength measured during gait, and postural stability. Methods The magnitude and duration of coactivation of agonist-antagonist muscle pairs at the knee and ankle were determined for both lower limbs (more and less-affected) in 14 patients with multiple sclerosis and 11 healthy subjects walking at a spontaneous speed, using 3D-gait analysis. Results In the patient group, coactivation was increased in the knee muscles during single support (proximal strategy) and in the ankle muscles during double support (distal strategy). The magnitude of coactivation was highest in the patients with the slowest gait, the greatest motor impairment and the most instability. Conclusion Increased muscle coactivation is likely a compensatory mechanism to limit the number of degrees of freedom during gait in patients with multiple sclerosis, particularly when postural stability is impaired.	[Boudarham, Julien; Hameau, Sophie; Hardy, Alexandre; Bensmail, Djamel; Roche, Nicolas] Univ Versailles St Quentin Yvelines, INSERM 1179, CHU Raymond Poincare, APHP,CIC 1429, Garches, France; [Zory, Raphael] Univ Nice Sophia Antipolis, LAMHESS, EA 6312, F-06189 Nice, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Cote d'Azur	Boudarham, J (corresponding author), Univ Versailles St Quentin Yvelines, INSERM 1179, CHU Raymond Poincare, APHP,CIC 1429, Garches, France.	jboudarham@gmail.com	Bensmail, Djamel/R-6035-2018; roche, nicolas/R-6080-2018	Bensmail, Djamel/0000-0001-9360-9330; 				ADAMS RW, 1990, BRAIN, V113, P1459, DOI 10.1093/brain/113.5.1459; Ansari Noureddin Nakhostin, 2006, Physiotherapy Theory and Practice, V22, P119, DOI 10.1080/09593980600724188; Benedetti MG, 1999, MULT SCLER J, V5, P363, DOI 10.1191/135245899678846393; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Callisaya ML, 2011, AGE AGEING, V40, P481, DOI 10.1093/ageing/afr055; Chow JW, 2012, CLIN NEUROPHYSIOL, V123, P1599, DOI 10.1016/j.clinph.2012.01.006; Damiano DL, 2000, ARCH PHYS MED REHAB, V81, P895, DOI 10.1053/apmr.2000.5579; Dempster W.T, 1955, SPACE REQUIREMENTS S, P55; Den Otter AR, 2007, GAIT POSTURE, V25, P342, DOI 10.1016/j.gaitpost.2006.04.007; Dietz V, 1995, ELECTROMYOGR MOTOR C, V97, P408, DOI 10.1016/0924-980X(95)00109-X; Falconer K, 1985, Electromyogr Clin Neurophysiol, V25, P135; Flegel Melanie, 2012, Int J MS Care, V14, P26, DOI 10.7224/1537-2073-14.1.26; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Harris JE, 2005, PHYS THER, V85, P150, DOI 10.1093/ptj/85.2.150; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Hermans G, 2012, MUSCLE NERVE, V45, P18, DOI 10.1002/mus.22219; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Kaipust JP, 2012, MOTOR CONTROL, V16, P229, DOI 10.1123/mcj.16.2.229; Kelleher KJ, 2010, DISABIL REHABIL, V32, P1242, DOI 10.3109/09638280903464497; Kepple TM, 1997, GAIT POSTURE, V6, P1, DOI 10.1016/S0966-6362(96)01094-6; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kwon OY, 2003, GAIT POSTURE, V18, P105, DOI 10.1016/S0966-6362(02)00166-2; Lamontagne A, 2000, J ELECTROMYOGR KINES, V10, P407, DOI 10.1016/S1050-6411(00)00028-6; Lamontagne A, 2001, ARCH PHYS MED REHAB, V82, P1696, DOI 10.1053/apmr.2001.26810; LaRocca NG, 2011, PATIENT, V4, P189, DOI 10.2165/11591150-000000000-00000; Lassmann H, 1999, PHILOS T ROY SOC B, V354, P1635, DOI 10.1098/rstb.1999.0508; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Mari S, 2014, CEREBELLUM, V13, P226, DOI 10.1007/s12311-013-0533-4; Martin CL, 2006, MULT SCLER J, V12, P620, DOI 10.1177/1352458506070658; Melzer I, 2009, AGE AGEING, V38, P119, DOI 10.1093/ageing/afn249; Rosa MCN, 2014, J ELECTROMYOGR KINES, V24, P1, DOI 10.1016/j.jelekin.2013.10.016; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Peterson DS, 2010, GAIT POSTURE, V31, P355, DOI 10.1016/j.gaitpost.2009.12.005; Socie MJ, 2013, GAIT POSTURE, V38, P51, DOI 10.1016/j.gaitpost.2012.10.012; Solnik S, 2010, EUR J APPL PHYSIOL, V110, P489, DOI 10.1007/s00421-010-1521-8; Sosnoff JJ, 2011, J NEUROL PHYS THER, V35, P129, DOI 10.1097/NPT.0b013e31822a8c40; Unnithan VB, 1996, MED SCI SPORT EXER, V28, P1498, DOI 10.1097/00005768-199612000-00009; van der Krogt MM, 2010, J REHABIL MED, V42, P656, DOI 10.2340/16501977-0579; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; YANG JF, 1985, ELECTROEN CLIN NEURO, V60, P485, DOI 10.1016/0013-4694(85)91108-3	40	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158267	10.1371/journal.pone.0158267	http://dx.doi.org/10.1371/journal.pone.0158267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336442	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200126
J	Chen, Y; Zeng, Y; Luo, F; Yuan, ZM				Chen, Yuan; Zeng, Ying; Luo, Feng; Yuan, Zheming			A New Algorithm to Optimize Maximal Information Coefficient	PLOS ONE			English	Article							MUTUAL INFORMATION; DEPENDENCE; ASSOCIATIONS	The maximal information coefficient (MIC) captures dependences between paired variables, including both functional and non-functional relationships. In this paper, we develop a new method, ChiMIC, to calculate the MIC values. The ChiMIC algorithm uses the chisquare test to terminate grid optimization and then removes the restriction of maximal grid size limitation of original ApproxMaxMI algorithm. Computational experiments show that ChiMIC algorithm can maintain same MIC values for noiseless functional relationships, but gives much smaller MIC values for independent variables. For noise functional relationship, the ChiMIC algorithm can reach the optimal partition much faster. Furthermore, the MCN values based on MIC calculated by ChiMIC can capture the complexity of functional relationships in a better way, and the statistical powers of MIC calculated by ChiMIC are higher than those calculated by ApproxMaxMI. Moreover, the computational costs of ChiMIC are much less than those of ApproxMaxMI. We apply the MIC values tofeature selection and obtain better classification accuracy using features selected by the MIC values from ChiMIC.	[Chen, Yuan; Luo, Feng; Yuan, Zheming] Hunan Agr Univ, Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China; [Zeng, Ying] Hunan Agr Univ, Orient Sci & Technol Coll, Changsha, Hunan, Peoples R China; [Luo, Feng] Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China; [Luo, Feng] Clemson Univ, Sch Comp, Clemson, SC 29634 USA; [Yuan, Zheming] Hunan Agr Univ, Hunan Prov Key Lab Germplasm Innovat & Utilizat C, Changsha, Hunan, Peoples R China	Hunan Agricultural University; Hunan Agricultural University; Hunan Agricultural University; Clemson University; Hunan Agricultural University	Luo, F; Yuan, ZM (corresponding author), Hunan Agr Univ, Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China.; Luo, F (corresponding author), Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China.; Luo, F (corresponding author), Clemson Univ, Sch Comp, Clemson, SC 29634 USA.; Yuan, ZM (corresponding author), Hunan Agr Univ, Hunan Prov Key Lab Germplasm Innovat & Utilizat C, Changsha, Hunan, Peoples R China.	luofeng@clemson.edu; zhmyuan@sina.com			Doctoral Foundation of Ministry of Education of China [20124320110002]; Science and Technology Planning Projects of Changsha, China [K1406018-21]; National Natural Science Foundation of China [31471789]	Doctoral Foundation of Ministry of Education of China(Ministry of Education, China); Science and Technology Planning Projects of Changsha, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Doctoral Foundation of Ministry of Education of China (No. 20124320110002, ZY), http://www.cutech.edu.cn/cn/index.htm; Science and Technology Planning Projects of Changsha, China (No. K1406018-21, ZY), http://www.cssti.cn/html/cskjw/index.html; and National Natural Science Foundation of China (No.31471789, FL), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese D, 2013, BIOINFORMATICS, V29, P407, DOI 10.1093/bioinformatics/bts707; Anderson TK, 2012, BIOINFORMATICS, V28, P1624, DOI 10.1093/bioinformatics/bts181; Blake CL, 1998, UCI REPOSITORY MACHI; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Das J, 2012, BIOINFORMATICS, V28, P1873, DOI 10.1093/bioinformatics/bts283; de Souza RS, 2014, MON NOT R ASTRON SOC, V440, P240, DOI 10.1093/mnras/stu274; Delicado P, 2009, STAT COMPUT, V19, P255, DOI 10.1007/s11222-008-9090-y; Hanson B, 2011, SCIENCE, V331, P649, DOI 10.1126/science.1203354; Heinisch O., 1963, PREIS S BIOM J, V1965, P203, DOI [10.1002/bimj.19650070312, DOI 10.1002/BIMJ.19650070312]; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kinney JB, 2014, P NATL ACAD SCI USA, V111, P3354, DOI 10.1073/pnas.1309933111; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Lee SC, 2014, STAT COMPUT, V24, P845, DOI 10.1007/s11222-013-9405-5; Lin C., 2012, ICML WORKSH MACH LEA; MOON YI, 1995, PHYS REV E, V52, P2318, DOI 10.1103/PhysRevE.52.2318; Moonesinghe R, 2012, INT J ENV RES PUB HE, V9, P3149, DOI 10.3390/ijerph9093149; Pearson K, 1920, BIOMETRIKA, V13, P25, DOI 10.1093/biomet/13.1.25; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Riccadonna S, 2012, ARXIV12103149; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Song L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-328; Speed T, 2011, SCIENCE, V334, P1502, DOI 10.1126/science.1215894; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Tang DM, 2014, EVOL BIOINFORM, V10, P11, DOI 10.4137/EBO.S13121; Tibshirani R., 2014, SCIENCE         1216; Walters-Williams J, 2009, LECT NOTES ARTIF INT, V5589, P389, DOI 10.1007/978-3-642-02962-2_49; Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604; Zhang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06662; Zhang ZQ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/825136; Zhao Y, 2014, ARXIV14033495	31	14	16	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157567	10.1371/journal.pone.0157567	http://dx.doi.org/10.1371/journal.pone.0157567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333001	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212800036
J	Dieudonne, PE; Tortosa, T; Fernandez-Baldor, FT; Canudo, JI; Diaz-Martinez, I				Dieudonne, Paul-Emile; Tortosa, Thierry; Torcida Fernandez-Baldor, Fidel; Ignacio Canudo, Jose; Diaz-Martinez, Ignacio			An Unexpected Early Rhabdodontid from Europe (Lower Cretaceous of Salas de los Infantes, Burgos Province, Spain) and a Re-Examination of Basal Iguanodontian Relationships	PLOS ONE			English	Article							ORNITHOPOD DINOSAUR; ORNITHISCHIA; PHYLOGENY; DISCOVERY; EVOLUTION; OSTEOLOGY; PATAGONIA; ONTOGENY; NEUQUEN; MYOLOGY	Disarticulated and incomplete remains from a new diminutive ornithopod are described. They come from the Cameros Basin in the north of Spain and were collected from the red clays of the Castrillo de la Reina Formation, ranging from Upper Barremian to Lower Aptian. The new ornithopod described here is slender and one of the smallest ever reported. An up-to-date phylogenetic analysis recovers this taxon as a basal iguanodontian. Its unique combination of characters makes it more derived than slender ornithopods like Hyphilophodon and Gasparinisaura, and bring very interesting insights into the basal iguanodontian phylogeny. Though possessing a minimum of three premaxillary teeth, this taxon also bears an extensor ilio-tibia-lis groove on the distal part of its femur. Moreover, its dentary and maxillary teeth are unique, remarkably similar to those regarded as having a "rhabdomorphan" affinity. This unknown taxon is suggested to be a stem taxon within Rhabdodontidae, a successful clade of basal iguanodonts from the Late Cretaceous of Europe. The Gondwanan ornithopods share the strongest affinities with this family, and we confirm Muttaburrasaurus as a sister taxon of the Rhabdodontidae within a newly defined clade, the Rhabdodontomorpha.	[Dieudonne, Paul-Emile; Ignacio Canudo, Jose] Univ Zaragoza, Fac Ciencias, Area Paleontol, Grp Aragosaurus IUCA, Pedro Cerbuna 12, E-50009 Zaragoza, Spain; [Tortosa, Thierry] Reserve Nat Natl St Victoire, Conseil Dept Bouches du Rhone, 52 Ave St Just, F-13256 Marseille 20, France; [Torcida Fernandez-Baldor, Fidel] Museo Dinosaurios Salas de los Infantes, Plaza Jesus Aparicio 9, Burgos 09600, Spain; [Torcida Fernandez-Baldor, Fidel] Colect Arqueol Paleontol Salense CAS, Plaza Jesus Aparicio 9, Burgos 09600, Spain; [Diaz-Martinez, Ignacio] Univ Nacl Rio Negro, CONICET, Inst Invest Paleobiol & Geol, Gen Roca 1242, RA-8332 Fisque Menuco Gen Roca, Rio Negro, Argentina	University of Zaragoza; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Dieudonne, PE (corresponding author), Univ Zaragoza, Fac Ciencias, Area Paleontol, Grp Aragosaurus IUCA, Pedro Cerbuna 12, E-50009 Zaragoza, Spain.	dpolmil@gmail.com	Martínez, Ignacio Díaz/I-2766-2015; Tortosa, Thierry/AAA-5522-2021	Martínez, Ignacio Díaz/0000-0001-5301-8384; Torcida, Fidel/0000-0003-4616-1777; Canudo Sanagustin, Jose Ignacio/0000-0003-1732-9155; Dieudonne, Paul-Emile/0000-0001-8283-7514	Spanish Ministerio de Economia y Competitividad [CGL2014-53548-P]; European Regional Development Fund; European Social Fund; Government of Aragon ("Grupos Consolidados"); "Direccion General de Patrimonio de la Junta de Castilla y Leon"; "Fundacion para el estudio de los dinosaurios de Castilla y Leon"; VINCI autoroutes company	Spanish Ministerio de Economia y Competitividad(Spanish Government); European Regional Development Fund(European Commission); European Social Fund(European Social Fund (ESF)); Government of Aragon ("Grupos Consolidados")(Gobierno de Aragon); "Direccion General de Patrimonio de la Junta de Castilla y Leon"; "Fundacion para el estudio de los dinosaurios de Castilla y Leon"; VINCI autoroutes company	The work is partially subsidized by the project CGL2014-53548-P of the Spanish Ministerio de Economia y Competitividad, the European Regional Development Fund, the European Social Fund, and the Government of Aragon ("Grupos Consolidados"). The fieldwork was financed by the "Direccion General de Patrimonio de la Junta de Castilla y Leon" and the "Fundacion para el estudio de los dinosaurios de Castilla y Leon."; This paper is part of the collaboration between the "Colectivo Arqueologico y Paleontologico Salense, CAS", the "Museo de los Dinosaurios de Salas de los Infantes" and Zaragoza University. It is partially subsidized by the project CGL2014-53548-P of the Spanish Ministerio de Economia y Competitividad, the European Regional Development Fund, the European Social Fund, and the Government of Aragon ("Grupos Consolidados"). The fieldwork was financed by the "Direccion General de Patrimonio de la Junta de Castilla y Leon" and the "Fundacion para el estudio de los dinosaurios de Castilla y Leon". We are very grateful to the Museo de Dinosaurios de Salas de los Infantes for their kind welcome and for permitting the access and study of the material from Vegagete. We are very grateful to the Museum d'Histoire Naturelle de Marseille (Sylvie Pichard and Stephane Jouves), and the Museum d'Histoire Naturelle d'Aix-en-Provence (Gilles Cheylan and Yves Dutour) for the access and the help brought on their material and collections. We are very also as much grateful to the British Museum of Natural History (Sandra Chapman, Paul Barrett) for kindly sending photos of the views required of the Zalmoxes specimens, which resulted in discoveries absolutely essential to the aim of this article in the first steps of its construction. We thank Luis Angel Izquierdo (Museo de Dinosaurios de Salas de los Infantes), Miguel Moreno and Jose Manuel Gasca (Zaragoza University), Matthew Herne (University of Queensland) for providing us extremely valuable help as well as useful commentaries and information. For their part, the Rhabdodon discoveries from Provence were largely possible thanks to the financial support of VINCI autoroutes company (Christian Caye, Philippe Laroche, and Samuel Maurice), and thanks to the valuable help of Frederic Pauvarel. Hans Larsson and Rupert Glasgow reviewed and edited the English of this paper.	ACCARIE H, 1995, CR ACAD SCI II, V320, P327; Agnolin FL, 2010, J SYST PALAEONTOL, V8, P257, DOI 10.1080/14772011003594870; Allain R., 2015, J VERTEBRATE PALEONT, V35; Allain R, 2012, NATURWISSENSCHAFTEN, V99, P369, DOI 10.1007/s00114-012-0911-7; Barrett PM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1147; Barrett PM, 2011, SPEC PAP PALAEONTOL, P131, DOI 10.1111/j.1475-4983.2011.01076.x; BARTHOLOMAI A, 1981, Memoirs of the Queensland Museum, V20, P319; BEUTHER A, 1966, GEOL JB S, V44, P103; Boyd C. A., 2015, PEERJ, V3, P1; Boyd CA, 2014, PEERJ, V2, DOI 10.7717/peerj.669; Brown CM, 2013, J VERTEBR PALEONTOL, V33, P495, DOI 10.1080/02724634.2013.746229; Brown CM, 2011, CAN J EARTH SCI, V48, P1342, DOI 10.1139/E11-017; Buchholz P.W., 2002, MESOZOIC WYOMING, P18; BUFFETAUT E, 1991, CR ACAD SCI II, V312, P943; Bunzel E., 1871, ABHANDLUNGEN KAISERL, V5, P1; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2011, PALAEONTOLOGY, V54, P667, DOI 10.1111/j.1475-4983.2011.01046.x; Calvo Jorge O., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P471; Cambiaso A.V., 2007, THESIS U BUENOS AIRE; Canudo JI, 2010, J IBER GEOL, V36, P205, DOI 10.5209/rev_JIGE.2010.v36.n2.8; Canudo JI, 2008, AMEGHINIANA, V45, P649; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; Chanthasit P., 2010, THESIS; Codrea VA, 2008, CR PALEVOL, V7, P289, DOI 10.1016/j.crpv.2008.03.008; COOPER M R, 1985, Annals of the South African Museum, V95, P281; Coria RA, 2002, J VERTEBR PALEONTOL, V22, P503, DOI 10.1671/0272-4634(2002)022[0503:ANIOFN]2.0.CO;2; Coria RA, 1996, J VERTEBR PALEONTOL, V16, P445, DOI 10.1080/02724634.1996.10011333; Diaz-Martinez JI, 2013, THESIS; Dilkes DW, 2000, T ROY SOC EDIN-EARTH, V90, P87, DOI 10.1017/S0263593300007185; Dodson P., 1980, Memoires de la Societe Geologique de France, V59, P81; DOLLO L, 1888, CR HEBD ACAD SCI, V106, P775; Fanti F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123475; Filippi LS, 2016, CRETACEOUS RES, V61, P209, DOI 10.1016/j.cretres.2015.12.018; Forster C.A., 1990, Journal of Vertebrate Paleontology, V10, P273; Foster JR, 2006, NEW MEXICO MUSEUM NA, V36, P119; Fuentes Vidarte C, 2001, ACT 1 JORN INT PAL D; Fukui T., 1965, Res Crust, V2, P60; Galton P.M., 1973, Brigham Young Univ Stud Geol, V20, P137; Galton P.M., 1974, Bulletin Br Mus nat Hist (Geol), V25, P3; GALTON P M, 1981, Palaeontologische Zeitschrift, V55, P271; Galton P.M., 1983, Geologica et Palaeontologica, V17, P207; Galton Peter M., 2014, Revue de Paleobiologie, V33, P97; Galton Peter M., 2009, Revue de Paleobiologie, V28, P211; GALTON PM, 1974, J PALEONTOL, V48, P1048; Gilmore C.W., 1915, P US NATL MUS, V49, P591, DOI DOI 10.5479/SI.00963801.49-2127.591; Gilmore CW, 1909, P US NATL MUSEUM, V36, P197; Godefroit P, 2009, GEODIVERSITAS, V31, P525, DOI 10.5252/g2009n3a3; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; GRIGORESCU D, 1985, CR ACAD SCI II, V301, P1365; HEINRICH RE, 1993, ZOOL J LINN SOC-LOND, V108, P179, DOI 10.1111/j.1096-3642.1993.tb00294.x; Herne MC, 2013, THESIS; Houssaye A, 2013, CRETACEOUS RES, V41, P127, DOI 10.1016/j.cretres.2012.11.005; Huh M, 2010, NEUES JAHRB GEOL P-A, V259, P1, DOI 10.1127/0077-7749/2010/0102; Canudo JI, 2009, B SOC GEOL FR, V180, P5, DOI 10.2113/gssgfbull.180.1.5; Ruiz-Omenaca JI, 2012, CR PALEVOL, V11, P435, DOI 10.1016/j.crpv.2012.06.001; Izquierdo Montero LA, 2005, 3 TROB JOV INV PAL S; Janensch W., 1955, Palaeontographica Suppl, V7, P105; Knoll F, 2010, GONDWANA RES, V17, P171, DOI 10.1016/j.gr.2009.03.010; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; MARTIN-CLOSAS C., 1998, REV SOC GEOLOGICA ES, V11, P253; Martinez RD, 1998, ACTA GEOLOGICA LEOPO, VXXI, P119; Mas R., 1993, REV SOC GEOLOGICA ES, V6, P129; Mateus O., 2011, ZOOTAXA, V2827; Matheron P, 1869, MEMOIRES ACAD IMPERI, V1868, P345; McDonald AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014075; Molnar Ralph E., 1996, Memoirs of the Queensland Museum, V39, P639; Moreno K, 2007, J MORPHOL, V268, P50, DOI 10.1002/jmor.10498; Neraudeau D, 2012, CRETACEOUS RES, V37, P1, DOI 10.1016/j.cretres.2012.01.006; Nopesa F., 1915, Jahrb Kgl Ungar Geol Reich Budapest, V23, P1; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Norman DB, 1980, ORNITHISCHIAN DINOSA, P1; Norman DB, 1984, 3 S MES TERR EC; Novas FE, 2004, AMEGHINIANA, V41, P75; Osi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044318; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; PARKS W. A., 1926, UNIV TORONTO STUDIES GEOL SER, V21, P1; PARKS WA, 1922, U TORONTO STUDIES GE, V13, P1; Peng Guangzhao, 1992, Vertebrata Palasiatica, V30, P39; Pereda Suberbiola Xabier, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P257; Pereda-Suberbiola X, 2009, B SOC GEOL FR, V180, P57, DOI 10.2113/gssgfbull.180.1.57; Piechowski R, 2014, J VERTEBR PALEONTOL, V34, P1383, DOI 10.1080/02724634.2014.873045; Pincemaille M, 1999, 4 EUR WORKSH VERT PA; Pincemaille M, 1997, ORNITHIPODE ORNITHOP; Pincemaille-Quillevere Marie, 2002, Oryctos, V4, P39; Rich Thomas H., 1999, National Science Museum Monographs, V15, P167; RICH THV, 1989, NATL GEOGR RES, V5, P15; Romer A, 1956, OSTEOLOGY REPTILES; Ruiz-Omenaca J. I, 2006, THESIS; Ruiz-Omenaca J.I., 1996, MAS MATAS, V15, P59; Ruiz-Omenaca JI, 2001, ACT 1 JORN INT PAL D; Ruiz-Omenaca JI, 1996, THESIS; Ruiz-Omenaca Jose Ignacio, 2007, P3; Salgado L, 1997, J PALEONTOL, V71, P933, DOI 10.1017/S0022336000035861; Santa Luca A. P., 1980, ANN S AFR MUS, V79, P159, DOI DOI 10.1038/264324A0; Schachner ER, 2011, J MORPHOL, V272, P1464, DOI 10.1002/jmor.10997; Scheetz R. D, 1999, THESIS; Schudack U, 2009, J IBER GEOL, V35, P141; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno P. C., 2005, STEM ARCHOSAURIA TAX; Sereno PC, 2012, ZOOKEYS, P1, DOI [10.3897/zookeys.226.2840, 10.3897/zookeys.223.2840]; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Taquet P, 1976, CAHIERS PALEONTOLOGI, P1; THULBORN R A, 1972, Palaeontology (Oxford), V15, P29; THULBORN RA, 1971, NATURE, V234, P75, DOI 10.1038/234075a0; Torcida Fernandez-Baldor F, 2005, REV ESPANOLA PALEONT, V10, P73; Fernandez-Baldor FT, 2011, ACTA PALAEONTOL POL, V56, P535, DOI 10.4202/app.2010.0003; Torres J.A., 1994, Munibe (Ciencias Naturales - Natur Zientziak), V46, P3; Tortosa T, 2014, ANN PALEONTOL, V100, P63, DOI 10.1016/j.annpal.2013.10.003; Weishampel D. B., 1998, Journal of Vertebrate Paleontology, V18, p85A; Weishampel David B., 2003, Journal of Systematic Palaeontology, V1, P65, DOI 10.1017/S1477201903001032; Weishampel DB, 1984, ADV ANATOMY EMBRYOLO, V87; Winkler D.A., 1988, Hunteria, V2, P1; Winkler DA, 1997, J VERTEBR PALEONTOL, V17, P330, DOI 10.1080/02724634.1997.10010978	115	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0156251	10.1371/journal.pone.0156251	http://dx.doi.org/10.1371/journal.pone.0156251			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333279	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000378212800006
J	Mazzola, G; Murphy, K; Ross, RP; Di Gioia, D; Biavati, B; Corvaglia, LT; Faldella, G; Stanton, C				Mazzola, Giuseppe; Murphy, Kiera; Ross, R. Paul; Di Gioia, Diana; Biavati, Bruno; Corvaglia, Luigi T.; Faldella, Giacomo; Stanton, Catherine			Early Gut Microbiota Perturbations Following Intrapartum Antibiotic Prophylaxis to Prevent Group B Streptococcal Disease	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; VERTICAL TRANSMISSION; BIFIDOBACTERIA; GENERATION; SEARCH; TOOL	The faecal microbiota composition of infants born to mothers receiving intrapartum antibiotic prophylaxis with ampicillin against group B Streptococcus was compared with that of control infants, at day 7 and 30 of life. Recruited newborns were both exclusive breastfed and mixed fed, in order to also study the effect of dietary factors on the microbiota composition. Massive parallel sequencing of the V3-V4 region of the 16S rRNA gene and qPCR analysis were performed. Antibiotic prophylaxis caused the most marked changes on the microbiota in breastfed infants, mainly resulting in a higher relative abundance of Enterobacteriaceae, compared with control infants (52% vs. 14%, p = 0.044) and mixed-fed infants (52% vs. 16%, p = 0.13 NS) at day 7 and in a lower bacterial diversity compared to mixed- fed infants and controls. Bifidobacteria were also particularly vulnerable and abundances were reduced in breastfed (p = 0.001) and mixed- fed antibiotic treated groups compared to nontreated groups. Reductions in bifidobacteria in antibiotic treated infants were also confirmed by qPCR. By day 30, the bifidobacterial population recovered and abundances significantly increased in both breastfed (p = 0.025) and mixed-fed (p = 0.013) antibiotic treated groups, whereas Enterobacteriaceae abundances remained highest in the breastfed antibiotic treated group (44%), compared with control infants (16%) and mixed-fed antibiotic treated group (28%). This study has therefore demonstrated the short term consequences of maternal intrapartum antibiotic prophylaxis on the infant faecal microbial population, particularly in that of breastfed infants.	[Mazzola, Giuseppe; Di Gioia, Diana; Biavati, Bruno] Univ Bologna, Dept Agr Sci, Bologna, Italy; [Murphy, Kiera; Stanton, Catherine] Teagasc Food Res Ctr, Food Biosci Dept, Fermoy, Cork, Ireland; [Murphy, Kiera] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Murphy, Kiera; Ross, R. Paul; Stanton, Catherine] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Corvaglia, Luigi T.; Faldella, Giacomo] St Orsola Marcello Malpighi Hosp, Neonatal Intens Care Unit, Bologna, Italy	University of Bologna; Teagasc; University College Cork; University College Cork; IRCCS Azienda Ospedaliero-Universitaria di Bologna	Di Gioia, D (corresponding author), Univ Bologna, Dept Agr Sci, Bologna, Italy.	diana.digioia@unibo.it	Stanton, Catherine/A-9549-2015; Ross, Paul/A-7584-2015	Stanton, Catherine/0000-0002-6724-7011; Ross, Paul/0000-0003-4876-8839; Di Gioia, Diana/0000-0002-0181-1572; Murphy, Kiera/0000-0002-6543-5158	Irish Department of Agriculture Food and Marine INFANTMET Project [10FDairy]; Science Foundation of Ireland; Global Grant Spinner project; Teagasc Walsh Fellowship; Alimentary Pharmabiotic Centre; EU FP7 MyNewGut project [613979]	Irish Department of Agriculture Food and Marine INFANTMET Project; Science Foundation of Ireland(Science Foundation Ireland); Global Grant Spinner project; Teagasc Walsh Fellowship; Alimentary Pharmabiotic Centre(Science Foundation Ireland); EU FP7 MyNewGut project	This work was part funded by the Irish Department of Agriculture Food and Marine INFANTMET Project (RefNo 10FDairy), Science Foundation of Ireland-funded Centre for Science, Engineering and Technology, the Alimentary Pharmabiotic Centre and by EU FP7 MyNewGut project (No.: 613979; www.mynewgut.eu). The research activity of GM and KM were supported by the Global Grant Spinner project 2013 and a Teagasc Walsh Fellowship, respectively.; The authors wish to thank Dr. Paul Cotter, Dr. Fiona Crispie and Ms. Vicki Murray for their technical assistance with MiSeq sequencing. This work was part funded by the Irish Department of Agriculture Food and Marine INFANTMET Project (RefNo 10FDairy), Science Foundation of Ireland-funded Centre for Science, Engineering and Technology, the Alimentary Pharmabiotic Centre and by EU FP7 MyNewGut project (No.: 613979; www.mynewgut.eu). The research activity of GM and KM were supported by the Global Grant Spinner project 2013 and a Teagasc Walsh Fellowship, respectively. Ethical Approval: all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee as indicated in the text and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.	Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Aloisio I, 2014, APPL MICROBIOL BIOT, V98, P6051, DOI 10.1007/s00253-014-5712-9; Aloisio I, 2012, APPL MICROBIOL BIOT, V96, P1561, DOI 10.1007/s00253-012-4138-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arboleya S, 2015, J PEDIATR-US, V166, P538, DOI 10.1016/j.jpeds.2014.09.041; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Di Gioia D, 2014, APPL MICROBIOL BIOT, V98, P563, DOI 10.1007/s00253-013-5405-9; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards RK, 2002, OBSTET GYNECOL, V100, P534, DOI 10.1016/S0029-7844(02)02096-3; El Aidy S, 2015, CURR OPIN BIOTECH, V32, P14, DOI 10.1016/j.copbio.2014.09.005; Fouhy F, 2012, ANTIMICROB AGENTS CH, V56, P5811, DOI 10.1128/AAC.00789-12; Guo XL, 2008, ANAEROBE, V14, P224, DOI 10.1016/j.anaerobe.2008.04.001; Ishizeki S, 2013, ANAEROBE, V23, P38, DOI 10.1016/j.anaerobe.2013.08.002; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Keski-Nisula L, 2013, ACTA PAEDIATR, V102, P480, DOI 10.1111/apa.12186; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marques TM, 2010, CURR OPIN BIOTECH, V21, P149, DOI 10.1016/j.copbio.2010.03.020; Martin R, 2009, APPL ENVIRON MICROB, V75, P965, DOI 10.1128/AEM.02063-08; Mathew JL, 2004, POSTGRAD MED J, V80, P196, DOI 10.1136/pgmj.2003.011973; Milani C, 2015, APPL ENVIRON MICROB, V81, P7078, DOI 10.1128/AEM.02037-15; Morelli L, 2008, J NUTR, V138, p1791S, DOI 10.1093/jn/138.9.1791S; Oddie S, 2002, BRIT MED J, V325, P308, DOI 10.1136/bmj.325.7359.308; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Stapleton PJM, 2016, ARCH DIS CHILD-FETAL, V101, P72, DOI 10.1136/archdischild-2015-308707; Tanaka S, 2009, FEMS IMMUNOL MED MIC, V56, P80, DOI 10.1111/j.1574-695X.2009.00553.x; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Yamasaki C, 2012, PEDIATR INT, V54, P651, DOI 10.1111/j.1442-200X.2012.03649.x	33	65	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157527	10.1371/journal.pone.0157527	http://dx.doi.org/10.1371/journal.pone.0157527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332552	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212800032
J	Zalewski, A; Zalewska, H; Lunneryd, SG; Andre, C; Mikusinski, G				Zalewski, Andrzej; Zalewska, Hanna; Lunneryd, Sven-Gunnar; Andre, Carl; Mikusinski, Grzegorz			Reduced Genetic Diversity and Increased Structure in American Mink on the Swedish Coast following Invasive Species Control	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; HETEROZYGOSITY-FITNESS CORRELATIONS; MUSTELA-VISON; MICROSATELLITE MARKERS; NEOVISON-VISON; N-E; ERADICATION; VARIABILITY; SOFTWARE; CONSERVATION	Eradication and population reductions are often used to mitigate the negative impacts of nonnative invasive species on native biodiversity. However, monitoring the effectiveness of nonnative species control programmes is necessary to evaluate the efficacy of these measures. Genetic monitoring could provide valuable insights into temporal changes in demographic, ecological, and evolutionary processes in invasive populations being subject to control programmes. Such programmes should cause a decrease in effective population size and/or in genetic diversity of the targeted non-native species and an increase in population genetic structuring over time. We used microsatellite DNA data from Americanmink (Neovison vison) to determine whether the removal of this predator on the Koster Islands archipelago and the nearby Swedish mainland affected genetic variation over six consecutive years of mink culling by trappers as part of a population control programme. We found that on Koster Islands allelic richness decreased (from on average 4.53 to 3.55), genetic structuring increased, and effective population size did not change. In contrast, the mink population from the Swedish coast showed no changes in genetic diversity or structure, suggesting the stability of this population over 6 years of culling. Effective population size did not change over time but was higher on the coast than on the islands across all years. Migration rates from the islands to the coast were almost two times higher than from the coast to the islands. Most migrants leaving the coast were localised on the southern edge of the archipelago, as expected from the direction of the sea current between the two sites. Genetic monitoring provided valuable information on temporal changes in the population of American mink suggesting that this approach can be used to evaluate and improve control programmes of invasive vertebrates.	[Zalewski, Andrzej; Zalewska, Hanna] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Lunneryd, Sven-Gunnar] Swedish Univ Agr Sci, Dept Aquat Resources, Lysekil, Sweden; [Andre, Carl] Univ Gothenburg, Dept Marine Sci Tjarno, Stromstad, Sweden; [Mikusinski, Grzegorz] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Swedish University of Agricultural Sciences; University of Gothenburg; Swedish University of Agricultural Sciences	Zalewski, A (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.	zalewski@ibs.bialowieza.pl	Zalewski, Andrzej/K-7271-2012; Andre, Carl/B-4237-2010	Zalewski, Andrzej/0000-0003-4518-2787; Andre, Carl/0000-0003-4404-7292; Mikusinski, Grzegorz/0000-0003-1400-913X	National Science Center Poland [N304 221835]	National Science Center Poland(National Science Centre, Poland)	This work was funded by National Science Center Poland (N N304 221835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2005, CONSERV BIOL, V19, P1509, DOI 10.1111/j.1523-1739.2005.00206.x; Abdelkrim J, 2009, BIOL INVASIONS, V11, P473, DOI 10.1007/s10530-008-9263-9; Abdelkrim J, 2007, CONSERV BIOL, V21, P719, DOI 10.1111/j.1523-1739.2007.00696.x; Allendorf F., 2007, CONSERVATION GENETIC; Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Anistoroaei R, 2006, ANIM GENET, V37, P185, DOI 10.1111/j.1365-2052.2006.01429.x; Banks PB, 2008, BOREAL ENVIRON RES, V13, P3; Bartoszewicz M, 2003, FOLIA ZOOL, V52, P225; Biedrzycka A, 2014, BIOL INVASIONS, V16, P1611, DOI 10.1007/s10530-013-0595-8; Blundell GM, 2002, MOL ECOL, V11, P289, DOI 10.1046/j.0962-1083.2001.01440.x; Bonesi L, 2007, BIOL CONSERV, V134, P470, DOI 10.1016/j.biocon.2006.09.006; Brusgaard K, 1998, ANIM GENET, V29, P153; Bryce R, 2011, BIOL CONSERV, V144, P575, DOI 10.1016/j.biocon.2010.10.013; Brzezinski M, 2012, BIOL CONSERV, V147, P68, DOI 10.1016/j.biocon.2011.11.012; Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Coltman DW, 1998, P ROY SOC B-BIOL SCI, V265, P803, DOI 10.1098/rspb.1998.0363; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Demandt MH, 2010, CONSERV GENET, V11, P249, DOI 10.1007/s10592-009-0027-6; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Elliott G, 2010, NEW ZEAL J ZOOL, V37, P1, DOI 10.1080/03014221003602166; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Farid A., 2004, Scientifur, V28, P228; Faubet P, 2008, GENETICS, V178, P1491, DOI 10.1534/genetics.107.082560; Fitak RR, 2013, CONSERV GENET, V14, P1233, DOI 10.1007/s10592-013-0511-x; Fleming MA, 1999, MOL ECOL, V8, P1352, DOI 10.1046/j.1365-294X.1999.00701_2.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Genovesi P, 2005, BIOL INVASIONS, V7, P127, DOI 10.1007/s10530-004-9642-9; GERELL R, 1970, OIKOS, V21, P160, DOI 10.2307/3543672; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grapputo A, 2005, MOL ECOL, V14, P4207, DOI 10.1111/j.1365-294X.2005.02740.x; Griffiths R, 2015, BIOL INVASIONS, V17, P1355, DOI 10.1007/s10530-014-0798-7; Harrison XA, 2011, MOL ECOL, V20, P4786, DOI 10.1111/j.1365-294X.2011.05283.x; Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x; Hutchinson WF, 2003, P ROY SOC B-BIOL SCI, V270, P2125, DOI 10.1098/rspb.2003.2493; Janecka JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089384; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Johnstone DL, 2013, MOL ECOL, V22, P2394, DOI 10.1111/mec.12186; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; King CM, 2014, BIOL INVASIONS, V16, P987, DOI 10.1007/s10530-013-0564-2; Larson S, 2002, MOL ECOL, V11, P1899, DOI 10.1046/j.1365-294X.2002.01599.x; Leberg P, 2005, J WILDLIFE MANAGE, V69, P1385, DOI 10.2193/0022-541X(2005)69[1385:GAFETE]2.0.CO;2; Li YM, 2005, BIOSCIENCE, V55, P147, DOI 10.1641/0006-3568(2005)055[0147:TTVSIC]2.0.CO;2; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Macdonald DW, 1999, MINK WATER VOLE ANAL; Melero Y, 2015, BIOL INVASIONS, V17, P2645, DOI 10.1007/s10530-015-0902-7; Melero Y, 2010, BIOL INVASIONS, V12, P3877, DOI 10.1007/s10530-010-9778-8; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nystrom V, 2006, OIKOS, V114, P84, DOI 10.1111/j.2006.0030-1299.14701.x; OConnell M, 1996, MOL ECOL, V5, P311, DOI 10.1111/j.1365-294X.1996.tb00320.x; Ozerov MY, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-88; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Polechova J, 2015, P NATL ACAD SCI USA, V112, P6401, DOI 10.1073/pnas.1421515112; Porteus T, 2012, EUR J WILDLIFE RES, V58, P403, DOI 10.1007/s10344-011-0589-8; Pritchard JK, 2000, GENETICS, V155, P945; Proctor MF, 2004, CAN J ZOOL, V82, P1108, DOI 10.1139/z04-077; RALLS K, 1988, Conservation Biology, V2, P185, DOI 10.1111/j.1523-1739.1988.tb00169.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Robertson BC, 2004, J APPL ECOL, V41, P1042, DOI 10.1111/j.0021-8901.2004.00984.x; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rosser AM, 2002, CONSERV BIOL, V16, P584, DOI 10.1046/j.1523-1739.2002.01635.x; Rowe G, 1999, ANIM CONSERV, V2, P85, DOI 10.1111/j.1469-1795.1999.tb00053.x; ROYCHOUDHURY AK, 1979, P INDIAN AS-ANIM SCI, V88, P311, DOI 10.1007/BF03179109; Russell JC, 2010, BIOL INVASIONS, V12, P1747, DOI 10.1007/s10530-009-9586-1; RYMAN N, 1981, OIKOS, V36, P257, DOI 10.2307/3544622; Ryman Nils, 1995, P341; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Skrbinsek T, 2012, MOL ECOL, V21, P862, DOI 10.1111/j.1365-294X.2011.05423.x; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veale AJ, 2013, MOL ECOL, V22, P5071, DOI 10.1111/mec.12453; Velando A, 2015, MOL ECOL, V24, P1007, DOI 10.1111/mec.13092; Vincent IR, 2003, CAN J ANIM SCI, V83, P597, DOI 10.4141/A03-001; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Warkentin IG, 2009, CONSERV BIOL, V23, P1056, DOI 10.1111/j.1523-1739.2008.01165.x; Wilson GM, 2000, J MAMMAL, V81, P186, DOI 10.1644/1545-1542(2000)081<0186:GVOWGG>2.0.CO;2; Zalewski A, 2011, DIVERS DISTRIB, V17, P757, DOI 10.1111/j.1472-4642.2011.00767.x; Zalewski A, 2010, BIOL CONSERV, V143, P1355, DOI 10.1016/j.biocon.2010.03.009; Zalewski A, 2009, MOL ECOL, V18, P1601, DOI 10.1111/j.1365-294X.2009.04131.x	87	12	13	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157972	10.1371/journal.pone.0157972	http://dx.doi.org/10.1371/journal.pone.0157972			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333328	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000378212800062
J	Du, YL; Zhang, JX; Yan, ZG; Ma, YQ; Yang, MM; Zhang, MZ; Zhang, ZY; Qin, L; Cao, QQ				Du, Yanli; Zhang, Jiaxin; Yan, Zengguang; Ma, Yongqiang; Yang, Mengmeng; Zhang, Minzhao; Zhang, Zhiyong; Qin, Ling; Cao, Qingqin			Host Preference and Performance of the Yellow Peach Moth (Conogethes punctiferalis) on Chestnut Cultivars	PLOS ONE			English	Article							SAYI COLEOPTERA-CURCULIONIDAE; INDUCED PLANT VOLATILES; PHYTOPHAGOUS INSECTS; HERBIVOROUS INSECTS; ELECTROANTENNOGRAPHIC RESPONSES; OVIPOSITION PREFERENCE; LEPIDOPTERA-PYRALIDAE; GUENEE LEPIDOPTERA; GRAPEVINE MOTH; EVOLUTION	Suitability of plant tissues as food for insects varies from plant to plant. In lepidopteran insects, fitness is largely dependent on the host-finding ability of the females. Existing studies have suggested that polyphagous lepidopterans preferentially select certain host plant species for oviposition. However, the mechanisms for host recognition and selection have not been fully elucidated. For the polyphagous yellow peach moth Conogethes punctiferalis, we explored the effect of chestnut cultivar on the performance and fitness and addressed the mechanisms of plant-volatile-mediated host recognition. By carrying out laboratory experiments and field investigation on four chestnut Castanea mollissima cultivars (Huaihuang, Huaijiu, Yanhong, and Shisheng), we found that C. punctiferalis females preferentially select Huaijiu for oviposition and infestation, and caterpillars fed on Huaijiu achieved slightly greater fitness than those fed on the other three chestnut cultivars, indicating that Huaijiu was a better suitable host for C. punctiferalis. Plant volatiles played important roles in host recognition by C. punctiferalis. All seven chestnut volatile compounds, alpha-pinene, camphene, beta-thujene, beta-pinene, eucalyptol, 3-carene, and nonanal, could trigger EAG responses in C. punctiferalis. The ubiquitous plant terpenoids, alpha-pinene, camphene and beta-pinene, and their specific combination at concentrations and proportions similar to the emissions from the four chestnut cultivars, was sufficient to elicit host recognition behavior of female C. punctiferalis. Nonanal and a mixture containing nonanal, that mimicked the emission of C. punctiferalis infested chestnut fruits, caused avoidance response. The outcome demonstrates the effects of chestnut cultivars on the performance of C. punctiferalis and reveals the preference-performance relationship between C. punctiferalis adults and their offspring. The observed olfactory plasticity in the plant-volatile-mediated host recognition may be important for the forming of the relationship between yellow peach moth and chestnuts since it allows the polyphagous herbivores to adjust to variation in volatile emission from their host plants.	[Du, Yanli; Zhang, Jiaxin; Yang, Mengmeng; Zhang, Minzhao; Zhang, Zhiyong; Qin, Ling] Beijing Agr Univ, Beijing Key Lab Agr Applicat & New Tech, Coll Plant Sci & Technol, Beijing, Peoples R China; [Yan, Zengguang] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China; [Ma, Yongqiang] China Agr Univ, Coll Sci, Beijing 100094, Peoples R China; [Cao, Qingqin] Beijing Agr Univ, Coll Biol Sci & Engn, Beijing, Peoples R China	Beijing University of Agriculture; Chinese Research Academy of Environmental Sciences; China Agricultural University; Beijing University of Agriculture	Yan, ZG (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China.	yanzg@craes.org.cn	cao, qingqin/W-5009-2019	Qin, Ling/0000-0002-9814-5771	Science and Technology Fund of Beijing Municipal Commission of Education [KZ201210020019]; National Natural Science Foundation of China [41271492]	Science and Technology Fund of Beijing Municipal Commission of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Science and Technology Fund of Beijing Municipal Commission of Education (KZ201210020019), and the National Natural Science Foundation of China (41271492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton S, 2007, ENTOMOL EXP APPL, V123, P1, DOI 10.1111/j.1570-7458.2007.00516.x; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; Bolter CJ, 1997, J CHEM ECOL, V23, P1003, DOI 10.1023/B:JOEC.0000006385.70652.5e; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Bruce TJA, 2011, PHYTOCHEMISTRY, V72, P1605, DOI 10.1016/j.phytochem.2011.04.011; Cha DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017033; Chen Bing-xu, 2010, Yingyong Shengtai Xuebao, V21, P464; Choi Kwang Sik, 2006, Journal of Korean Forestry Society, V95, P174; CRAIG TP, 1989, ECOLOGY, V70, P1691, DOI 10.2307/1938103; Craig TP, 2002, ECOL ENTOMOL, V27, P529, DOI 10.1046/j.1365-2311.2002.00448.x; DENNO RF, 1990, ECOLOGY, V71, P124, DOI 10.2307/1940253; DETHIER VG, 1982, ENTOMOL EXP APPL, V31, P49, DOI 10.1111/j.1570-7458.1982.tb03118.x; Dicke M, 1999, ENTOMOL EXP APPL, V91, P131, DOI 10.1023/A:1003608019062; Dicke M, 2000, ENTOMOL EXP APPL, V97, P237, DOI 10.1023/A:1004111624780; Dong YiZhi, 2012, Journal of Fruit Science, V29, P1052; Du YanLi, 2014, Acta Phytophylacica Sinica, V41, P187; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; FOX CW, 1993, OIKOS, V67, P577, DOI 10.2307/3545371; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; Hare JD, 2011, ANNU REV ENTOMOL, V56, P161, DOI 10.1146/annurev-ento-120709-144753; HONDA H, 1984, JPN J APPL ENTOMOL Z, V28, P82, DOI 10.1303/jjaez.28.82; HONDA H, 1979, APPL ENTOMOL ZOOL, V14, P464, DOI 10.1303/aez.14.464; Jaenike J., 1992, P245; JANZ N, 1994, OECOLOGIA, V99, P132, DOI 10.1007/BF00317093; JERMY T, 1984, AM NAT, V124, P609, DOI 10.1086/284302; Keesey IW, 2012, J KANSAS ENTOMOL SOC, V85, P145, DOI 10.2317/JKES111228.1; Keesey IW, 2012, ENVIRON ENTOMOL, V41, P933, DOI 10.1603/EN12065; KIRSTEN K, 1991, J APPL ENTOMOL, V111, P457, DOI 10.1111/j.1439-0418.1991.tb00348.x; Li DY, 2015, AUSTRAL ENTOMOL, V54, P149, DOI 10.1111/aen.12105; Linn CE, 2005, ENTOMOL EXP APPL, V116, P55, DOI 10.1111/j.1570-7458.2005.00310.x; Mayhew PJ, 1997, OIKOS, V79, P417, DOI 10.2307/3546884; Menken SBJ, 1998, ENDLESS FORMS, P145; Najar-Rodriguez AJ, 2010, J EXP BIOL, V213, P3388, DOI 10.1242/jeb.046284; RENWICK JAA, 1994, ANNU REV ENTOMOL, V39, P377, DOI 10.1146/annurev.en.39.010194.002113; RENWICK JAA, 1989, EXPERIENTIA, V45, P223, DOI 10.1007/BF01951807; SCHOONHOVEN LM, 2005, INSECT PLANT BIOL, P1; Scriber JM, 2002, EUR J ENTOMOL, V99, P225, DOI 10.14411/eje.2002.032; Stadler E, 1992, HERBIVORES THEIR INT, VII, P45; Szendrei Z, 2009, ENVIRON ENTOMOL, V38, P861, DOI 10.1603/022.038.0340; Tasin M, 2007, PHYTOCHEMISTRY, V68, P203, DOI 10.1016/j.phytochem.2006.10.015; Tasin M, 2010, CHEM SENSES, V35, P57, DOI 10.1093/chemse/bjp082; THOMPSON JN, 1988, EVOLUTION, V42, P1223, DOI 10.1111/j.1558-5646.1988.tb04182.x; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; Turlings TCJ, 2006, CURR OPIN PLANT BIOL, V9, P421, DOI 10.1016/j.pbi.2006.05.010; Waterhouse DF, 1993, ACIAR MONOGRAPH, V21, P1; Xiao W, 2012, J CHEM ECOL, V38, P1143, DOI 10.1007/s10886-012-0176-9	47	13	16	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157609	10.1371/journal.pone.0157609	http://dx.doi.org/10.1371/journal.pone.0157609			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27326856	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212400026
J	Amoakoh-Coleman, M; Agyepong, IA; Zuithoff, NPA; Kayode, GA; Grobbee, DE; Klipstein-Grobusch, K; Ansah, EK				Amoakoh-Coleman, Mary; Agyepong, Irene Akua; Zuithoff, Nicolaas P. A.; Kayode, Gbenga A.; Grobbee, Diederick E.; Klipstein-Grobusch, Kerstin; Ansah, Evelyn K.			Client Factors Affect Provider Adherence to Clinical Guidelines during First Antenatal Care	PLOS ONE			English	Article							QUALITY-OF-CARE; HYPERTENSION GUIDELINES; MATERNAL MORTALITY; MULTICENTER; PREVENTION; MANAGEMENT; SURVIVAL; REGION; PARITY	Background The first antenatal clinic (ANC) visit helps to distinguish pregnant women who require standard care, from those with specific problems and so require special attention. There are protocols to guide care providers to provide optimal care to women during ANC. Our objectives were to determine the level of provider adherence to first antenatal visit guidelines in the Safe Motherhood Protocol (SMP), and assess patient factors that determine complete provider adherence. Methods This cross-sectional study is part of a cohort study that recruited women who delivered in eleven health facilities and who had utilized antenatal care services during their pregnancy in the Greater Accra region of Ghana. A record review of the first antenatal visit of participants was carried out to assess the level of adherence to the SMP, using a thirteen-point checklist. Information on their socio-demographic characteristics and previous pregnancy history was collected using a questionnaire. Percentages of adherence levels and baseline characteristics were estimated and cluster-adjusted odds ratios (OR) calculated to identify determinants. Results A total of 948 women who had delivered in eleven public facilities were recruited with a mean age (SD) of 28.2 (5.4) years. Overall, complete adherence to guidelines pertained to only 48.1% of pregnant women. Providers were significantly more likely to completely adhere to guidelines when caring for multiparous women [OR = 5.43 (1.69-17.44), p<0.01] but less likely to do so when attending to women with history of previous pregnancy complications [OR = 0.50 (0.33-0.75), p<0.01]. Conclusion Complete provider adherence to first antenatal visit guidelines is low across different facility types in the Greater Accra region of Ghana and is determined by parity and history of previous pregnancy complication. Providers should be trained and supported to adhere to the guidelines during provision of care to all pregnant women.	[Amoakoh-Coleman, Mary; Zuithoff, Nicolaas P. A.; Kayode, Gbenga A.; Grobbee, Diederick E.; Klipstein-Grobusch, Kerstin] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands; [Amoakoh-Coleman, Mary; Agyepong, Irene Akua] Univ Ghana, Sch Publ Hlth, Legon, Ghana; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa; [Ansah, Evelyn K.] Ghana Hlth Serv, Div Res & Dev, Accra, Ghana	Utrecht University; Utrecht University Medical Center; University of Ghana; University of Witwatersrand; Ghana Health Service	Amoakoh-Coleman, M (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands.; Amoakoh-Coleman, M (corresponding author), Univ Ghana, Sch Publ Hlth, Legon, Ghana.	menba19@yahoo.com	Klipstein-Grobusch, Kerstin/F-5555-2016; Kayode, Gabenga A./C-8992-2015	Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Kayode, Gabenga A./0000-0001-6313-010X; Ansah, Evelyn/0000-0003-0401-8606; AMOAKOH-COLEMAN, MARY/0000-0002-0320-0396; Agyepong, Irene Akua/0000-0002-0193-5882	Netherlands Organization for Scientific Research (NWO) Global Health Policy; 396 Health Systems Research Program, Netherlands [07.45.102.00]; FOGARTY INTERNATIONAL CENTER [D43TW009140] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO) Global Health Policy(Netherlands Organization for Scientific Research (NWO)); 396 Health Systems Research Program, Netherlands(Netherlands Government); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Netherlands Organization for Scientific Research (NWO) Global Health Policy and 396 Health Systems Research Program, Netherlands, provided funds for the conduct of the study (Grant number: 07.45.102.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2001, J AM MED INFORM ASSN, P2; [Anonymous], 2013, DEF ADH GUID; Babinszki A, 1999, AM J OBSTET GYNECOL, V181, P669, DOI 10.1016/S0002-9378(99)70511-9; Bai J, 2002, AM J OBSTET GYNECOL, V186, P274, DOI 10.1067/mob.2002.119639; Burstin HR, 1999, AM J MED, V107, P437, DOI 10.1016/S0002-9343(99)00269-7; Burua A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0521-5; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Carroli G, 2001, PAEDIATR PERINAT EP, V15, P1; Cruz-Correa M, 2001, ARCH INTERN MED, V161, P2588, DOI 10.1001/archinte.161.21.2588; Cuspidi C, 2002, J HUM HYPERTENS, V16, P699, DOI 10.1038/sj.jhh.1001468; de la Sierra A, 2009, J HYPERTENS, V27, pS27, DOI 10.1097/01.hjh.0000356769.32130.95; Ghana Health Service, 2007, NAT SAF MOTH SERV PR; GRILLI R, 1994, MED CARE, V32, P202, DOI 10.1097/00005650-199403000-00002; Halm EA, UNDERSTANDING PHYS A; Howe LD, 2011, PAEDIATR PERINAT EP, V25, P192, DOI 10.1111/j.1365-3016.2010.01178.x; Issah K, 2011, INT J GYNECOL OBSTET, V113, P208, DOI 10.1016/j.ijgo.2011.01.007; Kersley, 2007, METHODS OBSERVATIONA; Komajda M, 2005, EUR HEART J, V26, P1653, DOI 10.1093/eurheartj/ehi251; Lawler FH, 1997, J FAM PRACTICE, V44, P369; Lin N D, 2006, AMIA Annu Symp Proc, P494; Lugtenberg M, 2009, QUAL SAF HEALTH CARE, V18, P385, DOI 10.1136/qshc.2008.028043; Malone DC, 2001, ANN PHARMACOTHER, V35, P1180; Mangin D, 2012, J PRIM HEALTH CARE, V4, P158, DOI 10.1071/HC12158; McKinlay JB, 2007, J GEN INTERN MED, V22, P289, DOI 10.1007/s11606-006-0075-2; Measure DHS, 2008, GHAN DEM HLGH SURV 2; Ministry of Health/Ghana Health Service RHU, 2013, MAT HLTH REC BOOK; Papaevangelou V, ADHERENCE SCREENING; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; Peters PJ, 2007, DRUG SAFETY, V30, P481, DOI 10.2165/00002018-200730060-00003; Sales AE, 2009, J GEN INTERN MED, V24, P1205, DOI 10.1007/s11606-009-1096-4; Schuster MA, 1997, ARCH PEDIAT ADOL MED, V151, P1085, DOI 10.1001/archpedi.1997.02170480015003; Scribano PV, 2001, ACAD EMERG MED, V8, P1147, DOI 10.1111/j.1553-2712.2001.tb01131.x; Shih TY, 2011, SEX TRANSM DIS, V38, P299, DOI 10.1097/OLQ.0b013e31820b8bb4; Styles M, 2011, MIDWIFERY, V27, P104, DOI 10.1016/j.midw.2009.12.003; Theodorou M, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/503821; Van Fenema E, 2012, INT J QUAL HEALTH C, V24, P72, DOI 10.1093/intqhc/mzr076; Villar J, 1997, ACTA OBSTET GYN SCAN, V76, P1, DOI 10.3109/00016349709047778; Worrall G, 1997, J FAM PRACTICE, V44, P374; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	40	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157542	10.1371/journal.pone.0157542	http://dx.doi.org/10.1371/journal.pone.0157542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322643	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212000022
J	Bohdan, N; Espin, S; Aguila, S; Teruel-Montoya, R; Vicente, V; Corral, J; Martinez-Martinez, I				Bohdan, Nataliya; Espin, Salvador; Aguila, Sonia; Teruel-Montoya, Raul; Vicente, Vicente; Corral, Javier; Martinez-Martinez, Irene			Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site	PLOS ONE			English	Article							FACTOR XA; EXPRESSION; SPECIFICITY; MECHANISM	Heparanase is an endoglycosidase that participates in morphogenesis, tissue repair, heparan sulphates turnover and immune response processes. It is over-expressed in tumor cells favoring the metastasis as it penetrates the endothelial layer that lines blood vessels and facilitates the metastasis by degradation of heparan sulphate proteoglycans of the extracellular matrix. Heparanase may also affect the hemostatic system in a non-enzymatic manner, up-regulating the expression of tissue factor, which is the initiator of blood coagulation, and dissociating tissue factor pathway inhibitor on the cell surface membrane of endothelial and tumor cells, thus resulting in a procoagulant state. Trying to check the effect of heparanase on heparin, a highly sulphated glycosaminoglycan, when it activates antithrombin, our results demonstrated that heparanase, but not proheparanase, interacted directly with antithrombin in a non-covalent manner. This interaction resulted in the activation of antithrombin, which is the most important endogenous anticoagulant. This activation mainly accelerated FXa inhibition, supporting an allosteric activation effect. Heparanase bound to the heparin binding site of antithrombin as the activation of Pro41Leu, Arg47Cys, Lys114Ala and Lys125Alaantithrombin mutants was impaired when it was compared to wild type antithrombin. Intrinsic fluorescence analysis showed that heparanase induced an activating conformational change in antithrombin similar to that induced by heparin and with a K-D of 18.81 pM. In conclusion, under physiological pH and low levels of tissue factor, heparanase may exert a non-enzymatic function interacting and activating the inhibitory function of antithrombin.	[Bohdan, Nataliya; Espin, Salvador; Aguila, Sonia; Teruel-Montoya, Raul; Vicente, Vicente; Corral, Javier; Martinez-Martinez, Irene] Univ Murcia, Hosp Univ Morales Meseguer, IMIB Arrixaca, Serv Hematol & Oncol Med,Ctr Reg Hemodonac, Murcia, Spain; [Teruel-Montoya, Raul; Vicente, Vicente; Corral, Javier; Martinez-Martinez, Irene] Inst Salud Carlos III ISCIIII, Ctr Invest Biomed Red Enfermedades Rara CIBERER, Grp Invest CB15 00055, Madrid, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; Meseguer General University Hospital Morales; University of Murcia; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Martinez-Martinez, I (corresponding author), Univ Murcia, Hosp Univ Morales Meseguer, IMIB Arrixaca, Serv Hematol & Oncol Med,Ctr Reg Hemodonac, Murcia, Spain.; Martinez-Martinez, I (corresponding author), Inst Salud Carlos III ISCIIII, Ctr Invest Biomed Red Enfermedades Rara CIBERER, Grp Invest CB15 00055, Madrid, Spain.	immlgi@um.es	Martínez-Martínez, Irene/AAM-8862-2020	Martínez-Martínez, Irene/0000-0002-1067-6464; Corral, Javier/0000-0003-0288-1107; Bohdan, Nataliya/0000-0002-2969-2843; Vicente, Vicente/0000-0002-4278-3264; Aguila, Sonia/0000-0001-5794-5177	Instituto de Salud Carlos III [CP13/00126, PI12/00657]; Fondo Europeo de Desarrollo Regional [PI12/00657]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional(European Commission)	This work was supported by CP13/00126 (Instituto de Salud Carlos III) and PI12/00657 (Instituto de Salud Carlos III & Fondo Europeo de Desarrollo Regional), URL: http://www.isciii.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila S, 2014, J THROMB HAEMOST, V12, P1131, DOI 10.1111/jth.12606; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Dempsey LA, 2000, GLYCOBIOLOGY, V10, P467, DOI 10.1093/glycob/10.5.467; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Langdown J, 2009, J MOL BIOL, V386, P1278, DOI 10.1016/j.jmb.2009.01.028; Luxembourg B, 2014, THROMB HAEMOSTASIS, V111, P249, DOI 10.1160/TH13-05-0402; Martinez-Martinez I, 2012, BLOOD, V120, P900, DOI 10.1182/blood-2012-01-406207; Martinez-Martinez I, 2010, HAEMATOL-HEMATOL J, V95, P1358, DOI 10.3324/haematol.2009.015487; Mushunje A, 2004, J THROMB HAEMOST, V2, P2170, DOI 10.1111/j.1538-7836.2004.01047.x; Nadir Y, 2006, J THROMB HAEMOST, V4, P2443, DOI 10.1111/j.1538-7836.2006.02212.x; Nadir Y, 2008, THROMB HAEMOSTASIS, V99, P133, DOI 10.1055/s-0037-1608919; Nadir Y, 2015, ANN HEMATOL, V94, P1213, DOI 10.1007/s00277-015-2345-8; Nadir Y, 2014, RAMBAM MAIMONIDES ME, V5, DOI 10.5041/RMMJ.10165; Nadir Y, 2014, THROMB RES, V133, pS90, DOI 10.1016/S0049-3848(14)50015-1; Olson ST, 2010, BIOCHIMIE, V92, P1587, DOI 10.1016/j.biochi.2010.05.011; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Parish CR, 2001, BIOCHIM BIOPHYS ACTA, V1471, P99, DOI DOI 10.1016/S0304-419X(01)00017-8; Peterson SB, 2010, J BIOL CHEM, V285, P14504, DOI 10.1074/jbc.M110.104166; Poon IKH, 2010, INT J BIOCHEM CELL B, V42, P1507, DOI 10.1016/j.biocel.2010.05.008; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P12369, DOI 10.1021/bi020406j; Shore JD, 1981, J BIOL CHEM, V256, P11; Thompson CA, 2013, J BIOL CHEM, V288, P10093, DOI 10.1074/jbc.C112.444562; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Vlodavsky I, 2007, THROMB RES, V120, pS112, DOI 10.1016/S0049-3848(07)70139-1; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Vlodavsky I, 2011, RAMBAM MAIMONIDES ME, V2, DOI 10.5041/RMMJ.10019; Zondlo NJ, 2013, ACCOUNTS CHEM RES, V46, P1039, DOI 10.1021/ar300087y	29	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157834	10.1371/journal.pone.0157834	http://dx.doi.org/10.1371/journal.pone.0157834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322195	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212000046
J	Phani, NM; Adhikari, P; Nagri, SK; D'Souza, SC; Satyamoorthy, K; Rai, PS				Phani, Nagaraja M.; Adhikari, Prabha; Nagri, Shivashankara K.; D'Souza, Sydney C.; Satyamoorthy, Kapaettu; Rai, Padmalatha S.			Replication and Relevance of Multiple Susceptibility Loci Discovered from Genome Wide Association Studies for Type 2 Diabetes in an Indian Population	PLOS ONE			English	Article							LARGE-SCALE ASSOCIATION; MULTIFACTOR DIMENSIONALITY REDUCTION; GENE-GENE INTERACTIONS; COMMON VARIANTS; ASIAN-INDIANS; TCF7L2; RISK; IGF2BP2; CDKAL1; POLYMORPHISMS	Aim Several genetic variants for type 2 diabetes (T2D) have been identified through genome wide association studies (GWAS) from Caucasian population; however replication studies were not consistent across various ethnicities. Objective of the current study is to examine the possible correlation of 9 most significant GWAS single nucleotide polymorphisms (SNPs) for T2D susceptibility as well as the interactive effect of these variants on the risk of T2D in an Indian population. Methods Case-control cohorts of 1156 individuals were genotyped for 9 SNPs from an Indian population. Association analyses were performed using logistic regression after adjusting for covariates. Multifactor dimensionality reduction (MDR) analysis was adopted to determine gene-gene interactions and discriminatory power of combined SNP effect was assessed by grouping individuals based on the number of risk alleles and by calculating area under the receiver-operator characteristic curve (AUC). Results We confirm the association of TCF7L2 (rs7903146) and SLC30A8 (rs13266634) with T2D. MDR analysis showed statistically significant interactions among four SNPs of SLC30A8 (rs13266634), IGF2BP2 (rs4402960), HHEX (rs1111875) and CDKN2A (rs10811661) genes. Cumulative analysis showed an increase in odds ratio against the baseline group of individuals carrying 5 to 6 risk alleles and discriminatory power of genetic test based on 9 variants showed higher AUC value when analyzed along with body mass index (BMI). Conclusion These results provide a strong evidence for independent association between T2D and SNPs for in TCF7L2 and SLC30A8. MDR analysis demonstrates that independently nonsignificant variants may interact with one another resulting in increased disease susceptibility in the population tested.	[Phani, Nagaraja M.; Satyamoorthy, Kapaettu; Rai, Padmalatha S.] Manipal Univ, Sch Life Sci, Dept Biotechnol, Manipal 576104, Karnataka, India; [Adhikari, Prabha; D'Souza, Sydney C.] Manipal Univ, Kasturba Med Coll, Dept Med, Mangalore 575001, Karnataka, India; [Nagri, Shivashankara K.] Manipal Univ, Kasturba Med Coll, Dept Med, Manipal 576104, Karnataka, India	Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal	Rai, PS (corresponding author), Manipal Univ, Sch Life Sci, Dept Biotechnol, Manipal 576104, Karnataka, India.	padmalatha.rai@manipal.edu		Satyamoorthy, Kapaettu/0000-0002-2368-5490	Indian Council of Medical Research (ICMR); Technology Information Forecasting and Assessment Council-Centre of Relevance and Excellence (TIFAC-CORE) in Pharmacogenomics at the School of Life Sciences, Government of India; Dr. TMA Pai Endowment Chair in Pharmacogenomics and Public Health Genomics, Manipal University	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Technology Information Forecasting and Assessment Council-Centre of Relevance and Excellence (TIFAC-CORE) in Pharmacogenomics at the School of Life Sciences, Government of India; Dr. TMA Pai Endowment Chair in Pharmacogenomics and Public Health Genomics, Manipal University	The authors would like to thank the Indian Council of Medical Research (ICMR), Technology Information Forecasting and Assessment Council-Centre of Relevance and Excellence (TIFAC-CORE) in Pharmacogenomics at the School of Life Sciences, Government of India, Dr. TMA Pai Endowment Chair in Pharmacogenomics and Public Health Genomics, Manipal University for financial and technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Indian Council of Medical Research (ICMR), Technology Information Forecasting and Assessment Council-Centre of Relevance and Excellence (TIFAC-CORE) in Pharmacogenomics at the School of Life Sciences, Government of India, Dr. TMA Pai Endowment Chair in Pharmacogenomics and Public Health Genomics, Manipal University for financial and technical support.	Bai HH, 2014, GENOME BIOL EVOL, V6, P3122, DOI 10.1093/gbe/evu242; Bodhini D, 2007, METABOLISM, V56, P1174, DOI 10.1016/j.metabol.2007.04.012; Brahmachari SK, 2008, J GENET, V87, P3; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Gupta V, 2010, ANN HUM GENET, V74, P361, DOI 10.1111/j.1469-1809.2010.00580.x; Keaton JM, 2014, HUM GENET, V133, P1487, DOI 10.1007/s00439-014-1486-5; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Motsinger Alison A., 2006, Human Genomics, V2, P318; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Ramachandran A, 1997, DIABETES RES CLIN PR, V36, P121, DOI 10.1016/S0168-8227(97)00040-5; Sainz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032273; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Sanghera DK, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.1000198; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tabassum Rubina, 2008, Genomic Med, V2, P93, DOI 10.1007/s11568-009-9031-7; Vimaleswaran KS, 2010, METABOLISM, V59, P457, DOI 10.1016/j.metabol.2009.07.034; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	36	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157364	10.1371/journal.pone.0157364	http://dx.doi.org/10.1371/journal.pone.0157364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310578	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800061
J	Samarakoon, R; Rehfuss, A; Khakoo, NS; Falke, LL; Dobberfuhl, AD; Helo, S; Overstreet, JM; Goldschmeding, R; Higgins, PJ				Samarakoon, Rohan; Rehfuss, Alexandra; Khakoo, Nidah S.; Falke, Lucas L.; Dobberfuhl, Amy D.; Helo, Sevann; Overstreet, Jessica M.; Goldschmeding, Roel; Higgins, Paul J.			Loss of expression of protein phosphatase magnesium-dependent 1A during kidney injury promotes fibrotic maladaptive repair	FASEB JOURNAL			English	Article						TGF-beta; PAI-1; CTGF; PTEN; renal fibrosis	ARISTOLOCHIC ACID NEPHROPATHY; RENAL FIBROSIS; OBSTRUCTIVE NEPHROPATHY; DOWN-REGULATION; TARGET GENES; DISEASE; TGF-BETA-1; SMAD; RESPONSES; DEGRADATION	Protein phosphatase magnesium-dependent-1A (PPM1A) dephosphorylates SMAD2/3, which suppresses TGF-beta signaling in keratinocytes and during Xenopus development; however, potential involvement of PPM1A in chronic kidney disease is unknown. PPM1A expression was dramatically decreased in the tubulointerstitium in obstructive and aristolochic acid nephropathy, which correlates with progression of fibrotic disease. Stable silencing of PPM1A in human kidney-2 human renal epithelial cells increased SMAD3 phosphorylation, stimulated expression of fibrotic genes, induced dedifferentiation, and orchestrated epithelial cell-cycle arrest via SMAD3-mediated connective tissue growth factor and plasminogen activator inhibitor-1 up-regulation. PPM1A stable suppression in normal rat kidney-49 renal fibroblasts, in contrast, promoted a SMAD3-dependent connective tissue growth factor and plasminogen activator inhibitor-1-induced proliferative response. Paracrine factors secreted by PPM1A-depleted epithelial cells augmented fibroblast proliferation (>50%) compared with controls. PPM1A suppression in renal cells further enhanced TGF-beta 1-induced SMAD3 phosphorylation and fibrotic gene expression, whereas PPM1A overexpression inhibited both responses. Moreover, phosphate tensin homolog on chromosome 10 depletion in human kidney-2 cells resulted in loss of expression and decreased nuclear levels of PPM1A, which enhanced SMAD3-mediated fibrotic gene induction and growth arrest that were reversed by ectopic PPM1A expression. Thus, phosphate tensin homolog on chromosome 10 is an upstream regulator of renal PPM1A deregulation. These findings establish PPM1A as a novel repressor of the SMAD3 pathway in renal fibrosis and as a new therapeutic target in patients with chronic kidney disease.-Samarakoon, R., Rehfuss, A., Khakoo, N. S., Falke, L. L., Dobberfuhl, A. D., Helo, S., Overstreet, J. M., Goldschmeding, R., Higgins, P. J. Loss of expression of protein phosphatase magnesium-dependent 1A during kidney injury promotes fibrotic maladaptive repair.	[Samarakoon, Rohan; Khakoo, Nidah S.; Higgins, Paul J.] Albany Med Ctr, Ctr Cell Biol & Canc Res, Albany, NY USA; [Rehfuss, Alexandra; Helo, Sevann] Albany Med Ctr, Div Urol, Albany, NY USA; [Falke, Lucas L.; Goldschmeding, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Dobberfuhl, Amy D.] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Overstreet, Jessica M.] Vanderbilt Univ Sch Med, Div Nephrol & Hypertens, Nashville, TN USA	Albany Medical College; Albany Medical College; Utrecht University; Utrecht University Medical Center; Stanford University; Vanderbilt University	Samarakoon, R; Higgins, PJ (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, 47 New Scotland Ave, Albany, NY 12208 USA.	samarar@mail.amc.edu; higginp@mail.amc.edu	Dobberfuhl, Amy/M-9285-2018; Falke, Lucas L/D-5288-2017	Dobberfuhl, Amy/0000-0003-3451-3878; Falke, Lucas L/0000-0003-0020-433X; Helo, Sevann/0000-0002-3274-3672	Charlotte Graver Foundation; Friedman Cancer Research Foundation; U.S. National Institutes of Health, National Institute of General Medical Sciences [GM057242]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057242] Funding Source: NIH RePORTER	Charlotte Graver Foundation; Friedman Cancer Research Foundation; U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Charlotte Graver Foundation, the Friedman Cancer Research Foundation, and the U.S. National Institutes of Health, National Institute of General Medical Sciences Grant GM057242 ( to P.J.H.). R.G. was previously employed (2008-2009 by, performs contract research for, and receives reagents for CTGF-related research from FibroGen.	Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bu S, 2008, J BIOL CHEM, V283, P19593, DOI 10.1074/jbc.M802417200; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Dendooven A, 2011, AM J PATHOL, V178, P1069, DOI 10.1016/j.ajpath.2010.12.005; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Dvashi Z, 2014, AM J PATHOL, V184, P2936, DOI 10.1016/j.ajpath.2014.07.022; Falke LL, 2014, NEPHROL DIAL TRANSPL, V29, pI30, DOI 10.1093/ndt/gft430; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Fukasawa H, 2006, KIDNEY INT, V69, P1733, DOI 10.1038/sj.ki.5000261; Fukasawa H, 2004, P NATL ACAD SCI USA, V101, P8687, DOI 10.1073/pnas.0400035101; Gokmen MR, 2013, ANN INTERN MED, V158, P469, DOI 10.7326/0003-4819-158-6-201303190-00006; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Lan HY, 2003, J AM SOC NEPHROL, V14, P1535, DOI 10.1097/01.ASN.0000067632.04658.B8; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Loeffler I, 2014, NEPHROL DIAL TRANSPL, V29, pI37, DOI 10.1093/ndt/gft267; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Overstreet JM, 2015, FASEB J, V29, P1258, DOI 10.1096/fj.14-262527; Overstreet JM, 2014, CELL SIGNAL, V26, P1427, DOI 10.1016/j.cellsig.2014.02.017; Perico N, 2012, NEPHROL DIAL TRANSPL, V27, P19, DOI 10.1093/ndt/gfs284; Samarakoon R, 2015, J PATHOL, V236, P421, DOI 10.1002/path.4538; Samarakoon R, 2013, CELL SIGNAL, V25, P2198, DOI 10.1016/j.cellsig.2013.07.007; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Samarakoon R, 2012, CELL TISSUE RES, V347, P117, DOI 10.1007/s00441-011-1181-y; Samarakoon R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022896; Samarakoon R, 2008, THROMB HAEMOSTASIS, V100, P976, DOI 10.1160/TH08-05-0273; Strutz F, 2003, SPRINGER SEMIN IMMUN, V24, P459, DOI 10.1007/s00281-003-0123-5; Yang JW, 2003, J AM SOC NEPHROL, V14, P3167, DOI 10.1097/01.ASN.0000099373.33259.B2; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yang X, 2011, J BIOL CHEM, V286, P42267, DOI 10.1074/jbc.M111.292284; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhou L, 2010, AM J PHYSIOL-RENAL, V298, pF1006, DOI 10.1152/ajprenal.00675.2009	34	18	18	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3308	3320		10.1096/fj.201500105R	http://dx.doi.org/10.1096/fj.201500105R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27328942	Green Published			2022-12-26	WOS:000384329800005
J	Harikumar, KG; Augustine, ML; Lee, LTO; Chow, BKC; Miller, LJ				Harikumar, Kaleeckal G.; Augustine, Mary Lou; Lee, Leo T. O.; Chow, Billy K. C.; Miller, Laurence J.			Structure and Function of Cross-class Complexes of G Protein-coupled Secretin and Angiotensin 1a Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; angiotensin; bioluminescence resonance energy transfer (BRET); calcium; dimerization; G protein-coupled receptor (GPCR)	CHOLECYSTOKININ RECEPTORS; OLIGOMERIC COMPLEXES; ENERGY-TRANSFER; ACTIVATION; DIMERIZATION; HOMEOSTASIS; REVEALS	Complexes of secretin (SecR) and angiotensin 1a (Atr1a) receptors have been proposed to be functionally important in osmoregulation, providing an explanation for overlapping and interdependent functions of hormones that bind and activate different classes of GPCRs. However, the nature of these cross-class complexes has not been well characterized and their signaling properties have not been systematically explored. We now use competitive inhibition of receptor bioluminescence resonance energy transfer and bimolecular fluorescence complementation to establish the dominant functionally important state as a symmetrical homodimeric form of SecR decorated by monomeric Atr1a, interacting through lipid-exposed faces of Atr1a TM1 and TM4. Conditions increasing prevalence of this complex exhibited negative allosteric modulatory impact on secretin-stimulated cAMP responses at SecR. In contrast, activating Atr1a with full agonist in such a complex exhibited a positive allosteric modulatory impact on the same signaling event. This modulation was functionally biased, with secretin-stimulated calcium responses unaffected, whereas angiotensin-stimulated calcium responses through the complex were reduced or absent. Further supporting this interpretation, Atr1a with mutations of lipid-exposed faces of TM1 and TM4 that did not affect its ability to bind or signal, could be expressed in the same cell as SecR, yet not exhibit either the negative or positive allosteric impact on cAMP observed with the inactive or activated states of wild type Atr1a on function, and not interfere with angiotensin-stimulated calcium responses like complexes with Atr1a. This may provide a more selective means of exploring the physiologic functional impact of this cross-class receptor complex without interfering with the function of either component receptor.	[Harikumar, Kaleeckal G.; Augustine, Mary Lou; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Lee, Leo T. O.] Univ Macau, Ctr Reprod Dev & Aging, Taipa, Macau, Peoples R China; [Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China	Mayo Clinic; Mayo Clinic Phoenix; University of Macau; University of Hong Kong	Miller, LJ (corresponding author), 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu	Chow, Billy/D-3064-2009; Lee, Leo T.O./AAB-1581-2021	Chow, Billy/0000-0003-3390-0307; Lee, Leo Tsz On/0000-0003-3691-478X; Harikumar, Kaleeckal/0000-0003-0411-5334	National Institutes of Health [DK046577]; Mayo Clinic; Fundo para o Desenvolvimento das Ciencias e da Tecnologia, Macao [FDCT101/2015/A3]; Hong Kong Government RGC [CRFHKU6/CRF/11G, HKU 764812M, HKU 765011M]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046577, R56DK046577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic; Fundo para o Desenvolvimento das Ciencias e da Tecnologia, Macao; Hong Kong Government RGC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK046577 (to L. J. M.) and the Mayo Clinic (to L. J. M.). The authors declare that they have no conflict of interest with the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Fundo para o Desenvolvimento das Ciencias e da Tecnologia Grant FDCT101/2015/A3, Macao.; Supported by Hong Kong Government RGC Grants CRFHKU6/CRF/11G, HKU 764812M, and HKU 765011M.	AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; Chu JYS, 2006, ANN NY ACAD SCI, V1070, P196, DOI 10.1196/annals.1317.012; Chu JYS, 2007, MOL CELL BIOL, V27, P2499, DOI 10.1128/MCB.01088-06; Chu JYS, 2011, KIDNEY INT, V79, P280, DOI 10.1038/ki.2010.397; Chu JYS, 2009, P NATL ACAD SCI USA, V106, P15961, DOI 10.1073/pnas.0903695106; Daniels D, 2012, BRAIN RES, V1486, P62, DOI 10.1016/j.brainres.2012.09.040; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; Gao F, 2009, MOL PHARMACOL, V76, P264, DOI 10.1124/mol.109.055756; Garcia GL, 2012, AM J PHYSIOL-CELL PH, V302, pC1202, DOI 10.1152/ajpcell.00273.2011; HAAS E, 1978, BIOCHEMISTRY-US, V17, P5064, DOI 10.1021/bi00616a032; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Harikumar K, 2010, GPCR MOL PHARM DRUG, P138; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2006, MOL PHARMACOL, V69, P363, DOI 10.1124/mol.105.015776; Harikurnar KG, 2008, BBA-BIOMEMBRANES, V1778, P2555, DOI 10.1016/j.bbamem.2008.07.008; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Lakowicz J.R, 1999, PRINCIPLES FLUORESCE, P368; Lee LTO, 2014, FASEB J, V28, P2632, DOI 10.1096/fj.13-246868; Lee VHY, 2010, FASEB J, V24, P5024, DOI 10.1096/fj.10-165399; Lisenbee CS, 2006, BIOCHEMISTRY-US, V45, P8216, DOI 10.1021/bi060494y; Milligan G, 2013, MOL PHARMACOL, V84, P158, DOI 10.1124/mol.113.084780; Pin JP, 2009, J PHYSIOL-LONDON, V587, P5337, DOI 10.1113/jphysiol.2009.179978; Poger D, 2014, BIOCHEMISTRY-US, V53, P2710, DOI 10.1021/bi401632z; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; ULRICH CD, 1993, GASTROENTEROLOGY, V105, P1534, DOI 10.1016/0016-5085(93)90162-6; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	28	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17332	17344		10.1074/jbc.M116.730754	http://dx.doi.org/10.1074/jbc.M116.730754			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27330080	Green Published, hybrid			2022-12-26	WOS:000382643800033
J	Zheng, H; Miyakawa, T; Sawano, Y; Asano, A; Okumura, A; Yamagoe, S; Tanokura, M				Zheng, Hai; Miyakawa, Takuya; Sawano, Yoriko; Asano, Atsuko; Okumura, Akinori; Yamagoe, Satoshi; Tanokura, Masaru			Crystal Structure of Human Leukocyte Cell-derived Chemotaxin 2 (LECT2) Reveals a Mechanistic Basis of Functional Evolution in a Mammalian Protein with an M23 Metalloendopeptidase Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemokine; metalloprotease; multifunctional protein; x-ray crystallography; zinc	HEPATOCELLULAR-CARCINOMA; GLYCYLGLYCINE ENDOPEPTIDASE; VAL58ILE POLYMORPHISM; BETA-CATENIN; PURIFICATION; AMYLOIDOSIS; EXPRESSION; IDENTIFICATION; LYSOSTAPHIN; COMPONENTS	Human leukocyte cell-derived chemotaxin 2 (LECT2), which is predominantly expressed in the liver, is a multifunctional protein. LECT2 is becoming a potential therapeutic target for several diseases of worldwide concern such as rheumatoid arthritis, hepatocellular carcinoma, and obesity. Here, we present the crystal structure of LECT2, the first mammalian protein whose structure contains an M23 metalloendopeptidase fold. The LECT2 structure adopts a conserved Zn(II) coordination configuration but lacks a proposed catalytic histidine residue, and its potential substrate-binding groove is blocked in the vicinity of the Zn(II)-binding site by an additional intrachain loop at the N terminus. Consistent with these structural features, LECT2 was found to be catalytically inactive as a metalloendopeptidase against various types of peptide sequences, including pentaglycine. In addition, a surface plasmon resonance analysis demonstrated that LECT2 bound to the c-Met receptor with micromolar affinity. These results indicate that LECT2 likely plays its critical roles by acting as a ligand for the corresponding protein receptors rather than as an enzymatically active peptidase. The intrachain loop together with the pseudo-active site groove in LECT2 structure may be specific for interactions between LECT2 and receptors. Our study reveals a mechanistic basis for the functional evolution of a mammalian protein with an M23 metalloendopeptidase fold and potentially broadens the implications for the biological importance of noncatalytic peptidases in the M23 family.	[Zheng, Hai; Miyakawa, Takuya; Sawano, Yoriko; Asano, Atsuko; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Sawano, Yoriko] Tokyo Med & Dent Univ, Dept Chem, Coll Liberal Arts & Sci, 2-8-30 Kounodai, Ichikawa, Chiba 2720827, Japan; [Okumura, Akinori] Natl Ctr Global Hlth & Med, Dept Diabet Complicat, Diabet Res Ctr, Res Inst,Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan; [Yamagoe, Satoshi] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU); National Center for Global Health & Medicine - Japan; National Institute of Infectious Diseases (NIID)	Tanokura, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp	Okumura, Akinori/AAT-4389-2021; Okumura, Akinori/B-6456-2017	Okumura, Akinori/0000-0002-3977-6207; Okumura, Akinori/0000-0002-3977-6207; Tanokura, Masaru/0000-0001-5072-2480	Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [26670229] Funding Source: KAKEN	Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); by the Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT; and by a grant-in-aid for scientific research (S) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Anson M, 2012, J CLIN INVEST, V122, P586, DOI 10.1172/JCI43937; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Chen CK, 2014, HEPATOLOGY, V59, P974, DOI 10.1002/hep.26738; Cohen DN, 2009, J MOL BIOL, V387, P607, DOI 10.1016/j.jmb.2009.02.001; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Firczuk M, 2005, J MOL BIOL, V354, P578, DOI 10.1016/j.jmb.2005.09.082; Firczuk M, 2007, FEMS MICROBIOL REV, V31, P676, DOI 10.1111/j.1574-6976.2007.00084.x; Graessler J, 2005, J RHEUMATOL, V32, P1654; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kameoka Y, 2000, ARTHRITIS RHEUM, V43, P1419, DOI 10.1002/1529-0131(200006)43:6<1419::AID-ANR28>3.0.CO;2-I; Kirchhofer D, 2004, J BIOL CHEM, V279, P39915, DOI 10.1074/jbc.M404795200; Kowalski A, 2015, CLIN NEPHROL, V84, P236, DOI 10.5414/CN108549; Lan F, 2014, DIABETES, V63, P1649, DOI 10.2337/db13-0728; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levdikov VM, 2012, P NATL ACAD SCI USA, V109, P5441, DOI 10.1073/pnas.1120087109; Liu HJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001249; Meisner J, 2012, P NATL ACAD SCI USA, V109, P5446, DOI 10.1073/pnas.1120113109; Mereuta OM, 2014, BLOOD, V123, P1479, DOI 10.1182/blood-2013-07-517938; Murphy CL, 2010, AM J KIDNEY DIS, V56, P1100, DOI 10.1053/j.ajkd.2010.08.013; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Okumura A, 2008, ARTHRITIS RHEUM, V58, P413, DOI 10.1002/art.23215; Okumura A, 2013, BIOSCI TRENDS, V7, P276, DOI 10.5582/bst.2013.v7.6.276; Okumura A, 2009, BIOSCI TRENDS, V3, P139; Ong HT, 2011, CANCER GENE THER, V18, P399, DOI 10.1038/cgt.2011.5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ovejero C, 2004, HEPATOLOGY, V40, P167, DOI 10.1002/hep.20286; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; Park P. W., 2004, HDB PROTEOLYTIC ENZY, P1004; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Peters NT, 2013, MOL MICROBIOL, V89, P690, DOI 10.1111/mmi.12304; Phesse TJ, 2008, MOL CELL BIOL, V28, P6094, DOI 10.1128/MCB.00539-08; Ragurnani S, 2008, PROTEINS, V72, P1096, DOI 10.1002/prot.22095; Ramadurai L, 1999, MICROBIOL-UK, V145, P801, DOI 10.1099/13500872-145-4-801; Sabala I, 2014, FEBS J, V281, P4112, DOI 10.1111/febs.12929; Saito T, 2004, J IMMUNOL, V173, P579, DOI 10.4049/jimmunol.173.1.579; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Segawa Y, 2001, BIOL PHARM BULL, V24, P425, DOI 10.1248/bpb.24.425; Singh SK, 2012, MOL MICROBIOL, V86, P1036, DOI 10.1111/mmi.12058; Spencer J, 2010, J MOL BIOL, V396, P908, DOI 10.1016/j.jmb.2009.12.021; Sugai M, 1997, J BACTERIOL, V179, P1193, DOI 10.1128/jb.179.4.1193-1202.1997; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; Vessillier S, 2001, EUR J BIOCHEM, V268, P1049, DOI 10.1046/j.1432-1327.2001.01967.x; Wang XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026845; Xiang Y, 2008, P NATL ACAD SCI USA, V105, P9552, DOI 10.1073/pnas.0803787105; Yamagoe S, 1998, BBA-GENE STRUCT EXPR, V1396, P105, DOI 10.1016/S0167-4781(97)00181-4; Yamagoe S, 1996, IMMUNOL LETT, V52, P9, DOI 10.1016/0165-2478(96)02572-2; Zheng H, 2013, ACTA CRYSTALLOGR F, V69, P316, DOI 10.1107/S1744309113003758; Zheng H, 2013, PROTEIN EXPRES PURIF, V88, P221, DOI 10.1016/j.pep.2013.01.008	51	12	14	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17133	17142		10.1074/jbc.M116.720375	http://dx.doi.org/10.1074/jbc.M116.720375			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27334921	Green Published, hybrid			2022-12-26	WOS:000382643800019
J	Chomvong, K; Bauer, S; Benjamin, DI; Li, X; Nomura, DK; Cate, JHD				Chomvong, Kulika; Bauer, Stefan; Benjamin, Daniel I.; Li, Xin; Nomura, Daniel K.; Cate, Jamie H. D.			Bypassing the Pentose Phosphate Pathway: Towards Modular Utilization of Xylose	PLOS ONE			English	Article							ENGINEERED SACCHAROMYCES-CEREVISIAE; ETHYLENE-GLYCOL; LIVER KETOHEXOKINASE; ESCHERICHIA-COLI; KEY INHIBITOR; YEAST; FERMENTATION; STRAINS; GLYCOLALDEHYDE; EXPRESSION	The efficient use of hemicellulose in the plant cell wall is critical for the economic conversion of plant biomass to renewable fuels and chemicals. Previously, the yeast Saccharomyces cerevisiae has been engineered to convert the hemicellulose-derived pentose sugars xylose and arabinose to D-xylulose-5-phosphate for conversion via the pentose phosphate pathway (PPP). However, efficient pentose utilization requires PPP optimization and may interfere with its roles in NADPH and pentose production. Here, we developed an alternative xylose utilization pathway that largely bypasses the PPP. In the new pathway, D-xylulose is converted to D-xylulose-1-phosphate, a novel metabolite to S. cerevisiae, which is then cleaved to glycolaldehyde and dihydroxyacetone phosphate. This synthetic pathway served as a platform for the biosynthesis of ethanol and ethylene glycol. The use of D-xylulose-1-phosphate as an entry point for xylose metabolism opens the way for optimizing chemical conversion of pentose sugars in S. cerevisiae in a modular fashion.	[Chomvong, Kulika] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Bauer, Stefan] Energy Biosci Inst, Berkeley, CA USA; [Benjamin, Daniel I.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Program Metab Biol, Berkeley, CA 94720 USA; [Li, Xin; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Cate, JHD (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	jcate@lbl.gov			Energy Biosciences Institute; NATIONAL CANCER INSTITUTE [R01CA172667] Funding Source: NIH RePORTER	Energy Biosciences Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Energy Biosciences Institute, http://energybiosciencesinstitute.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkim C, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0312-7; BAIS R, 1985, BIOCHEM J, V230, P53, DOI 10.1042/bj2300053; Cam Y, 2015, ACS SYNTH BIOL, DOI [10.1021/acssynbio.5b00103, DOI 10.1021/ACSSYNBIO.5B00103]; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; DONALDSON IA, 1993, BIOCHEM J, V291, P179, DOI 10.1042/bj2910179; Fernandes Sara, 2010, Bioeng Bugs, V1, P424, DOI 10.4161/bbug.1.6.12724; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Geertman JMA, 2006, FEMS YEAST RES, V6, P1193, DOI 10.1111/j.1567-1364.2006.00124.x; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Ha SJ, 2013, METAB ENG, V15, P134, DOI 10.1016/j.ymben.2012.11.005; Ha SJ, 2011, P NATL ACAD SCI USA, V108, P504, DOI 10.1073/pnas.1010456108; Hahn-Hagerdal B, 2007, ADV BIOCHEM ENG BIOT, V108, P147, DOI 10.1007/10_2007_062; Hanscho M, 2012, FEMS YEAST RES, V12, P796, DOI 10.1111/j.1567-1364.2012.00830.x; Jayakody LN, 2013, APPL MICROBIOL BIOT, V97, P6589, DOI 10.1007/s00253-013-4997-4; Jayakody LN, 2012, APPL MICROBIOL BIOT, V94, P273, DOI 10.1007/s00253-012-3918-2; Jayakody LN, 2011, BIOTECHNOL LETT, V33, P285, DOI 10.1007/s10529-010-0437-z; Jeppsson M, 2002, APPL ENVIRON MICROB, V68, P1604, DOI 10.1128/AEM.68.4.1604-1609.2002; Johansson B, 2002, FEMS YEAST RES, V2, P277, DOI 10.1016/S1567-1356(02)00114-9; Kim SJ, 2013, BIORESOURCE TECHNOL, V146, P274, DOI 10.1016/j.biortech.2013.07.081; KOTTER P, 1993, APPL MICROBIOL BIOT, V38, P776, DOI 10.1007/BF00167144; Kuyper M, 2004, FEMS YEAST RES, V4, P655, DOI 10.1016/j.femsyr.2004.01.003; Liu HW, 2013, APPL MICROBIOL BIOT, V97, P3409, DOI 10.1007/s00253-012-4618-7; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; McMillan J.D., 1993, XYLOSE FERMENTATION; MISHRA P, 1993, ADV APPL MICROBIOL, V39, P91, DOI 10.1016/S0065-2164(08)70594-X; Pereira B, 2016, METAB ENG, V34, P80, DOI 10.1016/j.ymben.2015.12.004; Pereira B, 2016, BIOTECHNOL BIOENG, V113, P376, DOI 10.1002/bit.25717; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Sonderegger M, 2004, APPL ENVIRON MICROB, V70, P2892, DOI 10.1128/AEM.70.5.2892-2897.2004; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; TANTIRUNGKIJ M, 1993, J FERMENT BIOENG, V75, P83, DOI 10.1016/0922-338X(93)90214-S; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; Walther T, 2012, FEBS LETT, V586, P4114, DOI 10.1016/j.febslet.2012.09.042; Wamelink M, 2008, J INHERIT METAB DIS, V31, P703, DOI 10.1007/s10545-008-1015-6; Yue HR, 2012, CHEM SOC REV, V41, P4218, DOI 10.1039/c2cs15359a	38	13	14	8	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158111	10.1371/journal.pone.0158111	http://dx.doi.org/10.1371/journal.pone.0158111			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336308	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200113
J	Liu, J; Gratz, J; Amour, C; Nshama, R; Walongo, T; Maro, A; Mduma, E; Platts-Mills, J; Boisen, N; Nataro, J; Haverstick, DM; Kabir, F; Lertsethtakarn, P; Silapong, S; Jeamwattanalert, P; Bodhidatta, L; Mason, C; Begum, S; Haque, R; Praharaj, I; Kang, G; Houpt, ER				Liu, Jie; Gratz, Jean; Amour, Caroline; Nshama, Rosemary; Walongo, Thomas; Maro, Athanasia; Mduma, Esto; Platts-Mills, James; Boisen, Nadia; Nataro, James; Haverstick, Doris M.; Kabir, Furqan; Lertsethtakarn, Paphavee; Silapong, Sasikorn; Jeamwattanalert, Pimmada; Bodhidatta, Ladaporn; Mason, Carl; Begum, Sharmin; Haque, Rashidul; Praharaj, Ira; Kang, Gagandeep; Houpt, Eric R.			Optimization of Quantitative PCR Methods for Enteropathogen Detection	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; ASYMPTOMATIC CHILDREN; RECTAL SWABS; VIRAL LOAD; DIARRHEA; INFANTS; DISEASE; GASTROENTERITIS; MULTICENTER; INFECTIONS	Detection and quantification of enteropathogens in stool specimens is useful for diagnosing the cause of diarrhea but is technically challenging. Here we evaluate several important determinants of quantification: specimen collection, nucleic acid extraction, and extraction and amplification efficiency. First, we evaluate the molecular detection and quantification of pathogens in rectal swabs versus stool, using paired flocked rectal swabs and whole stool collected from 129 children hospitalized with diarrhea in Tanzania. Swabs generally yielded a higher quantification cycle (Cq) (average 29.7, standard deviation 3.5 vs. 25.3 +/- 2.9 from stool, P<0.001) but were still able to detect 80% of pathogens with a Cq < 30 in stool. Second, a simplified total nucleic acid (TNA) extraction procedure was compared to separate DNA and RNA extractions and showed 92% (318/344) sensitivity and 98% (951/968) specificity, with no difference in Cq value for the positive results (Delta Cq((DNA+ RNA-TNA)) = -0.01 +/- 1.17, P = 0.972, N = 318). Third, we devised a quantification scheme that adjusts pathogen quantity to the specimen's extraction and amplification efficiency, and show that this better estimates the quantity of spiked specimens than the raw target Cq. In sum, these methods for enteropathogen quantification, stool sample collection, and nucleic acid extraction will be useful for laboratories studying enteric disease.	[Liu, Jie; Gratz, Jean; Platts-Mills, James; Houpt, Eric R.] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA USA; [Amour, Caroline; Nshama, Rosemary; Walongo, Thomas; Mduma, Esto] Haydom Global Hlth Inst, Haydom, Tanzania; [Maro, Athanasia] Kilimanjaro Clin Res Inst, Moshi, Tanzania; [Boisen, Nadia; Nataro, James] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Haverstick, Doris M.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Kabir, Furqan] Aga Khan Univ, Dept Pediat & Child Hlth, Karachi, Pakistan; [Lertsethtakarn, Paphavee; Silapong, Sasikorn; Jeamwattanalert, Pimmada; Bodhidatta, Ladaporn; Mason, Carl] Armed Forces Res Inst Med Sci AFRIMS, Dept Enter Dis, Bangkok, Thailand; [Begum, Sharmin; Haque, Rashidul] Int Ctr Diarrhoeal Dis Res Bangladesh ICDDR B, Dhaka, Bangladesh; [Praharaj, Ira; Kang, Gagandeep] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India	University of Virginia; University of Virginia; University of Virginia; Aga Khan University; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); International Centre for Diarrhoeal Disease Research (ICDDR); Christian Medical College & Hospital (CMCH) Vellore	Liu, J (corresponding author), Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA USA.	jl5yj@virginia.edu	Furqan Kabir/AAY-7400-2020; PRAHARAJ, IRA/AAE-9328-2019; Mason, Carl J/F-3538-2010; Mason, Carl/ABH-3298-2021	PRAHARAJ, IRA/0000-0002-0541-1146; Mason, Carl J/0000-0002-3676-2811; Mason, Carl/0000-0002-3676-2811; Kang, Gagandeep/0000-0002-3656-564X	Bill and Melinda Gates Foundation [OPP1019093]; Henry M. Jackson Foundation [SA2885/PO832803]; CDC [200-2015-M-64083]; Foundation for the NIH; National Institutes of Health/Fogarty International Center; Henry Jackson Foundation; CDC Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI114888] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Henry M. Jackson Foundation; CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Foundation for the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Henry Jackson Foundation; CDC Foundation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/, OPP1019093 to ERH), Henry M. Jackson Foundation (http://www.hjf.org/, SA2885/PO832803 to JL), and CDC (http://www.cdc.gov/, 200-2015-M-64083 to JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was undertaken in collaboration with the MAL-ED Network. MAL-ED is carried out as a collaborative project supported by the Bill & Melinda Gates Foundation, the Foundation for the NIH, and the National Institutes of Health/Fogarty International Center. We thank the staff and participants of the MAL-ED Network Project for their important contributions. This work was supported by Bill & Melinda Gates Foundation, Henry Jackson Foundation, and CDC Foundation. We thank Copan Italia for providing the flocked swabs, Martin Schutten and Suzan D. Pas (Erasmus MC, Department of Virology, Rotterdam, The Netherlands) for providing PhHV. The following reagents were obtained through BEI Resources, NIAID, NIH, as part of the Human Microbiome Project: enterovirus 71, Listeria monocytogenes, Cryptosporidium hominis, Cryptosporidium meleagridis, Schistosoma mansoni.	Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653; Barletta F, 2011, CLIN INFECT DIS, V53, P1223, DOI 10.1093/cid/cir730; Goldfarb DM, 2014, J CLIN MICROBIOL, V52, P3922, DOI 10.1128/JCM.01894-14; Barreira DMPG, 2010, J CLIN VIROL, V47, P60, DOI 10.1016/j.jcv.2009.11.012; Kabayiza JC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-447; Kapusinszky B, 2012, J CLIN MICROBIOL, V50, P3427, DOI 10.1128/JCM.01589-12; Kodani M, 2012, J CLIN MICROBIOL, V50, P1057, DOI 10.1128/JCM.05987-11; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lindsay B, 2013, J CLIN MICROBIOL, V51, P1740, DOI 10.1128/JCM.02713-12; Liu J, 2014, LANCET INFECT DIS, V14, P716, DOI 10.1016/S1473-3099(14)70808-4; Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12; Medus C, 2006, J FOOD PROTECT, V69, P1870, DOI 10.4315/0362-028X-69.8.1870; Mijatovic-Rustempasic S, 2013, J CLIN MICROBIOL, V51, P3047, DOI 10.1128/JCM.01192-13; Mukhopadhya I, 2013, J MED VIROL, V85, P1661, DOI 10.1002/jmv.23641; Phillips G, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-63; Platts-Mills JA, 2014, AM J TROP MED HYG, V90, P133, DOI 10.4269/ajtmh.13-0439; Shulman LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039455; Taniuchi M, 2013, J INFECT DIS, V208, P1794, DOI 10.1093/infdis/jit507; Teunis PFM, 2015, EPIDEMIOL INFECT, V143, P1710, DOI 10.1017/S095026881400274X; Tran TND, 2013, J VIROL METHODS, V187, P138, DOI 10.1016/j.jviromet.2012.09.021	20	70	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158199	10.1371/journal.pone.0158199	http://dx.doi.org/10.1371/journal.pone.0158199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336160	Green Submitted, Green Published, gold			2022-12-26	WOS:000378389200123
J	Moyes, KM; Sorensen, P; Bionaz, M				Moyes, K. M.; Sorensen, P.; Bionaz, M.			The Impact of Intramammary Escherichia coli Challenge on Liver and Mammary Transcriptome and Cross-Talk in Dairy Cows during Early Lactation Using RNAseq	PLOS ONE			English	Article							ACUTE-PHASE RESPONSE; GENE-EXPRESSION; CLINICAL MASTITIS; INFLAMMATION; RECEPTOR; PROTEIN; OSTEOPONTIN; METABOLISM; ACID; CYTOKINE	Our objective was to identify the biological response and the cross-talk between liver and mammary tissue after intramammary infection (IMI) with Escherichia coli (E. coli) using RNAseq technology. Sixteen cows were inoculated with live E. coli into one mammary quarter at similar to 4-6 weeks in lactation. For all cows, biopsies were performed at -144, 12 and 24 h relative to IMI in liver and at 24 h post-IMI in infected and non-infected (control) mammary quarters. For a subset of cows (n = 6), RNA was extracted from both liver and mammary tissue and sequenced using a 100 bp paired-end approach. Ingenuity Pathway Analysis and the Dynamic Impact Approach analysis of differentially expressed genes (overall effect False Discovery Rate <= 0.05) indicated that IMI induced an overall activation of inflammation at 12 h post-IMI and a strong inhibition of metabolism, especially related to lipid, glucose, and xenobiotics at 24 h post-IMI in liver. The data indicated in mammary tissue an overall induction of inflammatory response with little effect on metabolism at 24 h post-IMI. We identified a large number of up-stream regulators potentially involved in the response to IMI in both tissues but a relatively small core network of transcription factors controlling the response to IMI for liver whereas a large network in mammary tissue. Transcriptomic results in liver and mammary tissue were supported by changes in inflammatory and metabolic mediators in blood and milk. The analysis of potential cross-talk between the two tissues during IMI uncovered a large communication from the mammary tissue to the liver to coordinate the inflammatory response but a relatively small communication from the liver to the mammary tissue. Our results indicate a strong induction of the inflammatory response in mammary tissue and impairment of liver metabolism 24h post-IMI partly driven by the signaling from infected mammary tissue.	[Moyes, K. M.] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Sorensen, P.] Aarhus Univ, Ctr Quantitat Genet & Genom, Dept Mol Biol & Genet, DK-8830 Tjele, Denmark; [Bionaz, M.] Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA	University System of Maryland; University of Maryland College Park; Aarhus University; Oregon State University	Moyes, KM (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.; Bionaz, M (corresponding author), Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA.	kmoyes@umd.edu; massimo.bionaz@oregonstate.edu	Bionaz, Massimo/I-4222-2018	Bionaz, Massimo/0000-0002-0674-1892	EU programme 'Sustainable Animal Breeding' (SABRE); BIOSENS project - Danish Ministry of Food, Agriculture and Fisheries (Innovations Law); Lattec I/S; Danish Cattle Association; Aarhus University (AU); Work Package (WP) 5; Mammary gland function	EU programme 'Sustainable Animal Breeding' (SABRE); BIOSENS project - Danish Ministry of Food, Agriculture and Fisheries (Innovations Law); Lattec I/S; Danish Cattle Association; Aarhus University (AU); Work Package (WP) 5; Mammary gland function	The study was partly funded by the EU programme 'Sustainable Animal Breeding' (SABRE), Work Package (WP) 5, Mammary gland function and by the BIOSENS project granted by the Danish Ministry of Food, Agriculture and Fisheries (Innovations Law), Lattec I/S, the Danish Cattle Association, and Aarhus University (AU).	Ahuja HS, 2003, J BIOL REG HOMEOS AG, V17, P29; Ametaj BN, 2005, CAN J ANIM SCI, V85, P165, DOI 10.4141/A04-043; Bar D, 2008, J DAIRY SCI, V91, P2205, DOI 10.3168/jds.2007-0573; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bionaz M, 2007, J DAIRY SCI, V90, P1740, DOI 10.3168/jds.2006-445; BIONAZ M, 2013, PPAR RES, DOI DOI 10.1155/2013/684159; Bionaz M, 2012, PLOS ONE, P7; Bjerre-Harpoth V, 2012, J DAIRY SCI, V95, P2362, DOI 10.3168/jds.2011-4419; Bradford BJ, 2009, J NUTR, V139, P1451, DOI 10.3945/jn.109.108233; Budipitojo T, 2004, ANAT EMBRYOL, V208, P1, DOI 10.1007/s00429-003-0360-3; Buitenhuis B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-130; Cerone SI, 2007, GEN PHYSIOL BIOPHYS, V26, P14; Cha E, 2014, J DAIRY SCI, V97, P2101, DOI 10.3168/jds.2013-7067; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; De Bosscher K, 2000, J NEUROIMMUNOL, V109, P16, DOI 10.1016/S0165-5728(00)00297-6; Drackley J. K., 2001, Journal of Dairy Science, V84, pE100, DOI 10.3168/jds.S0022-0302(01)70204-4; Drackley JK, 2005, ITAL J ANIM SCI, V4, P323, DOI 10.4081/ijas.2005.323; Fogsgaard KK, 2012, J DAIRY SCI, V95, P630, DOI 10.3168/jds.2011-4350; Garcia M, 2015, J DAIRY SCI, V98, P7102, DOI 10.3168/jds.2014-9034; Garg M, 2013, PLOS ONE, V8; Hagen RM, 2010, FEBS LETT, V584, P2689, DOI 10.1016/j.febslet.2010.04.004; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hynes NE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003186; Ingvartsen KL, 2013, ANIMAL, V7, P112, DOI 10.1017/S175173111200170X; Ingvartsen KL, 2000, J DAIRY SCI, V83, P1573, DOI 10.3168/jds.S0022-0302(00)75029-6; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Jiang L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-443; Jorgensen HBH, 2012, PHYSIOL GENOMICS, V44, P595, DOI 10.1152/physiolgenomics.00084.2011; Kahles F, 2014, MOL METAB, V3, P384, DOI 10.1016/j.molmet.2014.03.004; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khatun M, 2013, ANIMAL, V7, P1721, DOI 10.1017/S1751731113001353; Kristensen TN, 2005, GENETICS, V171, P157, DOI 10.1534/genetics.104.039610; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Le Floc'h N, 2004, LIVEST PROD SCI, V87, P37, DOI 10.1016/j.livprodsci.2003.09.005; LE JM, 1989, LAB INVEST, V61, P588; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; MCDONALD TJ, 1983, FEBS LETT, V156, P349, DOI 10.1016/0014-5793(83)80527-4; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; McGuinness OP, 2005, ANNU REV NUTR, V25, P9, DOI 10.1146/annurev.nutr.24.012003.132159; Minuti A, 2015, PHYSL REP, V3; Moore JT, 2006, CHEMMEDCHEM, V1, P504, DOI 10.1002/cmdc.200600006; Moyes KM, 2015, J ANIM SCI, V93, P5586, DOI 10.2527/jas.2015-8945; Moyes KM, 2009, J DAIRY SCI, V92, P4301, DOI 10.3168/jds.2009-2170; Moyes KM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-542; Moyes KM, 2014, J ANIMAL SCI BIOTECH, V5; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; Paape MJ, 2003, VET RES, V34, P597, DOI 10.1051/vetres:2003024; Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002; Piantoni P, 2010, BMC GENOMICS, P11; Rittling SR, 2015, J DENT RES, V94, P1638, DOI 10.1177/0022034515605270; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Samdani P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12340; Schingoethe DJ, 1988, RUMINANT ANIMAL DIGE, P421; Seth D, 2014, WORLD J GASTROENTERO, V20, P13088, DOI 10.3748/wjg.v20.i36.13088; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Vels L, 2009, J DAIRY SCI, V92, P922, DOI 10.3168/jds.2008-1209; Waldron MR, 2006, J DAIRY SCI, V89, P596, DOI 10.3168/jds.S0022-0302(06)72123-3; Zhong J, 2006, BBA-MOL BASIS DIS, V1762, P468, DOI 10.1016/j.bbadis.2005.12.012; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	61	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157480	10.1371/journal.pone.0157480	http://dx.doi.org/10.1371/journal.pone.0157480			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336699	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200019
J	Chua, HC; Christensen, ETH; Hoestgaard-Jensen, K; Hartiadi, LY; Ramzan, I; Jensen, AA; Absalom, NL; Chebib, M				Chua, Han Chow; Christensen, Emilie T. H.; Hoestgaard-Jensen, Kirsten; Hartiadi, Leonny Y.; Ramzan, Iqbal; Jensen, Anders A.; Absalom, Nathan L.; Chebib, Mary			Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABA(A) Receptors: Functional Characteristics and Molecular Mechanism	PLOS ONE			English	Article							PIPER-METHYSTICUM; ENRICHED EXTRACT; ETOMIDATE; KAVALACTONES; INHIBITION; PROPOFOL; SITES; DRUG; ALPHA-1-BETA-3-DELTA; NEUROSTEROIDS	Extracts of the pepper plant kava (Piper methysticum) are effective in alleviating anxiety in clinical trials. Despite the long-standing therapeutic interest in kava, the molecular target(s) of the pharmacologically active constituents, kavalactones have not been established. gamma-Aminobutyric acid type A receptors (GABA(A)Rs) are assumed to be the in vivo molecular target of kavalactones based on data from binding assays, but evidence in support of a direct interaction between kavalactones and GABA(A)Rs is scarce and equivocal. In this study, we characterised the functional properties of the major anxiolytic kavalactone, kavain at human recombinant alpha 1 beta 2, beta 2 gamma 2L, alpha x beta 2 gamma 2L (x = 1, 2, 3 and 5), alpha 1 beta x gamma 2L (x = 1, 2 and 3) and alpha 4 beta 2 delta GABA(A)Rs expressed in Xenopus oocytes using the two-electrode voltage clamp technique. We found that kavain positively modulated all receptors regardless of the subunit composition, but the degree of enhancement was greater at alpha 4 beta 2 delta than at alpha 1 beta 2 gamma 2L GABA(A)Rs. The modulatory effect of kavain was unaffected by flumazenil, indicating that kavain did not enhance GABA(A)Rs via the classical benzodiazepine binding site. The beta 3N265M point mutation which has been previously shown to profoundly decrease anaesthetic sensitivity, also diminished kavain-mediated potentiation. To our knowledge, this study is the first report of the functional characteristics of a single kavalactone at distinct GABA(A)R subtypes, and presents the first experimental evidence in support of a direct interaction between a kavalactone and GABA(A)Rs.	[Chua, Han Chow; Christensen, Emilie T. H.; Hartiadi, Leonny Y.; Ramzan, Iqbal; Absalom, Nathan L.; Chebib, Mary] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Christensen, Emilie T. H.; Hoestgaard-Jensen, Kirsten; Jensen, Anders A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark	University of Sydney; University of Copenhagen	Chebib, M (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	mary.collins@sydney.edu.au	Chua, Han Chow/AFR-7940-2022; Jensen, Anders/AAJ-3335-2020	Chua, Han Chow/0000-0003-4477-174X; Jensen, Anders/0000-0002-7927-5052; Hartiadi, Leonny/0000-0001-9975-3448	International Postgraduate Research Scholarship; John Lamberton Scholarship; Lundbeck Foundation [R9-2007-928] Funding Source: researchfish; Novo Nordisk Fonden [NNF11OC1014338] Funding Source: researchfish	International Postgraduate Research Scholarship(Australian Government); John Lamberton Scholarship; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	HCC acknowledges the International Postgraduate Research Scholarship and John Lamberton Scholarship for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Department of Pharmacology, The University of Sydney, for managing and maintaining the Xenopus laevis colony. HCC acknowledges the International Postgraduate Research Scholarship and John Lamberton Scholarship for financial support.	Anke J, 2004, J ETHNOPHARMACOL, V93, P153, DOI 10.1016/j.jep.2004.04.009; [Anonymous], 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003383; Bianchi MT, 2003, J NEUROSCI, V23, P10934; Boonen G, 1998, PLANTA MED, V64, P504, DOI 10.1055/s-2006-957502; Cairney S, 2002, AUST NZ J PSYCHIAT, V36, P657, DOI 10.1046/j.1440-1614.2002.01027.x; Chua HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141359; DAVIES LP, 1992, PHARMACOL TOXICOL, V71, P120, DOI 10.1111/j.1600-0773.1992.tb00530.x; Desai R, 2009, ANESTHESIOLOGY, V111, P774, DOI 10.1097/ALN.0b013e3181b55fae; Dinh LD, 2001, PLANTA MED, V67, P306, DOI 10.1055/s-2001-14334; Fackelmann KA, 1992, SCI NEWS, V14, P424; Fagerlund MJ, 2010, BRIT J ANAESTH, V104, P472, DOI 10.1093/bja/aeq023; Feng HJ, 2014, BRIT J PHARMACOL, V171, P789, DOI 10.1111/bph.12507; Feng HJ, 2004, MOL PHARMACOL, V66, P988, DOI 10.1124/mol.104.002543; Feng HJ, 2004, MOL PHARMACOL, V66, P1517, DOI 10.1124/mol.104.003426; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Garcia PS, 2010, CURR NEUROPHARMACOL, V8, P2, DOI 10.2174/157015910790909502; Garrett KM, 2003, PSYCHOPHARMACOLOGY, V170, P33, DOI 10.1007/s00213-003-1520-0; Hartiadi LY, 2016, BIOCHEM PHARMACOL, V103, P98, DOI 10.1016/j.bcp.2015.12.021; HOLM E, 1991, ARZNEIMITTEL-FORSCH, V41-2, P673; JANSSEN CGM, 1987, J LABELLED COMPD RAD, V24, P909, DOI 10.1002/jlcr.2580240805; JANSSEN PAJ, 1971, ARZNEI-FORSCHUNG, V21, P1234; JUSSOFIE A, 1994, PSYCHOPHARMACOLOGY, V116, P469, DOI 10.1007/BF02247480; KELEDJIAN J, 1988, J PHARM SCI, V77, P1003, DOI 10.1002/jps.2600771203; Khom S, 2007, NEUROPHARMACOLOGY, V53, P178, DOI 10.1016/j.neuropharm.2007.04.018; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; Kuchta K, 2015, PLANTA MED, V81, P1647, DOI 10.1055/s-0035-1558295; Ligresti A, 2012, PHARMACOL RES, V66, P163, DOI 10.1016/j.phrs.2012.04.003; Lilienfeld SO, 2013, SCI AM MIND, P72; Mathews JM, 2005, DRUG METAB DISPOS, V33, P1555, DOI 10.1124/dmd.105.004317; McDonald D, 2000, DRUG ALCOHOL REV, V19, P217, DOI 10.1080/713659319; Ramzan I, 2004, MED AROM PLANTS, V37, P76; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; SALETU B, 1989, Human Psychopharmacology, V4, P169, DOI 10.1002/hup.470040304; Sarris J, 2013, PHYTOTHER RES, V27, P1723, DOI 10.1002/ptr.4916; Sarris J, 2009, PSYCHOPHARMACOLOGY, V205, P399, DOI 10.1007/s00213-009-1549-9; Sarris J, 2013, J CLIN PSYCHOPHARM, V33, P643, DOI 10.1097/JCP.0b013e318291be67; Sarris J, 2011, AUST NZ J PSYCHIAT, V45, P27, DOI 10.3109/00048674.2010.522554; Savage KM, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0986-5; Sebel LE, 2006, ANESTHESIOLOGY, V104, P1176, DOI 10.1097/00000542-200606000-00012; Showman AF, 2015, FITOTERAPIA, V100, P56, DOI 10.1016/j.fitote.2014.11.012; SINGH YN, 1992, J ETHNOPHARMACOL, V37, P13, DOI 10.1016/0378-8741(92)90003-A; Spigelman I, 2003, J NEUROPHYSIOL, V90, P903, DOI 10.1152/jn.01022.2002; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; Teschke R, 2011, FOOD CHEM TOXICOL, V49, P2503, DOI 10.1016/j.fct.2011.06.075; Teschke R, 2011, BRIT J CLIN PHARMACO, V71, P445, DOI 10.1111/j.1365-2125.2010.03775.x; Tsutsui R, 2009, J PHARMACOL SCI, V111, P293, DOI 10.1254/jphs.09167FP; Uebelhack R, 1998, PHARMACOPSYCHIATRY, V31, P187, DOI 10.1055/s-2007-979325; Walters RJ, 2000, NAT NEUROSCI, V3, P1274, DOI 10.1038/81800; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; *WHO, 2007, ASS RISK HEP KAV PRO; Yuan CS, 2002, PLANTA MED, V68, P1092, DOI 10.1055/s-2002-36338	53	48	49	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157700	10.1371/journal.pone.0157700	http://dx.doi.org/10.1371/journal.pone.0157700			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332705	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212800044
J	Hachiya, Y; Kawasaki, A; Oka, S; Kondo, Y; Ito, S; Matsumoto, I; Kusaoi, M; Amano, H; Suda, A; Setoguchi, K; Nagai, T; Shimada, K; Sugii, S; Okamoto, A; Chiba, N; Suematsu, E; Ohno, S; Katayama, M; Kono, H; Hirohata, S; Takasaki, Y; Hashimoto, H; Sumida, T; Nagaoka, S; Tohma, S; Furukawa, H; Tsuchiya, N				Hachiya, Yuki; Kawasaki, Aya; Oka, Shomi; Kondo, Yuya; Ito, Satoshi; Matsumoto, Isao; Kusaoi, Makio; Amano, Hirofumi; Suda, Akiko; Setoguchi, Keigo; Nagai, Tatsuo; Shimada, Kota; Sugii, Shoji; Okamoto, Akira; Chiba, Noriyuki; Suematsu, Eiichi; Ohno, Shigeru; Katayama, Masao; Kono, Hajime; Hirohata, Shunsei; Takasaki, Yoshinari; Hashimoto, Hiroshi; Sumida, Takayuki; Nagaoka, Shouhei; Tohma, Shigeto; Furukawa, Hiroshi; Tsuchiya, Naoyuki			Association of HLA-G 3 ' Untranslated Region Polymorphisms with Systemic Lupus Erythematosus in a Japanese Population: A Case-Control Association Study	PLOS ONE			English	Article							G GENE; LINKAGE DISEQUILIBRIUM; AUTOIMMUNE-DISEASES; CLASS-II; SUSCEPTIBILITY; RISK; VISUALIZATION; METAANALYSIS; EXPRESSION; HAPLOTYPES	HLA-G plays a role in fetal-maternal tolerance as well as immunoregulation, and has been suggested to be involved in autoimmune diseases and cancers. HLA-G encodes two potentially functional polymorphisms in the 3' untranslated region, 14bp insertion/deletion (14bp indel, rs371194629) and a single nucleotide polymorphism rs1063320, previously reported to affect HLA-G expression level or splicing isoform and to be associated with susceptibility to systemic lupus erythematosus (SLE). However, the results of SLE association studies are inconsistent, probably due to the small sample size of each study and lack of consideration of linkage disequilibrium (LD) with HLA-class II haplotypes in each population. In this study, we performed association studies of these polymorphisms on 843 patients with SLE and 778 healthy controls in a Japanese population, in many of whom HLA-DRB1 alleles have been genotyped at the four-digit level. LD was detected between DRB1*13:02, protective against multiple autoimmune diseases in the Japanese, and the rs1063320 G (D' = 0.86, r(2) = 0.02) and with 14bp del (D' = 0.62, r(2) = 0.01), but not between SLE-susceptible DRB1*15: 01 and HLA-G. Although significant association with overall SLE was not detected, 14bp ins allele was significantly associated with SLE with the age of onset <20 years, when compared with healthy controls (P = 0.0067, P-FDR = 0.039, OR 1.44, additive model) or with SLE patients with the age of onset >= 20 (P = 0.033, P-FDR = 0.0495, OR 2.09, additive model). This association remained significant after conditioning on DRB1*13: 02 or DRB1*15:01. On the other hand, significant association was detected between rs1063320 C and anti-RNP antibody and anti-Sm antibody positive SLE, which was dependent on negative LD with DRB1*13:02. eQTL analysis showed reduced HLA-G mRNA level in 14bp ins/ins individuals. In conclusion, our observations showed that HLA-G 14bp ins allele represents a genetic contribution on early-onset SLE independent of DRB1.	[Hachiya, Yuki; Kawasaki, Aya; Oka, Shomi; Furukawa, Hiroshi; Tsuchiya, Naoyuki] Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, Tsukuba, Ibaraki, Japan; [Hachiya, Yuki; Kawasaki, Aya; Kondo, Yuya; Matsumoto, Isao; Sumida, Takayuki; Furukawa, Hiroshi; Tsuchiya, Naoyuki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Masters Program Med Sci, Tsukuba, Ibaraki, Japan; [Oka, Shomi; Tohma, Shigeto; Furukawa, Hiroshi] Sagamihara Hosp, Natl Hosp Org, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan; [Kondo, Yuya; Ito, Satoshi; Matsumoto, Isao; Sumida, Takayuki] Univ Tsukuba, Fac Med, Dept Internal Med Rheumatol, Tsukuba, Ibaraki, Japan; [Ito, Satoshi] Niigata Rheumat Ctr, Dept Rheumatol, Shibata, Niigata, Japan; [Kusaoi, Makio; Amano, Hirofumi; Takasaki, Yoshinari] Juntendo Univ, Sch Med, Dept Internal Med & Rheumatol, Tokyo 113, Japan; [Suda, Akiko; Nagaoka, Shouhei] Yokohama Minami Kyosai Hosp, Dept Rheumatol, Yokohama, Kanagawa, Japan; [Suda, Akiko; Ohno, Shigeru] Yokohama City Univ, Med Ctr, Ctr Rheumat Dis, Yokohama, Kanagawa 232, Japan; [Setoguchi, Keigo] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Allergy & Immunol Dis, Tokyo, Japan; [Nagai, Tatsuo; Hirohata, Shunsei] Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Sagamihara, Kanagawa 228, Japan; [Shimada, Kota; Sugii, Shoji] Tokyo Metropolitan Tama Med Ctr, Dept Rheumatol, Fuchu, Tokyo, Japan; [Okamoto, Akira] Natl Hosp Org, Himeji Med Ctr, Dept Rheumatol, Himeji, Hyogo, Japan; [Chiba, Noriyuki] Morioka Hosp, Natl Hosp Org, Dept Rheumatol, Morioka, Iwate, Japan; [Suematsu, Eiichi] Natl Hosp Org, Kyushu Med Ctr, Dept Internal Med & Rheumatol, Clin Res Inst, Fukuoka, Fukuoka, Japan; [Katayama, Masao] Natl Hosp Org, Nagoya Med Ctr, Dept Internal Med, Nagoya, Aichi, Japan; [Kono, Hajime] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan; [Hashimoto, Hiroshi] Juntendo Univ, Sch Med, Tokyo 113, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; Juntendo University; Yokohama City University; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Kitasato University; Nagoya Medical Center; Teikyo University; Juntendo University	Kawasaki, A; Tsuchiya, N (corresponding author), Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, Tsukuba, Ibaraki, Japan.; Kawasaki, A; Tsuchiya, N (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Masters Program Med Sci, Tsukuba, Ibaraki, Japan.	a-kawasaki@umin.net; tsuchiya-tky@umin.net	Tsuchiya, Naoyuki/CAA-4545-2022; Ito, Satoshi/AAL-9615-2020; Hashimoto, Hiroshi/AAD-3667-2020	Tsuchiya, Naoyuki/0000-0002-6776-5580; Kono, Hajime/0000-0002-4578-8677	Japan Society for the Promotion of Science (JSPS) [25461467]; SENSHIN Medical Research Foundation; Grants-in-Aid for Scientific Research [16K09907, 26461474] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) (https://www.jsps.go.jp/english/index.html) KAKENHI (Grants-in-Aid for Scientific Research) Grant Number 25461467 and a research grant from SENSHIN Medical Research Foundation <https://www.smrf.or.jp/>, both awarded to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Carosella ED, 2015, ADV IMMUNOL, V127, P33, DOI 10.1016/bs.ai.2015.04.001; Castelli EC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00476; Catamo E, 2015, TISSUE ANTIGENS, V85, P458, DOI 10.1111/tan.12545; Chen XY, 2008, TISSUE ANTIGENS, V72, P335, DOI 10.1111/j.1399-0039.2008.01107.x; Consiglio CR, 2011, TISSUE ANTIGENS, V77, P540, DOI 10.1111/j.1399-0039.2011.01635.x; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Du Y, 2015, ANN RHEUM DIS, V74, P2070, DOI 10.1136/annrheumdis-2013-204441; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Fernando MMA, 2012, ANN RHEUM DIS, V71, P777, DOI 10.1136/annrheumdis-2011-200808; Furukawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087792; Graham RR, 2002, AM J HUM GENET, V71, P543, DOI 10.1086/342290; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hirayasu K, 2015, J HUM GENET, V60, P703, DOI 10.1038/jhg.2015.64; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z; Hviid TVF, 2005, HUM IMMUNOL, V66, P688, DOI 10.1016/j.humimm.2005.03.003; Kawashima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046806; Kolte AM, 2010, HUM IMMUNOL, V71, P482, DOI 10.1016/j.humimm.2010.02.001; Lau CS, 2006, LUPUS, V15, P715, DOI 10.1177/0961203306072311; Lee YH, 2015, RHEUMATOL INT, V35, P953, DOI 10.1007/s00296-014-3155-3; Lucena-Silva N, 2013, J RHEUMATOL, V40, P1104, DOI 10.3899/jrheum.120814; Martelli-Palomino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071742; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Pirri A, 2009, TRANSPL IMMUNOL, V20, P143, DOI 10.1016/j.trim.2008.09.012; Ramos PS, 2015, J HUM GENET, V60, P657, DOI 10.1038/jhg.2015.94; Rizzo R, 2008, TISSUE ANTIGENS, V71, P520, DOI 10.1111/j.1399-0039.2008.01037.x; Rizzo R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00592; Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187; Webb R, 2011, ANN RHEUM DIS, V70, P151, DOI 10.1136/ard.2010.141697; Wu FX, 2009, LUPUS, V18, P1259, DOI 10.1177/0961203309345756; Yamashita T, 1996, IMMUNOGENETICS, V44, P186, DOI 10.1007/BF02602584; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Zhang XL, 2014, HUM IMMUNOL, V75, P1171, DOI 10.1016/j.humimm.2014.10.008	38	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0158065	10.1371/journal.pone.0158065	http://dx.doi.org/10.1371/journal.pone.0158065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27331404	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212800074
J	Hagenaars, TJ; Fischer, EAJ; Jansen, CA; Rebel, JMJ; Spekreijse, D; Vervelde, L; Backer, JA; de Jong, MCM; Koets, AP				Hagenaars, T. J.; Fischer, E. A. J.; Jansen, C. A.; Rebel, J. M. J.; Spekreijse, D.; Vervelde, L.; Backer, J. A.; de Jong, M. C. M.; Koets, A. P.			Modelling the Innate Immune Response against Avian Influenza Virus in Chicken	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; MATHEMATICAL-MODEL; NK CELLS; INFECTION; DYNAMICS; EPIDEMIC; DUCKS	At present there is limited understanding of the host immune response to (low pathogenic) avian influenza virus infections in poultry. Here we develop a mathematical model for the innate immune response to avian influenza virus in chicken lung, describing the dynamics of viral load, interferon-alpha,-beta and-gamma, lung (i.e. pulmonary) cells and Natural Killer cells. We use recent results from experimentally infected chickens to validate some of the model predictions. The model includes an initial exponential increase of the viral load, which we show to be consistent with experimental data. Using this exponential growth model we show that the duration until a given viral load is reached in experiments with different inoculation doses is consistent with a model assuming a linear relationship between initial viral load and inoculation dose. Subsequent to the exponential-growth phase, the model results show a decline in viral load caused by both target-cell limitation as well as the innate immune response. The model results suggest that the temporal viral load pattern in the lungs displayed in experimental data cannot be explained by target-cell limitation alone. For biologically plausible parameter values the model is able to qualitatively match to data on viral load in chicken lungs up until approximately 4 days post infection. Comparison of model predictions with data on CD107-mediated degranulation of Natural Killer cells yields some discrepancy also for earlier days post infection.	[Hagenaars, T. J.; Fischer, E. A. J.; Rebel, J. M. J.; Backer, J. A.; Koets, A. P.] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands; [Jansen, C. A.; Vervelde, L.; Koets, A. P.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Fischer, E. A. J.; Spekreijse, D.; Koets, A. P.] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [de Jong, M. C. M.] Wageningen Univ, Quantitat Vet Epidemiol, NL-6700 AP Wageningen, Netherlands; [Rebel, J. M. J.] Wageningen UR Livestock Res, Wageningen, Netherlands; [Spekreijse, D.] Boehringer Ingelheim Anim Hlth Operat Bv, Weesp, Netherlands; [Vervelde, L.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Vervelde, L.] Univ Edinburgh, R D SVS, Edinburgh, Midlothian, Scotland; [Backer, J. A.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands	Wageningen University & Research; Utrecht University; Utrecht University; Wageningen University & Research; Wageningen University & Research; Boehringer Ingelheim; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Netherlands National Institute for Public Health & the Environment	Hagenaars, TJ (corresponding author), Wageningen UR, Cent Vet Inst, Lelystad, Netherlands.	thomas.hagenaars@wur.nl	Fischer, Egil Andreas Joor/F-6125-2010; Fischer, Egil A.J./A-1913-2010; Vervelde, Lonneke/C-7707-2013; de Jong, Mart C.M./GQQ-0825-2022	Fischer, Egil Andreas Joor/0000-0002-0599-701X; Fischer, Egil A.J./0000-0002-0599-701X; de Jong, Mart C.M./0000-0002-5339-1995; Rebel, Annemarie/0000-0003-4765-4215; Vervelde, Lonneke/0000-0003-2241-1743	Foundation for Economic Structure Strengthening (FES) in the Netherlands: FES Program on Avian Influenza; Netherlands Organization for Scientific Research (NWO) Veni grant [016.096.049]; EU sixth framework program Flupath [04220]; BBSRC [BBS/E/D/20241864] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864] Funding Source: researchfish	Foundation for Economic Structure Strengthening (FES) in the Netherlands: FES Program on Avian Influenza; Netherlands Organization for Scientific Research (NWO) Veni grant(Netherlands Organization for Scientific Research (NWO)); EU sixth framework program Flupath; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Foundation for Economic Structure Strengthening (FES) in the Netherlands: FES Program on Avian Influenza. The studies yielding the data on viral RNA during the first day after infection and the data on NKcell activation were also supported by the Netherlands Organization for Scientific Research (NWO) Veni grant 016.096.049 and the EU sixth framework program Flupath (grant 04220).	Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; BOCHAROV GA, 1994, J THEOR BIOL, V167, P323, DOI 10.1006/jtbi.1994.1074; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Burggraaf S, 2014, VIRUS RES, V185, P23, DOI 10.1016/j.virusres.2014.03.012; Capua I, 2002, ACTA TROP, V83, P7, DOI 10.1016/S0001-706X(02)00057-8; Chang DB, 2007, J THEOR BIOL, V246, P621, DOI 10.1016/j.jtbi.2007.02.004; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hancioglu B, 2007, J THEOR BIOL, V246, P70, DOI 10.1016/j.jtbi.2006.12.015; Howey R, 2012, EPIDEMICS-NETH, V4, P93, DOI 10.1016/j.epidem.2012.04.001; Howey R, 2009, J R SOC INTERFACE, V6, P835, DOI 10.1098/rsif.2008.0434; HYLKA VW, 1983, GEN COMP ENDOCR, V52, P108, DOI 10.1016/0016-6480(83)90163-6; Jansen CA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02478; Jansen CA, 2010, DEV COMP IMMUNOL, V34, P759, DOI 10.1016/j.dci.2010.02.009; Kagi D, 1995, EUR J IMMUNOL, V25, P3256, DOI 10.1002/eji.1830251209; Kaiser P, 2003, J VIROL, V77, P762, DOI 10.1128/JVI.77.1.762-768.2003; Mathur MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106171; Nowak MA, 1996, SCIENCE, V272, P74, DOI 10.1126/science.272.5258.74; Rebel JMJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-10; Schokker D, 2013, J THEOR BIOL, V330, P75, DOI 10.1016/j.jtbi.2013.04.005; Spekreijse D, 2011, VET MICROBIOL, V147, P59, DOI 10.1016/j.vetmic.2010.06.012; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583; van der Goot JA, 2008, VIROLOGY, V382, P91, DOI 10.1016/j.virol.2008.08.037; Warren HS, 1999, IMMUNOL CELL BIOL, V77, P64, DOI 10.1046/j.1440-1711.1999.00790.x	24	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157816	10.1371/journal.pone.0157816	http://dx.doi.org/10.1371/journal.pone.0157816			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27328069	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212400047
J	Bailly, S; Destors, M; Grillet, Y; Richard, P; Stach, B; Vivodtzev, I; Timsit, JF; Levy, P; Tamisier, R; Pepin, JL				Bailly, Sebastien; Destors, Marie; Grillet, Yves; Richard, Philippe; Stach, Bruno; Vivodtzev, Isabelle; Timsit, Jean-Francois; Levy, Patrick; Tamisier, Renaud; Pepin, Jean-Louis		Sci Council & Investigators French	Obstructive Sleep Apnea: A Cluster Analysis at Time of Diagnosis	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; WEIGHT-LOSS; CPAP; HYPERTENSION; NOCTURIA; BRAIN; HEART	Background The classification of obstructive sleep apnea is on the basis of sleep study criteria that may not adequately capture disease heterogeneity. Improved phenotyping may improve prognosis prediction and help select therapeutic strategies. Objectives: This study used cluster analysis to investigate the clinical clusters of obstructive sleep apnea. Methods An ascending hierarchical cluster analysis was performed on baseline symptoms, physical examination, risk factor exposure and co-morbidities from 18,263 participants in the OSFP (French national registry of sleep apnea). The probability for criteria to be associated with a given cluster was assessed using odds ratios, determined by univariate logistic regression. Results: Six clusters were identified, in which patients varied considerably in age, sex, symptoms, obesity, co-morbidities and environmental risk factors. The main significant differences between clusters were minimally symptomatic versus sleepy obstructive sleep apnea patients, lean versus obese, and among obese patients different combinations of co-morbidities and environmental risk factors. Conclusions Our cluster analysis identified six distinct clusters of obstructive sleep apnea. Our findings underscore the high degree of heterogeneity that exists within obstructive sleep apnea patients regarding clinical presentation, risk factors and consequences. This may help in both research and clinical practice for validating new prevention programs, in diagnosis and in decisions regarding therapeutic strategies.	[Bailly, Sebastien; Destors, Marie; Vivodtzev, Isabelle; Levy, Patrick; Tamisier, Renaud; Pepin, Jean-Louis] Univ Grenoble Alpes, INSERM, HP2, U1042, Grenoble, France; [Bailly, Sebastien; Timsit, Jean-Francois] Univ Paris Diderot, INSERM, IAME, UMR 1137, F-75018 Paris, France; [Destors, Marie; Levy, Patrick; Tamisier, Renaud; Pepin, Jean-Louis] Grenoble Alpes Univ Hosp, Lab EFCR, Pole THORAX & VAISSEAUX, Grenoble, France; [Grillet, Yves] Private Clin, Valence, France; [Richard, Philippe] Private Clin, St Omer, France; [Stach, Bruno] St Michel Private Clin, Valenciennes, France; [Timsit, Jean-Francois] Paris Diderot Univ, Bichat Hosp, Med & Infect Dis ICU, Paris, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Pepin, JL (corresponding author), Univ Grenoble Alpes, INSERM, HP2, U1042, Grenoble, France.; Pepin, JL (corresponding author), Grenoble Alpes Univ Hosp, Lab EFCR, Pole THORAX & VAISSEAUX, Grenoble, France.	jpepin@chu-grenoble.fr	LEVY, Patrick/AAX-2802-2020; Tamisier, Renaud/M-6858-2014; BAILLY, Sébastien SB/H-4648-2013; Destors, Marie/AAC-8151-2019	LEVY, Patrick/0000-0003-3174-7935; Tamisier, Renaud/0000-0003-1128-6529; BAILLY, Sébastien SB/0000-0002-2179-4650; Destors, Marie/0000-0001-5114-4395; Pepin, Jean Louis/0000-0003-3832-2358; Vivodtzev, Isabelle/0000-0002-5201-8603	Fond de dotation "Agir pour les maladies chroniques"	Fond de dotation "Agir pour les maladies chroniques"	This study received unrestricted GRANT from Fond de dotation "Agir pour les maladies chroniques". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzt M, 2006, ARCH INTERN MED, V166, P1716, DOI 10.1001/archinte.166.16.1716; Baguet JP, 2012, NAT REV CARDIOL, V9, P679, DOI 10.1038/nrcardio.2012.141; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Chirinos JA, 2014, NEW ENGL J MED, V370, P2265, DOI 10.1056/NEJMoa1306187; Destors M, 2015, SLEEP MED, V16, P652, DOI 10.1016/j.sleep.2014.10.019; Dixon JB, 2012, JAMA-J AM MED ASSOC, V308, P1142, DOI 10.1001/2012.jama.11580; Garrigue S, 2007, CIRCULATION, V115, P1703, DOI 10.1161/CIRCULATIONAHA.106.659706; Gasa M, 2013, J SLEEP RES, V22, P389, DOI 10.1111/jsr.12039; Jackson CL, 2015, ANNU REV PUBL HEALTH, V36, P417, DOI 10.1146/annurev-publhealth-031914-122838; Kendzerska T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001599; Lavie L, 2015, SLEEP MED REV, V20, P27, DOI 10.1016/j.smrv.2014.07.003; Lavie P, 2009, J SLEEP RES, V18, P397, DOI 10.1111/j.1365-2869.2009.00754.x; Mokhlesi B, 2016, EUR RESPIR J, V47, P1162, DOI 10.1183/13993003.01618-2015; Pathak RK, 2014, J AM COLL CARDIOL, V64, P2222, DOI 10.1016/j.jacc.2014.09.028; Pepin JL, 2012, THORAX, V67, P1025, DOI 10.1136/thoraxjnl-2012-202807; Pepin JL, 2010, AM J RESP CRIT CARE, V182, P954, DOI 10.1164/rccm.200912-1803OC; Randerath WJ, 2011, EUR RESPIR J, V37, P1000, DOI 10.1183/09031936.00099710; Rennard SI, 2015, ANN AM THORAC SOC, V12, P303, DOI 10.1513/AnnalsATS.201403-125OC; Sanchez-de-la-Torre M, 2015, J AM COLL CARDIOL, V66, P1023, DOI 10.1016/j.jacc.2015.06.1315; Sourial N, 2010, J CLIN EPIDEMIOL, V63, P638, DOI 10.1016/j.jclinepi.2009.08.008; Steiner S, 2010, CHEST, V137, P516, DOI 10.1378/chest.09-1136; Tonon C, 2007, SLEEP, V30, P305, DOI 10.1093/sleep/30.3.305; TSUCHIYA M, 1992, AM J ORTHOD DENTOFAC, V101, P533, DOI 10.1016/0889-5406(92)70128-W; Tufik S, 2010, SLEEP MED, V11, P441, DOI 10.1016/j.sleep.2009.10.005; Umlauf MG, 2003, SLEEP MED REV, V7, P403, DOI 10.1053/smrv.2002.0273; Wheelock CE, 2013, EUR RESPIR J, V42, P802, DOI 10.1183/09031936.00078812; Wozniak DR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007736.pub2; Ye LC, 2014, EUR RESPIR J, V44, P1600, DOI 10.1183/09031936.00032314	28	109	111	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157318	10.1371/journal.pone.0157318	http://dx.doi.org/10.1371/journal.pone.0157318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314230	gold, Green Submitted, Green Published			2022-12-26	WOS:000378030000018
J	Chinniah, R; Vijayan, M; Thirunavukkarasu, M; Mani, D; Raju, K; Ravi, PM; Sivanadham, R; Kandeepan, C; Mahalakshmi, N; Karuppiah, B				Chinniah, Rathika; Vijayan, Murali; Thirunavukkarasu, Manikandan; Mani, Dhivakar; Raju, Kamaraj; Ravi, Padma Malini; Sivanadham, Ramgopal; Kandeepan, C.; Mahalakshmi, N.; Karuppiah, Balakrishnan			Polymorphic Alu Insertion/Deletion in Different Caste and Tribal Populations from South India	PLOS ONE			English	Article							TAMIL-NADU; AFFINITIES; ELEMENTS; DIVERSITY	Seven human-specific Alu markers were studied in 574 unrelated individuals from 10 endogamous groups and 2 hill tribes of Tamil Nadu and Kerala states. DNA was isolated, amplified by PCR-SSP, and subjected to agarose gel electrophoresis, and genotypes were assigned for various Alu loci. Average heterozygosity among caste populations was in the range of 0.292-0.468. Among tribes, the average heterozygosity was higher for Paliyan (0.3759) than for Kani (0.2915). Frequency differences were prominent in all loci studied except Alu CD4. For Alu CD4, the frequency was 0.0363 in Yadavas, a traditional pastoral and herd maintaining population, and 0.2439 in Narikuravars, a nomadic gypsy population. The overall genetic difference (Gst) of 12 populations (castes and tribes) studied was 3.6%, which corresponds to the Gst values of 3.6% recorded earlier for Western Asian populations. Thus, our study confirms the genetic similarities between West Asian populations and South Indian castes and tribes and supported the large scale coastal migrations from Africa into India through West Asia. However, the average genetic difference (Gst) of Kani and Paliyan tribes with other South Indian tribes studied earlier was 8.3%. The average Gst of combined South and North Indian Tribes (CSNIT) was 9.5%. Neighbor joining tree constructed showed close proximity of Kani and Paliyan tribal groups to the other two South Indian tribes, Toda and Irula of Nilgiri hills studied earlier. Further, the analysis revealed the affinities among populations and confirmed the presence of North and South India specific lineages. Our findings have documented the highly diverse (micro differentiated) nature of South Indian tribes, predominantly due to isolation, than the endogamous population groups of South India. Thus, our study firmly established the genetic relationship of South Indian castes and tribes and supported the proposed large scale ancestral migrations from Africa, particularly into South India through West Asian corridor.	[Chinniah, Rathika; Mani, Dhivakar; Raju, Kamaraj; Ravi, Padma Malini; Sivanadham, Ramgopal; Karuppiah, Balakrishnan] Madurai Kamaraj Univ, Sch Biol Sci, Dept Immunol, Madurai 625021, Tamil Nadu, India; [Vijayan, Murali; Thirunavukkarasu, Manikandan] Bharathidasan Univ, Sch Biotechnol, Dept Biotechnol & Genet Engn, Tiruchirappalli 620024, Tamil Nadu, India; [Kandeepan, C.] APA Coll Arts & Culture, Dept Zool, Palani 624601, Tamil Nadu, India; [Mahalakshmi, N.] Reg Forens Sci Lab, Madurai 625020, Tamil Nadu, India	Madurai Kamaraj University; Bharathidasan University	Karuppiah, B (corresponding author), Madurai Kamaraj Univ, Sch Biol Sci, Dept Immunol, Madurai 625021, Tamil Nadu, India.	immunobala@mkuniversity.org	Sivanadham, Ramgopal/AAE-2160-2019; RAVI, PADMA MALINI/AAZ-9584-2021; Raju, Kamaraj/ABA-3018-2020; KANDEEPAN, CHITHAN/U-2428-2019; Raju, Kamaraj/AAZ-6655-2020	Sivanadham, Ramgopal/0000-0002-3977-8632; Raju, Kamaraj/0000-0002-5724-0780; RAVI, PADMA MALINI/0000-0001-5485-3058; Karuppiah, Balakrishnan/0000-0002-7494-5010				Balakrishnan K, 2012, INT J HUM GENET, V12, P45, DOI 10.1080/09723757.2012.11886162; Balakrishnan K, 1996, HUM BIOL, V68, P523; Balakrishnan V., 1981, BIOL PEOPLE TAMIL NA; Balakrishnan V, 1981, BIOL PEOPLE TAMIL NA, P103; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; BATZER MA, 1990, NUCLEIC ACIDS RES, V18, P6793, DOI 10.1093/nar/18.23.6793; BATZER MA, 1995, J MOL BIOL, V247, P418, DOI 10.1006/jmbi.1994.0150; BATZER MA, 1991, GENOMICS, V9, P481, DOI 10.1016/0888-7543(91)90414-A; BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; Bhasin MK., 2001, GENETICS CASTES TRIB; Cann RL, 2001, SCIENCE, V291, P1742, DOI 10.1126/science.1058948; CAVALLISTORZA LL, 1994, HIST GEOGRAPHY HUMAN; Das K, 1996, HUM BIOL, V68, P679; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; HOUCK CM, 1979, J MOL BIOL, V132, P289, DOI 10.1016/0022-2836(79)90261-4; Kanthimathi S, 2008, J GENET, V87, P2; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Majumder PP, 1999, EUR J HUM GENET, V7, P435, DOI 10.1038/sj.ejhg.5200317; Malhotra KC, 1981, BIOL PEOPLE TAMIL NA, P50; Mukherjee N, 2000, J GENET, V79, P41, DOI 10.1007/BF02728944; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Novick GE, 1996, BIOSCIENCE, V46, P32, DOI 10.2307/1312653; Ray DA, 2005, MOL PHYLOGENET EVOL, V35, P117, DOI 10.1016/j.ympev.2004.10.023; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; ROGERS J, 1983, NATURE, V301, P460, DOI 10.1038/301460e0; Rowold DJ, 2000, GENETICA, V108, P57, DOI 10.1023/A:1004099605261; Salem AH, 2003, MOL BIOL EVOL, V20, P1349, DOI 10.1093/molbev/msg150; Shanmugalakshmi S, 2003, TISSUE ANTIGENS, V61, P451, DOI 10.1034/j.1399-0039.2003.00061.x; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; ULLU E, 1982, CELL, V29, P195, DOI 10.1016/0092-8674(82)90103-9; Veerraju P., 2001, International Journal of Human Genetics, V1, P129; Vishwanathan H, 2004, ANN HUM GENET, V68, P128, DOI 10.1046/j.1529-8817.2003.00083.x; Vishwnathan H, 2003, HUM BIOL, V75, P873, DOI 10.1353/hub.2004.0013; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; Watkins WS, 2001, AM J HUM GENET, V68, P738, DOI 10.1086/318793; Welsh K, 1999, Rev Immunogenet, V1, P157; Xing J, 2005, MOL PHYLOGENET EVOL, V37, P872, DOI 10.1016/j.ympev.2005.04.015	37	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157468	10.1371/journal.pone.0157468	http://dx.doi.org/10.1371/journal.pone.0157468			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315142	gold, Green Published, Green Submitted			2022-12-26	WOS:000378030000027
J	Pinaya, WHD; Lobon-Cervia, FJ; Pita, P; de Souza, RB; Freire, J; Isaac, VJ				Diaz Pinaya, Walter Hugo; Lobon-Cervia, Francisco Javier; Pita, Pablo; de Souza, Ronald Buss; Freire, Juan; Isaac, Victoria Judith			Multispecies Fisheries in the Lower Amazon River and Its Relationship with the Regional and Global Climate Variability	PLOS ONE			English	Article							FISH; FLOODPLAIN; REGRESSION; MODEL; WATER; REPRODUCTION; UNIVARIATE; DYNAMICS; HISTORY; CATCHES	This paper aims to describe the spatial-temporal variability in catch of the main fishery resources of the Amazon River and floodplain lakes of the Lower Amazon, as well as relating the Catch per Unit of Effort with anomalies of some of the Amazon River, atmosphere and Atlantic Ocean system variables, determining the influence of the environment on the Amazonian fishery resources. Finfish landings data from the towns and villages of the Lower Amazon for the fisheries of three sites (Obidos, Santarem and Monte Alegre), were obtained for the period between January 1993 and December 2004. Analysis of variance, detrended correspondence analysis, redundancy analysis and multiple regression techniques were used for the statistical analysis of the distinct time series. Fisheries production in the Lower Amazon presents differences between the Amazon River and the floodplain lakes. Production in the Amazon River is approximately half of the one of the floodplain lakes. This variability occurs both along the Lower Amazon River region (longitudinal gradient) and laterally (latitudinal gradient) for every fishing ground studied here. The distinct environmental variables alone or in association act differently on the fishery stocks and the success of catches in each fishery group studied here. Important variables are the flooding events; the soil the sea surface temperatures; the humidity; the wind and the occurence of El Nino-Southern Oscillation events. Fishery productivity presents a large difference in quantity and distribution patterns between the river and floodplain lakes. This variability occurs in the region of the Lower Amazon as well as laterally for each fishery group studied, being dependent on the ecological characteristics and life strategies of each fish group considered here.	[Diaz Pinaya, Walter Hugo; Isaac, Victoria Judith] Fed Univ Para, Lab Fisheries Biol & Management Aquat Resources, BR-66059 Belem, Para, Brazil; [Diaz Pinaya, Walter Hugo; de Souza, Ronald Buss] Southern Reg Ctr Space Res, Natl Inst Space Res, Lab Meteorol & Satellite Oceanog, Santa Maria, RS, Brazil; [Lobon-Cervia, Francisco Javier] Natl Museum Nat Sci, Dept Evolutionary Ecol, Madrid, Spain; [Pita, Pablo] Univ Santiago de Compostela, Fac Econ & Business Adm, Dept Appl Econ, Santiago De Compostela, Galicia, Spain; [Freire, Juan] Univ A Coruna, Grp Recursos Marinos & Pesquerias, La Coruna, Galicia, Spain	Universidade Federal do Para; Instituto Nacional de Pesquisas Espaciais (INPE); Universidade de Santiago de Compostela; Universidade da Coruna	Pinaya, WHD (corresponding author), Fed Univ Para, Lab Fisheries Biol & Management Aquat Resources, BR-66059 Belem, Para, Brazil.; Pinaya, WHD (corresponding author), Southern Reg Ctr Space Res, Natl Inst Space Res, Lab Meteorol & Satellite Oceanog, Santa Maria, RS, Brazil.	wpinaya@ig.com.br	de Souza, Ronald Buss/AAP-7586-2021; PITA, PABLO/I-1694-2015; Pita, Pablo/AAA-5228-2019; Souza, Ronald Buss de/R-5867-2016; Isaac, Victoria J/I-2220-2013	de Souza, Ronald Buss/0000-0003-3346-3370; PITA, PABLO/0000-0001-9273-1481; Pita, Pablo/0000-0001-9273-1481; Souza, Ronald Buss de/0000-0003-3346-3370; Freire, Juan/0000-0003-4323-4918	Universidade Federal do Para; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior of Brazil; Brazilian National Council for Scientific and Technological Development [308646/2013-4]	Universidade Federal do Para; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding for translation and publishing was provided by the Pro-Reitoria de Pesquisa e Pos-Graduacao (www.propesp.ufpa.br) and Fundacao de Amparo e Desenvolvimento da Pesquisa (www.portalfadesp.org.br) from Universidade Federal do Para (www.portal.ufpa.br). WHDP was supported by Brazilian Ph.D. Scholarships from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior of Brazil (www.capes.gov.br). RBS was supported by Scholarship in Research Productivity PQ CNPq 308646/2013-4 from the Brazilian National Council for Scientific and Technological Development (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ACEITUNO P, 1988, MON WEATHER REV, V116, P505, DOI 10.1175/1520-0493(1988)116<0505:OTFOTS>2.0.CO;2; Alonso JC, 2003, P 2 LARG RIV S 2003; Alonso JC, 2005, MANEJO PESCA GRANDES, P19; [Anonymous], 1998, FRUTOS TAMBAQUI ECOL; Araujo-Lima CARM, 1998, J FISH BIOL, V53, P297, DOI 10.1006/jfbi.1998.0815; Araujo-Lima CARM, 1990, THESIS; ARAUJOLIMA CARM, 1986, SCIENCE, V234, P1256, DOI 10.1126/science.234.4781.1256; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Bailly D, 2008, RIVER RES APPL, V24, P1218, DOI 10.1002/rra.1147; Baran E, 2001, 2 AS WETL S PEN MAL, p[920, 1116]; Barthem R., 1997, CATFISH CONNECTION E; Barthem RB, 2004, PESCA OS RECURSOS PE, P11; Batista VS., 2007, Braz. J. Biol., V67, P651, DOI 10.1590/S1519-69842007000400009; Batista VS, 2012, PEIXES PESCA SOLIMOE; BAYLEY PB, 1988, ENVIRON BIOL FISH, V21, P127, DOI 10.1007/BF00004848; Bittencourt Maria Mercedes, 2007, Acta Amaz., V37, P303, DOI 10.1590/S0044-59672007000200019; BOHLKE J E, 1978, Acta Amazonica, V8, P657; Castello L, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150299; Castello L, 2011, FISH RES, V110, P356, DOI 10.1016/j.fishres.2011.05.002; CAUSTON D. R, 1988, INTRO VEGETATION ANA; Chiang JCH, 2013, J CLIMATE, V26, P8628, DOI 10.1175/JCLI-D-12-00487.1; Chuenpagdee R, 2008, RECONCILING FISHERIE, P575; Claro-Jr Luiz, 2004, Acta Amaz., V34, P133, DOI 10.1590/S0044-59672004000100018; Coe MT, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000740; Craig JF, 2004, FISH RES, V66, P271, DOI 10.1016/S0165-7836(03)00196-6; Cunico Almir Manoel, 2002, Acta Scientiarum Universidade Estadual de Maringa, V24, P383; da Rocha F.C., 2009, Acta Limnologica Brasiliensia, V21, P123; de Merona B, 1993, AQUAT LIVING RESOUR, V6, P97, DOI 10.1051/alr:1993010; de Ribeiro MCL., 1990, REGUL RIVER, V5, P195, DOI [10.1002/rrr.3450050302, DOI 10.1002/RRR.3450050302]; Ebisuzaki W, 1998, P 23 CLIM DIAGN PRED, P119; Espinoza JC, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047862; Fabre NN, 1997, P C BRAS LIMN UFSCAR, P154; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Fisch Gilberto, 1998, Acta Amazonica, V28, P101; Freitas C.E.C., 2006, CIENCIA CULTURA, V58, P30; Freitas CEC, 2013, HYDROBIOLOGIA, V705, P159, DOI 10.1007/s10750-012-1394-4; Gafny S, 1999, AQUAT BOT, V62, P249, DOI 10.1016/S0304-3770(98)00097-7; Gilmore R.M., 1986, SUMA ETNOLOGICA BRAS, P189; Goulding M., 1980, P1; Goulding M., 1988, RIO NEGRO RICH LIFE; Isaac VJ, 2008, FISHERIES MANAG ECOL, V15, P179, DOI 10.1111/j.1365-2400.2008.00599.x; Isaac V. J., 1996, Acta Amazonica, V26, P185; Isaac VJ, 2015, PEIXES PESCA AMAZONA, P201; Isaac VJ, 1998, CROSSING BOUNDARIES; Janac M, 2010, ECOL FRESHW FISH, V19, P644, DOI 10.1111/j.1600-0633.2010.00449.x; Jongman R. H. G., 1995, DATA ANAL COMMUNITY; Junk W.J., 1997, CENTRAL AMAZON FLOOD, P3, DOI DOI 10.1007/978-3-662-03416-3_1; Junk WJ, 2004, P 2 INT S MAN LARG R, V2, P117; Junk WJ, 1984, AMAZON LIMNOLOGY LAN, P215; Junk WJ, 1989, CANADIAN SPECIAL PUB, V106, P110, DOI DOI 10.1016/J.MATCHEMPHYS.2012.10.032; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; Knoppel HA, 1970, AMAZONIANA, V2; Koutroumanidis T, 2006, ENVIRON MODELL SOFTW, V21, P1711, DOI 10.1016/j.envsoft.2005.09.001; KRAMER DL, 1978, CAN J ZOOL, V56, P717, DOI 10.1139/z78-101; Lennon JJ, 2000, ECOGRAPHY, V23, P101, DOI 10.1034/j.1600-0587.2000.230111.x; Lorenzen K, 2006, CAN J FISH AQUAT SCI, V63, P1334, DOI 10.1139/F06-038; Loubens G., 1997, ICHTHYOL EXPLOR FRES, V8, P1; Lowe-McConnell R. H., 1987, ECOLOGICAL STUDIES T; Luz-Agostinho KDG, 2008, HYDROBIOLOGIA, V607, P187, DOI 10.1007/s10750-008-9390-4; Marchetti MP, 2001, ECOL APPL, V11, P530, DOI 10.2307/3060907; Marengo J, 1981, THESIS; MARENGO JA, 1992, INT J CLIMATOL, V12, P853, DOI 10.1002/joc.3370120808; Marengo JA, 2004, THEOR APPL CLIMATOL, V78, P79, DOI 10.1007/S00704-004-0045-8; MARQUES J, 1980, Acta Amazonica, V10, P357; Martelo J, 2008, FRESHWATER BIOL, V53, P2455, DOI 10.1111/j.1365-2427.2008.02065.x; MOURA AD, 1981, J ATMOS SCI, V38, P2653, DOI 10.1175/1520-0469(1981)038<2653:OTDODI>2.0.CO;2; Murchie KJ, 2008, RIVER RES APPL, V24, P197, DOI 10.1002/rra.1058; Nunes de Mello Jose Alberto, 2001, Acta Amazonica, V31, P331; Parsons D.G., 2000, Journal of Northwest Atlantic Fishery Science, V27, P11, DOI 10.2960/J.v27.a2; Peterman RM, 2003, CAN J FISH AQUAT SCI, V60, P809, DOI 10.1139/F03-069; Petrere M, 2010, BRAZ J BIOL, V70, P483, DOI 10.1590/S1519-69842010005000010; Petrere Jr M, 1992, PESCA AMAZONIA PARA, P72; Pinaya WHD, 2013, THESIS; Raffles H, 2003, LAT AM RES REV, V38, P165, DOI 10.1353/lar.2003.0041; RICHEY JE, 1989, SCIENCE, V246, P101, DOI 10.1126/science.246.4926.101; ROUBACH R, 1994, J APPL ICHTHYOL, V10, P134, DOI 10.1111/j.1439-0426.1994.tb00152.x; Ruffino M. L., 1998, Ecotropica, V4, P99; Ruffino M. L., 1995, NAGA ICLARM Q, V18, P41; RUFFINO ML, 1999, ACTA AMAZONICA, V29, P463, DOI DOI 10.1590/1809-43921999293476; Saint-Paul U, 2000, ENVIRON BIOL FISH, V57, P235, DOI 10.1023/A:1007699130333; Saint-Paul U, 1994, 0339366A BMFT; SALATI E, 1979, WATER RESOUR RES, V15, P1250, DOI 10.1029/WR015i005p01250; Sanchez-Botero Jorge Ivan, 2001, Acta Amazonica, V31, P437; Silva CO., 2004, PESCA RECURSOS PESQU, P185; Souza E.B., 2000, ACTA AMAZONICA, V30, P305, DOI DOI 10.1590/1809-43922000302318; Souza E. B., 2005, THEOR APPL CLIMATOL, V81, P177, DOI DOI 10.1007/S00704-004-0081-4; Souza JRS, 2004, ISSUES LOCAL GLOBAL, p[3756, 37]; Stergiou KI, 1997, FISH RES, V29, P55, DOI 10.1016/S0165-7836(96)00482-1; STERGIOU KI, 1989, J CONSEIL, V46, P16; Stergiou KI, 1996, FISH RES, V25, P105, DOI 10.1016/0165-7836(95)00389-4; Suzuki HI, 2009, BRAZ J BIOL, V69, P649, DOI 10.1590/S1519-69842009000300019; Tan XC, 2010, ENVIRON BIOL FISH, V88, P217, DOI 10.1007/s10641-010-9632-y; ter Braak C.J.F., 1995, DATA ANAL COMMUNITY, P69, DOI DOI 10.1017/CBO9780511525575.007; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Vallejos RO, 2013, ENVIRON MODELL SOFTW, V48, P202, DOI 10.1016/j.envsoft.2013.07.004; Vari Richard P., 1998, P1; Vieira EF, 1999, ACTA AMAZONICA, V29, P1; Wagner HH, 2013, ECOLOGY, V94, P2381, DOI 10.1890/12-1899.1; WALDHOFF D, 1996, ECOTROPICA, V2, P143; Wantzen KM, 2008, HYDROBIOLOGIA, V613, P1, DOI 10.1007/s10750-008-9466-1; Welcomme, 2008, INLAND FISHERIES ECO; Welcomme RL, 2006, RIVER RES APPL, V22, P377, DOI 10.1002/rra.914; Welcomme RL, 1999, FISHERIES MANAG ECOL, V6, P1, DOI 10.1046/j.1365-2400.1999.00137.x; Welcomme RL, 1985, 262 FAO FISH RES ENV; Welcomme RL, 2010, PHILOS T R SOC B, V365, P2881, DOI 10.1098/rstb.2010.0168; Welsch R. E, 2004, REGRESSION DIAGNOSTI; WINEMILLER KO, 1989, OECOLOGIA, V81, P225, DOI 10.1007/BF00379810; Wootton R.J., 1984, P1; Yoon JH, 2010, CLIM DYNAM, V34, P249, DOI 10.1007/s00382-009-0551-6; Zeug SC, 2008, RIVER RES APPL, V24, P90, DOI 10.1002/rra.1061	110	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157050	10.1371/journal.pone.0157050	http://dx.doi.org/10.1371/journal.pone.0157050			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314951	gold, Green Published, Green Submitted			2022-12-26	WOS:000378030000010
J	Louf, R; Barthelemy, M				Louf, Remi; Barthelemy, Marc			Patterns of Residential Segregation	PLOS ONE			English	Article							INCOME; NEIGHBORHOODS; INEQUALITY; CITIES; POOR; LIVE	The spatial distribution of income shapes the structure and organisation of cities and its understanding has broad societal implications. Despite an abundant literature, many issues remain unclear. In particular, all definitions of segregation are implicitely tied to a single indicator, usually rely on an ambiguous definition of income classes, without any consensus on how to define neighbourhoods and to deal with the polycentric organization of large cities. In this paper, we address all these questions within a unique conceptual framework. We avoid the challenge of providing a direct definition of segregation and instead start from a definition of what segregation is not. This naturally leads to the measure of representation that is able to identify locations where categories are over-or underrepresented. From there, we provide a new measure of exposure that discriminates between situations where categories co-locate or repel one another. We then use this feature to provide an unambiguous, parameter-free method to find meaningful breaks in the income distribution, thus defining classes. Applied to the 2014 American Community Survey, we find 3 emerging classes -low, middle and higher income-out of the original 16 income categories. The higher-income households are proportionally more present in larger cities, while lower-income households are not, invalidating the idea of an increased social polarisation. Finally, using the density-and not the distance to a center which is meaningless in polycentric cities-we find that the richer class is overrepresented in high density zones, especially for larger cities. This suggests that density is a relevant factor for understanding the income structure of cities and might explain some of the differences observed between US and European cities.	[Louf, Remi; Barthelemy, Marc] CEA, Inst Phys Theor, IPhT, CNRS URA 2306, F-91191 Gif Sur Yvette, France; [Louf, Remi] UCL, Ctr Adv Spatial Anal, London W1N 6TR, England; [Barthelemy, Marc] EHESS, Ctr Anal & Math Sociales, 190-198 Ave France, F-75244 Paris 13, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London	Barthelemy, M (corresponding author), CEA, Inst Phys Theor, IPhT, CNRS URA 2306, F-91191 Gif Sur Yvette, France.; Barthelemy, M (corresponding author), EHESS, Ctr Anal & Math Sociales, 190-198 Ave France, F-75244 Paris 13, France.	marc.barthelemy@cea.fr						Andersen H.S., 2002, HOUSING THEORY SOC, V19, P153, DOI [10.1080/140360902321122860, DOI 10.1080/140360902321122860]; Apparicio P., 2000, CYBERGEO EUROPEAN J; Atkinson R., 2004, GENTRIFICATION GLOBA; BALASSA B, 1965, MANCH SCH ECON SOC, V33, P99, DOI 10.1111/j.1467-9957.1965.tb00050.x; Bell W, 1954, SOC FORCES, V32, P357, DOI 10.2307/2574118; Billings SB, 2012, J URBAN ECON, V71, P312, DOI 10.1016/j.jue.2011.12.001; Brueckner J.K., 1987, HDB REGIONAL EC, VVol. 2, P821, DOI DOI 10.1016/S1574-0080(87)80006-8; Brueckner JK, 2009, REV ECON STAT, V91, P725, DOI 10.1162/rest.91.4.725; Brueckner JK, 1999, EUR ECON REV, V43, P91, DOI 10.1016/S0014-2921(98)00019-1; Chamboredon J.-C., 1970, LES GRANDS ENSEMBLES, P3; Chun Y, 2013, SPATIAL STATISTICS A; Cressie N., 2011, STAT SPATIO TEMPORAL; Duncan OD, 1955, AM SOCIOL REV, V20, P210, DOI 10.2307/2088328; Duranton G, 2005, REV ECON STUD, V72, P1077, DOI 10.1111/0034-6527.00362; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Ellis M, 2004, ANN ASSOC AM GEOGR, V94, P620, DOI 10.1111/j.1467-8306.2004.00417.x; Emirbayer M, 1997, AM J SOCIOL, V103, P281, DOI 10.1086/231209; Feller V, 1950, INTRO PROBABILITY TH; Glaeser EL, 2008, J URBAN ECON, V63, P1, DOI 10.1016/j.jue.2006.12.004; HAMNETT C, 1994, URBAN STUD, V31, P401, DOI 10.1080/00420989420080401; Ioannides YM, 2004, J URBAN ECON, V56, P435, DOI 10.1016/j.jue.2004.04.006; James DR, 1982, WORKING PAPER; Jane J., 1961, DEATH LIFE GREAT AM; Jargowsky PA, 1996, AM SOCIOL REV, V61, P984, DOI 10.2307/2096304; Jenkins SP, 2008, OXFORD REV EDUC, V34, P21, DOI 10.1080/03054980701542039; Jensen P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.035101; Lobmayer P, 2002, J EPIDEMIOL COMMUN H, V56, P183, DOI 10.1136/jech.56.3.183; Lobo AP, 2007, URBAN GEOGR, V28, P609, DOI 10.2747/0272-3638.28.7.609; Logan JR, 2011, URBAN GEOGR, V32, P334, DOI 10.2747/0272-3638.32.3.334; Louf R, 2015, MARBLE A PYTHON LIBR; Louf R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.198702; MAKSE HA, 1995, NATURE, V377, P608, DOI 10.1038/377608a0; Marcon E, 2009, J EC GEOGRAPHY; Massey D.S., 2003, BROOKINGS WHARTON PA, P1, DOI 10.1353/urb.2003.0012; Massey Douglas, 1993, AMERICAN APARTHEID S; Massey DS, 1996, DEMOGRAPHY, V33, P395, DOI 10.2307/2061773; MASSEY DS, 1988, SOC FORCES, V67, P281, DOI 10.2307/2579183; Reardon SF, 2011, AM J SOCIOL, V116, P1092, DOI 10.1086/657114; Reardon SF, 2004, SOCIOL METHODOL, V34, P121, DOI 10.1111/j.0081-1750.2004.00150.x; Reardon SF, 2002, SOCIOL METHODOL, V32, P33, DOI 10.1111/1467-9531.00110; Ripley BD, 1981, SPATIAL STATISTICS H; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Sassen S., 1991, GLOBAL CITY; Schwabe M, 2007, CYBERGEO, DOI 10.4000/cybergeo.24601; Sharma M, 2012, URBAN GEOGR, V33, P317, DOI 10.2747/0272-3638.33.3.317; Shevky E, 1961, SOCIAL AREA ANALYSIS; Spielman SE, 2013, ANN ASSOC AM GEOGR, V103, P67, DOI 10.1080/00045608.2012.685049; UN-HABITAT, 2013, STATE OF THE WORLDS; WHITE MJ, 1983, AM J SOCIOL, V88, P1008, DOI 10.1086/227768; WINSHIP C, 1977, SOC FORCES, V55, P1058, DOI 10.2307/2577572; Wong DWS, 2011, J GEOGR SYST, V13, P127, DOI 10.1007/s10109-010-0112-x	51	28	29	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157476	10.1371/journal.pone.0157476	http://dx.doi.org/10.1371/journal.pone.0157476			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JQ	27315283	gold, Green Published, Green Submitted			2022-12-26	WOS:000378030000030
J	Chai, BL; Tsoi, TV; Iwai, S; Liu, C; Fish, JA; Gu, C; Johnson, TA; Zylstra, G; Teppen, BJ; Li, H; Hashsham, SA; Boyd, SA; Cole, JR; Tiedje, JM				Chai, Benli; Tsoi, Tamara V.; Iwai, Shoko; Liu, Cun; Fish, Jordan A.; Gu, Cheng; Johnson, Timothy A.; Zylstra, Gerben; Teppen, Brian J.; Li, Hui; Hashsham, Syed A.; Boyd, Stephen A.; Cole, James R.; Tiedje, James M.			Sphingomonas wittichii Strain RW1 Genome-Wide Gene Expression Shifts in Response to Dioxins and Clay	PLOS ONE			English	Article							DIBENZO-P-DIOXIN; DEPENDENT TRANSPORT; DIOXYGENASE; SYSTEM; BIODEGRADATION; DEGRADATION; METABOLISM; MECHANISMS; MEMBRANE; SEQUENCE	Sphingomonas wittichii strain RW1 (RW1) is one of the few strains that can grow on dibenzo-p-dioxin (DD). We conducted a transcriptomic study of RW1 using RNA-Seq to outline transcriptional responses to DD, dibenzofuran (DF), and the smectite clay mineral saponite with succinate as carbon source. The ability to grow on DD is rare compared to growth on the chemically similar DF even though the same initial dioxygenase may be involved in oxidation of both substrates. Therefore, we hypothesized the reason for this lies beyond catabolic pathways and may concern genes involved in processes for cell-substrate interactions such as substrate recognition, transport, and detoxification. Compared to succinate (SUC) as control carbon source, DF caused over 240 protein-coding genes to be differentially expressed, whereas more than 300 were differentially expressed with DD. Stress response genes were up-regulated in response to both DD and DF. This effect was stronger with DD than DF, suggesting a higher toxicity of DD compared to DF. Both DD and DF caused changes in expression of genes involved in active cross-membrane transport such as TonB-dependent receptor proteins, but the patterns of change differed between the two substrates. Multiple transcription factor genes also displayed expression patterns distinct to DD and DF growth. DD and DF induced the catechol ortho-and the salicylate/gentisate pathways, respectively. Both DD and DF induced the shared down-stream aliphatic intermediate compound pathway. Clay caused category-wide down-regulation of genes for cell motility and chemotaxis, particularly those involved in the synthesis, assembly and functioning of flagella. This is an environmentally important finding because clay is a major component of soil microbes' microenvironment influencing local chemistry and may serve as a geosorbent for toxic pollutants. Similar to clay, DD and DF also affected expression of genes involved in motility and chemotaxis.	[Chai, Benli; Tsoi, Tamara V.; Iwai, Shoko; Fish, Jordan A.; Johnson, Timothy A.; Cole, James R.; Tiedje, James M.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [Liu, Cun; Johnson, Timothy A.; Teppen, Brian J.; Li, Hui; Boyd, Stephen A.] Michigan State Univ, Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Hashsham, Syed A.] Michigan State Univ, Civil & Environm Engn, E Lansing, MI 48824 USA; [Gu, Cheng] Nanjing Univ, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China; [Zylstra, Gerben] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08903 USA; [Iwai, Shoko] Second Genome Inc, San Francisco, CA 94080 USA; [Johnson, Timothy A.] USDA ARS, Natl Anim Dis Ctr, Food Safety & Enter Pathogens Res Unit, POB 70, Ames, IA 50010 USA	Michigan State University; Michigan State University; Michigan State University; Nanjing University; Rutgers State University New Brunswick; United States Department of Agriculture (USDA)	Tiedje, JM (corresponding author), Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA.	tiedjej@msu.edu	Boyd, Stephen A/G-5819-2010; Li, Hui/G-4055-2010; Gu, Cheng/I-2084-2012	Li, Hui/0000-0003-3298-5265; Hashsham, Syed/0000-0003-2398-7453; Chai, Benli/0000-0003-4140-4530; Zylstra, Gerben/0000-0003-0419-1353	National Institute of Environmental Health Sciences grant [5P42 ES004911-18/19]	National Institute of Environmental Health Sciences grant	This study was supported by the National Institute of Environmental Health Sciences grant 5P42 ES004911-18/19.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aravind L, 2001, GENOME RES, V11, P1365, DOI 10.1101/gr.181001; Armengaud J, 1999, J BACTERIOL, V181, P3452, DOI 10.1128/JB.181.11.3452-3461.1999; Armengaud J, 1998, J BACTERIOL, V180, P3954, DOI 10.1128/JB.180.15.3954-3966.1998; Armengaud J, 1998, EUR J BIOCHEM, V253, P437, DOI 10.1046/j.1432-1327.1998.2530437.x; Armengaud J, 2000, J BACTERIOL, V182, P2238, DOI 10.1128/JB.182.8.2238-2244.2000; Arroyo LJ, 2005, CLAY CLAY MINER, V53, P511, DOI 10.1346/CCMN.2005.0530507; BERTAZZI PA, 1993, EPIDEMIOLOGY, V4, P398, DOI 10.1097/00001648-199309000-00004; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; BUNZ PV, 1993, J BACTERIOL, V175, P6467; Chang YS, 2008, J MOL MICROB BIOTECH, V15, P152, DOI 10.1159/000121327; Codoy P, 2001, J BACTERIOL, V183, P5285, DOI [10.1128/JB.183.18.5285-5292.2001, DOI 10.1128/JB.183.18.5285-5292.2001]; Colquhoun DR, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/408690; Cornelissen G, 2005, ENVIRON SCI TECHNOL, V39, P6881, DOI 10.1021/es050191b; Coronado E, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00300; Field JA, 2008, CHEMOSPHERE, V71, P1005, DOI 10.1016/j.chemosphere.2007.10.039; Haines-Menges B, 2014, INFECT IMMUN, V82, P3667, DOI 10.1128/IAI.01854-14; HAPPE B, 1993, J BACTERIOL, V175, P7313, DOI 10.1128/JB.175.22.7313-7320.1993; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hartmann EM, 2014, ENVIRON MICROBIOL, V16, P162, DOI 10.1111/1462-2920.12264; Hiraishi A., 2003, MICROBES ENVIRON, V18, P105, DOI [10.1264/jsme2.18.105, DOI 10.1264/JSME2.18.105]; Hong HB, 2004, BIODEGRADATION, V15, P303, DOI 10.1023/B:BIOD.0000042185.04905.0d; Johnson DR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-250; Kachlany SC, 2001, TRENDS MICROBIOL, V9, P429, DOI 10.1016/S0966-842X(01)02161-8; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAUFFENBURGER DA, 1982, CELL BIOPHYS, V4, P177, DOI 10.1007/BF02918312; Liu C, 2009, ENVIRON SCI TECHNOL, V43, P2777, DOI 10.1021/es802381z; Merino S, 2006, FEMS MICROBIOL LETT, V263, P127, DOI 10.1111/j.1574-6968.2006.00403.x; Miller TR, 2010, J BACTERIOL, V192, P6101, DOI 10.1128/JB.01030-10; Min J, 2003, ENVIRON TOXICOL CHEM, V22, P2238, DOI 10.1897/02-465; Min J, 2003, ENVIRON TOXICOL CHEM, V22, P233, DOI 10.1002/etc.5620220201; Moreau PL, 2014, FEMS MICROBIOL LETT, V357, P151, DOI 10.1111/1574-6968.12534; Moreno-Forero SK, 2015, ISME J, V9, P150, DOI 10.1038/ismej.2014.101; Neugebauer H, 2005, J BACTERIOL, V187, P8300, DOI 10.1128/JB.187.24.8300-8311.2005; Palonen E, 2013, APPL ENVIRON MICROB, V79, P5970, DOI 10.1128/AEM.01891-13; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; R Core Team, 2012, R LANG ENV STAT COMP; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Seah SYK, 2007, J BACTERIOL, V189, P4038, DOI 10.1128/JB.01950-06; Skopelitou K, 2012, FUNCT INTEGR GENOMIC, V12, P157, DOI 10.1007/s10142-011-0248-x; Spohn G, 2001, HELICOBACTER PYLORI; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668; Wilkes H, 1996, APPL ENVIRON MICROB, V62, P367, DOI 10.1128/AEM.62.2.367-371.1996; WITTICH RM, 1992, APPL ENVIRON MICROB, V58, P1005, DOI 10.1128/AEM.58.3.1005-1010.1992	46	17	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157008	10.1371/journal.pone.0157008	http://dx.doi.org/10.1371/journal.pone.0157008			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309357	Green Submitted, gold, Green Published			2022-12-26	WOS:000378029800027
J	Houdayer, E; Cursi, M; Nuara, A; Zanini, S; Gatti, R; Comi, G; Leocani, L				Houdayer, Elise; Cursi, Marco; Nuara, Arturo; Zanini, Sonia; Gatti, Roberto; Comi, Giancarlo; Leocani, Letizia			Cortical Motor Circuits after Piano Training in Adulthood: Neurophysiologic Evidence	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; VENTRAL PREMOTOR; INTERHEMISPHERIC INHIBITION; NEURAL REORGANIZATION; CORTEX; BRAIN; PRECISION; STROKE; AREAS; MODULATION	The neuronal mechanisms involved in brain plasticity after skilled motor learning are not completely understood. We aimed to study the short-term effects of keyboard training in music-naive subjects on the motor/premotor cortex activity and interhemispheric interactions, using electroencephalography and transcranial magnetic stimulation (TMS). Twelve subjects (experimental group) underwent, before and after a two week-piano training: (1) hand-motor function tests: Jamar, grip and nine-hole peg tests; (2) electroencephalography, evaluating the mu rhythm task-related desynchronization (TRD) during keyboard performance; and (3) TMS, targeting bilateral abductor pollicis brevis (APB) and abductor digiti minimi (ADM), to obtain duration and area of ipsilateral silent period (ISP) during simultaneous tonic contraction of APB and ADM. Data were compared with 13 controls who underwent twice these measurements, in a two-week interval, without undergoing piano training. Every subject in the experimental group improved keyboard performance and left-hand nine-hole peg test scores. Pre-training, ISP durations were asymmetrical, left being longer than right. Post-training, right ISPAPB increased, leading to symmetrical ISPAPB. Mu TRD during motor performance became more focal and had a lesser amplitude than in pre-training, due to decreased activity over ventral premotor cortices. No such changes were evidenced in controls. We demonstrated that a 10-day piano-training was associated with balanced interhemispheric interactions both at rest and during motor activation. Piano training, in a short timeframe, may reshape local and inter-hemispheric motor cortical circuits.	[Houdayer, Elise; Cursi, Marco; Nuara, Arturo; Zanini, Sonia; Comi, Giancarlo; Leocani, Letizia] Ist Sci San Raffaele, Expt Neurophysiol Unit, Inst Expt Neurol INSPE, I-20132 Milan, Italy; [Zanini, Sonia; Gatti, Roberto] Ist Sci San Raffaele, Lab Movement Anal, I-20132 Milan, Italy; [Nuara, Arturo; Comi, Giancarlo; Leocani, Letizia] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Houdayer, E (corresponding author), Ist Sci San Raffaele, Expt Neurophysiol Unit, Inst Expt Neurol INSPE, I-20132 Milan, Italy.	houdayer.elise@hsr.it	Leocani, Letizia/ABH-4703-2020; Gatti, Roberto/J-6452-2018; Houdayer, Elise/K-1494-2016	Gatti, Roberto/0000-0002-4669-1287; CURSI, Marco/0000-0002-7928-0417; Leocani, Letizia/0000-0001-9326-6753; Houdayer, Elise/0000-0003-3153-0365	Joint Italian-Israeli laboratory San Raffaele-Weizmann (Italian Ministry of Foreign Affairs); Institute of Experimental Neurology (INSPE, San Raffaele); INSPE; San Raffaele International Postdoctoral Program	Joint Italian-Israeli laboratory San Raffaele-Weizmann (Italian Ministry of Foreign Affairs); Institute of Experimental Neurology (INSPE, San Raffaele); INSPE; San Raffaele International Postdoctoral Program	This study was supported by the Joint Italian-Israeli laboratory San Raffaele-Weizmann (Italian Ministry of Foreign Affairs) and the Institute of Experimental Neurology (INSPE, San Raffaele). Elise Houdayer was supported by the INSPE and by the San Raffaele International Postdoctoral Program.	Alemanno F, 2012, BRAIN RES, V1484, P39, DOI 10.1016/j.brainres.2012.09.030; Altenmuller E, 2009, ANN NY ACAD SCI, V1169, P395, DOI 10.1111/j.1749-6632.2009.04580.x; Andres FG, 1999, BRAIN, V122, P855, DOI 10.1093/brain/122.5.855; Arya KN, 2011, J BODYW MOV THER, V15, P528, DOI 10.1016/j.jbmt.2011.01.023; Avanzino L, 2007, J PHYSIOL-LONDON, V583, P99, DOI 10.1113/jphysiol.2007.134510; Baumer T, 2009, CLIN NEUROPHYSIOL, V120, P1724, DOI 10.1016/j.clinph.2009.07.035; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Chen JL, 2012, NEUROIMAGE, V59, P1200, DOI 10.1016/j.neuroimage.2011.08.012; Chen R, 2003, J NEUROPHYSIOL, V89, P1256, DOI 10.1152/jn.00950.2002; CONOVER WJ, 1982, BIOMETRICS, V38, P715, DOI 10.2307/2530051; Coppi E, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00209; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; Davare M, 2008, J PHYSIOL-LONDON, V586, P2735, DOI 10.1113/jphysiol.2008.152603; Davare M, 2009, CORTEX, V45, P1050, DOI 10.1016/j.cortex.2009.02.011; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Doyon J, 1997, BRAIN COGNITION, V34, P218, DOI 10.1006/brcg.1997.0899; Dum RP, 2005, J NEUROSCI, V25, P1375, DOI 10.1523/JNEUROSCI.3902-04.2005; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Elbert T, 1995, SCI NEW YORK THEN WA, P305; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Filippi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010198; Gallea C, 2005, NEUROREPORT, V16, P1271, DOI 10.1097/01.wnr.0000176514.17561.94; Giovannelli F, 2009, J PHYSIOL-LONDON, V587, P5393, DOI 10.1113/jphysiol.2009.175885; Grice KO, 2003, AM J OCCUP THER, V57, P570; Gryga M, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00037; GUIEU JD, 1999, HANDB EL CL, V6, P279; Hallett M, 1996, ACQUISITION OF MOTOR BEHAVIOR IN VERTEBRATES, P289; Honda M, 1998, BRAIN, V121, P2159, DOI 10.1093/brain/121.11.2159; Hosp JA, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/871296; Houdayer E, 2012, EUR J NEUROSCI, V35, P478, DOI 10.1111/j.1460-9568.2011.07960.x; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Iriarte J, 2003, J CLIN NEUROPHYSIOL, V20, P249, DOI 10.1097/00004691-200307000-00004; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Koessler L, 2009, NEUROIMAGE, V46, P64, DOI 10.1016/j.neuroimage.2009.02.006; Kuhtz-Buschbeck JP, 2001, EUR J NEUROSCI, V14, P382, DOI 10.1046/j.0953-816x.2001.01639.x; Lafleur MF, 2002, NEUROIMAGE, V16, P142, DOI 10.1006/nimg.2001.1048; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; MEYER BU, 1995, BRAIN, V118, P429, DOI 10.1093/brain/118.2.429; Muller-Putz GR, 2007, BRAIN RES, V1137, P84, DOI 10.1016/j.brainres.2006.12.052; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Nieuwboer A, 2009, PARKINSONISM RELAT D, V15, pS53, DOI 10.1016/S1353-8020(09)70781-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; PFURTSCHELLER G, 1989, ELECTROEN CLIN NEURO, V72, P250, DOI 10.1016/0013-4694(89)90250-2; PFURTSCHELLER G, 1981, ELECTROEN CLIN NEURO, V51, P253, DOI 10.1016/0013-4694(81)90139-5; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rojo N, 2011, BRAIN INJURY, V25, P787, DOI 10.3109/02699052.2011.576305; Sadato N, 1997, J NEUROSCI, V17, P9667; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Schneider S, 2007, J NEUROL, V254, P1339, DOI 10.1007/s00415-006-0523-2; Schneider S, 2010, MUSIC PERCEPT, V27, P271, DOI 10.1525/MP.2010.27.4.271; Spagnolo F, 2013, BRAIN STIMUL, V6, P892, DOI 10.1016/j.brs.2013.05.004; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; Trompetto C, 2004, EXP BRAIN RES, V158, P133, DOI 10.1007/s00221-004-1881-6; Tyc F, 2005, EUR J NEUROSCI, V21, P259, DOI 10.1111/j.1460-9568.2004.03835.x; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x; Zhuang P, 1997, ELECTROEN CLIN NEURO, V102, P374, DOI 10.1016/S0013-4694(96)96030-7	64	9	9	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157526	10.1371/journal.pone.0157526	http://dx.doi.org/10.1371/journal.pone.0157526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27309353	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800092
J	Chen, YC; Teng, TH; Tsai, JSC; Huang, HD; Chang, YL; Liang, CW				Chen, Yi-Chang; Teng, Tsung-Han; Tsai, Jane S. -C.; Huang, Hsien-Da; Chang, Yih-Leong; Liang, Cher-Wei			Single-Tube Reaction Using Perfluorocarbons: A Prerequisite Step Leading to the Whole-Slide In Situ Technique on Histopathological Slides	PLOS ONE			English	Article							MESSENGER-RNA; PCR; IMMUNOHISTOCHEMISTRY; HETEROGENEITY; AMPLIFICATION	Developing a robust, novel method for performing multiple reactions in a single tube is not only time-and cost-saving but also critical for future high-throughput whole-slide in situ techniques on diseased tissues. In this study, we introduce the use of perfluorocarbons and compound-coated magnetic particles to create pseudochambers in a single tube, allowing different reactions to be performed in different phases. Perfluorocarbons also serve as cell lysis buffer and polymerase chain reaction (PCR) buffer owing to their highly penetrating, repellent and emulsifiable properties. Using this method, nucleic acids can be isolated and purified from various sample types and sizes, followed by PCR, real-time PCR, or multiplex PCR in the same tube. No incubation or enzyme digesting time is needed and the risk of cross-contamination is reduced. Tests can be performed in microemulsions (water-in-oil droplets) containing sequence-specific captures and probes for further high-throughput detection. We present a simple, quick, and robust procedure as a prerequisite step to future high-throughput in situ techniques.	[Chen, Yi-Chang; Tsai, Jane S. -C.] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan; [Chen, Yi-Chang; Teng, Tsung-Han; Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Mol Med & Bioengn, Hsinchu, Taiwan; [Chang, Yih-Leong; Liang, Cher-Wei] Natl Taiwan Univ Hosp, Dept & Grad Inst Pathol, Taipei, Taiwan; [Chang, Yih-Leong; Liang, Cher-Wei] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	Industrial Technology Research Institute - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Liang, CW (corresponding author), Natl Taiwan Univ Hosp, Dept & Grad Inst Pathol, Taipei, Taiwan.; Liang, CW (corresponding author), Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan.	liangcherwei@gmail.com	Chen, Yi-Chen/GVU-0551-2022; Huang, Hsien-Da/AAA-7376-2019	LIANG, CHER-WEI/0000-0001-8903-6082; CHANG, YIH-LEONG/0000-0001-5309-0554	National Taiwan University Hospital [105-M3314]	National Taiwan University Hospital(National Taiwan University)	This study was partially supported by grant from National Taiwan University Hospital (Grant No. 105-M3314 to CWL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagasra O, 2007, NAT PROTOC, V2, P2782, DOI 10.1038/nprot.2007.395; Cooper LAD, 2015, LAB INVEST, V95, P366, DOI 10.1038/labinvest.2014.153; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; Heikenfeld J, 2011, J SOC INF DISPLAY, V19, P129, DOI 10.1889/JSID19.2.129; Heindl A, 2015, LAB INVEST, V95, P377, DOI 10.1038/labinvest.2014.155; Henke RT, 2006, METHODS, V38, P253, DOI 10.1016/j.ymeth.2005.11.013; Lemal DM, 2004, J ORG CHEM, V69, P1, DOI 10.1021/jo0302556; Levenson RM, 2015, LAB INVEST, V95, P397, DOI 10.1038/labinvest.2015.2; Liegl B, 2008, J PATHOL, V216, P64, DOI 10.1002/path.2382; Rimm DL, 2014, NAT METHODS, V11, P381, DOI 10.1038/nmeth.2896; Tao ZM, 2014, TRENDS BIOTECHNOL, V32, P466, DOI 10.1016/j.tibtech.2014.05.001; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896; Zhang X, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-16	13	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158018	10.1371/journal.pone.0158018	http://dx.doi.org/10.1371/journal.pone.0158018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336363	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200092
J	Chieffo, R; Straffi, L; Inuggi, A; Gonzalez-Rosa, JJ; Spagnolo, F; Coppi, E; Nuara, A; Houdayer, E; Comi, G; Leocani, L				Chieffo, Raffaella; Straffi, Laura; Inuggi, Alberto; Gonzalez-Rosa, Javier J.; Spagnolo, Francesca; Coppi, Elisabetta; Nuara, Arturo; Houdayer, Elise; Comi, Giancarlo; Leocani, Letizia			Motor Cortical Plasticity to Training Started in Childhood: The Example of Piano Players	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CONGENITAL MIRROR MOVEMENTS; INTERHEMISPHERIC INHIBITION; TRANSCALLOSAL INHIBITION; HAND PREFERENCE; CORTEX; BRAIN; REPRESENTATION; AREAS; REORGANIZATION	Converging evidence suggest that motor training is associated with early and late changes of the cortical motor system. Transcranial magnetic stimulation (TMS) offers the possibility to study plastic rearrangements of the motor system in physiological and pathological conditions. We used TMS to characterize long-term changes in upper limb motor cortical representation and interhemispheric inhibition associated with bimanual skill training in pianists who started playing in an early age. Ipsilateral silent period (iSP) and cortical TMS mapping of hand muscles were obtained from 30 strictly right-handed subjects (16 pianists, 14 naive controls), together with electromyographic recording of mirror movements (MMs) to voluntary hand movements. In controls, motor cortical representation of hand muscles was larger on the dominant (DH) than on the non-dominant hemisphere (NDH). On the contrary, pianists showed symmetric cortical output maps, being their DH less represented than in controls. In naive subjects, the iSP was smaller on the right vs left abductor pollicis brevis (APB) indicating a weaker inhibition from the NDH to the DH. In pianists, interhemispheric inhibition was more symmetric as their DH was better inhibited than in controls. Electromyographic MMs were observed only in naive subjects (7/14) and only to voluntary movement of the non-dominant hand. Subjects with MM had a lower iSP area on the right APB compared with all the others. Our findings suggest a more symmetrical motor cortex organization in pianists, both in terms of muscle cortical representation and interhemispheric inhibition. Although we cannot disentangle training-related from preexisting conditions, it is possible that long-term bimanual practice may reshape motor cortical representation and rebalance interhemispheric interactions, which in naive right-handed subjects would both tend to favour the dominant hemisphere.	[Chieffo, Raffaella; Straffi, Laura; Spagnolo, Francesca; Coppi, Elisabetta; Nuara, Arturo; Comi, Giancarlo; Leocani, Letizia] Hosp San Raffaele, Inst Sci, Dept Neurol, I-20132 Milan, Italy; [Chieffo, Raffaella; Straffi, Laura; Inuggi, Alberto; Gonzalez-Rosa, Javier J.; Spagnolo, Francesca; Coppi, Elisabetta; Nuara, Arturo; Houdayer, Elise; Comi, Giancarlo; Leocani, Letizia] Hosp San Raffaele, Inst Sci, Inst Expt Neurol INSPE, Expt Neurophysiol Unit, I-20132 Milan, Italy; [Chieffo, Raffaella; Spagnolo, Francesca; Coppi, Elisabetta; Nuara, Arturo; Comi, Giancarlo] Univ Vita Salute San Raffaele, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Leocani, L (corresponding author), Hosp San Raffaele, Inst Sci, Dept Neurol, I-20132 Milan, Italy.; Leocani, L (corresponding author), Hosp San Raffaele, Inst Sci, Inst Expt Neurol INSPE, Expt Neurophysiol Unit, I-20132 Milan, Italy.	letizia.leocani@hsr.it	Gonzalez-Rosa, Javier J./AAK-6791-2021; Gonzalez-Rosa, Javier J./K-1291-2014; Inuggi, Alberto/K-6261-2014; Leocani, Letizia/ABH-4703-2020; Inuggi, Alberto/AAF-8510-2019; Houdayer, Elise/K-1494-2016	Gonzalez-Rosa, Javier J./0000-0002-5609-1103; Gonzalez-Rosa, Javier J./0000-0002-5609-1103; Inuggi, Alberto/0000-0002-8840-5197; Inuggi, Alberto/0000-0002-8840-5197; CHIEFFO, RAFFAELLA/0000-0003-2288-1702; Houdayer, Elise/0000-0003-3153-0365; Leocani, Letizia/0000-0001-9326-6753	Joint Italian-Israeli Laboratory San Raffaele-Weizmann (Italian Ministry of Foreign Affairs); INSPE- Institute of Experimental Neurology, Scientific Institute Hospital San Raffaele, Milan	Joint Italian-Israeli Laboratory San Raffaele-Weizmann (Italian Ministry of Foreign Affairs); INSPE- Institute of Experimental Neurology, Scientific Institute Hospital San Raffaele, Milan	Supported through the Joint Italian-Israeli Laboratory San Raffaele-Weizmann (Italian Ministry of Foreign Affairs) and INSPE- Institute of Experimental Neurology, Scientific Institute Hospital San Raffaele, Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported through the Joint Italian-Israeli Laboratory San Raffaele-Weizmann (Italian Ministry of Foreign Affairs) and INSPE- Institute of Experimental Neurology, Scientific Institute Hospital San Raffaele, Milan.	Alagona G, 2001, STROKE, V32, P1304, DOI 10.1161/01.STR.32.6.1304; Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3<206::AID-HBM5>3.0.CO;2-7; Aranyi Z, 2002, EXP BRAIN RES, V145, P76, DOI 10.1007/s00221-002-1101-1; Armatas CA, 1996, J CLIN EXP NEUROPSYC, V18, P823, DOI 10.1080/01688639608408305; BENECKE R, 1991, EXP BRAIN RES, V83, P419; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Chieffo R, 2013, BRAIN STIMUL, V6, P322, DOI 10.1016/j.brs.2012.06.003; Cincotta M, 2008, CLIN NEUROPHYSIOL, V119, P744, DOI 10.1016/j.clinph.2007.11.047; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; COHEN LG, 1991, BRAIN, V114, P381, DOI 10.1093/brain/114.1.381; CONOVER WJ, 1982, BIOMETRICS, V38, P715, DOI 10.2307/2530051; Coppi E, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00209; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Gartner H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00636; Gaser C, 2003, ANN NY ACAD SCI, V999, P514, DOI 10.1196/annals.1284.062; GILBERT AN, 1992, NEUROPSYCHOLOGIA, V30, P601, DOI 10.1016/0028-3932(92)90065-T; Giovannelli F, 2009, J PHYSIOL-LONDON, V587, P5393, DOI 10.1113/jphysiol.2009.175885; GRAFTON ST, 1991, J NEUROPHYSIOL, V66, P735, DOI 10.1152/jn.1991.66.3.735; Grice KO, 2003, AM J OCCUP THER, V57, P570; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; Hubers A, 2008, EUR J NEUROSCI, V28, P364, DOI 10.1111/j.1460-9568.2008.06335.x; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Jancke L, 1997, BRAIN COGNITION, V34, P424, DOI 10.1006/brcg.1997.0922; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P177, DOI 10.1016/S0926-6410(00)00028-8; KARNI A, 1995, NATURE, V377, P155; Kim DE, 2004, HUM BRAIN MAPP, V23, P188, DOI 10.1002/hbm.20058; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; Kolb B, 1998, ANNU REV PSYCHOL, V49, P43, DOI 10.1146/annurev.psych.49.1.43; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Leocani L, 2000, BRAIN, V123, P1161, DOI 10.1093/brain/123.6.1161; Li SY, 2010, CEREB CORTEX, V20, P25, DOI 10.1093/cercor/bhp074; Lotze M, 2003, NEUROIMAGE, V20, P1817, DOI 10.1016/j.neuroimage.2003.07.018; MEYER BU, 1995, BRAIN, V118, P429, DOI 10.1093/brain/118.2.429; Nudo RJ, 1996, J NEUROSCI, V16, P785; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASCUALLEONE A, 1993, BRAIN, V116, P39, DOI 10.1093/brain/116.1.39; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; RASMUSSEN P, 1993, DEV MED CHILD NEUROL, V35, P699; RECANZONE GH, 1992, CEREB CORTEX, V2, P181, DOI 10.1093/cercor/2.3.181; Reitz M, 1998, NEUROSCI LETT, V256, P69, DOI 10.1016/S0304-3940(98)00748-4; Ridding MC, 2000, EXP BRAIN RES, V133, P249, DOI 10.1007/s002210000428; Rosenkranz K, 2007, J NEUROSCI, V27, P5200, DOI 10.1523/JNEUROSCI.0836-07.2007; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; Schnitzler A, 1996, EXP BRAIN RES, V112, P381; SCHOTT GD, 1981, J NEUROL NEUROSUR PS, V44, P586, DOI 10.1136/jnnp.44.7.586; Spagnolo F, 2013, BRAIN STIMUL, V6, P892, DOI 10.1016/j.brs.2013.05.004; Steele CJ, 2013, J NEUROSCI, V33, P1282, DOI 10.1523/JNEUROSCI.3578-12.2013; Triggs WJ, 1999, BRAIN RES, V835, P324, DOI 10.1016/S0006-8993(99)01629-7; Trompetto C, 2003, CLIN NEUROPHYSIOL, V114, P2181, DOI 10.1016/S1388-2457(03)00213-X; WASSERMANN EM, 1994, EXP BRAIN RES, V100, P121; WILSON SA, 1993, J NEUROL SCI, V118, P134, DOI 10.1016/0022-510X(93)90102-5; Zijdewind I, 2001, J NEUROPHYSIOL, V85, P1907, DOI 10.1152/jn.2001.85.5.1907	53	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157952	10.1371/journal.pone.0157952	http://dx.doi.org/10.1371/journal.pone.0157952			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336584	gold, Green Published, Green Submitted			2022-12-26	WOS:000378389200072
J	Kim, DJ; Yu, JH; Shin, MS; Shin, YW; Kim, MS				Kim, Dae-Jin; Yu, Ji Hee; Shin, Mi-Seon; Shin, Yong-Wook; Kim, Min-Seon			Hyperglycemia Reduces Efficiency of Brain Networks in Subjects with Type 2 Diabetes	PLOS ONE			English	Article							WHITE-MATTER ABNORMALITIES; SURFACE-BASED ANALYSIS; COGNITIVE DYSFUNCTION; INTEGRITY; SEGREGATION; INTEGRATION	Previous research has shown that the brain is an important target of diabetic complications. Since brain regions are interconnected to form a large-scale neural network, we investigated whether severe hyperglycemia affects the topology of the brain network in people with type 2 diabetes. Twenty middle-aged (average age: 54 years) individuals with poorly controlled diabetes (HbA1c: 8.9-14.6%, 74-136 mmol/mol) and 20 age-, sex-, and education-matched healthy volunteers were recruited. Graph theoretic network analysis was performed with axonal fiber tractography and tract-based spatial statistics (TBSS) using diffusion tensor imaging. Associations between the blood glucose level and white matter network characteristics were investigated. Individuals with diabetes had lower white matter network efficiency (P<0.001) and longer white matter path length (P<0.05) compared to healthy individuals. Higher HbA1c was associated with lower network efficiency (r = -0.53, P = 0.001) and longer network path length (r = 0.40, P<0.05). A disruption in local microstructural integrity was found in the multiple white matter regions and associated with higher HbA1c and fasting plasma glucose levels (corrected P<0.05). Poorer glycemic control is associated with lower efficiency and longer connection paths of the global brain network in individuals with diabetes. Chronic hyperglycemia in people with diabetes may disrupt the brain's topological integration, and lead to mental slowing and cognitive impairment.	[Kim, Dae-Jin] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Yu, Ji Hee] Korea Univ, Div Endocrinol & Metab, Dept Internal Med, Coll Med, Ansan, South Korea; [Shin, Mi-Seon] KEPCO Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Shin, Yong-Wook] Univ Ulsan, Sch Med, ASAN Med Ctr, Dept Psychiat, Seoul, South Korea; [Kim, Min-Seon] Univ Ulsan, Div Endocrinol & Metab, Coll Med, Seoul, South Korea; [Kim, Min-Seon] ASAN Med Ctr, Ctr Diabet, Seoul, South Korea	Indiana University System; Indiana University Bloomington; Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; Asan Medical Center	Shin, YW (corresponding author), Univ Ulsan, Sch Med, ASAN Med Ctr, Dept Psychiat, Seoul, South Korea.; Kim, MS (corresponding author), Univ Ulsan, Div Endocrinol & Metab, Coll Med, Seoul, South Korea.; Kim, MS (corresponding author), ASAN Med Ctr, Ctr Diabet, Seoul, South Korea.	shaman_korea@mac.com; mskim@amc.seoul.kr		Shin, Yong-Wook/0000-0002-0360-6118; Yu, Ji Hee/0000-0003-1907-2859; Kim, Dae-Jin/0000-0001-6664-0869	National Research Foundation of Korea [NRF-2014R1A6A3A01057664]; ASAN Institute for Life Sciences [14-326]	National Research Foundation of Korea(National Research Foundation of Korea); ASAN Institute for Life Sciences	This study was supported by grants from the National Research Foundation of Korea (NRF-2014R1A6A3A01057664), and the ASAN Institute for Life Sciences (14-326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers JW, 2007, DIABETES CARE, V30, P2613, DOI 10.2337/dc07-0850; Ariza P, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00255; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Colom Roberto, 2010, Dialogues Clin Neurosci, V12, P489; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deco G, 2015, NAT REV NEUROSCI, V16, P430, DOI 10.1038/nrn3963; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Hsu JL, 2012, NEUROIMAGE, V59, P1098, DOI 10.1016/j.neuroimage.2011.09.041; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; IVANCIUC O, 1993, J MATH CHEM, V12, P309, DOI 10.1007/BF01164642; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kawai N, 1998, ACT NEUR S, V71, P219; Kim DJ, 2016, NEUROIMAGE, V124, P550, DOI 10.1016/j.neuroimage.2015.09.012; Kim DJ, 2014, NEUROIMAGE, V100, P619, DOI 10.1016/j.neuroimage.2014.06.048; Kodl CT, 2008, DIABETES, V57, P3083, DOI 10.2337/db08-0724; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; McCrimmon RJ, 2012, LANCET, V379, P2291, DOI 10.1016/S0140-6736(12)60360-2; Meehan TP, 2012, NEUROSCI BIOBEHAV R, V36, P2232, DOI 10.1016/j.neubiorev.2012.08.002; Munshi M, 2006, DIABETES CARE, V29, P1794, DOI 10.2337/dc06-0506; Papo D, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00096; PLAVSIC D, 1993, J MATH CHEM, V12, P235, DOI 10.1007/BF01164638; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Reijmer YD, 2013, DIABETES, V62, P2112, DOI 10.2337/db12-1644; Reijmer YD, 2013, DIABETES CARE, V36, P137, DOI 10.2337/dc12-0493; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Ryan CM, 2000, DIABETES CARE, V23, P1486, DOI 10.2337/diacare.23.10.1486; Shimoji K, 2013, DIABETES CARE, V36, P696, DOI 10.2337/dc12-0666; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Sporns O., 2011, NETWORKS BRAIN; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; van Duinkerken E, 2012, DIABETOLOGIA, V55, P1218, DOI 10.1007/s00125-012-2488-2; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Woolrich Mark W, 2009, Neuroimage, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zhang AF, 2013, NEUROPSYCHOPHARMACOL, V38, P1451, DOI 10.1038/npp.2013.41; Zhang JY, 2014, DIABETES, V63, P3596, DOI 10.2337/db14-0342	40	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157268	10.1371/journal.pone.0157268	http://dx.doi.org/10.1371/journal.pone.0157268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336309	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200014
J	Loureiro, I; Escorial, MC; Chueca, MC				Loureiro, Inigo; Escorial, Maria-Concepcion; Chueca, Maria-Cristina			Pollen-Mediated Movement of Herbicide Resistance Genes in Lolium rigidum	PLOS ONE			English	Article							ANNUAL RYEGRASS; WIDESPREAD OCCURRENCE; PERENNIAL RYEGRASS; TRITICUM-AESTIVUM; ACETYL-COENZYME; FLOW; DISPERSAL; EVOLUTION; ALLELES; RELEASE	The transfer of herbicide resistance genes by pollen is a major concern in cross-pollinated species such as annual ryegrass (Lolium rigidum). A two-year study was conducted in the greenhouse, under favorable conditions for pollination, to generate information on potential maximum cross-pollination. This maximum cross-pollination rate was 56.1%. A three-year field trial was also conducted to study the cross-pollination rates in terms of distance and orientation to an herbicide-resistant pollen source. Under field conditions, cross-pollination rates varied from 5.5% to 11.6% in plants adjacent to the pollen source and decreased with increasing distances (1.5 to 8.9% at 15 m distance and up to 4.1% at 25 m in the downwind direction). Environmental conditions influenced the cross-pollination both under greenhouse and field conditions. Data were fit to an exponential decay model to predict gene flow at increasing distances. This model predicted an average gene flow of 7.1% when the pollen donor and recipient plants were at 0 m distance from each other. Pollen-mediated gene flow declined by 50% at 16.7 m from the pollen source, yet under downwind conditions gene flow of 5.2% was predicted at 25 m, the farthest distance studied. Knowledge of cross-pollination rates will be useful for assessing the spread of herbicide resistance genes in L. rigidum and in developing appropriate strategies for its mitigation.	[Loureiro, Inigo; Escorial, Maria-Concepcion; Chueca, Maria-Cristina] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Plant Protect, Weed Control Grp, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Chueca, MC (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Plant Protect, Weed Control Grp, Madrid, Spain.	chueca@inia.es	Loureiro, Iñigo/F-2451-2010; Escorial, María Concepción/ABG-2982-2020	Loureiro, Iñigo/0000-0003-3022-2002; Escorial Bonet, Maria Concepcion/0000-0001-5507-5956	Comision Interministerial de Ciencia y Tecnologia (CICYT) of Spain [AGL2004-07101-C02-01/AGR]	Comision Interministerial de Ciencia y Tecnologia (CICYT) of Spain(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT))	This work was supported by the Comision Interministerial de Ciencia y Tecnologia (CICYT) of Spain, project AGL2004-07101-C02-01/AGR.	Bagavathiannan MV, 2014, PEST MANAG SCI, V70, P1425, DOI 10.1002/ps.3775; Balfourier F, 1998, HEREDITY, V81, P100, DOI 10.1046/j.1365-2540.1998.00381.x; Busi R, 2008, THEOR APPL GENET, V117, P1281, DOI 10.1007/s00122-008-0862-8; Busi R, 2013, EVOL APPL, V6, P231, DOI 10.1111/j.1752-4571.2012.00282.x; Busi R, 2011, AGR ECOSYST ENVIRON, V142, P403, DOI 10.1016/j.agee.2011.06.012; Chandler S, 2008, CRIT REV PLANT SCI, V27, P25, DOI 10.1080/07352680802053916; Cunliffe KV, 2004, AUST J AGR RES, V55, P389, DOI 10.1071/AR03156; Darmency H, 1996, ACS SYM SER, V645, P209; Delye C, 2010, BASIC APPL ECOL, V11, P504, DOI 10.1016/j.baae.2010.06.008; DEVRIES AP, 1971, EUPHYTICA, V20, P152, DOI 10.1007/BF00056076; Duke SO, 2012, PEST MANAG SCI, V68, P505, DOI 10.1002/ps.2333; Giddings G, 2000, THEOR APPL GENET, V100, P971, DOI 10.1007/s001220051378; Giddings GD, 1997, THEOR APPL GENET, V94, P1000, DOI 10.1007/s001220050507; Heap I., 2015, INT SURVEY HERBICIDE; Jasieniuk M, 1996, WEED SCI, V44, P176, DOI 10.1017/S0043174500093747; Llewellyn RS, 2006, CROP PROT, V25, P520, DOI 10.1016/j.cropro.2005.08.007; Loureiro I, 2015, P 17 EWRS S WEED MAN, P112; Loureiro I, 2007, EUPHYTICA, V156, P25, DOI 10.1007/s10681-006-9345-7; Loureiro I, 2012, TRANSGENIC RES, V21, P1329, DOI 10.1007/s11248-012-9619-x; Loureiro I, 2010, CROP PROT, V29, P1248, DOI 10.1016/j.cropro.2010.07.005; Malone JM, 2014, WEED RES, V54, P78, DOI 10.1111/wre.12050; MAXWELL B D, 1992, Bulletin of the Ecological Society of America, V73, P264; Maxwell Bruce D., 1994, P1; McPherson Marc A., 2009, Environmental Biosafety Research, V8, P19, DOI 10.1051/ebr/2008023; Menchari Y, 2006, NEW PHYTOL, V171, P861, DOI 10.1111/j.1469-8137.2006.01788.x; Neve P, 2005, THEOR APPL GENET, V110, P1154, DOI 10.1007/s00122-005-1947-2; Owen MJ, 2014, WEED RES, V54, P314, DOI 10.1111/wre.12068; Owen MJ, 2007, AUST J AGR RES, V58, P711, DOI 10.1071/AR06283; POWLES SB, 1992, RESISTANCE 91 : ACHIEVEMENTS AND DEVELOPMENTS IN COMBATING PESTICIDE RESISTANCE, P75; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Rauch TA, 2010, WEED TECHNOL, V24, P281, DOI 10.1614/WT-D-09-00059.1; Renton M, 2014, PEST MANAG SCI, V70, P1394, DOI 10.1002/ps.3773; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Sosnoskie LM, 2012, WEED SCI, V60, P366, DOI 10.1614/WS-D-11-00151.1; STALLINGS GP, 1995, WEED SCI, V43, P95, DOI 10.1017/S0043174500080887; StatPoint Technologies Inc, 2010, STATGR CENT 16 US MA, P297; Tardif FJ, 1996, AUST J PLANT PHYSIOL, V23, P15, DOI 10.1071/PP9960015; Wang ZY, 2004, MOL BREEDING, V14, P47, DOI 10.1023/B:MOLB.0000037994.26287.17; Watrud LS, 2004, P NATL ACAD SCI USA, V101, P14533, DOI 10.1073/pnas.0405154101; WILKINS PW, 1992, EUPHYTICA, V64, P65; Willenborg CJ, 2010, TRANSGENIC RES, V19, P449, DOI 10.1007/s11248-009-9322-8; Yerka MK, 2012, WEED SCI, V60, P600, DOI 10.1614/WS-D-12-00030.1; Yu Q, 2014, PLANT PHYSIOL, V166, P1106, DOI 10.1104/pp.114.242750	43	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157892	10.1371/journal.pone.0157892	http://dx.doi.org/10.1371/journal.pone.0157892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336441	gold, Green Submitted, Green Published			2022-12-26	WOS:000378389200060
J	Soder, B; Meurman, JH; Soder, PO				Soder, Birgitta; Meurman, Jukka H.; Soder, Per-Osten			Dental Calculus Links Statistically to Angina Pectoris: 26-Year Observational Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ORAL-HEALTH; PORPHYROMONAS-GINGIVALIS; PERIODONTAL-DISEASE; PREVENTION; ASSOCIATION; ATHEROSCLEROSIS; SUPRAGINGIVAL; REMOVAL; REASONS	Objectives Dental infections, such as periodontitis, associate with atherosclerosis and its complications. We studied a cohort followed-up since 1985 for incidence of angina pectoris with the hypothesis that calculus accumulation, proxy for poor oral hygiene, links to this symptom. Methods In our Swedish prospective cohort study of 1676 randomly selected subjects followed-up for 26 years. In 1985 all subjects underwent clinical oral examination and answered a questionnaire assessing background variables such as socio-economic status and pack-years of smoking. By using data from the Center of Epidemiology, Swedish National Board of Health and Welfare, Sweden we analyzed the association of oral health parameters with the prevalence of in-hospital verified angina pectoris classified according to the WHO International Classification of Diseases, using descriptive statistics and logistic regression analysis. Results Of the 1676 subjects, 51 (28 women/23 men) had been diagnosed with angina pectoris at a mean age of 59.8 +/- 2.9 years. No difference was observed in age and gender between patients with angina pectoris and subjects without. Neither was there any difference in education level and smoking habits (in pack years), Gingival index and Plaque index between the groups. Angina pectoris patients had significantly more often their first maxillary molar tooth extracted (d. 16) than the other subjects (p = 0.02). Patients also showed significantly higher dental calculus index values than the subjects without angina pectoris (p = 0.01). Multiple regression analysis showed odds ratio 2.21 (95% confidence interval 1.17-4.17) in the association between high calculus index and angina pectoris (p = 0.015). Conclusion Our study hypothesis was confirmed by showing for the first time that high dental calculus score indeed associated with the incidence of angina pectoris in this cohort study.	[Soder, Birgitta; Soder, Per-Osten] Karolinska Inst, Dept Dent Med, Huddinge, Sweden; [Meurman, Jukka H.] Univ Helsinki, Dept Oral & Maxillofacial Dis, Helsinki, Finland; [Meurman, Jukka H.] Helsinki Univ Hosp, Helsinki, Finland	Karolinska Institutet; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Soder, B (corresponding author), Karolinska Inst, Dept Dent Med, Huddinge, Sweden.	birgitta.soder@ki.se		Meurman, Jukka/0000-0001-6702-6836	Swedish Ministry of Health and Social Affairs [F84/189]; Karolinska Institutet, Stockholm, Sweden, Helsinki University Hospital [EVO TYH20113334]; Medical Society of Finland; King Gustav V and Queen Victoria's Freemasons Foundation	Swedish Ministry of Health and Social Affairs; Karolinska Institutet, Stockholm, Sweden, Helsinki University Hospital; Medical Society of Finland; King Gustav V and Queen Victoria's Freemasons Foundation	The study was supported by grants from the Swedish Ministry of Health and Social Affairs (grants F84/189), by the Karolinska Institutet, Stockholm, Sweden, Helsinki University Hospital (EVO TYH20113334), The Medical Society of Finland, and by the King Gustav V and Queen Victoria's Freemasons Foundation.	Brennan RM, 2007, J PERIODONTOL, V78, P2104, DOI 10.1902/jop.2007.070155; Clerehugh V, 1986, Community Dent Health, V3, P135; Cotti E, 2011, INT J CARDIOL, V148, P4, DOI 10.1016/j.ijcard.2010.08.011; FRISKOPP J, 1982, ACTA ODONTOL SCAND, V40, P459, DOI 10.3109/00016358209025121; GREENE JC, 1964, J AM DENT ASSOC, V68, P7, DOI 10.14219/jada.archive.1964.0034; Janket SJ, 2004, CIRCULATION, V109, P1095, DOI 10.1161/01.CIR.0000118497.44961.1E; Jepsen S, 2011, PERIODONTOL 2000, V55, P167, DOI 10.1111/j.1600-0757.2010.00382.x; Johansson CS, 2008, J CLIN PERIODONTOL, V35, P199, DOI 10.1111/j.1600-051X.2007.01185.x; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Marfil-Alvarez R, 2014, J DENT RES, V93, P993, DOI 10.1177/0022034514548223; Meurman JH, 2004, CRIT REV ORAL BIOL M, V15, P403, DOI 10.1177/154411130401500606; Meurman JH, 2003, ORAL SURG ORAL MED O, V95, P300, DOI 10.1067/moe.2003.22; Moutsopoulos NM, 2006, ANN NY ACAD SCI, V1088, P251, DOI 10.1196/annals.1366.032; Nichols FC, 2006, ORAL MICROBIOL IMMUN, V21, P84, DOI 10.1111/j.1399-302X.2006.00264.x; Nichols FC, 2001, J PERIODONTAL RES, V36, P142, DOI 10.1034/j.1600-0765.2001.360302.x; Offenbacher S, 2009, J PERIODONTOL, V80, P190, DOI [10.1902/jop.2009.080007, 10.1902/jop.2009.080007 ]; Orlandi M, 2014, ATHEROSCLEROSIS, V236, P39, DOI 10.1016/j.atherosclerosis.2014.06.002; Pasqualini D, 2012, J ENDODONT, V38, P1570, DOI 10.1016/j.joen.2012.08.013; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Reyes L, 2013, J PERIODONTOL, V84, pS30, DOI [10.1902/jop.2013.1340012, 10.1111/jcpe.12079]; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; SOCRANSKY SS, 1963, ARCH ORAL BIOL, V8, P275, DOI 10.1016/0003-9969(63)90019-0; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Soder B, 2007, J PERIODONTAL RES, V42, P361, DOI 10.1111/j.1600-0765.2006.00957.x; Soder B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/569675; Soder PO, 2005, STROKE, V36, P1195, DOI 10.1161/01.STR.0000165916.90593.cb; Spalj S, 2004, COLLEGIUM ANTROPOL, V28, P833; Tan BTK, 2004, J PERIODONTOL, V75, P23, DOI 10.1902/jop.2004.75.1.23; THEILADE J, 1964, ARCH ORAL BIOL, V9, P97, DOI 10.1016/0003-9969(64)90051-2; THEILADE J, 1964, Acta Odontol Scand, V22, P379, DOI 10.3109/00016356409028213; Tonetti MS, 2015, J CLIN PERIODONTOL, V42, pS5, DOI 10.1111/jcpe.12368; Tonetti MS, 2015, J CLIN PERIODONT S16, V42, pS5, DOI [10.1111/jcpe.12368, DOI 10.1111/JCPE.12368]; Trovik TA, 2000, ACTA ODONTOL SCAND, V58, P89, DOI 10.1080/000163500429343; White DJ, 1997, EUR J ORAL SCI, V105, P508, DOI 10.1111/j.1600-0722.1997.tb00238.x; Ziebolz D, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-17	36	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157797	10.1371/journal.pone.0157797	http://dx.doi.org/10.1371/journal.pone.0157797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336307	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200047
J	Araujo-Mariz, C; Lopes, EP; Acioli-Santos, B; Maruza, M; Montarroyos, UR; Ximenes, RAD; Lacerda, HR; Miranda, DD; de Albuquerque, MDPM				Araujo-Mariz, Carolline; Lopes, Edmundo Pessoa; Acioli-Santos, Bartolomeu; Maruza, Magda; Montarroyos, Ulisses Ramos; de Alencar Ximenes, Ricardo Arraes; Lacerda, Heloisa Ramos; Miranda-Filho, Democrito de Barros; Militao de Albuquerque, Maria de Fatima P.			Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS	PLOS ONE			English	Article							DRUG-INDUCED HEPATOTOXICITY; ANTIRETROVIRAL THERAPY; RISK-FACTORS; INDUCED HEPATITIS; HIV; POLYMORPHISMS; NAT2; ASSOCIATION; CYP2E1; VIRUS	Hepatotoxicity is frequently reported as an adverse reaction during the treatment of tuberculosis. The aim of this study was to determine the incidence of hepatotoxicity and to identify predictive factors for developing hepatotoxicity after people living with HIV/AIDS (PLWHA) start treatment for tuberculosis. This was a prospective cohort study with PLWHA who were monitored during the first 60 days of tuberculosis treatment in Pernambuco, Brazil. Hepatotoxicity was considered increased levels of aminotransferase, namely those that rose to three times higher than the level before initiating tuberculosis treatment, these levels being associated with symptoms of hepatitis. We conducted a multivariate logistic regression analysis and the magnitude of the associations was expressed by the odds ratio with a confidence interval of 95%. Hepatotoxicity was observed in 53 (30.6%) of the 173 patients who started tuberculosis treatment. The final multivariate logistic regression model demonstrated that the use of fluconazole, malnutrition and the subject being classified as a phenotypically slow acetylator increased the risk of hepatotoxicity significantly. The incidence of hepatotoxicity during treatment for tuberculosis in PLWHA was high. Those classified as phenotypically slow acetylators and as malnourished should be targeted for specific care to reduce the risk of hepatotoxicity during treatment for tuberculosis. The use of fluconazole should be avoided during tuberculosis treatment in PLWHA.	[Araujo-Mariz, Carolline; Lopes, Edmundo Pessoa; de Alencar Ximenes, Ricardo Arraes; Lacerda, Heloisa Ramos] Univ Fed Pernambuco, Dept Med Trop, Recife, PE, Brazil; [Acioli-Santos, Bartolomeu] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Lab Virol, Recife, PE, Brazil; [Maruza, Magda] Hosp Correia Picanco, Secretaria Saude Pernambuco, Recife, PE, Brazil; [Montarroyos, Ulisses Ramos] Univ Fed Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil; [de Alencar Ximenes, Ricardo Arraes; Miranda-Filho, Democrito de Barros] Univ Fed Pernambuco, Fac Ciencias Med, Recife, PE, Brazil; [Militao de Albuquerque, Maria de Fatima P.] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Dept Saude Colet, Recife, PE, Brazil	Universidade Federal de Pernambuco; Fundacao Oswaldo Cruz; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Fundacao Oswaldo Cruz	Araujo-Mariz, C (corresponding author), Univ Fed Pernambuco, Dept Med Trop, Recife, PE, Brazil.	carollinedearaujo@gmail.com	Lopes, Edmundo/R-5159-2017; Montarroyos, Ulisses/AAJ-7527-2020; Araujo, Carolline/Z-2540-2019	Lopes, Edmundo/0000-0002-3470-1564; Araujo, Carolline/0000-0002-7651-9429	Brazilian Ministry of Health/Programa DST/AIDS/UNESCO [CSV 182/06]; Ministries of Science and Technology CNPq/MSSCTIE-DECIT [10567/2006-0]; CNPq [308311/2009-4, 301779/2009-0, 310911/2009-5]	Brazilian Ministry of Health/Programa DST/AIDS/UNESCO; Ministries of Science and Technology CNPq/MSSCTIE-DECIT; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors are grateful to the Brazilian Ministry of Health/Programa DST/AIDS/UNESCO (Projeto CSV 182/06) for their financial support and to the Ministries of Science and Technology CNPq/MSSCTIE-DECIT (Processo no 10567/2006-0). The authors were partially supported by CNPq (Productivity Grant 308311/2009-4 for R.A.A.X., Productivity Grant 301779/2009-0 for M.F.P.M.A., and Study Grant 310911/2009-5 for H.R.L.).; We are grateful to the Brazilian Ministry of Health/Programa DST/AIDS/UNESCO (Projeto CSV 182/06) for their financial support and to the Ministry of Science and Technology CNPq/MSSCTIE-DECIT (Processo no 10567/2006-0). The authors were partially supported by CNPq (Productivity Grant 308311/2009-4 for R.A.A.X. and Productivity Grant 301779/2009-0 for M.F.P.M.A. and Study Grant 310911/2009-5 for H.R.L.).	Ali AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064622; Anand A C, 2006, Med J Armed Forces India, V62, P45, DOI 10.1016/S0377-1237(06)80155-3; [Anonymous], 1987, MMWR-MORBID MORTAL W, V36, p1S; BENICHOU C, 1990, J HEPATOL, V11, P272; Breen RAM, 2006, THORAX, V61, P791, DOI 10.1136/thx.2006.058867; Cai Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047769; Carvalho CN, 2011, REV SAUDE PUBL, V45, P548, DOI 10.1590/S0034-89102011005000021; Costa GNO, 2012, MOL DIAGN THER, V16, P241, DOI 10.2165/11634480-000000000-00000; Teixeira RLD, 2011, MEM I OSWALDO CRUZ, V106, P716, DOI 10.1590/S0074-02762011000600011; El-Sadr WM, 2008, SEMIN RESP CRIT CARE, V29, P525, DOI 10.1055/s-0028-1085703; Gupta VH, 2013, J GASTROEN HEPATOL, V28, P1368, DOI 10.1111/jgh.12194; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144; Macallan DC, 1999, P NUTR SOC, V58, P743, DOI 10.1017/S002966519900097X; Coca NSM, 2010, REV SOC BRAS MED TRO, V43, P624, DOI 10.1590/S0037-86822010000600004; Mahmood K, 2007, PAK J MED SCI, V23, P33; Makhlouf HA, 2008, HEPATOL INT, V2, P353, DOI 10.1007/s12072-008-9085-y; Mankhatitham W, 2011, SE ASIAN J TROP MED, V42, P651; Marzuki OA, 2008, SINGAP MED J, V49, P688; Ministerio da Saude Secretaria de Vigilancia^ em Saude Programa Nacional de Controle da Tuberculose, 2013, MAN REC TUB, P288; MITCHELL JR, 1975, CLIN PHARMACOL THER, V18, P70; Mo PZ, 2014, INT J INFECT DIS, V28, P95, DOI 10.1016/j.ijid.2014.06.020; Possuelo LG, 2008, EUR J CLIN PHARMACOL, V64, P673, DOI 10.1007/s00228-008-0484-8; Pukenyte E, 2007, INT J TUBERC LUNG D, V11, P78; Sabbagh A, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-30; Santos NPC, 2013, INT J TUBERC LUNG D, V17, P499, DOI 10.5588/ijtld.12.0645; Scevola D, 2000, AIDS Read, V10, P365; [Secretaria de Vigilancia em Saude Departamento de Vigilancia Epidemiologica Ministerio da Saude], 2014, B EP O CONTR TUB BRA, V45; Sharma SK, 2002, AM J RESP CRIT CARE, V166, P916, DOI 10.1164/rccm.2108091; Sieleunou I, 2009, TROP MED INT HEALTH, V14, P36, DOI 10.1111/j.1365-3156.2008.02183.x; Singla N, 2014, TUBERCULOSIS, V94, P293, DOI 10.1016/j.tube.2014.02.003; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Ungo JR, 1998, AM J RESP CRIT CARE, V157, P1871, DOI 10.1164/ajrccm.157.6.9711039; Uriz J, 2007, AN SIST SANIT NAVAR, V30, P131; Vuilleumier Nicolas, 2006, Eur J Clin Pharmacol, V62, P423; Wang JL, 2010, ANTIMICROB AGENTS CH, V54, P2409, DOI 10.1128/AAC.01657-09; Yimer G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094271; Yimer G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027810; Zaverucha-do-Valle C, 2014, TUBERCULOSIS, V94, P299, DOI 10.1016/j.tube.2014.03.006	40	14	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157725	10.1371/journal.pone.0157725	http://dx.doi.org/10.1371/journal.pone.0157725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332812	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212800045
J	Halley, MR; Heckscher, CM; Kalavacharla, V				Halley, Matthew R.; Heckscher, Christopher M.; Kalavacharla, Venugopal			Multi-Generational Kinship, Multiple Mating, and Flexible Modes of Parental Care in a Breeding Population of the Veery (Catharus fuscescens), a Trans-Hemispheric Migratory Songbird	PLOS ONE			English	Article							INBREEDING AVOIDANCE; KIN RECOGNITION; NATAL DISPERSAL; MALE FEEDERS; COMPETITION; EVOLUTION; PATERNITY; NEST; PHILOPATRY; LIGHT	We discovered variable modes of parental care in a breeding population of color-banded Veeries (Catharus fuscescens), a Nearctic-Neotropical migratory songbird, long thought to be socially monogamous, and performed a multi-locus DNA microsatellite analysis to estimate parentage and kinship in a sample of 37 adults and 21 offspring. We detected multiple mating in both sexes, and four modes of parental care that varied in frequency within and between years including multiple male feeders at some nests, and males attending multiple nests in the same season, each with a different female. Unlike other polygynandrous systems, genetic evidence indicates that multi-generational patterns of kinship occur among adult Veeries at our study site, and this was corroborated by the capture of an adult male in 2013 that had been banded as a nestling in 2011 at a nest attended by multiple male feeders. All genotyped adults (n = 37) were related to at least one other bird in the sample at the cousin level or greater (r >= 0.125), and 81% were related to at least one other bird at the half-sibling level or greater (r >= 0.25, range 0.25-0.60). Although our sample size is small, it appears that the kin structure is maintained by natal philopatry in both sexes, and that Veeries avoid mating with close genetic kin. At nests where all adult feeders were genotyped (n = 9), the male(s) were unrelated to the female (mean r = -0.11 +/- 0.15), whereas genetic data suggest close kinship (r = 0.254) between two male co-feeders at the nests of two females in 2011, and among three of four females that were mated to the same polygynous male in 2012. To our knowledge, this is the first evidence of polygynandry occurring among multiple generations of close genetic kin on the breeding ground of a Nearctic-Neotropical migratory songbird.	[Halley, Matthew R.; Heckscher, Christopher M.; Kalavacharla, Venugopal] Delaware State Univ, Dept Agr & Nat Resources, Dover, DE 19901 USA; [Halley, Matthew R.; Kalavacharla, Venugopal] Delaware State Univ, Ctr Integrated Biol & Environm Res, Dover, DE 19901 USA; [Halley, Matthew R.] Drexel Univ, Acad Nat Sci, Philadelphia, PA 19104 USA; [Halley, Matthew R.] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA	Delaware State University; Delaware State University; Drexel University; Drexel University	Halley, MR (corresponding author), Delaware State Univ, Dept Agr & Nat Resources, Dover, DE 19901 USA.; Halley, MR (corresponding author), Delaware State Univ, Ctr Integrated Biol & Environm Res, Dover, DE 19901 USA.; Halley, MR (corresponding author), Drexel Univ, Acad Nat Sci, Philadelphia, PA 19104 USA.; Halley, MR (corresponding author), Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA.	matthewhalley@gmail.com		Heckscher, Christopher/0000-0002-5652-7632	Delaware EPSCoR from National Science Foundation [EPS-0814251]; CIBER from National Science Foundation [EPS-0814251]; State of Delaware; Delaware Division of Parks and Recreation; DSU Molecular Genetics AMP; Epigenomics Laboratory	Delaware EPSCoR from National Science Foundation; CIBER from National Science Foundation; State of Delaware; Delaware Division of Parks and Recreation; DSU Molecular Genetics AMP; Epigenomics Laboratory	The authors acknowledge support provided by Delaware EPSCoR and CIBER with funds from the National Science Foundation Grant EPS-0814251 and the State of Delaware. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are grateful to R. Trivers, M. Webster, K. Vulinec, R. Barczewski, A. Stein, and A. Halley for reviewing early drafts of the manuscript. Research was conducted with the support of the Delaware Division of Parks and Recreation, the staff of White Clay Creek State Park, and the DSU Molecular Genetics & Epigenomics Laboratory, including C. Bennett, R. Line, N. McFadden, P. Stampul, S. Taylor, B. Bruce, M. Wallrichs, V. Gomez-Bahamon, M. Gutierrez-Ramirez, L. Gonce, A. Todd, V. Ayyappan, K. Melmaiee, E. Fiedler, A. Brown, R. Kusi-Appah, and J. DeYoung. We acknowledge support provided by Delaware EPSCoR and CIBER with funds from the National Science Foundation Grant EPS-0814251 and the State of Delaware. The funders had no input into the content of the manuscript, nor did they require their approval before submission or publication. This research was conducted in compliance with the Guidelines to the Use of Wild Birds in Research.	ANNAN ORMSBY, 1961, JACK PINE WARBLER, V39, P62; Blaustein A.R., 1987, P287; Briskie JV, 1998, BEHAV ECOL SOCIOBIOL, V43, P181; Brown J.L., 1987, HELPING COMMUNAL BRE; BROWN JL, 1994, AM NAT, V143, P435, DOI 10.1086/285612; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Cockburn Andrew, 2004, P81, DOI 10.1017/CBO9780511606816.006; CRAIG JL, 1988, AM NAT, V131, P58, DOI 10.1086/284773; Creighton E, 2001, IBIS, V143, P322, DOI 10.1111/j.1474-919X.2001.tb04493.x; Davies N. B., 1992, DUNNOCK BEHAV SOCIAL; Day K. C., 1953, Bird-Banding, V24, P100; DILGER W. C., 1956, AUK, V73, P313; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Evans ML, 2008, AUK, V125, P67, DOI 10.1525/auk.2008.125.1.67; Gibbs HL, 1999, MOL ECOL, V8, P1551; Goetz JE, 2003, AUK, V120, P1044, DOI 10.1642/0004-8038(2003)120[1044:MPAMMF]2.0.CO;2; Greeney HF, 2015, WILSON J ORNITHOL, V127, P323, DOI 10.1676/wils-127-02-323-325.1; Halley MR, 2013, WILSON J ORNITHOL, V125, P823, DOI 10.1676/13-048.1; Halley MR, 2012, WILSON J ORNITHOL, V124, P396; Halley MR, 2014, THESIS; Hamilton W.D., 1971, MAN BEAST COMP SOCIA, P57; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hansson B, 2007, BEHAV ECOL, V18, P157, DOI 10.1093/beheco/arl062; Harding KC, 1925, B NE BIRD BANDING AS, V1, P4; HARTLEY IR, 1994, P ROY SOC B-BIOL SCI, V257, P67, DOI 10.1098/rspb.1994.0095; HATCHWELL BJ, 1992, ANIM BEHAV, V43, P595, DOI 10.1016/0003-3472(92)90082-K; Heckscher CM, 2015, J TROP ECOL, V31, P285, DOI 10.1017/S0266467415000024; Heckscher CM, 2011, AUK, V128, P531, DOI 10.1525/auk.2011.10280; Heckscher CM., 2007, THESIS; Hobson KA, 2015, AUK, V132, P540, DOI 10.1642/AUK-14-260.1; Houston A.I., 1985, P471; Howell S. N, 1997, IDENTIFICATION GUIDE; Koenig Walter D., 2004, P142, DOI 10.1017/CBO9780511606816.010; KOENIG WD, 1981, ANIM BEHAV, V29, P396, DOI 10.1016/S0003-3472(81)80099-1; Komdeur J, 1999, TRENDS ECOL EVOL, V14, P237, DOI 10.1016/S0169-5347(98)01573-0; Lack D., 1968, pvii; Lack D., 1954, P343; Ligon J. David, 2004, P5, DOI 10.1017/CBO9780511606816.002; Magrath RD, 1997, BEHAV ECOL SOCIOBIOL, V41, P185, DOI 10.1007/s002650050378; Marshall J. T., 2000, GRAY CHEEKED THRUSH; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Nakamura M, 1998, ANIM BEHAV, V55, P259, DOI 10.1006/anbe.1997.0725; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Riehl C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2245; Rimmer CC, 2002, AUK, V119, P583; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; SHELDON BC, 1994, ANIM BEHAV, V47, P163, DOI 10.1006/anbe.1994.1018; SHIELDS WM, 1984, AUK, V101, P780, DOI 10.2307/4086904; SKUTCH ALEXANDER F., 1961, CONDOR, V63, P198, DOI 10.2307/1365683; SKUTCH ALEXANDER F., 1935, AUK, V52, P257; Stearns S., 1987, EVOLUTION SEX ITS CO; Strong AM, 2004, AUK, V121, P446, DOI 10.1642/0004-8038(2004)121[0446:EOPBOR]2.0.CO;2; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Voelker G, 2013, MOL ECOL, V22, P3333, DOI 10.1111/mec.12305; WALTERS JR, 1992, AUK, V109, P90, DOI 10.2307/4088269; WEATHERHEAD PJ, 1994, BEHAV ECOL, V5, P426, DOI 10.1093/beheco/5.4.426; Webster MS, 2005, METHOD ENZYMOL, V395, P222, DOI 10.1016/S0076-6879(05)95014-3; Wheelwright NT, 1998, ECOLOGY, V79, P755, DOI 10.1890/0012-9658(1998)079[0755:PNDAIA]2.0.CO;2	61	8	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157051	10.1371/journal.pone.0157051	http://dx.doi.org/10.1371/journal.pone.0157051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27331399	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212800019
J	Kim, D; Griffin, BA; Kabeto, M; Escarce, J; Langa, KM; Shih, RA				Kim, Daniel; Griffin, Beth Ann; Kabeto, Mohammed; Escarce, Jose; Langa, Kenneth M.; Shih, Regina A.			Lagged Associations of Metropolitan Statistical Area- and State-Level Income Inequality with Cognitive Function: The Health and Retirement Study	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; NEIGHBORHOOD CONTEXT; RESERVE HYPOTHESIS; UNITED-STATES; OLDER-ADULTS; DEMENTIA; EDUCATION; IMPAIRMENT; DECLINE; WOMEN	Purpose Much variation in individual-level cognitive function in late life remains unexplained, with little exploration of area-level/contextual factors to date. Income inequality is a contextual factor that may plausibly influence cognitive function. Methods In a nationally-representative cohort of older Americans from the Health and Retirement Study, we examined state-and metropolitan statistical area (MSA)-level income inequality as predictors of individual-level cognitive function measured by the 27-point Telephone Interview for Cognitive Status (TICS-m) scale. We modeled latency periods of 8-20 years, and controlled for state-/metropolitan statistical area (MSA)-level and individual-level factors. Results Higher MSA-level income inequality predicted lower cognitive function 16-18 years later. Using a 16-year lag, living in a MSA in the highest income inequality quartile predicted a 0.9-point lower TICS-m score (beta = -0.86; 95% CI = -1.41,-0.31), roughly equivalent to the magnitude associated with five years of aging. We observed no associations for state-level income inequality. The findings were robust to sensitivity analyses using propensity score methods. Conclusions Among older Americans, MSA-level income inequality appears to influence cognitive function nearly two decades later. Policies reducing income inequality levels within cities may help address the growing burden of declining cognitive function among older populations within the United States.	[Kim, Daniel] Northeastern Univ, Bouve Coll Hlth Sci, Dept Hlth Sci, Boston, MA 02115 USA; [Griffin, Beth Ann; Escarce, Jose; Shih, Regina A.] RAND Corp, Santa Monica, CA USA; [Kabeto, Mohammed; Langa, Kenneth M.] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Kim, Daniel] Harvard Univ, TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Kim, Daniel] Paris Descartes Univ, Sorbonne Paris Cite, EHESP Sch Publ Hlth, Dept Social & Behav Sci, Paris, France; [Escarce, Jose] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Northeastern University; RAND Corporation; University of Michigan System; University of Michigan; Harvard University; Harvard T.H. Chan School of Public Health; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kim, D (corresponding author), Northeastern Univ, Bouve Coll Hlth Sci, Dept Hlth Sci, Boston, MA 02115 USA.; Kim, D (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA.; Kim, D (corresponding author), Paris Descartes Univ, Sorbonne Paris Cite, EHESP Sch Publ Hlth, Dept Social & Behav Sci, Paris, France.	dkim@neu.edu		Kim, Daniel/0000-0001-8907-6420; Langa, Kenneth/0000-0002-2798-1836	National Institute of Aging [R01 AG043960, U01 AG09740]; Social Security Administration	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Social Security Administration	This work was supported by a grant from the National Institute of Aging (R01 AG043960). The Health and Retirement Study is conducted by the Institute for Social Research at the University of Michigan, with grants from the National Institute on Aging (U01 AG09740) and the Social Security Administration. The funding bodies did not play any role in the study design; the collection, analysis, and interpretation of the data; the writing of the manuscript; or the decision to submit the paper for publication.	Allen KV, 2004, EUR J PHARMACOL, V490, P169, DOI 10.1016/j.ejphar.2004.02.054; Anttila T, 2002, NEUROLOGY, V59, P887, DOI 10.1212/WNL.59.6.887; Bassuk SS, 1999, ANN INTERN MED, V131, P165, DOI 10.7326/0003-4819-131-3-199908030-00002; Blakely TA, 2000, J EPIDEMIOL COMMUN H, V54, P318, DOI 10.1136/jech.54.4.318; Butler SM, 1996, J AM GERIATR SOC, V44, P675, DOI 10.1111/j.1532-5415.1996.tb01831.x; Chodosh J, 2007, AM J GERIAT PSYCHIAT, V15, P406, DOI 10.1097/01.JGP.0b013e31802c0c63; Crooks VC, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-8; Feart C, 2010, CURR OPIN CLIN NUTR, V13, P14, DOI 10.1097/MCO.0b013e3283331fe4; Fratiglioni L, 2007, J ALZHEIMERS DIS, V12, P11; Glymour MM, 2008, J EPIDEMIOL COMMUN H, V62, P532, DOI 10.1136/jech.2006.059469; Karlamangla AS, 2009, AM J EPIDEMIOL, V170, P331, DOI 10.1093/aje/kwp154; Karp A, 2006, DEMENT GERIATR COGN, V21, P65, DOI 10.1159/000089919; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY, P76; Kearns A, 2013, J EPIDEMIOL COMMUN H, V67, P87, DOI 10.1136/jech-2011-200415; Kennedy BP, 2003, HHHHEALTH NATIONS; Kim D, 2008, SOC SCI MED, V66, P1719, DOI 10.1016/j.socscimed.2007.12.030; Kim SY, 2012, ENVIRON HEALTH PERSP, V120, P1094, DOI 10.1289/ehp.1104721; Kondo N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4471; Lang IA, 2008, J AM GERIATR SOC, V56, P191, DOI 10.1111/j.1532-5415.2007.01557.x; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Le Carret N, 2003, DEV NEUROPSYCHOL, V23, P317, DOI 10.1207/S15326942DN2303_1; Lee SM, 2006, NEUROEPIDEMIOLOGY, V26, P93, DOI 10.1159/000090254; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; Masel MC, 2010, ETHNIC HEALTH, V15, P283, DOI 10.1080/13557851003681273; McCaffrey DF, 2013, STAT MED, V32, P3388, DOI 10.1002/sim.5753; McCaffrey DF, TWANG SAS VERSION 1; Ngandu T, 2007, NEUROLOGY, V69, P1442, DOI 10.1212/01.wnl.0000277456.29440.16; Sattler C, 2012, PSYCHIAT RES, V196, P90, DOI 10.1016/j.psychres.2011.11.012; Schwartz BS, 2004, ENVIRON HEALTH PERSP, V112, P314, DOI 10.1289/ehp.6727; Sheffield KM, 2009, AM J EPIDEMIOL, V169, P1092, DOI 10.1093/aje/kwp005; Shih RA, 2011, AM J PUBLIC HEALTH, V101, P1721, DOI 10.2105/AJPH.2011.300169; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stewart R, 1999, DIABETIC MED, V16, P93, DOI 10.1046/j.1464-5491.1999.00027.x; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; Tucker-Drob EA, 2009, DEV PSYCHOL, V45, P431, DOI 10.1037/a0014012; WELSH KA, 1993, NEUROPSY NEUROPSY BE, V6, P103; Wight RG, 2006, AM J EPIDEMIOL, V163, P1071, DOI 10.1093/aje/kwj176; Wilson RS, 2010, NEUROLOGY, V75, P990, DOI 10.1212/WNL.0b013e3181f25b5e	38	9	10	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157327	10.1371/journal.pone.0157327	http://dx.doi.org/10.1371/journal.pone.0157327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP0WX	27332986	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212800026
J	Kim, HJ; Lee, WJ; Kang, CM; Hwang, HK; Bang, SM; Song, SY; Seong, J				Kim, Hyun Ju; Lee, Woo Jung; Kang, Chang Moo; Hwang, Ho Kyoung; Bang, Seung Min; Song, Si Young; Seong, Jinsil			Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LONG-TERM SURVIVAL; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; DUCTAL ADENOCARCINOMA; PANCREATICODUODENECTOMY; CHEMORADIOTHERAPY; CHEMORADIATION; RADIOTHERAPY; EXPERIENCE	Purpose To evaluate the risk factors associated with loco-regional failure after surgical resection and to identify the subgroup that can obtain benefits from adjuvant radiotherapy (RT). Materials and Methods We identified patients treated with surgical resection for resectable pancreatic cancer at Severance hospital between January 1993 and December 2014. Patients who received any neoadjuvant or adjuvant RT were excluded. A total of 175 patients were included. Adjuvant chemotherapy was performed in 107 patients with either a gemcitabine-based regimen (65.4%) or 5-FU based one (34.9%). Results The median loco-regional failure-free survival (LRFFS) and overall survival (OS) were 23.9 and 33.6 months, respectively. A recurrence developed in 108 of 175 patients (61.7%). The predominant pattern of the first failure was distant (42.4%) and 47 patients (26.9%) developed local failure as the first site of recurrence. Multivariate analysis identified initial CA 19-9 >= 200 U/mL, N1 stage, perineural invasion (PNI), and resection margin as significant independent risk factors for LRFFS. Patients were divided into four groups according to the number of risk factors, including initial CA 19-9, N stage, and PNI. Patients exhibiting two risk factors had 3.2-fold higher loco-regional failure (P < 0.001) and patients with all risk factors showed a 6.5-fold increase (P < 0.001) compared with those with no risk factors. In the analysis for OS, patients with more than two risk factors also had 3.3-to 6-fold higher risk of death with statistical significance. Conclusion The results suggest that patients who exhibit more than two risk factors have a higher risk of locoregional failure and death. This subgroup could be benefited by the effective local adjuvant treatment.	[Kim, Hyun Ju; Seong, Jinsil] Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea; [Lee, Woo Jung; Kang, Chang Moo; Hwang, Ho Kyoung] Yonsei Univ, Coll Med, Div Hepatobiliary & Pancreas, Dept Surg, Seoul, South Korea; [Bang, Seung Min; Song, Si Young] Yonsei Univ, Coll Med, Dept Internal Med, Div Gastroenterol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Seong, J (corresponding author), Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea.	jsseong@yuhs.ac	Song, SY/E-2891-2012	Lee, Woo jung/0000-0001-9273-261X; Hwang, Ho Kyoung/0000-0003-4064-7776; Kang, Chang Moo/0000-0002-5382-4658; Song, Si Young/0000-0002-1417-4314; Bang, Seungmin/0000-0001-5209-8351				[Anonymous], 2012, ANN REPORT CAUSE DEA; Asiyanbola B, 2009, J GASTROINTEST SURG, V13, P752, DOI 10.1007/s11605-008-0762-x; Brennan MF, 1996, ANN SURG, V223, P506, DOI 10.1097/00000658-199605000-00006; Choti MA, 2004, NEW ENGL J MED, V350, P1249, DOI 10.1056/NEJMe048002; Corsini MM, 2008, J CLIN ONCOL, V26, P3511, DOI 10.1200/JCO.2007.15.8782; DOUGLASS HO, 1987, CANCER, V59, P2006; Ferrone CR, 2006, J CLIN ONCOL, V24, P2897, DOI 10.1200/JCO.2005.05.3934; GEER RJ, 1993, AM J SURG, V165, P68, DOI 10.1016/S0002-9610(05)80406-4; GRIFFIN JF, 1990, CANCER, V66, P56, DOI 10.1002/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO;2-6; Hallemeier Christopher L, 2011, Am J Clin Oncol, V34, P567, DOI 10.1097/COC.0b013e3181f946fc; Herman JM, 2008, J CLIN ONCOL, V26, P3503, DOI 10.1200/JCO.2007.15.8469; Hsu CC, 2010, ANN SURG ONCOL, V17, P981, DOI 10.1245/s10434-009-0743-7; KALSER MH, 1985, ARCH SURG-CHICAGO, V120, P899; Klinkenbijl JH, 1999, ANN SURG, V230, P776, DOI 10.1097/00000658-199912000-00006; Koom WS, 2009, INT J RADIAT ONCOL, V73, P1148, DOI 10.1016/j.ijrobp.2008.06.1483; Koshy MC, 2005, INT J RADIAT ONCOL, V61, P965, DOI 10.1016/j.ijrobp.2004.11.018; LUNDIN J, 1994, BRIT J CANCER, V69, P515, DOI 10.1038/bjc.1994.93; Neoptolemos JP, 2001, LANCET, V358, P1576, DOI 10.1016/S0140-6736(01)06651-X; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; NITECKI SS, 1995, ANN SURG, V221, P59, DOI 10.1097/00000658-199501000-00007; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Rutter CE, 2015, CANCER-AM CANCER SOC, V121, P4141, DOI 10.1002/cncr.29652; Salem AI, 2015, J SURG ONCOL, V112, P643, DOI 10.1002/jso.24048; Smeenk HG, 2007, ANN SURG, V246, P734, DOI 10.1097/SLA.0b013e318156eef3; WESTERDAHL J, 1993, HEPATO-GASTROENTEROL, V40, P384; Yeo CJ, 1997, ANN SURG, V225, P621, DOI 10.1097/00000658-199705000-00018	26	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157196	10.1371/journal.pone.0157196	http://dx.doi.org/10.1371/journal.pone.0157196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332708	gold, Green Submitted, Green Published			2022-12-26	WOS:000378212800022
J	Wang, YY; Xiao, D; Wang, R; Li, F; Zhang, F; Wang, S				Wang, Yingying; Xiao, Da; Wang, Ran; Li, Fei; Zhang, Fan; Wang, Su			Deep Sequencing-Based Transcriptome Analysis Reveals the Regulatory Mechanism of Bemisia tabaci (Hemiptera: Aleyrodidae) Nymph Parasitized by Encarsia sophia (Hymenoptera: Aphelinidae)	PLOS ONE			English	Article							STEAROYL-COA DESATURASE; BIOTYPE-B; SUPEROXIDE-DISMUTASE; CHELONUS-INANITUS; IMMUNE-RESPONSE; GENE-EXPRESSION; HONEY-BEE; HOMOPTERA; RESISTANCE; DROSOPHILA	The whitefly Bemisia tabaci is a genetically diverse complex with multiple cryptic species, and some are the most destructive invasive pests of many ornamentals and crops worldwide. Encarsia sophia is an autoparasitoid wasp that demonstrated high efficiency as biocontrol agent of whiteflies. However, the immune mechanism of B. tabaci parasitization by E. sophia is unknown. In order to investigate immune response of B. tabaci to E. Sophia parasitization, the transcriptome of E. sophia parasitized B. tabaci nymph was sequenced by Illumina sequencing. De novo assembly generated 393,063 unigenes with average length of 616 bp, in which 46,406 unigenes (15.8% of all unigenes) were successfully mapped. Parasitization by E. sophia had significant effects on the transcriptome profile of B. tabaci nymph. A total of 1482 genes were significantly differentially expressed, of which 852 genes were up-regulated and 630 genes were down-regulated. These genes were mainly involved in immune response, development, metabolism and host signaling pathways. At least 52 genes were found to be involved in the host immune response, 33 genes were involved in the development process, and 29 genes were involved in host metabolism. Taken together, the assembled and annotated transcriptome sequences provided a valuable genomic resource for further understanding the molecular mechanism of immune response of B. tabaci parasitization by E. sophia.	[Wang, Yingying; Xiao, Da; Wang, Ran; Zhang, Fan; Wang, Su] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Wang, Yingying; Li, Fei] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Beijing Academy of Agriculture & Forestry; Nanjing Agricultural University	Wang, S (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China.	wangsu@baafs.net.cn	wang, su/AAC-6313-2019		National Key Basic Research and Development Program (973 program) [2013CB127600]; National Basic Research Program of China [2013CB127600]	National Key Basic Research and Development Program (973 program)(National Basic Research Program of China); National Basic Research Program of China(National Basic Research Program of China)	This research was supported by the National Key Basic Research and Development Program (973 program 2013CB127600) to ZF.; This work was supported by National Basic Research Program of China (Grant Number: 2013CB127600) to ZF. We would like to thank DCS, YCL, JWC, and LY for their bioinformatics analysis of the data.	Ali A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24273; Alloatti A, 2011, BIOCHEM BIOPH RES CO, V412, P286, DOI 10.1016/j.bbrc.2011.07.084; Anspaugh DD, 2005, J INSECT PHYSIOL, V51, P523, DOI 10.1016/j.jinsphys.2004.12.008; Askew R.R., 1986, Symposia of the Royal Entomological Society of London, P225; Bangi E, 2012, EMBO REP, V13, P569, DOI 10.1038/embor.2012.44; Boulanger N, 2004, INFECT IMMUN, V72, P7140, DOI 10.1128/IAI.72.12.7140-7146.2004; Cahill M, 1996, B ENTOMOL RES, V86, P343, DOI 10.1017/S000748530003491X; Chen XX, 2000, CHINA ENTOMOLOGY 21, P242; Chiche L, 2004, CURR PROTEIN PEPT SC, V5, P341, DOI 10.2174/1389203043379477; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Chu Dong, 2005, Scientia Agricultura Sinica, V38, P76; Collier TR, 2001, OECOLOGIA, V129, P147, DOI 10.1007/s004420100706; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; COSTA HS, 1991, ENTOMOL EXP APPL, V61, P211, DOI 10.1007/BF00187724; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Cruz PL, 2014, J PEST SCI, V87, P639, DOI 10.1007/s10340-014-0612-4; DAHLMAN DL, 1977, J INVERTEBR PATHOL, V29, P227, DOI 10.1016/0022-2011(77)90198-7; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Feldhaar H, 2008, MICROBES INFECT, V10, P1082, DOI 10.1016/j.micinf.2008.07.010; Gan Ming, 2003, Acta Phytophylacica Sinica, V30, P255; Gandhe AS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-184; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102980; Hoddle MS, 1998, ANNU REV ENTOMOL, V43, P645, DOI 10.1146/annurev.ento.43.1.645; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; HOFFMANN JA, 1995, CURR OPIN IMMUNOL, V7, P4, DOI 10.1016/0952-7915(95)80022-0; Holt HL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-799; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Horowitz AR, 2004, J ECON ENTOMOL, V97, P2051, DOI 10.1603/0022-0493-97.6.2051; Hu JS, 2002, ARCH INSECT BIOCHEM, V49, P125, DOI 10.1002/arch.10015; Jaworski CC, 2015, J PEST SCI, V88, P793, DOI 10.1007/s10340-015-0698-3; Kaeslin M, 2005, J INSECT PHYSIOL, V51, P1330, DOI 10.1016/j.jinsphys.2005.08.003; Li LZ, 2001, CHINESE J INORG CHEM, V17, P761; Li ZX, 2006, PHYTOPARASITICA, V34, P431, DOI 10.1007/BF02981197; Liang P, 2012, ECOTOXICOLOGY, V21, P1889, DOI 10.1007/s10646-012-0922-3; Lin KJ, 2015, J PEST SCI, V88, P49, DOI 10.1007/s10340-014-0584-4; Luo C, 2011, INSECT SCI, V18, P84, DOI 10.1111/j.1744-7917.2010.01394.x; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; Moreno-Ripoll R, 2014, J PEST SCI, V87, P133, DOI 10.1007/s10340-013-0522-x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakamatsu Y, 2004, J INSECT PHYSIOL, V50, P135, DOI 10.1016/j.jinsphys.2003.10.005; Nauen R, 2005, ARCH INSECT BIOCHEM, V58, P200, DOI 10.1002/arch.20043; Nicolas E, 1996, DEV COMP IMMUNOL, V20, P175, DOI 10.1016/0145-305X(96)00017-1; Ntambi JM, 2004, LIPIDS, V39, P1061, DOI 10.1007/s11745-004-1331-2; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; PENNACCHIO F, 1995, ARCH INSECT BIOCHEM, V30, P351, DOI 10.1002/arch.940300405; Qian Ming-Hui, 2006, Acta Entomologica Sinica, V49, P568; Qiu P, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-10; Rath SS, 2005, J INVERTEBR PATHOL, V88, P70, DOI 10.1016/j.jip.2004.09.006; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Simmons AM, 2005, J AGR URBAN ENTOMOL, V22, P73; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Stettler P, 1998, J INSECT PHYSIOL, V44, P817, DOI 10.1016/S0022-1910(98)00014-6; Takeda T, 2006, PESTIC BIOCHEM PHYS, V86, P15, DOI 10.1016/j.pestbp.2005.11.012; Tang BZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091482; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Visser B, 2010, P NATL ACAD SCI USA, V107, P8677, DOI 10.1073/pnas.1001744107; Wan FH, 2009, SCI CHINA SER C, V52, P88, DOI 10.1007/s11427-008-0135-4; Wang P, 2004, APPL BIOCHEM BIOTECH, V119, P181, DOI 10.1385/ABAB:119:2:181; Wang RX, 1989, PROG PHYSL SCI, V20, P334; Wertheim B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r94; Williams MJ, 2005, GENES CELLS, V10, P813, DOI 10.1111/j.1365-2443.2005.00883.x; Wu SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074309; Xiao YF, 2011, BIOL CONTROL, V58, P239, DOI 10.1016/j.biocontrol.2011.06.004; Yang N, 2013, INSECT MOL BIOL, V22, P485, DOI 10.1111/imb.12038; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zang LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020324; Zeng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061479; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhang Qian-Qian, 2011, Acta Entomologica Sinica, V54, P1264; Zhang R, 2013, CHINESE B LIFE SCI, V4, P008; Zhang Shize, 2003, Chinese Journal of Biological Control, V19, P149; Zhang YB, 2015, J PEST SCI, V88, P225, DOI 10.1007/s10340-014-0592-4; Zhu JY, 2014, ARCH INSECT BIOCHEM, V87, P40, DOI 10.1002/arch.21179; Zhu Jia-Ying, 2013, PLoS ONE, V8, pe54411, DOI 10.1371/journal.pone.0054411; Zhu Jiaying, 2008, Acta Phytophylacica Sinica, V35, P563	81	3	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157684	10.1371/journal.pone.0157684	http://dx.doi.org/10.1371/journal.pone.0157684			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332546	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212800043
J	Wager, K; Zdebik, AA; Fu, S; Cooper, JD; Harvey, RJ; Russell, C				Wager, Kim; Zdebik, Anselm A.; Fu, Sonia; Cooper, Jonathan D.; Harvey, Robert J.; Russell, Claire			Neurodegeneration and Epilepsy in a Zebrafish Model of CLN3 Disease (Batten Disease)	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSES; MOUSE MODEL; LATE-INFANTILE; CELL-DEATH; SUBUNIT-C; DEPOSITION; PATHOLOGY; BEHAVIOR	The neuronal ceroid lipofuscinoses are a group of lysosomal storage disorders that comprise the most common, genetically heterogeneous, fatal neurodegenerative disorders of children. They are characterised by childhood onset, visual failure, epileptic seizures, psychomotor retardation and dementia. CLN3 disease, also known as Batten disease, is caused by autosomal recessive mutations in the CLN3 gene, 80-85% of which are a similar to 1 kb deletion. Currently no treatments exist, and after much suffering, the disease inevitably results in premature death. The aim of this study was to generate a zebrafish model of CLN3 disease using antisense morpholino injection, and characterise the pathological and functional consequences of Cln3 deficiency, thereby providing a tool for future drug discovery. The model was shown to faithfully recapitulate the pathological signs of CLN3 disease, including reduced survival, neuronal loss, retinopathy, axonopathy, loss of motor function, lysosomal storage of subunit c of mitochondrial ATP synthase, and epileptic seizures, albeit with an earlier onset and faster progression than the human disease. Our study provides proof of principle that the advantages of the zebrafish over other model systems can be utilised to further our understanding of the pathogenesis of CLN3 disease and accelerate drug discovery.	[Wager, Kim; Fu, Sonia; Russell, Claire] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, Royal Coll St, London NW1 0TU, England; [Zdebik, Anselm A.] UCL Med Sch, Dept Neurosci Physiol & Pharmacol, Royal Free Campus,Rowland Hill St, London NW3 2PF, England; [Zdebik, Anselm A.] UCL Med Sch, Dept Nephrol, Royal Free Campus,Rowland Hill St, London NW3 2PF, England; [Cooper, Jonathan D.] Kings Coll London, Pediat Storage Disorders Lab, Dept Basic & Clin Neurosci, Inst Psychiat Psychol & Neurosci,Maurice Wohl Cli, 5 Cutcombe Rd, London SE5 9RX, England; [Harvey, Robert J.] UCL Sch Pharm, Dept Pharmacol, 29-39 Brunswick Sq, London WC1N 1AX, England; [Wager, Kim] Oxford PharmaGenesis Ltd, Oxford OX13 5QJ, England	University of London; University of London Royal Veterinary College; University of London; University College London; University of London; University College London; University of London; King's College London; University of London; University College London	Russell, C (corresponding author), Univ London Royal Vet Coll, Dept Comparat Biomed Sci, Royal Coll St, London NW1 0TU, England.; Zdebik, AA (corresponding author), UCL Med Sch, Dept Neurosci Physiol & Pharmacol, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.; Zdebik, AA (corresponding author), UCL Med Sch, Dept Nephrol, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	a.zdebik@ucl.ac.uk; crussell@rvc.ac.uk	Harvey, Robert/D-3994-2016; Zebrafish, UCL/A-3125-2009; Cooper, Jonathan/V-9962-2019; Russell, Claire/A-4879-2012	Harvey, Robert/0000-0001-5956-6664; Cooper, Jonathan/0000-0003-1339-4750; Russell, Claire/0000-0002-6748-9301; Wager, Kim/0000-0001-8107-9600	Batten Disease Support and Research Association; Batten Disease Family Association; University of London Central Research Fund; Newlife; Royal Society; Bloomsbury Consortium; Peter Samuel Trust fund	Batten Disease Support and Research Association; Batten Disease Family Association; University of London Central Research Fund; Newlife; Royal Society(Royal Society of London); Bloomsbury Consortium; Peter Samuel Trust fund	This research was initially supported by a grant from the Batten Disease Support and Research Association to CR and JDC. Subsequent funding was provided by the Batten Disease Family Association to CR, RJH and KW and the University of London Central Research Fund, Newlife and The Royal Society to CR. KW was funded via a PhD scholarship from the Bloomsbury Consortium and supervised by CR and RJH. AZ received a grant from the Peter Samuel Trust fund. http://bdsra.org/,http://www.bdfauk.org.uk/, http://www.london.ac.uk/, http://www.newlifecharity.co.uk/, https://royalsociety.org/, http://www.bloomsbury.ac.uk/.	Aberg L, 2000, NEUROLOGY, V54, P1069, DOI 10.1212/WNL.54.5.1069; Anderson GW, 2013, BBA-MOL BASIS DIS, V1832, P1807, DOI 10.1016/j.bbadis.2012.11.014; Bond M, 2013, BBA-MOL BASIS DIS, V1832, P1842, DOI 10.1016/j.bbadis.2013.01.009; Boustany R M, 1988, Am J Med Genet Suppl, V5, P47; BOUSTANY RM, 1992, AM J MED GENET, V42, P533, DOI 10.1002/ajmg.1320420421; Carcel-Trullols J, 2015, BBA-MOL BASIS DIS, V1852, P2242, DOI 10.1016/j.bbadis.2015.04.027; Destexhe A, 1999, Prog Brain Res, V121, P289; Follo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021908; Fossale E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-57; Gerety SS, 2011, DEV BIOL, V350, P279, DOI 10.1016/j.ydbio.2010.11.030; Goebel H H, 1996, Semin Pediatr Neurol, V3, P270, DOI 10.1016/S1071-9091(96)80031-3; Granato M, 1996, DEVELOPMENT, V123, P399; Groh J, 2016, GLIA, V64, P792, DOI 10.1002/glia.22962; Haltia M, 2003, J NEUROPATH EXP NEUR, V62, P1; He CC, 2009, AUTOPHAGY, V5, P520, DOI 10.4161/auto.5.4.7768; Heath RJ, 2009, CURR OPIN GASTROEN, V25, P512, DOI 10.1097/MOG.0b013e32833104f1; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Holopainen JM, 2001, EUR J BIOCHEM, V268, P5851, DOI 10.1046/j.0014-2956.2001.02530.x; Jolly RD, 2002, NEUROCHEM INT, V40, P565, DOI 10.1016/S0197-0186(01)00128-0; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Kovacs AD, 2008, EXP NEUROL, V209, P288, DOI 10.1016/j.expneurol.2007.09.012; Kovacs AD, 2012, NEUROPHARMACOLOGY, V63, P769, DOI 10.1016/j.neuropharm.2012.05.040; Kovacs AD, 2011, NEUROPHARMACOLOGY, V60, P405, DOI 10.1016/j.neuropharm.2010.10.010; Kuhl TG, 2013, J CHILD NEUROL, V28, P1117, DOI 10.1177/0883073813494479; Lojewski X, 2014, HUM MOL GENET, V23, P2005, DOI 10.1093/hmg/ddt596; Mahmood F, 2013, DIS MODEL MECH, V6, P652, DOI 10.1242/dmm.009480; Mahmood F, 2013, BRAIN, V136, P1488, DOI 10.1093/brain/awt043; Vidal-Donet JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055526; Martin-Jimenez R, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0555-z; Mathias JR, 2012, FUTURE MED CHEM, V4, P1811, DOI [10.4155/FMC.12.115, 10.4155/fmc.12.115]; Mitchison HM, 2004, BRAIN PATHOL, V14, P86, DOI 10.1111/j.1750-3639.2004.tb00502.x; Mole SE, 2011, NEURONAL CEROID LIPO, Vxxx; Neverman NJ, 2015, BBA-MOL BASIS DIS, V1852, P2292, DOI 10.1016/j.bbadis.2015.04.026; Ostergaard JR, 2011, NEUROLOGY, V76, P1245, DOI 10.1212/WNL.0b013e31821435bd; Palmer DN, 2013, BBA-MOL BASIS DIS, V1832, P1882, DOI 10.1016/j.bbadis.2013.05.014; PALMER DN, 1995, AM J MED GENET, V57, P260, DOI 10.1002/ajmg.1320570230; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Persaud-Sawin DA, 2005, APOPTOSIS, V10, P973, DOI 10.1007/s10495-005-0733-6; Pontikis CC, 2005, NEUROBIOL DIS, V20, P823, DOI 10.1016/j.nbd.2005.05.018; Pontikis CC, 2004, BRAIN RES, V1023, P231, DOI 10.1016/j.brainres.2004.07.030; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Sallinen V, 2010, NEUROBIOL DIS, V40, P93, DOI 10.1016/j.nbd.2010.06.001; Schulz A, 2013, BBA-MOL BASIS DIS, V1832, P1801, DOI 10.1016/j.bbadis.2013.04.008; Seehafer SS, 2011, J NEUROIMMUNOL, V230, P169, DOI 10.1016/j.jneuroim.2010.08.024; Shacka JJ, 2012, BRAIN RES BULL, V88, P43, DOI 10.1016/j.brainresbull.2012.03.003; Shahwan A, 2005, LANCET NEUROL, V4, P239, DOI 10.1016/S1474-4422(05)70043-0; Sleat DE, 2004, J NEUROSCI, V24, P9117, DOI 10.1523/JNEUROSCI.2729-04.2004; Tyynela J, 2004, BRAIN PATHOL, V14, P349; Verity C, 2010, ARCH DIS CHILD, V95, P361, DOI 10.1136/adc.2009.173419; Wager K, 2014, J INHERIT METAB DIS, V37, P483, DOI 10.1007/s10545-014-9696-5; Wager K, 2013, AUTOPHAGY, V9, P1693, DOI 10.4161/auto.25082; Warrier V, 2013, BBA-MOL BASIS DIS, V1832, P1827, DOI 10.1016/j.bbadis.2013.03.017; Wittmann C, 2012, JOVE-J VIS EXP, DOI 10.3791/4203; Zdebik AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079765	54	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157365	10.1371/journal.pone.0157365	http://dx.doi.org/10.1371/journal.pone.0157365			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327661	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000378212400021
J	Abdul-Rahman, O; Kristof, E; Doan-Xuan, QM; Vida, A; Nagy, L; Horvath, A; Simon, J; Maros, T; Szentkiralyi, I; Palotas, L; Debreceni, T; Csizmadia, P; Szerafin, T; Fodor, T; Szanto, M; Toth, A; Kiss, B; Bacso, Z; Bai, P				Abdul-Rahman, Omar; Kristof, Endre; Quang-Minh Doan-Xuan; Vida, Andras; Nagy, Lilla; Horvath, Ambrus; Simon, Jozsef; Maros, Tamas; Szentkiralyi, Istvan; Palotas, Lehel; Debreceni, Tamas; Csizmadia, Peter; Szerafin, Tamas; Fodor, Tamas; Szanto, Magdolna; Toth, Attila; Kiss, Borbala; Bacso, Zsolt; Bai, Peter			AMP-Activated Kinase (AMPK) Activation by AICAR in Human White Adipocytes Derived from Pericardial White Adipose Tissue Stem Cells Induces a Partial Beige-Like Phenotype	PLOS ONE			English	Article							MITOCHONDRIAL DYNAMICS; BROWN FAT; ENERGY-EXPENDITURE; SIRT1; METABOLISM; OBESITY; THERMOGENESIS; ADIPOGENESIS; DYSFUNCTION; INHIBITION	Beige adipocytes are special cells situated in the white adipose tissue. Beige adipocytes, lacking thermogenic cues, morphologically look quite similar to regular white adipocytes, but with a markedly different response to adrenalin. White adipocytes respond to adrenergic stimuli by enhancing lipolysis, while in beige adipocytes adrenalin induces mitochondrial biogenesis too. A key step in the differentiation and function of beige adipocytes is the deacetylation of peroxisome proliferator-activated receptor (PPAR.) by SIRT1 and the consequent mitochondrial biogenesis. AMP-activated protein kinase (AMPK) is an upstream activator of SIRT1, therefore we set out to investigate the role of AMPK in beige adipocyte differentiation using human adipose-derived mesenchymal stem cells (hADMSCs) from pericardial adipose tissue. hADMSCs were differentiated to white and beige adipocytes and the differentiation medium of the white adipocytes was supplemented with 100 mu M [(2R, 3S, 4R, 5R)-5-(4-Carbamoyl-5-aminoimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl] methyl dihydrogen phosphate (AICAR), a known activator of AMPK. The activation of AMPK with AICAR led to the appearance of beige-like morphological properties in differentiated white adipocytes. Namely, smaller lipid droplets appeared in AICAR-treated white adipocytes in a similar fashion as in beige cells. Moreover, in AICAR-treated white adipocytes the mitochondrial network was more fused than in white adipocytes; a fused mitochondrial system was characteristic to beige adipocytes. Despite the morphological similarities between AICAR-treated white adipocytes and beige cells, functionally AICAR-treated white adipocytes were similar to white adipocytes. We were unable to detect increases in basal or cAMP-induced oxygen consumption rate (a marker of mitochondrial biogenesis) when comparing control and AICAR-treated white adipocytes. Similarly, markers of beige adipocytes such as TBX1, UCP1, CIDEA, PRDM16 and TMEM26 remained the same when comparing control and AICAR-treated white adipocytes. Our data point out that in human pericardial hADMSCs the role of AMPK activation in controlling beige differentiation is restricted to morphological features, but not to actual metabolic changes.	[Abdul-Rahman, Omar; Vida, Andras; Nagy, Lilla; Fodor, Tamas; Szanto, Magdolna; Bai, Peter] Univ Debrecen, Dept Med Chem, Fac Med, H-4032 Debrecen, Hungary; [Kristof, Endre] Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, H-4032 Debrecen, Hungary; [Quang-Minh Doan-Xuan; Bacso, Zsolt] Univ Debrecen, Dept Biophys & Cell Biol, Fac Med, H-4032 Debrecen, Hungary; [Horvath, Ambrus; Simon, Jozsef; Maros, Tamas; Szentkiralyi, Istvan; Palotas, Lehel; Debreceni, Tamas; Csizmadia, Peter; Szerafin, Tamas; Toth, Attila] Univ Debrecen, Dept Cardiol, Fac Med, H-4032 Debrecen, Hungary; [Kiss, Borbala] Univ Debrecen, Dept Dermatol, Fac Med, H-4032 Debrecen, Hungary; [Abdul-Rahman, Omar; Nagy, Lilla; Szanto, Magdolna] MTA DE Cell Biol & Signaling Res Grp, H-4032 Debrecen, Hungary; [Vida, Andras; Bai, Peter] MTA DE Lendulet Lab Cellular Metab, H-4032 Debrecen, Hungary; [Bai, Peter] Univ Debrecen, Res Ctr Mol Med, H-4032 Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Bai, P (corresponding author), Univ Debrecen, Dept Med Chem, Fac Med, H-4032 Debrecen, Hungary.; Bai, P (corresponding author), MTA DE Lendulet Lab Cellular Metab, H-4032 Debrecen, Hungary.; Bai, P (corresponding author), Univ Debrecen, Res Ctr Mol Med, H-4032 Debrecen, Hungary.	baip@med.unideb.hu	Kristóf, Endre/AGB-5046-2022; Tóth, Attila/F-4859-2010; Bacso, Zsolt/A-3615-2009	Kristóf, Endre/0000-0002-2215-6984; Tóth, Attila/0000-0001-6503-3653; Bacso, Zsolt/0000-0001-6885-3796; Szanto, Magdolna/0000-0002-7714-7065	Bolyai fellowship; NKFIH [K108308, K105872, C120732, C129074]; Momentum fellowship of the Hungarian Academy of Sciences; University of Debrecen;  [TAMOP-4.2.2.A-11/1/KONV-2012-0025]	Bolyai fellowship(Hungarian Academy of Sciences); NKFIH(National Research, Development & Innovation Office (NRDIO) - Hungary); Momentum fellowship of the Hungarian Academy of Sciences; University of Debrecen; 	This work was supported by a Bolyai fellowship to MS. Furthermore, by grants from NKFIH (K108308, K105872, C120732, C129074), TAMOP-4.2.2.A-11/1/KONV-2012-0025, the Momentum fellowship of the Hungarian Academy of Sciences and the University of Debrecen.	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Auwerx J, 2006, NAT MED, V12, P44, DOI 10.1038/nm0106-44; Bai P, 2015, TRENDS ENDOCRIN MET, V26, P75, DOI 10.1016/j.tem.2014.11.003; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Canto C, 2013, MOL ASPECTS MED, V34, P1168, DOI 10.1016/j.mam.2013.01.004; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carlucci A, 2008, TRENDS CELL BIOL, V18, P604, DOI 10.1016/j.tcb.2008.09.006; Christian M, 2015, ADIPOCYTE, V4, P50, DOI 10.4161/adip.29853; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Crane JD, 2015, NAT MED, V21, P166, DOI 10.1038/nm.3766; de Jong JMA, 2015, AM J PHYSIOL-ENDOC M, V308, pE1085, DOI 10.1152/ajpendo.00023.2015; DuBoff B, 2013, TRENDS NEUROSCI, V36, P325, DOI 10.1016/j.tins.2013.03.002; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Elabd C, 2009, STEM CELLS, V27, P2753, DOI 10.1002/stem.200; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Fodor T, 2016, PLOS ONE UNPUB; Fu T, 2014, MOL CELL BIOL, V34, P4130, DOI 10.1128/MCB.00596-14; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Fulco M, 2008, CELL CYCLE, V7, P3669, DOI 10.4161/cc.7.23.7164; Gustafson B, 2015, DIABETES, V64, P1670, DOI 10.2337/db14-1127; Hallberg M, 2008, MOL CELL BIOL, V28, P6785, DOI 10.1128/MCB.00504-08; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Imai S., 2014, TRENDS CELL BIOL; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Kristof E, 2015, SCI REP-UK, V5, DOI 10.1038/srep12540; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; Lopez M, 2015, ADIPOCYTE, V4, P141, DOI 10.4161/21623945.2014.983752; McGlashon JM, 2015, CELL METAB, V21, P692, DOI 10.1016/j.cmet.2015.04.008; Nagy L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069420; Oh CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7794; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pulinilkunnil T, 2011, J BIOL CHEM, V286, P8798, DOI 10.1074/jbc.M111.218719; Pyrzak B, 2015, ADV EXP MED BIOL, V866, P25, DOI 10.1007/5584_2015_149; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Quang MDX, 2013, CYTOM PART A, V83, P933, DOI 10.1002/cyto.a.22333; Rachid TL, 2015, MOL CELL ENDOCRINOL, V402, P86, DOI 10.1016/j.mce.2014.12.027; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2015, DIABETES, V64, P2369, DOI 10.2337/db15-0203; Shan TZ, 2013, FASEB J, V27, P1981, DOI 10.1096/fj.12-225755; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Tchkonia T, 2002, AM J PHYSIOL-REG I, V282, pR1286, DOI 10.1152/ajpregu.00653.2001; Tharp KM, 2015, DIABETES; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Valero T, 2014, CURR PHARM DESIGN, V20, P5507, DOI 10.2174/138161282035140911142118; van Dam AD, 2015, TRENDS MOL MED, V21, P571, DOI 10.1016/j.molmed.2015.07.003; Vargas D, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/196348; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Vila-Bedmar R, 2010, ENDOCRINOLOGY, V151, P980, DOI 10.1210/en.2009-0810; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Wang S, 2015, INT J OBESITY, V39, P967, DOI 10.1038/ijo.2015.23; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xin C, 2015, INT J OBES LOND; Xu S, 2015, BIOSCI REP; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110; Zhang HB, 2015, EMBO REP, V16, P1378, DOI 10.15252/embr.201540837; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004; Zorzano Antonio, 2009, Archives of Physiology and Biochemistry, V115, P1, DOI 10.1080/13813450802676335	67	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157644	10.1371/journal.pone.0157644	http://dx.doi.org/10.1371/journal.pone.0157644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322180	Green Published, Green Accepted, gold			2022-12-26	WOS:000378212000035
J	Chao, CN; Lin, MC; Fang, CY; Chen, PL; Chang, DC; Shen, CH; Wang, ML				Chao, Chun-Nun; Lin, Mien-Chun; Fang, Chiung-Yao; Chen, Pei-Lain; Chang, Deching; Shen, Cheng-Huang; Wang, Meilin			Gene Therapy for Human Lung Adenocarcinoma Using a Suicide Gene Driven by a Lung-Specific Promoter Delivered by JC Virus-Like Particles	PLOS ONE			English	Article							SURFACTANT PROTEIN-B; MAJOR CAPSID PROTEIN; MOLECULAR-BIOLOGY; GLIAL-CELLS; CANCER; EXPRESSION; ANTIGEN; KIDNEY; DNA; CHEMOTHERAPY	Lung adenocarcinoma, the most commonly diagnosed type of lung cancer, has a poor prognosis even with combined surgery, chemotherapy, or molecular targeted therapies. Most patients are diagnosed with an in-operable advanced or metastatic disease, both pointing to the necessity of developing effective therapies for lung adenocarcinoma. Surfactant protein B (SP-B) has been found to be overexpressed in lung adenocarcinoma. In addition, it has also been demonstrated that human lung adenocarcinoma cells are susceptible to the JC polyomavirus (JCPyV) infection. Therefore, we designed that the JCPyV virus-like particle (VLP) packaged with an SP-B promoter-driven thymidine kinase suicide gene (pSPB-tk) for possible gene therapy of human lung adenocarcinoma. Plasmids expressing the GFP (pSPB-gfp) or thymidine kinase gene (pSPB-tk) under the control of the human SP-B promoter were constructed. The promoter's tissue specificity was tested by transfection of pSPB-gfp into A549, CH27, and H460 human lung carcinoma cells and non-lung cells. The JCPyV VLP's gene transfer efficiency and the selective cytotoxicity of pSPB-tk combined with ganciclovir (GCV) were tested in vitro and in a xenograft mouse model. In the current study, we found that SP-B promoter-driven GFP was specifically expressed in human lung adenocarcinoma (A549) and large cell carcinoma (H460) cells. JCPyV VLPs were able to deliver a GFP reporter gene into A549 cells for expression. Selective cytotoxicity was observed in A549 but not non-lung cells that were transfected with pSPB-tk or infected with pSPB-tk-carrying JCPyV VLPs. In mice injected with pSPB-tk-carrying JCPyV VLPs through the tail vein and treated with ganciclovir (GCV), a potent 80% inhibition of growth of human lung adenocarcinoma nodules resulted. The JCPyV VLPs combined with the use of SP-B promoter demonstrates effectiveness as a potential gene therapy against human lung adenocarcinoma.	[Chao, Chun-Nun; Lin, Mien-Chun; Chang, Deching] Natl Chung Cheng Univ, Inst Mol Biol, Chiayi 621, Taiwan; [Chao, Chun-Nun] Chiayi Christian Hosp, Dept Pediat, Ditmanson Med Fdn, Chiayi, Taiwan; [Lin, Mien-Chun] Chiayi Christian Hosp, Ditmanson Med Fdn, Dept Urol, Chiayi, Taiwan; [Fang, Chiung-Yao; Shen, Cheng-Huang] Chiayi Christian Hosp, Ditmanson Med Fdn, Dept Med Res, Chiayi, Taiwan; [Chen, Pei-Lain] Cent Taiwan Univ Sci & Technol, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Shen, Cheng-Huang] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Wang, Meilin] Chung Shan Med Univ, Dept Microbiol & Immunol, Taichung, Taiwan	National Chung Cheng University; Chia-Yi Christian Hospital; Chia-Yi Christian Hospital; Chia-Yi Christian Hospital; Central Taiwan University Science & Technology; Asia University Taiwan; Chung Shan Medical University	Shen, CH (corresponding author), Chiayi Christian Hosp, Ditmanson Med Fdn, Dept Med Res, Chiayi, Taiwan.; Shen, CH (corresponding author), Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan.; Wang, ML (corresponding author), Chung Shan Med Univ, Dept Microbiol & Immunol, Taichung, Taiwan.	01712@cych.org.tw; wml@csmu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 104-2320-B-194-005]; Ditmanson Medical Foundation Chiayi Christian Hospital, Taiwan [CSMU-CYC-102-03]; National Science Council; Chung Shan Medical University; Ministry of Education	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ditmanson Medical Foundation Chiayi Christian Hospital, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan); Chung Shan Medical University; Ministry of Education	This work was supported by research grants from the Ministry of Science and Technology, MOST 104-2320-B-194-005, https://www.most.gov.tw/?l=ch (DC) and Ditmanson Medical Foundation Chiayi Christian Hospital, CSMU-CYC-102-03, http://www.cych.org.tw/cychweb/cych2/default.aspx (CHS MW), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. J. T. Chang for providing us CH27 human lung squamous carcinoma cells for the investigation. Upright fluorescence microscope was performed in the Instrument Center of Chung Shan Medical University, which is supported by National Science Council, Ministry of Education and Chung Shan Medical University.	Abdel-Aziz HO, 2007, APPL IMMUNOHISTO M M, V15, P394, DOI 10.1097/01.pai.0000213126.96590.64; Auperin A, 2010, LANCET, V375, P1267, DOI 10.1016/S0140-6736(10)60059-1; BALLARD PL, 1989, ENDOCR REV, V10, P165, DOI 10.1210/edrv-10-2-165; Boldorini R, 2005, ARCH PATHOL LAB MED, V129, P69; Chang DC, 1997, J GEN VIROL, V78, P1435, DOI 10.1099/0022-1317-78-6-1435; Chen LS, 2010, GENE THER, V17, P1033, DOI 10.1038/gt.2010.50; Chen PL, 2001, FEBS LETT, V500, P109, DOI 10.1016/S0014-5793(01)02598-4; Datta D, 2003, CHEST, V123, P2096, DOI 10.1378/chest.123.6.2096; Doronin K, 2001, J VIROL, V75, P3314, DOI 10.1128/JVI.75.7.3314-3324.2001; Eash S, 2004, AM J PATHOL, V164, P419, DOI 10.1016/S0002-9440(10)63132-X; Esfahani K, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00174; Fang CY, 2015, J UROLOGY, V193, P2100, DOI 10.1016/j.juro.2015.01.084; Fang CY, 2012, J VIROL METHODS, V182, P87, DOI 10.1016/j.jviromet.2012.03.017; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fillat C., 2003, Current Gene Therapy, V3, P13, DOI 10.2174/1566523033347426; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Khoor A, 1999, HUM PATHOL, V30, P695, DOI 10.1016/S0046-8177(99)90096-5; Lai JC, 2008, DNA REPAIR, V7, P1352, DOI 10.1016/j.dnarep.2008.04.016; Lin MC, 2014, ANTIVIR RES, V103, P25, DOI 10.1016/j.antiviral.2013.12.013; Liu CK, 1998, J VIROL, V72, P4643, DOI 10.1128/JVI.72.6.4643-4649.1998; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Miakotina OL, 1998, BBA-GENE STRUCT EXPR, V1442, P60, DOI 10.1016/S0167-4781(98)00121-3; Monao MCG, 1998, J VIROL, V72, P9918, DOI 10.1128/JVI.72.12.9918-9923.1998; Moon C, 2003, CLIN CANCER RES, V9, P5055; Nacht M, 2001, P NATL ACAD SCI USA, V98, P15203, DOI 10.1073/pnas.261414598; OREILLY MA, 1989, AM J PHYSIOL, V257, pL385, DOI 10.1152/ajplung.1989.257.6.L385; Ou WC, 1999, J GEN VIROL, V80, P39, DOI 10.1099/0022-1317-80-1-39; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sin DD, 2013, J CLIN ONCOL, V31, P4536, DOI 10.1200/JCO.2013.50.6105; Strayer M, 2002, AM J PHYSIOL-LUNG C, V282, pL394, DOI 10.1152/ajplung.00188.2001; Strayer MS, 1998, AM J RESP CELL MOL, V18, P1; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Wang ML, 2004, HUM GENE THER, V15, P1077, DOI 10.1089/hum.2004.15.1077; Weber T, 1997, INTERVIROLOGY, V40, P98, DOI 10.1159/000150537; Weill D, 2000, CHEST, V118, P966, DOI 10.1378/chest.118.4.966; White MK, 2004, VIROLOGY, V324, P1, DOI 10.1016/j.virol.2004.03.025; WHITSETT JA, 1995, PHYSIOL REV, V75, P749, DOI 10.1152/physrev.1995.75.4.749; Zheng H, 2007, J PATHOL, V212, P306, DOI 10.1002/path.2188	39	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157865	10.1371/journal.pone.0157865	http://dx.doi.org/10.1371/journal.pone.0157865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322500	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212000049
J	Jha, S; Ismail, N; Clark, D; Lewis, JJ; Omar, S; Dreyer, A; Chihota, V; Churchyard, G; Dowdy, DW				Jha, Swati; Ismail, Nazir; Clark, David; Lewis, James J.; Omar, Shaheed; Dreyer, Andries; Chihota, Violet; Churchyard, Gavin; Dowdy, David W.			Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active Tuberculosis	PLOS ONE			English	Article							SPUTUM SMEAR MICROSCOPY; XPERT MTB/RIF; BURDEN; FEASIBILITY; MULTICENTER; RESISTANCE; SETTINGS; ACCURACY; AFRICA; TESTS	Background Automated digital microscopy has the potential to improve the diagnosis of tuberculosis (TB), particularly in settings where molecular testing is too expensive to perform routinely. The cost-effectiveness of TB diagnostic algorithms using automated digital microscopy remains uncertain. Methods Using data from a demonstration study of an automated digital microscopy system (TBDx, Applied Visual Systems, Inc.), we performed an economic evaluation of TB diagnosis in South Africa from the health system perspective. The primary outcome was the incremental cost per new TB diagnosis made. We considered costs and effectiveness of different algorithms for automated digital microscopy, including as a stand-alone test and with confirmation of positive results with Xpert MTB/RIF ('Xpert', Cepheid, Inc.). Results were compared against both manual microscopy and universal Xpert testing. Results In settings willing to pay $2000 per incremental TB diagnosis, universal Xpert was the preferred strategy. However, where resources were not sufficient to support universal Xpert, and a testing volume of at least 30 specimens per day could be ensured, automated digital microscopy with Xpert confirmation of low-positive results could facilitate the diagnosis of 79-84% of all Xpert-positive TB cases, at 50-60% of the total cost. The cost-effectiveness of this strategy was $ 1280 per incremental TB diagnosis (95% uncertainty range, UR: $ 340$ 3440) in the base case, but improved under conditions likely reflective of many settings in sub-Saharan Africa: $ 677 per diagnosis (95% UR: $ 450-$ 935) when sensitivity of manual smear microscopy was lowered to 0.5, and $ 956 per diagnosis (95% UR: $ 40-$ 2910) when the prevalence of multidrug-resistant TB was lowered to 1%. Conclusions Although universal Xpert testing is the preferred algorithm for TB diagnosis when resources are sufficient, automated digital microscopy can identify the majority of cases and halve the cost of diagnosis and treatment when resources are more scarce and multidrug-resistant TB is not common.	[Jha, Swati; Dowdy, David W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ismail, Nazir; Omar, Shaheed; Dreyer, Andries] Natl Inst Communicable Dis, Ctr TB, Johannesburg, South Africa; [Ismail, Nazir] Univ Pretoria, Dept Med Microbiol, ZA-0002 Pretoria, South Africa; [Clark, David; Chihota, Violet; Churchyard, Gavin] Aurum Inst, Johannesburg, South Africa; [Lewis, James J.; Churchyard, Gavin] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, Dept Infect Dis Epidemiol, London WC1, England; [Dreyer, Andries; Churchyard, Gavin] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institute for Communicable Diseases (NICD); University of Pretoria; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand	Dowdy, DW (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	ddowdy1@jhmi.edu	Chihota, Violet/DWH-9372-2022; Omar, Shaheed Vally/AAB-5071-2020	Omar, Shaheed Vally/0000-0001-6983-1636; Chihota, Violet/0000-0003-1444-9266; Lewis, James/0000-0002-8603-2761; Churchyard, Gavin/0000-0002-4269-3699	B. Frank and Kathleen Polk Assistant Professorship in Epidemiology; Medical Research Council [MR/K007467/1, MR/K012126/1] Funding Source: researchfish; MRC [MR/K007467/1] Funding Source: UKRI	B. Frank and Kathleen Polk Assistant Professorship in Epidemiology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded in part by the B. Frank and Kathleen Polk Assistant Professorship in Epidemiology (to DWD). Applied Visual Systems, Inc., provided input as to parameter values and support for open-access publication fees but otherwise had no input into the design of the study or the decision to publish.	Andrews JR, 2013, CLIN INFECT DIS, V57, P1021, DOI 10.1093/cid/cit412; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Caminero JA, 2015, AM J RESP CRIT CARE, V191, P1352, DOI 10.1164/rccm.201504-0790ED; Cattamanchi A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-53; Department of Health RoSA, 2014, NAT TUB MAN GUID; Foster N, 2015, SOC SCI MED, V130, P42, DOI 10.1016/j.socscimed.2015.01.046; Glaziou P, 2015, CSH PERSPECT MED, V5, DOI [10.1101/cshperspect.a017798, 10.1055/s-0038-1651492]; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Ismail NA, 2015, AM J RESP CRIT CARE, V191, P1443, DOI 10.1164/rccm.201502-0390OC; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Lu CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056074; Marseille E, 2015, B WORLD HEALTH ORGAN, V93, P118, DOI 10.2471/BLT.14.138206; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Organization WH, 2014, XPERT MTB RIF IMPL M; Pantoja A, 2013, EUR RESPIR J, V42, P708, DOI 10.1183/09031936.00147912; Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Theron G, 2014, LANCET INFECT DIS, V14, P527, DOI 10.1016/S1473-3099(13)70360-8; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Van Deun A, 1998, INT J TUBERC LUNG D, V2, P756; Van Rie A, 2010, EXPERT REV MOL DIAGN, V10, P937, DOI [10.1586/erm.10.67, 10.1586/ERM.10.67]; van't Hoog AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082786; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization G, 2014, CHOOS INT AR COST EF	26	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157554	10.1371/journal.pone.0157554	http://dx.doi.org/10.1371/journal.pone.0157554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322162	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000378212000025
J	Ghaffarzadegan, T; Marungruang, N; Fak, F; Nyman, M				Ghaffarzadegan, Tannaz; Marungruang, Nittaya; Fak, Frida; Nyman, Margareta			Molecular Properties of Guar Gum and Pectin Modify Cecal Bile Acids, Microbiota, and Plasma Lipopolysaccharide-Binding Protein in Rats	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; URSODEOXYCHOLIC ACID; DIETARY FIBER; CHENODEOXYCHOLIC ACID; GAS-CHROMATOGRAPHY; DISEASE; MICE; FERMENTATION; MODULATION; EXCRETION	Bile acids (BAs) act as signaling molecules in various physiological processes, and are related to colonic microbiota composition as well as to different types of dietary fat and fiber. This study investigated whether guar gum and pectin-two fibers with distinct functional characteristics-affect BA profiles, microbiota composition, and gut metabolites in rats. Low-(LM) or high-methoxylated (HM) pectin, and low-, medium-, or high-molecular-weight (MW) guar gum were administered to rats that were fed either low-or high-fat diets. Cecal BAs, short-chain fatty acids (SCFA) and microbiota composition, and plasma lipopolysaccharide- binding protein (LBP) levels were analyzed, by using novel methodologies based on gas chromatography (BAs and SCFAs) and 16S rRNA gene sequencing on the Illumina MiSeq platform. Strong correlations were observed between cecal BA and SCFA levels, microbiota composition, and portal plasma LBP levels in rats on a high-fat diet. Notably, guar gum consumption with medium-MW increased the cecal amounts of cholic-, cheno-deoxycholic-, and ursodeoxycholic acids as well as alpha-, beta-, and omega-muricholic acids to a greater extent than other types of guar gum or the fiber-free control diet. In contrast, the amounts of cecal deoxycholic-and hyodeoxycholic acid were reduced with all types of guar gum independent of chain length. Differences in BA composition between pectin groups were less obvious, but cecal levels of alpha- and omega-muricholic acids were higher in rats fed LM as compared to HM pectin or the control diet. The inflammatory marker LBP was down-regulated in rats fed medium-MW guar gum and HM pectin; these two fibers decreased the cecal abundance of Oscillospira and an unclassified genus in Ruminococcaceae, and increased that of an unclassified family in RF32. These results indicate that the molecular properties of guar gum and pectin are important for their ability to modulate cecal BA formation, gut microbiota composition, and high-fat diet induced inflammation.	[Ghaffarzadegan, Tannaz; Marungruang, Nittaya; Fak, Frida; Nyman, Margareta] Lund Univ, Food Hlth Sci Ctr, Lund, Sweden	Lund University	Ghaffarzadegan, T (corresponding author), Lund Univ, Food Hlth Sci Ctr, Lund, Sweden.	tannaz.ghaffarzadegan@food-health-science.lu.se	Ghaffarzadegan, Tannaz/ABC-4411-2020; Nyman, Margareta/AAY-9466-2020	Nyman, Margareta/0000-0003-3660-2364; Ghaffarzadegan, Tannaz/0000-0001-6170-1474; Marungruang, Nittaya/0000-0001-9769-7980	Antidiabetic Food Centre; Per Hakansson Foundation; VINNOVA VINN Excellence Center at Lund University	Antidiabetic Food Centre; Per Hakansson Foundation; VINNOVA VINN Excellence Center at Lund University	The study was supported by the Antidiabetic Food Centre, a VINNOVA VINN Excellence Center at Lund University (http://www.ffsc.lu.se/afc), and Per Hakansson Foundation.	Araki Y, 2000, DIGEST LIVER DIS, V32, P691, DOI 10.1016/S1590-8658(00)80332-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGGREN AM, 1993, J SCI FOOD AGR, V63, P397, DOI 10.1002/jsfa.2740630405; Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carubbi F, 2002, BBA-MOL CELL BIOL L, V1580, P31, DOI 10.1016/S1388-1981(01)00184-6; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Espina-Ruiz M, 2014, J AGR FOOD CHEM, V62, P12620, DOI 10.1021/jf504829h; Fak F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127252; Fijan S, 2014, INT J ENV RES PUB HE, V11, P4745, DOI 10.3390/ijerph110504745; Fukiya S, 2009, FEMS MICROBIOL LETT, V293, P263, DOI 10.1111/j.1574-6968.2009.01531.x; Fuller S, 2016, PLANT FOOD HUM NUTR, V71, P1, DOI 10.1007/s11130-016-0529-6; Gaby AR, 2009, ALTERN MED REV, V14, P258; Ghaffarzadegan T, 2014, J CHROMATOGR B, V944, P69, DOI 10.1016/j.jchromb.2013.11.012; Hughes SA, 2007, J AGR FOOD CHEM, V55, P4589, DOI 10.1021/jf070293g; Im E, 2004, J NUTR, V134, P483, DOI 10.1093/jn/134.2.483; Jakobsdottir G, 2014, NUTRITION, V30, P497, DOI 10.1016/j.nut.2013.08.013; Jakobsdottir G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080476; Jakobsdottir G, 2013, BRIT J NUTR, V110, P1565, DOI 10.1017/S0007114513000809; Jakobsdottir G, 2013, SCAND J GASTROENTERO, V48, P696, DOI 10.3109/00365521.2013.786128; Jones RD, 2015, STEROIDS, V93, P87, DOI 10.1016/j.steroids.2014.11.002; Joyce SA, 2016, ANNU REV FOOD SCI T, V7, P313, DOI 10.1146/annurev-food-041715-033159; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Martinez-Moya P, 2013, INT IMMUNOPHARMACOL, V15, P372, DOI 10.1016/j.intimp.2012.11.017; McDonald JH, 2014, HDB BIOL STAT, P254; Nilsson U, 2005, BRIT J NUTR, V94, P705, DOI 10.1079/BJN20051531; NYMAN M, 1990, J NUTR, V120, P459, DOI 10.1093/jn/120.5.459; Paumgartner G, 2002, HEPATOLOGY, V36, P525, DOI 10.1053/jhep.2002.36088; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Rodriguez VA, 2016, ARCH BIOCHEM BIOPHYS, V591, P28, DOI 10.1016/j.abb.2015.12.006; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; Shih DM, 2013, FASEB J, V27, P3805, DOI 10.1096/fj.12-223008; Stenman LK, 2012, WORLD J GASTROENTERO, V18, P923, DOI 10.3748/wjg.v18.i9.923; Tsuchida T, 2012, METABOLISM, V61, P944, DOI 10.1016/j.metabol.2011.10.023; Vuksan V, 2011, BRIT J NUTR, V106, P1349, DOI 10.1017/S0007114511001711; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Woting A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040202; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580; Zhong YD, 2015, MOL NUTR FOOD RES, V59, P2066, DOI 10.1002/mnfr.201500187; Zhou HP, 2014, STEROIDS, V86, P62, DOI 10.1016/j.steroids.2014.04.016	43	25	28	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157427	10.1371/journal.pone.0157427	http://dx.doi.org/10.1371/journal.pone.0157427			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315087	Green Published, gold, Green Submitted			2022-12-26	WOS:000378030000025
J	Law, EC; Wilman, HR; Kelm, S; Shi, JY; Deane, CM				Law, Eleanor C.; Wilman, Henry R.; Kelm, Sebastian; Shi, Jiye; Deane, Charlotte M.			Examining the Conservation of Kinks in Alpha Helices	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; TRANSMEMBRANE HELICES; STRUCTURE ALIGNMENT; MEMBRANE-PROTEINS; DATA-BANK; PROLINE; DISTORTIONS; ACTIVATION; ALGORITHM; FEATURES	Kinks are a structural feature of alpha-helices and many are known to have functional roles. Kinks have previously tended to be defined in a binary fashion. In this paper we have deliberately moved towards defining them on a continuum, which given the unimodal distribution of kink angles is a better description. From this perspective, we examine the conservation of kinks in proteins. We find that kink angles are not generally a conserved property of homologs, pointing either to their not being functionally critical or to their function being related to conformational flexibility. In the latter case, the different structures of homologs are providing snapshots of different conformations. Sequence identity between homologous helices is informative in terms of kink conservation, but almost equally so is the sequence identity of residues in spatial proximity to the kink. In the specific case of proline, which is known to be prevalent in kinked helices, loss of a proline from a kinked helix often also results in the loss of a kink or reduction in its kink angle. We carried out a study of the seven transmembrane helices in the GPCR family and found that changes in kinks could be related both to subfamilies of GPCRs and also, in a particular subfamily, to the binding of agonists or antagonists. These results suggest conformational change upon receptor activation within the GPCR family. We also found correlation between kink angles in different helices, and the possibility of concerted motion could be investigated further by applying our method to molecular dynamics simulations. These observations reinforce the belief that helix kinks are key, functional, flexible points in structures.	[Law, Eleanor C.; Wilman, Henry R.; Deane, Charlotte M.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Kelm, Sebastian; Shi, Jiye] UCB Pharma, Informat, Slough, Berks, England; [Shi, Jiye] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai, Peoples R China	University of Oxford; UCB Pharma SA; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Deane, CM (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	deane@stats.ox.ac.uk		Kelm, Sebastian/0000-0001-7146-9322; Wilman, Henry/0000-0002-3362-1204; Deane, Charlotte/0000-0003-1388-2252; Law, Eleanor/0000-0001-5591-7316	Engineering and Physical Sciences Research Council [EP/G037280/1]; UCB Pharma; EPSRC [EP/G037280/1]; Engineering and Physical Sciences Research Council [1367765] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UCB Pharma(UCB Pharma SA); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council (https://www.epsrc.ac.uk/) grant EP/G037280/1 to ECL, and UCB Pharma (http://www.ucbpharma.co.uk/home) funding to ECL and HRW. SK and JS of UCB provided ideas for the design of the study and contributed to the editing of the manuscript. The funder provided support in the form of salaries for authors SK and JS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; The authors would like to thank the EPSRC (grant number EP/G037280/1) and UCB Pharma for funding, and the Oxford Protein Informatics Group for discussion.	Bansal M, 2000, J BIOMOL STRUCT DYN, V17, P811, DOI 10.1080/07391102.2000.10506570; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bettinelli I, 2011, CHEMMEDCHEM, V6, P1217, DOI 10.1002/cmdc.201100037; Choe S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3138906; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Deupi Xavier, 2012, Methods Mol Biol, V914, P219, DOI 10.1007/978-1-62703-023-6_13; Hall SE, 2009, J MOL GRAPH MODEL, V27, P944, DOI 10.1016/j.jmgm.2009.02.004; Isberg V, 2014, NUCLEIC ACIDS RES, V42, pD422, DOI 10.1093/nar/gkt1255; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kauko A, 2008, J MOL BIOL, V380, P170, DOI 10.1016/j.jmb.2008.04.052; Kelm S, 2009, BIOINFORMATICS, V25, P1086, DOI 10.1093/bioinformatics/btp102; Kneissl B, 2011, J CHEM INF MODEL, V51, P3017, DOI 10.1021/ci200278w; Kozma D, 2013, NUCLEIC ACIDS RES, V41, pD524, DOI 10.1093/nar/gks1169; Langelaan DN, 2013, BBA-BIOMEMBRANES, V1828, P1471, DOI 10.1016/j.bbamem.2013.02.005; Langelaan DN, 2010, J CHEM INF MODEL, V50, P2213, DOI 10.1021/ci100324n; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Lupyan D, 2005, BIOINFORMATICS, V21, P3255, DOI 10.1093/bioinformatics/bti527; Meruelo AD, 2011, PROTEIN SCI, V20, P1256, DOI 10.1002/pro.653; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Pedretti A, 2015, MOL INFORM, V34, P216, DOI 10.1002/minf.201400159; Tehan BG, 2014, PHARMACOL THERAPEUT, V143, P51, DOI 10.1016/j.pharmthera.2014.02.004; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; Traag VA, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016114; van der Kant R, 2014, INT J MOL SCI, V15, P7841, DOI 10.3390/ijms15057841; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Visiers I, 2000, PROTEIN ENG, V13, P603, DOI 10.1093/protein/13.9.603; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Werner T, 2013, J CHEM INF MODEL, V53, P2926, DOI 10.1021/ci400236s; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wilman HR, 2014, J CHEM INF MODEL, V54, P2585, DOI 10.1021/ci500403a; Wilman HR, 2014, PROTEINS, V82, P1960, DOI 10.1002/prot.24550; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	36	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157553	10.1371/journal.pone.0157553	http://dx.doi.org/10.1371/journal.pone.0157553			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314675	Green Published, gold, Green Submitted			2022-12-26	WOS:000378030000034
J	Saravu, K; Kumar, R; Ashok, H; Kundapura, P; Kamath, V; Kamath, A; Mukhopadhyay, C				Saravu, Kavitha; Kumar, Rishikesh; Ashok, Herikudru; Kundapura, Premananda; Kamath, Veena; Kamath, Asha; Mukhopadhyay, Chiranjay			Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India	PLOS ONE			English	Article							THAI-MYANMAR BORDER; SOUTH-WESTERN INDIA; CONTROLLED-TRIAL; RESISTANT; TERTIARY; SENSITIVITY; RESPONSES; EFFICACY	Background Several reports of chloroquine treatment failure and resistance in Plasmodium vivax malaria from Southeast Asian countries have been published. Present study was undertaken to assess the efficacy of chloroquine-primaquine (CQ-PQ) combined regimen for the treatment of P. vivax malaria patients who were catered by the selected primary health centres (PHCs) of Udupi taluk, Udupi district, Karnataka, India. Method Five PHCs were selected within Udupi taluk based on probability proportional to size. In-vivo therapeutic efficacy assessment of CQ (1500 mg over three days) plus PQ (210 mg over 14 days) regimen was carried out in accordance with the World Health Organization's protocol of 28 days follow-up among microscopically diagnosed monoinfection P. vivax cohort. Results In total, 161 participants were recruited in the study of which, 155 (96.3%) participants completed till day 28 follow-up, fully complied with the treatment regimen and showed adequate clinical and parasitological response. Loss to follow up was noted with 5 (3.1%) participants and non-compliance with treatment regimen occurred with one participant (0.6%). Glucose-6-phosphate dehydrogenase deficiency (G6PDd, <30% of normal mean activity) was noted among 5 (3.1%) participants and one of them did develop PQ induced dark-brown urination which subsided after PQ discontinuation. G6PDd patients were treated with PQ 45 mg/week for eight weeks while PQ was discontinued in one case with G6PD 1.4 U/g Hb due to complaint of reddish-brown coloured urine by 48 hours of PQ initiation. Nested polymerase chain reaction test revealed 45 (28%) cases asmixed (vivax and falciparum) malaria. Conclusions The CQ-PQ combined regimen remains outstandingly effective to treat uncomplicated P. vivax malaria in Udupi taluk and thus it should continue as first line regimen. For all P. vivax cases, G6PD screening before PQ administration must be mandatory and made available in all PHCs.	[Saravu, Kavitha; Kumar, Rishikesh] Manipal Univ, Kasturba Med Coll, Dept Med, Manipal, Karnataka, India; [Ashok, Herikudru] Dist Hlth Off, Udupi, Karnataka, India; [Kundapura, Premananda] Dist Malaria Off, Udupi, Karnataka, India; [Kamath, Veena; Kamath, Asha] Manipal Univ, Kasturba Med Coll, Dept Community Med, Manipal, Karnataka, India; [Mukhopadhyay, Chiranjay] Manipal Univ, Kasturba Med Coll, Dept Microbiol, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal	Saravu, K (corresponding author), Manipal Univ, Kasturba Med Coll, Dept Med, Manipal, Karnataka, India.	kavithasaravu@gmail.com	Saravu, Kavitha/H-4634-2019; Mukhopadhyay, Chiranjay/GLU-2887-2022	Saravu, Kavitha/0000-0001-6399-1129; Mukhopadhyay, Chiranjay/0000-0003-0402-1143; Kumar, Rishikesh/0000-0001-8993-4683; Kamath, Asha/0000-0003-0727-8067	Indian Council of Medical Research, New Delhi, India [AMR/46/2011-ECD-I, 80/931/2015-ECD-I]	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This study was supported by an extramural research grant (AMR/46/2011-ECD-I) from the Indian Council of Medical Research, New Delhi, India. RK is the recipient of senior research fellowship (80/931/2015-ECD-I) under the guidance of KS form the Indian Council of Medical Research, New Delhi, India. The funding council had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEUTLER E, 1966, BLOOD-J HEMATOL, V28, P553, DOI 10.1182/blood.V28.4.553.553; Directorate of National Vector Borne Disease Control Pro- gramme Directorate General of Health Services Ministry of Health and Family Welfare, 2013, NAT DRUG POL MAL; Dua VK, 1996, TROP MED INT HEALTH, V1, P816; Ganguly S, 2013, ANTIMICROB AGENTS CH, V57, P1246, DOI 10.1128/AAC.02050-12; Garg M, 1995, T ROY SOC TROP MED H, V89, P656, DOI 10.1016/0035-9203(95)90432-8; Joshi H, 2008, TRENDS PARASITOL, V24, P228, DOI 10.1016/j.pt.2008.01.007; Leslie T, 2004, T ROY SOC TROP MED H, V98, P168, DOI 10.1016/S0035-9203(03)00041-5; Maneeboonyang W, 2011, SE ASIAN J TROP MED, V42, P9; Nandy A, 2003, ANN TROP MED PARASIT, V97, P215, DOI 10.1179/000349803235001868; Phan GT, 2002, TROP MED INT HEALTH, V7, P858, DOI 10.1046/j.1365-3156.2002.00948.x; Phyo AP, 2011, CLIN INFECT DIS, V53, P977, DOI 10.1093/cid/cir631; Poravuth Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014501; Rishikesh K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0824-y; Rishikesh K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0669-4; Saravu K, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-370; Saravu K, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-304; Saravu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090419; Shalini S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-129; Singh RK, 2000, T ROY SOC TROP MED H, V94, P327, DOI 10.1016/S0035-9203(00)90305-5; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Srivastava HC, 2008, ANN TROP MED PARASIT, V102, P471, DOI 10.1179/136485908X311759; Takeuchi R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-308; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, 2009, METH SURV ANT DRUG E; World Health Organization, 2015, POINT OF CARE G6PD T; Yuan LL, 2015, ANTIMICROB AGENTS CH, V59, P1230, DOI 10.1128/AAC.04270-14	26	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157666	10.1371/journal.pone.0157666	http://dx.doi.org/10.1371/journal.pone.0157666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315280	Green Submitted, gold, Green Published			2022-12-26	WOS:000378030000043
J	Wongthida, P; Jengarn, J; Narkpuk, J; Koonyosying, P; Srisutthisamphan, K; Wanitchang, A; Leaungwutiwong, P; Teeravechyan, S; Jongkaewwattana, A				Wongthida, Phonphimon; Jengarn, Juggragarn; Narkpuk, Jaraspim; Koonyosying, Pongpisid; Srisutthisamphan, Kanjana; Wanitchang, Asawin; Leaungwutiwong, Pornsawan; Teeravechyan, Samaporn; Jongkaewwattana, Anan			In Vitro and In Vivo Attenuation of Vesicular Stomatitis Virus (VSV) by Phosphoprotein Deletion	PLOS ONE			English	Article							VACCINE VECTORS; NONHUMAN-PRIMATES; P-PROTEIN; INFECTION; GENE; NEUROVIRULENCE; HEMAGGLUTININ; GLYCOPROTEIN; POLYMERASE; PROTECTION	Vesicular stomatitis virus (VSV) is highly immunogenic and able to stimulate both innate and adaptive immune responses. However, its ability to induce adverse effects has held back the use of VSV as a potential vaccine vector. In this study we developed VSV-Delta P, a safe yet potent replication-defective recombinant VSV in which the phosphoprotein (P) gene was deleted. VSV-Delta P replicated only in supporting cells expressing P (BHK-P cells) and at levels more than 2 logs lower than VSV. In vivo studies indicated that the moderate replication of VSV-Delta P in vitro was associated with the attenuation of this virus in the mouse model, whereas mice intracranially injected with VSV succumbed to neurotoxicity. Furthermore, we constructed VSV and VSV-Delta P expressing a variety of antigens including hemagglutinin-neuraminidase (HN) from Newcastle disease virus (NDV), hemagglutinin (HA) from either a 2009 H1N1 pandemic influenza virus (pdm/09) or the avian H7N9. VSV and VSV-Delta P incorporated the foreign antigens on their surface resulting in induction of robust neutralizing antibody, serum IgG, and hemagglutination inhibition (HAI) titers against their corresponding viruses. These results indicated that VSV with P gene deletion was attenuated in vitro and in vivo, and possibly expressed the foreign antigen on its surface. Therefore, the P gene-deletion strategy may offer a potentially useful and safer approach for attenuating negative-sense RNA viruses which use phosphoprotein as a cofactor for viral replication.	[Wongthida, Phonphimon; Jengarn, Juggragarn; Narkpuk, Jaraspim; Wanitchang, Asawin; Teeravechyan, Samaporn; Jongkaewwattana, Anan] Natl Ctr Genet Engn & Biotechnol BIOTEC, Virol & Cell Technol Lab, 113 Thailand Sci Pk,Phahonyothin Rd, Klongluang 12120, Pathum Thani, Thailand; [Koonyosying, Pongpisid] Natl Ctr Genet Engn & Biotechnol BIOTEC, Protein Ligand Engn & Mol Biol Lab, 113 Thailand Sci Pk,Phahonyothin Rd, Klongluang 12120, Pathum Thani, Thailand; [Srisutthisamphan, Kanjana] Kasetsart Univ, Fac Sci, Dept Biochem, Ngam Wong Wan Rd, Bangkok 10900, Thailand; [Leaungwutiwong, Pornsawan] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Ratchawithi Rd, Bangkok 10400, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Kasetsart University; Mahidol University	Wongthida, P (corresponding author), Natl Ctr Genet Engn & Biotechnol BIOTEC, Virol & Cell Technol Lab, 113 Thailand Sci Pk,Phahonyothin Rd, Klongluang 12120, Pathum Thani, Thailand.	phonphimon.won@biotec.or.th		Koonyosying, Pongpisid/0000-0002-5311-2220; Teeravechyan, Samaporn/0000-0003-0776-9552; Jengarn, Juggragarn/0000-0003-2443-3727	Cluster Program Management Office, National Science and Technology Development Agency, Thailand [P-14-51228]	Cluster Program Management Office, National Science and Technology Development Agency, Thailand	This work was funded in part by grant P-14-51228 from the Cluster Program Management Office, National Science and Technology Development Agency, Thailand.	Albertini AAV, 2012, VIRUSES-BASEL, V4, P117, DOI 10.3390/v4010117; Ball LA, 1999, J VIROL, V73, P4705, DOI 10.1128/JVI.73.6.4705-4712.1999; BLONDEL D, 1990, J VIROL, V64, P1716, DOI 10.1128/JVI.64.4.1716-1725.1990; Canter DM, 1996, VIROLOGY, V219, P376, DOI 10.1006/viro.1996.0263; Cooper D, 2008, J VIROL, V82, P207, DOI 10.1128/JVI.01515-07; Diaz RM, 2007, CANCER RES, V67, P2840, DOI 10.1158/0008-5472.CAN-06-3974; Fang XK, 2012, VACCINE, V30, P1313, DOI 10.1016/j.vaccine.2011.12.085; FELLOWES ON, 1955, AM J VET RES, V16, P623; FIELDS BN, 1967, NEW ENGL J MED, V277, P889, DOI 10.1056/NEJM196711092771901; HANSON RP, 1950, J LAB CLIN MED, V36, P754; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Jayakar HR, 2002, J VIROL, V76, P8011, DOI 10.1128/JVI.76.16.8011-8018.2002; Johnson JE, 2007, VIROLOGY, V360, P36, DOI 10.1016/j.virol.2006.10.026; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kapadia SU, 2005, VIROLOGY, V340, P174, DOI 10.1016/j.virol.2005.06.016; KEENE JD, 1981, P NATL ACAD SCI-BIOL, V78, P6191, DOI 10.1073/pnas.78.10.6191; Kretzschmar E, 1997, J VIROL, V71, P5982, DOI 10.1128/JVI.71.8.5982-5989.1997; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Letchworth GJ, 1999, VET J, V157, P239, DOI 10.1053/tvjl.1998.0303; Majid A.M., 2006, HEPATITIS C VIRUSES; MASTERS PS, 1988, J VIROL, V62, P2651, DOI 10.1128/JVI.62.8.2651-2657.1988; Mondal A, 2014, J VIROL, V88, P1461, DOI 10.1128/JVI.02384-13; OHUCHI M, 1995, VIROLOGY, V212, P77, DOI 10.1006/viro.1995.1455; PATTERSON W. C., 1958, JOUR AMER VET MED ASSOC, V133, P57; QUIROZ E, 1988, AM J TROP MED HYG, V39, P312, DOI 10.4269/ajtmh.1988.39.312; Rabinovich S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106597; Ramsburg E, 2005, J VIROL, V79, P15043, DOI 10.1128/JVI.79.24.15043-15053.2005; Roberts A, 1998, J VIROL, V72, P4704, DOI 10.1128/JVI.72.6.4704-4711.1998; Roberts A, 1999, J VIROL, V73, P3723, DOI 10.1128/JVI.73.5.3723-3732.1999; Rose NF, 2001, CELL, V106, P539, DOI 10.1016/S0092-8674(01)00482-2; Schmeckpeper J, 2009, DIFFERENTIATION, V78, P169, DOI 10.1016/j.diff.2009.01.002; Schnell MJ, 1997, CELL, V90, P849, DOI 10.1016/S0092-8674(00)80350-5; Schnell MJ, 1998, EMBO J, V17, P1289, DOI 10.1093/emboj/17.5.1289; Sur JH, 2003, VET PATHOL, V40, P512, DOI 10.1354/vp.40-5-512; Uraki R, 2013, J VIROL, V87, P7874, DOI 10.1128/JVI.00076-13; van den Pol AN, 2002, J VIROL, V76, P1309, DOI 10.1128/JVI.76.3.1309-1327.2002; Vemula SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062496; Wagner R.R., 1996, RHABDOVIRIDAE VIRUSE; Walton TE, 1982, AM J TROP MED HYG, V1987, P166; Wanitchang A, 2011, ARCH VIROL, V156, P1031, DOI 10.1007/s00705-011-0947-6; WHELAN SPJ, 1995, P NATL ACAD SCI USA, V92, P8388, DOI 10.1073/pnas.92.18.8388	41	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157287	10.1371/journal.pone.0157287	http://dx.doi.org/10.1371/journal.pone.0157287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315286	Green Published, gold, Green Submitted			2022-12-26	WOS:000378030000017
J	Elbel, B; Corcoran, SP; Schwartz, AE				Elbel, Brian; Corcoran, Sean P.; Schwartz, Amy Ellen			Neighborhoods, Schools and Obesity: The Potential for Place-Based Approaches to Reduce Childhood Obesity	PLOS ONE			English	Article							NEW-YORK-CITY; BODY-MASS INDEX; HEALTH; ENVIRONMENTS; OVERWEIGHT; BEHAVIORS; QUALITY; ACCESS	A common policy approach to reducing childhood obesity aims to shape the environment in which children spend most of their time: neighborhoods and schools. This paper uses richly detailed data on the body mass index (BMI) of all New York City public school students in grades K-8 to assess the potential for place-based approaches to reduce child obesity. We document variation in the prevalence of obesity across NYC public schools and census tracts, and then estimate the extent to which this variation can be explained by differences in individual-level predictors (such as race and household income). Both unadjusted and adjusted variability across neighborhoods and schools suggest place-based policies have the potential to meaningfully reduce child obesity, but under most realistic scenarios the improvement would be modest.	[Elbel, Brian] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Elbel, Brian; Schwartz, Amy Ellen] NYU, Robert F Wagner Grad Sch Publ Serv, New York, NY 10003 USA; [Corcoran, Sean P.; Schwartz, Amy Ellen] NYU, Steinhardt Sch Culture Educ & Human Dev, New York, NY USA; [Schwartz, Amy Ellen] Syracuse Univ, Maxwell Sch, Syracuse, NY USA	New York University; New York University; New York University; Syracuse University	Elbel, B (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY USA.; Elbel, B (corresponding author), NYU, Robert F Wagner Grad Sch Publ Serv, New York, NY 10003 USA.	brian.elbel@nyumc.org		Corcoran, Sean/0000-0002-0640-2751; Elbel, Brian/0000-0003-1615-9430	National Institutes of Health [R01HD070739, R01DK097347]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health, Award Numbers R01HD070739 (AS) and R01DK097347 (BE). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black JL, 2010, HEALTH PLACE, V16, P489, DOI 10.1016/j.healthplace.2009.12.007; Black JL, 2010, AM J EPIDEMIOL, V171, P765, DOI 10.1093/aje/kwp458; Borders TF, 2006, J COMMUN HEALTH, V31, P57, DOI 10.1007/s10900-005-8189-8; Briefel RR, 2009, J AM DIET ASSOC, V109, pS91, DOI 10.1016/j.jada.2008.10.059; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Centers for Disease Control and Prevention, CUT OFFS DEF OUTL 20; Centers for Disease Control and Prevention, 2015, CHILDR HLTH BUILT EN; Cradock AL, 2014, HDB HLTH BEHAV CHANG; Drewnowski A., 2012, AM J PUBLIC HEALTH, V102, P74, DOI DOI 10.2105/AJPH.2012.300660; Economic Research Service (ERS) U.S. Department of Agriculture (USDA), FOOD ACC RES ATL; Grow HMG, 2010, SOC SCI MED, V71, P584, DOI 10.1016/j.socscimed.2010.04.018; Hoelscher DM, 2004, AM J PUBLIC HEALTH, V94, P1002, DOI 10.2105/AJPH.94.6.1002; Janssen I, 2004, PEDIATRICS, V113, P1187, DOI 10.1542/peds.113.5.1187; Karpyn A, 2012, CHILD OBES, V8, P28, DOI 10.1089/chi.2011.0113; Morrow JR, 2010, RES Q EXERCISE SPORT, V81, pS24, DOI 10.1080/02701367.2010.10599691; Nelson JA, 2004, AM J PUBLIC HEALTH, V94, P458, DOI 10.2105/AJPH.94.3.458; O'Malley PM, 2007, AM J PREV MED, V33, pS187, DOI 10.1016/j.amepre.2007.07.001; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pearce J, 2008, J EPIDEMIOL COMMUN H, V62, P198, DOI 10.1136/jech.2006.059196; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Rundle A, 2007, AM J HEALTH PROMOT, V21, P326, DOI 10.4278/0890-1171-21.4s.326; Rundle A, 2009, ENVIRON HEALTH PERSP, V117, P442, DOI 10.1289/ehp.11590; Rundle A, 2012, AM J EPIDEMIOL, V176, P986, DOI 10.1093/aje/kws187; Schwartz AE, 2016, JAMA PEDIATR, V170, P220, DOI 10.1001/jamapediatrics.2015.3778; Singh GK, 2010, HEALTH AFFAIR, V29, P503, DOI 10.1377/hlthaff.2009.0730; Stark JH, 2014, PREV MED, V64, P63, DOI 10.1016/j.ypmed.2014.03.026; Story M, 1999, INT J OBESITY, V23, pS43, DOI 10.1038/sj.ijo.0800859; Thorpe LE, 2004, AM J PUBLIC HEALTH, V94, P1496, DOI 10.2105/AJPH.94.9.1496; US Census Bureau, US CENS BUR PART STA; Veugelers PJ, 2005, AM J PUBLIC HEALTH, V95, P432, DOI 10.2105/AJPH.2004.045898	31	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157479	10.1371/journal.pone.0157479	http://dx.doi.org/10.1371/journal.pone.0157479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27309533	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800080
J	Sollberger, G; Amulic, B; Zychlinsky, A				Sollberger, Gabriel; Amulic, Borko; Zychlinsky, Arturo			Neutrophil Extracellular Trap Formation Is Independent of De Novo Gene Expression	PLOS ONE			English	Article							IMMUNITY	Neutrophils are essential innate immune cells whose responses are crucial in the clearance of invading pathogens. Neutrophils can respond to infection by releasing neutrophil extracellular traps (NETs). NETs are formed of chromatin and specific granular proteins and are released after execution of a poorly characterized cell death pathway. Here, we show that NET formation induced by PMA or Candida albicans is independent of RNA polymerase II and III-mediated transcription as well as of protein synthesis. Thus, neutrophils contain all the factors required for NET formation when they emerge from the bone marrow as differentiated cells.	[Sollberger, Gabriel; Amulic, Borko; Zychlinsky, Arturo] Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany	Max Planck Society	Sollberger, G; Amulic, B (corresponding author), Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany.	sollberger@mpiib-berlin.mpg.de; amulic@mpiib-berlin.mpg.de		Amulic, Borko/0000-0002-8518-8393; si yun, feng/0000-0002-3546-824X	Swiss National Science Foundation; EMBO long term fellowship	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EMBO long term fellowship(European Molecular Biology Organization (EMBO))	GS is supported by an Advanced PostDoc. Mobility fellowship from the Swiss National Science Foundation. BA was supported by an EMBO long term fellowship.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00413; Ermert D, 2009, J INNATE IMMUN, V1, P181, DOI 10.1159/000205281; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Harbort CJ, 2015, BLOOD, V126, P2842, DOI 10.1182/blood-2015-05-645424; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; KASAMA T, 1993, J EXP MED, V178, P63, DOI 10.1084/jem.178.1.63; LOSMAN MJ, 1992, J IMMUNOL, V148, P1561; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Subrahmanyam YVBK, 2001, BLOOD, V97, P2457, DOI 10.1182/blood.V97.8.2457	15	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157454	10.1371/journal.pone.0157454	http://dx.doi.org/10.1371/journal.pone.0157454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310721	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800075
J	Victor, JM; Debret, G; Lesne, A; Pascoe, L; Carrivain, P; Wainrib, G; Hugot, JP				Victor, Jean-Marc; Debret, Gaelle; Lesne, Annick; Pascoe, Leigh; Carrivain, Pascal; Wainrib, Gilles; Hugot, Jean-Pierre			Network Modeling of Crohn's Disease Incidence	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; EPIDEMIOLOGY; VARIANT; UPDATE; SUSCEPTIBILITY; PREVALENCE; MINNESOTA; COMPLEX; BINDING	Background Numerous genetic and environmental risk factors play a role in human complex genetic disorders (CGD). However, their complex interplay remains to be modelled and explained in terms of disease mechanisms. Methods and findings Crohn's Disease (CD) was modeled as a modular network of patho-physiological functions, each summarizing multiple gene-gene and gene-environment interactions. The disease resulted from one or few specific combinations of module functional states. Network aging dynamics was able to reproduce age-specific CD incidence curves as well as their variations over the past century in Western countries. Within the model, we translated the odds ratios (OR) associated to at-risk alleles in terms of disease propensities of the functional modules. Finally, the model was successfully applied to other CGD including ulcerative colitis, ankylosing spondylitis, multiple sclerosis and schizophrenia. Conclusion Modeling disease incidence may help to understand disease causative chains, to delineate the potential of personalized medicine, and to monitor epidemiological changes in CGD.	[Victor, Jean-Marc; Debret, Gaelle; Lesne, Annick; Carrivain, Pascal] CNRS, UMR 7600, Lab Phys Theor Matiere Condensee, Paris, France; [Victor, Jean-Marc; Debret, Gaelle; Lesne, Annick; Carrivain, Pascal] Sorbonne Univ, Univ Paris 06, Paris, France; [Victor, Jean-Marc; Lesne, Annick] Univ Montpellier, CNRS, Inst Genet Mol Montpellier, UMR 5535, F-34059 Montpellier, France; [Pascoe, Leigh] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, Paris, France; [Wainrib, Gilles] Ecole Normale Super, 24 Rue Lhomond, F-75231 Paris, France; [Wainrib, Gilles; Hugot, Jean-Pierre] Univ Paris Diderot, Sorbonne Paris Cite, Labex Inflamex, Paris, France; [Hugot, Jean-Pierre] INSERM, UMR 1149, Paris, France; [Hugot, Jean-Pierre] Hop Robert Debre, AP HP, F-75019 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Foundation Jean Dausset-CEPH; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Victor, JM (corresponding author), CNRS, UMR 7600, Lab Phys Theor Matiere Condensee, Paris, France.; Victor, JM (corresponding author), Sorbonne Univ, Univ Paris 06, Paris, France.; Victor, JM (corresponding author), Univ Montpellier, CNRS, Inst Genet Mol Montpellier, UMR 5535, F-34059 Montpellier, France.; Hugot, JP (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Labex Inflamex, Paris, France.; Hugot, JP (corresponding author), INSERM, UMR 1149, Paris, France.; Hugot, JP (corresponding author), Hop Robert Debre, AP HP, F-75019 Paris, France.	victor@lptmc.jussieu.fr; jean-pierre.hugot@rdb.aphp.fr	Victor, Jean-Marc/AAB-1362-2020; Lesne, Annick/W-9444-2018	Hugot, Jean-Pierre/0000-0002-8446-6056; Lesne, Annick/0000-0002-6647-612X	ANR, Investissements d'Avenir programme [ANR-11-IDEX-0005-02]; CNRS; INSERM; Universite Paris Diderot-Sorbonne Paris-Cite; Universite Pierre et Marie Curie; Universite Paris 13; Association Francois Aupetit; Sorbonne-Paris-Cite Laboratoire d'excellence INFLAMEX	ANR, Investissements d'Avenir programme(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Diderot-Sorbonne Paris-Cite; Universite Pierre et Marie Curie; Universite Paris 13; Association Francois Aupetit; Sorbonne-Paris-Cite Laboratoire d'excellence INFLAMEX	This work was supported by ANR, Investissements d'Avenir programme ANR-11-IDEX-0005-02 Sorbonne-Paris-Cite Laboratoire d'excellence INFLAMEX, CNRS, INSERM, Universite Paris Diderot-Sorbonne Paris-Cite, Universite Pierre et Marie Curie, Universite Paris 13 and Association Francois Aupetit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by ANR, Investissements d'Avenir programme ANR-11-IDEX-0005-02 Sorbonne-Paris-Cite Laboratoire d'excellence INFLAMEX, CNRS, INSERM, Universite Paris Diderot-Sorbonne Paris-Cite, Universite Pierre et Marie Curie, Universite Paris 13 and Association Francois Aupetit.	Aguilar C, 2014, J ALLERGY CLIN IMMUN, V134, P1131, DOI 10.1016/j.jaci.2014.04.031; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; CARBONE LD, 1992, ARTHRITIS RHEUM, V35, P1476, DOI 10.1002/art.1780351211; Chouraki V, 2011, ALIMENT PHARM THER, V33, P1133, DOI 10.1111/j.1365-2036.2011.04628.x; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; CROHN BB, 1984, JAMA-J AM MED ASSOC, V251, P73, DOI 10.1001/jama.251.1.73; Debret G, 2011, HIST PHIL LIFE SCI, V33, P497; Gavrilov LA, 2001, J THEOR BIOL, V213, P527, DOI 10.1006/jtbi.2001.2430; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Gordon H, 2015, INFLAMM BOWEL DIS, V21, P1428, DOI 10.1097/MIB.0000000000000393; Gunesh S, 2008, ALIMENT PHARM THER, V27, P211, DOI 10.1111/j.1365-2036.2007.03576.x; Hugot JP, 2003, LANCET, V362, P2012, DOI 10.1016/S0140-6736(03)15024-6; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Lapidus A, 1997, GUT, V41, P480, DOI 10.1136/gut.41.4.480; Li XJ, 2007, SCHIZOPHR RES, V97, P43, DOI 10.1016/j.schres.2007.09.027; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Muise AM, 2012, GUT, V61, P1028, DOI 10.1136/gutjnl-2011-300078; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; PHADKE JG, 1987, J EPIDEMIOL COMMUN H, V41, P5, DOI 10.1136/jech.41.1.5; ROSE JDR, 1988, GUT, V29, P346, DOI 10.1136/gut.29.3.346; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Thevenot R, 1978, ESSAI HIST FROID ART; Wei Z, 2013, AM J HUM GENET, V92, P1008, DOI 10.1016/j.ajhg.2013.05.002; Yang SK, 2008, INFLAMM BOWEL DIS, V14, P542, DOI 10.1002/ibd.20310	32	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156138	10.1371/journal.pone.0156138	http://dx.doi.org/10.1371/journal.pone.0156138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309539	Green Submitted, Green Published, gold			2022-12-26	WOS:000378029800002
J	Hodge, K; Tunghirun, C; Kamkaew, M; Limjindaporn, T; Yenchitsomanus, PT; Chimnaronk, S				Hodge, Kenneth; Tunghirun, Chairat; Kamkaew, Maliwan; Limjindaporn, Thawornchai; Yenchitsomanus, Pa-thai; Chimnaronk, Sarin			Identification of a Conserved RNA-dependent RNA Polymerase (RdRp)-RNA Interface Required for Flaviviral Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dengue virus (DENV); viral polymerase; viral protein; viral replication; virology; RNA-dependent RNA polymerase (RdRp); untranslated region (UTR); viral non-structural protein (NS) 5; yeast three-hybrid (Y3H)	YEAST 3-HYBRID SYSTEM; 3'-TERMINAL STEM-LOOP; 3 UNTRANSLATED REGION; C VIRUS POLYMERASE; DENGUE VIRUS; VIRAL-RNA; PROTEIN INTERACTIONS; CYCLIZATION SEQUENCES; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE	Dengue virus, an approximate to 10.7-kb positive-sense RNA virus, is the most common arthropod-communicated pathogen in the world. Despite dengue's clear epidemiological importance, mechanisms for its replication remain elusive. Here, we probed the entire dengue genome for interactions with viral RNA-dependent RNA polymerase (RdRp), and we identified the dominant interaction as a loop-forming ACAG motif in the 3 positive-stranded terminus, complicating the prevailing model of replication. A subset of interactions coincides with known flaviviral recombination sites inside the viral protein-coding region. Specific recognition of the RNA element occurs via an arginine patch in the C-terminal thumb domain of RdRp. We also show that the highly conserved nature of the consensus RNA motif may relate to its tolerance to various mutations in the interacting region of RdRp. Disruption of the interaction resulted in loss of viral replication ability in cells. This unique RdRp-RNA interface is found throughout flaviviruses, implying possibilities for broad disease interventions.	[Hodge, Kenneth; Tunghirun, Chairat; Kamkaew, Maliwan; Chimnaronk, Sarin] Mahidol Univ, Inst Mol Biosci, Lab RNA Biol, Salaya Campus, Phutthamonthon 73170, Nakhon Pathom, Thailand; [Limjindaporn, Thawornchai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anat, Bangkok 10700, Thailand; [Yenchitsomanus, Pa-thai] Mahidol Univ, Siriraj Hosp, Fac Med, Div Mol Med,Dept Res & Dev, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University	Chimnaronk, S (corresponding author), Mahidol Univ, Inst Mol Biosci, Lab RNA Biol, Salaya Campus, Phutthamonthon 73170, Nakhon Pathom, Thailand.	sarin.chi@mahidol.ac.th			Mahidol University, Thailand; Thailand Research Fund [RSA5680054]	Mahidol University, Thailand; Thailand Research Fund(Thailand Research Fund (TRF))	This work was supported by grants-in-aid for scientific research from Mahidol University, Thailand (to S. C. and P. Y.), a senior research scholar grant from the Thailand Research Fund (to P. Y.), and Mid-Career Grant RSA5680054 from Thailand Research Fund (to S. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Bernstein DS, 2002, METHODS, V26, P123, DOI 10.1016/S1046-2023(02)00015-4; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997; Chen SP, 2008, ARCH VIROL, V153, P1175, DOI 10.1007/s00705-008-0090-1; Cheng JC, 1999, J VIROL, V73, P7044, DOI 10.1128/JVI.73.8.7044-7049.1999; Choi KH, 2006, STRUCTURE, V14, P1107, DOI 10.1016/j.str.2006.05.020; Choksupmanee O, 2012, BIOCHEMISTRY-US, V51, P2840, DOI 10.1021/bi2018267; Chuang CK, 2009, VIROLOGY, V394, P286, DOI 10.1016/j.virol.2009.08.030; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; CUI T, 1995, NUCLEIC ACIDS RES, V23, P377, DOI 10.1093/nar/23.3.377; D'Agostino VG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072426; DOLAN JW, 1990, GENE DEV, V4, P492, DOI 10.1101/gad.4.4.492; DREHER TW, 1988, J MOL BIOL, V201, P31, DOI 10.1016/0022-2836(88)90436-6; Dyson MR, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn151; Elghonemy S, 2005, VIROLOGY, V331, P238, DOI 10.1016/j.virol.2004.11.008; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4; Holden KL, 2006, VIROLOGY, V344, P439, DOI 10.1016/j.virol.2005.08.034; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hook B, 2005, RNA, V11, P227, DOI 10.1261/rna.7202705; Kamkaew M, 2015, PROTEIN EXPRES PURIF, V112, P43, DOI 10.1016/j.pep.2015.04.008; Kao CC, 2000, J VIROL, V74, P11121, DOI 10.1128/JVI.74.23.11121-11128.2000; Karpala AJ, 2005, IMMUNOL CELL BIOL, V83, P211, DOI 10.1111/j.1440-1711.2005.01331.x; Khromykh AA, 2003, J VIROL, V77, P10623, DOI 10.1128/JVI.77.19.10623-10629.2003; Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001; Li DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019447; Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13; Oh JW, 2000, J BIOL CHEM, V275, P17710, DOI 10.1074/jbc.M908781199; Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194; SASSANFAR M, 1993, NATURE, V364, P550, DOI 10.1038/364550a0; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Siegel RW, 1997, P NATL ACAD SCI USA, V94, P11238, DOI 10.1073/pnas.94.21.11238; SONG CZ, 1995, J MOL BIOL, V254, P6, DOI 10.1006/jmbi.1995.0594; Sztuba-Solinska J, 2013, NUCLEIC ACIDS RES, V41, P5075, DOI 10.1093/nar/gkt203; Tilgner M, 2005, VIROLOGY, V331, P375, DOI 10.1016/j.virol.2004.07.022; Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410; Wurster SE, 2010, RNA, V16, P253, DOI 10.1261/rna.1880410; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	27	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17437	17449		10.1074/jbc.M116.724013	http://dx.doi.org/10.1074/jbc.M116.724013			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27334920	Green Published, hybrid			2022-12-26	WOS:000382643800042
J	Campbell, SJ; Stern, DB				Campbell, Stephen J.; Stern, David B.			Activation of an Endoribonuclease by Non-intein Protein Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSBA MESSENGER-RNA; CHLAMYDOMONAS-REINHARDTII; POLY(A)-BINDING PROTEIN; CHLOROPLAST; TRANSLATION; GENES; DEGRADATION; EXPRESSION; RB47	The Chlamydomonas reinhardtii chloroplast-localized poly(A)-binding protein RB47 is predicted to contain a non-conserved linker (NCL) sequence flanked by highly conserved N-and C-terminal sequences, based on the corresponding cDNA. RB47 was purified from chloroplasts in association with an endoribonuclease activity; however, protein sequencing failed to detect the NCL. Furthermore, while recombinant RB47 including the NCL did not display endoribonuclease activity in vitro, versions lacking the NCL displayed strong activity. Both full-length and shorter forms of RB47 could be detected in chloroplasts, with conversion to the shorter form occurring in chloroplasts isolated from cells grown in the light. This conversion could be replicated in vitro in chloroplast extracts in a light-dependent manner, where epitope tags and protein sequencing showed that the NCL was excised from a full-length recombinant substrate, together with splicing of the flanking sequences. The requirement for endogenous factors and light differentiates this protein splicing from autocatalytic inteins, and may allow the chloroplast to regulate the activation of RB47 endoribonuclease activity. We speculate that this protein splicing activity arose to post-translationally repair proteins that had been inactivated by deleterious insertions or extensions.	[Campbell, Stephen J.; Stern, David B.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research	Stern, DB (corresponding author), Boyce Thompson Inst Plant Res, 533 Tower Rd, Ithaca, NY 14853 USA.	ds28@cornell.edu	Stern, David B/H-7852-2012	Stern, David/0000-0002-0653-6602	National Science Foundation [MCB-1244106]; Direct For Biological Sciences [1244106] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation award MCB-1244106. The authors declare that they have no conflicts of interest with the contents of this article.	Alergand T, 2006, PLANT CELL PHYSIOL, V47, P540, DOI 10.1093/pcp/pcj023; Barkan A, 2011, PLANT PHYSIOL, V155, P1520, DOI 10.1104/pp.110.171231; Bouabe H., 2008, J PROTEOM BIOINFORM, V1, P336; Bruick RK, 1998, J CELL BIOL, V143, P1145, DOI 10.1083/jcb.143.5.1145; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; DANON A, 1994, EMBO J, V13, P2227, DOI 10.1002/j.1460-2075.1994.tb06500.x; DANON A, 1991, EMBO J, V10, P3993, DOI 10.1002/j.1460-2075.1991.tb04974.x; DANON A, 1994, SCIENCE, V266, P1717, DOI 10.1126/science.7992056; Derrien B, 2009, J BIOL CHEM, V284, P15408, DOI 10.1074/jbc.M109.002733; FONG SE, 1992, CURR GENET, V21, P485, DOI 10.1007/BF00351659; FONG SE, 1992, CURR GENET, V21, P527, DOI 10.1007/BF00351664; Germain A, 2013, WIRES RNA, V4, P295, DOI 10.1002/wrna.1161; Hicks A, 2002, J BIOL CHEM, V277, P3325, DOI 10.1074/jbc.M108979200; KLEIN U, 1983, PLANT PHYSIOL, V72, P481, DOI 10.1104/pp.72.2.481; Lange H, 2009, TRENDS PLANT SCI, V14, P497, DOI 10.1016/j.tplants.2009.06.007; Lemay JF, 2010, RNA BIOL, V7, P291, DOI 10.4161/rna.7.3.11649; Mason CB, 2006, NAT PROTOC, V1, P2227, DOI 10.1038/nprot.2006.348; Mathys S, 1999, GENE, V231, P1, DOI 10.1016/S0378-1119(99)00103-1; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Smith RWP, 2010, BIOCHEM J, V426, P1, DOI 10.1042/BJ20091571; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; STERN DB, 1993, MOL CELL BIOL, V13, P2277, DOI 10.1128/MCB.13.4.2277; Stoppel R, 2012, J EXP BOT, V63, P1663, DOI 10.1093/jxb/err401; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Warren EH, 2006, SCIENCE, V313, P1444, DOI 10.1126/science.1130660; Yohn CB, 1998, J CELL BIOL, V142, P435, DOI 10.1083/jcb.142.2.435; Yohn CB, 1996, MOL CELL BIOL, V16, P3560; Yohn CB, 1998, P NATL ACAD SCI USA, V95, P2238, DOI 10.1073/pnas.95.5.2238	30	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					15911	15922		10.1074/jbc.M116.727768	http://dx.doi.org/10.1074/jbc.M116.727768			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27311716	Green Published, hybrid			2022-12-26	WOS:000380585400001
J	Bouaicha, S; Slankamenac, K; Moor, BK; Tok, S; Andreisek, G; Finkenstaedt, T				Bouaicha, Samy; Slankamenac, Ksenija; Moor, Beat K.; Tok, Sina; Andreisek, Gustav; Finkenstaedt, Tim			Cross-Sectional Area of the Rotator Cuff Muscles in MRI - Is there Evidence for a Biomechanical Balanced Shoulder?	PLOS ONE			English	Article							LATISSIMUS-DORSI TRANSFER; STRENGTH; TEARS; ARTHROPLASTY; STABILITY; ADULTS; VOLUME; APPROPRIATE; MODEL; YOUNG	Objective To provide in-vivo evidence for the common biomechanical concept of transverse and craniocaudal force couples in the shoulder that are yielded by both the rotator cuff muscles (RCM) and the deltoid and to quantitatively evaluate and correlate the cross-sectional areas (CSA) of the corresponding RCM as a surrogate marker for muscle strength using MRI. Materials and Methods Fifty patients (mean age, 36 years; age range, 18-57 years; 41 male, 9 female) without rotator cuff tears were included in this retrospective study. Data were assessed by two readers. The CSA (mm(2)) of all rotator cuff muscles was measured on parasagittal T1-weighted FSE sequence at two different positions (at the established "y-position" and at a more medial slice in the presumably maximal CSA for each muscle, i.e., the "set position"). The CSA of the deltoid was measured on axial intermediate-weighted FSE sequences at three positions. CSA measurements were obtained using 1.5 Tesla MR-arthrographic shoulder. Pearson's correlation for the corresponding CSA of the force couple as well as was the intraclass correlation coefficient for the inter-and intra-reader agreement was calculated. Results The mean CSA was 770 mm(2) (+/- 167) and 841 mm(2) (+/- 191) for the supraspinatus (in the y- and set-positions, respectively) and 984 mm(2) (+/- 241) and 1568 mm(2) (+/- 338) for the infraspinatus. The mean CSA was 446 mm(2) (+/- 129) and 438 mm(2) (+/- 128) for the teres minor (in the y-and set-positions, respectively) and 1953 mm(2) (+/- 553) and 2343 mm(2) (+/- 587) for the subscapularis. The three measurements of the deltoid revealed a CSA of 3063 mm(2) (+/- 839) for the upper edge, 3829 mm(2) (+/- 836) for the lower edge and 4069 mm(2) (+/- 937) for the middle of the glenoid. At the set position Pearson's correlation of the transverse force couple (subscapularis/infraspinatus) showed a moderate positive correlation of r = 0.583 (p<0.0001) and a strong correlation when the CSA of the teres minor was added to the infraspinatus CSA (r = 0.665, p = 0.0008) and a strong positive correlation of the craniocaudal force couple (supraspinatus/deltoid) that ranged from r = 0.565-0.698 (p<0.0001). Inter-reader agreement (ranged from 0.841 to 0.997, p = 0.0007) and intra-reader agreement were excellent (ranged from 0.863 to 0.999, p = 0.0006). Conclusion The significant correlation of the CSA of the RCM that form the transverse (subscapularis/infraspinatus-teres minor) and craniocaudal (supraspinatus/deltoid) force couple measured by MR-arthrography supports the biomechanical concept of a dynamically balanced shoulder in patients with an intact rotator cuff.	[Bouaicha, Samy; Slankamenac, Ksenija] Univ Zurich Hosp, Div Trauma, CH-8091 Zurich, Switzerland; [Moor, Beat K.] Univ Hosp Bern, Inselspital, Dept Orthopaed, CH-3010 Bern, Switzerland; [Tok, Sina] Schulthess Clin, Spine Ctr, Dept Neurosurg, Zurich, Switzerland; [Andreisek, Gustav; Finkenstaedt, Tim] Univ Zurich, Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern; Schulthess Clinic; University of Zurich; University Zurich Hospital	Finkenstaedt, T (corresponding author), Univ Zurich, Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, Zurich, Switzerland.	tim.finkenstaedt@usz.ch		Finkenstaedt, Sina/0000-0002-5368-478X; Slankamenac, Ksenija/0000-0002-3568-9253; Finkenstaedt, Tim/0000-0002-8807-7306				Ackland DC, 2009, J ANAT, V215, P184, DOI 10.1111/j.1469-7580.2009.01090.x; Akagi R, 2009, AGE AGEING, V38, P564, DOI 10.1093/ageing/afp122; Bamman MM, 2000, MED SCI SPORT EXER, V32, P1307, DOI 10.1097/00005768-200007000-00019; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; De ste Croix MBA, 2003, SPORTS MED, V33, P727, DOI 10.2165/00007256-200333100-00002; Evans JD, 1996, STRAIGHTFORWARD STAT, P591; Farshad M, 2010, INT ORTHOP, V34, P1075, DOI 10.1007/s00264-010-1125-2; Favre P, 2012, J BIOMECH, V45, P2248, DOI 10.1016/j.jbiomech.2012.06.010; Flurin PH, 2013, BULL HOSP JT DIS, V71, pS101; Fuchs B, 1999, J SHOULDER ELB SURG, V8, P599, DOI 10.1016/S1058-2746(99)90097-6; GERBER C, 1992, CLIN ORTHOP RELAT R, P152; Gerber C, 2007, J SHOULDER ELB SURG, V16, P691, DOI 10.1016/j.jse.2007.02.122; Gerber C, 2009, J AM ACAD ORTHOP SUR, V17, P284, DOI 10.5435/00124635-200905000-00003; Guery J, 2006, J BONE JOINT SURG AM, V88A, P1742, DOI 10.2106/JBJS.E.00851; Hansen ML, 2008, J BONE JOINT SURG AM, V90A, P316, DOI 10.2106/JBJS.F.00880; Holzbaur KRS, 2007, J BIOMECH, V40, P742, DOI 10.1016/j.jbiomech.2006.11.011; Lehtinen J, 2003, ACTA ORTHOP SCAND, V74, P722, DOI 10.1080/00016470310018270; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; LIPPITT S, 1993, CLIN ORTHOP RELAT R, P20; Masuda K, 2003, J SPORT SCI, V21, P851, DOI 10.1080/0264041031000102042; McMahon PJ, 2002, CLIN ORTHOP RELAT R, pS18, DOI 10.1097/01.blo.0000031987.92980.86; Meyer DC, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-247; Meyer DC, 2011, AM J SPORT MED, V39, P1456, DOI 10.1177/0363546510396305; Saul KR, 2015, J APPL BIOMECH, V31, P484, DOI 10.1123/jab.2014-0177; SHARKEY NA, 1995, AM J SPORT MED, V23, P270, DOI 10.1177/036354659502300303; Spencer EE, 2008, AM J SPORT MED, V36, P99, DOI 10.1177/0363546507307504; Thompson WO, 1996, AM J SPORT MED, V24, P286, DOI 10.1177/036354659602400307; Vidt ME, 2012, J BIOMECH, V45, P334, DOI 10.1016/j.jbiomech.2011.10.007; Werner CML, 2006, J SHOULDER ELB SURG, V15, P736, DOI 10.1016/j.jse.2005.11.002; Yanagisawa O, 2009, MAGN RESON MED SCI, V8, P65, DOI 10.2463/mrms.8.65; Zanetti M, 1998, INVEST RADIOL, V33, P163, DOI 10.1097/00004424-199803000-00006	31	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157946	10.1371/journal.pone.0157946	http://dx.doi.org/10.1371/journal.pone.0157946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336464	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000378389200071
J	Liew, SM; Khoo, EM; Ho, BK; Lee, YK; Omar, M; Ayadurai, V; Yusoff, FM; Suli, Z; Mudin, RN; Goh, PP; Chinna, K				Liew, Su May; Khoo, Ee Ming; Ho, Bee Kiau; Lee, Yew Kong; Omar, Mimi; Ayadurai, Vickneswari; Yusoff, Fazlina Mohamed; Suli, Zailiza; Mudin, Rose Nani; Goh, Pik Pin; Chinna, Karuthan			Dengue in Malaysia: Factors Associated with Dengue Mortality from a National Registry	PLOS ONE			English	Article							SHOCK SYNDROME	Background The increasing incidence and geographical distribution of dengue has had significant impact on global healthcare services and resources. This study aimed to determine the factors associated with dengue-related mortality in a cohort of Malaysian patients. Methods This was a retrospective cohort study of patients in the Malaysian National Dengue Registry of 2013. The outcome measure was dengue-related mortality. Associations between socio-demographic and clinical variables with the outcome were analysed using multivariate analysis. Results There were 43 347 cases of which 13081 were serologically confirmed. The mean age was 30.0 years (SD 15.7); 60.2% were male. The incidence of dengue increased towards the later part of the calendar year. There were 92 probable dengue mortalities, of which 41 were serologically confirmed. Multivariate analysis in those with positive serology showed that increasing age (OR 1.03; CI: 1.01-1.05), persistent vomiting (OR 13.34; CI: 1.92-92.95), bleeding (OR 5.84; CI 2.17-15.70) and severe plasma leakage (OR 66.68; CI: 9.13487.23) were associated with mortality. Factors associated with probable dengue mortality were increasing age (OR 1.04; CI: 1.03-1.06), female gender (OR 1.53; CI: 1.01-2.33), nausea and/or vomiting (OR 1.80; CI: 1.17-2.77), bleeding (OR 3.01; CI: 1.29-7.04), lethargy and/or restlessness (OR 5.97; CI: 2.26-15.78), severe plasma leakage (OR 14.72; CI: 1.54-140.70), and shock (OR 1805.37; CI: 125.44-25982.98), in the overall study population. Conclusions Older persons and those with persistent vomiting, bleeding or severe plasma leakage, which were associated with mortality, at notification should be monitored closely and referred early if indicated. Doctors and primary care practitioners need to detect patients with dengue early before they develop these severe signs and symptoms.	[Liew, Su May; Khoo, Ee Ming; Lee, Yew Kong] Univ Malaya, Dept Primary Care Med, Fac Med, Kuala Lumpur 50603, Malaysia; [Ho, Bee Kiau] Minist Hlth Malaysia, Klin Kesihatan Bandar Bot, Klang 42000, Malaysia; [Omar, Mimi] Minist Hlth Malaysia, Klin Kesihatan Kelana Jaya, Petaling Jaya 47301, Malaysia; [Ayadurai, Vickneswari] Minist Hlth Malaysia, Klin Kesihatan Taman Medan, Petaling Jaya 46000, Malaysia; [Yusoff, Fazlina Mohamed] Minist Hlth Malaysia, Klin Kesihatan Seksyen Shah Alam 19, Shah Alam 40300, Malaysia; [Suli, Zailiza; Mudin, Rose Nani] Minist Hlth Malaysia, Vector Borne Dis Sect, Putrajaya 62590, Malaysia; [Goh, Pik Pin] Minist Hlth Malaysia, Natl Clin Res Ctr, Kuala Lumpur 50586, Malaysia; [Chinna, Karuthan] Univ Malaya, Dept Social & Prevent Med, Fac Med, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Universiti Malaya	Liew, SM (corresponding author), Univ Malaya, Dept Primary Care Med, Fac Med, Kuala Lumpur 50603, Malaysia.	su_mayliew@um.edu.my	Lee, Yew Kong/K-4339-2013; LIEW, Su May/B-8852-2010; KHOO, EE MING/B-8785-2010; Suli, Zailiza/AAG-4045-2019	Lee, Yew Kong/0000-0002-3034-8601; LIEW, Su May/0000-0003-2865-7955; KHOO, EE MING/0000-0003-3191-1264; 	National Clinical Research Center, Ministry of Health Malaysia	National Clinical Research Center, Ministry of Health Malaysia	This work was supported by the National Clinical Research Center, Ministry of Health Malaysia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476; Carrasco L R, 2014, PLOS NEGLECT TROP D, V8, pe2972, DOI DOI 10.1371/J0URNAL.PNTD.0002972; Cheah W K, 2014, Med J Malaysia, V69 Suppl A, P59; Fairos WY Wan, 2010, INT J MATH COMPUTATI, V4, P1; Halstead SB, 1997, EPIDEMIOLOGY DENGUE, pxi; Hanley KA, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P1; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382; Mia MS, 2013, ASIAN PAC J TROP MED, V6, P462, DOI 10.1016/S1995-7645(13)60075-9; Ministry of Health Malaysia, 2010, MAN DENG INF AD; Mohd-Zaki AH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003159; Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412; Skae FMT, 1902, BRIT MED J, V1902, P1581, DOI 10.1136/bmj.2.2185.1581-a; Thomas L, 2010, J CLIN VIROL, V48, P96, DOI 10.1016/j.jcv.2010.03.008; WHO, 1997, DENG HAEM FEV DIAGN; WHO/SEARO, 2011, COMPR GUID PREV CONT; World Health Organization, 2012, HDB CLIN MAN DENG; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2011, TECHN PAP DENG CALL; World Health Organization, 2015, GLOB AL RESP IMP DEN; Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667	21	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157631	10.1371/journal.pone.0157631	http://dx.doi.org/10.1371/journal.pone.0157631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336440	gold, Green Published, Green Submitted			2022-12-26	WOS:000378389200027
J	Waljee, AK; Wiitala, WL; Govani, S; Stidham, R; Saini, S; Hou, J; Feagins, LA; Khan, N; Good, CB; Vijan, S; Higgins, PDR				Waljee, Akbar K.; Wiitala, Wyndy L.; Govani, Shail; Stidham, Ryan; Saini, Sameer; Hou, Jason; Feagins, Linda A.; Khan, Nabeel; Good, Chester B.; Vijan, Sandeep; Higgins, Peter D. R.			Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort	PLOS ONE			English	Article							HEALTH-CARE-SYSTEM; ULCERATIVE-COLITIS; CROHNS-DISEASE; NETWORK METAANALYSIS; OSTEOPOROSIS; QUALITY; AZATHIOPRINE; GUIDELINES; FRACTURES; EFFICACY	Background and Aims Corticosteroids are effective for the short-term treatment of inflammatory bowel disease (IBD). Long-term use, however, is associated with significant adverse effects. To define the: (1) frequency and duration of corticosteroid use, (2) frequency of escalation to corticosteroid-sparing therapy, (3) rate of complications related to corticosteroid use, (4) rate of appropriate bone density measurements (dual energy X-ray absorptiometry [ DEXA] scans), and (5) factors associated with escalation and DEXA scans. Methods Retrospective review of Veterans Health Administration (VHA) data from 2002-2010. Results Of the 30,456 Veterans with IBD, 32% required at least one course of corticosteroids during the study time period, and 17% of the steroid users had a prolonged course. Among these patients, only 26.2% underwent escalation of therapy. Patients visiting a gastroenterology (GI) physician were significantly more likely to receive corticosteroid-sparing medications. Factors associated with corticosteroid-sparing medications included younger age (OR = 0.96 per year, 95% CI: 0.95, 0.97), male gender (OR = 2.00,95% CI: 1.16,3.46), GI visit during the corticosteroid evaluation period (OR = 8.01,95% CI: 5.85,10.95) and the use of continuous corticosteroids vs. intermittent corticosteroids (OR = 2.28,95% CI: 1.33,3.90). Rates of complications per 1000 person-years after IBD diagnosis were higher among corticosteroid users (venous thromboembolism [VTE] 9.0%; fragility fracture 2.6%; Infections 54.3) than non-corticosteroid users (VTE 4.9%; fragility fracture 1.9%; Infections 26.9). DEXA scan utilization rates among corticosteroid users were only 7.8%. Conclusions Prolonged corticosteroid therapy for the treatment of IBD is common and is associated with significant harm to patients. Patients with prolonged use of corticosteroids for IBD should be referred to gastroenterology early and universal efforts to improve the delivery of high quality care should be undertaken.	[Waljee, Akbar K.; Wiitala, Wyndy L.; Saini, Sameer; Vijan, Sandeep] VA Ann Arbor Hlth Care Syst, VA Ctr Clin Management Res, Ann Arbor, MI USA; [Waljee, Akbar K.; Govani, Shail; Stidham, Ryan; Saini, Sameer; Vijan, Sandeep; Higgins, Peter D. R.] Univ Michigan Hlth Syst, Div Gastroenterol & Hepatol, Dept Internal Med, Ann Arbor, MI USA; [Hou, Jason] Michael E DeBakey VA Med Ctr, Houston VA HSR&D Ctr Excellence, Dept Internal Med, Div Gastroenterol & Hepatol, Houston, TX USA; [Hou, Jason] Baylor Coll Med, Med Ctr, Dept Med, Houston, TX 77030 USA; [Feagins, Linda A.] VA North Texas Hlth Care Syst, Div Gastroenterol & Hepatol, Dept Internal Med, Dallas, TX USA; [Feagins, Linda A.] Univ Texas SW Med Ctr Dallas, Div Gastroenterol, Dallas, TX 75390 USA; [Feagins, Linda A.] Univ Texas SW Med Ctr Dallas, Div Hepatol, Dallas, TX 75390 USA; [Khan, Nabeel] Philadelphia VA Med Ctr, Div Gastroenterol, Dept Internal Med, Philadelphia, PA USA; [Khan, Nabeel] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Good, Chester B.] Vet Affairs Pittsburgh Healthcare Syst, Ctr Hlth Equity Res & Promot, Pittsburgh, PA USA; [Good, Chester B.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Waljee, AK (corresponding author), VA Ann Arbor Hlth Care Syst, VA Ctr Clin Management Res, Ann Arbor, MI USA.; Waljee, AK (corresponding author), Univ Michigan Hlth Syst, Div Gastroenterol & Hepatol, Dept Internal Med, Ann Arbor, MI USA.	awaljee@med.umich.edu	Good, Chester B/K-2818-2019; Waljee, Akbar K/G-2067-2010	Good, Chester B/0000-0003-4388-4558; Waljee, Akbar K/0000-0003-1964-8790; Feagins, Linda/0000-0001-7758-3257	Veteran's Health Administration Health Services Research and Development Career Development Award (CDA-2) [1IK2HX000775]; National Institutes of Health Research Project Grant Program (R01) [GM097117]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK101687] Funding Source: NIH RePORTER	Veteran's Health Administration Health Services Research and Development Career Development Award (CDA-2); National Institutes of Health Research Project Grant Program (R01); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A.K.W.'s research is funded by a Veteran's Health Administration Health Services Research and Development Career Development Award (CDA-2) 1IK2HX000775. P.D.R.H.'s research is supported by National Institutes of Health Research Project Grant Program (R01) GM097117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardizzone S, 2006, GUT, V55, P47, DOI 10.1136/gut.2005.068809; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Bernstein CN, 2003, GASTROENTEROLOGY, V124, P795, DOI 10.1053/gast.2003.50106; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Higgins PDR, 2015, CLIN GASTROENTEROL H, V13, P316, DOI 10.1016/j.cgh.2014.07.017; Hou JK, 2014, DIGEST DIS SCI, V59, P2406, DOI 10.1007/s10620-014-3174-7; KEENE GS, 1993, BRIT MED J, V307, P1248, DOI 10.1136/bmj.307.6914.1248; Kerr EA, 2004, ANN INTERN MED, V141, P272, DOI 10.7326/0003-4819-141-4-200408170-00007; Kornbluth A, 2006, AM J GASTROENTEROL, V101, P1546, DOI 10.1111/j.1572-0241.2006.00571.x; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727; Liu CF, 2010, HEALTH SERV RES, V45, P1268, DOI 10.1111/j.1475-6773.2010.01123.x; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; LUKERT BP, 1990, ANN INTERN MED, V112, P352, DOI 10.7326/0003-4819-112-5-352; Melmed Gil Y, 2013, Gastroenterol Hepatol (N Y), V9, P286; Melmed GY, 2013, INFLAMM BOWEL DIS, V19, P662, DOI 10.1097/mib.0b013e31828278a2; PEARSON DC, 1995, ANN INTERN MED, V123, P132, DOI 10.7326/0003-4819-123-2-199507150-00009; Plevy SE, 2002, AM J GASTROENTEROL, V97, P1607; Reddy SI, 2005, AM J GASTROENTEROL, V100, P1357, DOI 10.1111/j.1572-0241.2005.40849.x; Stidham RW, 2014, ALIMENT PHARM THER, V39, P1349, DOI 10.1111/apt.12749; Stidham RW, 2014, ALIMENT PHARM THER, V39, P660, DOI 10.1111/apt.12644; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; Wang AS, 2013, AM J SURG, V206, P410, DOI 10.1016/j.amjsurg.2012.11.018	22	84	86	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158017	10.1371/journal.pone.0158017	http://dx.doi.org/10.1371/journal.pone.0158017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336296	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000378389200091
J	Pei, XC; Zhu, JH; Yang, R; Tan, ZJ; An, MR; Shi, JQ; Lubman, DM				Pei, Xiucong; Zhu, Jianhui; Yang, Rui; Tan, Zhijing; An, Mingrui; Shi, Jiaqi; Lubman, David M.			CD90 and CD24 Co-Expression Is Associated with Pancreatic Intraepithelial Neoplasias	PLOS ONE			English	Article							LASER CAPTURE MICRODISSECTION; STEM-CELL MARKERS; PROTEOMIC ANALYSIS; EXPRESSION; CARCINOMA; TUMOR; THY-1; CD133; ADENOCARCINOMAS; PHENOTYPE	Thy-1 (CD90) has been shown to be a potential marker for several different types of cancer. However, reports on CD90 expression in pancreatic intraepithelial neoplasia (PanIN) lesions are still limited where PanINs are the most important precursor lesion of pancreatic ductal adenocarcinoma (PDAC). Herein, we investigate candidate markers for PanIN lesions by examining the distribution and trend of CD90 and CD24 expression as well as their co-expression in various stages of PanINs. Thirty cases of PanINs, which were confirmed histopathologically and clinically, were used to evaluate protein expression of CD90 and CD24 by immunofluoresence double staining. CD90 was found to be mainly expressed in stroma around lesion ducts while not observed in acini and islets in PanINs. CD90 also showed increased expression in PanIN III compared to PanIN III. CD24 was mainly present in the cytoplasm and membrane of pancreatic ductal epithelia, especially in the apical epithelium of the duct. CD24 had higher expression in PanIN III compared with PanIN IIIIII or PanIN III. CD90 was expressed around CD24 sites, but there was little overlap between cells that expressed each of these proteins. A correlation analysis showed that these two proteins have a moderate relationship with PanIN stages respectively. These results suggest that co-expression of CD90 and CD24 may have an important role in the development and progression of PanINs, which is also conducive to early detection and treatment of PDAC.	[Pei, Xiucong; Zhu, Jianhui; Yang, Rui; Tan, Zhijing; An, Mingrui; Lubman, David M.] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA; [Pei, Xiucong] Shenyang Med Coll, Sch Publ Hlth, Dept Toxicol, Liaoning 110034, Peoples R China; [Shi, Jiaqi] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Shenyang Medical College; University of Michigan System; University of Michigan	Lubman, DM (corresponding author), Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA.	dmlubman@umich.edu	; Zhu, Jianhui/H-4665-2011	Shi, Jiaqi/0000-0003-4893-1587; Zhu, Jianhui/0000-0002-0051-7777	U.S. National Institutes of Health [R01.GM 49500]; National Natural Science Foundation of China in China [81373029]; China Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049500] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China in China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received support from three funding sources, which are listed below: (1) Grant R01.GM 49500 is supported by the U.S. National Institutes of Health; (2) Grant 81373029 is supported by the National Natural Science Foundation of China in China; (3) China Scholarship Council (no number) has supported the first author, Xiucong Pei, to work in the United States as a visiting scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong T, 2004, CLIN CANCER RES, V10, P7427, DOI 10.1158/1078-0432.CCR-03-0825; Bi YL, 2016, J SURG ONCOL, V113, P144, DOI 10.1002/jso.24124; Bukovsky A, 2009, AGING-US, V1, P157, DOI 10.18632/aging.100024; Chen YP, 2015, INT J CLIN EXP PATHO, V8, P11287; Cherciu Irina, 2014, Curr Health Sci J, V40, P153, DOI 10.12865/CHSJ.40.03.01; Cid-Arregui A, 2015, WORLD J GASTROENTERO, V21, P9297, DOI 10.3748/wjg.v21.i31.9297; Codony-Servat J, 2015, TRANSL LUNG CANCER R, V4, P689, DOI 10.3978/j.issn.2218-6751.2015.12.11; Distler M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/474905; Foygel K, 2013, GASTROENTEROLOGY, V145, P885, DOI 10.1053/j.gastro.2013.06.011; Fujita N, 1996, INT J CANCER, V66, P544; Fujita Y, 2016, CANCER SCI, V107, P385, DOI 10.1111/cas.12896; Garcia-Carracedo D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120851; Guillot-Delost M, 2012, J IMMUNOL, V188, P981, DOI 10.4049/jimmunol.1101592; Haeryfar SMM, 2004, J IMMUNOL, V173, P3581, DOI 10.4049/jimmunol.173.6.3581; He JT, 2013, ELECTROPHORESIS, V34, P1627, DOI 10.1002/elps.201200566; He JT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010744; Hernandez YG, 2016, WORLD J GASTRO ONCOL, V8, P18, DOI 10.4251/wjgo.v8.i1.18; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Ikenaga N, 2010, HUM PATHOL, V41, P1466, DOI 10.1016/j.humpath.2010.04.004; Ishiura Y, 2010, BIOCHEM BIOPH RES CO, V396, P329, DOI 10.1016/j.bbrc.2010.04.092; Jacob J, 2004, PANCREATOLOGY, V4, P454, DOI 10.1159/000079824; Kohlgraf KG, 2003, CANCER RES, V63, P5011; Kure S, 2012, INT J ONCOL, V41, P1314, DOI 10.3892/ijo.2012.1565; Kwon GY, 2007, INT J RADIAT ONCOL, V69, P1150, DOI 10.1016/j.ijrobp.2007.04.071; Kwon MS, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S9-S4; Lehmann GM, 2010, AM J PHYSIOL-CELL PH, V299, pC672, DOI 10.1152/ajpcell.00451.2009; Loertscher R, 2002, TRANSPL IMMUNOL, V9, P93, DOI 10.1016/S0966-3274(02)00013-8; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Nestl A, 2001, CANCER RES, V61, P1569; PONT S, 1987, BIOCHIMIE, V69, P315, DOI 10.1016/0300-9084(87)90022-8; Rasheed ZA, 2012, J GASTROEN HEPATOL, V27, P15, DOI 10.1111/j.1440-1746.2011.07015.x; Saalbach A, 2005, ONCOGENE, V24, P4710, DOI 10.1038/sj.onc.1208559; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Shimizu K, 2009, PANCREAS, V38, pE207, DOI 10.1097/MPA.0b013e3181bb5037; Thakolwiboon Smathorn, 2014, J Proteomics Bioinform, V7, P296; Triviai I, 2015, HAEMATOLOGICA, V100, P768, DOI 10.3324/haematol.2014.118463; Wang L, 2011, WORLD J GASTROENTERO, V17, P1434, DOI 10.3748/wjg.v17.i11.1434; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhao J, 2015, NEOPLASMA, V62, P567, DOI 10.4149/neo_2015_068; Zhu JH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115507, 10.1371/journal.pone.0097616]; Zhu JH, 2013, J PROTEOME RES, V12, P2791, DOI 10.1021/pr400139c; Zhu JH, 2012, J PROTEOME RES, V11, P2272, DOI 10.1021/pr201059g	42	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0158021	10.1371/journal.pone.0158021	http://dx.doi.org/10.1371/journal.pone.0158021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332878	Green Published, gold			2022-12-26	WOS:000378212800068
J	Rajasekaran, B; Uriu, K; Valentin, G; Tinevez, JY; Oates, AC				Rajasekaran, Bhavna; Uriu, Koichiro; Valentin, Guillaume; Tinevez, Jean-Yves; Oates, Andrew C.			Object Segmentation and Ground Truth in 3D Embryonic Imaging	PLOS ONE			English	Article							CELL BIOLOGY; MICROSCOPY; RECONSTRUCTION; TRACKING; MIGRATION; ACCURATE; NUCLEI	Many questions in developmental biology depend on measuring the position and movement of individual cells within developing embryos. Yet, tools that provide this data are often challenged by high cell density and their accuracy is difficult to measure. Here, we present a three-step procedure to address this problem. Step one is a novel segmentation algorithm based on image derivatives that, in combination with selective post-processing, reliably and automatically segments cell nuclei from images of densely packed tissue. Step two is a quantitative validation using synthetic images to ascertain the efficiency of the algorithm with respect to signal-to-noise ratio and object density. Finally, we propose an original method to generate reliable and experimentally faithful ground truth datasets: Sparse-dense dual-labeled embryo chimeras are used to unambiguously measure segmentation errors within experimental data. Together, the three steps outlined here establish a robust, iterative procedure to fine-tune image analysis algorithms and microscopy settings associated with embryonic 3D image data sets.	[Rajasekaran, Bhavna; Uriu, Koichiro; Valentin, Guillaume; Tinevez, Jean-Yves; Oates, Andrew C.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Rajasekaran, Bhavna; Uriu, Koichiro] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Uriu, Koichiro] RIKEN, Theoret Biol Lab, Saitama, Japan; [Valentin, Guillaume; Oates, Andrew C.] MRC Natl Inst Med Res, London, England; [Oates, Andrew C.] UCL, Dept Cell & Dev Biol, London, England; [Uriu, Koichiro] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Valentin, Guillaume] Genoway, Lyon, France; [Tinevez, Jean-Yves] Inst Pasteur, Imagopole CiTech, Paris, France; [Oates, Andrew C.] Francis Crick Inst, Mill Hill Lab, London, England	Max Planck Society; Max Planck Society; RIKEN; MRC National Institute for Medical Research; University of London; University College London; Kanazawa University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Francis Crick Institute	Oates, AC (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.; Oates, AC (corresponding author), MRC Natl Inst Med Res, London, England.; Oates, AC (corresponding author), UCL, Dept Cell & Dev Biol, London, England.; Oates, AC (corresponding author), Francis Crick Inst, Mill Hill Lab, London, England.	andrew.oates@crick.ac.uk	Tinevez, Jean-Yves/O-4551-2019; Tinevez, Jean-Yves/E-8398-2012; Valentin, Guillaume/AAL-9185-2020; Zebrafish, UCL/A-3125-2009; Tinevez, Jean-Yves/L-7581-2015	Tinevez, Jean-Yves/0000-0002-0998-4718; Tinevez, Jean-Yves/0000-0002-0998-4718; Tinevez, Jean-Yves/0000-0002-0998-4718; Valentin, Guillaume/0000-0003-4596-6282; Uriu, Koichiro/0000-0003-1802-2470	Max Planck Society through Max Planck Institute for Molecular Cell Biology and Genetics; European Research Council under European Communities 7th Framework Programme /[ERC grant] [207634]; Wellcome Trust [WT098025MA]; Medical Research Council [MC_UP_1202/3]; Japan Society for the Promotion of Science [11J02685]; European Molecular Biology Organisation EMBO-LTF [ALTF 1572-2011]; The Francis Crick Institute [10124] Funding Source: researchfish; MRC [MC_UP_1202/3] Funding Source: UKRI	Max Planck Society through Max Planck Institute for Molecular Cell Biology and Genetics; European Research Council under European Communities 7th Framework Programme /[ERC grant]; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Molecular Biology Organisation EMBO-LTF; The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the following sources of funding: Max Planck Society through the Max Planck Institute for Molecular Cell Biology and Genetics, http://www.mpi-cbg.de: BR GV JYT AO; European Research Council under the European Communities 7th Framework Programme [FP7/2007-2013]/[ERC grant 207634], http://erc.europa.eu/ funding-and-grants BR AO; Wellcome Trust [WT098025MA], http://www.wellcome.ac.uk/funding/ GV AO; Medical Research Council [MC_UP_1202/3], http://www.mrc.ac.uk/funding/AO; Japan Society for the Promotion of Science [11J02685], https://www.jsps.go.jp/english/KU; European Molecular Biology Organisation EMBO-LTF [ALTF 1572-2011], http://www.embo.org/funding-awards GV.	Akaike H, 1980, BAYESIAN STAT, P143, DOI DOI 10.1007/BF02888350; Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; Amat F, 2014, NAT METHODS, V11, P951, DOI [10.1038/NMETH.3036, 10.1038/nmeth.3036]; Blanchard GB, 2009, NAT METHODS, V6, P458, DOI [10.1038/nmeth.1327, 10.1038/NMETH.1327]; Braumann UD, 2005, IEEE T MED IMAGING, V24, P1286, DOI 10.1109/TMI.2005.855437; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Eils R, 2003, J CELL BIOL, V161, P477, DOI 10.1083/jcb.200302097; Figueiredo MAT, 2002, IEEE T PATTERN ANAL, V24, P381, DOI 10.1109/34.990138; Gelasca ED, 2008, IEEE IMAGE PROC, P1816, DOI 10.1109/ICIP.2008.4712130; Gerlich D, 2003, NAT CELL BIOL, pS14, DOI 10.1038/ncb1033; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Herrgen Leah, 2009, V546, P243, DOI 10.1007/978-1-60327-977-2_15; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Lawton AK, 2013, DEVELOPMENT, V140, P573, DOI 10.1242/dev.090381; Li G, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-40; Long FH, 2009, NAT METHODS, V6, P667, DOI [10.1038/NMETH.1366, 10.1038/nmeth.1366]; Megason Sean G., 2009, V546, P317, DOI 10.1007/978-1-60327-977-2_19; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Morrison AH, 2012, COLD SPRING HARB PRO, V2012, P398, DOI [10.1101/pdb.top068536, DOI 10.1101/PDB.TOP068536]; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Parker JR, 2010, ALGORITHMS IMAGE PRO; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Roysam B, 2006, HDB BIOL CONFOCAL MI, P316; Santella A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-580; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schroter C, 2008, DEV DYNAM, V237, P545, DOI 10.1002/dvdy.21458; Stegmaier J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090036; Supatto W, 2009, NAT PROTOC, V4, P1397, DOI 10.1038/nprot.2009.130; Tinevez JY, 2012, METHOD ENZYMOL, V506, P291, DOI 10.1016/B978-0-12-391856-7.00039-1; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; YOUNG SJ, 1987, J ELECTRON MICR TECH, V6, P207, DOI 10.1002/jemt.1060060211	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0150853	10.1371/journal.pone.0150853	http://dx.doi.org/10.1371/journal.pone.0150853			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332860	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212800001
J	Sheller, S; Papaconstantinou, J; Urrabaz-Garza, R; Richardson, L; Saade, G; Salomon, C; Menon, R				Sheller, Samantha; Papaconstantinou, John; Urrabaz-Garza, Rheanna; Richardson, Lauren; Saade, George; Salomon, Carlos; Menon, Ramkumar			Amnion-Epithelial-Cell-Derived Exosomes Demonstrate Physiologic State of Cell under Oxidative Stress	PLOS ONE			English	Article							SITE-SPECIFIC PHOSPHORYLATION; PROGESTERONE-RECEPTOR; 1ST TRIMESTER; EXTRACELLULAR VESICLES; MATERNAL CIRCULATION; PLACENTAL EXOSOMES; SIGNALING PATHWAYS; TROPHOBLAST CELLS; PRETERM BIRTH; EMERGING ROLE	At term, the signals of fetal maturity and feto-placental tissue aging prompt uterine readiness for delivery by transitioning quiescent myometrium to an active stage. It is still unclear how the signals reach the distant myometrium. Exosomes are a specific type of extracellular vesicle (EVs) that transport molecular signals between cells, and are released from a wide range of cells, including the maternal and fetal cells. In this study, we hypothesize that i) exosomes act as carriers of signals in utero-placental compartments and ii) exosomes reflect the physiologic status of the origin cells. The primary aims of this study were to determine exosomal contents in exosomes derived from primary amnion epithelial cells (AEC). We also determined the effect of oxidative stress on AEC derived exosomal cargo contents. AEC were isolated from amniotic membrane obtained from normal, term, not in labor placentae at delivery, and culture under standard conditions. Oxidative stress was induced using cigarette smoke extract for 48 hours. AEC-conditioned media were collected and exosomes isolated by differential centrifugations. Both growth conditions (normal and oxidative stress induced) produced cup shaped exosomes of around 50 nm, expressed exosomes enriched markers, such as CD9, CD63, CD81 and HSC70, embryonic stem cell marker Nanog, and contained similar amounts of cell free AEC DNA. Using confocal microscopy, the colocalization of histone (H) 3, heat shock protein (HSP) 70 and activated form of prosenescence and term parturition associated marker p38 mitogen activated protein kinase (MAPK) (P-p38 MAPK) co-localized with exosome enrich marker CD9. HSP70 and P-p38 MAPK were significantly higher in exosomes from AEC grown under oxidative stress conditions than standard conditions (p<0.05). Finally, mass spectrometry and bioinformatics analysis identified 221 different proteins involved in immunomodulatory response and cell-to-cell communication. This study determined AEC exosome characteristics and their cargo reflected the physiologic status of the cell of origin and suggests that AEC-derived exosomal p38 MAPK plays a major role in determining the fate of pregnancy. Understanding the propagation of fetal signals and their mechanisms in normal term pregnancies can provide insights into pathologic activation of such signals associated with spontaneous preterm parturitions.	[Sheller, Samantha; Urrabaz-Garza, Rheanna; Richardson, Lauren; Saade, George; Menon, Ramkumar] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX 77555 USA; [Sheller, Samantha; Papaconstantinou, John] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Salomon, Carlos] Univ Queensland, Fac Hlth Sci, Ctr Clin Diagnost, Exosome Biol Lab,UQ Ctr Clin Res, Herston, Qld, Australia	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Queensland	Menon, R (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX 77555 USA.	ram.menon@utmb.edu	Sheller, Samantha/T-8681-2019; Sheller-Miller, Samantha/K-8582-2019; Salomon, Carlos F/L-2167-2013	Sheller-Miller, Samantha/0000-0002-3991-1747; Salomon, Carlos F/0000-0003-4474-0046; Richardson, Lauren/0000-0001-8392-2833	March of Dimes Center of Ohio, Cincinnati, OH; University of Texas Medical Branch at Galveston, TX	March of Dimes Center of Ohio, Cincinnati, OH; University of Texas Medical Branch at Galveston, TX	This study is supported by Innovative catalyst grant funding from March of Dimes Center of Ohio, Cincinnati, OH to RM and partially by RM's Faculty development funds from University of Texas Medical Branch at Galveston, TX. Authors declare *all* the funding or sources of support received during this specific study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported by Innovative catalyst grant funding from March of Dimes Center of Ohio, Cincinnati, OH to R Menon and partially by R. Menon's Faculty development funds from University of Texas Medical Branch at Galveston, TX. Authors declare all the funding or sources of support received during this specific study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu Z, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00442; Atay S, 2011, EXP CELL RES, V317, P1192, DOI 10.1016/j.yexcr.2011.01.014; Atay S, 2011, AM J REPROD IMMUNOL, V65, P65, DOI 10.1111/j.1600-0897.2010.00880.x; Beck CA, 1996, J BIOL CHEM, V271, P1209, DOI 10.1074/jbc.271.2.1209; Beck CA, 1996, J BIOL CHEM, V271, P19546, DOI 10.1074/jbc.271.32.19546; Behnia F, 2016, AM J REPROD IMMUNOL, V75, P505, DOI 10.1111/aji.12496; Behnia F, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.05.041; Blackburn S., 2014, FETAL NEONATAL PHYSI; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Bredeson S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113799; Bullerdiek J, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-27; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Cai X, 2015, TRENDS GENET, V31, P564, DOI 10.1016/j.tig.2015.06.001; Casey ML, 1997, ANN NY ACAD SCI, V828, P273, DOI 10.1111/j.1749-6632.1997.tb48548.x; Challis JRG, 2005, J OBSTET GYNAECOL RE, V31, P492, DOI 10.1111/j.1447-0756.2005.00342.x; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Corrado C, 2013, INT J MOL SCI, V14, P5338, DOI 10.3390/ijms14035338; Da CL, 2016, ONCOL REP, V35, P2767, DOI 10.3892/or.2016.4661; De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203; Delorme-Axford E, 2013, AUTOPHAGY, V9, P2173, DOI 10.4161/auto.26558; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Dressing GE, 2014, MOL ENDOCRINOL, V28, P442, DOI 10.1210/me.2013-1196; Fabregat I, 2016, J CLIN MED, V5; FOX H, 1981, CLIN ENDOCRINOL META, V10, P57, DOI 10.1016/S0300-595X(81)80038-2; Frydrychowicz M, 2015, SCAND J IMMUNOL, V81, P2, DOI 10.1111/sji.12247; Gao Y, 2012, EUR J HISTOCHEM, V56, P208, DOI 10.4081/ejh.2012.e33; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Harding CV, 2013, J CELL BIOL, V200, P367, DOI 10.1083/jcb.201212113; Hornung D, 1998, FERTIL STERIL, V69, P909, DOI 10.1016/S0015-0282(98)00044-2; Izumi M, 2009, J REPROD IMMUNOL, V81, P39, DOI 10.1016/j.jri.2009.02.007; Kambe S, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121616; Karrasch T, 2006, J CELL PHYSIOL, V207, P809, DOI 10.1002/jcp.20626; Kobayashi M, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-4; Koike C, 2014, CELL REPROGRAM, V16, P298, DOI 10.1089/cell.2013.0090; Kshirsagar SK, 2012, PLACENTA, V33, P982, DOI 10.1016/j.placenta.2012.10.005; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Li JYZ, 2014, HYPERTENS PREGNANCY, V33, P102, DOI 10.3109/10641955.2013.832772; Liga A, 2015, LAB CHIP, V15, P2388, DOI 10.1039/c5lc00240k; Lin Jin, 2015, ScientificWorldJournal, V2015, P657086, DOI 10.1155/2015/657086; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Menon R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00567; Menon R, 2014, AM J PATHOL, V184, P1740, DOI 10.1016/j.ajpath.2014.02.011; Menon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083416; Menon R, 2011, OBSTET GYNECOL, V118, P121, DOI 10.1097/AOG.0b013e3182204eaa; Merlino AA, 2007, J CLIN ENDOCR METAB, V92, P1927, DOI 10.1210/jc.2007-0077; Mesiano S, 2002, J CLIN ENDOCR METAB, V87, P2924, DOI 10.1210/jc.87.6.2924; Mesiano S, 2007, SEMIN REPROD MED, V25, P5, DOI 10.1055/s-2006-956771; Mesiano S, 2011, REPROD SCI, V18, P6, DOI 10.1177/1933719110382922; Mincheva-Nilsson L, 2014, AM J REPROD IMMUNOL, V72, P440, DOI 10.1111/aji.12311; Mincheva-Nilsson L, 2010, AM J REPROD IMMUNOL, V63, P520, DOI 10.1111/j.1600-0897.2010.00822.x; Mitchell MD, 2015, AM J OBSTET GYNECOL, V213, pS173, DOI 10.1016/j.ajog.2015.07.001; Olivieri F, 2015, ONCOTARGET, V6, P35509, DOI 10.18632/oncotarget.5899; Ouyang Y, 2014, PLACENTA, V35, pS69, DOI 10.1016/j.placenta.2013.11.002; Papageorgis P, 2015, J ONCOL, V2015, DOI 10.1155/2015/587193; Phaneuf S., 1995, ADV EXP MED BIOL, V395, P435; Phillippe M, 2014, NEW ENGL J MED, V370, P2534, DOI 10.1056/NEJMcibr1404324; Polettini J, 2014, PLACENTA, V35, P188, DOI 10.1016/j.placenta.2013.12.012; Polettini J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137188; Polettini J, 2014, AM J OBSTET GYNECOL, V210, pS402, DOI 10.1016/j.ajog.2013.10.861; Rana S, 2011, BIOCHEM SOC T, V39, P559, DOI 10.1042/BST0390559; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Record M, 2014, PLACENTA, V35, P297, DOI 10.1016/j.placenta.2014.02.009; Redman CWG, 2008, PLACENTA, V29, pS73, DOI 10.1016/j.placenta.2007.11.016; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Rice GE, 2015, J CLIN ENDOCR METAB, V100, pE1280, DOI 10.1210/jc.2015-2270; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2010, J MATERN-FETAL NEO M, V23, P320, DOI 10.3109/14767050903168465; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Sadovsky Y, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023036; Saito S, 2012, CURR MOL MED, V12, P1340, DOI 10.2174/156652412803833625; Salomon C., 2013, PLOS ONE, V8, P1; Salomon C, 2016, DIABETES, V65, P598, DOI 10.2337/db15-0966; Salomon C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/693157; Salomon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098667; Salomon C, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00175; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079636; Sarker S, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-204; Shynlova O, 2013, REPROD SCI, V20, P154, DOI 10.1177/1933719112446084; Shynlova O, 2009, EUR J OBSTET GYN R B, V144, pS2, DOI 10.1016/j.ejogrb.2009.02.044; Smith R, 2002, REGUL PEPTIDES, V108, P159, DOI 10.1016/S0167-0115(02)00105-2; Southcombe J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020245; Stenqvist AC, 2013, J IMMUNOL, V191, P5515, DOI 10.4049/jimmunol.1301885; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Swaminathan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047400; Teng Z, 2013, CELL TRANSPLANT, V22, P267, DOI 10.3727/096368912X655055; Urbanelli L, 2013, GENES-BASEL, V4, P152, DOI 10.3390/genes4020152; Valbonesi P, 2008, PLACENTA, V29, P725, DOI 10.1016/j.placenta.2008.05.004; Vargas A, 2014, FASEB J, V28, P3703, DOI 10.1096/fj.13-239053; Yeh YH, 2016, ONCOL REP, V35, P2887, DOI 10.3892/or.2016.4664; Zhang B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00518; ZHANG YX, 1995, MOL ENDOCRINOL, V9, P1029, DOI 10.1210/me.9.8.1029; Zhao HX, 2010, DIFFERENTIATION, V80, P123, DOI 10.1016/j.diff.2010.03.002	93	83	84	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157614	10.1371/journal.pone.0157614	http://dx.doi.org/10.1371/journal.pone.0157614			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333275	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212800038
J	Barker, JH; Kaufman, JW; Apicella, MA; Weiss, JP				Barker, Jason H.; Kaufman, Justin W.; Apicella, Michael A.; Weiss, Jerrold P.			Evidence Suggesting That Francisella tularensis O-Antigen Capsule Contains a Lipid A-Like Molecule That Is Structurally Distinct from the More Abundant Free Lipid A	PLOS ONE			English	Article							ESCHERICHIA-COLI; LEGIONELLA-PNEUMOPHILA; MASS-SPECTROMETRY; OUTER-MEMBRANE; LIPOPOLYSACCHARIDE; ACID; IDENTIFICATION; NOVICIDA; LPS; POLYSACCHARIDE	Francisella tularensis, the Gram-negative bacterium that causes tularemia, produces a high molecular weight capsule that is immunologically distinct from Francisella lipopolysaccharide but contains the same O-antigen tetrasaccharide. To pursue the possibility that the capsule of Francisella live vaccine strain (LVS) has a structurally unique lipid anchor, we have metabolically labeled Francisella with [C-14] acetate to facilitate highly sensitive compositional analysis of capsule-associated lipids. Capsule was purified by two independent methods and yielded similar results. Autoradiographic and immunologic analysis confirmed that this purified material was largely devoid of low molecular weight LPS and of the copious amounts of free lipid A that the Francisellae accumulate. Chemical hydrolysis yielded [C-14]labeled free fatty acids characteristic of Francisella lipid A but with a different molar ratio of 3-OH C18:0 to 3-OH C16:0 and different composition of non-hydroxylated fatty acids (mainly C14:0 rather than C16:0) than that of free Francisella lipid A. Mild acid hydrolysis to induce selective cleavage of KDO-lipid A linkage yielded a [C-14]-labeled product that partitioned during Bligh/Dyer extraction and migrated during thin-layer chromatography like lipid A. These findings suggest that the O-antigen capsule of Francisella contains a covalently linked and structurally distinct lipid A species. The presence of a discrete lipid A-like molecule associated with capsule raises the possibility that Francisella selectively exploits lipid A structural heterogeneity to regulate synthesis, transport, and stable bacterial surface association of the O-antigen capsular layer.	[Barker, Jason H.; Kaufman, Justin W.; Apicella, Michael A.; Weiss, Jerrold P.] Univ Iowa, Inflammat Program, Iowa City, IA USA; [Barker, Jason H.; Kaufman, Justin W.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Barker, Jason H.; Kaufman, Justin W.; Apicella, Michael A.; Weiss, Jerrold P.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Apicella, Michael A.; Weiss, Jerrold P.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Barker, JH (corresponding author), Univ Iowa, Inflammat Program, Iowa City, IA USA.; Barker, JH (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	jason-barker@uiowa.edu		Weiss, Jerrold/0000-0003-1476-4485; Barker, Jason/0000-0001-6679-1026	National Institutes of Health (National Institute of Allergy and Infectious Diseases) [1R01AI104728-01A1, P01AI044642-12]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in whole or part by National Institutes of Health (National Institute of Allergy and Infectious Diseases) Grants 1R01AI104728-01A1 and P01AI044642-12 (www. niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011060; Barker JH, 2014, INNATE IMMUN-LONDON, V20, P88, DOI 10.1177/1753425913485308; Chalabaev S, 2010, J BIOL CHEM, V285, P34330, DOI 10.1074/jbc.M110.166314; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Chong A, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00138; Cowley SC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00026; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; Giardina PC, 2001, J BIOL CHEM, V276, P5883, DOI 10.1074/jbc.M009273200; GOLDMAN RC, 1982, J BACTERIOL, V151, P1210, DOI 10.1128/JB.151.3.1210-1221.1982; Gunn JS, 2007, ANN NY ACAD SCI, V1105, P202, DOI 10.1196/annals.1409.006; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; HOOD AM, 1977, J HYG-CAMBRIDGE, V79, P47, DOI 10.1017/S0022172400052840; JANTZEN E, 1979, J CLIN MICROBIOL, V10, P928, DOI 10.1128/JCM.10.6.928-930.1979; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; Katz SS, 1999, J BIOL CHEM, V274, P36579, DOI 10.1074/jbc.274.51.36579; Kooistra O, 2002, EUR J BIOCHEM, V269, P560, DOI 10.1046/j.0014-2956.2001.02683.x; Li YY, 2012, P NATL ACAD SCI USA, V109, P8716, DOI 10.1073/pnas.1202908109; Lindemann SR, 2011, INFECT IMMUN, V79, P581, DOI 10.1128/IAI.00863-10; Lu Zhaohua, 2014, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V33, P235, DOI 10.1089/mab.2014.0022; MAITRA SK, 1978, P NATL ACAD SCI USA, V75, P3993, DOI 10.1073/pnas.75.8.3993; McLendon MK, 2007, INFECT IMMUN, V75, P5518, DOI 10.1128/IAI.01288-06; Peleg A, 2005, J BACTERIOL, V187, P5259, DOI 10.1128/JB.187.15.5259-5266.2005; PETERSON AA, 1985, J BACTERIOL, V162, P738, DOI 10.1128/JB.162.2.738-745.1985; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rasmussen JA, 2014, INFECT IMMUN, V82, P1523, DOI 10.1128/IAI.01640-13; Roche MI, 2011, HYBRIDOMA, V30, P19, DOI 10.1089/hyb.2010.0083; SANDSTROM G, 1988, INFECT IMMUN, V56, P1194; Schilling B, 2007, ANAL CHEM, V79, P1034, DOI 10.1021/ac061654e; Sestito SE, 2014, CHEMBIOCHEM, V15, P734, DOI 10.1002/cbic.201300805; Shaffer SA, 2007, J AM SOC MASS SPECTR, V18, P1080, DOI 10.1016/j.jasms.2007.03.008; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Tran AX, 2008, J BIOL CHEM, V283, P20342, DOI 10.1074/jbc.M802503200; VINOGRADOV EV, 1991, CARBOHYD RES, V214, P289, DOI 10.1016/0008-6215(91)80036-M; Wang XY, 2006, BIOCHEMISTRY-US, V45, P14427, DOI 10.1021/bi061767s; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Whittaker P, 2007, J AOAC INT, V90, P465	37	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157842	10.1371/journal.pone.0157842	http://dx.doi.org/10.1371/journal.pone.0157842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27326857	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212400050
J	Saika, A; Koike, H; Fukuoka, T; Yamamoto, S; Kishimoto, T; Morita, T				Saika, Azusa; Koike, Hideaki; Fukuoka, Tokuma; Yamamoto, Shuhei; Kishimoto, Takahide; Morita, Tomotake			A Gene Cluster for Biosynthesis of Mannosylerythritol Lipids Consisted of 4-O-beta-D-Mannopyranosyl-(2R, 3S)-Erythritol as the Sugar Moiety in a Basidiomycetous Yeast Pseudozyma tsukubaensis	PLOS ONE			English	Article							AQUEOUS-PHASE BEHAVIOR; GLYCOLIPID BIOSURFACTANTS; EFFICIENT PRODUCTION; IDENTIFICATION; DIASTEREOMERS; TRANSFORMATION; ANTARCTICA; PRODUCER; CELLS	Mannosylerythritol lipids (MELs) belong to the glycolipid biosurfactants and are produced by various fungi. The basidiomycetous yeast Pseudozyma tsukubaensis produces diastereomer type of MEL-B, which contains 4-O-beta-D-mannopyranosyl-(2R, 3S)-erythritol (R-form) as the sugar moiety. In this respect it differs from conventional type of MELs, which contain 4-O-beta-D-mannopyranosyl-(2S, 3R)-erythritol (S-form) as the sugar moiety. While the biosynthetic gene cluster for conventional type of MELs has been previously identified in Ustilago maydis and Pseudozyma antarctica, the genetic basis for MEL biosynthesis in P. tsukubaensis is unknown. Here, we identified a gene cluster involved in MEL biosynthesis in P. tsukubaensis. Among these genes, PtEMT1, which encodes erythritol/mannose transferase, had greater than 69% identity with homologs from strains in the genera Ustilago, Melanopsichium, Sporisorium and Pseudozyma. However, phylogenetic analysis placed PtEMT1p in a separate clade from the other proteins. To investigate the function of PtEMT1, we introduced the gene into a P. antarctica mutant strain, Delta PaEMT1, which lacks MEL biosynthesis ability owing to the deletion of PaEMT1. Using NMR spectroscopy, we identified the biosynthetic product as MEL-A with altered sugar conformation. These results indicate that PtEMT1p catalyzes the sugar conformation of MELs. This is the first report of a gene cluster for the biosynthesis of diastereomer type of MEL.	[Saika, Azusa; Fukuoka, Tokuma; Morita, Tomotake] Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem, Tsukuba, Ibaraki, Japan; [Koike, Hideaki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Yamamoto, Shuhei; Kishimoto, Takahide] Toyobo Co Ltd, Tsuruga Inst Biotechnol, Tsuruga, Fukui, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Toyobo Co., Ltd	Morita, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem, Tsukuba, Ibaraki, Japan.	morita-tomotake@aist.go.jp	Morita, Tomotake/L-7073-2018; Saika, Azusa/M-4077-2018; Fukuoka, Tokuma/C-9802-2011	Morita, Tomotake/0000-0001-6956-3096; Saika, Azusa/0000-0001-9423-0285; Fukuoka, Tokuma/0000-0003-1814-7046	Japan Science and technology Agency (JST) under Adaptable and Seamless Technology Transfer Program Target-driven RD [AS2621413N]	Japan Science and technology Agency (JST) under Adaptable and Seamless Technology Transfer Program Target-driven RD	This work has been supported by Japan Science and technology Agency (JST) under Adaptable and Seamless Technology Transfer Program through Target-driven R&D (AS2621413N). JST had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Toyobo Co., Ltd. provided support in the form of salaries for authors SY and TK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Crich D, 2002, TETRAHEDRON, V58, P35, DOI 10.1016/S0040-4020(01)01087-0; Feldbrugge M, 2013, APPL MICROBIOL BIOT, V97, P3253, DOI 10.1007/s00253-013-4777-1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fukuoka T, 2008, CARBOHYD RES, V343, P2947, DOI 10.1016/j.carres.2008.08.034; Fukuoka Tokuma, 2007, J Oleo Sci, V56, P435; Fukuoka T, 2008, CARBOHYD RES, V343, P555, DOI 10.1016/j.carres.2007.11.023; Fukuoka T, 2012, CARBOHYD RES, V351, P81, DOI 10.1016/j.carres.2012.01.019; HASKINS RH, 1955, CAN J MICROBIOL, V1, P749, DOI 10.1139/m55-089; Hewald S, 2005, APPL ENVIRON MICROB, V71, P3033, DOI 10.1128/AEM.71.6.3033-3040.2005; Hewald S, 2006, APPL ENVIRON MICROB, V72, P5469, DOI 10.1128/AEM.00506-06; Imura T, 2004, J AM CHEM SOC, V126, P10804, DOI 10.1021/ja0400281; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kahmann R, 1999, CURR OPIN MICROBIOL, V2, P647, DOI 10.1016/S1369-5274(99)00038-7; Kitamoto D, 2002, J BIOSCI BIOENG, V94, P187, DOI 10.1263/jbb.94.187; KITAMOTO D, 1990, AGR BIOL CHEM TOKYO, V54, P37, DOI 10.1080/00021369.1990.10869919; Kitamoto D, 2001, BIOTECHNOL LETT, V23, P1709, DOI 10.1023/A:1012464717259; Kitamoto D, 2009, CURR OPIN COLLOID IN, V14, P315, DOI 10.1016/j.cocis.2009.05.009; Konishi M, 2008, APPL MICROBIOL BIOT, V78, P37, DOI 10.1007/s00253-007-1292-2; Konishi M, 2015, BIOTECHNOL LETT, V37, P1679, DOI 10.1007/s10529-015-1837-x; Konishi M, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00409-13; Konishi M, 2011, J BIOSCI BIOENG, V111, P702, DOI 10.1016/j.jbiosc.2011.02.004; Lorenz S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00053-14; Marchand G, 2007, J MICROBIOL METH, V70, P519, DOI 10.1016/j.mimet.2007.06.014; Morita T, 2008, J OLEO SCI, V57, P123, DOI 10.5650/jos.57.123; Morita T, 2008, J BIOSCI BIOENG, V105, P493, DOI 10.1263/jbb.105.493; Morita T, 2007, J BIOSCI BIOENG, V104, P517, DOI 10.1263/jbb.104.517; Morita T, 2007, FEMS YEAST RES, V7, P286, DOI 10.1111/j.1567-1364.2006.00154.x; Morita T, 2006, APPL MICROBIOL BIOT, V73, P305, DOI 10.1007/s00253-006-0466-7; Morita T, 2015, APPL MICROBIOL BIOT, V99, P5833, DOI 10.1007/s00253-015-6575-4; Morita T, 2015, J OLEO SCI, V64, P133, DOI 10.5650/jos.ess14185; Morita T, 2013, APPL MICROBIOL BIOT, V97, P4691, DOI 10.1007/s00253-013-4858-1; Morita T, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00064-13; Morita T, 2012, APPL MICROBIOL BIOT, V96, P931, DOI 10.1007/s00253-012-4230-x; Morita T, 2010, YEAST, V27, P905, DOI 10.1002/yea.1794; Morita T, 2010, APPL MICROBIOL BIOT, V88, P679, DOI 10.1007/s00253-010-2762-5; Morita T, 2010, J OLEO SCI, V59, P451, DOI 10.5650/jos.59.451; Morita T, 2010, J OLEO SCI, V59, P267, DOI 10.5650/jos.59.267; Morita T, 2009, APPL MICROBIOL BIOT, V83, P1017, DOI 10.1007/s00253-009-1945-4; Morita T, 2008, J OLEO SCI, V57, P557, DOI 10.5650/jos.57.557; Rau U, 2005, APPL MICROBIOL BIOT, V68, P607, DOI 10.1007/s00253-005-1906-5; Rau U, 2005, APPL MICROBIOL BIOT, V66, P551, DOI 10.1007/s00253-004-1672-9; Saika Azusa, 2014, Genome Announc, V2, DOI 10.1128/genomeA.00878-14; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sharma R, 2014, GENOME BIOL EVOL, V6, P2034, DOI 10.1093/gbe/evu148; Takahashi M, 2012, J OLEO SCI, V61, P457, DOI 10.5650/jos.61.457; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teichmann B, 2007, MOL MICROBIOL, V66, P525, DOI 10.1111/j.1365-2958.2007.05941.x; Teichmann B, 2011, MOL MICROBIOL, V79, P1483, DOI 10.1111/j.1365-2958.2010.07533.x; Van Bogaert INA, 2013, MOL MICROBIOL, V88, P501, DOI 10.1111/mmi.12200; Worakitkanchanakul W, 2008, COLLOID SURFACE B, V65, P106, DOI 10.1016/j.colsurfb.2008.03.009; Yamamoto S, 2012, J OLEO SCI, V61, P407, DOI 10.5650/jos.61.407; Yoshikawa J, 2014, APPL MICROBIOL BIOT, V98, P823, DOI 10.1007/s00253-013-5376-x	52	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157858	10.1371/journal.pone.0157858	http://dx.doi.org/10.1371/journal.pone.0157858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327162	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212400052
J	Le, MT; Lanaspa, MA; Cicerchi, CM; Rana, J; Scholten, JD; Hunter, BL; Rivard, CJ; Randolph, RK; Johnson, RJ				Le, MyPhuong T.; Lanaspa, Miguel A.; Cicerchi, Christina M.; Rana, Jatinder; Scholten, Jeffrey D.; Hunter, Brandi L.; Rivard, Christopher J.; Randolph, R. Keith; Johnson, Richard J.			Bioactivity-Guided Identification of Botanical Inhibitors of Ketohexokinase	PLOS ONE			English	Article							SUGAR-SWEETENED BEVERAGES; SOFT DRINK CONSUMPTION; CHOW-FED RATS; METABOLIC SYNDROME; INSULIN-RESISTANCE; CIRCULATING CONCENTRATIONS; OVERWEIGHT/OBESE HUMANS; DIABETES-MELLITUS; FRUCTOSE INFUSION; KIDNEY-DISEASE	Objective In developed countries with westernized diets, the excessive consumption of added sugar in beverages and highly refined and processed foods is associated with increased risk for obesity, diabetes, and cardiovascular diseases. As a major constituent of added sugars, fructose has been shown to cause a variety of adverse metabolic effects, such as impaired insulin sensitivity, hypertriglyceridemia, and oxidative stress. Recent studies have shown that ketohexokinase isoform C is the key enzyme responsible in fructose metabolism that drive's fructose's adverse effects. The objective of this study was to identify botanical ingredients with potential for inhibitory activity against ketohexokinase-C and fructose-induced metabolic effects by using a series of in vitro model systems. Methods Extracts from 406 botanicals and 1200 purified phytochemicals were screened (initial concentration of 50 mu g/mL and 50 mu M, respectively) for their inhibitory activity using a cell free, recombinant human ketohexokinase-C assay. Dose response evaluations were conducted on botanical extracts and phytochemicals that inhibited ketohexokinase-C by > 30% and > 40%, respectively. Two different extract lots of the top botanical candidates were further evaluated in lysates of HepG2 cells overexpressing ketohexokinase-C for inhibition of fructose-induced ATP depletion. In addition, extracts were evaluated in intact Hep G2 cells for inhibition of fructose-induced elevation of triglyceride and uric acid production. Results Among the botanical extracts, phloretin (Malus domestica) extracts were the most potent (IC50: 8.9-9.2 mu g/mL) followed by extracts of Angelica archangelica (IC50: 22.6 mu g/mL-57.3 mu g/mL). Among the purified phytochemicals, methoxy-isobavachalcone (Psoralea corylifolia, IC50 = 0.2 mu M) exhibited the highest potency against ketohexokinase isoform C activity followed by osthole (Angelica archangelica, IC50 = 0.7 mu M), cratoxyarborenone E (Cratoxylum prunifolium, IC50 = 1.0 mu M), and alpha-/gamma-mangostin (Cratoxylum prunifolium, IC50 = 1.5 mu M). Extracts of Angelica archangelica, Garcinia mangostana, Petroselinum crispum, and Scutellaria baicalensis exhibited ketohexokinase inhibitory activity and blocked fructose-induced ATP depletion and fructose-induced elevation in triglyerides and uric acid. Conclusions Angelica archangelica, Garcinia mangostana, Petroselinum crispum, and Scutellaria baicalensis were the top four botanical candidiates identified with inhibitory activity against ketohexokinase-C. Future studies are needed to show proof of mechanism and the efficacy of these botanical extracts in humans to blunt the negative metabolic effects of fructose-containing added sugars.	[Le, MyPhuong T.; Lanaspa, Miguel A.; Cicerchi, Christina M.; Hunter, Brandi L.; Rivard, Christopher J.; Johnson, Richard J.] Univ Colorado, Dept Med, Div Renal Dis & Hypertens, Anschutz Med Campus, Aurora, CO USA; [Rana, Jatinder; Scholten, Jeffrey D.; Randolph, R. Keith] Amway Res & Dev, Ada, MI USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Le, MT (corresponding author), Univ Colorado, Dept Med, Div Renal Dis & Hypertens, Anschutz Med Campus, Aurora, CO USA.	myphuong.le@ucdenver.edu	Lanaspa, Miguel/AAO-4971-2020		RJJ; Amway Research and Development; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK095930, P30DK048520] Funding Source: NIH RePORTER	RJJ; Amway Research and Development; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by funding from startup funds of RJJ and research funding from Amway Research and Development that was received by RJJ.	ADELMAN RC, 1967, J BIOL CHEM, V242, P3360; Aeberli I, 2013, DIABETES CARE, V36, P150, DOI 10.2337/dc12-0540; Asipu A, 2003, DIABETES, V52, P2426, DOI 10.2337/diabetes.52.9.2426; BERGSTROM J, 1968, ACTA MED SCAND, V184, P359; Bray GA, 2010, CURR OPIN LIPIDOL, V21, P51, DOI 10.1097/MOL.0b013e3283346ca2; Chan TF, 2014, NUTRIENTS, V6, P2088, DOI 10.3390/nu6052088; Chaudhury RR, 2001, TRADITIONAL MED ASIA, P1; Chistokhodova N, 2002, J ETHNOPHARMACOL, V81, P277, DOI 10.1016/S0378-8741(02)00097-1; Cirillo P, 2009, J AM SOC NEPHROL, V20, P545, DOI 10.1681/ASN.2008060576; Cox CL, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-68; Cox CL, 2011, J CLIN ENDOCR METAB, V96, pE2034, DOI 10.1210/jc.2011-1050; Dale KS, 2009, ASIA PAC J CLIN NUTR, V18, P114; Davis JN, 2005, AM J CLIN NUTR, V82, P1004, DOI 10.1093/ajcn/82.5.1004; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Diggle CP, 2009, J HISTOCHEM CYTOCHEM, V57, P763, DOI 10.1369/jhc.2009.953190; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Farah V, 2006, AUTON NEUROSCI; Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140; Gersch MS, 2007, AM J PHYSIOL-RENAL, V293, pF1256, DOI 10.1152/ajprenal.00181.2007; HARMALA P, 1992, PHYTOCHEM ANALYSIS, V3, P42, DOI 10.1002/pca.2800030108; Hayward BE, 1998, EUR J BIOCHEM, V257, P85, DOI 10.1046/j.1432-1327.1998.2570085.x; Ishimoto T, 2012, P NATL ACAD SCI USA, V109, P4320, DOI 10.1073/pnas.1119908109; Islam MN, 2011, METABOLOMICS, V7, P446, DOI 10.1007/s11306-010-0269-9; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Kawasaki T, 2004, METABOLISM, V53, P583, DOI 10.1016/j.metabol.2003.12.007; Kondo M, 2009, J AGR FOOD CHEM, V57, P8788, DOI 10.1021/jf901012f; Koyama M, 1998, AM J PATHOL, V153, P537, DOI 10.1016/S0002-9440(10)65596-4; Lanaspa MA, 2007, P NATL ACAD SCI USA, V104, P13672, DOI 10.1073/pnas.0702752104; Lanaspa MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3434; Lanaspa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048801; Liu TP, 2005, CLIN EXP PHARMACOL P, V32, P649, DOI 10.1111/j.0305-1870.2005.04245.x; Liu TP, 2005, HORM METAB RES, V37, P146, DOI 10.1055/s-2005-861299; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Luthria DL, 2006, J SCI FOOD AGR, V86, P1350, DOI 10.1002/jsfa.2521; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Marek G, 2014, DIABETES; Nakayama T, 2010, AM J PHYSIOL-RENAL, V298, pF712, DOI 10.1152/ajprenal.00433.2009; Page KA, 2013, JAMA-J AM MED ASSOC, V309, P63, DOI 10.1001/jama.2012.116975; RAIVIO KO, 1975, METABOLISM, V24, P861, DOI 10.1016/0026-0495(75)90133-X; Roman CL, 2014, BBA-GEN SUBJECTS, V1840, P3475, DOI 10.1016/j.bbagen.2014.09.011; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Steinmann B, 2001, METABOLIC MOL BASES, P1489; TERRIER F, 1989, RADIOLOGY, V171, P557, DOI 10.1148/radiology.171.2.2704824; Van den Berghe G, 1986, Prog Biochem Pharmacol, V21, P1; Vorster HH, 2014, AM J CLIN NUTR, V99, P1479, DOI 10.3945/ajcn.113.069005; Wadden TA, 2004, OBES RES, V12, p151S, DOI 10.1038/oby.2004.282; Wadden TA, 2012, CIRCULATION, V125, P1157, DOI 10.1161/CIRCULATIONAHA.111.039453; Walker EB, 2007, J SEP SCI, V30, P1229, DOI 10.1002/jssc.200700024; Wang HY, 2012, J ZHEJIANG UNIV-SC B, V13, P851, DOI 10.1631/jzus.B1200150; Wang JW, 2014, J NUTR, V144, P81, DOI 10.3945/jn.113.182519; Welsh JA, 2011, AM J CLIN NUTR; Yadav H, 2007, J PHARMACOL SCI, V105, P12, DOI 10.1254/jphs.FP0060092; Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	55	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157458	10.1371/journal.pone.0157458	http://dx.doi.org/10.1371/journal.pone.0157458			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322374	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212000017
J	Takemoto, K; Kajihara, K				Takemoto, Kazuhiro; Kajihara, Kosuke			Human Impacts and Climate Change Influence Nestedness and Modularity in Food-Web and Mutualistic Networks	PLOS ONE			English	Article							SEED-DISPERSAL NETWORKS; ECOLOGICAL NETWORKS; POLLINATION NETWORKS; COMMUNITY STABILITY; BIODIVERSITY; ARCHITECTURE; PERSISTENCE; ECOSYSTEMS; DIVERSITY; EVOLUTION	Theoretical studies have indicated that nestedness and modularity-non-random structural patterns of ecological networks-influence the stability of ecosystems against perturbations; as such, climate change and human activity, as well as other sources of environmental perturbations, affect the nestedness and modularity of ecological networks. However, the effects of climate change and human activities on ecological networks are poorly understood. Here, we used a spatial analysis approach to examine the effects of climate change and human activities on the structural patterns of food webs and mutualistic networks, and found that ecological network structure is globally affected by climate change and human impacts, in addition to current climate. In pollination networks, for instance, nestedness increased and modularity decreased in response to increased human impacts. Modularity in seed-dispersal networks decreased with temperature change (i.e., warming), whereas food web nestedness increased and modularity declined in response to global warming. Although our findings are preliminary owing to data-analysis limitations, they enhance our understanding of the effects of environmental change on ecological communities.	[Takemoto, Kazuhiro; Kajihara, Kosuke] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan	Kyushu Institute of Technology	Takemoto, K (corresponding author), Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan.	takemoto@bio.kyutech.ac.jp	Takemoto, Kazuhiro/H-2915-2019	Takemoto, Kazuhiro/0000-0002-6355-1366	Japan Society for the Promotion of Science [25700030]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Young Scientists (A) from the Japan Society for the Promotion of Science (no. 25700030). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Baiser B, 2012, GLOBAL ECOL BIOGEOGR, V21, P579, DOI 10.1111/j.1466-8238.2011.00705.x; Barabasi AL, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0375; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2010, SCIENCE, V329, P765, DOI 10.1126/science.1194255; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Becker E, 2012, BIOINFORMATICS, V28, P84, DOI 10.1093/bioinformatics/btr621; Bellisario B, 2012, AQUAT ECOL, V46, P431, DOI 10.1007/s10452-012-9412-1; Dalsgaard B, 2013, ECOGRAPHY, V36, P1331, DOI 10.1111/j.1600-0587.2013.00201.x; Diniz JAF, 2008, GLOBAL ECOL BIOGEOGR, V17, P479, DOI 10.1111/j.1466-8238.2008.00395.x; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dorresteijn I, 2015, P ROY SOC B-BIOL SCI, V282, P105, DOI 10.1098/rspb.2015.1602; Feng WF, 2014, SCI REP-UK, V4, DOI 10.1038/srep05912; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gilarranz LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10737; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hautier Y, 2015, SCIENCE, V348, P336, DOI 10.1126/science.aaa1788; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoang H, 2003, J BUS VENTURING, V18, P165, DOI 10.1016/S0883-9026(02)00081-2; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jonhson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074025; Kondoh M, 2010, ECOLOGY, V91, P3123, DOI 10.1890/09-2219.1; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Marczak LB, 2011, ECOLOGY, V92, P276, DOI 10.1890/10-0760.1; MCGUINNESS KA, 1984, BIOL REV, V59, P423, DOI 10.1111/j.1469-185X.1984.tb00711.x; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Parr CS, 2005, TRENDS ECOL EVOL, V20, P362, DOI 10.1016/j.tree.2005.04.023; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Rezende EL, 2007, OIKOS, V116, P1919, DOI 10.1111/j.2007.0030-1299.16029.x; Rohr RP, 2014, SCIENCE, V345, P416, DOI 10.1126/science.1253497; Saavedra S, 2016, ECOL EVOL, V6, P997, DOI 10.1002/ece3.1930; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schleuning M, 2014, ECOL LETT, V17, P454, DOI 10.1111/ele.12245; Sebastian-Gonzalez E, 2015, GLOBAL ECOL BIOGEOGR, V24, P293, DOI 10.1111/geb.12270; Staniczenko PPA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2422; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Takemoto K., 2012, STATIS TICAL MACHINE, P45, DOI DOI 10.1002/9781118346990.CH2; Takemoto K, 2014, BIOSYSTEMS, V121, P29, DOI 10.1016/j.biosystems.2014.06.002; Takemoto K, 2013, BIOSYSTEMS, V113, P149, DOI 10.1016/j.biosystems.2013.06.003; Takemoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061348; Takemoto K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036107; Takemoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025874; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson RM, 2012, TRENDS ECOL EVOL, V27, P689, DOI 10.1016/j.tree.2012.08.005; Trojelsgaard K, 2013, GLOBAL ECOL BIOGEOGR, V22, P149, DOI 10.1111/j.1466-8238.2012.00777.x; Welti EAR, 2015, ECOL EVOL, V5, P326, DOI 10.1002/ece3.1371	58	20	20	7	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157929	10.1371/journal.pone.0157929	http://dx.doi.org/10.1371/journal.pone.0157929			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322185	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212000055
J	Krauss, P; Tziridis, K; Buerbank, S; Schilling, A; Schulze, H				Krauss, Patrick; Tziridis, Konstantin; Buerbank, Stefanie; Schilling, Achim; Schulze, Holger			Therapeutic Value of Ginkgo biloba Extract EGb 761 (R) in an Animal Model (Meriones unguiculatus) for Noise Trauma Induced Hearing Loss and Tinnitus	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; GAP DETECTION; ACOUSTIC TRAUMA; DOUBLE-BLIND; GUINEA-PIGS; EGB-761; PREVENTION; RESPONSES; STRESS; RATS	Noise induced hearing loss (NIHL) is a common disease in modern societies and may lead to maladaptations within the auditory system that finally result in subjective tinnitus. Available therapies may only alleviate the symptoms rather than restore normal hearing. In a previous study we demonstrated that the prophylactic application of Ginkgo biloba extract EGb 761 (R) significantly reduces NIHL and tinnitus development in our Mongolian gerbil (Meriones unguiculatus) animal model. Here, we tested whether the application of EGb 761 (R) has beneficial effects after the formation of permanent NIHL and tinnitus. To this end we monitored the therapeutic effects of EGb 761 (R) on noise trauma-induced changes in signal processing within the auditory system of our animal model by behavioral (acoustic startle response, ASR) and electrophysiological approaches (auditory brainstem responses, ABR). We found that-in contrast to vehicle-three weeks of daily oral EGb 761 (R) treatment (100 mg/kg body weight) led to a restoration of hearing thresholds back to pre-trauma conditions. In addition, all 9 animals that displayed behavioral signs of subjective tinnitus showed improvement, with 7 of them showing complete relief of tinnitus symptoms during the time of EGb 761 (R) treatment. After discontinuation of EGb 761 (R) treatment, tinnitus related behavior reappeared in all but one of these animals while auditory thresholds remained restored. A detailed analysis of ABR waves revealed that EGb 761 (R) treatment did not simply change auditory processing back to pre-trauma conditions, but led to subtle changes of ABR wave amplitude and latency at different levels of the auditory pathway, with an overall increase of response to low stimulus intensities and a decrease at high intensities. The functional relevance of these changes may be the observed improvement of hearing thresholds while at the same time suppression of responses to high stimulus intensities may point to a global inhibitory mechanism that counteracts tinnitus.	[Krauss, Patrick; Tziridis, Konstantin; Buerbank, Stefanie; Schilling, Achim; Schulze, Holger] Univ Erlangen Nurnberg, Expt Otolaryngol, Waldstr 1, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Schulze, H (corresponding author), Univ Erlangen Nurnberg, Expt Otolaryngol, Waldstr 1, D-91054 Erlangen, Germany.	holger.schulze@uk-erlangen.de		Krauss, Patrick/0000-0002-6611-7733	Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing	Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing	This work was supported by the Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany. We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing.	Abdel-Kader R, 2007, PHARMACOL RES, V56, P493, DOI 10.1016/j.phrs.2007.09.011; Ahlf S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044519; AXELSSON A, 1985, British Journal of Audiology, V19, P271, DOI 10.3109/03005368509078983; DeFeudis FV, 2004, DRUG DEVELOP RES, V62, P1, DOI 10.1002/ddr.10351; Drew S, 2001, BRIT MED J, V322, P73, DOI 10.1136/bmj.322.7278.73; Eckert A, 2005, ANN NY ACAD SCI, V1056, P474, DOI 10.1196/annals.1352.023; Eggermont JJ, 2013, HEARING RES, V295, P140, DOI 10.1016/j.heares.2012.01.005; Fehske CJ, 2009, PHARMACOL RES, V60, P68, DOI 10.1016/j.phrs.2009.02.012; Galazyuk A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00088; Guitton Matthieu J., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/80904; HALFORD JBS, 1991, J PSYCHOSOM RES, V35, P383, DOI 10.1016/0022-3999(91)90033-K; HENRY KR, 1979, J AM AUDITORY SOC, V4, P173; Jezova D, 2002, J PHYSIOL PHARMACOL, V53, P337; JONES DA, 1984, J EPIDEMIOL COMMUN H, V38, P75, DOI 10.1136/jech.38.1.75; Katzenell U, 2001, OTOL NEUROTOL, V22, P321, DOI 10.1097/00129492-200105000-00009; Kopke R, 2005, ACTA OTO-LARYNGOL, V125, P235, DOI 10.1080/00016480410023038; Langguth B, 2009, EXPERT OPIN EMERG DR, V14, P687, DOI 10.1517/14728210903206975; Le Prell CG, 2007, HEARING RES, V226, P22, DOI 10.1016/j.heares.2006.10.006; Lockwood AH, 2002, NEW ENGL J MED, V347, P904, DOI 10.1056/NEJMra013395; Luo Y, 2002, P NATL ACAD SCI USA, V99, P12197, DOI 10.1073/pnas.182425199; Massieu L, 2004, BRAIN RES, V1002, P76, DOI 10.1016/j.brainres.2003.12.018; Muller WE, 2003, PHARMACOPSYCHIATRY, V36, pS24; Mwilambwe-Tshilobo L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137749; NEGRI B, 1991, HNO, V39, P192; Oishi N, 2011, EXPERT OPIN EMERG DR, V16, P235, DOI 10.1517/14728214.2011.552427; Pang KCH, 2015, J NEUROTRAUM, V32, P801, DOI 10.1089/neu.2014.3451; Passchier-Vermeer W, 2000, ENVIRON HEALTH PERSP, V108, P123, DOI 10.1289/ehp.00108s1123; Sadlier M, 2008, J LARYNGOL OTOL, V122, P31, DOI 10.1017/S0022215107007438; Schindowski K, 2001, J NEURAL TRANSM, V108, P969, DOI 10.1007/s007020170016; Sendowski I, 2006, HEARING RES, V221, P119, DOI 10.1016/j.heares.2006.08.010; STANGE G, 1975, ARCH OTO-RHINO-LARYN, V209, P203, DOI 10.1007/BF00453774; STANGE G, 1976, ARZNEIMITTEL-FORSCH, V26, P367; Suneja SK, 1998, EXP NEUROL, V151, P273, DOI 10.1006/exnr.1998.6812; Tchantchou F, 2007, FASEB J, V21, P2400, DOI 10.1096/fj.06-7649com; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Tziridis K, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00022; Tziridis K, 2012, JOVE-J VIS EXP, DOI 10.3791/4433; Tziridis K, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/427298; von Boetticher A, 2011, NEUROPSYCH DIS TREAT, V7, P441, DOI 10.2147/NDT.S22793; Walter M., 2012, OPEN J ACOUSTICS, V2, P34, DOI DOI 10.4236/0JA.2012.21004; Weible AP, 2014, CURR BIOL, V24, P1447, DOI 10.1016/j.cub.2014.05.031; Woelk H, 2007, J PSYCHIATR RES, V41, P472, DOI 10.1016/j.jpsychires.2006.05.004; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Yang TH, 2011, J NUTR BIOCHEM, V22, P886, DOI 10.1016/j.jnutbio.2010.08.009; Yoshitake T, 2010, BRIT J PHARMACOL, V159, P659, DOI 10.1111/j.1476-5381.2009.00580.x; Zheng YW, 2012, NEUROPHARMACOLOGY, V62, P940, DOI 10.1016/j.neuropharm.2011.09.027	49	16	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157574	10.1371/journal.pone.0157574	http://dx.doi.org/10.1371/journal.pone.0157574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315063	Green Submitted, gold, Green Published			2022-12-26	WOS:000378030000037
J	Mei, YQ; Pan, ZF; Chen, WT; Xu, MH; Zhu, DY; Yu, YP; Lou, YJ				Mei, Yu-qin; Pan, Zong-fu; Chen, Wen-teng; Xu, Min-hua; Zhu, Dan-yan; Yu, Yong-ping; Lou, Yi-jia			A Flavonoid Compound Promotes Neuronal Differentiation of Embryonic Stem Cells via PPAR-beta Modulating Mitochondrial Energy Metabolism	PLOS ONE			English	Article							NEURAL DIFFERENTIATION; SKELETAL-MUSCLE; IN-VITRO; RECEPTORS; NEUROGENESIS; EXPRESSION; PROTECTS; ICARITIN; PATHWAY; NEURODEGENERATION	Relatively little is known regarding mitochondrial metabolism in neuronal differentiation of embryonic stem (ES) cells. By using a small molecule, present research has investigated the pattern of cellular energy metabolism in neural progenitor cells derived from mouse ES cells. Flavonoid compound 4a faithfully facilitated ES cells to differentiate into neurons morphologically and functionally. The expression and localization of peroxisome proliferator-activated receptors (PPARs) were examined in neural progenitor cells. PPAR-beta expression showed robust upregulation compared to solvent control. Treatment with PPAR-beta agonist L165041 alone or together with compound 4a significantly promoted neuronal differentiation, while antagonist GSK0660 blocked the neurogenesis-promoting effect of compound 4a. Consistently, knockdown of PPAR-beta in ES cells abolished compound 4a-induced neuronal differentiation. Interestingly, we found that mitochondrial fusion protein Mfn2 was also abolished by sh-PPAR-beta, resulting in abnormal mitochondrial Ca2+ ([Ca2+](M)) transients as well as impaired mitochondrial bioenergetics. In conclusion, we demonstrated that by modulating mitochondrial energy metabolism through Mfn2 and mitochondrial Ca2+, PPAR-beta took an important role in neuronal differentiation induced by flavonoid compound 4a.	[Mei, Yu-qin; Pan, Zong-fu; Xu, Min-hua; Zhu, Dan-yan; Lou, Yi-jia] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol & Toxicol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Wen-teng; Yu, Yong-ping] Zhejiang Univ, Coll Pharmaceut Sci, Inst Mat Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Lou, YJ (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol & Toxicol, Hangzhou 310003, Zhejiang, Peoples R China.	yijialou@zju.edu.cn			National Natural Science Foundation of China [81573513, 81173135, 90813026]; Zhejiang Provincial Natural Science Foundation of China [LZ12H31001, Z2110655]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China (No 81573513, No 81173135, No 90813026; http://www.nsfc.gov.cn), and by Zhejiang Provincial Natural Science Foundation of China (No LZ12H31001, No Z2110655; http://www.zjnsf.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin S, 2013, NEUROCHEM INT, V63, P322, DOI 10.1016/j.neuint.2013.06.012; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Cheng AW, 2010, ASN NEURO, V2, P243, DOI 10.1042/AN20100019; Cimini A, 2005, NEUROSCIENCE, V130, P325, DOI 10.1016/j.neuroscience.2004.09.043; Coatesworth W, 2006, CELL CALCIUM, V39, P217, DOI 10.1016/j.ceca.2005.10.012; D'Angelo B, 2011, J CELL PHYSIOL, V226, P2170, DOI 10.1002/jcp.22552; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Di Loreto S, 2007, J CELL PHYSIOL, V211, P837, DOI 10.1002/jcp.20996; Ding L, 2007, CELL BIOL INT, V31, P1002, DOI 10.1016/j.cellbi.2007.03.013; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Fonteriz RI, 2010, CELL CALCIUM, V48, P61, DOI 10.1016/j.ceca.2010.07.001; Fornazari M, 2011, J BIOENERG BIOMEMBR, V43, P531, DOI 10.1007/s10863-011-9374-3; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Hall MG, 2008, PPAR RES, V2008, DOI 10.1155/2008/780452; Huang PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020655; Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001; Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Li YQ, 2009, J MOL CELL CARDIOL, V46, P876, DOI 10.1016/j.yjmcc.2009.02.020; Liang XG, 2012, J CELL BIOCHEM, V113, P2884, DOI 10.1002/jcb.24164; Liu D, 2008, ANN NY ACAD SCI, V1147, P275, DOI 10.1196/annals.1427.028; Merkwirth C, 2008, CELL, V135, P1165, DOI 10.1016/j.cell.2008.12.005; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Ou LL, 2011, MOL DIVERS, V15, P665, DOI 10.1007/s11030-010-9289-7; Parekh A, 2009, CURR BIOL, V19, pR200, DOI 10.1016/j.cub.2009.01.012; QIU GT, 2000, ACAD J SUMS, V21, P100; Solanki L, 2015, ADV NUTR, V6, P64, DOI 10.3945/an.114.007500; Teslaa T, 2015, EMBO J, V34, P138, DOI 10.15252/embj.201490446; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Wang DY, 2011, ACTA PHARMACOL SIN, V32, P425, DOI 10.1038/aps.2011.5; Wang Z, 2007, NEUROSCIENCE, V145, P911, DOI 10.1016/j.neuroscience.2006.12.059; Wang ZQ, 2009, CHEM-BIOL INTERACT, V179, P375, DOI 10.1016/j.cbi.2008.12.007; Williams DR, 2008, NAT PROTOC, V3, P835, DOI 10.1038/nprot.2008.47; Williams DR, 2007, J AM CHEM SOC, V129, P9258, DOI 10.1021/ja072817z; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Wu JY, 2013, NEUROCHEM INT, V62, P92, DOI 10.1016/j.neuint.2012.09.016; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Yan HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4334; Yu SL, 2012, J BIOL CHEM, V287, P42195, DOI 10.1074/jbc.M112.410381; Zhu DY, 2010, J CELL BIOCHEM, V109, P498, DOI 10.1002/jcb.22426; Zhu DY, 2005, ACTA PHARMACOL SIN, V26, P477, DOI 10.1111/j.1745-7254.2005.00076.x	46	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157747	10.1371/journal.pone.0157747	http://dx.doi.org/10.1371/journal.pone.0157747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315062	gold, Green Submitted, Green Published			2022-12-26	WOS:000378030000050
J	Bal-Theoleyre, L; Lalande, A; Kober, F; Giorgi, R; Collart, F; Piquet, P; Habib, G; Avierinos, JF; Bernard, M; Guye, M; Jacquier, A				Bal-Theoleyre, Laurence; Lalande, Alain; Kober, Frank; Giorgi, Roch; Collart, Frederic; Piquet, Philippe; Habib, Gilbert; Avierinos, Jean-Francois; Bernard, Monique; Guye, Maxime; Jacquier, Alexis			Aortic Function's Adaptation in Response to Exercise-Induced Stress Assessing by 1.5T MRI: A Pilot Study in Healthy Volunteers	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; MARFAN-SYNDROME; FLOW; DISTENSIBILITY; PREDICTION; STRAIN; VALVE; REST; WALL	Aim Evaluation of the aortic "elastic reserve" might be a relevant marker to assess the risk of aortic event. Our aim was to compare regional aortic elasticity at rest and during supine bicycle exercise at 1.5 T MRI in healthy individuals. Methods Fifteen volunteers (8 men), with a mean age of 29 (23-41) years, completed the entire protocol. Images were acquired immediately following maximal exercise. Retrospective cine sequences were acquired to assess compliance, distensibility, maximum rates of systolic distension and diastolic recoil at four different locations: ascending aorta, proximal descending aorta, distal descending aorta and aorta above the coeliac trunk level. Segmental aortic pulse wave velocity (PWV) was assessed by through plane velocity-encoded MRI. Results Exercise induced a significant decrease of aortic compliance and distensibility, and a significant increase of the absolute values of maximum rates of systolic distension and diastolic recoil at all sites (p<10-3). At rest and during stress, ascending aortic compliance was statistically higher compared to the whole descending aorta (p <= 0.0007). We found a strong correlation between the rate pressure product and aortic distensibility at all sites (r = - 0.6 to - 0.75 according to the site, p<10-4). PWV measured at the proximal and distal descending aorta increased significantly during stress (p = 0.02 and p = 0.008, respectively). Conclusion Assessment of regional aortic function during exercise is feasible using MRI. During stress, aortic elasticity decreases significantly in correlation with an increase of the PWV. Further studies are required to create thresholds for ascending aorta dysfunction among patients with aneurysms, and to monitor the impact of medication on aortic remodeling.	[Bal-Theoleyre, Laurence; Kober, Frank; Bernard, Monique; Guye, Maxime; Jacquier, Alexis] Aix Marseille Univ, CRMBM CEMEREM, UMR CNRS 7339, Marseille, France; [Jacquier, Alexis] La Timone Hosp, Dept Radiol & Cardiovasc Imaging, Marseille, France; [Bal-Theoleyre, Laurence; Piquet, Philippe] La Timone Hosp, Dept Vasc Surg & Vasc Med, Marseille, France; [Lalande, Alain] Univ Burgundy, LE2I, UMR CNRS 6306, Dijon, France; [Lalande, Alain] Univ Hosp Dijon, MRI Dept, Dijon, France; [Giorgi, Roch] Aix Marseille Univ, SESSTIM, UMR S INSERM 912, Marseille, France; [Giorgi, Roch] La Timone Hosp, Dept Biostat, Marseille, France; [Giorgi, Roch] La Timone Hosp, ICT, Marseille, France; [Collart, Frederic] La Timone Hosp, Dept Cardiac Surg, Marseille, France; [Collart, Frederic; Piquet, Philippe; Habib, Gilbert; Avierinos, Jean-Francois; Jacquier, Alexis] La Timone Hosp, Aort Ctr, Marseille, France; [Habib, Gilbert; Avierinos, Jean-Francois] La Timone Hosp, Dept Cardiol, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Bourgogne; CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Lalande, A (corresponding author), Univ Burgundy, LE2I, UMR CNRS 6306, Dijon, France.; Lalande, A (corresponding author), Univ Hosp Dijon, MRI Dept, Dijon, France.	alain.lalande@u-bourgogne.fr	Kober, Frank/L-8737-2013; Lalande, Alain/T-1050-2017; Bernard, Monique/Q-7254-2017; Jacquier, Alexis/ABD-6454-2020; GIORGI, Roch/A-6438-2009; Stefanadis, Christodoulos/ABH-2232-2020	Kober, Frank/0000-0002-7869-3615; Bernard, Monique/0000-0002-3179-8698; GIORGI, Roch/0000-0001-6135-3078; Stefanadis, Christodoulos/0000-0001-5974-6454; Avierinos, Jean Francois/0000-0002-3775-8371; Lalande, Alain/0000-0002-7970-366X				Ahimastos AA, 2007, JAMA-J AM MED ASSOC, V298, P1539, DOI 10.1001/jama.298.13.1539; Aquaro GD, 2011, AM J CARDIOL, V108, P81, DOI 10.1016/j.amjcard.2011.03.005; Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063; Boutouyrie P, 2014, NEPHROL DIAL TRANSPL, V29, P232, DOI 10.1093/ndt/gft309; Cruickshank JK, 2009, HYPERTENSION, V53, P602, DOI 10.1161/HYPERTENSIONAHA.108.128033; Doonan RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026151; Elefteriades JA, 2015, J THORAC CARDIOV SUR, V149, pS10, DOI 10.1016/j.jtcvs.2014.07.066; Groenink M, 2001, RADIOLOGY, V219, P535, DOI 10.1148/radiology.219.2.r01ma01535; Groenink M, 2013, EUR HEART J, V34, P3491, DOI 10.1093/eurheartj/eht334; Herment A, 2011, MAGN RESON MED, V65, P986, DOI 10.1002/mrm.22678; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; Hope MD, 2011, JACC-CARDIOVASC IMAG, V4, P781, DOI 10.1016/j.jcmg.2011.05.004; Kim EK, 2013, INT J CARDIOVAS IMAG, V29, P57, DOI 10.1007/s10554-013-0206-x; Kroner ESJ, 2013, INT J CARDIOL, V167, P2977, DOI 10.1016/j.ijcard.2012.08.057; Kumar A, 2010, CAN J CARDIOL, V26, P313, DOI 10.1016/S0828-282X(10)70396-2; Lalande A, 2008, J MAGN RESON IMAGING, V28, P1180, DOI 10.1002/jmri.21565; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Laurent S, 2014, HYPERTENSION, V64, P709, DOI 10.1161/HYPERTENSIONAHA.114.03282; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; MOHIADDIN RH, 1993, J APPL PHYSIOL, V74, P492, DOI 10.1152/jappl.1993.74.1.492; Nelson AJ, 2009, J HYPERTENS, V27, P535, DOI 10.1097/HJH.0b013e32831e4599; O'Rourke MF, 2002, AM J HYPERTENS, V15, P426, DOI 10.1016/S0895-7061(01)02319-6; Peres P, 2010, BRAZ J MED BIOL RES, V43, P397, DOI 10.1590/S0100-879X2010000400011; Puntmann VO, 2012, HYPERTENSION, V59, P712, DOI 10.1161/HYPERTENSIONAHA.111.183335; Redheuil A, 2010, HYPERTENSION, V55, P319, DOI 10.1161/HYPERTENSIONAHA.109.141275; Rose JL, 2010, MAGN RESON IMAGING, V28, P255, DOI 10.1016/j.mri.2009.07.001; Rose JL, 2005, COMPUT CARDIOL, V32, P411; Teixido-Tura G, 2014, INT J CARDIOL, V171, P56, DOI 10.1016/j.ijcard.2013.11.044; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Voges I, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-77; Weber TF, 2011, EUR J RADIOL, V80, P103, DOI 10.1016/j.ejrad.2010.06.045; Weigang E, 2008, EUR J CARDIO-THORAC, V34, P11, DOI 10.1016/j.ejcts.2008.03.047; Westenberg JJM, 2011, J MAGN RESON IMAGING, V34, P526, DOI 10.1002/jmri.22646; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	34	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157704	10.1371/journal.pone.0157704	http://dx.doi.org/10.1371/journal.pone.0157704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310400	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800125
J	Luo, X; Huang, Y; Chen, YM; Tu, Z; Hu, JL; Tavis, JE; Huang, AL; Hu, Y				Luo, Xuan; Huang, Yao; Chen, Yanmeng; Tu, Zeng; Hu, Jieli; Tavis, John E.; Huang, Ailong; Hu, Yuan			Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							ROLLING CIRCLE AMPLIFICATION; CYTIDINE DEAMINASES; NONHEPATOTOXIC DEGRADATION; NATURAL-HISTORY; IN-VITRO; CCCDNA; REPLICATION; HYPERMUTATION; MUTAGENESIS; INHIBITION	Chronic Hepatitis B Virus (HBV) infections can progresses to liver cirrhosis and hepatocellular carcinoma (HCC). The HBV covalently-closed circular DNA cccDNA is a key to HBV persistence, and its degradation can be induced by the cellular deaminase APOBEC3. This study aimed to measure the distribution of intrahepatic cccDNA levels and evaluate the association between levels of cccDNA and APOBEC3 in HCC patients. Among 49 HCC patients, 35 matched cancerous and contiguous noncancerous liver tissues had detectable cccDNA, and the median intrahepatic cccDNA in the cancerous tissues (CT) was significantly lower than in the contiguous noncancerous tissues (CNCT) (p = 0.0033). RCA (rolling circle amplification), followed by 3D-PCR identified positive amplification in 27 matched HCC patients. Sequence analysis indicated G to A mutations accumulated to higher levels in CT samples compared to CNCT samples, and the dinucleotide context showed preferred editing in the GpA context. Among 7 APOBEC3 genes, APOBEC3B was the only one upregulated in cancerous tissues both at the transcriptional and protein levels (p < 0.05). This implies APOBEC3B may contribute to cccDNA editing and subsequent degradation in cancerous tissues.	[Luo, Xuan; Huang, Yao; Chen, Yanmeng; Hu, Jieli; Huang, Ailong; Hu, Yuan] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Affiliated Hosp 2, Minist Educ,Inst Viral Hepatitis,Dept Infect Dis, Chongqing, Peoples R China; [Tu, Zeng] Chongqing Med Univ, Dept Microbiol, Coll Basic Med Sci, Chongqing, Peoples R China; [Tavis, John E.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, Ctr Liver, St Louis, MO 63103 USA; [Huang, Ailong] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Luo, Xuan] Chongqing Med Univ, Dept Inspect, Affiliated Hosp 1, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Saint Louis University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Chongqing Medical University	Huang, AL; Hu, Y (corresponding author), Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Affiliated Hosp 2, Minist Educ,Inst Viral Hepatitis,Dept Infect Dis, Chongqing, Peoples R China.; Huang, AL (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.	ahuang1964@163.com; biotottyhy@hotmail.com		, jieli/0000-0002-9869-659X	National Sciences Foundation of China award [81471945]; Natural Science Foundation Project of CQ CSTC [cstc2014jcyjA10075]; Major National Science and Technology program [2013ZX10002002]; Chongqing Postdoctoral Science Foundation [Xm2014006]; Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJ1400205]	National Sciences Foundation of China award; Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Major National Science and Technology program; Chongqing Postdoctoral Science Foundation; Scientific and Technological Research Program of Chongqing Municipal Education Commission	This work was supported by a National Sciences Foundation of China award (http://www.nsfc.gov.cn/) (81471945) to Y. Hu. This fund provided the publication. This work was supported by a Natural Science Foundation Project of CQ CSTC (http://www.cstc.gov.cn/)(cstc2014jcyjA10075) to Y. Hu. This fund provided the data collection and analysis. This work was supported by a Major National Science and Technology program (http://www.nhfpc.gov.cn/) (2013ZX10002002) to AL.H. This fund provided study design. This work was supported by a Chongqing Postdoctoral Science Foundation (http://www.cqhrss.gov.cn/u/cqhrss/) (Xm2014006) to Z.T. This fund provided the data collection and analysis. This work was supported by the Scientific and Technological Research Program of Chongqing Municipal Education Commission (http://www.cqedu.cn/) (KJ1400205) to Z.T. This fund provided the data collection and analysis.	Bai FG, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/849290; Bonvin M, 2007, J GEN VIROL, V88, P3270, DOI 10.1099/vir.0.83149-0; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Chisari FV, 2014, SCIENCE, V344, DOI 10.1126/science.1254082; Cougot D, 2005, J CLIN VIROL, V34, pS75, DOI 10.1016/S1386-6532(05)80014-9; Dandri M, 2000, HEPATOLOGY, V32, P139, DOI 10.1053/jhep.2000.8701; Deng Y, 2014, CANCER LETT, V343, P161, DOI 10.1016/j.canlet.2013.09.041; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fujii R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh147; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gao WF, 2007, J VIROL, V81, P6164, DOI 10.1128/JVI.02721-06; Gao YT, 2010, J VIROL METHODS, V169, P181, DOI 10.1016/j.jviromet.2010.07.031; Guo JT, 2015, ANTIVIR RES, V122, P91, DOI 10.1016/j.antiviral.2015.08.005; Hai H, 2014, WORLD J GASTROENTERO, V20, P6236, DOI 10.3748/wjg.v20.i20.6236; Hu Y, 2013, ANTIVIR RES, V99, P221, DOI 10.1016/j.antiviral.2013.06.007; Kitamura K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003361; Kock J, 2008, J GEN VIROL, V89, P1184, DOI 10.1099/vir.0.83507-0; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089046; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Margeridon S, 2008, ANTIMICROB AGENTS CH, V52, P3068, DOI 10.1128/AAC.01318-07; Moraleda G, 1997, J VIROL, V71, P9392, DOI 10.1128/JVI.71.12.9392-9399.1997; Nguyen DH, 2007, J VIROL, V81, P4465, DOI 10.1128/JVI.02510-06; Ohba K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097787; Pak V, 2011, J VIROL, V85, P8538, DOI 10.1128/JVI.02645-10; Reaiche-Miller GY, 2013, VIROLOGY, V446, P357, DOI 10.1016/j.virol.2013.08.014; Seeger C., 2007, FIELDS VIROLOGY, V1, P2977; Seeger C, 2015, VIROLOGY; Smith HC, 2012, SEMIN CELL DEV BIOL, V23, P258, DOI 10.1016/j.semcdb.2011.10.004; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Tavis JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003125; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Vieira VC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/683095; Wang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107162; Wang Q, 2013, ANN SURG ONCOL, V20, P3761, DOI 10.1245/s10434-013-3046-y; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wong DKH, 2006, J HEPATOL, V45, P553, DOI 10.1016/j.jhep.2006.05.014; Wong DKH, 2004, HEPATOLOGY, V40, P727, DOI 10.1002/hep.20353; Xu RZ, 2007, HEPATOLOGY, V46, P1810, DOI 10.1002/hep.21893; Zhang TW, 2013, HUM MOL GENET, V22, P1262, DOI 10.1093/hmg/dds513; Zhang Xiao-Dong, 2014, Cancer Biology Medicine, V11, P182, DOI 10.7497/j.issn.2095-3941.2014.03.004	45	21	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157708	10.1371/journal.pone.0157708	http://dx.doi.org/10.1371/journal.pone.0157708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310677	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800127
J	Rout, N				Rout, Namita			Enhanced Th1/Th17 Functions of CD161(+) CD8(+) T Cells in Mucosal Tissues of Rhesus Macaques	PLOS ONE			English	Article							HUMAN TH17 CELLS; LYMPHOCYTE RESPONSES; MAIT CELLS; EXPRESSION; SUBSETS; NK; ACCUMULATE; DEFINES; NKR-P1A; SYSTEM	Expression of the C-type lectin-like receptor CD161 by human T cells is associated with type-17 responses, which play critical regulatory roles in immunity and inflammation at mucosal sites. However, the functions of CD161-expressing T cells in macaques, the pre-clinical model of several human diseases, remain unknown. This study examined the phenotypic and functional characteristics of CD161(+) T cells in peripheral blood, mucosal tissues and lymph nodes of rhesus macaques. Majority of CD161-expressing T cells in peripheral blood and lung/intestinal mucosal tissues of rhesus macaques were found to be CD8(+)CD4(-) in phenotype. There was a significant enrichment of CD161(+) CD8(+) T cells in the lungs and colonic mucosa (16.1%+/- 6.6 and 16.8%+/- 5.7) in comparison to peripheral blood (4.2%+/- 1.2) and mesenteric lymph nodes (1.3%+/- 0.8). Regardless of the tissue compartment, CD161(+) CD8(+) T cells mainly comprised of gamma delta T cells and TCR V alpha 7.2(+) MAIT cells (up to 80%), and displayed Th1 and Th17 cytokine responses to mitogen stimulation. Mucosal CD161(+) CD8(+) T cells were characterized by very high expression of CD69, a recent activation marker that is preferentially expressed on tissue resident cells. Furthermore, lung and colonic mucosal CD161(+) CD8(+) T cells showed enhanced IFN-gamma, IL-17, and Perforin production in comparison to those in blood. Thus, macaque CD161(+) CD8(+) T cells represent mucosal tissue-homing innate-like CD8(+) T-cell populations with Th1/Th17 type cytokine and cytotoxic effector functions that can potentially enhance the recruitment of adaptive immune cells and control initial pathogen burden/dissemination in tissues. Analysis of their role in early immune responses to mucosal pathogens will be valuable in the design of vaccines and therapeutics.	[Rout, Namita] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA	Tulane University	Rout, N (corresponding author), Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA.	nrout@tulane.edu			Research Infrastructure Program of the United States National Institutes of Health; Research Infrastructure Program of the TNPRC Pilot Study Grant; Research Infrastructure Program of the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI126683] Funding Source: NIH RePORTER	Research Infrastructure Program of the United States National Institutes of Health; Research Infrastructure Program of the TNPRC Pilot Study Grant; Research Infrastructure Program of the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by start-up funds from Research Infrastructure Programs of the United States National Institutes of Health and the TNPRC Pilot Study Grant.; This study was supported by the Research Infrastructure Programs of the National Institutes of Health and the TNPRC Pilot Study Grant. Maury Duplantis, and all animal care staff of the department of veterinary medicine are gratefully acknowledged for coordinating the blood and tissue collections. Technical assistance of the flow cytometry core facility staff at the Tulane National Primate Research Center, for flow cytometric analysis is greatly appreciated. The NIH Tetramer Core Facility is acknowledged for provision of PBS-57-loaded CD1d tetramers, and the NIH Nonhuman Primate Reagent Resource provided the alpha 4 beta 7, CD4, and CD8 antibodies.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Chen ZW, 2011, CELL MOL LIFE SCI, V68, P2409, DOI 10.1007/s00018-011-0703-9; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Eberhard JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111323; Evans DT, 2003, J VIROL, V77, P2400, DOI 10.1128/JVI.77.4.2400-2409.2003; Fergusson JR, 2016, MUCOSAL IMMUNOL, V9, P401, DOI 10.1038/mi.2015.69; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Gao YF, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00302; Germain C, 2011, J BIOL CHEM, V286, P37964, DOI 10.1074/jbc.M111.285312; GIORDA R, 1990, SCIENCE, V249, P1298, DOI 10.1126/science.2399464; Gonzalez Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123591; Hintz M, 2001, FEBS LETT, V509, P317, DOI 10.1016/S0014-5793(01)03191-X; Iiai T, 2002, CLIN EXP IMMUNOL, V129, P92, DOI 10.1046/j.1365-2249.2002.01886.x; Ishihara S, 1999, EUR J IMMUNOL, V29, P2406, DOI 10.1002/(SICI)1521-4141(199908)29:08<2406::AID-IMMU2406>3.3.CO;2-6; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Kunkel EJ, 2002, AM J PATHOL, V160, P347, DOI 10.1016/S0002-9440(10)64378-7; LANIER LL, 1994, J IMMUNOL, V153, P2417; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; O'Keeffe J, 2004, EUR J IMMUNOL, V34, P2110, DOI 10.1002/eji.200424958; Poggi A, 1998, EUR J IMMUNOL, V28, P1611, DOI 10.1002/(SICI)1521-4141(199805)28:05<1611::AID-IMMU1611>3.0.CO;2-6; Rout N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002928; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Takahashi T, 2006, J IMMUNOL, V176, P211, DOI 10.4049/jimmunol.176.1.211; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789; Wang ZC, 2006, J VIROL, V80, P2771, DOI 10.1128/JVI.80.6.2771-2783.2006	35	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157407	10.1371/journal.pone.0157407	http://dx.doi.org/10.1371/journal.pone.0157407			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309719	Green Submitted, gold, Green Published			2022-12-26	WOS:000378029800068
J	Spiga, R; Batton-Hubert, M; Sarazin, M				Spiga, Radia; Batton-Hubert, Mireille; Sarazin, Marianne			Predicting Fluctuating Rates of Hospitalizations in Relation to Influenza Epidemics and Meteorological Factors	PLOS ONE			English	Article							VITAMIN-D; UNITED-STATES; A VIRUS; TRANSMISSION; ILLNESS; SEASONALITY; HUMIDITY	Introduction In France, rates of hospital admissions increase at the peaks of influenza epidemics. Predicting influenza-associated hospitalizations could help to anticipate increased hospital activity. The purpose of this study is to identify predictors of influenza epidemics through the analysis of meteorological data, and medical data provided by general practitioners. Methods Historical data were collected from Meteo France, the Sentinelles network and hospitals' information systems for a period of 8 years (2007-2015). First, connections between meteorological and medical data were estimated with the Pearson correlation coefficient, Principal component analysis and classification methods (Ward and k-means). Epidemic states of tested weeks were then predicted for each week during a one-year period using linear discriminant analysis. Finally, transition probabilities between epidemic states were calculated with the Markov Chain method. Results High correlations were found between influenza-associated hospitalizations and the variables: Sentinelles and emergency department admissions, and anti-correlations were found between hospitalizations and each of meteorological factors applying a time lag of: -13, -12 and -32 days respectively for temperature, absolute humidity and solar radiation. Epidemic weeks were predicted accurately with the linear discriminant analysis method; however there were many misclassifications about intermediate and non-epidemic weeks. Transition probability to an epidemic state was 100% when meteorological variables were below: 2 degrees C, 4 g/m(3) and 32 W/m(2), respectively for temperature, absolute humidity and solar radiation. This probability was 0% when meteorological variables were above: 6 degrees C, 5.8g/m(3) and 74W/m(2). Conclusion These results confirm a good correlation between influenza-associated hospitalizations, meteorological factors and general practitioner's activity, the latter being the strongest predictor of hospital activity.	[Spiga, Radia] Ctr Hosp Univ, Serv Sante Publ & Informat Med, St Etienne, France; [Batton-Hubert, Mireille] Ecole Natl Super Mines, Inst Fayol, Unite Mixte Rech 6158, St Etienne, France; [Sarazin, Marianne] Inst Natl Sante & Rech Med, Unite Mixte Rech Sante 1136, Paris, France; [Sarazin, Marianne] Univ Paris 06, Sorbonne Univ, Paris, France; [Sarazin, Marianne] Ecole Natl Super Mines, Ctr Ingn & Sante, St Etienne, France; [Sarazin, Marianne] Ctr Hosp, Dept Med Informat, Firminy, France	CHU de St Etienne; IMT - Institut Mines-Telecom; Mines Saint-Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; IMT - Institut Mines-Telecom; Mines Saint-Etienne	Spiga, R (corresponding author), Ctr Hosp Univ, Serv Sante Publ & Informat Med, St Etienne, France.	Radia.Spiga@chu-st-etienne.fr		SPIGA, RADIA/0000-0002-3146-4129				Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Axelsen JB, 2014, P NATL ACAD SCI USA, V111, P9538, DOI 10.1073/pnas.1321656111; Beard JA, 2011, J CLIN VIROL, V50, P194, DOI 10.1016/j.jcv.2010.12.006; Borella E, 2014, ANN NY ACAD SCI, V1317, P76, DOI 10.1111/nyas.12321; Boyle JR, 2011, MED J AUSTRALIA, V194, pS28; Bresee J, 2013, NEW ENGL J MED, V368, P589, DOI 10.1056/NEJMp1300375; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Cannell JJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-29; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dao CN, 2010, J INFECT DIS, V202, P881, DOI 10.1086/655904; DAVIES R, 1975, OPER RES QUART, V26, P599, DOI 10.2307/3008064; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Fleming DM, 2007, EPIDEMIOL INFECT; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garza RC, 2013, EMERG INFECT DIS, V19, P938, DOI 10.3201/eid1906.120916; Hufty A, 2001, INTRODUCTION A LA CL; Husson F, TECHNICAL REPORT AGR; Jhung MA, 2014, AM J INFECT CONTROL, V42, P7, DOI 10.1016/j.ajic.2013.06.018; Juzeniene A, 2010, INT J INFECT DIS, V14, pE1099, DOI 10.1016/j.ijid.2010.09.002; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Shaman J, 2009, PLOS CURR, V1; Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109; Shaman J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020743; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; te Beest DE, 2013, AM J EPIDEMIOL, V178, P1469, DOI 10.1093/aje/kwt132; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; van Noort SP, 2012, J THEOR BIOL, V298, P131, DOI 10.1016/j.jtbi.2011.12.020; Yaari R, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0298; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	34	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157492	10.1371/journal.pone.0157492	http://dx.doi.org/10.1371/journal.pone.0157492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310145	Green Submitted, Green Published, gold			2022-12-26	WOS:000378029800084
J	Sinha, D; Srivastava, S; D'Silva, P				Sinha, Devanjan; Srivastava, Shubhi; D'Silva, Patrick			Functional Diversity of Human Mitochondrial J-proteins Is Independent of Their Association with the Inner Membrane Presequence Translocase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (Hsp70); chaperone DnaJ (DnaJ); mitochondria; mitochondrial transport; molecular chaperone; protein folding; J-protiens; import motor; mtHsp70	TIM23 PREPROTEIN TRANSLOCASE; IMPORT MOTOR; PRECURSOR PROTEINS; OVARIAN-CANCER; MCJ GENE; J-DOMAIN; HSP70; YEAST; METHYLATION; CHAPERONES	Mitochondrial J-proteins play a critical role in governing Hsp70 activity and, hence, are essential for organellar protein translocation and folding. In contrast to yeast, which has a single J-protein Pam18, humans involve two J-proteins, DnaJC15 and DnaJC19, associated with contrasting cellular phenotype, to transport proteins into the mitochondria. Mutation in DnaJC19 results in dilated cardiomyopathy and ataxia syndrome, whereas expression of DnaJC15 regulates the response of cancer cells to chemotherapy. In the present study we have comparatively assessed the biochemical properties of the J-protein paralogs in relation to their association with the import channel. Both DnaJC15 and DnaJC19 formed two distinct subcomplexes with Magmas at the import channel. Knockdown analysis suggested an essential role for Magmas and DnaJC19 in organellar protein translocation and mitochondria biogenesis, whereas DnaJC15 had dispensable supportive function. The J-proteins were found to have equal affinity for Magmas and could stimulate mitochondrial Hsp70 ATPase activity by equivalent levels. Interestingly, we observed that DnaJC15 exhibits bifunctional properties. At the translocation channel, it involves conserved interactions and mechanism to translocate the precursors into mitochondria. In addition to protein transport, DnaJC15 also showed a dual role in yeast where its expression elicited enhanced sensitivity of cells to cisplatin that required the presence of a functional J-domain. The amount of DnaJC15 expressed in the cell was directly proportional to the sensitivity of cells. Our analysis indicates that the differential cellular phenotype displayed by human mitochondrial J-proteins is independent of their activity and association with Magmas at the translocation channel.	[Sinha, Devanjan; Srivastava, Shubhi; D'Silva, Patrick] Indian Inst Sci, Dept Biochem, Biol Sci Bldg, Bangalore 560012, Karnataka, India; [Sinha, Devanjan] Banaras Hindu Univ, Dept Zool, Inst Sci, Varanasi 221005, Uttar Pradesh, India	Indian Institute of Science (IISC) - Bangalore; Banaras Hindu University (BHU)	D'Silva, P (corresponding author), Indian Inst Sci, Dept Biochem, Biol Sci Bldg, Bangalore 560012, Karnataka, India.	patrick@biochem.iisc.ernet.in	D'Silva, Patrick/L-6653-2019; Sinha, Devanjan/A-3953-2017	Sinha, Devanjan/0000-0001-5060-2075	Swarnajayanti Fellowship, Department of Science and Technology (DST), India; Council of Scientific and Industrial Research Fellowship; Department of Science and Technology INSPIRE Fellowship	Swarnajayanti Fellowship, Department of Science and Technology (DST), India(Department of Science & Technology (India)); Council of Scientific and Industrial Research Fellowship(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology INSPIRE Fellowship(Department of Science & Technology (India))	This work was supported by Swarnajayanti Fellowship, Department of Science and Technology (DST), India (to P. D. S), Council of Scientific and Industrial Research Fellowship (to D. S), and Department of Science and Technology INSPIRE Fellowship (to S. S). The authors declare that they have no conflicts of interest with the contents of this article.	Bauer MF, 1999, J MOL BIOL, V289, P69, DOI 10.1006/jmbi.1999.2751; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Buttner S, 2006, J CELL BIOL, V175, P521, DOI 10.1083/jcb.200608098; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; D'Silva PR, 2008, MOL BIOL CELL, V19, P424, DOI 10.1091/mbc.E07-08-0748; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657; ERNSTER L, 1981, J CELL BIOL, V91, pS227, DOI 10.1083/jcb.91.3.227s; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Goswami AV, 2010, J BIOL CHEM, V285, P19472, DOI 10.1074/jbc.M110.105957; Hatle KM, 2007, MOL CELL BIOL, V27, P2952, DOI 10.1128/MCB.01804-06; Hatle KM, 2013, MOL CELL BIOL, V33, P2302, DOI 10.1128/MCB.00189-13; Kamenskii P A, 2007, Mol Biol (Mosk), V41, P216; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Lindsey JC, 2006, INT J CANCER, V118, P346, DOI 10.1002/ijc.21353; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Madeo F, 2004, CURR OPIN MICROBIOL, V7, P655, DOI 10.1016/j.mib.2004.10.012; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Mokranjac D, 2005, J BIOL CHEM, V280, P31608, DOI 10.1074/jbc.M502397200; Mokranjac D, 2007, J BIOL CHEM, V282, P18037, DOI 10.1074/jbc.M701895200; Mokranjac D, 2006, EMBO J, V25, P4675, DOI 10.1038/sj.emboj.7601334; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ojala T, 2012, PEDIATR RES, V72, P432, DOI 10.1038/pr.2012.92; Okamoto K, 2002, EMBO J, V21, P3659, DOI 10.1093/emboj/cdf358; Schusdziarra C, 2013, HUM MOL GENET, V22, P1348, DOI 10.1093/hmg/dds541; Shridhar V, 2001, CANCER RES, V61, P4258; Sinha D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.72; Sinha D, 2014, MOL CELL BIOL, V34, P1757, DOI 10.1128/MCB.01527-13; Sinha D, 2010, HUM MOL GENET, V19, P1248, DOI 10.1093/hmg/ddq002; Srivastava S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.355; Strathdee G, 2005, GYNECOL ONCOL, V97, P898, DOI 10.1016/j.ygyno.2005.03.023; Strathdee G, 2004, CARCINOGENESIS, V25, P693, DOI 10.1093/carcin/bgh066; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0	43	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17345	17359		10.1074/jbc.M116.738146	http://dx.doi.org/10.1074/jbc.M116.738146			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27330077	hybrid, Green Published			2022-12-26	WOS:000382643800034
J	Boutet, C; Moussa, SAM; Celle, S; Laurent, B; Barthelemy, JC; Barral, FG; Roche, F				Boutet, Claire; Moussa, Syad Abdirahman Mohamed; Celle, Sebastien; Laurent, Bernard; Barthelemy, Jean-Claude; Barral, Fabrice-Guy; Roche, Frederic			Supra-Epiglottic Upper Airway Volume in Elderly Patients with Obstructive Sleep Apnea Hypopnea Syndrome	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEART HEALTH; OLDER-ADULTS; FOLLOW-UP; WEIGHT; MORTALITY; 3D; ASSOCIATIONS; INDIVIDUALS; NOCTURIA	Objective Small upper airway measurements areas and high body mass index are recognized risk factors for obstructive sleep apnea syndrome (OSAS) in non-elderly populations; however, there is limited information regarding elderly patients. We evaluated whether upper airway volume is associated with OSAS and OSAS treated with continuous positive airway pressure (CPAP) treatment and whether BMI is correlated with upper airway volume and measurements in elderly subjects. Methods In 60 volunteers aged 75.58 +/- 0.9 years: 20 OSAS, 20 OSAS chronically treated with CPAP, and 20 controls, semi-automatic segmentation, retropalatal distance and transverse diameter of the supra-epiglottic upper airway were evaluated using 3DT1-weighted magnetic resonance imaging. Anteroposterior to transverse diameter ratio was defined as retropalatar diameter/transverse diameter. Results There were no significant differences in supra-epiglottic upper airway volume between OSAS, CPAP treated patients, and controls. There were significant differences in retropalatal distance and anteroposterior to transverse diameter ratio between OSAS, CPAP treated patients, and controls (P = 0.008 and P<0.0001 respectively). There was a significant correlation between body mass index and retropalatal distance (P<0.05) but not with supra-epiglottic upper airway volume. Conclusion In elderly subjects, OSAS and body mass index are not associated with changes in supra-epiglottic upper airway volume but are associated with modification of pharynx shape.	[Boutet, Claire] CHU St Etienne, INSERM, U1059, Dept Radiol,Pole IMOFON,Univ Lyon, St Etienne, France; [Moussa, Syad Abdirahman Mohamed; Barral, Fabrice-Guy] CHU St Etienne, Pole IMOFON, Dept Radiol, St Etienne, France; [Celle, Sebastien; Barthelemy, Jean-Claude; Roche, Frederic] CHU, Pole NOL, Clin Physiol & VISAS Ctr, EA SNA EPIS 4607, Brest, France; [Celle, Sebastien; Barthelemy, Jean-Claude; Roche, Frederic] Univ St Etienne, COMUE Lyon St Etienne, Fac Med St Etienne, St Etienne, France; [Laurent, Bernard] Lyon Neurosci Res Ctr, Ctr Memory Resources & Res Unit, North St Etienne Univ Hosp Ctr, Cent Integrat Pain,Neurol Neuropsychol,Pain Ctr, Bron, France	CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de St Etienne; CHU Brest; Universite de Bretagne Occidentale; Universite Jean Monnet; CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm)	Boutet, C (corresponding author), CHU St Etienne, INSERM, U1059, Dept Radiol,Pole IMOFON,Univ Lyon, St Etienne, France.	claireboutet@yahoo.fr	Barthelemy, Jean-Claude/AAE-7180-2019; BOUTET, Claire/B-8031-2016	BOUTET, Claire/0000-0001-9850-4124; Roche, Frederic/0000-0001-6115-7958	French Ministry of Health; L'Association de Recherche SYNAPSE	French Ministry of Health; L'Association de Recherche SYNAPSE	This study was supported by a grant from the French Ministry of Health (Cellule Projet Hospitalier de Recherche Clinique National, Direction de la Recherche Clinique, CHU Saint-Etienne; Appel d'Offre1998 and Appel d'Offre 2002) and by a grant from L'Association de Recherche SYNAPSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANCOLIISRAEL S, 1991, SLEEP, V14, P486, DOI 10.1093/sleep/14.6.486; Auerbach S., 2014, GERIATRIC NEUROLOGY, P347; Barthelemy JC, 2007, NEUROEPIDEMIOLOGY, V29, P18, DOI 10.1159/000108914; Brown DL, 2010, SLEEP MED, V11, P540, DOI 10.1016/j.sleep.2010.01.008; Canales MT, 2008, SLEEP MED, V9, P637, DOI 10.1016/j.sleep.2007.08.021; Carlisle T, 2014, EUR RESPIR J, V44, P685, DOI 10.1183/09031936.00177213; Ciscar MA, 2001, EUR RESPIR J, V17, P79, DOI 10.1183/09031936.01.17100790; Corda L, 2009, SLEEP BREATH, V13, P187, DOI 10.1007/s11325-008-0219-1; Eckert DJ, 2009, PROG CARDIOVASC DIS, V51, P313, DOI 10.1016/j.pcad.2008.02.003; Endeshaw YW, 2004, J AM GERIATR SOC, V52, P957, DOI 10.1111/j.1532-5415.2004.52264.x; Furuhashi A, 2013, J ORAL REHABIL, V40, P582, DOI 10.1111/joor.12059; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Johansson P, 2015, EUR J CARDIOVASC NUR, V14, P222, DOI 10.1177/1474515114524072; Johansson P, 2012, AGE AGEING, V41, P468, DOI 10.1093/ageing/afs019; Johansson P, 2011, SLEEP MED, V12, P748, DOI 10.1016/j.sleep.2011.03.012; Keys A, 2014, INT J EPIDEMIOL, V43, P655, DOI 10.1093/ije/dyu058; Kezirian EJ, 2009, SLEEP, V32, P253, DOI 10.1093/sleep/32.2.253; Kim EJ, 2011, ACTA OTO-LARYNGOL, V131, P527, DOI 10.3109/00016489.2010.535561; Kim YC, 2014, MAGN RESON MED, V71, P1501, DOI 10.1002/mrm.24808; Mayer P, 1996, EUR RESPIR J, V9, P1801, DOI 10.1183/09031936.96.09091801; Mortimore IL, 1996, THORAX, V51, P190, DOI 10.1136/thx.51.2.190; Newman AB, 2005, ARCH INTERN MED, V165, P2408, DOI 10.1001/archinte.165.20.2408; Okubo M, 2006, SLEEP, V29, P909, DOI 10.1093/sleep/29.7.909; Onen SH, 2012, J AM MED DIR ASSOC, V13, P752, DOI 10.1016/j.jamda.2012.07.003; Pavlova MK, 2008, SLEEP, V31, P241, DOI 10.1093/sleep/31.2.241; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; RODENSTEIN DO, 1990, THORAX, V45, P722, DOI 10.1136/thx.45.10.722; Schendel SA, 2012, J ORAL MAXIL SURG, V70, P2174, DOI 10.1016/j.joms.2011.10.013; Spira AP, 2008, J AM GERIATR SOC, V56, P45, DOI 10.1111/j.1532-5415.2007.01506.x; Strobel RJ, 1996, SLEEP, V19, P104, DOI 10.1093/sleep/19.2.104; Sutherland K, 2011, SLEEP, V34, P469, DOI 10.1093/sleep/34.4.469; Umlauf MG, 2004, SLEEP, V27, P139, DOI 10.1093/sleep/27.1.139; Wagshul ME, 2013, MAGN RESON MED, V70, P1580, DOI 10.1002/mrm.24608; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Yucel A, 2005, AM J NEURORADIOL, V26, P2624	35	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157720	10.1371/journal.pone.0157720	http://dx.doi.org/10.1371/journal.pone.0157720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336305	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200036
J	Wang, J; Xiong, KC; Liu, YH				Wang, Jia; Xiong, Ke-Cai; Liu, Ying-Hong			De novo Transcriptome Analysis of Chinese Citrus Fly, Bactrocera minax (Diptera: Tephritidae), by High-Throughput Illumina Sequencing	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; PUPAL DIAPAUSE DEVELOPMENT; GENE-EXPRESSION; TETRADACUS MINAX; ECDYSONE RECEPTOR; COTTON BOLLWORM; HSP60; EVOLUTIONARY; MICROSATELLITES; TRANSFERASES	The Chinese citrus fly, Bactrocera minax (Enderlein), is one of the most devastating pests of citrus in the temperate areas of Asia. So far, studies involving molecular biology and physiology of B. minax are still scarce, partly because of the lack of genomic information and inability to rear this insect in laboratory. In this study, de novo assembly of a transcriptome was performed using Illumina sequencing technology. A total of 20,928,907 clean reads were obtained and assembled into 33,324 unigenes, with an average length of 908.44 bp. Unigenes were annotated by alignment against NCBI non-redundant protein (Nr), Swiss-Prot, Clusters of Orthologous Groups (COG), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes Pathway (KEGG) database. Genes potentially involved in stress tolerance, including 20 heat shock protein (Hsps) genes, 26 glutathione S-transferases (GSTs) genes, and 2 ferritin subunit genes, were identified. These genes may play roles in stress tolerance in B. minax diapause stage. It has previously been found that 20E application on B. minax pupae could avert diapause, but the underlying mechanisms remain unknown. Thus, genes encoding enzymes in 20E biosynthesis pathway, including Neverland, Spook, Phantom, Disembodied, Shadow, Shade, and Cyp18a1, and genes encoding 20E receptor proteins, ecdysone receptor (EcR) and ultraspiracle (USP), were identified. The expression patterns of 20E-related genes among developmental stages and between 20E-treated and untreated pupae demonstrated their roles in diapause program. In addition, 1,909 simple sequence repeats (SSRs) were detected, which will contribute to molecular marker development. The findings in this study greatly improve our genetic understanding of B. minax, and lay the foundation for future studies on this species.	[Wang, Jia; Xiong, Ke-Cai; Liu, Ying-Hong] Southwest Univ, Coll Plant Protect, Inst Entomol, Chongqing, Peoples R China	Southwest University - China	Wang, J (corresponding author), Southwest Univ, Coll Plant Protect, Inst Entomol, Chongqing, Peoples R China.	aimarjia@126.com	liu, ying/GXF-4294-2022; LIU, YING/GZL-7252-2022		National Natural Science Foundation of China [31401742]; China Postdoctoral Science Foundation [2014M552307]; Fundamental Research Funds for Central Universities [XDJK2013C149, 2362015XK04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This study was financially supported by the National Natural Science Foundation of China (31401742), the China Postdoctoral Science Foundation (2014M552307), and the Fundamental Research Funds for the Central Universities (XDJK2013C149 and 2362015XK04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwood AJ, 1999, RAFFLES B ZOOL, P1; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bao B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-224; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Chen EH, 2012, FLA ENTOMOL, V95, P593, DOI 10.1653/024.095.0309; Denlinger D.L., 2012, INSECT ENDOCRINOLOGY, P430, DOI DOI 10.1016/B978-0-12-384749-2.10010-X; Dhillon MK, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.40; Dong YC, 2013, J PEST SCI, V86, P429, DOI 10.1007/s10340-013-0493-y; Dong YC, 2014, J PEST SCI, V87, P647, DOI 10.1007/s10340-014-0605-3; Dong YC, 2014, INT J BIOL SCI, V10, P1051, DOI 10.7150/ijbs.9438; Dorji C, 2006, B ENTOMOL RES, V96, P531, DOI 10.1079/BER2006455; Drew RAI, 2006, J ECON ENTOMOL, V99, P1651, DOI 10.1603/0022-0493-99.5.1651; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Gao Li-zhi, 2013, Scientia Agricultura Sinica, V46, P3285; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guittard E, 2011, DEV BIOL, V349, P35, DOI 10.1016/j.ydbio.2010.09.023; Hamburger AE, 2005, J MOL BIOL, V349, P558, DOI 10.1016/j.jmb.2005.03.074; Han P, 2011, J PEST SCI, V84, P289, DOI 10.1007/s10340-011-0363-4; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hower V, 2009, MOL BIOSYST, V5, P422, DOI 10.1039/b816714c; IKAWA S, 1992, P NATL ACAD SCI USA, V89, P2012, DOI 10.1073/pnas.89.6.2012; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jiang XZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04806; JONES M, 1994, P NATL ACAD SCI USA, V91, P858, DOI 10.1073/pnas.91.3.858; Kaufman BA, 2003, J CELL BIOL, V163, P457, DOI 10.1083/jcb.200306132; King AM, 2015, ANNU REV ENTOMOL, V60, P59, DOI 10.1146/annurev-ento-011613-162107; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; KOLL H, 1992, CELL, V68, P1163, DOI 10.1016/0092-8674(92)90086-R; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Lin T, 2015, J ASIA-PAC ENTOMOL, V18, P439, DOI 10.1016/j.aspen.2015.04.011; Liu HQ, 2015, CURR PHARM BIOTECHNO, V16, P77, DOI 10.2174/138920101601150105105751; Lu ZC, 2014, NEOTROP ENTOMOL, V43, P362, DOI 10.1007/s13744-014-0216-y; Lu ZC, 2014, FLA ENTOMOL, V97, P597, DOI 10.1653/024.097.0235; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; Nichol H, 2002, ANNU REV ENTOMOL, V47, P535, DOI 10.1146/annurev.ento.47.091201.145237; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ragland GJ, 2010, P NATL ACAD SCI USA, V107, P14909, DOI 10.1073/pnas.1007075107; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Sim C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00189; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Spindler KD, 2009, CELL MOL LIFE SCI, V66, P3837, DOI 10.1007/s00018-009-0112-5; Swevers L, 1996, INSECT BIOCHEM MOLEC, V26, P217, DOI 10.1016/0965-1748(95)00097-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tran HT, 2001, J MOL ENDOCRINOL, V27, P191, DOI 10.1677/jme.0.0270191; Tu CPD, 2005, METHOD ENZYMOL, V401, P204, DOI 10.1016/S0076-6879(05)01013-X; Tu XB, 2015, SCI REP-UK, V5, DOI 10.1038/srep11402; Van Schoubroeck F., 1999, THESIS; Wang AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106988; Wang J, 2014, J ECON ENTOMOL, V107, P1519, DOI 10.1603/EC13539; [王小蕾 WANG Xiao-ki], 2009, [环境昆虫学报, Journal of Environmental Entomology], V31, P73; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Xing-Jian, 1995, Entomological Knowledge, V32, P310; Wei DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080046; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384; Young SC, 2012, J INSECT PHYSIOL, V58, P102, DOI 10.1016/j.jinsphys.2011.10.005; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100558; Zhang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063168; Zhang Q, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-751; Zhang Y., 2005, B AGR SCI TECH, V2, P22; ZHANG Y-A, 1989, Bulletin OEPP, V19, P649, DOI 10.1111/j.1365-2338.1989.tb01154.x; Zhou XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106932	81	16	19	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157656	10.1371/journal.pone.0157656	http://dx.doi.org/10.1371/journal.pone.0157656			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27331903	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212800042
J	Caballes, CF; Pratchett, MS; Kerr, AM; Rivera-Posada, JA				Caballes, Ciemon Frank; Pratchett, Morgan S.; Kerr, Alexander M.; Rivera-Posada, Jairo A.			The Role of Maternal Nutrition on Oocyte Size and Quality, with Respect to Early Larval Development in The Coral-Eating Starfish, Acanthaster planci	PLOS ONE			English	Article							OF-THORNS STARFISH; ARBACIA-LIXULA ECHINODERMATA; GREEN SEA-URCHIN; EGG QUALITY; PHENOTYPIC PLASTICITY; POPULATION DIFFERENCES; FERTILIZATION; OUTBREAKS; GROWTH; CONSEQUENCES	Variation in local environmental conditions can have pronounced effects on the population structure and dynamics of marine organisms. Previous studies on crown-of-thorns starfish, Acanthaster planci, have primarily focused on effects of water quality and nutrient availability on larval growth and survival, while the role of maternal nutrition on reproduction and larval development has been overlooked. To examine the effects of maternal nutrition on oocyte size and early larval development in A. planci, we pre-conditioned females for 60 days on alternative diets of preferred coral prey (Acropora abrotanoides) versus non-preferred coral prey (Porites rus) and compared resulting gametes and progeny to those produced by females that were starved over the same period. Females fed ad libitum with Acropora increased in weight, produced heavier gonads and produced larger oocytes compared to Porites-fed and starved females. Fed starfish (regardless of whether it was Acropora or Porites) produced bigger larvae with larger stomachs and had a higher frequency of normal larvae that reached the late bipinnaria / early brachiolaria stage compared to starved starfish. Females on Acropora diet also produced a higher proportion of larvae that progressed to more advanced stages faster compared to Porites-fed starfish, which progressed faster than starved starfish. These results suggest that maternal provisioning can have important consequences for the quality and quantity of progeny. Because food quality (coral community structure) and quantity (coral abundance) varies widely among reef locations and habitats, local variation in maternal nutrition of A. planci is likely to moderate reproductive success and may explain temporal and spatial fluctuations in abundance of this species.	[Caballes, Ciemon Frank; Pratchett, Morgan S.; Kerr, Alexander M.; Rivera-Posada, Jairo A.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Kerr, Alexander M.] Univ Guam, Marine Lab, UOG Stn, Mangilao, GU 96923 USA; [Rivera-Posada, Jairo A.] Univ Antioquia, Environm Corp, Medellin, Colombia	James Cook University; University of Guam; Universidad de Antioquia	Caballes, CF (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	ciemon.caballes@my.jcu.edu.au	Pratchett, Morgan S/A-9256-2010; Caballes, Ciemon Frank/D-7846-2016; Pratchett, Morgan/AAW-5179-2020	Pratchett, Morgan S/0000-0002-1862-8459; Caballes, Ciemon Frank/0000-0003-1865-6713; Pratchett, Morgan/0000-0002-1862-8459	Australian Research Council Centre of Excellence for Coral Reef Studies; ARC Centre of Excellence for Coral Reef Studies	Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	This study was funded by the Australian Research Council Centre of Excellence for Coral Reef Studies PhD research allocation to CFC and annual research appropriation to MSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the ARC Centre of Excellence for Coral Reef Studies for providing support and the University of Guam Marine Laboratory, through Prof. Laurie Raymundo, for providing workspace and assistance in specimen collection. We are grateful to Prof. Maria Byrne and Dr. Makoto Kitamura for providing technical advice. We also thank Joseph Cummings, Jason Miller, Travis Reynolds, Jordan Gault, Samuel Nietze, Mareen Moller, Andres Reyes and Maia Raymundo for laboratory and field assistance.	Anderson DT, 2001, INVERTEBRATE ZOOLOGY, P374; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Ayukai T, 1996, PRACTICAL HDB LARGE; BABCOCK RC, 1994, BIOL BULL-US, V186, P17, DOI 10.2307/1542033; Balch T, 2001, ECHINOD ST, V6, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENZIE JAH, 1994, BIOL BULL-US, V186, P139, DOI 10.2307/1542048; Bertram DF, 1998, ECOLOGY, V79, P315, DOI 10.2307/176885; BIRKELAND C, 1982, MAR BIOL, V69, P175, DOI 10.1007/BF00396897; Boidron-Metairon Isabelle F., 1995, P223; Bosch I., 1991, ANTARCT J US, V1991, P168; Brodie J, 2005, MAR POLLUT BULL, V51, P266, DOI 10.1016/j.marpolbul.2004.10.035; Burdick D., 2008, STATUS CORAL REEF EC; Byrne M, 2008, MAR BIOL, V155, P473, DOI 10.1007/s00227-008-1045-5; Byrne M, 2008, FUNCT ECOL, V22, P643, DOI 10.1111/j.1365-2435.2008.01427.x; BYRNE M, 1991, BIOL BULL, V180, P332, DOI 10.2307/1542335; Caballes C.F., 2014, ECHINODERMS ECOLOGY, DOI DOI 10.13140/RG.2.1.3719.5129; Caballes CF, 2009, THESIS; Cheney D.P., 1974, Proceedings int Coral Reef Symp, V2, P591; Cole AJ, 2011, MAR ECOL PROG SER, V422, P155, DOI 10.3354/meps08917; Conand C., 1985, ECHINODERMATA, P499; De'ath G, 1998, J EXP MAR BIOL ECOL, V220, P83, DOI 10.1016/S0022-0981(97)00085-3; deJongWestman M, 1995, CAN J ZOOL, V73, P2080, DOI 10.1139/z95-245; Endean R., 1977, Proceedings int Coral Reef Symp, V3, P185; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; George SB, 1996, OCEANOL ACTA, V19, P297; GEORGE SB, 1990, J EXP MAR BIOL ECOL, V141, P107, DOI 10.1016/0022-0981(90)90217-Z; George SB, 1999, J EXP MAR BIOL ECOL, V237, P203, DOI 10.1016/S0022-0981(98)00205-6; GEORGE SB, 1994, J EXP MAR BIOL ECOL, V175, P121, DOI 10.1016/0022-0981(94)90179-1; GEORGE SB, 1990, INVERTEBR REPROD DEV, V17, P111, DOI 10.1080/07924259.1990.9672098; GEORGE SB, 1991, INVERTEBR REPROD DEV, V20, P237, DOI 10.1080/07924259.1991.9672204; Hayashi R., 1973, Proceedings of the Japanese Society for Systematic Zoology, VNo. 9, P59; Henderson J, 1969, MAR QLD FISH NOTES, V3, P69; HOEGHGULDBERG O, 1995, AM ZOOL, V35, P415; HUGHES TP, 1987, MAR ECOL PROG SER, V35, P259, DOI 10.3354/meps035259; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; KEESING JK, 1992, J EXP MAR BIOL ECOL, V156, P89, DOI 10.1016/0022-0981(92)90018-6; Keesing JK, 1990, THESIS; KETTLE BT, 1987, B MAR SCI, V41, P541; Lawrence JM, 2003, COMP BIOCHEM PHYS A, V134, P71; Levitan DR, 1996, NATURE, V382, P153, DOI 10.1038/382153a0; LUCAS J S, 1973, Micronesica, V9, P197; LUCAS JS, 1982, J EXP MAR BIOL ECOL, V65, P173, DOI 10.1016/0022-0981(82)90043-0; MARSH JA, 1970, ECOLOGY, V51, P254; McEdward L, 1995, MARINE INVERTEBRATE, P49; Meidel SK, 1999, J EXP MAR BIOL ECOL, V240, P161, DOI 10.1016/S0022-0981(99)00046-5; Mercier A, 2009, ADV MAR BIOL, V55, P1, DOI 10.1016/S0065-2881(09)55001-8; Mortensen T., 1931, DAN VIDENSK SELSK NA, V4, P1; Mortensen T., 1938, KONGELIGE DANSKE VID, V7, P1; NIMITZ SMA, 1976, BIOL BULL, V151, P357; Okaji K, 1997, CORAL REEFS, V16, P47, DOI 10.1007/s003380050058; Okaji K., 1991, P291; OLSON RR, 1987, LIMNOL OCEANOGR, V32, P895, DOI 10.4319/lo.1987.32.4.0895; PATTON JS, 1977, MAR BIOL, V44, P235, DOI 10.1007/BF00387705; Pearson R. G., 1969, Fish Notes Qd, V3, P27; Podolsky RD, 1996, AM NAT, V148, P160, DOI 10.1086/285916; Podolsky RD, 2006, INTEGR COMP BIOL, V46, P577, DOI 10.1093/icb/icl026; Pratchett MS, 2009, MAR ENVIRON RES, V67, P230, DOI 10.1016/j.marenvres.2009.03.001; Pratchett MS, 2014, OCEANOGR MAR BIOL, V52, P133; Pratchett MS, 2001, MAR ECOL PROG SER, V214, P111, DOI 10.3354/meps214111; Prowse TAA, 2008, MAR BIOL, V153, P337, DOI 10.1007/s00227-007-0809-7; RAPPAPORT R, 1994, DEV BIOL, V164, P258, DOI 10.1006/dbio.1994.1196; Reitzel AM, 2005, J EXP MAR BIOL ECOL, V317, P189, DOI 10.1016/j.jembe.2004.11.018; Russell MP, 1998, J EXP MAR BIOL ECOL, V220, P1, DOI 10.1016/S0022-0981(97)00079-8; SCHEIBLING RE, 1982, MAR BIOL, V70, P51, DOI 10.1007/BF00397296; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shirai H., 1988, Invertebrate Endocrinology, V2, P453; SINERVO B, 1988, EVOLUTION, V42, P885, DOI 10.1111/j.1558-5646.1988.tb02509.x; STIMSON JS, 1987, B MAR SCI, V41, P889; Suzuki G, 2016, DIVERSITY-BASEL, V8, DOI 10.3390/d8020009; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; VENABLE DL, 1992, AM NAT, V140, P287, DOI 10.1086/285413; Veron JEN, 1997, OUTSTANDING UNIVERSA, P152; Wolfe K, 2015, MAR ECOL PROG SER, V539, P179, DOI 10.3354/meps11495; Wolfe K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122010; XU RA, 1990, COMP BIOCHEM PHYS A, V96, P33, DOI 10.1016/0300-9629(90)90037-S; XU RA, 1990, J EXP MAR BIOL ECOL, V136, P23, DOI 10.1016/0022-0981(90)90098-W; Yamaguchi M., 1973, P369; YAMAGUCHI M, 1974, Micronesica, V10, P57; YAMAGUCHI M, 1984, MAR BIOL, V83, P33, DOI 10.1007/BF00393083; YAMAGUCHI M, 1977, Micronesica, V13, P283; Zann LP, 1992, CROWN OF THORNS STAR	83	40	40	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0158007	10.1371/journal.pone.0158007	http://dx.doi.org/10.1371/journal.pone.0158007			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327627	Green Published, gold, Green Accepted			2022-12-26	WOS:000378212400068
J	Favennec, M; Hennart, B; Verbanck, M; Pigeyre, M; Caiazzo, R; Raverdy, V; Verkindt, H; Leloire, A; Guillemin, GJ; Yengo, L; Allorge, D; Froguel, P; Pattou, F; Poulain-Godefroy, O				Favennec, Marie; Hennart, Benjamin; Verbanck, Marie; Pigeyre, Marie; Caiazzo, Robert; Raverdy, Violeta; Verkindt, Helene; Leloire, Audrey; Guillemin, Gilles J.; Yengo, Loic; Allorge, Delphine; Froguel, Philippe; Pattou, Francois; Poulain-Godefroy, Odile			Post-Bariatric Surgery Changes in Quinolinic and Xanthurenic Acid Concentrations Are Associated with Glucose Homeostasis	PLOS ONE			English	Article							MORBIDLY OBESE-PATIENTS; TRYPTOPHAN-METABOLISM; DIABETES-MELLITUS; IMMUNE ACTIVATION; WEIGHT; INFLAMMATION; KYNURENINES; MARKERS; CELLS	Background An increase of plasma kynurenine concentrations, potentially bioactive metabolites of tryptophan, was found in subjects with obesity, resulting from low-grade inflammation of the white adipose tissue. Bariatric surgery decreases low-grade inflammation associated with obesity and improves glucose control. Objective Our goal was to determine the concentrations of all kynurenine metabolites after bariatric surgery and whether they were correlated with glucose control improvement. Design Kynurenine metabolite concentrations, analysed by liquid or gas chromatography coupled with tandem mass spectrometry, circulating inflammatory markers, metabolic traits, and BMI were measured before and one year after bariatric surgery in 44 normoglycemic and 47 diabetic women with obesity. Associations between changes in kynurenine metabolites concentrations and in glucose control and metabolic traits were analysed between baseline and twelve months after surgery. Results Tryptophan and kynurenine metabolite concentrations were significantly decreased one year after bariatric surgery and were correlated with the decrease of the usCRP in both groups. Among all the kynurenine metabolites evaluated, only quinolinic acid and xanthurenic acid were significantly associated with glucose control improvement. The one year delta of quinolinic acid concentrations was negatively associated with the delta of fasting glucose (p = 0.019) and HbA1c (p = 0.014), whereas the delta of xanthurenic acid was positively associated with the delta of insulin sensitivity index (p = 0.0018). Conclusion Bariatric surgery has induced a global down-regulation of kynurenine metabolites, associated with weight loss. Our results suggest that, since kynurenine monoxygenase diverts the kynurenine pathway toward the synthesis of xanthurenic acid, its inhibition may also contribute to glucose homeostasis.	[Favennec, Marie; Verbanck, Marie; Leloire, Audrey; Yengo, Loic; Froguel, Philippe; Poulain-Godefroy, Odile] Univ Lille, UMR 8199, EGID, F-59000 Lille, France; [Favennec, Marie; Verbanck, Marie; Leloire, Audrey; Yengo, Loic; Froguel, Philippe; Poulain-Godefroy, Odile] CNRS, UMR 8199, F-59000 Lille, France; [Favennec, Marie; Verbanck, Marie; Leloire, Audrey; Yengo, Loic; Froguel, Philippe; Poulain-Godefroy, Odile] Inst Pasteur, F-59000 Lille, France; [Hennart, Benjamin; Allorge, Delphine] Univ Lille, EA 4483, IMPECS, IMPact Environm Chim Sante Humaine, F-59000 Lille, France; [Hennart, Benjamin; Allorge, Delphine] CHU Lille, Serv Toxicol Genopathies, F-59000 Lille, France; [Pigeyre, Marie; Caiazzo, Robert; Raverdy, Violeta; Verkindt, Helene; Pattou, Francois] Univ Lille, EGID, U1190, F-59000 Lille, France; [Pigeyre, Marie; Caiazzo, Robert; Raverdy, Violeta; Verkindt, Helene; Pattou, Francois] INSERM, U1190, F-59000 Lille, France; [Pigeyre, Marie; Caiazzo, Robert; Raverdy, Violeta; Verkindt, Helene; Pattou, Francois] CHU Lille, Chirurg Gen & Endocrinienne, F-59000 Lille, France; [Guillemin, Gilles J.] Macquarie Univ, Neuroinflammat Grp, Sydney, NSW 2109, Australia; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Macquarie University; Imperial College London	Froguel, P; Poulain-Godefroy, O (corresponding author), Univ Lille, UMR 8199, EGID, F-59000 Lille, France.; Froguel, P; Poulain-Godefroy, O (corresponding author), CNRS, UMR 8199, F-59000 Lille, France.; Froguel, P; Poulain-Godefroy, O (corresponding author), Inst Pasteur, F-59000 Lille, France.; Froguel, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England.	philippe.froguel@good.ibl.fr; odile.poulain@good.ibl.fr	Guillemin, Gilles J/C-3878-2015; Poulain-Godefroy, Odile/AAF-5474-2021; caiazzo, robert/Y-9692-2019; Pattou, Francois/O-6151-2017; Yengo, Loic/D-2692-2017; FROGUEL, Philippe/O-6799-2017	Guillemin, Gilles J/0000-0001-8105-4470; caiazzo, robert/0000-0001-5383-0540; Pattou, Francois/0000-0001-8388-3766; Yengo, Loic/0000-0002-4272-9305; FROGUEL, Philippe/0000-0003-2972-0784; Verbanck, Marie/0000-0002-1669-572X; allorge, delphine/0000-0003-2356-3319; HENNART, Benjamin/0000-0003-0302-6049; Pigeyre, Marie/0000-0003-2984-8366; POULAIN-GODEFROY, Odile/0000-0001-8805-9450	CNRS; Societe Francophone du Diabete; European Genomic Institute for Diabetes (E.G.I.D.) [ANR-10-LABX-46]; European Commission; Conseil Regional du Nord-Pas de Calais; CHRU de Lille; Australian Research Council [ARCF20100397]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Societe Francophone du Diabete; European Genomic Institute for Diabetes (E.G.I.D.); European Commission(European CommissionEuropean Commission Joint Research Centre); Conseil Regional du Nord-Pas de Calais(Region Hauts-de-FranceRegion Ile-de-France); CHRU de Lille; Australian Research Council(Australian Research Council)	This work was supported by grants from the CNRS (http://www.cnrs.fr/); the "Societe Francophone du Diabete"(http://www.sfdiabete.org/), "European Genomic Institute for Diabetes" (E.G.I.D., ANR-10-LABX-46; http://www.egid.fr) and European Commission (http://ec.europa.eu). MF is supported by a doctoral grant from the "Conseil Regional du Nord-Pas de Calais" (http://www.nordpasdecalais.fr) and from the "CHRU de Lille" (http://www.chru-lille.fr/). GJG is supported by the Australian Research Council (ARCF20100397)(http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasheim ET, 2008, AM J CLIN NUTR, V87, P362, DOI 10.1093/ajcn/87.2.362; Brand T, 2011, CLIN CHEM, V57, P1376, DOI 10.1373/clinchem.2011.163824; Brandacher G, 2006, OBES SURG, V16, P541, DOI 10.1381/096089206776945066; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Caiazzo R, 2010, BRIT J SURG, V97, P884, DOI 10.1002/bjs.6993; CONNICK JH, 1985, MED HYPOTHESES, V18, P371, DOI 10.1016/0306-9877(85)90104-5; Favennec M, 2015, OBESITY, V23, P2066, DOI 10.1002/oby.21199; HATTORI M, 1984, Acta Vitaminologica et Enzymologica, V6, P221; Ho JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148361; KOTAKE Y, 1975, ACTA VITAMINOL ENZYM, V29, P236; Lasselin J, 2014, J CLIN ENDOCR METAB, V99, pE53, DOI 10.1210/jc.2013-2673; Meyramov G, 1998, TRANSPLANT P, V30, P2682, DOI 10.1016/S0041-1345(98)00788-X; Do MT, 2014, TOXICOL APPL PHARM, V280, P138, DOI 10.1016/j.taap.2014.07.021; Moore SC, 2014, METABOLOMICS, V10, P259, DOI 10.1007/s11306-013-0574-1; Mumphrey MB, 2013, NEUROGASTROENT MOTIL, V25, pE70, DOI 10.1111/nmo.12034; Nicoletti CF, 2013, SURG OBES RELAT DIS, V9, P1008, DOI 10.1016/j.soard.2013.07.004; O'Brien PE, 2010, J GASTROEN HEPATOL, V25, P1358, DOI 10.1111/j.1440-1746.2010.06391.x; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Oxenkrug G, 2011, Am J Neuroprot Neuroregen, V3, P48; Oxenkrug GF, 2013, HEPAT RES TREAT, V2013, P1; Oxenkrug GF, 2015, MOL NEUROBIOL, V52, P805, DOI 10.1007/s12035-015-9232-0; Perng W, 2014, OBESITY, V22, P2570, DOI 10.1002/oby.20901; Preumont V, 2007, DIABETES CARE, V30, P1187, DOI 10.2337/dc06-1915; Ritz P, 2013, SURG OBES RELAT DIS, V9, P118, DOI 10.1016/j.soard.2011.10.022; Robinson CM, 2006, CYTOKINE, V35, P53, DOI 10.1016/j.cyto.2006.07.007; SHIBATA K, 1995, BIOSCI BIOTECH BIOCH, V59, P2060, DOI 10.1271/bbb.59.2060; Strasser B, 2014, EUR J NUTR, P1; Theofylaktopoulou D, 2013, CLIN EXP IMMUNOL, V173, P121, DOI 10.1111/cei.12092; Wolowczuk I., 2012, AM J PHYSIOL-REG I, V303, pR135, DOI DOI 10.1152/ajpregu.00373.2011	30	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0158051	10.1371/journal.pone.0158051	http://dx.doi.org/10.1371/journal.pone.0158051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327770	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212400069
J	Forster, A; Wenz, H; Bohme, J; Al-Zghloul, M; Groden, C				Foerster, Alex; Wenz, Holger; Boehme, Johannes; Al-Zghloul, Mansour; Groden, Christoph			Hyperintense Acute Reperfusion Marker on FLAIR in Posterior Circulation Infarction	PLOS ONE			English	Article							BRAIN-BARRIER DISRUPTION; HEMORRHAGIC TRANSFORMATION; ARTERIAL TERRITORIES; STROKE PATIENTS; FLUID; GADOLINIUM; IMAGES; THROMBOLYSIS; ENHANCEMENT; FREQUENCY	Purpose In the present study, we aimed to investigate the frequency of blood brain barrier injury in posterior circulation infarction as demonstrated by the hyperintense acute reperfusion marker (HARM) on fluid attenuated inversion recovery images (FLAIR). Methods From a MRI report database we identified patients with posterior circulation infarction who underwent MRI, including perfusion-weighted images (PWI), within 12 hours after onset and follow-up MRI within 24 hours and analyzed diffusion-weighted images (DWI), PWI, FLAIR, and MR angiography (MRA). On FLAIR images, the presence of HARM was noted by using pre-specified criteria (focal enhancement in the subarachnoid space and/or the ventricles). Results Overall 16 patients (median age of patients 68.5 (IQR 55.5-82.75) years) with posterior circulation infarction were included. Of these, 13 (81.3%) demonstrated PCA occlusion, and 3 (18.7%) patients BA occlusion on MRA. Initial DWI demonstrated ischemic lesions in the thalamus (68.8%), splenium (18.8%), hippocampus (75%), occipital lobe (81.3%), mesencephalon (18.8%), pons (18.8%), and cerebellum (50%). On follow-up MRA recanalization was noted in 10 (62.5%) patients. On follow-up FLAIR images, HARM was observed in 8 (50%) patients. In all of these, HARM was detected remote from the acute ischemic lesion. HARM was more frequently observed in patients with vessel recanalization (p = 0.04), minor infarction growth (p = 0.01), and smaller ischemic lesions on follow-up DWI (p = 0.05). Conclusions HARM is a frequent finding in posterior circulation infarction and associated with vessel recanalization, minor infarction growth as well as smaller infarction volumes in the course. Neuroradiologists should be cognizant of the fact that HARM may be present on short interval follow-up FLAIR images in patients with acute ischemic infarction who initially underwent MRI and received intravenous gadolinium-based contrast agents.	[Foerster, Alex; Wenz, Holger; Boehme, Johannes; Al-Zghloul, Mansour; Groden, Christoph] Heidelberg Univ, Univ Med Mannheim, Dept Neuroradiol, Mannheim, Germany	Ruprecht Karls University Heidelberg	Forster, A (corresponding author), Heidelberg Univ, Univ Med Mannheim, Dept Neuroradiol, Mannheim, Germany.	alex.foerster@umm.de		Forster, Alex/0000-0002-8679-0060				Barr TL, 2010, STROKE, V41, pE123, DOI 10.1161/STROKEAHA.109.570515; BOGOUSSLAVSKY J, 1988, STROKE, V19, P1083, DOI 10.1161/01.STR.19.9.1083; Dornak T, 2015, INT J STROKE, V10, P1224, DOI 10.1111/ijs.12626; Forster A, 2011, CEREBROVASC DIS, V32, P349, DOI 10.1159/000330346; Forster Alex, 2011, Curr Treat Options Cardiovasc Med, V13, P268, DOI 10.1007/s11936-011-0119-8; Henning EC, 2008, J CEREBR BLOOD F MET, V28, P882, DOI 10.1038/sj.jcbfm.9600598; Kassner A, 2005, AM J NEURORADIOL, V26, P2213; Kohrmann M, 2012, STROKE, V43, P259, DOI 10.1161/STROKEAHA.111.632356; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Lee H, 2015, KOREAN J RADIOL, V16, P906, DOI 10.3348/kjr.2015.16.4.906; Lee M, 2012, J NEUROL SCI, V313, P142, DOI 10.1016/j.jns.2011.08.048; Mamourian AC, 2000, AM J NEURORADIOL, V21, P105; Mathews VP, 1999, RADIOLOGY, V211, P257, DOI 10.1148/radiology.211.1.r99mr25257; Montaner J, 2001, STROKE, V32, P2762, DOI 10.1161/hs1201.99512; Morris JM, 2007, AM J NEURORADIOL, V28, P1964, DOI 10.3174/ajnr.A0694; Ostwaldt AC, 2014, CEREBROVASC DIS, V37, P141, DOI 10.1159/000357422; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Rozanski M, 2010, EUR RADIOL, V20, P2990, DOI 10.1007/s00330-010-1881-9; Tatu L, 1998, NEUROLOGY, V50, P1699, DOI 10.1212/WNL.50.6.1699; Tatu L, 1996, NEUROLOGY, V47, P1125, DOI 10.1212/WNL.47.5.1125; Warach S, 2004, STROKE, V35, P2659, DOI 10.1161/01.STR.0000144051.32131.09; Wu JL, 2011, J MAGN RESON IMAGING, V34, P791, DOI 10.1002/jmri.22687	22	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157738	10.1371/journal.pone.0157738	http://dx.doi.org/10.1371/journal.pone.0157738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27326459	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212400036
J	Mashima, I; Theodorea, CF; Thaweboon, B; Thaweboon, S; Nakazawa, F				Mashima, Izumi; Theodorea, Citra Fragrantia; Thaweboon, Boonyanit; Thaweboon, Sroisiri; Nakazawa, Futoshi			Identification of Veillonella Species in the Tongue Biofilm by Using a Novel One-Step Polymerase Chain Reaction Method	PLOS ONE			English	Article							GENUS VEILLONELLA; SP NOV.; BACTERIAL-FLORA; ORAL MICROFLORA; HEALTHY-ADULTS; ENAMEL; PERIODONTITIS; COLONIZATION; TOBETSUENSIS; MICROBIOME	Six Veillonella species have been frequently isolated from human oral cavities including infectious sites. Recently, it was reported that diet, smoking, and possibly socioeconomic status can influence the bacterial profile in oral cavities. In addition, oral hygiene habits may also influence oral microbiota in terms of both numbers and diversity of microorganisms. In this study, the identification of Veillonella species in tongue biofilms of Thai children, divided into three groups dependent on their status of oral hygiene. For this, we used a novel one-step PCR method with species-specific primer sets based on sequences of the rpoB gene. As shown in the results, the number of isolates of Veillonella species was 101 strains from only 10 of 89 subjects. However, the total number of bacteria was high for all subjects. Since it was reported in previous studies that Veillonella species were easy to isolate in human tongue biofilms at high numbers, the results obtained in this study may suggest country-or age-specific differences. Moreover, Veillonella species were detected predominantly in subjects who had poor oral hygiene compared to those with good or moderate oral hygiene. From these results, there is a possibility that Veillonella species may be an index of oral hygiene status. Furthermore, V. rogosae was a predominant species in tongue biofilms of Thai children, whereas V. parvula and V. denticariosi were not isolated at all. These characteristics of the distribution and frequency of Veillonella species are similar to those reported in previous studies. Although further studies are needed in other countries, in this study, a successful novel one-step PCR method was established to detect Veillonella species in human oral cavities easily and effectively. Furthermore, this is the first report investigating the distribution and frequency of Veillonella species in tongue biofilms of Thai children.	[Mashima, Izumi] Japan Soc Promot Sci, Chiyoda Ku, 5-3-1 Kouji Machi, Tokyo 1020083, Japan; [Mashima, Izumi; Theodorea, Citra Fragrantia; Nakazawa, Futoshi] Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Microbiol, 1757 Kanazawa, Ishikari, Hokkaido 0610293, Japan; [Theodorea, Citra Fragrantia] Univ Indonesia, Dept Oral Biol, Fac Dent, Jalan Salemba Raya 4, Jakarta 10430, Indonesia; [Thaweboon, Boonyanit; Thaweboon, Sroisiri] Mahidol Univ, Dept Oral Microbiol, Fac Dent, 6 Yothi St, Bangkok 10400, Thailand	Japan Society for the Promotion of Science; Health Sciences University of Hokkaido; University of Indonesia; Mahidol University	Nakazawa, F (corresponding author), Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Microbiol, 1757 Kanazawa, Ishikari, Hokkaido 0610293, Japan.	nakazawa@hoku-iryo-u.ac.jp	Theodorea, Citra Fragrantia/AAD-4106-2021	Theodorea, Citra Fragrantia/0000-0002-9310-9659; Mashima, Izumi/0000-0001-6436-1268	Japan Society for the Promotion of Sciences (JSPS) [15J30007]; Scientific Research from KAKENHI [26462793]; Research Project of the Research Institute of Personalized Health Sciences [2014-200-3]; Health Sciences University of Hokkaido; Faculty of Dentistry Grant [0517.031/00437]; Mahidol University; Grants-in-Aid for Scientific Research [26462793] Funding Source: KAKEN	Japan Society for the Promotion of Sciences (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Scientific Research from KAKENHI; Research Project of the Research Institute of Personalized Health Sciences; Health Sciences University of Hokkaido; Faculty of Dentistry Grant; Mahidol University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants-in-aid from the Japan Society for the Promotion of Sciences (JSPS) (https://www.jsps.go.jp/) Fellows (grant No. 15J30007), Scientific Research from KAKENHI (grant No. 26462793), 2014-2015 Research Project of the Research Institute of Personalized Health Sciences (No. 2014-200-3), Health Sciences University of Hokkaido (http://www.hoku-iryo-u.ac.jp/~kotaisa/index.html), and Faculty of Dentistry Grant (2015) (Grant No. 0517.031/00437), Mahidol University (http://www.dt.mahidol.ac.th). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Arif N, 2008, INT J SYST EVOL MICR, V58, P581, DOI 10.1099/ijs.0.65093-0; BAUMGARTNER JC, 1991, J ENDODONT, V17, P380; Beighton D, 2008, ORAL MICROBIOL IMMUN, V23, P344, DOI 10.1111/j.1399-302X.2007.00424.x; Belstrom D, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23609; Brook I, 2011, J DENT RES, V90, P704, DOI 10.1177/0022034510391794; Byun R, 2007, INT J SYST EVOL MICR, V57, P2844, DOI 10.1099/ijs.0.65096-0; DELWICHE EA, 1985, ANNU REV MICROBIOL, V39, P175, DOI 10.1146/annurev.mi.39.100185.001135; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; GREENE JC, 1964, J AM DENT ASSOC, V68, P7, DOI 10.14219/jada.archive.1964.0034; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Haffajee AD, 2006, PERIODONTOL 2000, V42, P219, DOI 10.1111/j.1600-0757.2006.00191.x; Haraszthy VI, 2007, J AM DENT ASSOC, V138, P1113, DOI 10.14219/jada.archive.2007.0325; Heller D, 2012, ARCH ORAL BIOL, V57, P973, DOI 10.1016/j.archoralbio.2012.02.003; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Igarashi E, 2009, ORAL MICROBIOL IMMUN, V24, P310, DOI 10.1111/j.1399-302X.2009.00513.x; JUMAS BE, 2004, INT J SYST EVOL MICR, V54, P1311; Kanasi E, 2010, CARIES RES, V44, P485, DOI 10.1159/000320158; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Khemaleelakul S, 2002, ORAL SURG ORAL MED O, V94, P746, DOI 10.1067/moe.2002.129535; Kolenbrander PE, 1992, PROKARYOTES; Mancl KA, 2013, WOUND REPAIR REGEN, V21, P352, DOI 10.1111/wrr.12034; Marchandin H, 2003, MICROBIOL-SGM, V149, P1493, DOI 10.1099/mic.0.26132-0; Mashima I., 2015, International Journal of Current Microbiology and Applied Sciences, V4, P150; Mashima I, 2013, ANAEROBE, V22, P77, DOI 10.1016/j.anaerobe.2013.04.015; Mashima I, 2013, INT J SYST EVOL MICR, V63, P1443, DOI 10.1099/ijs.0.042515-0; Mashima I, 2011, CURR MICROBIOL, V63, P403, DOI 10.1007/s00284-011-9993-2; Matera G, 2009, CLIN VACCINE IMMUNOL, V16, P1804, DOI 10.1128/CVI.00310-09; MAYS TD, 1982, INT J SYST BACTERIOL, V32, P28, DOI 10.1099/00207713-32-1-28; NYVAD B, 1987, SCAND J DENT RES, V95, P369; Periasamy S, 2010, J BACTERIOL, V192, P2965, DOI 10.1128/JB.01631-09; Peters LB, 2001, J ENDODONT, V27, P76, DOI 10.1097/00004770-200102000-00002; Ready D, 2006, ANTIMICROB AGENTS CH, V50, P2866, DOI 10.1128/AAC.00217-06; Ready D, 2012, INT J ANTIMICROB AG, V40, P188, DOI 10.1016/j.ijantimicag.2012.04.007; ROGOSA M, 1958, J BACTERIOL, V76, P455, DOI 10.1128/JB.76.4.455-456.1958; ROGOSA M, 1965, J BACTERIOL, V90, P704, DOI 10.1128/JB.90.3.704-709.1965; Rogosa M, 1984, BERGEYS MANUAL SYSTE, V1, P680; Sato T, 1997, ORAL MICROBIOL IMMUN, V12, P350, DOI 10.1111/j.1399-302X.1997.tb00737.x; Silva-Boghossian CM, 2013, J PERIODONTOL, V84, pE9, DOI 10.1902/jop.2013.120639; SUNDQVIST G, 1992, ORAL MICROBIOL IMMUN, V7, P257, DOI 10.1111/j.1399-302X.1992.tb00584.x; SUTTER VL, 1984, REV INFECT DIS, V6, pS62; Tanwir F, 2009, ACTA ODONTOL SCAND, V67, P129, DOI 10.1080/00016350802208406; Tomczyk J, 2012, HOMO, V63, P311, DOI 10.1016/j.jchb.2012.06.002; WILLIAMS BL, 1979, J CLIN PERIODONTOL, V6, P210, DOI 10.1111/j.1600-051X.1979.tb01923.x; Wittgow W C Jr, 1975, J Endod, V1, P168, DOI 10.1016/S0099-2399(75)80115-4; WU DY, 1991, DNA CELL BIOL, V10, P233, DOI 10.1089/dna.1991.10.233	47	29	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157516	10.1371/journal.pone.0157516	http://dx.doi.org/10.1371/journal.pone.0157516			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27326455	gold, Green Submitted, Green Published			2022-12-26	WOS:000378212400024
J	Merz, B; Nothlings, U; Wahl, S; Haftenberger, M; Schienkiewitz, A; Adamski, J; Suhre, K; Wang-Sattler, R; Grallert, H; Thorand, B; Pischon, T; Bachlechner, U; Floegel, A; Peters, A; Boeing, H				Merz, Benedikt; Noethlings, Ute; Wahl, Simone; Haftenberger, Marjolein; Schienkiewitz, Anja; Adamski, Jerzy; Suhre, Karsten; Wang-Sattler, Rui; Grallert, Harald; Thorand, Barbara; Pischon, Tobias; Bachlechner, Ursula; Floegel, Anna; Peters, Annette; Boeing, Heiner			Specific Metabolic Markers Are Associated with Future Waist-Gaining Phenotype in Women	PLOS ONE			English	Article							GERMAN HEALTH INTERVIEW; RISK-FACTORS; CARDIOVASCULAR-DISEASE; HIP CIRCUMFERENCES; SEXUAL-DIMORPHISM; FAT DISTRIBUTION; EPIC-GERMANY; WEIGHT-GAIN; OBESITY; ADULTS	Objective Our study aims to identify metabolic markers associated with either a gain in abdominal (measured by waist circumference) or peripheral (measured by hip circumference) body fat mass. Methods Data of 4 126 weight-gaining adults (18-75 years) from three population-based, prospective German cohort studies (EPIC, KORA, DEGS) were analysed regarding a waist-gaining (WG) or hip-gaining phenotype (HG). The phenotypes were obtained by calculating the differences of annual changes in waist minus hip circumference. The difference was displayed for all cohorts. The highest 10% of this difference were defined as WG whereas the lowest 10% were defined as HG. A total of 121 concordant metabolite measurements were conducted using Biocrates AbsoluteIDQ1 kits in EPIC and KORA. Sex-specific associations with metabolite concentration as independent and phenotype as the dependent variable adjusted for confounders were calculated. The Benjamini-Hochberg method was used to correct for multiple testing. Results Across studies both sexes gained on average more waist than hip circumference. We could identify 12 metabolites as being associated with the WG (n = 8) or HG (n = 4) in men, but none were significant after correction for multiple testing; 45 metabolites were associated with the WG (n = 41) or HG (n = 4) in women. For WG, n = 21 metabolites remained significant after correction for multiple testing. Respective odds ratios (OR) ranged from 0.66 to 0.73 for tryptophan, the diacyl-phosphatidylcholines (PC) C32:3, C36: 0, C38:0, C38:1, C42:2, C42:5, the acyl-alkyl-PCs C32:2, C34:0, C36:0, C36:1, C36:2, C38:0, C38:2, C40:1, C40:2, C40:5, C40:6, 42:2, C42:3 and lyso-PC C17:0. Conclusion Both weight-gaining men and women showed a clear tendency to gain more abdominal than peripheral fat. Gain of abdominal fat seems to be related to an initial metabolic state reflected by low concentrations of specific metabolites, at least in women. Thus, higher levels of specific PCs may play a protective role in gaining waist circumference.	[Merz, Benedikt; Noethlings, Ute] Univ Bonn, Dept Nutr & Food Sci, Bonn, Germany; [Wahl, Simone; Wang-Sattler, Rui; Grallert, Harald] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Wahl, Simone; Grallert, Harald; Thorand, Barbara; Peters, Annette] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Wahl, Simone; Grallert, Harald; Thorand, Barbara] German Ctr Diabet Res DZD, Neuherberg, Germany; [Haftenberger, Marjolein; Schienkiewitz, Anja] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany; [Adamski, Jerzy] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Genome Anal Ctr, Inst Expt Genet, Neuherberg, Germany; [Suhre, Karsten] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Suhre, Karsten] Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar; [Pischon, Tobias] Max Delbruck Ctr Mol Med MDC, Mol Epidemiol Res Grp, Berlin, Germany; [Merz, Benedikt; Bachlechner, Ursula; Floegel, Anna; Boeing, Heiner] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany	University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Robert Koch Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Merz, B (corresponding author), Univ Bonn, Dept Nutr & Food Sci, Bonn, Germany.; Merz, B (corresponding author), German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany.	benemerz@uni-bonn.de	Pischon, Tobias/HGE-8577-2022; Peters, Annette/A-6117-2011; Nöthlings, Ute/B-2713-2010; Wang-Sattler, Rui/B-5354-2014; Thorand, Barbara/B-5349-2014; Grallert, Harald/B-3424-2013; Suhre, Karsten/AAF-1778-2020; Schienkiewitz, Anja/A-8463-2019	Pischon, Tobias/0000-0003-1568-767X; Peters, Annette/0000-0001-6645-0985; Wang-Sattler, Rui/0000-0002-8794-8229; Thorand, Barbara/0000-0002-8416-6440; Suhre, Karsten/0000-0001-9638-3912; Schienkiewitz, Anja/0000-0003-3821-9772; Floegel, Anna/0000-0001-9806-4288; Merz, Benedikt/0000-0002-6856-3390; Adamski, Jerzy/0000-0001-9259-0199	"Kompetenznetz Adipositas (Competence Network Obesity)" - Federal Ministry of Education and Research [FKZ: 01GI1121B]; "Biomedical Research Program" funds at Weill Cornell Medical College in Qatar - Qatar Foundation; Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; KORA research within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ	"Kompetenznetz Adipositas (Competence Network Obesity)" - Federal Ministry of Education and Research; "Biomedical Research Program" funds at Weill Cornell Medical College in Qatar - Qatar Foundation; Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; KORA research within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ	BM, MH and UB were supported by the "Kompetenznetz Adipositas (Competence Network Obesity)" funded by the Federal Ministry of Education and Research (FKZ: 01GI1121B) (http://www.gesundheitsforschung-bmbf.de/de/2042.php). KS is supported by "Biomedical Research Program" funds at Weill Cornell Medical College in Qatar, a program funded by the Qatar Foundation. The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ.	Barber MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041456; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergmann K E, 1999, Gesundheitswesen, V61 Spec No, pS115; Bergmann MM, 1999, ANN NUTR METAB, V43, P225, DOI 10.1159/000012789; Blouin K, 2008, J STEROID BIOCHEM, V108, P272, DOI 10.1016/j.jsbmb.2007.09.001; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; Borruel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114112; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Cheung BMY, 2012, CURR ATHEROSCLER REP, V14, P160, DOI 10.1007/s11883-012-0227-2; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Esmaillzadeh A, 2006, INT J CARDIOL, V108, P338, DOI 10.1016/j.ijcard.2005.05.019; Fischer LM, 2010, AM J CLIN NUTR, V92, P1113, DOI 10.3945/ajcn.2010.30064; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Floegel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021103; Ford ES, 2008, DIABETES CARE, V31, P1138, DOI [10.2337/dc07-2159, 10.2337/dc08-1138]; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; German JB, 2005, METABOLOMICS, V1, P3, DOI 10.1007/s11306-005-1102-8; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Haftenberger M, J CLIN NUTR; HANKINSON SE, 1994, CANCER EPIDEM BIOMAR, V3, P51; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Herder C, 2011, CLIN PHARMACOL THER, V90, P52, DOI 10.1038/clpt.2011.93; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jourdan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040009; Kamtsiuris P, 2013, BUNDESGESUNDHEITSBLA, V56, P620, DOI 10.1007/s00103-012-1650-9; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; Lanfer A, 2014, OBESITY, V22, P957, DOI 10.1002/oby.20604; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lissner L, 2001, OBES RES, V9, P644, DOI 10.1038/oby.2001.85; Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x; Mensink GBM, 2013, BUNDESGESUNDHEITSBLA, V56, P786, DOI 10.1007/s00103-012-1656-3; Neamat-Allah J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091586; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Quehenberger O, 2011, NEW ENGL J MED, V365, P1812, DOI 10.1056/NEJMra1104901; Romisch-Margl W, 2012, METABOLOMICS, V8, P133, DOI 10.1007/s11306-011-0293-4; Scheidt-Nave C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-730; Schwarzer G., 2015, GEN PACKAGE METAANAL; Seidell JC, 2001, AM J CLIN NUTR, V74, P315; Snijder MB, 2004, INT J OBESITY, V28, P402, DOI 10.1038/sj.ijo.0802567; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Spencer EA, 2004, PUBLIC HEALTH NUTR, V7, P723, DOI 10.1079/PHN2004600; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Tanaka T, 2011, PLASMA AMINO ACID PR; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.20; Wannamethee SG, 2005, J EPIDEMIOL COMMUN H, V59, P134, DOI 10.1136/jech.2003.015651; Wedick NM, 2009, OBESITY, V17, P1609, DOI 10.1038/oby.2008.666; Wolfenstetter Silke B, 2012, Psychosoc Med, V9, pDoc09, DOI 10.3205/psm000087; World Health Organization, OB PREV MAN GLOB EP; Wu CL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095300, 10.1371/journal.pone.0102589]; Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x; Zhao XJ, 2010, METABOLOMICS, V6, P362, DOI 10.1007/s11306-010-0203-1	60	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157733	10.1371/journal.pone.0157733	http://dx.doi.org/10.1371/journal.pone.0157733			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322650	Green Published, Green Accepted, gold			2022-12-26	WOS:000378212000043
J	Stock, NK; Petras, P; Melter, O; Kapounova, G; Vopalkova, P; Kubele, J; Vanis, V; Tkadlec, J; Bukackova, E; Machova, I; Jindrak, V				Stock, Nina Katharina; Petras, Petr; Melter, Oto; Kapounova, Gabriela; Vopalkova, Petra; Kubele, Jan; Vanis, Vaclav; Tkadlec, Jan; Bukackova, Eva; Machova, Ivana; Jindrak, Vlastimil			Importance of Multifaceted Approaches in Infection Control: A Practical Experience from an Outbreak Investigation	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; INTENSIVE-CARE-UNIT; TYPING METHODS; HAND HYGIENE; MRSA; PREVENTION; GUIDELINES; WORKLOAD; BURNOUT	Background This study presents the results of a multidisciplinary, nosocomial MRSA outbreak investigation in an 8-bed medical intensive care unit (ICU). The identification of seven MRSA positive patients in the beginning of 2014 led to the closure of the ward for several weeks. A multidisciplinary, retrospective investigation was initiated in order to identify the reason and the source for the outbreak, describe MRSA transmission in the department and identify limitations in infection control. Methods The investigation comprised an epidemiological description of MRSA cases from 2012 to 2014 and a characterization of MRSA isolates, including phage-, spa-and PFGE-typing. Additionally, MRSA screening was performed from the hospital staff and the environment. To identify the reason for the outbreak, work-related, psychological and behavioral factors were investigated by impartial audits and staff interviews. Results Thirty-one MRSA cases were registered during the study period, and 36 isolates were investigated. Molecular typing determined the outbreak strain (phage type 54/812, PFGE type A4, spa type t003) and identified the probable index case. Nasal carriage in one employee and a high environmental contamination with the outbreak strain was documented. Important gaps in nursing procedures and general management were identified. Elevated stress levels and communication problems preceded the outbreak. Compliance with hand hygiene and isolation procedures was evaluated as appropriate. Conclusion This study demonstrates the complexity of controlling hospital-associated infections. The combined use of different typing methods is beneficial for outbreak investigations. Psychological, behavioral and other work-related factors have an important impact on the spread of nosocomial pathogens. These factors should be addressed and integrated in routine infection control practice.	[Stock, Nina Katharina; Petras, Petr; Vanis, Vaclav; Machova, Ivana; Jindrak, Vlastimil] Natl Inst Publ Hlth NIPH, Prague, Czech Republic; [Stock, Nina Katharina] ECDC, European Program Publ Hlth Microbiol EUPHEM, Stockholm, Sweden; [Melter, Oto; Tkadlec, Jan; Bukackova, Eva] Fac Med 2, Dept Med Microbiol, Prague, Czech Republic; [Melter, Oto; Tkadlec, Jan; Bukackova, Eva] Univ Hosp Motol, Prague, Czech Republic; [Kapounova, Gabriela; Vopalkova, Petra; Kubele, Jan; Vanis, Vaclav] Na Homolce Hosp, Dept Clin Microbiol, Prague, Czech Republic; [Kapounova, Gabriela; Vopalkova, Petra; Kubele, Jan; Vanis, Vaclav] Na Homolce Hosp, Antibiot Ctr, Prague, Czech Republic; [Stock, Nina Katharina] Univ Wurzburg, Inst Hyg & Microbiol, D-97070 Wurzburg, Germany	National Institute of Public Health (SZU) - Czech Republic; European Centre for Disease Prevention & Control; Charles University Prague; Motol University Hospital; Na Homolce Hospital; Na Homolce Hospital; University of Wurzburg	Stock, NK; Jindrak, V (corresponding author), Natl Inst Publ Hlth NIPH, Prague, Czech Republic.; Stock, NK (corresponding author), ECDC, European Program Publ Hlth Microbiol EUPHEM, Stockholm, Sweden.; Stock, NK (corresponding author), Univ Wurzburg, Inst Hyg & Microbiol, D-97070 Wurzburg, Germany.	nkstock2015@gmail.com; vlastimil.jindrak@gmail.com	Tkadlec, Jan/ABD-9485-2020	Tkadlec, Jan/0000-0002-0892-924X	Internal Grant Agency (IGA) of the Ministry of Health of the Czech Republic [NT12395-5/2011]; Internal Grant of the Ministry of Health of the Czech Republic - RVO; University Hospital Motol, Prague [00064203]	Internal Grant Agency (IGA) of the Ministry of Health of the Czech Republic; Internal Grant of the Ministry of Health of the Czech Republic - RVO; University Hospital Motol, Prague	This study was supported by grant No. NT12395-5/2011 from the Internal Grant Agency (IGA) of the Ministry of Health of the Czech Republic and by the Internal Grant of the Ministry of Health of the Czech Republic - RVO, University Hospital Motol, Prague (No. 00064203), awarded to Oto Melter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammon AGP, 2001, EMPFEHLUNGEN UNTERSU; [Anonymous], WHO EV HAND HYG RED; Azoulay E, 2009, AM J RESP CRIT CARE, V180, P853, DOI 10.1164/rccm.200810-1614OC; BLAIR JE, 1961, B WORLD HEALTH ORGAN, V24, P771; Cardenas PA, 2013, INT MICROBIOL, V16, P81, DOI 10.2436/20.1501.01.182; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; Coia JE, 2006, J HOSP INFECT, V63, pS1, DOI 10.1016/j.jhin.2006.01.001; de Lassence A, 2006, CLIN INFECT DIS, V42, P170, DOI 10.1086/498898; Devriese LA, 2005, INT J SYST EVOL MICR, V55, P1569, DOI 10.1099/ijs.0.63413-0; Dulon M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-138; ( ECDC) ECfDPaC, 2014, ANTIMICROBIAL RESIST; Embriaco N, 2007, CURR OPIN CRIT CARE, V13, P482, DOI 10.1097/MCC.0b013e3282efd28a; Gastmeier P, 2008, CURR OPIN INFECT DIS, V21, P357, DOI 10.1097/QCO.0b013e3283013933; GEHA DJ, 1994, J CLIN MICROBIOL, V32, P1768, DOI 10.1128/JCM.32.7.1768-1772.1994; Gurses AP, 2009, HEALTH SERV RES, V44, P422, DOI 10.1111/j.1475-6773.2008.00934.x; Haill C, 2013, J HOSP INFECT, V83, P219, DOI 10.1016/j.jhin.2012.11.019; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; HEBERT GA, 1985, J CLIN MICROBIOL, V22, P409; Jernigan JA, 1996, AM J EPIDEMIOL, V143, P496, DOI 10.1093/oxfordjournals.aje.a008770; Kampf G, 2009, DTSCH ARZTEBL INT, V106, P649, DOI 10.3238/arztebl.2009.0649; Khan Anjum, 2009, Can J Infect Control, V24, P12; Kiekkas P, 2008, J NURS SCHOLARSHIP, V40, P385, DOI 10.1111/j.1547-5069.2008.00254.x; Kock R, 2014, EUROSURVEILLANCE, V24, P19; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lindsay JA, 2014, INFECT GENET EVOL, V21, P548, DOI 10.1016/j.meegid.2013.04.017; LINGNAU W, 1994, INFECTION, V22, pS135, DOI 10.1007/BF01793578; Malachowa N, 2010, CELL MOL LIFE SCI, V67, P3057, DOI 10.1007/s00018-010-0389-4; Marimuthu K, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-34; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Parer S, 2012, INFECT CONT HOSP EP, V33, P167, DOI 10.1086/663703; Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17; Garcia MS, 2010, JAMA-J AM MED ASSOC, V303, P2260, DOI 10.1001/jama.2010.757; Shanafelt TD, 2010, ANN SURG, V251, P995, DOI 10.1097/SLA.0b013e3181bfdab3; Sharma Parul, 2014, Indian J Occup Environ Med, V18, P52, DOI 10.4103/0019-5278.146890; Stefani S, 2012, INT J ANTIMICROB AG, V39, P273, DOI 10.1016/j.ijantimicag.2011.09.030; Valentin A, 2011, INTENS CARE MED, V37, P1575, DOI 10.1007/s00134-011-2300-7; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Vonberg RP, 2006, INFECT CONT HOSP EP, V27, P1123, DOI 10.1086/507922; WHO, 2009, GUIDELINES ON HAND H; Zingg W, 2015, LANCET INFECT DIS, V15, P212, DOI 10.1016/S1473-3099(14)70854-0	40	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157981	10.1371/journal.pone.0157981	http://dx.doi.org/10.1371/journal.pone.0157981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322433	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212000059
J	Vallega, KA; Liu, NN; Myers, JS; Yu, KX; Sang, QXA				Vallega, Karin A.; Liu, NingNing; Myers, Jennifer S.; Yu, Kaixian; Sang, Qing-Xiang Amy			Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; OBESITY; BIOMARKER; MORTALITY	Introduction African American (AA) women diagnosed with breast cancer are more likely to have aggressive subtypes. Investigating differentially expressed genes between patient populations may help explain racial health disparities. Resistin, one such gene, is linked to inflammation, obesity, and breast cancer risk. Previous studies indicated that resistin expression is higher in serum and tissue of AA breast cancer patients compared to Caucasian American (CA) patients. However, resistin expression levels have not been compared between AA and CA patients in a stage- and subtype-specific context. Breast cancer prognosis and treatments vary by subtype. This work investigates differential resistin gene expression in human breast cancer tissues of specific stages, receptor subtypes, and menopause statuses in AA and CA women. Methods Differential gene expression analysis was performed using human breast cancer gene expression data from The Cancer Genome Atlas. We performed inter-race resistin gene expression level comparisons looking at receptor status and stage-specific data between AA and CA samples. DESeq was run to test for differentially expressed resistin values. Results Resistin RNA was higher in AA women overall, with highest values in receptor negative subtypes. Estrogen-, progesterone-, and human epidermal growth factor receptor 2-negative groups showed statistically significant elevated resistin levels in Stage I and II AA women compared to CA women. In inter-racial comparisons, AA women had significantly higher levels of resistin regardless of menopause status. In whole population comparisons, resistin expression was higher among Stage I and III estrogen receptor negative cases. In comparisons of molecular subtypes, resistin levels were significant higher in triple negative than in luminal A breast cancer. Conclusion Resistin gene expression levels were significantly higher in receptor negative subtypes, especially estrogen receptor negative cases in AA women. Resistin may serve as an early breast cancer biomarker and possible therapeutic target for AA breast cancer.	[Vallega, Karin A.; Liu, NingNing; Myers, Jennifer S.; Sang, Qing-Xiang Amy] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Yu, Kaixian] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA; [Sang, Qing-Xiang Amy] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Sang, QXA (corresponding author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.; Sang, QXA (corresponding author), Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.	qxsang@chem.fsu.edu			Florida State University	Florida State University	This work was in part supported by grants from the Florida State University and an Endowed Chair Professorship in Cancer Research from anonymous donors to QXAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Alokail MS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-54; Amend K, 2006, CANCER RES, V66, P8327, DOI 10.1158/0008-5472.CAN-06-1927; American Cancer Society, 2015, BREAST CANC FACTS FI; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Dal Maso L, 2008, INT J CANCER, V123, P2188, DOI 10.1002/ijc.23747; Dalamaga M, 2014, BIOMARK MED, V8, P107, DOI 10.2217/bmm.13.99; Dalamaga M, 2013, MENOPAUSE, V20, P845, DOI [10.1097/GME.0b013e31827f06dc, 10.1097/gme.0b013e31827f06dc]; Dalamaga M, 2013, CLIN BIOCHEM, V46, P584, DOI 10.1016/j.clinbiochem.2013.01.001; Danforth DN, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3429; Deshmukh SK, 2015, RESISTIN INTERLEUKIN; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Gapstur SM, 1996, HORMONE RECEPTOR STA; Gaudet MM, 2010, CANCER EPIDEMIOL, V34, P580, DOI 10.1016/j.canep.2010.05.014; Kang JH, 2007, J KOREAN MED SCI, V22, P117, DOI 10.3346/jkms.2007.22.1.117; Lee YC, 2012, GYNECOL ONCOL, V125, P742, DOI 10.1016/j.ygyno.2012.02.032; Lewis A., 2006, J TRANSL MED, V12, P1; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Mehrotra J, 2004, CLIN CANCER RES, V10, P2052, DOI 10.1158/1078-0432.CCR-03-0514; Montazeri A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-278; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Stead LA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2242; Stewart PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082460; Sun CA, 2010, BREAST CANCER RES TR, V123, P869, DOI 10.1007/s10549-010-0792-4	26	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157741	10.1371/journal.pone.0157741	http://dx.doi.org/10.1371/journal.pone.0157741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314854	Green Submitted, gold, Green Published			2022-12-26	WOS:000378030000048
J	Komninou, ER; Remiao, MH; Lucas, CG; Domingues, WB; Basso, AC; Jornada, DS; Deschamps, JC; Beck, RCR; Pohlmann, AR; Bordignon, V; Seixas, FK; Campos, VF; Guterres, SS; Collares, T				Komninou, Eliza Rossi; Remiao, Mariana Harter; Lucas, Caroline Gomes; Domingues, William Borges; Basso, Andrea Cristina; Jornada, Denise Soledade; Deschamps, Joao Carlos; Ruver Beck, Ruy Carlos; Pohlmann, Adriana Raffin; Bordignon, Vilceu; Seixas, Fabiana Kommling; Campos, Vinicius Farias; Guterres, Silvia Staniscuaski; Collares, Tiago			Effects of Two Types of Melatonin-Loaded Nanocapsules with Distinct Supramolecular Structures: Polymeric (NC) and Lipid-Core Nanocapsules (LNC) on Bovine Embryo Culture Model	PLOS ONE			English	Article							IN-VITRO DEVELOPMENT; OXIDATIVE STRESS; GENE-EXPRESSION; NANOPARTICLES; PREIMPLANTATION; IMPLANTATION; MATURATION; DELIVERY; OOCYTE; MOUSE	Melatonin has been used as a supplement in culture medium to improve the efficiency of in vitro produced mammalian embryos. Through its ability to scavenge toxic oxygen derivatives and regulate cellular mRNA levels for antioxidant enzymes, this molecule has been shown to play a protective role against damage by free radicals, to which in vitro cultured embryos are exposed during early development. In vivo and in vitro studies have been performed showing that the use of nanocapsules as active substances carriers increases stability, bioavailability and biodistribution of drugs, such as melatonin, to the cells and tissues, improving their antioxidant properties. These properties can be modulated through the manipulation of formula composition, especially in relation to the supramolecular structures of the nanocapsule core and the surface area that greatly influences drug release mechanisms in biological environments. This study aimed to evaluate the effects of two types of melatonin-loaded nanocapsules with distinct supramolecular structures, polymeric (NC) and lipid-core (LNC) nanocapsules, on in vitro cultured bovine embryos. Embryonic development, apoptosis, reactive oxygen species (ROS) production, and mRNA levels of genes involved in cell apoptosis, ROS and cell pluripotency were evaluated after supplementation of culture medium with non-encapsulated melatonin (Mel), melatonin-loaded polymeric nanocapsules (Mel-NC) and melatonin-loaded lipid-core nanocapsules (Mel-LNC) at 10(-6), 10(-9), and 10(-12) M drug concentrations. The highest hatching rate was observed in embryostreated with 10(-9) M Mel-LNC. When compared to Mel and Mel-NC treatments at the same concentration (10(-9) M), Mel-LNC increased embryo cell number, decreased cell apoptosis and ROS levels, down-regulated mRNA levels of BAX, CASP3, and SHC1 genes, and upregulated mRNA levels of CAT and SOD2 genes. These findings indicate that nanoencapsulation with LNC increases the protective effects of melatonin against oxidative stress and cell apoptosis during in vitro embryo culture in bovine species.	[Komninou, Eliza Rossi; Remiao, Mariana Harter; Lucas, Caroline Gomes; Domingues, William Borges; Deschamps, Joao Carlos; Seixas, Fabiana Kommling; Campos, Vinicius Farias; Collares, Tiago] Univ Fed Pelotas, Biotecnol Ctr Dev Tecnol, Grp Pesquisa Oncol Celular & Mol, PPGB, BR-96010900 Pelotas, RS, Brazil; [Basso, Andrea Cristina] In Vitro Brasil SA, BR-13800970 Mogi Mirim, SP, Brazil; [Jornada, Denise Soledade; Ruver Beck, Ruy Carlos; Guterres, Silvia Staniscuaski] Univ Fed Rio Grande do Sul, Fac Farm, Av Ipiranga 2752, BR-90610000 Porto Alegre, RS, Brazil; [Pohlmann, Adriana Raffin] Univ Fed Rio Grande do Sul, Inst Quim, Dept Quim Organ, BR-91501970 Porto Alegre, RS, Brazil; [Bordignon, Vilceu] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada	Universidade Federal de Pelotas; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; McGill University	Collares, T (corresponding author), Univ Fed Pelotas, Biotecnol Ctr Dev Tecnol, Grp Pesquisa Oncol Celular & Mol, PPGB, BR-96010900 Pelotas, RS, Brazil.; Guterres, SS (corresponding author), Univ Fed Rio Grande do Sul, Fac Farm, Av Ipiranga 2752, BR-90610000 Porto Alegre, RS, Brazil.	silvia.guterres@ufrgs.br; tiago.collares@pq.cnpq.br	Guterres, Silvia S/B-6420-2015; Collares, Tiago/K-2779-2019; Beck, Ruy C. R./D-7735-2011; Seixas, Fabiana Kommling/X-2706-2018; Pohlmann, Adriana Raffin/B-9910-2008; Domingues, William Borges/AAM-5818-2021; Cristina Basso, Andrea/AHC-5589-2022; Campos, Vinicius Farias/G-3546-2012; Komninou, Eliza Rossi/J-7031-2014; Collares, Tiago/S-2117-2016	Guterres, Silvia S/0000-0002-6085-6826; Collares, Tiago/0000-0002-1535-3795; Beck, Ruy C. R./0000-0001-6262-1097; Seixas, Fabiana Kommling/0000-0003-4204-2500; Pohlmann, Adriana Raffin/0000-0001-5222-1807; Domingues, William Borges/0000-0002-4351-2271; Campos, Vinicius Farias/0000-0003-2119-293X; Komninou, Eliza Rossi/0000-0001-6591-408X; Collares, Tiago/0000-0002-1535-3795; Bordignon, Vilceu/0000-0001-7076-7707; , Andrea Cristina Basso/0000-0002-8679-5232; Gomes Lucas, Caroline/0000-0003-3029-7987				Amarnath D, 2007, J REPROD DEVELOP, V53, P1247, DOI 10.1262/jrd.19096; Arias-Alvarez M, 2013, THERIOGENOLOGY, V79, P323, DOI 10.1016/j.theriogenology.2012.09.019; Asgari Z, 2012, CELL J, V14, P203; Barkalina N, 2015, HUM REPROD UPDATE, V21, P627, DOI 10.1093/humupd/dmv027; Barkalina N, 2014, NANOMED-NANOTECHNOL, V10, P921, DOI 10.1016/j.nano.2014.01.001; Barkalina N, 2014, NANOMED-NANOTECHNOL, V10, P859, DOI 10.1016/j.nano.2013.10.011; Campos VF, 2011, THERIOGENOLOGY, V75, P1476, DOI 10.1016/j.theriogenology.2011.01.009; Campos VF, 2011, THERIOGENOLOGY, V76, P1552, DOI 10.1016/j.theriogenology.2011.06.027; Cebrian-Serrano A, 2013, REPROD DOMEST ANIM, V48, P738, DOI 10.1111/rda.12154; Chattoraj A, 2008, COMP BIOCHEM PHYS A, V150, P301, DOI 10.1016/j.cbpa.2008.03.014; Choi J, 2008, MOL REPROD DEV, V75, P1127, DOI 10.1002/mrd.20861; Cruz MHC, 2014, ANIM REPROD SCI, V145, P150, DOI 10.1016/j.anireprosci.2014.01.011; Duarte AA, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13098-7; El-Gibaly I, 2003, INT J PHARM, V260, P5, DOI 10.1016/S0378-5173(03)00149-2; El-Raey M, 2011, MOL REPROD DEV, V78, P250, DOI 10.1002/mrd.21295; Feng RL, 2012, INT J NANOMED, V7, P4089, DOI 10.2147/IJN.S33607; Fiel LA, 2011, SOFT MATTER, V7, P7240, DOI 10.1039/c1sm05508a; Fiorentino I, 2015, EXP CELL RES, V330, P240, DOI 10.1016/j.yexcr.2014.09.017; Fischer TW, 2013, J PINEAL RES, V54, P303, DOI 10.1111/jpi.12018; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Gao C, 2012, J PINEAL RES, V52, P305, DOI 10.1111/j.1600-079X.2011.00944.x; Gou ML, 2011, CURR DRUG TARGETS, V12, P1131, DOI 10.2174/138945011795906642; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Hoffmeister CRD, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-251; Ishizuka B, 2000, J PINEAL RES, V28, P48, DOI 10.1034/j.1600-079x.2000.280107.x; Jager E, 2009, J BIOMED NANOTECHNOL, V5, P130, DOI 10.1166/jbn.2009.1004; Jornada DS, 2012, SOFT MATTER, V8, P6646, DOI 10.1039/c2sm25754h; Kang JT, 2009, J PINEAL RES, V46, P22, DOI 10.1111/j.1600-079X.2008.00602.x; Karja NWK, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-54; Kumar A, 2015, THERIOGENOLOGY, V83, P1402, DOI 10.1016/j.theriogenology.2014.12.023; Lane M, 2005, REPROD FERT DEVELOP, V17, P371, DOI 10.1071/RD04102; Lord T, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106450; Lucas CG, 2015, REPROD TOXICOL, V58, P131, DOI 10.1016/j.reprotox.2015.10.004; Manjunatha BM, 2009, REPROD DOMEST ANIM, V44, P12, DOI 10.1111/j.1439-0531.2007.00982.x; Mora-Huertas CE, 2010, INT J PHARMACEUT, V385, P113, DOI 10.1016/j.ijpharm.2009.10.018; Oliveira CP, 2013, SOFT MATTER, V9, P1141, DOI 10.1039/c2sm26959g; Ourique AF, 2010, J BIOMED NANOTECHNOL, V6, P214, DOI 10.1166/jbn.2010.1120; Papis K, 2007, J PINEAL RES, V43, P321, DOI 10.1111/j.1600-079X.2007.00479.x; Pardeike J, 2009, INT J PHARMACEUT, V366, P170, DOI 10.1016/j.ijpharm.2008.10.003; Pers-Kamczyc E, 2010, THERIOGENOLOGY, V74, P581, DOI 10.1016/j.theriogenology.2010.03.011; Pohlmann AR, 2010, METHODS MOL BIOL, V610, P109, DOI 10.1007/978-1-60327-029-8_7; Pohlmann AR, 2013, EXPERT OPIN DRUG DEL, V10, P623, DOI 10.1517/17425247.2013.769956; Poletto FS, 2015, J NANOSCI NANOTECHNO, V15, P827, DOI 10.1166/jnn.2015.9182; Proietti S, 2014, EXPERT OPIN DRUG MET, V10, P1193, DOI 10.1517/17425255.2014.943183; Reis CP, 2006, NANOMED-NANOTECHNOL, V2, P8, DOI 10.1016/j.nano.2005.12.003; Rivara S, 2005, J MED CHEM, V48, P4049, DOI 10.1021/jm048956y; Rodriguez-Alvarez L, 2010, ZYGOTE, V18, P269, DOI 10.1017/S0967199409990323; Rodriguez-Osorio N, 2007, J PINEAL RES, V43, P283, DOI 10.1111/j.1600-079X.2007.00475.x; Sakatani M, 2004, MOL REPROD DEV, V67, P77, DOI 10.1002/mrd.20014; Schaffazick SR, 2007, PHARMAZIE, V62, P354, DOI 10.1691/ph.2007.5.6087; Schaffazick SR, 2006, J BRAZIL CHEM SOC, V17, P562, DOI 10.1590/S0103-50532006000300020; Schaffazick SR, 2005, INT J PHARMACEUT, V289, P209, DOI 10.1016/j.ijpharm.2004.11.003; Schultze E, 2014, EUR J PHARM BIOPHARM, V87, P55, DOI 10.1016/j.ejpb.2014.02.003; Shi JM, 2009, J PINEAL RES, V47, P318, DOI 10.1111/j.1600-079X.2009.00717.x; Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4; Takada L, 2012, RES VET SCI, V92, P124, DOI 10.1016/j.rvsc.2010.11.004; Takahashi M, 2012, J REPROD DEVELOP, V58, P1, DOI 10.1262/jrd.11-138N; Tian XZ, 2014, J PINEAL RES, V57, P239, DOI 10.1111/jpi.12163; Venturini CG, 2011, COLLOID SURFACE A, V375, P200, DOI 10.1016/j.colsurfa.2010.12.011; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093641; Wang F, 2013, J PINEAL RES, V55, P267, DOI 10.1111/jpi.12069; Zhang LM, 2013, J PINEAL RES, V54, P24, DOI 10.1111/j.1600-079X.2012.01016.x; Zhao MX, 2011, BIOMATERIALS, V32, P5223, DOI 10.1016/j.biomaterials.2011.03.060; Zhao T, 2014, SCI REP-UK, V4, DOI 10.1038/srep03793	64	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157561	10.1371/journal.pone.0157561	http://dx.doi.org/10.1371/journal.pone.0157561			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310006	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800096
J	Yuan, SZ; Zhang, N; Xu, L; Zhou, L; Ge, XN; Guo, X; Yang, HC				Yuan, Shuaizhen; Zhang, Ning; Xu, Lei; Zhou, Lei; Ge, Xinna; Guo, Xin; Yang, Hanchun			Induction of Apoptosis by the Nonstructural Protein 4 and 10 of Porcine Reproductive and Respiratory Syndrome Virus	PLOS ONE			English	Article							SYNDROME PRRS VIRUS; CELL-DEATH PROGRAM; ARTERIVIRUS REPLICASE; MOLECULAR-BIOLOGY; ECONOMIC-IMPACT; UNITED-STATES; BCL-2 FAMILY; IN-VITRO; ACTIVATION; CLEAVAGE	Infection by most viruses triggers apoptosis in host cells, and viruses manipulate this cell response to promote viral replication, virus spread, and cell killing. Porcine reproductive and respiratory syndrome virus (PRRSV) has been shown to induce apoptosis both in vitro and in vivo, while the regulatory roles of PRRSV-encoded products in apoptosis are not fully understood. In the present study, we first showed a biphasic apoptosis regulation by a highly pathogenic PRRSV strain JXwn06. It was indicated that PRRSV infection delays apoptosis at early infection but activates apoptosis at late infection in MARC-145 cells. In PRRSV-infected MARC-145 cells, procaspase-8, -9 and -12 were activated at late infection, demonstrating the involvements of death receptor pathway, mitochondrial pathway and endoplasmic reticulum (ER) stress pathway in inducing apoptosis. PRRSV was also shown to induce a similar apoptosis process in pulmonary alveolar macrophages (PAMs) with an early initiation. Next, the PRRSV-encoded apoptosis inducers were screened, indicating that the nonstructural protein (Nsp) 4 and Nsp10 of PRRSV are pro-apoptotic. In the presence of Nsp4, it was confirmed that procaspase-8, -9 and -12 were cleaved, and Nsp4 facilitates the cleavage of procaspase-9 by activating B-cell lymphoma 2 interacting mediator of cell death (Bim), a pro-apoptotic protein. In addition, Nsp4 was shown to induce the degradation of an anti-apoptotic protein, B-cell lymphoma-extra large (Bcl-xL). Nsp10 was shown to activate procaspase-8 and -9 but procaspase-12 and to upregulate the expression of BH3-only pro-apoptotic protein BH3 interacting-domain death agonist (Bid) and its active form, truncated Bid (tBid). Clearly, the participation of both activated caspase-8 and Bid is required for Nsp10-induced apoptosis, indicating a crosstalk between extrinsic-and mitochondria-dependent pathways. Together, our findings suggest that PRRSV infection regulates apoptosis in a two-phase manner and activates all three apoptotic pathways; the Nsp4 and Nsp10 of PRRSV function as apoptosis inducers with different molecular basis.	[Yuan, Shuaizhen; Zhang, Ning; Xu, Lei; Zhou, Lei; Ge, Xinna; Guo, Xin; Yang, Hanchun] China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100094, Peoples R China; [Yang, Hanchun] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Yang, HC (corresponding author), China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100094, Peoples R China.; Yang, HC (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	yanghanchun1@cau.edu.cn		Zhou, Lei/0000-0002-8837-3965	National Natural Science Funds from National Natural Science Foundation of China [31330077]; National Key Basic Research Plan Grant from the Chinese Ministry of Science and Technology [2014CB542700]; earmarked fund for Modern Agro-industry Technology Research System of China from the Chinese Ministry of Agriculture [CARS-36]	National Natural Science Funds from National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Plan Grant from the Chinese Ministry of Science and Technology; earmarked fund for Modern Agro-industry Technology Research System of China from the Chinese Ministry of Agriculture	This work was supported by Key project of National Natural Science Funds from National Natural Science Foundation of China (31330077), http://www.nsfc.gov.cn/nsfc/; National Key Basic Research Plan Grant (2014CB542700) from the Chinese Ministry of Science and Technology, http://program.most.gov.cn/; The earmarked fund for Modern Agro-industry Technology Research System of China (CARS-36) from the Chinese Ministry of Agriculture, http://119.253.58.231/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Key project of National Natural Science Funds from National Natural Science Foundation of China (31330077) and National Key Basic Research Plan Grant (2014CB542700) from the Chinese Ministry of Science and Technology, and the earmarked fund for Modern Agro-industry Technology Research System of China (CARS-36) from the Chinese Ministry of Agriculture.	Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chau DHW, 2007, APOPTOSIS, V12, P513, DOI 10.1007/s10495-006-0013-0; Chen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064877; Costers S, 2008, ARCH VIROL, V153, P1453, DOI 10.1007/s00705-008-0135-5; DENBOON JA, 1995, J VIROL, V69, P4500, DOI 10.1128/JVI.69.7.4500-4505.1995; Duan X, 1997, ARCH VIROL, V142, P2483, DOI 10.1007/s007050050256; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Fang Y, 2012, P NATL ACAD SCI USA, V109, pE2920, DOI 10.1073/pnas.1211145109; Fang Y, 2010, VIRUS RES, V154, P61, DOI 10.1016/j.virusres.2010.07.030; Fernandez A, 2002, VIRUS RES, V83, P103, DOI 10.1016/S0168-1702(01)00426-9; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Garner MG, 2001, REV SCI TECH OIE, V20, P671, DOI 10.20506/rst.20.3.1303; Han MY, 2014, VET MICROBIOL, V174, P279, DOI 10.1016/j.vetmic.2014.10.007; Han MY, 2014, VIRUS RES, V194, P100, DOI 10.1016/j.virusres.2014.09.007; Han MY, 2013, VIRUS RES, V172, P54, DOI 10.1016/j.virusres.2012.12.012; Hardwick J M, 1997, Adv Pharmacol, V41, P295, DOI 10.1016/S1054-3589(08)61063-7; He Q, 2015, VIRUS RES, V201, P32, DOI 10.1016/j.virusres.2015.02.014; He YL, 2012, VET MICROBIOL, V160, P455, DOI 10.1016/j.vetmic.2012.05.040; Herold S, 2012, J LEUKOCYTE BIOL, V92, P75, DOI 10.1189/jlb.1011530; Huo YZ, 2013, VIROLOGY, V444, P233, DOI 10.1016/j.virol.2013.06.015; Karniychuk UU, 2011, MICROB PATHOGENESIS, V51, P194, DOI 10.1016/j.micpath.2011.04.001; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim DY, 2009, VIRUS GENES, V38, P118, DOI 10.1007/s11262-008-0303-4; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; KRAMMER PH, 1994, CURR OPIN IMMUNOL, V6, P279, DOI 10.1016/0952-7915(94)90102-3; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Labarque G, 2003, VET RES, V34, P249, DOI 10.1051/vetres:2003001; Lee C, 2004, VIRUS RES, V104, P33, DOI 10.1016/j.virusres.2004.03.001; Lee SM, 2007, VIROLOGY, V365, P419, DOI 10.1016/j.virol.2007.04.001; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Li Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004216; Lin CW, 2006, FEMS IMMUNOL MED MIC, V46, P375, DOI 10.1111/j.1574-695X.2006.00045.x; Ma ZT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069387; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; MENG XJ, 1994, J GEN VIROL, V75, P1795, DOI 10.1099/0022-1317-75-7-1795; MEULENBERG JJM, 1995, VIROLOGY, V206, P155, DOI 10.1016/S0042-6822(95)80030-1; Mu Y, 2015, VIROLOGY, V484, P136, DOI 10.1016/j.virol.2015.05.019; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; O'Brien V, 1998, J GEN VIROL, V79, P1833, DOI 10.1099/0022-1317-79-8-1833; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Prikhod'ko EA, 2004, VIROLOGY, V329, P53, DOI 10.1016/j.virol.2004.08.012; Prikhod'ko GG, 2002, J VIROL, V76, P5701, DOI 10.1128/JVI.76.11.5701-5710.2002; Ramanathan MP, 2006, VIROLOGY, V345, P56, DOI 10.1016/j.virol.2005.08.043; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Rossow KD, 1998, VET PATHOL, V35, P1, DOI 10.1177/030098589803500101; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Seybert A, 2000, J VIROL, V74, P9586, DOI 10.1128/JVI.74.20.9586-9593.2000; Shafee N, 2003, J GEN VIROL, V84, P2191, DOI 10.1099/vir.0.19022-0; Sirinarumitr T, 1998, J GEN VIROL, V79, P2989, DOI 10.1099/0022-1317-79-12-2989; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Suarez P, 1996, J VIROL, V70, P2876; Sur JH, 1997, J VIROL, V71, P9170, DOI 10.1128/JVI.71.12.9170-9179.1997; Sur JH, 1998, VET PATHOL, V35, P506, DOI 10.1177/030098589803500605; Takada E, 2006, EXP CELL RES, V312, P3728, DOI 10.1016/j.yexcr.2006.06.036; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; van Aken D, 2006, J GEN VIROL, V87, P3473, DOI 10.1099/vir.0.82269-0; van Dinten LC, 2000, J VIROL, V74, P5213, DOI 10.1128/JVI.74.11.5213-5223.2000; van Dinten LC, 1999, J VIROL, V73, P2027, DOI 10.1128/JVI.73.3.2027-2037.1999; vanDinten LC, 1996, J VIROL, V70, P6625, DOI 10.1128/JVI.70.10.6625-6633.1996; Yatim N, 2011, IMMUNITY, V35, P478, DOI 10.1016/j.immuni.2011.10.010; Yin ST, 2012, VIRUS RES, V166, P103, DOI 10.1016/j.virusres.2012.03.010; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang HM, 2009, J PROTEOME RES, V8, P3091, DOI 10.1021/pr900002f; Zhang HM, 2010, ARCH VIROL, V155, P571, DOI 10.1007/s00705-010-0611-6; Zhou L, 2010, VIRUS RES, V154, P31, DOI 10.1016/j.virusres.2010.07.016; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08	71	21	23	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156518	10.1371/journal.pone.0156518	http://dx.doi.org/10.1371/journal.pone.0156518			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310256	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800007
J	Zhou, XZ; Wei, YT; Qiu, S; Xu, Y; Zhang, T; Zhang, SC				Zhou, Xuezhi; Wei, Yantao; Qiu, Suo; Xu, Yue; Zhang, Ting; Zhang, Shaochong			Propofol Decreases Endoplasmic Reticulum Stress-Mediated Apoptosis in Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CEREBRAL-ISCHEMIA; ER STRESS; MITOCHONDRIAL DYSFUNCTION; MACULAR DEGENERATION; PROAPOPTOTIC BAX; UP-REGULATION; IN-VITRO; KAPPA-B; BCL-2	Age-related macular degeneration (AMD) is the major cause of loss of sight globally. There is currently no effective treatment available. Retinal pigment epithelial (RPE) cells are an important part of the outer blood-retina barrier and their death is a determinant of AMD. Propofol, a common clinically used intravenous anesthetic agent, has been shown to act as an efficacious neuroprotective agent with antioxidative and anti-inflammatory properties in vivo and in vitro. However, little is known about its effects on RPE cells. The purpose of our research was to investigate whether propofol could protect RPE cells from apoptosis through endoplasmic reticulum (ER) stress-dependent pathways. To this end, prior to stimulation with thapsigargin (TG), ARPE-19 cells were pretreated with varying concentrations of propofol. A protective effect of propofol in TG-treated ARPE-9 was apparent, TUNEL and flow cytometric assays showed decreased apoptosis. We further demonstrated that propofol pretreatment attenuated or inhibited the effects caused by TG, such as upregulation of Bax, BiP, C/EBP homologous protein (CHOP), active caspase 12, and cleaved caspase 3, and downregulation of Bcl2. It also decreased the TG-induced levels of ER stress-related molecules such as p-PERK, p-eIF2 alpha, and ATF4. Furthermore, it downregulated the expression of nuclear factor kappa B (NF-kappa B). This study elucidated novel propofol-induced cellular mechanisms for antiapoptotic activities in RPE cells undergoing ER stress and demonstrated the potential value of using propofol in the treatment of AMD.	[Zhou, Xuezhi; Wei, Yantao; Qiu, Suo; Xu, Yue; Zhang, Ting; Zhang, Shaochong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, SC (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhshaochong@sohu.com	Xu, yue/HGE-1737-2022; Qiu, Suo/HGD-2041-2022	Zhou, Xuezhi/0000-0002-4501-1817	Fund for National Natural Science Foundation [81441025, 81170866]	Fund for National Natural Science Foundation	This study was supported by the Fund for National Natural Science Foundation (81441025) and the Fund for National Natural Science Foundation (81170866).	Acquaviva R, 2004, ANESTHESIOLOGY, V101, P1363; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AKAO Y, 1994, CANCER RES, V54, P2468; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Cano M, 2014, FREE RADICAL BIO MED, V69, P1, DOI 10.1016/j.freeradbiomed.2014.01.004; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Del Priore LV, 2002, INVEST OPHTH VIS SCI, V43, P3312; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Distelhorst CW, 1996, CELL CALCIUM, V19, P473, DOI 10.1016/S0143-4160(96)90056-1; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Engelhard K, 2004, ANESTHESIOLOGY, V101, P912, DOI 10.1097/00000542-200410000-00016; Engelhard K, 2004, EUR J ANAESTH, V21, P530, DOI 10.1017/S0265021504007057; Grasshoff C, 2002, ANESTH ANALG, V95, P920, DOI 10.1213/01.ANE.0000025705.93185.09; Gui B, 2012, INFLAMMATION, V35, P1632, DOI 10.1007/s10753-012-9478-x; Ha JH, 2014, J NUTR, V144, P799, DOI 10.3945/jn.113.186957; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hardy B, 2010, J MOL MED, V88, P1157, DOI 10.1007/s00109-010-0657-7; He JG, 2013, NEUROL SCI, V34, P165, DOI 10.1007/s10072-012-0978-0; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hutchens MP, 2006, NEUROCRIT CARE, V4, P54, DOI 10.1385/NCC:4:1:054; Iijima T, 2006, BRAIN RES, V1099, P25, DOI 10.1016/j.brainres.2006.04.117; Inagi R, 2010, CURR OPIN PHARMACOL, V10, P156, DOI 10.1016/j.coph.2009.11.006; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Klee M, 2009, EMBO J, V28, P1757, DOI 10.1038/emboj.2009.90; Kubo K, 2011, BRAIN RES, V1387, P125, DOI 10.1016/j.brainres.2011.02.079; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Leitman J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090803; Li J, 2016, J NEUROSURG ANESTH, V28, P51, DOI 10.1097/ANA.0000000000000181; Lin JH, 2010, ADV EXP MED BIOL, V664, P115, DOI 10.1007/978-1-4419-1399-9_14; Lynch K, 2000, ENDOCRINOLOGY, V141, P4209, DOI 10.1210/en.141.11.4209; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Oslowski CM, 2011, CURR OPIN CELL BIOL, V23, P207, DOI 10.1016/j.ceb.2010.11.005; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Salminen A, 2010, MOL MED, V16, P535, DOI 10.2119/molmed.2010.00070; Salvado L, 2013, DIABETOLOGIA, V56, P1372, DOI 10.1007/s00125-013-2867-3; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Solaroglu I, 2004, BIOL NEONATE, V85, P221, DOI 10.1159/000075835; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Susuki S, 2009, J BIOL CHEM, V284, P8312, DOI 10.1074/jbc.M809354200; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Takayanagi S, 2013, CELL STRESS CHAPERON, V18, P11, DOI 10.1007/s12192-012-0351-5; Vasileiou I, 2009, EUR J PHARMACOL, V605, P1, DOI 10.1016/j.ejphar.2009.01.007; Vosler PS, 2009, STROKE, V40, P3149, DOI 10.1161/STROKEAHA.108.543769; Wang HY, 2011, J NEUROCHEM, V119, P210, DOI 10.1111/j.1471-4159.2011.07400.x; Wang P, 2013, EUR REV MED PHARMACO, V17, P1722; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xi HJ, 2011, BRAIN RES, V1410, P24, DOI 10.1016/j.brainres.2011.06.060; Yamani L, 2015, CELL SIGNAL, V27, P2555, DOI 10.1016/j.cellsig.2015.09.016; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhong YL, 2014, CELL BIOCHEM FUNCT, V32, P720, DOI 10.1002/cbf.3077	54	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157590	10.1371/journal.pone.0157590	http://dx.doi.org/10.1371/journal.pone.0157590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311010	Green Submitted, gold, Green Published			2022-12-26	WOS:000378029800103
J	Ng, CA; Gravel, AE; Perry, MD; Arnold, AA; Marcotte, I; Vandenberg, JI				Ng, Chai-Ann; Gravel, Andree E.; Perry, Matthew D.; Arnold, Alexandre A.; Marcotte, Isabelle; Vandenberg, Jamie I.			Tyrosine Residues from the S4-S5 Linker of Kv11.1 Channels Are Critical for Slow Deactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; gating; hERG; ion channel; nuclear magnetic resonance (NMR); potassium channel; site-directed mutagenesis; Kv11; 1; S4S5 linker; lipid membrane	BURIED SALT BRIDGES; CRYSTAL-STRUCTURE; SWISS-MODEL; AROMATIC INTERACTIONS; PROTEIN STABILITY; ACTIVATION GATE; HERG; ENVIRONMENT; MUTATIONS; FAMILY	Slow deactivation of Kv11.1 channels is critical for its function in the heart. The S4-S5 linker, which joins the voltage sensor and pore domains, plays a critical role in this slow deactivation gating. Here, we use NMR spectroscopy to identify the membrane-bound surface of the S4S5 linker, and we show that two highly conserved tyrosine residues within the KCNH subfamily of channels are membrane-associated. Site-directed mutagenesis and electrophysiological analysis indicates that Tyr-542 interacts with both the pore domain and voltage sensor residues to stabilize activated conformations of the channel, whereas Tyr-545 contributes to the slow kinetics of deactivation by primarily stabilizing the transition state between the activated and closed states. Thus, the two tyrosine residues in the Kv11.1 S4S5 linker play critical but distinct roles in the slow deactivation phenotype, which is a hallmark of Kv11.1 channels.	[Ng, Chai-Ann; Perry, Matthew D.; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, 405 Liverpool St, Darlinghurst, NSW, Australia; [Ng, Chai-Ann; Perry, Matthew D.; Vandenberg, Jamie I.] Univ New South Wales, St Vincents Clin Sch, Victoria St, Darlinghurst, NSW 2010, Australia; [Gravel, Andree E.; Arnold, Alexandre A.; Marcotte, Isabelle] Univ Quebec, Dept Chem, Montreal, PQ H3C 3P8, Canada; [Marcotte, Isabelle] Ctr Quebecois Mat Fonctionnels, Quebec City, PQ, Canada; [Marcotte, Isabelle] GRASP, Montreal, PQ, Canada	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of Quebec; University of Quebec Montreal	Vandenberg, JI (corresponding author), Victor Chang Cardiac Res Inst, 405 Liverpool St, Darlinghurst, NSW, Australia.; Marcotte, I (corresponding author), Univ Quebec, Dept Chim, Downtown Stn, POB 8888, Montreal, PQ H3C 3P8, Canada.; Vandenberg, JI (corresponding author), Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Res Programme Cardiac Electro, 405 Liverpool St, Darlinghurst, NSW 2010, Australia.	marcotte.isabelle@uqam.ca; j.vandenberg@victorchang.edu.au	Vandenberg, Jamie I/B-6608-2013	Vandenberg, Jamie I/0000-0002-3859-3716; Ng, Chai Ann/0000-0002-3120-5450; Arnold, Alexandre/0000-0001-9624-6416	National Health and Medical Research Council of Australia [App1074386, 1019693]; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research training program; Groupe de Recherche Axesur la Structure des Proteines (GRASP)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research training program(Canadian Institutes of Health Research (CIHR)); Groupe de Recherche Axesur la Structure des Proteines (GRASP)	This work was supported in part by National Health and Medical Research Council of Australia Program Grant App1074386 and Fellowship 1019693 (to J. I. V.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Natural Sciences and Engineering Research Council of Canada, the Canadian Institutes of Health Research training program, and the Groupe de Recherche Axesur la Structure des Proteines (GRASP).	Alonso-Ron C, 2008, BIOPHYS J, V94, P3893, DOI 10.1529/biophysj.107.116731; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Ng CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031640; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; de la Pena P, 2011, J BIOL CHEM, V286, P19065, DOI 10.1074/jbc.M111.238899; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Grant AO, 2009, CIRC-ARRHYTHMIA ELEC, V2, P185, DOI 10.1161/CIRCEP.108.789081; Gravel AE, 2013, BBA-BIOMEMBRANES, V1828, P1494, DOI 10.1016/j.bbamem.2013.02.012; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Ju PC, 2009, J BIOL CHEM, V284, P1000, DOI 10.1074/jbc.M806400200; Klabunde R. E., 2012, CARDIOVASCULAR PHYSL, P9; Liu SG, 1996, BIOPHYS J, V70, P2704, DOI 10.1016/S0006-3495(96)79840-5; Lorinczi E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7672; LOEWENTHAL R, 1992, J MOL BIOL, V224, P759, DOI 10.1016/0022-2836(92)90560-7; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Y, 2001, J PHYSIOL-LONDON, V537, P843, DOI 10.1113/jphysiol.2001.012690; MARQUSEE S, 1994, PROTEIN SCI, V3, P2217, DOI 10.1002/pro.5560031207; Ng CA, 2014, J BIOL CHEM, V289, P25822, DOI 10.1074/jbc.M114.558379; Ng CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077032; Nolandt OV, 2012, BBA-BIOMEMBRANES, V1818, P1142, DOI 10.1016/j.bbamem.2012.01.007; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Perry MD, 2016, J PHYSIOL-LONDON, V594, P4031, DOI 10.1113/JP271805; Piper DR, 2003, P NATL ACAD SCI USA, V100, P10534, DOI 10.1073/pnas.1832721100; RANCE M, 1983, J MAGN RESON, V52, P221, DOI 10.1016/0022-2364(83)90190-7; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; SEELIG J, 1980, Q REV BIOPHYS, V13, P19, DOI 10.1017/S0033583500000305; SERRANO L, 1991, J MOL BIOL, V218, P465, DOI 10.1016/0022-2836(91)90725-L; Smith PL, 2002, J GEN PHYSIOL, V119, P275, DOI 10.1085/jgp.119.3.275; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Tan PS, 2012, J GEN PHYSIOL, V140, P293, DOI 10.1085/jgp.201110761; Tissot AC, 1996, BIOCHEMISTRY-US, V35, P6786, DOI 10.1021/bi952930e; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Van Slyke AC, 2010, BIOPHYS J, V99, P2841, DOI 10.1016/j.bpj.2010.08.030; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	46	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17293	17302		10.1074/jbc.M116.729392	http://dx.doi.org/10.1074/jbc.M116.729392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27317659	Green Published, hybrid			2022-12-26	WOS:000382643800030
J	Kim, JH; Hong, SJ; Park, CY; Park, JH; Choi, SC; Woo, SK; Yu, JW; Cheon, GJ; Joo, HJ; Lim, DS				Kim, Jong-Ho; Hong, Soon Jun; Park, Chi-Yeon; Park, Jae Hyung; Choi, Seung-Cheol; Woo, Sang-Keun; Yu, Jung Woo; Cheon, Gi Jeong; Joo, Hyung Joon; Lim, Do-Sun			Intramyocardial Adipose-Derived Stem Cell Transplantation Increases Pericardial Fat with Recovery of Myocardial Function after Acute Myocardial Infarction	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; CARDIOVASCULAR RISK-FACTORS; CORONARY-ARTERY-DISEASE; ADIPONECTIN PROTECTS; GENERAL-POPULATION; DIASTOLIC FUNCTION; CARDIAC-FUNCTION; EPICARDIAL FAT; TISSUE; ASSOCIATION	Intramyocardial injection of adipose-derived stem cells (ASC) with other cell types in acute myocardial infarction (AMI) animal models has consistently shown promising clinical regenerative capacities. We investigated the effects of intramyocardial injections of mouse ASC (mASC) with mouse endothelial cells (mEC) on left ventricular function and generation of pericardial fat in AMI rats. AMI rat models were created by ligating left anterior descending coronary artery and were randomly assigned into four groups: control (n = 10), mASC (n = 10), mEC (n = 10) and mASC+mEC (n = 10) via direct intramyocardial injections, and each rat received 1x10(6) cells around three peri-infarct areas. Echocardiography and cardiac positron emission tomography (PET) were compared at baseline and on 28 days after AMI. Changes in left ventricular ejection fraction measured by PET, increased significantly in mASC and mASC+mEC groups compared to mEC and control groups. Furthermore, significant decreases in fibrosis were confirmed after sacrifice on 28 days in mASC and mASC + mEC groups. Successful cell engraftment was confirmed by positive Y-Chromosome staining in the transplantation region. Pericardial fat increased significantly in mASC and mASC+mEC groups compared to control group, and pericardial fat was shown to originate from the AMI rat. mASC group expressed higher adiponectin and lower leptin levels in plasma than control group. In addition, pericardial fat from AMI rats demonstrated increased phospho-AMPK levels and reduced phospho-ACC levels. Intramyocardial mASC transplantation after AMI in rats increased pericardial fat, which might play a protective role in the recovery of myocardial function after ischemic myocardial damage.	[Kim, Jong-Ho; Hong, Soon Jun; Park, Chi-Yeon; Park, Jae Hyung; Choi, Seung-Cheol; Joo, Hyung Joon; Lim, Do-Sun] Korea Univ, Coll Med, Dept Cardiol, Cardiovasc Ctr, Seoul 136705, South Korea; [Woo, Sang-Keun; Yu, Jung Woo] Korea Inst Radiol & Med Sci KIRAMS, Mol Imaging Res Ctr, Seoul, South Korea; [Cheon, Gi Jeong] Seoul Natl Univ Hosp, Canc Res Inst, Dept Nucl Med, Seoul 110744, South Korea	Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Seoul National University Hospital	Hong, SJ (corresponding author), Korea Univ, Coll Med, Dept Cardiol, Cardiovasc Ctr, Seoul 136705, South Korea.	psyche94@gmail.com	Joo, Hyung Joon/Q-4875-2016; Cheon, Gi Jeong/AAA-5702-2020; Park, Chi-Yeon/ABH-9980-2020; Cheon, Gi Jeong/G-6064-2018	Joo, Hyung Joon/0000-0003-1846-8464; Cheon, Gi Jeong/0000-0002-1360-5186; Kim, Jong-Ho/0000-0002-1309-0821; Park, Chi-Yeon/0000-0002-9400-9078	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare [HI14C0209, A120275]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea [NRF-2014R1A2A1A11051998]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare (Grant number: HI14C0209 and A120275), and by a grant of the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. NRF-2014R1A2A1A11051998), Republic of Korea.; We are grateful to I-Rang Lim, Lisa Im, Ha-Rim Seo, Ji-Hyun Choi, Mina Kim (Echocardiography), and Sang-A Jo (Statistics) for expert technical assistance. This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare (Grant number: HI14C0209), and by a grant of the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. NRF-2014R1A2A1A11051998), Republic of Korea.	Al Moudi M, 2014, J GERIATR CARDIOL, V11, P229, DOI 10.11909/j.issn.1671-5411.2014.03.008; Bachner-Hinenzon N, 2010, AM J PHYSIOL-HEART C, V299, pH664, DOI 10.1152/ajpheart.00017.2010; Bai XW, 2010, EUR HEART J, V31, P489, DOI 10.1093/eurheartj/ehp568; Camici PG, 2008, CIRCULATION, V117, P103, DOI 10.1161/CIRCULATIONAHA.107.702993; Carlson S, 2011, CARDIOVASC RES, V91, P99, DOI 10.1093/cvr/cvr061; Chaowalit N, 2008, EUR HEART J, V29, P695, DOI 10.1093/eurheartj/ehm643; Dasgupta B, 2012, MOL CELL BIOL, V32, P2837, DOI 10.1128/MCB.05853-11; de Vos AM, 2008, EUR HEART J, V29, P777, DOI 10.1093/eurheartj/ehm564; Dzielinska Z, 2003, THROMB RES, V110, P365, DOI 10.1016/j.thromres.2003.08.004; Fontes-Carvalho R, 2015, EXPERT OPIN THER TAR, V19, P1283, DOI 10.1517/14728222.2015.1019468; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Ghantous CM, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/534320; Gimeno RE, 2014, TRENDS ENDOCRIN MET, V25, P303, DOI 10.1016/j.tem.2014.03.001; Gonon AT, 2008, CARDIOVASC RES, V78, P116, DOI 10.1093/cvr/cvn017; Grossini E, 2014, J ENDOCRINOL, V222, P137, DOI 10.1530/JOE-14-0170; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hasan-Ali H, 2011, CORONARY ARTERY DIS, V22, P264, DOI 10.1097/MCA.0b013e3283452431; Hong SJ, 2013, INT J CARDIOL, V164, P205, DOI 10.1016/j.ijcard.2011.06.128; Hong SJ, 2010, CURR OPIN ORGAN TRAN, V15, P86, DOI 10.1097/MOT.0b013e328334f074; Iacobellis G, 2007, INT J CARDIOL, V115, P272, DOI 10.1016/j.ijcard.2006.04.016; Iozzo P, 2011, DIABETES CARE, V34, pS371, DOI 10.2337/dc11-s250; Kang HJ, 2006, CIRCULATION, V114, pI145, DOI 10.1161/CIRCULATIONAHA.105.001107; Kim JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147853; Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Mahabadi AA, 2013, J AM COLL CARDIOL, V61, P1388, DOI 10.1016/j.jacc.2012.11.062; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; Marelli D, 1992, Cell Transplant, V1, P383; Matsuura N, 2015, INT J CARDIOL, V179, P360, DOI 10.1016/j.ijcard.2014.11.099; Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218; Pahk K, 2013, NUCL MED MOLEC IMAG, V47, P104, DOI 10.1007/s13139-013-0206-8; Pei HF, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0322-0; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Potian JA, 2003, J IMMUNOL, V171, P3426, DOI 10.4049/jimmunol.171.7.3426; Quercioli A, 2013, EUR HEART J, V34, P2063, DOI 10.1093/eurheartj/eht085; Ruberg FL, 2010, OBESITY, V18, P1116, DOI 10.1038/oby.2009.363; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Tracy RE, 2004, VIRCHOWS ARCH, V445, P22, DOI 10.1007/s00428-004-1036-y; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426; Wang P, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-36; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Yuhki K, 2005, NAT MED, V11, P1048, DOI 10.1038/nm1005-1048	44	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158067	10.1371/journal.pone.0158067	http://dx.doi.org/10.1371/journal.pone.0158067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336402	gold, Green Published, Green Submitted			2022-12-26	WOS:000378389200103
J	Chiaverano, LM; Bayha, KW; Graham, WM				Chiaverano, Luciano M.; Bayha, Keith W.; Graham, William M.			Local versus Generalized Phenotypes in Two Sympatric Aurelia Species: Understanding Jellyfish Ecology Using Genetics and Morphometrics	PLOS ONE			English	Article							MORPHOLOGICAL VARIATION; EVOLUTIONARY GENETICS; MOLECULAR EVIDENCE; GEOGRAPHIC-VARIATION; SEQUENCE ALIGNMENT; DIVERGENCE TIMES; PLASTICITY; SCYPHOZOA; BLOOMS; RHIZOSTOMEAE	For individuals living in environmentally heterogeneous environments, a key component for adaptation and persistence is the extent of phenotypic differentiation in response to local environmental conditions. In order to determine the extent of environmentally induced morphological variation in a natural population distributed along environmental gradients, it is necessary to account for potential genetic differences contributing to morphological differentiation. In this study, we set out to quantify geographic morphological variation in the moon jellyfish Aurelia exposed at the extremes of a latitudinal environmental gradient in the Gulf of Mexico (GoM). We used morphological data based on 28 characters, and genetic data taken from mitochondrial cytochrome oxidase I (COI) and nuclear internal transcribed spacer 1 (ITS-1). Molecular analyses revealed the presence of two genetically distinct species of Aurelia co-occurring in the GoM: Aurelia sp. 9 and Aurelia c.f. sp. 2, named for its divergence from (for COI) and similarity to (for ITS-1) Aurelia sp. 2 (Brazil). Neither species exhibited significant population genetic structure between the Northern and the Southeastern Gulf of Mexico; however, they differed greatly in the degree of geographic morphological variation. The morphology of Aurelia sp. 9 exhibited ecophenotypic plasticity and varied significantly between locations, while morphology of Aurelia c.f. sp. 2 was geographically invariant (i.e., canalized). The plastic, generalist medusae of Aurelia sp. 9 are likely able to produce environmentally-induced, "optimal" phenotypes that confer high relative fitness in different environments. In contrast, the non-plastic generalist individuals of Aurelia c.f. sp. 2 likely produce environmentally-independent phenotypes that provide the highest fitness across environments. These findings suggest the two Aurelia lineages co-occurring in the GoM were likely exposed to different past environmental conditions (i.e., different selective pressures) and evolved different strategies to cope with environmental variation. This study highlights the importance of using genetics and morphometric data to understand jellyfish ecology, evolution and systematics.	[Chiaverano, Luciano M.; Graham, William M.] Univ So Mississippi, Dept Marine Sci, Stennis Space Ctr, MS 39529 USA; [Bayha, Keith W.] Amer Assoc Advancement Sci, Washington, DC USA	University of Southern Mississippi	Chiaverano, LM (corresponding author), Univ So Mississippi, Dept Marine Sci, Stennis Space Ctr, MS 39529 USA.	luciano.chiaverano@usm.edu			Mississippi-Alabama Sea Grant Consortium [R/CEH-1]; National Science Foundation [OCE-9733441]; DISL tech support	Mississippi-Alabama Sea Grant Consortium; National Science Foundation(National Science Foundation (NSF)); DISL tech support	This research was funded by the Mississippi-Alabama Sea Grant Consortium (R/CEH-1) and the National Science Foundation (OCE-9733441) to WMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Toby Bolton, Daniela del Valle, Heather Fletcher, John Higgins III, and Kelly Sutherland for their valuable assistant in the field. We also thank Inia Soto-Ramos for generating isothermal lines in Fig 2. We appreciate the help of Dauphin Island Sea Lab boat captains, including Rodney Collier, Russell Wilson, Clark Lollar, and Tom Guoba. We would like to thank DISL tech support, especially Kyle Weis, Al Gunter and Laura Linn for their assistance in the lab. We thank the personnel of the Keys Marine Lab for their valuable help in the field and laboratory facilities. Most of the genetic data were collected while visiting the lab of Dr. Michael N Dawson (University of California Merced). We also thank Dr. Giorio Aglieri and an anonymous reviewer for their comments and suggestions, which helped to improve our manuscript. This research was funded by the Mississippi-Alabama Sea Grant Consortium (R/CEH-1) and the National Science Foundation (OCE-9733441).	Alvarado-Serrano DF, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-160; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Ausubel FM, 1988, MOL REPROD DEV; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baranova O, 2014, SEAWATER TEMPERATURE; Bayha K, 2005, THESIS; Bayha KM, 2010, BIOL BULL-US, V219, P249, DOI 10.1086/BBLv219n3p249; Bayha KM, 2010, INTEGR COMP BIOL, V50, P436, DOI 10.1093/icb/icq074; Bolton TF, 2004, MAR ECOL PROG SER, V278, P125, DOI 10.3354/meps278125; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chiaverano LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077039; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; Novaes JLC, 2012, REV BIOL TROP, V60, P721; Crispo E, 2008, J EVOLUTION BIOL, V21, P1460, DOI 10.1111/j.1420-9101.2008.01592.x; Crispo E, 2010, J EVOLUTION BIOL, V23, P2091, DOI 10.1111/j.1420-9101.2010.02069.x; Crispo E, 2007, EVOLUTION, V61, P2469, DOI 10.1111/j.1558-5646.2007.00203.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Daryanabard R, 2008, J MAR BIOL ASSOC UK, V88, P477, DOI 10.1017/S0025315408000945; Dawson MN, 2009, HYDROBIOLOGIA, V616, P193, DOI 10.1007/s10750-008-9591-x; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Dawson MN, 2005, INVERTEBR SYST, V19, P361, DOI 10.1071/IS03035; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P11968, DOI 10.1073/pnas.0503811102; Dawson MN, 2005, HYDROBIOLOGIA, V537, P185, DOI 10.1007/s10750-004-2840-8; Dawson MN, 2005, J MAR BIOL ASSOC UK, V85, P679, DOI 10.1017/S0025315405011604; Dawson MN, 2003, MAR BIOL, V143, P369, DOI 10.1007/s00227-003-1070-3; Dawson MN, 2001, HYDROBIOLOGIA, V451, P259, DOI 10.1023/A:1011869215330; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Delannoy CMJ, 2011, AQUACULTURE, V311, P255, DOI 10.1016/j.aquaculture.2010.11.033; Donaldson-Matasci MC, 2008, EVOL ECOL RES, V10, P493; Dong ZJ, 2010, MAR POLLUT BULL, V60, P954, DOI 10.1016/j.marpolbul.2010.04.022; Doyle TK, 2008, J PLANKTON RES, V30, P963, DOI 10.1093/plankt/fbn052; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fenner PJ, 1996, TOXICON, V34, P41; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Garcia H., 2014, SEAWATER NITRATES; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Govindarajan AF, 2005, MAR BIOL, V146, P213, DOI 10.1007/s00227-004-1434-3; Greenberg N, 1996, MAR BIOL, V125, P401, DOI 10.1007/BF00346320; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; He JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145314; Holland BS, 2004, MAR BIOL, V145, P1119, DOI 10.1007/s00227-004-1409-4; Holt RD, 1997, AM NAT, V149, P563, DOI 10.1086/286005; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Ishii H, 2003, J PLANKTON RES, V25, P1447, DOI 10.1093/plankt/fbg094; Ishii H, 1998, J PLANKTON RES, V20, P805, DOI 10.1093/plankt/20.5.805; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Kolbasova GD, 2015, POLAR BIOL, V38, P1439, DOI 10.1007/s00300-015-1707-y; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Rouzic A, 2013, EVOL BIOL, V40, P317, DOI 10.1007/s11692-012-9218-z; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Lind MI, 2011, EVOLUTION, V65, P684, DOI 10.1111/j.1558-5646.2010.01122.x; Lleonart J, 2000, J THEOR BIOL, V205, P85, DOI 10.1006/jtbi.2000.2043; Lohrenz SE, 1997, MAR ECOL PROG SER, V155, P45, DOI 10.3354/meps155045; Lucas CH, 1996, J PLANKTON RES, V18, P987, DOI 10.1093/plankt/18.6.987; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; Lucas CH, 1998, MAR BIOL, V131, P629, DOI 10.1007/s002270050355; Marko PB, 2002, MOL BIOL EVOL, V19, P2005, DOI 10.1093/oxfordjournals.molbev.a004024; Miyake Hiroshi, 1997, South Pacific Study, V17, P273; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Murren CJ, 2015, HEREDITY, V115, P293, DOI 10.1038/hdy.2015.8; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Pigliucci M., 2001, SYN ECO EVO; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2012, ANNU REV MAR SCI, V4, P209, DOI 10.1146/annurev-marine-120709-142751; Rambaut A, 2009, FIGTREE V1 3 1 TREE; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Robinson KL, 2015, ICES J MAR SCI, V72, P2301, DOI 10.1093/icesjms/fsv088; Robinson KL, 2013, LIMNOL OCEANOGR, V58, P235, DOI 10.4319/lo.2013.58.1.0235; RODEN C L, 1990, Northeast Gulf Science, V11, P63; Roff Derek A., 1992; Saint-Laurent R, 2003, MOL ECOL, V12, P315, DOI 10.1046/j.1365-294X.2003.01735.x; Scheiner SM, 2012, ECOL EVOL, V2, P751, DOI 10.1002/ece3.217; Schroth W, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-1; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Stearns S.C., 1992, pi; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; Stibor H, 2003, OECOLOGIA, V135, P202, DOI 10.1007/s00442-003-1189-4; Stopar K, 2010, MOL PHYLOGENET EVOL, V57, P417, DOI 10.1016/j.ympev.2010.07.004; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torres-Dowdall J, 2012, EVOLUTION, V66, P3432, DOI 10.1111/j.1558-5646.2012.01694.x; vanTienderen PH, 1997, EVOLUTION, V51, P1372, DOI [10.1111/j.1558-5646.1997.tb01460.x, 10.2307/2411189]; Whitman D. W., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P1	94	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0156588	10.1371/journal.pone.0156588	http://dx.doi.org/10.1371/journal.pone.0156588			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332545	gold, Green Published			2022-12-26	WOS:000378212800010
J	Sasai, K; Katayama, H; Hawke, DH; Sen, S				Sasai, Kaori; Katayama, Hiroshi; Hawke, David H.; Sen, Subrata			Aurora-C Interactions with Survivin and INCENP Reveal Shared and Distinct Features Compared with Aurora-B Chromosome Passenger Protein Complex	PLOS ONE			English	Article							KINASE-ACTIVITY; LOCALIZATION; BOREALIN; BINDING; OVEREXPRESSION; AMPLIFICATION; AIE1	Aurora-C, a member of the Aurora kinase family that can complement Aurora-B function in mitosis is either moderately expressed or repressed in most adult somatic tissues but is active in early embryonic development and expressed at elevated levels in multiple human cancers. Aurora-C overexpression reportedly plays a role in tumorigenic transformation. We performed detailed characterization of Aurora-C interactions with members of the Chromosome Passenger Complex (CPC), Survivin and Inner Centromere Protein (INCENP) in reference to known Aurora-B interactions to understand the functional significance of Aurora-C overexpression in human cancer cells. The results revealed that silencing of Aurora-C or -B individually does not affect localization of the other kinase and the two kinases exist predominantly in independent complexes in vivo. Presence of Aurora-C and -B in molecular complexes of varying as well as overlapping sizes and co-existence in INCENP overexpressing cells indicated oligomerization of ternary complexes under different physiological conditions in vivo. Furthermore, Aurora-C and -B stabilized INCENP through interaction with and phosphorylation of the IN box domain while Aurora-C was activated following Survivin phosphorylation on Serine 20. Phosphorylation of Survivin residue Serine 20 by Aurora-C and -B appears important for proper chromosome segregation. Taken together, our study suggests that Aurora-C, expressed at low levels in somatic cells, functions as a catalytic component of the CPC together with Aurora-B through mitosis. Elevated expression of Aurora-C in cancer cells alters the structural and functional characteristics of the Aurora-B-CPC leading to chromosomal instability.	[Sasai, Kaori; Katayama, Hiroshi; Sen, Subrata] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Hawke, David H.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Sasai, Kaori; Katayama, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Oncol, Okayama 7008530, Japan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Okayama University	Katayama, H; Sen, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA.; Katayama, H (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Oncol, Okayama 7008530, Japan.	hkatayama@cc.okayama-u.ac.jp; ssen@mdanderson.org			National Institutes of Health, NIH.GOV [RO1CA089716]; UT MD Anderson Cancer Center	National Institutes of Health, NIH.GOV(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT MD Anderson Cancer Center	The study was supported by funding from the National Institutes of Health, NIH.GOV (RO1CA089716) and from the UT MD Anderson Cancer Center to SS.	Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Brown JR, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-39; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Chen HL, 2005, J BIOMED SCI, V12, P297, DOI 10.1007/s11373-005-0980-0; Chen J, 2003, J BIOL CHEM, V278, P486, DOI 10.1074/jbc.M211119200; Chen SH, 2002, DNA CELL BIOL, V21, P41, DOI 10.1089/10445490252810302; Dieterich K, 2007, NAT GENET, V39, P661, DOI 10.1038/ng2027; Fernandez-Miranda G, 2011, DEVELOPMENT, V138, P2661, DOI 10.1242/dev.066381; Fujii S, 2015, TUMOR BIOL, V36, P8147, DOI 10.1007/s13277-015-3553-5; Gabillard JC, 2011, BIOCHEM BIOPH RES CO, V408, P647, DOI 10.1016/j.bbrc.2011.04.078; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Khan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026512; Kimmins S, 2007, MOL ENDOCRINOL, V21, P726, DOI 10.1210/me.2006-0332; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Lens SMA, 2006, MOL BIOL CELL, V17, P1897, DOI 10.1091/mbc.E05-08-0727; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Li XY, 2004, J BIOL CHEM, V279, P47201, DOI 10.1074/jbc.M403029200; Murata-Hori M, 2002, CURR BIOL, V12, P894, DOI 10.1016/S0960-9822(02)00848-5; Santos MA, 2011, HUM REPROD, V26, P1868, DOI 10.1093/humrep/der111; Sasai K, 2004, CELL MOTIL CYTOSKEL, V59, P249, DOI 10.1002/cm.20039; Schindler K, 2012, P NATL ACAD SCI USA, V109, pE2215, DOI 10.1073/pnas.1120517109; Scrittori L, 2005, MOL BIOL CELL, V16, P292, DOI 10.1091/mbc.E04-06-0447; Slattery SD, 2009, CELL CYCLE, V8, P2984; Tang CJC, 2006, DEV BIOL, V290, P398, DOI 10.1016/j.ydbio.2005.11.036; Tseng TC, 1998, DNA CELL BIOL, V17, P823, DOI 10.1089/dna.1998.17.823; Tsou JH, 2011, J PATHOL, V225, P243, DOI 10.1002/path.2934; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Wheatley SP, 2004, J BIOL CHEM, V279, P5655, DOI 10.1074/jbc.M311299200; Wu SR, 2011, J BIOL CHEM, V286, P28662, DOI 10.1074/jbc.M111.270710; Yan XM, 2005, GENES CELLS, V10, P617, DOI 10.1111/j.1365-2443.2005.00863.x; Zekri A, 2012, ONCOL RES, V20, P241, DOI 10.3727/096504013X13589503482978; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	38	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157305	10.1371/journal.pone.0157305	http://dx.doi.org/10.1371/journal.pone.0157305			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332895	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212800025
J	Zheng, X; Tang, SW; Zhu, SY; Dai, QZ; Liu, TM				Zheng, Xia; Tang, Shouwei; Zhu, Siyuan; Dai, Qiuzhong; Liu, Touming			Identification of an NAC Transcription Factor Family by Deep Transcriptome Sequencing in Onion (Allium cepa L.)	PLOS ONE			English	Article							EXPRESSED SEQUENCE; REVEALS; ARABIDOPSIS; DOMAIN; GENE; SELECTION; PATTERNS; DISTINCT; MEMBER	Although onion has been used extensively in the past for cytogenetic studies, molecular analysis has been lacking because the availability of genetic resources is limited. NAM, ATAF, and CUC (NAC) transcription factors (TFs) are plant-specific proteins, and they play key roles in plant growth, development, and stress tolerance. However, none of the onion NAC (CepNAC) genes had been identified thus far. In this study, the transcriptome of onion leaves was analyzed by Illumina paired-end sequencing. Approximately 102.9 million clean sequence reads were produced and used for de novo assembly, which generated 117,189 non-redundant transcripts. Of these transcripts, 39,472 were annotated for their function. In order to mine the CepNAC TFs, CepNAC genes were searched from the transcripts assembled, resulting in the identification of all 39 CepNAC genes. These 39 CepNAC proteins were subjected to phylogenetic analysis together with 47 NAC proteins of known function that were previously identified in other species. The results showed that they can be divided into five groups (NAC-I-V). Interestingly, the NAC-IV and -V groups were found to be likely related to the processes of secondary wall synthesis and stress response, respectively. The transcriptome analysis generated a substantial amount of transcripts, which will aid immensely in identifying important genes and accelerating our understanding of onion growth and development. Moreover, the discovery of 39 CepNAC TFs and the identification of the sequence conservation between them and NAC proteins published will provide a basis for further characterization and validation of their functions in the future.	[Liu, Touming] Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China; Chinese Acad Agr Sci, Ctr Southern Econ Crops, Changsha, Hunan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Bast Fiber Crops, CAAS; Chinese Academy of Agricultural Sciences	Liu, TM (corresponding author), Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China.	liutouming@gmail.com			Technology Innovation Program of China [CAAS-ASTIP-IBFC]	Technology Innovation Program of China	This work was supported by Technology Innovation Program of China (grant number: CAAS-ASTIP-IBFC), http://www.caas.cn/en/research/research_program/index.shtml. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Ernst HA, 2004, EMBO REP, V5, P297, DOI 10.1038/sj.embor.7400093; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han XM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0591-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kim SG, 2007, PLANTA, V226, P647, DOI 10.1007/s00425-007-0513-3; Koenig Daniel, 2013, Proc Natl Acad Sci U S A, V110, pE2655, DOI 10.1073/pnas.1309606110; Kuhl JC, 2004, PLANT CELL, V16, P114, DOI 10.1105/tpc.017202; Liu TM, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0399-x; Liu TM, 2014, PLANT MOL BIOL, V86, P85, DOI 10.1007/s11103-014-0214-9; Liu TM, 2014, MOL GENET GENOMICS, V289, P675, DOI 10.1007/s00438-014-0842-4; Liu TM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-125; Lou Qian, 2014, J Exp Bot, V65, P3157, DOI 10.1093/jxb/eru168; McCallum J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-168; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Pinheiro GL, 2009, GENE, V444, P10, DOI 10.1016/j.gene.2009.05.012; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Rajkumar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135387; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Sun XD, 2016, MOL GENET GENOMICS, V291, P647, DOI 10.1007/s00438-015-1131-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Xu B, 2014, SCIENCE, V343, P1505, DOI 10.1126/science.1248417; Zhao CS, 2008, PLANT J, V53, P425, DOI 10.1111/j.1365-313X.2007.03350.x; Zhou SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133312	33	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157871	10.1371/journal.pone.0157871	http://dx.doi.org/10.1371/journal.pone.0157871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27331904	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212800053
J	Smith, GR; Birtwistle, MR				Smith, Gregory R.; Birtwistle, Marc R.			A Mechanistic Beta-Binomial Probability Model for mRNA Sequencing Data	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; SEQ EXPERIMENTS; QUANTIFICATION; HYBRIDIZATION; CANCER; TOOL; END	A main application for mRNA sequencing (mRNAseq) is determining lists of differentially-expressed genes (DEGs) between two or more conditions. Several software packages exist to produce DEGs from mRNAseq data, but they typically yield different DEGs, sometimes markedly so. The underlying probability model used to describe mRNAseq data is central to deriving DEGs, and not surprisingly most softwares use different models and assumptions to analyze mRNAseq data. Here, we propose a mechanistic justification to model mRNAseq as a binomial process, with data from technical replicates given by a binomial distribution, and data from biological replicates well-described by a beta-binomial distribution. We demonstrate good agreement of this model with two large datasets. We show that an emergent feature of the beta-binomial distribution, given parameter regimes typical for mRNAseq experiments, is the well-known quadratic polynomial scaling of variance with the mean. The so-called dispersion parameter controls this scaling, and our analysis suggests that the dispersion parameter is a continually decreasing function of the mean, as opposed to current approaches that impose an asymptotic value to the dispersion parameter at moderate mean read counts. We show how this leads to current approaches overestimating variance for moderately to highly expressed genes, which inflates false negative rates. Describing mRNAseq data with a beta-binomial distribution thus may be preferred since its parameters are relatable to the mechanistic underpinnings of the technique and may improve the consistency of DEG analysis across softwares, particularly for moderately to highly expressed genes.	[Smith, Gregory R.; Birtwistle, Marc R.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Birtwistle, MR (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	marc.birtwistle@mssm.edu		Smith, Gregory/0000-0003-0112-6134; Birtwistle, Marc/0000-0002-0341-0705	Icahn School of Medicine at Mount Sinai; IBM Faculty Award; NIH [P50 GM071558, R01GM104184, R21CA196418, U54HG008098]; NATIONAL CANCER INSTITUTE [R21CA196418] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG008098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104184, P50GM071558] Funding Source: NIH RePORTER	Icahn School of Medicine at Mount Sinai; IBM Faculty Award(International Business Machines (IBM)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Icahn School of Medicine at Mount Sinai, an IBM Faculty Award, and the NIH Grants P50 GM071558 (Systems Biology Center New York), R01GM104184, R21CA196418 and U54HG008098 (LINCS Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2002, MOL BIOL CELL, Vxxxiv; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bowtell DDL, 1999, NAT GENET, V21, P25, DOI 10.1038/4455; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Bubendorf L, 1999, CANCER RES, V59, P803; Cai GS, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S13-S5; Cole KA, 1999, NAT GENET, V21, P38, DOI 10.1038/4466; Debouck C, 1999, NAT GENET, V21, P48, DOI 10.1038/4475; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gierlinski M, 2015, BIOINFORMATICS, V31, P3625, DOI 10.1093/bioinformatics/btv425; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Hardcastle TJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-135; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ogunnaike BA, 2010, RANDOM PHENOMENA FUN, Vxli; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Soumillon M., 2014, CHARACTERIZATION DIR; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vente A, 1999, NAT GENET, V22, P22, DOI 10.1038/8734; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weisstein EW, BETA BINOMIAL DISTRI; Yu DN, 2013, BIOINFORMATICS, V29, P1275, DOI 10.1093/bioinformatics/btt143; Zhang WQ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0694-1; Zhang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103207; Zhou YH, 2011, BIOINFORMATICS, V27, P2672, DOI 10.1093/bioinformatics/btr449	43	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157828	10.1371/journal.pone.0157828	http://dx.doi.org/10.1371/journal.pone.0157828			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27326762	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212400049
J	Akorli, J; Gendrin, M; Pels, NAP; Yeboah-Manu, D; Christophides, GK; Wilson, MD				Akorli, Jewelna; Gendrin, Mathilde; Pels, Nana Adjoa P.; Yeboah-Manu, Dorothy; Christophides, George K.; Wilson, Michael D.			Seasonality and Locality Affect the Diversity of Anopheles gambiae and Anopheles coluzzii Midgut Microbiota from Ghana	PLOS ONE			English	Article							RNA GENE DATABASE; MOLECULAR-FORMS; INCIPIENT SPECIATION; GUT MICROBIOTA; ADULT; IDENTIFICATION; POPULATION; SEQUENCES; MOSQUITOS; MALARIA	Symbiotic bacteria can have important implications in the development and competence of disease vectors. In Anopheles mosquitoes, the composition of the midgut microbiota is largely influenced by the larval breeding site, but the exact factors shaping this composition are currently unknown. Here, we examined whether the proximity to urban areas and seasons have an impact on the midgut microbial community of the two major malaria vectors in Africa, An. coluzzii and An. gambiae. Larvae and pupae were collected from selected habitats in two districts of Ghana during the dry and rainy season periods. The midgut microbiota of adults that emerged from these collections was determined by 454-pyrosequencing of the 16S ribosomal DNA. We show that in both mosquito species, Shewanellaceae constituted on average of 54% and 73% of the midgut microbiota from each site in the dry and rainy season, respectively. Enterobacteriaceae was found in comparatively low abundance below 1% in 22/30 samples in the dry season, and in 25/38 samples in the rainy season. Our data indicate that seasonality and locality significantly affect both the diversity of microbiota and the relative abundance of bacterial families with a positive impact of dry season and peri-urban settings.	[Akorli, Jewelna; Pels, Nana Adjoa P.; Wilson, Michael D.] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Parasitol, POB LG 581, Legon, Accra, Ghana; [Yeboah-Manu, Dorothy] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Bacteriol, POB LG 581, Legon, Accra, Ghana; [Gendrin, Mathilde; Christophides, George K.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Sir Alexander Fleming Bldg, London SW7 2AZ, England	University of Ghana; University of Ghana; Imperial College London	Akorli, J (corresponding author), Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Parasitol, POB LG 581, Legon, Accra, Ghana.	jewelna.akorli@gmail.com	Akorli, Jewelna/ABC-4963-2021; Gendrin, Mathilde/I-4334-2012; Yeboah-Manu, Dorothy/A-1933-2016	Akorli, Jewelna/0000-0002-3972-0860; Gendrin, Mathilde/0000-0001-6405-6458; Christophides, George/0000-0002-3323-1687; Yeboah-Manu, Dorothy/0000-0002-1663-6287	Noguchi Memorial Institute for Medical Research Postdoctoral Fellowship - Bill and Melinda Gates Foundation	Noguchi Memorial Institute for Medical Research Postdoctoral Fellowship - Bill and Melinda Gates Foundation	This study was funded by the Noguchi Memorial Institute for Medical Research Postdoctoral Fellowship supported by Bill and Melinda Gates Foundation, to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguie B, 2017, GRIDEXTRA MISCELLANE; Bahia AC, 2014, ENVIRON MICROBIOL, V16, P2980, DOI 10.1111/1462-2920.12381; Bando H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01641; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Briones AM, 2008, ISME J, V2, P74, DOI 10.1038/ismej.2007.95; Buck M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22806; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chavshin AR, 2012, ACTA TROP, V121, P129, DOI 10.1016/j.actatropica.2011.10.015; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Coetzee M, 2004, AM J TROP MED HYG, V70, P103, DOI 10.4269/ajtmh.2004.70.103; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771; Corena MD, 2005, J EXP BIOL, V208, P3263, DOI 10.1242/jeb.01739; Dada N, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-391; De Silva PM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819563; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Diabate A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-5; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Gaio AD, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-105; Gendrin M, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P525, DOI 10.5772/55107; Gendrin M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6921; Ghana Statistical Service, 2012, DRAFT NAT HOUS POL 2; GILLIES MT, 1968, S AFRICAN I MED RES, V54, P127; Gimonneau G, 2012, MED VET ENTOMOL, V26, P9, DOI 10.1111/j.1365-2915.2011.00957.x; Gimonneau G, 2014, INFECT GENET EVOL, V28, P715, DOI 10.1016/j.meegid.2014.09.029; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; JADIN JEAN, 1967, ANN SOC BELG MED TROP PARASITOL MYCOL HUM ANIM, V47, P331; Jervis-Bardy J, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0083-8; Kabula B. I., 2011, Tanzania Journal of Health Research, V13, P163, DOI 10.4314/thrb.v13i3.66915; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Ndiath MO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-269; Nishiguchi MK, 2002, METH TOOLS BIOSCI ME, P249; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Peck GW, 2006, J MED ENTOMOL, V43, P25, DOI 10.1603/0022-2585(2006)043[0025:EOBQAD]2.0.CO;2; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398; Ricci I, 2012, PATHOG GLOB HEALTH, V106, P380, DOI 10.1179/2047773212Y.0000000051; Rosenberg R, 2008, TRENDS PARASITOL, V24, P487, DOI 10.1016/j.pt.2008.07.009; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Wotton RS, 1997, MED VET ENTOMOL, V11, P65, DOI 10.1111/j.1365-2915.1997.tb00291.x; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209	55	43	44	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157529	10.1371/journal.pone.0157529	http://dx.doi.org/10.1371/journal.pone.0157529			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322614	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212000021
J	Pascual, G; Sotomayor, S; Rodriguez, M; Perez-Kohler, B; Kuhnhardt, A; Fernandez-Gutierrez, M; San Roman, J; Bellon, JM				Pascual, Gemma; Sotomayor, Sandra; Rodriguez, Marta; Perez-Koehler, Barbara; Kuehnhardt, Andree; Fernandez-Gutierrez, Mar; San Roman, Julio; Manuel Bellon, Juan			Cytotoxicity of Cyanoacrylate-Based Tissue Adhesives and Short-Term Preclinical In Vivo Biocompatibility in Abdominal Hernia Repair	PLOS ONE			English	Article							N-BUTYL CYANOACRYLATE; MESH FIXATION; MEDICAL ADHESIVE; PATCH FIXATION; CLINICAL-TRIAL; GLUE; N-BUTYL-2-CYANOACRYLATE; SUTURE; SAFETY; EXPERIENCE	Background Cyanoacrylate(CA)-based tissue adhesives, although not widely used, are a feasible option to fix a mesh during abdominal hernia repair, due to its fast action and great bond strength. Their main disadvantage, toxicity, can be mitigated by increasing the length of their alkyl chain. The objective was to assess the in vitro cytotoxicity and in vivo biocompatibility in hernia repair of CAs currently used in clinical practice (Glubran(n-butyl) and Ifabond(n-hexyl)) and a longer-chain CA (OCA(n-octyl)), that has never been used in the medical field. Methods Formaldehyde release and cytotoxicity of unpolymerized(UCAs) and polymerized CAs (PCAs) were evaluated by macroscopic visual assessment, flow cytometry and Alamar Blue assays. In the preclinical evaluation, partial defects were created in the rabbit abdominal wall and repaired by fixing polypropylene prostheses using the CAs. At 14 days post-surgery, animals were euthanized for morphology, macrophage response and cell damage analyses. Results Formaldehyde release was lower as the molecular weight of the monomer increased. The longest side-chain CA(OCA) showed the highest cytotoxicity in the UCA condition. However, after polymerization, was the one that showed better behavior on most occasions. In vivo, all CAs promoted optimal mesh fixation without displacements or detachments. Seroma was evident with the use of Glubran, (four of six animals: 4/6) and Ifabond (2/6), but it was reduced with the use of OCA (1/6). Significantly greater macrophage responses were observed in groups where Glubran and Ifabond were used vs. sutures and OCA. TUNEL-positive cells were significantly higher in the Glubran and OCA groups vs. the suture group. Conclusions Although mild formaldehyde release occurred, OCA was the most cytotoxic during polymerization but the least once cured. The CAs promoted proper mesh fixation and have potential to replace traditional suturing techniques in hernia repair; the CAs exhibited good tissue integration and effective short-term biocompatibility, with the slightest seroma and macrophage response induced by OCA.	[Pascual, Gemma; Sotomayor, Sandra] Univ Alcala, Fac Med & Hlth Sci, Dept Med & Med Special, Madrid, Spain; [Pascual, Gemma; Sotomayor, Sandra; Rodriguez, Marta; Perez-Koehler, Barbara; Fernandez-Gutierrez, Mar; San Roman, Julio; Manuel Bellon, Juan] Networking Biomed Res Ctr Bioengn Biomat & Nanome, Madrid, Spain; [Rodriguez, Marta; Perez-Koehler, Barbara; Kuehnhardt, Andree; Manuel Bellon, Juan] Univ Alcala, Dept Surg Med & Social Sci, Fac Med & Hlth Sci, Madrid, Spain; [Fernandez-Gutierrez, Mar; San Roman, Julio] Inst Polymer Sci & Technol ICTP CSIC, Biomat Grp, Madrid, Spain	Universidad de Alcala; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidad de Alcala; Consejo Superior de Investigaciones Cientificas (CSIC)	Bellon, JM (corresponding author), Networking Biomed Res Ctr Bioengn Biomat & Nanome, Madrid, Spain.; Bellon, JM (corresponding author), Univ Alcala, Dept Surg Med & Social Sci, Fac Med & Hlth Sci, Madrid, Spain.	juanm.bellon@uah.es	Fernandez-gutierrez, Mar/AAV-1378-2020; Fernández-Gutiérrez, Ma. Mar/D-3860-2014; Köhler, Bárbara Pérez/M-1858-2019; PASCUAL, GEMMA/M-6564-2016	Fernández-Gutiérrez, Ma. Mar/0000-0003-1739-1987; Köhler, Bárbara Pérez/0000-0002-5061-1526; Sotomayor Nunez, Sandra/0000-0003-4998-762X; PASCUAL, GEMMA/0000-0002-1623-4384	Ministerio de Economia y Competitividad, Spain [SAF2014-55022-P]	Ministerio de Economia y Competitividad, Spain(Spanish Government)	The study was supported by Grant SAF2014-55022-P from Ministerio de Economia y Competitividad, Spain.	Agresta F, 2007, SURG LAPARO ENDO PER, V17, P91, DOI 10.1097/SLE.0b013e31803c9b7f; Bhatia SK, 2008, CELL BIOL TOXICOL, V24, P315, DOI 10.1007/s10565-007-9040-z; Dilege E, 2010, J INVEST SURG, V23, P262, DOI 10.3109/08941939.2010.481008; Duarte AP, 2012, PROG POLYM SCI, V37, P1031, DOI 10.1016/j.progpolymsci.2011.12.003; Edmonson MB, 2001, AM J EMERG MED, V19, P240; Farouk R, 1996, BRIT J SURG, V83, P1100, DOI 10.1002/bjs.1800830819; Fortelny RH, 2007, SURG ENDOSC, V21, P1781, DOI 10.1007/s00464-007-9243-7; Cerda DG, 2015, SURG TODAY, V45, P939, DOI 10.1007/s00595-014-1056-4; Hollander JE, 1998, ACAD EMERG MED, V5, P1012, DOI 10.1111/j.1553-2712.1998.tb02782.x; Jenkins ED, 2010, HERNIA, V14, P505, DOI 10.1007/s10029-010-0670-3; Jourdan IC, 1998, SURG LAPAROSC ENDOSC, V8, P291, DOI 10.1097/00019509-199808000-00011; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kukleta JF, 2012, HERNIA, V16, P153, DOI 10.1007/s10029-011-0887-9; Kull S, 2009, J SURG RES, V157, pE15, DOI 10.1016/j.jss.2009.01.034; Ladwa N, 2013, INT J SURG, V11, P128, DOI 10.1016/j.ijsu.2012.12.013; Lee YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079761; Leggat PA, 2007, ANZ J SURG, V77, P209, DOI 10.1111/j.1445-2197.2007.04020.x; Lim JI, 2012, MATER LETT, V81, P251, DOI 10.1016/j.matlet.2012.05.027; Lin JC, 2000, J BIOMED MATER RES, V53, P799, DOI 10.1002/1097-4636(2000)53:6<799::AID-JBM22>3.0.CO;2-#; Losi P, 2010, J SURG RES, V163, pE53, DOI 10.1016/j.jss.2010.05.003; Mizrahi B, 2011, ACTA BIOMATER, V7, P3150, DOI 10.1016/j.actbio.2011.04.022; Montanaro L, 2001, BIOMATERIALS, V22, P59, DOI 10.1016/S0142-9612(00)00163-0; Negoescu A, 1996, J HISTOCHEM CYTOCHEM, V44, P959, DOI 10.1177/44.9.8773561; Osmond MH, 1999, ACAD EMERG MED, V6, P171, DOI 10.1111/j.1553-2712.1999.tb00151.x; Paajanen H, 2011, BRIT J SURG, V98, P1245, DOI 10.1002/bjs.7598; Shen YM, 2012, SURGERY, V151, P550, DOI 10.1016/j.surg.2011.09.031; Silvestri A, 2006, AESTHET PLAST SURG, V30, P695, DOI 10.1007/s00266-006-0139-z; Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P751, DOI 10.1163/156856299X00621; Taira BR, 2010, J EMERG MED, V38, P546, DOI 10.1016/j.jemermed.2008.10.009; Testini M, 2010, CAN J SURG, V53, P155; TORIUMI DM, 1990, ARCH OTOLARYNGOL, V116, P546; TSENG YC, 1990, J BIOMED MATER RES, V24, P1355, DOI 10.1002/jbm.820241007; Vauthier C, 2003, ADV DRUG DELIVER REV, V55, P519, DOI 10.1016/S0169-409X(03)00041-3; Vote BJT, 2000, CLIN EXP OPHTHALMOL, V28, P437, DOI 10.1046/j.1442-9071.2000.00351.x; Wang MG, 2013, SURG ENDOSC, V27, P3792, DOI 10.1007/s00464-013-2970-z; Yamamoto LG, 2000, AM J EMERG MED, V18, P511	36	58	59	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157920	10.1371/journal.pone.0157920	http://dx.doi.org/10.1371/journal.pone.0157920			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322731	gold, Green Submitted, Green Published			2022-12-26	WOS:000378212000053
J	Tabata, J; Ichiki, RT; Tanaka, H; Kageyama, D				Tabata, Jun; Ichiki, Ryoko T.; Tanaka, Hirotaka; Kageyama, Daisuke			Sexual versus Asexual Reproduction: Distinct Outcomes in Relative Abundance of Parthenogenetic Mealybugs following Recent Colonization	PLOS ONE			English	Article							PINEAPPLE MEALYBUG; SCALE INSECTS; ENDOSYMBIONTS; EVOLUTION; WILT; PHEROMONE; ANTS	Asexual reproduction, including parthenogenesis in which embryos develop within a female without fertilization, is assumed to confer advantages over sexual reproduction, which includes a "cost of males." Sexual reproduction largely predominates in animals, however, indicating that this cost is outweighed by the genetic and/or ecological benefits of sexuality, including the acquisition of advantageous mutations occurring in different individuals and the elimination of deleterious mutations. But the evolution of sexual reproduction remains unclear, because we have limited examples that demonstrate the relative success of sexual lineages in the face of competition from asexual lineages in the same environment. Here we investigated a sympatric occurrence of sexual and asexual reproduction in the pineapple mealybug, Dysmicoccus brevipes. This pest invaded southwestern Japan, including Okinawa and Ishigaki Islands, in the 1930s in association with imported pineapple plants. Our recent censuses demonstrated that on Okinawa sexually reproducing individuals can coexist with and even dominate asexual individuals in the presence of habitat and resource competition, which is considered to be severe for this nearly immobile insect. Molecular phylogeny based on partial DNA sequences in the mitochondrial and nuclear genomes, as well as the endosymbiotic bacterial genome, revealed that the asexual lineage diverged from a common sexual ancestor in the relatively recent past. In contrast, only the asexual lineage exhibiting obligate apomictic thelytoky was discovered on Ishigaki. Co-existence of the two lineages cannot be explained by the results of laboratory experiments, which showed that the intrinsic rate of increase in the sexual lineage was not obviously superior to that of the asexual lineage. Differences in biotic and/or abiotic selective forces operating on the two islands might be the cause of this discrepancy. This biological system offers a unique opportunity to assess the relative success of sexual versus asexual lineages with an unusual morphology and life cycle.	[Tabata, Jun] Natl Inst Agroenvironm Sci, 3-1-3 Kannondai, Tsukuba, Ibaraki 3058604, Japan; [Ichiki, Ryoko T.] Japan Int Res Ctr Agr Sci, 1-1 Ohwashi, Tsukuba, Ibaraki 3058686, Japan; [Tanaka, Hirotaka] Tottori Prefectural Museum, 2-124 Higashi Machi, Tottori 6800011, Japan; [Kageyama, Daisuke] Natl Inst Agrobiol Sci, 1-2 Ohwashi, Tsukuba, Ibaraki 3058634, Japan	National Institute for Agro-Environmental Sciences (NIAES) Japan; Japan International Research Center for Agricultural Sciences; National Institute of Agrobiological Sciences - Japan	Tabata, J (corresponding author), Natl Inst Agroenvironm Sci, 3-1-3 Kannondai, Tsukuba, Ibaraki 3058604, Japan.	jtabata@affrc.go.jp	Kageyama, Daisuke/B-4460-2010	Kageyama, Daisuke/0000-0002-9026-9825; Tabata, Jun/0000-0001-9095-2694	Showa Seitoku Memorial Foundation [H24-3]; Japan Society for the Promotion of Science [16K08103]	Showa Seitoku Memorial Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the grant-in-aid for scientific research (H24-3) from the Showa Seitoku Memorial Foundation (http://www.f-showa.or.jp) and the grant-in-aid for scientific research (16K08103) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp) to JT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, TABLES OF MONTHLY CL, V4, P11; BEARDSLEY JOHN W., 1965, PROC HAWAII ENTOMOL SOC, V19, P55; Ben-Dov Y., 1994, SYSTEMATIC CATALOGUE; Bertin A, 2013, ANN ENTOMOL SOC AM, V106, P604, DOI 10.1603/AN13030; Carter W, 1942, J ECON ENTOMOL, V35, P10, DOI 10.1093/jee/35.1.10; de Alfonso I, 2012, J AGR FOOD CHEM, V60, P11959, DOI 10.1021/jf304065d; Dunkelblum E, 1999, PHEROMONES OF NON-LEPIDOPTERAN INSECTS ASSOCIATED WITH AGRICULTURAL PLANTS, P251; Garcia M, 2016, SCALENET A LITERATUR, V1, P27; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Ito K, 1938, J ECON ENTOMOL, V31, P291, DOI 10.1093/jee/31.2.291; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kawai S., 1980, SCALE INSECTS OF JAP; Kohama T, 2002, B OKINAWA PREF MUS, V28, P55; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Lively CM, 2010, J HERED, V101, pS13, DOI 10.1093/jhered/esq010; LOHER W, 1981, P NATL ACAD SCI-BIOL, V78, P7835, DOI 10.1073/pnas.78.12.7835; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Meirmans S, 2012, Q REV BIOL, V87, P19, DOI 10.1086/663945; Meirmans S, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P21, DOI 10.1007/978-90-481-2770-2_2; NUR U, 1971, AM ZOOL, V11, P301; Nur U., 1980, Symposia of the Royal Entomological Society of London, P97; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; ROHRBACH KG, 1988, PLANT DIS, V72, P558, DOI 10.1094/PD-72-0558; Ross L, 2012, ECOL EVOL, V2, P1071, DOI 10.1002/ece3.222; Ross L, 2010, BIOL REV, V85, P807, DOI 10.1111/j.1469-185X.2010.00127.x; Ross L, 2009, CURR BIOL, V19, pR184, DOI 10.1016/j.cub.2008.12.023; Schwander T, 2011, CURR BIOL, V21, P1129, DOI 10.1016/j.cub.2011.05.026; Sether DM, 1998, PHYTOPATHOLOGY, V88, P1224, DOI 10.1094/PHYTO.1998.88.11.1224; Shoda M, 2012, BREEDING SCI, V62, P352, DOI 10.1270/jsbbs.62.352; SMITH JM, 1978, EVOLUTION SEX; Tabata J, 2015, J CHEM ECOL, V41, P194, DOI 10.1007/s10886-015-0545-2; Tabata J, 2012, NATURWISSENSCHAFTEN, V99, P567, DOI 10.1007/s00114-012-0935-z; Thailayil J, 2011, P NATL ACAD SCI USA, V108, P13677, DOI 10.1073/pnas.1104738108; Thao ML, 2002, APPL ENVIRON MICROB, V68, P3190, DOI 10.1128/AEM.68.7.3190-3197.2002; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueda S, 2008, P ROY SOC B-BIOL SCI, V275, P2319, DOI 10.1098/rspb.2008.0573; van der Kooi CJ, 2014, EVOLUTION, V68, P1883, DOI 10.1111/evo.12402; VOGLER AP, 1993, MOL ECOL, V2, P375, DOI 10.1111/j.1365-294X.1993.tb00030.x; von Dohlen CD, 2001, NATURE, V412, P433, DOI 10.1038/35086563; West SA, 1999, J EVOLUTION BIOL, V12, P1003; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; Xu J, 2011, J INSECT PHYSIOL, V57, P385, DOI 10.1016/j.jinsphys.2010.12.006	45	9	10	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0156587	10.1371/journal.pone.0156587	http://dx.doi.org/10.1371/journal.pone.0156587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322381	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212000007
J	Volkov, P; Olsson, AH; Gillberg, L; Jorgensen, SW; Brons, C; Eriksson, KF; Groop, L; Jansson, PA; Nilsson, E; Ronn, T; Vaag, A; Ling, C				Volkov, Petr; Olsson, Anders H.; Gillberg, Linn; Jorgensen, Sine W.; Brons, Charlotte; Eriksson, Karl-Fredrik; Groop, Leif; Jansson, Per-Anders; Nilsson, Emma; Ronn, Tina; Vaag, Allan; Ling, Charlotte			A Genome-Wide mQTL Analysis in Human Adipose Tissue Identifies Genetic Variants Associated with DNA Methylation, Gene Expression and Metabolic Traits	PLOS ONE			English	Article							BODY-MASS INDEX; SKELETAL-MUSCLE; 1ST-DEGREE RELATIVES; SUSCEPTIBILITY LOCI; GLYCEMIC TRAITS; TWINS REVEALS; PATTERNS; IMPACT; METAANALYSIS; EPIGENETICS	Little is known about the extent to which interactions between genetics and epigenetics may affect the risk of complex metabolic diseases and/or their intermediary phenotypes. We performed a genome-wide DNA methylation quantitative trait locus (mQTL) analysis in human adipose tissue of 119 men, where 592,794 single nucleotide polymorphisms (SNPs) were related to DNA methylation of 477,891 CpG sites, covering 99% of RefSeq genes. SNPs in significant mQTLs were further related to gene expression in adipose tissue and obesity related traits. We found 101,911 SNP-CpG pairs (mQTLs) in cis and 5,342 SNP-CpG pairs in trans showing significant associations between genotype and DNA methylation in adipose tissue after correction for multiple testing, where cis is defined as distance less than 500 kb between a SNP and CpG site. These mQTLs include reported obesity, lipid and type 2 diabetes loci, e.g. ADCY3/POMC, APOA5, CETP, FADS2, GCKR, SORT1 and LEPR. Significant mQTLs were overrepresented in intergenic regions meanwhile underrepresented in promoter regions and CpG islands. We further identified 635 SNPs in significant cis-mQTLs associated with expression of 86 genes in adipose tissue including CHRNA5, G6PC2, GPX7, RPL27A, THNSL2 and ZFP57. SNPs in significant mQTLs were also associated with body mass index (BMI), lipid traits and glucose and insulin levels in our study cohort and public available consortia data. Importantly, the Causal Inference Test (CIT) demonstrates how genetic variants mediate their effects on metabolic traits (e.g. BMI, cholesterol, highdensity lipoprotein (HDL), hemoglobin A1c (HbA1c) and homeostatic model assessment of insulin resistance (HOMA-IR)) via altered DNA methylation in human adipose tissue. This study identifies genome-wide interactions between genetic and epigenetic variation in both cis and trans positions influencing gene expression in adipose tissue and in vivo (dys) metabolic traits associated with the development of obesity and diabetes.	[Volkov, Petr; Olsson, Anders H.; Nilsson, Emma; Ronn, Tina; Ling, Charlotte] Lund Univ, Clin Res Ctr, Ctr Diabet, Dept Clin Sci Epigenet & Diabet, Malmo, Sweden; [Olsson, Anders H.; Gillberg, Linn; Jorgensen, Sine W.; Brons, Charlotte; Nilsson, Emma; Vaag, Allan] Rigshosp, Dept Endocrinol Diabet & Metab, DK-2100 Copenhagen, Denmark; [Eriksson, Karl-Fredrik] Lund Univ, Dept Clin Sci, Vasc Dis, Malmo, Sweden; [Groop, Leif] Lund Univ, Ctr Diabet, Clin Res Ctr, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Jansson, Per-Anders] Univ Gothenburg, Sahlgrenska Univ Hosp, Ctr Excellence Cardiovasc & Metab Res, Lundberg Lab Diabet Res,Dept Mol & Clin Med,Inst, Gothenburg, Sweden	Lund University; Rigshospitalet; University of Copenhagen; Lund University; Lund University; Sahlgrenska University Hospital; University of Gothenburg	Ling, C (corresponding author), Lund Univ, Clin Res Ctr, Ctr Diabet, Dept Clin Sci Epigenet & Diabet, Malmo, Sweden.	charlotte.ling@med.lu.se	Ling, Charlotte/Q-2432-2015; Gillberg, Linn/A-1417-2017	Ling, Charlotte/0000-0003-0587-7154; Gillberg, Linn/0000-0003-0588-1663; Ronn, Tina/0000-0001-7622-800X; Brons, Charlotte/0000-0002-6653-9020; Vaag, Allan Arthur/0000-0002-3690-2191	Swedish Research Council [2013/3018, 523-2010-1062]; Region Skane (ALF); Knut and Alice Wallenberg Foundation; Novo Nordisk Foundation; EFSD/Lilly Fellowship; Soderberg Foundation; Swedish Diabetes foundation; Pahlsson Foundation; EXODIAB; Linne grant [B31 5631/2006]; Danish Strategic Research Council; Danish Council for Independent Research; Rigshospitalet; University of Copenhagen; Steno Diabetes Center; Danish Diabetes Academy; Novo Nordisk Fonden [NNF14OC0010995] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Region Skane (ALF); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); EFSD/Lilly Fellowship; Soderberg Foundation; Swedish Diabetes foundation; Pahlsson Foundation; EXODIAB; Linne grant; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Rigshospitalet; University of Copenhagen; Steno Diabetes Center; Danish Diabetes Academy; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Swedish Research Council (2013/3018, http://www.vr.se/, CL; 523-2010-1062, http://www.vr.se/, CL), Region Skane (ALF), Knut and Alice Wallenberg Foundation, Novo Nordisk Foundation, EFSD/Lilly Fellowship, Soderberg Foundation, The Swedish Diabetes foundation, Pahlsson Foundation, EXODIAB, Linne grant (B31 5631/2006), The Danish Strategic Research Council, The Danish Council for Independent Research, Rigshospitalet, University of Copenhagen, Steno Diabetes Center, and Danish Diabetes Academy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Swedish Research Council, Region Skane (ALF), Knut and Alice Wallenberg Foundation, Novo Nordisk Foundation, EFSD/Lilly Fellowship, Soderberg Foundation, The Swedish Diabetes foundation, Pahlsson Foundation, EXO-DIAB, Linne grant (B31 5631/2006), The Danish Strategic Research Council, The Danish Council for Independent Research, Rigshospitalet, University of Copenhagen, Steno Diabetes Center, Danish Diabetes Academy.	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Brons C, 2008, J CLIN ENDOCR METAB, V93, P3885, DOI 10.1210/jc.2008-0630; Brons C, 2010, J CLIN ENDOCR METAB, V95, P3048, DOI 10.1210/jc.2009-2413; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Cheung YH, 2011, HUM GENET, V129, P161, DOI 10.1007/s00439-010-0908-2; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Das SK, 2014, WORLD J DIABETES, V5, P97, DOI 10.4239/wjd.v5.i2.97; Dayeh TA, 2013, DIABETOLOGIA, V56, P1036, DOI 10.1007/s00125-012-2815-7; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Drong AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055923; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Elgzyri T, 2012, J CLIN ENDOCR METAB, V97, pE1332, DOI 10.1210/jc.2011-3037; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002695; Franks PW, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-88; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Groop L, 2014, MOL CELL ENDOCRINOL, V382, P726, DOI 10.1016/j.mce.2013.04.002; Grundberg E, 2013, AM J HUM GENET, V93, P876, DOI 10.1016/j.ajhg.2013.10.004; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hindorff LA, CATALOG PUBLISHED GE; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jacobsen SC, 2012, DIABETOLOGIA, V55, P3341, DOI 10.1007/s00125-012-2717-8; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jorgensen SW, 2015, DIABETOLOGIA, V58, P178, DOI 10.1007/s00125-014-3406-6; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kilpelainen TO, 2011, NAT GENET, V43, P753, DOI 10.1038/ng.866; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Ling C, 2007, J CLIN INVEST, V117, P3427, DOI 10.1172/JCI30938; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Lowe JK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000365; Ma L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-55; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Mahajan A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004876; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Millstein J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-23; Nilsson E, 2014, DIABETES, V63, P2962, DOI 10.2337/db13-1459; Nitert MD, 2012, DIABETES, V61, P3322, DOI 10.2337/db11-1653; Ollikainen M, 2010, HUM MOL GENET, V19, P4176, DOI 10.1093/hmg/ddq336; Olsson AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004735; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Ronn T, 2015, HUM MOL GENET, V24, P3792, DOI 10.1093/hmg/ddv124; Ronn T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003572; Ryckman KK, 2014, HUM GENET, V133, P1049, DOI 10.1007/s00439-014-1450-4; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schwender Holger, 2013, TRIO TESTING SNPS SN; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shiina T, 2004, TISSUE ANTIGENS, V64, P631, DOI 10.1111/j.1399-0039.2004.00327.x; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Williams MJ, 2012, CELL MOL LIFE SCI, V69, P3819, DOI 10.1007/s00018-012-1022-5; Yang BT, 2011, DIABETOLOGIA, V54, P360, DOI 10.1007/s00125-010-1967-6; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005; Zhu AZX, 2013, ADDICTION, V108, P1818, DOI 10.1111/add.12250; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	87	58	61	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157776	10.1371/journal.pone.0157776	http://dx.doi.org/10.1371/journal.pone.0157776			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322064	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212000044
J	Chair, H; Traore, RE; Duval, MF; Rivallan, R; Mukherjee, A; Aboagye, LM; Van Rensburg, J; Andrianavalona, V; de Carvalho, MAAP; Saborio, F; Prana, MS; Komolong, B; Lawac, F; Lebot, V				Chair, H.; Traore, R. E.; Duval, M. F.; Rivallan, R.; Mukherjee, A.; Aboagye, L. M.; Van Rensburg, J.; Andrianavalona, V.; Pinheiro de Carvalho, M. A. A.; Saborio, F.; Prana, M. Sri; Komolong, B.; Lawac, F.; Lebot, V.			Genetic Diversification and Dispersal of Taro (Colocasia esculenta (L.) Schott)	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE MARKERS; PAPUA-NEW-GUINEA; SOUTHEAST-ASIA; RAPD MARKERS; SWEET-POTATO; DIVERSITY; PLANTS; ORIGIN; GENOTYPE; OCEANIA	Taro (Colocasia esculenta (L.) Schott) is widely distributed in tropical and sub-tropical areas. However, its origin, diversification and dispersal remain unclear. While taro genetic diversity has been documented at the country and regional levels in Asia and the Pacific, few reports are available from Americas and Africa where it has been introduced through human migrations. We used eleven microsatellite markers to investigate the diversity and diversification of taro accessions from nineteen countries in Asia, the Pacific, Africa and America. The highest genetic diversity and number of private alleles were observed in Asian accessions, mainly from India. While taro has been diversified in Asia and the Pacific mostly via sexual reproduction, clonal reproduction with mutation appeared predominant in African and American countries investigated. Bayesian clustering revealed a first genetic group of diploids from the Asia-Pacific region and to a second diploid-triploid group mainly from India. Admixed cultivars between the two genetic pools were also found. In West Africa, most cultivars were found to have originated from India. Only one multi-locus lineage was assigned to the Asian pool, while cultivars in Madagascar originated from India and Indonesia. The South African cultivars shared lineages with Japan. The Caribbean Islands cultivars were found to have originated from the Pacific, while in Costa Rica they were from India or admixed between Indian and Asian groups. Taro dispersal in the different areas of Africa and America is thus discussed in the light of available records of voyages and settlements.	[Chair, H.; Duval, M. F.; Rivallan, R.] CIRAD, UMR AGAP, Montpellier, France; [Traore, R. E.] Univ Ouagadougou, UFR SVT, Ouagadougou, Burkina Faso; [Mukherjee, A.] CTCRI, Thiruvananthapuram, Kerala, India; [Aboagye, L. M.] CSRI, Accra, Ghana; [Van Rensburg, J.] ARC, Pretoria, South Africa; [Andrianavalona, V.] FOFIFA, Antananarivo, Madagascar; [Pinheiro de Carvalho, M. A. A.] Univ Madeira, BG ISOPlexis, Funchal, Portugal; [Saborio, F.] Univ Costa Rica, San Jose, Costa Rica; [Prana, M. Sri] LIPI, Bogor, West Java, Indonesia; [Komolong, B.] LAE, NARI, Lae, Morobe Province, Guinea; [Lawac, F.] VARTC, Santo, Vanuatu; [Lebot, V.] CIRAD, UMR AGAP, Port Vila, Vanuatu	CIRAD; Universite de Montpellier; Indian Council of Agricultural Research (ICAR); ICAR - Central Tuber Crops Research Institute; Agricultural Research Council of South Africa; Universidade da Madeira; Universidad Costa Rica; Indonesian Institute of Sciences; CIRAD	Chair, H (corresponding author), CIRAD, UMR AGAP, Montpellier, France.	hana.chair@cirad.fr			Europe-Aid project "Adapting clonally propagated crops to climatic and commercial changes" [DCI-FOOD/2010/230-267 SPC]; French Foreign Ministry; CIRAD	Europe-Aid project "Adapting clonally propagated crops to climatic and commercial changes"; French Foreign Ministry; CIRAD	This study was funded by grant no. DCI-FOOD/2010/230-267 SPC, Europe-Aid project "Adapting clonally propagated crops to climatic and commercial changes." RET was supported by a doctoral grant from the French Foreign Ministry and grant from CIRAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud-Haond S, 2005, J HERED, V96, P434, DOI 10.1093/jhered/esi043; Attri B. L., 2013, Indian Forester, V139, P452; Beaujard P, 2011, AZANIA, V46, P169, DOI 10.1080/0067270X.2011.580142; Blench R. M., 2009, ETHNOBOTANY RES APPL, V7, P363, DOI DOI 10.17348/ERA.7.0.363-380; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Burlakova LE, 2009, RESTOR ECOL, V17, P433, DOI 10.1111/j.1526-100X.2008.00429.x; COATES DJ, 1988, CYTOLOGIA, V53, P551, DOI 10.1508/cytologia.53.551; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Duss RP, 1897, FLORE PHANEROGAMIQUE; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fullagar R, 2006, J ARCHAEOL SCI, V33, P595, DOI 10.1016/j.jas.2005.07.020; Fuller DQ, 2011, ANTIQUITY, V85, P544, DOI 10.1017/S0003598X00067934; Goncalves RF, 2013, FOOD CHEM, V141, P3480, DOI 10.1016/j.foodchem.2013.06.009; Horrocks M, 2007, J ARCHAEOL SCI, V34, P739, DOI 10.1016/j.jas.2006.07.011; Hu K, 2009, MOL ECOL RESOUR, V9, P582, DOI 10.1111/j.1755-0998.2008.02441.x; Hunt HV, 2013, GENET RESOUR CROP EV, V60, P1695, DOI 10.1007/s10722-012-9952-1; Irwin SV, 1998, EUPHYTICA, V99, P183, DOI 10.1023/A:1018309417762; Isshiki S, 1999, J JPN SOC HORTIC SCI, V68, P774, DOI 10.2503/jjshs.68.774; Ivancic Anton, 1999, Pacific Science, V53, P273; Jianchu X., 2001, BOTANY, V55, P14, DOI DOI 10.1007/BF02864543; Kreike CM, 2004, THEOR APPL GENET, V109, P761, DOI 10.1007/s00122-004-1691-z; KURUVILLA KM, 1981, EUPHYTICA, V30, P405, DOI 10.1007/BF00034004; Kusuma P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1394-7; Lakhanpaul S, 2003, GENET RESOUR CROP EV, V50, P603, DOI 10.1023/A:1024498408453; LEBOT V, 1991, EUPHYTICA, V56, P55; Lebot V, 2004, GENET RESOUR CROP EV, V51, P381, DOI 10.1023/B:GRES.0000023453.30948.4d; Lebot V., 2009, TROPICAL ROOT AND TU; LOY TH, 1992, ANTIQUITY, V66, P898, DOI 10.1017/S0003598X00044811; Mace ES, 2002, GENOME, V45, P823, DOI [10.1139/g02-045, 10.1139/G02-045]; MATTHEWS P, 1992, JPN J BREED, V42, P825; Matthews P.J., 1991, INDO PACIFIC PREHIST, V11, P69, DOI [10.7152/bippa.v11i0.11374, DOI 10.7152/BIPPA.V11I0.11374]; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Ndaeyo NU, 2003, INDIAN J AGR SCI, V73, P194; Nunes RSC, 2012, HORTIC BRAS, V30, P106, DOI 10.1590/S0102-05362012000100018; Ochiai T, 2001, EUPHYTICA, V122, P219, DOI 10.1023/A:1012967922502; Osada M., 2002, SANCTIONS AND HONORA; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perrier X., 2006, DARWIN SOFTWARE; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; PORTERES ROLAND, 1960, JOUR AGRIC TROP ET BOT APPL, V7, P169; Pritchard JK, 2000, GENETICS, V155, P945; Quero-Garcia J, 2006, EUPHYTICA, V151, P187, DOI 10.1007/s10681-006-9139-y; Ramanatha RV, 2010, THE GLOBAL DIVERSITY; Risterucci AM, 2000, THEOR APPL GENET, V101, P948, DOI 10.1007/s001220051566; Rodriguez Manzano A., 2001, Plant Genetic Resources Newsletter, P31; Roullier C, 2013, HEREDITY, V110, P594, DOI 10.1038/hdy.2013.14; Roullier C, 2013, P NATL ACAD SCI USA, V110, P2205, DOI 10.1073/pnas.1211049110; Sampson JF, 2012, BIOL J LINN SOC, V105, P218, DOI 10.1111/j.1095-8312.2011.01787.x; Sanou H, 2015, CROP SCI, V55, P749, DOI 10.2135/cropsci2014.02.0165; Sanou J, 2012, AGROFOREST SYST, V85, P431, DOI 10.1007/s10457-011-9405-4; Santosa E, 2007, MOL ECOL NOTES, V7, P814, DOI 10.1111/j.1471-8286.2007.01713.x; Sardos J, 2012, GENET RESOUR CROP EV, V59, P805, DOI 10.1007/s10722-011-9720-7; Saur Etienne, 2003, Bois et Forets des Tropiques, P85; Scarcelli N, 2011, GENETICA, V139, P1055, DOI 10.1007/s10709-011-9607-8; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Singh D, 2008, GENET RESOUR CROP EV, V55, P811, DOI 10.1007/s10722-007-9286-6; Teixeira H, 2014, PLOS ONE, V9; Vandenbroucke H, 2015, GENET RESOUR CROP EV	60	41	42	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157712	10.1371/journal.pone.0157712	http://dx.doi.org/10.1371/journal.pone.0157712			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314588	Green Published, Green Submitted, gold			2022-12-26	WOS:000378030000046
J	Singh, R				Singh, Raghvendra			Model Predicts That MKP1 and TAB1 Regulate p38 alpha Nuclear Pulse and Its Basal Activity through Positive and Negative Feedback Loops in Response to IL-1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; P38 MAP-KINASE; RECEPTOR-ASSOCIATED KINASE; NF-KAPPA-B; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; INDUCED APOPTOSIS; GENE-EXPRESSION; DOWN-REGULATION; INDEPENDENT ACTIVATION	Interleukin-1 mediates inflammation and stress response through nuclear activity of p38 alpha. Although IL-1 receptor is not degraded, p38 alpha activation is transient. IL-1 also causes cell migration and EMT by modulating cell-cell junctions. Although molecules involved in p38 activation are known, mechanism of the transient nuclear response and its basal activity remains unknown. By mathematical modeling of IL1/p38 signaling network, we show that IL-1 induces robust p38 alpha activation both in the nucleus and in the cytoplasm/membrane. While nuclear response consists of an acute phase, membrane response resembles a step change. Following stimulation, p38 alpha activity returns to a basal level in absence of receptor degradation. While nuclear pulse is controlled by MKP1 through a negative feedback to pp38, its basal activity is controlled by both TAB1 and MKP1 through a positive feedback loop. Our model provides insight into the mechanism of p38 alpha activation, reason for its transient nuclear response, and explanation of the basal activity of MKK3/6 and p38 alpha, which has been experimentally observed by other groups.	[Singh, Raghvendra] Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Singh, R (corresponding author), Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India.	raghvend@iitk.ac.in			Indian Institute of Technology Kanpur grant [IITK/CHE/20090282]	Indian Institute of Technology Kanpur grant	This work was supported by Indian Institute of Technology Kanpur grant IITK/CHE/20090282 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Indian Institute of Technology Kanpur grant IITK/CHE/20090282 to RS.	Bakin AV, 2002, J CELL SCI, V115, P3193; Bani-Hani AH, 2008, J UROLOGY, V180, P461, DOI 10.1016/j.juro.2008.04.001; Carlson CJ, 2003, DIABETES, V52, P634, DOI 10.2337/diabetes.52.3.634; CHARLES CH, 1993, P NATL ACAD SCI USA, V90, P5292, DOI 10.1073/pnas.90.11.5292; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; CURTIS BM, 1990, J IMMUNOL, V144, P1295; De Nicola GF, 2013, NAT STRUCT MOL BIOL, V20, P1182, DOI 10.1038/nsmb.2668; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FACCIOLI LH, 1990, AGENTS ACTIONS, V30, P344, DOI 10.1007/BF01966298; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Gallez-Hawkins G, 2002, SCAND J IMMUNOL, V55, P592, DOI 10.1046/j.1365-3083.2002.01099.x; Gang L, 2006, J BIOL CHEM, V281, P6087, DOI 10.1074/jbc.M507610200; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gong XW, 2010, J CELL BIOCHEM, V110, P1420, DOI 10.1002/jcb.22675; Gorog DA, 2004, CARDIOVASC RES, V61, P123, DOI 10.1016/j.cardiores.2003.09.034; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hu J, 2002, J IMMUNOL, V168, P3910, DOI 10.4049/jimmunol.168.8.3910; Hu JH, 2007, CELL SIGNAL, V19, P393, DOI 10.1016/j.cellsig.2006.07.010; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Inagaki M, 2008, J BIOL CHEM, V283, P33080, DOI 10.1074/jbc.M807574200; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kim SY, 2002, NEUROREPORT, V13, P2483, DOI 10.1097/00001756-200212200-00021; Kojima T, 2003, CELL COMMUN ADHES, V10, P437, DOI 10.1080/714040465; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Liao P, 2002, CIRC RES, V90, P190, DOI 10.1161/hh0202.104220; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; MATSUSHIMA K, 1986, J IMMUNOL, V137, P3183; McDermott EP, 2002, J BIOL CHEM, V277, P7808, DOI 10.1074/jbc.M108133200; McMullen ME, 2005, J BIOL CHEM, V280, P20995, DOI 10.1074/jbc.M407060200; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Nagata Y, 1999, BLOOD, V94, P853, DOI 10.1182/blood.V94.3.853.415a12_853_863; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2012, P NATL ACAD SCI USA, V109, P3365, DOI 10.1073/pnas.1116188109; Pathak S, 2012, EMBO J, V31, P1394, DOI 10.1038/emboj.2012.8; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rastogi R, 2011, AM J RESP CRIT CARE, V183, P500, DOI 10.1164/rccm.201005-0792OC; Ridley SH, 1997, J IMMUNOL, V158, P3165; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Tanno M, 2003, CIRC RES, V93, P254, DOI 10.1161/01.RES.0000083490.43943.85; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tomida T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9350; Volpe F, 1997, FEBS LETT, V419, P41, DOI 10.1016/S0014-5793(97)01426-9; Waas WF, 2001, J BIOL CHEM, V276, P5676, DOI 10.1074/jbc.M008787200; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yamamoto T, 2005, J HEPATOL, V42, P707, DOI 10.1016/j.jhep.2004.12.033; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	63	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157572	10.1371/journal.pone.0157572	http://dx.doi.org/10.1371/journal.pone.0157572			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314954	Green Submitted, gold, Green Published			2022-12-26	WOS:000378030000036
J	Asher, E; Abu-Much, A; Goldenberg, I; Segev, A; Sabbag, A; Mazin, I; Shlezinger, M; Atar, S; Zahger, D; Polak, A; Beigel, R; Matetzky, S				Asher, Elad; Abu-Much, Arsalan; Goldenberg, Ilan; Segev, Amit; Sabbag, Avi; Mazin, Israel; Shlezinger, Meital; Atar, Shaul; Zahger, Doron; Polak, Arthur; Beigel, Roy; Matetzky, Shlomi		Platelets Thrombosis Sheba-PLATIS	Incidence and Clinical Features of Early Stent Thrombosis in the Era of New P2y12 Inhibitors (PLATIS-2)	PLOS ONE			English	Article							DUAL-ANTIPLATELET THERAPY; PERCUTANEOUS CORONARY INTERVENTION; ZOTAROLIMUS-ELUTING STENT; CLOPIDOGREL THERAPY; PREMATURE DISCONTINUATION; INTRACORONARY ULTRASOUND; PLATELET REACTIVITY; IMPLANTATION; PREDICTORS; TRIAL	Early stent thrombosis (EST) (<= 30 days after stent implantation) is a relatively rare but deleterious complication of percutaneous coronary intervention (PCI). Administration of newer P2Y12 inhibitors (prasugrel and ticagrelor) combined with aspirin has been shown to reduce the incidence of sub-acute and late stent thrombosis, compared with clopidogrel. We investigated the "real life" incidence of EST in patients from a large acute coronary syndrome (ACS) national registry, where newer P2Y12 inhibitors are widely used. Patients were derived from the ACS Israeli Survey (ACSIS), conducted during 2006, 2008, 2010 and 2013. Major adverse cardiac events (MACE) at 30days were defined as all-cause death, recurrent ACS, EST and stroke. Of the 4717 ACS patients who underwent PCI and stenting, 83% received clopidogrel and 17% newer P2Y12 inhibitors. The rate of EST was similar in both groups (1.7% in the newer P2Y12 inhibitor group vs. 1.4% in the clopidogrel-treated patients, p = 0.42). Results were consistent after multivariate analysis (adjusted HR = 1.06 [p = 0.89]). MACE occurred in 6.4% in the newer P2Y12 inhibitor group compared with 9.2% in the clopidogrel group (P < 0.01). However, multivariate logistic regression modeling showed that treatment with newer P2Y12 inhibitors was not significantly associated with the secondary endpoint of MACE when compared with clopidogrel therapy [OR = 1.26 95%CI (0.93-1.73), P = 0.136]. The incidence of "real life" EST at 1month is relatively low, and appears to be similar in patients who receive newer P2Y12 inhibitors as well as in those who receive clopidogrel.	[Asher, Elad; Abu-Much, Arsalan; Goldenberg, Ilan; Segev, Amit; Sabbag, Avi; Mazin, Israel; Shlezinger, Meital; Beigel, Roy; Matetzky, Shlomi] Sheba Med Ctr, Leviev Heart Ctr, Tel Hashomer, Israel; [Asher, Elad; Abu-Much, Arsalan; Goldenberg, Ilan; Segev, Amit; Sabbag, Avi; Mazin, Israel; Shlezinger, Meital; Beigel, Roy; Matetzky, Shlomi] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Atar, Shaul] Galilee Med Ctr, Div Cardiol, Nahariyya, Israel; [Zahger, Doron] Soroka Med Ctr, Dept Cardiol, Beer Sheva, Israel; [Polak, Arthur] Hadassah Univ Hosp, Inst Heart, IL-91120 Jerusalem, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Western Galilee Hospital; Ben Gurion University; Soroka Medical Center; Hebrew University of Jerusalem	Asher, E (corresponding author), Sheba Med Ctr, Leviev Heart Ctr, Tel Hashomer, Israel.; Asher, E (corresponding author), Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	el.asher@gmail.com	Asher, Elad/I-3544-2019; sabbag, avi/AFU-5323-2022; Sabbag, Avi/AAA-1532-2021	Asher, Elad/0000-0003-3381-605X; sabbag, avi/0000-0003-4295-6679; SEgev, Amit/0000-0002-2290-0400				[Anonymous], 2015, PROMETHEOUS TRIAL SO; Aoki J, 2009, CIRCULATION, V119, P687, DOI 10.1161/CIRCULATIONAHA.108.804203; Asher E, 2016, THROMB HAEMOSTASIS, V115, P433, DOI 10.1160/TH15-05-0384; Beinart R, 2010, AM HEART J, V159, P118, DOI 10.1016/j.ahj.2009.09.020; Buonamici P, 2007, J AM COLL CARDIOL, V49, P2312, DOI 10.1016/j.jacc.2007.01.094; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; COLOMBO A, 1995, CIRCULATION, V91, P1676, DOI 10.1161/01.CIR.91.6.1676; Colombo A, 2014, J AM COLL CARDIOL, V64, P2086, DOI 10.1016/j.jacc.2014.09.008; Costa F, 2015, EUR HEART J, V36, P1242, DOI 10.1093/eurheartj/ehv038; Dangas GD, 2011, CIRCULATION, V123, P1745, DOI 10.1161/CIRCULATIONAHA.110.981688; Feres F, 2012, AM HEART J, V164, P810, DOI 10.1016/j.ahj.2012.09.009; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Gilard M, 2015, J AM COLL CARDIOL, V65, P777, DOI 10.1016/j.jacc.2014.11.008; GOLDBERG SL, 1994, J AM COLL CARDIOL, V24, P996, DOI 10.1016/0735-1097(94)90861-3; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; James S, 2009, AM HEART J, V157, P599, DOI 10.1016/j.ahj.2009.01.003; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Kirtane AJ, 2014, AM COLL CARDIOL, V64; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Monassier JP, 1997, CATHETER CARDIO DIAG, V42, P243, DOI 10.1002/(SICI)1097-0304(199711)42:3<243::AID-CCD1>3.0.CO;2-C; Montalescot G, 2014, NEW ENGL J MED, V371, P1016, DOI 10.1056/NEJMoa1407024; NAKAMURA S, 1994, CIRCULATION, V89, P2026, DOI 10.1161/01.CIR.89.5.2026; Nakano M, 2014, J AM COLL CARDIOL, V63, P2510, DOI 10.1016/j.jacc.2014.02.607; Park DW, 2006, AM J CARDIOL, V98, P352, DOI 10.1016/j.amjcard.2006.02.039; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Piccolo R, 2014, ANGIOLOGY, V65, P130, DOI 10.1177/0003319712467530; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Schulz-Schupke S, 2015, EUR HEART J, V36, P1252, DOI 10.1093/eurheartj/ehu523; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Steg PG, 2013, CIRCULATION, V128, P1055, DOI 10.1161/CIRCULATIONAHA.113.002589; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Urban P, 2006, CIRCULATION, V113, P1434, DOI 10.1161/CIRCULATIONAHA.104.532242; van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	39	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157437	10.1371/journal.pone.0157437	http://dx.doi.org/10.1371/journal.pone.0157437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310147	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800071
J	Gliszczynska, A; Niezgoda, N; Gladkowski, W; Czarnecka, M; Switalska, M; Wietrzyk, J				Gliszczynska, Anna; Niezgoda, Natalia; Gladkowski, Witold; Czarnecka, Marta; Switalska, Marta; Wietrzyk, Joanna			Synthesis and Biological Evaluation of Novel Phosphatidylcholine Analogues Containing Monoterpene Acids as Potent Antiproliferative Agents	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; PHOSPHOLIPASE-D; CELLS; INHIBITION; FARNESOL; LACTONE	The synthesis of novel phosphatidylcholines with geranic and citronellic acids in sn-1 and sn-2 positions is described. The structured phospholipids were obtained in high yields (59-87%) and evaluated in vitro for their cytotoxic activity against several cancer cell lines of different origin: MV4-11, A-549, MCF-7, LOVO, LOVO/DX, HepG2 and also towards non-cancer cell line BALB/3T3 (normal mice fibroblasts). The phosphatidylcholines modified with monoterpene acid showed a significantly higher antiproliferative activity than free monoterpene acids. The highest activity was observed for the terpene-phospholipids containing the isoprenoid acids in sn-1 position of phosphatidylcholine and palmitic acid in sn-2.	[Gliszczynska, Anna; Niezgoda, Natalia; Gladkowski, Witold; Czarnecka, Marta] Wroclaw Univ Environm & Life Sci, Dept Chem, Norwida 25, PL-50375 Wroclaw, Poland; [Switalska, Marta; Wietrzyk, Joanna] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Expt Oncol, Weigla 12, PL-53114 Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Gliszczynska, A (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Chem, Norwida 25, PL-50375 Wroclaw, Poland.	anna.gliszczynska@wp.pl	Gładkowski, Witold/A-5750-2017; Niezgoda, Natalia/A-2387-2017; Czarnecka, Marta/B-6787-2017; Wietrzyk, Joanna/O-4392-2018; Niezgoda, Natalia/HHN-1650-2022; Gliszczyńska, Anna/A-2601-2017	Gładkowski, Witold/0000-0002-3271-779X; Niezgoda, Natalia/0000-0002-1154-9707; Wietrzyk, Joanna/0000-0003-4980-6606; Niezgoda, Natalia/0000-0002-1154-9707; Gliszczyńska, Anna/0000-0002-0218-6369; Switalska, Marta/0000-0001-7920-2251	National Science Center of Poland [2013/09/D/NZ9/02457]; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	National Science Center of Poland(National Science Centre, Poland); Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	This project was financed by National Science Center of Poland no. 2013/09/D/NZ9/02457. Publication was supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018 (http://know.wroc.pl).	ADANY I, 1994, CANCER LETT, V79, P175, DOI 10.1016/0304-3835(94)90257-7; Bezrukov SM, 2000, CURR OPIN COLLOID IN, V5, P237, DOI 10.1016/S1359-0294(00)00061-3; Biodrowska K, 2012, PRZEM CHEM, V91, P692; Burke YD, 1997, LIPIDS, V32, P151, DOI 10.1007/s11745-997-0019-y; Chrencik JE, 2015, CELL, V161, P1633, DOI 10.1016/j.cell.2015.06.002; D'Arrigo P, 2007, CHEM PHYS LIPIDS, V147, P113, DOI 10.1016/j.chemphyslip.2007.03.008; D'Arrigo P, 2010, MOLECULES, V15, P1354, DOI 10.3390/molecules15031354; Fasoli E, 2006, ORG BIOMOL CHEM, V4, P2974, DOI 10.1039/b604636c; Fujita K, 2005, BIOORGAN MED CHEM, V13, P6742, DOI 10.1016/j.bmc.2005.07.023; Gliszczynska A, 2016, CHEM BIODIVERS, V13, P477, DOI 10.1002/cbdv.201500127; GUPTA CM, 1977, P NATL ACAD SCI USA, V74, P4315, DOI 10.1073/pnas.74.10.4315; HARKER WG, 1991, BIOCHEMISTRY-US, V30, P9953, DOI 10.1021/bi00105a020; Hernandez V, 2005, EUR J PHARM SCI, V26, P162, DOI 10.1016/j.ejps.2005.05.007; Hrdaka N, 2008, J NUTR SCI VITAMINOL, V54, P255, DOI 10.3177/jnsv.54.255; Ichihara K, 2005, CHEM PHYS LIPIDS, V137, P94, DOI 10.1016/j.chemphyslip.2005.06.001; Innis SM, 2007, AM J CLIN NUTR, V85, P702, DOI 10.1093/ajcn/85.3.702; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Lambert DM, 2000, EUR J PHARM SCI, V11, pS15, DOI 10.1016/S0928-0987(00)00161-5; Lee TC, 1998, BBA-LIPID LIPID MET, V1394, P129, DOI 10.1016/S0005-2760(98)00107-6; Masuda T, 2008, J AGR FOOD CHEM, V56, P597, DOI 10.1021/jf072893l; MATTSON FH, 1962, J LIPID RES, V3, P281; MORGADO MAP, 1995, J CHEM TECHNOL BIOT, V63, P181, DOI 10.1002/jctb.280630214; Niezgoda N, 2015, AUST J CHEM, V68, P1065, DOI 10.1071/CH14606; Niezgoda N, 2013, AUST J CHEM, V66, P354, DOI 10.1071/CH12404; Peng JN, 2002, TETRAHEDRON LETT, V43, P9699, DOI 10.1016/S0040-4039(02)02369-9; Rioja A, 2000, FEBS LETT, V467, P291, DOI 10.1016/S0014-5793(00)01168-6; Schlegel RA, 2003, NUTR BIOCH PHOSPHOLI; SINGH A, 1990, J LIPID RES, V31, P1522; Singh SB, 2000, BIOORG MED CHEM LETT, V10, P235, DOI 10.1016/S0960-894X(99)00666-6; SZUHAJ BF, 2003, NUTR BIOCH PHOSPHOLI; TAKAMI M, 1994, BIOSCI BIOTECH BIOCH, V58, P1716, DOI 10.1271/bbb.58.1716; Vance DE, 2002, BIOCH LIPIDS LIPOPRO; Wang T, 2008, OILY PRESS LIPID LIB; White SH, 2001, J BIOL CHEM, V276, P32395, DOI 10.1074/jbc.R100008200; Wuryatmo E, 2003, J AGR FOOD CHEM, V51, P2637, DOI 10.1021/jf026183l; Yamamoto Y, 2008, BIOORG MED CHEM LETT, V18, P4044, DOI 10.1016/j.bmcl.2008.05.113; Yamamoto Y, 2008, J AM OIL CHEM SOC, V85, P313, DOI 10.1007/s11746-008-1206-1; Yang T, 2011, METAB ENG, V13, P414, DOI 10.1016/j.ymben.2011.01.011	38	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157278	10.1371/journal.pone.0157278	http://dx.doi.org/10.1371/journal.pone.0157278			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310666	gold, Green Published, Green Submitted			2022-12-26	WOS:000378029800049
J	Hillreiner, M; Flinspach, C; Pfaffl, MW; Kliem, H				Hillreiner, Maria; Flinspach, Claudia; Pfaffl, Michael W.; Kliem, Heike			Effect of the Ketone Body Beta-Hydroxybutyrate on the Innate Defense Capability of Primary Bovine Mammary Epithelial Cells	PLOS ONE			English	Article							DAIRY-CATTLE; ESCHERICHIA-COLI; GENE-EXPRESSION; SUBCLINICAL KETOSIS; MASTITIS PATHOGENS; LIPOTEICHOIC ACID; HOST-DEFENSE; IN-VITRO; COWS; GLAND	Negative energy balance and ketosis are thought to cause impaired immune function and to increase the risk of clinical mastitis in dairy cows. The present in vitro study aimed to investigate the effect of elevated levels of the predominant ketone body beta-hydroxybutyrate on the innate defense capability of primary bovine mammary epithelial cells (pbMEC) challenged with the mastitis pathogen Escherichia coli (E. coli). Therefore, pbMEC of healthy dairy cows in mid-lactation were isolated from milk and challenged in culture with 3 mM BHBA and E. coli. pbMEC stimulated with E. coli for 6 h or 30 h showed an up-regulation of several innate immune genes, whereas co-stimulation of pbMEC with 3 mM BHBA and E. coli resulted in the down-regulation of CCL2, SAA3, LF and C3 gene expression compared to the challenge with solely the bacterial stimulus. These results indicated that increased BHBA concentrations may be partially responsible for the higher mastitis susceptibility of dairy cows in early lactation. Elevated levels of BHBA in blood and milk during negative energy balance and ketosis are likely to impair innate immune function in the bovine mammary gland by attenuating the expression of a broad range of innate immune genes.	[Hillreiner, Maria; Flinspach, Claudia; Pfaffl, Michael W.; Kliem, Heike] Tech Univ Munich, Chair Anim Physiol & Immunol, Freising Weihenstephan, Germany	Technical University of Munich	Kliem, H (corresponding author), Tech Univ Munich, Chair Anim Physiol & Immunol, Freising Weihenstephan, Germany.	kliem@wzw.tum.de	Pfaffl, Michael/G-6622-2013	Pfaffl, Michael/0000-0002-3192-1019	German Research Foundation (DFG); Technische Universitat Munchen; "Vereinigung zur Forderung der Milchwissenschaftlichen Forschung an der Technischen Universitat Muchen e. V." (Freising, Germany)	German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen; "Vereinigung zur Forderung der Milchwissenschaftlichen Forschung an der Technischen Universitat Muchen e. V." (Freising, Germany)	This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding program Open Access Publishing. Furthermore, this study was funded by the "Vereinigung zur Forderung der Milchwissenschaftlichen Forschung an der Technischen Universitat Muchen e. V." (Freising, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alluwaimi AM, 2004, RES VET SCI, V77, P211, DOI 10.1016/j.rvsc.2004.04.006; ANDERSSON L, 1988, VET CLIN N AM-FOOD A, V4, P233, DOI 10.1016/S0749-0720(15)31046-X; BAIRD GD, 1982, J DAIRY SCI, V65, P1, DOI 10.3168/jds.S0022-0302(82)82146-2; Boudjellab N, 2000, COMP BIOCHEM PHYS A, V127, P191, DOI 10.1016/S1095-6433(00)00257-9; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CARROLL EJ, 1982, AM J VET RES, V43, P1661; CORREA MT, 1993, J DAIRY SCI, V76, P1305, DOI 10.3168/jds.S0022-0302(93)77461-5; Danowski K, 2013, J ANIM PHYSIOL AN N, V97, P647, DOI 10.1111/j.1439-0396.2012.01305.x; Dirksen G, 2006, PAREY, V47, P1325; Duffield TF, 2009, J DAIRY SCI, V92, P571, DOI 10.3168/jds.2008-1507; ERB HN, 1988, J DAIRY SCI, V71, P2557, DOI 10.3168/jds.S0022-0302(88)79845-8; GRAY GD, 1982, AM J VET RES, V43, P757; Griesbeck-Zilch B, 2008, J DAIRY SCI, V91, P2215, DOI 10.3168/jds.2007-0752; Gross J, 2011, J DAIRY SCI, V94, P1820, DOI 10.3168/jds.2010-3707; Gunther J, 2009, VET RES, V40, DOI 10.1051/vetres/2009014; Hsu Kenneth, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P290; Hunziker W, 1998, J MAMMARY GLAND BIOL, V3, P287, DOI 10.1023/A:1018715511178; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kruger S, 2000, INFECT IMMUN, V68, P328, DOI 10.1128/IAI.68.1.328-334.2000; Kutila T, 2003, ACTA VET SCAND, V44, P35, DOI 10.1186/1751-0147-44-35; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutzow YCS, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-18; McArt JAA, 2012, J DAIRY SCI, V95, P5056, DOI 10.3168/jds.2012-5443; Molenaar AJ, 2009, BIOMARKERS, V14, P26, DOI 10.1080/13547500902730714; Nguyen DAD, 1998, J MAMMARY GLAND BIOL, V3, P233, DOI 10.1023/A:1018707309361; OLTENACU PA, 1994, VET RES, V25, P208; Pfaffl MW, 2003, J DAIRY SCI, V86, P538, DOI 10.3168/jds.S0022-0302(03)73632-7; PRAKASH BS, 1987, J STEROID BIOCHEM, V28, P623, DOI 10.1016/0022-4731(87)90389-X; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; SCHULTZ LH, 1968, J DAIRY SCI, V51, P1133, DOI 10.3168/jds.S0022-0302(68)87141-3; Seegers H, 2003, VET RES, V34, P475, DOI 10.1051/vetres:2003027; Sordillo LM, 1997, J DAIRY SCI, V80, P1851, DOI 10.3168/jds.S0022-0302(97)76121-6; Sorg D., 2013, Animal Genetic Resources, P91; Sorg D, 2013, ANIMAL, V7, P799, DOI 10.1017/S1751731112002315; Sorg D, 2012, IN VITRO CELL DEV-AN, V48, P550, DOI 10.1007/s11626-012-9544-6; Strandberg Y, 2005, CYTOKINE, V31, P72, DOI 10.1016/j.cyto.2005.02.010; Suriyasathaporn W, 2000, VET RES, V31, P397, DOI 10.1051/vetres:2000128; Suriyasathaporn W, 1999, VET IMMUNOL IMMUNOP, V68, P177, DOI 10.1016/S0165-2427(99)00017-3; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wellnitz O, 2006, VET MED-CZECH, V51, P125, DOI 10.17221/5531-VETMED; Wellnitz O, 2016, J DAIRY SCI, V99, P4851, DOI 10.3168/jds.2016-10927; Wheeler TT, 2012, ANIMAL, V6, P415, DOI 10.1017/S1751731111002151; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	43	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157774	10.1371/journal.pone.0157774	http://dx.doi.org/10.1371/journal.pone.0157774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310007	gold, Green Published			2022-12-26	WOS:000378029800135
J	Holdbrook, DA; Huber, RG; Piggot, TJ; Bond, PJ; Khalid, S				Holdbrook, Daniel A.; Huber, Roland G.; Piggot, Thomas J.; Bond, Peter J.; Khalid, Syma			Dynamics of Crowded Vesicles: Local and Global Responses to Membrane Composition	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ESCHERICHIA-COLI; SIMULATIONS; PROTEINS; MODEL; INSERTION; GROMACS; FUSION; DETAIL; AREA	The bacterial cell envelope is composed of a mixture of different lipids and proteins, making it an inherently complex organelle. The interactions between integral membrane proteins and lipids are crucial for their respective spatial localization within bacterial cells. We have employed microsecond timescale coarse-grained molecular dynamics simulations of vesicles of varying sizes and with a range of protein and lipid compositions, and used novel approaches to measure both local and global system dynamics, the latter based on spherical harmonics analysis. Our results suggest that both hydrophobic mismatch, enhanced by embedded membrane proteins, and curvature based sorting, due to different modes of undulation, may drive assembly in vesicular systems. Interestingly, the modes of undulation of the vesicles were found to be altered by the specific protein and lipid composition of the vesicle. Strikingly, lipid dynamics were shown to be coupled to proteins up to 6 nm from their surface, a substantially larger distance than has previously been observed, resulting in multi-layered annular rings enriched with particular types of phospholipid. Such large protein- lipid complexes may provide a mechanism for long-range communication. Given the complexity of bacterial membranes, our results suggest that subtle changes in lipid composition may have major implications for lipid and protein sorting under a curvature-based membrane-sorting model.	[Holdbrook, Daniel A.; Huber, Roland G.; Bond, Peter J.] ASTAR, Bioinformat Inst, 30 Biopolis Str,07-01 Matrix, Singapore 138671, Singapore; [Piggot, Thomas J.] Def Sci & Technol Lab, Salisbury SP4 0JQ, Wilts, England; [Bond, Peter J.] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore; [Holdbrook, Daniel A.; Piggot, Thomas J.; Khalid, Syma] Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Defence Science & Technology Laboratory; National University of Singapore; University of Southampton	Bond, PJ (corresponding author), ASTAR, Bioinformat Inst, 30 Biopolis Str,07-01 Matrix, Singapore 138671, Singapore.; Bond, PJ (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.; Khalid, S (corresponding author), Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England.	peterjb@bii.a-star.edu.sg; s.khalid@soton.ac.uk	Khalid, Syma/P-6868-2019; Huber, Roland G/AAG-6353-2019; Khalid, Syma/B-8108-2009	Khalid, Syma/0000-0002-3694-5044; Huber, Roland G/0000-0001-5093-5988; Khalid, Syma/0000-0002-3694-5044; Bond, Peter/0000-0003-2900-098X; Holdbrook, Daniel Aitor/0000-0002-8116-9208	BBSRC [BB/H000658/1]; Ministry of Education in Singapore (MOE AcRF Tier 3) [MOE2012-T3-1-008]; Biotechnology and Biological Sciences Research Council [BB/H000658/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministry of Education in Singapore (MOE AcRF Tier 3)(Ministry of Education, Singapore); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	TJP was funded by the BBSRC grant no: BB/H000658/1. PJB acknowledges support from the Ministry of Education in Singapore (MOE AcRF Tier 3 Grant Number MOE2012-T3-1-008). The authors wish to acknowledge that High performance computing was provided by the University of Southampton through the IridisIII supercomputer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBARA S, 1972, BIOCHIM BIOPHYS ACTA, V270, P301; Apajalahti T, 2010, FARADAY DISCUSS, V144, P411, DOI 10.1039/b901487j; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bond PJ, 2008, BIOCHEMISTRY-US, V47, P11321, DOI 10.1021/bi800642m; Bond PJ, 2008, BIOPHYS J, V95, P3802, DOI 10.1529/biophysj.108.128686; Bond PJ, 2007, J STRUCT BIOL, V157, P593, DOI 10.1016/j.jsb.2006.10.004; Bond PJ, 2006, J AM CHEM SOC, V128, P2697, DOI 10.1021/ja0569104; Braun AR, 2015, BIOPHYS J, V108, P1848, DOI 10.1016/j.bpj.2015.03.029; Braun AR, 2014, J CHEM THEORY COMPUT, V10, P4160, DOI 10.1021/ct500460u; Braun AR, 2011, BIOPHYS J, V100, P2112, DOI 10.1016/j.bpj.2011.03.009; Casuso I, 2012, NAT NANOTECHNOL, V7, P525, DOI [10.1038/nnano.2012.109, 10.1038/NNANO.2012.109]; Chen JM, 2013, PROTEIN SCI, V22, P510, DOI 10.1002/pro.2230; de Vries AH, 2004, J AM CHEM SOC, V126, P4488, DOI 10.1021/ja0398417; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Goose JE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003033; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones E., SCIPY OPEN SOURCE SC; Khalid S, 2015, BIOCHEM SOC T, V43, P162, DOI 10.1042/BST20140262; Khalid Syma, 2013, Methods Mol Biol, V924, P635, DOI 10.1007/978-1-62703-017-5_25; KITO M, 1975, EUR J BIOCHEM, V54, P55, DOI 10.1111/j.1432-1033.1975.tb04113.x; Knecht V, 2007, BIOPHYS J, V92, P4254, DOI 10.1529/biophysj.106.103572; Koldso H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003911; Markvoort AJ, 2006, J PHYS CHEM B, V110, P22780, DOI 10.1021/jp064888a; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2003, J AM CHEM SOC, V125, P15233, DOI 10.1021/ja0352092; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Nielsen SO, 2004, BIOPHYS J, V87, P2107, DOI 10.1529/biophysj.104.040311; Niemela PS, 2010, J AM CHEM SOC, V132, P7574, DOI 10.1021/ja101481b; Noguchi H, 2001, J CHEM PHYS, V115, P9547, DOI 10.1063/1.1414314; Orsi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028637; Parton DL, 2011, BIOPHYS J, V101, P691, DOI 10.1016/j.bpj.2011.06.048; Periole X, 2007, J AM CHEM SOC, V129, P10126, DOI 10.1021/ja0706246; Reddy T, 2015, STRUCTURE, V23, P584, DOI 10.1016/j.str.2014.12.019; Stansfeld PJ, 2011, STRUCTURE, V19, P1562, DOI 10.1016/j.str.2011.10.002; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291	37	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156963	10.1371/journal.pone.0156963	http://dx.doi.org/10.1371/journal.pone.0156963			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310814	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000378029800023
J	Thorburn, AN; Tseng, HY; Donovan, C; Hansbro, NG; Jarnicki, AG; Foster, PS; Gibson, PG; Hansbro, PM				Thorburn, Alison N.; Tseng, Hsin-Yi; Donovan, Chantal; Hansbro, Nicole G.; Jarnicki, Andrew G.; Foster, Paul S.; Gibson, Peter G.; Hansbro, Philip M.			TLR2, TLR4 AND MyD88 Mediate Allergic Airway Disease (AAD) and Streptococcus pneumoniae-Induced Suppression of AAD	PLOS ONE			English	Article							REGULATORY T-CELLS; OBSTRUCTIVE PULMONARY-DISEASE; TOLL-LIKE RECEPTOR-4; RESPIRATORY-INFECTION; IMMUNE-RESPONSE; COMPONENTS; LIPOPOLYSACCHARIDE; EXPRESSION; AGONISTS; RECOGNITION	Background Exposure to non-pathogenic Streptococcus pneumoniae and vaccination are inversely associated with asthma. Studies in animal models demonstrate that airway administration of S. pneumoniae (live or killed), or its vaccines or components, suppresses the characteristic features of asthma in mouse models of allergic airway disease (AAD). These components could be developed into immunoregulatory therapies. S. pneumoniae components are recognized by Toll-like receptors (TLR) 2 and TLR4, and both induce inflammatory cell responses through the adaptor protein myeloid differentiation primary response gene 88 (MyD88). The involvement of TLR2, TLR4 and MyD88 in the pathogenesis of AAD and asthma is incompletely understood, and has not been studied in S. pneumoniae-mediated suppression of AAD. We investigated the role of TLR2, TLR4 and MyD88 in the development of AAD and S. pneumoniae-mediated suppression of AAD. Methods and Findings OVA-induced AAD and killed S. pneumoniae-mediated suppression of AAD were assessed in wild-type, TLR2(-/-), TLR4(-/-), TLR2/4(-/-) and MyD88(-/-) BALB/c mice. During OVA-induced AAD, TLR2, TLR4 and MyD88 were variously involved in promoting eosinophil accumulation in bronchoalveolar lavage fluid and blood, and T-helper type (Th) 2 cytokine release from mediastinal lymph node T cells and splenocytes. However, all were required for the induction of airways hyperresponsiveness (AHR). In S. pneumoniae-mediated suppression of AAD, TLR2, TLR4 and MyD88 were variously involved in the suppression of eosinophilic and splenocyte Th2 responses but all were required for the reduction in AHR. Conclusions These results highlight important but complex roles for TLR2, TLR4 and MyD88 in promoting the development of OVA-induced AAD, but conversely in the S. pneumoniae-mediated suppression of AAD, with consistent and major contributions in both the induction and suppression of AHR. Thus, TLR signaling is likely required for both the development of asthma and the suppression of asthma by S. pneumoniae, and potentially other immunoregulatory therapies.	[Hansbro, Philip M.] Hunter Med Res Inst, Prior Res Ctr Hlth Lungs, Newcastle, NSW, Australia; Univ Newcastle, Newcastle, NSW 2300, Australia	Hunter Medical Research Institute; University of Newcastle; University of Newcastle	Hansbro, PM (corresponding author), Hunter Med Res Inst, Prior Res Ctr Hlth Lungs, Newcastle, NSW, Australia.	Philip.Hansbro@newcastle.edu.au	Hansbro, Phil/G-7486-2013; Foster, Paul/G-5057-2013; Tseng, Cindy Hsin-Yi/AAB-8958-2022; gibson, peter/G-6194-2014	Hansbro, Phil/0000-0002-4741-3035; Tseng, Cindy Hsin-Yi/0000-0002-7499-7515; , Paul/0000-0002-0827-8299; gibson, peter/0000-0001-5865-489X	Hill family; Asthma Foundation of NSW; Australian Research Council of Australia [DP110101107]; NHMRC [1079187]; Gladys Brawn Memorial Trust; Medical Research Council [MR/K006584/1] Funding Source: researchfish	Hill family; Asthma Foundation of NSW; Australian Research Council of Australia(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Gladys Brawn Memorial Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	PMH was funded to perform these studies by The Hill family and the Asthma Foundation of NSW, and Australian Research Council (DP110101107) of Australia. PMH is supported by Research Fellowships from the NHMRC (1079187) and the Gladys Brawn Memorial Trust.	Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Aryan Z, 2014, INT ARCH ALLERGY IMM, V164, P46, DOI 10.1159/000362553; Asquith KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001339; Beckett EL, 2013, J ALLERGY CLIN IMMUN, V131, P752, DOI 10.1016/j.jaci.2012.11.053; Beckett EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039460; Beigelman A, 2014, CURR OPIN ALLERGY CL, V14, P137, DOI 10.1097/ACI.0000000000000036; Bjornvold M, 2009, GENES IMMUN, V10, P181, DOI 10.1038/gene.2008.100; Bortolatto J, 2008, CLIN EXP ALLERGY, V38, P1668, DOI 10.1111/j.1365-2222.2008.03036.x; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Clarke TB, 2011, CELL HOST MICROBE, V9, P404, DOI 10.1016/j.chom.2011.04.012; Conroy H, 2008, ONCOGENE, V27, P168, DOI 10.1038/sj.onc.1210910; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Essilfie AT, 2015, THORAX, V70, P458, DOI 10.1136/thoraxjnl-2014-206067; Essilfie AT, 2012, THORAX, V67, P588, DOI 10.1136/thoraxjnl-2011-200160; Essilfie AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002244; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Goodridge HS, 2007, PARASITE IMMUNOL, V29, P127, DOI 10.1111/j.1365-3024.2006.00926.x; Hallstrand TS, 2014, CLIN IMMUNOL, V151, P1, DOI 10.1016/j.clim.2013.12.003; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hansbro PM, 2014, J BIOL CHEM, V289, P18214, DOI 10.1074/jbc.M114.548594; Hansbro PM, 2013, EXPERT OPIN INV DRUG, V22, P49, DOI 10.1517/13543784.2013.732997; Hardy MP, 2004, BIOCHEM J, V380, P83, DOI 10.1042/BJ20040030; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hollingsworth JW, 2006, J IMMUNOL, V176, P5856, DOI 10.4049/jimmunol.176.10.5856; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; Horvat JC, 2010, J IMMUNOL, V184, P4159, DOI 10.4049/jimmunol.0902287; Horvat JC, 2010, J ALLERGY CLIN IMMUN, V125, P617, DOI 10.1016/j.jaci.2009.10.018; Hsu ACY, 2015, AM J RESP CRIT CARE, V191, P1012, DOI 10.1164/rccm.201501-0188OC; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Kaiko GE, 2008, J IMMUNOL, V180, P2225, DOI 10.4049/jimmunol.180.4.2225; Kaiko GE, 2008, IMMUNOLOGY, V123, P326, DOI 10.1111/j.1365-2567.2007.02719.x; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Klein M, 2008, J INFECT DIS, V198, P1028, DOI 10.1086/591626; Koedel U, 2004, BRAIN, V127, P1437, DOI 10.1093/brain/awh171; Krishnaswamy JK, 2012, AM J RESP CELL MOL, V47, P852, DOI 10.1165/rcmb.2011-0414OC; Letiembre M, 2005, INFECT IMMUN, V73, P8397, DOI 10.1128/IAI.73.12.8397-8401.2005; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Patel PS, 2015, J IMMUNOL, V194, P5838, DOI 10.4049/jimmunol.1500251; Preston JA, 2011, EUR RESPIR J, V37, P53, DOI 10.1183/09031936.00049510; Preston JA, 2007, VACCINE, V25, P8154, DOI 10.1016/j.vaccine.2007.09.034; Puggioni F, 2005, ALLERGY, V60, P678, DOI 10.1111/j.1398-9995.2005.00762.x; Regueiro V, 2009, INFECT IMMUN, V77, P714, DOI 10.1128/IAI.00852-08; Schmeck B, 2006, RESP RES, V7, P7149; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Shalaby KH, 2012, J IMMUNOL, V189, P2793, DOI 10.4049/jimmunol.1201194; Starkey MR, 2013, MUCOSAL IMMUNOL, V6, P569, DOI 10.1038/mi.2012.99; Starkey MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042588; Starkey MR, 2013, CURR OPIN PHARMACOL, V13, P337, DOI 10.1016/j.coph.2013.03.005; Starkhammar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104114; Tan AM, 2010, J IMMUNOL, V184, P3535, DOI 10.4049/jimmunol.0900340; Tay HL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004549; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Thorburn AN, 2013, J IMMUNOL, V191, P4112, DOI 10.4049/jimmunol.1201232; Thorburn AN, 2012, J IMMUNOL, V188, P4611, DOI 10.4049/jimmunol.1101299; Thorburn AN, 2010, THORAX, V65, P1053, DOI 10.1136/thx.2009.131508; Thorburn AN, 2010, AM J RESP CELL MOL, V43, P511, DOI 10.1165/rcmb.2009-0342TR; Tomlinson G, 2014, J IMMUNOL, V193, P3736, DOI 10.4049/jimmunol.1401413; Velasco G, 2005, AM J RESP CELL MOL, V32, P218, DOI 10.1165/rcmb.2003-0435OC; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zhu JK, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/781235	61	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156402	10.1371/journal.pone.0156402	http://dx.doi.org/10.1371/journal.pone.0156402			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309732	gold, Green Published			2022-12-26	WOS:000378029800003
J	Berthoud, VM; Minogue, PJ; Lambert, PA; Snabb, JI; Beyer, EC				Berthoud, Viviana M.; Minogue, Peter J.; Lambert, Paul A.; Snabb, Joseph I.; Beyer, Eric C.			The Cataract-linked Mutant Connexin50D47A Causes Endoplasmic Reticulum Stress in Mouse Lenses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; cataract; cell death; connexin; endoplasmic reticulum stress (ER stress); gap junction; unfolded protein response (UPR)	UNFOLDED PROTEIN RESPONSE; ALPHA-B-CRYSTALLIN; ER STRESS; CELL-DEATH; PULVERULENT CATARACTS; EYE LENS; MUTATION; MICE; MICROPHTHALMIA; DEGRADATION	Mice expressing connexin50D47A (Cx50D47A) exhibit nuclear cataracts and impaired differentiation. Cx50D47A does not traffic properly, and homozygous mutant lenses show increased levels of the stress-responsive B-crystallins. Therefore, we assessed whether expression of Cx50D47A led to endoplasmic reticulum (ER) stress in the lens in vivo. Although pharmacologic induction of ER stress can be transduced by three different pathways, we found no evidence for activation of the IRE1 or ATF6 pathways in Cx50D47A-expressing lenses. In contrast, heterozygous and homozygous Cx50D47A lenses showed an increase in phosphorylated PERK immunoreactivity and in the ratio of phosphorylated to total EIF2 (2.4- and 3.3-fold, respectively) compared with wild type. Levels of ATF4 were similar in wild type and heterozygous lenses but elevated in homozygotes (391%). In both heterozygotes and homozygotes, levels of calreticulin protein were increased (184 and 262%, respectively), as was Chop mRNA (1.9- and 12.4-fold, respectively). CHOP protein was increased in homozygotes (384%). TUNEL staining was increased in Cx50D47A lenses, especially in homozygous mice. Levels of two factors that may be pro-survival, Irs2 and Trib3, were greatly increased in homozygous lenses. These results suggest that expression of Cx50D47A induces ER stress, triggering activation of the PERK-ATF4 pathway, which potentially contributes to the lens pathology and leads to increased expression of anti-apoptotic factors, allowing cell survival.	[Berthoud, Viviana M.; Minogue, Peter J.; Snabb, Joseph I.; Beyer, Eric C.] Univ Chicago, Dept Pediat, KCBD-5,900 E 57th St, Chicago, IL 60637 USA; [Lambert, Paul A.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Berthoud, VM (corresponding author), Univ Chicago, Dept Pediat, KCBD-5,900 E 57th St, Chicago, IL 60637 USA.	vberthou@peds.bsd.uchicago.edu	Beyer, Eric/V-1317-2019	Beyer, Eric/0000-0001-8044-1356	National Institutes of Health [RO1EY08368]; NIDDK [2T35DK062719]; NATIONAL EYE INSTITUTE [R01EY008368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK062719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant RO1EY08368 (to E. C. B.) and NIDDK Grant 2T35DK062719 (to P. A. L. as a trainee). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Alapure BV, 2012, EXP EYE RES, V102, P28, DOI 10.1016/j.exer.2012.06.004; Alge CS, 2002, INVEST OPHTH VIS SCI, V43, P3575; Arora A, 2008, J MED GENET, V45, P155, DOI 10.1136/jmg.2007.051029; Bassnett S, 1997, J CELL BIOL, V137, P37, DOI 10.1083/jcb.137.1.37; Berthoud VM, 2013, INVEST OPHTH VIS SCI, V54, P7614, DOI 10.1167/iovs.13-13188; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DASGUPTA S, 1992, EXP EYE RES, V54, P461, DOI 10.1016/0014-4835(92)90058-Z; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; FAVOR J, 1983, MUTAT RES, V110, P367, DOI 10.1016/0027-5107(83)90153-7; Firtina Z, 2011, GENE EXPR PATTERNS, V11, P135, DOI 10.1016/j.gep.2010.10.005; Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033; Hamanaka RB, 2009, ONCOGENE, V28, P910, DOI 10.1038/onc.2008.428; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Ikesugi K, 2006, EXP EYE RES, V83, P508, DOI 10.1016/j.exer.2006.01.033; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Klooster R, 2009, J IMMUNOL METHODS, V342, P1, DOI 10.1016/j.jim.2008.10.009; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Minogue PJ, 2009, INVEST OPHTH VIS SCI, V50, P5837, DOI 10.1167/iovs.09-3759; Mulhern ML, 2006, INVEST OPHTH VIS SCI, V47, P3951, DOI 10.1167/iovs.06-0193; Ng CL, 2010, EXP CELL RES, V316, P2113, DOI 10.1016/j.yexcr.2010.04.010; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Rashid HO, 2015, AUTOPHAGY, V11, P1956, DOI 10.1080/15548627.2015.1091141; Rong P, 2002, DEVELOPMENT, V129, P167; Sathyanarayana P, 2008, BLOOD, V111, P5390, DOI 10.1182/blood-2007-10-119743; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sellitto C, 2004, INVEST OPHTH VIS SCI, V45, P3196, DOI 10.1167/iovs.04-0194; Steele EC, 1998, CURR EYE RES, V17, P883, DOI 10.1076/ceyr.17.9.883.5144; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; Tattersall D, 2009, HUM MOL GENET, V18, P4734, DOI 10.1093/hmg/ddp436; Watson GW, 2010, BIOCHEM BIOPH RES CO, V401, P192, DOI 10.1016/j.bbrc.2010.09.023; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; Xi JH, 2008, J BIOL CHEM, V283, P5801, DOI 10.1074/jbc.M708704200; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7	36	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17569	17578		10.1074/jbc.M115.707950	http://dx.doi.org/10.1074/jbc.M115.707950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27317663	Green Published, hybrid			2022-12-26	WOS:000383241300009
J	Pakchuen, S; Ishibashi, M; Takakusagi, E; Shirahige, K; Sutani, T				Pakchuen, Sujiraporn; Ishibashi, Mai; Takakusagi, Emi; Shirahige, Katsuhiko; Sutani, Takashi			Physical Association of Saccharomyces cerevisiae Polo-like Kinase Cdc5 with Chromosomal Cohesin Facilitates DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ChIP-sequencing (ChIP-seq); chromosomes; DNA damage response; Saccharomyces cerevisiae; serine; threonine protein kinase; polo-like kinase; cohesin; priming phosphorylation	SISTER-CHROMATID SEPARATION; DOUBLE-STRAND BREAKS; ANAPHASE TRANSITION; CUT2 PROTEOLYSIS; FISSION YEAST; SUBUNIT SCC1; PLK1 DOCKING; BOX DOMAIN; PHOSPHORYLATION; REPLICATION	At the onset of anaphase, a protease called separase breaks the link between sister chromatids by cleaving the cohesin subunit Scc1. This irreversible step in the cell cycle is promoted by degradation of the separase inhibitor, securin, and polo-like kinase (Plk) 1-dependent phosphorylation of the Scc1 subunit. Plk could recognize substrates through interaction between its phosphopeptide interaction domain, the polo-box domain, and a phosphorylated priming site in the substrate, which has been generated by a priming kinase beforehand. However, the physiological relevance of this targeting mechanism remains to be addressed for many of the Plk1 substrates. Here, we show that budding yeast Plk1, Cdc5, is pre-deposited onto cohesin engaged in cohesion on chromosome arms in G(2)/M phase cells. The Cdc5-cohesin association is mediated by direct interaction between the polo-box domain of Cdc5 and Scc1 phosphorylated at multiple sites in its middle region. Alanine substitutions of the possible priming phosphorylation sites (scc1-15A) impair Cdc5 association with chromosomal cohesin, but they make only a moderate impact on mitotic cell growth even in securin-deleted cells (pds1), where Scc1 phosphorylation by Cdc5 is indispensable. The same scc1-15A pds1 double mutant, however, exhibits marked sensitivity to the DNA-damaging agent phleomycin, suggesting that the priming phosphorylation of Scc1 poses an additional layer of regulation that enables yeast cells to adapt to genotoxic environments.	[Pakchuen, Sujiraporn; Ishibashi, Mai; Shirahige, Katsuhiko; Sutani, Takashi] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo 1130032, Japan; [Pakchuen, Sujiraporn; Takakusagi, Emi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268503, Japan	University of Tokyo; Tokyo Institute of Technology	Sutani, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo 1130032, Japan.	tsutani@iam.u-tokyo.ac.jp		Pakchuen, Sujiraporn/0000-0003-1107-098X; Shirahige, Katsuhiko/0000-0002-7862-1144; Sutani, Takashi/0000-0002-9959-9513	Chromosome Orchestration System; Japan Society for the Promotion of Science	Chromosome Orchestration System; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grant-in-aid for scientific Research on innovative areas (Chromosome Orchestration System) (to K.S.) and grants-in-aid for scientific research (A) (to K.S. and T.S.) from Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi Y, 2008, CELL CYCLE, V7, P765, DOI 10.4161/cc.7.6.5530; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Attner MA, 2013, P NATL ACAD SCI USA, V110, P14278, DOI 10.1073/pnas.1311845110; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; Blancher C, 2001, Methods Mol Med, V57, P145, DOI 10.1385/1-59259-136-1:145; Brar GA, 2006, NATURE, V441, P532, DOI 10.1038/nature04794; Burke D, 2000, METHODS YEAST GENETI, P155; Chan KL, 2012, CELL, V150, P961, DOI 10.1016/j.cell.2012.07.028; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hornig NCD, 2002, CURR BIOL, V12, P973, DOI 10.1016/S0960-9822(02)00847-3; Hornig NCD, 2004, EMBO J, V23, P3144, DOI 10.1038/sj.emboj.7600303; Jeppsson K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004680; Kaina B, 2004, CYTOGENET GENOME RES, V104, P77, DOI 10.1159/000077469; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kumada K, 1998, CURR BIOL, V8, P633, DOI 10.1016/S0960-9822(98)70250-7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lee KS, 2008, CELL CYCLE, V7, P141, DOI 10.4161/cc.7.2.5272; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lin CY, 2000, P NATL ACAD SCI USA, V97, P12589, DOI 10.1073/pnas.220423497; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Merrill BJ, 1999, GENETICS, V153, P595; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; MOORE CW, 1988, CANCER RES, V48, P6837; Nakato R, 2013, GENES CELLS, V18, P589, DOI 10.1111/gtc.12058; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Ocampo-Hafalla MT, 2007, CHROMOSOMA, V116, P531, DOI 10.1007/s00412-007-0118-4; Oppermann FS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.012351; POVIRK LF, 1977, NUCLEIC ACIDS RES, V4, P3573, DOI 10.1093/nar/4.10.3573; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Ratsima H, 2011, P NATL ACAD SCI USA, V108, pE914, DOI 10.1073/pnas.1106448108; Rossio V, 2010, J CELL BIOL, V191, P981, DOI 10.1083/jcb.201007025; Sherwood R, 2010, GENE DEV, V24, P2723, DOI 10.1101/gad.1976710; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011; Song S, 2000, MOL CELL BIOL, V20, P286, DOI 10.1128/MCB.20.1.286-298.2000; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Sutani T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8815; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2001, EMBO REP, V2, P487, DOI 10.1093/embo-reports/kve113; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Valk E, 2014, MOL BIOL CELL, V25, P3456, DOI 10.1091/mbc.E14-02-0774; WRIGHT APH, 1989, YEAST, V5, P51, DOI 10.1002/yea.320050107; Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819	65	5	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17228	17246		10.1074/jbc.M116.727438	http://dx.doi.org/10.1074/jbc.M116.727438			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27325700	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000382643800025
J	Lin, CY; Pakpour, AH; Burri, A; Montazeri, A				Lin, Chung-Ying; Pakpour, Amir H.; Burri, Andrea; Montazeri, Ali			Rasch Analysis of the Premature Ejaculation Diagnostic Tool (PEDT) and the International Index of Erectile Function (IIEF) in an Iranian Sample of Prostate Cancer Patients	PLOS ONE			English	Article							PSYCHOMETRIC EVALUATION; WHOQOL-BREF; DYSFUNCTION; VERSION; ITEM; PREVALENCE; SCALE; MEN; VALIDATION; DOMAIN	Background Male sexual dysfunction is an increasing problem across a variety of general and clinical populations, such as cancer populations; especially among prostate cancer patients who tend to receive treatments that often result in erectile dysfunction (ED) and/or premature ejaculation (PE). Therefore, in order to diagnose ED and PE in these populations, adequate and efficient instruments such as the International Index of Erectile Function 5-item version (IIEF-5) and the Premature Ejaculation Diagnostic Tool (PEDT) are needed. However, since this is an important topic additional evidence of psychometric properties of the IIEF-5 and the PEDT in such samples are required. Thus the aim of the present study was to use Rasch models to investigate the construct validity, local dependency, score order, and differential item functioning (DIF) of both questionnaires in a sample of prostate cancer patients. Methods Prostate cancer patients (n = 1058, mean +/- SD age = 64.07 +/- 6.84 years) who visited urology clinics were invited to fill out the IIEF-5 and the PEDT. Construct validity was examined using infit and outfit mean square (MnSq) and local dependency using correlations between each two residual Rasch scores. Score order was investigated using step and average measures of difficulty and DIF using DIF contrast. Results All IIEF-5 and PEDT items had acceptable infit and outfit MnSq. Step measures revealed that all but two items had disordered categories in terms of scores 1 to 3. Only one local dependency was found, and no items displayed DIF across age, educational level, and help seeking. Conclusions The results showed that both the IIEF-5 and the PEDT had sound psychometric properties in the Rasch analyses, although some score disordering could be detected in both instruments. The results of no DIF items in both instruments suggest using them to compare ED and PE across age and educational level is adequate.	[Lin, Chung-Ying] Hong Kong Polytech Univ, Fac Hlth & Social Sci, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Pakpour, Amir H.] Qazvin Univ Med Sci, Social Determinants Hlth Res Ctr, Qazvin, Iran; [Burri, Andrea] Auckland Univ Technol, Hlth & Rehabil Res Inst, Auckland, New Zealand; [Burri, Andrea] North Shore Hosp, Waitemata Pain Serv, Dept Anaesthesia & Perioperat Med, Auckland, New Zealand; [Montazeri, Ali] ACECR, Iranian Inst Hlth Sci Res, Hlth Metr Res Ctr, Mental Hlth Res Grp, Tehran, Iran	Hong Kong Polytechnic University; Qazvin University of Medical Sciences (QUMS); Auckland University of Technology; Academic Center for Education, Culture & Research (ACECR)	Pakpour, AH (corresponding author), Qazvin Univ Med Sci, Social Determinants Hlth Res Ctr, Qazvin, Iran.	pakpour_amir@yahoo.com	Pakpour, Amir H./C-6160-2014; Montazeri, Ali/C-9276-2009; Lin, Chung-Ying/I-5434-2016	Pakpour, Amir H./0000-0002-8798-5345; Montazeri, Ali/0000-0002-5198-9539; Lin, Chung-Ying/0000-0002-2129-4242; Burri, Andrea/0000-0002-4705-3551				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amin L, 2012, J CLIN EPIDEMIOL, V65, P1117, DOI 10.1016/j.jclinepi.2012.04.014; ANDERSEN BL, 1985, CANCER-AM CANCER SOC, V55, P1835, DOI 10.1002/1097-0142(19850415)55:8<1835::AID-CNCR2820550832>3.0.CO;2-K; Aytac IA, 1999, BJU INT, V84, P50; Bodie J, 2003, J UROLOGY, V169, P2262, DOI 10.1097/01.ju.0000063940.19080.58; Brock GB, 2009, J SEX MED, V6, P2115, DOI 10.1111/j.1743-6109.2009.01362.x; Cappelleri JC, 1999, UROLOGY, V54, P346, DOI 10.1016/S0090-4295(99)00099-0; Chang CC, 2015, J CLIN EPIDEMIOL, V68, P674, DOI 10.1016/j.jclinepi.2015.01.018; Chang KC, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0148-6; DeRogatis LR, 2008, J SEX MED, V5, P289, DOI 10.1111/j.1743-6109.2007.00668.x; DeRoos YS, 1993, J SOC SERV RES, V16, P1; Hobart J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13120; Jafari P, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-127; Karakiewicz P, 2005, UROLOGY, V65, P131, DOI 10.1016/j.urology.2004.08.054; Khan A, 2013, J CLIN EPIDEMIOL, V66, P681, DOI 10.1016/j.jclinepi.2012.12.014; Kriston L, 2008, J SEX MED, V5, P92, DOI 10.1111/j.1743-6109.2007.00474.x; Lee SW, 2013, INT J IMPOT RES, V25, P12, DOI 10.1038/ijir.2012.27; Lin CY, 2017, J HEALTH PSYCHOL, V22, P397, DOI 10.1177/1359105315603474; Linacre J. M., 2009, USERS GUIDE WINSTEPS; Pakpour AH, 2014, SEX MED-UK, V2, P31, DOI 10.1002/sm2.21; Pakpour AH, 2014, J SEX MARITAL THER, V40, P541, DOI 10.1080/0092623X.2013.788110; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Rosen RC, 1997, J UROLOGY, V49, P822, DOI DOI 10.1016/S0090-4295(97)00238-0; Saigal CS, 2006, ARCH INTERN MED, V166, P207, DOI 10.1001/archinte.166.2.207; Scott NW, 2009, J CLIN EPIDEMIOL, V62, P288, DOI 10.1016/j.jclinepi.2008.06.003; Siegel T, 2001, J UROLOGY, V165, P430, DOI 10.1097/00005392-200102000-00019; Strobl C, 2015, PSYCHOMETRIKA, V80, P289, DOI 10.1007/s11336-013-9388-3; Su CT, 2014, PSYCHOL ASSESSMENT, V26, P980, DOI 10.1037/a0036764; Symonds T, 2007, EUR UROL, V52, P565, DOI 10.1016/j.eururo.2007.01.028; Tang WS, 2011, J SEX MED, V8, P2071, DOI 10.1111/j.1743-6109.2011.02280.x; Waldinger MD, 2004, INT J IMPOT RES, V16, P369, DOI 10.1038/sj.ijir.3901172; Wang WC, 2005, APPL PSYCH MEAS, V29, P296, DOI 10.1177/0146621605276281; Weber MF, 2013, MED J AUSTRALIA, V199, P107, DOI 10.5694/mja12.11548	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157460	10.1371/journal.pone.0157460	http://dx.doi.org/10.1371/journal.pone.0157460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP3JL	27336626	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200018
J	Liu, XQ; Xu, YH; Zhang, R; Huang, YB; He, WQ; Sang, L; Chen, SB; Nong, LB; Li, X; Mao, P; Li, YM				Liu, Xiaoqing; Xu, Yonghao; Zhang, Rong; Huang, Yongbo; He, Weiqun; Sang, Ling; Chen, Sibei; Nong, Lingbo; Li, Xi; Mao, Pu; Li, Yimin			Survival Predictors for Severe ARDS Patients Treated with Extracorporeal Membrane Oxygenation: A Retrospective Study in China	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; MORTALITY RISK; ADULT PATIENTS; LIFE-SUPPORT; FAILURE; ECMO	Extracorporeal membrane oxygenation (ECMO) is increasingly being applied as life support for acute respiratory distress syndrome (ARDS) patients. However, the outcomes of this procedure have not yet been characterized in severe ARDS patients. The aim of this study was to evaluate the outcomes of severe ARDS patients supported with ECMO and to identify potential predictors of mortality in these patients. A total of 38 severe ARDS patients (aged 51.39 +/- 13.27 years, 32 males) who were treated with ECMO in the specialized medical intensive care unit of Guangzhou Institute of Respiratory Diseases from July 2009 to December 2014 were retrospectively reviewed. The clinical data of the patients on the day before ECMO initiation, on the first day of ECMO treatment and on the day of ECMO removal were collected and analyzed. All patients were treated with veno-venous ECMO after a median mechanical ventilation duration of 6.4 +/- 7.6 days. Among the 20 patients (52.6%) who were successfully weaned from ECMO, 16 patients (42.1%) survived to hospital discharge. Of the identified pre-ECMO factors, advanced age, a long duration of ventilation before ECMO, a higher Acute Physiology and Chronic Health Evaluation II (APACHE II) score, underlying lung disease, and pulmonary barotrauma prior to ECMO were associated with unsuccessful weaning from ECMO. Furthermore, multiple logistic regression analysis indicated that both barotrauma pre-ECMO and underlying lung disease were independent predictors of hospital mortality. In conclusion, for severe ARDS patients treated with ECMO, barotrauma prior to ECMO and underlying lung disease may be major predictors of ARDS prognosis based on multivariate analysis.	[Liu, Xiaoqing; Xu, Yonghao; Zhang, Rong; Huang, Yongbo; He, Weiqun; Sang, Ling; Chen, Sibei; Nong, Lingbo; Li, Xi; Mao, Pu; Li, Yimin] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou 510120, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Li, YM (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou 510120, Peoples R China.	dryiminli@vip.163.com		Huang, Yongbo/0000-0001-6798-0451	Natural Science Foundation of China [81361128003, 81400060]; China Postdoctoral Science Foundation [2014M562158]; Natural Science Foundation of Guangdong Province, China [2015A030313480, 2015A030313456]; National Natural Science Foundation of China [81361128003, 81400060]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Natural Science Foundation of China (http://www.nsfc.gov.cn/, NO. 81361128003 for YL and 81400060 for YH), China Postdoctoral Science Foundation (http://jj.chinapostdoctor.org.cn/, NO. 2014M562158 for YH) and Natural Science Foundation of Guangdong Province, China (http://www.gdstc.gov.cn/, NO. 2015A030313480 for YL and 2015A030313456 for XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Natural Science Foundation of China (Nos. 81361128003 and 81400060), the China Postdoctoral Science Foundation (No. 2014M562158), and the Natural Science Foundation of Guangdong Province, China (Nos. 2015A030313480 and 2015A030313456).	Abrams D, 2013, INTENS CARE MED, V39, P2028, DOI 10.1007/s00134-013-3035-4; Agerstrand CL, 2014, ASAIO J, V60, P255, DOI 10.1097/MAT.0000000000000062; Beiderlinden M, 2006, INTENS CARE MED, V32, P1627, DOI 10.1007/s00134-006-0262-y; Brodie D, 2011, NEW ENGL J MED, V365, P1905, DOI 10.1056/NEJMct1103720; Brogan TV, 2009, INTENS CARE MED, V35, P2105, DOI 10.1007/s00134-009-1661-7; Chang WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042687; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Eisner MD, 2002, AM J RESP CRIT CARE, V165, P978, DOI 10.1164/ajrccm.165.7.2109059; Gattinoni L, 2011, CRIT CARE, V15, DOI 10.1186/cc10490; Gorjup V, 2012, RESP CARE, V57, P1178, DOI 10.4187/respcare.01393; Hemmila MR, 2004, ANN SURG, V240, P595, DOI 10.1097/01.sla.0000141159.90676.2d; Hirshberg E, 2013, CURR OPIN CRIT CARE, V19, P38, DOI 10.1097/MCC.0b013e32835c2ac8; Holzgraefe B, 2010, MINERVA ANESTESIOL, V76, P1043; Iacono A, 2010, EUR J CARDIO-THORAC, V37, P969, DOI 10.1016/j.ejcts.2009.09.039; Laffey JG, 2013, AM J RESP CRIT CARE, V187, P671, DOI 10.1164/rccm.201301-0168ED; Maclaren Graeme, 2007, Crit Care Resusc, V9, P76; MORRIS AH, 1994, AM J RESP CRIT CARE, V149, P295, DOI 10.1164/ajrccm.149.2.8306022; Noah MA, 2013, ASAIO J, V59, P328, DOI 10.1097/MAT.0b013e31829119c6; Paden ML, 2013, ASAIO J, V59, P202, DOI 10.1097/MAT.0b013e3182904a52; Pappalardo F, 2013, INTENS CARE MED, V39, P275, DOI 10.1007/s00134-012-2747-1; Peek GJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-163; Peek GJ, 1997, CHEST, V112, P759, DOI 10.1378/chest.112.3.759; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rehder KJ, 2013, RESP CARE, V58, P1291, DOI 10.4187/respcare.02155; Rehder KJ, 2011, EXPERT REV RESP MED, V5, P627, DOI [10.1586/ers.11.57, 10.1586/ERS.11.57]; Roch A, 2014, INTENS CARE MED, V40, P74, DOI 10.1007/s00134-013-3135-1; Roch A, 2010, INTENS CARE MED, V36, P1899, DOI 10.1007/s00134-010-2021-3; Schmidt M, 2013, INTENS CARE MED, V39, P1704, DOI 10.1007/s00134-013-3037-2; Sigurdsson MI, 2013, ACTA ANAESTH SCAND, V57, P37, DOI 10.1111/aas.12001; Terragni P, 2014, CURR OPIN CRIT CARE, V20, P86, DOI 10.1097/MCC.0000000000000053; Zampieri FG, 2013, J CRIT CARE, V28, P998, DOI 10.1016/j.jcrc.2013.07.047; ZAPOL WM, 1979, JAMA-J AM MED ASSOC, V242, P2193, DOI 10.1001/jama.242.20.2193	32	11	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158061	10.1371/journal.pone.0158061	http://dx.doi.org/10.1371/journal.pone.0158061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336170	Green Submitted, Green Published, gold			2022-12-26	WOS:000378389200101
J	Shahabuddin, ASM; Nostlinger, C; Delvaux, T; Sarker, M; Bardaji, A; De Brouwere, V; Broerse, JEW				Shahabuddin, A. S. M.; Nostlinger, Christiana; Delvaux, Therese; Sarker, Malabika; Bardaji, Azucena; De Brouwere, Vincent; Broerse, Jacqueline E. W.			What Influences Adolescent Girls' Decision-Making Regarding Contraceptive Methods Use and Childbearing? A Qualitative Exploratory Study in Rangpur District, Bangladesh	PLOS ONE			English	Article							TEENAGE PREGNANCY; RURAL BANGLADESH; OUTCOMES; MOTHERS; WOMEN; MATTER	Background Bangladesh has the highest rate of adolescent pregnancy in South Asia. Child marriage is one of the leading causes of pregnancies among adolescent girls. Although the country's contraceptive prevalence rate is quite satisfactory, only 52% of married adolescent girls use contraceptive methods. This qualitative study is aimed at exploring the factors that influence adolescent girls' decision-making process in relation to contraceptive methods use and childbearing. Methods and Results We collected qualitative data from study participants living in Rangpur district, Bangladesh. We conducted 35 in-depth interviews with married adolescent girls, 4 key informant interviews, and one focus group discussion with community health workers. Adolescent girls showed very low decision-making autonomy towards contraceptive methods use and childbearing. Decisions were mainly made by either their husbands or mothers-in-law. When husbands were unemployed and financially dependent on their parents, then the mothers-in-law played most important role for contraceptive use and childbearing decisions. Lack of reproductive health knowledge, lack of negotiation and communication ability with husbands and family members, and mistrust towards contraceptive methods also appeared as influential factors against using contraception resulting in early childbearing among married adolescent girls. Conclusions Husbands and mothers-in-law of newly married adolescent girls need to be actively involved in health interventions so that they make more informed decisions regarding contraceptive use to delay pregnancies until 20 years of age. Misunderstanding and distrust regarding contraceptives can be diminished by engaging the wider societal actors in health intervention including neighbours, and other family members.	[Shahabuddin, A. S. M.; Delvaux, Therese; De Brouwere, Vincent] Inst Trop Med, Dept Publ Hlth, Woman & Child Hlth Res Ctr, B-2000 Antwerp, Belgium; [Nostlinger, Christiana] Inst Trop Med, Unit HIV AIDS Policy, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Sarker, Malabika] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Shahabuddin, A. S. M.; Bardaji, Azucena] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Shahabuddin, A. S. M.; Broerse, Jacqueline E. W.] Vrije Univ Amsterdam, Athena Inst Res Innovat & Commun Hlth & Life Sci, Amsterdam, Netherlands	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Bangladesh Rural Advancement Committee BRAC; BRAC University; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Vrije Universiteit Amsterdam	Shahabuddin, ASM (corresponding author), Inst Trop Med, Dept Publ Hlth, Woman & Child Hlth Res Ctr, B-2000 Antwerp, Belgium.; Shahabuddin, ASM (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.; Shahabuddin, ASM (corresponding author), Vrije Univ Amsterdam, Athena Inst Res Innovat & Commun Hlth & Life Sci, Amsterdam, Netherlands.	shahab@itg.be	Alonso, Azucena Bardají/V-5978-2018; Bardají, Azucena/AAE-9145-2019	Alonso, Azucena Bardají/0000-0002-5135-0540; Sarker, Malabika/0000-0001-7293-8805	European Commission (EC); Department of Economy, Science and Innovation of Flemish Government, Belgium; European Commission; BRAC head office	European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); Department of Economy, Science and Innovation of Flemish Government, Belgium; European Commission(European CommissionEuropean Commission Joint Research Centre); BRAC head office	This study, part of a PhD research, was funded by the European Commission (EC) and the Department of Economy, Science and Innovation of Flemish Government, Belgium. The first author is particularly grateful to Pr. Vincent De Brouwere as he also added funds for conducting this research.; The authors would like to acknowledge the European Commission and the Department of Economy, Science and Innovation of Flemish Government, Belgium for funding. The first author is particularly grateful to Pr. Vincent De Brouwere as he also added funds for conducting this research. The authors are also grateful to all the BRAC IMNCS project staff working in Rangpur district and BRAC head office for their support to conduct this research smoothly. In addition, authors are thankful to Kristof De Coster (Public Health Department, Institute of Tropical Medicine) for editing the manuscript, all research assistants, translators, Nurul Islam Biplob and Shabnam Mostari (James P Grant School of Public Health, BRAC University) for recruiting and coordinating research assistants.	Adams Melissa K, 2013, Int J Gynaecol Obstet, V123 Suppl 1, pe7, DOI 10.1016/j.ijgo.2013.07.004; Asaduzzaman M., 2009, ASIAN SOC SCI, V5, P147, DOI [10.5539/ass.v5n3p147, DOI 10.5539/ASS.V5N3P147]; Bangladesh Bank, 2015, FOR DIR INV FDI BANG; Blanc AK, 2009, INT PERSPECT SEX R H, V35, P63, DOI 10.1363/ipsrh.35.063.09; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chen XK, 2008, J CLIN EPIDEMIOL, V61, P688, DOI 10.1016/j.jclinepi.2007.08.009; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; Chowdhury AMR, 2013, LANCET, V382, P1734, DOI 10.1016/S0140-6736(13)62148-0; Conde-Agudelo A, 2005, AM J OBSTET GYNECOL, V192, P342, DOI 10.1016/j.ajog.2004.10.593; Deb S, 2011, INT Q COMMUNITY HEAL, V31, P401, DOI 10.2190/IQ.31.4.g; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Gayen Kaberi, 2006, Healthc Q, V9, P110; Gayen K, 2010, SOC SCI MED, V71, P1584, DOI 10.1016/j.socscimed.2010.08.002; Grant MJ, 2008, STUD FAMILY PLANN, V39, P369, DOI 10.1111/j.1728-4465.2008.00181.x; Hameed W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104633; Haque SE, 2012, WOMEN HEALTH ISS, V22, pE171, DOI 10.1016/j.whi.2011.08.004; Hossain MB, 2012, STUD FAMILY PLANN, V27, P98; Kabir H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-31; Kadir MM, 2003, J BIOSOC SCI, V35, P545, DOI 10.1017/S0021932003005984; Kamal SMM, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1492, DOI 10.1177/1010539513503868; Kamal SMM, 2015, J BIOSOC SCI, V47, P120, DOI 10.1017/S0021932013000746; Kamal SMM, 2012, EUR J CONTRACEP REPR, V17, P144, DOI 10.3109/13625187.2011.646014; Kamal SMM, 2010, ASIA-PAC J PUBLIC HE, V22, P436, DOI 10.1177/1010539510370780; Khan NR, 2014, J DHAKA MED COLL, V23, P7; Lloyd CB, 2008, POPULATION STUDIES, V62, P13; Mukhopadhyay P, 2010, J HEALTH POPUL NUTR, V28, P494; National Institute of Population Research and Training (NIPORT), 2015, BANGL DEM HLTH SURV; Ochako R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1483-1; Rahman M. A., 2014, Journal of Medicine, V15, P9; Santos KA, 2012, CAD SAUDE PUBLICA, V28, P655, DOI 10.1590/S0102-311X2012000400005; Sayem AM, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-16; Schuler SR, 2010, J DEV STUD, V46, P379, DOI 10.1080/00220380903318095; Shahidul Islam M., 2014, ASIAN SOCIAL SCI, V10, P189, DOI [10.5539/ass.v10n2p189, DOI 10.5539/ASS.V10N2P189]; Shattuck D, 2011, AM J PUBLIC HEALTH, V101, P1089, DOI 10.2105/AJPH.2010.300091; United Nations Children's Fund, 2014, PROGR PROSP, DOI [10.1016/j.landurbplan.2012.01.010, DOI 10.1016/J.LANDURBPLAN.2012.01.010]; Williamson Lisa M, 2009, Reprod Health, V6, P3, DOI 10.1186/1742-4755-6-3; Yue K, 2010, PATIENT EDUC COUNS, V81, P402, DOI 10.1016/j.pec.2010.07.018	37	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157664	10.1371/journal.pone.0157664	http://dx.doi.org/10.1371/journal.pone.0157664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP3JL	27336673	Green Published, gold			2022-12-26	WOS:000378389200030
J	Yoon, S; Kim, JE; Kim, GH; Kang, HJ; Kim, BR; Jeon, S; Im, JJ; Hyun, H; Moon, S; Lim, SM; Lyoo, IK				Yoon, Sujung; Kim, Jieun E.; Kim, Geon Ha; Kang, Hee Jin; Kim, Bori R.; Jeon, Saerom; Im, Jooyeon Jamie; Hyun, Heejung; Moon, Sohyeon; Lim, Soo Mee; Lyoo, In Kyoon			Subregional Shape Alterations in the Amygdala in Patients with Panic Disorder	PLOS ONE			English	Article							CEREBRAL GLUCOSE-METABOLISM; NEUROANATOMICAL HYPOTHESIS; PREFRONTAL CORTEX; FEAR; EMOTION; BRAIN; ANXIETY; ATTACKS; HUMANS; SEGMENTATION	Background The amygdala has been known to play a pivotal role in mediating fear-related responses including panic attacks. Given the functionally distinct role of the amygdalar subregions, morphometric measurements of the amygdala may point to the pathophysiological mechanisms underlying panic disorder. The current study aimed to determine the global and local morphometric alterations of the amygdala related to panic disorder. Methods Volumetric and surface-based morphometric approach to high-resolution three-dimensional T1-weighted images was used to examine the structural variations of the amygdala, with respect to extent and location, in 23 patients with panic disorder and 31 matched healthy individuals. Results There were no significant differences in bilateral amygdalar volumes between patients with panic disorder and healthy individuals despite a trend-level right amygdalar volume reduction related to panic disorder (right, beta = -0.23, p = 0.09, Cohen's d = 0.51; left, beta = -0.18, p = 0.19, Cohen's d = 0.45). Amygdalar subregions were localized into three groups including the superficial, centromedial, and laterobasal groups based on the cytoarchitectonically defined probability map. Surface-based morphometric analysis revealed shape alterations in the laterobasal and centromedial groups of the right amygdala in patients with panic disorder (false discovery rate corrected p < 0.05). Conclusions The current findings suggest that subregion-specific shape alterations in the right amygdala may be involved in the development and maintenance of panic disorder, which may be attributed to the cause or effects of amygdalar hyperactivation.	[Yoon, Sujung; Kim, Jieun E.; Kim, Geon Ha; Kang, Hee Jin; Kim, Bori R.; Jeon, Saerom; Im, Jooyeon Jamie; Hyun, Heejung; Moon, Sohyeon; Lyoo, In Kyoon] Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea; [Yoon, Sujung; Kim, Jieun E.; Kang, Hee Jin; Kim, Bori R.; Jeon, Saerom; Hyun, Heejung; Lyoo, In Kyoon] Ewha Womans Univ, Dept Brain & Cognit Sci, Seoul, South Korea; [Kim, Geon Ha] Ewha Womans Univ, Sch Med, Mokdong Hosp, Dept Neurol, Seoul, South Korea; [Im, Jooyeon Jamie] Seoul Natl Univ, Coll Nat Sci, Interdisciplinary Program Neurosci, Seoul 151742, South Korea; [Moon, Sohyeon; Lyoo, In Kyoon] Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Lim, Soo Mee] Ewha Womans Univ, Coll Med, Dept Radiol, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University; Seoul National University (SNU); Ewha Womans University; Ewha Womans University	Lyoo, IK (corresponding author), Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea.; Lyoo, IK (corresponding author), Ewha Womans Univ, Dept Brain & Cognit Sci, Seoul, South Korea.; Lyoo, IK (corresponding author), Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul, South Korea.	inkylyoo@ewha.ac.kr			National Research Foundation of Korea [2015M3C7A1028373, 2015M3C7A1028376, 2013R1A2A2A01010309]; Ewha Womans University Research Grant from Ewha Womans University	National Research Foundation of Korea(National Research Foundation of Korea); Ewha Womans University Research Grant from Ewha Womans University	This project was supported by grants of 2015M3C7A1028373 (IKL), 2015M3C7A1028376 (JEK), and 2013R1A2A2A01010309 (SY) from the National Research Foundation of Korea (http://www.nrf.re.kr/nrf_eng_cms/) and by the Ewha Womans University Research Grant of 2015 (SY) from Ewha Womans University (http://www.ewha.ac.kr/mbs/ewhaen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R., 2000, AMYGDALA FUNCTIONAL, P587; American Psychiatric Association, 2000, DIAGN CRIT DSM 4 TR; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Asami T, 2009, PSYCHIAT RES-NEUROIM, V173, P128, DOI 10.1016/j.pscychresns.2008.10.004; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Bisaga A, 1998, AM J PSYCHIAT, V155, P1178, DOI 10.1176/ajp.155.9.1178; Bookstein F. L, 1991, MORPHOMETRIC TOOLS F; Boshuisen ML, 2002, BIOL PSYCHIAT, V52, P126, DOI 10.1016/S0006-3223(02)01355-0; Brown VM, 2014, NEUROPSYCHOPHARMACOL, V39, P351, DOI 10.1038/npp.2013.197; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carter RM, 2006, NEUROIMAGE, V29, P1007, DOI 10.1016/j.neuroimage.2005.09.011; COX BJ, 1994, COMPR PSYCHIAT, V35, P349, DOI 10.1016/0010-440X(94)90274-7; Craske MG, 2010, DEPRESS ANXIETY, V27, P93, DOI 10.1002/da.20654; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Del Casale A, 2013, PSYCHIAT DANUB, V25, P108; Dresler T, 2013, J NEURAL TRANSM, V120, P3, DOI 10.1007/s00702-012-0811-1; Dresler T, 2011, J NEURAL TRANSM, V118, P263, DOI 10.1007/s00702-010-0540-2; Feinstein JS, 2013, NAT NEUROSCI, V16, P270, DOI 10.1038/nn.3323; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Garakani A, 2007, EUR NEUROPSYCHOPHARM, V17, P672, DOI 10.1016/j.euroneuro.2007.04.002; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hayano F, 2009, PSYCHIAT CLIN NEUROS, V63, P266, DOI 10.1111/j.1440-1819.2009.01960.x; J-H Lee, 2013, J ANTENNAS PROPAG, V2013, P8, DOI DOI 10.1371/J0URNAL; Joshi SH, 2016, BIOL PSYCHIAT, V79, P282, DOI 10.1016/j.biopsych.2015.02.029; Kelley R, 2013, BIPOLAR DISORD, V15, P795, DOI 10.1111/bdi.12114; Kent JM, 2005, AM J PSYCHIAT, V162, P1379, DOI 10.1176/appi.ajp.162.7.1379; Kim JE, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-20; Kim JE, 2010, ARCH GEN PSYCHIAT, V67, P1187, DOI 10.1001/archgenpsychiatry.2010.148; KLEIN DF, 1993, ARCH GEN PSYCHIAT, V50, P306; Knight DC, 2005, NEUROIMAGE, V26, P1193, DOI 10.1016/j.neuroimage.2005.03.020; LABAR KS, 1995, J NEUROSCI, V15, P6846; Lai CH, 2010, EUR NEUROPSYCHOPHARM, V20, P676, DOI 10.1016/j.euroneuro.2010.06.002; Lane Richard D, 2000, COGNITIVE NEUROSCIEN; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEY RG, 1979, BRAIN LANG, V7, P127, DOI 10.1016/0093-934X(79)90010-5; Lyoo IK, 2011, ARCH GEN PSYCHIAT, V68, P701, DOI 10.1001/archgenpsychiatry.2011.70; MacNamara A, 2015, BEHAV BRAIN RES, V287, P34, DOI 10.1016/j.bbr.2015.03.035; MARGRAF J, 1987, J NERV MENT DIS, V175, P558, DOI 10.1097/00005053-198709000-00008; Massana G, 2003, NEUROIMAGE, V19, P80, DOI 10.1016/S1053-8119(03)00036-3; Nicholson AA, 2015, NEUROPSYCHOPHARMACOL, V40, P2317, DOI 10.1038/npp.2015.79; Pessoa L, 2010, NEUROPSYCHOLOGIA, V48, P3416, DOI 10.1016/j.neuropsychologia.2010.06.038; Pfleiderer B, 2007, WORLD J BIOL PSYCHIA, V8, P269, DOI 10.1080/15622970701216673; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; Sakai Y, 2005, NEUROREPORT, V16, P927, DOI 10.1097/00001756-200506210-00010; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; SHEAR MK, 1994, ARCH GEN PSYCHIAT, V51, P346; Shekhar A, 1999, ANN NY ACAD SCI, V877, P747, DOI 10.1111/j.1749-6632.1999.tb09315.x; Sobanski T, 2010, PSYCHOL MED, V40, P1879, DOI 10.1017/S0033291709991930; Styner M, 2005, P NATL ACAD SCI USA, V102, P4872, DOI 10.1073/pnas.0501117102; Styner M, 2003, MED IMAGE ANAL, V7, P207, DOI 10.1016/S1361-8415(02)00110-X; Tuescher O, 2011, J ANXIETY DISORD, V25, P251, DOI 10.1016/j.janxdis.2010.09.010; Uchida RR, 2003, BRAZ J MED BIOL RES, V36, P925, DOI 10.1590/S0100-879X2003000700014; Veer IM, 2015, PSYCHIAT RES-NEUROIM, V233, P436, DOI 10.1016/j.pscychresns.2015.07.016; Whalen P.J., 2009, HUMAN AMYGDALA; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Wiest G, 2006, ARCH NEUROL-CHICAGO, V63, P1798, DOI 10.1001/archneur.63.12.1798; Yoon S, 2013, J PSYCHIATR RES, V47, P1446, DOI 10.1016/j.jpsychires.2013.06.015; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	64	10	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157856	10.1371/journal.pone.0157856	http://dx.doi.org/10.1371/journal.pone.0157856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336300	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200058
J	Raman, K; Aeschbacher, S; Bossard, M; Hochgruber, T; Zimmermann, AJ; Kaufmann, BA; Pumpol, K; Rickenbacker, P; Pare, G; Conen, D				Raman, Kripa; Aeschbacher, Stefanie; Bossard, Matthias; Hochgruber, Thomas; Zimmermann, Andreas J.; Kaufmann, Beat A.; Pumpol, Katrin; Rickenbacker, Peter; Pare, Guillaume; Conen, David			Whole Blood Gene Expression Differentiates between Atrial Fibrillation and Sinus Rhythm after Cardioversion	PLOS ONE			English	Article							RISK-FACTOR; FOLLOW-UP; PREVALENCE; MANAGEMENT; STROKE; DEATH	Background Treatment to restore sinus rhythm among patients with atrial fibrillation (AF) has limited long-term success rates. Gene expression profiling may provide new insights into AF pathophysiology. Objective To identify biomarkers and improve our understanding of AF pathophysiology by comparing whole blood gene expression before and after electrical cardioversion (ECV). Methods In 46 patients with persistent AF that underwent ECV, whole blood samples were collected 1-2 hours before and 4 to 6 weeks after successful cardioversion. The paired samples were sent for microarray and plasma biomarker comparison. Results Of 13,942 genes tested, expression of SLC25A20 and PDK4 had the strongest associations with AF. Post-cardioversion, SLC25A20 and PDK4 expression decreased by 0.8 (CI 0.7-0.8, p = 2.0x10(-6)) and 0.7 (CI 0.6-0.8, p = 3.0x10(-5)) fold respectively. Median N-terminal proB-type natriuretic peptide (NT-proBNP) concentrations decreased from 127.7 pg/mL to 44.9 pg/mL (p = 2.3x10(-13)) after cardioversion. AF discrimination models combining NT-proBNP and gene expression (NT-proBNP + SLC25A20 area under the curve = 0.88, NT-proBNP + PDK4 AUC = 0.86) had greater discriminative capacity as compared with NT-proBNP alone (AUC = 0.82). Moreover, a model including NT-proBNP, SLC25A20 and PDK4 significantly improved AF discrimination as compared with other models(AUC = 0.87, Net Reclassification Index >0.56, p<5.8x10(-3)). We validated the association between SLC25A20 and PDK4 with AF in an independent sample of 17 patients. Conclusion This study demonstrates that SLC25A20, PDK4, and NT-proBNP have incremental utility as biomarkers discriminating AF from sinus rhythm. Elevated SLC25A20 and PDK4 expression during AF indicates an important role for energy metabolism in AF.	[Raman, Kripa; Bossard, Matthias; Pare, Guillaume] David Braley Cardiac Vasc & Stroke Res Inst, Populat Hlth Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada; [Raman, Kripa; Pare, Guillaume] David Braley Cardiac Vasc & Stroke Res Inst, Thrombosis & Atherosclerosis Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada; [Raman, Kripa] McMaster Univ, Dept Med Sci, 1280 Main St West, Hamilton, ON L8S 4K1, Canada; [Aeschbacher, Stefanie; Hochgruber, Thomas; Zimmermann, Andreas J.; Conen, David] Univ Basel Hosp, Div Internal Med, Dept Med, Petersgraben 4, CH-4031 Basel, Switzerland; [Aeschbacher, Stefanie; Bossard, Matthias; Hochgruber, Thomas; Zimmermann, Andreas J.; Pumpol, Katrin; Conen, David] Univ Basel Hosp, Cardiovasc Res Inst Basel, Spitalstr 2, CH-4031 Basel, Switzerland; [Bossard, Matthias; Kaufmann, Beat A.; Rickenbacker, Peter] Univ Basel Hosp, Div Cardiol, Dept Med, Petersgraben 4, CH-4031 Basel, Switzerland; [Bossard, Matthias] Hamilton Hlth Sci, Div Cardiol, Hamilton Gen Hosp, 237 Barton St East, Hamilton, ON L8L 2X2, Canada; [Rickenbacker, Peter] Kantonsspital Bruderholz, Div Cardiol, CH-4101 Bruderholz, Switzerland; [Pare, Guillaume] McMaster Univ, Michael G DeGroote Sch Med, Dept Pathol & Mol Med, 1280 Main St West, Hamilton, ON L8S 4K1, Canada	Population Health Research Institute; McMaster University; McMaster University; University of Basel; University of Basel; University of Basel; McMaster University; Kantonsspital Baselland; McMaster University	Conen, D (corresponding author), Univ Basel Hosp, Div Internal Med, Dept Med, Petersgraben 4, CH-4031 Basel, Switzerland.; Conen, D (corresponding author), Univ Basel Hosp, Cardiovasc Res Inst Basel, Spitalstr 2, CH-4031 Basel, Switzerland.	david.conen@usb.ch	Pare, Guillaume/T-9631-2018; Kaufmann, Beat/AAB-7805-2022; Aeschbacher, Stefanie/E-4935-2017	Pare, Guillaume/0000-0002-6795-4760; Kaufmann, Beat/0000-0001-6295-3630	Mach Gaensslen Foundation; Swiss National Science Foundation [PP00P3_133681, PP00P3_159322, 3232B0_141603, 310030_149718]; University of Basel; "Freiwillige Akademische Gesellschaft (FAG)" Basel	Mach Gaensslen Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel; "Freiwillige Akademische Gesellschaft (FAG)" Basel	This study was supported by a grant of the Mach Gaensslen Foundation (to David Conen). David Conen and Beat A. Kaufmann have received grants from the Swiss National Science Foundation (PP00P3_133681 and PP00P3_159322 to David Conen, 3232B0_141603 and 310030_149718 to Beat Kaufmann). Matthias Bossard was supported by a grant of the University of Basel and the "Freiwillige Akademische Gesellschaft (FAG)" Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed HS, 2013, JAMA-J AM MED ASSOC, V310, P2050, DOI 10.1001/jama.2013.280521; Barth AS, 2005, CIRC RES, V96, P1022, DOI 10.1161/01.RES.0000165480.82737.33; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Bouwens M, 2007, AM J CLIN NUTR, V86, P1515, DOI 10.1093/ajcn/86.5.1515; Cappato R, 2009, J AM COLL CARDIOL, V53, P1798, DOI 10.1016/j.jacc.2009.02.022; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; Deshmukh A, 2015, CIRC-ARRHYTHMIA ELEC, V8, P32, DOI 10.1161/CIRCEP.114.001632; Dobson MG, 2007, EXPERT REV MOL DIAGN, V7, P359, DOI 10.1586/14737159.7.4.359; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Harrel Jr FE, 2015, HMISC PACKAGE MISCEL; Jeoung Nam Ho, 2010, Korean Diabetes J, V34, P274, DOI 10.4093/kdj.2010.34.5.274; Lin HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096794; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Ohki R, 2005, INT J CARDIOL, V102, P233, DOI 10.1016/j.ijcard.2004.05.026; PANDE SV, 1975, P NATL ACAD SCI USA, V72, P883, DOI 10.1073/pnas.72.3.883; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Pathak RK, 2015, J AM COLL CARDIOL, V65, P2159, DOI 10.1016/j.jacc.2015.03.002; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Raman K, 2016, STROKE, V47, P652, DOI 10.1161/STROKEAHA.115.011854; RAMSAY RR, 1975, FEBS LETT, V54, P21, DOI 10.1016/0014-5793(75)81059-3; Ritchie ME, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002276; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schmid R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-349; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	30	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157550	10.1371/journal.pone.0157550	http://dx.doi.org/10.1371/journal.pone.0157550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332823	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212800034
J	Thomas, JA; Collins, CR; Das, S; Hackett, F; Graindorge, A; Bell, D; Deu, E; Blackman, MJ				Thomas, James A.; Collins, Christine R.; Das, Sujaan; Hackett, Fiona; Graindorge, Arnault; Bell, Donald; Deu, Edgar; Blackman, Michael J.			Development and Application of a Simple Plaque Assay for the Human Malaria Parasite Plasmodium falciparum	PLOS ONE			English	Article							KNOWLESI MEROZOITES; ERYTHROCYTES; SENSITIVITY; COMMITMENT; SCHIZONTS; CULTURE; INVITRO; EGRESS; CYCLE	Malaria is caused by an obligate intracellular protozoan parasite that replicates within and destroys erythrocytes. Asexual blood stages of the causative agent of the most virulent form of human malaria, Plasmodium falciparum, can be cultivated indefinitely in vitro in human erythrocytes, facilitating experimental analysis of parasite cell biology, biochemistry and genetics. However, efforts to improve understanding of the basic biology of this important pathogen and to develop urgently required new antimalarial drugs and vaccines, suffer from a paucity of basic research tools. This includes a simple means of quantifying the effects of drugs, antibodies and gene modifications on parasite fitness and replication rates. Here we describe the development and validation of an extremely simple, robust plaque assay that can be used to visualise parasite replication and resulting host erythrocyte destruction at the level of clonal parasite populations. We demonstrate applications of the plaque assay by using it for the phenotypic characterisation of two P. falciparum conditional mutants displaying reduced fitness in vitro.	[Thomas, James A.; Collins, Christine R.; Das, Sujaan; Hackett, Fiona; Bell, Donald; Deu, Edgar; Blackman, Michael J.] Francis Crick Inst, Mill Hill Lab, Mill Hill, London NW7 1AA, England; [Graindorge, Arnault] Univ Geneva, Dept Microbiol & Mol Med, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland; [Blackman, Michael J.] Univ London London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England; [Das, Sujaan] Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8TA, Lanark, Scotland	University of Geneva; University of London; London School of Hygiene & Tropical Medicine	Blackman, MJ (corresponding author), Francis Crick Inst, Mill Hill Lab, Mill Hill, London NW7 1AA, England.; Blackman, MJ (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England.	mike.blackman@crick.ac.uk		Thomas, James/0000-0002-1991-1838; Graindorge, Arnault/0000-0002-6076-3646	United Kingdom Medical Research Council [U117532063]; Francis Crick Institute; Wellcome Trust [099950/Z/12/Z]; European Commission Framework Programme 7 [242095]; EviMalAR PhD studentship; Medical Research Council [1365576] Funding Source: researchfish; The Francis Crick Institute [10363, 10043] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Francis Crick Institute; Wellcome Trust(Wellcome TrustEuropean Commission); European Commission Framework Programme 7; EviMalAR PhD studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	This work was supported by the United Kingdom Medical Research Council (http://www.mrc.ac.uk/) (U117532063 to MJB), the Francis Crick Institute (https://www.crick.ac.uk/), the Wellcome Trust (099950/Z/12/Z to ED and ISSF2 funding to the London School of Hygiene and Tropical Medicine) and European Commission Framework Programme 7 contract no. 242095 (EviMalAR; http://www.evimalar.org/). JAT is in receipt of a Francis Crick Institute PhD studentship whilst SD was funded by an EviMalAR PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisue N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017775; BANNISTER LH, 1975, PARASITOLOGY, V71, P483, DOI 10.1017/S0031182000047247; BRUCE MC, 1990, PARASITOLOGY, V100, P191, DOI 10.1017/S0031182000061199; CHAPARAS SD, 1959, P SOC EXP BIOL MED, V102, P431, DOI 10.3181/00379727-102-25275; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; Das S, 2015, CELL HOST MICROBE, V18, P433, DOI 10.1016/j.chom.2015.09.007; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; DULBECCO R, 1953, COLD SPRING HARB SYM, V18, P273, DOI 10.1101/SQB.1953.018.01.039; Edouard S, 2013, FUTURE MICROBIOL, V8, P1301, DOI 10.2217/fmb.13.98; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; INSELBURG J, 1983, J PARASITOL, V69, P584, DOI 10.2307/3281374; Jensen JB, 1976, SCIENCE, V20, P193; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; JOHNSON JG, 1980, PARASITOLOGY, V80, P539, DOI 10.1017/S0031182000000998; Jones ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep21800; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; McCoubrie JE, 2007, INFECT IMMUN, V75, P5565, DOI 10.1128/IAI.00405-07; Miller SK, 2002, J BIOL CHEM, V277, P47524, DOI 10.1074/jbc.M206974200; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Moon RW, 2013, P NATL ACAD SCI USA, V110, P531, DOI 10.1073/pnas.1216457110; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Ndiaye D, 2010, AM J TROP MED HYG, V82, P228, DOI 10.4269/ajtmh.2010.09-0470; Noedl H, 2002, ANTIMICROB AGENTS CH, V46, P1658, DOI 10.1128/AAC.46.6.1658-1664.2002; Prommana P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073783; Ruecker A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.400820; SAUL A, 1982, B WORLD HEALTH ORGAN, V60, P755; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Smith TG, 2000, PARASITOLOGY, V121, P127, DOI 10.1017/S0031182099006265; Sullivan K, 2012, J VIROL METHODS, V179, P81, DOI 10.1016/j.jviromet.2011.10.003; Tham WH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005343; Wagner JC, 2014, NAT METHODS, V11, P915, DOI [10.1038/NMETH.3063, 10.1038/nmeth.3063]; Williams JL, 1999, AM J TROP MED HYG, V60, P7, DOI 10.4269/ajtmh.1999.60.7; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	35	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157873	10.1371/journal.pone.0157873	http://dx.doi.org/10.1371/journal.pone.0157873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332706	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000378212800055
J	Xie, S; Zhang, Z; Chang, FY; Wang, YS; Zhang, ZX; Zhou, ZY; Guo, H				Xie, Sheng; Zhang, Zhe; Chang, Feiyan; Wang, Yishi; Zhang, Zhenxia; Zhou, Zhenyu; Guo, Hua			Subcortical White Matter Changes with Normal Aging Detected by Multi-Shot High Resolution Diffusion Tensor Imaging	PLOS ONE			English	Article							HUMAN BRAIN; FIBER TRACKING; IN-VIVO; AGE; INTEGRITY; MRI; ANISOTROPY; MICROSTRUCTURE; VOLUME; DYSMYELINATION	Subcortical white matter builds neural connections between cortical and subcortical regions and constitutes the basis of neural networks. It plays a very important role in normal brain function. Various studies have shown that white matter deteriorates with aging. However, due to the limited spatial resolution provided by traditional diffusion imaging techniques, microstructural information from subcortical white matter with normal aging has not been comprehensively assessed. This study aims to investigate the deterioration effect with aging in the subcortical white matter and provide a baseline standard for pathological disorder diagnosis. We apply our newly developed multi-shot high resolution diffusion tensor imaging, using self-feeding multiplexed sensitivity-encoding, to measure subcortical white matter changes in regions of interest of healthy persons with a wide age range. Results show significant fractional anisotropy decline and radial diffusivity increasing with age, especially in the anterior part of the brain. We also find that subcortical white matter has more prominent changes than white matter close to the central brain. The observed changes in the subcortical white matter may be indicative of a mild demyelination and a loss of myelinated axons, which may contribute to normal age-related functional decline.	[Xie, Sheng; Chang, Feiyan; Zhang, Zhenxia] China Japan Friendship Hosp, Dept Radiol, Beijing, Peoples R China; [Zhang, Zhe; Wang, Yishi; Guo, Hua] Tsinghua Univ, Dept Biomed Engn, Ctr Biomed Imaging Res, Beijing 100084, Peoples R China; [Zhou, Zhenyu] GE Healthcare China, Beijing, Peoples R China	China-Japan Friendship Hospital; Tsinghua University; General Electric	Xie, S (corresponding author), China Japan Friendship Hosp, Dept Radiol, Beijing, Peoples R China.; Guo, H (corresponding author), Tsinghua Univ, Dept Biomed Engn, Ctr Biomed Imaging Res, Beijing 100084, Peoples R China.	xs_mri@126.com; huaguo@tsinghua.edu.cn		Zhang, Zhe/0000-0001-8220-8443	National Natural Science Foundation of China [61271132, 61571258]; Beijing Natural Science Foundation [7142091]; Ministry of Science and Technology of China grant [2012IM030100]; GE Healthcare China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Ministry of Science and Technology of China grant; GE Healthcare China(General Electric)	This work was funded by National Natural Science Foundation of China (61271132 and 61571258) (http://www.nsfc.gov.cn/) (HG), Beijing Natural Science Foundation (7142091) (http://www.bjkw.gov.cn/n244495/n244682/2665091.html) (HG), and a Ministry of Science and Technology of China grant (2012IM030100) (http://www.most.gov.cn/eng/organization/) (HG). The above funders provided support in the form of salaries for authors Zhe Zhang and Yishi Wang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Author Zhenyu Zhou is employed by GE Healthcare China. GE Healthcare China provided support in the form of salary for author Zhenyu Zhou, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Bammer R, 2009, MAGN RESON IMAGING C, V17, P175, DOI 10.1016/j.mric.2009.01.011; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Bhagat YA, 2004, J MAGN RESON IMAGING, V20, P216, DOI 10.1002/jmri.20102; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Chen NK, 2013, NEUROIMAGE, V72, P41, DOI 10.1016/j.neuroimage.2013.01.038; Chun T, 2000, AM J NEURORADIOL, V21, P1078; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Engelhardt Eliasz, 2009, Dement. neuropsychol., V3, P228, DOI 10.1590/S1980-57642009DN30300009; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Hsu JL, 2010, NEUROIMAGE, V49, P32, DOI 10.1016/j.neuroimage.2009.08.031; Huang F, 2010, MAGN RESON MED, V64, P1078, DOI 10.1002/mrm.22504; Hugenschmidt CE, 2008, CEREB CORTEX, V18, P433, DOI 10.1093/cercor/bhm080; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; Madden DJ, 2009, NEUROPSYCHOL REV, V19, P415, DOI 10.1007/s11065-009-9113-2; Mcnab JA, 2009, NEUROIMAGE, V46, P775, DOI 10.1016/j.neuroimage.2009.01.008; MEIERRUGE W, 1992, ANN NY ACAD SCI, V673, P260, DOI 10.1111/j.1749-6632.1992.tb27462.x; Miller KL, 2011, NEUROIMAGE, V57, P167, DOI 10.1016/j.neuroimage.2011.03.070; Moseley M, 2002, NMR BIOMED, V15, P553, DOI 10.1002/nbm.785; Naganawa S, 2003, EUR RADIOL, V13, P6, DOI 10.1007/s00330-002-1549-1; Nunes RG, 2005, MAGN RESON MED, V53, P1474, DOI 10.1002/mrm.20499; Nusbaum AO, 2001, AM J NEURORADIOL, V22, P136; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Pal D, 2011, J CLIN NEUROSCI, V18, P193, DOI 10.1016/j.jocn.2010.05.033; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Porter DA, 2009, MAGN RESON MED, V62, P468, DOI 10.1002/mrm.22024; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sullivan EV, 2006, CEREB CORTEX, V16, P1030, DOI 10.1093/cercor/bhj045; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Sullivan EV, 2010, DEV NEUROPSYCHOL, V35, P233, DOI 10.1080/87565641003689556; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X; Truong TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091424; Vernooij MW, 2008, NEUROIMAGE, V43, P470, DOI 10.1016/j.neuroimage.2008.07.052; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Zhang Z, 2015, NEUROIMAGE, V105, P552, DOI 10.1016/j.neuroimage.2014.10.022	45	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157533	10.1371/journal.pone.0157533	http://dx.doi.org/10.1371/journal.pone.0157533			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332713	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212800033
J	Larbig, R; Dittrich, R; Kochhaeuser, S; Leitz, P; Guener, F; Korsukewitz, C; Dechering, D; Pott, C; Wasmer, K; Schmitges, J; Kerckhoff, M; Eckardt, L; Moennig, G				Larbig, Robert; Dittrich, Ralf; Kochhaeuser, Simon; Leitz, Patrick; Guener, Fatih; Korsukewitz, Catharina; Dechering, Dirk; Pott, Christian; Wasmer, Kristina; Schmitges, Jan; Kerckhoff, Monika; Eckardt, Lars; Moennig, Gerold			Influence of Clinical Parameters and Anticoagulation on Intraprocedural Cerebral Microembolic Signals during Pulmonary Vein Isolation	PLOS ONE			English	Article							ATRIAL-FIBRILLATION ABLATION; CATHETER ABLATION; RADIOFREQUENCY	Objective We had the objective to determine the impact of clinical parameters and anticoagulation status on cerebral microembolic signals (MES) during pulmonary vein isolation (PVI) for atrial fibrillation (AF). Background Thromboembolism and stroke are the most feared complications of PVI. MES can help to evaluate embolic burden. It is unknown whether clinical parameters have an impact on embolic risk during PVI. Methods In this retrospective analysis we investigated the impact of clinical parameters, including the CHADS(2)- and CHA(2)DS(2)-VASc-score, pulmonary vein variants and echocardiographic parameters on MES rates in patients that underwent PVI using three different ablation approaches (radiofrequency ablation (iRF), pulmonary vein ablation catheter (PVAC) with deactivated electrode pair 1 or 5 (PVAC-red) or PVAC without deactivation (PVAC-all). Results 118 AF patients (61 +/- 12 years) were included between 2011 and 2013 (Median: 489 MES during PVI). Patients were more likely to have more MES (within 4th quartile) with the PVAC-all approach (60.7% vs. 25.0%(iRF) vs. 14.3% (PVAC-red) respectively (p<0.001). Patients with oral anticoagulation (OAC) pre-ablation were more likely to have lower MES-counts (1st-3rd quartile); (65.6% vs. 35.7%; p = 0.005). Additionally, patients with lower MES counts (1st-3rd quartile) had significantly higher INR values than those in the 4th quartile (1.78 vs. 1.09; p = 0.029). 2 patients developed a potentially thromboembolic event during the procedure. Conclusion Clinical predictors of cerebral emboli and stroke do not correlate with cerebral embolic burden during PVI. Pre-ablation OAC and increased INR values correlate with decreased MES-rates. Therefore, it might be beneficial to perform PVI with pre-ablation anticoagulation even in low risk patients.	[Larbig, Robert; Kochhaeuser, Simon; Leitz, Patrick; Guener, Fatih; Dechering, Dirk; Pott, Christian; Wasmer, Kristina; Kerckhoff, Monika; Eckardt, Lars; Moennig, Gerold] Univ Munster, Dept Cardiovasc Med, Div Electrophysiol, Albert Schweitzer Campus 1,Bldg A1, D-48149 Munster, Germany; [Dittrich, Ralf; Korsukewitz, Catharina] Univ Munster, Dept Neurol, Albert Schweitzer Campus 1,Bldg A1, D-48149 Munster, Germany; [Schmitges, Jan] Helios Klinikum Krefeld, Dept Urol, Lutherpl 40, D-47805 Krefeld, Germany	University of Munster; University of Munster; Helios Kliniken	Larbig, R (corresponding author), Univ Munster, Dept Cardiovasc Med, Div Electrophysiol, Albert Schweitzer Campus 1,Bldg A1, D-48149 Munster, Germany.	Robert.Larbig@ukmuenster.de						[Anonymous], 1995, Stroke, V26, P1123; Antz M, 2015, HERZ, V40, P45, DOI 10.1007/s00059-014-4196-9; Bittner A, 2011, EUROPACE, V13, P1394, DOI 10.1093/europace/eur145; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Di Biase L, 2014, CIRCULATION, V129, P2638, DOI 10.1161/CIRCULATIONAHA.113.006426; Duytschaever M, 2013, J CARDIOVASC ELECTR, V24, P855, DOI 10.1111/jce.12148; Gaita F, 2011, J CARDIOVASC ELECTR, V22, P961, DOI 10.1111/j.1540-8167.2011.02050.x; Kiss A, 2014, INT J CARDIOL, V174, P276, DOI 10.1016/j.ijcard.2014.03.175; Kochhauser S, 2015, CLIN RES CARDIOL, V104, P234, DOI 10.1007/s00392-014-0777-0; Raviele A, 2012, J CARDIOVASC ELECTR, V23, P890, DOI 10.1111/j.1540-8167.2012.02381.x; Zellerhoff S, 2014, EUROPACE, V16, P341, DOI 10.1093/europace/eut282	11	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157886	10.1371/journal.pone.0157886	http://dx.doi.org/10.1371/journal.pone.0157886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327662	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400057
J	Sakudo, A; Toyokawa, Y; Imanishi, Y				Sakudo, Akikazu; Toyokawa, Yoichi; Imanishi, Yuichiro			Nitrogen Gas Plasma Generated by a Static Induction Thyristor as a Pulsed Power Supply Inactivates Adenovirus	PLOS ONE			English	Article							VIRUCIDAL EFFICACY; STERILIZATION; SALMONELLA; MICROORGANISMS; CELLS	Adenovirus is one of the most important causative agents of iatrogenic infections derived from contaminated medical devices or finger contact. In this study, we investigated whether nitrogen gas plasma, generated by applying a short high-voltage pulse to nitrogen using a static induction thyristor power supply (1.5 kilo pulse per second), exhibited a virucidal effect against adenoviruses. Viral titer was reduced by one log within 0.94 min. Results from detection of viral capsid proteins, hexon and penton, by Western blotting and immunochromatography were unaffected by the plasma treatment. In contrast, analysis using the polymerase chain reaction suggested that plasma treatment damages the viral genomic DNA. Reactive chemical products (hydrogen peroxide, nitrate, and nitrite), ultraviolet light (UV-A) and slight temperature elevations were observed during the operation of the gas plasma device. Viral titer versus intensity of each potential virucidal factor were used to identify the primary mechanism of disinfection of adenovirus. Although exposure to equivalent levels of UV-A or heat treatment did not inactivate adenovirus, treatment with a relatively low concentration of hydrogen peroxide efficiently inactivated the virus. Our results suggest the nitrogen gas plasma generates reactive chemical products that inactivate adenovirus by damaging the viral genomic DNA.	[Sakudo, Akikazu; Toyokawa, Yoichi] Univ Ryukyus, Sch Hlth Sci, Lab Biometab Chem, Nishihara, Okinawa 90301, Japan; [Sakudo, Akikazu] Osaka Univ, Microbial Dis Res Inst, Dept Virol, Suita, Osaka 565, Japan; [Imanishi, Yuichiro] NGK Insulators Ltd, Mizuho Ku, Nagoya, Aichi, Japan	University of the Ryukyus; Osaka University; NGK Insulators Ltd	Sakudo, A (corresponding author), Univ Ryukyus, Sch Hlth Sci, Lab Biometab Chem, Nishihara, Okinawa 90301, Japan.; Sakudo, A (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Virol, Suita, Osaka 565, Japan.	sakudo@med.u-ryukyu.ac.jp	Sakudo, Akikazu/B-1368-2014		Bio-oriented Technology Research Advancement Institution (BRAIN); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; Amano Institute of Technology; Uruma Academic Research Fund; Takahashi Industrial and Economic Research Foundation; Japan Society for the Promotion of Science [22110514, 24110717, 16K04997]; Kieikai Research Foundation; NGK Insulators Ltd.	Bio-oriented Technology Research Advancement Institution (BRAIN); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; Amano Institute of Technology; Uruma Academic Research Fund; Takahashi Industrial and Economic Research Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kieikai Research Foundation(Kieikai Research Foundation); NGK Insulators Ltd.	This work was supported by a Grant-in-Aid for the Promotion of Basic Research Activities for Innovative Biosciences from the Bio-oriented Technology Research Advancement Institution (BRAIN), the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, a Grant-in-Aid from Amano Institute of Technology, a Grant-in-Aid from Uruma Academic Research Fund, a Grant-in-Aid from Takahashi Industrial and Economic Research Foundation, and Grant-in-Aids for Scientific Research (No. 22110514, 24110717, and 16K04997) from the Japan Society for the Promotion of Science as well as a Grant-in-Aid from the Kieikai Research Foundation. The funders had no role in study design, data collection, analysis, decision, and preparation of the manuscript or publishing. NGK Insulators Ltd. provided support in the form of salaries for author (YI), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	[Anonymous], 1987, GUID STAND PROT TEST; [Anonymous], AD 10 EXPR SYST 1 US; Belikov AV, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0194-3; Berrie E, 2011, LETT APPL MICROBIOL, V52, P555, DOI 10.1111/j.1472-765X.2011.03033.x; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bol'shakov AA, 2004, AIAA J, V42, P823, DOI 10.2514/1.9562; Cvelbar U, 2009, J APPL PHYS, V106, DOI 10.1063/1.3245336; Fernandez A, 2013, FOOD MICROBIOL, V33, P24, DOI 10.1016/j.fm.2012.08.007; Fernandez A, 2012, FOOD RES INT, V45, P678, DOI 10.1016/j.foodres.2011.04.009; Ghebremedhin B, 2014, EUR J MICROBIOL IMMU, V4, P26, DOI 10.1556/EuJMI.4.2014.1.2; Goyal SM, 2014, J HOSP INFECT, V86, P255, DOI 10.1016/j.jhin.2014.02.003; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Kanegae Y, 1994, United States patent, Patent No. [US 5,731,172, 5731172]; Kawamura K, 2012, MICROBIOL IMMUNOL, V56, P431, DOI 10.1111/j.1348-0421.2012.00457.x; Kowalski RP, 2001, AM J OPHTHALMOL, V132, P777, DOI 10.1016/S0002-9394(01)01128-X; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Laroussi M, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/341; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Laroussi M, 2002, APPL PHYS LETT, V81, P772, DOI 10.1063/1.1494863; Laroussi M., 2012, PLASMA MED; Maeda K, 2015, FOOD CONTROL, V52, P54, DOI 10.1016/j.foodcont.2014.12.012; Marsili L, 2002, RADIAT PHYS CHEM, V65, P507, DOI 10.1016/S0969-806X(02)00367-5; Mitamura K, 2008, JPN J MED PHARM SCI, V60, P143; Moisan M, 2002, PURE APPL CHEM, V74, P349, DOI 10.1351/pac200274030349; Nwachuku N, 2005, APPL ENVIRON MICROB, V71, P5633, DOI 10.1128/AEM.71.9.5633-5636.2005; Rexroad J, 2003, J PHARM SCI, V92, P665, DOI 10.1002/jps.10340; Rutala WA, 2006, ANTIMICROB AGENTS CH, V50, P1419, DOI 10.1128/AAC.50.4.1419-1424.2006; Sakudo A., 2011, STERILIZATION DISINF; Sakudo A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/694269; Sakudo A, 2016, INT J NANOMED, V11, P1847, DOI 10.2147/IJN.S104926; Sakudo Akikazu, 2014, Front Biosci (Elite Ed), V6, P69; Sakudo A, 2013, MICROBIOL IMMUNOL, V57, P536, DOI 10.1111/1348-0421.12061; Shintani H, 2016, GAS PLASMA STERILIZATION IN MICROBIOLOGY: THEORY, APPLICATIONS, PITFALLS AND NEW PERSPECTIVES, P1; Shintani H., 2015, INT J CLIN PHARM TOX, V4, P150, DOI DOI 10.19070/2167-910X-1500027; Shintani H, 2015, APPL MICROBIO OPEN A, V1, pe101, DOI [10.4172/amoa.1000e101, DOI 10.4172/AMOA.1000E101]; Shintani H, 2010, EXP THER MED, V1, P731, DOI 10.3892/etm.2010.136; Shintani Hideharu, 2007, Biocontrol Science, V12, P131; Tuladhar E, 2012, J HOSP INFECT, V80, P110, DOI 10.1016/j.jhin.2011.10.012; Tuteja U., 2000, Indian Journal of Experimental Biology, V38, P1259; Walker CM, 2007, ENVIRON SCI TECHNOL, V41, P5460, DOI 10.1021/es070056u; Wold WSM, 1999, AD METH PROT; Zimmermann JL, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/50/505201	43	29	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157922	10.1371/journal.pone.0157922	http://dx.doi.org/10.1371/journal.pone.0157922			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322066	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212000054
J	Ali, SM; Mehmood, CA; Khan, B; Jawad, M; Farid, U; Jadoon, JK; Ali, M; Tareen, NK; Usman, S; Majid, M; Anwar, SM				Ali, S. M.; Mehmood, C. A.; Khan, B.; Jawad, M.; Farid, U.; Jadoon, J. K.; Ali, M.; Tareen, N. K.; Usman, S.; Majid, M.; Anwar, S. M.			Stochastic and Statistical Analysis of Utility Revenues and Weather Data Analysis for Consumer Demand Estimation in Smart Grids	PLOS ONE			English	Article								In smart grid paradigm, the consumer demands are random and time-dependent, owning towards stochastic probabilities. The stochastically varying consumer demands have put the policy makers and supplying agencies in a demanding position for optimal generation management. The utility revenue functions are highly dependent on the consumer deterministic stochastic demand models. The sudden drifts in weather parameters effects the living standards of the consumers that in turn influence the power demands. Considering above, we analyzed stochastically and statistically the effect of random consumer demands on the fixed and variable revenues of the electrical utilities. Our work presented the Multi-Variate Gaussian Distribution Function (MVGDF) probabilistic model of the utility revenues with time-dependent consumer random demands. Moreover, the Gaussian probabilities outcome of the utility revenues is based on the varying consumer n demands data-pattern. Furthermore, Standard Monte Carlo (SMC) simulations are performed that validated the factor of accuracy in the aforesaid probabilistic demand-revenue model. We critically analyzed the effect of weather data parameters on consumer demands using correlation and multi-linear regression schemes. The statistical analysis of consumer demands provided a relationship between dependent (demand) and independent variables (weather data) for utility load management, generation control, and network expansion.	[Ali, S. M.; Mehmood, C. A.; Khan, B.; Farid, U.; Jadoon, J. K.; Tareen, N. K.] COMSATS Inst IT, Dept Elect Engn, Abbottabad, Kpk, Pakistan; [Jawad, M.] COMSATS Inst IT, Dept Elect Engn, Lahore, Pakistan; [Ali, M.] COMSATS Inst IT, Dept Comp Sci, Abbottabad, Kpk, Pakistan; [Usman, S.] COMSATS Inst IT, Dept Elect Engn, Sahiwal, Pakistan; [Majid, M.] Univ Engn & Technol, Dept Comp Engn, Taxila, Pakistan; [Anwar, S. M.] Univ Engn & Technol, Software Engn Dept, Taxila, Pakistan	COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI); University of Engineering & Technology Taxila; University of Engineering & Technology Taxila	Farid, U (corresponding author), COMSATS Inst IT, Dept Elect Engn, Abbottabad, Kpk, Pakistan.	umarfarid@ciit.net.pk	Farid, Umar/Z-1203-2019; Mehmood, Chaudhry/ABB-5669-2021; Majid, Muhammad/Z-5667-2019; Anwar, Syed/AAN-4398-2020; Jawad, Muhammad/H-5765-2018	Mehmood, Chaudhry/0000-0003-1796-3180; Majid, Muhammad/0000-0003-3662-2525; Anwar, Syed/0000-0002-8179-3959; Jawad, Muhammad/0000-0003-3730-2128				Ali SM, 2014, INT CONF ELECTRO INF, P459, DOI 10.1109/EIT.2014.6871808; Awad A., 2012, 2012 INT C SMART GRI, P1; Bienstock D, 2013, IEEE DECIS CONTR P, P4335, DOI 10.1109/CDC.2013.6760556; Blum, 2012, 2012 46 ANN C INF SC, P1, DOI [10.1109/CISS.2012.6310731, DOI 10.1109/CISS.2012.6310731]; Deng RL, 2014, IEEE T POWER SYST, V29, P2823, DOI 10.1109/TPWRS.2014.2311127; Dickert J., 2011, 2011 IEEE PES TRONDH, P1; Goddard NH, 2012, SUST INTERNET ICT; Goude Y, 2014, IEEE T SMART GRID, V5, P440, DOI 10.1109/TSG.2013.2278425; Harsha P, 2013, IEEE T SMART GRID, V4, P2274, DOI 10.1109/TSG.2013.2278238; He Y., 2013, P IEEE PES INN SMART, P1; Hobby JD, 2012, IEEE T SMART GRID, V3, P217, DOI 10.1109/TSG.2011.2167353; Hong T, 2014, IEEE T SMART GRID, V5, P456, DOI 10.1109/TSG.2013.2274373; Hosseini SS, 2013, 2013 INTERNATIONAL CONFERENCE ON POWER, ENERGY AND CONTROL (ICPEC), P728, DOI 10.1109/ICPEC.2013.6527751; Imamura Akiyuki, 2013, 2013 IEEE Region 10 Humanitarian Technology Conference (R10-HTC), P148, DOI 10.1109/R10-HTC.2013.6669032; Kekatos V., 2013, 2013 IEEE PES INN SM, P1; Li J, 2014, 2014 INTERNATIONAL CONFERENCE ON POWER SYSTEM TECHNOLOGY (POWERCON), P852, DOI 10.1109/POWERCON.2014.6993892; Liu M, CONTROL SYSTEMS TECH, VPP, P1; Ma T, 2014, IEEE T IND APPL, V50, P2323, DOI 10.1109/TIA.2013.2296620; Niyato D, 2013, IEEE T SMART GRID, V4, P21, DOI 10.1109/TSG.2012.2224677; Sahibzada M. A, 2013, IREE, V8, P262; Samadi M., 2013, 2013 21 IR C EL ENG, P1, DOI DOI 10.1109/IRANIANCEE.2013.6599801; Shafiq M. Zubair, 2013, Performance Evaluation Review, V41, P17; Sheikhalr A., 2013, IEEE GRENOBLE POWERT, P1; Shengrong Bu, 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications. Workshops, P307, DOI 10.1109/INFCOMW.2011.5928828; Shi D, 2014, IEEE POW ENER SOC GE; Shirzeh H, 2013, P IEEE EN MAY 2013, P1; Tigas K., 2012, P IEEE INT C REN EN, P1; Verzijlbergh RA, 2013, IEEE INT C NETW SENS, P889, DOI 10.1109/ICNSC.2013.6548855; Zhou Y., 2012, 2012 IEEE PES Innovative Smart Grid Technologies (ISGT), DOI 10.1109/ISGT.2012.6175805	29	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0156849	10.1371/journal.pone.0156849	http://dx.doi.org/10.1371/journal.pone.0156849			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314229	gold, Green Published, Green Submitted			2022-12-26	WOS:000378030000005
J	Hector, RD; Dando, O; Landsberger, N; Kilstrup-Nielsen, C; Kind, PC; Bailey, MES; Cobb, SR				Hector, Ralph D.; Dando, Owen; Landsberger, Nicoletta; Kilstrup-Nielsen, Charlotte; Kind, Peter C.; Bailey, Mark E. S.; Cobb, Stuart R.			Characterisation of CDKL5 Transcript Isoforms in Human and Mouse	PLOS ONE			English	Article							INTEGRATIVE GENOMICS VIEWER; MENTAL-RETARDATION; INFANTILE SPASMS; C-TERMINUS; ARRAY-CGH; GENE; MUTATIONS; ENCEPHALOPATHIES; PREDICTION; DISORDER	Mutations in the X-linked Cyclin-Dependent Kinase-Like 5 gene (CDKL5) cause early onset infantile spasms and subsequent severe developmental delay in affected children. Deleterious mutations have been reported to occur throughout the CDKL5 coding region. Several studies point to a complex CDKL5 gene structure in terms of exon usage and transcript expression. Improvements in molecular diagnosis and more extensive research into the neurobiology of CDKL5 and pathophysiology of CDKL5 disorders necessitate an updated analysis of the gene. In this study, we have analysed human and mouse CDKL5 transcript patterns both bioinformatically and experimentally. We have characterised the predominant brain isoform of CDKL5, a 9.7 kb transcript comprised of 18 exons with a large 6.6 kb 3'-untranslated region (UTR), which we name hCDKL5_1. In addition we describe new exonic regions and a range of novel splice and UTR isoforms. This has enabled the description of an updated gene model in both species and a standardised nomenclature system for CDKL5 transcripts. Profiling revealed tissue-and brain development stage-specific differences in expression between transcript isoforms. These findings provide an essential backdrop for the diagnosis of CDKL5-related disorders, for investigations into the basic biology of this gene and its protein products, and for the rational design of gene-based and molecular therapies for these disorders.	[Hector, Ralph D.; Cobb, Stuart R.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Dando, Owen; Kind, Peter C.] Univ Edinburgh, Patrick Wild Ctr, Edinburgh, Midlothian, Scotland; [Dando, Owen; Kind, Peter C.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Dando, Owen; Kind, Peter C.] Inst Stem Cell Biol & Regenerat Med, Ctr Brain Dev & Repair, Bangalore, Karnataka, India; [Landsberger, Nicoletta] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Kilstrup-Nielsen, Charlotte] Univ Insubria, Dept Theoret & Appl Sci, Div Biomed Res, Busto Arsizio, Italy; [Bailey, Mark E. S.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of Edinburgh; University of Edinburgh; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; University of Milan; University of Insubria; University of Glasgow	Cobb, SR (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	stuart.cobb@glasgow.ac.uk	Hector, Ralph D/AAB-5455-2019	Hector, Ralph D/0000-0002-3778-1483; Kind, Peter/0000-0002-4256-9639; Dando, Owen/0000-0002-6269-6408; Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077; Landsberger, Nicoletta/0000-0003-0820-3155; Bailey, Mark E. S./0000-0002-9788-2278	Chief Scientist Office of the Scottish Government [ETM/334]; Rett Syndrome Association Scotland; Italian parents' association L'Albero di Greta; Medical Research Council [MR/K014137/1] Funding Source: researchfish; Chief Scientist Office [ETM/334] Funding Source: researchfish; MRC [MR/K014137/1] Funding Source: UKRI	Chief Scientist Office of the Scottish Government; Rett Syndrome Association Scotland; Italian parents' association L'Albero di Greta; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Chief Scientist Office of the Scottish Government (grant ETM/334) and the Rett Syndrome Association Scotland provided funding to SRC and MESB. NL and CKN are supported by the Italian parents' association L'Albero di Greta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091613; Artuso R, 2010, BRAIN DEV-JPN, V32, P17, DOI 10.1016/j.braindev.2009.02.004; Bahi-Buisson N, 2008, BRAIN, V131, P2647, DOI 10.1093/brain/awn197; Bahi-Buisson N, 2008, EPILEPSIA, V49, P1027, DOI 10.1111/j.1528-1167.2007.01520.x; Bahi-Buisson N, 2010, AM J MED GENET B, V153B, P202, DOI 10.1002/ajmg.b.30974; Bartnik M, 2011, GENET MED, V13, P447, DOI 10.1097/GIM.0b013e31820605f5; Bertani I, 2006, J BIOL CHEM, V281, P32048, DOI 10.1074/jbc.M606325200; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Christodoulou J, 2003, HUM MUTAT, V21, P466, DOI 10.1002/humu.10194; Diebold B, 2014, EUR J HUM GENET, V22, P270, DOI 10.1038/ejhg.2013.133; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fehr S, 2015, J NEURODEV DISORD, V7, DOI 10.1186/1866-1955-7-2; Fehr S, 2013, EUR J HUM GENET, V21, P266, DOI 10.1038/ejhg.2012.156; Fichou Y, 2011, J HUM GENET, V56, P52, DOI 10.1038/jhg.2010.143; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Intusoma U, 2011, EUR J PAEDIATR NEURO, V15, P432, DOI 10.1016/j.ejpn.2011.01.005; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Katz Y, 2015, BIOINFORMATICS, V31, P2400, DOI 10.1093/bioinformatics/btv034; Kilstrup-Nielsen C, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/728267; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; La Montanara P, 2015, J BIOL CHEM, V290, P4512, DOI 10.1074/jbc.M114.589762; Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; McMahon AC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1900; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Montini E, 1998, GENOMICS, V51, P427, DOI 10.1006/geno.1998.5391; Montini E, 1997, HUM MOL GENET, V6, P1137, DOI 10.1093/hmg/6.7.1137; Moseley BD, 2012, PEDIATR NEUROL, V46, P101, DOI 10.1016/j.pediatrneurol.2011.11.007; Nemos C, 2009, CLIN GENET, V76, P357, DOI 10.1111/j.1399-0004.2009.01194.x; Pecorelli A, 2015, FREE RADICAL BIO MED, V86, P156, DOI 10.1016/j.freeradbiomed.2015.05.010; Rademacher N, 2011, NEUROGENETICS, V12, P165, DOI 10.1007/s10048-011-0277-6; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rusconi L, 2008, J BIOL CHEM, V283, P30101, DOI 10.1074/jbc.M804613200; Tao J, 2004, AM J HUM GENET, V75, P1149, DOI 10.1086/426460; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tzschach A, 2008, AM J MED GENET A, V146A, P197, DOI 10.1002/ajmg.a.32070; Vavouri T, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r110; Vitezic M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1177; Vorozheykin PS, 2015, MOL BIOL+, V49, P755, DOI 10.1134/S0026893315050192; Wang ITJ, 2012, P NATL ACAD SCI USA, V109, P21516, DOI 10.1073/pnas.1216988110; Weaving LS, 2004, AM J HUM GENET, V75, P1079, DOI 10.1086/426462; Williamson SL, 2012, HUM GENET, V131, P187, DOI 10.1007/s00439-011-1058-x; Yamashita R, 2012, NUCLEIC ACIDS RES, V40, pD150, DOI 10.1093/nar/gkr1005; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhu YC, 2013, P NATL ACAD SCI USA, V110, P9118, DOI 10.1073/pnas.1300003110	50	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157758	10.1371/journal.pone.0157758	http://dx.doi.org/10.1371/journal.pone.0157758			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315173	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000378030000052
J	Lopez, AG; Seoane, JM; Sanjuan, MAF				Lopez, Alvaro G.; Seoane, Jesus M.; Sanjuan, Miguel A. F.			Decay Dynamics of Tumors	PLOS ONE			English	Article							MODEL; HALLMARKS; GROWTH	The fractional cell kill is a mathematical expression describing the rate at which a certain population of cells is reduced to a fraction of itself. We investigate the mathematical function that governs the rate at which a solid tumor is lysed by a cell population of cytotoxic lymphocytes. We do it in the context of enzyme kinetics, using geometrical and analytical arguments. We derive the equations governing the decay of a tumor in the limit in which it is plainly surrounded by immune cells. A cellular automaton is used to test such decay, confirming its validity. Finally, we introduce a modification in the fractional cell kill so that the expected dynamics is attained in the mentioned limit. We also discuss the potential of this new function for non-solid and solid tumors which are infiltrated with lymphocytes.	[Lopez, Alvaro G.; Seoane, Jesus M.; Sanjuan, Miguel A. F.] Univ Rey Juan Carlos, Nonlinear Dynam Chaos & Complex Syst Grp, Dept Fis, Tulipan S-N, Madrid, Spain	Universidad Rey Juan Carlos	Lopez, AG (corresponding author), Univ Rey Juan Carlos, Nonlinear Dynam Chaos & Complex Syst Grp, Dept Fis, Tulipan S-N, Madrid, Spain.	alvaro.lopez@urjc.es	Sanjuán, Miguel AF/B-7709-2011; Lopez, Alvaro Garcia/Y-9898-2019; García, Alvaro/B-8422-2015	Sanjuán, Miguel AF/0000-0003-3515-0837; Lopez, Alvaro Garcia/0000-0002-2485-4639; 	Spanish Ministry of Economy and Competitiveness [FIS2013-40653-P]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness under project number FIS2013-40653-P.	de Pillis L. G., 2005, CANCER RES, V6, P235; De Pillis LG, 2003, MATH COMPUT MODEL, V37, P1221, DOI 10.1016/S0895-7177(03)00133-X; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Ferreira SC, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021907; Garcia A., 2016, FRACTIONAL CELL KILL; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Holling C. S., 1959, Canadian Entomologist, V91, P385; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; KUZNETSOV VA, 1994, B MATH BIOL, V56, P295, DOI 10.1007/BF02460644; Lopez AG, 2014, B MATH BIOL, V76, P2884, DOI 10.1007/s11538-014-0037-5; Lotka AJ, 1920, P NATL ACAD SCI USA, V6, P410, DOI 10.1073/pnas.6.7.410; Mallet DG, 2006, J THEOR BIOL, V239, P334, DOI 10.1016/j.jtbi.2005.08.002; Michaelis L, 1913, BIOCHEM Z, V49, P333; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Norton L, 2005, ONCOLOGIST, V10, P370, DOI 10.1634/theoncologist.10-6-370; Schaller G, 2006, PHILOS T R SOC A, V364, P1443, DOI 10.1098/rsta.2006.1780; Sonnenschein C, 2013, J BIOSCIENCES, V38, P651, DOI 10.1007/s12038-013-9335-6; Sonnenschein C, 2011, CANCER RES, V71, P4334, DOI 10.1158/0008-5472.CAN-11-0639; VOLTERRA VITO, 1926, MEM R ACCAD NAZ LINCEI CL FIS MAT E NAT, V2, P31; Witz IP, 2006, CANCER LETT, V242, P1, DOI 10.1016/j.canlet.2005.12.005	23	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157689	10.1371/journal.pone.0157689	http://dx.doi.org/10.1371/journal.pone.0157689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310010	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800122
J	Zbinden, A; Durig, R; Shah, C; Boni, J; Schupbach, J				Zbinden, Andrea; Durig, Roland; Shah, Cyril; Boni, Jurg; Schupbach, Jorg			Importance of an Early HIV Antibody Differentiation Immunoassay for Detection of Dual Infection with HIV-1 and HIV-2	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; GUINEA-BISSAU; WEST-AFRICA; VIRAL LOAD; VIRUS; INDIVIDUALS; PROTECTION; ASSAYS	Background HIV-2 is primarily endemic in West Africa and India, however, in time of global migration, a possible HIV-2 infection or co-infection with HIV-1 should be recognized right at the time of HIV diagnosis, in order to enable optimized antiretroviral treatment. Laboratory HIV testing consists of a combined HIV1/2/O antibody + antigen screening test and subsequent confirmation and type differentiation by a serological test formatted as a multi-line or multi-spot assay. CDC has proposed a revised alternative HIV diagnostic strategy which, in case of a reactive result in a combined HIV1/2/O antibody + antigen screening test, comprises an HIV-1 nucleic acid test (NAT) for HIV confirmation instead of an antibody differentiation immunoassay (ADI). Only a negative NAT must be further investigated by an ADI, thus saving expenses for ADI in most instances. We have investigated this alternative strategy with respect to its recognition of dual HIV-1 and HIV-2 infection. Methods and Results Anonymized data of HIV notifications of patients newly diagnosed with HIV in Switzerland between 2007 and 2014 were analysed retrospectively. In a total of 4'679 notifications, we found 35 HIV-2 infections, 9 (25.7%) of which were dually infected with HIV-1. In 7 of the 9 dual HIV-1 and HIV-2 infections, HIV-1 RNA testing at the time of HIV diagnosis was positive with concentrations from 102 to 94'300 copies/mL plasma. HIV-1 RNA data were not available for the other two cases. Conclusions The alternative CDC strategy would have missed the concomitant HIV-2 infection in at least 7, but probably even more, of the 9 dually infected patients, as the detectable HIV-1 RNA would have precluded a supplemental ADI. Early ADI is mandatory for diagnosis of dual HIV-1/HIV-2 infection and guidance of appropriate therapy.	[Zbinden, Andrea; Shah, Cyril; Boni, Jurg; Schupbach, Jorg] Univ Zurich, Inst Med Virol, CH-8057 Zurich, Switzerland; [Durig, Roland] Maihof Praxis, CH-6004 Luzern, Switzerland; [Shah, Cyril; Boni, Jurg; Schupbach, Jorg] Univ Zurich, Swiss Natl Ctr Retroviruses, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich	Zbinden, A (corresponding author), Univ Zurich, Inst Med Virol, CH-8057 Zurich, Switzerland.	zbinden.andrea@virology.uzh.ch	Boeni, Juerg/B-8386-2015					Andersson S, 2000, ARCH INTERN MED, V160, P3286, DOI 10.1001/archinte.160.21.3286; Boni J, 2004, J MED VIROL, V72, P1, DOI 10.1002/jmv.10535; Centers for Disease Control and Prevention Association of Public Health Laboratories, 2014, LAB TEST DIAGN HIV I; Damond F, 2011, J CLIN MICROBIOL, V49, P3491, DOI 10.1128/JCM.02389-10; de Mendoza C, 2014, AIDS REV, V16, P152; Faria NR, 2012, J GEN VIROL, V93, P889, DOI 10.1099/vir.0.038638-0; Gunthard HF, 2009, CLIN INFECT DIS, V48, pE117, DOI 10.1086/598987; Jallow S, 2009, J CLIN MICROBIOL, V47, P2200, DOI 10.1128/JCM.01654-08; Landman R, 2009, AIDS, V23, P426, DOI 10.1097/QAD.0b013e328321305a; Norrgren H, 1999, AIDS, V13, P701, DOI 10.1097/00002030-199904160-00011; Ramos EM, 2013, J CLIN VIROL, V58, pE104, DOI 10.1016/j.jcv.2013.08.018; Raugi DN, 2013, AIDS, V27, P2441, DOI 10.1097/QAD.0b013e328362e856; Schupbach J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131828; Schutten M, 2000, NEW ENGL J MED, V342, P1758, DOI 10.1056/NEJM200006083422317; Taylor N, 2014, WIEN KLIN WOCHENSCHR, V126, P212, DOI 10.1007/s00508-013-0493-1; TRAVERS K, 1995, SCIENCE, V268, P1612, DOI 10.1126/science.7539936; Westheimer E, 2014, J CLIN VIROL, V61, P623, DOI 10.1016/j.jcv.2014.10.010	17	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157690	10.1371/journal.pone.0157690	http://dx.doi.org/10.1371/journal.pone.0157690			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310138	gold, Green Published, Green Accepted			2022-12-26	WOS:000378029800123
J	Fife, CM; Sagnella, SM; Teo, WS; Po'uha, ST; Byrne, FL; Yeap, YYC; Ng, DCH; Davis, TP; McCarroll, JA; Kavallaris, M				Fife, C. M.; Sagnella, S. M.; Teo, W. S.; Po'uha, S. T.; Byrne, F. L.; Yeap, Y. Y. C.; Ng, D. C. H.; Davis, T. P.; McCarroll, J. A.; Kavallaris, M.			Stathmin mediates neuroblastoma metastasis in a tubulin-independent manner via RhoA/ROCK signaling and enhanced transendothelial migration	ONCOGENE			English	Article							CELL LUNG-CANCER; DEPENDENT PROTEIN-KINASE; POTENTIAL TARGET; RHOA ACTIVATION; POOR-PROGNOSIS; LIVING CELLS; IN-VITRO; EXPRESSION; PHOSPHOPROTEIN; PHOSPHORYLATION	Neuroblastoma, the most common solid tumor of young children, frequently presents with aggressive metastatic disease and for these children the 5-year survival rates are dismal. Metastasis, the movement of cancer cells from one site to another, involves remodeling of the cytoskeleton including altered microtubule dynamics. The microtubule-destabilizing protein, stathmin, has recently been shown to mediate neuroblastoma metastasis although precise functions remain poorly defined. In this study we investigated stathmin's contribution to the metastatic process and potential mechanism(s) by which it exerts these effects. Stathmin suppression significantly reduced neuroblastoma cell invasion of 3D tumor spheroids into an extracellular matrix. Moreover, inhibiting stathmin expression significantly reduced transendothelial migration in two different neuroblastoma cell lines in vitro. Inhibition of ROCK, a key regulator of cell migration, in neuroblastoma cells highlighted that stathmin regulates transendothelial migration through ROCK signaling. Reduced stathmin expression in neuroblastoma cells significantly increased the activation of the RhoA small GTPase. Notably, re-expression of either wild type or a phospho-mimetic stathmin mutant (4E) made defective in tubulin binding returned cell migration and transendothelial migration back to control levels, indicating that stathmin may influence these processes in neuroblastoma cells independent of tubulin binding. Finally, stathmin suppression in neuroblastoma cells significantly reduced whole body, lung, kidney and liver metastases in an experimental metastases mouse model. In conclusion, stathmin suppression interferes with the metastatic process via RhoA/ROCK signaling in neuroblastoma cells. These findings highlight the importance of stathmin to the metastatic process and its potential as a therapeutic target for the treatment of neuroblastoma.	[Fife, C. M.; Sagnella, S. M.; Teo, W. S.; Po'uha, S. T.; McCarroll, J. A.; Kavallaris, M.] UNSW Australia, Childrens Canc Inst, Lowy Canc Res Ctr, Tumour Biol & Targeting Program, Sydney, NSW, Australia; [Fife, C. M.; Sagnella, S. M.; Teo, W. S.; Po'uha, S. T.; McCarroll, J. A.; Kavallaris, M.] UNSW Australia, ARC Ctr Excellence Convergent Bionano Sci & Techn, Sydney, NSW, Australia; [Fife, C. M.; Sagnella, S. M.; Teo, W. S.; Po'uha, S. T.; McCarroll, J. A.; Kavallaris, M.] UNSW Australia, Australian Ctr NanoMed, Sydney, NSW, Australia; [Byrne, F. L.] UNSW Australia, Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Yeap, Y. Y. C.; Ng, D. C. H.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Yeap, Y. Y. C.; Ng, D. C. H.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Davis, T. P.] Monash Univ, Monash Inst Pharmaceut Sci, ARC Ctr Convergent Bionanosci & Technol, Melbourne, Vic, Australia; [Davis, T. P.] Univ Warwick, Dept Chem, Coventry, W Midlands, England	Children's Cancer Institute; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Melbourne; University of Queensland; Monash University; University of Warwick	McCarroll, JA; Kavallaris, M (corresponding author), UNSW Australia, Lowy Canc Res Ctr, Childrens Canc Inst, Tumour Biol & Targeting Program, POB 81, Randwick, NSW 2031, Australia.	jmccarroll@ccia.unsw.edu.au; m.kavallaris@ccia.unsw.edu.au	McCarroll, Joshua/E-8481-2010; Byrne, Frances/AAW-7748-2020; Davis, Thomas/B-6395-2008; Ng, Dominic/C-7291-2015	McCarroll, Joshua/0000-0001-8807-3623; Byrne, Frances/0000-0002-8897-8438; Davis, Thomas/0000-0003-2581-4986; Ng, Dominic/0000-0003-4657-159X	Cancer Council New South Wales; Kids Cancer Project; ARC Future Fellowship [FT120100193]; Hope Funds for Cancer Research Fellowship [HFCR-14-06-04]; Cancer Institute NSW Career Development Fellowship [15/CDF/1-02]; NHMRC Senior Research Fellowships [APP1058299]; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology [CE140100036]; Cancer Institute of New South Wales	Cancer Council New South Wales(Cancer Council New South Wales); Kids Cancer Project; ARC Future Fellowship(Australian Research Council); Hope Funds for Cancer Research Fellowship; Cancer Institute NSW Career Development Fellowship; NHMRC Senior Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology(Australian Research Council); Cancer Institute of New South Wales	We thank the Children's Cancer Institute, which is affiliated with the University of New South Wales (UNSW Australia), and Sydney Children's Hospital Network and by grants from the Cancer Council New South Wales (to MK), Kids Cancer Project (to MK), ARC Future Fellowship (to DCHN; FT120100193), Hope Funds for Cancer Research Fellowship (to FLB; HFCR-14-06-04), Cancer Institute NSW Career Development Fellowship (15/CDF/1-02) and NHMRC Senior Research Fellowships (to MK; APP1058299). MK and TPD are funded by the Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology (project number CE140100036). This research was supported by a Cancer Institute of New South Wales infrastructure award.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Amayed P, 2002, J BIOL CHEM, V277, P22718, DOI 10.1074/jbc.M111605200; Ara T, 2006, CANCER METAST REV, V25, P645, DOI 10.1007/s10555-006-9028-9; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Belletti B, 2005, CURR MED CHEM, V12, P1589, DOI 10.2174/0929867054367149; Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Belletti B, 2011, EXPERT OPIN THER TAR, V15, P1249, DOI 10.1517/14728222.2011.620951; Belletti B, 2010, MOL CELL BIOL, V30, P2229, DOI 10.1128/MCB.00723-09; BERETTA L, 1993, J BIOL CHEM, V268, P20076; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Bieche I, 2003, GENOMICS, V81, P400, DOI 10.1016/S0888-7543(03)00031-4; Budde PP, 2001, J CELL BIOL, V153, P149, DOI 10.1083/jcb.153.1.149; Byrne FL, 2014, ONCOGENE, V33, P882, DOI 10.1038/onc.2013.11; CHNEIWEISS H, 1989, J NEUROCHEM, V53, P856, DOI 10.1111/j.1471-4159.1989.tb11783.x; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Daniel C, 2004, LAB INVEST, V84, P588, DOI 10.1038/labinvest.3700078; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FEUERSTEIN N, 1983, J BIOL CHEM, V258, P786; Fife CM, 2014, BRIT J PHARMACOL, V171, P5507, DOI 10.1111/bph.12704; Giampietro C, 2005, ENDOCRINOLOGY, V146, P1825, DOI 10.1210/en.2004-0972; Goukassian D, 2001, FASEB J, V15, P1877, DOI 10.1096/fj.01-0065com; Gutierrez JC, 2007, PEDIATR SURG INT, V23, P637, DOI 10.1007/s00383-007-1933-7; HAILAT N, 1990, ONCOGENE, V5, P1615; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; HANASH SM, 1988, J BIOL CHEM, V263, P12813; Hsieh SY, 2010, MOL CARCINOGEN, V49, P476, DOI 10.1002/mc.20627; Jeon TY, 2010, BRIT J CANCER, V102, P710, DOI 10.1038/sj.bjc.6605537; Jin KL, 2004, FASEB J, V18, P287, DOI 10.1096/fj.03-0973com; KOPPEL J, 1990, J BIOL CHEM, V265, P3703; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Maris JM, N ENGL J MED, V362, P2202; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; McCarroll JA, 2015, CANCER RES, V75, P415, DOI 10.1158/0008-5472.CAN-14-2740; McCarroll JA, 2010, CANCER RES, V70, P4995, DOI 10.1158/0008-5472.CAN-09-4487; Mistry SJ, 2007, MOL CANCER RES, V5, P773, DOI 10.1158/1541-7786.MCR-06-0290; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Niethammer P, 2004, SCIENCE, V303, P1862, DOI 10.1126/science.1094108; Ozon S, 2002, MOL BIOL CELL, V13, P698, DOI 10.1091/mbc.01-07-0362; PASMANTIER R, 1986, ENDOCRINOLOGY, V119, P1229, DOI 10.1210/endo-119-3-1229; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Sadow PM, 2008, ENDOCR PATHOL, V19, P97, DOI 10.1007/s12022-008-9028-0; SCHUBART UK, 1992, DIFFERENTIATION, V51, P21, DOI 10.1111/j.1432-0436.1992.tb00676.x; Singer S, 2009, CANCER RES, V69, P2234, DOI 10.1158/0008-5472.CAN-08-3338; SOBEL A, 1989, J BIOL CHEM, V264, P3765; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Sun J, 2001, CIRCULATION, V103, P2967, DOI 10.1161/01.CIR.103.24.2967; Trovik J, 2011, CLIN CANCER RES, V17, P3368, DOI 10.1158/1078-0432.CCR-10-2412; Van Sluis GL, 2009, BLOOD, V114, P1968, DOI 10.1182/blood-2009-04-217679; Verma NK, 2009, J BIOL CHEM, V284, P12349, DOI 10.1074/jbc.M807761200; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29	56	23	24	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 26	2017	36	4					501	511		10.1038/onc.2016.220	http://dx.doi.org/10.1038/onc.2016.220			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8II	27321182				2022-12-26	WOS:000394166700007
J	Khan, S; Sikander, M; Ebeling, MC; Ganju, A; Kumari, S; Yallapu, MM; Hafeez, BB; Ise, T; Nagata, S; Zafar, N; Behrman, SW; Wan, JY; Ghimire, HM; Sahay, P; Pradhan, P; Chauhan, SC; Jaggi, M				Khan, S.; Sikander, M.; Ebeling, M. C.; Ganju, A.; Kumari, S.; Yallapu, M. M.; Hafeez, B. B.; Ise, T.; Nagata, S.; Zafar, N.; Behrman, S. W.; Wan, J. Y.; Ghimire, H. M.; Sahay, P.; Pradhan, P.; Chauhan, S. C.; Jaggi, M.			MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression	ONCOGENE			English	Article							FOCAL ADHESION KINASE; CELL-MIGRATION; PROTEIN-KINASE; OVARIAN-CANCER; SURVIVAL; MUCINS; EXPRESSION; MOTILITY; GROWTH; ROLES	Although MUC13, a transmembrane mucin, is aberrantly expressed in pancreatic ductal adenocarcinoma (PDAC) and generally correlates with increased expression of HER2, the underlying mechanism remains poorly understood. Herein, we found that MUC13 co-localizes and interacts with HER2 in PDAC cells (reciprocal co-immunoprecipitation, immunofluorescence, proximity ligation, co-capping assays) and tissues (immunohistofluorescence). The results from this study demonstrate that MUC13 functionally interacts and activates HER2 at p1248 in PDAC cells, leading to stimulation of HER2 signaling cascade, including ERK1/2, FAK, AKT and PAK1 as well as regulation of the growth, cytoskeleton remodeling and motility, invasion of PDAC cells-all collectively contributing to PDAC progression. Interestingly, all of these phenotypic effects of MUC13-HER2 co-localization could be effectively compromised by depleting MUC13 and mediated by the first and second EGF-like domains of MUC13. Further, MUC13-HER2 co-localization also holds true in PDAC tissues with a strong functional correlation with events contributing to increased degree of disorder and cancer aggressiveness. In brief, findings presented here provide compelling evidence of a functional ramification of MUC13-HER2: this interaction could be potentially exploited for targeted therapeutics in a subset of patients harboring an aggressive form of PDAC.	[Khan, S.; Sikander, M.; Ganju, A.; Kumari, S.; Yallapu, M. M.; Hafeez, B. B.; Chauhan, S. C.; Jaggi, M.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Canc Res Bldg,19 South Manassas,Ave Suite 226, Memphis, TN 38163 USA; [Khan, S.; Sikander, M.; Ganju, A.; Kumari, S.; Yallapu, M. M.; Hafeez, B. B.; Chauhan, S. C.; Jaggi, M.] Univ Tennessee, Ctr Hlth Sci, Ctr Canc Res, Memphis, TN 38163 USA; [Ebeling, M. C.] Sanford Res, Canc Biol Res Ctr, Sioux Falls, SD USA; [Ise, T.; Nagata, S.] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Ctr Drug Design Res, Ibaraki, Osaka, Japan; [Zafar, N.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol, Memphis, TN 38163 USA; [Behrman, S. W.] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA; [Wan, J. Y.] Univ Tennessee, Ctr Hlth Sci, Dept Biostat & Epidemiol, Memphis, TN 38163 USA; [Ghimire, H. M.; Sahay, P.; Pradhan, P.] Univ Memphis, Dept Phys, Memphis, TN 38152 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Sanford Health; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Memphis	Chauhan, SC; Jaggi, M (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Canc Res Bldg,19 South Manassas,Ave Suite 226, Memphis, TN 38163 USA.	schauha1@uthsc.edu; mjaggi@uthsc.edu	Ganju, Aditya/AAM-3757-2021; Ganju, Aditya/AAK-4870-2021; Nagata, Satoshi/B-5781-2008	Ganju, Aditya/0000-0003-1258-0105; Nagata, Satoshi/0000-0001-9156-5215	National Institutes of Health [R01 CA142736, U01 CA162106A, R01 EB003682, K22CA174841]; Department of Defense [PC130870]; College of Pharmacy Dean's Seed/Instrument Grants of the University of Tennessee Health Science Center; Grants of the University of Memphis; Herb Kosten Foundation [UT 14-0558]; NATIONAL CANCER INSTITUTE [R01CA142736, U01CA162106, K22CA174841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); College of Pharmacy Dean's Seed/Instrument Grants of the University of Tennessee Health Science Center; Grants of the University of Memphis; Herb Kosten Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was partially supported by grants from the National Institutes of Health (R01 CA142736 to SCC, U01 CA162106A to SCC and MJ; R01 EB003682 to PP; K22CA174841 to MMY), the Department of Defense (PC130870 to SCC and MJ), the College of Pharmacy 2014 and 2015 Dean's Seed/Instrument Grants of the University of Tennessee Health Science Center (to SCC, MJ and MMY) and Grants of the University of Memphis (to PP). We acknowledge the Herb Kosten Foundation for pancreatic cancer research support (UT 14-0558 to SCC). We are also thankful to Cathy Christopherson for editorial assistance.	Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Chaturvedi P, 2008, CANCER RES, V68, P2065, DOI 10.1158/0008-5472.CAN-07-6041; Chauhan SC, 2012, MOL CANCER THER, V11, P24, DOI 10.1158/1535-7163.MCT-11-0598; Chauhan SC, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-21; Chauhan SC, 2009, CANCER RES, V69, P765, DOI 10.1158/0008-5472.CAN-08-0587; Damania D, 2010, BIOPHYS J, V99, P989, DOI 10.1016/j.bpj.2010.05.023; Grothey A, 2000, ONCOGENE, V19, P4864, DOI 10.1038/sj.onc.1203838; Guddo F, 1998, J CLIN PATHOL, V51, P667, DOI 10.1136/jcp.51.9.667; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Jaggi M, 2005, CANCER RES, V65, P483; Jonckheere Nicolas, 2008, Critical Reviews in Oncogenesis, V14, P177; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Kaur S, 2013, NAT REV GASTRO HEPAT, V10, P607, DOI 10.1038/nrgastro.2013.120; Khan S, 2014, ONCOTARGET, V5, P7599, DOI 10.18632/oncotarget.2281; Khan S, 2012, MOL CARCINOGEN, V51, P679, DOI 10.1002/mc.20821; Koos B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8294; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Maher DM, 2011, MOL CANCER RES, V9, P531, DOI 10.1158/1541-7786.MCR-10-0443; Parry S, 2001, BIOCHEM BIOPH RES CO, V283, P715, DOI 10.1006/bbrc.2001.4775; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Pradhan P, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/2/026012; Pradhan P, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3524523; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Schlaepfer DD, 1997, J BIOL CHEM, V272, P13189, DOI 10.1074/jbc.272.20.13189; Senapati S, 2010, TRENDS BIOCHEM SCI, V35, P236, DOI 10.1016/j.tibs.2009.10.003; Settleman J, 2015, ONCOTARGET, V6, P588, DOI 10.18632/oncotarget.3036; Subramanian H, 2009, CANCER RES, V69, P5357, DOI 10.1158/0008-5472.CAN-08-3895; Subramanian H, 2008, P NATL ACAD SCI USA, V105, P20118, DOI 10.1073/pnas.0804723105; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200	29	21	21	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 26	2017	36	4					491	500		10.1038/onc.2016.218	http://dx.doi.org/10.1038/onc.2016.218			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8II	27321183	Green Accepted			2022-12-26	WOS:000394166700006
J	Semack, A; Sandhu, M; Malik, RU; Vaidehi, N; Sivaramakrishnan, S				Semack, Ansley; Sandhu, Manbir; Malik, Rabia U.; Vaidehi, Nagarajan; Sivaramakrishnan, Sivaraj			Structural Elements in the G(s) and G(q) C Termini That Mediate Selective G Protein-coupled Receptor (GPCR) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; fluorescence resonance energy transfer (FRET); G protein; G protein-coupled receptor (GPCR); molecular dynamics; Receptor Conformation	HETEROTRIMERIC G-PROTEIN; BETA(2) ADRENERGIC-RECEPTOR; ALPHA-HELICAL DOMAIN; MOLECULAR-DYNAMICS; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; VASOPRESSIN RECEPTOR; SYNTHETIC PEPTIDES; BINDING-SITE	Although the importance of the C terminus of the subunit of the heterotrimeric G protein in G protein-coupled receptor (GPCR)-G protein pairing is well established, the structural basis of selective interactions remains unknown. Here, we combine live cell FRET-based measurements and molecular dynamics simulations of the interaction between the GPCR and a peptide derived from the C terminus of the G subunit (G peptide) to dissect the molecular mechanisms of G protein selectivity. We observe a direct link between G peptide binding and stabilization of the GPCR conformational ensemble. We find that cognate and non-cognate G peptides show deep and shallow binding, respectively, and in distinct orientations within the GPCR. Binding of the cognate G peptide stabilizes the agonist-bound GPCR conformational ensemble resulting in favorable binding energy and lower flexibility of the agonist-GPCR pair. We identify three hot spot residues (G(s)/G(q)-Gln-384/Leu-349, Gln-390/Glu-355, and Glu-392/Asn-357) that contribute to selective interactions between the 2-adrenergic receptor (2-AR)-G(s) and V-1A receptor (V1AR)-G(q). The G(s) and G(q) peptides adopt different orientations in 2-AR and V1AR, respectively. The 2-AR/G(s) peptide interface is dominated by electrostatic interactions, whereas the V1AR/G(q) peptide interactions are predominantly hydrophobic. Interestingly, our study reveals a role for both favorable and unfavorable interactions in G protein selection. Residue Glu-355 in G(q) prevents this peptide from interacting strongly with 2-AR. Mutagenesis to the G(s) counterpart (E355Q) imparts a cognate-like interaction. Overall, our study highlights the synergy in molecular dynamics and FRET-based approaches to dissect the structural basis of selective G protein interactions.	[Semack, Ansley; Malik, Rabia U.; Sivaramakrishnan, Sivaraj] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Sandhu, Manbir; Vaidehi, Nagarajan] Beckman Res Inst City Hope, Dept Mol Immunol, Duarte, CA 91010 USA; [Malik, Rabia U.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Minnesota System; University of Minnesota Twin Cities; City of Hope; Beckman Research Institute of City of Hope; University of Michigan System; University of Michigan	Sivaramakrishnan, S (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 4-130 MCB,420 Washington Ave SE, Twin Cities Minneapolis, MN 55455 USA.	sivaraj@umn.edu	Sandhu, Manbir/AAI-2124-2019	Sandhu, Manbir/0000-0003-1182-7268	American Heart Association Scientist Development Grant [13SDG14270009]; National Institutes of Health [1DP2 CA186752-01, 1-R01-GM-105646-01-A1, R01 GM097261-04]; NATIONAL CANCER INSTITUTE [DP2CA186752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097261, R01GM105646] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Scientist Development Grant 13SDG14270009 and National Institutes of Health Grants 1DP2 CA186752-01 and 1-R01-GM-105646-01-A1 (to S. S.) and R01 GM097261-04 (to N.V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharya S, 2008, BIOPHYS J, V94, P2027, DOI 10.1529/biophysj.107.117648; Cheng LL, 2004, J MED CHEM, V47, P2375, DOI 10.1021/jm030611c; CHINI B, 1995, EMBO J, V14, P2176, DOI 10.1002/j.1460-2075.1995.tb07211.x; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; Cotte N, 2000, EUR J BIOCHEM, V267, P4253, DOI 10.1046/j.1432-1033.2000.01472.x; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Granier S, 2012, NAT CHEM BIOL, V8, P670, DOI 10.1038/nchembio.1025; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; HAMM HE, 1994, METHOD ENZYMOL, V237, P423; Hermans E, 2009, Bull Mem Acad R Med Belg, V164, P255; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibrahim BS, 2005, J MOL BIOL, V348, P1191, DOI 10.1016/j.jmb.2005.03.034; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kostenis E, 1997, J BIOL CHEM, V272, P19107, DOI 10.1074/jbc.272.31.19107; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LIU J, 1995, P NATL ACAD SCI USA, V92, P11642, DOI 10.1073/pnas.92.25.11642; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Lubecka EA, 2015, EUR BIOPHYS J BIOPHY, V44, P727, DOI 10.1007/s00249-015-1071-4; Malik RU, 2013, J BIOL CHEM, V288, P17167, DOI 10.1074/jbc.M113.464065; MOUILLAC B, 1995, J BIOL CHEM, V270, P25771, DOI 10.1074/jbc.270.43.25771; Niesen MJM, 2011, J AM CHEM SOC, V133, P13197, DOI 10.1021/ja205313h; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; RASENICK MM, 1994, J BIOL CHEM, V269, P21519; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rodrigo J, 2007, MOL ENDOCRINOL, V21, P512, DOI 10.1210/me.2006-0202; Sapay N, 2009, SOFT MATTER, V5, P3295, DOI 10.1039/b902376c; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Skiba NP, 1999, J BIOL CHEM, V274, P8770, DOI 10.1074/jbc.274.13.8770; Slessareva JE, 2003, J BIOL CHEM, V278, P50530, DOI 10.1074/jbc.M304417200; Van Eps N, 2006, P NATL ACAD SCI USA, V103, P16194, DOI 10.1073/pnas.0607972103; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Yang CS, 1999, J BIOL CHEM, V274, P2379, DOI 10.1074/jbc.274.4.2379; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	54	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17929	17940		10.1074/jbc.M116.735720	http://dx.doi.org/10.1074/jbc.M116.735720			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27330078	Green Published, hybrid			2022-12-26	WOS:000383241300036
J	Bate, C; Nolan, W; McHale-Owen, H; Williams, A				Bate, Clive; Nolan, William; McHale-Owen, Harriet; Williams, Alun			Sialic Acid within the Glycosylphosphatidylinositol Anchor Targets the Cellular Prion Protein to Synapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; glycosylphosphatidylinositol (GPI anchor); prion; sialic acid; synapse	LIPID RAFTS; MEMBRANE DOMAINS; (GPI)-ANCHORED PROTEINS; PLASMA-MEMBRANE; SCRAPIE; CELLS; GANGLIOSIDES; CHOLESTEROL; SURFACE; BRAIN	Although the cellular prion protein (PrPC) is concentrated at synapses, the factors that target PrPC to synapses are not understood. Here we demonstrate that exogenous PrPC was rapidly targeted to synapses in recipient neurons derived from Prnp knock-out((0/0)) mice. The targeting of PrPC to synapses was dependent upon both neuronal cholesterol concentrations and the lipid and glycan composition of its glycosylphosphatidylinositol (GPI) anchor. Thus, the removal of either an acyl chain or sialic acid from the GPI anchor reduced the targeting of PrPC to synapses. Isolated GPIs (derived from PrPC) were also targeted to synapses, as was IgG conjugated to these GPIs. The removal of sialic acid from GPIs prevented the targeting of either the isolated GPIs or the IgG-GPI conjugate to synapses. Competition studies showed that pretreatment with sialylated GPIs prevented the targeting of PrPC to synapses. These results are consistent with the hypothesis that the sialylated GPI anchor attached to PrPC acts as a synapse homing signal.	[Bate, Clive; Nolan, William; McHale-Owen, Harriet] Royal Vet Coll, Dept Pathol & Pathogen Biol, Hawkshead Lane, N Mymms AL9 7TA, Herts, England; [Williams, Alun] Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 OES, England	University of London; University of London Royal Veterinary College; University of Cambridge	Williams, A (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 OES, England.	aw510@cam.ac.uk			European Commission FP6 "Neuroprion," Network of Excellence	European Commission FP6 "Neuroprion," Network of Excellence	This work was supported by the European Commission FP6 "Neuroprion," Network of Excellence. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Bate C, 2016, J BIOL CHEM, V291, P160, DOI 10.1074/jbc.M115.672394; Bate C, 2012, J BIOL CHEM, V287, P7935, DOI 10.1074/jbc.M111.275743; Bate C, 2011, J BIOL CHEM, V286, P8752, DOI 10.1074/jbc.M110.186833; Brown DR, 2001, TRENDS NEUROSCI, V24, P85, DOI 10.1016/S0166-2236(00)01689-1; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; Cancellotti E, 2005, J BIOL CHEM, V280, P42909, DOI 10.1074/jbc.M509557200; Cantu L, 2011, CHEM PHYS LIPIDS, V164, P796, DOI 10.1016/j.chemphyslip.2011.09.005; Chen R, 1998, P NATL ACAD SCI USA, V95, P9512, DOI 10.1073/pnas.95.16.9512; Crespo PM, 2002, J BIOL CHEM, V277, P44731, DOI 10.1074/jbc.M204604200; CRICK DC, 1995, J NEUROCHEM, V65, P1365; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; Galvan C, 2005, MOL CELL NEUROSCI, V30, P304, DOI 10.1016/j.mcn.2005.07.003; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; Hering H, 2003, J NEUROSCI, V23, P3262; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; Ingham V, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-115; Legler DF, 2004, FASEB J, V18, P73, DOI 10.1096/fj.03-1338fje; Li RL, 2003, BIOCHEM BIOPH RES CO, V303, P446, DOI 10.1016/S0006-291X(03)00354-1; Lipton AM, 2001, ARCH NEUROL-CHICAGO, V58, P1233, DOI 10.1001/archneur.58.8.1233; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Lledo PM, 1996, P NATL ACAD SCI USA, V93, P2403, DOI 10.1073/pnas.93.6.2403; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Maglio LE, 2006, BRAIN RES, V1097, P11, DOI 10.1016/j.brainres.2006.04.056; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; Medof ME, 1996, FASEB J, V10, P574, DOI 10.1096/fasebj.10.5.8621057; Nicholson TB, 2006, J CELL BIOL, V175, P647, DOI 10.1083/jcb.200605001; Ohmi Y, 2012, NEUROCHEM RES, V37, P1185, DOI 10.1007/s11064-012-0764-7; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Premkumar DRD, 2001, J CELL BIOCHEM, V82, P234, DOI 10.1002/jcb.1154; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puig B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024624; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Simons M, 1999, MOL BIOL CELL, V10, P3187, DOI 10.1091/mbc.10.10.3187; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	50	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17093	17101		10.1074/jbc.M116.731117	http://dx.doi.org/10.1074/jbc.M116.731117			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27325697	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000382643800015
J	Malachowa, N; Kobayashi, SD; Porter, AR; Braughton, KR; Scott, DP; Gardner, DJ; Missiakas, DM; Schneewind, O; Deleo, FR				Malachowa, Natalia; Kobayashi, Scott D.; Porter, Adeline R.; Braughton, Kevin R.; Scott, Dana P.; Gardner, Donald J.; Missiakas, Dominique M.; Schneewind, Olaf; Deleo, Frank R.			Contribution of Staphylococcus aureus Coagulases and Clumping Factor A to Abscess Formation in a Rabbit Model of Skin and Soft Tissue Infection	PLOS ONE			English	Article							FACTOR-BINDING-PROTEIN; INTRAVENOUS INJECTION; VASCULAR-PERMEABILITY; CUTANEOUS INFECTIONS; IMMUNE-RESPONSES; MOUSE MODEL; FACTOR-I; VIRULENCE; SURFACE; ROLES	Staphylococcus aureus produces numerous factors that facilitate survival in the human host. S. aureus coagulase (Coa) and von Willebrand factor-binding protein (vWbp) are known to clot plasma through activation of prothrombin and conversion of fibrinogen to fibrin. In addition, S. aureus clumping factor A (ClfA) binds fibrinogen and contributes to platelet aggregation via a fibrinogen-or complement-dependent mechanism. Here, we evaluated the contribution of Coa, vWbp and ClfA to S. aureus pathogenesis in a rabbit model of skin and soft tissue infection. Compared to skin abscesses caused by the Newman wild-type strain, those caused by isogenic coa, vwb, or clfA deletion strains, or a strain deficient in coa and vwb, were significantly smaller following subcutaneous inoculation in rabbits. Unexpectedly, we found that fibrin deposition and abscess capsule formation appear to be independent of S. aureus coagulase activity in the rabbit infection model. Similarities notwithstanding, S. aureus strains deficient in coa and vwb elicited reduced levels of several proinflammatory molecules in human blood in vitro. Although a specific mechanism remains to be determined, we conclude that S. aureus Coa, vWbp and ClfA contribute to abscess formation in rabbits.	[Malachowa, Natalia; Kobayashi, Scott D.; Porter, Adeline R.; Braughton, Kevin R.; Deleo, Frank R.] NIAID, Bacteriol Lab, Rocky Mt Labs, NIH, Hamilton, MT USA; [Scott, Dana P.; Gardner, Donald J.] NIAID, Rocky Mt Vet Branch, Rocky Mt Labs, NIH, Hamilton, MT USA; [Missiakas, Dominique M.; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Chicago	Deleo, FR (corresponding author), NIAID, Bacteriol Lab, Rocky Mt Labs, NIH, Hamilton, MT USA.	fdeleo@niaid.nih.gov		Kobayashi, Scott/0000-0002-5705-1381; DeLeo, Frank/0000-0003-3150-2516	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052474, ZIGAI001048, R01AI110937, ZIAAI001079] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; BERNHEIMER AW, 1965, ANN NY ACAD SCI, V128, P112, DOI 10.1111/j.1749-6632.1965.tb11633.x; Bjerketorp J, 2002, MICROBIOL-SGM, V148, P2037, DOI 10.1099/00221287-148-7-2037; Boucher H, 2010, CLIN INFECT DIS, V51, pS183, DOI 10.1086/653519; Carson F.L., 2009, HISTOTECHNOLOGY SELF, V3rd; Chan LNC, 2015, INFECT IMMUN, V83, P4427, DOI 10.1128/IAI.01061-15; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; CHEUNG AL, 1994, J CLIN INVEST, V94, P1815, DOI 10.1172/JCI117530; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; CRIBIER B, 1992, DERMATOLOGY, V185, P175, DOI 10.1159/000247443; Croisier-Bertin D, 2011, ANTIMICROB AGENTS CH, V55, P3557, DOI 10.1128/AAC.01773-09; DENAVASQUEZ S, 1950, J PATHOL BACTERIOL, V62, P429, DOI 10.1002/path.1700620315; Edens HA, 2003, CURR OPIN HEMATOL, V10, P25, DOI 10.1097/00062752-200301000-00005; FREEDMAN LAWRENCE R., 1960, YALE JOUR BIOL AND MED, V32, P272; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Hair PS, 2008, J INFECT DIS, V198, P125, DOI 10.1086/588825; Hair PS, 2010, INFECT IMMUN, V78, P1717, DOI 10.1128/IAI.01065-09; Higgins J, 2006, FEMS MICROBIOL LETT, V258, P290, DOI 10.1111/j.1574-6968.2006.00229.x; Holley MM, 2012, J IMMUNOL, V188, P1360, DOI 10.4049/jimmunol.1101660; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kielian T, 2004, J NEUROPATH EXP NEUR, V63, P381, DOI 10.1093/jnen/63.4.381; Kobayashi SD, 2015, AM J PATHOL, V185, P1518, DOI 10.1016/j.ajpath.2014.11.030; Kobayashi SD, 2012, MBIO, V3, DOI 10.1128/mBio.00170-12; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Krishna S, 2012, CURR OPIN MICROBIOL, V15, P28, DOI 10.1016/j.mib.2011.11.003; Kroh HK, 2009, P NATL ACAD SCI USA, V106, P7786, DOI 10.1073/pnas.0811750106; Kwiecinski J, 2014, APMIS, V122, P1240, DOI 10.1111/apm.12295; Landrum ML, 2012, JAMA-J AM MED ASSOC, V308, P50, DOI 10.1001/jama.2012.7139; Lin YC, 2011, BIOCHEMISTRY-US, V50, P7157, DOI 10.1021/bi200435n; Loeb L, 1904, J MED RES, V10, P407; Loof TG, 2015, MICROBIOL-SGM, V161, P621, DOI 10.1099/mic.0.000019; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malachowa N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117713; McAdow M, 2012, INFECT IMMUN, V80, P3389, DOI 10.1128/IAI.00562-12; McAdow M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002307; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Neves F, 2015, INNATE IMMUN-LONDON, V21, P787, DOI 10.1177/1753425915606209; OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x; ROGERS DE, 1957, J EXP MED, V105, P99, DOI 10.1084/jem.105.2.99; ROGERS DE, 1956, J EXP MED, V103, P713, DOI 10.1084/jem.103.6.713; Spaulding AR, 2012, VACCINE, V30, P5099, DOI 10.1016/j.vaccine.2012.05.067; Strandberg KL, 2010, J INFECT DIS, V202, P1690, DOI 10.1086/657156; Vanassche T, 2011, J THROMB HAEMOST, V9, P2436, DOI 10.1111/j.1538-7836.2011.04529.x; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; WISEMAN GM, 1975, BACTERIOL REV, V39, P317, DOI 10.1128/MMBR.39.4.317-344.1975	53	28	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158293	10.1371/journal.pone.0158293	http://dx.doi.org/10.1371/journal.pone.0158293			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336691	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200129
J	Rempoulakis, P; Taret, G; ul Haq, I; Wornayporn, V; Ahmad, S; Tomas, US; Dammalage, T; Gembinsky, K; Franz, G; Caceres, C; Vreysen, MJB				Rempoulakis, Polychronis; Taret, Gustavo; ul Haq, Ihsan; Wornayporn, Viwat; Ahmad, Sohel; Tomas, Ulysses Sto; Dammalage, Thilakasiri; Gembinsky, Keke; Franz, Gerald; Caceres, Carlos; Vreysen, Marc J. B.			Evaluation of Quality Production Parameters and Mating Behavior of Novel Genetic Sexing Strains of the Mediterranean Fruit Fly Ceratitis capitata (Wiedemann) (Diptera: Tephritidae)	PLOS ONE			English	Article							STERILE INSECT TECHNIQUE; MARKING; ERADICATION; ATTRACTANTS; SUPPRESSION; HAWAII; ADULTS; FLIES	The Mediterranean fruit fly Ceratitis capitata (Wiedemann) (Diptera: Tephritidae) is one of the most important pest of fruits and vegetables in tropical and subtropical countries. The sterile insect technique (SIT) as a component of area-wide integrated pest management (AW-IPM) approaches is being used for the successful management of this pest. VIENNA 8 is a genetic sexing strain (GSS) that has a white pupae (wp) and temperature sensitive lethal (tsl) mutation, the latter killing all female embryos when eggs are exposed to high temperatures (34 degrees C). The use of this GSS permits production and the release of only males which has increased the cost effectiveness of the SIT several fold for this pest. An efficient method of identification of recaptured sterile males can further increase the cost effectiveness of the SIT for this pest. Therefore, VIENNA 8-Sergeant2 (Sr-2) strain and the transgenic strain VIENNA 8-1260 having visible markers were constructed. All three strains were evaluated for egg production, egg hatch, and egg sterility parameters under semi mass-rearing conditions and mating competitiveness in field cages. VIENNA 8-1260 females produced significantly fewer eggs as compared with the two other strains, which produced similar numbers of eggs. However, egg hatch of all strains was similar. Egg hatch of eggs produced by untreated females that had mated with adult males that had been irradiated with 100 Gy as pupae 2 days before emergence, was different for the three strains, i.e., egg hatch of 0.63%, 0.77%, 0.89% for VIENNA 8, VIENNA 8-1260, and VIENNA 8-Sr-2, respectively. Differences in male mating competitiveness of the three strains against wild-type males were gradually reduced with successive generations under semi mass-rearing conditions. However, VIENNA 8 males adapted faster to laboratory conditions as compared with VIENNA 8-Sr-2 and VIENNA 8-1260 males with respect to mating competitiveness. VIENNA 8 males of the F-10 generation were equally competitive with wild-type males, whereas the mating competitiveness of VIENNA 8-Sr-2 and VIENNA 8-1260 males was similar but lower as compared with wild-type males. Males from all three strains copulated earlier than wild-type males. Results are discussed in relation with the potential benefits of incorporating novel strains for more effective SIT application.	[Rempoulakis, Polychronis; Taret, Gustavo; ul Haq, Ihsan; Wornayporn, Viwat; Ahmad, Sohel; Tomas, Ulysses Sto; Dammalage, Thilakasiri; Gembinsky, Keke; Franz, Gerald; Caceres, Carlos; Vreysen, Marc J. B.] IAEA, Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, A-1400 Vienna, Austria; [Rempoulakis, Polychronis] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; [ul Haq, Ihsan] Natl Agr Res Ctr, Islamabad, Pakistan	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; Macquarie University; National Agricultural Research Council - Pakistan	ul Haq, I (corresponding author), IAEA, Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, A-1400 Vienna, Austria.; ul Haq, I (corresponding author), Natl Agr Res Ctr, Islamabad, Pakistan.	imihsan@yahoo.com	Rempoulakis, Polychronis/P-2731-2019	Rempoulakis, Polychronis/0000-0002-3947-0064				Aluja M, 2008, ANNU REV ENTOMOL, V53, P473, DOI 10.1146/annurev.ento.53.103106.093350; [Anonymous], 1992, FRUIT FLIES EC SIGNI; [Anonymous], 2002, ANN REPORT; BUSCHPETERSEN E, 1989, ENTOMOL EXP APPL, V51, P241, DOI 10.1007/BF00347887; CALKINS CO, 1983, FLA ENTOMOL, V66, P512, DOI 10.2307/3494025; Calkins CO, 1989, FRUIT FLIES THEIR BI, P153; CAYOL JP, 1994, J APPL ENTOMOL, V117, P338, DOI 10.1111/j.1439-0418.1994.tb00744.x; Cayol JP, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P843; Enkerlin W, 1996, J ECON ENTOMOL, V89, P946, DOI 10.1093/jee/89.4.946; EPPO European and Mediterranean Plant Protection Organization, 2013, PQR EPPO DAT QUAR PE; FAO/IAEA/USDA, 2019, PROD QUAL CONTR STER; Fischer K., 2000, J ECON ENTOMOL, V91, P1406; Fischer K., 1998, J ECON ENTOMOL, V93, P394; Fisher K., 2000, Area-wide control of fruit flies and other insect pests. Joint proceedings of the international conference on area-wide control of insect pests, 28 May-2 June, 1998 and the Fifth International Symposium on Fruit Flies of Economic Importance, Penang, Malaysia, 1-5 June, 1998, P543; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Franz G., 2000, Area-wide control of fruit flies and other insect pests. Joint proceedings of the international conference on area-wide control of insect pests, 28 May-2 June, 1998 and the Fifth International Symposium on Fruit Flies of Economic Importance, Penang, Malaysia, 1-5 June, 1998, P511; Gourzi P, 2000, MOL GEN GENET, V264, P127, DOI 10.1007/s004380000294; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HENDRICHS J, 1995, J APPL ENTOMOL, V119, P371, DOI 10.1111/j.1439-0418.1995.tb01303.x; Hendrichs J, 2002, FLA ENTOMOL, V85, P1, DOI 10.1653/0015-4040(2002)085[0001:MASITP]2.0.CO;2; HOOPER GHS, 1987, ENTOMOL EXP APPL, V44, P161, DOI 10.1007/BF00367625; Katsoyannos BI, 1999, J ECON ENTOMOL, V92, P583, DOI 10.1093/jee/92.3.583; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Lance DR, 2000, ANN ENTOMOL SOC AM, V93, P1179, DOI 10.1603/0013-8746(2000)093[1179:CASAWC]2.0.CO;2; Liquido NJ, 1991, ENTOMOLOGICAL SOC AM, V77; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; MCINNIS DO, 1994, ANN ENTOMOL SOC AM, V87, P231, DOI 10.1093/aesa/87.2.231; MCINNIS DO, 1993, FRUIT FLIES, P95; McInnis DO, 2002, FLA ENTOMOL, V85, P126, DOI 10.1653/0015-4040(2002)085[0126:MAROMD]2.0.CO;2; Niyazi N, 2005, ANN ENTOMOL SOC AM, V98, P119, DOI 10.1603/0013-8746(2005)098[0119:GAMCOC]2.0.CO;2; Robinson AS, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P95, DOI 10.1007/1-4020-4051-2_4; ROBINSON AS, 1982, GENETICA, V58, P229, DOI 10.1007/BF00128017; ROBINSON AS, 1999, TRENDS ENTOMOL, V2, P81; Roessler Y., 1989, WORLD CROP PESTS FRU, V3, P329; ROSSLER Y, 1980, ENTOMOPHAGA, V25, P275, DOI 10.1007/BF02371927; ROSSLER Y, 1979, ENTOMOPHAGA, V24, P411, DOI 10.1007/BF02374180; SCHROEDER WJ, 1981, P HAWAII ENTOMOL SOC, V23, P437; SCHROEDER WJ, 1972, J ECON ENTOMOL, V65, P1217, DOI 10.1093/jee/65.4.1217; Scolari F, 2008, NEW BIOTECHNOL, V25, P76, DOI 10.1016/j.nbt.2008.02.001; STEINER LF, 1961, J ECON ENTOMOL, V54, P30, DOI 10.1093/jee/54.1.30; VARGAS RI, 1986, J ECON ENTOMOL, V79, P864, DOI 10.1093/jee/79.3.864; Vreysen MJB, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P325, DOI 10.1007/1-4020-4051-2_12; Wimmer EA, 2005, NAT BIOTECHNOL, V23, P432, DOI 10.1038/nbt0405-432	43	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157679	10.1371/journal.pone.0157679	http://dx.doi.org/10.1371/journal.pone.0157679			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336737	Green Submitted, gold, Green Published			2022-12-26	WOS:000378389200031
J	Becker, EA; Yao, AI; Seitzer, PM; Kind, T; Wang, T; Eigenheer, R; Shao, KSY; Yarov-Yarovoy, V; Facciotti, MT				Becker, Erin A.; Yao, Andrew I.; Seitzer, Phillip M.; Kind, Tobias; Wang, Ting; Eigenheer, Rich; Shao, Katie S. Y.; Yarov-Yarovoy, Vladimir; Facciotti, Marc T.			A Large and Phylogenetically Diverse Class of Type 1 Opsins Lacking a Canonical Retinal Binding Site	PLOS ONE			English	Article							SENSORY RHODOPSIN II; MULTIPLE SEQUENCE ALIGNMENT; STRUCTURE PREDICTION; HALOALKALIPHILIC ARCHAEA; INTERACTIVE TREE; STRUCTURAL BASIS; ACTIVE STATE; EVOLUTION; PROTEINS; ACCURACY	Opsins are photosensitive proteins catalyzing light-dependent processes across the tree of life. For both microbial (type 1) and metazoan (type 2) opsins, photosensing depends upon covalent interaction between a retinal chromophore and a conserved lysine residue. Despite recent discoveries of potential opsin homologs lacking this residue, phylogenetic dispersal and functional significance of these abnormal sequences have not yet been investigated. We report discovery of a large group of putatively non-retinal binding opsins, present in a number of fungal and microbial genomes and comprising nearly 30% of opsins in the Halobacteriacea, a model clade for opsin photobiology. We report phylogenetic analyses, structural modeling, genomic context analysis and biochemistry, to describe the evolutionary relationship of these recently described proteins with other opsins, show that they are expressed and do not bind retinal in a canonical manner. Given these data, we propose a hypothesis that these abnormal opsin homologs may represent a novel family of sensory opsins which may be involved in taxis response to one or more non-light stimuli. If true, this finding would challenge our current understanding of microbial opsins as a light-specific sensory family, and provides a potential analogy with the highly diverse signaling capabilities of the eukaryotic G-protein coupled receptors (GPCRs), of which metazoan type 2 opsins are a light-specific sub-clade.	[Becker, Erin A.; Yao, Andrew I.; Seitzer, Phillip M.; Kind, Tobias; Wang, Ting; Facciotti, Marc T.] Univ Calif Davis, Genome Ctr, One Shields Ave, Davis, CA 95616 USA; [Becker, Erin A.; Facciotti, Marc T.] Univ Calif Davis, Microbiol Grad Grp, One Shields Ave, Davis, CA 95616 USA; [Yao, Andrew I.; Seitzer, Phillip M.; Facciotti, Marc T.] Univ Calif Davis, Dept Biomed Engn, One Shields Ave, Davis, CA 95616 USA; [Seitzer, Phillip M.] Proteome Software, 1340 SW Bertha Blvd, Portland, OR USA; [Eigenheer, Rich] Calif Dept Food & Agr, 1220 N St, Sacramento, CA 95814 USA; [Shao, Katie S. Y.] Williams Coll, 880 Main St, Williamstown, MA 01267 USA; [Yarov-Yarovoy, Vladimir] Univ Calif Davis, Dept Physiol & Membrane Biol, One Shields Ave, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; California Department of Food & Agriculture; Williams College; University of California System; University of California Davis	Facciotti, MT (corresponding author), Univ Calif Davis, Genome Ctr, One Shields Ave, Davis, CA 95616 USA.; Facciotti, MT (corresponding author), Univ Calif Davis, Microbiol Grad Grp, One Shields Ave, Davis, CA 95616 USA.; Facciotti, MT (corresponding author), Univ Calif Davis, Dept Biomed Engn, One Shields Ave, Davis, CA 95616 USA.	mtfacciotti@ucdavis.edu	Yarov-Yarovoy, Vladimir/ABE-5454-2020; Kind, Tobias/A-7553-2010; Facciotti, Marc/AAF-9227-2020	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834; Facciotti, Marc/0000-0003-4453-3274; Kind, Tobias/0000-0002-1908-4916; Becker, Erin/0000-0002-6832-0233	National Science Foundation [EF0949453]	National Science Foundation(National Science Foundation (NSF))	Funding for this work came from the National Science Foundation [EF0949453] and departmental and bridge funds to MTF. The funder provided support in the form of salaries for author PMS, AIY, EAB and MTF but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Becker EA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004784; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Bonneau R, 2002, J MOL BIOL, V322, P65, DOI 10.1016/S0022-2836(02)00698-8; Borshchevskiy V, 2014, ACTA CRYSTALLOGR D, V70, P2675, DOI 10.1107/S1399004714017295; Brown LS, 2014, BBA-BIOENERGETICS, V1837, P553, DOI 10.1016/j.bbabio.2013.05.006; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dallakyan S, 2015, SMALL MOLECULE LIBRA; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Feuda R, 2012, P NATL ACAD SCI USA, V109, P18868, DOI 10.1073/pnas.1204609109; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Friedman N, 1994, BIOCHEMISTRY-US, V33, P6; Fu HY, 2010, J BACTERIOL, V192, P5866, DOI 10.1128/JB.00642-10; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Grote M, 2014, BBA-BIOENERGETICS, V1837, P533, DOI 10.1016/j.bbabio.2013.08.006; Gu Jinbao, 2013, PLoS ONE, V8, P1; Gushchin I, 2011, J MOL BIOL, V412, P591, DOI 10.1016/j.jmb.2011.07.022; Gutlein M, 2014, CHES MAPPER 2 0 FOR, P1; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hongjian Li, 2012, 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), P77, DOI 10.1109/CIBCB.2012.6217214; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inoue K, 2014, BBA-BIOENERGETICS, V1837, P562, DOI 10.1016/j.bbabio.2013.05.005; Ishchenko A, 2013, J PHOTOCH PHOTOBIO B, V123, P55, DOI 10.1016/j.jphotobiol.2013.03.008; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Koyanagi M, 2013, BIOCHIM BIOPHYS ACTA, V1837, P710, DOI DOI 10.1016/J.BBABI0.2013.09.003; Landau EM, 2003, FEBS LETT, V555, P51, DOI 10.1016/S0014-5793(03)01082-2; Larusso ND, 2008, J MOL EVOL, V66, P417, DOI 10.1007/s00239-008-9076-6; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Mackin KA, 2014, MOL BIOL EVOL, V31, P85, DOI 10.1093/molbev/mst171; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; McCarren J, 2007, ENVIRON MICROBIOL, V9, P846, DOI 10.1111/j.1462-2920.2006.01203.x; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MULLEN E, 1981, FEBS LETT, V130, P187, DOI 10.1016/0014-5793(81)81116-7; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Pebay-Peyroula E, 2002, BBA-BIOMEMBRANES, V1565, P196, DOI 10.1016/S0005-2736(02)00569-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price M, FAST TREE COMPARISON; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Proteome Software Inc, SCAFFOLD V4 0 3; Rambaut A, FIGTREE V12 05; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sander T, 2015, J CHEM INF MODEL, V55, P460, DOI 10.1021/ci500588j; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Schweiger U, 1994, BACTERIORHODOPSIN CA, P535; Seitzer P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-18; Shen LB, 2013, SCI WORLD J, DOI 10.1155/2013/435651; Siddaramappa S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-165; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Sudo Y, 2011, J BIOL CHEM, V286, P5967, DOI 10.1074/jbc.M110.190058; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Tastan O, 2014, BBA-BIOENERGETICS, V1837, P656, DOI 10.1016/j.bbabio.2013.11.021; The Global Proteome Machine Organization, 2013, X TAND CYLCONE; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wang T, 2014, STABLE CLOSURE OF TH; Xu Y, 2001, INT J SYST EVOL MICR, V51, P1693, DOI 10.1099/00207713-51-5-1693; Xu Y, 1999, INT J SYST BACTERIOL, V49, P261, DOI 10.1099/00207713-49-1-261; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004; ZHUKOVSKY EA, 1991, SCIENCE, V251, P558, DOI 10.1126/science.1990431	77	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0156543	10.1371/journal.pone.0156543	http://dx.doi.org/10.1371/journal.pone.0156543			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327432	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212400006
J	Gray, KA; Gresty, KJ; Chen, NH; Zhang, V; Gutteridge, CE; Peatey, CL; Chavchich, M; Waters, NC; Cheng, Q				Gray, Karen-Ann; Gresty, Karryn J.; Chen, Nanhua; Zhang, Veronica; Gutteridge, Clare E.; Peatey, Christopher L.; Chavchich, Marina; Waters, Norman C.; Cheng, Qin			Correlation between Cyclin Dependent Kinases and Artemisinin-Induced Dormancy in Plasmodium falciparum In Vitro	PLOS ONE			English	Article							HUMAN MALARIA PARASITES; CELL-CYCLE; PROTEIN-KINASE; CDC2-RELATED KINASE; PFMRK; CDK; INHIBITORS; EXPRESSION; DISCOVERY; IDENTIFICATION	Background Artemisinin-induced dormancy provides a plausible explanation for recrudescence following artemisinin monotherapy. This phenomenon shares similarities with cell cycle arrest where cyclin dependent kinases (CDKs) and cyclins play an important role. Methods Transcription profiles of Plasmodium falciparum CDKs and cyclins before and after dihydroartemisinin (DHA) treatment in three parasite lines, and the effect of CDK inhibitors on parasite recovery from DHA-induced dormancy were investigated. Results After DHA treatment, parasites enter a dormancy phase followed by a recovery phase. During the dormancy phase parasites up-regulate pfcrk1, pfcrk4, pfcyc2 and pfcyc4, and down-regulate pfmrk, pfpk5, pfpk6, pfcrk3, pfcyc1 and pfcyc3. When entering the recovery phase parasites immediately up-regulate all CDK and cyclin genes. Three CDK inhibitors, olomoucine, WR636638 and roscovitine, produced distinct effects on different phases of DHA-induced dormancy, blocking parasites recovery. Conclusions The up-regulation of PfCRK1 and PfCRK4, and down regulation of other CDKs and cyclins correlate with parasite survival in the dormant state. Changes in CDK expression are likely to negatively regulate parasite progression from G1 to S phase. These findings provide new insights into the mechanism of artemisinin-induced dormancy and cell cycle regulation of P. falciparum, opening new opportunities for preventing recrudescence following artemisinin treatment.	[Gray, Karen-Ann; Gresty, Karryn J.; Chen, Nanhua; Zhang, Veronica; Peatey, Christopher L.; Chavchich, Marina; Cheng, Qin] Australian Army Malaria Inst, Drug Resistance & Diagnost, Brisbane, Qld, Australia; [Gray, Karen-Ann; Gresty, Karryn J.; Peatey, Christopher L.; Cheng, Qin] QIMR Berghofer Med Res Inst, Clin Trop Med, Brisbane, Qld, Australia; [Zhang, Veronica] Univ Queensland, Sch Biochem, Brisbane, Qld, Australia; [Gutteridge, Clare E.] US Naval Acad, Annapolis, MD 21402 USA; [Waters, Norman C.] Walter Reed Army Inst Res, Silver Spring, MD USA	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Queensland; United States Department of Defense; United States Navy; United States Naval Academy; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Cheng, Q (corresponding author), Australian Army Malaria Inst, Drug Resistance & Diagnost, Brisbane, Qld, Australia.; Cheng, Q (corresponding author), QIMR Berghofer Med Res Inst, Clin Trop Med, Brisbane, Qld, Australia.; Waters, NC (corresponding author), Walter Reed Army Inst Res, Silver Spring, MD USA.	noman.c.waters2.mil@mail.mil; qin.cheng@defence.gov.au	Cheng, Qin/AAO-2198-2020	Cheng, Qin/0000-0001-7776-4437	NHMRC, Australia [GNT1021273]	NHMRC, Australia(National Health and Medical Research Council (NHMRC) of Australia)	The work was partially funded by NHMRC, Australia (GNT1021273). NC, CP, MC and QC are employees of the Department of Defence, Australia. CEG and NCW are employees of Department of Defense, USA. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Bhattacharjee AK, 2004, J MED CHEM, V47, P5418, DOI 10.1021/jm040108f; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bracchi-Ricard V, 2000, BIOCHEM J, V347, P255, DOI 10.1042/0264-6021:3470255; BUNNELL BA, 1990, P NATL ACAD SCI USA, V87, P7467, DOI 10.1073/pnas.87.19.7467; Chen NH, 2014, ANTIMICROB AGENTS CH, V58, P4773, DOI 10.1128/AAC.02647-14; Chen YQ, 2006, MOL BIOCHEM PARASIT, V149, P48, DOI 10.1016/j.molbiopara.2006.04.004; Codd A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-56; Doerig C, 2000, Prog Cell Cycle Res, V4, P163; DOERIG C, 1995, MOL BIOCHEM PARASIT, V70, P167, DOI 10.1016/0166-6851(95)00033-W; Doerig C, 2008, TRENDS PARASITOL, V24, P570, DOI 10.1016/j.pt.2008.08.007; Efferth T, 2001, INT J ONCOL, V18, P767; Fennell C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-99; Geyer JA, 2005, BBA-PROTEINS PROTEOM, V1754, P160, DOI 10.1016/j.bbapap.2005.07.031; Geyer JA, 2009, BIOORG MED CHEM LETT, V19, P1982, DOI 10.1016/j.bmcl.2009.02.042; Graeser R, 1996, MOL BIOCHEM PARASIT, V82, P37, DOI 10.1016/0166-6851(96)02716-8; Halbert J, 2010, EUKARYOT CELL, V9, P952, DOI 10.1128/EC.00005-10; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Iwanaga T, 2013, PARASITOL INT, V62, P423, DOI 10.1016/j.parint.2013.05.003; Jirage D, 2010, MOL BIOCHEM PARASIT, V172, P9, DOI 10.1016/j.molbiopara.2010.03.009; Keenan SA, 2004, J MOL GRAPH MODEL, V22, P241, DOI 10.1016/j.jmgm.2003.09.002; Kozlov Sergei, 2010, Infectious Disorders - Drug Targets, V10, P165; Krylov DM, 2003, CURR BIOL, V13, P173, DOI 10.1016/S0960-9822(03)00008-3; LaCrue AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026689; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch K, 2000, J BIOL CHEM, V275, P8952, DOI 10.1074/jbc.275.12.8952; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Leete TH, 1996, PARASITOL TODAY, V12, P442, DOI 10.1016/0169-4758(96)10068-5; Li ZY, 2001, BIOCHEM BIOPH RES CO, V288, P1207, DOI 10.1006/bbrc.2001.5920; Manhani KK, 2005, J MOL MODEL, V12, P42, DOI 10.1007/s00894-005-0002-1; Merckx A, 2003, J BIOL CHEM, V278, P39839, DOI 10.1074/jbc.M301625200; Meshnick SR, 1996, MICROBIOL REV, V60, P301, DOI 10.1128/MMBR.60.2.301-315.1996; Mok S, 2015, SCIENCE, V347, P431, DOI 10.1126/science.1260403; Mok S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-391; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Natalang O, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-388; Nilkaeo A, 2006, BIOMED RES-TOKYO, V27, P131, DOI 10.2220/biomedres.27.131; Peatey CL, 2015, J INFECT DIS, V212, P426, DOI 10.1093/infdis/jiv048; Rangarajan R, 2006, EXP PARASITOL, V112, P202, DOI 10.1016/j.exppara.2005.11.002; Roques M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005273; Shaw PJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2040-0; Shock JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r134; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tucker MS, 2012, ANTIMICROB AGENTS CH, V56, P302, DOI 10.1128/AAC.05540-11; Waters NC, 2000, MOL BIOCHEM PARASIT, V107, P45, DOI 10.1016/S0166-6851(99)00229-7; Willoughby JA, 2009, J BIOL CHEM, V284, P2203, DOI 10.1074/jbc.M804491200; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P1872, DOI 10.1128/AAC.01636-09; Woodard CL, 2003, J MED CHEM, V46, P3877, DOI 10.1021/jm0300983	48	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157906	10.1371/journal.pone.0157906	http://dx.doi.org/10.1371/journal.pone.0157906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27326764	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400061
J	Grueneisen, J; Sawicki, LM; Schaarschmidt, BM; Suntharalingam, S; von der Ropp, S; Wetter, A; Ruhlmann, V; Quick, HH; Forsting, M; Umutlu, L				Grueneisen, Johannes; Sawicki, Lino Morris; Schaarschmidt, Benedikt Michael; Suntharalingam, Saravanabavaan; von der Ropp, Sara; Wetter, Axel; Ruhlmann, Verena; Quick, Harald H.; Forsting, Michael; Umutlu, Lale			Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI	PLOS ONE			English	Article							APPARENT DIFFUSION-COEFFICIENT; POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; CELL LUNG-CANCER; WHOLE-BODY MRI; RESPONSE ASSESSMENT; FDG-PET/CT; HODGKIN-LYMPHOMA; DIAGNOSTIC-VALUE; WEIGHTED MRI	Background The aim of this study was to assess the applicability of a fast MR-protocol for whole-body staging of lymphoma patients using an integrated PET/MR system. Methods A total of 48 consecutive lymphoma patients underwent 52 clinically indicated PET/CT and subsequent PET/MRI examinations with the use of 18F-FDG. For PET/MR imaging, a fast whole-body MR-protocol was implemented. A radiologist and a nuclear medicine physician interpreted MRI and PET/MRI datasets in consensus and were instructed to identify manifestations of lymphoma on a site-specific analysis. The accuracy for the identification of active lymphoma disease was calculated and the tumor stage for each examination was determined. Furthermore, radiation doses derived from administered tracer activities and CT protocol parameters were estimated and the mean scan duration of PET/CT and PET/MR imaging was determined. Statistical analysis was performed to compare the diagnostic performance of PET/MRI and MRI alone. The results of PET/CT imaging, all available histopathological samples as well as results of prior examinations and follow-up imaging were used for the determination of the reference standard. Results Active lymphoma disease was present in 28/52 examinations. PET/MRI revealed higher values of diagnostic accuracy for the identification of active lymphoma disease in those 52 examinations in comparison to MRI, however, results of the two ratings did not differ significantly. On a site specific analysis, PET/MRI showed a significantly higher accuracy for the identification of nodal manifestation of lymphoma (p<0.05) if compared to MRI, whereas ratings for extranodal regions did not reveal a significant difference. In addition, PET/MRI enabled correct identification of lymphoma stage in a higher percentage of patients than MRI (94% vs. 83%). Furthermore, SUVs derived from PET/MRI were significantly higher than in PET/CT, however, there was a strong positive correlation between SUVmax and SUVmean of the two imaging modalities (R = 0.91 p<0.001 and R = 0.87, p<0.001). Average scan duration of whole-body PET/CT and PET/MRI examinations amounted to 17.3 +/- 1.9 min and 27.8 +/- 3.7 min, respectively. Estimated mean effective-dose for whole-body PET/CT scans were 64.4% higher than for PET/MRI. Conclusions Our results demonstrate the usefulness of 18F-FDG PET data as a valuable additive to MRI for a more accurate evaluation of patients with lymphomas. With regard to patient comfort related to scan duration and a markedly reduced radiation exposure, fast PET/MRI may serve as a powerful alternative to PET/CT for a diagnostic workup of lymphoma patients.	[Grueneisen, Johannes; Suntharalingam, Saravanabavaan; von der Ropp, Sara; Wetter, Axel; Forsting, Michael; Umutlu, Lale] Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Sawicki, Lino Morris; Schaarschmidt, Benedikt Michael] Univ Dusseldorf, Univ Hosp Dusseldorf, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany; [Ruhlmann, Verena] Univ Duisburg Essen, Univ Hosp Essen, Dept Nucl Med, Essen, Germany; [Quick, Harald H.] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Quick, Harald H.] Univ Duisburg Essen, Univ Hosp Essen, High Field & Hybrid MR Imaging, Essen, Germany	University of Duisburg Essen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Grueneisen, J (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	Johannes.grueneisen@uk-essen.de		Schaarschmidt, Benedikt Michael/0000-0001-6331-7679				Abdulqadhr G, 2011, ACTA RADIOL, V52, P173, DOI 10.1258/ar.2010.100246; Antoch G, 2003, RADIOLOGY, V229, P526, DOI 10.1148/radiol.2292021598; Barrington SF, 2014, J CLIN ONCOL, V32, P3048, DOI 10.1200/JCO.2013.53.5229; Beiderwellen K, 2015, EUR J NUCL MED MOL I, V42, P56, DOI 10.1007/s00259-014-2902-8; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Brix G, 2014, NUKLEARMED-NUCL MED, V53, P217, DOI 10.3413/Nukmed-0663-14-04; Cheson BD, 2015, CHIN CLIN ONCOL, V4, DOI 10.3978/j.issn.2304-3865.2014.11.03; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Cheson BD, 2011, J CLIN ONCOL, V29, P1844, DOI 10.1200/JCO.2010.32.5225; Christner JA, 2010, AM J ROENTGENOL, V194, P881, DOI 10.2214/AJR.09.3462; Clement C. H., 2008, Annals of the ICRP, V38, P1, DOI 10.1016/j.icrp.2008.08.003; Cremerius U, 1998, NUCL MED COMMUN, V19, P1055, DOI 10.1097/00006231-199811000-00005; Fueger BJ, 2009, MOL IMAGING BIOL, V11, P269, DOI 10.1007/s11307-009-0200-9; Gallamini A, 2014, HAEMATOLOGICA, V99, P1107, DOI 10.3324/haematol.2013.103218; Giraudo C, 2016, INVEST RADIOL, V51, P163, DOI 10.1097/RLI.0000000000000218; Grueneisen J, 2015, EUR J RADIOL, V84, P2097, DOI 10.1016/j.ejrad.2015.08.010; Grueneisen J, 2014, J NUCL MED, V55, P1930, DOI 10.2967/jnumed.114.146886; Gu J, 2011, AM J ROENTGENOL, V197, pW384, DOI 10.2214/AJR.10.5692; Heacock L, 2015, AM J ROENTGENOL, V204, P842, DOI 10.2214/AJR.14.13181; Heusch P, 2013, ROFO-FORTSCHR RONTG, V185, P1059, DOI 10.1055/s-0033-1350110; Heusch P, 2015, EUR J NUCL MED MOL I, V42, P42, DOI 10.1007/s00259-014-2885-5; Heusch P, 2013, EUR J RADIOL, V82, P870, DOI 10.1016/j.ejrad.2013.01.008; Juweid ME, 2005, J CLIN ONCOL, V23, P4652, DOI 10.1200/JCO.2005.01.891; Kostakoglu L, 2014, EUR J NUCL MED MOL I, V41, P1004, DOI 10.1007/s00259-013-2686-2; Littooij AS, 2014, EUR RADIOL, V24, P1153, DOI 10.1007/s00330-014-3114-0; Mayerhoefer ME, 2014, CLIN CANCER RES, V20, P2984, DOI 10.1158/1078-0432.CCR-13-3355; Moog F, 1997, RADIOLOGY, V203, P795, DOI 10.1148/radiology.203.3.9169707; Nakayama M, 2013, ANN NUCL MED, V27, P163, DOI 10.1007/s12149-012-0669-1; Platzek I, 2014, ACAD RADIOL, V21, P1314, DOI 10.1016/j.acra.2014.05.019; Quick HH, 2014, J MAGN RESON IMAGING, V39, P243, DOI 10.1002/jmri.24523; Rakheja R, 2013, AM J ROENTGENOL, V201, P1115, DOI 10.2214/AJR.13.11304; Reiner CS, 2014, EUR J NUCL MED MOL I, V41, P649, DOI 10.1007/s00259-013-2654-x; Romera MC, 2012, REV ESP MED NUCL IMA, V31, P135, DOI 10.1016/j.remn.2011.05.011; Schafer JF, 2014, RADIOLOGY, V273, P220, DOI 10.1148/radiol.14131732; van Ufford HMEQ, 2011, AM J ROENTGENOL, V196, P662, DOI 10.2214/AJR.10.4743; Wen JC, 2013, JAMA OPHTHALMOL, V131, P56, DOI 10.1001/jamaophthalmol.2013.564	36	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157880	10.1371/journal.pone.0157880	http://dx.doi.org/10.1371/journal.pone.0157880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327617	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212400056
J	He, HZ; Ye, A; Kim, J				He, Hongzhi; Ye, An; Kim, Joomyeong			Transcriptional Truncation of the Long Coding Imprinted Gene Usp29	PLOS ONE			English	Article							REGION	Usp29 (Ubiquitin-specific protease 29) is a paternally expressed gene located upstream of another imprinted gene Peg3. In the current study, the transcription of this long coding gene spanning a 250-kb genomic distance was truncated using a knockin allele. According to the results, paternal transmission of the mutant allele resulted in reduced body and litter sizes whereas the maternal transmission caused no obvious effects. In the paternal mutant, the expression levels of Usp29 were reduced to 14-18% level of the wild-type littermates due to the Poly-A signal included in the knockin cassette. Expression analyses further revealed an unusual female-specific up-regulation of the adjacent imprinted gene Zfp264 in the mutant. Consistent with this, the promoter of Zfp264 was hypomethylated only in the female mutant. Interestingly, this female-specific hypomethylation by the knockin allele was not detected in the offspring of an interspecific crossing, indicating its sensitivity to genetic background. Overall, the results suggest that the transcription of Usp29 may be involved in DNA methylation setting of Zfp264 promoter in a sex-specific manner.	[He, Hongzhi; Ye, An; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu			National Institutes of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097074, R01GM066225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (J.K. R01-GM066225, R01-GM097074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Drs. Hana Kim and Michelle Thiaville for their help in the initial stage of the construction of KO vectors, and Dr. Scott Herke for his help in NGS-based bisulfite sequencing. We also like to thank the members of JooKim Lab for their thoughtful feedback and discussion on the manuscript. This research was supported by the National Institute of Health (R01-GM066225 and R01-GM097074 to J.K.).	Angrand P O, 1999, Nucleic Acids Res, V27, pe16, DOI 10.1093/nar/27.17.e16; Barlow DP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018382; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Flisikowski K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015116; He Hongzhi, 2014, Genomics & Informatics, V12, P105, DOI 10.5808/GI.2014.12.3.105; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Kim J, 2000, GENOME RES, V10, P1138, DOI 10.1101/gr.10.8.1138; Kim J, 2007, GENOMICS, V90, P85, DOI 10.1016/j.ygeno.2007.03.012; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Kim J, 2012, HUM MOL GENET, V21, P2677, DOI 10.1093/hmg/dds092; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Lee SM, 2016, METHODSX, V3, P1, DOI 10.1016/j.mex.2015.11.008; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Liu JH, 2011, EMBO J, V30, P846, DOI 10.1038/emboj.2011.11; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Martin Y, 2015, ONCOGENE, V34, P1058, DOI 10.1038/onc.2014.38; McGraw S, 2015, NUCLEIC ACIDS RES, V43, P1485, DOI 10.1093/nar/gku1386; Pauler FM, 2012, CURR OPIN GENET DEV, V22, P283, DOI 10.1016/j.gde.2012.02.005; Thiaville MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075417; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0158004	10.1371/journal.pone.0158004	http://dx.doi.org/10.1371/journal.pone.0158004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327533	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212400067
J	Li, J; Jin, W; Qin, YL; Zhao, WM; Chang, CF; Xu, CS				Li, Jun; Jin, Wei; Qin, Yanli; Zhao, Weiming; Chang, Cuifang; Xu, Cunshuan			Expression Profile and Function Analysis of LncRNAs during Priming Phase of Rat Liver Regeneration	PLOS ONE			English	Article							LONG NONCODING RNA; HEPATOCELLULAR-CARCINOMA; GASTRIC-CANCER; TUMOR-GROWTH; PARTIAL-HEPATECTOMY; SIGNALING PATHWAYS; UP-REGULATION; CELL-GROWTH; IL-6/STAT3; ANRIL	Emerging evidences have revealed that long non-coding RNAs (lncRNAs) functioned in a wide range of physiological and pathophysiological processes including rat liver regeneration, and could regulate gene expression in the transcriptional and post-transcriptional levels. However, the underlying mechanism for lncRNAs participation in liver regeneration is largely unknown. To define the mechanisms how the lncRNAs regulate LR, we performed bio-chip technology, high-throughput sequencing and RT-PCR to detect the expression of lncRNAs at 0, 2 and 6 h during LR after 2/3 hepatectomy (PH). The results indicated that 28 lncRNAs were involved in LR. Bioinformatics analysis predicated 465 co-expression target genes including 10 regulatory genes were related to these 28 lncRNAs. Ingenuity Pathway Analysis (IPA) was employed to analyze the signaling pathways and physiological activities that regulated by these genes, and the results suggested that these genes were potentially related to ILK, SAPK/JNK and ERK/MAPK signaling pathways, and possibly regulate many important physiological activities in LR in terms of cell proliferation, cell differentiation, cell survival, apoptosis and necrosis.	[Li, Jun; Jin, Wei; Qin, Yanli; Zhao, Weiming; Chang, Cuifang; Xu, Cunshuan] Henan Normal Univ, Coll Life Sci, Xinxiang 453007, Henan Province, Peoples R China; [Li, Jun; Jin, Wei; Qin, Yanli; Zhao, Weiming; Chang, Cuifang; Xu, Cunshuan] Henan Normal Univ, State Key Lab Cultivat Base Cell Differentiat Reg, Xinxiang 453007, Henan Province, Peoples R China; [Li, Jun; Jin, Wei; Qin, Yanli; Zhao, Weiming; Chang, Cuifang; Xu, Cunshuan] Henan Normal Univ, Henan Bioengn Key Lab, Xinxiang 453007, Henan Province, Peoples R China; [Li, Jun; Jin, Wei; Qin, Yanli; Zhao, Weiming; Chang, Cuifang; Xu, Cunshuan] Henan Normal Univ, Henan Engn Lab Bioengn & Drug Dev, Xinxiang 453007, Henan Province, Peoples R China	Henan Normal University; Henan Normal University; Henan Normal University; Henan Normal University	Chang, CF; Xu, CS (corresponding author), Henan Normal Univ, Coll Life Sci, Xinxiang 453007, Henan Province, Peoples R China.; Chang, CF; Xu, CS (corresponding author), Henan Normal Univ, State Key Lab Cultivat Base Cell Differentiat Reg, Xinxiang 453007, Henan Province, Peoples R China.; Chang, CF; Xu, CS (corresponding author), Henan Normal Univ, Henan Bioengn Key Lab, Xinxiang 453007, Henan Province, Peoples R China.; Chang, CF; Xu, CS (corresponding author), Henan Normal Univ, Henan Engn Lab Bioengn & Drug Dev, Xinxiang 453007, Henan Province, Peoples R China.	changcuifang@163.com; cellkeylab@126.com			Natural Science Foundation of China [31572270, 31201093]; Natural Science Foundation of Henan [142300413212, 112300413204]; Key Project of Science Research in Colleges and Universities [15A180042]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Henan; Key Project of Science Research in Colleges and Universities	This work was supported by the Natural Science Foundation of China (No. 31572270 and No. 31201093), Natural Science Foundation of Henan (No. 142300413212 and No. 112300413204), and the Key Project of Science Research in Colleges and Universities (No. 15A180042).	Arab K, 2014, MOL CELL, V55, P604, DOI 10.1016/j.molcel.2014.06.031; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Cai Y, 2015, ONCOTARGETS THER, V8, P2657, DOI 10.2147/OTT.S90485; Chang CJ, 2012, BRIT J CANCER, V106, P243, DOI 10.1038/bjc.2011.551; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Duminuco R, 2015, CELL CYCLE, V14, P2924, DOI 10.1080/15384101.2015.1064205; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hortelano S, 2007, FRONT BIOSCI-LANDMRK, V12, P13, DOI 10.2741/2045; Hu XW, 2014, CANCER CELL, V26, P344, DOI 10.1016/j.ccr.2014.07.009; Huang LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132798; Huang MD, 2015, J HEMATOL ONCOL, V8, DOI [10.1186/s13045-015-0146-0, 10.1186/s13045-015-0153-1]; Huang YK, 2015, WORLD J GASTROENTERO, V21, P9863, DOI 10.3748/wjg.v21.i34.9863; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Jiao H, 2015, CELL PHYSIOL BIOCHEM, V36, P2317, DOI 10.1159/000430195; Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lepoivre C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-914; Li M, 2014, CELL MOL BIOL LETT, V19, P181, DOI 10.2478/s11658-014-0188-2; Maass PG, 2014, J MOL MED, V92, P337, DOI 10.1007/s00109-014-1131-8; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Park SA, 2015, SCI REP-UK, V5, DOI 10.1038/srep16492; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Schaukowitch K, 2014, NEUROSCIENCE, V264, P25, DOI 10.1016/j.neuroscience.2013.12.009; Sell S, 2003, INT J BIOCHEM CELL B, V35, P267, DOI 10.1016/S1357-2725(02)00182-6; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Tuo YL, 2015, EUR REV MED PHARMACO, V19, P3403; Wang X, 2015, TUMOUR BIOL; Wang Y, 2015, ONCOTARGET; Wen YK, 2015, INT J BIOL SCI, V11, P1236, DOI 10.7150/ijbs.12118; Wu J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0229-3; Xie M, 2015, ONCOTARGET, V6, P33587, DOI 10.18632/oncotarget.5599; Xu Cunshuan, 2004, Genomics Proteomics & Bioinformatics, V2, P109; Xu D, 2013, HEPATOLOGY, V58, P739, DOI 10.1002/hep.26361; Xu MJ, 2015, HEPATOLOGY, V61, P692, DOI 10.1002/hep.27447; Xue M, 2015, CANC SCI; Yamaguchi H, 2014, CANCER RES TREAT, V46, P209, DOI 10.4143/crt.2014.46.3.209; Yang Fangfang, 2015, Eur J Pharmacol, V754, P105, DOI 10.1016/j.ejphar.2015.02.015; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yang GD, 2014, BBA-GENE REGUL MECH, V1839, P1097, DOI 10.1016/j.bbagrm.2014.08.012; Yang YW, 2014, ELIFE, V3, DOI 10.7554/eLife.02046; Zhang EB, 2014, ONCOTARGET, V5, P2276, DOI 10.18632/oncotarget.1902; Zhang K, 2014, GENE, V547, P1, DOI 10.1016/j.gene.2014.06.043; Zheng KB, 2015, ONCOL REP, V34, P272, DOI 10.3892/or.2015.3983; Zhou Q., 2015, TUMOUR BIOL	52	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0156128	10.1371/journal.pone.0156128	http://dx.doi.org/10.1371/journal.pone.0156128			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27326854	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400002
J	Kato, H; Suzuki, K; Bannai, M; Moore, DR				Kato, Hiroyuki; Suzuki, Katsuya; Bannai, Makoto; Moore, Daniel R.			Protein Requirements Are Elevated in Endurance Athletes after Exercise as Determined by the Indicator Amino Acid Oxidation Method	PLOS ONE			English	Article							AEROBIC EXERCISE; YOUNG MEN; CURRENT RECOMMENDATIONS; NITROGEN-BALANCE; ADULT HUMANS; HUMAN MUSCLE; ENERGY-COST; RECOVERY; INTENSITY; METABOLISM	A higher protein intake has been recommended for endurance athletes compared with healthy non-exercising individuals based primarily on nitrogen balance methodology. The aim of this study was to determine the estimated average protein requirement and recommended protein intake in endurance athletes during an acute 3-d controlled training period using the indicator amino acid oxidation method. After 2-d of controlled diet (1.4 g protein/kg/d) and training (10 and 5km/d, respectively), six male endurance-trained adults (28 +/- 4 y of age; Body weight, 64.5 +/- 10.0 kg; VO(2)peak, 60.3 +/- 6.7 ml.kg(-1).min(-1); means +/- SD) performed an acute bout of endurance exercise (20 km treadmill run) prior to consuming test diets providing variable amounts of protein (0.2-2.8 g.kg(-1).d(-1)) and sufficient energy. Protein was provided as a crystalline amino acid mixture based on the composition of egg protein with [1-C-13]phenylalanine provided to determine whole body phenylalanine flux, (CO2)-C-13 excretion, and phenylalanine oxidation. The estimated average protein requirement was determined as the breakpoint after biphasic linear regression analysis with a recommended protein intake defined as the upper 95% confidence interval. Phenylalanine flux (68.8 +/- 8.5 mu mol.kg(-1).h(-1)) was not affected by protein intake. (CO2)-C-13 excretion displayed a robust bi-phase linear relationship (R-2 = 0.86) that resulted in an estimated average requirement and a recommended protein intake of 1.65 and 1.83 g protein.kg(-1).d(-1), respectively, which was similar to values based on phenylalanine oxidation (1.53 and 1.70 g.kg(-1).d(-1), respectively). We report a recommended protein intake that is greater than the RDA (0.8 g.kg(-1).d(-1)) and current recommendations for endurance athletes (1.2-1.4 g.kg(-1).d(-1)). Our results suggest that the metabolic demand for protein in endurance-trained adults on a higher volume training day is greater than their sedentary peers and current recommendations for athletes based primarily on nitrogen balance methodology.	[Kato, Hiroyuki; Suzuki, Katsuya; Bannai, Makoto] Ajinomoto Co Inc, Frontier Res Labs, Inst Innovat, Kawasaki, Kanagawa, Japan; [Kato, Hiroyuki; Moore, Daniel R.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada	Ajinomoto Co Inc; University of Toronto	Moore, DR (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.	dr.moore@utoronto.ca	Phillips, Stuart/B-2343-2009	Phillips, Stuart/0000-0002-1956-4098; Moore, Daniel/0000-0001-5865-4398; Kato, Hiroyuki/0000-0003-2408-917X	Ajinomoto Co., Inc.	Ajinomoto Co., Inc.	This study was funded by Ajinomoto Co., Inc. The funder provided support in the form of salaries for authors [HK, SK, MB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2009, J AM DIET ASSOC, V109, P509, DOI 10.1016/j.jada.2009.01.005; Bartlett JD, 2015, EUR J SPORT SCI, V15, P3, DOI 10.1080/17461391.2014.920926; Benardot D, 2016, MED SCI SPORT EXER, V48, P543; Borsheim E, 2004, J APPL PHYSIOL, V96, P674, DOI 10.1152/japplphysiol.00333.2003; Breen L, 2011, J PHYSIOL-LONDON, V589, P4011, DOI 10.1113/jphysiol.2011.211888; Burke LM, 2003, INT J SPORT NUTR EXE, V13, P521, DOI 10.1123/ijsnem.13.4.521; Burke LM, 2011, J SPORT SCI, V29, pS17, DOI 10.1080/02640414.2011.585473; Campbell B, 2007, J INT SOC SPORT NUTR, V4, DOI 10.1186/1550-2783-4-8; Crouter SE, 2004, MED SCI SPORT EXER, V36, P1433, DOI 10.1249/01.MSS.0000135794.01507.48; Di Donato DM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1025, DOI 10.1152/ajpendo.00487.2013; Elango R, 2008, J NUTR, V138, P243, DOI 10.1093/jn/138.2.243; Elango R, 2007, AM J CLIN NUTR, V86, P360, DOI 10.1093/ajcn/86.2.360; Elango R, 2012, BRIT J NUTR, V108, pS22, DOI 10.1017/S0007114512002504; Elango R, 2011, AM J CLIN NUTR, V94, P1545, DOI 10.3945/ajcn.111.012815; Elango R, 2010, CURR OPIN CLIN NUTR, V13, P52, DOI 10.1097/MCO.0b013e328332f9b7; Elango R, 2009, J NUTR, V139, P1082, DOI 10.3945/jn.108.101147; FORBES GB, 1973, NUTR REV, V31, P297; GOLLNICK PD, 1974, J PHYSIOL-LONDON, V241, P45, DOI 10.1113/jphysiol.1974.sp010639; Harber MP, 2010, AM J PHYSIOL-REG I, V299, pR1254, DOI 10.1152/ajpregu.00348.2010; Harber MP, 2009, AM J PHYSIOL-REG I, V296, pR708, DOI [10.1152/ajpregu.00354.2009, 10.1152/ajpregu.90906.2008]; Hawley JA, 1997, SPORTS MED, V24, P73, DOI 10.2165/00007256-199724020-00001; HOERR RA, 1989, AM J PHYSIOL, V257, pE426, DOI 10.1152/ajpendo.1989.257.3.E426; Houltham SD, 2014, APPL PHYSIOL NUTR ME, V39, P219, DOI 10.1139/apnm-2013-0182; Howarth KR, 2010, J APPL PHYSIOL, V109, P431, DOI 10.1152/japplphysiol.00108.2009; Humayun MA, 2007, AM J CLIN NUTR, V86, P995, DOI 10.1093/ajcn/86.4.995; IOC Nutition Working Group, 2012, NUTR ATHL PRACT GUID; Jonesab Andrew M., 1996, J SPORTS SCI, V14, P321, DOI [10.1080/02640419608727717, DOI 10.1080/02640419608727717]; Koller A, 1998, J SPORT MED PHYS FIT, V38, P10; Lamont LS, 2001, MED SCI SPORT EXER, V33, P237; LEMON PWR, 1980, J APPL PHYSIOL, V48, P624, DOI 10.1152/jappl.1980.48.4.624; MARGARIA R, 1963, J APPL PHYSIOL, V18, P367, DOI 10.1152/jappl.1963.18.2.367; Mariotti F, 2000, AM J CLIN NUTR, V72, P954; MATTHEWS DE, 1980, AM J PHYSIOL, V238, pE473, DOI 10.1152/ajpendo.1980.238.5.E473; Millward DJ, 2012, AM J CLIN NUTR, V95, P1498, DOI 10.3945/ajcn.112.036830; Millward DJ, 2001, P NUTR SOC, V60, P3, DOI 10.1079/PNS200064; Okazaki K, 2009, J APPL PHYSIOL, V107, P770, DOI 10.1152/japplphysiol.91264.2008; PHILLIPS SM, 1993, J APPL PHYSIOL, V75, P2134, DOI 10.1152/jappl.1993.75.5.2134; Pikosky MA, 2006, J NUTR, V136, P379, DOI 10.1093/jn/136.2.379; Pillai RR, 2015, J NUTR, V145, P954, DOI 10.3945/jn.114.208439; Porszasz J, 2003, MED SCI SPORT EXER, V35, P1596, DOI 10.1249/01.MSS.0000084593.56786.DA; Rafii M, 2008, AM J PHYSIOL-ENDOC M, V294, pE475, DOI 10.1152/ajpendo.00604.2007; Rafii M, 2015, J NUTR, V145, P18, DOI 10.3945/jn.114.197517; Rowlands DS, 2011, MED SCI SPORT EXER, V43, P44, DOI 10.1249/MSS.0b013e3181e93316; Seiler S., 2009, SPORTSCIENCE, V13, P32; Sheffield-Moore M, 2004, AM J PHYSIOL-ENDOC M, V287, pE513, DOI 10.1152/ajpendo.00334.2003; Shiman R, 1998, J BIOL CHEM, V273, P34760, DOI 10.1074/jbc.273.52.34760; Stellingwerff T, 2012, INT J SPORT NUTR EXE, V22, P392, DOI 10.1123/ijsnem.22.5.392; Stephens TV, 2015, J NUTR, V145, P73, DOI 10.3945/jn.114.198622; Tang MH, 2014, AM J CLIN NUTR, V100, P1212, DOI 10.3945/ajcn.114.090324; Tang MH, 2014, AM J CLIN NUTR, V99, P891, DOI 10.3945/ajcn.112.042325; Tarnopolsky M, 2004, NUTRITION, V20, P662, DOI 10.1016/j.nut.2004.04.008; Thorpe JM, 1999, J NUTR, V129, P343, DOI 10.1093/jn/129.2.343; van Loon LJC, 2001, J PHYSIOL-LONDON, V536, P295, DOI 10.1111/j.1469-7793.2001.00295.x; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; WHO, 2007, WHO TECH REP SER, V935, P1; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916; ZELLO GA, 1990, AM J PHYSIOL, V259, pE835, DOI 10.1152/ajpendo.1990.259.6.E835; ZELLO GA, 1990, NUTR RES, V10, P1353, DOI 10.1016/S0271-5317(05)80128-9; ZELLO GA, 1995, J NUTR, V125, P2907	59	70	72	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157406	10.1371/journal.pone.0157406	http://dx.doi.org/10.1371/journal.pone.0157406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322029	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212000014
J	Muckenhuber, J; Pollak, L; Stein, KV; Dorner, TE				Muckenhuber, Johanna; Pollak, Lorenz; Stein, Katharina Viktoria; Dorner, Thomas Ernst			Individual Cognitive Social Capital and Its Relationship with Pain and Sick Leave Due to Pain in the Austrian Population	PLOS ONE			English	Article							MUSCULOSKELETAL PAIN; PREVALENCE; HEALTH; LIFE; DEPRESSION	Background Individual cognitive social capital has repeatedly been shown to be linked to health disparities in many dimensions. The aim of the study was to investigate the association between social capital and pain-related measures. Methods 15,474 subjects older than 15 years were personally interviewed on subjective health, quality of life, health behaviour, and utilisation of healthcare in the Austrian Health Interview Survey. An indicator for cognitive social capital at the individual level consisting of nine questions targeted at different social resources was built and its association with pain-related items analysed. Results Odds ratios, adjusted for age, chronic diseases, and educational level for having suffered from severe pain in the last 12 months were 2.02 (95% CI 1.77-2.03) in the lowest tertile and 1.30 (95% CI 1.14-1.47) in the middle tertile of social capital for men. The corresponding odds ratios for women were 2.28 (95% CI 2.01-2.59) and 1.30 (95% CI 1.15-1.46). In both sexes, pain intensity increased significantly with decreasing level of social capital. The proportion of subjects that have been on sick leave in the last 12 months due to pain were 16.3%, 12.0%, and 7.7% (P<0.001) from lowest to highest tertile of social capital in men, and 16.5%, 12.3%, and 6.7%, respectively (P<0.001) in women. Conclusion Our findings indicate that low cognitive social capital at individual level is significantly associated not only with higher prevalence of pain and higher pain intensity, but also with a higher chance for sick leave due to pain in employed subjects.	[Muckenhuber, Johanna] Graz Univ, Dept Sociol, Graz, Austria; [Pollak, Lorenz; Stein, Katharina Viktoria; Dorner, Thomas Ernst] Med Univ Vienna, Inst Social Med, Ctr Publ Hlth, Vienna, Austria	University of Graz; Medical University of Vienna	Muckenhuber, J (corresponding author), Graz Univ, Dept Sociol, Graz, Austria.	johanna.muckenhuber@uni-graz.at		Dorner, Thomas Ernst/0000-0002-5218-1160				Allebeck P, 2013, EUR J PUBLIC HEALTH, V23, P1, DOI 10.1093/eurpub/cks180; [Anonymous], 1984, DISTINCTION SOCIAL C; Aslund C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-715; Bergmann S, 2004, PAIN, V108, P115, DOI 10.1016/j.pain.2003.12.013; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Carpiano RM, 2008, SOCIAL CAPITAL HLTH, P83; Carroll LJ, 2004, PAIN, V107, P134, DOI 10.1016/j.pain.2003.10.009; Cohen S, 2000, SOCIAL SUPPORT MEASU; Coulter A, 2012, J AMBUL CARE MANAG, V35, P80, DOI 10.1097/JAC.0b013e318249e0fd; CROOK J, 1989, PAIN, V36, P49, DOI 10.1016/0304-3959(89)90111-5; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Dorner T, 2010, EUR J PAIN; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Friessem CH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-299; Gatchel R., 2002, PSYCHOL APPROACHES P; Hamano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013214; Harpham T., 2008, SOCIAL CAPITAL HLTH; Hasselstrom J, 2002, EUR J PAIN, V6, P375, DOI 10.1016/S1090-3801(02)00025-3; Holtzman S, 2004, J HEALTH PSYCHOL, V9, P677, DOI 10.1177/1359105304045381; Hoogendoorn WE, 2000, SPINE, V25, P2114, DOI 10.1097/00007632-200008150-00017; Islam M Kamrul, 2006, Int J Equity Health, V5, P3, DOI 10.1186/1475-9276-5-3; Kawachi I., 2008, SOCIAL CAPITAL HLTH, P1, DOI DOI 10.1007/978-0-387-71311-3_1; Kikuchi S, 2008, EUR SPINE J, V17, pS421, DOI 10.1007/s00586-008-0747-1; Kim D, 2006, J EPIDEMIOL COMMUN H, V60, P116, DOI 10.1136/jech.2005.038281; Kim D, 2007, SOCIAL CAPITAL HLTH; Klimont J., 2007, OSTERREICHISCHE GESU; Loury G, 1992, HARV J AFR AM PUBLIC; Macfarlane GJ, 2009, ANN RHEUM DIS, V68, P1591, DOI 10.1136/ard.2008.093088; Muckenhuber J, 2013, AGEING SOC, V33, P853, DOI 10.1017/S0144686X12000219; Pieber K, 2012, J REHABIL MED, V44, P658, DOI 10.2340/16501977-1010; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Saastamoinen P, 2005, PAIN, V114, P364, DOI 10.1016/j.pain.2004.12.033; Stein KV, 2010, SCHMERZ, V24, P468, DOI 10.1007/s00482-010-0962-7; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Thomten J, 2011, ARCH WOMEN MENT HLTH, V14, P493, DOI 10.1007/s00737-011-0244-0; Verhaeghe PP, 2015, SOC NETWORKS, V40, P174, DOI 10.1016/j.socnet.2014.10.001; World Health Organization (WHO), 1998, WHOQOL US MAN; Wright M, 2015, POLIT STUD-LONDON, V63, P642, DOI 10.1111/1467-9248.12113; Ziersch AM, 2005, SOC SCI MED, V60, P71, DOI 10.1016/j.socscimed.2004.04.027	39	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157909	10.1371/journal.pone.0157909	http://dx.doi.org/10.1371/journal.pone.0157909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP0WR	27322649	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212000052
J	Camara, DCP; Codeo, CT; Juliano, SA; Lounibos, LP; Riback, TIS; Pereira, GR; Honorio, NA				Portela Camara, Daniel Cardoso; Codeo, Claudia Torres; Juliano, Steven A.; Lounibos, L. Philip; Souza Riback, Thais Irene; Pereira, Glaucio Rocha; Honorio, Nildimar Alves			Seasonal Differences in Density But Similar Competitive Impact of Aedes albopictus (Skuse) on Aedes aegypti (L.) in Rio de Janeiro, Brazil	PLOS ONE			English	Article							LARVAL COMPETITION; CONTAINER MOSQUITOS; INTERSPECIFIC COMPETITION; DENGUE VECTORS; SOUTH FLORIDA; URBAN FOREST; DIPTERA; CULICIDAE; COEXISTENCE; POPULATIONS	Previous studies have shown that the negative effects of density of Ae. albopictus on Ae. aegypti exceed those of Ae. aegypti on Ae. albopictus for population growth, adult size, survivorship, and developmental rate. This competitive superiority has been invoked to explain the displacement of Ae. aegypti by Ae. albopictus in the southeastern USA. In Brazil, these species coexist in many vegetated suburban and rural areas. We investigated a related, but less-well-studied question: do effects of Ae. albopictus on Ae. aegypti larval development and survival occur under field conditions at realistic densities across multiple seasons in Brazil? We conducted additive competition experiments in a vegetated area of Rio de Janeiro where these species coexist. We tested the hypothesis that Ae. aegypti (the focal species, at a fixed density) suffers negative effects on development and survivorship across a gradient of increasing densities of Ae. albopictus (the associate species) in three seasons. The results showed statistically significant effects of both season and larval density on Ae. aegypti survivorship, and significant effects of season on development rate, with no significant season-density interactions. Densities of Aedes larvae in these habitats differed among seasons by a factor of up to 7x. Overall, Spring was the most favorable season for Ae. aegypti survivorship and development. Results showed that under natural conditions the negative competitive effects of Ae. albopictus on Ae. aegypti were expressed primarily as lower survivorship. Coexistence between Ae. aegypti and Ae. albopictus in vegetated areas is likely affected by seasonal environmental differences, such as detrital resource levels or egg desiccation, which can influence competition between these species. Interactions between these Aedes are important in Brazil, where both species are well established and widely distributed and vector dengue, Zika and chikungunya viruses.	[Portela Camara, Daniel Cardoso; Honorio, Nildimar Alves] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Transmissores Hematozoarios LATHEMA, Rio De Janeiro, Brazil; [Portela Camara, Daniel Cardoso; Pereira, Glaucio Rocha; Honorio, Nildimar Alves] Fundacao Oswaldo Cruz, DIRAC IOC VPAAPS, Nucleo Operac Sentinela Mosquitos Vetores NOSMOVE, Rio De Janeiro, Brazil; [Codeo, Claudia Torres; Souza Riback, Thais Irene] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil; [Juliano, Steven A.] Illinois State Univ, Sch Biol Sci, Behav Ecol Evolut & Systemat Sect, Normal, IL 61761 USA; [Lounibos, L. Philip] Univ Florida, Florida Med Entomol Lab, Vero Beach, FL USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Illinois State University; State University System of Florida; University of Florida	Camara, DCP (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Transmissores Hematozoarios LATHEMA, Rio De Janeiro, Brazil.; Camara, DCP (corresponding author), Fundacao Oswaldo Cruz, DIRAC IOC VPAAPS, Nucleo Operac Sentinela Mosquitos Vetores NOSMOVE, Rio De Janeiro, Brazil.	dcpcamara.ioc@gmail.com	Câmara, Daniel C. P./S-3504-2018	Câmara, Daniel C. P./0000-0002-5439-4477; Juliano, Steven/0000-0002-6178-4553	US National Institutes of Health Fogarty International Center FIRCA grant [R03TW007446-01A1]; INCT-EM/CNPq - PAPES V grant, Rede Dengue FIOCRUZ [407744/2012-6]; Instituto Oswaldo Cruz, Brazil; FOGARTY INTERNATIONAL CENTER [R03TW007446] Funding Source: NIH RePORTER	US National Institutes of Health Fogarty International Center FIRCA grant; INCT-EM/CNPq - PAPES V grant, Rede Dengue FIOCRUZ; Instituto Oswaldo Cruz, Brazil; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was funded by US National Institutes of Health Fogarty International Center FIRCA grant R03TW007446-01A1 - received by LPL and SAJ, by INCT-EM/CNPq - PAPES V grant 407744/2012-6, Rede Dengue FIOCRUZ and funds from Instituto Oswaldo Cruz, Brazil, received by NAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar Ducineia Barros, 2008, Acta Amaz., V38, P357, DOI 10.1590/S0044-59672008000200021; Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497; Alto BW, 2005, ECOLOGY, V86, P3279, DOI 10.1890/05-0209; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], MEM I O CRUZ; Bargielowski IE, 2015, INFECT GENET EVOL, V36, P456, DOI 10.1016/j.meegid.2015.08.016; Bargielowski IE, 2013, P NATL ACAD SCI USA, V110, P2888, DOI 10.1073/pnas.1219599110; Barrera R, 1996, ECOL ENTOMOL, V21, P117, DOI 10.1111/j.1365-2311.1996.tb01178.x; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2; Bloch EM, 2016, EMERG INFEC IN PRESS; Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304; Chave J, 2010, BIOGEOSCIENCES, V7, P43, DOI 10.5194/bg-7-43-2010; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Christophers, 1960, AEDES AEGYPTI L YELL; Costanzo KS, 2005, ECOLOGY, V86, P3289, DOI 10.1890/05-0583; Daugherty MP, 2000, J MED ENTOMOL, V37, P364, DOI 10.1603/0022-2585(2000)037[0364:ICAARF]2.0.CO;2; Lima-Camara Tamara Nunes de, 2006, Cad. Saúde Pública, V22, P2079, DOI 10.1590/S0102-311X2006001000013; Fernald E. A., 1985, WATER RESOURCES ATLA; Fox J., 2019, R COMPANION APPL REG, V.; GILOTRA SK, 1967, B WORLD HEALTH ORGAN, V37, P437; Goldberg D.E., 2001, DESIGN ANAL EXPT, P77; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Honorio NA, 2006, MEM I OSWALDO CRUZ, V101, P225, DOI 10.1590/S0074-02762006000200017; Honorio NA, 2001, REV SAUDE PUBL, V35, P385, DOI 10.1590/S0034-89102001000400009; Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003; HORNBY JA, 1994, J AM MOSQUITO CONTR, V10, P397; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811; Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4; Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2; Juliano SA, 2010, ISR J ECOL EVOL, V56, P325, DOI 10.1560/IJEE.55.3-4.325; Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611; Lima-Camara TN, 2013, MEM I OSWALDO CRUZ, V108, P18, DOI 10.1590/0074-0276130381; Lounibos LP, 2010, ANN ENTOMOL SOC AM, V103, P757, DOI 10.1603/AN09142; Lounibos LP, 2002, J VECTOR ECOL, V27, P86; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Lourenco-de-Oliveira R, 2004, J VECTOR ECOL, V29, P94; Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056; Maciel-De-Freitas R, 2006, J MED ENTOMOL, V43, P1112, DOI 10.1603/0022-2585(2006)43[1112:MODVBT]2.0.CO;2; Pancetti FGM, 2015, REV SOC BRAS MED TRO, V48, P87, DOI 10.1590/0037-8682-0155-2014; Moore CG, 1999, J AM MOSQUITO CONTR, V15, P221; MORAES RM, 1999, REV BRAS BOT, V22, P9, DOI DOI 10.1590/S0100-84041999000100002; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; MORELLATO LPC, 1992, J TROP ECOL, V8, P205, DOI 10.1017/S0266467400006362; Murrell EG, 2008, J MED ENTOMOL, V45, P375, DOI 10.1603/0022-2585(2008)45[375:DTATOO]2.0.CO;2; Murrell EG, 2011, ANN ENTOMOL SOC AM, V104, P688, DOI 10.1603/AN10158; Nazni WA, 2009, SE ASIAN J TROP MED, V40, P40; O'Neal PA, 2013, J ANIM ECOL, V82, P256, DOI 10.1111/j.1365-2656.2012.02017.x; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x; Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009; RSTudio Team, 2012, RSTUDIO RELEASES SHI; SOTA T, 1992, ENTOMOL EXP APPL, V63, P155, DOI 10.1007/BF00343575; TABACHNICK W J, 1991, American Entomologist, V37, P14; Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727; Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520; Tripet F, 2011, AM J TROP MED HYG, V85, P265, DOI 10.4269/ajtmh.2011.10-0677; Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14; Williamson M., 1996, BIOL INVASIONS	62	30	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157120	10.1371/journal.pone.0157120	http://dx.doi.org/10.1371/journal.pone.0157120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322537	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212000009
J	Qi, ZT; Xu, W; Meng, FC; Zhang, QH; Chen, CL; Shao, R				Qi, Zhitao; Xu, Wei; Meng, Fancui; Zhang, Qihuan; Chen, Chenglung; Shao, Rong			Cloning and Expression of beta-Defensin from Soiny Mullet (Liza haematocheila), with Insights of its Antibacterial Mechanism	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; LIPID-BILAYERS; FORCE-FIELD; MEMBRANE; PEPTIDES; VALIDATION; DNA	Beta-defensins are important part of innate immunity of fish, which are the first defense line against invading pathogens. In this study, the beta-defensin (Lh beta-defensin) gene was cloned from spleen tissue of soiny mullet (Liza haematocheila). Lh beta-defensin cDNA was 747 bp in length, encoding 63 amino acids. Sequence alignment revealed that Lh beta-defensin contained six conserved cysteine residues and shared 97.5% sequence identities with grouper (Epinephelus coioides) beta-defensin. Realtime PCR revealed that Lh beta-defensin was highest expressed in the immune related organs, such as spleen, kidney and gut of healthy fish. Following Streptococcus dysgalactiae infection, Lh beta-defensin was up-regulated in immune related organs, e.g. 17.6-fold in spleen and 10.87-fold in gut at 24 h post infection (hpi). Lh beta-defensin possessed a monomeric structure of a three-stranded anti-parallel beta-sheet and an a-helix stabilized by three disulfide bonds formed by Cys30-Cys58, Cys36-Cys52, and Cys40-Cys59. In addition to the experimental work, computer simulation was also carried out to determine the possible conformation of beta-defensin and its interaction with palmitoylo-leoylphosphatidylglycerol (POPG), a model of bacteria membrane. The Lh beta-defensin was found to form dimeric structure stabilized by the van der Waals contacts of Leu35 and Cys37 in two anti-parallel beta 1-strands and the cation-p interaction between Tyr32 and Arg54 respectively in the two beta 1-strands. The most important interactions between beta-defensin and membrane are the electrostatic interactions between Arg residues in beta-defensin and head group of POPG bilayer as well as hydrogen bond interactions between them. Our results were useful for further understanding the potential mechanism of antimicrobial property of fish beta-defensins.	[Qi, Zhitao; Xu, Wei; Zhang, Qihuan; Shao, Rong] Yancheng Inst Technol, Key Lab Biochem & Biotechnol Marine Wetland Jiang, Yancheng 224051, Jiangsu, Peoples R China; [Qi, Zhitao] Yancheng Inst Technol, Key Lab Aquaculture & Ecol Coastal Pool Jiangsu P, Yancheng 224051, Jiangsu, Peoples R China; [Meng, Fancui] Tianjin Inst Pharmaceut Res, Tianjin 300193, Peoples R China; [Chen, Chenglung] Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung 80424, Taiwan	Yancheng Institute of Technology; Yancheng Institute of Technology; National Sun Yat Sen University	Shao, R (corresponding author), Yancheng Inst Technol, Key Lab Biochem & Biotechnol Marine Wetland Jiang, Yancheng 224051, Jiangsu, Peoples R China.; Chen, CL (corresponding author), Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung 80424, Taiwan.	chen1@mail.nsysu.edu.tw; sr@163.com	xu, wei/AAF-3827-2022; xu, wei/AFI-5965-2022		Major Projects of Natural Science Research in Universities and Colleges in Jiangsu Province [15KJA240001]; National Natural Science Foundation of China [31302221, 31272666]; Jiangsu Province [BK2011418, BK20151297]; "Qinglan" project of Jiangsu province	Major Projects of Natural Science Research in Universities and Colleges in Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province; "Qinglan" project of Jiangsu province	This work was supported by the Major Projects of Natural Science Research in Universities and Colleges in Jiangsu Province (Grant no. 15KJA240001) and partially by the National Natural Science Foundation of China (Grant no. 31302221 and 31272666) and Jiangsu Province (Grant no. BK2011418 and BK20151297). ZQ was financially supported by the "Qinglan" project of Jiangsu province.	[Anonymous], 2009, PRIM VERS 2 1; Casadei E, 2009, MOL IMMUNOL, V46, P3358, DOI 10.1016/j.molimm.2009.07.018; Chaturvedi P, 2015, PROBIOTICS ANTIMICRO, V7, P207, DOI 10.1007/s12602-015-9197-3; Cuesta A, 2011, MOL IMMUNOL, V48, P1432, DOI 10.1016/j.molimm.2011.03.022; Domanski J, 2010, J MEMBRANE BIOL, V236, P255, DOI 10.1007/s00232-010-9296-8; Dong JJ, 2015, GENE, V566, P23, DOI 10.1016/j.gene.2015.04.025; FUJII G, 1993, PROTEIN SCI, V2, P1301, DOI 10.1002/pro.5560020813; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia-Valtanen P, 2014, ANTIVIR RES, V101, P136, DOI 10.1016/j.antiviral.2013.11.009; Guo ML, 2012, FISH SHELLFISH IMMUN, V32, P828, DOI 10.1016/j.fsi.2012.02.005; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jambeck JPM, 2012, J CHEM THEORY COMPUT, V8, P2938, DOI 10.1021/ct300342n; Jambeck JPM, 2012, J PHYS CHEM B, V116, P3164, DOI 10.1021/jp212503e; Katzenback Barbara A., 2015, Biology-Basel, V4, P607, DOI 10.3390/biology4040607; Kluver E, 2006, J PEPT SCI, V12, P243, DOI 10.1002/psc.749; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Li JG, 2013, BBA-BIOMEMBRANES, V1828, P1112, DOI 10.1016/j.bbamem.2012.12.015; Liang T, 2013, COMP BIOCHEM PHYS B, V166, P91, DOI 10.1016/j.cbpb.2013.07.006; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Nam BH, 2010, FISH SHELLFISH IMMUN, V28, P267, DOI 10.1016/j.fsi.2009.11.004; Ngo AT, 2014, BBA-BIOMEMBRANES, V1838, P2861, DOI 10.1016/j.bbamem.2014.07.020; Penberthy WT, 2011, CELL MOL LIFE SCI, V68, P2231, DOI 10.1007/s00018-011-0715-5; Qi ZT, 2016, FISH SHELLFISH IMMUN, V49, P194, DOI 10.1016/j.fsi.2015.12.029; Qi ZT, 2015, MOL IMMUNOL, V63, P245, DOI 10.1016/j.molimm.2014.07.006; Rivas L, 2010, J APPL BIOMED, V8, P159, DOI 10.2478/v10136-009-0019-3; Sawai MV, 2001, BIOCHEMISTRY-US, V40, P3810, DOI 10.1021/bi002519d; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Slutsky MM, 2004, PROTEIN SCI, V13, P2244, DOI 10.1110/ps.04702104; Sudheendra US, 2015, EUR J MED CHEM, V91, P91, DOI 10.1016/j.ejmech.2014.08.021; Tu JB, 2015, EVOL BIOINFORM, V11, DOI 10.4137/EBO.S25580; Wang GL, 2012, FISH SHELLFISH IMMUN, V33, P522, DOI 10.1016/j.fsi.2012.06.003; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Zhao W, 2008, BIOCHIMIE, V90, P930, DOI 10.1016/j.biochi.2008.02.025; Zhao W, 2007, BIOPHYS J, V92, P1114, DOI 10.1529/biophysj.106.086272; Zhu SY, 2013, DEV COMP IMMUNOL, V39, P79, DOI 10.1016/j.dci.2012.02.011; Zou J, 2007, MOL IMMUNOL, V44, P638, DOI 10.1016/j.molimm.2006.01.012	40	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157544	10.1371/journal.pone.0157544	http://dx.doi.org/10.1371/journal.pone.0157544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322675	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212000023
J	Ramu, VS; Paramanantham, A; Ramegowda, V; Mohan-Raju, B; Udayakumar, M; Senthil-Kumar, M				Ramu, Vemanna S.; Paramanantham, Anjugam; Ramegowda, Venkategowda; Mohan-Raju, Basavaiah; Udayakumar, Makarla; Senthil-Kumar, Muthappa			Transcriptome Analysis of Sunflower Genotypes with Contrasting Oxidative Stress Tolerance Reveals Individual- and Combined-Biotic and Abiotic Stress Tolerance Mechanisms	PLOS ONE			English	Article							RICE ORYZA-SATIVA; GENE-EXPRESSION; HEAT-SHOCK; HIGH LIGHT; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; TRANSGENIC TOBACCO; RESPONSES; DROUGHT; IDENTIFICATION	In nature plants are often simultaneously challenged by different biotic and abiotic stresses. Although the mechanisms underlying plant responses against single stress have been studied considerably, plant tolerance mechanisms under combined stress is not understood. Also, the mechanism used to combat independently and sequentially occurring many number of biotic and abiotic stresses has also not systematically studied. From this context, in this study, we attempted to explore the shared response of sunflower plants to many independent stresses by using meta-analysis of publically available transcriptome data and transcript profiling by quantitative PCR. Further, we have also analyzed the possible role of the genes so identified in contributing to combined stress tolerance. Meta-analysis of transcriptomic data from many abiotic and biotic stresses indicated the common representation of oxidative stress responsive genes. Further, menadione-mediated oxidative stress in sunflower seedlings showed similar pattern of changes in the oxidative stress related genes. Based on this a large scale screening of 55 sunflower genotypes was performed under menadione stress and those contrasting in oxidative stress tolerance were identified. Further to confirm the role of genes identified in individual and combined stress tolerance the contrasting genotypes were individually and simultaneously challenged with few abiotic and biotic stresses. The tolerant hybrid showed reduced levels of stress damage both under combined stress and few independent stresses. Transcript profiling of the genes identified from meta-analysis in the tolerant hybrid also indicated that the selected genes were up-regulated under individual and combined stresses. Our results indicate that menadione-based screening can identify genotypes not only tolerant to multiple number of individual biotic and abiotic stresses, but also the combined stresses.	[Paramanantham, Anjugam; Senthil-Kumar, Muthappa] Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India; [Ramu, Vemanna S.; Ramegowda, Venkategowda; Mohan-Raju, Basavaiah; Udayakumar, Makarla] Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India; [Ramu, Vemanna S.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK USA; [Ramegowda, Venkategowda] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); University of Agricultural Sciences Bangalore; Noble Research Institute; University of Arkansas System; University of Arkansas Fayetteville	Senthil-Kumar, M (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	skmuthappa@nipgr.ac.in	Mohan Raju, Basavaiah/HDN-8937-2022; Senthil-Kumar, Muthappa/AAF-6389-2020	Mohan Raju, Basavaiah/0000-0002-7566-7286; Vemanna, Ramu/0000-0002-9729-8768	National Institute of Plant Genome Research (NIPGR); DBT-Ramalingaswami re-entry fellowship grant [BT/RLF/re-entry/23/2012]; Indian Council of Agricultural Research niche area of excellence program [10-(6)/2005 EPD, 10 (15) 2012 EPD]	National Institute of Plant Genome Research (NIPGR)(Department of Biotechnology (DBT) India); DBT-Ramalingaswami re-entry fellowship grant; Indian Council of Agricultural Research niche area of excellence program	Combined stress tolerance projects at MSK lab are supported by National Institute of Plant Genome Research (NIPGR) core funding and DBT-Ramalingaswami re-entry fellowship grant (BT/RLF/re-entry/23/2012). MUK lab is supported by Indian Council of Agricultural Research niche area of excellence program (F. No. 10-(6)/2005 EPD & F. No. 10 (15) 2012 EPD). VSR is currently Fulbright-Nehru postdoctoral fellow under United States-India Educational Foundation (USIEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Albuquerque MCD, 2003, SEED SCI TECHNOL, V31, P465, DOI 10.15258/sst.2003.31.2.23; Alignan M, 2006, NEW PHYTOL, V170, P523, DOI 10.1111/j.1469-8137.2006.01696.x; Atkinson NJ, 2013, PLANT PHYSIOL, V162, P2028, DOI 10.1104/pp.113.222372; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Babitha KC, 2013, TRANSGENIC RES, V22, P327, DOI 10.1007/s11248-012-9645-8; Balazadeh S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00234; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Borges AV, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017143; Breuer C, 2012, EMBO J, V31, P4488, DOI 10.1038/emboj.2012.294; Carrera J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r96; Chamnongpol S, 1996, PLANT J, V10, P491, DOI 10.1046/j.1365-313X.1996.10030491.x; Chang LC, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-368; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; DATTA K, 1989, PLANT CELL, V1, P945, DOI 10.1105/tpc.1.9.945; Dehkhoda A., 2013, INT J FARM ALLI SCI, V2, P1319; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Fernandez P, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-11; Fernandez-Ocana A, 2011, J PLANT PHYSIOL, V168, P1303, DOI 10.1016/j.jplph.2011.01.020; Fisher RA, 1960, THE DESIGN OF EXPERI; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Garg N, 2009, PLANT BIOSYST, V143, P81, DOI 10.1080/11263500802633626; Gascuel Q, 2015, MOL PLANT PATHOL, V16, P109, DOI 10.1111/mpp.12164; Gay C, 1999, ANAL BIOCHEM, V273, P149, DOI 10.1006/abio.1999.4208; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hema R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099110; Hewezi T, 2008, ANN BOT-LONDON, V102, P127, DOI 10.1093/aob/mcn071; Hewezi T, 2006, J EXP BOT, V57, P3109, DOI 10.1093/jxb/erl080; Hey SJ, 2010, ANN BOT-LONDON, V105, P197, DOI 10.1093/aob/mcp285; Jajic Ivan, 2015, Plants-Basel, V4, P393, DOI 10.3390/plants4030393; Jayaprakash TL, 1998, ANN BOT-LONDON, V82, P513, DOI 10.1006/anbo.1998.0712; Jocic S., 2010, Helia, V33, P173, DOI 10.2298/HEL1053173J; KENDALL AC, 1983, PLANTA, V159, P505, DOI 10.1007/BF00409139; Kim SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063290; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; Koussevitzky S, 2008, J BIOL CHEM, V283, P34197, DOI 10.1074/jbc.M806337200; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kumar B. R. P., 2000, Helia, V23, P1; Kumar D, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0122690, 10.1371/jo]; Kumar G, 1999, THEOR APPL GENET, V99, P359, DOI 10.1007/s001220051245; Lai Z, 2005, THEOR APPL GENET, V111, P1532, DOI 10.1007/s00122-005-0082-4; Landoni M, 2013, J EXP BOT, V64, P4313, DOI 10.1093/jxb/ert237; Li J, 2013, MICRO NANO LETT, V8, P8, DOI 10.1049/mnl.2012.0578; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Linder P, 2009, TRENDS PLANT SCI, V14, P344, DOI 10.1016/j.tplants.2009.03.007; Liu HT, 2003, PLANT PHYSIOL, V132, P1186, DOI 10.1104/pp.102.018564; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.010497; Lyngdoh IE, 2004, JOURNAL OF PLANT BIO, V31, P21; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Madgwick JW, 2011, EUR J PLANT PATHOL, V130, P117, DOI 10.1007/s10658-010-9739-1; Mentzen WI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-99; Cecchini NM, 2011, PLANT PHYSIOL, V155, P1947, DOI 10.1104/pp.110.167163; Mittler R, 2012, TRENDS BIOCHEM SCI, V37, P118, DOI 10.1016/j.tibs.2011.11.007; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Narsai R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-93; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Oracz K, 2009, PLANT PHYSIOL, V150, P494, DOI 10.1104/pp.109.138107; Pastori GM, 2002, PLANT PHYSIOL, V129, P460, DOI 10.1104/pp.011021; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; PRASAD TK, 1994, PLANT PHYSIOL, V105, P619, DOI 10.1104/pp.105.2.619; Prasch CM, 2013, PLANT PHYSIOL, V162, P1849, DOI 10.1104/pp.113.221044; Ramegowda V, 2015, J PLANT PHYSIOL, V176, P47, DOI 10.1016/j.jplph.2014.11.008; Ramegowda V, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-193; Ramegowda V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040397; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Reichheld JP, 1999, PLANT J, V17, P647, DOI 10.1046/j.1365-313X.1999.00413.x; Rengel D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045249; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Roche J, 2007, PLANTA, V226, P601, DOI 10.1007/s00425-007-0508-0; Rowe HC, 2008, GENETICS, V180, P2237, DOI 10.1534/genetics.108.091439; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Senthil-Kumar M, 2003, J EXP BOT, V54, P2569, DOI 10.1093/jxb/erg278; Senthil-Kumar M, 2007, J PLANT PHYSIOL, V164, P111, DOI 10.1016/j.jplph.2006.09.009; Shaik R, 2014, PLANT PHYSIOL, V164, P481, DOI 10.1104/pp.113.225862; Shaik R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077261; Sharma R, 2013, MOL PLANT, V6, P250, DOI 10.1093/mp/sss147; Singh DP, 2004, MOL PLANT PATHOL, V5, P57, DOI 10.1111/j.1364-3703.2004.00203.x; Srikanthbabu V, 2002, J PLANT PHYSIOL, V159, P535, DOI 10.1078/0176-1617-00650; Suzuki N, 2014, NEW PHYTOL, V203, P32, DOI 10.1111/nph.12797; Takahashi H, 1997, PLANT J, V11, P993, DOI 10.1046/j.1365-313X.1997.11050993.x; TURNER JG, 1974, PHYTOPATHOLOGY, V64, P885, DOI 10.1094/Phyto-64-885; UMA S, 1995, ANN BOT-LONDON, V76, P43, DOI 10.1006/anbo.1995.1076; Wasternack C, 2002, PROG NUCLEIC ACID RE, V72, P165, DOI 10.1016/S0079-6603(02)72070-9; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Xia JG, 2013, NUCLEIC ACIDS RES, V41, pW63, DOI 10.1093/nar/gkt338; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Yi HC, 2002, PLANT J, V32, P285, DOI 10.1046/j.1365-313X.2002.01425.x	90	43	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157522	10.1371/journal.pone.0157522	http://dx.doi.org/10.1371/journal.pone.0157522			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314499	Green Published, Green Submitted, gold			2022-12-26	WOS:000378030000032
J	Song, SY; Ding, MY; Li, H; Song, XP; Fan, WL; Zhang, XM; Xu, HB				Song, Shuyan; Ding, Mingyue; Li, Hong; Song, Xiaopeng; Fan, Wenliang; Zhang, Xuming; Xu, Haibo			Frequency Specificity of fMRI in Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							HILBERT-HUANG TRANSFORM; FUNCTIONAL CONNECTIVITY; REGIONAL HOMOGENEITY; BRAIN ACTIVITY; PERFUSION CHANGES; DEFAULT MODE; HIPPOCAMPAL; NETWORK; LATERALIZATION; CORTEX	Medial temporal lobe epilepsy (mTLE) is a system-level disease characterized by aberrant neuronal synchronization and widespread alterations in function. Previous studies have focused on the amplitude analysis of the blood oxygenation level-dependent (BOLD) signals to reveal the aberrant alterations in mTLE. However, these methods did not work well in the cases where the amplitudes of two oscillations are correlated but the underlying oscillations are neither phase coherent nor frequency consistent. To address this problem, we investigated the differences of frequency specificity between patients with mTLE and healthy controls using the extreme-point symmetric mode decomposition (ESMD) method. In this method, the BOLD signals were decomposed into a set of intrinsic mode functions (IMFs) and the instantaneous frequency of each IMF was calculated using the direct interpolation strategy. The intrinsic frequency (denoted as Freq) for every voxel was obtained by the weighted sum of the instantaneous frequencies of all the IMFs. The Freq was used as an index to evaluate the altered frequency specificity of 41 patients with mTLE (17 right-side, 24 left-side) and 24 healthy control subjects. The results show that the peak of frequency distribution curve for the patients moves towards the higher frequency than that for the healthy controls. Compared with the healthy control group, the patients with left mTLE demonstrate higher Freq in the default mode network, middle frontal gyrus, insula, middle temporal gyrus and calcarine gyrus; the patients with right mTLE demonstrate higher Freq in the precuneus and occipital lobe. For the three groups, the distinct frequency distribution appears in the left and right hippocampus due to the hippocampal structural and functional asymmetries. The preliminary results imply that the frequency-specific correlated oscillations in the distributed brain regions can provide information about the nature of diseases affecting the brain and the alterations of frequency specificity are associated with the pathological characteristics of mTLE.	[Song, Shuyan; Ding, Mingyue; Zhang, Xuming] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Key Lab Image Proc & Intelligent Control, Sch Life Sci & Technol,Minist Educ, Wuhan 430074, Peoples R China; [Li, Hong] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Radiol, Hangzhou 310003, Zhejiang, Peoples R China; [Song, Xiaopeng] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China; [Fan, Wenliang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan 430074, Peoples R China; [Xu, Haibo] Wuhan Univ, Zhongnan Hosp, Dept Radiol, Wuhan 430072, Peoples R China	Huazhong University of Science & Technology; Zhejiang University; Peking University; Huazhong University of Science & Technology; Wuhan University	Zhang, XM (corresponding author), Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Key Lab Image Proc & Intelligent Control, Sch Life Sci & Technol,Minist Educ, Wuhan 430074, Peoples R China.; Xu, HB (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Radiol, Wuhan 430072, Peoples R China.	zxmboshi@hust.edu.cn; xuhaibo1120@hotmail.com	Zhang, Xuming/AAS-7462-2020	Fan, Wenliang/0000-0001-8949-6775	National Nature Science Foundation of China [81171386, 81372369]; National Key Scientific Instrument and Equipment Development Project [2013YQ160551]; Fundamental Research Funds for the Central Universities [2015TS094]; Science and Technology Program of Wuhan, China [2015060101010027]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Scientific Instrument and Equipment Development Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Science and Technology Program of Wuhan, China	This work was supported by grants from the National Nature Science Foundation of China (81171386(to HX), 81372369(to HX), http://www.nsfc.gov.cn/) and by the National Key Scientific Instrument and Equipment Development Project (Grant No.: 2013YQ160551 (to MD), http://www.most.gov.cn/). This work is also supported by the Fundamental Research Funds for the Central Universities (No.: 2015TS094 (to XZ), http://www.moe.gov.cn/) and Science and Technology Program of Wuhan, China (No.: 2015060101010027 (to XZ), http://www.whst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baria AT, 2013, NEUROIMAGE, V73, P144, DOI 10.1016/j.neuroimage.2013.01.072; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blumenfeld H, 2004, CEREB CORTEX, V14, P892, DOI 10.1093/cercor/bhh048; Bouilleret V, 2002, ANN NEUROL, V51, P202, DOI 10.1002/ana.10087; Deng F, 2013, IEEE T BIO-MED ENG, V60, P42, DOI 10.1109/TBME.2012.2221125; Dinkelacker V, 2015, EPILEPSIA, V56, P1217, DOI 10.1111/epi.13051; He BJ, 2013, J NEUROSCI, V33, P4672, DOI 10.1523/JNEUROSCI.2922-12.2013; Huang NE, 2003, APPL STOCH MODEL BUS, V19, P245, DOI 10.1002/asmb.501; James GA, 2013, J NEUROSURG, V119, P288, DOI 10.3171/2013.3.JNS121041; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Lister JP, 2006, HIPPOCAMPUS, V16, P946, DOI 10.1002/hipo.20221; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; Morgan VL, 2008, HUM BRAIN MAPP, V29, P57, DOI 10.1002/hbm.20362; Morgan VL, 2010, EPILEPSY RES, V88, P168, DOI 10.1016/j.eplepsyres.2009.10.018; Nelissen N, 2006, NEUROIMAGE, V32, P684, DOI 10.1016/j.neuroimage.2006.04.185; Pereira FRS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-66; Pryor KO, 2015, BRIT J ANAESTH, V115, P104, DOI 10.1093/bja/aev038; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Song XP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16376; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Tae WS, 2005, NEUROIMAGE, V24, P101, DOI 10.1016/j.neuroimage.2004.08.005; Tracy JI, 2015, CURR OPIN NEUROL, V28, P158, DOI 10.1097/WCO.0000000000000178; Vannest J, 2008, EPILEPSY BEHAV, V12, P410, DOI 10.1016/j.yebeh.2007.11.012; Wagner K, 2008, EPILEPSY BEHAV, V12, P382, DOI 10.1016/j.yebeh.2007.11.003; Wang JL, 2013, ADV DATA SCI ADAPT, V5, DOI 10.1142/S1793536913500155; Woolard AA, 2012, PSYCHIAT RES-NEUROIM, V201, P48, DOI 10.1016/j.pscychresns.2011.07.016; Wu CWW, 2008, NEUROIMAGE, V42, P1047, DOI 10.1016/j.neuroimage.2008.05.035; Wurina, 2012, NEUROSCI BULL, V28, P449, DOI 10.1007/s12264-012-1255-1; Xie HB, 2006, COMPUT METH PROG BIO, V82, P114, DOI 10.1016/j.cmpb.2006.02.009; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zeng HW, 2013, EPILEPSIA, V54, P658, DOI 10.1111/epi.12066; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040	38	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157342	10.1371/journal.pone.0157342	http://dx.doi.org/10.1371/journal.pone.0157342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314671	gold, Green Published, Green Submitted			2022-12-26	WOS:000378030000021
J	February, EC; Higgins, SI				February, Edmund Carl; Higgins, Steven Ian			Rapid Leaf Deployment Strategies in a Deciduous Savanna	PLOS ONE			English	Article							NUTRIENT RESORPTION; TREE; WATER; PHENOLOGY; EVERGREEN; PATTERNS; GROWTH; DECOMPOSITION; NITROGEN; TRAITS	Deciduous plants avoid the costs of maintaining leaves in the unfavourable season, but carry the costs of constructing new leaves every year. Deciduousness is therefore expected in ecological situations with pronounced seasonality and low costs of leaf construction. In our study system, a seasonally dry tropical savanna, many trees are deciduous, suggesting that leaf construction costs must be low. Previous studies have, however, shown that nitrogen is limiting in this system, suggesting that leaf construction costs are high. Here we examine this conundrum using a time series of soil moisture availability, leaf phenology and nitrogen distribution in the tree canopy to illustrate how trees resorb nitrogen before leaf abscission and use stored reserves of nitrogen and carbon to construct new leaves at the onset of the growing season. Our results show that trees deployed leaves shortly before and in anticipation of the first rains with its associated pulse of nitrogen mineralisation. Our results also show that trees rapidly constructed a full canopy of leaves within two weeks of the first rains. We detected an increase in leaf nitrogen content that corresponded with the first rains and with the movement of nitrogen to more distal branches, suggesting that stored nitrogen reserves are used to construct leaves. Furthermore the stable carbon isotope ratios (delta C-13) of these leaves suggest the use of stored carbon for leaf construction. Our findings suggest that the early deployment of leaves using stored nitrogen and carbon reserves is a strategy that is integrally linked with the onset of the first rains. This strategy may confer a competitive advantage over species that deploy leaves at or after the onset of the rains.	[February, Edmund Carl] Univ Cape Town, Dept Biol Sci, ZA-7701 Rondebosch, South Africa; [Higgins, Steven Ian] Univ Otago, Dept Bot, POB 56, Dunedin 9054, New Zealand; [Higgins, Steven Ian] Senckenberg Gesell Naturforsch, Biodivers & Climate Res Ctr BiK F, Senckenberganlage 25, D-60325 Frankfurt, Germany	University of Cape Town; University of Otago; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN)	February, EC (corresponding author), Univ Cape Town, Dept Biol Sci, ZA-7701 Rondebosch, South Africa.	Edmund.February@uct.ac.za	Higgins, Steven I/A-5138-2012	Higgins, Steven I/0000-0001-5695-9665; February, Edmund/0000-0001-9790-0395	Andrew W Mellon Foundation of New York; South African Nation Research Foundation; Deutsche Forschungsgemeinschaft	Andrew W Mellon Foundation of New York; South African Nation Research Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The Andrew W Mellon Foundation of New York funded both ECF and SIH. The South African Nation Research Foundation funded ECF. The Deutsche Forschungsgemeinschaft funded SIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald S, 2007, J VEG SCI, V18, P583, DOI 10.1111/j.1654-1103.2007.tb02572.x; Badeck FW, 2005, RAPID COMMUN MASS SP, V19, P1381, DOI 10.1002/rcm.1912; BARBER STANLEY A., 1962, SOIL SCI, V93, P39, DOI 10.1097/00010694-196201000-00007; Barton Jr J. H., 1986, KOEDOE, V29, P39, DOI DOI 10.4102/K0ED0E.V29I1.518; BERNHARDREVERSAT F, 1982, OIKOS, V38, P321, DOI 10.2307/3544672; BRUGNOLI E, 1988, PLANT PHYSIOL, V88, P1418, DOI 10.1104/pp.88.4.1418; BUTTROSE M. S., 1966, VTTIS BER REBENFORSCH, V5, P455; CHAPIN FS, 1983, ECOLOGY, V64, P376, DOI 10.2307/1937083; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Chidumayo EN, 2001, J VEG SCI, V12, P347, DOI 10.2307/3236848; Coetsee C, 2012, ENVIRON MANAGE, V49, P387, DOI 10.1007/s00267-011-9779-0; Craine JM, 2008, NEW PHYTOL, V179, P829, DOI 10.1111/j.1469-8137.2008.02513.x; Cramer MD, 2009, OECOLOGIA, V161, P15, DOI 10.1007/s00442-009-1364-3; Damesin C, 1998, FUNCT ECOL, V12, P778, DOI 10.1046/j.1365-2435.1998.00259.x; DAVIES WJ, 1991, ANNU REV PLANT PHYS, V42, P55, DOI 10.1146/annurev.pp.42.060191.000415; Eamus D, 1999, TRENDS ECOL EVOL, V14, P11, DOI 10.1016/S0169-5347(98)01532-8; February EC, 2013, AUSTRAL ECOL, V38, P66, DOI 10.1111/j.1442-9993.2012.02376.x; February EC, 2010, S AFR J BOT, V76, P517, DOI 10.1016/j.sajb.2010.04.001; February EC, 2007, J BIOGEOGR, V34, P270, DOI 10.1111/j.1365-2699.2006.01583.x; Franco AC, 2005, TREES-STRUCT FUNCT, V19, P326, DOI 10.1007/s00468-004-0394-z; Frost PGH, 1986, RESPONSES SAVANNAS S; Givnish TJ, 2002, SILVA FENN, V36, P703, DOI 10.14214/sf.535; Helle G, 2004, PLANT CELL ENVIRON, V27, P367, DOI 10.1111/j.0016-8025.2003.01159.x; Higgins SI, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0572; Higgins SI, 2011, J BIOGEOGR, V38, P2165, DOI 10.1111/j.1365-2699.2011.02549.x; Higgins SI, 2010, ECOLOGY, V91, P1682, DOI 10.1890/08-1368.1; Jarvis P, 2007, TREE PHYSIOL, V27, P929, DOI 10.1093/treephys/27.7.929; Kozovits AR, 2007, FUNCT ECOL, V21, P1034, DOI 10.1111/j.1365-2435.2007.01325.x; Mucina L., 2006, VEGETATION S AFRICA; MURALI KS, 1993, OECOLOGIA, V94, P114, DOI 10.1007/BF00317311; Pallardy SG, 2008, PHYSIOLOGY OF WOODY PLANTS, 3RD EDITION, P233; Plummer M., 2003, P 3 INT WORKSHOP DIS; Ratnam J, 2008, OECOLOGIA, V157, P141, DOI 10.1007/s00442-008-1047-5; Rossatto DR, 2009, FUNCT ECOL, V23, P689, DOI 10.1111/j.1365-2435.2009.01568.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Santa-Regina I, 1997, J VEG SCI, V8, P651, DOI 10.2307/3237369; Scholes R.J., 1993, AFRICAN SAVANNA SYNT; van der Waal C, 2009, J ECOL, V97, P430, DOI 10.1111/j.1365-2745.2009.01498.x; Williams CA, 2009, OECOLOGIA, V161, P469, DOI 10.1007/s00442-009-1405-y; Williams RJ, 1997, ECOLOGY, V78, P2542, DOI 10.1890/0012-9658(1997)078[2542:LPOWSI]2.0.CO;2	40	17	17	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157833	10.1371/journal.pone.0157833	http://dx.doi.org/10.1371/journal.pone.0157833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310398	Green Submitted, gold, Green Published			2022-12-26	WOS:000378029800138
J	Gadd, VL; Patel, PJ; Jose, S; Horsfall, L; Powell, EE; Irvine, KM				Gadd, Victoria L.; Patel, Preya J.; Jose, Sara; Horsfall, Leigh; Powell, Elizabeth E.; Irvine, Katharine M.			Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation	PLOS ONE			English	Article							PREDICT CARDIOVASCULAR EVENTS; C-VIRUS; SINUSOIDAL ENDOTHELIUM; ANTIVIRAL RESPONSE; DUCTULAR REACTION; IN-VIVO; EXPRESSION; CIRRHOSIS; FIBROSIS; CELLS	Background and Aims Liver and systemic inflammatory factors influence monocyte phenotype and function, which has implications for hepatic recruitment and subsequent inflammatory and fibrogenic responses, as well as host defence. Methods Peripheral blood monocyte surface marker (CD14, CD16, CD163, CSF1R, CCR2, CCR4, CCR5, CXCR3, CXCR4, CX3CR1, HLA-DR, CD62L, SIGLEC-1) expression and capacity for phagocytosis, oxidative burst and LPS-stimulated TNF production were assessed in patients with hepatitis C (HCV) (n = 39) or non-alcoholic fatty liver disease (NAFLD) (n = 34) (classified as non-advanced disease, compensated cirrhosis and decompensated cirrhosis) and healthy controls (n = 11) by flow cytometry. Results The selected markers exhibited similar monocyte-subset-specific expression patterns between patients and controls. Monocyte phenotypic signatures differed between NAFLD and HCV patients, with an increased proportion of CD16(+) non-classical monocytes in NAFLD, but increased expression of CXCR3 and CXCR4 in HCV. In both cohorts, monocyte CCR2 expression was reduced and CCR4 elevated over controls. CD62L expression was specifically elevated in patients with decompensated cirrhosis and positively correlated with the model-for-end-stage-liver-disease score. Functionally, monocytes from patients with decompensated cirrhosis had equal phagocytic capacity, but displayed features of dysfunction, characterised by lower HLA-DR expression and blunted oxidative responses. Lower monocyte TNF production in response to LPS stimulation correlated with time to death in 7 (46%) of the decompensated patients who died within 8 months of recruitment. Conclusions Chronic HCV and NAFLD differentially affect circulating monocyte phenotype, suggesting specific injury-induced signals may contribute to hepatic monocyte recruitment and systemic activation state. Monocyte function, however, was similarly impaired in patients with both HCV and NAFLD, particularly in advanced disease, which likely contributes to the increased susceptibility to infection in these patients.	[Gadd, Victoria L.; Patel, Preya J.; Jose, Sara; Horsfall, Leigh; Powell, Elizabeth E.; Irvine, Katharine M.] Univ Queensland, Ctr Liver Dis Res, Sch Med, Translat Res Inst, Brisbane, Qld, Australia; [Patel, Preya J.; Horsfall, Leigh; Powell, Elizabeth E.] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4102, Australia	University of Queensland	Irvine, KM (corresponding author), Univ Queensland, Ctr Liver Dis Res, Sch Med, Translat Res Inst, Brisbane, Qld, Australia.	katharine.irvine@gmail.com	Powell, Elizabeth/B-4455-2011; Irvine, Katharine M/A-5559-2011	Powell, Elizabeth/0000-0001-5008-8061; Irvine, Katharine M/0000-0002-6716-1605; Jose, Sara/0000-0002-3791-9120; Gadd, Victoria/0000-0003-1819-8660	National Health and Medical Research Foundation; Princess Alexandra Hospital Foundation, an Australian Liver Foundation Pauline Hall Fellowship; National Health and Medical Research Foundation Practitioner Fellowship [APP1044650]	National Health and Medical Research Foundation; Princess Alexandra Hospital Foundation, an Australian Liver Foundation Pauline Hall Fellowship; National Health and Medical Research Foundation Practitioner Fellowship	This study was funded by grants from the National Health and Medical Research Foundation (www.nhmrc.gov.au) and the Princess Alexandra Hospital Foundation, an Australian Liver Foundation Pauline Hall Fellowship to KMI (www.liver.org.au/pauline-hall-fellowship) and National Health and Medical Research Foundation Practitioner Fellowship to EEP (APP1044650).	Albillos A, 2004, J HEPATOL, V40, P624, DOI 10.1016/j.jhep.2003.12.010; Aspinall AI, 2010, HEPATOLOGY, V51, P2030, DOI 10.1002/hep.23591; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Bernsmeier C, 2015, GASTROENTEROLOGY, V148, P603, DOI 10.1053/j.gastro.2014.11.045; Berres ML, 2009, LIVER INT, V29, P536, DOI 10.1111/j.1478-3231.2008.01870.x; Berry PA, 2011, INTENS CARE MED, V37, P453, DOI 10.1007/s00134-010-2099-7; Bolen CR, 2013, J INTERF CYTOK RES, V33, P15, DOI 10.1089/jir.2012.0037; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Cannon JG, 2014, PHYSL REPORTS, P2; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Erhardt A, 2011, J IMMUNOL, V186, P5284, DOI 10.4049/jimmunol.1003750; Fahey S, 2014, CELL MOL IMMUNOL, V11, P25, DOI 10.1038/cmi.2013.37; Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937; Gadd VL, 2013, LIVER INT, V33, P569, DOI 10.1111/liv.12050; Hall MW, 2013, CRIT CARE MED, V41, P224, DOI 10.1097/CCM.0b013e318267633c; Karlmark KR, 2010, HEPATOLOGY, V52, P1769, DOI 10.1002/hep.23894; Kim MS, 2006, J CELL BIOCHEM, V97, P512, DOI 10.1002/jcb.20649; Kjaergaard AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092331; Krinninger P, 2014, J CLIN ENDOCR METAB, V99, P2500, DOI 10.1210/jc.2013-2611; Leber B, 2012, SEMIN RESP CRIT CARE, V33, P80, DOI 10.1055/s-0032-1301737; Leentjens J, 2012, AM J RESP CRIT CARE, V186, P838, DOI 10.1164/rccm.201204-0645OC; Liaskou E, 2013, HEPATOLOGY, V57, P385, DOI 10.1002/hep.26016; Martinez Fernando O, 2009, J Biol, V8, P99, DOI 10.1186/jbiol206; Matsubara T, 2013, HEPATOLOGY, V57, P1416, DOI 10.1002/hep.25965; Melino M, 2016, AM J PATHOL; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Moore JK, 2015, CYTOTHERAPY, V17, P1604, DOI 10.1016/j.jcyt.2015.07.016; Munshaw S, 2012, HEPATOLOGY, V56, P544, DOI 10.1002/hep.25655; Nguyen N, 2014, J GASTROEN HEPATOL, V29, P860, DOI 10.1111/jgh.12462; Nieto JC, 2015, J LEUKOCYTE BIOL, V98, P819, DOI 10.1189/jlb.3AB0315-106R; Oo YH, 2012, J HEPATOL, V57, P1044, DOI 10.1016/j.jhep.2012.07.008; Poitou C, 2011, ARTERIOSCL THROM VAS, V31, P2322, DOI 10.1161/ATVBAHA.111.230979; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Rodriguez-Munoz Y, 2011, ALIMENT PHARM THER, V34, P960, DOI 10.1111/j.1365-2036.2011.04807.x; Rogacev KS, 2014, ARTERIOSCL THROM VAS, V34, P2120, DOI 10.1161/ATVBAHA.114.304172; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Saiman Y, 2015, HEPATOL RES, V45, P794, DOI 10.1111/hepr.12411; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Shi Y, 2015, J HEPATOL, V63, P60, DOI 10.1016/j.jhep.2015.02.020; Sipeki N, 2014, WORLD J GASTROENTERO, V20, P2564, DOI 10.3748/wjg.v20.i10.2564; Stansfield BK, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0040-3; Tacke F, 2011, LIVER INT, V31, P842, DOI 10.1111/j.1478-3231.2011.02504.x; Terada R, 2003, LAB INVEST, V83, P665, DOI 10.1097/01.LAB.0000067498.89585.06; Thalheimer U, 2005, GUT, V54, P556, DOI 10.1136/gut.2004.048181; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Wald O, 2004, EUR J IMMUNOL, V34, P1164, DOI 10.1002/eji.200324441; Wang Y, 2016, HORM METAB RES, V48, P54, DOI 10.1055/s-0035-1547233; Wang YF, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-32; Wasmuth HE, 2005, J HEPATOL, V42, P195, DOI 10.1016/j.jhep.2004.10.019; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Xu HP, 2008, BLOOD, V112, P1166, DOI 10.1182/blood-2007-06-098327; Ye H, 2013, WORLD J GASTROENTERO, V19, P2818, DOI 10.3748/wjg.v19.i18.2818; York MR, 2007, ARTHRITIS RHEUM-US, V56, P1010, DOI 10.1002/art.22382; Zhang JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017484; Zimmermann HW, 2016, HEPATOLOGY, V63, P233, DOI 10.1002/hep.28285; Zimmermann HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011049	56	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157771	10.1371/journal.pone.0157771	http://dx.doi.org/10.1371/journal.pone.0157771			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309850	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800134
J	Kelch, NS; Neves, FS; Fernandes, GW; Wirth, R				Kelch, Nina-S.; Neves, Frederico S.; Fernandes, G. Wilson; Wirth, Rainer			Mechanisms Driving Galling Success in a Fragmented Landscape: Synergy of Habitat and Top-Down Factors along Temperate Forest Edges	PLOS ONE			English	Article							FAGUS-SYLVATICA L.; SPECIES RICHNESS; INSECTS; CECIDOMYIIDAE; DIVERSITY; PARADIGM; DIPTERA; FAUNA; FIELD; SIZE	Edge effects play key roles in the anthropogenic transformation of forested ecosystems and their biota, and are therefore a prime field of contemporary fragmentation research. We present the first empirical study to address edge effects on the population level of a widespread galling herbivore in a temperate deciduous forest. By analyzing edge effects on abundance and trophic interactions of beech gall midge (Mikiola fagi Htg.), we found 30% higher gall abundance in the edge habitat as well as lower mortality rates due to decreased top-down control, especially by parasitoids. Two GLM models with similar explanatory power (58%) identified habitat specific traits (such as canopy closure and altitude) and parasitism as the best predictors of gall abundance. Further analyses revealed a crucial influence of light exposure (46%) on top-down control by the parasitoid complex. Guided by a conceptual framework synthesizing the key factors driving gall density, we conclude that forest edge proliferation of M. fagi is due to a complex interplay of abiotic changes and trophic control mechanisms. Most prominently, it is caused by the microclimatic regime in forest edges, acting alone or in synergistic concert with top-down pressure by parasitoids. Contrary to the prevailing notion that specialists are edge-sensitive, this turns M. fagi into a winner species in fragmented temperate beech forests. In view of the increasing proportion of edge habitats and the documented benefits from edge microclimate, we call for investigations exploring the pest status of this galling insect and the modulators of its biological control.	[Kelch, Nina-S.; Wirth, Rainer] Univ Kaiserslautern, Plant Ecol & Systemat, D-67663 Kaiserslautern, Germany; [Neves, Frederico S.; Fernandes, G. Wilson] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Fernandes, G. Wilson] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of Kaiserslautern; Universidade Federal de Minas Gerais; Stanford University	Wirth, R (corresponding author), Univ Kaiserslautern, Plant Ecol & Systemat, D-67663 Kaiserslautern, Germany.	wirth@rhrk.uni-kl.de	Wirth, Rainer/I-1552-2013; Fernandes, Geraldo/AAN-5602-2021; Neves, Frederico/E-5777-2013	Wirth, Rainer/0000-0001-8042-3123; Fernandes, Geraldo/0000-0003-1559-6049; Neves, Frederico/0000-0002-2691-3743				Allan E, 2011, ECOL LETT, V14, P1246, DOI 10.1111/j.1461-0248.2011.01694.x; Altamirano A, 2016, J INSECT CONSERV, V20, P119, DOI 10.1007/s10841-016-9845-2; [Anonymous], 2012, SCIENCE, DOI DOI 10.1126/science.1215904; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Brose K., 1957, KLIMA ATLAS RHEINLAN; Brunet Jorg, 2010, Ecological Bulletins, V53, P77; Colinet H, 2015, ANNU REV ENTOMOL, V60, P123, DOI 10.1146/annurev-ento-010814-021017; COURTNEY SP, 1982, ECOL ENTOMOL, V7, P131, DOI 10.1111/j.1365-2311.1982.tb00651.x; Crawley MJ, 2013, THE R BOOK, P1076; de Almeida WR, 2008, ENTOMOL EXP APPL, V129, P251, DOI 10.1111/j.1570-7458.2008.00774.x; de Araujo WS, 2012, BIODIVERS CONSERV, V21, P2991, DOI 10.1007/s10531-012-0333-z; Dziurzynski A, 1961, ACTA ZOOL CRAC, V15, P9; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Eschrich W, 1989, TREES-STRUCT FUNCT, V3, P1, DOI 10.1007/BF00202394; Espirito-Santo MM, 2007, ANN ENTOMOL SOC AM, V100, P95, DOI 10.1603/0013-8746(2007)100[95:HMSOGI]2.0.CO;2; Evans J, 2001, FORESTS HDB OVERVIEW; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FERNANDES GW, 1988, OECOLOGIA, V76, P161, DOI 10.1007/BF00379948; FERNANDES GW, 1992, OECOLOGIA, V90, P14, DOI 10.1007/BF00317803; Fernandes GW, 2003, TREES-STRUCT FUNCT, V17, P407, DOI 10.1007/s00468-003-0252-4; Geiger M., 2010, GEOGRAPHIE PFALZ; Gripenberg S, 2007, OIKOS, V116, P181, DOI [10.1111/j.2006.0030-1299.15266.x, 10.1111/j.0030-1299.2007.15266.x]; Hagen M, 2012, ADV ECOL RES, V46, P89, DOI 10.1016/B978-0-12-396992-7.00002-2; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Holt Robert D., 1996, P313; Hulme PE, 1996, J ECOL, V84, P609, DOI 10.2307/2261482; JENSEN PB, 1948, PHYSIOL PLANTARUM, V1, P95, DOI 10.1111/j.1399-3054.1948.tb07113.x; Juliao GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114986; Juliao GR, 2004, BIODIVERS CONSERV, V13, P2055, DOI 10.1023/B:BIOC.0000040006.81958.f2; Kampichler C, 2002, EUR J ENTOMOL, V99, P79, DOI 10.14411/eje.2002.014; Kirst GO, 2006, BIOCH PHYS PFL, V165, P445; Kramer K, 2010, FOREST ECOL MANAG, V259, P2213, DOI 10.1016/j.foreco.2009.12.023; Kruess A, 2000, OECOLOGIA, V122, P129, DOI 10.1007/PL00008829; Lampe KH, 1989, NACHR DTSCH GES ALLG, V3, P64; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; Lemmon PE, 1957, FOREST SCI, V2, P319; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Maldonado-Lopez Y, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00355.1; Malinga GM, 2014, OECOLOGIA, V176, P511, DOI 10.1007/s00442-014-3024-5; Martinez JJI, 2005, LANDSCAPE ECOL, V20, P1013, DOI 10.1007/s10980-005-7753-z; Martinson HM, 2014, ECOL LETT, V17, P1178, DOI 10.1111/ele.12305; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; National Committee of World Cultural and Natural Heritage, 1990, NOM FIL BAN CHIANG A; Peuke AD, 2002, NEW PHYTOL, V154, P373, DOI 10.1046/j.1469-8137.2002.00400.x; Price P.W., 1986, Ecological Research, V1, P1, DOI 10.1007/BF02361200; Raman A, 2011, FLORA, V206, P517, DOI 10.1016/j.flora.2010.08.004; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Schreiber HJ, 1998, THESIS; Skuhravy VV, 1996, ANZ SCHADLINGSKD PFL, V69, P56, DOI 10.1007/BF01906276; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Urban J., 2000, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V48, P97; Urban J., 2000, Journal of Forest Science (Prague), V46, P543; Urban J., 2000, Journal of Forest Science (Prague), V46, P114; Valladares G, 2006, CONSERV BIOL, V20, P212, DOI 10.1111/j.1523-1739.2006.00337.x; Valladares G, 2012, OIKOS, V121, P299, DOI 10.1111/j.1600-0706.2011.19671.x; Wimp GM, 2011, ECOL LETT, V14, P863, DOI 10.1111/j.1461-0248.2011.01656.x; Wirth Rainer, 2008, V69, P423, DOI 10.1007/978-3-540-72954-9_17; Yukawa J, 2000, POPUL ECOL, V42, P105, DOI 10.1007/PL00011989	60	7	7	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157448	10.1371/journal.pone.0157448	http://dx.doi.org/10.1371/journal.pone.0157448			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310599	Green Submitted, Green Published, gold			2022-12-26	WOS:000378029800074
J	Kobayashi, T; Sasaki, S; Utsumi, Y; Fujita, N; Umeda, K; Sawada, T; Kubo, A; Abe, J; Colleoni, C; Ball, S; Nakamura, Y				Kobayashi, Taiki; Sasaki, Satoshi; Utsumi, Yoshinori; Fujita, Naoko; Umeda, Kazuhiro; Sawada, Takayuki; Kubo, Akiko; Abe, Jun-ichi; Colleoni, Christophe; Ball, Steven; Nakamura, Yasunori			Comparison of Chain-Length Preferences and Glucan Specificities of Isoamylase-Type alpha-Glucan Debranching Enzymes from Rice, Cyanobacteria, and Bacteria	PLOS ONE			English	Article							STARCH GRANULE INITIATION; AMYLOPECTIN BIOSYNTHESIS; BIOCHEMICAL-CHARACTERIZATION; ARABIDOPSIS LACKING; BRANCHING ENZYMES; SUGARY-1 MUTANTS; HOMO-OLIGOMER; R-ENZYME; GLYCOGEN; PURIFICATION	It has been believed that isoamylase (ISA)-type alpha-glucan debranching enzymes (DBEs) play crucial roles not only in a-glucan degradation but also in the biosynthesis by affecting the structure of glucans, although molecular basis on distinct roles of the individual DBEs has not fully understood. In an attempt to relate the roles of DBEs to their chain-length specificities, we analyzed the chain-length distribution of DBE enzymatic reaction products by using purified DBEs from various sources including rice, cyanobacteria, and bacteria. When DBEs were incubated with phytoglycogen, their chain-length specificities were divided into three groups. First, rice endosperm ISA3 (OsISA3) and Eschericia coli GlgX (EcoGlgX) almost exclusively debranched chains having degree of polymerization (DP) of 3 and 4. Second, OsISA1, Pseudomonas amyloderamosa ISA (PsaISA), and rice pullulanase (OsPUL) could debranch a wide range of chains of DP >= 3. Third, both cyanobacteria ISAs, Cyanothece ATCC 51142 ISA (CytISA) and Synechococcus elongatus PCC7942 ISA (ScoISA), showed the intermediate chain-length preference, because they removed chains of mainly DP3-4 and DP3-6, respectively, while they could also react to chains of DP5-10 and 7-13 to some extent, respectively. In contrast, all these ISAs were reactive to various chains when incubated with amylopectin. In addition to a great variation in chain-length preferences among various ISAs, their activities greatly differed depending on a variety of glucans. Most strikingly, cyannobacteria ISAs could attack branch points of pullulan to a lesser extent although no such activity was found in OsISA1, OsISA3, EcoGlgX, and PsaISA. Thus, the present study shows the high possibility that varied chain-length specificities of ISA-type DBEs among sources and isozymes are responsible for their distinct functions in glucan metabolism.	[Kobayashi, Taiki; Sasaki, Satoshi; Utsumi, Yoshinori; Fujita, Naoko; Umeda, Kazuhiro; Sawada, Takayuki; Kubo, Akiko; Nakamura, Yasunori] Akita Prefectural Univ, Fac Bioresource Sci, Akita, Japan; [Abe, Jun-ichi] Kagoshima Univ, Fac Agr, Kagoshima 890, Japan; [Colleoni, Christophe; Ball, Steven] Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct, Villeneuve Dascq, France; [Nakamura, Yasunori] Akita Nat Sci Lab, Akita, Japan; [Utsumi, Yoshinori] RIKEN Ctr Sustainable Resource Sci, Plant Genom Network Res Team, Yokohama, Kanagawa, Japan; [Umeda, Kazuhiro] M3 Inc, Minato Ku, Tokyo, Japan; [Sawada, Takayuki] TDK Coorporat, Adv Agr Dev Grp, Akita, Japan; [Kubo, Akiko] Ezaki Glico Co Ltd, Inst Hlth Sci, Nishiyodagawa Ku, Osaka, Japan	Akita Prefectural University; Kagoshima University; Universite de Lille - ISITE; Universite de Lille; RIKEN; TDK Corporation; Ezaki Glico Co., Ltd.	Nakamura, Y (corresponding author), Akita Prefectural Univ, Fac Bioresource Sci, Akita, Japan.; Nakamura, Y (corresponding author), Akita Nat Sci Lab, Akita, Japan.	nakayn@silver.plala.or.jp	Colleoni, Christophe/AAP-2411-2021; Utsumi, Yoshinori/AAR-1844-2020	Utsumi, Yoshinori/0000-0002-9196-7123; Ball, Steven/0000-0003-1629-1650	Ministry of Education, Sports, Science and Technology [20248002]; Research Project Fund of APU President	Ministry of Education, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Project Fund of APU President	The present study was funded by the Ministry of Education, Sports, Science and Technology [Grant-in-Aid for Scientific Research (A), 20248002] and the Research Project Fund of APU President to YN and NF, respectively.; The present study was funded by the Ministry of Education, Sports, Science and Technology [Grant-in-Aid for Scientific Research (A), 20248002] and the Research Project Fund of APU President to Y.N. and N.F., respectively. The DNA sequence analysis was performed with the aid of the Biotechnology Center, APU. The DNA sequencing in this study was conducted with the aid of the Biotechnology Center, APU. We thank Drs. Hikaru Satoh and Eiji Suzuki for providing us with rice cultivars and Cyanobacteria cells, respectively. We also thank Ms. Masami Ono for growing rice plants in the experimental field of APU. The Pseudomonas amyloderamosa ISA (PsaISA) was kindly provided by Hayashibara Biochemical Laboratories Inc. (Okayama, Japan).	Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; Ball S, 2011, J EXP BOT, V62, P1775, DOI 10.1093/jxb/erq411; Beatty MK, 1999, PLANT PHYSIOL, V119, P255, DOI 10.1104/pp.119.1.255; Bertoft E, 2015, STARCH METABOLISM ST, P3; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Bustos R, 2004, P NATL ACAD SCI USA, V101, P2215, DOI 10.1073/pnas.0305920101; Cenci U, 2013, PLANT CELL, V25, P3961, DOI 10.1105/tpc.113.118174; Colleoni C, 1999, PLANT PHYSIOL, V120, P1005, DOI 10.1104/pp.120.4.1005; Colleoni C., 2012, ESSENTIAL REV EXPT B, V5, P217; Dauvillee D, 2005, J BACTERIOL, V187, P1465, DOI 10.1128/JB.187.4.1465-1473.2005; Dauvillee D, 2001, PLANT PHYSIOL, V125, P1710, DOI 10.1104/pp.125.4.1710; Dauvillee D, 2001, PLANT PHYSIOL, V125, P1723, DOI 10.1104/pp.125.4.1723; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; Deschamps P, 2008, MOL BIOL EVOL, V25, P536, DOI 10.1093/molbev/msm280; Dinges JR, 2003, PLANT CELL, V15, P666, DOI 10.1105/tpc.007575; FOX JD, 1991, ANAL BIOCHEM, V195, P93, DOI 10.1016/0003-2697(91)90300-I; Fujita N, 1999, PLANTA, V208, P283, DOI 10.1007/s004250050560; Fujita N, 2003, PLANT CELL PHYSIOL, V44, P607, DOI 10.1093/pcp/pcg079; Fujita N, 2009, J EXP BOT, V60, P1009, DOI 10.1093/jxb/ern349; Hennen-Bierwagen TA, 2012, ESSENTIAL REV EXPT B, V5, P179; HIZUKURI S, 1986, CARBOHYD RES, V147, P342, DOI 10.1016/S0008-6215(00)90643-8; Hizukuri S., 1996, CARBOHYDRATES FOOD, P347; Hussain H, 2003, PLANT CELL, V15, P133, DOI 10.1105/tpc.006635; JAMES MG, 1995, PLANT CELL, V7, P417, DOI 10.1105/tpc.7.4.417; JEANNINGROS R, 1976, BIOCHIM BIOPHYS ACTA, V438, P186, DOI 10.1016/0005-2744(76)90235-7; JENKINS JPJ, 1993, STARCH-STARKE, V45, P417; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kubo A, 1999, PLANT PHYSIOL, V121, P399, DOI 10.1104/pp.121.2.399; Kubo A, 2005, PLANT PHYSIOL, V137, P43, DOI 10.1104/pp.104.051359; Kubo A, 2010, PLANT PHYSIOL, V153, P956, DOI 10.1104/pp.110.155259; Lee E. Y. C., 1971, ENZYMES, V5, P191; Lin QH, 2013, NEW PHYTOL, V200, P1009, DOI 10.1111/nph.12446; Lin QH, 2012, PLANT PHYSIOL, V158, P679, DOI 10.1104/pp.111.189704; Mouille G, 1996, PLANT CELL, V8, P1353; Nakamura Y, 1996, PHYSIOL PLANTARUM, V97, P491, DOI [10.1111/j.1399-3054.1996.tb00508.x, 10.1034/j.1399-3054.1996.970311.x]; Nakamura Y, 1996, PLANT SCI, V121, P1, DOI 10.1016/S0168-9452(96)04504-9; Nakamura Y, 2005, PLANT CELL PHYSIOL, V46, P539, DOI 10.1093/pcp/pci045; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Nakamura Y, 1996, PLANTA, V199, P209, DOI 10.1007/BF00196561; Nakamura Y, 1997, PLANT J, V12, P143, DOI 10.1046/j.1365-313X.1997.12010143.x; Nakamura Y., 2015, STARCH-STARKE, P161, DOI DOI 10.1007/978-4-431-55495-0_5; Nakamura Y, 2010, PLANT CELL PHYSIOL, V51, P776, DOI 10.1093/pcp/pcq035; O'Shea MG, 1998, CARBOHYD RES, V307, P1, DOI 10.1016/S0008-6215(97)10085-4; Pfister B, 2014, PLANT PHYSIOL, V165, P1457, DOI 10.1104/pp.114.241455; ROMEO T, 1988, GENE, V70, P363, DOI 10.1016/0378-1119(88)90208-9; Sawada T, 2014, ARCH BIOCHEM BIOPHYS, V562, P9, DOI 10.1016/j.abb.2014.07.032; Shimonaga T, 2008, PLANT CELL PHYSIOL, V49, P103, DOI 10.1093/pcp/pcm172; Sim L, 2014, J BIOL CHEM, V289, P22991, DOI 10.1074/jbc.M114.565044; Song HN, 2010, PROTEINS, V78, P1847, DOI 10.1002/prot.22697; Streb S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092174; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Sundberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075223; Suzuki E, 2007, BBA-GEN SUBJECTS, V1770, P763, DOI 10.1016/j.bbagen.2007.01.006; Suzuki E, 2013, PLANT CELL PHYSIOL, V54, P465, DOI 10.1093/pcp/pcs190; Takashima Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2308, DOI 10.1271/bbb.70215; TAKEDA Y, 1986, CARBOHYD RES, V148, P299, DOI 10.1016/S0008-6215(00)90397-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Utsumi Y, 2009, J APPL GLYCOSCI, V56, P215, DOI [DOI 10.5458/JAG.56.215, 10.5458/jag.56.215]; Utsumi Y, 2006, PLANTA, V225, P75, DOI 10.1007/s00425-006-0331-z; Utsumi Y, 2011, PLANT PHYSIOL, V156, P61, DOI 10.1104/pp.111.173435; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; Wattebled F, 2008, PLANT PHYSIOL, V148, P1309, DOI 10.1104/pp.108.129379; Wong KS, 2003, J CEREAL SCI, V37, P139, DOI 10.1006/jcrs.2002.0485; YOKOBAYA, 1970, BIOCHIM BIOPHYS ACTA, V212, P458, DOI 10.1016/0005-2744(70)90252-4; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699	65	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157020	10.1371/journal.pone.0157020	http://dx.doi.org/10.1371/journal.pone.0157020			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309534	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800028
J	Kriengwatana, B; Terry, J; Chladkova, K; Escudero, P				Kriengwatana, Buddhamas; Terry, Josephine; Chladkova, Katerina; Escudero, Paola			Speaker and Accent Variation Are Handled Differently: Evidence in Native and Non-Native Listeners	PLOS ONE			English	Article							SPEECH SOUND DISCRIMINATION; PERCEPTUAL ADAPTATION; VOWEL NORMALIZATION; TALKER VARIABILITY; ENGLISH; SPOKEN; PITCH; IDENTIFICATION; RECOGNITION; SEX	Listeners are able to cope with between-speaker variability in speech that stems from anatomical sources (i.e. individual and sex differences in vocal tract size) and sociolinguistic sources (i.e. accents). We hypothesized that listeners adapt to these two types of variation differently because prior work indicates that adapting to speaker/sex variability may occur pre-lexically while adapting to accent variability may require learning from attention to explicit cues (i.e. feedback). In Experiment 1, we tested our hypothesis by training native Dutch listeners and Australian-English (AusE) listeners without any experience with Dutch or Flemish to discriminate between the Dutch vowels /I/ and /epsilon/ from a single speaker. We then tested their ability to classify /I/ and /epsilon/ vowels of a novel Dutch speaker (i.e. speaker or sex change only), or vowels of a novel Flemish speaker (i.e. speaker or sex change plus accent change). We found that both Dutch and AusE listeners could successfully categorize vowels if the change involved a speaker/sex change, but not if the change involved an accent change. When AusE listeners were given feedback on their categorization responses to the novel speaker in Experiment 2, they were able to successfully categorize vowels involving an accent change. These results suggest that adapting to accents may be a two-step process, whereby the first step involves adapting to speaker differences at a pre-lexical level, and the second step involves adapting to accent differences at a contextual level, where listeners have access to word meaning or are given feedback that allows them to appropriately adjust their perceptual category boundaries.	[Kriengwatana, Buddhamas] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [Kriengwatana, Buddhamas] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Terry, Josephine; Escudero, Paola] Univ Western Sydney, MARCS Inst Brain Behav & Dev, Sydney, NSW, Australia; [Terry, Josephine; Escudero, Paola] Australian Natl Univ, ARC Ctr Excellence Dynam Language, Canberra, ACT, Australia; [Chladkova, Katerina] Univ Amsterdam, Amsterdam Ctr Language & Commun, Phonet Sci, Amsterdam, Netherlands; [Chladkova, Katerina] Univ Leipzig, Inst Psychol, D-04109 Leipzig, Germany	Leiden University; Leiden University - Excl LUMC; University of Amsterdam; Western Sydney University; Australian National University; University of Amsterdam; Leipzig University	Kriengwatana, B (corresponding author), Leiden Univ, Inst Biol Leiden, Leiden, Netherlands.; Kriengwatana, B (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	bkrieng@alumni.uwo.ca	Chládková, Kateřina/K-2039-2015; Escudero, Paola/Q-5310-2019	Chládková, Kateřina/0000-0003-2009-1897; Escudero, Paola/0000-0002-8071-7663; Kriengwatana, Buddhamas (Pralle)/0000-0002-4258-883X	Australian Research Council [DP130102181]; Australian Research Council Centre of Excellence for the Dynamics of Language [CE140100041]	Australian Research Council(Australian Research Council); Australian Research Council Centre of Excellence for the Dynamics of Language(Australian Research Council)	This research and the work of BK, KC, and JT was conducted with support from the Australian Research Council grant DP130102181 awarded to PE. KC's work was also supported by the Australian Research Council Centre of Excellence for the Dynamics of Language, where PE is the Chief Investigator (project number CE140100041).	Adank P, 2004, J ACOUST SOC AM, V116, P3099, DOI 10.1121/1.1795335; Adank P, 2004, J ACOUST SOC AM, V116, P1729, DOI 10.1121/1.1779271; Adank P, 2012, HUM BRAIN MAPP, V33, P360, DOI 10.1002/hbm.21218; ASSMANN PF, 1982, J ACOUST SOC AM, V71, P975, DOI 10.1121/1.387579; Bachorowski J, 1993, JASA, V106, P1054; Boersma P., 1992, PRAAT DOING PHONETIC; Bradlow AR, 2008, COGNITION, V106, P707, DOI 10.1016/j.cognition.2007.04.005; BURDICK CK, 1975, J ACOUST SOC AM, V58, P415, DOI 10.1121/1.380686; Clarke CM, 2004, J ACOUST SOC AM, V116, P3647, DOI 10.1121/1.1815131; Clopper CG, 2004, LANG SPEECH, V47, P207, DOI 10.1177/00238309040470030101; Dadwani R, 2015, P 18 INT C PHON SCI, P1; Dahan D, 2008, COGNITION, V108, P710, DOI 10.1016/j.cognition.2008.06.003; Deutsch D, 2009, J ACOUST SOC AM, V125, pEL208, DOI 10.1121/1.3113892; DEWSON JH, 1964, SCIENCE, V144, P555, DOI 10.1126/science.144.3618.555; DEWSON JH, 1969, EXP NEUROL, V24, P579, DOI 10.1016/0014-4886(69)90159-9; Diehl RL, 2004, ANNU REV PSYCHOL, V55, P149, DOI 10.1146/annurev.psych.55.090902.142028; DOOLING RJ, 1990, PERCEPT PSYCHOPHYS, V47, P568, DOI 10.3758/BF03203109; Escudero P, 2007, P 16 INT C PHON SCI, P1413; Escudero P, 2014, SPEECH SCI TECHN C, P80; Escudero P, 2015, P 18 INT C PHON SCI, P1; Escudero P, 2011, J ACOUST SOC AM, V129, pEL1, DOI 10.1121/1.3525042; Escudero P, 2010, LANG SPEECH, V53, P343, DOI 10.1177/0023830910371447; Evans BG, 2004, J ACOUST SOC AM, V115, P352, DOI 10.1121/1.1635413; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Fitch WTS, 1994, THESIS; Flynn N., 2011, YORK PAPERS LINGUIST, V2, P1; GERSTMAN LJ, 1968, IEEE T ACOUST SPEECH, VAU16, P78, DOI 10.1109/TAU.1968.1161953; Goldinger SD, 1998, PSYCHOL REV, V105, P251, DOI 10.1037/0033-295X.105.2.251; Goldinger SD, 1996, J EXP PSYCHOL LEARN, V22, P1166, DOI 10.1037/0278-7393.22.5.1166; Goldinger SD, 2007, 16 INT C PHON SCI, VXVI, P49; Goudbeek M, 2008, SPEECH COMMUN, V50, P109, DOI 10.1016/j.specom.2007.07.003; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Johnson Keith, 1997, TALKER VARIABILITY S, P145; Kraljic T, 2008, COGNITION, V107, P54, DOI 10.1016/j.cognition.2007.07.013; Kriengwatana B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01243; Kriengwatana B, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01543; KUHL PK, 1983, INFANT BEHAV DEV, V6, P263, DOI 10.1016/S0163-6383(83)80036-8; LADEFOGED P, 1957, J ACOUST SOC AM, V29, P98, DOI 10.1121/1.1908694; LASS NJ, 1976, J ACOUST SOC AM, V59, P675, DOI 10.1121/1.380917; LOBANOV BM, 1971, J ACOUST SOC AM, V49, P606, DOI 10.1121/1.1912396; LOVEDAY L, 1981, LANG SPEECH, V24, P71, DOI 10.1177/002383098102400105; Macmillan NA, 2005, DETECTION THEORY USE; Magnuson JS, 2007, J EXP PSYCHOL HUMAN, V33, P391, DOI 10.1037/0096-1523.33.2.391; Monahan PJ, 2010, LANG COGNITIVE PROC, V25, P808, DOI 10.1080/01690965.2010.490047; MULLENNIX JW, 1989, J ACOUST SOC AM, V85, P365, DOI 10.1121/1.397688; NEAREY TM, 1989, J ACOUST SOC AM, V85, P2088, DOI 10.1121/1.397861; Norris D, 2003, COGNITIVE PSYCHOL, V47, P204, DOI 10.1016/S0010-0285(03)00006-9; Nygaard LC, 1998, PERCEPT PSYCHOPHYS, V60, P355, DOI 10.3758/BF03206860; Ohms VR, 2012, ANIM COGN, V15, P155, DOI 10.1007/s10071-011-0441-2; Ohms VR, 2010, P ROY SOC B-BIOL SCI, V277, P1003, DOI 10.1098/rspb.2009.1788; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Pierrehumbert JB, 2006, J PHONETICS, V34, P516, DOI 10.1016/j.wocn.2006.06.003; Samuel AG, 2009, ATTEN PERCEPT PSYCHO, V71, P1207, DOI 10.3758/APP.71.6.1207; Schmale R, 2012, DEVELOPMENTAL SCI, V15, P732, DOI 10.1111/j.1467-7687.2012.01175.x; Seidl A, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00448, 10.3389/fpsyg.2012.00479]; Smith DRR, 2014, ACTA PSYCHOL, V148, P81, DOI 10.1016/j.actpsy.2014.01.010; Stroup W.W., 2012, GEN LINEAR MIXED MOD; Sumner M, 2011, COGNITION, V119, P131, DOI 10.1016/j.cognition.2010.10.018; SYRDAL AK, 1986, J ACOUST SOC AM, V79, P1086, DOI 10.1121/1.393381; Trude AM, 2013, J MEM LANG, V69, P349, DOI 10.1016/j.jml.2013.05.002; Trude AM, 2012, LANG COGNITIVE PROC, V27, P979, DOI 10.1080/01690965.2011.597153; Tuinman A, 2012, J MEM LANG, V66, P530, DOI 10.1016/j.jml.2012.02.001; Tuomainen J, 2013, BRAIN RES, V1490, P170, DOI 10.1016/j.brainres.2012.10.067; van der Zande P, 2014, J PHONETICS, V43, P38, DOI 10.1016/j.wocn.2014.01.003; van Heugten M, 2014, J EXP PSYCHOL GEN, V143, P340, DOI 10.1037/a0032192; van Leussen JW, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01000; vanBezooijen R, 1995, LANG SPEECH, V38, P253, DOI 10.1177/002383099503800303; von Kriegstein K, 2006, NEUROIMAGE, V32, P368, DOI 10.1016/j.neuroimage.2006.02.045; WEISMAN R, 1994, J COMP PSYCHOL, V108, P363, DOI 10.1037/0735-7036.108.4.363; Weisman RG, 2004, BEHAV PROCESS, V66, P289, DOI 10.1016/j.beproc.2004.03.010; White KS, 2011, DEVELOPMENTAL SCI, V14, P372, DOI 10.1111/j.1467-7687.2010.00986.x	72	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156870	10.1371/journal.pone.0156870	http://dx.doi.org/10.1371/journal.pone.0156870			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27309889	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000378029800017
J	Plaisted, WC; Zavala, A; Hingco, E; Tran, H; Coleman, R; Lane, TE; Loring, JF; Walsh, CM				Plaisted, Warren C.; Zavala, Angel; Hingco, Edna; Tran, Ha; Coleman, Ronald; Lane, Thomas E.; Loring, Jeanne F.; Walsh, Craig M.			Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis	PLOS ONE			English	Article							NERVOUS-SYSTEM INFLAMMATION; RAT MODEL; AUTOIMMUNE ENCEPHALOMYELITIS; DISEASE; DEMYELINATION; RECOVERY; NEUROPROTECTION; DIFFERENTIATION; CORONAVIRUS; CONVERSION	We have recently described sustained clinical recovery associated with dampened neuroinflammation and remyelination following transplantation of neural precursor cells (NPCs) derived from human embryonic stem cells (hESCs) in a viral model of the human demyelinating disease multiple sclerosis. The hNPCs used in that study were derived by a novel direct differentiation method (direct differentiation, DD-NPCs) that resulted in a unique gene expression pattern when compared to hNPCs derived by conventional methods. Since the therapeutic potential of human NPCs may differ greatly depending on the method of derivation and culture, we wanted to determine whether NPCs differentiated using conventional methods would be similarly effective in improving clinical outcome under neuroinflammatory demyelinating conditions. For the current study, we utilized hNPCs differentiated from a human induced pluripotent cell line via an embryoid body intermediate stage (EB-NPCs). Intraspinal transplantation of EB-NPCs into mice infected with the neurotropic JHM strain of mouse hepatitis virus (JHMV) resulted in decreased accumulation of CD4+ T cells in the central nervous system that was concomitant with reduced demyelination at the site of injection. Dampened neuroinflammation and remyelination was correlated with a transient increase in CD4+FOXP3+ regulatory T cells (Tregs) concentrated within the peripheral lymphatics. However, compared to our earlier study, pathological improvements were modest and did not result in significant clinical recovery. We conclude that the genetic signature of NPCs is critical to their effectiveness in this model of viral-induced neurologic disease. These comparisons will be useful for understanding what factors are critical for the sustained clinical improvement.	[Plaisted, Warren C.; Zavala, Angel; Hingco, Edna; Walsh, Craig M.] Univ Calif Irvine, Dept Mol Biol & Biochem, Sue & Bill Gross Stem Cell Ctr, Multiple Sclerosis Res Ctr,Inst Immunol, Irvine, CA 92717 USA; [Tran, Ha; Coleman, Ronald; Loring, Jeanne F.] Scripps Res Inst, Dept Physiol Chem, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Lane, Thomas E.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA	University of California System; University of California Irvine; Scripps Research Institute; Utah System of Higher Education; University of Utah	Walsh, CM (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Sue & Bill Gross Stem Cell Ctr, Multiple Sclerosis Res Ctr,Inst Immunol, Irvine, CA 92717 USA.; Loring, JF (corresponding author), Scripps Res Inst, Dept Physiol Chem, Ctr Regenerat Med, La Jolla, CA 92037 USA.; Lane, TE (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA.	tom.lane@path.utah.edu; jloring@scripps.edu; cwalsh@uci.edu		Walsh, Craig/0000-0001-7808-2817	National Institutes of Health [NS082174, R01NS092042]; National Multiple Sclerosis Society [RG4925, CA1058]; California Institute for Regenerative Medicine [TR3-05603, CL1-00502]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092042, T32NS082174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health Training Grant NS082174 to WCP; National Institutes of Health R01NS092042 to TEL, JFL; National Multiple Sclerosis Society RG4925 to TEL; California Institute for Regenerative Medicine TR3-05603 to CMW, JFL; California Institute for Regenerative Medicine CL1-00502 to JFL; National Multiple Sclerosis Society CA1058 to CMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonowiz M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003145; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Cao W, 2011, IMMUNITY, V35, P273, DOI 10.1016/j.immuni.2011.06.011; Carbajal KS, 2011, JOVE-J VIS EXP, DOI 10.3791/2834; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen L, 2014, STEM CELL REP, V2, P825, DOI 10.1016/j.stemcr.2014.04.005; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Emre N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012148; Fainstein N, 2013, GLIA, V61, P140, DOI 10.1002/glia.22420; Fainstein N, 2013, NEUROBIOL DIS, V49, P41, DOI 10.1016/j.nbd.2012.08.004; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gao L, 2014, INT J MOL SCI, V15, P4431, DOI 10.3390/ijms15034431; Gao W, 2009, CELL CYCLE, V8, P1444, DOI 10.4161/cc.8.9.8348; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Hatch MN, 2009, J NEUROIMMUNOL, V212, P74, DOI 10.1016/j.jneuroim.2009.05.002; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huss DJ, 2016, IMMUNOLOGY, V148, P276, DOI 10.1111/imm.12609; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Lane TE, 1997, TRENDS MICROBIOL, V5, P9, DOI 10.1016/S0966-842X(97)81768-4; Laterza C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3597; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Nazmi A, 2014, VIRAL IMMUNOL, V27, P48, DOI 10.1089/vim.2013.0090; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Park J, 2011, MOL PHARMACEUT, V8, P143, DOI 10.1021/mp100203a; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pluchino S, 2009, ANN NEUROL, V66, P343, DOI 10.1002/ana.21745; Riley J, 2014, NEUROSURGERY, V74, P77, DOI 10.1227/NEU.0000000000000156; Sakaguchi S, 2006, CURR TOP MICROBIOL, V305, P51, DOI 10.1007/3-540-29714-6_3; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Trandem K, 2010, J IMMUNOL, V184, P4391, DOI 10.4049/jimmunol.0903918; Uchida N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004371; van Gorp S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt209; Wang YC, 2011, CELL RES, V21, P1551, DOI 10.1038/cr.2011.148; Weinger JG, 2012, STEM CELLS, V30, P2584, DOI 10.1002/stem.1234; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540	42	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157620	10.1371/journal.pone.0157620	http://dx.doi.org/10.1371/journal.pone.0157620			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310015	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800109
J	Russo, F; D'Este, M; Vadala, G; Cattani, C; Papalia, R; Alini, M; Denaro, V				Russo, Fabrizio; D'Este, Matteo; Vadala, Gianluca; Cattani, Caterina; Papalia, Rocco; Alini, Mauro; Denaro, Vincenzo			Platelet Rich Plasma and Hyaluronic Acid Blend for the Treatment of Osteoarthritis: Rheological and Biological Evaluation	PLOS ONE			English	Article							INTRAARTICULAR INJECTION; KNEE OSTEOARTHRITIS; RHEUMATOID-ARTHRITIS; CLINICAL-APPLICATION; CHONDRAL DEFECTS; MOLECULAR-WEIGHT; SYNOVIAL-FLUID; CARTILAGE; JOINT; REGENERATION	Introduction Osteoarthritis (OA) is the most common musculoskeletal disease. Current treatments for OA are mainly symptomatic and inadequate since none results in restoration of fully functional cartilage. Hyaluronic Acid (HA) intra-articular injections are widely accepted for the treatment of pain associated to OA. The goal of HA viscosupplementation is to reduce pain and improve viscoelasticity of synovial fluid. Platelet-rich plasma (PRP) has been also employed to treat OA to possibly induce cartilage regeneration. The combination of HA and PRP could supply many advantages for tissue repair. Indeed, it conjugates HA viscosupplementation with PRP regenerative properties. The aim of this study was to evaluate the rheological and biological properties of different HA compositions in combination with PRP in order to identify (i) the viscoelastic features of the HA-PRP blends, (ii) their biological effect on osteoarthritic chondrocytes and (iii) HA formulations suitable for use in combination with PRP. Materials and Methods HA/PRP blends have been obtained mixing human PRP and three different HA at different concentrations: 1) Sinovial, 0.8% (SN); 2) Sinovial Forte 1.6% (SF); 3) Sinovial HL 3.2% (HL); 4) Hyalubrix 1.5% (HX). Combinations of phosphate buffered saline (PBS) and the four HA types were used as control. Rheological measurements were performed on an Anton PaarMCR-302 rheometer. Amplitude sweep, frequency sweep and rotational measurements were performed and viscoelastic properties were evaluated. The rheological data were validated performing the tests in presence of Bovine Serum Albumin (BSA) up to ultra-physiological concentration (7%). Primary osteoarthritic chondrocytes were cultured in vitro with the HA and PRP blends in the culture medium for one week. Cell viability, proliferation and glycosaminoglycan (GAG) content were assessed. Results PRP addition to HA leads to a decrease of viscoelastic shear moduli and increase of the crossover point, due to a pure dilution effect. For viscosupplements with HA concentration below 1% the viscoelasticity is mostly lost. Results were validated also in presence of proteins, which in synovial fluid are more abundant than HA. Chondrocytes proliferated overtime in all different culture conditions. The proliferation rate was higher in chondrocytes cultured in the media containing PRP compared to the cultures with different HA alone. GAG content was significantly higher in chondrocytes cultured in PRP and HL blend. Discussion We investigated the rheological and biological properties of four different HA concentrations when combined with PRP giving insights on viscoelastic and biological properties of a promising approach for future OA therapy. Our data demonstrate that PRP addition is not detrimental to the viscosupplementation effect of HA. Viscosupplements containing low HA concentration are not indicated for combination with PRP, as the viscoelastic properties are lost. Although having the same rheological behavior of SF and HX, HL was superior in stimulating extracellular matrix production in vitro.	[Russo, Fabrizio; Vadala, Gianluca; Cattani, Caterina; Papalia, Rocco; Denaro, Vincenzo] Campus Biomed Univ Rome, Dept Orthopaed & Trauma Surg, Via Alvaro Portillo 200, I-00128 Rome, Italy; [D'Este, Matteo; Alini, Mauro] AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland	University Campus Bio-Medico - Rome Italy	Vadala, G (corresponding author), Campus Biomed Univ Rome, Dept Orthopaed & Trauma Surg, Via Alvaro Portillo 200, I-00128 Rome, Italy.	g.vadala@gmail.com	Vadalà, Gianluca/B-1538-2014; Alini, Mauro/AAG-7961-2020; D'Este, Matteo/AAB-2835-2022; Russo, Fabrizio/AAE-4285-2020; Denaro, Vincenzo/K-9567-2016	Vadalà, Gianluca/0000-0001-7142-1660; D'Este, Matteo/0000-0002-0424-8172; Russo, Fabrizio/0000-0002-8566-8952; Denaro, Vincenzo/0000-0003-4739-9795; Papalia, Rocco/0000-0002-6069-4871	Young Investigator Grant of the Italian Ministry of Health [GR-2010-2318448]	Young Investigator Grant of the Italian Ministry of Health	This work was supported by the Young Investigator Grant of the Italian Ministry of Health (GR-2010-2318448) to GV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andia I, 2014, EXPERT OPIN BIOL TH, V14, P635, DOI 10.1517/14712598.2014.889677; Andia I, 2012, EXPERT OPIN BIOL TH, V12, P7, DOI 10.1517/14712598.2012.632765; [Anonymous], 2000, ARTHRITIS RHEUM, V43, P1905, DOI DOI 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P; Ayhan E, 2014, WORLD J ORTHOP, V5, P351, DOI 10.5312/wjo.v5.i3.351; Balazs EA, 2004, CHEM BIOL HYALURONAN, V1st; Baltzer AWA, 2009, OSTEOARTHR CARTILAGE, V17, P152, DOI 10.1016/j.joca.2008.06.014; Bernstein J, 2004, J BONE JOINT SURG AM, V86A, P2567, DOI 10.2106/00004623-200411000-00032; BLUMBERG BS, 1957, BIOCHEM J, V66, P342, DOI 10.1042/bj0660342; Castellacci E, 2004, DRUG EXP CLIN RES, V30, P67; Chen WH, 2014, BIOMATERIALS, V35, P9599, DOI 10.1016/j.biomaterials.2014.07.058; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; DAHL LB, 1985, ANN RHEUM DIS, V44, P817, DOI 10.1136/ard.44.12.817; Di Matteo B, 2015, Musculoskelet Surg, V99, P1, DOI 10.1007/s12306-014-0340-1; Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51; Fam H, 2007, BIORHEOLOGY, V44, P59; Flanigan DC, 2010, MED SCI SPORT EXER, V42, P1795, DOI 10.1249/MSS.0b013e3181d9eea0; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; GOTOH S, 1993, ANN RHEUM DIS, V52, P817, DOI 10.1136/ard.52.11.817; Handl M, 2007, PHYSIOL RES, V56, P243, DOI 10.33549/physiolres.930917; IWATA H, 1993, CLIN ORTHOP RELAT R, P285; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Juni P, 2007, ARTHRITIS RHEUM-US, V56, P3610, DOI 10.1002/art.23026; Kon E, 2011, ARTHROSCOPY, V27, P1490, DOI 10.1016/j.arthro.2011.05.011; Kon E, 2010, KNEE SURG SPORT TR A, V18, P472, DOI 10.1007/s00167-009-0940-8; Kruger JP, 2012, J ORTHOP RES, V30, P845, DOI 10.1002/jor.22005; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Liebman J, 2001, SJ ENNA, DOI [10.1002/0471141755.ph1202s12, DOI 10.1002/0471141755.PH1202S12]; Lippross S, 2011, ARTHRITIS RHEUM-US, V63, P3344, DOI 10.1002/art.30547; Malhotra R, 2015, Musculoskelet Surg, V99, P243, DOI 10.1007/s12306-015-0378-8; Marshall K Wayne, 2003, Foot Ankle Clin, V8, P221, DOI 10.1016/S1083-7515(03)00046-9; Marshall KW, 2003, FOOT ANKLE CLIN, V8, pviii; Marx R E, 2001, Implant Dent, V10, P225; Milano G, 2010, OSTEOARTHR CARTILAGE, V18, P971, DOI 10.1016/j.joca.2010.03.013; Milano G, 2012, ARTHROSCOPY, V28, P688, DOI 10.1016/j.arthro.2011.09.016; Moreland LW, 2003, ARTHRITIS RES THER, V5, P54, DOI 10.1186/ar623; OGSTON AG, 1953, J PHYSIOL-LONDON, V119, P244, DOI 10.1113/jphysiol.1953.sp004842; OGSTON AG, 1950, BIOCHEM J, V46, P364, DOI 10.1042/bj0460364; Paoloni J, 2011, CLIN J SPORT MED, V21, P37, DOI 10.1097/JSM.0b013e31820758c7; Patti AM, 2001, TISSUE CELL, V33, P294, DOI 10.1054/tice.2001.0178; Prasadam I, 2013, J MOL MED, V91, P369, DOI 10.1007/s00109-012-0953-5; Raeissadat SA, 2015, CLIN MED INSIGHTS-AR, V8, P1, DOI 10.4137/CMAMD.S17894; Richmond J, 2010, J BONE JOINT SURG AM, V92A, P990, DOI 10.2106/JBJS.I.00982; Saito M, 2009, CLIN EXP RHEUMATOL, V27, P201; Sheth U, 2012, J BONE JOINT SURG AM, V94A, P298, DOI 10.2106/JBJS.K.00154; Strauss EJ, 2009, AM J SPORT MED, V37, P1636, DOI 10.1177/0363546508326984; Sun Y, 2010, INT ORTHOP, V34, P589, DOI 10.1007/s00264-009-0793-2; Thompson CL, 2015, J ORTHOP RES, V33, P1552, DOI 10.1002/jor.22913; Thysen S, 2015, DIS MODEL MECH, V8, P17, DOI 10.1242/dmm.016881; Vadala G, 2015, J TISSUE ENG REGEN M, V9, P679, DOI 10.1002/term.1719; Vitanzo Peter C Jr, 2006, Am J Orthop (Belle Mead NJ), V35, P421; WEIGEL PH, 1986, J THEOR BIOL, V119, P219, DOI 10.1016/S0022-5193(86)80076-5; Wu CC, 2011, BIOMATERIALS, V32, P5847, DOI 10.1016/j.biomaterials.2011.05.002; Xie XT, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4493; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013; Zhu Y, 2013, OSTEOARTHR CARTILAGE, V21, P1627, DOI 10.1016/j.joca.2013.07.017	55	50	52	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157048	10.1371/journal.pone.0157048	http://dx.doi.org/10.1371/journal.pone.0157048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310019	gold, Green Published, Green Submitted			2022-12-26	WOS:000378029800031
J	Domanova, W; Krycer, J; Chaudhuri, R; Yang, PY; Vafaee, F; Fazakerley, D; Humphrey, S; James, D; Kuncic, Z				Domanova, Westa; Krycer, James; Chaudhuri, Rima; Yang, Pengyi; Vafaee, Fatemeh; Fazakerley, Daniel; Humphrey, Sean; James, David; Kuncic, Zdenka			Unraveling Kinase Activation Dynamics Using Kinase-Substrate Relationships from Temporal Large-Scale Phosphoproteomics Studies	PLOS ONE			English	Article							INSULIN-RESISTANCE; ELONGATION-FACTOR-2 KINASE; PHOSPHORYLATION NETWORKS; PROTEIN; REVEALS; PATTERNS; SURVIVAL; DATABASE; COMPLEX; SITES	In response to stimuli, biological processes are tightly controlled by dynamic cellular signaling mechanisms. Reversible protein phosphorylation occurs on rapid time-scales (milliseconds to seconds), making it an ideal carrier of these signals. Advances in mass spectrometry-based proteomics have led to the identification of many tens of thousands of phosphorylation sites, yet for the majority of these the kinase is unknown and the underlying network topology of signaling networks therefore remains obscured. Identifying kinase substrate relationships (KSRs) is therefore an important goal in cell signaling research. Existing consensus sequence motif based prediction algorithms do not consider the biological context of KSRs, and are therefore insensitive to many other mechanisms guiding kinase-substrate recognition in cellular contexts. Here, we use temporal information to identify biologically relevant KSRs from Large-scale In Vivo Experiments (KSR-LIVE) in a data-dependent and automated fashion. First, we used available phosphorylation databases to construct a repository of existing experimentally-predicted KSRs. For each kinase in this database, we used time-resolved phosphoproteomics data to examine how its substrates changed in phosphorylation over time. Although substrates for a particular kinase clustered together, they often exhibited a different temporal pattern to the phosphorylation of the kinase. Therefore, although phosphorylation regulates kinase activity, our findings imply that substrate phosphorylation likely serve as a better proxy for kinase activity than kinase phosphorylation. KSR-LIVE can thereby infer which kinases are regulated within a biological context. Moreover, KSR-LIVE can also be used to automatically generate positive training sets for the subsequent prediction of novel KSRs using machine learning approaches. We demonstrate that this approach can distinguish between Akt and Rps6kb1, two kinases that share the same linear consensus motif, and provide evidence suggesting IRS-1 S265 as a novel Akt site. KSR-LIVE is an open-access algorithm that allows users to dissect phosphorylation signaling within a specific biological context, with the potential to be included in the standard analysis workflow for studying temporal high-throughput signal transduction data.	[Domanova, Westa; Krycer, James; Chaudhuri, Rima; Vafaee, Fatemeh; Fazakerley, Daniel; James, David; Kuncic, Zdenka] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Domanova, Westa; Kuncic, Zdenka] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Krycer, James; Chaudhuri, Rima; Fazakerley, Daniel; James, David] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia; [Yang, Pengyi] NIEHS, NIH, Durham, NC 27709 USA; [Vafaee, Fatemeh] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; [Humphrey, Sean] Max Planck Inst Biochem, Dept Prote & Signal Transduct, Klopferspitz 18A, D-82152 Martinsried, Germany; [James, David] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Sydney; Max Planck Society; University of Sydney	James, D; Kuncic, Z (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.; Kuncic, Z (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.; James, D (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.; James, D (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.	david.james@sydney.edu.au; zdenka.kuncic@sydney.edu.au	Yang, Pengyi/B-1002-2010; Fazakerley, Daniel/J-2652-2019; Humphrey, Sean/AAC-1425-2019	Yang, Pengyi/0000-0003-1098-3138; Fazakerley, Daniel/0000-0001-8241-2903; Krycer, James/0000-0003-1536-7270; Kuncic, Zdenka/0000-0001-6765-3215; Vafaee, Fatemeh/0000-0002-7521-2417; Humphrey, Sean/0000-0002-2666-9744; James, David/0000-0001-5946-5257	NHMRC [GNT1061122]; Australian Postgraduate Award scholarship	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award scholarship	This work is supported by the NHMRC (project grant GNT1061122). DJ is an NHMRC Senior Principal Research Fellow. JK is an NHMRC Early Career Fellow. WD is supported by an Australian Postgraduate Award scholarship.	Ahmed S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134708; Blom N, 2004, BIOCH BIOPHYS RES CO, V4, P1633; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Cao GF, 2011, BIOCHEM BIOPH RES CO, V414, P499, DOI 10.1016/j.bbrc.2011.09.094; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Emdal KB, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005769; Hornbeck P V, 2011, NUCL ACIDS RES; Humphrey SJ, 2015, NAT BIOTECHNOL, V33, P990, DOI 10.1038/nbt.3327; Humphrey SJ, 2013, CELL METAB, P1; Humphrey SJ, 2015, PROTEIN PHOSPHORYLAT, Vxx; Lawlor MA, 2001, J CELL SCI, V114, P2903; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Package T, FEBS OPEN BIO; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rowland AF, 2011, TRAFFIC, V12, P672, DOI 10.1111/j.1600-0854.2011.01178.x; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Song CX, 2012, MOL CELL PROTEOMICS, V11, P1070, DOI 10.1074/mcp.M111.012625; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tape CJ, 2014, ANAL CHEM, V86, P10296, DOI 10.1021/ac5025842; Tseng GC, 2005, BIOMETRICS, V61, P10, DOI 10.1111/j.0006-341X.2005.031032.x; Ubersax JA, 2007, MECH SPECIFICITY PRO, V8; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wang XM, 2014, MOL CELL BIOL, V34, P4088, DOI 10.1128/MCB.01035-14; Wong MKL, 2015, FEBS OPEN BIO, V5, P226, DOI 10.1016/j.fob.2015.03.002; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Yang CY, 2008, BIOINFORMATICS, V24, pI14, DOI 10.1093/bioinformatics/btn297; Yang G, 2015, CELL REP, V12, P937, DOI 10.1016/j.celrep.2015.07.016; Yang P, 2015, POSITIVE UNLABELED E; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	42	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157763	10.1371/journal.pone.0157763	http://dx.doi.org/10.1371/journal.pone.0157763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336693	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200041
J	Nunes, CA; Braga, RF; Figueira, JEC; Neves, FD; Fernandes, GW				Nunes, Cassio Alencar; Braga, Rodrigo Fagundes; Cortes Figueira, Jose Eugenio; Neves, Frederico de Siqueira; Fernandes, G. Wilson			Dung Beetles along a Tropical Altitudinal Gradient: Environmental Filtering on Taxonomic and Functional Diversity	PLOS ONE			English	Article							SPECIES-DIVERSITY; BETA-DIVERSITY; SCARABAEINAE ASSEMBLAGES; ELEVATIONAL GRADIENTS; ECOSYSTEM FUNCTION; COMMUNITY; RICHNESS; TURNOVER; FOREST; ALPHA	Mountains provide an interesting context in which to study the many facets of biodiversity in response to macroclimate, since environmental conditions change rapidly due to elevation. Although the decrease in biodiversity with increasing elevation is generally accepted, our understanding of the variation of functional diversity along altitudinal gradients is still poorly known. The partitioning of diversity into spatial components can help to understand the processes that influence the distribution of species, and these studies are urgently needed in face of the increasing threats to mountain environments throughout the world. We describe the distribution of dung beetle diversity along an altitudinal gradient on a tropical mountain in southeastern Brazil, including the spatial partitioning of taxonomic and functional diversities. The altitudinal gradient ranged from 800 up to 1400m a.s.l. and we collected dung beetles at every 100 m of altitude. We used the Rao Index to calculate gamma, alpha and beta diversity for taxonomic and functional diversity of dung beetles. Climatic, soil and vegetation variables were used to explain variation in community attributes along the altitudinal gradient. Dung beetle richness declined with altitude and was related to climatic and vegetation variables, but functional diversity did not follow the same pattern. Over 50% of. taxonomic diversity was caused by among altitudes diversity (beta), while almost 100% of functional diversity was due to the a component. Contrasting beta taxonomic with beta functional diversity, we suggest that there is ecological redundancy among communities and that the environment is filtering species in terms of the Grinnellian niche, rather than the Eltonian niche. beta taxonomic diversity is caused mainly by the turnover component, reinforcing the hypothesis of environmental filtering. Global warmingmay have strong effects on mountain communities due to upslope range shifts and extinctions, and these events will lead to an even larger than previously expected loss of diversity as dung beetles. taxonomic diversity is caused mainly by the beta component.	[Nunes, Cassio Alencar; Cortes Figueira, Jose Eugenio] Univ Fed Minas Gerais, Lab Ecol Populacoes, Dept Biol Geral, Inst Ciencias Biol, CP 486, BR-31270901 Belo Horizonte, MG, Brazil; [Braga, Rodrigo Fagundes] Univ Fed Lavras, Lab Ecol & Conservac Invertebrados, Dept Biol, Setor Ecol, CP 3037, BR-37200000 Lavras, MG, Brazil; [Neves, Frederico de Siqueira] Univ Fed Minas Gerais, Lab Ecol Insetos, Dept Biol Geral, Inst Ciencias Biol, CP 486, BR-31270901 Belo Horizonte, MG, Brazil; [Fernandes, G. Wilson] Univ Fed Minas Gerais, Ecol Evolut & Biodiversidade DBG, ICB, CP 486, BR-31270901 Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Lavras; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Nunes, CA (corresponding author), Univ Fed Minas Gerais, Lab Ecol Populacoes, Dept Biol Geral, Inst Ciencias Biol, CP 486, BR-31270901 Belo Horizonte, MG, Brazil.	cassioalencarnunes@gmail.com	Nunes, Cássio Alencar/I-5528-2019; Fernandes, Geraldo/AAN-5602-2021; Neves, Frederico/E-5777-2013; Côrtes-Figueira, José Eugênio/D-3933-2016	Nunes, Cássio Alencar/0000-0002-2783-0210; Fernandes, Geraldo/0000-0003-1559-6049; Neves, Frederico/0000-0002-2691-3743; Côrtes-Figueira, José Eugênio/0000-0001-6399-2025	Conselho Nacional do Desenvolvimento Cientifico (CNPq)/PELD; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); CNPq [132879/2013-1]	Conselho Nacional do Desenvolvimento Cientifico (CNPq)/PELD(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was funded by Conselho Nacional do Desenvolvimento Cientifico (CNPq)/PELD and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). This study was part of CA Nunes' MSc and was supported by CNPq (Proc. 132879/2013-1).	Almeida S, 2011, BIOTROPICA, V43, P704, DOI 10.1111/j.1744-7429.2011.00751.x; Andresen E, 2005, BIOTROPICA, V37, P291, DOI 10.1111/j.1744-7429.2005.00039.x; Audino LD, 2014, BIOL CONSERV, V169, P248, DOI 10.1016/j.biocon.2013.11.023; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Braga RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057786; Carmona CP, 2012, J APPL ECOL, V49, P1084, DOI 10.1111/j.1365-2664.2012.02193.x; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Coutinho ES, 2015, MYCORRHIZA, V25, P627, DOI 10.1007/s00572-015-0636-5; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Dainese M, 2015, PERSPECT PLANT ECOL, V17, P44, DOI 10.1016/j.ppees.2014.09.002; De Bello F, 2005, J APPL ECOL, V42, P824, DOI 10.1111/j.1365-2664.2005.01079.x; de Bello F, 2013, J VEG SCI, V24, P807, DOI 10.1111/jvs.12008; de Bello F, 2013, ECOGRAPHY, V36, P393, DOI 10.1111/j.1600-0587.2012.07438.x; de Bello F, 2010, J VEG SCI, V21, P992, DOI 10.1111/j.1654-1103.2010.01195.x; de Bello F, 2009, J VEG SCI, V20, P475, DOI 10.1111/j.1654-1103.2009.01042.x; de Carvalho F, 2014, J MT SCI-ENGL, V11, P875, DOI 10.1007/s11629-013-2792-4; de Carvalho F, 2012, APPL SOIL ECOL, V52, P9, DOI 10.1016/j.apsoil.2011.10.001; Dehling DM, 2014, ECOGRAPHY, V37, P1047, DOI 10.1111/ecog.00623; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Escobar F, 2005, GLOBAL ECOL BIOGEOGR, V14, P327, DOI 10.1111/j.1466-822x.2005.00161.x; Escobar F, 2007, ECOGRAPHY, V30, P193, DOI [10.1111/j.2007.0906-7590.04818.x, 10.1111/j.0906-7590.2007.04818.x]; FERNANDES GW, 1988, OECOLOGIA, V76, P161, DOI 10.1007/BF00379948; Freitas GHS, 2012, IBIS, V154, P738, DOI 10.1111/j.1474-919X.2012.01268.x; Giulietti AM, 1987, B BOT U SAO PAULO, V9, P1, DOI DOI 10.11606/ISSN.2316-9052.V9I0P1-151; Grytnes J.A., 2007, ENCY BIODIVERSITY, V2, P1, DOI DOI 10.1016/B978-012226865-6/00503-1; Halffter G., 1982, NESTING BEHAV DUNG B; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Herzog SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064963; Jackson ST, 2009, SCIENCE, V324, P596, DOI 10.1126/science.1171659; Jankowski JE, 2009, J ANIM ECOL, V78, P315, DOI 10.1111/j.1365-2656.2008.01487.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kamino L. H. Y., 2008, MEGADIVERSIDADE, V4, P39; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Larsen TH, 2012, BIOTROPICA, V44, P82, DOI 10.1111/j.1744-7429.2011.00768.x; Laurance WF, 2011, BIOL CONSERV, V144, P548, DOI 10.1016/j.biocon.2010.10.010; Lobo JM, 2000, ANN ENTOMOL SOC AM, V93, P115, DOI 10.1603/0013-8746(2000)093[0115:BAEFAT]2.0.CO;2; Louzada J, 2010, LANDSCAPE ECOL, V25, P631, DOI 10.1007/s10980-010-9448-3; Madeira JA, 1999, J TROP ECOL, V15, P463, DOI 10.1017/S0266467499000954; McCain CM, 2007, ECOLOGY, V88, P76, DOI 10.1890/0012-9658(2007)88[76:AAMED]2.0.CO;2; McCain CM, 2010, GLOBAL ECOL BIOGEOGR, V19, P541, DOI 10.1111/j.1466-8238.2010.00528.x; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Meynard CN, 2011, GLOBAL ECOL BIOGEOGR, V20, P893, DOI 10.1111/j.1466-8238.2010.00647.x; Mota GS, 2012, VARIACAO ESTRUTURA C; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2009, OIKOS, V118, P481, DOI 10.1111/j.1600-0706.2009.17268.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pavoine S, 2011, BIOL REV, V86, P792, DOI 10.1111/j.1469-185X.2010.00171.x; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; R Core Team, 2021, R LANGUAGE ENV STAT; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rapini A., 2008, MEGADIVERSIDADE, V4, P15, DOI DOI 10.1590/S0100-84042011000200012; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Slade EM, 2011, BIOL CONSERV, V144, P166, DOI 10.1016/j.biocon.2010.08.011; Spector S, 2006, COLEOPTS BULL, V60, P71, DOI 10.1649/0010-065X(2006)60[71:SDBCSS]2.0.CO;2; Sundqvist MK, 2013, ANNU REV ECOL EVOL S, V44, P261, DOI 10.1146/annurev-ecolsys-110512-135750; Swenson NG, 2012, ECOLOGY, V93, pS112, DOI 10.1890/11-0402.1; Vasconcelos M. F., 2008, MEGADIVERSIDADE, V4, P221; Vaz-de-Mello FZ, 2011, ZOOTAXA, P1; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Villeger S, 2013, GLOBAL ECOL BIOGEOGR, V22, P671, DOI 10.1111/geb.12021; Villeger S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040679; von Humboldt A., 1805, ESSAI GEOGRAPHIE PLA; Wagner H., 2013, PACKAGE VEGAN COMMUN, V2, P1	70	72	75	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157442	10.1371/journal.pone.0157442	http://dx.doi.org/10.1371/journal.pone.0157442			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336589	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200017
J	Oizumi, R; Kuniya, T; Enatsu, Y				Oizumi, Ryo; Kuniya, Toshikazu; Enatsu, Yoichi			Reconsideration of r/K Selection Theory Using Stochastic Control Theory and Nonlinear Structured Population Models	PLOS ONE			English	Article							K-SELECTION; LIFE	Despite the fact that density effects and individual differences in life history are considered to be important for evolution, these factors lead to several difficulties in understanding the evolution of life history, especially when population sizes reach the carrying capacity. r/K selection theory explains what types of life strategies evolve in the presence of density effects and individual differences. However, the relationship between the life schedules of individuals and population size is still unclear, even if the theory can classify life strategies appropriately. To address this issue, we propose a few equations on adaptive life strategies in r/K selection where density effects are absent or present. The equations detail not only the adaptive life history but also the population dynamics. Furthermore, the equations can incorporate temporal individual differences, which are referred to as internal stochasticity. Our framework reveals that maximizing density effects is an evolutionarily stable strategy related to the carrying capacity. A significant consequence of our analysis is that adaptive strategies in both selections maximize an identical function, providing both population growth rate and carrying capacity. We apply our method to an optimal foraging problem in a semelparous species model and demonstrate that the adaptive strategy yields a lower intrinsic growth rate as well as a lower basic reproductive number than those obtained with other strategies. This study proposes that the diversity of life strategies arises due to the effects of density and internal stochasticity.	[Oizumi, Ryo] Minist Hlth Labour & Welf Japan, Director Gen Off Policy Planning & Evaluat, Chiyoda Ku, 1-2-2 Kasumigaseki, Tokyo 1008916, Japan; [Kuniya, Toshikazu] Kobe Univ, Grad Sch Syst Informat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan; [Enatsu, Yoichi] Tokyo Univ Sci, Dept Math Informat Sci, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan	Kobe University; Tokyo University of Science	Oizumi, R (corresponding author), Minist Hlth Labour & Welf Japan, Director Gen Off Policy Planning & Evaluat, Chiyoda Ku, 1-2-2 Kasumigaseki, Tokyo 1008916, Japan.	oizumi@ms.u-tokyo.ac.jp		Oizumi, Ryo/0000-0001-7813-1236	Grants-in-Aid for Scientific Research [15K17585] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Engen S, 2013, AM NAT, V181, P725, DOI 10.1086/670257; GURTIN ME, 1974, ARCH RATION MECH AN, V54, P280; LANGLAIS M, 1988, J MATH BIOL, V26, P319, DOI 10.1007/BF00277394; Lauenroth WK, 2008, J ECOL, V96, P1023, DOI 10.1111/j.1365-2745.2008.01415.x; LEON JA, 1976, J THEOR BIOL, V60, P301, DOI 10.1016/0022-5193(76)90062-X; Lv QM, 2007, J THEOR BIOL, V244, P640, DOI 10.1016/j.jtbi.2006.09.009; MAC ARTHUR ROBERT H., 1967; Magal P, 2009, CTR MANIFOLDS SEMILI, V202; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; Oizumi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098746; Oizumi R, 2013, J THEOR BIOL, V323, P76, DOI 10.1016/j.jtbi.2013.01.020; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Reznick D, 2002, ECOLOGY, V83, P1509, DOI 10.2307/3071970; Salguero-Gomez R, 2010, J ECOL, V98, P250, DOI 10.1111/j.1365-2745.2009.01635.x; Uvarov B. P., 1921, Bulletin of Entomological Research London, V12, P135, DOI 10.1017/S0007485300044989; Webb GF, 2008, LECT NOTES MATH, V1936, P1; Yong J., 1999, STOCHASTIC CONTROLS, V43	18	7	7	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157715	10.1371/journal.pone.0157715	http://dx.doi.org/10.1371/journal.pone.0157715			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336169	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200035
J	Rasheed, H; Hegazy, RA; Gawdat, HI; Mehaney, DA; Kamel, MM; Fawzy, MM; Nooh, MM; Darwish, HA				Rasheed, Hoda; Hegazy, Rehab A.; Gawdat, Heba I.; Mehaney, Dina A.; Kamel, Marwa M.; Fawzy, Marwa M.; Nooh, Mohammed M.; Darwish, Hebatallah A.			Serum Vitamin D and Vitamin D Receptor Gene Polymorphism in Mycosis Fungoides Patients: A Case Control Study	PLOS ONE			English	Article							T-CELL LYMPHOMA; SUN EXPOSURE; RISK; CALCITRIOL; THERAPY; CANCER	Background Vitamin D has been considered a key player in various malignancies including cutaneous cancers. To date, mycosis fungoides (MF) has been the least studied in relation to vitamin D. Furthermore, the vitamin D receptor (VDR) single nucleotide polymorphisms (SNPs) have not been tackled before in the context of MF, despite their incrimination in numerous diseases. Aim of study To assess the role of vitamin D in MF by measuring its serum level, and studying VDR SNPs (TaqI, BsmI, FokI) in different stages of MF. Patients and Methods 48 patients with various stages of MF, and 45 healthy controls were included. Complete history, full clinical examination and a five mm punch skin biopsy were performed to all recruited patients. Venous blood samples were withdrawn from both patients and controls to determine the serum vitamin D level and VDR gene polymorphisms. Results Serum vitamin D level was significantly lower in patients (5.3-33.7 nmol/L)] compared to controls (8.3-90.1 nmol/L)] (P<0.001). A significant difference was observed between patients and controls regarding the FokI polymorphism only, being higher in patients (P = 0.039). Also Vitamin D serum levels differed significantly in patients with FokI genotypes (P = 0.014). No significant correlations were detected between any of the studied parameters and the demographic and clinical data of the included subjects. Conclusion Depressed vitamin D and FokI polymorphism are potentially involved in the context of MF. VDR gene polymorphisms warrant further larger scale investigations to detect the exact genes involved in the pathogenesis of such an enigmatic disease.	[Rasheed, Hoda; Hegazy, Rehab A.; Gawdat, Heba I.; Kamel, Marwa M.; Fawzy, Marwa M.] Cairo Univ, Fac Med, Dept Dermatol, Cairo, Egypt; [Mehaney, Dina A.] Cairo Univ, Fac Med, Clin & Chem Pathol Dept, Cairo, Egypt; [Nooh, Mohammed M.; Darwish, Hebatallah A.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Gawdat, HI (corresponding author), Cairo Univ, Fac Med, Dept Dermatol, Cairo, Egypt.	heba.gawdat@yahoo.com		Nooh, Mohammed/0000-0001-9794-4099; Darwish, Hebatallah/0000-0001-5482-5559				Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; Adorini L, 2006, CURR TOP MED CHEM, V6, P1297, DOI 10.2174/156802606777864890; Afzal S, 2013, J INVEST DERMATOL, V133, P629, DOI 10.1038/jid.2012.395; Al-Temaimi RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142265; BAGOT M, 1995, LANCET, V346, P376; Bid Hemant Kumar, 2009, Indian J Med Sci, V63, P187, DOI 10.4103/0019-5359.53164; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Chaudhry M, 2001, CANCER CHEMOTH PHARM, V47, P429, DOI 10.1007/s002800000251; Chen TC, 2000, CLIN CANCER RES, V6, P901; Chiang KC, 2012, ANTICANCER AGENTS ME; Drake MT, 2010, J CLIN ONCOL, V28, P4191, DOI 10.1200/JCO.2010.28.6674; FRENCH LE, 1995, LANCET, V346, P376, DOI 10.1016/S0140-6736(95)92255-5; FRENCH LE, 1994, LANCET, V344, P686, DOI 10.1016/S0140-6736(94)92122-9; Girardi M, 2004, NEW ENGL J MED, V350, P1978, DOI 10.1056/NEJMra032810; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Kelly JL, 2012, CANCER CAUSE CONTROL, V23, P1017, DOI 10.1007/s10552-012-9967-0; Kim EJ, 2005, J CLIN INVEST, V115, P798, DOI 10.1172/JCI200524826; Kricker A, 2008, INT J CANCER, V122, P144, DOI 10.1002/ijc.23003; LAHIRI DK, 1993, BIOCHEM GENET, V31, P321, DOI 10.1007/BF00553174; Lips P, 2001, J CLIN ENDOCR METAB, V86, P1212, DOI 10.1210/jc.86.3.1212; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mason RS, 2012, ANTICANCER AGENTS ME; MCKENNA MJ, 1992, AM J MED, V93, P69, DOI 10.1016/0002-9343(92)90682-2; Mostafa WZ, 2015, J ADV RES, V6, P793, DOI 10.1016/j.jare.2014.01.011; Nemazannikova N, 2013, J PHARM PHARMACOL, V65, P2, DOI 10.1111/j.2042-7158.2012.01527.x; Olsen E, 2007, BLOOD, V110, P1713, DOI 10.1182/blood-2007-03-055749; Purdue MP, 2007, HAEMATOLOGICA, V92, P1145, DOI 10.3324/haematol.11053; Talpur R, 2008, BRIT J DERMATOL, V159, P105, DOI 10.1111/j.1365-2133.2008.08612.x; Talpur R, 2014, CL LYMPH MYELOM LEUK, V14, P518, DOI 10.1016/j.clml.2014.06.023; Tang J. Y., 2012, J AM ACAD DERMATOL, V67, DOI DOI 10.1016/j.jaad.2012.05.044; THOMSEN K, 1995, LANCET, V345, P1583, DOI 10.1016/S0140-6736(95)91137-5; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Uitterlinden AG, 2004, J STEROID BIOCHEM, V89-90, P187, DOI 10.1016/j.jsbmb.2004.03.083; Zasloff M, 2006, NAT MED, V12, P388, DOI 10.1038/nm0406-388	36	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158014	10.1371/journal.pone.0158014	http://dx.doi.org/10.1371/journal.pone.0158014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336155	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200090
J	Focareta, L; Cole, AG				Focareta, Laura; Cole, Alison G.			Analyses of Sox-B and Sox-E Family Genes in the Cephalopod Sepia officinalis: Revealing the Conserved and the Unusual	PLOS ONE			English	Article							NEURAL CREST DEVELOPMENT; CENTRAL-NERVOUS-SYSTEM; IDIOSEPIUS-NOTOIDES; APICAL ORGAN; INNER-EAR; EXPRESSION; EVOLUTION; CARTILAGE; NEUROGENESIS; DIFFERENTIATION	Cephalopods provide an unprecedented opportunity for comparative studies of the developmental genetics of organ systems that are convergent with analogous vertebrate structures. The Sox-family of transcription factors is an important class of DNA-binding proteins that are known to be involved in many aspects of differentiation, but have been largely unstudied in lophotrochozoan systems. Using a degenerate primer strategy we have isolated coding sequence for three members of the Sox-family of transcription factors from a cephalopod mollusk, the European cuttlefish Sepia officinalis: Sof-SoxE, Sof-SoxB1, and Sof-SoxB2. Analyses of their expression patterns during organogenesis reveals distinct spatial and temporal expression domains. Sof-SoxB1 shows early ectodermal expression throughout the developing epithelium, which is gradually restricted to presumptive sensory epithelia. Expression within the nervous system appears by mid-embryogenesis. Sof-SoxB2 expression is similar to Sof-SoxB1 within the developing epithelia in early embryogenesis, however appears in largely non-overlapping expression domains within the central nervous system and is not expressed in the maturing sensory epithelium. In contrast, Sof-SoxE is expressed throughout the presumptive mesodermal territories at the onset of organogenesis. As development proceeds, Sof-SoxE expression is elevated throughout the developing peripheral circulatory system. This expression disappears as the circulatory system matures, but expression is maintained within undifferentiated connective tissues throughout the animal, and appears within the nervous system near the end of embryogenesis. SoxB proteins are widely known for their role in neural specification in numerous phylogenetic lineages. Our data suggests that Sof-SoxB genes play similar roles in cephalopods. In contrast, Sof-SoxE appears to be involved in the early stages of vasculogenesis of the cephalopod closed circulatory system, a novel role for a member of this gene family.	[Focareta, Laura; Cole, Alison G.] Biogem Scarl, I-83031 Ariano Irpino, Italy		Cole, AG (corresponding author), Biogem Scarl, I-83031 Ariano Irpino, Italy.	agcole05@gmail.com	Cole, Alison G./J-8436-2019	Cole, Alison G./0000-0002-7515-7489	BIOGEM doctoral scholarship from the Universita degli Studi del Sannio [246680]	BIOGEM doctoral scholarship from the Universita degli Studi del Sannio	This work was supported by a BIOGEM doctoral scholarship from the Universita degli Studi del Sannio to LF and Marie Curie FP7-Reintegration Grant no. 246680: "SepiaCartilage" to AGC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1965, LOLIGO PEALII BIOLOG, V128, P24; Baratte S, 2007, DEV GENES EVOL, V217, P353, DOI 10.1007/s00427-007-0147-2; Baratte S, 2009, J COMP NEUROL, V517, P539, DOI 10.1002/cne.22174; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Buresi A, 2014, J COMP NEUROL, V522, P3004, DOI 10.1002/cne.23562; Buresi A, 2013, J COMP NEUROL, V521, P1482, DOI 10.1002/cne.23231; Buresi A, 2012, GENE EXPR PATTERNS, V12, P109, DOI 10.1016/j.gep.2012.02.001; Cole AG, 2011, EUR CELLS MATER, V21, P122, DOI 10.22203/eCM.v021a10; Cole AG, 2004, ZOOLOGY, V107, P261, DOI 10.1016/j.zool.2004.05.001; Cole AG, 2004, ACTA ZOOL-STOCKHOLM, V85, P69, DOI 10.1111/j.0001-7272.2004.00159.x; Cole AG, 2009, ZOOLOGY, V112, P2, DOI 10.1016/j.zool.2008.01.003; Cremazy F, 2001, MECH DEVELOP, V109, P371, DOI 10.1016/S0925-4773(01)00529-9; de Santa Barbara P., 2000, DEV DYNAM, V217, P293; Dong ZM, 2014, GENE, V544, P177, DOI 10.1016/j.gene.2014.04.053; Fiorito G, 2014, INVERTEBR NEUROSCI, V14, P13, DOI 10.1007/s10158-013-0165-x; Focareta L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109627; Fuchs J, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-13; Grasso FW, 2009, BRAIN BEHAV EVOLUT, V74, P231, DOI 10.1159/000258669; Guo Z, 2010, J COMP NEUROL, V518, P4395, DOI 10.1002/cne.22463; Hong CS, 2005, SEMIN CELL DEV BIOL, V16, P694, DOI 10.1016/j.semcdb.2005.06.005; Jager M, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-12; Juliano CE, 2006, DEV BIOL, V300, P406, DOI 10.1016/j.ydbio.2006.07.035; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Kerner P, 2009, EVOL DEV, V11, P513, DOI 10.1111/j.1525-142X.2009.00359.x; Kiefer JC, 2007, DEV DYNAM, V236, P2356, DOI 10.1002/dvdy.21218; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Le Gouar M, 2004, DEV GENES EVOL, V214, P250, DOI 10.1007/s00427-004-0399-z; LEMAIRE J, 1970, Bulletin de la Societe Zoologique de France, V95, P773; Lin YS, 2009, SCI CHINA SER C, V52, P813, DOI 10.1007/s11427-009-0111-7; Magie CR, 2005, DEV GENES EVOL, V215, P618, DOI 10.1007/s00427-005-0022-y; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Mattiello T, 2012, DEV DYNAM, V241, P390, DOI 10.1002/dvdy.23722; Meulemans D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000787; Meulemans D, 2007, INT J BIOL SCI, V3, P356; Miyagi S, 2009, CELL MOL LIFE SCI, V66, P3675, DOI 10.1007/s00018-009-0097-0; Moltschaniwskyj NA, 2007, REV FISH BIOL FISHER, V17, P455, DOI 10.1007/s11160-007-9056-8; Moniot B, 2004, DEVELOPMENT, V131, P3795, DOI 10.1242/dev.01259; Navet S, 2009, GENE EXPR PATTERNS, V9, P461, DOI 10.1016/j.gep.2009.08.001; Neves J, 2007, J COMP NEUROL, V503, P487, DOI 10.1002/cne.21299; Okuda Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000936; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Phochanukul N, 2010, INT J BIOCHEM CELL B, V42, P453, DOI 10.1016/j.biocel.2009.06.013; Reginensi A, 2011, HUM MOL GENET, V20, P1143, DOI 10.1093/hmg/ddq558; Romagny S, 2012, J EXP BIOL, V215, P4125, DOI 10.1242/jeb.078295; Russell S, 2000, MECH DEVELOP, V93, P185; Rychel AL, 2007, J EXP ZOOL PART B, V308B, P325, DOI 10.1002/jez.b.21157; Sandberg M, 2005, NAT NEUROSCI, V8, P995, DOI 10.1038/nn1493; Santerre C, 2014, COMP BIOCHEM PHYS A, V167, P68, DOI 10.1016/j.cbpa.2013.09.018; Scheinker V, 2005, BIOCHEM BIOPH RES CO, V338, P1204, DOI 10.1016/j.bbrc.2005.10.069; Schepers GE, 2000, NUCLEIC ACIDS RES, V28, P1473, DOI 10.1093/nar/28.6.1473; Schlierf B, 2002, NUCLEIC ACIDS RES, V30, P5509, DOI 10.1093/nar/gkf690; Schreiner S, 2007, DEVELOPMENT, V134, P3271, DOI 10.1242/dev.003350; Semmler H, 2010, DEV GROWTH DIFFER, V52, P701, DOI 10.1111/j.1440-169X.2010.01207.x; Shinzato C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-311; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Taguchi S, 2002, ZOOL SCI, V19, P57, DOI 10.2108/zsj.19.57; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; Wei Z, 2011, P NATL ACAD SCI USA, V108, P9143, DOI 10.1073/pnas.1018513108; Wilson MJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-120; Wollesen T, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0037-z; Wollesen T, 2010, CELL TISSUE RES, V342, P161, DOI 10.1007/s00441-010-1051-z; Wollesen T, 2010, EVOL DEV, V12, P113, DOI 10.1111/j.1525-142X.2010.00398.x; Yoshida M, 2010, EVOL DEV, V12, P25, DOI 10.1111/j.1525-142X.2009.00388.x; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhong L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016570	66	17	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157821	10.1371/journal.pone.0157821	http://dx.doi.org/10.1371/journal.pone.0157821			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27331398	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212800052
J	Mosing, M; Waldmann, AD; MacFarlane, P; Iff, S; Auer, U; Bohm, SH; Bettschart-Wolfensberger, R; Bardell, D				Mosing, Martina; Waldmann, Andreas D.; MacFarlane, Paul; Iff, Samuel; Auer, Ulrike; Bohm, Stephan H.; Bettschart-Wolfensberger, Regula; Bardell, David			Horses Auto-Recruit Their Lungs by Inspiratory Breath Holding Following Recovery from General Anaesthesia	PLOS ONE			English	Article							ELECTRICAL-IMPEDANCE TOMOGRAPHY; BLOOD-FLOW DISTRIBUTION; ANESTHETIZED HORSE; VENTILATION; PERFUSION; INFANTS; SURGERY; INJURY; VOLUME; EIT	This study evaluated the breathing pattern and distribution of ventilation in horses prior to and following recovery from general anaesthesia using electrical impedance tomography (EIT). Six horses were anaesthetised for 6 hours in dorsal recumbency. Arterial blood gas and EIT measurements were performed 24 hours before (baseline) and 1, 2, 3, 4, 5 and 6 hours after horses stood following anaesthesia. At each time point 4 representative spontaneous breaths were analysed. The percentage of the total breath length during which impedance remained greater than 50% of the maximum inspiratory impedance change (breath holding), the fraction of total tidal ventilation within each of four stacked regions of interest (ROI) (distribution of ventilation) and the filling time and inflation period of seven ROI evenly distributed over the dorsoventral height of the lungs were calculated. Mixed effects multi-linear regression and linear regression were used and significance was set at p<0.05. All horses demonstrated inspiratory breath holding until 5 hours after standing. No change from baseline was seen for the distribution of ventilation during inspiration. Filling time and inflation period were more rapid and shorter in ventral and slower and longer in most dorsal ROI compared to baseline, respectively. In a mixed effects multi-linear regression, breath holding was significantly correlated with PaCO2 in both the univariate and multivariate regression. Following recovery from anaesthesia, horses showed inspiratory breath holding during which gas redistributed from ventral into dorsal regions of the lungs. This suggests auto-recruitment of lung tissue which would have been dependent and likely atelectic during anaesthesia.	[Mosing, Martina; Bettschart-Wolfensberger, Regula] Univ Zurich, Vetsuisse Fac, Zurich, Switzerland; [Waldmann, Andreas D.; Bohm, Stephan H.] Swisstom AG, Landquart, Switzerland; [Iff, Samuel] Univ Bern, CTU Bern, Bern, Switzerland; [Bardell, David] Univ Liverpool, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England; [Auer, Ulrike] Vet Univ Vienna, A-1030 Vienna, Austria; [MacFarlane, Paul] Univ Bristol, Langford Vet Serv, Bristol, Avon, England	University of Zurich; University of Bern; University of Liverpool; University of Veterinary Medicine Vienna; University of Bristol	Bardell, D (corresponding author), Univ Liverpool, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England.	david.bardell@liverpool.ac.uk	Waldmann, Andreas/AAA-1892-2021	Waldmann, Andreas/0000-0002-4917-7347; Iff, Samuel/0000-0002-4441-5465; MacFarlane, Paul/0000-0002-3167-4855; Mosing, Martina/0000-0002-6190-5642; Ulrike, Auer/0000-0003-0390-2678	Stiftung Forschung fur das Pferd [F-53320-03-01]	Stiftung Forschung fur das Pferd	Stiftung Forschung fur das Pferd, http://www.forschungpferd.ch/, funded the study. Grant (reference number F-53320-03-01) was awarded to Martina Mosing at University of Zurich, Switzerland. The funder (Stiftung Forschung fur das Pferd) provided support in the form of consumables, running costs and purchase of the horses used in the study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding of authors' salaries was provided and the specific roles of the authors are articulated in the "author contributions" section.	Adler A, 2006, PHYSIOL MEAS, V27, pS25, DOI 10.1088/0967-3334/27/5/S03; Adler A, 2009, PHYSIOL MEAS, V30, pS35, DOI 10.1088/0967-3334/30/6/S03; AMIS TC, 1984, AM J VET RES, V45, P1597; Berggren SM., 1942, ACTA PHYSIOL SCAND, V4, P4, DOI [10.1111/j.1365-201X.1942.tb11004.x, DOI 10.1111/J.1365-201X.1942.TB11004.X]; Costa ELV, 2008, CRIT CARE MED, V36, P1230, DOI 10.1097/CCM.0b013e31816a0380; Costa ELV, 2009, CURR OPIN CRIT CARE, V15, P18, DOI 10.1097/MCC.0b013e3283220e8c; Curtis R A, 2006, Equine Vet J Suppl, P567; DOBSON A, 1985, Q J EXP PHYSIOL CMS, V70, P283, DOI 10.1113/expphysiol.1985.sp002909; EICHENWALD EC, 1993, J APPL PHYSIOL, V75, P2665, DOI 10.1152/jappl.1993.75.6.2665; Figueiredo JP, 2012, AM J VET RES, V73, P799, DOI 10.2460/ajvr.73.6.799; Frerichs I, 2002, IEEE T MED IMAGING, V21, P646, DOI 10.1109/TMI.2002.800585; Frerichs I, 2006, AM J RESP CRIT CARE, V174, P772, DOI 10.1164/rccm.200512-1942OC; Gaggero PO, 2012, PHYSIOL MEAS, V33, P831, DOI 10.1088/0967-3334/33/5/831; HAHN G, 1995, PHYSIOL MEAS, V16, pA161, DOI 10.1088/0967-3334/16/3A/016; Hlastala MP, 1996, J APPL PHYSIOL, V81, P1051, DOI 10.1152/jappl.1996.81.3.1051; JOLLY S, 1995, EQUINE VET J S, V18, P13; Kalchofner KS, 2009, VET ANAESTH ANALG, V36, P426, DOI 10.1111/j.1467-2995.2009.00477.x; KOSCH PC, 1984, J APPL PHYSIOL, V57, P1126, DOI 10.1152/jappl.1984.57.4.1126; Kowalczyk L, 2014, VET ANAESTH ANALG, V41, P592, DOI 10.1111/vaa.12151; LITTLEJO.A, 1970, BRIT VET J, V126, P617, DOI 10.1016/S0007-1935(17)48019-5; Love EJ, 2006, VET ANAESTH ANALG, V33, P179, DOI 10.1111/j.1467-2995.2005.00247.x; Mosing M, 2016, VET ANAESTH ANALG, V43, P611, DOI 10.1111/vaa.12357; Muders T, 2012, CRIT CARE MED, V40, P903, DOI 10.1097/CCM.0b013e318236f452; NYMAN G, 1989, EQUINE VET J, V21, P274, DOI 10.1111/j.2042-3306.1989.tb02167.x; NYMAN G, 1990, EQUINE VET J, V22, P317, DOI 10.1111/j.2042-3306.1990.tb04280.x; Radke OC, 2012, ANESTHESIOLOGY, V116, P1227, DOI 10.1097/ALN.0b013e318256ee08; Schaefer MS, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-51; Schramel J, 2012, RESP PHYSIOL NEUROBI, V180, P258, DOI 10.1016/j.resp.2011.11.018; Victorino JA, 2004, AM J RESP CRIT CARE, V169, P791, DOI 10.1164/rccm.200301-133OC; Vogt B, 2012, J APPL PHYSIOL, V113, P1154, DOI 10.1152/japplphysiol.01630.2011; Wolf GK, 2013, CRIT CARE MED, V41, P1296, DOI 10.1097/CCM.0b013e3182771516; Young S., 1989, Journal of the Association of Veterinary Anaesthetists of Great Britain and Ireland, V16, P24, DOI 10.1111/j.1467-2995.1989.tb00064.x	32	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0158080	10.1371/journal.pone.0158080	http://dx.doi.org/10.1371/journal.pone.0158080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27331910	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000378212800075
J	Jona, A; Miltenyi, Z; Poliska, S; Balint, BL; Illes, A				Jona, Adam; Miltenyi, Zsofia; Poliska, Szilard; Balint, Balint Laszlo; Illes, Arpad			Effect of Bleomycin Hydrolase Gene Polymorphism on Late Pulmonary Complications of Treatment for Hodgkin Lymphoma	PLOS ONE			English	Article							GERM-CELL CANCER; CHEMOTHERAPY; EXPRESSION; TOXICITY; CLONING	Background Bleomycin hydrolase (BLMH), an enzyme that inactivates bleomycin, may be a potential candidate that could influence pulmonary function in ABVD (doxorubicin, bleomycin, vin-blastin, dacarbasine)-treated Hodgkin lymphoma (HL) patients. Patients and Methods We hypothesized that the BLMH gene SNP A1450G (rs1050565) influences BLMH activity and late pulmonary toxicity. St. George Respiratory Questionnaire, lung scintigraphy and spirometry were used to determine lung function. TaqMan genotyping assay was used to determine genotype distribution of 131 previously treated HL patients. Results Significantly more favorable results were seen in the wild-type A/A genotype group than those in the group containing the mutated allele: A/G+G/G in retrospective pulmonary tests of ABVD treated patients. Conclusion Besides limitations of the current study, bleomycin pharmacokinetics should be further evaluated in patients with BLMH variations, hence identify those cases even in the frontline setting, where bleomycin should be omitted and replaced with targeted therapy.	[Jona, Adam; Miltenyi, Zsofia; Illes, Arpad] Univ Debrecen, Dept Hematol, Fac Med, Debrecen, Hungary; [Poliska, Szilard; Balint, Balint Laszlo] Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Genom Med & Bioinformat Core Facil, Debrecen, Hungary	University of Debrecen; University of Debrecen	Jona, A (corresponding author), Univ Debrecen, Dept Hematol, Fac Med, Debrecen, Hungary.	jona.adam1@gmail.com		Balint, Balint/0000-0002-6163-7190				Avivi I, 2012, ANN HEMATOL, V91, P215, DOI 10.1007/s00277-011-1255-7; Bromme D, 1996, BIOCHEMISTRY-US, V35, P6706, DOI 10.1021/bi960092y; de Haas EC, 2008, J CLIN ONCOL, V26, P1817, DOI 10.1200/JCO.2007.14.1606; Dorr R T, 1992, Semin Oncol, V19, P3; Ferrando AA, 1996, CANCER RES, V56, P1746; Froudarakis M, 2013, CRIT REV ONCOL HEMAT, V87, P90, DOI 10.1016/j.critrevonc.2012.12.003; Jona A, 2014, EXPERT OPIN DRUG SAF, V13, P1291, DOI 10.1517/14740338.2014.946901; Koldamova RP, 1998, BIOCHEMISTRY-US, V37, P2282, DOI 10.1021/bi9722204; MORRIS G, 1992, MOL PHARMACOL, V42, P57; Nuver J, 2005, PHARMACOGENET GENOM, V15, P399, DOI 10.1097/01213011-200506000-00005; OKEN MM, 1981, CANCER TREAT REP, V65, P485; Sleijfer S, 2001, CHEST, V120, P617, DOI 10.1378/chest.120.2.617; Tuimala J, 2002, CARCINOGENESIS, V23, P1003, DOI 10.1093/carcin/23.6.1003; UMEZAWA H, 1966, J ANTIBIOT, V19, P200	14	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157651	10.1371/journal.pone.0157651	http://dx.doi.org/10.1371/journal.pone.0157651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327270	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400029
J	Hautea, DM; Taylo, LD; Masanga, APL; Sison, MLJ; Narciso, JO; Quilloy, RB; Hautea, RA; Shotkoski, FA; Shelton, AM				Hautea, Desiree M.; Taylo, Lourdes D.; Masanga, Anna Pauleen L.; Sison, Maria Luz J.; Narciso, Josefina O.; Quilloy, Reynaldo B.; Hautea, Randy A.; Shotkoski, Frank A.; Shelton, Anthony M.			Field Performance of Bt Eggplants (Solanum melongena L.) in the Philippines: Cry1Ac Expression and Control of the Eggplant Fruit and Shoot Borer (Leucinodes orbonalis Guenee)	PLOS ONE			English	Article							BASE-LINE SENSITIVITY; INSECTICIDAL PROTEIN; HELICOVERPA-ARMIGERA; TRANSGENIC COTTON; FARMERS HEALTH; TOXIN; CROPS; GENE; LEPIDOPTERA; VARIABILITY	Plants expressing Cry proteins from the bacterium, Bacillus thuringiensis (Bt), have become a major tactic for controlling insect pests in maize and cotton globally. However, there are few Bt vegetable crops. Eggplant (Solanum melongena) is a popular vegetable grown throughout Asia that is heavily treated with insecticides to control the eggplant fruit and shoot borer, Leucinodes orbonalis (EFSB). Herein we provide the first publicly available data on field performance in Asia of eggplant engineered to produce the Cry1Ac protein. Replicated field trials with five Bt eggplant open-pollinated (OP) lines from transformation event EE-1 and their non-Bt comparators were conducted over three cropping seasons in the Philippines from 2010-2012. Field trials documented levels of Cry1Ac protein expressed in plants and evaluated their efficacy against the primary target pest, EFSB. Cry1Ac concentrations ranged from 0.75-24.7 ppm dry weight with the highest in the terminal leaves (or shoots) and the lowest in the roots. Cry1Ac levels significantly increased from the vegetative to the reproductive stage. Bt eggplant lines demonstrated excellent control of EFSB. Pairwise analysis of means detected highly significant differences between Bt eggplant lines and their non-Bt comparators for all field efficacy parameters tested. Bt eggplant lines demonstrated high levels of control of EFSB shoot damage (98.6-100%) and fruit damage (98.1-99.7%) and reduced EFSB larval infestation (95.8-99.3%) under the most severe pest pressure during trial 2. Moths that emerged from larvae collected from Bt plants in the field and reared in their Bt eggplant hosts did not produce viable eggs or offspring. These results demonstrate that Bt eggplant lines containing Cry1Ac event EE-1 provide outstanding control of EFSB and can dramatically reduce the need for conventional insecticides.	[Hautea, Desiree M.; Taylo, Lourdes D.; Masanga, Anna Pauleen L.; Sison, Maria Luz J.; Narciso, Josefina O.; Quilloy, Reynaldo B.] Univ Philippines Los Banos, Coll Agr, CSC, Inst Plant Breeding, Laguna 4031, Philippines; [Hautea, Randy A.] Int Serv Acquisit Agribiotech Applicat, Los Banos 4030, Laguna, Philippines; [Shotkoski, Frank A.] Cornell Univ, Int Programs, Ithaca, NY 14853 USA; [Shelton, Anthony M.] Cornell NYSAES, Dept Entomol, Geneva, NY 14456 USA	University of the Philippines System; University of the Philippines Los Banos; Cornell University	Hautea, DM (corresponding author), Univ Philippines Los Banos, Coll Agr, CSC, Inst Plant Breeding, Laguna 4031, Philippines.	dmh.uplb@gmail.com			United States Agency for International Development (USAID) [GDG-A-00-02-00017-00]; Republic of the Philippines Department of Agriculture- Biotechnology Program Office (DA-Biotech BPO); University of the Philippine Los Banos (UPLB); United States Agency for International Development (USAID) through Cornell University Agricultural Biotechnology Support Project II (ABSPII); Instiute of the Plant Breeding, College of Agriculture, University of the Philippine Los Banos (UPLB)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Republic of the Philippines Department of Agriculture- Biotechnology Program Office (DA-Biotech BPO); University of the Philippine Los Banos (UPLB); United States Agency for International Development (USAID) through Cornell University Agricultural Biotechnology Support Project II (ABSPII)(United States Agency for International Development (USAID)); Instiute of the Plant Breeding, College of Agriculture, University of the Philippine Los Banos (UPLB)	This research was funded through the United States Agency for International Development (USAID Cooperative Agreement GDG-A-00-02-00017-00) to Cornell University Agricultural Biotechnology Support Project II (ABSPII), and matching funds from the Republic of the Philippines Department of Agriculture- Biotechnology Program Office (DA-Biotech BPO) and the University of the Philippine Los Banos (UPLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the critical support and valuable contributions of these institutions. This research was co-funded by the United States Agency for International Development (USAID) through Cornell University Agricultural Biotechnology Support Project II (ABSPII), the Republic of the Philippines Department of Agriculture-Biotechnology Program Office (DA-Biotech BPO) and the Instiute of the Plant Breeding, College of Agriculture, University of the Philippine Los Banos (UPLB). We thank the Maharashtra Hybrid Seeds Co. Pvt. Ltd. (Mahyco) for providing access to eggplant event EE-1 and regulatory-related information, and for various technical assistance/advice in the conduct of laboratory and field activities; and Cornell University and Sathguru Management Consultants for facilitating the technology transfer. We also acknowledge the assistance of UPLB Foundation Inc., the executing agency for the ABSPII project in the Philippines.	Adamczyk JJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.32; Adamczyk JJ, 2001, J ECON ENTOMOL, V94, P284, DOI 10.1603/0022-0493-94.1.284; Adamczyk John J. Jr., 2001, Journal of Insect Science (Tucson), V1, P1; Alam SN, 2003, AVRDC TECHNICAL B, V28; Andersson HC, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1879; [Anonymous], 2007, SER HARM REG OV BIOT, V42; [Anonymous], 2009, REP EXP COMM E UNPUB; Bakhsh A, 2011, CZECH J GENET PLANT, V47, P1, DOI 10.17221/131/2010-CJGPB; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Center for Environmental Risk Assessment ( CERA), 2013, GM CROP DAT; Center for Environmental Risk Assessment ILSI Research Foundation, 2011, Environ Biosafety Res, V10, P27, DOI 10.1051/ebr:2012002; Chen S, 2009, ACTA GOSSYPII SINICA, V12, P189; Chupungco AR, 2011, PHILIPP J CROP SCI, V36, P37; Del Prado-Lu JL, 2015, ENVIRON HEALTH PREV, V20, P53, DOI 10.1007/s12199-014-0425-3; Dong HZ, 2007, J AGRON CROP SCI, V193, P21, DOI 10.1111/j.1439-037X.2006.00240.x; Fearing PL, 1997, MOL BREEDING, V3, P169, DOI 10.1023/A:1009611613475; Fitt G, 1998, PEST MANAGEMENT - FUTURE CHALLENGES, VOLS 1 AND 2, PROCEEDINGS, P189; Francisco S. R, 2009, PROJECTED IMPACTS AG, P35; Francisco SR, 2014, SOCIOECONOMIC IMPACT, P205; Gregory P, 2008, EXP AGR, V44, P277, DOI 10.1017/S0014479708006352; Guevarra MLD, 2012, PHILIPP J CROP SCI, V37, P81; Guo Wang-Zhen, 2001, Acta Genetica Sinica, V28, P668; Hautea DM, 2011, TRANSGENIC HORTICULTURAL CROPS: CHALLENGES AND OPPORTUNITIES, P155; Hautea DM, 2016, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.ks.13, DOI 10.5061/DRYAD.KS.13]; HOBBS SLA, 1993, PLANT MOL BIOL, V21, P17, DOI 10.1007/BF00039614; Holt H, 1998, 9 AUSTR COTT C P, P331; Jalali SK, 2010, PEST MANAG SCI, V66, P809, DOI 10.1002/ps.1963; James C., 2013, GLOBAL STATUS COMMER; Kennedy George G., 2008, V5, P1; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Koch MS, 2012, REV FOOD SAFETY BT C, P305; Kranthi KR, 2005, CURR SCI INDIA, V89, P291; Krishna VV, 2008, AGR ECON-BLACKWELL, V38, P167, DOI 10.1111/j.1574-0862.2008.00290.x; Lu JL, 2012, PHILIPP J CROP SCI, V37, P93; Mahon R., 2002, AUST COTTON GROWER, V22, P18; Mainali RP., 2014, INT J APPL SCI BIOTE, V2, P18, DOI DOI 10.3126/IJASBT.V2I1.10001; Murenga M., 2012, African Journal of Biotechnology, V11, P11181; Naranjon Steven E., 2008, V5, P159, DOI 10.1007/978-1-4020-8373-0_6; National Seed Industry Council, POL GUID TEST VEG CR; Olsen KM, 2005, J ECON ENTOMOL, V98, P1382, DOI 10.1603/0022-0493-98.4.1382; Olsen KM, 2005, J ECON ENTOMOL, V98, P1007, DOI 10.1603/0022-0493-98.3.1007; Panda Niranjan, 1995; Philippines Statistics Authority-Bureau of Agricultural Statistics, CROPSTAT 2005 2014; Poongothai S., 2010, J PLANT BREED CROP S, V2, P96; Quicoy C., 2010, PRODUCTIVITY TECHNIC; Quicoy C., 2014, SOCIOECONOMIC IMPACT, P97; Ranjithkumar L, 2013, CURR SCI INDIA, V105, P366; Rao CK, TRANSGENIC BT TECHNO; Ripalda RR, 2012, PHILIPP J CROP SCI, V37, P1; Salunke PB, 2014, BIOSCAN S, V9, P313; SAS INSTITUTE, 2001, SAS STAT 9 US GUID; Shelton AM, 2010, CROP PROT, V29, P412, DOI 10.1016/j.cropro.2010.02.016; Shelton Anthony M, 2012, GM Crops Food, V3, P175, DOI 10.4161/gmcr.19762; Szekacs A, 2010, ENVIRON TOXICOL CHEM, V29, P182, DOI 10.1002/etc.5; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; Talekar NS, 2002, AVRDC PUBLICATION, V02-534; Wan P, 2005, J ECON ENTOMOL, V98, P195, DOI 10.1603/0022-0493-98.1.195; Wang Fei, 2014, Australian Journal of Crop Science, V8, P18; Wu G, 2002, THEOR APPL GENET, V104, P727, DOI 10.1007/s001220100689; Xia LanQin, 2005, Acta Agronomica Sinica, V31, P197	60	18	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157498	10.1371/journal.pone.0157498	http://dx.doi.org/10.1371/journal.pone.0157498			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322533	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212000019
J	Obruca, S; Sedlacek, P; Krzyzanek, V; Mravec, F; Hrubanova, K; Samek, O; Kucera, D; Benesova, P; Marova, I				Obruca, Stanislav; Sedlacek, Petr; Krzyzanek, Vladislav; Mravec, Filip; Hrubanova, Kamila; Samek, Ota; Kucera, Dan; Benesova, Pavla; Marova, Ivana			Accumulation of Poly(3-hydroxybutyrate) Helps Bacterial Cells to Survive Freezing	PLOS ONE			English	Article							INTRACELLULAR ICE FORMATION; POLYHYDROXYALKANOATE PRODUCTION; PSEUDOMONAS; PROTEIN; PROTECTION	Accumulation of polyhydroxybutyrate (PHB) seems to be a common metabolic strategy adopted by many bacteria to cope with cold environments. This work aimed at evaluating and understanding the cryoprotective effect of PHB. At first a monomer of PHB, 3-hydroxybutyrate, was identified as a potent cryoprotectant capable of protecting model enzyme (lipase), yeast (Saccharomyces cerevisiae) and bacterial cells (Cupriavidus necator) against the adverse effects of freezing-thawing cycles. Further, the viability of the frozen-thawed PHB accumulating strain of C. necator was compared to that of the PHB non-accumulating mutant. The presence of PHB granules in cells was revealed to be a significant advantage during freezing. This might be attributed to the higher intracellular level of 3-hydroxybutyrate in PHB accumulating cells (due to the action of parallel PHB synthesis and degradation, the so-called PHB cycle), but the cryoprotective effect of PHB granules seems to be more complex. Since intracellular PHB granules retain highly flexible properties even at extremely low temperatures (observed by cryo-SEM), it can be expected that PHB granules protect cells against injury from extracellular ice. Finally, thermal analysis indicates that PHB-containing cells exhibit a higher rate of transmembrane water transport, which protects cells against the formation of intracellular ice which usually has fatal consequences.	[Obruca, Stanislav; Sedlacek, Petr; Mravec, Filip; Kucera, Dan; Benesova, Pavla; Marova, Ivana] Brno Univ Technol, Fac Chem, Mat Res Ctr, Purkynova 118, Brno 61200, Czech Republic; [Krzyzanek, Vladislav; Hrubanova, Kamila; Samek, Ota] Acad Sci Czech Republ, Vvi, Inst Sci Instruments, Kralovopolska 147, Brno 61264, Czech Republic	Brno University of Technology; Czech Academy of Sciences; Institute of Scientific Instruments of the Czech Academy of Sciences	Obruca, S (corresponding author), Brno Univ Technol, Fac Chem, Mat Res Ctr, Purkynova 118, Brno 61200, Czech Republic.	Stana.O@seznam.cz	Márová, Ivana/AAI-7406-2020; Mravec, Filip/G-7170-2015; Krzyzanek, Vladislav/C-6275-2008; Hrubanová, Kamila KD/D-3799-2012; Samek, Ota/E-2887-2013	Mravec, Filip/0000-0001-6114-4751; Krzyzanek, Vladislav/0000-0002-7996-2979; Hrubanová, Kamila KD/0000-0002-1872-7748; Samek, Ota/0000-0001-8188-7608; Obruca, Stanislav/0000-0002-9270-195X; Sedlacek, Petr/0000-0002-6211-9643; Kucera, Dan/0000-0002-3750-5964	project "Materials Research Centre at FCH BUT - Sustainability and Development" of the Ministry of Education, Youth and Sports of the Czech Republic [LO1211]; Czech Science Foundation (GACR) [GA15-20645S]	project "Materials Research Centre at FCH BUT - Sustainability and Development" of the Ministry of Education, Youth and Sports of the Czech Republic; Czech Science Foundation (GACR)(Grant Agency of the Czech Republic)	This study was funded by the project "Materials Research Centre at FCH BUT - Sustainability and Development" No. LO1211 of the Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz, LO1211) and by the project GA15-20645S of the Czech Science Foundation (GACR, https://gacr.cz/, GA15-20645S) to SO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MM, 2000, BIOTECHNOL APPL BIOC, V32, P145, DOI 10.1042/BA20000014; Ayub ND, 2007, PLASMID, V58, P240, DOI 10.1016/j.plasmid.2007.05.003; Ayub ND, 2009, EXTREMOPHILES, V13, P59, DOI 10.1007/s00792-008-0197-z; Baek K.-H., 2012, JACEN, V1, P43, DOI [10.4236/jacen.2012.11006, DOI 10.4236/JACEN.2012.11006]; BONTHRONE KM, 1992, FEMS MICROBIOL LETT, V103, P269, DOI 10.1111/j.1574-6968.1992.tb05848.x; BREDA M, 1992, CRYOBIOLOGY, V29, P281, DOI 10.1016/0011-2240(92)90027-Y; Brigham CJ, 2012, APPL ENVIRON MICROB, V78, P8033, DOI 10.1128/AEM.01693-12; Ciesielski S, 2014, CURR MICROBIOL, V69, P594, DOI 10.1007/s00284-014-0629-1; Coder DM, 1997, CURRENT PROTOCOLS CY; De Maayer P, 2014, EMBO REP, V15, P508, DOI 10.1002/embr.201338170; Doan VT, 2013, APPL MICROBIOL BIOT, V97, P6271, DOI 10.1007/s00253-012-4528-8; Fuller BJ, 2004, CRYOLETTERS, V25, P375; Goh LK, 2014, APPL BIOCHEM BIOTECH, V172, P1585, DOI 10.1007/s12010-013-0634-z; Goh YS, 2012, MICROBIOL RES, V167, P211, DOI 10.1016/j.micres.2011.08.002; Goller K, 1999, J MOL CATAL B-ENZYM, V7, P37, DOI 10.1016/S1381-1177(99)00043-0; Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4; Iustman LJR, 2008, FEMS MICROBIOL LETT, V284, P218, DOI DOI 10.1111/J.1574-6968.2008.01203.X; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jendrossek D, 2014, ENVIRON MICROBIOL, V16, P2357, DOI 10.1111/1462-2920.12356; Kadouri D, 2005, CRIT REV MICROBIOL, V31, P55, DOI 10.1080/10408410590899228; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; Mezzina MP, 2015, ENVIRON MICROBIOL, V17, P1765, DOI 10.1111/1462-2920.12636; Mori S, 2012, CRYOBIOLOGY, V65, P242, DOI 10.1016/j.cryobiol.2012.06.010; Obruca S, 2016, APPL MICROBIOL BIOT, V100, P1365, DOI 10.1007/s00253-015-7162-4; Obruca S, 2014, APPL MICROBIOL BIOT, V98, P5883, DOI 10.1007/s00253-014-5653-3; Otun SO, 2015, PHARM RES-DORDR, V32, P1316, DOI 10.1007/s11095-014-1535-8; Panoff JM, 1998, CRYOBIOLOGY, V36, P75, DOI 10.1006/cryo.1997.2069; Pastor JM, 2010, BIOTECHNOL ADV, V28, P782, DOI 10.1016/j.biotechadv.2010.06.005; Pavez P, 2009, CURR MICROBIOL, V59, P636, DOI 10.1007/s00284-009-9485-9; Pinsirodom P., 2001, CURRENT PROTOCOLS FO; Raberg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095907; Roberts Mary F, 2005, Saline Syst, V1, P5, DOI 10.1186/1746-1448-1-5; Ruiz JA, 2001, APPL ENVIRON MICROB, V67, P225, DOI 10.1128/AEM.67.1.225-230.2001; Seki S, 2009, CRYOBIOLOGY, V58, P157, DOI 10.1016/j.cryobiol.2008.11.011; Sorokulova I, 2015, APPL MICROBIOL BIOT, V99, P5397, DOI 10.1007/s00253-015-6681-3; Soto G, 2012, EXTREMOPHILES, V16, P455, DOI 10.1007/s00792-012-0445-0; Sudesh K, 2000, CAN J MICROBIOL, V46, P304, DOI 10.1139/cjm-46-4-304; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; TAMIYA T, 1985, CRYOBIOLOGY, V22, P446, DOI 10.1016/0011-2240(85)90156-7; URIBELARREA JL, 1985, BIOTECHNOL LETT, V7, P75, DOI 10.1007/BF01026672	41	55	56	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157778	10.1371/journal.pone.0157778	http://dx.doi.org/10.1371/journal.pone.0157778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315285	Green Published, gold, Green Submitted			2022-12-26	WOS:000378030000055
J	Zawbaa, HM; Szlek, J; Grosan, C; Jachowicz, R; Mendyk, A				Zawbaa, Hossam M.; Szlek, Jakub; Grosan, Crina; Jachowicz, Renata; Mendyk, Aleksander			Computational Intelligence Modeling of the Macromolecules Release from PLGA Microspheres-Focus on Feature Selection	PLOS ONE			English	Article							DRUG-DELIVERY	Poly-lactide-co-glycolide (PLGA) is a copolymer of lactic and glycolic acid. Drug release from PLGA microspheres depends not only on polymer properties but also on drug type, particle size, morphology of microspheres, release conditions, etc. Selecting a subset of relevant properties for PLGA is a challenging machine learning task as there are over three hundred features to consider. In this work, we formulate the selection of critical attributes for PLGA as a multiobjective optimization problem with the aim of minimizing the error of predicting the dissolution profile while reducing the number of attributes selected. Four bioinspired optimization algorithms: antlion optimization, binary version of antlion optimization, grey wolf optimization, and social spider optimization are used to select the optimal feature set for predicting the dissolution profile of PLGA. Besides these, LASSO algorithm is also used for comparisons. Selection of crucial variables is performed under the assumption that both predictability and model simplicity are of equal importance to the final result. During the feature selection process, a set of input variables is employed to find minimum generalization error across different predictive models and their settings/architectures. The methodology is evaluated using predictive modeling for which various tools are chosen, such as Cubist, random forests, artificial neural networks (monotonic MLP, deep learning MLP), multivariate adaptive regression splines, classification and regression tree, and hybrid systems of fuzzy logic and evolutionary computations (fugeR). The experimental results are compared with the results reported by Szl.k. We obtain a normalized root mean square error (NRMSE) of 15.97% versus 15.4%, and the number of selected input features is smaller, nine versus eleven.	[Zawbaa, Hossam M.; Grosan, Crina] Univ Babes Bolyai, Fac Math & Comp Sci, R-3400 Cluj Napoca, Romania; [Zawbaa, Hossam M.] Beni Suef Univ, Fac Comp & Informat, Bani Suwayf, Egypt; [Szlek, Jakub; Jachowicz, Renata; Mendyk, Aleksander] Jagiellonian Univ, Coll Med, Dept Pharmaceut Technol & Biopharmaceut, Krakow, Poland; [Grosan, Crina] Brunel Univ, Coll Engn Design & Phys Sci, London, England	Babes Bolyai University from Cluj; Egyptian Knowledge Bank (EKB); Beni Suef University; Jagiellonian University; Collegium Medicum Jagiellonian University; Brunel University	Zawbaa, HM (corresponding author), Univ Babes Bolyai, Fac Math & Comp Sci, R-3400 Cluj Napoca, Romania.; Zawbaa, HM (corresponding author), Beni Suef Univ, Fac Comp & Informat, Bani Suwayf, Egypt.	hossam.zawbaa@gmail.com	Zawbaa, Hossam M./O-6203-2014; Grosan, Crina/B-8435-2011	Zawbaa, Hossam M./0000-0001-6548-2993; Szlek, Jakub/0000-0003-1537-9650; Mendyk, Aleksander/0000-0002-4394-9115; Grosan, Crina/0000-0003-1049-2136	IPROCOM Marie Curie initial training network through the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grants [316555]; Romanian National Authority for Scientific Research, CNDI-UEFISCDI [PN-II-PT-PCCA-2011-3.2-0917]	IPROCOM Marie Curie initial training network through the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grants; Romanian National Authority for Scientific Research, CNDI-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was supported by the IPROCOM Marie Curie initial training network, funded through the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grants agreement No. 316555, and by the Romanian National Authority for Scientific Research, CNDI-UEFISCDI, project number PN-II-PT-PCCA-2011-3.2-0917.	Aiello S, 2015, CONTRIBUTIONS H2O AI; Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004; [Anonymous], 2009, ICH Q8R2 PHARM DEV T; Barat A, 2008, J PHARMACEUT BIOMED, V48, P361, DOI 10.1016/j.jpba.2008.02.031; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2016, RANDOM FORESTS; Breiman L., 2017, CLASSIFICATION REGRE; Bujard A, 2012, FUGER FUZZY GENETIC; Cannon AJ, 2015, MONMLP MONOTONE MULT; Chung TW, 2006, J MICROENCAPSUL, V23, P15, DOI 10.1080/02652040500286110; Corrigan OI, 2009, EUR J PHARM SCI, V37, P477, DOI 10.1016/j.ejps.2009.04.004; Cuevas E, 2013, EXPERT SYST APPL, V40, P6374, DOI 10.1016/j.eswa.2013.05.041; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Davies S., 1994, IEEE AAAI FALL S REL, P37; Emary E, 2016, NEUROCOMPUTING, V172, P371, DOI 10.1016/j.neucom.2015.06.083; Emary E, 2015, ADV INTELL SYST, V334, P1, DOI 10.1007/978-3-319-13572-4_1; Fister I, 2013, ELEKTROTEH VESTN, V80, P116; Fredenberg S, 2011, INT J PHARMACEUT, V415, P34, DOI 10.1016/j.ijpharm.2011.05.049; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Hong Zhang, 1999, IJCNN'99. International Joint Conference on Neural Networks. Proceedings (Cat. No.99CH36339), P1820, DOI 10.1109/IJCNN.1999.832655; Jones TC, 2008, ANIM BEHAV, V76, P2011, DOI 10.1016/j.anbehav.2008.07.033; Kapoor DN, 2015, THER DELIV, V6, P41, DOI [10.4155/tde.14.91, 10.4155/TDE.14.91]; Karr C., 1991, AI Expert, V6, P26; Kim Y., 2004, P 21 INT C MACHINE L, P60; Kuhn M, 2014, C CODE CUBIST R QUIN; Meng XB, 2016, J EXP THEOR ARTIF IN, V28, P673, DOI 10.1080/0952813X.2015.1042530; Milborrow S., 2011, EARTH MULTIVARIATE A; Mirjalili S, 2015, ADV ENG SOFTW, V83, P80, DOI 10.1016/j.advengsoft.2015.01.010; Mirjalili S, 2014, ADV ENG SOFTW, V69, P46, DOI 10.1016/j.advengsoft.2013.12.007; Ojha VK, 2015, INT J NANOMED, V10, P1119, DOI 10.2147/IJN.S71847; Quinlan J. R., 1992, Proceedings of the 5th Australian Joint Conference on Artificial Intelligence. AI '92, P343; Rantanen J, 2015, J PHARM SCI-US, V104, P3612, DOI 10.1002/jps.24594; Sammut C, 2010, ENCY MACHINE LEARNIN, DOI [10.1007/978-0-387-30164-8_11, 10.1007/978-0-387-30164-8]; Segura C, 2015, GECCO'15: PROCEEDINGS OF THE 2015 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P489, DOI 10.1145/2739480.2754802; Szlek J, 2013, INT J NANOMED, V8, P4601, DOI 10.2147/IJN.S53364; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; US Food & Drug Administration, 2004, GUID IND PAT FRAM IN; Valdez F, 2015, SPRINGER HANDBOOK OF COMPUTATIONAL INTELLIGENCE, P1533; Versypt ANF, 2014, COMPUT CHEM ENG, V71, P241, DOI 10.1016/j.compchemeng.2014.05.022; Versypt ANF, 2013, J CONTROL RELEASE, V165, P29, DOI 10.1016/j.jconrel.2012.10.015; Yang LJ, 2016, EXPERT SYST APPL, V44, P156, DOI 10.1016/j.eswa.2015.08.034; YAO X, 1993, INT J INTELL SYST, V8, P539, DOI 10.1002/int.4550080406; Yip EC, 2008, P NATL ACAD SCI USA, V105, P11818, DOI 10.1073/pnas.0710603105; Zawbaa HM, NEUROCOMPUT IN PRESS; Zawbaa HM, 2015, 7 INT C SOFT COMP PA	46	13	14	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157610	10.1371/journal.pone.0157610	http://dx.doi.org/10.1371/journal.pone.0157610			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315205	Green Published, gold			2022-12-26	WOS:000378030000041
J	Dupuy, AM; Curinier, C; Kuster, N; Huet, F; Leclercq, F; Davy, JM; Cristol, JP; Roubille, F				Dupuy, Anne Marie; Curinier, Corentin; Kuster, Nils; Huet, Fabien; Leclercq, Florence; Davy, Jean Marc; Cristol, Jean Paul; Roubille, Francois			Multi-Marker Strategy in Heart Failure: Combination of ST2 and CRP Predicts Poor Outcome	PLOS ONE			English	Article							SOLUBLE ST2; ROC CURVE	Natriuretic peptides (BNP and NT-proBNP) are recognized as gold-standard predictive markers in Heart Failure (HF). However, currently ST2 (member of the interleukin 1 receptor family) has emerged as marker of inflammation, fibrosis and cardiac stress. We evaluated ST2 and CRP as prognostic markers in 178 patients with chronic heart failure in comparison with other classical markers such as clinical established parameters but also biological markers: NT-proBNP, hs-cTnT alone or in combination. In multivariate analysis, subsequent addition of ST2 led to age, CRP and ST2 as the only remaining predictors of all-cause mortality (HR 1.03, HR 1.61 and HR 2.75, respectively) as well as of cardiovascular mortality (HR 1.00, HR 2.27 and HR 3.78, respectively). The combined increase of ST2 and CRP was significant for predicting worsened outcomes leading to identify a high risk subgroup that individual assessment of either marker. The same analysis was performed with ST2 in combination with Barcelona score. Overall, our findings extend previous data demonstrating that ST2 in combination with CRP as a valuable tool for identifying patients at risk of death.	[Dupuy, Anne Marie; Kuster, Nils; Cristol, Jean Paul] Univ Hosp Montpellier, Ctr Ressources Biol Montpellier, Dept Biochem, Montpellier, France; [Curinier, Corentin; Huet, Fabien; Leclercq, Florence; Davy, Jean Marc; Roubille, Francois] Univ Hosp Montpellier, Dept Cardiol, Montpellier, France; [Cristol, Jean Paul; Roubille, Francois] Univ Montpellier, CNRS UMR 9214, INSERM, PhyMedExp,U1046, F-34059 Montpellier, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Roubille, F (corresponding author), Univ Hosp Montpellier, Dept Cardiol, Montpellier, France.; Roubille, F (corresponding author), Univ Montpellier, CNRS UMR 9214, INSERM, PhyMedExp,U1046, F-34059 Montpellier, France.	francois.roubille@gmail.com		dupuy, anne marie/0000-0001-6538-3944				Araujo JP, 2009, J CARD FAIL, V15, P256, DOI 10.1016/j.cardfail.2008.10.030; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Dieplinger B, 2015, CLIN CHIM ACTA, V443, P57, DOI 10.1016/j.cca.2014.09.021; Dieplinger B, 2009, CLIN CHIM ACTA, V409, P33, DOI 10.1016/j.cca.2009.08.010; Gaggin HK, 2013, BBA-MOL BASIS DIS, V1832, P2442, DOI 10.1016/j.bbadis.2012.12.014; Heringlake M, 2013, J AM COLL CARDIOL, V61, P672, DOI 10.1016/j.jacc.2012.09.059; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Kempf T, 2007, J AM COLL CARDIOL, V50, P1054, DOI 10.1016/j.jacc.2007.04.091; Kempf Tibor, 2009, Heart Fail Clin, V5, P537, DOI 10.1016/j.hfc.2009.04.006; Lassus J, 2013, INT J CARDIOL, V168, P2186, DOI 10.1016/j.ijcard.2013.01.228; Lupon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085466; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Nagarajan V, 2012, HEART, V98, P1778, DOI 10.1136/heartjnl-2012-301779; Oshikawa K, 2002, AM J RESP CRIT CARE, V165, P1005, DOI 10.1164/ajrccm.165.7.2105109; Oshikawa K, 2001, AM J RESP CRIT CARE, V164, P277, DOI 10.1164/ajrccm.164.2.2008120; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Roubille F, 2014, EXPERT REV CARDIOVAS, V12, P111, DOI 10.1586/14779072.2013.839942; Sun RR, 2014, EUR REV MED PHARMACO, V18, P2927; Tajima S, 2007, EXP LUNG RES, V33, P81, DOI 10.1080/01902140701198583; Wu AHB, 2003, AM J CARDIOL, V92, P628, DOI 10.1016/S0002-9149(03)00741-0	23	25	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157159	10.1371/journal.pone.0157159	http://dx.doi.org/10.1371/journal.pone.0157159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311068	gold, Green Published, Green Submitted			2022-12-26	WOS:000378029800038
J	Gowanlock, Z; Sriram, S; Martin, A; Xenocostas, A; Lazo-Langner, A				Gowanlock, Zachary; Sriram, Swetha; Martin, Alison; Xenocostas, Anargyros; Lazo-Langner, Alejandro			Erythropoietin Levels in Elderly Patients with Anemia of Unknown Etiology	PLOS ONE			English	Article							QUALITY-OF-LIFE; UNEXPLAINED ANEMIA; RISK; EQUATION; COHORT; IMPACT	Background In many elderly patients with anemia, a specific cause cannot be identified. This study investigates whether erythropoietin levels are inappropriately low in these cases of "anemia of unknown etiology" and whether this trend persists after accounting for confounders. Methods This study includes all anemic patients over 60 years old who had erythropoietin measured between 2005 and 2013 at a single center. Three independent reviewers used defined criteria to assign each patient's anemia to one of ten etiologies: chronic kidney disease, iron deficiency, chronic disease, confirmed myelodysplastic syndrome (MDS), suspected MDS, vitamin B-12 deficiency, folate deficiency, anemia of unknown etiology, other etiology, or multifactorial etiology. Iron deficiency anemia served as the comparison group in all analyses. We used linear regression to model the relationship between erythropoietin and the presence of each etiology, sequentially adding terms to the model to account for the hemoglobin concentration, estimated glomerular filtration rate (eGFR) and Charlson Comorbidity Index. Results A total of 570 patients met the inclusion criteria. Linear regression analysis showed that erythropoietin levels in chronic kidney disease, anemia of chronic disease and anemia of unknown etiology were lower by 48%, 46% and 27%, respectively, compared to iron deficiency anemia even after adjusting for hemoglobin, eGFR and comorbidities. Conclusions We have shown that erythropoietin levels are inappropriately low in anemia of unknown etiology, even after adjusting for confounders. This suggests that decreased erythropoietin production may play a key role in the pathogenesis of anemia of unknown etiology.	[Gowanlock, Zachary; Sriram, Swetha; Martin, Alison; Xenocostas, Anargyros; Lazo-Langner, Alejandro] Univ Western Ontario, Div Hematol, Dept Med, London, ON, Canada; [Xenocostas, Anargyros; Lazo-Langner, Alejandro] Univ Western Ontario, Dept Oncol, London, ON, Canada; [Lazo-Langner, Alejandro] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Lazo-Langner, A (corresponding author), Univ Western Ontario, Div Hematol, Dept Med, London, ON, Canada.; Lazo-Langner, A (corresponding author), Univ Western Ontario, Dept Oncol, London, ON, Canada.; Lazo-Langner, A (corresponding author), Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada.	alejandro.lazolangner@lhsc.on.ca	Xenocostas, Anargyros/G-3358-2011; Lazo-Langner, Alejandro/E-6993-2011; Lazo-Langner, Alejandro/G-3318-2011	Lazo-Langner, Alejandro/0000-0001-6869-8431; Lazo-Langner, Alejandro/0000-0001-6869-8431	Program of Experimental Medicine, Department of Medicine, Western University; Janssen Inc.	Program of Experimental Medicine, Department of Medicine, Western University; Janssen Inc.(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This study was partially funded by the Program of Experimental Medicine, Department of Medicine, Western University. AX has received funding from Janssen Inc., not related to the present work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artz AS, 2011, J GERONTOL A-BIOL, V66, P925, DOI 10.1093/gerona/glr090; Balducci L, 2006, CRIT REV ONCOL HEMAT, V58, P156, DOI 10.1016/j.critrevonc.2005.09.003; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Denny WA, 2012, J MED CHEM, V55, P2943, DOI 10.1021/jm300314a; Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599; Ferrucci L, 2007, BRIT J HAEMATOL, V136, P849, DOI 10.1111/j.1365-2141.2007.06502.x; Ferrucci L, 2006, ARCH INTERN MED, V166, P1380, DOI 10.1001/archinte.166.13.1380; Giagounidis A, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.92.92; HIROTA Y, 1988, EUR J HAEMATOL, V40, P83; Jelkmann W, 1998, J INTERF CYTOK RES, V18, P555, DOI 10.1089/jir.1998.18.555; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Juarez-Cedillo T, 2014, ANN HEMATOL, V93, P2057, DOI 10.1007/s00277-014-2155-4; Kling PJ, 1996, BRIT J HAEMATOL, V95, P241, DOI 10.1046/j.1365-2141.1996.d01-1919.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lucca U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001920; Malgor L. A., 1998, Acta Physiologica Pharmacologica et Therapeutica Latinoamericana, V48, P99; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Mercadal L, 2012, CLIN J AM SOC NEPHRO, V7, P35, DOI 10.2215/CJN.04690511; Peterson TJ, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.273.273; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Sriram S, 2016, HEMATOLOGY; Sriram S, ERYTHROPOIETIN ANEMI; Thein M, 2009, MEDICINE, V88, P107, DOI 10.1097/MD.0b013e31819d89d5; World Health Organization, 2011, SER FERR CONC ASS IR; Xu CL, 2014, BIOL TRACE ELEM RES, V162, P142, DOI 10.1007/s12011-014-0166-6; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214	29	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157279	10.1371/journal.pone.0157279	http://dx.doi.org/10.1371/journal.pone.0157279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310832	gold, Green Submitted, Green Published			2022-12-26	WOS:000378029800050
J	Kassem, A; Lindholm, C; Lerner, UH				Kassem, Ali; Lindholm, Catharina; Lerner, Ulf H.			Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL	PLOS ONE			English	Article							NF-KAPPA-B; PORPHYROMONAS-GINGIVALIS; RHEUMATOID-ARTHRITIS; SEPTIC ARTHRITIS; OSTEOMYELITIS; DIFFERENTIATION; ACTIVATION; EXPRESSION; INDUCTION; CYTOKINES	Severe Staphylococcus aureus (S. aureus) infections pose an immense threat to population health and constitute a great burden for the health care worldwide. Inter alia, S. aureus septic arthritis is a disease with high mortality and morbidity caused by destruction of the infected joints and systemic bone loss, osteoporosis. Toll-Like receptors (TLRs) are innate immune cell receptors recognizing a variety of microbial molecules and structures. S. aureus recognition via TLR2 initiates a signaling cascade resulting in production of various cytokines, but the mechanisms by which S. aureus causes rapid and excessive bone loss are still unclear. We, therefore, investigated how S. aureus regulates periosteal/endosteal osteoclast formation and bone resorption. S. aureus stimulation of neonatal mouse parietal bone induced ex vivo bone resorption and osteoclastic gene expression. This effect was associated with increased mRNA and protein expression of receptor activator of NF-kappa B ligand (RANKL) without significant change in osteoprotegerin (OPG) expression. Bone resorption induced by S. aureus was abolished by OPG. S. aureus increased the expression of osteoclastogenic cytokines and prostaglandins in the parietal bones but the stimulatory effect of S. aureus on bone resorption and Tnfsf11 mRNA expression was independent of these cytokines and prostaglandins. Stimulation of isolated periosteal osteoblasts with S. aureus also resulted in increased expression of Tnfsf11 mRNA, an effect lost in osteoblasts from Tlr2 knockout mice. S. aureus stimulated osteoclastogenesis in isolated periosteal cells without affecting RANKL-stimulated resorption. In contrast, S. aureus inhibited RANKL-induced osteoclast formation in bone marrow macrophages. These data show that S. aureus enhances bone resorption and periosteal osteoclast formation by increasing osteoblast RANKL production through TLR2. Our study indicates the importance of using different in vitro approaches for studies of how S. aureus regulates osteoclastogenesis to obtain better understanding of the complex mechanisms of S. aureus induced bone destruction in vivo.	[Kassem, Ali; Lerner, Ulf H.] Umea Univ, Dept Mol Periodontol, Umea, Sweden; [Lindholm, Catharina; Lerner, Ulf H.] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Ctr Bone & Arthrit Res,Inst Med, Gothenburg, Sweden; [Lindholm, Catharina] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	Umea University; University of Gothenburg; University of Gothenburg	Lerner, UH (corresponding author), Umea Univ, Dept Mol Periodontol, Umea, Sweden.; Lerner, UH (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Ctr Bone & Arthrit Res,Inst Med, Gothenburg, Sweden.	ulf.lerner@umu.se		Lerner, Ulf/0000-0002-3579-1960	Swedish Research Council; County Council of Vasterbotten; Swedish National Graduate School in Odontological Sciences; Swedish Rheumatism Association; Royal 80-Year Fund of King Gustav V; Lundberg Foundation; COMBINE; ALF/LUA research grant from Sahlgrenska University Hospital in Gothenburg	Swedish Research Council(Swedish Research CouncilEuropean Commission); County Council of Vasterbotten; Swedish National Graduate School in Odontological Sciences; Swedish Rheumatism Association; Royal 80-Year Fund of King Gustav V; Lundberg Foundation(European Commission); COMBINE; ALF/LUA research grant from Sahlgrenska University Hospital in Gothenburg	This work was supported by The Swedish Research Council, the County Council of Vasterbotten, the Swedish National Graduate School in Odontological Sciences, the Swedish Rheumatism Association, the Royal 80-Year Fund of King Gustav V, COMBINE, ALF/LUA research grant from Sahlgrenska University Hospital in Gothenburg and the Lundberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2006, PEDIATR RES, V59, P96, DOI 10.1203/01.pdr.0000191137.12774.b2; Belli E, 2002, J CRANIOFAC SURG, V13, P765, DOI 10.1097/00001665-200211000-00010; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; BREMELL T, 1991, INFECT IMMUN, V59, P2615, DOI 10.1128/IAI.59.8.2615-2623.1991; BREMELL T, 1992, INFECT IMMUN, V60, P2976, DOI 10.1128/IAI.60.7.2976-2985.1992; Calfee DP, 2012, CURR OPIN INFECT DIS, V25, P385, DOI 10.1097/QCO.0b013e3283553441; Chen QB, 2014, CELL PHYSIOL BIOCHEM, V34, P1890, DOI 10.1159/000366387; Choo MK, 2009, BONE, V45, P579, DOI 10.1016/j.bone.2009.05.009; Claro T, 2013, MICROBIOL-SGM, V159, P147, DOI 10.1099/mic.0.063016-0; Conaway HH, 2011, J BIOL CHEM, V286, P31425, DOI 10.1074/jbc.M111.247734; Conaway HH, 2009, FASEB J, V23, P3526, DOI 10.1096/fj.09-132548; Costa AG, 2011, NAT REV RHEUMATOL, V7, P447, DOI 10.1038/nrrheum.2011.77; Dhaliwal Sandeep, 2012, Am J Orthop (Belle Mead NJ), V41, pE100; Dodwell ER, 2013, CURR OPIN PEDIATR, V25, P58, DOI 10.1097/MOP.0b013e32835c2b42; Edwards JR, 2011, NAT REV RHEUMATOL, V7, P235, DOI 10.1038/nrrheum.2011.23; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Garcia-Arias M, 2011, BEST PRACT RES CL RH, V25, P407, DOI 10.1016/j.berh.2011.02.001; Granholm S, 2007, J ENDOCRINOL, V195, P415, DOI 10.1677/JOE-07-0338; Granholm S, 2013, BONE, V52, P83, DOI 10.1016/j.bone.2012.09.019; Herman S, 2008, ARTHRITIS RHEUM-US, V58, P3041, DOI 10.1002/art.23943; Ji JD, 2009, J IMMUNOL, V183, P7223, DOI 10.4049/jimmunol.0900072; Kassem A, 2015, J BIOL CHEM, V290, P20147, DOI 10.1074/jbc.M115.655787; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim J, 2013, J BONE MINER RES, V28, P2381, DOI 10.1002/jbmr.1973; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kishimoto T, 2012, J PERIODONTAL RES, V47, P446, DOI 10.1111/j.1600-0765.2011.01452.x; Koga K, 2002, NAT MED, V11, P880; Lerner UH, 1998, CLIN ORTHOP RELAT R, P244; LERNER UH, 1987, J BONE MINER RES, V2, P375; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; LJUNGGREN O, 1991, J BONE MINER RES, V6, P543; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Matsumoto C, 2012, BIOCHEM BIOPH RES CO, V428, P110, DOI 10.1016/j.bbrc.2012.10.016; Meghji S, 1998, BRIT J RHEUMATOL, V37, P1095; Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]; Nagano F, 2013, J PERIODONTAL RES, V48, P420, DOI 10.1111/jre.12021; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Pacifici R, 1996, J BONE MINER RES, V11, P1043; Peltola H, 2014, NEW ENGL J MED, V370, P352, DOI 10.1056/NEJMra1213956; Sanchez CJ, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-187; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Sims NA, 2014, CALCIFIED TISSUE INT, V94, P2, DOI 10.1007/s00223-013-9766-y; Sims NA, 2010, BMB REP, V43, P513, DOI 10.5483/BMBRep.2010.43.8.513; Somayaji SN, 2008, INFECT IMMUN, V76, P5120, DOI 10.1128/IAI.00228-08; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Suzaki A, 2014, J ORTHOP RES, V32, P910, DOI 10.1002/jor.22627; Takayanagi H, 2012, NAT REV RHEUMATOL, V8, P684, DOI 10.1038/nrrheum.2012.167; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tarkowski A, 2006, BEST PRACT RES CL RH, V20, P1029, DOI 10.1016/j.berh.2006.08.001; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tong SYC, 2012, SEMIN IMMUNOPATHOL, V34, P185, DOI 10.1007/s00281-011-0300-x; Trouillet-Assant S, 2015, J INFECT DIS, V211, P571, DOI 10.1093/infdis/jiu386; Verdrengh M, 2007, J ORTHOP RES, V25, P304, DOI 10.1002/jor.20317; Verdrengh M, 2010, BONE, V46, P752, DOI 10.1016/j.bone.2009.10.028; Walsh MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00511; Widaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040586; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Wright JA, 2010, INT J MED MICROBIOL, V300, P193, DOI 10.1016/j.ijmm.2009.10.003; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang J, 2009, J LEUKOCYTE BIOL, V86, P823, DOI 10.1189/jlb.0309206; Young AB, 2011, BONE, V48, P857, DOI 10.1016/j.bone.2010.11.015; Zanotti S, 2011, J BIOL CHEM, V286, P4576, DOI 10.1074/jbc.M110.161893; Zhang P, 2011, J BIOL CHEM, V286, P24159, DOI 10.1074/jbc.M110.198085; Zhuang LF, 2014, CLIN ORAL IMPLANTS R	65	40	44	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156708	10.1371/journal.pone.0156708	http://dx.doi.org/10.1371/journal.pone.0156708			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311019	gold, Green Submitted, Green Published			2022-12-26	WOS:000378029800012
J	Munyan, BG; Neer, SM; Beidel, DC; Jentsch, F				Munyan, Benson G., III; Neer, Sandra M.; Beidel, Deborah C.; Jentsch, Florian			Olfactory Stimuli Increase Presence in Virtual Environments	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; REALITY EXPOSURE THERAPY; ANXIETY DISORDERS; MEMORY; PREVALENCE; COMORBIDITY; EXTINCTION; ODORS; CUES; CARE	Background Exposure therapy (EXP) is the most empirically supported treatment for anxiety and trauma-related disorders. EXP consists of repeated exposure to a feared object or situation in the absence of the feared outcome in order to extinguish associated anxiety. Key to the success of EXP is the need to present the feared object/event/situation in as much detail and utilizing as many sensory modalities as possible, in order to augment the sense of presence during exposure sessions. Various technologies used to augment the exposure therapy process by presenting multi-sensory cues (e.g., sights, smells, sounds). Studies have shown that scents can elicit emotionally charged memories, but no prior research has examined the effect of olfactory stimuli upon the patient's sense of presence during simulated exposure tasks. Methods 60 adult participants navigated a mildly anxiety-producing virtual environment (VE) similar to those used in the treatment of anxiety disorders. Participants had no autobiographical memory associated with the VE. State anxiety, Presence ratings, and electrodermal (EDA) activity were collected throughout the experiment. Results Utilizing a Bonferroni corrected Linear Mixed Model, our results showed statistically significant relationships between olfactory stimuli and presence as assessed by both the Igroup Presence Questionnaire (IPQ: R-2 = 0.85, (F(3,52) = 6.625, p = 0.0007) and a single item visual-analogue scale (R-2 = 0.85, (F(3,52) = 5.382, p = 0.0027). State anxiety was unaffected by the presence or absence of olfactory cues. EDA was unaffected by experimental condition. Conclusion Olfactory stimuli increase presence in virtual environments that approximate those typical in exposure therapy, but did not increase EDA. Additionally, once administered, the removal of scents resulted in a disproportionate decrease in presence. Implications for incorporating the use of scents to increase the efficacy of exposure therapy is discussed.	[Munyan, Benson G., III; Neer, Sandra M.; Beidel, Deborah C.; Jentsch, Florian] Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Munyan, BG (corresponding author), Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA.	benson.munyan@knights.ucf.edu			Sigma Xi, The Scientific Research Society	Sigma Xi, The Scientific Research Society	This research was supported by a Grant-In-Aid of Research from Sigma Xi, The Scientific Research Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a Grant-In-Aid of Research from Sigma Xi, The Scientific Research Society. We wish to thank Fallen Planet Studios for VE consulting and creation. We also wish to thank Aaron Necaise and Vincent Van Berkum who were instrumental in data collection.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Beidel DC, 2011, J ANXIETY DISORD, V25, P224, DOI 10.1016/j.janxdis.2010.09.006; Blanchard EB, 2003, BEHAV RES THER, V41, P79, DOI 10.1016/S0005-7967(01)00131-0; Bouchard Stephane, 2006, Technol Health Care, V14, P19; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Carlson N. R., 2013, PHYSL BEHAV; Chen Y, 2006, 16 INT C ART REAL TE; Chu S, 2002, MEM COGNITION, V30, P511, DOI 10.3758/BF03194952; Copeland WE, 2007, ARCH GEN PSYCHIAT, V64, P577, DOI 10.1001/archpsyc.64.5.577; Davey HM, 2007, J CLIN EPIDEMIOL, V60, P356, DOI 10.1016/j.jclinepi.2006.07.015; Delahanty DL, 1997, J CONSULT CLIN PSYCH, V65, P560, DOI 10.1037/0022-006X.65.4.560; Difede J, 2002, CYBERPSYCHOL BEHAV, V5, P529, DOI 10.1089/109493102321018169; Dinh HQ, 1999, VIRT REAL 1999 P IEE; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Emmelkamp PMG, 2001, CYBERPSYCHOL BEHAV, V4, P335, DOI 10.1089/109493101300210222; Fleurkens P, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.21359; Foa EB., 2006, PATHOLOGICAL ANXIETY, P3, DOI DOI 10.1037/0022-006X.72.5.879; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Hasson D., 2005, International Electronic Journal of Health Education, V8, P178; Herz RS, 2000, SCIENCES, V40, P34, DOI 10.1002/j.2326-1951.2000.tb03507.x; Herz RS, 1998, ANN NY ACAD SCI, V855, P670, DOI 10.1111/j.1749-6632.1998.tb10643.x; Hodges LF, 1994, GITGVU9406; Hoffman H. G., 1998, Virtual Reality, V3, P226, DOI 10.1007/BF01408703; Ijsselsteijn W, 2001, PRESENCE-TELEOP VIRT, V10, P298, DOI 10.1162/105474601300343621; Jackman AH, 2005, LARYNGOSCOPE, V115, P2209, DOI 10.1097/01.mlg.0000183194.17484.bb; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KLINE NA, 1985, J CLIN PSYCHIAT, V46, P383; Kolasinski E. M., 1995, SIMULATOR SICKNESS V; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; LEON AC, 1995, BRIT J PSYCHIAT, V166, P19, DOI 10.1192/S0007125000293355; Lepine JP, 2002, J CLIN PSYCHIAT, V63, P4; Lombard M., 1997, J COMPUT-MEDIAT COMM, V3, DOI DOI 10.1111/J.1083-6101.1997.TB00072.X; McLay RN, 2011, CYBERPSYCH BEH SOC N, V14, P223, DOI 10.1089/cyber.2011.0003; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Owens ME, 2013, DOES VIRTUAL REALITY; Pavlov I. P., 1902, WORK DIGESTIVE GLAND; Penny K. I., 1996, J R STAT SOC C-APPL, V45, P73, DOI 10.2307/2986224; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Pietrzak RH, 2011, PSYCHIAT RES, V189, P251, DOI 10.1016/j.psychres.2011.07.019; Powers MB, 2008, J ANXIETY DISORD, V22, P561, DOI 10.1016/j.janxdis.2007.04.006; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Proust M, 1925, SWANNS WAY; Reips UD, 2008, BEHAV RES METHODS, V40, P699, DOI 10.3758/BRM.40.3.699; Rescorla RA, 2006, J EXP PSYCHOL ANIM B, V32, P135, DOI 10.1037/0097-7403.32.2.135; Rescorla RA, 2000, J EXP PSYCHOL ANIM B, V26, P251, DOI 10.1037//0097-7403.26.3.251; Resick PA, 2012, J CONSULT CLIN PSYCH, V80, P201, DOI 10.1037/a0026602; Rizzo A, 2010, ANN NY ACAD SCI, V1208, P114, DOI 10.1111/j.1749-6632.2010.05755.x; Rothbaum BO, 2001, J CLIN PSYCHIAT, V62, P617, DOI 10.4088/JCP.v62n0808; Schubert T, 2001, PRESENCE-VIRTUAL AUG, V10, P266, DOI 10.1162/105474601300343603; Schuemie MJ, 2001, CYBERPSYCHOL BEHAV, V4, P183, DOI 10.1089/109493101300117884; Short J., 1976, SOCIAL PSYCHOL TELEC; Slater M, 1999, IEEE COMPUT GRAPH, V19, P6, DOI 10.1109/38.749116; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; SPIELBERGER CD, 1984, J PERS ASSESS, V48, P95; Spoont MR, 2014, PSYCHIAT SERV, V65, P654, DOI 10.1176/appi.ps.201200324; Vermetten E, 2003, J CLIN PSYCHIAT, V64, P202, DOI 10.4088/JCP.v64n0214; Watson JB, 1920, J EXP PSYCHOL, V3, P1, DOI 10.1037/h0069608; Welzl H, 2001, BEHAV BRAIN RES, V125, P205, DOI 10.1016/S0166-4328(01)00302-3; Wiederhold BK, 2002, IEEE T INF TECHNOL B, V6, P218, DOI 10.1109/TITB.2002.802378; Wilson D. A., 2006, LEARNING SMELL; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686	65	27	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157568	10.1371/journal.pone.0157568	http://dx.doi.org/10.1371/journal.pone.0157568			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310253	Green Submitted, Green Published, gold			2022-12-26	WOS:000378029800098
J	Rahman, MM; Rahman, MM; Tareque, MI; Ferdos, J; Jesmin, SS				Rahman, Md. Mosfequr; Rahman, Md. Mizanur; Tareque, Md. Ismail; Ferdos, Jannatul; Jesmin, Syeda S.			Maternal Pregnancy Intention and Professional Antenatal Care Utilization in Bangladesh: A Nationwide Population-Based Survey	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; SUB-SAHARAN AFRICA; UNINTENDED PREGNANCY; PRENATAL-CARE; HEALTH-CARE; REPRODUCTIVE HEALTH; INDUCED-ABORTION; WOMEN; SERVICES; ASSOCIATION	Objective To investigate the association between maternal pregnancy intention and professional antenatal and delivery care utilization. Methods Our data were derived from the 2011 nationally representative Bangladesh Demographic Health Survey. We included antenatal and delivery care utilization data of the most recent live births for women for the previous three years (n = 4672). We used multilevel logistic regression models to assess the relationship between pregnancy intention and use of professional antenatal and delivery care, with adjustment for potential confounding variables. Results Approximately 13% and 16% of children were reported by their mothers as unwanted and mistimed at the time of conception, respectively. Among the women, 55% received at least one professional antenatal care service; 21% received four or more professional antenatal services, while 32% were attended by professionals during deliveries. Mothers of children whose pregnancies had been unwanted had a greater risk for not seeking professional antenatal and professional delivery care than those whose pregnancies had been wanted [1 >= ANC from professionals: AOR: 0.66; 95% CI: 0.51-0.93; 4 >= ANC from professionals: AOR: 0.56; 95% CI: 0.37-0.84; and delivery care from professionals: AOR: 0.70; 95% CI: 0.50-0.97]. Women who were married after age 18, had secondary or higher level of education, and were from the wealthiest households were more likely to utilize antenatal and delivery care. Conclusion Unwanted pregnancy is significantly associated with lower utilization of professional antenatal and delivery care services in Bangladesh. Reducing unwanted births and promoting access to professional antenatal and delivery care are crucial for achieving the Sustainable Development Goals (SDGs) 3 in Bangladesh.	[Rahman, Md. Mosfequr; Rahman, Md. Mizanur; Tareque, Md. Ismail; Ferdos, Jannatul] Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh; [Rahman, Md. Mizanur] Univ Tokyo, Sch Int Hlth, Dept Global Hlth Policy, Tokyo, Japan; [Jesmin, Syeda S.] Univ N Texas, Dept Sociol, Dallas, TX USA	University of Rajshahi; University of Tokyo; University of North Texas System	Rahman, MM (corresponding author), Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh.	mosfeque@gmail.com	Rahman, Md. Mosfequr/D-9107-2017; Rahman, Mosfequr/D-2973-2011	Rahman, Md. Mosfequr/0000-0002-2402-5814; Rahman, Mosfequr/0000-0002-2402-5814; Tareque, Md Ismail/0000-0002-6507-1171				Acharya DR, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-15; Alio AP, 2011, INT J GYNECOL OBSTET, V112, P83, DOI 10.1016/j.ijgo.2010.08.024; Anwar I, 2008, B WORLD HEALTH ORGAN, V86, P252, DOI 10.2471/BLT.07.042754; Anwar I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120309; Bangladesh Bureau of Statistics [BBS], 2011, REPORT OF THE HOUSEH; Barrett G, 2002, SOC SCI MED, V55, P545, DOI 10.1016/S0277-9536(01)00187-3; Bernstein S, 2005, STUD FAMILY PLANN, V36, P127, DOI 10.1111/j.1728-4465.2005.00050.x; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Carroli G, 2001, PAEDIATR PERINAT EP, V15, P1; Cripe SM, 2008, INT J GYNECOL OBSTET, V100, P104, DOI 10.1016/j.ijgo.2007.08.003; Dibaba Y, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-50; Eggleston E, 2000, SOC SCI MED, V51, P1011, DOI 10.1016/S0277-9536(00)00010-1; El Arifeen S, 2014, LANCET, V384, P1366, DOI 10.1016/S0140-6736(14)60955-7; Erol N, 2010, EUR J CONTRACEP REPR, V15, P290, DOI 10.3109/13625187.2010.500424; Exavery A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-35; Fanslow J, 2008, AUST NZ J OBSTET GYN, V48, P391, DOI 10.1111/j.1479-828X.2008.00866.x; Furuta M, 2006, INT FAM PLAN PERSPEC, V32, P17, DOI 10.1363/3201706; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gausia K, 2009, PSYCHOL MED, V39, P999, DOI 10.1017/S0033291708004455; Gross K, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-16; Guliani H, 2014, HEALTH POLICY PLANN, V29, P589, DOI 10.1093/heapol/czt045; Hindin MJ, 2008, DHS ANALYTICAL STUDI; Jejeebhoy SJ, 1995, WOMENS EDUCATION AUT; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Koenig MA, 2007, INT FAM PLAN PERSPEC, V33, P75, DOI 10.1363/3307507; Kost K, 1998, FAM PLANN PERSPECT, V30, P79, DOI 10.2307/2991664; Magadi MA, 2007, SOC SCI MED, V64, P1311, DOI 10.1016/j.socscimed.2006.11.004; Marcus SM, 2009, PRIMARY CARE, V36, P151, DOI 10.1016/j.pop.2008.10.011; Marston C, 2003, POP STUD-J DEMOG, V57, P77, DOI 10.1080/0032472032000061749; Mayer JP, 1997, BIRTH-ISS PERINAT C, V24, P247, DOI 10.1111/j.1523-536X.1997.tb00598.x; Moore AM, 2010, SOC SCI MED, V70, P1737, DOI 10.1016/j.socscimed.2010.02.009; Nasreen HE, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-22; National Institute of Population Research and Training (NIPORT), 2015, ICF INTERNATIONAL BA; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2013, BANGLADESH DEMOGRAPH; National Institute of Population Research and Training (NIPORT); Mitra and Associates; and Macro International, 2009, BANGLADESH DEMOGRAPH; Nicolaidis C, 2007, J GEN INTERN MED, V22, P1216, DOI 10.1007/s11606-007-0262-9; Pallitto CC, 2013, INT J GYNECOL OBSTET, V120, P3, DOI 10.1016/j.ijgo.2012.07.003; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Rahman M, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0095-7; Rahman M, 2014, ASIA-PAC J PUBLIC HE, V26, P160, DOI 10.1177/1010539511423301; Rahman M, 2012, J INTERPERS VIOLENCE, V27, P2999, DOI 10.1177/0886260512441072; Rahman M, 2012, MATERN CHILD HLTH J, V16, P1206, DOI 10.1007/s10995-011-0897-3; Rahman M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-913; Rutstein S., 2004, DHS COMPARATIVE REPO; Santelli J, 2003, PERSPECT SEX REPRO H, V35, P94, DOI 10.1111/j.1931-2393.2003.tb00111.x; Schmidt JO, 2010, HEALTH POLICY, V96, P98, DOI 10.1016/j.healthpol.2010.01.008; Silverman JG, 2007, BJOG-INT J OBSTET GY, V114, P1246, DOI 10.1111/j.1471-0528.2007.01481.x; Singh A, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1481, DOI 10.1177/1010539513498769; Singh A, 2012, POP STUD-J DEMOG, V66, P223, DOI 10.1080/00324728.2012.697568; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; Stephenson R, 2012, PUBLIC HEALTH REP, V127, P96; Taft AJ, 2015, AUST NZ J PUBL HEAL, V39, P177, DOI 10.1111/1753-6405.12339; Twisk JWR, 2006, APPLIED MULTILEVEL A; United Nations, 2015, TRANSFORMING OUR WOR; Wado YD, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-36	55	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157760	10.1371/journal.pone.0157760	http://dx.doi.org/10.1371/journal.pone.0157760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27309727	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800133
J	Shen, AL; Moran, SA; Glover, EA; Drinkwater, NR; Swearingen, RE; Teixeira, LB; Bradfield, CA				Shen, Anna L.; Moran, Susan A.; Glover, Edward A.; Drinkwater, Norman R.; Swearingen, Rebecca E.; Teixeira, Leandro B.; Bradfield, Christopher A.			Association of a Chromosomal Rearrangement Event with Mouse Posterior Polymorphous Corneal Dystrophy and Alterations in Csrp2bp, Dzank1, and Ovol2 Gene Expression	PLOS ONE			English	Article							IRIDOCORNEAL ENDOTHELIAL SYNDROME; VIII COLLAGEN; GENOME-WIDE; MUTATIONS; ATAC; MICE; GENERATION; COMPLEX; COL8A2; CELLS	We have previously described a mouse model of human posterior polymorphous corneal dystrophy (PPCD) and localized the causative mutation to a 6.2 Mbp region of chromosome 2, termed Ppcd1. We now show that the gene rearrangement linked to mouse Ppcd1 is a 3.9 Mbp chromosomal inversion flanked by 81 Kbp and 542 bp deletions. This recombination event leads to deletion of Csrp2bp Exons 8 through 11, Dzank1 Exons 20 and 21, and the pseudogene Znf133. In addition, we identified translocation of novel downstream sequences to positions adjacent to Csrp2bp Exon 7 and Dzank1 Exon 20. Twelve novel fusion transcripts involving Csrp2bp or Dzank1 linked to downstream sequences have been identified. Eight are expressed at detectable levels in PPCD1 but not wildtype eyes. Upregulation of two Csrp2bp fusion transcripts, as well as upregulation of the adjacent gene, Ovol2, was observed. Absence of the PPCD1 phenotype in animals haploinsufficient for Csrp2bp or both Csrp2bp and Dzank1 rules out haploinsufficiency of these genes as a cause of mouse PPCD1. Complementation experiments confirm that PPCD1 embryonic lethality is due to disruption of Csrp2bp expression. The ocular expression pattern of Csrp2bp is consistent with a role for this protein in corneal development and pathogenesis of PPCD1.	[Shen, Anna L.; Moran, Susan A.; Glover, Edward A.; Drinkwater, Norman R.; Swearingen, Rebecca E.; Bradfield, Christopher A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI USA; [Teixeira, Leandro B.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Bradfield, Christopher A.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI USA; [Shen, Anna L.; Teixeira, Leandro B.; Bradfield, Christopher A.] Univ Wisconsin, McPherson Eye Res Inst, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shen, AL; Bradfield, CA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI USA.; Bradfield, CA (corresponding author), Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI USA.; Shen, AL; Bradfield, CA (corresponding author), Univ Wisconsin, McPherson Eye Res Inst, Madison, WI USA.	alshen@wisc.edu; bradfield@oncology.wisc.edu	Teixeira, Leandro B C/H-9272-2015; Teixeira, Leandro/AAU-6094-2021	Teixeira, Leandro B C/0000-0001-9960-678X; Teixeira, Leandro/0000-0001-9960-678X	National Eye Institute, National Institutes of Health (NIH) [EY021376]; Core Grant for Vision Research - National Eye Institute, NIH [P30 EY016665]; University of Wisconsin Carbone Cancer Center - Cancer Center Support Grant from the National Cancer Institute, NIH [P30 CA014520]; Wellcome Trust; NIH [U01HG004085, U01HG004080]; Children's Hospital of Oakland Research Institute (CHORI) [U42RR024244]; NATIONAL EYE INSTITUTE [P30EY016665, R01EY021376] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Core Grant for Vision Research - National Eye Institute, NIH; University of Wisconsin Carbone Cancer Center - Cancer Center Support Grant from the National Cancer Institute, NIH; Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Oakland Research Institute (CHORI); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by Grant EY021376 from the National Eye Institute, National Institutes of Health (NIH) (nei.nih.gov) to CAB. Portions of this study utilized shared resources supported by the Core Grant for Vision Research funded by the National Eye Institute, NIH, to the University of Wisconsin-Madison (P30 EY016665) and the University of Wisconsin Carbone Cancer Center, funded by Cancer Center Support Grant P30 CA014520 from the National Cancer Institute, NIH (www.cancer.gov). The authors thank the Wellcome Trust Sanger Institute Mouse Genetics Project, supported by the Wellcome Trust (www.wellcome.ac.uk). NIH grants to Velocigene at Regeneron Inc (U01HG004085) and the CSD Consortium (U01HG004080) funded the generation of gene-targeted ES cells for 8500 genes in the KOMP Program and archived and distributed by the KOMP Repository at UC Davis and Children's Hospital of Oakland Research Institute (CHORI) (U42RR024244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiguzel E, 2006, ARTERIOSCL THROM VAS, V26, P56, DOI 10.1161/01.ATV.0000194155.96456.b7; Aldave AJ, 2013, CLIN GENET, V84, P109, DOI 10.1111/cge.12191; Aldave AJ, 2007, AM J MED GENET A, V143A, P2549, DOI 10.1002/ajmg.a.31978; Aldave AJ, 2013, JAMA OPHTHALMOL, V131, P1583, DOI 10.1001/jamaophthalmol.2013.5036; Aldave AJ, 2009, CORNEA, V28, P801, DOI 10.1097/ICO.0b013e31819672fb; Anderson NJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P624; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Brandt JD, 1999, OPHTHALMOLOGY; Brigid H, 1994, MANIPULATING MOUSE E; CIBIS GW, 1977, ARCH OPHTHALMOL-CHIC, V95, P1529; Cockerham GC, 2002, CORNEA, V21, P787, DOI 10.1097/00003226-200211000-00012; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Davidson AE, 2016, AM J HUM GENET, V98, P75, DOI 10.1016/j.ajhg.2015.11.018; Evans CJ, 2015, ANN HUM GENET, V79, P1, DOI 10.1111/ahg.12090; Gheldof A, 2012, CELL MOL LIFE SCI, V69, P2527, DOI 10.1007/s00018-012-0935-3; Guelman S, 2009, MOL CELL BIOL, V29, P1176, DOI 10.1128/MCB.01599-08; Harewood L, 2014, HUM MOL GENET, V23, pR76, DOI 10.1093/hmg/ddu278; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; HEON E, 1995, HUM MOL GENET, V4, P485, DOI 10.1093/hmg/4.3.485; Hickner Paul V., 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-358; Hopfer U, 2005, FASEB J, V19, P1232, DOI 10.1096/fj.04-3019com; Howell DN, 1997, INVEST OPHTH VIS SCI, V38, P1896; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Krebs AR, 2011, MOL CELL, V44, P410, DOI 10.1016/j.molcel.2011.08.037; Lai IN, 2010, MOL VIS, V16, P2829; Liskova P, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9495; Liskova P, 2013, JAMA OPHTHALMOL, V131, P1296, DOI 10.1001/jamaophthalmol.2013.405; Liskova P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045495; Liu YQ, 2008, INVEST OPHTH VIS SCI, V49, P1843, DOI 10.1167/iovs.07-0789; Luo MZ, 2003, METH MOL B, V236, P3; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Postigo AA, 2003, EMBO J, V22, P2443, DOI 10.1093/emboj/cdg225; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; Schmedt T, 2012, EXP EYE RES, V95, P24, DOI 10.1016/j.exer.2011.08.002; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Suganuma T, 2010, CELL, V142, P726, DOI 10.1016/j.cell.2010.07.045; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Williams M, 2002, ENVIRON MOL MUTAGEN, V39, P22, DOI 10.1002/em.10040; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	42	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157577	10.1371/journal.pone.0157577	http://dx.doi.org/10.1371/journal.pone.0157577			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310661	Green Submitted, Green Published, gold			2022-12-26	WOS:000378029800101
J	Soderman, M; Rhedin, S; Tolfvenstam, T; Rotzen-Ostlund, M; Albert, J; Broliden, K; Lindblom, A				Soderman, Martina; Rhedin, Samuel; Tolfvenstam, Thomas; Rotzen-Ostlund, Maria; Albert, Jan; Broliden, Kristina; Lindblom, Anna			Frequent Respiratory Viral Infections in Children with Febrile Neutropenia - A Prospective Follow-Up Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CELL TRANSPLANT RECIPIENTS; RHINOVIRUS C INFECTIONS; ONCOLOGY PATIENTS; HUMAN BOCAVIRUS; US CHILDREN; VIRUSES; ILLNESS; CANCER; LEUKEMIA	Objective Febrile neutropenia is common in children undergoing chemotherapy for the treatment of malignancies. In the majority of cases, the cause of the fever is unknown. Although respiratory viruses are commonly associated with this condition, the etiologic significance of this finding remains unclear and is therefore the subject of this study. Study design Nasopharyngeal aspirates were collected during 87 episodes of febrile neutropenia in children age 0-18 years, being treated at a children's oncology unit between January 2013 and June 2014. Real-time polymerase chain reaction was used to determine the presence of 16 respiratory viruses. Follow-up samples were collected from children who tested positive for one or more respiratory viruses. Rhinoviruses were genotyped by VP4/ VP2 sequencing. Fisher's exact test and Mann-Whitney U test were used for group comparisons. Results At least one respiratory virus was detected in samples from 39 of 87 episodes of febrile neutropenia (45%), with rhinoviruses the most frequently detected. Follow-up samples were collected after a median of 28 days (range, 9-74 days) in 32 of the 39 virus-positive episodes. The respiratory viral infection had resolved in 25 episodes (78%). The same virus was detected at follow-up in one coronavirus and six rhinovirus episodes. Genotyping revealed a different rhinovirus species in two of the six rhinovirus infections. Conclusion The frequency of respiratory viral infections in this group of patients suggests an etiologic role in febrile neutropenia. However, these findings must be confirmed in larger patient cohorts.	[Soderman, Martina; Rhedin, Samuel; Tolfvenstam, Thomas; Broliden, Kristina; Lindblom, Anna] Karolinska Inst, Ctr Mol Med, Infect Dis Unit, Dept Med Solna, Stockholm, Sweden; [Soderman, Martina; Rhedin, Samuel; Tolfvenstam, Thomas; Broliden, Kristina; Lindblom, Anna] Karolinska Univ Hosp, Stockholm, Sweden; [Tolfvenstam, Thomas] Publ Hlth Agcy Sweden, Unit Highly Pathogen Viruses, Stockholm, Sweden; [Rotzen-Ostlund, Maria; Albert, Jan] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Rotzen-Ostlund, Maria; Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Lindblom, Anna] Karolinska Univ Hosp, Astrid Lindgrens Childrens Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Public Health Agency of Sweden; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Lindblom, A (corresponding author), Karolinska Inst, Ctr Mol Med, Infect Dis Unit, Dept Med Solna, Stockholm, Sweden.; Lindblom, A (corresponding author), Karolinska Univ Hosp, Stockholm, Sweden.; Lindblom, A (corresponding author), Karolinska Univ Hosp, Astrid Lindgrens Childrens Hosp, Stockholm, Sweden.	anna.lindblom@ki.se	Arthur Rhedin, Samuel/H-4653-2019	Arthur Rhedin, Samuel/0000-0001-5798-2875; Tolfvenstam, Thomas/0000-0003-3549-8083; Berggren, Anna/0000-0002-4012-699X	Swedish Children's Cancer Foundation; Swedish Society of Medicine	Swedish Children's Cancer Foundation; Swedish Society of Medicine	This study was supported financially by grants from the Swedish Children's Cancer Foundation (barncancerfonden.se) and the Swedish Society of Medicine (http://www.sls.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper CM, 2008, J CLIN VIROL, V43, P120, DOI 10.1016/j.jcv.2008.04.008; Averbuch D, 2013, HAEMATOLOGICA, V98, P1826, DOI 10.3324/haematol.2013.091025; Castagnola E, 2007, CLIN INFECT DIS, V45, P1296, DOI 10.1086/522533; Chemaly RF, 2014, CLIN INFECT DIS, V59, pS344, DOI 10.1093/cid/ciu623; Cheng S, 2011, BRIT J CANCER, V105, P606, DOI 10.1038/bjc.2011.213; Dotan A, 2014, J PEDIAT HEMATOL ONC, V36, pE271, DOI 10.1097/MPH.0000000000000043; Dyrdak R, 2015, INFECT DIS LONDON EN, P1; El-Mahallawy HA, 2011, PEDIATR BLOOD CANCER, V57, P283, DOI 10.1002/pbc.22926; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HALL CB, 1986, NEW ENGL J MED, V315, P77, DOI 10.1056/NEJM198607103150201; Iwane MK, 2011, J INFECT DIS, V204, P1702, DOI 10.1093/infdis/jir634; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Jartti T, 2004, J MED VIROL, V72, P695, DOI 10.1002/jmv.20027; Johnston DL, 2013, MYCOSES, V56, P482, DOI 10.1111/myc.12063; Kobayashi R, 2008, J PEDIAT HEMATOL ONC, V30, P886, DOI 10.1097/MPH.0b013e3181864a80; Koskenvuo M, 2008, PEDIATR INFECT DIS J, V27, P974, DOI 10.1097/INF.0b013e31817b0799; Koskenvuo M, 2008, EUR J PEDIATR, V167, P1011, DOI 10.1007/s00431-007-0631-8; Lindblom A, 2010, J CLIN VIROL, V47, P234, DOI 10.1016/j.jcv.2009.11.026; Linsuwanon P, 2009, J INFECTION, V59, P115, DOI 10.1016/j.jinf.2009.05.009; Loeffelholz MJ, 2014, PEDIATRICS, V134, P1144, DOI 10.1542/peds.2014-2132; Loria C, 2015, PEDIATR TRANSPLANT, V19, P94, DOI 10.1111/petr.12383; Lv H, 2013, EXP THER MED, V5, P201, DOI 10.3892/etm.2012.738; Martin ET, 2013, J INFECT DIS, V207, P982, DOI 10.1093/infdis/jis934; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Paulus SC, 2005, EUR J CANCER, V41, P2132, DOI 10.1016/j.ejca.2005.04.037; Peck AJ, 2007, BLOOD, V110, P1681, DOI 10.1182/blood-2006-12-060343; Rhedin S, 2014, PEDIATRICS, V133, pE538, DOI 10.1542/peds.2013-3042; Schenk T, 2011, PEDIATR INFECT DIS J, V30, P82, DOI 10.1097/INF.0b013e3181f12fcf; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; Suryadevara M, 2012, CLIN PEDIATR, V51, P1164, DOI 10.1177/0009922812456736; Tivejung-Lindell A, 2009, J MED VIROL, V81, P167, DOI 10.1002/jmv.21368; Torres JP, 2012, PEDIATR INFECT DIS J, V31, P889, DOI 10.1097/INF.0b013e31825c4b7e; van der Zalm MM, 2009, J PEDIATR-US, V154, P396, DOI 10.1016/j.jpeds.2008.08.036; Wisdom A, 2009, J CLIN MICROBIOL, V47, P3958, DOI 10.1128/JCM.00993-09; Xiang ZC, 2010, J CLIN VIROL, V49, P94, DOI 10.1016/j.jcv.2010.07.013	37	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157398	10.1371/journal.pone.0157398	http://dx.doi.org/10.1371/journal.pone.0157398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309354	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800066
J	Wen, Z; Zhang, J; Li, JL; Dai, JK; Lin, FC; Wu, GY				Wen, Zhi; Zhang, Jie; Li, Jielan; Dai, Jiankun; Lin, Fuchun; Wu, Guangyao			Altered Activation in Cerebellum Contralateral to Unilateral Thalamotomy May Mediate Tremor Suppression in Parkinson's Disease: A Short-Term Regional Homogeneity fMRI Study	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; THALAMIC-STIMULATION; FEATURES	Background Ventral intermediate nucleus thalamotomy is an effective treatment for Parkinson's disease tremor. However, its mechanism is still unclear. Purpose We used resting-state fMRI to investigate short-term ReHo changes after unilateral thalamotomy in tremor-dominant PD, and to speculate about its possible mechanism on tremor suppression. Methods 26 patients and 31 healthy subjects (HS) were recruited. Patients were divided into two groups according to right- (rPD) and left-side (IPD) thalamotomy. Tremor was assessed using the 7-item scale from the Unified Parkinson's disease rating scale motor score (mUPDRS). Patients were scanned using resting state fMRI after 12h withdrawal of medication, both preoperatively (PDpre) and 7-day postoperatively (PDpost), whereas healthy subjects were scanned once. The regions associated with tremor and altered ReHo due to thalamic ablation were examined. Results The impact of unilateral VIM thalamotomy was characterized in the frontal, parietal, temporal regions, basal ganglia, thalamus, and cerebellum. Compared with PDpre, significantly reduced ReHo was found in the left cerebellum in patients with rPD(post), and slightly decreased ReHo in the cerebellum vermis in patients with IPDpost, which was significantly higher than HS. We demonstrated a positive correlation between the ReHo values in the cerebellum ( in rPD, peak coordinate [-12, -54, -21], R = 0.64, P = 0.0025, and peak coordinate [-9, -54, -18], R = 0.71, P = 0.0025; in IPD, peak coordinate [ 3, -45, -15], R = 0.71, P = 0.004) in the pre-surgical condition, changes of ReHo induced by thalamotomy ( in rPD, R = 0.63, P = 0.021, R = 0.6, P = 0.009; in IPD, R = 0.58, P = 0.028) and tremor scores contralateral to the surgical side, respectively. Conclusion The specific area that may be associated with PD tremor and altered ReHo due to thalamic ablation is the cerebellum. The neural basis underlying thalamotomy is complex; cerebellum involvement is far beyond cerebello-thalamic tract breakage.	[Wen, Zhi; Li, Jielan; Wu, Guangyao] Wuhan Univ, Zhongnan Hosp, Dept Magnet Resonance Imaging, Wuhan 430072, Hubei, Peoples R China; [Zhang, Jie] Wuhan Univ, Zhongnan Hosp, Dept Neurosurg, Wuhan 430072, Hubei, Peoples R China; [Dai, Jiankun; Lin, Fuchun] Chinese Acad Sci, Wuhan Inst Phys & Math, Key State Lab Atom & Mol Phys, Natl Ctr Magnet Resonance, Wuhan, Hubei, Peoples R China; [Dai, Jiankun] Univ Chinese Acad Sci, Beijing, Peoples R China	Wuhan University; Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, GY (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Magnet Resonance Imaging, Wuhan 430072, Hubei, Peoples R China.; Zhang, J (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Neurosurg, Wuhan 430072, Hubei, Peoples R China.	zhangjie8790@163.com; wuguangy2002@163.com	Lin, Fuchun/D-2371-2012; Lin, Fuchun/M-2789-2019	Lin, Fuchun/0000-0002-2282-6474; Lin, Fuchun/0000-0002-2282-6474; Wen, Zhi/0000-0003-2946-3650; dai, jiankun/0000-0002-2461-6737; Wu, Guangyao/0000-0002-0456-3682	National Science Fund of China [81171315]	National Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Fund of China (http://www.nsfc.gov.cn/) Grant Nos. 81171315 to GW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Science Fund of China (Grant Nos. 81171315 to Guangyao Wu).	Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; DEIBER MP, 1993, BRAIN, V116, P267, DOI 10.1093/brain/116.1.267; Duval C, 2016, NEUROBIOL DIS, V85, P49, DOI 10.1016/j.nbd.2015.10.009; Dwarakanath S, 2014, CLIN NEUROL NEUROSUR, V125, P131, DOI 10.1016/j.clineuro.2014.07.016; Fukuda M, 2004, NEUROIMAGE, V21, P608, DOI 10.1016/j.neuroimage.2003.09.068; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; Hassler R., 1959, INTRO STEREOTAXIS AT, P230; Helmich RC, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0378-8; Helmich RC, 2012, BRAIN, V135, P3206, DOI 10.1093/brain/aws023; Helmich RC, 2011, ANN NEUROL, V69, P269, DOI 10.1002/ana.22361; Herz DM, 2014, HUM BRAIN MAPP, V35, P3227, DOI 10.1002/hbm.22397; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jiang L, 2015, NEUROSCIENTIST REV J, DOI [10.1177/1073858415595004, DOI 10.1177/1073858415595004]; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Mure H, 2011, NEUROIMAGE, V54, P1244, DOI 10.1016/j.neuroimage.2010.09.028; Prodoehl J, 2013, JAMA NEUROL, V70, P100, DOI 10.1001/jamaneurol.2013.582; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tahmasian M, 2015, CORTEX, V73, P80, DOI 10.1016/j.cortex.2015.08.005; Tessitore A, 2012, NEUROLOGY, V79, P2226, DOI 10.1212/WNL.0b013e31827689d6; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang DL, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00006; Zhang JQ, 2015, PARKINSONISM RELAT D, V21, P23, DOI 10.1016/j.parkreldis.2014.10.017; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	30	5	5	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157562	10.1371/journal.pone.0157562	http://dx.doi.org/10.1371/journal.pone.0157562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310133	gold, Green Submitted, Green Published			2022-12-26	WOS:000378029800097
J	Metheetrairut, C; Adams, BD; Nallur, S; Weidhaas, JB; Slack, FJ				Metheetrairut, C.; Adams, B. D.; Nallur, S.; Weidhaas, J. B.; Slack, F. J.			cel-mir-237 and its homologue, hsa-miR-125b, modulate the cellular response to ionizing radiation	ONCOGENE			English	Article							NEGATIVE BREAST-CANCER; DNA-DAMAGE RESPONSE; LOCOREGIONAL RECURRENCE; ELEGANS MICRORNAS; MESSENGER-RNAS; C. ELEGANS; EXPRESSION; TARGETS; MIR-125B; MIRNAS	Elucidating the mechanisms involved in sensitizing radioresistant tumors to ionizing radiation (IR) treatments while minimizing injury to surrounding normal tissue is an important clinical goal. Due to their sequence-derived specificity and properties as gene regulators in IR-affected pathways, microRNAs (miRNAs) could serve as adjuvant therapeutic agents that alter cellular sensitivity to radiation treatment. To identify radiosensitizing miRNAs, we initially utilized the Caenorhabditis elegans vulval cell model, an in vivo system developed to study IR-dependent radiosensitivity as a measure of clonogenic cell death. We tested several candidate miRNA-deletion mutants post gamma-irradiation and identified cel-mir-237 as a miRNA which when deleted caused animals to be more resistant to IR, whereas cel-mir-237 overexpressing strains were IR sensitive. In addition, wild-type animals downregulated cel-mir-237 levels post IR in a time-dependent manner. We identified jun-1 (JUN transcription factor homolog) as a novel target of cel-mir-237. Specifically, jun-1 transcript levels increased in wild-type animals post gamma-irradiation, and loss of cel-mir-237 also resulted in higher jun-1 expression. As expected, loss of jun-1 resulted in IR sensitivity, similar to the phenotype of cel-mir-237 overexpressors. As miR-237 is the homolog of human miR-125, we validated our findings in MCF-7 and MDA-MB-231 breast cancer cell lines, which harbor lower hsa-miR-125b levels than normal human mammary epithelial cells (HMECs). Forced expression of hsa-miR-125b in these cells resulted in radiosensitivity, as seen by reduced clonogenic survival, enhanced apoptotic activity and enhanced senescence post IR. Finally, re-expression of c-JUN in MDA-MB-231 cells promoted radioresistance and abrogated miR-125-mediated radiosensitization. Our findings suggest that overexpression of cel-mir-237 and its homolog, hsa-miR-125b, functions as sensitizers to gamma-irradiation in both a nematode in vivo model and breast cancer cells, and could potentially be utilized as an adjuvant therapeutic to enhance radiation sensitivity.	[Metheetrairut, C.; Adams, B. D.; Slack, F. J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Adams, B. D.; Slack, F. J.] Harvard Med Sch, BIDMC Canc Ctr, Dept Pathol, Inst RNA Med, 3 Blackfan Circle, Boston, MA 02115 USA; [Nallur, S.; Weidhaas, J. B.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Metheetrairut, C.] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok 10700, Thailand; [Weidhaas, J. B.] UCLA, Sch Med, Div Mol & Cellular Oncol, Los Angeles, CA 90095 USA	Yale University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Yale University; Mahidol University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Slack, FJ (corresponding author), Harvard Med Sch, BIDMC Canc Ctr, Dept Pathol, Inst RNA Med, 3 Blackfan Circle, Boston, MA 02115 USA.	fslack@bidmc.harvard.edu	Adams, Brian D./D-9476-2017	Adams, Brian D./0000-0001-8372-2970; Metheetrairut, Chanatip/0000-0002-4394-5085	National Institutes of Health National Center; NIH [R01 CA157749, R01 CA131301];  [5T32 HG003198-10]; NATIONAL CANCER INSTITUTE [R01CA131301, R01CA157749] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG003198] Funding Source: NIH RePORTER	National Institutes of Health National Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Geoffrey Lyon, Yale Cell Sorter Core Facility, for assistance with fluorescence- activated cell sorting and analysis, the Yale Cesium Irradiator Shared Resource for use of gamma-irradiator, Valerie Horsley for use of imaging equipment, and to Shirin Bahmanyar for providing space and making equipment available for these studies. We thank Alan Jiao and Catherine O. Adams for critical reading of this manuscript. Nematode strains used in this work were provided by the C. elegans Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. This work was supported by grants to FJS and JBW from the NIH (R01 CA157749 and R01 CA131301). BDA was supported by a training grant (5T32 HG003198-10).	Adams BD, 2016, CANCER RES, V76, P927, DOI 10.1158/0008-5472.CAN-15-2321; Adams BD, 2014, CURR BIOL, V24, pR762, DOI 10.1016/j.cub.2014.06.043; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Babar IA, 2011, CANCER BIOL THER, V12, P908, DOI 10.4161/cbt.12.10.17681; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BERNHARD EJ, 1995, RADIAT ENVIRON BIOPH, V34, P79, DOI 10.1007/BF01275210; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; BRENNER S, 1974, GENETICS, V77, P71; Brown JM, CANC BIOL THER, V2, P477; Cheng CJ, 2015, NATURE, V518, P107, DOI 10.1038/nature13905; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Emmrich S, 2014, GENE DEV, V28, P858, DOI 10.1101/gad.233791.113; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esquela-Kerscher A, 2005, DEV DYNAM, V234, P868, DOI 10.1002/dvdy.20572; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Feliciano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076247; Feng HY, 2012, METHODS MOL BIOL, V786, P21, DOI 10.1007/978-1-61779-292-2_2; Ferracin M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-130; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garofalo M, 2013, DRUG RESIST UPDATE, V16, P47, DOI 10.1016/j.drup.2013.05.001; Gefen N, 2010, LEUKEMIA, V24, P89, DOI 10.1038/leu.2009.208; Girard LR, 2007, NUCLEIC ACIDS RES, V35, pD472, DOI 10.1093/nar/gkl894; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Iliakis G, 1997, SEMIN ONCOL, V24, P602; Isik Meltem, 2013, Methods Mol Biol, V940, P77, DOI 10.1007/978-1-62703-110-3_7; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Kappelmann M, 2013, ONCOGENE, V32, P2984, DOI 10.1038/onc.2012.307; Kato M, 2009, ONCOGENE, V28, P2419, DOI 10.1038/onc.2009.106; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Le MTN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002242; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin KY, 2016, ONCOGENE, V35, P3376, DOI 10.1038/onc.2015.396; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowery AJ, 2012, BREAST CANCER RES TR, V133, P831, DOI 10.1007/s10549-011-1891-6; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Metheetrairut C, 2013, CURR OPIN GENET DEV, V23, P12, DOI 10.1016/j.gde.2013.01.002; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Misso G, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.47; Nyholm AM, 2014, BMC DERMATOL, V14, DOI 10.1186/1471-5945-14-8; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Praitis V, 2001, GENETICS, V157, P1217; Puissegur MP, 2012, LEUKEMIA, V26, P2224, DOI 10.1038/leu.2012.95; Rajabi Hasan, 2010, Genes Cancer, V1, P62; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Shiiba M, 2013, BRIT J CANCER, V108, P1817, DOI 10.1038/bjc.2013.175; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Song R, 2014, NATURE, V510, P115, DOI 10.1038/nature13413; Stiernagle T., 2006, MAINTENANCE C ELEGAN; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Surdziel E, 2011, BLOOD, V117, P4338, DOI 10.1182/blood-2010-06-289058; Tan GY, 2012, J BIOL CHEM, V287, P33036, DOI 10.1074/jbc.M112.383273; Tang J, 2012, INT J MOL SCI, V13, P13414, DOI 10.3390/ijms131013414; The C, 2006, WORMBOOK, DOI 10.1895/wormbook.1.54.1; van Haaften G, 2006, CURR BIOL, V16, P1344, DOI 10.1016/j.cub.2006.05.047; Weidhaas JB, 2006, P NATL ACAD SCI USA, V103, P9946, DOI 10.1073/pnas.0603791103; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Welker NC, 2007, RNA, V13, P1090, DOI 10.1261/rna.542107; Wu DY, 2013, ONCOL LETT, V5, P829, DOI 10.3892/ol.2013.1123; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zaky SS, 2011, ANN SURG ONCOL, V18, P2858, DOI 10.1245/s10434-011-1669-4; Zhang C, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1116-2; Zhang L, 2014, GENE DEV, V28, P2532, DOI 10.1101/gad.248377.114; Zhang LA, 2011, CELL STEM CELL, V8, P294, DOI 10.1016/j.stem.2011.01.014; Zhang Y, 2011, CANCER RES, V71, P1; Zhao ZY, 2010, GENETICS, V184, P853, DOI 10.1534/genetics.109.110270	79	14	16	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 26	2017	36	4					512	524		10.1038/onc.2016.222	http://dx.doi.org/10.1038/onc.2016.222			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8II	27321180	Green Submitted, Green Accepted			2022-12-26	WOS:000394166700008
J	Ronquillo, CC; Hanke-Gogokhia, C; Revelo, MP; Frederick, JM; Jiang, L; Baehr, W				Ronquillo, Cecinio C.; Hanke-Gogokhia, Christin; Revelo, Monica P.; Frederick, Jeanne M.; Jiang, Li; Baehr, Wolfgang			Ciliopathy-associated IQCB1/NPHP5 protein is required for mouse photoreceptor outer segment formation	FASEB JOURNAL			English	Article						Senior-LOken syndrome; nephronophthisis; Leber congenital amaurosis; nephrocystins	SENIOR-LOKEN-SYNDROME; PIGMENTOSA GTPASE REGULATOR; LEBER CONGENITAL AMAUROSIS; RETINAL DEGENERATION; CILIARY TRAFFICKING; TRANSITION ZONE; DOMAIN PROTEIN; PRIMARY CILIUM; NPHP6 GENE; MUTATIONS	Null mutations in the human IQCB1/NPHP5 (nephrocystin-5) gene that encodes NPHP5 are the most frequent cause of Senior-LOken syndrome, a ciliopathy that is characterized by Leber congenital amaurosis and nephronophthisis. We generated germline Nphp5-knockout mice by placing a -Geo gene trap in intron 4, thereby truncating NPHP5 at Leu87 and removing all known functional domains. At eye opening, Nphp5(-/-) mice exhibited absence of scotopic and photopic electroretinogram responses, a phenotype that resembles Leber congenital amaurosis. Outer segment transmembrane protein accumulation in Nphp5(-/-) endoplasmic reticulum was evident as early as postnatal day (P)6. EGFP-CETN2, a centrosome and transition zone marker, identified basal bodies in Nphp5(-/-) photoreceptors, but without fully developed transition zones. Ultrastructure of P6 and 10 Nphp5(-/-) photoreceptors revealed aberrant transition zones of reduced diameter. Nphp5(-/-) photoreceptor degeneration was complete at 1 mo of age but was delayed significantly in Nphp5(-/-);Nrl(-/-) (cone only) retina. Nphp5(-/-) mouse embryonic fibroblast developed normal cilia, and Nphp5(-/-) kidney histology at 1 yr of age showed no significant pathology. Results establish that nephrocystin-5 is essential for photoreceptor outer segment formation but is dispensable for kidney and mouse embryonic fibroblast ciliary formation.	[Ronquillo, Cecinio C.; Hanke-Gogokhia, Christin; Frederick, Jeanne M.; Jiang, Li; Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Hanke-Gogokhia, Christin] Univ Potsdam, Dept Biochem & Biol, Potsdam, Germany; [Revelo, Monica P.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Jiang, Li] Sichuan Acad Med Sci, Chengdu, Peoples R China; [Jiang, Li] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Potsdam; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Jiang, L; Baehr, W (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA.	li.jiang@hsc.utah.edu; wbaehr@hsc.utah.edu			U.S. National Institutes of Health (NIH), National Eye Institute (NEI) National Research Service Award Grant [1F31EY021972-01A1]; NIH NEI [EY08123, EY019298, EY014800-039003]; Research to Prevent Blindness; Retina Research Foundation (Houston, TX, USA); Foundation for Retina Research; Nelson Trust Award	U.S. National Institutes of Health (NIH), National Eye Institute (NEI) National Research Service Award Grant; NIH NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Retina Research Foundation (Houston, TX, USA); Foundation for Retina Research; Nelson Trust Award	This work was supported by a U.S. National Institutes of Health (NIH), National Eye Institute (NEI) National Research Service Award Grant 1F31EY021972-01A1 (to C.C.R.), NIH NEI Grants EY08123 and EY019298 (to W.B.) and Grant EY014800-039003 (NEI Core Grant), and unrestricted grants to the Department of Ophthalmology (University of Utah) from Research to Prevent Blindness, the Retina Research Foundation (Houston, TX, USA), and the Foundation for Retina Research. W.B. is a recipient of a Research to Prevent Blindness Senior Investigator and Nelson Trust Award. This work was part of a Ph.D. thesis for the Interdepartmental Graduate Program in Neuroscience (University of Utah Health Science Center) (C.C.R.). The authors declare no conflicts of interest.	ALUBAIDI MR, 1990, J BIOL CHEM, V265, P20563; Anand M, 2012, EXPERT OPIN THER TAR, V16, P541, DOI 10.1517/14728222.2012.680956; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; Baehr W., 2007, V45, P71; Barbelanne M, 2015, HUM MOL GENET, V24, P2185, DOI 10.1093/hmg/ddu738; Barbelanne M, 2013, HUM MOL GENET, V22, P2482, DOI 10.1093/hmg/ddt100; Bizet AA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9666; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Chaki M, 2011, KIDNEY INT, V80, P1239, DOI 10.1038/ki.2011.284; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Cideciyan AV, 2011, HUM MOL GENET, V20, P1411, DOI 10.1093/hmg/ddr022; Collin GB, 2012, INVEST OPHTH VIS SCI, V53, P967, DOI 10.1167/iovs.11-8766; Cook SA, 2009, J AM SOC NEPHROL, V20, P753, DOI 10.1681/ASN.2008040412; Czarnecki PG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7023; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Donaldson JC, 2002, J BIOL CHEM, V277, P29028, DOI 10.1074/jbc.M111697200; Estrada-Cuzcano A, 2011, INVEST OPHTH VIS SCI, V52, P834, DOI 10.1167/iovs.10-5221; Friedel Roland H., 2007, Briefings in Functional Genomics & Proteomics, V6, P180, DOI 10.1093/bfgp/elm022; Gerner M, 2010, KIDNEY INT, V77, P891, DOI 10.1038/ki.2010.27; Goldstein O, 2013, INVEST OPHTH VIS SCI, V54, P7005, DOI 10.1167/iovs.13-12915; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Halbritter J, 2013, AM J HUM GENET, V93, P915, DOI 10.1016/j.ajhg.2013.09.012; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Hanke-Gogokhia C, 2016, J BIOL CHEM, V291, P7142, DOI 10.1074/jbc.M115.710954; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Jaszai J, 2007, EXP EYE RES, V85, P585, DOI 10.1016/j.exer.2006.03.022; Jiang L, 2015, FASEB J, V29, P4866, DOI 10.1096/fj.15-275677; Jiang L, 2015, J BIOL CHEM, V290, P12765, DOI 10.1074/jbc.M115.638437; Jiang ST, 2008, HUM MOL GENET, V17, P3368, DOI 10.1093/hmg/ddn231; Jiang ST, 2009, HUM MOL GENET, V18, P1566, DOI 10.1093/hmg/ddp068; Jones BW, 2011, J COMP NEUROL, V519, P2713, DOI 10.1002/cne.22703; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McEwen DP, 2007, P NATL ACAD SCI USA, V104, P15917, DOI 10.1073/pnas.0704140104; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Morrow EM, 1998, TRENDS CELL BIOL, V8, P353, DOI 10.1016/S0962-8924(98)01341-5; Murga-Zamalloa CA, 2010, MOL VIS, V16, P1373; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Rachel R, 2012, CILIA, V1, P1; Rachel RA, 2015, HUM MOL GENET, V24, P3775, DOI 10.1093/hmg/ddv123; Rachel RA, 2012, J CLIN INVEST, V122, P1233, DOI 10.1172/JCI60981; Ronquillo CC, 2012, VISION RES, V75, P88, DOI 10.1016/j.visres.2012.07.003; Ronquillo C, 2013, INVEST OPHTH VIS SCI, V54; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schafer T, 2008, HUM MOL GENET, V17, P3655, DOI 10.1093/hmg/ddn260; Schuermann MJ, 2002, AM J HUM GENET, V70, P1240, DOI 10.1086/340317; Shiba D, 2012, DIFFERENTIATION, V83, pS91, DOI 10.1016/j.diff.2011.11.006; Sillibourne JE, 2013, BIOL OPEN, V2, P535, DOI 10.1242/bio.20134457; Stone EM, 2011, ARCH OPHTHALMOL-CHIC, V129, P81, DOI 10.1001/archophthalmol.2010.330; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wolf MTF, 2011, PEDIATR NEPHROL, V26, P181, DOI 10.1007/s00467-010-1585-z; Won J, 2011, HUM MOL GENET, V20, P482, DOI 10.1093/hmg/ddq494; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Ying GX, 2014, J NEUROSCI, V34, P6377, DOI 10.1523/JNEUROSCI.0067-14.2014; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhang HB, 2015, FASEB J, V29, P932, DOI 10.1096/fj.14-257915; Zhao CT, 2011, EMBO J, V30, P2532, DOI 10.1038/emboj.2011.165	64	27	27	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3400	3412		10.1096/fj.201600511R	http://dx.doi.org/10.1096/fj.201600511R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27328943	Green Published			2022-12-26	WOS:000384329800012
J	Thomas, JC; Cooper, JM; Clayton, NS; Wang, CS; White, MA; Abell, C; Owen, D; Mott, HR				Thomas, Jemima C.; Cooper, Jonathan M.; Clayton, Natasha S.; Wang, Chensu; White, Michael A.; Abell, Chris; Owen, Darerca; Mott, Helen R.			Inhibition of Ral GTPases Using a Stapled Peptide Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; cell signaling; peptide chemical synthesis; peptides; protein-protein interaction; small GTPase; Ral; Ras; stapled peptides; therapeutics	PROTEIN-PROTEIN INTERACTIONS; SMALL-MOLECULE INHIBITORS; CANCER; COMPLEX; ACTIVATION; EXOCYST; PHOSPHORYLATION; AUTOPHAGY; AFFINITY; MEDIATE	Aberrant Ras signaling drives numerous cancers, and drugs to inhibit this are urgently required. This compelling clinical need combined with recent innovations in drug discovery including the advent of biologic therapeutic agents, has propelled Ras back to the forefront of targeting efforts. Activated Ras has proved extremely difficult to target directly, and the focus has moved to the main downstream Ras-signaling pathways. In particular, the Ras-Raf and Ras-PI3K pathways have provided conspicuous enzyme therapeutic targets that were more accessible to conventional drug-discovery strategies. The Ras-RalGEF-Ral pathway is a more difficult challenge for traditional medicinal development, and there have, therefore, been few inhibitors reported that disrupt this axis. We have used our structure of a Ral-effector complex as a basis for the design and characterization of -helical-stapled peptides that bind selectively to active, GTP-bound Ral proteins and that compete with downstream effector proteins. The peptides have been thoroughly characterized biophysically. Crucially, the lead peptide enters cells and is biologically active, inhibiting isoform-specific RalB-driven cellular processes. This, therefore, provides a starting point for therapeutic inhibition of the Ras-RalGEF-Ral pathway.	[Thomas, Jemima C.; Clayton, Natasha S.; Owen, Darerca; Mott, Helen R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Thomas, Jemima C.; Abell, Chris] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Cooper, Jonathan M.; Wang, Chensu; White, Michael A.] UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; [Thomas, Jemima C.] Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England	University of Cambridge; University of Cambridge; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of London; Institute of Cancer Research - UK	Owen, D; Mott, HR (corresponding author), Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	do202@cam.ac.uk; hrm28@cam.ac.uk	Mott, Helen/AAV-3873-2020	Mott, Helen/0000-0002-7890-7097; Cooper, Jonathan/0000-0002-7468-2062	Cambridge Cancer Centre Pump Priming award; BBSRC (Biotechnology and Biological Sciences Research Council); National Institutes of Health [CA71443]; Welch Foundation [I- 1414]; MRC [MR/J007803/1, MC_PC_14116] Funding Source: UKRI; Medical Research Council [MR/J007803/1, MC_PC_14116] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA071443] Funding Source: NIH RePORTER	Cambridge Cancer Centre Pump Priming award; BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a Cambridge Cancer Centre Pump Priming award (to C. A., D. O., and H. R. M.), a BBSRC (Biotechnology and Biological Sciences Research Council) studentship (to N. S. C.), National Institutes of Health Grant CA71443, and Welch Foundation Grant I- 1414 (to M. A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Campbell LJ, 2015, BIOCHEMISTRY-US, V54, P1380, DOI 10.1021/bi501530u; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Chu Q, 2015, MEDCHEMCOMM, V6, P111, DOI 10.1039/c4md00131a; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Fenwick RB, 2009, BIOCHEMISTRY-US, V48, P2192, DOI 10.1021/bi802129d; Fenwick RB, 2010, STRUCTURE, V18, P985, DOI 10.1016/j.str.2010.05.013; Fiordalisi JJ, 2003, J BIOL CHEM, V278, P41718, DOI 10.1074/jbc.M305733200; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Grossmann TN, 2012, P NATL ACAD SCI USA, V109, P17942, DOI 10.1073/pnas.1208396109; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kauffman WB, 2015, TRENDS BIOCHEM SCI, V40, P749, DOI 10.1016/j.tibs.2015.10.004; Kim YW, 2011, NAT PROTOC, V6, P761, DOI 10.1038/nprot.2011.324; Leshchiner ES, 2015, P NATL ACAD SCI USA, V112, P1761, DOI 10.1073/pnas.1413185112; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Martin Timothy D, 2012, Small GTPases, V3, P126, DOI 10.4161/sgtp.19571; Martin TD, 2012, J BIOL CHEM, V287, P14827, DOI 10.1074/jbc.M112.344986; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Neel Nicole F, 2011, Genes Cancer, V2, P275, DOI 10.1177/1947601911407329; Neyraud V, 2012, J BIOL CHEM, V287, P29397, DOI 10.1074/jbc.M112.357764; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Patgiri A, 2011, NAT CHEM BIOL, V7, P585, DOI [10.1038/NCHEMBIO.612, 10.1038/nchembio.612]; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Popovic M, 2016, J STRUCT BIOL, V193, P106, DOI 10.1016/j.jsb.2015.12.006; Prasannan S, 2007, BIOMOL NMR ASSIGN, V1, P147, DOI 10.1007/s12104-007-9040-1; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Saito R, 2013, ONCOGENE, V32, P894, DOI 10.1038/onc.2012.101; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Shirakawa R, 2009, J BIOL CHEM, V284, P21580, DOI 10.1074/jbc.M109.012112; Spiegel J, 2014, ANGEW CHEM INT EDIT, V53, P2498, DOI 10.1002/anie.201308568; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walensky LD, 2014, J MED CHEM, V57, P6275, DOI 10.1021/jm4011675; Wang H, 2010, CANCER RES, V70, P8760, DOI 10.1158/0008-5472.CAN-10-0952; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wittrup K Dane, 2012, Methods Enzymol, V502, pxiii, DOI [10.1016/B978-0-12-396962-0.00013-6, 10.1016/B978-0-12-416039-2.00031-8]; Yan C, 2014, NATURE, V515, P443, DOI 10.1038/nature13713; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047	55	15	16	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18310	18325		10.1074/jbc.M116.720243	http://dx.doi.org/10.1074/jbc.M116.720243			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27334922	Green Published, hybrid			2022-12-26	WOS:000383241800024
J	Henriques, ST; Deplazes, E; Lawrence, N; Cheneval, O; Chaousis, S; Inserra, M; Thongyoo, P; King, GF; Mark, AE; Vetter, I; Craik, DJ; Schroeder, CI				Henriques, Sonia Troeira; Deplazes, Evelyne; Lawrence, Nicole; Cheneval, Olivier; Chaousis, Stephanie; Inserra, Marco; Thongyoo, Panumart; King, Glenn F.; Mark, Alan E.; Vetter, Irina; Craik, David J.; Schroeder, Christina I.			Interaction of Tarantula Venom Peptide ProTx-II with Lipid Membranes Is a Prerequisite for Its Inhibition of Human Voltage-gated Sodium Channel Na(V)1.7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane bilayer; peptides; sodium channel; toxin; transmembrane domain; NaV1; 7; analgesic; gating modifier toxin; peptide-lipid interactions; voltage-gated ion channel	CYCLOTIDE KALATA B1; SEA-ANEMONE TOXIN; AUTOIMMUNE-DISEASES; POTASSIUM CHANNEL; FORCE-FIELD; THERAPEUTIC TARGETS; GATING MODIFIERS; SENSOR TOXIN; SPIDER-VENOM; ION CHANNELS	ProTx-II is a disulfide-rich peptide toxin from tarantula venom able to inhibit the human voltage-gated sodium channel 1.7 (hNa(V)1.7), a channel reported to be involved in nociception, and thus it might have potential as a pain therapeutic. ProTx-II acts by binding to the membrane-embedded voltage sensor domain of hNa(V)1.7, but the precise peptide channel-binding site and the importance of membrane binding on the inhibitory activity of ProTx-II remain unknown. In this study, we examined the structure and membrane-binding properties of ProTx-II and several analogues using NMR spectroscopy, surface plasmon resonance, fluorescence spectroscopy, and molecular dynamics simulations. Our results show a direct correlation between ProTx-II membrane binding affinity and its potency as an hNa(V)1.7 channel inhibitor. The data support a model whereby a hydrophobic patch on the ProTx-II surface anchors the molecule at the cell surface in a position that optimizes interaction of the peptide with the binding site on the voltage sensor domain. This is the first study to demonstrate that binding of ProTx-II to the lipid membrane is directly linked to its potency as an hNa(V)1.7 channel inhibitor.	[Henriques, Sonia Troeira; Deplazes, Evelyne; Lawrence, Nicole; Cheneval, Olivier; Chaousis, Stephanie; Inserra, Marco; Thongyoo, Panumart; King, Glenn F.; Mark, Alan E.; Vetter, Irina; Craik, David J.; Schroeder, Christina I.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Deplazes, Evelyne; Mark, Alan E.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Vetter, Irina] Univ Queensland, Sch Pharm, Brisbane, Qld 4102, Australia; [Thongyoo, Panumart] Thammasat Univ, Fac Sci & Technol, Dept Chem, Med Chem Res Unit, Bangkok 12121, Thailand	University of Queensland; University of Queensland; University of Queensland; Thammasat University	Henriques, ST; Schroeder, CI (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	s.henriques@uq.edu.au; c.schroeder@imb.uq.edu.au	Lawrence, Nicole/A-5573-2017; Craik, David/B-1695-2010; Cheneval, Olivier/O-1384-2017; Deplazes, Evelyne/F-4618-2012; Vetter, Irina/A-6035-2010; Schroeder, Cristina I./K-2042-2014; Deplazes, Evelyne/P-7573-2019; Mark, Alan E/A-8799-2011; King, Glenn F/J-5059-2012; Henriques, Sonia Troeira/J-3500-2016	Lawrence, Nicole/0000-0002-9013-1770; Craik, David/0000-0003-0007-6796; Cheneval, Olivier/0000-0003-0109-7767; Deplazes, Evelyne/0000-0003-2052-5536; Vetter, Irina/0000-0002-3594-9588; Schroeder, Cristina I./0000-0002-6737-6374; Deplazes, Evelyne/0000-0003-2052-5536; Mark, Alan E/0000-0001-5880-4798; King, Glenn F/0000-0002-2308-2200; Henriques, Sonia Troeira/0000-0001-9564-9651; Thongyoo, Panumart/0000-0001-9918-8805	Australian National Health and Medical Research Center [APP1080405, APP1071293, APP1044414, APP1072113]; Australian Research Council in the form of an Australian Research Council Discovery Outstanding Researcher Grant [DP130102153, FT130101215]; Australian Research Council Australian Laureate Fellowship [FL150100146]; Institute for Molecular Bioscience Industry Fellowship	Australian National Health and Medical Research Center; Australian Research Council in the form of an Australian Research Council Discovery Outstanding Researcher Grant(Australian Research Council); Australian Research Council Australian Laureate Fellowship(Australian Research Council); Institute for Molecular Bioscience Industry Fellowship	This work was supported in part by Australian National Health and Medical Research Center Project Grant APP1080405 (to C. I. S. and S. T. H.), Early Career Fellowship APP1071293 (to E. D.), Principal Research Fellowship APP1044414 and Program Grant APP1072113 (to G. F. K.), Australian Research Council in the form of an Australian Research Council Discovery Outstanding Researcher Grant DP130102153 (to A. E. M.), Future Fellowship FT130101215 (to I. V.), Australian Research Council Australian Laureate Fellowship FL150100146 (to D. J. C.), and an Institute for Molecular Bioscience Industry Fellowship (to C. I. S.). This research was undertaken with the assistance of resources provided at the NCI National Facility systems at the Australian National University through the National Computational Merit Allocation Scheme supported by the Australian Government. The authors declare that they have no conflicts of interest with the contents of this article.	Amand HL, 2012, BBA-BIOMEMBRANES, V1818, P2669, DOI 10.1016/j.bbamem.2012.06.006; Bae C, 2016, ELIFE, V5, DOI 10.7554/eLife.11273; Bagal S, 2013, J MED CHEM, V56, P593, DOI 10.1021/jm3011433; Beeton Christine, 2011, Inflammation & Allergy Drug Targets, V10, P313; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Cohen L, 2006, J BIOL CHEM, V281, P20673, DOI 10.1074/jbc.M603212200; Conibear AC, 2012, BIOCHEMISTRY-US, V51, P9718, DOI 10.1021/bi301363a; Daleke DL, 2008, CURR OPIN HEMATOL, V15, P191, DOI 10.1097/MOH.0b013e3282f97af7; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; Deplazes E, 2016, BBA-BIOMEMBRANES, V1858, P872, DOI 10.1016/j.bbamem.2016.02.002; Dilly S, 2011, CHEMBIOCHEM, V12, P1808, DOI 10.1002/cbic.201100236; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gupta K, 2015, ELIFE, V4, DOI 10.7554/eLife.06774; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2015, CHEM BIOL, V22, P1087, DOI 10.1016/j.chembiol.2015.07.012; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Henriques ST, 2009, BIOCHEMISTRY-US, V48, P4198, DOI 10.1021/bi900009d; Henriques ST, 2005, FEBS LETT, V579, P4498, DOI 10.1016/j.febslet.2005.06.085; Henriques ST, 2005, BBA-BIOMEMBRANES, V1669, P75, DOI 10.1016/j.bbamem.2004.11.017; Herzig V, 2015, TOXINS, V7, P4366, DOI 10.3390/toxins7104366; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; Jung HH, 2010, BIOPHYS J, V99, P638, DOI 10.1016/j.bpj.2010.04.061; King GF, 2014, ACS CHEM NEUROSCI, V5, P749, DOI 10.1021/cn500171p; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; Knapp O, 2012, TOXINS, V4, P1236, DOI 10.3390/toxins4111236; Koziara KB, 2014, J COMPUT AID MOL DES, V28, P221, DOI 10.1007/s10822-014-9713-7; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Maier O, 2002, CHEM PHYS LIPIDS, V116, P3, DOI 10.1016/S0009-3084(02)00017-8; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; Mao YC, 2008, TOXICON, V51, P230, DOI 10.1016/j.toxicon.2007.09.008; McGivern JG, 2007, EXPERT OPIN THER TAR, V11, P265, DOI 10.1517/14728222.11.3.265; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; Mihailescu M, 2014, P NATL ACAD SCI USA, V111, pE5463, DOI 10.1073/pnas.1415324111; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Mishra A, 2011, P NATL ACAD SCI USA, V108, P16883, DOI 10.1073/pnas.1108795108; Moran Y, 2009, TOXICON, V54, P1089, DOI 10.1016/j.toxicon.2009.02.028; Norton RS, 2004, CURR MED CHEM, V11, P3041, DOI 10.2174/0929867043363947; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Pan M, 2014, CHEM COMMUN, V50, P5837, DOI 10.1039/c4cc00779d; Park JH, 2014, J MED CHEM, V57, P6623, DOI 10.1021/jm500687u; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Poger D, 2012, J CHEM THEORY COMPUT, V8, P4807, DOI 10.1021/ct300675z; Poger D, 2010, J COMPUT CHEM, V31, P1117, DOI 10.1002/jcc.21396; Pokorny A, 2006, BIOPHYS J, V91, P2184, DOI 10.1529/biophysj.106.085027; Posokhov YO, 2007, BIOPHYS J, V93, pL20, DOI 10.1529/biophysj.107.112375; Prevette LE, 2015, BIOPHYS CHEM, V207, P40, DOI 10.1016/j.bpc.2015.08.003; Priest BT, 2007, TOXICON, V49, P194, DOI 10.1016/j.toxicon.2006.09.014; Rothbard JB, 2005, ADV DRUG DELIVER REV, V57, P495, DOI 10.1016/j.addr.2004.10.003; Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Smith JJ, 2005, J BIOL CHEM, V280, P11127, DOI 10.1074/jbc.M412552200; Stock RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036003; Tang M, 2007, J AM CHEM SOC, V129, P11438, DOI 10.1021/ja072511s; Tikhonov DB, 2011, J BIOL CHEM, V286, P2998, DOI 10.1074/jbc.M110.175406; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vetter I, 2012, BIOCHEM PHARMACOL, V83, P1562, DOI 10.1016/j.bcp.2012.02.022; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xiao YC, 2010, MOL PHARMACOL, V78, P1124, DOI 10.1124/mol.110.066332; Yang ST, 2003, FEBS LETT, V540, P229, DOI 10.1016/S0014-5793(03)00266-7; Zager RA, 2000, J AM SOC NEPHROL, V11, P894, DOI 10.1681/ASN.V115894	74	55	56	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17049	17065		10.1074/jbc.M116.729095	http://dx.doi.org/10.1074/jbc.M116.729095			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27311819	Green Published, hybrid			2022-12-26	WOS:000382643800012
J	Cordeau, E; Arnaudguilhem, C; Bouyssiere, B; Hagege, A; Martinez, J; Subra, G; Cantel, S; Enjalbal, C				Cordeau, Emmanuelle; Arnaudguilhem, Carine; Bouyssiere, Brice; Hagege, Agnes; Martinez, Jean; Subra, Gilles; Cantel, Sonia; Enjalbal, Christine			Investigation of Elemental Mass Spectrometry in Pharmacology for Peptide Quantitation at Femtomolar Levels	PLOS ONE			English	Article							ICP-MS; SELENIUM; PLASMA; PROTEINS; QUANTIFICATION; SELENOCYSTEINE; INTERFERENCES; SPECIATION; CHEMISTRY; SULFUR	In the search of new robust and environmental-friendly analytical methods able to answer quantitative issues in pharmacology, we explore liquid chromatography (LC) associated with elemental mass spectrometry (ICP-MS) to monitor peptides in such complex biological matrices. The novelty is to use mass spectrometry to replace radiolabelling and radioactivity measurements, which represent up-to now the gold standard to measure organic compound concentrations in life science. As a proof of concept, we choose the vasopressin (AVP)/V1A receptor system for model pharmacological assays. The capacity of ICP-MS to provide highly sensitive quantitation of metallic and hetero elements, whatever the sample medium, prompted us to investigate this technique in combination with appropriate labelling of the peptide of interest. Selenium, that is scarcely present in biological media, was selected as a good compromise between ICP-MS response, covalent tagging ability using conventional sulfur chemistry and peptide detection specificity. Applying selenium monitoring by elemental mass spectrometry in pharmacology is challenging due to the very high salt content and organic material complexity of the samples that produces polyatomic aggregates and thus potentially mass interferences with selenium detection. Hyphenation with a chromatographic separation was found compulsory. Noteworthy, we aimed to develop a straightforward quantitative protocol that can be performed in any laboratory equipped with a standard macrobore LC-ICP-MS system, in order to avoid time-consuming sample treatment or special implementation of instrumental set-up, while allowing efficient suppression of all mass interferences to reach the targeted sensitivity. Significantly, a quantification limit of 57 ng Se L-1 (72 femtomoles of injected Se) was achieved, the samples issued from the pharmacological assays being directly introduced into the LC-ICP-MS system. The established method was successfully validated and applied to the measurement of the vasopressin ligand affinity for its V1A receptor through the determination of the dissociation constant (Kd) which was compared to the one recorded with conventional radioactivity assays.	[Cordeau, Emmanuelle; Martinez, Jean; Subra, Gilles; Cantel, Sonia; Enjalbal, Christine] Univ Montpellier, IBMM, ENSCM, CNRS,UMR 5247, Pl Eugene Bataillon, F-34095 Montpellier 5, France; [Arnaudguilhem, Carine; Bouyssiere, Brice] Helioparc, Lab Chim Analyt Bioinorgan & Environm LCABIE IPRE, UMR 5254, 2 Av Pr Angot, F-64053 Pau, France; [Hagege, Agnes] Univ Lyon 1, ISA, CNRS, UMR 5280, 5 Rue Doua, F-69100 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Pau et des Pays de l'Adour; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Enjalbal, C (corresponding author), Univ Montpellier, IBMM, ENSCM, CNRS,UMR 5247, Pl Eugene Bataillon, F-34095 Montpellier 5, France.	enjalbal@univ-montp2.fr	Martinez, Jean/R-9421-2019	Martinez, Jean/0000-0002-9267-4621; BOUYSSIERE, Brice/0000-0001-5878-6067	Agence Nationale de la Recherche (ANR) [ANR-13-BSV5-0003-01]; Conseil Regional d'Aquitaine [20071303002PFM]; FEDER [31486/08011464]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); FEDER(European Commission)	Agence Nationale de la Recherche (ANR, project ANR-13-BSV5-0003-01) (http://www.agencenationale-recherche.fr), Conseil Regional d'Aquitaine (20071303002PFM) (http://www.aquitaine.fr), and FEDER (31486/08011464) (http://www.europe-enfrance.gouv.fr/Configuration-Generale-Pagessecondaires/FEDER) are also acknowledged for their financial supports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN P, 1991, ANAL CHEM, V63, P1497, DOI 10.1021/ac00014a028; Armishaw CJ, 2006, J BIOL CHEM, V281, P14136, DOI 10.1074/jbc.M512419200; Besse D, 1997, J PEPT SCI, V3, P442, DOI 10.1002/(SICI)1099-1387(199711)3:6<442::AID-PSC122>3.0.CO;2-2; CONE JE, 1976, P NATL ACAD SCI USA, V73, P2659, DOI 10.1073/pnas.73.8.2659; Cotte N, 2000, EUR J BIOCHEM, V267, P4253, DOI 10.1046/j.1432-1033.2000.01472.x; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Davies M, 1998, CHARACTERIZATION REC, P1; DEAGEN JT, 1991, J INORG BIOCHEM, V41, P261, DOI 10.1016/0162-0134(91)80018-D; Dufailly V, 2006, ANAL CHIM ACTA, V565, P214, DOI 10.1016/j.aca.2006.02.046; EVANS EH, 1993, J ANAL ATOM SPECTROM, V8, P1, DOI 10.1039/ja9930800001; Ge Y, 2009, INT J BIOCHEM CELL B, V41, P900, DOI 10.1016/j.biocel.2008.08.032; Giusti P, 2005, J ANAL ATOM SPECTROM, V20, P1101, DOI 10.1039/b506620d; He Y, 2014, APPL SPECTROSC REV, V49, P492, DOI 10.1080/05704928.2013.860899; Jager S, 2003, Curr Pharm Biotechnol, V4, P463, DOI 10.2174/1389201033377382; Janghorbani M, 1989, MIKROCHIM ACTA, V99, P315; Kretschy D, 2012, ANAL CHIM ACTA, V750, P98, DOI 10.1016/j.aca.2012.06.040; LARSEN EH, 1994, J ANAL ATOM SPECTROM, V9, P1099, DOI 10.1039/ja9940901099; Leclercq A, 2015, ANAL CHIM ACTA, V885, P33, DOI 10.1016/j.aca.2015.03.049; Moller LH, 2015, J ANAL ATOM SPECTROM, V30, P277, DOI 10.1039/c4ja00277f; Moller LH, 2014, METALLOMICS, V6, P1639, DOI 10.1039/c4mt00085d; Moroder L, 2005, J PEPT SCI, V11, P187, DOI 10.1002/psc.654; Mueller L, 2014, ANAL BIOANAL CHEM, V406, P6963, DOI 10.1007/s00216-014-8143-7; Muttenthaler M, 2010, J MED CHEM, V53, P8585, DOI 10.1021/jm100989w; Polatajko A, 2004, J ANAL ATOM SPECTROM, V19, P114, DOI 10.1039/b308756p; ROWAN JT, 1989, APPL SPECTROSC, V43, P976, DOI 10.1366/0003702894204065; Sanz-Medel A, 2012, TRAC-TREND ANAL CHEM, V40, P52, DOI 10.1016/j.trac.2012.07.020; Schaumloffel D, 2003, ANAL CHEM, V75, P6837, DOI 10.1021/ac034819h; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Vandemeulebroucke A, 2015, BIOCHEMISTRY-US, V54, P6692, DOI 10.1021/acs.biochem.5b00939; Walden H, 2010, ACTA CRYSTALLOGR D, V66, P352, DOI 10.1107/S0907444909038207; Wessjohann LA, 2007, BIOL CHEM, V388, P997, DOI 10.1515/BC.2007.138	31	5	5	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157943	10.1371/journal.pone.0157943	http://dx.doi.org/10.1371/journal.pone.0157943			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336163	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200068
J	Hosokawa, S; Konuma, S; Nakamura, Y				Hosokawa, Shinya; Konuma, Susumu; Nakamura, Yoshiyuki			Accumulation of Trace Metal Elements (Cu, Zn, Cd, and Pb) in Surface Sediment via Decomposed Seagrass Leaves: A Mesocosm Experiment Using Zostera marina L.	PLOS ONE			English	Article							POSIDONIA-OCEANICA; HEAVY-METALS; EELGRASS; CARBON; GROWTH; ECOSYSTEMS; NITROGEN; SYSTEM; WATERS; COPPER	Accumulation of Cu, Zn, Cd, and Pb in the sediment of seagrass ecosystems was examined using mesocosm experiments containing Zostera marina (eelgrass) and reference pools. Lead was approximately 20-fold higher in the surface sediment in the eelgrass pool than in eelgrass leaves and epiphytes on the eelgrass leaves, whereas zinc and cadmium were significantly lower in the surface sediment than in the leaves, with intermediate concentrations in epiphytes. Copper concentrations were similar in both the surface sediment and leaves but significantly lower in epiphytes. Carbon and nitrogen contents increased significantly with increasing delta C-13 in surface sediments of both the eelgrass and reference pools. Copper, Zn, Cd, and Pb also increased significantly with increasing delta C-13 in the surface sediment in the eelgrass pool but not in the reference pool. By decomposition of eelgrass leaves with epiphytes, which was examined in the eelgrass pool, copper and lead concentrations increased more than 2-fold and approximately a 10-fold, whereas zinc and cadmium concentrations decreased. The high copper and lead concentrations in the surface sediment result from accumulation in decomposed, shed leaves, whereas zinc and cadmium remobilized from decomposed shed leaves but may remain at higher concentrations in the leaves than in the original sediments. The results of our mesocosm study demonstrate that whether the accumulation or remobilization of trace metals during the decomposition of seagrass leaves is trace metal dependent, and that the decomposed seagrass leaves can cause copper and lead accumulation in sediments in seagrass ecosystems.	[Hosokawa, Shinya] Port & Airport Res Inst, Marine Environm Informat Grp, 3-1-1 Nagase, Yokosuka, Kanagawa 2390826, Japan; [Konuma, Susumu; Nakamura, Yoshiyuki] Port & Airport Res Inst, Coastal & Estuarine Environm Res Grp, 3-1-1 Nagase, Yokosuka, Kanagawa 2390826, Japan; [Konuma, Susumu] Nihon Univ, Dept Civil Engn, Chiyoda Ku, 1-8 Kanda Surugadai, Tokyo 1018308, Japan; [Nakamura, Yoshiyuki] Yokohama Natl Univ, Dept Civil Engn, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan	Port & Airport Research Institute; Port & Airport Research Institute; Nihon University; Yokohama National University	Hosokawa, S (corresponding author), Port & Airport Res Inst, Marine Environm Informat Grp, 3-1-1 Nagase, Yokosuka, Kanagawa 2390826, Japan.	hosokawa@pari.go.jp		Hosokawa, Shinya/0000-0002-4683-4700	Steel Industry Foundation for the Advancement of Environmental Protection Technology	Steel Industry Foundation for the Advancement of Environmental Protection Technology(Steel Industry Foundation for the Advancement of Environmental Protection Technology)	This work was supported by the Steel Industry Foundation for the Advancement of Environmental Protection Technology (http://sept.or.jp/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrhman MA, 2003, MAR ECOL PROG SER, V248, P67, DOI 10.3354/meps248067; BURKHOLDER JM, 1992, MAR ECOL PROG SER, V81, P163, DOI 10.3354/meps081163; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Clark JS, 2003, ECOLOGY, V84, P17, DOI 10.1890/0012-9658(2003)084[0017:CHTITT]2.0.CO;2; Cloern JE, 2002, LIMNOL OCEANOGR, V47, P713, DOI 10.4319/lo.2002.47.3.0713; DRIFMEYER JE, 1980, AM J BOT, V67, P1089, DOI 10.2307/2442201; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003793; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Harris LA, 2004, MAR ECOL PROG SER, V281, P233, DOI 10.3354/meps281233; Hibino T, 1999, REP PORT HARBOUR RES, V38, P29; Hosokawa S, 2015, MAR ECOL PROG SER, V523, P41, DOI 10.3354/meps11146; Hosokawa S, 2011, ECOL MODEL, V222, P105, DOI 10.1016/j.ecolmodel.2010.09.015; Hosokawa S, 2009, OIKOS, V118, P1158, DOI 10.1111/j.1600-0706.2009.17288.x; Kaldy JE, 2006, MAR POLLUT BULL, V52, P342, DOI 10.1016/j.marpolbul.2005.11.019; Kuwae T, 2008, ECOLOGY, V89, P599, DOI 10.1890/07-1442.1; Lewis MA, 2009, ENVIRON TOXICOL CHEM, V28, P644, DOI 10.1897/08-201.1; LYNGBY JE, 1989, HYDROBIOLOGIA, V176, P189, DOI 10.1007/BF00026554; LYNGBY JE, 1982, AQUAT BOT, V14, P59, DOI 10.1016/0304-3770(82)90086-9; Macinnis-Ng CMO, 2004, J EXP MAR BIOL ECOL, V302, P63, DOI 10.1016/j.jembe.2003.10.002; MANTOURA RFC, 1978, ESTUAR COAST MAR SCI, V6, P387, DOI 10.1016/0302-3524(78)90130-5; Marin-Guirao L, 2005, MAR ENVIRON RES, V60, P317, DOI 10.1016/j.marenvres.2004.11.002; MUKAI H, 1979, AQUAT BOT, V7, P47, DOI 10.1016/0304-3770(79)90006-8; NADAOKA K, 1989, J FLUID MECH, V204, P359, DOI 10.1017/S0022112089001783; Nakaoka M., 2001, OTSUCHI MAR SCI, V26, P7; Nicastro A, 2012, MAR ECOL PROG SER, V456, P53, DOI 10.3354/meps09635; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; R Development Core Team, 2014, R LANG ENV STAT COMP; Richir J, 2013, AQUAT TOXICOL, V140, P157, DOI 10.1016/j.aquatox.2013.05.018; SAND-JENSEN K, 1975, Ophelia, V14, P185; Sanz-Lazaro C, 2012, BIOGEOSCIENCES, V9, P2497, DOI 10.5194/bg-9-2497-2012; Schaller J, 2011, SCI TOTAL ENVIRON, V409, P4891, DOI 10.1016/j.scitotenv.2011.08.006; Schaller J, 2010, CHEMOSPHERE, V79, P169, DOI 10.1016/j.chemosphere.2010.01.015; Schneider G, 2016, FUNCTIONS DATASETS A; Serrano O, 2016, SCI TOTAL ENVIRON, V541, P883, DOI 10.1016/j.scitotenv.2015.09.017; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; SHORT FT, 1987, AQUAT BOT, V27, P41, DOI 10.1016/0304-3770(87)90085-4; SHORT FT, 1995, LIMNOL OCEANOGR, V40, P740, DOI 10.4319/lo.1995.40.4.0740; Simpson SL, 2013, CSIRO LAND AND WATER; Takai N, 2002, LIMNOL OCEANOGR, V47, P730, DOI 10.4319/lo.2002.47.3.0730; Tanaka N, 2011, MAR BIOL, V158, P871, DOI 10.1007/s00227-010-1614-2; Tipping E, 2003, ENVIRON POLLUT, V125, P213, DOI 10.1016/S0269-7491(03)00058-7; Watanabe K, 2015, GLOBAL CHANGE BIOL, V21, P2612, DOI 10.1111/gcb.12924	42	8	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157983	10.1371/journal.pone.0157983	http://dx.doi.org/10.1371/journal.pone.0157983			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336306	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200080
J	Parodis, I; Arnaud, L; Gerhardsson, J; Zickert, A; Sundelin, B; Malmstrom, V; Svenungsson, E; Gunnarsson, I				Parodis, Ioannis; Arnaud, Laurent; Gerhardsson, Jakob; Zickert, Agneta; Sundelin, Birgitta; Malmstrom, Vivianne; Svenungsson, Elisabet; Gunnarsson, Iva			Antiphospholipid Antibodies in Lupus Nephritis	PLOS ONE			English	Article							ANTICARDIOLIPIN ANTIBODIES; CLASSIFICATION CRITERIA; SYNDROME NEPHROPATHY; ANNEXIN-II; ERYTHEMATOSUS; DISEASE; ASSOCIATIONS; PLASMINOGEN; VALIDATION; STATEMENT	Lupus nephritis (LN) is a major manifestation of systemic lupus erythematosus (SLE). It remains unclear whether antiphospholipid antibodies (aPL) alter the course of LN. We thus investigated the impact of aPL on short-term and long-term renal outcomes in patients with LN. We assessed levels of aPL cross-sectionally in SLE patients diagnosed with (n = 204) or without (n = 294) LN, and prospectively in 64 patients with active biopsy-proven LN (52 proliferative, 12 membranous), before and after induction treatment (short-term outcomes). Long-term renal outcome in the prospective LN cohort was determined by the estimated glomerular filtration rate (eGFR) and the Chronic Kidney Disease (CKD) stage, after a median follow-up of 11.3 years (range: 3.3-18.8). Cross-sectional analysis revealed no association between LN and IgG/IgM anticardiolipin or anti-beta(2)-glycoprotein I antibodies, or lupus anticoagulant. Both aPL positivity and levels were similar in patients with active LN and non-renal SLE. Following induction treatment for LN, serum IgG/IgM aPL levels decreased in responders (p < 0.005 for all), but not in non-responders. Both at active LN and post-treatment, patients with IgG, but not IgM, aPL had higher creatinine levels compared with patients without IgG aPL. Neither aPL positivity nor levels were associated with changes in eGFR from either baseline or post-treatment through long-term follow-up. Moreover, aPL positivity and levels both at baseline and post-treatment were similar in patients with a CKD stage >= 3 versus 1-2 at the last follow-up. In conclusion, neither aPL positivity nor levels were found to be associated with the occurrence of LN in SLE patients. However, IgG aPL positivity in LN patients was associated with a short-term impairment of the renal function while no effect on long-term renal outcome was observed. Furthermore, IgG and IgM aPL levels decreased following induction treatment only in responders, indicating that aPL levels are affected by immunosuppressive drugs in a response-dependent manner.	[Parodis, Ioannis; Arnaud, Laurent; Gerhardsson, Jakob; Zickert, Agneta; Malmstrom, Vivianne; Svenungsson, Elisabet; Gunnarsson, Iva] Karolinska Inst, Dept Med, Karolinska Univ Hosp, Rheumatol Unit, Stockholm, Sweden; [Sundelin, Birgitta] Karolinska Inst, Dept Oncol Pathol, Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Parodis, I (corresponding author), Karolinska Inst, Dept Med, Karolinska Univ Hosp, Rheumatol Unit, Stockholm, Sweden.	ioannis.parodis@karolinska.se	Parodis, Ioannis/AAD-2693-2020	Parodis, Ioannis/0000-0002-4875-5395; ARNAUD, Laurent/0000-0002-8077-8394; Svenungsson, Elisabet/0000-0003-3396-3244	Swedish Research Council; Swedish Rheumatism Association; King Gustaf V's 80-year Foundation; Swedish Heart-Lung Foundation; Foundation in memory of Clas Groschinsky; Stockholm County Council; Karolinska Institutet Foundations	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; King Gustaf V's 80-year Foundation; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Foundation in memory of Clas Groschinsky; Stockholm County Council(Stockholm County Council); Karolinska Institutet Foundations(Karolinska Institutet)	This study was supported by grants from the Swedish Research Council, Swedish Rheumatism Association, King Gustaf V's 80-year Foundation, Swedish Heart-Lung Foundation, Foundation in memory of Clas Groschinsky, Stockholm County Council and Karolinska Institutet Foundations.	ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67; Allen KL, 2012, BLOOD, V119, P884, DOI 10.1182/blood-2011-03-344671; Arnaud L, 2015, AUTOIMMUN REV, V14, P192, DOI 10.1016/j.autrev.2014.10.019; AUSTIN HA, 1983, AM J MED, V75, P382, DOI 10.1016/0002-9343(83)90338-8; Berden AE, 2010, J AM SOC NEPHROL, V21, P2169, DOI 10.1681/ASN.2010030274; Bhandari S, 1998, QJM-MON J ASSOC PHYS, V91, P401, DOI 10.1093/qjmed/91.6.401; Bu C, 2008, CLIN RHEUMATOL, V27, P171, DOI 10.1007/s10067-007-0673-3; Cervera R, 2002, ARTHRITIS RHEUM-US, V46, P1019, DOI 10.1002/art.10187; CERVERA R, 1993, MEDICINE, V72, P113, DOI 10.1097/00005792-199303000-00005; Cesarman-Maus G, 2006, BLOOD, V107, P4375, DOI 10.1182/blood-2005-07-2636; Conti F, 2016, LUPUS, V25, P719, DOI 10.1177/0961203315627199; Daugas E, 2002, J AM SOC NEPHROL, V13, P42, DOI 10.1681/ASN.V13142; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; FARRUGIA E, 1992, AM J KIDNEY DIS, V20, P463, DOI 10.1016/S0272-6386(12)70258-5; Fofi C, 2001, CLIN EXP RHEUMATOL, V19, P75; FRAMPTON G, 1991, KIDNEY INT, V39, P1225, DOI 10.1038/ki.1991.155; Gerhardsson J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0614-5; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2000, J RHEUMATOL, V29, P288, DOI DOI 10.3899/JRHEUM.110550; GULKO PS, 1993, J RHEUMATOL, V20, P1684; HUGHES GRV, 1986, J RHEUMATOL, V13, P486; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2012, AM J KIDNEY DIS, V60, P683, DOI 10.1053/j.ajkd.2012.08.019; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Liang MH, 2006, ARTHRITIS RHEUM-US, V54, P421, DOI 10.1002/art.21625; Loizou S, 2000, RHEUMATOLOGY, V39, P962, DOI 10.1093/rheumatology/39.9.962; Mehrani T, 2011, J RHEUMATOL, V38, P450, DOI 10.3899/jrheum.100650; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Moroni G, 2004, AM J KIDNEY DIS, V43, P28, DOI 10.1053/j.ajkd.2003.09.011; Nochy D, 1999, J AM SOC NEPHROL, V10, P507; Parodis I, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2014-000061; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Salle V, 2008, J CLIN IMMUNOL, V28, P291, DOI 10.1007/s10875-008-9188-1; Salle V, 2016, J CLIN PATHOL, V69, P533, DOI 10.1136/jclinpath-2015-203139; Salle V, 2012, EUR J INTERN MED, V23, P665, DOI 10.1016/j.ejim.2012.04.006; Song D, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4142; Stratta P, 1999, RENAL FAILURE, V21, P49, DOI 10.3109/08860229909066969; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tektonidou MG, 2004, ARTHRITIS RHEUM-US, V50, P2569, DOI 10.1002/art.20433; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Yung S, 2010, J AM SOC NEPHROL, V21, P1912, DOI 10.1681/ASN.2009080805; Zheng H, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2736; Zickert A, 2014, LUPUS SCI MED, V1, DOI 10.1136/lupus-2014-000018	45	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158076	10.1371/journal.pone.0158076	http://dx.doi.org/10.1371/journal.pone.0158076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336701	gold, Green Published, Green Submitted			2022-12-26	WOS:000378389200107
J	Gichohi-Wainaina, WN; Tanaka, T; Towers, GW; Verhoef, H; Veenemans, J; Talsma, EF; Harryvan, J; Boekschoten, MV; Feskens, EJ; Melse-Boonstra, A				Gichohi-Wainaina, Wanjiku N.; Tanaka, Toshiko; Towers, G. Wayne; Verhoef, Hans; Veenemans, Jacobien; Talsma, Elise F.; Harryvan, Jan; Boekschoten, Mark V.; Feskens, Edith J.; Melse-Boonstra, Alida			Associations between Common Variants in Iron-Related Genes with Haematological Traits in Populations of African Ancestry	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BLOOD-CELL TRAITS; SERUM IRON; TRANSFERRIN SATURATION; DEFICIENCY ANEMIA; TMPRSS6; HEMOGLOBIN; AMERICANS; FERRITIN; SAMPLE	Background Large genome-wide association (GWA) studies of European ancestry individuals have identified multiple genetic variants influencing iron status. Studies on the generalizability of these associations to African ancestry populations have been limited. These studies are important given interethnic differences in iron status and the disproportionate burden of iron deficiency among African ancestry populations. Methods We tested the associations of 20 previously identified iron status-associated single nucleotide polymorphisms (SNPs) in 628 Kenyans, 609 Tanzanians, 608 South Africans and 228 African Americans. In each study, we examined the associations present between 20 SNPs with ferritin and haemoglobin, adjusting for age, sex and CRP levels. Results In the meta analysis including all 4 African ancestry cohorts, we replicated previously reported associations with lowered haemoglobin concentrations for rs2413450 (beta = -0.19, P = 0.02) and rs4820268 (beta = -0.16, P = 0.04) in TMPRSS6. An association with increased ferritin concentrations was also confirmed for rs1867504 in TF (beta = 1.04, P = <0.0001) in the meta analysis including the African cohorts only. Conclusions In all meta analyses, we only replicated 4 of the 20 single nucleotide polymorphisms reported to be associated with iron status in large GWA studies of European ancestry individuals. While there is now evidence for the associations of a number of genetic variants with iron status in both European and African ancestry populations, the considerable lack of concordance highlights the importance of continued ancestry-specific studies to elucidate the genetic underpinnings of iron status in ethnically diverse populations.	[Gichohi-Wainaina, Wanjiku N.; Harryvan, Jan; Feskens, Edith J.; Melse-Boonstra, Alida] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Gichohi-Wainaina, Wanjiku N.] IITA, Dar Es Salaam, Tanzania; [Tanaka, Toshiko] NIA, Translat Gerontol Branch, Baltimore, MD 21224 USA; [Towers, G. Wayne] North West Univ, Ctr Excellence Nutr, Potchefstroom Campus, Potchefstroom, South Africa; [Verhoef, Hans] Wageningen Univ, Cell Biol & Immunol Grp, NL-6700 AP Wageningen, Netherlands; [Verhoef, Hans] London Sch Hyg & Trop Med, MRC, Int Nutr Grp, London WC1, England; [Verhoef, Hans] Med Res Council Banjul, Banjul, Gambia; [Veenemans, Jacobien] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Veenemans, Jacobien] Admiraal De Ruyter Hosp, Dept Med Microbiol & Immunol, Goes, Netherlands; [Talsma, Elise F.] CIAT, HarvestPlus, Cali, Colombia; [Boekschoten, Mark V.] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); North West University - South Africa; Wageningen University & Research; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Amphia Hospital; Alliance; International Center for Tropical Agriculture - CIAT; Wageningen University & Research	Gichohi-Wainaina, WN (corresponding author), Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.; Gichohi-Wainaina, WN (corresponding author), IITA, Dar Es Salaam, Tanzania.	wngichohi@gmail.com	Verhoef, Hans/L-3024-2015; Feskens, Edith/ABI-1446-2020; Verhoef, Hans/AGD-5388-2022; Boekschoten, Mark/AAS-4597-2021; Melse, Alida/AAH-2446-2019	Verhoef, Hans/0000-0002-9346-9689; Feskens, Edith/0000-0001-5819-2488; Boekschoten, Mark/0000-0002-2139-0795; Towers, Wayne/0000-0003-2655-168X; Gichohi-Wainaina, Wanjiku/0000-0002-3605-0304; Talsma, Elise/0000-0002-6034-4708	European Union's Seventh Framework Programme [FP7] [211484]; Netherlands Organisation for Scientific Research (NWO)/WOTRO [W93-413, WAO93-441, WIZ93-465]; UNICEF; Cornelis Visser Foundation; Wageningen University (Interdisciplinary Research and Education Fund); South African Medical Research Council (Self-Initiated Research Grants), Cape Town, South Africa; Unilever R&D, Vlaardingen, The Netherlands; European Union (EU) [MC-IRSES-2008-230786]; Intramural Research Program of the NIH; National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000965] Funding Source: NIH RePORTER	European Union's Seventh Framework Programme [FP7]; Netherlands Organisation for Scientific Research (NWO)/WOTRO(Netherlands Organization for Scientific Research (NWO)); UNICEF; Cornelis Visser Foundation; Wageningen University (Interdisciplinary Research and Education Fund); South African Medical Research Council (Self-Initiated Research Grants), Cape Town, South Africa; Unilever R&D, Vlaardingen, The Netherlands(Netherlands Government); European Union (EU)(CGIAREuropean Commission); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Kenyan cohort research was conducted within the framework of INSTAPA Project, funded by the European Union's Seventh Framework Programme [FP7/2007-2013] under grant agreement nr 211484. The Tanzanian cohort research was supported through funding from the Netherlands Organisation for Scientific Research (NWO)/WOTRO [W93-413, WAO93-441, as well as WIZ93-465, UNICEF, Cornelis Visser Foundation and Wageningen University (Interdisciplinary Research and Education Fund). The PURE study was supported through grants provided by the South African Medical Research Council (Self-Initiated Research Grants), Cape Town, South Africa, with further support from a fellowship provided by Unilever R&D, Vlaardingen, The Netherlands, and from the European Union (EU) funded staff exchange European-South African Partnership in Nutrition Research program (grant MC-IRSES-2008-230786). The BLSA was supported through funding by the Intramural Research Program of the NIH, National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidoo M, 2001, GENET EPIDEMIOL, V21, P201, DOI 10.1002/gepi.1029; An P, 2012, HUM MOL GENET, V21, P2124, DOI 10.1093/hmg/dds028; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Aslan D, 2007, ACTA HAEMATOL-BASEL, V118, P244, DOI 10.1159/000112726; Atkinson SH, 2008, BLOOD, V112, P4276, DOI 10.1182/blood-2008-06-162008; Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456; Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; Beutler E, 2005, BLOOD, V106, P740, DOI 10.1182/blood-2005-02-0713; Beutler E, 2000, BLOOD, V96, P4071, DOI 10.1182/blood.V96.13.4071.h8004071_4071_4074; Blanco-Rojo R, 2014, INT J MOL SCI, V15, P4077, DOI 10.3390/ijms15034077; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Chen Z, 2013, HUM MOL GENET, V22, P2529, DOI 10.1093/hmg/ddt087; Coad J, 2011, CURR OPIN CLIN NUTR, V14, P625, DOI 10.1097/MCO.0b013e32834be6fd; De Falco L, 2013, HAEMATOLOGICA, V98, P845, DOI 10.3324/haematol.2012.075515; Ding KY, 2013, G3-GENES GENOM GENET, V3, P1061, DOI 10.1534/g3.113.006452; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Galesloot TE, 2013, J MED GENET, V50, P593, DOI 10.1136/jmedgenet-2013-101673; Gan W, 2012, AM J CLIN NUTR, V95, P626, DOI 10.3945/ajcn.111.025684; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; GARN SM, 1981, AM J CLIN NUTR, V34, P1645, DOI 10.1093/ajcn/34.9.1645; Gomez F, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a008524; Gordon D, 2003, Pac Symp Biocomput, P490; Jonker FAM, 2014, J INFECTION, V69, pS23, DOI 10.1016/j.jinf.2014.08.007; Kullo IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013011; Lee PL, 2001, BRIT J HAEMATOL, V115, P329, DOI 10.1046/j.1365-2141.2001.03096.x; Li J, 2015, HUM MOL GENET, V24, P572, DOI 10.1093/hmg/ddu454; Li J, 2013, HUM MOL GENET, V22, P1457, DOI 10.1093/hmg/dds534; Lo KS, 2011, HUM GENET, V129, P307, DOI 10.1007/s00439-010-0925-1; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; McLaren CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038339; McLaren CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017390; Meynard D, 2014, BLOOD, V123, P168, DOI 10.1182/blood-2013-06-427757; Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012; Njajou OT, 2006, HUM HERED, V61, P222, DOI 10.1159/000094777; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Patel A, 2012, MATERN CHILD NUTR, V8, P28, DOI 10.1111/j.1740-8709.2011.00385.x; Pfeiffer RM, 2003, GENET EPIDEMIOL, V25, P136, DOI 10.1002/gepi.10245; Pichler I, 2011, HUM MOL GENET, V20, P1232, DOI 10.1093/hmg/ddq552; RCore Team, 2020, R LANG ENV STAT COMP; Scherag A, 2003, HUM HERED, V56, P56, DOI 10.1159/000073733; Shock N.W., 1984, NORMAL HUMAN AGING B; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Talsma EF, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0256-5; Tanaka T, 2010, BLOOD, V115, P94, DOI 10.1182/blood-2009-07-232496; Tishkoff SA, 2004, NAT GENET, V36, pS21, DOI 10.1038/ng1438; Traglia M, 2011, J MED GENET, V48, P629, DOI 10.1136/jmedgenet-2011-100061; Trenor CC, 2000, BLOOD, V96, P1113, DOI 10.1182/blood.V96.3.1113.015k03_1113_1118; Trey JE, 1995, CRIT REV ONCOL HEMAT, V21, P1, DOI 10.1016/1040-8428(94)00141-3; Veenemans J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001125; Vitamin and Mineral Nutrition Information System, 2011, WHONMHNHDMNM111 VIT; Weiss G, 2010, NAT REV GASTRO HEPAT, V7, P50, DOI 10.1038/nrgastro.2009.201; Whitfield JB, 2000, AM J HUM GENET, V66, P1246, DOI 10.1086/302862; Whitfield JB, 2001, ALCOHOL CLIN EXP RES, V25, P1037, DOI 10.1097/00000374-200107000-00014; World Health Organization, 2008, WHO GLOBAL DATABASE; YIP R, 1984, AM J CLIN NUTR, V39, P427, DOI 10.1093/ajcn/39.3.427; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P115	59	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157996	10.1371/journal.pone.0157996	http://dx.doi.org/10.1371/journal.pone.0157996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332551	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000378212800065
J	Agha, NA; Willumeit-Romer, R; Laipple, D; Luthringer, B; Feyerabend, F				Agha, Nezha Ahmad; Willumeit-Roemer, Regine; Laipple, Daniel; Luthringer, Berengere; Feyerabend, Frank			The Degradation Interface of Magnesium Based Alloys in Direct Contact with Human Primary Osteoblast Cells	PLOS ONE			English	Article							HUMAN BONE TISSUE; IN-VITRO; SILVER NANOPARTICLES; DIFFERENTIATION; GADOLINIUM; CORROSION; BIOCOMPATIBILITY; PROLIFERATION; PRECIPITATION; RETENTION	Magnesium alloys have been identified as a new generation material of orthopaedic implants. In vitro setups mimicking physiological conditions are promising for material/degradation analysis prior to in vivo studies however the direct influence of cell on the degradation mechanism has never been investigated. For the first time, the direct, active, influence of human primary osteoblasts on magnesium-based materials (pure magnesium, Mg-2Ag and Mg-10Gd alloys) is studied for up to 14 days. Several parameters such as composition of the degradation interface (directly beneath the cells) are analysed with a scanning electron microscope equipped with energy dispersive X-ray and focused ion beam. Furthermore, influence of the materials on cell metabolism is examined via different parameters like active mineralisation process. The results are highlighting the influences of the selected alloying element on the initial cells metabolic activity.	[Agha, Nezha Ahmad; Willumeit-Roemer, Regine; Luthringer, Berengere; Feyerabend, Frank] Helmholtz Zentrum Geesthacht, Inst Mat Res, Div Metall Biomat, D-21502 Geesthacht, Germany; [Laipple, Daniel] Helmholtz Zentrum Geesthacht, Inst Mat Res, Div Mat Phys, D-21502 Geesthacht, Germany	Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Agha, NA (corresponding author), Helmholtz Zentrum Geesthacht, Inst Mat Res, Div Metall Biomat, D-21502 Geesthacht, Germany.	Nezha.Ahmad@hzg.de	Feyerabend, Frank/A-1124-2010; Luthringer, Bérengère/G-9039-2017; Willumeit, Regine/I-8029-2013	Feyerabend, Frank/0000-0001-9532-0207; Luthringer, Bérengère/0000-0002-8248-6715; Willumeit, Regine/0000-0002-6004-6946; Ahmad Agha, Nezha/0000-0003-0368-0606	People Program (Marie Curie Actions) European Union's Seventh Framework Program FP7 under REA grant [289163]	People Program (Marie Curie Actions) European Union's Seventh Framework Program FP7 under REA grant	The research leading to these results has received funding from the People Program (Marie Curie Actions) of the European Union's Seventh Framework Program FP7/2007-2013/ under REA grant agreement no 289163. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha NA, 2016, MAT SCI ENG C-MATER, V58, P817, DOI 10.1016/j.msec.2015.09.067; Albers CE, 2013, NANOTOXICOLOGY, V7, P30, DOI 10.3109/17435390.2011.626538; [Anonymous], EURASIP J WIRELESS C, DOI DOI 10.11646/Z00TAXA.3989.1.1; Asharani PV, 2011, NANOTOXICOLOGY, V5, P43, DOI 10.3109/17435390.2010.489207; Barrere F, 2002, BIOMATERIALS, V23, P1921, DOI 10.1016/S0142-9612(01)00318-0; Barros LF, 2003, CELL DEATH DIFFER, V10, P687, DOI 10.1038/sj.cdd.4401236; Belluci MM, 2013, J NUTR BIOCHEM, V24, P1488, DOI 10.1016/j.jnutbio.2012.12.008; BIGI A, 1992, CALCIFIED TISSUE INT, V50, P439, DOI 10.1007/BF00296775; Burmester A, 2017, J BIOMED MATER RES B, V105, P165, DOI 10.1002/jbm.b.33542; Burmester Anna, 2014, Biomatter, V4, pe967616, DOI 10.4161/21592527.2014.967616; Castellani C, 2011, ACTA BIOMATER, V7, P432, DOI 10.1016/j.actbio.2010.08.020; CHU CS, 1988, J TRAUMA, V28, P1488, DOI 10.1097/00005373-198810000-00016; Cortizo MC, 2004, BIOL TRACE ELEM RES, V100, P151, DOI 10.1385/BTER:100:2:151; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Dai YC, 2002, IN VITRO CELL DEV-AN, V38, P373; Darrah TH, 2009, METALLOMICS, V1, P479, DOI 10.1039/b905145g; Fernandez E, 1999, J MATER SCI-MATER M, V10, P169, DOI 10.1023/A:1008937507714; Feyerabend F, 2015, ACTA BIOMATER, V25, P384, DOI 10.1016/j.actbio.2015.07.029; Gallagher JA, 2003, METH MOLEC MED, V80, P3; Contreras RG, 2010, IN VIVO, V24, P507; Gibby WA, 2004, INVEST RADIOL, V39, P138, DOI 10.1097/01.rli.0000112789.57341.01; Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191; Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021; Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010; Iskandar ME, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5512-5; Ji YJ, 2000, BIOMED ENVIRON SCI, V13, P287; JOHNSON JR, 1990, J INFECT DIS, V162, P1145, DOI 10.1093/infdis/162.5.1145; Kannan MB, 2015, COLLOID SURFACE B, V126, P603, DOI 10.1016/j.colsurfb.2015.01.015; Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q; Kindberg GM, 2010, EUR RADIOL, V20, P1636, DOI 10.1007/s00330-010-1716-8; Kostova Irena, 2007, Metal-Based Drugs, P15925, DOI 10.1155/2007/15925; LIEDBERG H, 1990, BRIT J UROL, V65, P379, DOI 10.1111/j.1464-410X.1990.tb14760.x; Liu W, 2010, NANOTOXICOLOGY, V4, P319, DOI 10.3109/17435390.2010.483745; Luthringer BJC, 2014, MAGNESIUM RES, V27, P142, DOI 10.1684/mrh.2015.0375; Ma J, 2016, J BIOMED MATER RES A, V104, P347, DOI 10.1002/jbm.a.35570; Magda D, 2006, SEMIN CANCER BIOL, V16, P466, DOI 10.1016/j.semcancer.2006.09.002; MORENO EC, 1977, CALC TISS RES, V24, P47, DOI 10.1007/BF02223296; Mueller WD, 2009, J BIOMED MATER RES A, V90A, P487, DOI 10.1002/jbm.a.32106; Muller L, 2006, ACTA BIOMATER, V2, P181, DOI 10.1016/j.actbio.2005.11.001; Neve A, 2011, CELL TISSUE RES, V343, P289, DOI 10.1007/s00441-010-1086-1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N; Song YH, 2002, CHEMOSPHERE, V48, P1029, DOI 10.1016/S0045-6535(02)00183-2; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; Suvorova E. I., 2001, European Cells & Materials, V1, P27; Tie D, 2013, EUR CELLS MATER, V25, P284, DOI 10.22203/eCM.v025a20; VEREECKE G, 1990, J CRYST GROWTH, V104, P820, DOI 10.1016/0022-0248(90)90108-W; White GW, 2006, INVEST RADIOL, V41, P272, DOI 10.1097/01.rli.0000186569.32408.95; Willumeit R, 2014, INT J MOL SCI, V15, P7639, DOI 10.3390/ijms15057639; Willumeit R, 2013, ACTA BIOMATER, V9, P8722, DOI 10.1016/j.actbio.2013.02.042; Willumeit R, 2011, ACTA BIOMATER, V7, P2704, DOI 10.1016/j.actbio.2011.03.004; Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008; Wu LL, 2014, ACTA BIOMATER, V10, P2843, DOI 10.1016/j.actbio.2014.02.010; Yang L, 2012, CORROS ENG SCI TECHN, V47, P335, DOI 10.1179/1743278212Y.0000000024; Yoshizawa S, 2014, ACTA BIOMATER, V10, P2834, DOI 10.1016/j.actbio.2014.02.002; Zhang JC, 2012, J RARE EARTH, V30, P831, DOI 10.1016/S1002-0721(12)60139-2; Zhang SX, 2009, MAT SCI ENG C-MATER, V29, P1907, DOI 10.1016/j.msec.2009.03.001; Zhao N, 2015, METALLOMICS, V7, P113, DOI 10.1039/c4mt00244j; Zhao N, 2014, INT J MOL SCI, V15, P5263, DOI 10.3390/ijms15045263	59	43	43	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157874	10.1371/journal.pone.0157874	http://dx.doi.org/10.1371/journal.pone.0157874			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327435	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400054
J	Atageldiyeva, K; Fujita, Y; Yanagimachi, T; Mizumoto, K; Takeda, Y; Honjo, J; Takiyama, Y; Abiko, A; Makino, Y; Haneda, M				Atageldiyeva, Kuralay; Fujita, Yukihiro; Yanagimachi, Tsuyoshi; Mizumoto, Katsutoshi; Takeda, Yasutaka; Honjo, Jun; Takiyama, Yumi; Abiko, Atsuko; Makino, Yuichi; Haneda, Masakazu			Sodium-Glucose Cotransporter 2 Inhibitor and a Low Carbohydrate Diet Affect Gluconeogenesis and Glycogen Content Differently in the Kidney and the Liver of Non-Diabetic Mice	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEPATIC GLUCONEOGENESIS; INSULIN SENSITIVITY; GLYCEMIC CONTROL; RISK-FACTORS; SUGAR INTAKE; WEIGHT-LOSS; RAT-BRAIN; FAT DIET; OBESITY	A low carbohydrate diet (LCHD) as well as sodium glucose cotransporter 2 inhibitors (SGLT2i) may reduce glucose utilization and improve metabolic disorders. However, it is not clear how different or similar the effects of LCHD and SGLT2i are on metabolic parameters such as insulin sensitivity, fat accumulation, and especially gluconeogenesis in the kidney and the liver. We conducted an 8-week study using non-diabetic mice, which were fed ad-libitum with LCHD or a normal carbohydrate diet (NCHD) and treated with/without the SGLT-2 inhibitor, ipragliflozin. We compared metabolic parameters, gene expression for transcripts related to glucose and fat metabolism, and glycogen content in the kidney and the liver among the groups. SGLT2i but not LCHD improved glucose excursion after an oral glucose load compared to NCHD, although all groups presented comparable non-fasted glycemia. Both the LCHD and SGLT2i treatments increased calorie-intake, whereas only the LCHD increased body weight compared to the NCHD, epididimal fat mass and developed insulin resistance. Gene expression of certain gluconeogenic enzymes was simultaneously upregulated in the kidney of SGLT2i treated group, as well as in the liver of the LCHD treated group. The SGLT2i treated groups showed markedly lower glycogen content in the liver, but induced glycogen accumulation in the kidney. We conclude that LCHD induces deleterious metabolic changes in the non-diabetic mice. Our results suggest that SGLT2i induced gluconeogenesis mainly in the kidney, whereas for LCHD it was predominantly in the liver.	[Atageldiyeva, Kuralay; Fujita, Yukihiro; Yanagimachi, Tsuyoshi; Mizumoto, Katsutoshi; Takeda, Yasutaka; Honjo, Jun; Takiyama, Yumi; Abiko, Atsuko; Makino, Yuichi; Haneda, Masakazu] Asahikawa Med Univ, Dept Internal Med, Div Metab Biosyst Sci, Asahikawa, Hokkaido, Japan	Asahikawa Medical College	Fujita, Y (corresponding author), Asahikawa Med Univ, Dept Internal Med, Div Metab Biosyst Sci, Asahikawa, Hokkaido, Japan.	yfujita@asahikawa-med.ac.jp	Atageldiyeva, Kuralay/M-5106-2019	Atageldiyeva, Kuralay/0000-0002-7048-1511; Takeda, Yasutaka/0000-0002-2129-8657				Abdul-Ghani MA, 2011, ENDOCR REV, V32, P515, DOI 10.1210/er.2010-0029; Al-Khalifa A, 2009, NUTRITION, V25, P1177, DOI 10.1016/j.nut.2009.04.004; Balakumar P, 2014, PHARMACOL RES, V82, P34, DOI 10.1016/j.phrs.2014.03.008; Bolinder J, 2014, DIABETES OBES METAB, V16, P159, DOI 10.1111/dom.12189; Bonner C, 2015, NAT MED, V21, P512, DOI 10.1038/nm.3828; Caminhotto RD, 2015, ARCH ENDOCRIN METAB, V59, P568, DOI 10.1590/2359-3997000000106; Devenny JJ, 2012, OBESITY, V20, P1645, DOI 10.1038/oby.2012.59; Dombrowski F, 2007, DIABETOLOGIA, V50, P2580, DOI 10.1007/s00125-007-0838-2; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Gopinath B, 2013, OBESITY, V21, P1884, DOI 10.1002/oby.20405; Green CJ, 2014, NUTRIENTS, V6, P5018, DOI 10.3390/nu6115018; Handa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104948; HELLER RF, 1994, MED HYPOTHESES, V42, P307, DOI 10.1016/0306-9877(94)90004-3; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; HOROBIN R W, 1971, Histochemical Journal, V3, P1, DOI 10.1007/BF01686501; Hu T, 2015, NUTRIENTS, V7, P7978, DOI 10.3390/nu7095377; Ikeda S, 2015, DIABETES OBES METAB, V17, DOI 10.1111/dom.12538; Izumida Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3316; Katsuyama Hisayuki, 2016, J Clin Med Res, V8, P237, DOI 10.14740/jocmr2467w; Kern M, 2016, METABOLISM, V65, P114, DOI 10.1016/j.metabol.2015.10.010; Komiya C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151511; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Liang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030555; Maniecka-Bryla I, 2011, MED LAV, V102, P523; Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704; Michel MC, 2015, N-S ARCH PHARMACOL, V388, P801, DOI 10.1007/s00210-015-1134-1; NOMURA F, 1987, INT J OBESITY, V11, P603; O'Malley D, 2006, DIABETES, V55, P3381, DOI 10.2337/db06-0531; Obata A, 2016, ENDOCRINOLOGY, V157, P1029, DOI 10.1210/en.2015-1588; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; RITCHIE S, 1957, AM J PATHOL, V33, P1035; Ross AP, 2015, J DIABETES COMPLICAT, V29, P329, DOI 10.1016/j.jdiacomp.2014.12.017; Ross SM, 2015, HOLIST NURS PRACT, V29, P114, DOI 10.1097/HNP.0000000000000080; Ross SM, 2015, HOLIST NURS PRACT, V29, P53, DOI 10.1097/HNP.0000000000000066; STUMVOLL M, 1995, J CLIN INVEST, V96, P2528, DOI 10.1172/JCI118314; Suzuki M, 2012, J PHARMACOL EXP THER, V341, P692, DOI 10.1124/jpet.112.191593; Tahara A, 2013, EUR J PHARMACOL, V715, P246, DOI 10.1016/j.ejphar.2013.05.014; Tsunoda N, 1998, METABOLISM, V47, P724, DOI 10.1016/S0026-0495(98)90037-3; Vallon V, 2014, AM J PHYSIOL-RENAL, V306, pF194, DOI 10.1152/ajprenal.00520.2013; WIRTHENSOHN G, 1986, PHYSIOL REV, V66, P469, DOI 10.1152/physrev.1986.66.2.469; WIRTHENSOHN G, 1983, MINER ELECTROL METAB, V9, P203; Yu AS, 2013, AM J PHYSIOL-CELL PH, V304, pC240, DOI 10.1152/ajpcell.00317.2012; Yu AS, 2010, AM J PHYSIOL-CELL PH, V299, pC1277, DOI 10.1152/ajpcell.00296.2010; Zalesin KC, 2011, MED CLIN N AM, V95, P919, DOI 10.1016/j.mcna.2011.06.005	45	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157672	10.1371/journal.pone.0157672	http://dx.doi.org/10.1371/journal.pone.0157672			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327650	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400033
J	Hayashi, S; Sugiyama, S; Shimura, K; Tobayama, G; Togashi, T				Hayashi, Shoji; Sugiyama, Shuta; Shimura, Kojiro; Tobayama, Go; Togashi, Toshio			A Study of Deposition Coatings Formed by Electroformed Metallic Materials	PLOS ONE			English	Article								Major joining methods of dental casting metal include brazing and laser welding. However, brazing cannot be applied for electroformed metals since heat treatment could affect the fit, and, therefore, laser welding is used for such metals. New methods of joining metals that do not impair the characteristics of electroformed metals should be developed. When new coating is performed on the surface of the base metal, surface treatment is usually performed before re-coating. The effect of surface treatment is clinically evaluated by peeling and flex tests. However, these testing methods are not ideal for deposition coating strength measurement of electroformed metals. There have been no studies on the deposition coating strength and methods to test electroformed metals. We developed a new deposition coating strength test for electroformed metals. The influence of the negative electrolytic method, which is one of the electrochemical surface treatments, on the strength of the deposition coating of electroformed metals was investigated, and the following conclusions were drawn: 1. This process makes it possible to remove residual deposits on the electrodeposited metal surface layer. 2. Cathode electrolysis is a simple and safe method that is capable of improving the surface treatment by adjustments to the current supply method and current intensity. 3. Electrochemical treatment can improve the deposition coating strength compared to the physical or chemical treatment methods. 4. Electro-deposition coating is an innovative technique for the deposition coating of electroformed metal.	[Hayashi, Shoji; Sugiyama, Shuta; Shimura, Kojiro; Tobayama, Go; Togashi, Toshio] Kanagawa Dent Univ, Yokohama Clin, Div Implantol, Dept Highly Adv Stomatol, Yokohama, Kanagawa, Japan		Hayashi, S (corresponding author), Kanagawa Dent Univ, Yokohama Clin, Div Implantol, Dept Highly Adv Stomatol, Yokohama, Kanagawa, Japan.	s.hayashi@kdu.ac.jp						Hayashi S, 1985, Kanagawa Shigaku, V20, P58; Hayashi S, 1984, Kanagawa Shigaku, V19, P149; Hayashi S, 1986, Kanagawa Shigaku, V21, P260; Hayashi S., 2004, C NAZ COLL DOC OD RO; Hayashi S., 2000, CONTRIVE NEW ELECTRO, V25, P15; Hayashi S., 2001, CONTRIVE NEW ELECTRO, V26, P15; Hayashi S., 1997, P 98 C JAP PROSTH SO, V41, pP108; Hayashi S., 1995, P 93 C JAP PROSTH SO, V39, pP24; Hayashi S., 1993, P 90 C JAP PROSTH SO, V37, pP67; Hayashi S., 2004, 16 C INT OD CTR CULT, P18; Hayashi S., 1999, P 102 C JAP PROSTH S, V43, pP132; Hayashi S., 2000, P 104 C JAP PROSTH S, V44, pP162; Hayashi S., 1993, P 91 C JAP PROSTH SO, V37, pP76; Hayashi S., 1999, P 100 C JAP PROSTH S, pP333; Hayashi S., 1999, J JPN PROSTHODONT SO, V43, P122; Plating study group, 2013, MECH ENG SERIES, P31; Plating study group, 2013, MECH ENG SERIES, P13; Sawada T., 1992, KANAGAWA SHIGAKU, V27-2, P238; Ukiya M., 1981, KANAGAWA SHIGAKU, V16-3, P387; Yamada N., 1992, KANAGAWA SHIGAKU, V27-3, P384	20	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0154257	10.1371/journal.pone.0154257	http://dx.doi.org/10.1371/journal.pone.0154257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27326757	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400001
J	Moser, MAJ; Arcand, S; Lin, HB; Wojnarowicz, C; Sawicka, J; Banerjee, T; Luo, YG; Beck, GR; Luke, PP; Sawicki, G				Moser, Michael A. J.; Arcand, Steve; Lin, Han-Bin; Wojnarowicz, Chris; Sawicka, Jolanta; Banerjee, Tamalina; Luo, Yigang; Beck, Gavin R.; Luke, Patrick P.; Sawicki, Grzegorz			Protection of the Transplant Kidney from Preservation Injury by Inhibition of Matrix Metalloproteinases	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MYOSIN LIGHT-CHAIN; MACHINE PERFUSION; GRAFT FUNCTION; COLD-STORAGE; BIOMARKERS; ALLOGRAFT; MMP-2; ISCHEMIA/REPERFUSION; EXPRESSION	Background Matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, play an important role in ischemic injury to the heart, yet it is not known if these MMPs are involved in the injury that occurs to the transplant kidney. We therefore studied the pharmacologic protection of transplant kidneys during machine cold perfusion. Methods Human kidney perfusates were analyzed for the presence of injury markers such as cytochrome c oxidase, lactate dehydrogenase, and neutrophil-gelatinase associated lipocalin (NGAL), and MMP-2 and MMP-9 were measured. The effects of MMP inhibitors MMP-2 siRNA and doxycycline were studied in an animal model of donation after circulatory determination of death (DCDD). Results Markers of injury were present in all analyzed perfusates, with higher levels seen in perfusates from human kidneys donated after controlled DCDD compared to brain death and in perfusate from kidneys with delayed graft function. When rat kidneys were perfused at 4 degrees C for 22 hours with the addition of MMP inhibitors, this resulted in markedly reduced levels of MMP-2, MMP-9 and analyzed injury markers. Conclusions Based on our study, MMPs are involved in preservation injury and the supplementation of preservation solution with MMP inhibitors is a potential novel strategy in protecting the transplant kidney from preservation injury.	[Moser, Michael A. J.; Luo, Yigang; Beck, Gavin R.] Dept Surg, Saskatoon, SK, Canada; [Moser, Michael A. J.; Luo, Yigang; Beck, Gavin R.] Saskatchewan Renal Transplant Program, Saskatoon, SK, Canada; [Arcand, Steve; Lin, Han-Bin; Sawicka, Jolanta; Sawicki, Grzegorz] Univ Saskatchewan, Dept Pharmacol, Saskatoon, SK S7N 0W0, Canada; [Lin, Han-Bin] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [Wojnarowicz, Chris] Univ Saskatchewan, Dept Vet Pathol, Prairie Diagnost Serv, Saskatoon, SK, Canada; [Banerjee, Tamalina] Saskatoon Hlth Reg, Dept Lab Med & Pathol, Saskatoon, SK, Canada; [Luke, Patrick P.] London Hlth Sci Ctr, Multi Organ Transplant Program, London, ON, Canada; [Sawicki, Grzegorz] Med Univ Wroclaw, Dept Clin Chem, Wroclaw, Poland	University of Saskatchewan; University of Saskatchewan; University of Ottawa; University of Ottawa Heart Institute; University of Saskatchewan; University of Saskatchewan; London Health Sciences Centre; Wroclaw Medical University	Moser, MAJ (corresponding author), Dept Surg, Saskatoon, SK, Canada.; Moser, MAJ (corresponding author), Saskatchewan Renal Transplant Program, Saskatoon, SK, Canada.; Sawicki, G (corresponding author), Univ Saskatchewan, Dept Pharmacol, Saskatoon, SK S7N 0W0, Canada.; Sawicki, G (corresponding author), Med Univ Wroclaw, Dept Clin Chem, Wroclaw, Poland.	mike.moser@usask.ca; greg.sawicki@usask.ca	Moser, Mike/AAG-9669-2021; Sawicki, Grzegorz/ABA-3357-2021	Moser, Mike/0000-0003-0735-199X; Sawicki, Grzegorz/0000-0003-1596-2133	Royal University Hospital Foundation Grant; Saskatchewan Transplant Program Startup Funding; Department of Surgery Research Chair Startup Funds	Royal University Hospital Foundation Grant; Saskatchewan Transplant Program Startup Funding; Department of Surgery Research Chair Startup Funds	Support was provided to MM by Royal University Hospital Foundation Grant [http://www.ruhf.org], Saskatchewan Transplant Program Startup Funding [www.saskatoonhealthregion.ca/locations_services/Services/organ-tissue-donation/Pages/Saskatchewan-Transplant-Program.aspx], and Department of Surgery Research Chair Startup Funds [http://medicine.usask.ca/department/clinical/surgery.php#DepartmentofSurgery]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Bhangoo RS, 2012, NEPHROL DIAL TRANSPL, V27, P3305, DOI 10.1093/ndt/gfr806; Cadete VJJ, 2013, CAN J CARDIOL, V29, P1495, DOI 10.1016/j.cjca.2013.03.014; Cadete VJJ, 2013, BRIT J PHARMACOL, V170, P380, DOI 10.1111/bph.12289; Cannon RM, 2013, J AM COLL SURGEONS, V216, P625, DOI 10.1016/j.jamcollsurg.2012.12.025; Cheung PY, 2000, CIRCULATION, V101, P1833, DOI 10.1161/01.CIR.101.15.1833; Cook HC, 1994, MANUAL HISTOLOGIC TE, P161; Funk JA, 2012, AM J PHYSIOL-RENAL, V302, pF853, DOI 10.1152/ajprenal.00035.2011; Gill J, 2014, TRANSPLANTATION, V97, P668, DOI 10.1097/01.TP.0000438637.29214.10; Han WK, 2008, KIDNEY INT, V73, P863, DOI 10.1038/sj.ki.5002715; Hrapchak BB, 1987, THEORY PRACTICE HIST, P167; Humar A, 1997, CLIN TRANSPLANT, V11, P623; Jassem W, 2004, KIDNEY INT, V66, P514, DOI 10.1111/j.1523-1755.2004.761_9.x; Kayler LK, 2011, AM J TRANSPLANT, V11, P2657, DOI 10.1111/j.1600-6143.2011.03817.x; Kunugi S, 2011, LAB INVEST, V91, P170, DOI 10.1038/labinvest.2010.174; Lam VWT, 2013, J SURG RES, V180, P176, DOI 10.1016/j.jss.2012.10.055; Moers C, 2010, TRANSPLANTATION, V90, P966, DOI 10.1097/TP.0b013e3181f5c40c; Moers C, 2009, NEW ENGL J MED, V360, P7, DOI 10.1056/NEJMoa0802289; Radhakrishnan J, 2007, AM J PHYSIOL-HEART C, V292, pH767, DOI 10.1152/ajpheart.00468.2006; Saidi RF, 2007, AM J TRANSPLANT, V7, P2769, DOI 10.1111/j.1600-6143.2007.01993.x; Sawicki G, 2005, CIRCULATION, V112, P544, DOI 10.1161/CIRCULATIONAHA.104.531616; Schroppell B, 2014, KIDNEY INT, V86, P251, DOI 10.1038/ki.2014.18; Schulz R, 2007, ANNU REV PHARMACOL, V47, P211, DOI 10.1146/annurev.pharmtox.47.120505.105230; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Yan Q, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-141; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667; Zager RA, 2004, KIDNEY INT, V65, P2123, DOI 10.1111/j.1523-1755.2004.00638.x; Zhao Hong, 2013, World J Nephrol, V2, P84, DOI 10.5527/wjn.v2.i3.84; Zhou HZ, 2007, BIOCHEM BIOPH RES CO, V358, P189, DOI 10.1016/j.bbrc.2007.04.094	29	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157508	10.1371/journal.pone.0157508	http://dx.doi.org/10.1371/journal.pone.0157508			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327879	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400022
J	Zhao, S; Mei, Y; Wang, JL; Zhang, K; Ma, R				Zhao, Song; Mei, Yu; Wang, Jianli; Zhang, Kai; Ma, Rong			Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; ASPIRATE FLUID; MAMMARY DUCTOSCOPY; TUMOR-MARKERS; CA 15-3; CARCINOEMBRYONIC ANTIGEN; SCREENING MAMMOGRAPHY; SERUM-LEVELS; WOMEN; PERFORMANCE	Background The aim of this study was to assess the diagnostic values of three breast tumor markers (i.e., CEA, CA153 and CA125) in milk and nipple discharge in the prediction of different breast diseases diagnoses. Methods Three hundred thirty-six patients (96 breast cancer and 240 benign disease patients) with nipple discharge and a control group of 56 healthy parturient participants were enrolled in the present study. Nipple discharge samples were preoperatively collected from the patients, and milk was collected from the colostrum of the parturient participants. The samples were assayed for the CEA, CA153 and CA125 levels. Cutoff values were determined for the detection of breast diseases using ROC curves. Results The levels of CEA, CA153 and CA125 were significantly different between the nipple discharge and the milk (all ps < 0.001). In the nipple discharge, the CEA and CA153 levels in the breast cancer group were significantly greater than those in the benign group (all ps < 0.001), and cutoff values of 263.3 ng/mL and 1235.3 U/mL, respectively, were established. However, the expression of CA125 did not differ significantly between the breast cancer and benign groups. Conclusion Differences in the apparent expression levels of CEA, CA153 and CA125 in patients with nipple discharge and healthy persons were validated. The present data suggest that CEA and CA153 might potentially be useful in the differential diagnoses of benign tumors and breast cancer. CA125 did not seem to be useful for breast cancer detection.	[Zhao, Song; Zhang, Kai; Ma, Rong] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China; [Mei, Yu] Jinan Matern & Child Care Hosp, Dept Breast Surg, Jinan, Shandong, Peoples R China; [Wang, Jianli] Shandong Univ, Sch Med, Dept Pathophysiol, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Zhang, K; Ma, R (corresponding author), Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China.	zk0827019@sina.com; marongw2000@163.com	ma, rong/GVU-3096-2022; wang, jian/GVS-0711-2022					Baitchev G, 2003, INT SURG, V88, P83; Barak V, 2004, CLIN BIOCHEM, V37, P529, DOI 10.1016/j.clinbiochem.2004.05.009; Bidard FC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3114; Deutscher SL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-519; Dooley WC, 2002, ANN SURG ONCOL, V9, P920, DOI 10.1007/BF02557531; Duffy MJ, 2010, CLIN CHIM ACTA, V411, P1869, DOI 10.1016/j.cca.2010.08.039; Furuya C, 2012, PATHOL INT, V62, P381, DOI 10.1111/j.1440-1827.2012.02811.x; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Kamali S, 2014, BREAST CANCER-TOKYO, V21, P154, DOI 10.1007/s12282-012-0377-7; Kapenhas-Valdes E, 2008, ANN SURG ONCOL, V15, P2720, DOI 10.1245/s10434-008-0012-1; Kim MJ, 2010, RADIOLOGY, V254, P691, DOI 10.1148/radiol.09091031; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Lakshmanan I, 2012, ONCOGENE, V31, P805, DOI 10.1038/onc.2011.297; Lee JS, 2013, ANN ONCOL, V24, P1225, DOI 10.1093/annonc/mds604; Louie LD, 2006, AM J SURG, V192, P530, DOI 10.1016/j.amjsurg.2006.06.004; Montroni I, 2010, BREAST CANCER RES TR, V123, P895, DOI 10.1007/s10549-010-0815-1; Moon HJ, 2015, ULTRASCHALL MED, V36, P255, DOI 10.1055/s-0034-1366288; Oda M, 2012, CANCER SCI, V103, P1172, DOI 10.1111/j.1349-7006.2012.02267.x; Olopade OI, 2001, ANN ONCOL, V12, P895, DOI 10.1023/A:1011176107455; Sauter ER, 2007, CANCER DETECT PREV, V31, P50, DOI 10.1016/j.cdp.2006.12.004; Sauter ER, 2010, DIAGN CYTOPATHOL, V38, P244, DOI 10.1002/dc.21177; Shao YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133830; Simpson JS, 2009, CAN J SURG, V52, pE245; Stieber P, 2015, CLIN CHIM ACTA, V448, P228, DOI 10.1016/j.cca.2015.06.022; Stieber Petra, 2003, Clin Lab, V49, P15; Sturgeon CM, 2008, CLIN CHEM, V54, pE11, DOI 10.1373/clinchem.2008.105601; Taylor K, 2013, BREAST, V22, P268, DOI 10.1016/j.breast.2013.03.004; Tice JA, 2005, CANCER EPIDEM BIOMAR, V14, P324, DOI 10.1158/1055-9965.EPI-04-0289; Vargas Hernan I, 2002, Curr Treat Options Oncol, V3, P157, DOI 10.1007/s11864-002-0061-9; Vaughan A, 2009, BREAST J, V15, P254, DOI [10.1111/j.1524-4741.2008.00671.x, 10.1111/j.1524-4741.2009.00714.x]; Winger R, 2014, ONCOL RES TREAT, V37, P628, DOI 10.1159/000368338; Wu SG, 2014, BREAST, V23, P88, DOI 10.1016/j.breast.2013.11.003; Zhao YS, 2009, CANCER EPIDEM BIOMAR, V18, P732, DOI 10.1158/1055-9965.EPI-08-0715	33	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157639	10.1371/journal.pone.0157639	http://dx.doi.org/10.1371/journal.pone.0157639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327081	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400027
J	Matamales, M; Gotz, J; Bertran-Gonzalez, J				Matamales, Miriam; Gotz, Jurgen; Bertran-Gonzalez, Jesus			Quantitative Imaging of Cholinergic Interneurons Reveals a Distinctive Spatial Organization and a Functional Gradient across the Mouse Striatum	PLOS ONE			English	Article							COMPARTMENTAL ORGANIZATION; NUCLEUS-ACCUMBENS; NEURONS; ACETYLCHOLINESTERASE; ACETYLTRANSFERASE; MODULATION; MORPHOLOGY; RECEPTORS; PATTERNS; DENSITY	Information processing in the striatum requires the postsynaptic integration of glutamatergic and dopaminergic signals, which are then relayed to the output nuclei of the basal ganglia to influence behavior. Although cellularly homogeneous in appearance, the striatum contains several rare interneuron populations which tightly modulate striatal function. Of these, cholinergic interneurons (CINs) have been recently shown to play a critical role in the control of reward-related learning; however how the striatal cholinergic network is functionally organized at the mesoscopic level and the way this organization influences striatal function remains poorly understood. Here, we systematically mapped and digitally reconstructed the entire ensemble of CINs in the mouse striatum and quantitatively assessed differences in densities, spatial arrangement and neuropil content across striatal functional territories. This approach demonstrated that the rostral portion of the striatum contained a higher concentration of CINs than the caudal striatum and that the cholinergic content in the core of the ventral striatum was significantly lower than in the rest of the regions. Additionally, statistical comparison of spatial point patterns in the striatal cholinergic ensemble revealed that only a minor portion of CINs (17%) aggregated into cluster and that they were predominantly organized in a random fashion. Furthermore, we used a fluorescence reporter to estimate the activity of over two thousand CINs in naive mice and found that there was a decreasing gradient of CIN overall function along the dorsomedial-to-ventrolateral axis, which appeared to be independent of their propensity to aggregate within the striatum. Altogether this work suggests that the regulation of striatal function by acetylcholine across the striatum is highly heterogeneous, and that signals originating in external afferent systems may be principally determining the function of CINs in the striatum.	[Matamales, Miriam; Gotz, Jurgen; Bertran-Gonzalez, Jesus] Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld, Australia	University of Queensland	Matamales, M; Bertran-Gonzalez, J (corresponding author), Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld, Australia.	matamales@uq.edu.au; j.bertrangonzalez@uq.edu.au	Götz, Jürgen/C-2448-2014; Matamales, Miriam/J-5189-2014; Bertran-Gonzalez, J/L-1410-2017	Götz, Jürgen/0000-0001-8501-7896; Matamales, Miriam/0000-0001-9978-0091; Bertran-Gonzalez, J/0000-0002-3794-1782	Australian Research Council [DP13300101932]; National Health and Medical Research Council [APP1037746, APP1003150]; Estate of Dr Clem Jones AO, the State Government of Queensland	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Estate of Dr Clem Jones AO, the State Government of Queensland	The research reported in the manuscript was supported by the Estate of Dr Clem Jones AO, the State Government of Queensland, and by grants from the Australian Research Council (DP13300101932) and the National Health and Medical Research Council (APP1037746, APP1003150) to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2013, J NEUROSCI, V33, P4854, DOI 10.1523/JNEUROSCI.4791-12.2013; Aosaki T, 2010, GERIATR GERONTOL INT, V10, pS148, DOI 10.1111/j.1447-0594.2010.00588.x; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Bernacer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001174; Bertran-Gonzalez J, 2013, J NEUROSCI, V33, P16060, DOI 10.1523/JNEUROSCI.1927-13.2013; Bertran-Gonzalez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053195; BOLAM JP, 1984, NEUROSCIENCE, V12, P711, DOI 10.1016/0306-4522(84)90165-9; Bradfield LA, 2013, THALAMOSTRIATAL PATH, P1; Brauer K, 2000, BRAIN RES, V858, P151, DOI 10.1016/S0006-8993(00)01938-7; BURKE RE, 1990, NEUROSCI LETT, V108, P58, DOI 10.1016/0304-3940(90)90706-F; BUTCHER SG, 1974, BRAIN RES, V71, P167, DOI 10.1016/0006-8993(74)90202-9; Ciceri G, 2013, NAT NEUROSCI; Diggle P., 2003, STAT ANAL SPATIAL PO; Doig NM, 2014, J NEUROSCI, V34, P3101, DOI 10.1523/JNEUROSCI.4627-13.2014; Eglen SJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-68; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00124; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Gonzales KK, 2015, ANN N Y ACAD SCI; GRAYBIEL AM, 1986, NATURE, V323, P625, DOI 10.1038/323625a0; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hansson K, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00005; Harper CA, 2018, SEX ABUSE-J RES TR, V30, P533, DOI 10.1177/1079063216681561; HERKENHAM M, 1981, NATURE, V291, P415, DOI 10.1038/291415a0; Krosnowski K, 2012, NEUROSCIENCE, V213, P161, DOI 10.1016/j.neuroscience.2012.04.024; KUBOTA Y, 1993, J COMP NEUROL, V332, P499, DOI 10.1002/cne.903320409; Laurent V, 2014, J NEUROSCI, V34, P1358, DOI 10.1523/JNEUROSCI.4592-13.2014; Mailly P, 2013, J NEUROSCI, V33, P5718, DOI 10.1523/JNEUROSCI.5248-12.2013; Matamales M, 2016, NEURON, V90, P362, DOI 10.1016/j.neuron.2016.03.006; MCGEER PL, 1971, BRAIN RES, V35, P308, DOI 10.1016/0006-8993(71)90625-1; MEREDITH GE, 1989, NEUROSCIENCE, V31, P327, DOI 10.1016/0306-4522(89)90377-1; MESULAM MM, 1984, BRAIN RES, V311, P245, DOI 10.1016/0006-8993(84)90087-8; Owen DM, 2012, METHOD ENZYMOL, V504, P221, DOI 10.1016/B978-0-12-391857-4.00011-2; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Paxinos G., 1982, RAT BRAIN STEREOTAXI, P1, DOI [10.1016/B978-0-12-547620-1.50006-0pp, DOI 10.1016/B978-0-12-547620-1.50006-0PP]; PHELPS PE, 1986, J NEUROCYTOL, V15, P595, DOI 10.1007/BF01611860; REA MA, 1981, BRAIN RES, V219, P317, DOI 10.1016/0006-8993(81)90294-8; Ripley B.D., 1988, STAT INFERENCE SPATI; SCHWABER JS, 1987, J COMP NEUROL, V263, P309, DOI 10.1002/cne.902630302; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; WILSON CJ, 1990, J NEUROSCI, V10, P508; Wouterlood FG, 2012, J COMP NEUROL, V520, P2123, DOI 10.1002/cne.23031	45	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157682	10.1371/journal.pone.0157682	http://dx.doi.org/10.1371/journal.pone.0157682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314496	gold, Green Published, Green Submitted			2022-12-26	WOS:000378030000045
J	Gagic, V; Petrovic-Obradovic, O; Frund, J; Kavallieratos, NG; Athanassiou, CG; Stary, P; Tomanovic, Z				Gagic, Vesna; Petrovic-Obradovic, Olivera; Fruend, Jochen; Kavallieratos, Nickolas G.; Athanassiou, Christos G.; Stary, Petr; Tomanovic, Zeljko			The Effects of Aphid Traits on Parasitoid Host Use and Specialist Advantage	PLOS ONE			English	Article							ECOLOGICAL SPECIALIZATION; COMMUNITY ECOLOGY; SPECIES RICHNESS; PATTERNS; HYMENOPTERA; ASSEMBLAGES; BRACONIDAE; DIVERSITY; HOMOPTERA; EVOLUTION	Specialization is a central concept in ecology and one of the fundamental properties of parasitoids. Highly specialized parasitoids tend to be more efficient in host-use compared to generalized parasitoids, presumably owing to the trade-off between host range and hostuse efficiency. However, it remains unknown how parasitoid host specificity and host-use depends on host traits related to susceptibility to parasitoid attack. To address this question, we used data from a 13-year survey of interactions among 142 aphid and 75 parasitoid species in nine European countries. We found that only aphid traits related to local resource characteristics seem to influence the trade-off between host-range and efficiency: more specialized parasitoids had an apparent advantage (higher abundance on shared hosts) on aphids with sparse colonies, ant-attendance and without concealment, and this was more evident when host relatedness was included in calculation of parasitoid specificity. More traits influenced average assemblage specialization, which was highest in aphids that are monophagous, monoecious, large, highly mobile (easily drop from a plant), without myrmecophily, habitat specialists, inhabit non-agricultural habitats and have sparse colonies. Differences in aphid wax production did not influence parasitoid host specificity and host-use. Our study is the first step in identifying host traits important for aphid parasitoid host specificity and host-use and improves our understanding of bottom-up effects of aphid traits on aphid-parasitoid food web structure.	[Gagic, Vesna] CSIRO, GPO Box 2583, Brisbane, Qld 4001, Australia; [Gagic, Vesna; Tomanovic, Zeljko] Univ Belgrade, Fac Biol, Inst Zool, Belgrade, Serbia; [Petrovic-Obradovic, Olivera] Univ Belgrade, Fac Agr, Belgrade, Serbia; [Fruend, Jochen] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Fruend, Jochen] Univ Gottingen, Agrarokol, D-37073 Gottingen, Germany; [Kavallieratos, Nickolas G.] Agr Univ Athens, Dept Crop Sci, Lab Agr Zool & Entomol, GR-11855 Athens, Greece; [Kavallieratos, Nickolas G.] Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Lab Agr Entomol, Attica, Greece; [Athanassiou, Christos G.] Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Lab Entomol & Agr Zool, Magnissia, Greece; [Stary, Petr] Acad Sci Czech Republic, Ctr Biol, Inst Entomol, Lab Aphidol,Dept Expt Ecol, Ceske Budejovice, Czech Republic	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Belgrade; University of Belgrade; University of Guelph; University of Gottingen; Agricultural University of Athens; University of Thessaly; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Gagic, V (corresponding author), CSIRO, GPO Box 2583, Brisbane, Qld 4001, Australia.; Gagic, V (corresponding author), Univ Belgrade, Fac Biol, Inst Zool, Belgrade, Serbia.	vesna.gagic@csiro.au	Gagic, Vesna/L-1203-2017; Athanassiou, Christos/ABE-8867-2020; Kavallieratos, Nickolas G./AAB-7500-2022; Fründ, Jochen/AAV-3105-2020	Gagic, Vesna/0000-0002-3214-7547; Kavallieratos, Nickolas G./0000-0001-5851-5013; Fründ, Jochen/0000-0002-7079-3478; Kavallieratos, Nickolas/0000-0003-4342-1289; Zeljko, Tomanovic/0000-0002-5063-5480	Multilateral European project [SEE-ERA.NET 9608]; Serbian Ministry of Education and Science [III43001]; German Research Foundation (DFG)	Multilateral European project; Serbian Ministry of Education and Science(Ministry of Education, Science & Technological Development, Serbia); German Research Foundation (DFG)(German Research Foundation (DFG))	The study was funded by the Multilateral European project SEE-ERA.NET 9608 and the Serbian Ministry of Education and Science (III43001). The research by P. S. was conducted with institutional support RVO: 60077344. J. F. was supported by a research fellowship of the German Research Foundation (DFG).	Askew R. R., 1994, P177; Blackman R.L., 2021, APHIDS WORLDS PLANTS; BLACKMAN R.L., 2006, APHIDS WORLDS HERBAC; Blackman R.L., 2000, J ECON ENTOMOL, V2; Bulgarella M, 2015, ECOL EVOL, V5, P3695, DOI 10.1002/ece3.1621; Cagnolo L, 2011, J ANIM ECOL, V80, P342, DOI 10.1111/j.1365-2656.2010.01778.x; CAPPUCCINO N, 1987, ECOLOGY, V68, P1634, DOI 10.2307/1939856; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Combes C, 1997, INT J PARASITOL, V27, P1, DOI 10.1016/S0020-7519(96)00168-3; Desneux N, 2012, ECOL LETT, V15, P453, DOI 10.1111/j.1461-0248.2012.01754.x; Desneux N, 2009, ANN ENTOMOL SOC AM, V102, P925, DOI 10.1603/008.102.0603; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; Elias M, 2013, CURR BIOL, V23, P1355, DOI 10.1016/j.cub.2013.05.066; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; GROSS P, 1993, ANNU REV ENTOMOL, V38, P251, DOI 10.1146/annurev.en.38.010193.001343; HAWKINS BA, 1990, J ANIM ECOL, V59, P57, DOI 10.2307/5158; HAWKINS BA, 1987, NATURE, V326, P788, DOI 10.1038/326788a0; HAWKINS BA, 1988, J ANIM ECOL, V57, P137, DOI 10.2307/4769; Heie O.E., 1995, FAUNA ENTOMOLOGICA S, V31; HEIE O.E., 1992, FAUNA ENTOMOLOGICA S, V25, P190; Heie OE, 1982, FAUNA ENTOMOLOGICA S, V9; Heie OE, 1994, FAUNA ENTOMOLOGICA S, V28; Heie OE, 1986, FAUNA ENTOMOLOGICA S, V17; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Henri DC, 2011, ADV ECOL RES, V45, P135, DOI 10.1016/B978-0-12-386475-8.00004-6; Henry LM, 2010, ECOL APPL, V20, P242, DOI 10.1890/08-1869.1; Hrcek J, 2013, OECOLOGIA, V173, P521, DOI 10.1007/s00442-013-2619-6; Husson F., 2017, FACTOMINER MULTIVARI, V1, P38; Husson F, 2010, CHAPMAN HALL CRC COM; Husson F, 2013, MISSMDA HANDLING MIS; Josse J, 2012, J CLASSIF, V29, P91, DOI 10.1007/s00357-012-9097-0; Kavallieratos NG, 2004, APPL ENTOMOL ZOOL, V39, P527, DOI 10.1303/aez.2004.527; Krasnov BR, 2004, INT J PARASITOL, V34, P1289, DOI 10.1016/j.ijpara.2004.08.003; LAWTON JH, 1979, J ANIM ECOL, V48, P619, DOI 10.2307/4183; Mackauer M., 1997, VERTICAL FOOD WEB IN, P191, DOI [10.1007/978-3-642-60725-7_11, DOI 10.1007/978-3-642-60725-7_11]; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; Petchey OL, 2008, AM NAT, V171, P568, DOI 10.1086/587068; Porter EE, 1998, OECOLOGIA, V116, P234, DOI 10.1007/s004420050584; Poulin R, 1998, ECOL LETT, V1, P118; Poulin R, 2004, EVOL ECOL, V18, P231, DOI 10.1023/B:EVEC.0000035029.55952.68; Poulin R, 2003, PARASITOLOGY, V126, P473, DOI 10.1017/S0031182003002993; R Development Core Team, 2014, R LANG ENV STAT COMP; Rasmann S, 2011, AM NAT, V177, P728, DOI 10.1086/659948; Raymond L, 2016, J PEST SCI, V89, P7, DOI 10.1007/s10340-015-0687-6; Rejmanek M., 1981, ENTOMOL SCAND S, V15, P341; Shaw Mark R., 1994, P111; SHEEHAN W, 1989, ECOLOGY, V70, P993, DOI 10.2307/1941367; Sloan D, 1994, AM NAT, V144, P692; Stadler B, 2002, J APPL ENTOMOL, V126, P258, DOI 10.1046/j.1439-0418.2002.00640.x; Stadler B., 1997, VERTICAL FOOD WEB IN, P241, DOI [10.1007/978-3-642-60725-7_14, DOI 10.1007/978-3-642-60725-7_14]; Stary P., 1970, BIOL APHID PARASITES; Stilmant D, 2008, OECOLOGIA, V156, P905, DOI 10.1007/s00442-008-1036-8; Stireman JO, 2003, ECOLOGY, V84, P296, DOI 10.1890/0012-9658(2003)084[0296:DOPHAI]2.0.CO;2; Stone GN, 2002, ANNU REV ENTOMOL, V47, P633, DOI 10.1146/annurev.ento.47.091201.145247; Straub CS, 2011, AM NAT, V177, P389, DOI 10.1086/658177; vanSteenis MJ, 1996, J INSECT BEHAV, V9, P283, DOI 10.1007/BF02213871; Vazquez DP, 2002, AM NAT, V159, P606, DOI 10.1086/339991; VOLKL W, 1992, J ANIM ECOL, V61, P273, DOI 10.2307/5320; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; [No title captured]	62	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157674	10.1371/journal.pone.0157674	http://dx.doi.org/10.1371/journal.pone.0157674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309729	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800120
J	Lewis, AM; Croughan, WD; Aranibar, N; Lee, AG; Warrack, B; Abu-Absi, NR; Patel, R; Drew, B; Borys, MC; Reily, MD; Li, ZJ				Lewis, Amanda M.; Croughan, William D.; Aranibar, Nelly; Lee, Alison G.; Warrack, Bethanne; Abu-Absi, Nicholas R.; Patel, Rutva; Drew, Barry; Borys, Michael C.; Reily, Michael D.; Li, Zheng Jian			Understanding and Controlling Sialylation in a CHO Fc-Fusion Process	PLOS ONE			English	Article							OXIDATIVE STRESS; GENE-EXPRESSION; GLYCOSYLATION PROFILE; INTERMITTENT HYPOXIA; ANTIOXIDANT DEFENSE; MONOCLONAL-ANTIBODY; DISSOLVED-OXYGEN; CELLS; DEHYDROGENASE; METABOLISM	A Chinese hamster ovary (CHO) bioprocess, where the product is a sialylated Fc-fusion protein, was operated at pilot and manufacturing scale and significant variation of sialylation level was observed. In order to more tightly control glycosylation profiles, we sought to identify the cause of variability. Untargeted metabolomics and transcriptomics methods were applied to select samples from the large scale runs. Lower sialylation was correlated with elevated mannose levels, a shift in glucose metabolism, and increased oxidative stress response. Using a 5-L scale model operated with a reduced dissolved oxygen set point, we were able to reproduce the phenotypic profiles observed at manufacturing scale including lower sialylation, higher lactate and lower ammonia levels. Targeted transcriptomics and metabolomics confirmed that reduced oxygen levels resulted in increased mannose levels, a shift towards glycolysis, and increased oxidative stress response similar to the manufacturing scale. Finally, we propose a biological mechanism linking large scale operation and sialylation variation. Oxidative stress results from gas transfer limitations at large scale and the presence of oxygen dead-zones inducing upregulation of glycolysis and mannose biosynthesis, and downregulation of hexosamine biosynthesis and acetyl-CoA formation. The lower flux through the hexosamine pathway and reduced intracellular pools of acetyl-CoA led to reduced formation of N-acetylglucosamine and N-acetylneuraminic acid, both key building blocks of N-glycan structures. This study reports for the first time a link between oxidative stress and mammalian protein sialyation. In this study, process, analytical, metabolomic, and transcriptomic data at manufacturing, pilot, and laboratory scales were taken together to develop a systems level understanding of the process and identify oxygen limitation as the root cause of glycosylation variability.	[Lewis, Amanda M.; Croughan, William D.; Lee, Alison G.; Abu-Absi, Nicholas R.; Patel, Rutva; Drew, Barry; Borys, Michael C.; Li, Zheng Jian] Bristol Myers Squibb Co, Global Mfg & Supply, Biol Dev, Devens, MA USA; [Aranibar, Nelly; Warrack, Bethanne; Reily, Michael D.] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ USA	Bristol-Myers Squibb; Bristol-Myers Squibb	Lewis, AM (corresponding author), Bristol Myers Squibb Co, Global Mfg & Supply, Biol Dev, Devens, MA USA.	amanda.lewis@bms.com		Lee, Alison/0000-0001-8305-3332	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	All authors declare a financial competing interest, based on paid employment by Bristol-Myers Squibb, who funded this research. This commercial affiliation does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Abu-Absi NR, 2014, PHARM BIOPROCESS, V2, DOI 10.4155/PBP.14.24; Agblevor FA, 2004, BIOTECHNOL LETT, V26, P1207, DOI 10.1023/B:BILE.0000036596.95796.42; Baker KN, 2001, BIOTECHNOL BIOENG, V73, P188, DOI 10.1002/bit.1051; Balasubramanian MN, 2013, AM J PHYSIOL-ENDOC M, V304, pE789, DOI 10.1152/ajpendo.00015.2013; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Butler M, 2006, CYTOTECHNOLOGY, V50, P57, DOI 10.1007/s10616-005-4537-x; Cartularo L, 2015, TOXICOL APPL PHARM, V288, P399, DOI 10.1016/j.taap.2015.08.011; CHOTIGEAT W, 1994, CYTOTECHNOLOGY, V15, P217, DOI 10.1007/BF00762396; Ciofani G, 2014, BBA-GEN SUBJECTS, V1840, P495, DOI 10.1016/j.bbagen.2013.10.009; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Corpas FJ, 1999, PLANT PHYSIOL, V121, P921, DOI 10.1104/pp.121.3.921; Downs CA, 2011, MICROVASC RES, V82, P311, DOI 10.1016/j.mvr.2011.09.013; Etchison JR, 1997, CLIN CHEM, V43, P533; Filosa S, 2003, BIOCHEM J, V370, P935, DOI 10.1042/BJ20021614; Funato Y, 2013, BIOCHEM BIOPH RES CO, V440, P737, DOI 10.1016/j.bbrc.2013.09.138; Go S, 2007, BIOCHEM BIOPH RES CO, V357, P537, DOI 10.1016/j.bbrc.2007.03.181; Graf A, 2013, INT J BIOCHEM CELL B, V45, P175, DOI 10.1016/j.biocel.2012.07.002; Hadziahmetovic M, 2011, AM J PATHOL, V179, P335, DOI 10.1016/j.ajpath.2011.03.033; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Hnatyshyn S, 2013, BIOANALYSIS, V5, P1195, DOI [10.4155/BIO.13.86, 10.4155/bio.13.86]; Hossler P, 2009, GLYCOBIOLOGY; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kucharzewska P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116740; Kunkel JP, 1998, J BIOTECHNOL, V62, P55, DOI 10.1016/S0168-1656(98)00044-3; Lavie L, 2009, EUR RESPIR J, V33, P1467, DOI 10.1183/09031936.00086608; Lewis AM, 2015, BIOTECHNOLOGY BIOENG; Li F, 2006, BIOTECHNOL PROGR, V22, P696, DOI 10.1021/bp0504041; Liu B, 2014, J BIOTECHNOL, V170, P17, DOI 10.1016/j.jbiotec.2013.11.007; Liu X, 2015, NUCL FUNCTIONS PLANT, P81; Makarenko VV, 2014, AM J PHYSIOL-CELL PH, V306, pC745, DOI 10.1152/ajpcell.00313.2013; Markely LRA, 2010, ANAL BIOCHEM, V407, P128, DOI 10.1016/j.ab.2010.07.029; McAtee AG, 2014, PHARM BIOPROCESS, V2, P63, DOI 10.4155/PBP.13.65; McCracken NA, 2014, BIOTECHNOL PROGR, V30, P547, DOI 10.1002/btpr.1906; McLain AL, 2011, FREE RADICAL RES, V45, P29, DOI 10.3109/10715762.2010.534163; Morel Y, 1999, BIOCHEM J, V342, P481, DOI 10.1042/0264-6021:3420481; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Prabhakar NR, 2007, ANTIOXID REDOX SIGN, V9, P1397, DOI 10.1089/ars.2007.1732; Restelli V, 2006, BIOTECHNOL BIOENG, V94, P481, DOI 10.1002/bit.20875; RIGOBELLO MP, 1994, CELL BIOCHEM FUNCT, V12, P69, DOI 10.1002/cbf.290120110; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Senesi S, 2010, BIOL CHEM, V391, P1, DOI 10.1515/BC.2009.146; Sharma V, 2014, BIOCHEM BIOPH RES CO, V453, P220, DOI 10.1016/j.bbrc.2014.06.021; Shirato K, 2011, J CLIN BIOCHEM NUTR, V48, P20, DOI 10.3164/jcbn.11-015FR; Teruya R, 2013, ACTA CIR BRAS, V28, P848, DOI 10.1590/S0102-86502013001200007; Vexler ZS, 2003, BRAIN RES, V960, P90, DOI 10.1016/S0006-8993(02)03777-0; Visser WF, 2002, BIOCHEM BIOPH RES CO, V299, P494, DOI 10.1016/S0006-291X(02)02663-3; Wong DCF, 2010, BIOTECHNOL BIOENG, V107, P516, DOI 10.1002/bit.22828; Wong NSC, 2010, BIOTECHNOL BIOENG, V107, P321, DOI 10.1002/bit.22812; Xing ZZ, 2009, BIOTECHNOL BIOENG, V103, P733, DOI 10.1002/bit.22287; Zhou XF, 2009, PLANT J, V60, P79, DOI 10.1111/j.1365-313X.2009.03931.x	51	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157111	10.1371/journal.pone.0157111	http://dx.doi.org/10.1371/journal.pone.0157111			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310468	gold, Green Published, Green Submitted			2022-12-26	WOS:000378029800034
J	McNeilly, C; Cosh, S; Vu, T; Nichols, J; Henningham, A; Hofmann, A; Fane, A; Smeesters, PR; Rush, CM; Hafner, LM; Ketheesan, N; Sriprakash, KS; McMillan, DJ				McNeilly, Celia; Cosh, Samantha; Vu, Therese; Nichols, Jemma; Henningham, Anna; Hofmann, Andreas; Fane, Anne; Smeesters, Pierre R.; Rush, Catherine M.; Hafner, Louise M.; Ketheesan, Natkuman; Sriprakash, Kadaba S.; McMillan, David J.			Predicted Coverage and Immuno-Safety of a Recombinant C-Repeat Region Based Streptococcus pyogenes Vaccine Candidate	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; M-PROTEIN; RHEUMATIC-FEVER; ANTIBODIES; EMM; COLONIZATION; IMMUNIZATION; PERSISTENCE; PROTECTION; DIVERSITY	The C-terminal region of the M-protein of Streptococcus pyogenes is a major target for vaccine development. The major feature is the C-repeat region, consisting of 35-42 amino acid repeat units that display high but not perfect identity. SV1 is a S. pyogenes vaccine candidate that incorporates five 14mer amino acid sequences (called J14(i) variants) from differing C-repeat units in a single recombinant construct. Here we show that the J14(i) variants chosen for inclusion in SV1 are the most common variants in a dataset of 176 unique M-proteins. Murine antibodies raised against SV1 were shown to bind to each of the J14(i) variants present in SV1, as well as variants not present in the vaccine. Antibodies raised to the individual J14(i) variants were also shown to bind to multiple but different combinations of J14(i) variants, supporting the underlying rationale for the design of SV1. A Lewis Rat Model of valvulitis was then used to assess the capacity of SV1 to induce deleterious immune response associated with rheumatic heart disease. In this model, both SV1 and the M5 positive control protein were immunogenic. Neither of these antibodies were cross-reactive with cardiac myosin or collagen. Splenic T cells from SV1/CFA and SV1/alum immunized rats did not proliferate in response to cardiac myosin or collagen. Subsequent histological examination of heart tissue showed that 4 of 5 mice from the M5/CFA group had valvulitis and inflammatory cell infiltration into valvular tissue, whereas mice immunised with SV1/CFA, SV1/alum showed no sign of valvulitis. These results suggest that SV1 is a safe vaccine candidate that will elicit antibodies that recognise the vast majority of circulating GAS M-types.	[McNeilly, Celia; Cosh, Samantha; Vu, Therese; Sriprakash, Kadaba S.; McMillan, David J.] QIMR Berghofer Med Res Inst, Bacterial Pathogenesis Lab, 300 Herston Rd, Herston, Qld 4006, Australia; [Nichols, Jemma; McMillan, David J.] Univ Sunshine Coast, Sch Hlth & Sport Sci, Inflammat & Healing Res Cluster, Maroochydore, Qld 4558, Australia; [Henningham, Anna] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia; [Henningham, Anna] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Hofmann, Andreas] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Struct Chem Program, Nathan, Qld 4111, Australia; [Hofmann, Andreas] Queensland Trop Hlth Alliance, Smithfield, Qld, Australia; [Fane, Anne; Rush, Catherine M.; Ketheesan, Natkuman] James Cook Univ, Australian Inst Trop Med, Townsville, Qld 4811, Australia; [Smeesters, Pierre R.] Univ Libre Bruxelles, Fac Sci, Inst Biol & Med Mol, Lab Genet & Physiol Bacterienne, Gosselies, Belgium; [Smeesters, Pierre R.] Murdoch Children Res Inst, Melbourne, Vic 3052, Australia; [Hafner, Louise M.] Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Brisbane, Qld 4001, Australia; [Hafner, Louise M.] Queensland Univ Technol, IHBI, Brisbane, Qld 4001, Australia	QIMR Berghofer Medical Research Institute; University of the Sunshine Coast; University of Queensland; University of Queensland; Griffith University; James Cook University; Universite Libre de Bruxelles; Murdoch Children's Research Institute; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	McMillan, DJ (corresponding author), QIMR Berghofer Med Res Inst, Bacterial Pathogenesis Lab, 300 Herston Rd, Herston, Qld 4006, Australia.; McMillan, DJ (corresponding author), Univ Sunshine Coast, Sch Hlth & Sport Sci, Inflammat & Healing Res Cluster, Maroochydore, Qld 4558, Australia.	david.mcmillan@usc.edu.au	Hofmann, Andreas/M-9870-2019; Henningham, Anna/C-7355-2017; McMillan, David/P-5582-2016; Rush, Catherine M/L-4308-2013; Cosh, Samantha/M-6363-2016; Smeesters, Pierre/I-7723-2012	Hofmann, Andreas/0000-0003-4408-5467; Henningham, Anna/0000-0002-0554-6593; McMillan, David/0000-0002-9339-0639; Rush, Catherine M/0000-0002-3044-9488; Cosh, Samantha/0000-0002-0679-2067; Smeesters, Pierre/0000-0002-2642-9919; Ketheesan, Natkunam/0000-0002-4870-706X; Sriprakash, Kadaba/0000-0001-7844-323X; Vu, Therese/0000-0003-2831-2957	National Health and Medical Research Council of Australia; National Heart Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation(National Heart Foundation of Australia)	This work was funded by the National Health and Medical Research Council of Australia and National Heart Foundation. The funders had no role in the study design, data analysis, and preparation of the manuscript or decision to submit the article for publication.; This work was funded by the National Health and Medical Research Council of Australia and National Heart Foundation. The funders had no role in the study design, data analysis, and preparation of the manuscript or decision to submit the article for publication. Members of the M-protein study group provided the isolates that emm-sequences were derived from for analysis of the distribution of J14<INF>i</INF>.	Abdissa A, 2006, CLIN INFECT DIS, V42, P1362, DOI 10.1086/503422; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Batzloff MR, 2005, J INFECT DIS, V192, P1450, DOI 10.1086/466528; Batzloff MR, 2003, J INFECT DIS, V187, P1598, DOI 10.1086/374800; Bauer MJ, 2012, VACCINE, V30, P2197, DOI 10.1016/j.vaccine.2011.12.115; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; BESSEN D, 1990, J IMMUNOL, V145, P1251; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Cunningham MW, 1997, INFECT IMMUN, V65, P3913, DOI 10.1128/IAI.65.9.3913-3923.1997; Dale JB, 2011, VACCINE, V29, P8175, DOI 10.1016/j.vaccine.2011.09.005; Dale JB, 1999, VACCINE, V17, P193, DOI 10.1016/S0264-410X(98)00150-9; De Amicis KM, 2014, VACCINE, V32, P4104, DOI 10.1016/j.vaccine.2013.08.043; Dinkla K, 2007, MICROBES INFECT, V9, P922, DOI 10.1016/j.micinf.2007.03.011; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Good MF, 2013, HUM VACC IMMUNOTHER, V9, P2393, DOI 10.4161/hv.25506; Gorton D, 2009, INFECT IMMUN, V77, P2177, DOI 10.1128/IAI.01514-08; Gryllos L, 2001, MOL MICROBIOL, V42, P61; Guilherme L, 2013, AM J CARDIOVASC DRUG, V13, P1, DOI 10.1007/s40256-013-0005-8; Henningham A, 2013, MBIO, V4, DOI 10.1128/mBio.00509-13; Hofmann A, 2009, J APPL CRYSTALLOGR, V42, P137, DOI 10.1107/S0021889808037229; Ji YD, 1997, INFECT IMMUN, V65, P2080, DOI 10.1128/IAI.65.6.2080-2087.1997; JOHNSON DR, 1992, J INFECT DIS, V166, P374, DOI 10.1093/infdis/166.2.374; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; LANCEFIELD RC, 1959, J EXP MED, V110, P271, DOI 10.1084/jem.110.2.271; McMillan DJ, 2013, CLIN MICROBIOL INFEC, V19, pE222, DOI 10.1111/1469-0691.12134; McMillan DJ, 2004, FEMS IMMUNOL MED MIC, V40, P249, DOI 10.1016/S0928-8244(04)00003-3; Parks T, 2012, CURR OPIN INFECT DIS, V25, P145, DOI 10.1097/QCO.0b013e3283511d27; PHILLIPS GN, 1981, P NATL ACAD SCI-BIOL, V78, P4689, DOI 10.1073/pnas.78.8.4689; Postol E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060969; Rush CM, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00116; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; SCOTT JR, 1986, J EXP MED, V164, P1641, DOI 10.1084/jem.164.5.1641; Smeesters PR, 2008, VACCINE, V26, P5835, DOI 10.1016/j.vaccine.2008.08.037; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; Steer AC, 2009, J CLIN MICROBIOL, V47, P2502, DOI 10.1128/JCM.00312-09; Tamayo E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-233; van Sorge NM, 2014, CELL HOST MICROBE, V15, P729, DOI 10.1016/j.chom.2014.05.009; Veasy LG, 2004, PEDIATRICS, V113, pE168, DOI 10.1542/peds.113.3.e168; Vohra H, 2005, RES MICROBIOL, V156, P575, DOI 10.1016/j.resmic.2004.12.009; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Weeratunga S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-201	44	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156639	10.1371/journal.pone.0156639	http://dx.doi.org/10.1371/journal.pone.0156639			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310707	gold, Green Published, Green Accepted			2022-12-26	WOS:000378029800010
J	Boy, JD; Uitermark, J				Boy, John D.; Uitermark, Justus			How to Study the City on Instagram	PLOS ONE			English	Article							BIG DATA; DIMENSIONS; DYNAMICS; WORLD	We introduce Instagram as a data source for use by scholars in urban studies and neighboring disciplines and propose ways to operationalize key concepts in the study of cities. These data can help shed light on segregation, the formation of subcultures, strategies of distinction, and status hierarchies in the city. Drawing on two datasets of geotagged Instagram posts from Amsterdam and Copenhagen collected over a twelve-week period, we present a proof of concept for how to explore and visualize sociospatial patterns and divisions in these two cities. We take advantage of both the social and the geographic aspects of the data, using network analysis to identify distinct groups of users and metrics of unevenness and diversity to identify socio-spatial divisions. We also discuss some of the limitations of these data and methods and suggest ways in which they can complement established quantitative and qualitative approaches in urban scholarship.	[Boy, John D.; Uitermark, Justus] Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands; [Uitermark, Justus] Erasmus Univ, Dept Sociol, Rotterdam, Netherlands	University of Amsterdam; Erasmus University Rotterdam	Boy, JD (corresponding author), Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands.	jboy@uva.nl		Uitermark, Justus/0000-0002-5274-1455; Boy, John/0000-0003-2118-4702	Research Council of Norway [231344]; Netherlands Organization for Scientific Research [451-12-035]	Research Council of Norway(Research Council of Norway); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was funded in part by the Research Council of Norway (no. 231344) and the Netherlands Organization for Scientific Research (no. 451-12-035).	Abou-Moustafa KT, 2014, DIVERGENCE MEASURES; Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Anderson E., 2012, THE COSMOPOLITAN CAN; Batty M., 2003, THE NEW SCIENCE OF C; Bellah R. N., 1985, HABITS OF THE HEART; Blokland T, 2010, J ETHN MIGR STUD, V36, P313, DOI 10.1080/13691830903387436; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bourdieu P., 1996, PHOTOGRAPHY A MIDDLE; Boy JD., 2015, KIJKEENS TOOL RES, DOI [10.5281/zenodo.34500, DOI 10.5281/ZENODO.34500]; Boyd D., 2014, ITS COMPLICATED THE; Boyd D, 2012, INFORM COMMUN SOC, V15, P662, DOI 10.1080/1369118X.2012.678878; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Buford May Ruben, 2014, URBAN NIGHTLIFE ENTE; Burawoy M., 2009, THE EXTENDED CASE ME; Burken JJ, 2006, MED C CONTR AUTOMAT, P1; Charles CZ, 2003, ANNU REV SOCIOL, V29, P167, DOI 10.1146/annurev.soc.29.010202.100002; Cranshaw J, 2012, SIXTH INTERNATIONAL; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Desmond M, 2014, THEOR SOC, V43, P547, DOI 10.1007/s11186-014-9232-5; Duggan M, 2015, MOBILE MESSAGING AND; Duncan OD, 1955, AM SOCIOL REV, V20, P210, DOI 10.2307/2088328; Fischer Claude, 1982, TO DWELL AMONG FRIEN; Frias-Martinez V, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P239, DOI 10.1109/SocialCom-PASSAT.2012.19; Goodchild MF, 2007, INT J SPAT DATA INFR, V2, P24; Hannerz U., 1980, EXPLORING THE CITY; Hochman Nadav, 2013, First Monday, V18, P32, DOI 10.5210/fm.v18i7.4711; Hochman N, 2012, SIXTH INTERNATIONAL; Hudson-Smith A, 2009, J LOCAT BASED SERV, V3, P118, DOI 10.1080/17489720902950366; Hunter MA, 2010, CITY COMMUNITY, V9, P165, DOI 10.1111/j.1540-6040.2010.01320.x; Kelley MJ, 2013, GEOJOURNAL, V78, P181, DOI 10.1007/s10708-011-9439-1; Kitchin R, 2014, GEOJOURNAL, V79, P1, DOI 10.1007/s10708-013-9516-8; Lane N.D., 2008, PROC WORKSHOP MOBILE, P11, DOI DOI 10.1145/1411759.1411763; Lofland LH, 1998, THE PUBLIC REALM EXP; Maffesoli M., 1996, THE TIME OF THE TRIB; Manovich L, 2012, DEBATES IN THE DIGITAL HUMANITIES, P460; MASSEY DS, 1988, SOC FORCES, V67, P281, DOI 10.2307/2579183; Massey DS, 1998, AMERICAN APARTHEID S; McCracken H, 2015, INSTAGRAMS ALL NEW S; Mitchell JC, 1969, SOCIAL NETWORKS IN U; Molotch HarveyLuskin., 1972, MANAGED INTEGRATION; Park RE, 1915, AM J SOCIOL, V20, P577, DOI 10.1086/212433; Roberto E., 2015, MEASURING INEQUALITY; Robson G, 2001, INT J URBAN REGIONAL, V25, P70, DOI 10.1111/1468-2427.00298; SALTON G, 1988, INFORM PROCESS MANAG, V24, P513, DOI 10.1016/0306-4573(88)90021-0; Schwartz R, 2014, THE SOCIAL MEDIA LIF; Sennett Richard, 1977, THE FALL OF PUBLIC M; Shelton T, 2014, GEOFORUM, V52, P167, DOI 10.1016/j.geoforum.2014.01.006; Silva T. H., 2013, URBCOMP 13, P1, DOI [10.1145/2505821.2505836, DOI 10.1145/2505821, DOI 10.1145/2505821.2505836]; Silva TH, 2013, IEEE SYMP COMP COMMU; Silva TH, 2013, 2013 9TH IEEE INTERNATIONAL CONFERENCE ON DISTRIBUTED COMPUTING IN SENSOR SYSTEMS (IEEE DCOSS 2013), P123, DOI 10.1109/DCOSS.2013.59; Silva TH, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON GREEN COMPUTING AND COMMUNICATIONS, CONFERENCE ON INTERNET OF THINGS, AND CONFERENCE ON CYBER, PHYSICAL AND SOCIAL COMPUTING (GREENCOM 2012), P382, DOI 10.1109/GreenCom.2012.62; Silver D, 2010, SOC FORCES, V88, P2293, DOI 10.1353/sof.2010.0041; Sui D, 2011, INT J GEOGR INF SCI, V25, P1737, DOI 10.1080/13658816.2011.604636; Talbot D, 2007, REGULATING THE NIGHT; Tilly C., 2003, URBAN INEQUALITY EVI; Traag VA, 2015, LOUVAIN IGRAPH IMPLE, DOI [10.5281/zenodo.35117, DOI 10.5281/ZENODO.35117]; Tufekci Z, 2014, EIGHTH INTERNATIONAL; Uitermark J, 2016, SOCIAL NETWORKS FORT; van Liempt I, 2015, URBAN STUD, V52, P407, DOI 10.1177/0042098014552933; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yu Zheng, 2012, WWW 2012	61	43	45	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158161	10.1371/journal.pone.0158161	http://dx.doi.org/10.1371/journal.pone.0158161			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP3JL	27336728	Green Submitted, Green Published, gold			2022-12-26	WOS:000378389200119
J	Den Uyl, PA; Richardson, LL; Jain, S; Dick, GJ				Den Uyl, Paul A.; Richardson, Laurie L.; Jain, Sunit; Dick, Gregory J.			Unraveling the Physiological Roles of the Cyanobacterium Geitlerinema sp BBD and Other Black Band Disease Community Members through Genomic Analysis of a Mixed Culture	PLOS ONE			English	Article							FACULTATIVE ANOXYGENIC PHOTOSYNTHESIS; MICROCOLEUS-CHTONOPLASTES; ROSEOFILUM-REPTOTAENIUM; PHORMIDIUM-CORALLYTICUM; MICROBIAL COMMUNITIES; PHYLOGENETIC ANALYSIS; HYDROGEN METABOLISM; SIDERASTREA-SIDEREA; CARIBBEAN REEF; MICROCYSTIN-LR	Black band disease (BBD) is a cyanobacterial-dominated polymicrobial mat that propagates on and migrates across coral surfaces, necrotizing coral tissue. Culture-based laboratory studies have investigated cyanobacteria and heterotrophic bacteria isolated from BBD, but the metabolic potential of various BBD microbial community members and interactions between them remain poorly understood. Here we report genomic insights into the physiological and metabolic potential of the BBD-associated cyanobacterium Geitlerinema sp. BBD 1991 and six associated bacteria that were also present in the non-axenic culture. The essentially complete genome of Geitlerinema sp. BBD 1991 contains a sulfide quinone oxidoreductase gene for oxidation of sulfide, suggesting a mechanism for tolerating the sulfidic conditions of BBD mats. Although the operon for biosynthesis of the cyanotoxin microcystin was surprisingly absent, potential relics were identified. Genomic evidence for mixed-acid fermentation indicates a strategy for energy metabolism under the anaerobic conditions present in BBD during darkness. Fermentation products may supply carbon to BBD heterotrophic bacteria. Among the six associated bacteria in the culture, two are closely related to organisms found in culture-independent studies of diseased corals. Their metabolic pathways for carbon and sulfur cycling, energy metabolism, and mechanisms for resisting coral defenses suggest adaptations to the coral surface environment and biogeochemical roles within the BBD mat. Polysulfide reductases were identified in a Flammeovirgaceae genome (Bacteroidetes) and the sox pathway for sulfur oxidation was found in the genome of a Rhodospirillales bacterium (Alphaproteobacteria), revealing mechanisms for sulfur cycling, which influences virulence of BBD. Each genomic bin possessed a pathway for conserving energy from glycerol degradation, reflecting adaptations to the glycerol-rich coral environment. The presence of genes for detoxification of reactive oxygen species and resistance to antibiotics suggest mechanisms for combating coral defense strategies. This study builds upon previous research on BBD and provides new insights into BBD disease etiology.	[Den Uyl, Paul A.; Jain, Sunit; Dick, Gregory J.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Dick, Gregory J.] Univ Michigan, Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Dick, Gregory J.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Richardson, Laurie L.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; Florida International University	Dick, GJ (corresponding author), Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA.; Dick, GJ (corresponding author), Univ Michigan, Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.; Dick, GJ (corresponding author), Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	gdick@umich.edu	Dick, Gregory/D-8901-2012	Dick, Gregory/0000-0001-7666-6288	National Science Foundation [EAR1035955, OCE-1208784]; Alfred P. Sloan Foundation [BR2013-027]; Ocean Sciences	National Science Foundation(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Ocean Sciences	This work was supported by National Science Foundation (http://www.nsf.gov) grant EAR1035955 and an Alfred P. Sloan Foundation (http://www.sloan.org) Fellowship (grant number BR2013-027) in Ocean Sciences to GJD and National Science Foundation (http://www.nsf.gov) award OCE-1208784 to LLR.	Antonius A., 1982, Proceedings of the International Coral Reef Symposium, P7; Antonius A., 1976, 10 M ASS ISL MAR LAB, V10, P3; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Bothe H, 2010, MICROBIOL MOL BIOL R, V74, P529, DOI 10.1128/MMBR.00033-10; Bronstein M, 2000, J BACTERIOL, V182, P3336, DOI 10.1128/JB.182.12.3336-3344.2000; Brownell AC, 2014, REV BIOL TROP, V62, P1; CARLTON RG, 1995, FEMS MICROBIOL ECOL, V18, P155, DOI 10.1016/0168-6496(95)00052-C; Casamatta D, 2012, PHYCOLOGIA, V51, P489, DOI 10.2216/11-10.1; Chen T, 2005, MOL CELL PROTEOMICS, V4, P958, DOI 10.1074/mcp.M400185-MCP200; Codd G. A., 2005, HARMFUL CYANOBACTERI, P11; COHEN Y, 1986, APPL ENVIRON MICROB, V51, P398, DOI 10.1128/AEM.51.2.398-407.1986; COHEN Y, 1975, J BACTERIOL, V123, P855, DOI 10.1128/JB.123.3.855-861.1975; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Darling AE, 2014, PEERJ, V2, DOI 10.7717/peerj.243; DEWIT R, 1988, FEMS MICROBIOL ECOL, V53, P203, DOI 10.1016/0378-1097(88)90443-0; DEWIT R, 1987, FEMS MICROBIOL ECOL, V45, P7, DOI 10.1016/0378-1097(87)90036-X; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDMUNDS PJ, 1991, CORAL REEFS, V10, P161, DOI 10.1007/BF00572175; Frias-Lopez J, 2003, APPL ENVIRON MICROB, V69, P2409, DOI 10.1128/AEM.69.4.2409-2413.2003; Frias-Lopez J, 2004, APPL ENVIRON MICROB, V70, P5955, DOI 10.1128/AEM.70.10.5955-5962.2004; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Gantar M, 2011, MAR DRUGS, V9, P2089, DOI 10.3390/md9102089; Gantar M, 2009, MICROB ECOL, V58, P856, DOI 10.1007/s00248-009-9540-x; GARLICK S, 1977, J BACTERIOL, V129, P623, DOI 10.1128/JB.129.2.623-629.1977; Glas MS, 2012, ISME J, V6, P1526, DOI 10.1038/ismej.2012.2; Jormakka M, 2008, NAT STRUCT MOL BIOL, V15, P730, DOI 10.1038/nsmb.1434; Kana BD, 2001, J BACTERIOL, V183, P7076, DOI 10.1128/JB.183.24.7076-7086.2001; Kelsic ED, 2015, NATURE, V521, P516, DOI 10.1038/nature14485; Kimes NE, 2013, ENVIRON MICROBIOL, V15, P2082, DOI 10.1111/1462-2920.12130; Kramarsky-Winter E, 2014, MICROB ECOL, V67, P177, DOI 10.1007/s00248-013-0309-x; KUMA K, 1992, MAR CHEM, V37, P15, DOI 10.1016/0304-4203(92)90054-E; Lesser MP, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P405, DOI 10.1007/978-94-007-0114-4_23; Libro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081821; Madigan M.T., 2008, INT MICROBIOL, V11, P65; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Miller AW, 2012, J INVERTEBR PATHOL, V109, P27, DOI 10.1016/j.jip.2011.09.007; Miller AW, 2011, FEMS MICROBIOL ECOL, V75, P231, DOI 10.1111/j.1574-6941.2010.00991.x; Morrissey J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00043; MUSCATIN.L, 1967, SCIENCE, V156, P516, DOI 10.1126/science.156.3774.516; Myers JL, 2007, APPL ENVIRON MICROB, V73, P5173, DOI 10.1128/AEM.00900-07; Myers JL, 2009, FEMS MICROBIOL ECOL, V67, P242, DOI 10.1111/j.1574-6941.2008.00619.x; Nagy CI, 2014, J BACTERIOL, V196, P3430, DOI 10.1128/JB.01864-14; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Richardson LL, 2008, REV BIOL TROP, V56, P119; Richardson L. L., 1997, P 8 INT COR REEF S, V1, P597; Richardson LL, 2007, FEMS MICROBIOL LETT, V272, P182, DOI 10.1111/j.1574-6968.2007.00751.x; Richardson Laurie L., 2014, Life-Basel, V4, P968, DOI 10.3390/life4040968; Richardson LL, 2009, DIS AQUAT ORGAN, V87, P79, DOI 10.3354/dao02083; Richardson LL, 1996, MICROBIAL ECOL, V32, P323; Richardson LL, 2003, FEMS MICROBIOL ECOL, V43, P287, DOI 10.1016/S0168-6496(03)00025-4; Richardson LL, 2004, CORAL HEALTH AND DISEASE, P325; Richardson LL, 2001, HYDROBIOLOGIA, V460, P71, DOI 10.1023/A:1013187723831; Richardson LL, 2015, DIS OF CORAL, P345; Rosenberg E, 2004, CORAL HLTH DIS; ROtzler K., 1983, PSZNI MAR ECOL, V4, P301, DOI DOI 10.1111/J.1439-0485.1983.TB00116.X; Rutzler K, 1983, PSZNI MAR ECOL, V4, P329, DOI DOI 10.1111/J.1439-0485.1983.TB00118.X; Sato Y, 2016, ENVIRON MICROBIOL, V18, P752, DOI 10.1111/1462-2920.13122; Sato Y, 2009, P R SOC B, V276, P2795, DOI 10.1098/rspb.2009.0481; SCHAUDER R, 1993, ARCH MICROBIOL, V159, P491, DOI 10.1007/BF00249025; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekar R, 2008, MAR ECOL PROG SER, V362, P85, DOI 10.3354/meps07496; Sekar R, 2006, APPL ENVIRON MICROB, V72, P5963, DOI 10.1128/AEM.00843-06; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1016/S0168-6445(97)00056-9; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanic D, 2011, ENVIRON MICROBIOL, V13, P900, DOI 10.1111/j.1462-2920.2010.02388.x; Suescun-Bolivar LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047182; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Tamagnini P, 2002, MICROBIOL MOL BIOL R, V66, P1, DOI 10.1128/MMBR.66.1.1-20.2002; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; Tooming-Klunderud A, 2008, MICROBIOL-SGM, V154, P1886, DOI 10.1099/mic.0.2007/015875-0; TRENCH RK, 1971, PROC R SOC SER B-BIO, V177, P237, DOI 10.1098/rspb.1971.0025; Viehman S, 2006, DIS AQUAT ORGAN, V69, P119, DOI 10.3354/dao069119; Voss JD, 2007, MICROB ECOL, V54, P730, DOI 10.1007/s00248-007-9234-1; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Yutin N, 2005, ENVIRON MICROBIOL, V7, P2027, DOI 10.1111/j.1462-2920.2005.00843.x; Zegura B, 2003, TOXICON, V41, P41, DOI 10.1016/S0041-0101(02)00207-6	85	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157953	10.1371/journal.pone.0157953	http://dx.doi.org/10.1371/journal.pone.0157953			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336619	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200073
J	Nichols, WA; Henderson, BJ; Marotta, CB; Yu, CY; Richards, C; Dougherty, DA; Lester, HA; Cohen, BN				Nichols, Weston A.; Henderson, Brandon J.; Marotta, Christopher B.; Yu, Caroline Y.; Richards, Chris; Dougherty, Dennis A.; Lester, Henry A.; Cohen, Bruce N.			Mutation Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Reduces Low-Sensitivity alpha 4 beta 2, and Increases alpha 5 alpha 4 beta 2, Nicotinic Receptor Surface Expression	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTORS; ATTENTION CIRCUITRY; MICE LACKING; SUBUNIT; ALPHA-5; STOICHIOMETRY; ACTIVATION; ALPHA-5-SUBUNIT; EXCITABILITY; DELETION	A number of mutations in alpha 4 beta 2-containing (alpha 4 beta 2*) nicotinic acetylcholine (ACh) receptors (nAChRs) are linked to autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE), including one in the beta 2 subunit called beta 2V287L. Two alpha 4 beta 2* subtypes with different subunit stoichiometries and ACh sensitivities co-exist in the brain, a high-sensitivity subtype with (alpha 4)(2)(beta 2)(3) subunit stoichiometry and a low-sensitivity subtype with (alpha 4)(3)(beta 2)(2) stoichiometry. The a5 nicotinic subunit also co-assembles with alpha 4 beta 2 to form a high-sensitivity a5 alpha 4 beta 2 nAChR. Previous studies suggest that the beta 2V287L mutation suppresses low-sensitivity alpha 4 beta 2* nAChR expression in a knock-in mouse model and also that alpha 5 co-expression improves the surface expression of ADNFLE mutant nAChRs in a cell line. To test these hypotheses further, we expressed mutant and wild-type (WT) nAChRs in oocytes and mammalian cell lines, and measured the effects of the beta 2V287L mutation on surface receptor expression and the ACh response using electrophysiology, a voltage-sensitive fluorescent dye, and superecliptic pHluorin (SEP). The beta 2V287L mutation reduced the EC50 values of high-and low-sensitivity alpha 4 beta 2 nAChRs expressed in Xenopus oocytes for ACh by a similar factor and suppressed low-sensitivity alpha 4 beta 2 expression. In contrast, it did not affect the EC50 of alpha 5 alpha 4 beta 2 nAChRs for ACh. Measurements of the ACh responses of WT and mutant nAChRs expressed in mammalian cell lines using a voltage-sensitive fluorescent dye and whole-cell patch-clamping confirm the oocyte data. They also show that, despite reducing the maximum response, beta 2V287L increased the alpha 4 beta 2 response to a sub-saturating ACh concentration (1 mu M). Finally, imaging SEP-tagged alpha 5, alpha 4, beta 2, and beta 2V287L subunits showed that beta 2V287L reduced total alpha 4 beta 2 nAChR surface expression, increased the number of beta 2 subunits per alpha 4 beta 2 receptor, and increased surface alpha 5 alpha 4 beta 2 nAChR expression. Thus, the beta 2V287L mutation alters the subunit composition and sensitivity of alpha 4 beta 2 nAChRs, and increases alpha 5 alpha 4 beta 2 surface expression.	[Nichols, Weston A.; Henderson, Brandon J.; Yu, Caroline Y.; Lester, Henry A.; Cohen, Bruce N.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Marotta, Christopher B.; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Richards, Chris] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA	California Institute of Technology; California Institute of Technology; University of Kentucky	Cohen, BN (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	bncohen@caltech.edu			National Institutes of Health [NS034407, DA017279, DA033721, DA030877]; Rose Hills foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rose Hills foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants to D.A.D. (NS034407), H.A.L. (DA017279), B.J.H. (DA033721), and C.R. (DA030877) from the National Institutes of Health (http://www.nih.gov/) and to C.Y.Y. from the Rose Hills foundation (http://rosehillsfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CDC, 2012, BIOL PSYCHIAT, V71, P120, DOI 10.1016/j.biopsych.2011.09.011; Ballesteros-Yanez I, 2010, P NATL ACAD SCI USA, V107, P11567, DOI 10.1073/pnas.1006269107; Becchetti A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00022; Bloem B, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00017; Brown RWB, 2007, J NEUROCHEM, V103, P204, DOI 10.1111/j.1471-4159.2007.04700.x; Combi R, 2004, J NEUROL, V251, P923, DOI 10.1007/s00415-004-0541-x; De Fusco M, 2000, NAT GENET, V26, P275; Ferini-Strambi L, 2012, NEUROLOGIST, V18, P343, DOI 10.1097/NRL.0b013e31826a99b8; Figl A, 1998, J PHYSIOL-LONDON, V513, P655, DOI 10.1111/j.1469-7793.1998.655ba.x; Gambardella A, 2000, NEUROLOGY, V55, P1467, DOI 10.1212/WNL.55.10.1467; Gotti C, 2008, MOL PHARM; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Henderson BJ, 2014, J GEN PHYSIOL, V143, P51, DOI 10.1085/jgp.201311102; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; Ishida S, 2013, NAT GENET, V45, P552, DOI 10.1038/ng.2601; Jin XC, 2014, MOL PHARMACOL, V85, P11, DOI 10.1124/mol.113.089979; Kedmi M, 2004, PHYSIOL GENOMICS, V17, P221, DOI 10.1152/physiolgenomics.00202.2003; Kurth S, 2010, J NEUROSCI, V30, P13211, DOI 10.1523/JNEUROSCI.2532-10.2010; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Lozada AF, 2012, J NEUROSCI, V32, P8391, DOI 10.1523/JNEUROSCI.6247-11.2012; Manfredi I, 2009, HUM MOL GENET, V18, P1075, DOI 10.1093/hmg/ddp004; Marotta CB, 2014, NEUROPHARMACOLOGY, V77, P342, DOI 10.1016/j.neuropharm.2013.09.028; Miles TF, 2013, BIOPHYS J, V105, P887, DOI 10.1016/j.bpj.2013.07.015; Milligan CJ, 2014, ANN NEUROL, V75, P581, DOI 10.1002/ana.24128; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Motulsky H., 2014, INTUITIVE BIOSTATIST; O'Neill HC, 2013, PHARMACOL BIOCHEM BE, V103, P603, DOI 10.1016/j.pbb.2012.10.014; OCHOA ELM, 1994, CELL MOL NEUROBIOL, V14, P315, DOI 10.1007/BF02088714; Picard F, 2006, BRAIN, V129, P2047, DOI 10.1093/brain/awl156; Proulx E, 2014, CELL MOL LIFE SCI, V71, P1225, DOI 10.1007/s00018-013-1481-3; QUIRION R, 1994, SYNAPSE, V17, P92, DOI 10.1002/syn.890170205; Raggenbass M, 2002, J NEUROBIOL, V53, P580, DOI 10.1002/neu.10152; RamirezLatorre J, 1996, NATURE, V380, P347, DOI 10.1038/380347a0; Richards CI, 2011, J BIOL CHEM, V286, P31241, DOI 10.1074/jbc.M111.256024; Rodrigues-Pinguet N, 2003, J PHYSIOL-LONDON, V550, P11, DOI 10.1113/jphysiol.2003.036681; Rodrigues-Pinguet NO, 2005, MOL PHARMACOL, V68, P487, DOI 10.1124/mol.105.011155; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Sansoni V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061306; SCHEFFER IE, 1995, BRAIN, V118, P61, DOI 10.1093/brain/118.1.61; Shiba Y, 2015, NEUROSCI RES, V100, P46, DOI 10.1016/j.neures.2015.06.003; SINE SM, 1984, BIOPHYS J, V46, P277, DOI 10.1016/S0006-3495(84)84022-9; Son CD, 2009, MOL PHARMACOL, V75, P1137, DOI 10.1124/mol.108.054494; Teper Y, 2007, J NEUROSCI, V27, P10128, DOI 10.1523/JNEUROSCI.3042-07.2007; Tian MK, 2011, J NEUROSCI, V31, P16458, DOI 10.1523/JNEUROSCI.3600-11.2011; WADA E, 1990, BRAIN RES, V526, P45, DOI 10.1016/0006-8993(90)90248-A; Xu J, 2011, MOL PSYCHIATR, V16, P1048, DOI 10.1038/mp.2010.78; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	49	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158032	10.1371/journal.pone.0158032	http://dx.doi.org/10.1371/journal.pone.0158032			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336596	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000378389200095
J	Omata, Y; Nakamura, S; Koyama, T; Yasui, T; Hirose, J; Izawa, N; Matsumoto, T; Imai, Y; Seo, S; Kurokawa, M; Tsutsumi, S; Kadono, Y; Morimoto, C; Aburatani, H; Miyamoto, T; Tanaka, S				Omata, Yasunori; Nakamura, Shinya; Koyama, Takuma; Yasui, Tetsuro; Hirose, Jun; Izawa, Naohiro; Matsumoto, Takumi; Imai, Yuuki; Seo, Sachiko; Kurokawa, Mineo; Tsutsumi, Shuichi; Kadono, Yuho; Morimoto, Chikao; Aburatani, Hiroyuki; Miyamoto, Takeshi; Tanaka, Sakae			Identification of Nedd9 as a TGF-beta-Smad2/3 Target Gene Involved in RANKL-Induced Osteoclastogenesis by Comprehensive Analysis	PLOS ONE			English	Article							SUBSTRATE LYMPHOCYTE TYPE; TGF-BETA; HUMAN GENOME; EXPRESSION; PROTEIN; CANCER; CELLS; HEF1; METHYLATION; FAMILY	TGF-beta is a multifunctional cytokine that is involved in cell proliferation, differentiation and function. We previously reported an essential role of the TGF-beta-Smad2/3 pathways in RANKL-induced osteoclastogenesis. Using chromatin immunoprecipitation followed by sequencing, we comprehensively identified Smad2/3 target genes in bone marrow macrophages. These genes were enriched in the gene population upregulated by TGF-beta and downregulated by RANKL. Recent studies have revealed that histone modifications, such as trimethylation of histone H3 lysine 4 (H3K4me3) and lysine 27 (H3K27me3), critically regulate key developmental steps. We identified Nedd9 as a Smad2/3 target gene whose histone modification pattern was converted from H3K4me3(+)/H3K4me27(+) to H3K4me3 (+)/H3K4me27(-) by TGF-beta. Nedd9 expression was increased by TGF-beta and suppressed by RANKL. Overexpression of Nedd9 partially rescued an inhibitory effect of a TGF-beta inhibitor, while gene silencing of Nedd9 suppressed RANKL-induced osteoclastogenesis. RANKL-induced osteoclastogenesis were reduced and stimulatory effects of TGF-beta on RANKL-induced osteoclastogenesis were partially abrogated in cells from Nedd9-deficient mice although knockout mice did not show abnormal skeletal phenotypes. These results suggest that Nedd9 is a Smad2/3 target gene implicated in RANKL-induced osteoclastogenesis.	[Omata, Yasunori; Nakamura, Shinya; Koyama, Takuma; Yasui, Tetsuro; Hirose, Jun; Izawa, Naohiro; Matsumoto, Takumi; Kadono, Yuho; Miyamoto, Takeshi; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 113, Japan; [Imai, Yuuki] Ehime Univ, Grad Sch Med, Proteosci Ctr, Div Integrat Pathophysiol, Matsuyama, Ehime 7910295, Japan; [Seo, Sachiko; Kurokawa, Mineo] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo, Japan; [Tsutsumi, Shuichi; Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Morimoto, Chikao] Juntendo Univ, Dept Therapy Dev & Innovat Immune Disorders & Can, Tokyo, Japan; [Miyamoto, Takeshi] Keio Univ, Dept Orthoped Surg, Tokyo, Japan	University of Tokyo; Ehime University; University of Tokyo; University of Tokyo; Juntendo University; Keio University	Tanaka, S (corresponding author), Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 113, Japan.	TANAKAS-ORT@h.u-tokyo.ac.jp	Hirose, Jun/AAO-8474-2020; Imai, Yuuki/ABC-4687-2020; Tanaka, Sakae/Y-3061-2019; Kadono, Yuho/AAO-2405-2020	Tanaka, Sakae/0000-0001-9210-9414; 	Japanese Ministry of Education, Culture, Sports, Science and Technology [26253075]; Grants-in-Aid for Scientific Research [15H04961] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (#26253075). The URL is as follows; https://www.jsps.go.jp/j-grantsinai/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Huang W, 2003, CALCIFIED TISSUE INT, V73, P584, DOI 10.1007/s00223-003-0059-8; Ikushima H, 2012, CELL TISSUE RES, V347, P37, DOI 10.1007/s00441-011-1179-5; Inamoto S, 2007, ONCOGENE, V26, P893, DOI 10.1038/sj.onc.1209848; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Katayose T, 2015, BIOCHEM BIOPH RES CO, V460, P1069, DOI 10.1016/j.bbrc.2015.03.156; Law SF, 1998, MOL CELL BIOL, V18, P3540, DOI 10.1128/MCB.18.6.3540; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Liu XH, 2000, EMBO J, V19, P6759, DOI 10.1093/emboj/19.24.6759; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; Minegishi M, 1996, J EXP MED, V184, P1365, DOI 10.1084/jem.184.4.1365; Miyagishi M, 2003, OLIGONUCLEOTIDES, V13, P325, DOI 10.1089/154545703322617005; Miyagishi Makoto, 2004, Methods Mol Biol, V252, P483; Morimoto K, 2014, PROSTATE, V74, P901, DOI 10.1002/pros.22809; Omata Y, 2015, J BONE MINER RES, V30, P869, DOI 10.1002/jbmr.2418; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Seo S, 2005, J IMMUNOL, V175, P3492, DOI 10.4049/jimmunol.175.6.3492; Shagisultanova E, 2015, GENE, V567, P1, DOI 10.1016/j.gene.2015.04.086; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanaka S, 2007, AM J NEPHROL, V27, P466, DOI 10.1159/000106484; Tang Simon Y, 2013, Bonekey Rep, V2, P255, DOI 10.1038/bonekey.2012.255; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Tornillo G, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0443-5; Yasui T, 2011, J BONE MINER RES, V26, P2665, DOI 10.1002/jbmr.464; Yasui T, 2011, J BONE MINER RES, V26, P1447, DOI 10.1002/jbmr.357; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zheng MZ, 2002, J BIOL CHEM, V277, P39599, DOI 10.1074/jbc.M202263200	33	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157992	10.1371/journal.pone.0157992	http://dx.doi.org/10.1371/journal.pone.0157992			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336669	Green Submitted, Green Published, gold			2022-12-26	WOS:000378389200083
J	van der Meij, R; van Ede, F; Maris, E				van der Meij, Roemer; van Ede, Freek; Maris, Eric			Rhythmic Components in Extracranial Brain Signals Reveal Multifaceted Task Modulation of Overlapping Neuronal Activity	PLOS ONE			English	Article							PARALLEL FACTOR-ANALYSIS; BETA-BAND OSCILLATIONS; ANTICIPATORY ALPHA; SPATIAL ATTENTION; EEG-DATA; CORTICAL NETWORKS; BLIND SEPARATION; OCCIPITAL CORTEX; MOTOR CORTEX; SYNCHRONIZATION	Oscillatory neuronal activity is implicated in many cognitive functions, and its phase coupling between sensors may reflect networks of communicating neuronal populations. Oscillatory activity is often studied using extracranial recordings and compared between experimental conditions. This is challenging, because there is overlap between sensor-level activity generated by different sources, and this can obscure differential experimental modulations of these sources. Additionally, in extracranial data, sensor-level phase coupling not only reflects communicating populations, but can also be generated by a current dipole, whose sensor-level phase coupling does not reflect source-level interactions. We present a novel method, which is capable of separating and characterizing sources on the basis of their phase coupling patterns as a function of space, frequency and time (trials). Importantly, this method depends on a plausible model of a neurobiological rhythm. We present this model and an accompanying analysis pipeline. Next, we demonstrate our approach, using magnetoencephalographic (MEG) recordings during a cued tactile detection task as a case study. We show that the extracted components have overlapping spatial maps and frequency content, which are difficult to resolve using conventional pairwise measures. Because our decomposition also provides trial loadings, components can be readily contrasted between experimental conditions. Strikingly, we observed heterogeneity in alpha and beta sources with respect to whether their activity was suppressed or enhanced as a function of attention and performance, and this happened both in task relevant and irrelevant regions. This heterogeneity contrasts with the common view that alpha and beta amplitude over sensory areas are always negatively related to attention and performance.	[van der Meij, Roemer; van Ede, Freek; Maris, Eric] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Montessorilaan 3, NL-6525 HR Nijmegen, Netherlands; [van der Meij, Roemer] Univ Calif San Diego, Dept Cognit Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA; [van Ede, Freek] Univ Oxford, Dept Psychiat, Oxford Ctr Human Brain Act, Oxford OX3 7JX, England	Radboud University Nijmegen; University of California System; University of California San Diego; University of Oxford	Maris, E (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Montessorilaan 3, NL-6525 HR Nijmegen, Netherlands.	e.maris@donders.ru.nl	van Ede, Freek/AAV-9013-2020	van Ede, Freek/0000-0002-7434-1751	European Union's Seventh Framework Programme [600925]	European Union's Seventh Framework Programme	This work was supported from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no600925 to RM, FE, and EM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Malte Koster for assistance in data collection. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no600925.	Anemuller J, 2003, NEURAL NETWORKS, V16, P1311, DOI 10.1016/j.neunet.2003.08.003; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bro R., 1998, MULTIWAY ANAL FOOD I; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Carrol JD, 1970, PSYCHOMETRIKA, V35; CHAPMAN RM, 1995, BRAIN COGNITION, V27, P288, DOI 10.1006/brcg.1995.1024; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Engel AK, 2013, NEURON, V80, P867, DOI 10.1016/j.neuron.2013.09.038; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Fransen AMM, 2015, NEUROIMAGE, V118, P256, DOI 10.1016/j.neuroimage.2015.06.003; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gould IC, 2011, J NEUROPHYSIOL, V105, P1318, DOI 10.1152/jn.00653.2010; Haegens S, 2012, J COGNITIVE NEUROSCI, V24, P677, DOI 10.1162/jocn_a_00164; Haegens S, 2011, J NEUROSCI, V31, P5197, DOI 10.1523/JNEUROSCI.5199-10.2011; Harshman R. A., 1970, FDN PARAFAC PROCEDUR, P1; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Hyvarinen A, 2010, NEUROIMAGE, V49, P257, DOI 10.1016/j.neuroimage.2009.08.028; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jones SR, 2010, J NEUROSCI, V30, P13760, DOI 10.1523/JNEUROSCI.2969-10.2010; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; Kiers HAL, 1999, J CHEMOMETR, V13, P275, DOI 10.1002/(SICI)1099-128X(199905/08)13:3/4<275::AID-CEM543>3.0.CO;2-B; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Maris E, 2013, NEUROIMAGE, V74, P99, DOI 10.1016/j.neuroimage.2013.02.007; Maris E, 2012, PSYCHOPHYSIOLOGY, V49, P549, DOI 10.1111/j.1469-8986.2011.01320.x; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Miwakeichi F, 2004, NEUROIMAGE, V22, P1035, DOI 10.1016/j.neuroimage.2004.03.039; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Morup M, 2006, NEUROIMAGE, V29, P938, DOI 10.1016/j.neuroimage.2005.08.005; Morup M, 2008, NEUROIMAGE, V42, P1439, DOI 10.1016/j.neuroimage.2008.05.062; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Oostenveld R., 2011, COMPUTATIONAL INTELL, V2011; Palva S, 2012, TRENDS COGN SCI, V16, P219, DOI 10.1016/j.tics.2012.02.004; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Pfurtscheller G, 1997, INT J PSYCHOPHYSIOL, V26, P121, DOI 10.1016/S0167-8760(97)00760-5; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Sidiropoulos ND, 2000, IEEE T SIGNAL PROCES, V48, P810, DOI 10.1109/78.824675; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; van der Meij R, 2015, HUM BRAIN MAPP, V36, P2655, DOI 10.1002/hbm.22798; van der Meij R, 2012, J NEUROSCI, V32, P111, DOI 10.1523/JNEUROSCI.4816-11.2012; van Ede F, 2015, J NEUROPHYSIOL, V113, P1556, DOI 10.1152/jn.00788.2014; van Ede F, 2012, J NEUROPHYSIOL, V108, P2352, DOI 10.1152/jn.00347.2012; van Ede F, 2011, J NEUROSCI, V31, P2016, DOI 10.1523/JNEUROSCI.5630-10.2011; van Ede F, 2010, NEUROIMAGE, V51, P867, DOI 10.1016/j.neuroimage.2010.02.053; Vinck M, 2010, NEUROIMAGE, V51, P112, DOI 10.1016/j.neuroimage.2010.01.073; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Worden MS, 2000, J NEUROSCI, V20	60	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0154881	10.1371/journal.pone.0154881	http://dx.doi.org/10.1371/journal.pone.0154881			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336159	gold, Green Published			2022-12-26	WOS:000378389200002
J	Pollard, AK; Craig, EL; Chakrabarti, L				Pollard, Amelia Kate; Craig, Emma Louise; Chakrabarti, Lisa			Mitochondrial Complex 1 Activity Measured by Spectrophotometry Is Reduced across All Brain Regions in Ageing and More Specifically in Neurodegeneration	PLOS ONE			English	Article							PURKINJE-CELL DEGENERATION; TRANSPORT CHAIN COMPLEXES; RESPIRATORY-CHAIN; OXIDATIVE-PHOSPHORYLATION; DYSFUNCTION; MUTATION; TISSUES; SAMPLES; DAMAGE; HEART	Mitochondrial function, in particular complex 1 of the electron transport chain (ETC), has been shown to decrease during normal ageing and in neurodegenerative disease. However, there is some debate concerning which area of the brain has the greatest complex 1 activity. It is important to identify the pattern of activity in order to be able to gauge the effect of age or disease related changes. We determined complex 1 activity spectrophotometrically in the cortex, brainstem and cerebellum of middle aged mice (70-71 weeks), a cerebellar ataxic neurodegeneration model (pcd(5J)) and young wild type controls. We share our updated protocol on the measurements of complex1 activity and find that mitochondrial fractions isolated from frozen tissues can be measured for robust activity. We show that complex 1 activity is clearly highest in the cortex when compared with brainstem and cerebellum (p<0.003). Cerebellum and brainstem mitochondria exhibit similar levels of complex 1 activity in wild type brains. In the aged brain we see similar levels of complex 1 activity in all three-brain regions. The specific activity of complex 1 measured in the aged cortex is significantly decreased when compared with controls (p<0.0001). Both the cerebellum and brainstem mitochondria also show significantly reduced activity with ageing (p<0.05). The mouse model of ataxia predictably has a lower complex 1 activity in the cerebellum, and although reductions are measured in the cortex and brain stem, the remaining activity is higher than in the aged brains. We present clear evidence that complex 1 activity decreases across the brain with age and much more specifically in the cerebellum of the pcd(5j) mouse. Mitochondrial impairment can be a region specific phenomenon in disease, but in ageing appears to affect the entire brain, abolishing the pattern of higher activity in cortical regions.	[Pollard, Amelia Kate; Craig, Emma Louise; Chakrabarti, Lisa] Univ Nottingham, Sch Vet Med & Sci, Loughborough, England	University of Nottingham	Chakrabarti, L (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Loughborough, England.	lisa.chakrabarti@nottingham.ac.uk	Craig, Emma/GSN-6593-2022	Chakrabarti, Lisa/0000-0001-7213-6837	Biotechnology and Biological Sciences Research Council (BBSRC); University of Nottingham Doctoral Training Fellowship; University of Nottingham Undergraduate Research Project; BBSRC; University of Nottingham; HEFCE; Biotechnology and Biological Sciences Research Council [1270875] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Nottingham Doctoral Training Fellowship; University of Nottingham Undergraduate Research Project; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Nottingham; HEFCE(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (http://www.bbsrc.ac.uk/), the University of Nottingham Doctoral Training Fellowship awarded to AKP, and the University of Nottingham Undergraduate Research Project funding to ELC. HEFCE provided funding for LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was funded by the BBSRC and the University of Nottingham.	Burtscher J, 2015, MITOCHONDRION, V25, P104, DOI 10.1016/j.mito.2015.10.007; Chakrabarti L, 2006, MAMM GENOME, V17, P103, DOI 10.1007/s00335-005-0096-x; Chakrabarti L, 2010, MITOCHONDRIAL DYSFUN, V55, P328; Chakrabarti L, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-24; Davies SMK, 2001, FREE RADICAL BIO MED, V31, P181, DOI 10.1016/S0891-5849(01)00576-7; Fang EF, 2016, NAT REV MOL CELL BIO, V17, P308, DOI 10.1038/nrm.2016.14; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939; Gross VS, 2012, ISOLATION FUNCTIONAL, V418, P213; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Kumaran S, 2004, CHEM-BIOL INTERACT, V148, P11, DOI 10.1016/j.cbi.2003.10.010; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Moran M, 2012, FREE RADICAL BIO MED, V53, P595, DOI 10.1016/j.freeradbiomed.2012.05.009; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016; Perfeito R, 2012, FREE RADICAL BIO MED, V53, P1791, DOI 10.1016/j.freeradbiomed.2012.08.569; Petrosillo G, 2009, FREE RADICAL BIO MED, V46, P88, DOI 10.1016/j.freeradbiomed.2008.09.031; Rygiel KA, 2014, NEUROBIOL AGING, V35, P2230, DOI 10.1016/j.neurobiolaging.2014.02.027; Sandhu SK, 2003, BIOGERONTOLOGY, V4, P19, DOI 10.1023/A:1022473219044; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Sigma-Aldrich, 2013, TECHN B BRADF REAG B, P3; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Tatarkova Z, 2011, PHYSIOL RES, V60, P281, DOI 10.33549/physiolres.932019; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Ventura B, 2002, BBA-BIOENERGETICS, V1553, P249, DOI 10.1016/S0005-2728(01)00246-8; Wang TY, 2007, BRAIN RES, V1140, P26, DOI 10.1016/j.brainres.2006.07.065; Yamaguchi R, 2007, CELL DEATH DIFFER, V14, P616, DOI 10.1038/sj.cdd.4402035; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619	33	45	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157405	10.1371/journal.pone.0157405	http://dx.doi.org/10.1371/journal.pone.0157405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333203	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000378212800028
J	Roman, J; Nevins, J; Altabet, M; Koopman, H; McCarthy, J				Roman, Joe; Nevins, John; Altabet, Mark; Koopman, Heather; McCarthy, James			Endangered Right Whales Enhance Primary Productivity in the Bay of Fundy	PLOS ONE			English	Article							ATLANTIC RIGHT WHALES; EUBALAENA-GLACIALIS; GULF; PHYTOPLANKTON; ZOOPLANKTON; ADAPTATION; NITRATE; BLOOMS; GROWTH; FRESH	Marine mammals have recently been documented as important facilitators of rapid and efficient nutrient recycling in coastal and offshore waters. Whales enhance phytoplankton nutrition by releasing fecal plumes near the surface after feeding and by migrating from highly productive, high-latitude feeding areas to low-latitude nutrient-poor calving areas. In this study, we measured NH4+ and PO43- release rates from the feces of North Atlantic right whales (Eubalaena glacialis), a highly endangered baleen whale. Samples for this species were primarily collected by locating aggregations of whales in surface-active groups (SAGs), which typically consist of a central female surrounded by males competing for sexual activity. When freshly collected feces were incubated in seawater, high initial rates of N release were generally observed, which decreased to near zero within 24 hours of sampling, a pattern that is consistent with the active role of gut microflora on fecal particles. We estimate that at least 10% of particulate N in whale feces becomes available as NH4+ within 24 hours of defecation. Phosphorous was also abundant in fecal samples: initial release rates of PO43- were higher than for NH4+, yielding low N/P nutrient ratios over the course of our experiments. The rate of PO43- release was thus more than sufficient to preclude the possibility that nitrogenous nutrients supplied by whales would lead to phytoplankton production limited by P availability. Phytoplankton growth experiments indicated that NH4+ released from whale feces enhance productivity, as would be expected, with no evidence that fecal metabolites suppress growth. Although North Atlantic right whales are currently rare (approximately 450 individuals), they once numbered about 14,000 and likely played a substantial role in recycling nutrients in areas where they gathered to feed and mate. Even though the NH4+ released from fresh whale fecal material is a small fraction of total whale fecal nitrogen, and recognizing the fact that the additional nitrogen released in whale urine would be difficult to measure in a field study, the results of this study support the idea that the distinctive isotopic signature of the released NH4+ could be used to provide a conservative estimate of the contribution of the whale pump to primary productivity in coastal regions where whales congregate.	[Roman, Joe] Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05405 USA; [Nevins, John; McCarthy, James] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Altabet, Mark] Univ Massachusetts Dartmouth, Dept Estuarine & Ocean Sci, Dartmouth, MA USA; [Koopman, Heather] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA	University of Vermont; Harvard University; University of Massachusetts System; University Massachusetts Dartmouth; University of North Carolina; University of North Carolina Wilmington	Roman, J (corresponding author), Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05405 USA.	romanjoe@gmail.com			U.S. Marine Mammal Commission; Sarah and Daniel Hrdy Fellowship in Conservation Biology at Harvard University; Museum of Comparative Zoology, Harvard University	U.S. Marine Mammal Commission; Sarah and Daniel Hrdy Fellowship in Conservation Biology at Harvard University; Museum of Comparative Zoology, Harvard University	This work was supported by the U.S. Marine Mammal Commission and the Museum of Comparative Zoology, Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It was also supported by a Sarah and Daniel Hrdy Fellowship in Conservation Biology at Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.oeb.harvard.edu/employment/hrdy.html). http://www.mcz.harvard.edu/).	Altabet MA, 2006, HANDB ENVIRON CHEM, V2, P251, DOI 10.1117/698_2_008; BARRIE A, 1984, SPECTROSC-INT J, V3, P439; Baumgartner MF, 2003, MAR ECOL PROG SER, V264, P155, DOI 10.3354/meps264155; Brown MW, 1995, MARINE PROTECTED ARE, P90; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; Doughty CE, 2016, P NATL ACAD SCI USA, V113, P868, DOI 10.1073/pnas.1502549112; EMERSON CW, 1986, OPHELIA, V26, P165, DOI 10.1080/00785326.1986.10421986; Hamilton PK, 2016, OCEAN FLOOR IN PRESS; Koopman HN, 2014, OCEANOGRAPHY, V27, P14; Kraus Scott D., 2001, Journal of Cetacean Research and Management Special Issue, V2, P237; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Latasa M, 1997, LIMNOL OCEANOGR, V42, P289, DOI 10.4319/lo.1997.42.2.0289; Lavery TJ, 2014, MAR MAMMAL SCI, V30, P888, DOI 10.1111/mms.12108; LOHRENZ SE, 1992, J PLANKTON RES, V14, P201, DOI 10.1093/plankt/14.2.201; LONGHURST AR, 1989, PROG OCEANOGR, V22, P47, DOI 10.1016/0079-6611(89)90010-4; Martin J. L., 2006, CANADIAN TECHNICAL R; McCarthy JJ, 2007, ESTUAR COAST SHELF S, V74, P493, DOI 10.1016/j.ecss.2007.05.005; McCarthy JJ, 1999, DEEP-SEA RES PT II, V46, P1623, DOI 10.1016/S0967-0645(99)00038-7; MCCARTHY JJ, 1981, CAN B FISH AQUAT SCI, P211; Monsarrat S, 2016, CONSERV BIOL, V30, P783, DOI 10.1111/cobi.12664; Montoya JP, 2007, ECOL METHOD CONCEPT, P176, DOI 10.1002/9780470691854.ch7; MURISON LD, 1989, CAN J ZOOL, V67, P1411, DOI 10.1139/z89-200; Nicol S, 2010, FISH FISH, V11, P203, DOI 10.1111/j.1467-2979.2010.00356.x; Parks SE, 2005, J ACOUST SOC AM, V117, P3297, DOI 10.1121/1.1882946; Parks SE, 2007, MAR MAMMAL SCI, V23, P868, DOI 10.1111/j.1748-7692.2007.00154.x; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pershing AJ, 2015, SCIENCE, V350, P809, DOI 10.1126/science.aac9819; Ratnarajah L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114067; Rolland RM, 2005, GEN COMP ENDOCR, V142, P308, DOI 10.1016/j.ygcen.2005.02.002; Rolland Rosalind M., 2006, Journal of Cetacean Research and Management, V8, P121; Roman J, 2014, FRONT ECOL ENVIRON, V12, P377, DOI 10.1890/130220; Roman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013255; Savoca MS, 2014, P NATL ACAD SCI USA, V111, P4157, DOI 10.1073/pnas.1317120111; Sigman DM, 1997, MAR CHEM, V57, P227, DOI 10.1016/S0304-4203(97)00009-1; Smith LV, 2013, J EXP MAR BIOL ECOL, V446, P1, DOI 10.1016/j.jembe.2013.04.010; Townsend DW, 2005, DEEP-SEA RES PT II, V52, P2603, DOI 10.1016/j.dsr2.2005.06.028; Townsend DW, 2001, CONT SHELF RES, V21, P347, DOI 10.1016/S0278-4343(00)00093-5; Turner JT, 2015, PROG OCEANOGR, V130, P205, DOI 10.1016/j.pocean.2014.08.005; Vander Zanden MJ, 1997, CAN J FISH AQUAT SCI, V54, P1142, DOI 10.1139/cjfas-54-5-1142; Waser NAD, 1998, LIMNOL OCEANOGR, V43, P215, DOI 10.4319/lo.1998.43.2.0215; Wing SR, 2014, MAR ECOL PROG SER, V510, P1, DOI 10.3354/meps10923; Zhang L, 2007, ANAL CHEM, V79, P5297, DOI 10.1021/ac070106d	42	12	13	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0156553	10.1371/journal.pone.0156553	http://dx.doi.org/10.1371/journal.pone.0156553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27331902	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212800009
J	Carles, S; Charles, MA; Forhan, A; Slama, R; Heude, B; Botton, J				Carles, Sophie; Charles, Marie-Aline; Forhan, Anne; Slama, Remy; Heude, Barbara; Botton, Jeremie		EDEN Mother Child Study Grp	A Novel Method to Describe Early Offspring Body Mass Index (BMI) Trajectories and to Study Its Determinants	PLOS ONE			English	Article							MATERNAL SMOKING; PARENTAL SMOKING; CHILD OVERWEIGHT; BIRTH COHORT; PATERNAL SMOKING; POSTNATAL WEIGHT; EARLY GROWTH; FOLLOW-UP; PREGNANCY; OBESITY	Background Accurately characterizing children's body mass index (BMI) trajectories and studying their determinants is a statistical challenge. There is a need to identify early public health measures for obesity prevention. We describe a method that allows studies of the determinants of height, weight and BMI growth up to five years of age. We illustrated this method using maternal smoking during pregnancy as one of the early-life factors that is potentially involved in prenatal programming of obesity. Methods Individual height and weight trajectories were fitted using the Jenss-Bayley model on 28,381 and 30,515 measurements, respectively, from 1,666 children to deduce BMI trajectories. We assessed global associations between smoking and growth trajectories and cross-sectional associations at specific ages. Results Children exposed in late pregnancy had a 0.24 kg/m(2) (95% confidence interval: 0.07, 0.41) higher BMI at 5 years of age compared with non-exposed children. Although the BMIs of children exposed during late pregnancy became significantly higher compared with those of non-exposed children from 2 years onwards, the trajectories began to diverge during the first weeks of life. Conclusion Our method is relevant for studies on the relationships between individual-level exposures and the dynamics and shapes of BMI growth during childhood, including key features such as instantaneous growth velocities and the age or BMI value at the BMI infancy peak that benefit from the monotonic pattern of height and weight growth.	[Carles, Sophie; Charles, Marie-Aline; Forhan, Anne; Heude, Barbara; Botton, Jeremie] Epidemiol & Biostat Sorbonne Paris Cite Ctr CRESS, INSERM, UMR1153, Early Determinants Childs Hlth & Dev Team ORCHAD, F-75014 Paris, France; [Carles, Sophie; Charles, Marie-Aline; Forhan, Anne; Heude, Barbara] Paris Descartes Univ, Paris, France; [Carles, Sophie; Botton, Jeremie] Univ Paris 11, Villejuif, France; [Slama, Remy] CNRS, INSERM, Team Environm Epidemiol Appl Reprod & Resp Hlth, Grenoble, France; [Slama, Remy] Univ Grenoble Alpes Joint Res Ctr, Inst Adv Biosci, U1209, Grenoble, France; [Botton, Jeremie] Univ Paris 11, Fac Pharm, Lab Biomath, F-92290 Chatenay Malabry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Universite Paris Saclay	Carles, S (corresponding author), Epidemiol & Biostat Sorbonne Paris Cite Ctr CRESS, INSERM, UMR1153, Early Determinants Childs Hlth & Dev Team ORCHAD, F-75014 Paris, France.; Carles, S (corresponding author), Paris Descartes Univ, Paris, France.; Carles, S (corresponding author), Univ Paris 11, Villejuif, France.	sophie.carles@inserm.fr	Charles, Marie Aline/F-8567-2017; Botton, Jérémie/I-1584-2019; Slama, Remy/M-1755-2013; Charles, Marie Aline/S-1866-2019; de Lauzon-Guillain, Blandine/P-4659-2016; Heude, Barbara/GLU-9626-2022; Heude, Barbara/G-3095-2016	Charles, Marie Aline/0000-0003-4025-4390; Botton, Jérémie/0000-0002-4814-6370; Slama, Remy/0000-0002-8980-8529; Charles, Marie Aline/0000-0003-4025-4390; de Lauzon-Guillain, Blandine/0000-0001-5887-8842; Heude, Barbara/0000-0002-1565-1629; Heude, Barbara/0000-0002-1565-1629				Bauer DJ, 2007, MULTIVAR BEHAV RES, V42, P757, DOI 10.1080/00273170701710338; Bonet M, 2013, MATERN CHILD HLTH J, V17, P714, DOI 10.1007/s10995-012-1053-4; Botton J, 2008, AM J CLIN NUTR, V87, P1760, DOI 10.1093/ajcn/87.6.1760; Botton J, 2014, ANN NUTR METAB, V65, P156, DOI 10.1159/000362203; Brisbois TD, 2012, OBES REV, V13, P347, DOI 10.1111/j.1467-789X.2011.00965.x; Chen AM, 2006, INT J EPIDEMIOL, V35, P121, DOI 10.1093/ije/dyi218; Chen H, 2007, OBES RES CLIN PRACT, V1, P155, DOI 10.1016/j.orcp.2007.07.004; Chirwa ED, 2014, ANN HUM BIOL, V41, P166, DOI 10.3109/03014460.2013.839742; Comets E, 2012, SAEMIX R VERSION SAE; DiFranza JR, 2004, PEDIATRICS, V113, P1007; Durmus B, 2011, AM J CLIN NUTR, V94, P164, DOI 10.3945/ajcn.110.009225; Eriksson JG, 2011, AM J CLIN NUTR, V94, p1799S, DOI 10.3945/ajcn.110.000638; Florath I, 2014, PEDIATR OBES, V9, P121, DOI 10.1111/j.2047-6310.2012.00146.x; Gilman SE, 2008, AM J EPIDEMIOL, V168, P522, DOI 10.1093/aje/kwn175; Heude B., 2015, INT J EPIDEMIOLOGY; Howe LD, 2012, INT J EPIDEMIOL, V41, P722, DOI 10.1093/ije/dys025; Howe LD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015186; Iliadou AN, 2010, INT J EPIDEMIOL, V39, P1193, DOI 10.1093/ije/dyq064; Iniguez C, 2013, AM J EPIDEMIOL, V178, P1067, DOI 10.1093/aje/kwt085; Ino T, 2010, PEDIATR INT, V52, P94, DOI 10.1111/j.1442-200X.2009.02883.x; Jaddoe VWV, 2007, AM J EPIDEMIOL, V165, P1207, DOI 10.1093/aje/kwm014; Kwok MK, 2010, PEDIATRICS, V126, pE46, DOI 10.1542/peds.2009-2642; Leary SD, 2006, OBESITY, V14, P2284, DOI 10.1038/oby.2006.268; Mendez MA, 2008, AM J CLIN NUTR, V87, P1906, DOI 10.1093/ajcn/87.6.1906; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Riedel C, 2014, INT J EPIDEMIOL, V43, P1593, DOI 10.1093/ije/dyu150; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Silverwood RJ, 2009, INT J OBESITY, V33, P929, DOI 10.1038/ijo.2009.108; Timmermans SH, 2014, PEDIATR OBES, V9, pE14, DOI 10.1111/j.2047-6310.2012.00141.x; Toschke AM, 2003, AM J EPIDEMIOL, V158, P1068, DOI 10.1093/aje/kwg258; von Kries R, 2008, INT J EPIDEMIOL, V37, P210, DOI 10.1093/ije/dym239; Wen XZ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-38; Ziyab AH, 2014, J EPIDEMIOL COMMUN H, V68, P934, DOI 10.1136/jech-2014-203808	35	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157766	10.1371/journal.pone.0157766	http://dx.doi.org/10.1371/journal.pone.0157766			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327164	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212400040
J	Singh, RP; Jha, PN				Singh, Rajnish Prakash; Jha, Prabhat Nath			The Multifarious PGPR Serratia marcescens CDP-13 Augments Induced Systemic Resistance and Enhanced Salinity Tolerance of Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							GROWTH-PROMOTING BACTERIA; PLANT-GROWTH; ACC-DEAMINASE; PSEUDOMONAS-AERUGINOSA; RHIZOBACTERIA PGPR; LIPID-PEROXIDATION; OXIDATIVE STRESS; INDIAN MUSTARD; SALT; PROLINE	The present study demonstrates the plant growth promoting (PGP) potential of a bacterial isolate CDP-13 isolated from 'Capparis decidua' plant, and its ability to protect plants from the deleterious effect of biotic and abiotic stressors. Based on 16S rRNA gene sequence analysis, the isolate was identified as Serratia marcescens. Among the PGP traits, the isolate was found to be positive for ACC deaminase activity, phosphate solubilization, production of siderophore, indole acetic acid production, nitrogen fixation, and ammonia production. CDP-13 showed growth at an increased salt (NaCl) concentration of up to 6%, indicating its potential to survive and associate with plants growing in saline soil. The inoculation of S. marcescens enhanced the growth of wheat plant under salinity stress (150-200 mM). It significantly reduced inhibition of plant growth (15 to 85%) caused by salt stressors. Application of CDP-13 also modulated concentration (20 to 75%) of different osmoprotectants (proline, malondialdehyde, total soluble sugar, total protein content, and indole acetic acid) in plants suggesting its role in enabling plants to tolerate salt stressors. In addition, bacterial inoculation also reduced the disease severity caused by fungal infection, which illustrated its ability to confer induced systemic resistance (ISR) in host plants. Treatment of wheat plants with the test organism caused alteration in anti-oxidative enzymes activities (Superoxide dismutase, Catalase, and Peroxidase) under various salinity levels, and therefore minimizes the salinity-induced oxidative damages to the plants. Colonization efficiency of strain CDP-13 was confirmed by CFU count, epi-fluorescence microscopy, and ERIC-PCR-based DNA fingerprinting approach. Hence, the study indicates that bacterium CDP-13 enhances plant growth, and has potential for the amelioration of salinity stress in wheat plants. Likewise, the results also provide insights into biotechnological approaches to using PGPR as an alternative to chemicals and pesticides.	[Singh, Rajnish Prakash; Jha, Prabhat Nath] BITS, Dept Biol Sci, Pilani 333031, Rajasthan, India	Birla Institute of Technology & Science Pilani (BITS Pilani)	Jha, PN (corresponding author), BITS, Dept Biol Sci, Pilani 333031, Rajasthan, India.	prabhatn.jha@gmail.com			Department of Biotechnology, Govt. of India, New Delhi [BT/PR14527/AGR/21/326/2010]	Department of Biotechnology, Govt. of India, New Delhi(Department of Biotechnology (DBT) India)	This research was financially supported by the Department of Biotechnology (File No. BT/PR14527/AGR/21/326/2010), Govt. of India, New Delhi. The fund was granted to PNJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel E, 2012, MALAYS J MICROBIOL, V8, P259, DOI 10.21161/mjm.44412; ANDREAE WA, 1960, PLANT PHYSIOL, V35, P220, DOI 10.1104/pp.35.2.220; Lucas JA, 2014, PLANT PHYSIOL BIOCH, V82, P44, DOI 10.1016/j.plaphy.2014.05.007; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Ashrafuzzaman M, 2009, AFR J BIOTECHNOL, V8, P1247; BAISAK R, 1994, PLANT CELL PHYSIOL, V35, P489; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Belimov AA, 2005, SOIL BIOL BIOCHEM, V37, P241, DOI 10.1016/j.soilbio.2004.07.033; Ben Ahmed C, 2010, J AGR FOOD CHEM, V58, P4216, DOI 10.1021/jf9041479; Bhattacharyya PN, 2012, WORLD J MICROB BIOT, V28, P1327, DOI 10.1007/s11274-011-0979-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bui EN, 2013, J ARID ENVIRON, V92, P14, DOI 10.1016/j.jaridenv.2012.12.014; Cappuccino JG., 1992, MICROBIOLOGY LAB MAN, P188, DOI DOI 10.2307/1309615; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Connelly MB, 2004, J BACTERIOL, V186, P4159, DOI 10.1128/JB.186.13.4159-4167.2004; Daneshmand F, 2010, ACTA PHYSIOL PLANT, V32, P91, DOI 10.1007/s11738-009-0384-2; Dimkpa C, 2009, PLANT CELL ENVIRON, V32, P1682, DOI 10.1111/j.1365-3040.2009.02028.x; Dobereiner J., 1995, AZOSPIRILLUM 6 RELAT, P3, DOI [10.1007/978-3-642-79906-8_1, DOI 10.1007/978-3-642-79906-8_1]; DWORKIN M, 1958, J BACTERIOL, V75, P592, DOI 10.1128/JB.75.5.592-603.1958; George P, 2013, WORLD J MICROB BIOT, V29, P109, DOI 10.1007/s11274-012-1163-6; Giri B, 2003, BIOL FERT SOILS, V38, P170, DOI 10.1007/s00374-003-0636-z; Glick BR, 2007, CRIT REV PLANT SCI, V26, P227, DOI 10.1080/07352680701572966; Glick BR, 2004, ADV APPL MICROBIOL, V56, P291, DOI 10.1016/S0065-2164(04)56009-4; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Gupta B, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/701596; Gupta G, 2013, APPL SOIL ECOL, V64, P252, DOI 10.1016/j.apsoil.2012.12.016; HANSON AD, 1978, PLANT PHYSIOL, V62, P305, DOI 10.1104/pp.62.2.305; Harley JP, 2002, LAB EXERCISES MICROB, V5th; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Holbrook AA, 1961, ADV CHEM SER, V28, P159, DOI DOI 10.1021/BA-1961-0028.CH018; Hussain AI, 2008, FOOD CHEM, V108, P986, DOI 10.1016/j.foodchem.2007.12.010; IRIGOYEN JJ, 1992, PHYSIOL PLANTARUM, V84, P55, DOI 10.1111/j.1399-3054.1992.tb08764.x; JANA S, 1982, AQUAT BOT, V12, P345, DOI 10.1016/0304-3770(82)90026-2; Jha CK, 2012, J BASIC MICROB, V52, P285, DOI 10.1002/jobm.201100113; Ji SH, 2014, MICROBIOL RES, V169, P83, DOI 10.1016/j.micres.2013.06.003; Jiang CY, 2008, CHEMOSPHERE, V72, P157, DOI 10.1016/j.chemosphere.2008.02.006; Johri JK, 1999, CURR MICROBIOL, V39, P89, DOI 10.1007/s002849900424; Karthikeyan R., 2007, Research Journal of Microbiology, V2, P50; Kerepesi I, 2000, CROP SCI, V40, P482, DOI 10.2135/cropsci2000.402482x; Kurbanoglu EB, 2015, BRAZ J MICROBIOL, V46, P631, DOI 10.1590/S1517-838246246220131143; Lau S, 2008, PLANT CELL, V20, P1738, DOI 10.1105/tpc.108.060418; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Matysik J, 2002, CURR SCI INDIA, V82, P525; Mayak S, 2004, PLANT PHYSIOL BIOCH, V42, P565, DOI 10.1016/j.plaphy.2004.05.009; MILLAR RL, 1970, PHYTOPATHOLOGY, V60, P104, DOI 10.1094/Phyto-60-104; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Morgan PW, 1997, PHYSIOL PLANTARUM, V100, P620, DOI 10.1034/j.1399-3054.1997.1000325.x; Morris CE, 1997, APPL ENVIRON MICROB, V63, P1570, DOI 10.1128/AEM.63.4.1570-1576.1997; NAGVI SSM, 1999, HDB PLANT CROP PHYSL, P709; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; Ozden M, 2009, SCI HORTIC-AMSTERDAM, V119, P163, DOI 10.1016/j.scienta.2008.07.031; Patakas A, 2002, PLANT SCI, V163, P361, DOI 10.1016/S0168-9452(02)00140-1; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Penrose DM, 2001, CAN J MICROBIOL, V47, P77, DOI 10.1139/cjm-47-1-77; Press CM, 2001, PHYTOPATHOLOGY, V91, P593, DOI 10.1094/PHYTO.2001.91.6.593; Rahi P, 2009, INDIAN J MICROBIOL, V49, P128, DOI 10.1007/s12088-009-0026-9; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Saravanakumar D, 2007, J APPL MICROBIOL, V102, P1283, DOI 10.1111/j.1365-2672.2006.03179.x; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sheng XF, 2008, CAN J MICROBIOL, V54, P417, DOI [10.1139/W08-020, 10.1139/w08-020]; Singh D, 2011, INDIAN J TRADIT KNOW, V10, P146; Singh RP, 2015, J PLANT PHYSIOL, V184, P57, DOI 10.1016/j.jplph.2015.07.002; Stearns JC, 2003, BIOTECHNOL ADV, V21, P193, DOI 10.1016/S0734-9750(03)00024-7; Syrmis MW, 2004, J MED MICROBIOL, V53, P1089, DOI 10.1099/jmm.0.45611-0; Tewolde FT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00448; Tsavkelova EA, 2007, ARCH MICROBIOL, V188, P655, DOI 10.1007/s00203-007-0286-x; Unyayar S, 2006, MUTAGENESIS, V21, P77, DOI 10.1093/mutage/gel001; Wang SL, 2008, BIORESOURCE TECHNOL, V99, P3411, DOI 10.1016/j.biortech.2007.08.016; Yue HT, 2007, PLANT SOIL, V297, P139, DOI 10.1007/s11104-007-9327-0; Zahir ZA, 2009, ARCH MICROBIOL, V191, P415, DOI 10.1007/s00203-009-0466-y	70	127	132	6	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0155026	10.1371/journal.pone.0155026	http://dx.doi.org/10.1371/journal.pone.0155026			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322827	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212000002
J	Lecube, A; Sanchez, E; Gomez-Peralta, F; Abreu, C; Valls, J; Mestre, O; Romero, O; Martinez, MD; Sampol, G; Ciudin, A; Hernandez, C; Simo, R				Lecube, Albert; Sanchez, Enric; Gomez-Peralta, Fernando; Abreu, Cristina; Valls, Joan; Mestre, Olga; Romero, Odile; Dolores Martinez, Maria; Sampol, Gabriel; Ciudin, Andreea; Hernandez, Cristina; Simo, Rafael			Global Assessment of the Impact of Type 2 Diabetes on Sleep through Specific Questionnaires. A Case-Control Study	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; GLYCEMIC CONTROL; LATENCY TEST; QUALITY; APNEA; SCALE; OBESE; DEPRESSION; DISORDERS; DURATION	Type 2 diabetes (T2D) is an independent risk factor for sleep breathing disorders. However, it is unknown whether T2D affects daily somnolence and quality of sleep independently of the impairment of polysomnographic parameters. Material and Methods A case-control study including 413 patients with T2D and 413 non-diabetic subjects, matched by age, gender, BMI, and waist and neck circumferences. A polysomnography was performed and daytime sleepiness was evaluated using the Epworth Sleepiness Scale (ESS). In addition, 135 subjects with T2D and 45 controls matched by the same previous parameters were also evaluated through the Pittsburgh Sleep Quality Index (PSQI) to calculate sleep quality. Results Daytime sleepiness was higher in T2D than in control subjects (p = 0.003), with 23.9% of subjects presenting an excessive daytime sleepiness (ESS>10). Patients with fasting plasma glucose (FPG >= 13.1 mmol/l) were identified as the group with a higher risk associated with an ESS>10 (OR 3.9, 95% CI 1.8-7.9, p = 0.0003). A stepwise regression analyses showed that the presence of T2D, baseline glucose levels and gender but not polysomnographic parameters (i.e apnea-hyoapnea index or sleeping time spent with oxigen saturation lower than 90%) independently predicted the ESS score. In addition, subjects with T2D showed higher sleep disturbances [PSQI: 7.0 (1.0-18.0) vs. 4 (0.0-12.0), p<0.001]. Conclusion The presence of T2D and high levels of FPG are independent risk factors for daytime sleepiness and adversely affect sleep quality. Prospective studies addressed to demonstrate whether glycemia optimization could improve the sleep quality in T2D patients seem warranted.	[Lecube, Albert; Sanchez, Enric; Dolores Martinez, Maria] Univ Lleida, Hosp Univ Arnau de Vilanova, Biomed Res Inst Lleida IRBLLEIDA, Endocrinol & Nutr Dept, Av Rovira Roure 80, Lleida 25198, Spain; [Lecube, Albert; Mestre, Olga; Ciudin, Andreea; Hernandez, Cristina; Simo, Rafael] Univ Autonoma Barcelona, Inst Recerca, Diabet & Metab Res Unit,Inst Salud Carlos ISCII 3, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Pg Vall Hebron 119-129, Barcelona 08035, Spain; [Lecube, Albert; Mestre, Olga; Romero, Odile; Sampol, Gabriel; Ciudin, Andreea; Hernandez, Cristina; Simo, Rafael] Univ Autonoma Barcelona, Hosp Univ Vall Hebron VHIR, Pg Vall Hebron 119-129, Barcelona 08035, Spain; [Gomez-Peralta, Fernando; Abreu, Cristina] Segovia Gen Hosp, Endocrinol & Nutr Unit, C Miguel Servet S-N, Segovia 40002, Spain; [Valls, Joan] Biomed Res Inst Lleida IRBLLEIDA, Biostat & Epidemiol Unit, Av Rovira Roure 80, Lleida 25198, Spain; [Romero, Odile] Univ Autonoma Barcelona, Inst Salud Carlos ISCIII 3, CIBER Enfermedades Respiratorias CIBERES, Sleep Unit,Neurophysiol Dept,Inst Recerca, Pg Vall Hebron 119-129, Barcelona 08035, Spain; [Sampol, Gabriel] Univ Autonoma Barcelona, Inst Salud Carlos ISCIII 3, CIBER Enfermedades Respiratorias CIBERES, Sleep Unit,Pneumol Dept,Inst Recerca, Pg Vall Hebron 119-129, Barcelona 08035, Spain	Universitat de Lleida; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Lecube, A (corresponding author), Univ Lleida, Hosp Univ Arnau de Vilanova, Biomed Res Inst Lleida IRBLLEIDA, Endocrinol & Nutr Dept, Av Rovira Roure 80, Lleida 25198, Spain.; Lecube, A (corresponding author), Univ Autonoma Barcelona, Inst Recerca, Diabet & Metab Res Unit,Inst Salud Carlos ISCII 3, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Pg Vall Hebron 119-129, Barcelona 08035, Spain.; Lecube, A (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall Hebron VHIR, Pg Vall Hebron 119-129, Barcelona 08035, Spain.	alecube@gmail.com	CIUDIN, ANDREEA/O-5250-2016; Romero, Odile/N-8109-2015; Gomez-Peralta, Fernando/J-8249-2019; Lecube, Albert/H-3813-2019; Sánchez, Enric/K-8225-2017; Valls, Joan/GXM-6532-2022	CIUDIN, ANDREEA/0000-0001-5622-0203; Romero, Odile/0000-0002-0147-596X; Gomez-Peralta, Fernando/0000-0003-0106-0091; Lecube, Albert/0000-0001-9684-0183; Sánchez, Enric/0000-0001-7345-1601; Simo Canonge, Rafael/0000-0003-0475-3096; Hernandez, Cristina/0000-0002-3109-1721; Valls, Joan/0000-0002-4806-7568; ABREU, CRISTINA/0000-0002-9238-443X	de Instituto de Salud Carlos III ISCIII (Fondo de Investigacion Sanitaria) [FI12/00803]; European Union (European Regional Development Fund); Fundacion Sociedad Espanola Endocrinologia y Nutricion (FSEEN); European Union (Fondo Europeo de Desarrollo Regional, FEDER); European Union ("Una manera de hacer Europa")	de Instituto de Salud Carlos III ISCIII (Fondo de Investigacion Sanitaria); European Union (European Regional Development Fund)(European Commission); Fundacion Sociedad Espanola Endocrinologia y Nutricion (FSEEN); European Union (Fondo Europeo de Desarrollo Regional, FEDER)(European Commission); European Union ("Una manera de hacer Europa")	This work was supported by grants from de Instituto de Salud Carlos III ISCIII (Fondo de Investigacion Sanitaria, FI12/00803), European Union (European Regional Development Fund, Fondo Europeo de Desarrollo Regional, FEDER, "Una manera de hacer Europa"), and Fundacion Sociedad Espanola Endocrinologia y Nutricion (FSEEN). CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM) and CIBER de Enfermedades Respiratorias (CIBERES) are an initiative of the Instituto Carlos III.	Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; Basta M, 2008, J CLIN SLEEP MED, V4, P19; Benbadis SR, 1999, ANN INTERN MED, V130, P289, DOI 10.7326/0003-4819-130-4-199902160-00014; Bixler EO, 2005, J CLIN ENDOCR METAB, V90, P4510, DOI 10.1210/jc.2005-0035; Buysse D J, 1989, Psychiatry Res, V28, P193; Chasens Eileen R, 2008, Issues Ment Health Nurs, V29, P1134, DOI 10.1080/01612840802319878; Cuellar NG, 2008, J CLIN SLEEP MED, V4, P50; Dixon JB, 2007, OBESITY, V15, P2504, DOI 10.1038/oby.2007.297; Foster GD, 2009, DIABETES CARE, V32, P1017, DOI 10.2337/dc08-1776; Hayashino Y, 2008, EXP CLIN ENDOCR DIAB, V116, P1, DOI 10.1055/s-2007-984442; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Kendzerska TB, 2014, SLEEP MED REV, V18, P321, DOI 10.1016/j.smrv.2013.08.002; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Lamond N, 2000, SLEEP, V23, P415; Lecube A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119073; Lecube A, 2015, J DIABETES, V7, P133, DOI 10.1111/1753-0407.12197; Lecube A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004692; Lou PA, 2015, DIABETES RES CLIN PR, V109, P178, DOI 10.1016/j.diabres.2015.04.012; Luyster FS, 2011, DIABETES EDUCATOR, V37, P347, DOI 10.1177/0145721711400663; Meng LL, 2015, J DIABETES COMPLICAT, V29, P882, DOI 10.1016/j.jdiacomp.2015.06.011; Punjabi NM, 2005, J APPL PHYSIOL, V99, P1998, DOI 10.1152/japplphysiol.00695.2005; R Core Team, 2021, R LANGUAGE ENV STAT; Ramachandran SK, 2009, ANESTHESIOLOGY, V110, P928, DOI 10.1097/ALN.0b013e31819c47b6; Sampol Gabriel, 2012, Endocrinol Nutr, V59, P95, DOI 10.1016/j.endonu.2011.12.003; Shaw JE, 2008, DIABETES RES CLIN PR, V81, P2, DOI 10.1016/j.diabres.2008.04.025; Tasali E, 2008, CHEST, V133, P496, DOI 10.1378/chest.07-0828; Taub LFM, 2008, BIOL RES NURS, V9, P231, DOI 10.1177/1099800407311016; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	30	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157579	10.1371/journal.pone.0157579	http://dx.doi.org/10.1371/journal.pone.0157579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315083	Green Published, gold, Green Submitted			2022-12-26	WOS:000378030000038
J	Weel, IC; Baergen, RN; Romao-Veiga, M; Borges, VT; Ribeiro, VR; Witkin, SS; Bannwart-Castro, C; Peracoli, JC; De Oliveira, L; Peracoli, MT				Weel, Ingrid C.; Baergen, Rebecca N.; Romao-Veiga, Mariana; Borges, Vera T.; Ribeiro, Vanessa R.; Witkin, Steven S.; Bannwart-Castro, Camila; Peracoli, Jose C.; De Oliveira, Leandro; Peracoli, Maria T.			Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; EARLY-ONSET; SYNCYTIAL KNOTS; SOLUBLE ENDOGLIN; IN-VITRO; PATHOPHYSIOLOGY; PATHOGENESIS; HYPOXIA; RESTRICTION	Preeclampsia (PE) is considered the leading cause of maternal and perinatal morbidity and mortality. The placenta seems to play an essential role in this disease, probably due to factors involved in its formation and development. The present study aimed to investigate the association between placental lesions, cytokines and angiogenic factors in pregnant women with preeclampsia (PE). We evaluated 20 normotensive pregnant women, 40 with early-onset PE and 80 with late-onset PE. Placental samples were analyzed for histopathology, immunohistochemistry and determination of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-10 (IL-10), transforming growth factor-beta 1 (TGF-beta 1), tumor necrosis factor-alpha (TNF-alpha), placental growth factor (PlGF), vascular endothelial growth factor (VEGF), fms-like tyrosine-kinase-1 (Flt-1) and endoglin (Eng) levels. Higher percentages of increased syncytial knots and increased perivillous fibrin deposits, and greater levels of TNF-alpha, TGF-beta 1 and Flt-1 were detected in placentas from early-onset PE. Levels of IL-10, VEGF and PlGF were decreased in PE versus normotensive placentas. Both the TNF-alpha/IL-10 and sFlt-1/PlGF ratios were higher in placental homogenate of early-onset PE than late-onset PE and control groups. The more severe lesions and the imbalance between TNF-alpha/IL-10 and PlGF/sFlt-1 in placentas from early-onset PE allows differentiation of early and late-onset PE and suggests higher placental impairment in early-onset PE.	[Weel, Ingrid C.; Romao-Veiga, Mariana; Borges, Vera T.; Bannwart-Castro, Camila; Peracoli, Jose C.; De Oliveira, Leandro] Sao Paulo State Univ, Botucatu Med Sch, Dept Obstet & Gynaecol, BR-18618970 Botucatu, SP, Brazil; [Baergen, Rebecca N.] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Witkin, Steven S.] Weill Cornell Med Coll, Dept Obstet & Gynecol, New York, NY USA; [Ribeiro, Vanessa R.; Peracoli, Maria T.] Sao Paulo State Univ, Inst Biosci, Dept Microbiol & Immunol, BR-18618970 Botucatu, SP, Brazil	Universidade Estadual Paulista; Cornell University; NewYork-Presbyterian Hospital; Cornell University; Universidade Estadual Paulista	Peracoli, MT (corresponding author), Sao Paulo State Univ, Inst Biosci, Dept Microbiol & Immunol, BR-18618970 Botucatu, SP, Brazil.	peracoli@ibb.unesp.br	CASTRO, CAMILA FERREIRA Ferreira/AAJ-8778-2020; Veiga, Mariana Romão/J-1590-2015; Witkin, Steven/AAF-3812-2019; Peracoli, Jose Carlos/GME-1756-2022; Witkin, Steven/AAW-8602-2021; Peracoli, Maria/AAD-2409-2019; Ribeiro, Vanessa Rocha/B-1460-2016; BORGES, VERA T/B-7363-2014; Ribeiro Vasques, Vanessa Rocha/AAU-7634-2021; De Oliveira, Leandro/G-3476-2012; Peracoli, Maria Terezinha/G-4034-2012; Peracoli, Jose Carlos/G-4923-2012	Veiga, Mariana Romão/0000-0002-8990-0237; Witkin, Steven/0000-0002-3502-3929; Ribeiro, Vanessa Rocha/0000-0001-7629-7689; BORGES, VERA T/0000-0002-9347-9641; Ribeiro Vasques, Vanessa Rocha/0000-0001-7629-7689; De Oliveira, Leandro/0000-0002-8422-9907; Peracoli, Maria Terezinha/0000-0002-0936-9512; Peracoli, Jose Carlos/0000-0002-3273-3001; Ferreira Bannwart Castro, Camila/0000-0002-8010-4496				[Anonymous], 2002, OBSTET GYNECOL, V99, P159; Baltajian K, 2014, HYPERTENS PREGNANCY, V33, P427, DOI 10.3109/10641955.2014.926914; Cristofalo R, 2013, FREE RADICAL RES, V47, P268, DOI 10.3109/10715762.2013.765951; De Oliveira L, 2013, PREGNANCY HYPERTENS, V3, P191, DOI 10.1016/j.preghy.2013.02.003; Devisme L, 2013, INT J GYNECOL OBSTET, V120, P165, DOI 10.1016/j.ijgo.2012.08.023; Feng C, 2011, ARCH GYNECOL OBSTET, V283, P161, DOI 10.1007/s00404-009-1303-x; George EM, 2011, CURR HYPERTENS REP, V13, P269, DOI 10.1007/s11906-011-0204-0; Gu Y, 2008, J CLIN ENDOCR METAB, V93, P260, DOI 10.1210/jc.2007-1550; Guller S, 2008, ANN NY ACAD SCI, V1127, P129, DOI 10.1196/annals.1434.015; Hayashi M, 2004, AM J OBSTET GYNECOL, V190, P456, DOI 10.1016/j.ajog.2003.07.032; Heazell AEP, 2007, PLACENTA, V28, pS33, DOI 10.1016/j.placenta.2006.10.007; Hennessy A, 1999, J IMMUNOL, V163, P3491; Hung TH, 2004, AM J PATHOL, V164, P1049, DOI 10.1016/S0002-9440(10)63192-6; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Kane SC, 2014, AUST NZ J OBSTET GYN, V54, P101, DOI 10.1111/ajo.12151; KAPLAN C, 1991, ARCH PATHOL LAB MED, V115, P709; Kim SC, 2012, J OBSTET GYNAECOL RE, V38, P665, DOI 10.1111/j.1447-0756.2011.01773.x; Kovo M, 2012, PRENATAL DIAG, V32, P632, DOI 10.1002/pd.3872; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Loukeris K, 2010, PEDIATR DEVEL PATHOL, V13, P305, DOI 10.2350/09-08-0692-OA.1; Makris A, 2006, PLACENTA, V27, P445, DOI 10.1016/j.placenta.2005.05.003; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; Nagy JA, 2003, TRENDS CARDIOVAS MED, V13, P169, DOI 10.1016/S1050-1738(03)00056-2; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Ogge G, 2011, J PERINAT MED, V39, P641, DOI [10.1515/JPM.2011.098, 10.1515/jpm.2011.098]; Peracoli JC, 2013, J REPROD IMMUNOL, V100, P129, DOI 10.1016/j.jri.2013.08.003; Pratt A, 2015, ANGIOGENESIS, V18, P115, DOI 10.1007/s10456-014-9452-3; Raghupathy R, 2013, MED PRIN PRACT, V22, P8, DOI 10.1159/000354200; Rajakumar A, 2012, HYPERTENSION, V59, P256, DOI 10.1161/HYPERTENSIONAHA.111.182170; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Redman C W G, 2011, Rev Med Interne, V32 Suppl 1, pS41, DOI 10.1016/j.revmed.2011.03.331; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Sankar KD, 2012, ANAT CELL BIOL, V45, P86, DOI 10.5115/acb.2012.45.2.86; Sikkema JM, 2002, PLACENTA, V23, P337, DOI 10.1053/plac.2001.0785; Silasi M, 2010, OBSTET GYN CLIN N AM, V37, P239, DOI 10.1016/j.ogc.2010.02.013; Souza D. A. de, 2011, Jornal Brasileiro de Patologia e Medicina Laboratorial, V47, P71, DOI 10.1590/S1676-24442011000100010; Stark MW, 2014, PEDIATR DEVEL PATHOL, V17, P181, DOI 10.2350/13-09-1378-OA.1; Tripathi R, 2008, ANN ANAT, V190, P477, DOI 10.1016/j.aanat.2008.08.002; Tsatsaris V, 2003, J CLIN ENDOCR METAB, V88, P5555, DOI 10.1210/jc.2003-030528; van der Merwe JL, 2010, HYPERTENS PREGNANCY, V29, P457, DOI 10.3109/10641950903572282; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Vinnars MT, 2011, ACTA OBSTET GYN SCAN, V90, P19, DOI 10.1111/j.1600-0412.2010.01012.x; Wang Y., 2006, Spectral Analysis of Signals. The Missing Data Case; Weed S, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.003; Zhou P, 2012, INFLAMM RES, V61, P1005, DOI 10.1007/s00011-012-0507-x	47	66	70	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157584	10.1371/journal.pone.0157584	http://dx.doi.org/10.1371/journal.pone.0157584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315098	gold, Green Published, Green Submitted			2022-12-26	WOS:000378030000039
J	Zhang, FY; Li, JJ; Liu, HW; Liang, QF; Qi, QS				Zhang, Fengyu; Li, Jiaojiao; Liu, Huaiwei; Liang, Quanfeng; Qi, Qingsheng			ATP-Based Ratio Regulation of Glucose and Xylose Improved Succinate Production	PLOS ONE			English	Article							ENGINEERED ESCHERICHIA-COLI; ACID PRODUCTION; METABOLIC EVOLUTION; ENZYMATIC SACCHARIFICATION; SACCHAROMYCES-CEREVISIAE; CONSERVING PATHWAYS; MOTHER LIQUOR; L-ARABINOSE; FERMENTATION; PYRUVATE	We previously engineered E. coli YL104H to efficiently produce succinate from glucose. Furthermore, the present study proved that YL104H could also co-utilize xylose and glucose for succinate production. However, anaerobic succinate accumulation using xylose as the sole carbon source failed, probably because of an insufficient supply of energy. By analyzing the ATP generation under anaerobic conditions in the presence of glucose or xylose, we indicated that succinate production was affected by the intracellular ATP level, which can be simply regulated by the substrate ratio of xylose to glucose. This finding was confirmed by succinate production using an artificial mixture containing different xylose to glucose ratios. Using xylose mother liquor, a waste containing both glucose and xylose derived from xylitol production, a final succinate titer of 61.66 g/L with an overall productivity of 0.95 g/L/h was achieved, indicating that the regulation of the intracellular ATP level may be a useful and efficient strategy for succinate production and can be extended to other anaerobic processes.	[Zhang, Fengyu; Li, Jiaojiao; Liu, Huaiwei; Liang, Quanfeng; Qi, Qingsheng] Shandong Univ, State Key Lab Microbial Technol, Dept, Jinan 250100, Peoples R China	Shandong University	Liang, QF (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Dept, Jinan 250100, Peoples R China.	liangquanfeng@sdu.edu.cn	Liu, Huaiwei/GOG-9430-2022	Liu, Huaiwei/0000-0002-0483-5318	National Basic Research Program of China [2012CB725202]; National Natural Science Foundation of China [31170097]; Shandong Science and Technology Development Plan [2015GSF121042]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Science and Technology Development Plan	This work was financially supported by a grant from the National Basic Research Program of China (2012CB725202), a grant from the National Natural Science Foundation of China (31170097) and a grant from Shandong Science and Technology Development Plan (2015GSF121042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by a grant from the National Basic Research Program of China (2012CB725202), a grant from the National Natural Science Foundation of China (31170097) and a grant from Shandong Science and Technology Development Plan (2015GSF121042).	Andersson C, 2007, BIOTECHNOL PROGR, V23, P381, DOI 10.1021/bp060301y; Andersson C, 2010, BIOPROC BIOSYST ENG, V33, P711, DOI 10.1007/s00449-009-0393-y; Bao HJ, 2014, ENZYME MICROB TECH, V66, P10, DOI 10.1016/j.enzmictec.2014.04.017; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; Cabrera R, 2011, J BIOL CHEM, V286, P5774, DOI 10.1074/jbc.M110.163162; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; Causey TB, 2004, P NATL ACAD SCI USA, V101, P2235, DOI 10.1073/pnas.0308171100; Chatterjee R, 2001, APPL ENVIRON MICROB, V67, P148, DOI 10.1128/AEM.67.1.148-154.2001; Cheng HR, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-43; Donnelly MI, 1998, APPL BIOCHEM BIOTECH, V70-2, P187, DOI 10.1007/BF02920135; El-Semman IE, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-41; Gu PF, 2013, APPL MICROBIOL BIOT, V97, P4121, DOI 10.1007/s00253-012-4665-0; Hadicke O, 2015, BIOTECHNOL BIOENG, V112, P2195, DOI 10.1002/bit.25623; Hahn-Hagerdal B, 2001, Adv Biochem Eng Biotechnol, V73, P53; Hasona A, 2004, J BACTERIOL, V186, P7593, DOI 10.1128/JB.186.22.7593-7600.2004; Holladay J.E., 2007, TOP VALUE ADDED CHEM, DOI 10.2172/921839; Jantama K, 2008, BIOTECHNOL BIOENG, V101, P881, DOI 10.1002/bit.22005; Jantama K, 2008, BIOTECHNOL BIOENG, V99, P1140, DOI 10.1002/bit.21694; Lai YT, 2015, J CRANIOFAC SURG, V26, pE193, DOI 10.1097/SCS.0000000000001464; Lee SJ, 2005, APPL ENVIRON MICROB, V71, P7880, DOI 10.1128/AEM.71.12.7880-7887.2005; Lehninger A., 2005, LEHNINGER PRINCIPLES; Li YK, 2013, BIORESOURCE TECHNOL, V149, P333, DOI 10.1016/j.biortech.2013.09.077; Li ZL, 2013, APPL BIOCHEM BIOTECH, V171, P555, DOI 10.1007/s12010-013-0414-9; Liang LY, 2013, BIORESOURCE TECHNOL, V143, P405, DOI 10.1016/j.biortech.2013.06.031; Liang QF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13200; Liu RM, 2013, BIORESOURCE TECHNOL, V149, P84, DOI 10.1016/j.biortech.2013.09.052; Liu RM, 2012, APPL MICROBIOL BIOT, V94, P959, DOI 10.1007/s00253-012-3896-4; Martinez A, 2007, BIOTECHNOL LETT, V29, P397, DOI 10.1007/s10529-006-9252-y; McKinlay JB, 2007, APPL MICROBIOL BIOT, V76, P727, DOI 10.1007/s00253-007-1057-y; Noda S, 2006, J BACTERIOL, V188, P6869, DOI 10.1128/JB.00452-06; Saha BC, 2010, NEW BIOTECHNOL, V27, P10, DOI 10.1016/j.nbt.2009.10.005; Saha BC, 2005, BIOTECHNOL PROGR, V21, P816, DOI 10.1021/bp049564n; Sanchez AM, 2005, METAB ENG, V7, P229, DOI 10.1016/j.ymben.2005.03.001; Sawisit A, 2015, BIORESOURCE TECHNOL, V193, P433, DOI 10.1016/j.biortech.2015.06.108; Song H, 2006, ENZYME MICROB TECH, V39, P352, DOI 10.1016/j.enzmictec.2005.11.043; Stouthamer A.H, 1979, INT REV BIOCH MICROB, V21; Vemuri GN, 2002, APPL ENVIRON MICROB, V68, P1715, DOI 10.1128/AEM.68.4.1715-1727.2002; Wang D, 2011, PROCESS BIOCHEM, V46, P365, DOI 10.1016/j.procbio.2010.09.012; Wisselink HW, 2007, APPL ENVIRON MICROB, V73, P4881, DOI 10.1128/AEM.00177-07; Yokota A, 1997, J FERMENT BIOENG, V83, P132, DOI 10.1016/S0922-338X(97)83571-4; Zhang XL, 2009, P NATL ACAD SCI USA, V106, P20180, DOI 10.1073/pnas.0905396106; Zhou JW, 2009, BIOTECHNOL ADV, V27, P94, DOI 10.1016/j.biotechadv.2008.10.005; Zhu XN, 2014, METAB ENG, V24, P87, DOI 10.1016/j.ymben.2014.05.003; Zhu YH, 2008, APPL ENVIRON MICROB, V74, P6649, DOI 10.1128/AEM.01610-08	44	12	12	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157775	10.1371/journal.pone.0157775	http://dx.doi.org/10.1371/journal.pone.0157775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315279	gold, Green Published, Green Submitted			2022-12-26	WOS:000378030000054
J	Griffin, JM; Kho, D; Graham, ES; Nicholson, LFB; O'Carroll, SJ				Griffin, Jarred M.; Kho, Dan; Graham, E. Scott; Nicholson, Louise F. B.; O'Carroll, Simon J.			Statins Inhibit Fibrillary beta-Amyloid Induced Inflammation in a Model of the Human Blood Brain Barrier	PLOS ONE			English	Article							NF-KAPPA-B; COA REDUCTASE INHIBITORS; ENDOTHELIAL-CELLS; ALZHEIMERS-DISEASE; IN-VITRO; OXIDATIVE STRESS; DOWN-REGULATION; TIGHT JUNCTION; MULTIPLE-SCLEROSIS; ACTIVATION	Background Astrocytes and cerebral endothelial cells are important components of the blood-brain barrier (BBB). Disruption to this barrier through inflammation is a major contributor to Alzheimer's disease (AD) pathology. The amyloid beta (A beta) protein is known to exist in several forms and is a key modulator of AD that is known to cause inflammation and changes to BBB function. While one of these forms, fibrillary A beta (fA beta), is known to cause endothelial cell death at the BBB, no studies have looked specifically at its role on inflammation in a model of the human BBB. Aims To determine if fA beta is inflammatory to the human BBB. As statins have been shown to be anti-inflammatory and protective in AD, we also tested if these could inhibit the inflammatory effect of fA beta. Methods Using cultured cerebral endothelial cells and astrocytes we determined changes in cytokine release, cell toxicity and barrier function in response to fibrillary beta-amyloid(1-42) (fA beta(1-42)) alone and in combination with statins. Results fA beta(1-42) induced inflammatory cytokine release from endothelial cells in the absence of cell toxicity. It also induced astrocyte cytokine release and cell death and caused a loss of barrier integrity. Statin treatment inhibited all of these effects. Conclusions We conclude that fA beta(1-42) has both inflammatory and cytotoxic effects on the BBB and the protective effect of statins in AD may in part be through inhibiting these effects.	[Griffin, Jarred M.; Kho, Dan; Graham, E. Scott; Nicholson, Louise F. B.; O'Carroll, Simon J.] Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Ctr Brain Res, Auckland 1, New Zealand; [Griffin, Jarred M.; Nicholson, Louise F. B.; O'Carroll, Simon J.] Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Dept Anat & Med Imaging, Auckland 1, New Zealand; [Kho, Dan; Graham, E. Scott] Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Dept Pharmacol & Clin Pharmacol, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	O'Carroll, SJ (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Ctr Brain Res, Auckland 1, New Zealand.; O'Carroll, SJ (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Dept Anat & Med Imaging, Auckland 1, New Zealand.	s.ocarroll@auckland.ac.nz		Nicholson, Louise/0000-0003-1737-7624; Graham, Scott/0000-0002-2925-9126; Kho, Dan/0000-0001-7193-2954; Griffin, Jarred/0000-0002-3013-8057	Maurice Phyllis Paykel Trust; New Zealand Lotteries Health Fund	Maurice Phyllis Paykel Trust; New Zealand Lotteries Health Fund	The authors greatly acknowledge funding from the Maurice Phyllis Paykel Trust to LFBN and SJO and New Zealand Lotteries Health Fund to SJO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors greatly acknowledge funding from the Maurice Phyllis Paykel Trust to LN and SO and New Zealand Lotteries Health Fund to SO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Aguirre-Rueda D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122843; Andras IE, 2008, MOL PHARMACOL, V73, P1424, DOI 10.1124/mol.107.042028; Brkic M, 2015, J NEUROSCI, V35, P12766, DOI 10.1523/JNEUROSCI.0006-15.2015; Burkert K, 2012, NEUROCHEM INT, V60, P573, DOI 10.1016/j.neuint.2011.09.002; Buttmann M, 2007, J NEUROCHEM, V102, P1001, DOI 10.1111/j.1471-4159.2007.04563.x; Capurro V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056870; Carrano A, 2012, NEURODEGENER DIS, V10, P329, DOI 10.1159/000334916; Carrano A, 2011, ANTIOXID REDOX SIGN, V15, P1167, DOI 10.1089/ars.2011.3895; Dichtl W, 2003, ARTERIOSCL THROM VAS, V23, P58, DOI 10.1161/01.ATV.0000043456.48735.20; Eisenhauer PB, 2000, J NEUROSCI RES, V60, P804, DOI 10.1002/1097-4547(20000615)60:6<804::AID-JNR13>3.3.CO;2-T; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Frigerio S, 2006, NEUROL SCI, V27, P261, DOI 10.1007/s10072-006-0681-0; Hensley K, 2010, J ALZHEIMERS DIS, V21, P1, DOI 10.3233/JAD-2010-1414; Hofman FM, 1998, BLOOD, V92, P3064, DOI 10.1182/blood.V92.9.3064.421a10_3064_3072; Ifergan I, 2006, ANN NEUROL, V60, P45, DOI 10.1002/ana.20875; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Jiang F, 2015, NEUROCHEM RES, V40, P1954, DOI 10.1007/s11064-015-1691-1; Jiang X., 2012, INT J ALZHEIMERS DIS, V2012, P109324, DOI DOI 10.1155/2012/109324; Kallmann BA, 2002, FASEB J, V16, P589, DOI 10.1096/fj.01-0594fje; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kaur U, 2015, CURR TOP MED CHEM, V15, P446, DOI 10.2174/1568026615666150114160543; Keaney J, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500472; Koizumi K, 2016, CELL MOL NEUROBIOL, V36, P155, DOI 10.1007/s10571-015-0256-9; Lamoke F, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0304-x; Li YK, 2012, NEUROPSYCHOPHARMACOL, V37, P1867, DOI 10.1038/npp.2012.34; Liang YJ, 2008, CARDIOLOGY, V110, P182, DOI 10.1159/000111928; Lim JH, 2007, BRAIN RES, V1164, P1, DOI 10.1016/j.brainres.2007.06.020; Liu WJ, 2016, EXP CELL RES, V343, P248, DOI 10.1016/j.yexcr.2016.03.026; Luscombe PRTaM, 1987, BRIT J CANCER, V56, P279, DOI [10.1038/bjc.1987.190, DOI 10.1038/BJC.1987.190]; Merlini M, 2011, ACTA NEUROPATHOL, V122, P293, DOI 10.1007/s00401-011-0834-y; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; Mincheva-Tasheva S, 2013, NEUROSCIENTIST, V19, P175, DOI 10.1177/1073858412444007; Morishita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084387; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; O'Carroll SJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0346-0; Pac-Soo C, 2011, J ALZHEIMERS DIS, V27, P1, DOI [10.3233/JAD-2011-110524, 10.1097/WAD.0b013e31821f5787]; Pannu R, 2007, J NEUROCHEM, V101, P182, DOI 10.1111/j.1471-4159.2006.04354.x; Park L, 2005, J NEUROSCI, V25, P1769, DOI 10.1523/JNEUROSCI.5207-04.2005; Park R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.258; Qosa H, 2014, BBA-MOL BASIS DIS, V1842, P1806, DOI 10.1016/j.bbadis.2014.06.029; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Ridker P M, 2000, Curr Cardiol Rep, V2, P269, DOI 10.1007/s11886-000-0080-8; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; SAHEKI A, 1994, PHARMACEUT RES, V11, P305, DOI 10.1023/A:1018975928974; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Smits HA, 2001, J IMMUNOL, V166, P6869, DOI 10.4049/jimmunol.166.11.6869; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sparks DL, 2011, NAT REV NEUROL, V7, P662, DOI 10.1038/nrneurol.2011.165; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Stuve O, 2003, CURR OPIN NEUROL, V16, P393, DOI 10.1097/01.wco.0000073942.19076.d1; Sutinen EM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-199; Tamagno E, 2006, FREE RADICAL BIO MED, V41, P202, DOI 10.1016/j.freeradbiomed.2006.01.021; Thal DR, 2012, EXP NEUROL, V236, P1, DOI 10.1016/j.expneurol.2012.04.021; Tong XK, 2005, J NEUROSCI, V25, P11165, DOI 10.1523/JNEUROSCI.4031-05.2005; Wan WB, 2015, J NEUROCHEM, V134, P382, DOI 10.1111/jnc.13122; Wan WB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/301575; Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1; White JA, 2005, NEUROBIOL DIS, V18, P459, DOI 10.1016/j.nbd.2004.12.013; Wilhelmus MMM, 2007, AM J PATHOL, V171, P1989, DOI 10.2353/ajpath.2007.070050; Yang CH, 2015, J SURG RES, V194, P591, DOI 10.1016/j.jss.2014.11.030; Yang Dongmei, 2013, J Behav Brain Sci, V3, P100; Yang SP, 2004, NEUROBIOL AGING, V25, P283, DOI 10.1016/S0197-4580(03)00111-8; Yu HC, 2013, INT J BIOL SCI, V9, P966, DOI 10.7150/ijbs.6996	66	16	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157483	10.1371/journal.pone.0157483	http://dx.doi.org/10.1371/journal.pone.0157483			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309956	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800082
J	Kinner, SA; Forsyth, SJ				Kinner, Stuart A.; Forsyth, Simon J.			Development and Validation of a National System for Routine Monitoring of Mortality in People Recently Released from Prison	PLOS ONE			English	Article							EX-PRISONERS; DEATH INDEX; HEALTH OUTCOMES; MENTAL-DISORDER; RECORD LINKAGE; COHORT; RISK; AUSTRALIA; ACCURACY; SUICIDE	Background People released from prison are at increased risk of death. However, no country has established a system for routine monitoring of mortality in this population. The aims of this study were to (a) evaluate a system for routine monitoring of deaths after release from prison in Australia and (b) estimate the number of deaths annually within 28 and 365 days of prison release from 2000 to 2013. Methods Persons released from prison and deaths were identified in records held by Centrelink, Australia's national provider of unemployment benefits. Estimates generated in this manner were compared with those from a study that probabilistically linked correctional records with the National Death Index (NDI), for each calendar year 2000 to 2007. Using Centrelink data, national estimates of mortality within 28 and 365 days of release were produced for each calendar year 2000 to 2013. Findings Compared with estimates based on linkage with the NDI, the estimated crude mortality rate based on Centrelink records was on average 52% lower for deaths within 28 days of release and 24% lower for deaths within 365 days of release. Nationally, over the period 2000 to 2013, we identified an average of 32 deaths per year within 28 days of release and 188 deaths per year within 365 days of release. The crude mortality rate for deaths within both 28 and 365 days of release increased over this time. Conclusions Using routinely collected unemployment benefits data we detected the majority of deaths in people recently released from prison in Australia. These data may be sufficient for routine monitoring purposes and it may be possible to adopt a similar approach in other countries. Routine surveillance of mortality in ex-prisoners serves to highlight their extreme vulnerability and provides a basis for evaluating policy reforms designed to reduce preventable deaths.	[Kinner, Stuart A.] Griffith Univ, Griffith Criminol Inst, Brisbane, Qld 4111, Australia; [Kinner, Stuart A.] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld 4111, Australia; [Kinner, Stuart A.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Kinner, Stuart A.] Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia; [Kinner, Stuart A.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Kinner, Stuart A.] Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia; [Forsyth, Simon J.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia	Griffith University; Griffith University; Menzies Health Institute Queensland; University of Melbourne; Mater Research; University of Queensland; Monash University; Murdoch Children's Research Institute; University of Queensland	Kinner, SA (corresponding author), Griffith Univ, Griffith Criminol Inst, Brisbane, Qld 4111, Australia.; Kinner, SA (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld 4111, Australia.; Kinner, SA (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.; Kinner, SA (corresponding author), Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia.; Kinner, SA (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia.; Kinner, SA (corresponding author), Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia.	s.kinner@griffith.edu.au	Forsyth, Simon J/N-9522-2013	Forsyth, Simon J/0000-0002-3100-3584	National Health and Medical Research Council [456107]; NHMRC Senior Research Fellowship [APP1078168]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The MARC project was funded by National Health and Medical Research Council (www.nhmrc.gov.au) project grant #456107. Stuart Kinner is supported by NHMRC Senior Research Fellowship APP1078168. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2015, 451702015 ABS; Baker A, 2015, DEATHS CUSTODY AUSTR; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Brook EL, 2008, AUST NZ J PUBL HEAL, V32, P19, DOI 10.1111/j.1753-6405.2008.00160.x; Choi BCK, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/875253; Csete J, 2010, INT J PRISONER HLTH, V6, P3; Cutcher Z, 2014, AUST NZ J PUBL HEAL, V38, P424, DOI 10.1111/1753-6405.12207; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Forsyth SJ, 2014, ADDICTION, V109, P1676, DOI 10.1111/add.12646; Freudenberg N, 2005, AM J PUBLIC HEALTH, V95, P1725, DOI 10.2105/AJPH.2004.056325; Graham A, 2003, AUST NZ J CRIMINOL, V36, P94, DOI 10.1375/000486503764805365; Kariminia A, 2007, INT J EPIDEMIOL, V36, P310, DOI 10.1093/ije/dyl225; Kariminia A, 2005, AUST NZ J PUBL HEAL, V29, P572, DOI 10.1111/j.1467-842X.2005.tb00253.x; Kelman C, 2000, AUST NZ J PUBL HEAL, V24, P201, DOI 10.1111/j.1467-842X.2000.tb00143.x; Kinner SA, 2013, ADDICTION, V108, P38, DOI 10.1111/add.12010; Kinner SA, 2011, MED J AUSTRALIA, V195, P64, DOI 10.5694/j.1326-5377.2011.tb03208.x; Kinner SA, 2010, ADDICTION, V105, P1555, DOI 10.1111/j.1360-0443.2010.03030.x; Larney S, 2011, EVALUATION REV, V35, P118, DOI 10.1177/0193841X11401695; Magliano D, 2003, AUST NZ J PUBL HEAL, V27, P649, DOI 10.1111/j.1467-842X.2003.tb00615.x; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Ministry of Justice, 2013, SAF CUST STAT ENGL W; Noonan M, 2010, MORTALITY LOCAL JAIL; Pratt D, 2006, LANCET, V368, P119, DOI 10.1016/S0140-6736(06)69002-8; Rosen DL, 2008, AM J PUBLIC HEALTH, V98, P2278, DOI 10.2105/AJPH.2007.121855; SAS Institute, 2010, SAS SYST WIND VERS; Souza KA, 2010, CRIM JUSTICE BEHAV, V37, P1330, DOI 10.1177/0093854810379969; Spittal MJ, 2014, J EPIDEMIOL COMMUN H, V68, P993, DOI 10.1136/jech-2014-204295; Stewart LM, 2004, AUST NZ J PUBL HEAL, V28, P32, DOI 10.1111/j.1467-842X.2004.tb00629.x; van Dooren K, 2013, AUST NZ J PUBL HEAL, V37, P377, DOI 10.1111/1753-6405.12087; Visher CA, 2011, JUSTICE Q, V28, P698, DOI 10.1080/07418825.2010.535553	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157328	10.1371/journal.pone.0157328	http://dx.doi.org/10.1371/journal.pone.0157328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27309540	Green Published, gold			2022-12-26	WOS:000378029800054
J	Borowiec, AS; Sion, B; Chalmel, F; Rolland, AD; Lemonnier, L; De Clerck, T; Bokhobza, A; Derouiche, S; Dewailly, E; Slomianny, C; Mauduit, C; Benahmed, M; Roudbaraki, M; Jegou, B; Prevarskaya, N; Bidaux, G				Borowiec, Anne-Sophie; Sion, Benoit; Chalmel, Frederic; Rolland, Antoine D.; Lemonnier, Loic; De Clerck, Tatiana; Bokhobza, Alexandre; Derouiche, Sandra; Dewailly, Etienne; Slomianny, Christian; Mauduit, Claire; Benahmed, Mohamed; Roudbaraki, Morad; Jegou, Bernard; Prevarskaya, Natalia; Bidaux, Gabriel			Cold/menthol TRPM8 receptors initiate the cold-shock response and protect germ cells from cold-shock-induced oxidation	FASEB JOURNAL			English	Article						hypothermia; spermatogenesis; apoptosis	HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; BIOLOGICAL SIGNIFICANCE; REGULATORY MECHANISM; SPERMATOGENIC CELLS; DNA-DAMAGE; EXPRESSION; APOPTOSIS; STRESS; CHANNEL; TRANSCRIPTOME	Testes of most male mammals present the particularity of being externalized from the body and are consequently slightly cooler than core body temperature (4-8 degrees C below). Although, hypothermia of the testis is known to increase germ cells apoptosis, little is known about the underlying molecular mechanisms, including cold sensors, transduction pathways, and apoptosis triggers. In this study, using a functional knockout mouse model of the cold and menthol receptors, dubbed transient receptor potential melastatine 8 (TRPM8) channels, we found that TRPM8 initiated the cold-shock response by differentially modulating cold- and heat-shock proteins. Besides, apoptosis of germ cells increased in proportion to the cooling level in control mice but was independent of temperature in knockout mice. We also observed that the rate of germ cell death correlated positively with the reactive oxygen species level and negatively with the expression of the detoxifying enzymes. This result suggests that the TRPM8 sensor is a key determinant of germ cell fate under hypothermic stimulation.Borowiec, A.-S., Sion, B., Chalmel, F., Rolland, A. D., Lemonnier, L., De Clerck, T., Bokhobza, A., Derouiche, S., Dewailly, E., Slomianny, C., Mauduit, C., Benahmed, M., Roudbaraki, M., Jegou, B., Prevarskaya, N., Bidaux, G. Cold/menthol TRPM8 receptors initiate the cold-shock response and protect germ cells from cold-shock-induced oxidation.	[Borowiec, Anne-Sophie; Lemonnier, Loic; De Clerck, Tatiana; Bokhobza, Alexandre; Derouiche, Sandra; Dewailly, Etienne; Slomianny, Christian; Roudbaraki, Morad; Prevarskaya, Natalia; Bidaux, Gabriel] Univ Lille, INSERM, Physiol Cellulaire PHYCEL, U1003, Lille, France; [Sion, Benoit] Univ Auvergne, Clermont Univ, Pharmacol Fondamentale & Clin Douleur, INSERM,U1107,Neurodol, Clermont Ferrand, France; [Chalmel, Frederic; Rolland, Antoine D.; Jegou, Bernard] INSERM, Irset U1085, Campus Beaulieu, Rennes, France; [Mauduit, Claire; Benahmed, Mohamed] INSERM, Ctr Mediterraneen Med Mol C3M, Team 5, U1065, Nice, France; [Bidaux, Gabriel] Biophoton Team, UMR8523, Lab Phys Lasers Atomes & Mol PhLAM, Villeneuve Dascq, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP)	Bidaux, G (corresponding author), Grp Hosp EST, INSERM, U1060, IHU Opera,CarMeN Lab, Batiment B13,59 Blvd Pinel, F-69500 Bron, France.	gabriel.bidaux@univ-lyon1.fr	Chalmel, Frédéric/AAM-1079-2021; ROLLAND, Antoine D/B-2611-2012; Chalmel, Frederic/M-1297-2016; Carmen, Team3/Y-7384-2019; Lemonnier, Loic/L-7289-2018; Chalmel, Frédéric/L-5360-2018; Slomianny, Christian/L-8285-2018; Bidaux, Gabriel/F-1294-2016	Chalmel, Frédéric/0000-0002-0535-3628; ROLLAND, Antoine D/0000-0002-9758-4406; Carmen, Team3/0000-0002-3614-0924; Lemonnier, Loic/0000-0001-6200-5382; Chalmel, Frédéric/0000-0002-0535-3628; JEGOU, Bernard/0000-0003-0623-3609; Lab, Carmen/0000-0002-5935-3236; bokhobza, Alexandre/0000-0001-7953-4328; Bidaux, Gabriel/0000-0002-6162-3223; Morad, Roudbaraki/0000-0001-5751-3323; Prevarskaya, natacha/0000-0003-0316-197X	Genoway team and Charles River Laboratories (Lyon, France); INSERM; Ministere de l'Education Nationale; Ligue Nationale Contre le Cancer; Region Nord-Pas-de-Calais; ANR [TRPM8/REPROD]; Fondation pour la recherche medicale	Genoway team and Charles River Laboratories (Lyon, France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Education Nationale; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Region Nord-Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); ANR(French National Research Agency (ANR)); Fondation pour la recherche medicale(Fondation pour la Recherche Medicale)	The authors thank the whole Genoway team and Charles River Laboratories (Lyon, France) for their support and their expertise; and Delphine Taillieu and Melanie Besegher for technical assistance in animal housing at Animalerie High-Tech de l'Institut de Medecine Predictive et de Recherche Therapeutique de Lille. The Trpm8<SUP>-/-</SUP> mouse line was designed by G.B. and Genoway Inc. The Trpm8<SUP>-/-</SUP> mouse line was established by Genoway Inc. and housed at Charles River Laboratories. This work was supported by grants from INSERM, Ministere de l'Education Nationale, Ligue Nationale Contre le Cancer, Region Nord-Pas-de-Calais, and ANR Grant TRPM8/REPROD. A.-S.B. was supported by Fondation pour la recherche medicale. Author Contributions: A.-S. Borowiec and G. Bidaux designed research; A.-S. Borowiec, B. Sion, F. Chalmel, A. D. Rolland, L. Lemonnier, T. De Clerck, A. Bokhobza, S. Derouiche, E. Dewailly, C. Slomianny, C. Mauduit, and G. Bidaux performed research; A.-S. Borowiec, B. Sion, F. Chalmel, A. D. Rolland, L. Lemonnier, C. Slomianny, M. Benahmed, M. Roudbaraki, B. Jegou, and G. Bidaux analyzed data; and A.-S. Borowiec, B. Sion, F. Chalmel, A. D. Rolland, L. Lemonnier, B. Jegou, N. Prevarskaya, and G. Bidaux wrote the paper. The authors declare no conflicts of interest.	Abeele FV, 2006, J BIOL CHEM, V281, P40174, DOI 10.1074/jbc.M605779200; Aitken RJ, 2013, INT J DEV BIOL, V57, P265, DOI 10.1387/ijdb.130146ja; Aitken RJ, 2012, J BIOL CHEM, V287, P33048, DOI 10.1074/jbc.M112.366690; Andersson DA, 2007, J NEUROSCI, V27, P3347, DOI 10.1523/JNEUROSCI.4846-06.2007; Avivar-Valderas A, 2011, MOL CELL BIOL, V31, P3616, DOI 10.1128/MCB.05164-11; Bidaux G, 2005, ENDOCR-RELAT CANCER, V12, P367, DOI 10.1677/erc.1.00969; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; Bidaux G, 2016, CHANNELS, V10, P320, DOI 10.1080/19336950.2016.1168551; Bidaux G, 2015, P NATL ACAD SCI USA, V112, pE3345, DOI 10.1073/pnas.1423357112; BlancoRodriguez J, 1997, J ANDROL, V18, P535; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Chabory E, 2010, J ANIM SCI, V88, P1321, DOI 10.2527/jas.2009-2583; Chabory E, 2009, J CLIN INVEST, V119, P2074, DOI 10.1172/JCI38940; Chalmel F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-86; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; CHOWDHURY AK, 1970, J REPROD FERTIL, V22, P205, DOI 10.1530/jrf.0.0220205; Danno S, 2000, AM J PATHOL, V156, P1685, DOI 10.1016/S0002-9440(10)65039-0; Darde TA, 2015, NUCLEIC ACIDS RES, V43, pW109, DOI 10.1093/nar/gkv345; De Blas GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006095; Denda M, 2010, EXP DERMATOL, V19, P791, DOI 10.1111/j.1600-0625.2010.01154.x; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Gan HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2995; Gibbs GM, 2011, P NATL ACAD SCI USA, V108, P7034, DOI 10.1073/pnas.1015935108; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hofmann S, 2012, MOL BIOL CELL, V23, P3786, DOI 10.1091/mbc.E12-04-0296; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishii T, 2005, FREE RADICAL RES, V39, P697, DOI 10.1080/10715760500130517; Kaushik S, 2003, CLIN CHIM ACTA, V333, P69, DOI 10.1016/S0009-8981(03)00171-2; Lardenois A, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq030; Liu DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036994; MACDONALD J, 1954, FERTIL STERIL, V5, P205; Martinez-Lopez P, 2011, J CELL PHYSIOL, V226, P1620, DOI 10.1002/jcp.22493; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Nocchi L, 2014, AGING CELL, V13, P540, DOI 10.1111/acel.12208; Ohdate T, 2010, GENES CELLS, V15, P59, DOI 10.1111/j.1365-2443.2009.01365.x; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pino JA, 2013, REPRODUCTION, V145, P203, DOI 10.1530/REP-12-0330; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Selman C, 2000, FREE RADICAL BIO MED, V28, P1279, DOI 10.1016/S0891-5849(00)00263-X; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Tsuzi D, 2004, FEBS LETT, V569, P301, DOI 10.1016/j.febslet.2004.05.077; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voituron Y, 2006, CRYOBIOLOGY, V52, P74, DOI 10.1016/j.cryobiol.2005.09.006; Wang X, 2003, FERTIL STERIL, V80, P531, DOI 10.1016/S0015-0282(03)00756-8; WHO, 2001, ANN I SUPER SANITA, V37, pI; Yazawa T, 2003, MOL REPROD DEV, V66, P60, DOI 10.1002/mrd.10328; Zhang KY, 2007, BIOCHEM BIOPH RES CO, V360, P327, DOI 10.1016/j.bbrc.2007.06.071; Zhang Z, 2004, J ANDROL, V25, P57; Zhu SY, 2014, EUR J PHARMACOL, V725, P1, DOI 10.1016/j.ejphar.2014.01.001; Zhu X., 2016, FASEB J, V30, P624	60	14	14	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3155	3170		10.1096/fj.201600257R	http://dx.doi.org/10.1096/fj.201600257R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27317670	hybrid, Green Published			2022-12-26	WOS:000382816300016
J	Volpers, M; Claassens, NJ; Noor, E; van der Oost, J; de Vos, WM; Kengen, SWM; dos Santos, VAPM				Volpers, Michael; Claassens, Nico J.; Noor, Elad; van der Oost, John; de Vos, Willem M.; Kengen, Serve W. M.; dos Santos, Vitor A. P. Martins			Integrated In Silico Analysis of Pathway Designs for Synthetic Photo-Electro-Autotrophy	PLOS ONE			English	Article							CARBON FIXATION; MICROBIAL-PRODUCTION; ESCHERICHIA-COLI; ASSIMILATION; EXPRESSION; DIOXIDE; GROWTH; ENERGY; FUELS; THERMODYNAMICS	The strong advances in synthetic biology enable the engineering of novel functions and complex biological features in unprecedented ways, such as implementing synthetic autotrophic metabolism into heterotrophic hosts. A key challenge for the sustainable production of fuels and chemicals entails the engineering of synthetic autotrophic organisms that can effectively and efficiently fix carbon dioxide by using sustainable energy sources. This challenge involves the integration of carbon fixation and energy uptake systems. A variety of carbon fixation pathways and several types of photosystems and other energy uptake systems can be chosen and, potentially, modularly combined to design synthetic autotrophic metabolism. Prior to implementation, these designs can be evaluated by the combination of several computational pathway analysis techniques. Here we present a systematic, integrated in silico analysis of photo-electro-autotrophic pathway designs, consisting of natural and synthetic carbon fixation pathways, a proton-pumping rhodopsin photosystem for ATP regeneration and an electron uptake pathway. We integrated Flux Balance Analysis of the heterotrophic chassis Escherichia coli with kinetic pathway analysis and thermodynamic pathway analysis (Max-min Driving Force). The photo-electro-autotrophic designs are predicted to have a limited potential for anaerobic, autotrophic growth of E. coli, given the relatively low ATP regenerating capacity of the proton pumping rhodopsin photosystems and the high ATP maintenance of E. coli. If these factors can be tackled, our analysis indicates the highest growth potential for the natural reductive tricarboxylic acid cycle and the synthetic pyruvate synthase-pyruvate carboxylate - glyoxylate bicycle. Both carbon fixation cycles are very ATP efficient, while maintaining fast kinetics, which also results in relatively low estimated protein costs for these pathways. Furthermore, the synthetic bicycles are highly thermodynamic favorable under conditions analysed. However, the most important challenge identified for improving photo-electro-autotrophic growth is increasing the proton-pumping rate of the rhodopsin photosystems, allowing for higher ATP regeneration. Alternatively, other designs of autotrophy may be considered, therefore the herein presented integrated modeling approach allows synthetic biologists to evaluate and compare complex pathway designs before experimental implementation.	[Volpers, Michael; dos Santos, Vitor A. P. Martins] Wageningen Univ, Lab Syst & Synthet Biol, Dreijenpl 10, NL-6703 HB Wageningen, Netherlands; [Volpers, Michael; dos Santos, Vitor A. P. Martins] LifeGlimmer GmbH, Markelstr 39a, D-12136 Berlin, Germany; [Claassens, Nico J.; van der Oost, John; de Vos, Willem M.; Kengen, Serve W. M.] Wageningen Univ, Microbiol Lab, Dreijenpl 10, NL-6703 HB Wageningen, Netherlands; [Noor, Elad] ETH, Inst Mol Syst Biol, Auguste Piccard Hof 1, CH-8093 Zurich, Switzerland; [de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, Haartmaninkatu 3, Helsinki 00014, Finland	Wageningen University & Research; Wageningen University & Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Helsinki	dos Santos, VAPM (corresponding author), Wageningen Univ, Lab Syst & Synthet Biol, Dreijenpl 10, NL-6703 HB Wageningen, Netherlands.; dos Santos, VAPM (corresponding author), LifeGlimmer GmbH, Markelstr 39a, D-12136 Berlin, Germany.	vitor.martinsdossantos@wur.nl	van+der+Oost, John/Y-2548-2019; Noor, Elad/AAN-9042-2020	Noor, Elad/0000-0001-8776-4799; Kengen, Serve/0000-0001-6139-8946; martins dos santos, vitor/0000-0002-2352-9017	LifeGlimmer GmbH; Wageningen University by the IP/OP program Systems Biology [KB-17003.02-024]; European Molecular Biology Organisation Long-Term Fellowship [ALTF 510-2014]; Netherlands Organization for Scientific Research through a Spinoza grant	LifeGlimmer GmbH; Wageningen University by the IP/OP program Systems Biology; European Molecular Biology Organisation Long-Term Fellowship; Netherlands Organization for Scientific Research through a Spinoza grant	LifeGlimmer GmbH provided support in the form of salaries for authors MV and VAPMdS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. N.J.C is supported by Wageningen University by the IP/OP program Systems Biology (KB-17003.02-024), www.wageningenur.nl. E.N. is funded by an European Molecular Biology Organisation Long-Term Fellowship (ALTF 510-2014), www.embo.org. W.M.d. V. acknowledges financial support by the Netherlands Organization for Scientific Research through a Spinoza grant, www.nwo.nl. None of these funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ECOSAL ESCHERICHIA C; Azai C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082345; Balashov SP, 2010, BIOCHEMISTRY-US, V49, P9792, DOI 10.1021/bi1014166; Bar-Even A, 2013, BBA-BIOENERGETICS, V1827, P1039, DOI 10.1016/j.bbabio.2012.10.013; Bar-Even A, 2012, BBA-BIOENERGETICS, V1817, P1646, DOI 10.1016/j.bbabio.2012.05.002; Bar-Even A, 2012, J EXP BOT, V63, P2325, DOI 10.1093/jxb/err417; Bar-Even A, 2010, P NATL ACAD SCI USA, V107, P8889, DOI 10.1073/pnas.0907176107; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berg IA, 2011, APPL ENVIRON MICROB, V77, P1925, DOI 10.1128/AEM.02473-10; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Bernsel A, 2009, TRENDS MICROBIOL, V17, P444, DOI 10.1016/j.tim.2009.07.005; Bonacci W, 2012, P NATL ACAD SCI USA, V109, P478, DOI 10.1073/pnas.1108557109; Boyle NR, 2011, METAB ENG, V13, P150, DOI 10.1016/j.ymben.2011.01.005; Boyle PM, 2012, METAB ENG, V14, P223, DOI 10.1016/j.ymben.2011.10.003; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Ceroni F, 2015, NAT METHODS, V12, P415, DOI [10.1038/NMETH.3339, 10.1038/nmeth.3339]; Chen Q, 2016, METAB ENG, V35, P83, DOI 10.1016/j.ymben.2016.02.001; Claassens NJ, 2013, TRENDS BIOTECHNOL, V31, P633, DOI 10.1016/j.tibtech.2013.08.006; Davidi D, 2016, P NATL ACAD SCI USA, V113, P3401, DOI 10.1073/pnas.1514240113; Ducat DC, 2012, CURR OPIN CHEM BIOL, V16, P337, DOI 10.1016/j.cbpa.2012.05.002; Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74; Engqvist MKM, 2015, J MOL BIOL, V427, P205, DOI 10.1016/j.jmb.2014.06.015; Estelmann S, 2011, J BACTERIOL, V193, P1191, DOI 10.1128/JB.01155-10; Fast AG, 2012, CURR OPIN CHEM ENG, V1, P380, DOI 10.1016/j.coche.2012.07.005; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003575; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; Ganapathy S, 2015, BIOCHEM J, V467, P333, DOI 10.1042/BJ20141210; Gerosa L, 2015, CELL SYST, V1, P270, DOI 10.1016/j.cels.2015.09.008; Goldbeck CP, 2013, ACS SYNTH BIOL, V2, P150, DOI 10.1021/sb300119v; Gong FY, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0268-1; Guadalupe-Medina V, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-125; Hawkins AS, 2013, CURR OPIN BIOTECH, V24, P376, DOI 10.1016/j.copbio.2013.02.017; Huber H, 2008, P NATL ACAD SCI USA, V105, P7851, DOI 10.1073/pnas.0801043105; Imam S, 2015, PHOTOSYNTH RES, V123, P167, DOI 10.1007/s11120-014-0061-1; IVANOVSKY RN, 1993, ARCH MICROBIOL, V159, P257, DOI 10.1007/BF00248481; Jaschke PR, 2011, METHOD ENZYMOL, DOI [10.1016/B978-0-12-385075-100023-8, DOI 10.1016/B978-0-12-385075-100023-8]; Jensen HM, 2010, P NATL ACAD SCI USA, V107, P19213, DOI 10.1073/pnas.1009645107; Keller MW, 2013, P NATL ACAD SCI USA, V110, P5840, DOI 10.1073/pnas.1222607110; Kirchman DL, 2013, ENV MICROBIOL REP, V5, P188, DOI 10.1111/j.1758-2229.2012.00367.x; Konneke M, 2014, P NATL ACAD SCI USA, V111, P8239, DOI 10.1073/pnas.1402028111; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Liebermeister W, 2014, P NATL ACAD SCI USA, V111, P8488, DOI 10.1073/pnas.1314810111; LIU CL, 1984, J BACTERIOL, V159, P375, DOI 10.1128/JB.159.1.375-380.1984; Lovley DR, 2013, CURR OPIN BIOTECH, V24, P385, DOI 10.1016/j.copbio.2013.02.012; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Mainguet SE, 2013, METAB ENG, V19, P116, DOI 10.1016/j.ymben.2013.06.004; Mattozzi MD, 2013, METAB ENG, V16, P130, DOI 10.1016/j.ymben.2013.01.005; Muller JEN, 2015, METAB ENG, V28, P190, DOI 10.1016/j.ymben.2014.12.008; Noor E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003483; Noor E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003098; Noor E, 2012, BIOINFORMATICS, V28, P2037, DOI 10.1093/bioinformatics/bts317; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pandit AV, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-76; Pinchuk GE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000822; Rabaey K, 2011, CURR OPIN BIOTECH, V22, P371, DOI 10.1016/j.copbio.2011.01.010; Rabaey K, 2010, NAT REV MICROBIOL, V8, P706, DOI 10.1038/nrmicro2422; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Schiel-Bengelsdorf B, 2012, FEBS LETT, V586, P2191, DOI 10.1016/j.febslet.2012.04.043; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Schuchmann K, 2014, NAT REV MICROBIOL, V12, P809, DOI 10.1038/nrmicro3365; Shastri AA, 2005, BIOTECHNOL PROGR, V21, P1617, DOI 10.1021/bp050246d; Siegel JB, 2015, P NATL ACAD SCI USA, V112, P3704, DOI 10.1073/pnas.1500545112; Stone KM, 2013, BIOPHYS J, V104, P472, DOI 10.1016/j.bpj.2012.11.3831; Tikh I, 2013, SYNTHETIC BIOLOGY: TOOLS AND APPLICATIONS, P303, DOI 10.1016/B978-0-12-394430-6.00016-9; Tikh IB, 2014, APPL MICROBIOL BIOT, V98, P3111, DOI 10.1007/s00253-014-5527-8; Tishkov VI, 2006, BIOMOL ENG, V23, P89, DOI 10.1016/j.bioeng.2006.02.003; Wang SN, 2013, APPL ENVIRON MICROB, V79, P6176, DOI 10.1128/AEM.02015-13; Wang Y, 2015, BIOTECHNOL BIOENG, V112, P947, DOI 10.1002/bit.25504; Wegener KM, 2010, MOL CELL PROTEOMICS, V9, DOI 10.1074/mcp.M110.000109	71	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157851	10.1371/journal.pone.0157851	http://dx.doi.org/10.1371/journal.pone.0157851			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336167	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200057
J	Kaur, S; Harjai, K; Chhibber, S				Kaur, Sandeep; Harjai, Kusum; Chhibber, Sanjay			In Vivo Assessment of Phage and Linezolid Based Implant Coatings for Treatment of Methicillin Resistant S. aureus (MRSA) Mediated Orthopaedic Device Related Infections	PLOS ONE			English	Article							PROSTHETIC JOINT INFECTION; BURN WOUND-INFECTION; MOUSE THIGH MODEL; STAPHYLOCOCCUS-AUREUS; RHEUMATOID-ARTHRITIS; BACTERIAL-INFECTIONS; ANTIMICROBIAL PROPERTIES; KNEE ARTHROPLASTY; ELUTION KINETICS; HIP-REPLACEMENT	Staphylococcus comprises up to two-thirds of all pathogens in orthopaedic implant infections with two species respectively Staphylococcus aureus and Staphylococcus epidermidis, being the predominate etiological agents isolated. Further, with the emergence of methicillin-resistant S. aureus (MRSA), treatment of S. aureus implant infections has become more difficult, thus representing a devastating complication. Use of local delivery system consisting of S. aureus specific phage along with linezolid (incorporated in biopolymer) allowing gradual release of the two agents at the implant site represents a new, still unexplored treatment option (against orthopaedic implant infections) that has been studied in an animal model of prosthetic joint infection. Naked wire, hydroxypropyl methylcellulose (HPMC) coated wire and phage and/or linezolid coated K-wire were surgically implanted into the intra-medullary canal of mouse femur bone of respective groups followed by inoculation of S. aureus ATCC 43300(MRSA). Mice implanted with K-wire coated with both the agents i.e phage as well as linezolid (dual coated wires) showed maximum reduction in bacterial adherence, associated inflammation of the joint as well as faster resumption of locomotion and motor function of the limb. Also, all the coating treatments showed no emergence of resistant mutants. Use of dual coated implants incorporating lytic phage (capable of self-multiplication) as well as linezolid presents an attractive and aggressive early approach in preventing as well as treating implant associated infections caused by methicillin resistant S. aureus strains as assessed in a murine model of experimental joint infection.	[Kaur, Sandeep; Harjai, Kusum; Chhibber, Sanjay] Panjab Univ, Dept Microbiol, Chandigarh 160014, India	Panjab University	Chhibber, S (corresponding author), Panjab Univ, Dept Microbiol, Chandigarh 160014, India.	sanjaychhibber8@gmail.com	Kaur, Sandeep/T-1863-2019	Kaur, Sandeep/0000-0003-3146-1611	Council of Scientific and Industrial Research, New Delhi, India [09/135/(0632)/2011/EMR-I]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by 09/135/(0632)/2011/EMR-I, Council of Scientific and Industrial Research, New Delhi, India, SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson SB, 2002, RHEUMATOLOGY, V41, P972, DOI 10.1093/rheumatology/41.9.972; Alt V, 2006, BIOMATERIALS, V27, P4627, DOI 10.1016/j.biomaterials.2006.04.035; Amemori T, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0255-2; Ament PW, 2002, AM FAM PHYSICIAN, V65, P663; Anagnostakos K, 2008, J BIOMED MATER RES B, V87B, P173, DOI 10.1002/jbm.b.31088; Antoci V, 2007, CLIN ORTHOP RELAT R, P200, DOI 10.1097/BLO.0b013e31811ff866; Aviv M, 2007, J BIOMED MATER RES A, V83A, P10, DOI 10.1002/jbm.a.31184; Barman Tarani Kanta, 2011, Indian J Med Res, V134, P688, DOI 10.4103/0971-5916.90997; Bernthal NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012580; Boylan CJ, 2003, ANTIMICROB AGENTS CH, V47, P1700, DOI 10.1128/AAC.47.5.1700-1706.2003; BRANS TA, 1994, BURNS, V20, pS48, DOI 10.1016/0305-4179(94)90090-6; Calum H, 2009, CLIN EXP IMMUNOL, V156, P102, DOI 10.1111/j.1365-2249.2008.03861.x; Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044; Camussi G, 1998, DRUGS, V55, P613, DOI 10.2165/00003495-199855050-00001; Capparelli R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028377; Carmody LA, 2010, J INFECT DIS, V201, P264, DOI 10.1086/649227; Charnley J, 1970, ACRYLIC CEMENT ORTHO, P118; Chhibber S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056022; Choudhary M, 2014, BIOMED RES INT, V15; Comeau AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000799; Dai TH, 2011, VIRULENCE, V2, P296, DOI 10.4161/viru.2.4.16840; Darouiche RO, 2007, J BONE JOINT SURG AM, V89A, P792, DOI 10.2106/JBJS.F.00414; Davis IJ, 2005, ORAL MICROBIOL IMMUN, V20, P191, DOI 10.1111/j.1399-302X.2005.00218.x; Deacon RMJ, 2013, JOVE, V75, P2609; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Drago L, 2014, CLIN ORTHOP RELAT R, V472, P3311, DOI 10.1007/s11999-014-3558-1; Dryden MS, 2011, J ANTIMICROB CHEMOTH, V66, pIV7, DOI 10.1093/jac/dkr072; Duckworth DH, 2002, BIODRUGS, V16, P57, DOI 10.2165/00063030-200216010-00006; Edin ML, 1996, CLIN ORTHOP RELAT R, P245; FERRANTE A, 1993, J IMMUNOL, V151, P4821; Frommholz D, 2012, RHEUMATOL INT, V32, P3999, DOI 10.1007/s00296-011-2337-5; Fujimura S, 2009, J ORTHOP SCI, V14, P658, DOI 10.1007/s00776-009-1366-3; Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105; Grossman TH, 2015, ANTIMICROB AGENTS CH, V59, P2567, DOI 10.1128/AAC.04354-14; Hagens S, 2006, MICROB DRUG RESIST, V12, P164, DOI 10.1089/mdr.2006.12.164; Hanssen AD, 1998, J BONE JOINT SURG AM, V80A, P910, DOI 10.2106/00004623-199806000-00016; Hartog A, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-59; Hayes G, 2013, VET COMP ORTHOPAED, V26, P251, DOI 10.3415/VCOT-12-05-0065; Hendriks JGE, 2005, J BONE JOINT SURG BR, V87B, P272, DOI 10.1302/0301-620X.87B2.14781; Heron DF, 1941, AM J SURG, V3, P18; Hess A, 2011, P NATL ACAD SCI USA, V108, P3731, DOI 10.1073/pnas.1011774108; Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015; Holtfreter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071142; Isefuku S, 2001, J ORTHOP RES, V19, P950, DOI 10.1016/S0736-0266(01)00022-5; Jackson J, 2011, DRUG DELIV TRANSL RE, V1, P121, DOI 10.1007/s13346-011-0015-5; Jacques C, 2006, VITAM HORM, V74, P371, DOI 10.1016/S0083-6729(06)74016-X; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Kalff KM, 2010, EUR J PHARMACOL, V641, P108, DOI 10.1016/j.ejphar.2010.05.022; Kalore Niraj V, 2011, Open Orthop J, V5, P86, DOI 10.2174/1874325001105010086; Kaur S, 2010, APPL ENVIRON MICROB, V78, P8227; Kaur S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090411; Kendall RW, 1996, CLIN ORTHOP RELAT R, P273; Khan AI, 2010, LAB MED, V41, P173; Kluin OS, 2013, EXPERT OPIN DRUG DEL, V10, P341, DOI 10.1517/17425247.2013.751371; Knezevic P, 2013, RES MICROBIOL, V164, P55, DOI 10.1016/j.resmic.2012.08.008; Kumari S, 2010, J MICROBIOL BIOTECHN, V20, P935, DOI 10.4014/jmb.0909.09010; Kutscha-Lissberg F, 2003, ANTIMICROB AGENTS CH, V47, P3964, DOI 10.1128/AAC.47.12.3964-3966.2003; Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554; Letkiewicz S, 2010, FEMS IMMUNOL MED MIC, V60, P99, DOI 10.1111/j.1574-695X.2010.00723.x; Liu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057483; Loc-Carrillo Catherine, 2011, Bacteriophage, V1, P111; Los JM, 2008, APPL ENVIRON MICROB, V74, P5113, DOI 10.1128/AEM.00306-08; Louie A, 2011, ANTIMICROB AGENTS CH, V55, P3453, DOI 10.1128/AAC.01565-10; Lovering AM, 2002, J ANTIMICROB CHEMOTH, V50, P73, DOI 10.1093/jac/dkf066; Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4; Lucke M, 2005, BONE, V36, P770, DOI 10.1016/j.bone.2005.01.008; Matsumoto Kazuaki, 2015, J Infect Chemother, V21, P889, DOI 10.1016/j.jiac.2015.08.004; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Moran E, 2007, J INFECTION, V55, P1, DOI 10.1016/j.jinf.2007.01.007; Moran E, 2010, J ANTIMICROB CHEMOTH, V65, piii45, DOI 10.1093/jac/dkq305; Mulcahy ME, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003092; Nijsten MWN, 2000, CRIT CARE MED, V28, P458, DOI 10.1097/00003246-200002000-00028; Niska JA, 2013, ANTIMICROB AGENTS CH, V57, P5080, DOI 10.1128/AAC.00702-13; OLITZKI L, 1948, BACTERIOL REV, V12, P149, DOI 10.1128/MMBR.12.2.149-172.1948; Pabary R, 2015, ANTIMICROB AGENTS CH; Patel A, 2008, J BONE JOINT SURG BR, V90B, P1401, DOI 10.1302/0301-620X.90B11.20771; Patted SM, 2013, BIOMED RES-INDIA, V24, P33; Portanova JP, 1996, J EXP MED, V184, P883, DOI 10.1084/jem.184.3.883; Prabhakara R, 2013, INFECT IMMUN, V81, P1306, DOI 10.1128/IAI.01304-12; Rajasekaran Narendiran, 2014, Open J Rheumatol Autoimmune Dis, V4, P62; Rana B, 2002, J ANTIMICROB CHEMOTH, V50, P747, DOI 10.1093/jac/dkf207; Raschke MJ, 2004, UNFALLCHIRURG, V107, P653, DOI 10.1007/s00113-004-0828-5; Rathbone CR, 2011, J ORTHOP RES, V29, P1070, DOI 10.1002/jor.21343; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rich J, 2005, DIABETES, V54, P2904, DOI 10.2337/diabetes.54.10.2904; Rosslenbroich SB, 2012, SCI WORLD J, DOI 10.1100/2012/578251; Ruan MZC, 2013, OSTEOARTHR CARTILAGE, V21, P1355, DOI 10.1016/j.joca.2013.06.016; Ryan EM, 2012, FEMS IMMUNOL MED MIC, V65, P395, DOI 10.1111/j.1574-695X.2012.00977.x; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; Sachdeva AK, 2011, BRAIN RES BULL, V86, P165, DOI 10.1016/j.brainresbull.2011.06.007; Santos SB, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-148; Sasakawa T, 2005, INT IMMUNOPHARMACOL, V5, P1291, DOI 10.1016/j.intimp.2005.03.014; Schroeder K, 2012, J ORTHOP RES, V30, P190, DOI 10.1002/jor.21516; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Snir N, 2013, ORTHOPEDICS, V36, pE1412, DOI 10.3928/01477447-20131021-24; Stefansdottir A, 2009, SCAND J INFECT DIS, V41, P831, DOI 10.3109/00365540903186207; Sugarman B, 1989, Infect Dis Clin North Am, V3, P187; Sulakvelidze A, 2001, ANN MED, V33, P507, DOI 10.3109/07853890108995959; Tan HL, 2012, INT J ARTIF ORGANS, V35, P832, DOI 10.5301/ijao.5000163; Tande AJ, 2014, CLIN MICROBIOL REV, V27, P302, DOI 10.1128/CMR.00111-13; Tanimoto A, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0802-0; Teterycz D, 2010, INT J INFECT DIS, V14, pE913, DOI 10.1016/j.ijid.2010.05.014; Tian Z, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0151-9; Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8; Vermeirsch H, 2007, PHARMACOL BIOCHEM BE, V87, P349, DOI 10.1016/j.pbb.2007.05.010; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; Walls RJ, 2008, J BONE JOINT SURG BR, V90B, P292, DOI 10.1302/0301-620X.90B3.20155; WAN AT, 1991, CLIN CHEM, V37, P1683; Wang J, 2014, ANTIMICROB AGENTS CH, V58, P3008, DOI 10.1128/AAC.01666-13; Whicher J, 2001, ANN CLIN BIOCHEM, V38, P483, DOI 10.1258/0004563011901299; Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863; Wikler M.A., 2012, CLIN LAB STANDARDS I, V26, pM07; Yoshizawa S, 2012, ANTIMICROB AGENTS CH, V56, P1744, DOI 10.1128/AAC.05430-11; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55	115	63	65	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157626	10.1371/journal.pone.0157626	http://dx.doi.org/10.1371/journal.pone.0157626			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333300	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212800039
J	Zeitz, J; Ak, M; Muller-Mottet, S; Scharl, S; Biedermann, L; Fournier, N; Frei, P; Pittet, V; Scharl, M; Fried, M; Rogler, G; Vavricka, S				Zeitz, Jonas; Ak, Melike; Muller-Mottet, Severine; Scharl, Sylvie; Biedermann, Luc; Fournier, Nicolas; Frei, Pascal; Pittet, Valerie; Scharl, Michael; Fried, Michael; Rogler, Gerhard; Vavricka, Stephan		Swiss IBD Cohort Study Grp	Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; QUALITY-OF-LIFE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; EXTRAINTESTINAL MANIFESTATIONS; CROHNS-DISEASE; ULCERATIVE-COLITIS; HLA ASSOCIATION; COHORT; PREVALENCE; PREDICTORS	Background Pain is a common symptom related to inflammatory bowel disease (IBD). In addition to abdominal pain, pain can also be an extraintestinal manifestation of IBD. Pain treatment is challenging and a substantial part of IBD patients are treated with opioids. Therefore, a better knowledge on pain symptoms is crucial for a better therapeutic approach to this clinical problem. Methods Patients of the Swiss IBD Cohort Study (SIBDCS) (n = 2152) received a questionnaire regarding pain intensity, pain localization and impact of pain on daily life and social activities. Furthermore, the questionnaire investigated the use of pain-specific medication. Results A vast majority of patients (71%) experienced pain during the disease course. For a substantial part of patients (49% in UC and 55% in CD) pain is a longstanding problem (>5 years). Pain in UC was of shorter duration compared to CD (p < 0.01). Abdominal pain (59.5%) and back pain (38.3%) were the main pain localizations. 67% of patients took pain medication; 24% received no pain treatment. The general quality of life was significantly lower in patients suffering of pain compared to those without pain (38 vs. 77; (-100 very bad; 100 very good) p<0.0001). Conclusions Prevalence of pain is high in patients of the SIBDCS. It is a longstanding problem for the majority of the patients affected. Pain was found to be undertreated in the SIBDCS and was significantly associated with health-related quality of life. Thus, an increased awareness is mandatory to address this frequent complication in the course of IBD.	[Zeitz, Jonas; Ak, Melike; Scharl, Sylvie; Biedermann, Luc; Scharl, Michael; Fried, Michael; Rogler, Gerhard; Vavricka, Stephan] Univ Zurich, Univ Zurich Hosp, Div Gastroenterol & Hepatol, Zurich, Switzerland; [Muller-Mottet, Severine] Zurcher Rehabil Ctr Wald, Div Pulmonol, Wald, Switzerland; [Fournier, Nicolas; Pittet, Valerie] Univ Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland; [Frei, Pascal] Gastroenterol Bethanien, Zurich, Switzerland; [Scharl, Michael; Rogler, Gerhard] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Vavricka, Stephan] Triemli Spital, Div Gastroenterol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Lausanne; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Triemli Hospital	Zeitz, J (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Gastroenterol & Hepatol, Zurich, Switzerland.	jonas.zeitz@usz.ch	Rogler, Gerhard/O-5308-2015; Biedermann, Luc/J-2654-2017	Rogler, Gerhard/0000-0002-1733-9188; Scharl, Michael/0000-0002-6729-1469; Pittet, Valerie/0000-0003-2208-966X	Swiss National Science Foundation [3347CO-108792]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by a research grant from the Swiss National Science Foundation to GR for the Swiss IBD Cohort (Grant No. 3347CO-108792; www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghazadeh R, 2005, J GASTROEN HEPATOL, V20, P1691, DOI 10.1111/j.1440-1746.2005.03905.x; Ananthakrishnan AN, 2012, ANN INTERN MED, V156, P350, DOI 10.7326/0003-4819-156-5-201203060-00007; Bernstein CN, 2001, AM J GASTROENTEROL, V96, P1116; Bielefeldt K, 2002, GASTROENTEROLOGY, V122, P394, DOI 10.1053/gast.2002.31026; Bielefeldt K, 2009, INFLAMM BOWEL DIS, V15, P778, DOI 10.1002/ibd.20848; BJARNASON I, 1993, GASTROENTEROLOGY, V104, P1832, DOI 10.1016/0016-5085(93)90667-2; Blondel-Kucharski F, 2001, AM J GASTROENTEROL, V96, P2915; Brynskov J, 1999, EUR J GASTROEN HEPAT, V11, P997, DOI 10.1097/00042737-199909000-00008; Casellas F, 2001, EUR J GASTROEN HEPAT, V13, P567, DOI 10.1097/00042737-200105000-00017; D'Inca R, 2009, DIGEST LIVER DIS, V41, P565, DOI 10.1016/j.dld.2009.01.013; de Vlam K, 2000, J RHEUMATOL, V27, P2860; Lanna CCD, 2008, CLIN RHEUMATOL, V27, P503, DOI 10.1007/s10067-007-0797-5; Fujimura T, 2009, INT J UROL, V16, P522, DOI 10.1111/j.1442-2042.2009.02291.x; Hazratjee N, 2013, AM J GASTROENTEROL, V108, P1024, DOI 10.1038/ajg.2012.343; Heikenen JB, 1999, INFLAMM BOWEL DIS, V5, P158, DOI 10.1097/00054725-199908000-00002; Hussain KB, 2001, AM J GASTROENTEROL, V96, P2737, DOI 10.1111/j.1572-0241.2001.04133.x; Irvine EJ, 1996, SCAND J GASTROENTERO, V31, P26, DOI 10.3109/00365529609095550; Jakobsson U, 2002, J CLIN NURS, V11, P430, DOI 10.1046/j.1365-2702.2002.00624.x; KAUFMANN HJ, 1987, ANN INTERN MED, V107, P513, DOI 10.7326/0003-4819-107-4-513; Kefalakes H, 2009, EUR J CLIN PHARMACOL, V65, P963, DOI 10.1007/s00228-009-0719-3; Kukreja M, 2015, SEMIN THORAC CARDIOV, V27, P299, DOI 10.1053/j.semtcvs.2015.08.007; Lakatos L, 2003, WORLD J GASTROENTERO, V9, P2300; Long MD, 2016, J CLIN GASTROENTEROL, V50, P152, DOI 10.1097/MCG.0000000000000421; Luo JH, 2015, J AM GERIATR SOC, V63, P2349, DOI 10.1111/jgs.13796; Miner PB, 1997, AM J GASTROENTEROL, V92, pS1; Nagel B, 2002, SCHMERZ, V16, P263, DOI 10.1007/s00482-002-0162-1; Naliboff BD, 2012, AM J GASTROENTEROL, V107, P451, DOI 10.1038/ajg.2011.377; Orchard TR, 1998, GUT, V42, P387, DOI 10.1136/gut.42.3.387; Padua L, 2009, MUSCLE NERVE, V40, P200, DOI 10.1002/mus.21308; Palm O, 2005, J RHEUMATOL, V32, P1755; Pittet V, 2009, INT J EPIDEMIOL, V38, P922, DOI 10.1093/ije/dyn180; Rath HC, 1998, MED KLIN, V93, P395, DOI 10.1007/BF03042635; Ryan JL, 2013, INFLAMM BOWEL DIS, V19, P2666, DOI 10.1097/MIB.0b013e3182a82b15; Salvarani C, 2001, SCAND J GASTROENTERO, V36, P1307; Schirbel A, 2010, WORLD J GASTROENTERO, V16, P3168, DOI 10.3748/wjg.v16.i25.3168; Siebert U, 2013, INFLAMM BOWEL DIS, V19, P847, DOI 10.1097/MIB.0b013e31827f278e; Siegel CA, 2009, INFLAMM BOWEL DIS, V15, P769, DOI 10.1002/ibd.20844; Srinath A, 2014, INFLAMM BOWEL DIS, V20, P2433, DOI 10.1097/MIB.0000000000000170; Sveaas SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108688; Takeuchi K, 2006, CLIN GASTROENTEROL H, V4, P196, DOI 10.1016/S1542-3565(05)00980-8; Turkcapar N, 2006, RHEUMATOL INT, V26, P663, DOI 10.1007/s00296-005-0044-9; van der Have M, 2015, J CROHNS COLITIS, V9, P276, DOI 10.1093/ecco-jcc/jju025; van Erp SJ, 2016, J CROHNS COLITIS, V10, P166, DOI 10.1093/ecco-jcc/jjv195; Vavricka SR, 2015, INFLAMM BOWEL DIS, V21, P1982, DOI 10.1097/MIB.0000000000000392; Vavricka SR, 2015, INFLAMM BOWEL DIS, V21, P1794, DOI 10.1097/MIB.0000000000000429; Vavricka SR, 2011, AM J GASTROENTEROL, V106, P110, DOI 10.1038/ajg.2010.343; Veloso FT, 1996, J CLIN GASTROENTEROL, V23, P29, DOI 10.1097/00004836-199607000-00009; Wagtmans MJ, 1998, J CLIN GASTROENTEROL, V27, P129, DOI 10.1097/00004836-199809000-00005; Zippi M, 2014, WORLD J GASTROENTERO, V20, P17463, DOI 10.3748/wjg.v20.i46.17463	49	72	73	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0156666	10.1371/journal.pone.0156666	http://dx.doi.org/10.1371/journal.pone.0156666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332879	Green Published, Green Accepted, gold			2022-12-26	WOS:000378212800013
J	Ren, W; Huang, SY; Ren, Y; Choo, KKR				Ren, Wei; Huang, Shiyong; Ren, Yi; Choo, Kim-Kwang Raymond			LiPISC: A Lightweight and Flexible Method for Privacy-Aware Intersection Set Computation	PLOS ONE			English	Article								Privacy-aware intersection set computation (PISC) can be modeled as secure multi-party computation. The basic idea is to compute the intersection of input sets without leaking privacy. Furthermore, PISC should be sufficiently flexible to recommend approximate intersection items. In this paper, we reveal two previously unpublished attacks against PISC, which can be used to reveal and link one input set to another input set, resulting in privacy leakage. We coin these as Set Linkage Attack and Set Reveal Attack. We then present a lightweight and flexible PISC scheme (LiPISC) and prove its security (including against Set Linkage Attack and Set Reveal Attack).	[Ren, Wei; Huang, Shiyong; Choo, Kim-Kwang Raymond] China Univ Geosci, Sch Comp Sci, Wuhan 430074, Hubei, Peoples R China; [Ren, Wei] China Univ Geosci, Hubei Key Lab Intelligent Geoinformat Proc, Wuhan 430074, Hubei, Peoples R China; [Ren, Yi] Natl Chiao Tung Univ, Dept Comp Sci, Hsinchu, Taiwan; [Choo, Kim-Kwang Raymond] Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia	China University of Geosciences; China University of Geosciences; National Yang Ming Chiao Tung University; University of South Australia	Ren, W (corresponding author), China Univ Geosci, Sch Comp Sci, Wuhan 430074, Hubei, Peoples R China.; Ren, W (corresponding author), China Univ Geosci, Hubei Key Lab Intelligent Geoinformat Proc, Wuhan 430074, Hubei, Peoples R China.	weirencs@cug.edu.cn	Choo, Kim-Kwang Raymond/A-3634-2009; Ren, Wei/P-1369-2018	Choo, Kim-Kwang Raymond/0000-0001-9208-5336; Ren, Wei/0000-0001-8590-1737	National Science Foundation China [61170217]	National Science Foundation China(National Natural Science Foundation of China (NSFC))	This work was supported by National Science Foundation China, No. 61170217 (http://npd.nsfc.gov.cn) (WR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcora CG, 2012, PROC INT CONF DATA, P9, DOI 10.1109/ICDE.2012.99; Bunea R, 2012, INT CONF DAT MIN WOR, P539, DOI 10.1109/ICDMW.2012.112; Choo K K R, 2009, ADV INFORM SECURITY, V41, DOI [10.1007/978-0-387-87969-7, DOI 10.1007/978-0-387-87969-7]; Choo KKR, 2007, COMPUT J, V50, P591, DOI 10.1093/comjnl/bxm019; Choo KKR, 2005, LECT NOTES COMPUT SC, V3788, P585; Guanciale R, 2014, ANN CONF PRIV SECUR, P112, DOI 10.1109/PST.2014.6890930; He M, 2014, IBM J RES DEV, V58, DOI 10.1147/JRD.2014.2338091; Celdran AH, 2014, IEEE COMMUN MAG, V52, P90, DOI 10.1109/MCOM.2014.6871675; Jie W, 2007, PARALLEL COMPUT, V33, P572, DOI 10.1016/j.parco.2007.05.001; Li N, 2014, IEEE ICC, P945, DOI 10.1109/ICC.2014.6883441; Liu F, 2014, INT CONF CLOUD ENG, P135, DOI 10.1109/IC2E.2014.18; Patsakis Constantinos, 2013, INF INT SYST APPL II, P1; Pentafronimos G., 2011, 2011 IEEE Symposium on Computers and Communications (ISCC 2011), P876, DOI 10.1109/ISCC.2011.5983952; Perera C, 2015, IEEE CLOUD COMPUT, V2, P44, DOI 10.1109/MCC.2015.78; Perera C, 2015, IT PROF, V17, P32, DOI 10.1109/MITP.2015.34; Shoaran Maryam, 2013, 2013 IEEE International Conference on Big Data, P597, DOI 10.1109/BigData.2013.6691628; Tang XY, 2013, IEEE T KNOWL DATA EN, V25, P2895, DOI 10.1109/TKDE.2012.229; Thapa A, 2015, IEEE T PARALL DISTR, V26, P1547, DOI 10.1109/TPDS.2014.2329016; Vidyalakshmi BS, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON SERVICES COMPUTING (SCC 2014), P456, DOI 10.1109/SCC.2014.67; Wang TT, 2014, 2014 INTERNATIONAL CONFERENCE ON CLOUD COMPUTING AND INTERNET OF THINGS (CCIOT), P26, DOI 10.1109/CCIOT.2014.7062500; Wicker SB, 2011, P IEEE, V99, P330, DOI 10.1109/JPROC.2010.2073670; Zhao DD, 2013, 2013 IEEE 11TH INTERNATIONAL CONFERENCE ON DEPENDABLE, AUTONOMIC AND SECURE COMPUTING (DASC), P58, DOI 10.1109/DASC.2013.38; Zhao JQ, 2014, J COMPUT SYST SCI, V80, P994, DOI 10.1016/j.jcss.2014.02.006; Zhiyi Shao, 2013, 2013 5th International Conference on Intelligent Networking and Collaborative Systems, P323, DOI 10.1109/INCoS.2013.60	24	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157752	10.1371/journal.pone.0157752	http://dx.doi.org/10.1371/journal.pone.0157752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27326763	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400037
J	Chenji, S; Jha, S; Lee, D; Brown, M; Seres, P; Mah, D; Kalra, S				Chenji, Sneha; Jha, Shankar; Lee, Dawon; Brown, Matthew; Seres, Peter; Mah, Dennell; Kalra, Sanjay			Investigating Default Mode and Sensorimotor Network Connectivity in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							RESTING-STATE NETWORKS; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; MOTOR CORTEX; FMRI DATA; ALSFRS-R; STIMULATION; IMPAIRMENT; DIAGNOSIS; SCALE	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative condition characterized by degeneration of upper motor neurons (UMN) arising from the motor cortex in the brain and lower motor neurons (LMN) in the brainstem and spinal cord. Cerebral changes create differences in brain activity captured by functional magnetic resonance imaging (fMRI), including the spontaneous and simultaneous activity occurring between regions known as the resting state networks (RSNs). Progressive neurodegeneration as observed in ALS may lead to a disruption of RSNs which could provide insights into the disease process. Previous studies have reported conflicting findings of increased, decreased, or unaltered RSN functional connectivity in ALS and do not report the contribution of UMN changes to RSN connectivity. We aimed to bridge this gap by exploring two networks, the default mode network (DMN) and the sensorimotor network (SMN), in 21 ALS patients and 40 age-matched healthy volunteers. An UMN score dichotomized patients into UMN+ and UMN-groups. Subjects underwent resting state fMRI scan on a high field MRI operating at 4.7 tesla. The DMN and SMN changes between subject groups were compared. Correlations between connectivity and clinical measures such as the ALS Functional Rating Scale-Revised (ALSFRS-R), disease progression rate, symptom duration, UMN score and finger tapping were assessed. Significant group differences in resting state networks between patients and controls were absent, as was the dependence on degree of UMN burden. However, DMN connectivity was increased in patients with greater disability and faster progression rate, and SMN connectivity was reduced in those with greater motor impairment. These patterns of association are in line with literature supporting loss of inhibitory interneurons.	[Chenji, Sneha; Kalra, Sanjay] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada; [Brown, Matthew] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada; [Seres, Peter; Kalra, Sanjay] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Mah, Dennell; Kalra, Sanjay] Univ Alberta, Div Neurol, Edmonton, AB, Canada; [Jha, Shankar; Lee, Dawon] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Chenji, S (corresponding author), Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada.	chenji@ualberta.ca	Chenji, Sneha/AAK-2381-2020	Chenji, Sneha/0000-0002-0635-1528; Kalra, Sanjay/0000-0003-4762-8746	University of Alberta Hospital Foundation; ALS Society of Canada; Amyotrophic Lateral Sclerosis Association	University of Alberta Hospital Foundation(University of Alberta); ALS Society of Canada; Amyotrophic Lateral Sclerosis Association	The article includes data funded by grants received by SK from the University of Alberta Hospital Foundation, ALS Society of Canada and Amyotrophic Lateral Sclerosis Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2011, CEREB CORTEX, V21, P2291, DOI 10.1093/cercor/bhr002; Agosta F, 2013, NEUROBIOL AGING, V34, P419, DOI 10.1016/j.neurobiolaging.2012.04.015; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Alonso A, 2009, EUR J NEUROL, V16, P745, DOI 10.1111/j.1468-1331.2009.02586.x; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Beghi E, 2006, BBA-MOL BASIS DIS, V1762, P1150, DOI 10.1016/j.bbadis.2006.09.008; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Douaud G, 2011, BRAIN, V134, P3467, DOI 10.1093/brain/awr279; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fekete T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085190; Golestani AM, 2011, BRAIN CONNECT, V1, P159, DOI 10.1089/brain.2011.0003; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Han Jing, 2006, Chinese Medical Sciences Journal, V21, P228; Heimrath J, 2014, AMYOTROPH LAT SCL FR, V15, P537, DOI 10.3109/21678421.2014.911914; Kimura F, 2006, NEUROLOGY, V66, P265, DOI 10.1212/01.wnl.0000194316.91908.8a; Lloyd CM, 2000, BRAIN, V123, P2289, DOI 10.1093/brain/123.11.2289; Luo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045470; Ma XJ, 2015, NEUROL SCI, V36, P2097, DOI 10.1007/s10072-015-2319-6; Mohammadi B, 2009, EXP NEUROL, V217, P147, DOI 10.1016/j.expneurol.2009.01.025; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Polman CH, 2005, NEUROLOGY, V64, P996, DOI 10.1212/01.WNL.0000154522.86947.86; Schmidt R, 2014, HUM BRAIN MAPP, V35, P4386, DOI 10.1002/hbm.22481; Schoenfeld MA, 2005, J NEUROL, V252, P944, DOI 10.1007/s00415-005-0787-y; Tedeschi G, 2012, NEUROBIOL AGING, V33, P886, DOI 10.1016/j.neurobiolaging.2010.07.011; Trojsi F, 2015, NEUROBIOL AGING, V36, P413, DOI 10.1016/j.neurobiolaging.2014.06.025; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Verstraete E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013664; Vucic S, 2008, BRAIN, V131, P1540, DOI 10.1093/brain/awn071; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Woo JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105753; Yokota T, 1996, J NEUROL NEUROSUR PS, V61, P596, DOI 10.1136/jnnp.61.6.596; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhou FQ, 2014, NEUROSCI LETT, V558, P192, DOI 10.1016/j.neulet.2013.11.022; Ziemann U, 1997, NEUROLOGY, V49, P1292, DOI 10.1212/WNL.49.5.1292	41	56	59	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157443	10.1371/journal.pone.0157443	http://dx.doi.org/10.1371/journal.pone.0157443			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322194	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212000016
J	Alkhayal, KA; Awadalia, ZH; Vaali-Mohammed, MA; Al Obeed, OA; Al Wesaimer, A; Halwani, R; Zubaidi, AM; Khan, Z; Abdulla, MH				Alkhayal, Khayal A.; Awadalia, Zainab H.; Vaali-Mohammed, Mansoor-Ali; Al Obeed, Omar A.; Al Wesaimer, Alanoud; Halwani, Rabih; Zubaidi, Ahmed M.; Khan, Zahid; Abdulla, Maha-Hamadien			Association of Vitamin D Receptor Gene Polymorphisms with Colorectal Cancer in a Saudi Arabian Population	PLOS ONE			English	Article							COLON-CANCER; UNITED-STATES; BSMI POLYMORPHISM; DIETARY CALCIUM; PROSTATE-CANCER; OVARIAN-CANCER; D DEFICIENCY; RISK; MORTALITY; METAANALYSIS	Background Vitamin D, causally implicated in bone diseases and human malignancies, exerts its effects through binding to the vitamin D receptor (VDR). VDR is a transcription factor modulating the expression of several genes in different pathways. Genetic variants in the VDR gene have been associated with several cancers in different population including colorectal cancer. Objective To assess the association of VDR gene polymorphisms in relation with colorectal cancer (CRC) in a Saudi population. Methods The polymorphisms of VDR gene (BsmI, FokI, ApaI and TaqI) were analyzed by the polymerase chain reaction amplification of segments of interest followed by Sanger sequencing. One hundred diagnosed CRC patients and 100 healthy control subjects that were age and gender matched were recruited. Results We did not observe significant association of any of the four VDR polymorphisms with colorectal cancer risk in the overall analysis. Although not statistically significant, the AA genotype of BsmI conferred about two-fold protection against CRCs compared to the GG genotype. Stratification of the study subjects based on age and gender suggests statistically significant association of CRC with the 'C' allele of ApaI in patients >57 years of age at disease diagnosis and BsmI polymorphism in females. In addition, statistically significant differences were observed for the genotypic distributions of VDR-BsmI, ApaI and TaqI SNPs between Saudi Arabian population and several of the International HapMap project populations. Conclusion Despite the absence of correlation of the examined VDR polymorphisms with CRCs in the combined analysis, ApaI and BsmI loci are statistically significantly associated with CRC in elderly and female patients, respectively. These findings need further validation in larger cohorts prior to utilizing these SNPs as potential screening markers for colorectal cancers in Saudi population.	[Alkhayal, Khayal A.; Awadalia, Zainab H.; Vaali-Mohammed, Mansoor-Ali; Al Obeed, Omar A.; Zubaidi, Ahmed M.; Abdulla, Maha-Hamadien] King Saud Univ, Coll Med, King Khalid Univ Hosp, Colorectal Res Chair,Dept Surg, Riyadh 11461, Saudi Arabia; [Al Wesaimer, Alanoud] Prince Sultan Mil Med City, Dept Internal Med, Riyadh, Saudi Arabia; [Halwani, Rabih] King Saud Univ, Coll Med, Prince Naif Ctr Immunol Res, Riyadh 11461, Saudi Arabia; [Halwani, Rabih] King Saud Univ, Coll Med, Asthma Res Chair, Dept Pediat, Riyadh 11461, Saudi Arabia; [Khan, Zahid] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia	King Saud University; Prince Sultan Military Medical City; King Saud University; King Saud University; King Saud University	Abdulla, MH (corresponding author), King Saud Univ, Coll Med, King Khalid Univ Hosp, Colorectal Res Chair,Dept Surg, Riyadh 11461, Saudi Arabia.; Khan, Z (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia.	zkhan@ksu.edu.sa; mabdulla@ksu.edu.sa	Halwani, Rabih/AAN-1568-2021; Vaali-Mohammed, Mansoor-Ali/G-4772-2012	Halwani, Rabih/0000-0002-6516-7771; Vaali-Mohammed, Mansoor-Ali/0000-0002-6437-711X; Al-Khayal, Khayal/0000-0001-8296-808X; Zubaidi, Ahmad/0000-0003-0994-5310	King Saud University	King Saud University(King Saud University)	The study was funded by King Saud University, through Vice Deanship of Research Chairs. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by King Saud University, through Vice Deanship of Research Chairs.	Alsanea N, 2015, ANN SAUDI MED, V35, P196, DOI 10.5144/0256-4947.2015.196; Atoum MF, 2014, ASIAN PAC J CANCER P, V15, P7337, DOI 10.7314/APJCP.2014.15.17.7337; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Bentley RW, 2012, NEW ZEAL MED J, V125, P47; El Mouzan MI, 2008, ANN SAUDI MED, V28, P169, DOI 10.5144/0256-4947.2008.169; ELHAZMI MAF, 1995, J MED GENET, V32, P623, DOI 10.1136/jmg.32.8.623; Flugge J, 2007, EUR J CLIN PHARMACOL, V63; Gandini Sara, 2014, Adv Exp Med Biol, V810, P69; GARLAND CF, 1980, INT J EPIDEMIOL, V9, P227, DOI 10.1093/ije/9.3.227; GARLAND FC, 1990, PREV MED, V19, P614, DOI 10.1016/0091-7435(90)90058-R; Hamadien MA, 2015, TUMOUR BIOL; HANCHETTE CL, 1992, CANCER, V70, P2861, DOI 10.1002/1097-0142(19921215)70:12<2861::AID-CNCR2820701224>3.0.CO;2-G; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hughes David J, 2011, J Gastrointest Cancer, V42, P149, DOI 10.1007/s12029-010-9168-6; Hussain AN, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0190-3; Ingles SA, 2001, CANCER CAUSE CONTROL, V12, P607, DOI 10.1023/A:1011292002475; Kadiyska T, 2007, INT J COLORECTAL DIS, V22, P395, DOI 10.1007/s00384-006-0163-0; Kostner K, 2009, ANTICANCER RES, V29, P3511; Kupfer SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026123; Laczmanska I, 2014, TUMOR BIOL, V35, P12397, DOI 10.1007/s13277-014-2554-0; LEFKOWITZ ES, 1994, INT J EPIDEMIOL, V23, P1133, DOI 10.1093/ije/23.6.1133; Li C, 2009, DIGEST DIS SCI, V54, P634, DOI 10.1007/s10620-008-0375-y; Ma J, 1998, CANCER EPIDEM BIOMAR, V7, P385; Meeker S, 2016, WORLD J GASTROENTERO, V22, P933, DOI 10.3748/wjg.v22.i3.933; Mohapatra S, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-37; Nabi G, 2015, MED HYPOTHESES, V85, P117, DOI 10.1016/j.mehy.2015.04.006; Ochs-Balcom HM, 2008, CARCINOGENESIS, V29, P1788, DOI 10.1093/carcin/bgn166; Park K, 2006, CANCER LETT, V237, P199, DOI 10.1016/j.canlet.2005.05.048; Perna L, 2013, CANCER EPIDEMIOL, V37, P905, DOI 10.1016/j.canep.2013.09.007; Raimondi S, 2014, MUTAT RES-FUND MOL M, V769, P17, DOI 10.1016/j.mrfmmm.2014.06.001; Sarkissyan M, 2014, CANCER-AM CANCER SOC, V120, P1387, DOI 10.1002/cncr.28565; Schwartz GG, 1990, ANTICANCER RES; Serrano D, 2016, EUR J CANCER PREV, V25, P85, DOI 10.1097/CEJ.0000000000000132; SITRIN MD, 1991, CANCER RES, V51, P5608; Takeshige Nobuyuki, 2015, Asian Pac J Cancer Prev, V16, P2019; Theodoratou E, 2008, INT J CANCER, V123, P2170, DOI 10.1002/ijc.23769; Tong WM, 1998, EUR J CANCER, V34, P2119, DOI 10.1016/S0959-8049(98)00267-6; Tuffaha M, 2015, N AM J MED SCI, V7, P467, DOI 10.4103/1947-2714.168675; Uhry Z, 2013, CANCER EPIDEMIOL, V37, P270, DOI 10.1016/j.canep.2012.12.007; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Xu YQ, 2014, TUMOR BIOL, V35, P4153, DOI 10.1007/s13277-013-1544-y; Xue LX, 1999, JNCI-J NATL CANCER I, V91, P176, DOI 10.1093/jnci/91.2.176; Yaylim-Eraltan I, 2007, CELL BIOCHEM FUNCT, V25, P731, DOI 10.1002/cbf.1386; Yu K, 2014, ASIAN PAC J CANCER P, V15, P4801, DOI 10.7314/APJCP.2014.15.12.4801	44	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0155236	10.1371/journal.pone.0155236	http://dx.doi.org/10.1371/journal.pone.0155236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309378	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800001
J	Ballhausen, MB; Vandamme, P; de Boer, W				Ballhausen, Max-Bernhard; Vandamme, Peter; de Boer, Wietse			Trait Differentiation within the Fungus-Feeding (Mycophagous) Bacterial Genus Collimonas	PLOS ONE			English	Article							PHYLOGENETIC SIGNAL; SP NOV.; SOIL; COMMUNITIES; FUNGIVORANS; GROWTH; EXPRESSION; DIVERSITY; IMPACT	The genus Collimonas consists of facultative, fungus-feeding (mycophagous) bacteria. To date, 3 species (C. fungivorans, C. pratensis and C. arenae) have been described and over 100 strains have been isolated from different habitats. Functional traits of Collimonas bacteria that are potentially involved in interactions with soil fungi mostly negatively (fungal inhibition e.g.), but also positively (mineral weathering e.g.), affect fungal fitness. We hypothesized that variation in such traits between Collimonas strains leads to different mycophagous bacterial feeding patterns. We investigated a) whether phylogenetically closely related Collimonas strains possess similar traits, b) how far phylogenetic resolution influences the detection of phylogenetic signal (possession of similar traits by related strains) and c) if there is a pattern of co-occurrence among the studied traits. We measured genetically encoded (nifH genes, antifungal collimomycin gene cluster e.g.) as well as phenotypically expressed traits (chitinase-and siderophore production, fungal inhibition and others) and related those to a high-resolution phylogeny (MLSA), constructed by sequencing the housekeeping genes gyrB and rpoB and concatenating those with partial 16S rDNA sequences. Additionally, high-resolution and 16S rDNA derived phylogenies were compared. We show that MLSA is superior to 16SrDNA phylogeny when analyzing trait distribution and relating it to phylogeny at fine taxonomic resolution (a single bacterial genus). We observe that several traits involved in the interaction of collimonads and their host fungus (fungal inhibition e.g.) carry phylogenetic signal. Furthermore, we compare Collimonas trait possession with sister genera like Herbaspirillum and Janthinobacterium.	[Ballhausen, Max-Bernhard; de Boer, Wietse] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [Vandamme, Peter] Univ Ghent, Microbiol Lab, Ghent, Belgium; [de Boer, Wietse] Wageningen Univ, Dept Soil Qual, Wageningen, Netherlands; [Ballhausen, Max-Bernhard] Inst Vegetable & Ornamental Crops, Dept Plant Hlth, Grossbeeren Erfurt eV, Grossbeeren, Germany	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Ghent University; Wageningen University & Research; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ)	de Boer, W (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands.; de Boer, W (corresponding author), Wageningen Univ, Dept Soil Qual, Wageningen, Netherlands.	w.deboer@nioo.knaw.nl	de Boer, Wietse/C-2737-2011; Vandamme, Peter AR/B-7967-2009; Vandamme, Peter/ABG-3431-2021; KNAW, NIOO-KNAW/A-4320-2012	de Boer, Wietse/0000-0002-5380-2993; Vandamme, Peter AR/0000-0002-5581-7937; Vandamme, Peter/0000-0002-5581-7937; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organization for Scientific Research, division Earth and Life Sciences (NWO-ALW) [819.01.016]	Netherlands Organization for Scientific Research, division Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO))	This research was supported by a grant from the Netherlands Organization for Scientific Research, division Earth and Life Sciences (NWO-ALW), grant number 819.01.016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2005, SOIL SCI PLANT NUTR, V51, P303, DOI 10.1111/j.1747-0765.2005.tb00034.x; Bai YN, 2016, ENVIRON MICROBIOL, V18, P38, DOI 10.1111/1462-2920.12545; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Cheng X, 2013, ENV MICROBIOL REP, V5, P608, DOI 10.1111/1758-2229.12061; de Boer W, 2004, INT J SYST EVOL MICR, V54, P857, DOI 10.1099/ijs.0.02920-0; De Boer W, 1998, SOIL BIOL BIOCHEM, V30, P193, DOI 10.1016/S0038-0717(97)00100-4; De Boer W, 2001, APPL ENVIRON MICROB, V67, P3358, DOI 10.1128/AEM.67.8.3358-3362.2001; DEROOIJVANDERGOES PCEM, 1995, EUR J PLANT PATHOL, V101, P149, DOI 10.1007/BF01874761; Deveau A, 2007, NEW PHYTOL, V175, P743, DOI 10.1111/j.1469-8137.2007.02148.x; Diaz S, 2013, ECOL EVOL, V3, P2958, DOI 10.1002/ece3.601; Eydallin G, 2014, ENVIRON MICROBIOL, V16, P813, DOI 10.1111/1462-2920.12208; Folse HJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00338; Fritsche K, 2014, ENVIRON MICROBIOL, V16, P1334, DOI 10.1111/1462-2920.12440; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Hakvag S, 2009, MAR DRUGS, V7, P576, DOI 10.3390/md7040576; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hoppener-Ogawa S, 2008, INT J SYST EVOL MICR, V58, P414, DOI 10.1099/ijs.0.65375-0; Hoppener-Ogawa S, 2009, ISME J, V3, P190, DOI 10.1038/ismej.2008.97; Hoppener-Ogawa S, 2007, APPL ENVIRON MICROB, V73, P4191, DOI 10.1128/AEM.00387-07; Hoppener-Ogawa S, 2009, ENVIRON MICROBIOL, V11, P1444, DOI 10.1111/j.1462-2920.2009.01872.x; Hornung C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055045; Kielak AM, 2013, APPL ENVIRON MICROB, V79, P263, DOI 10.1128/AEM.02546-12; Krause S, 2014, J EVOLUTION BIOL, V27, P1240, DOI 10.1111/jeb.12401; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Leveau JHJ, 2010, ENVIRON MICROBIOL, V12, P281, DOI 10.1111/j.1462-2920.2009.02010.x; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Mannisto MK, 2006, SYST APPL MICROBIOL, V29, P229, DOI 10.1016/j.syapm.2005.09.001; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; Martiny JBH, 2015, SCIENCE, V350, DOI 10.1126/science.aac9323; Mela F, 2012, ENV MICROBIOL REP, V4, P424, DOI 10.1111/j.1758-2229.2012.00336.x; Mela F, 2011, ISME J, V5, P1494, DOI 10.1038/ismej.2011.29; Moore E., 2004, MOL MICROBIAL ECOLOG; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Nissinen RM, 2012, FEMS MICROBIOL ECOL, V82, P510, DOI 10.1111/j.1574-6941.2012.01464.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Perez-Miranda S, 2007, J MICROBIOL METHODS; Rudnick MB, 2015, ENV MICROBIOL REP, V7, P709, DOI 10.1111/1758-2229.12290; Rudnick MB, 2015, SOIL BIOL BIOCHEM, V88, P73, DOI 10.1016/j.soilbio.2015.04.015; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharp CE, 2014, ISME J, V8, P1166, DOI 10.1038/ismej.2013.237; Sutherland IW, 1996, MICROBIOL-UK, V142, P867, DOI 10.1099/00221287-142-4-867; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tremblay J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-587; Uroz S, 2007, APPL ENVIRON MICROB, V73, P3019, DOI 10.1128/AEM.00121-07; Uroz S, 2009, SOIL BIOL BIOCHEM, V41, P2178, DOI 10.1016/j.soilbio.2009.07.031; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wolf AB, 2015, EARLY COLONIZERS OF; Xavier JB, 2011, MOL MICROBIOL, V79, P166, DOI 10.1111/j.1365-2958.2010.07436.x; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	51	8	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157552	10.1371/journal.pone.0157552	http://dx.doi.org/10.1371/journal.pone.0157552			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309848	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800095
J	Nichols, JA; Bednar, MS; Murray, WM				Nichols, Jennifer A.; Bednar, Michael S.; Murray, Wendy M.			Surgical Simulations Based on Limited Quantitative Data: Understanding How Musculoskeletal Models Can Be Used to Predict Moment Arms and Guide Experimental Design	PLOS ONE			English	Article							PROXIMAL ROW CARPECTOMY; TOTAL SHOULDER ARTHROPLASTY; TIBIOFEMORAL CONTACT FORCES; TENDON TRANSFER; 4-CORNER ARTHRODESIS; EXTERNAL ROTATION; MOTOR TENDONS; MUSCLE; WRIST; KINEMATICS	The utility of biomechanical models and simulations to examine clinical problems is currently limited by the need for extensive amounts of experimental data describing how a given procedure or disease affects the musculoskeletal system. Methods capable of predicting how individual biomechanical parameters are altered by surgery are necessary for the efficient development of surgical simulations. In this study, we evaluate to what extent models based on limited amounts of quantitative data can be used to predict how surgery influences muscle moment arms, a critical parameter that defines how muscle force is transformed into joint torque. We specifically examine proximal row carpectomy and scaphoid-excision four-corner fusion, two common surgeries to treat wrist osteoarthritis. Using models of these surgeries, which are based on limited data and many assumptions, we perform simulations to formulate a hypothesis regarding how these wrist surgeries influence muscle moment arms. Importantly, the hypothesis is based on analysis of only the primary wrist muscles. We then test the simulation-based hypothesis using a cadaveric experiment that measures moment arms of both the primary wrist and extrinsic thumb muscles. The measured moment arms of the primary wrist muscles are used to verify the hypothesis, while those of the extrinsic thumb muscles are used as cross-validation to test whether the hypothesis is generalizable. The moment arms estimated by the models and measured in the cadaveric experiment both indicate that a critical difference between the surgeries is how they alter radial-ulnar deviation versus flexion-extension moment arms at the wrist. Thus, our results demonstrate that models based on limited quantitative data can provide novel insights. This work also highlights that synergistically utilizing simulation and experimental methods can aid the design of experiments and make it possible to test the predictive limits of current computer simulation techniques.	[Nichols, Jennifer A.; Murray, Wendy M.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Murray, Wendy M.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Murray, Wendy M.] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Nichols, Jennifer A.; Murray, Wendy M.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Nichols, Jennifer A.; Bednar, Michael S.; Murray, Wendy M.] Edward Hines Jr VA Hosp, Hines, IL USA; [Bednar, Michael S.] Loyola Univ Chicago, Stritch Sch Med, Dept Orthopaed Surg & Rehabil, Maywood, IL USA; [Nichols, Jennifer A.] Univ Utah, Dept Orthopaed, Salt Lake City, UT USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Shirley Ryan AbilityLab; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago; Utah System of Higher Education; University of Utah	Murray, WM (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.; Murray, WM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.; Murray, WM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.; Murray, WM (corresponding author), Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA.; Murray, WM (corresponding author), Edward Hines Jr VA Hosp, Hines, IL USA.	w-murray@northwestern.edu	Murray, Wendy/AAD-6257-2022; Nichols, Jennifer A./T-3583-2019; Murray, Wendy/B-7629-2009; Murray, Wendy M./D-1520-2009; Nichols, Jennifer/O-8942-2015	Murray, Wendy/0000-0002-7547-621X; Murray, Wendy M./0000-0002-7547-621X; Nichols, Jennifer/0000-0001-5167-9197	National Institutes of Health (NIH) [F31 AG041627, T32 HD007418]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG041627] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Institutes of Health (NIH) under the following award numbers: F31 AG041627 (funding awarded to JAN) and T32 HD007418 (predoctoral fellow and trainee: JAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland DC, 2012, J BONE JOINT SURG AM, V94A, P1886, DOI 10.2106/JBJS.J.01861; Ackland DC, 2010, J BONE JOINT SURG AM, V92A, P1221, DOI 10.2106/JBJS.I.00001; Afschrift M, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-111; AN KN, 1983, J BIOMECH, V16, P419, DOI 10.1016/0021-9290(83)90074-X; Arnold A S, 2000, Comput Aided Surg, V5, P108, DOI 10.3109/10929080009148877; Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; Asakawa DS, 2004, J BONE JOINT SURG AM, V86A, P348, DOI 10.2106/00004623-200402000-00019; Association AM, 2015, ICD 9 CM 2015 PROF E; Blankenhorn BD, 2007, J HAND SURG-AM, V32A, P37, DOI 10.1016/j.jhsa.2006.10.014; Brandon SCE, 2014, J BIOMECH, V47, P1409, DOI 10.1016/j.jbiomech.2014.01.038; Buffi JH, 2015, ANN BIOMED ENG, V43, P404, DOI 10.1007/s10439-014-1144-z; Cohen MS, 2001, J HAND SURG-AM, V26A, P94, DOI 10.1053/jhsu.2001.20160; Crossley KM, 2012, OSTEOARTHR CARTILAGE, V20, P1243, DOI 10.1016/j.joca.2012.07.011; Crouch DL, 2011, J HAND SURG-AM, V36A, P1644, DOI 10.1016/j.jhsa.2011.07.019; Dacho AK, 2008, J PLAST RECONSTR AES, V61, P1210, DOI 10.1016/j.bjps.2007.08.007; DELP SL, 1995, COMPUT BIOL MED, V25, P21, DOI 10.1016/0010-4825(95)98882-E; Donnelly CJ, 2012, J BIOMECH, V45, P1491, DOI 10.1016/j.jbiomech.2012.02.010; Favre P, 2008, J SHOULDER ELB SURG, V17, P650, DOI 10.1016/j.jse.2007.12.010; Gao F, 2011, AM J PHYS MED REHAB, V90, P364, DOI 10.1097/PHM.0b013e318214f699; Gerus P, 2013, J BIOMECH, V46, P2778, DOI 10.1016/j.jbiomech.2013.09.005; Hartzler RU, 2012, J SHOULDER ELB SURG, V21, P1370, DOI 10.1016/j.jse.2012.01.026; Hoenecke HR, 2014, J SHOULDER ELB SURG, V23, P1128, DOI 10.1016/j.jse.2013.11.025; Holzbaur KRS, 2005, ANN BIOMED ENG, V33, P829, DOI 10.1007/s10439-005-3320-7; Hui HEJ, 2007, FOOT ANKLE INT, V28, P441, DOI 10.3113/FAI.2007.0441; LaRoque ES, 2008, J BONE JOINT SURG AM, V90A, P1979, DOI 10.2106/JBJS.G.01015; Lenhart RL, 2014, MED SCI SPORT EXER, V46, P557, DOI 10.1249/MSS.0b013e3182a78c3a; Lieber RL, 2005, J HAND SURG-AM, V30A, P273, DOI 10.1016/j.jhsa.2004.10.003; Liu J, 1998, J BONE JOINT SURG AM, V80A, P853, DOI 10.2106/00004623-199806000-00009; Loren GJ, 1996, J BIOMECH, V29, P331, DOI 10.1016/0021-9290(95)00055-0; Magermans DJ, 2004, CLIN BIOMECH, V19, P116, DOI 10.1016/j.clinbiomech.2003.09.008; Mogk JPM, 2011, J BIOMECH, V44, P669, DOI 10.1016/j.jbiomech.2010.11.004; Mulford JS, 2009, J HAND SURG-EUR VOL, V34E, P256, DOI 10.1177/1753193408100954; Murray WM, 2006, J BONE JOINT SURG AM, V88A, P2009, DOI 10.2106/JBJS.E.00973; Nakajima T, 1999, CLIN BIOMECH, V14, P265, DOI 10.1016/S0268-0033(98)00075-8; Nakajima T., 2002, Journal of Musculoskeletal Research, V6, P147, DOI 10.1142/S0218957702000903; Neptune RR, 2000, CLIN BIOMECH, V15, P528, DOI 10.1016/S0268-0033(00)00005-X; Nichols JA, 2015, CLIN BIOMECH, V30, P424, DOI 10.1016/j.clinbiomech.2015.03.015; Nichols JA, 2013, J BIOMECH, V46, P192, DOI 10.1016/j.jbiomech.2012.10.035; Omokawa S, 2000, CLIN ORTHOP RELAT R, P262; Richards C, 2010, J BIOMECH, V43, P2595, DOI 10.1016/j.jbiomech.2010.05.006; Saul KR, 2015, COMPUT METHOD BIOMEC, V18, P1445, DOI 10.1080/10255842.2014.916698; Scheys L, 2008, GAIT POSTURE, V28, P640, DOI 10.1016/j.gaitpost.2008.04.010; Schmidt CC, 2010, J SHOULDER ELB SURG, V19, P1157, DOI 10.1016/j.jse.2010.05.027; Schuind F, 1994, J Shoulder Elbow Surg, V3, P191, DOI 10.1016/S1058-2746(09)80035-9; Shah MA, 2003, J HAND SURG-AM, V28A, P661, DOI 10.1016/S0363-5023(03)00180-1; Sheehan FT, 2012, CLIN BIOMECH, V27, P525, DOI 10.1016/j.clinbiomech.2011.12.012; Siston RA, 2006, J ORTHOP RES, V24, P1607, DOI 10.1002/jor.20163; Sobczak S, 2013, CLIN BIOMECH, V28, P187, DOI 10.1016/j.clinbiomech.2012.12.008; Sobczak S, 2011, CLIN BIOMECH, V26, P718, DOI 10.1016/j.clinbiomech.2011.03.002; Steele KM, 2012, J BIOMECH, V45, P2564, DOI 10.1016/j.jbiomech.2012.07.028; Tang CY, 2002, J BIOMECH, V35, P1143, DOI 10.1016/S0021-9290(02)00059-3; Tang JB, 1997, J ORTHOPAED RES, V15, P324, DOI 10.1002/jor.1100150303; Tang JB, 1999, J HAND SURG-AM, V24A, P121; Tang JB, 1997, J ORTHOPAED RES, V15, P69, DOI 10.1002/jor.1100150111; Vanhove W, 2008, J HAND SURG-EUR VOL, V33E, P118, DOI 10.1177/1753193408087116; Veeger HEJ, 2004, J HAND SURG-BRIT EUR, V29B, P259, DOI 10.1016/j.jhsb.2004.01.004; Ward SR, 2010, J ORTHOP SPORT PHYS, V40, P729, DOI 10.2519/jospt.2010.3279; Weiss APC, 2004, J HAND SURG-AM, V29A, P796, DOI 10.1016/j.jhsa.2004.04.023; Wohlman SJ, 2013, J BIOMECH, V46, P1014, DOI 10.1016/j.jbiomech.2012.10.044	60	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157346	10.1371/journal.pone.0157346	http://dx.doi.org/10.1371/journal.pone.0157346			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310013	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800057
J	Shackleford, GM; Shi, XH; Swanson, KS; Mahdi, MY; Gonzalez-Gomez, I; Asgharzadeh, S; D'Apuzzo, M; Erdreich-Epstein, A; Moats, RA				Shackleford, Gregory M.; Shi, Xiang-He; Swanson, Kimberly S.; Mahdi, Min Y.; Gonzalez-Gomez, Ignacio; Asgharzadeh, Shahab; D'Apuzzo, Massimo; Erdreich-Epstein, Anat; Moats, Rex A.			BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BARHL1 HOMEOBOX GENE; SUPER-ENHANCERS; SONIC HEDGEHOG; GROWTH-FACTOR; CELL-LINES; TRANSCRIPTION FACTORS; RETROVIRAL VECTORS; CURRENT CONSENSUS; BRAIN-TUMORS	Medulloblastomas are the most common malignant pediatric brain tumor and have been divided into four major molecular subgroups. Animal models that mimic the principal molecular aberrations of these subgroups will be important tools for preclinical studies and allow greater understanding of medulloblastoma biology. We report a new transgenic model of medulloblastoma that possesses a unique combination of desirable characteristics including, among others, the ability to incorporate multiple and variable genes of choice and to produce bioluminescent tumors from a limited number of somatic cells within a normal cellular environment. This model, termed BarTeL, utilizes a Barhl1 homeobox gene promoter to target expression of a bicistronic transgene encoding both the avian retroviral receptor TVA and an eGFP-Luciferase fusion protein to neonatal cerebellar granule neuron precursor (cGNP) cells, which are cells of origin for the sonic hedgehog (SHH) subgroup of human medulloblastomas. The Barhl1 promoter-driven transgene is expressed strongly in mammalian cGNPs and weakly or not at all in mature granule neurons. We efficiently induced bioluminescent medulloblastomas expressing eGFP-luciferase in BarTeL mice by infection of a limited number of somatic cGNPs with avian retroviral vectors encoding the active N-terminal fragment of SHH and a stabilized MYCN mutant. Detection and quantification of the increasing bioluminescence of growing tumors in young BarTeL mice was facilitated by the declining bioluminescence of their uninfected maturing cGNPs. Inclusion of eGFP in the transgene allowed enriched sorting of cGNPs from neonatal cerebella. Use of a single bicistronic avian vector simultaneously expressing both Shh and Mycn oncogenes increased the medulloblastoma incidence and aggressiveness compared to mixed virus infections. Bioluminescent tumors could also be produced by ex vivo transduction of neonatal BarTeL cerebellar cells by avian retroviruses and subsequent implantation into nontransgenic cerebella. Thus, BarTeL mice provide a versatile model with opportunities for use in medulloblastoma biology and therapeutics.	[Shackleford, Gregory M.; Shi, Xiang-He; Swanson, Kimberly S.; Asgharzadeh, Shahab; Erdreich-Epstein, Anat] Univ So Calif, Dept Pediat, Div Hematol Oncol & Blood & Marrow Transplantat, Saban Res Inst,Childrens Hosp Los Angeles, Los Angeles, CA 90089 USA; [Shackleford, Gregory M.; Shi, Xiang-He; Swanson, Kimberly S.; Asgharzadeh, Shahab; Erdreich-Epstein, Anat] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Shackleford, Gregory M.] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Shackleford, Gregory M.; Swanson, Kimberly S.; Mahdi, Min Y.; Moats, Rex A.] Univ So Calif, Childrens Hosp Los Angeles, Dept Radiol, Saban Res Inst, Los Angeles, CA USA; [Shackleford, Gregory M.; Swanson, Kimberly S.; Mahdi, Min Y.; Moats, Rex A.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Gonzalez-Gomez, Ignacio; Erdreich-Epstein, Anat] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Moats, Rex A.] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [D'Apuzzo, Massimo] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA 91010 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of Southern California; Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of Southern California; University of Southern California; City of Hope	Shackleford, GM (corresponding author), Univ So Calif, Dept Pediat, Div Hematol Oncol & Blood & Marrow Transplantat, Saban Res Inst,Childrens Hosp Los Angeles, Los Angeles, CA 90089 USA.; Shackleford, GM (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA.; Shackleford, GM (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.; Shackleford, GM (corresponding author), Univ So Calif, Childrens Hosp Los Angeles, Dept Radiol, Saban Res Inst, Los Angeles, CA USA.; Shackleford, GM (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA.	shacklef@usc.edu		Erdreich-Epstein, Anat/0000-0003-4269-4373; Asgharzadeh, Shahab/0000-0002-0510-3848	Jean Perkins Foundation; Pediatric Brain Tumor Foundation; Neil Bogart Memorial Fund; T.J. Martell Foundation for Leukemia, Cancer and AIDS Research; ThinkCure; Nautica Malibu Triathlon	Jean Perkins Foundation; Pediatric Brain Tumor Foundation; Neil Bogart Memorial Fund; T.J. Martell Foundation for Leukemia, Cancer and AIDS Research; ThinkCure; Nautica Malibu Triathlon	This work was supported in part by the Jean Perkins Foundation, the Pediatric Brain Tumor Foundation, the Neil Bogart Memorial Fund, the T.J. Martell Foundation for Leukemia, Cancer and AIDS Research, ThinkCure, and the Nautica Malibu Triathlon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVRAHAM H, 1989, MOL CELL BIOL, V9, P2058, DOI 10.1128/MCB.9.5.2058; Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Binning MJ, 2008, CANCER RES, V68, P7838, DOI 10.1158/0008-5472.CAN-08-1899; Browd SR, 2006, CANCER RES, V66, P2666, DOI 10.1158/0008-5472.CAN-05-2198; Buhren J, 2000, J NEUROPATH EXP NEUR, V59, P229; Bulfone A, 2000, HUM MOL GENET, V9, P1443, DOI 10.1093/hmg/9.9.1443; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Chellappa R, 2008, MOL CELL BIOL, V28, P1905, DOI 10.1128/MCB.01454-07; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Erdreich-Epstein A, 2006, GENE CHROMOSOME CANC, V45, P169, DOI 10.1002/gcc.20280; FEKETE DM, 1993, MOL CELL BIOL, V13, P2604, DOI 10.1128/MCB.13.4.2604; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; FRIEDMAN HS, 1985, J NEUROPATH EXP NEUR, V44, P592, DOI 10.1097/00005072-198511000-00005; FRIEDMAN HS, 1988, AM J PATHOL, V130, P472; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goslin, 1998, CULTURING NERVE CELL, P419; Gray PA, BARHL1 IN SITU HYBRI; Hare CB, 1997, CANCER CHEMOTH PHARM, V39, P187; HE XM, 1991, LAB INVEST, V64, P833; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Holland EC, 2000, TOXICOL PATHOL, V28, P171, DOI 10.1177/019262330002800122; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kahl CA, 2008, GENE THER, V15, P1079, DOI 10.1038/gt.2008.50; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Korshunov A, 2012, ACTA NEUROPATHOL, V123, P515, DOI 10.1007/s00401-011-0918-8; Koster J., R2 GENOMICS ANAL VIS; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Li SG, 2004, J NEUROSCI, V24, P3104, DOI 10.1523/JNEUROSCI.4444-03.2004; Li SG, 2002, DEVELOPMENT, V129, P3523; Li SG, 2006, DEV DYNAM, V235, P2260, DOI 10.1002/dvdy.20858; Lin CY, 2016, NATURE, V530, P57, DOI 10.1038/nature16546; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Margol AS, 2015, CLIN CANCER RES, V21, P1457, DOI 10.1158/1078-0432.CCR-14-1144; Markant SL, 2012, NEUROPATH APPL NEURO, V38, P228, DOI 10.1111/j.1365-2990.2011.01235.x; Martin P, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-4; Moxon-Emre I, 2014, J CLIN ONCOL, V32, P1760, DOI 10.1200/JCO.2013.52.3290; National Cancer Institute, CANC GEN AN PROJ SAG; NEBEL BR, 1961, SCIENCE, V134, P832, DOI 10.1126/science.134.3482.832; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Orsulic S, 2002, MAMM GENOME, V13, P543, DOI 10.1007/s00335-002-4003-4; Packer RJ, 2008, J CHILD NEUROL, V23, P1122, DOI 10.1177/0883073808320758; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; PETROPOULOS CJ, 1991, J VIROL, V65, P3728, DOI 10.1128/JVI.65.7.3728-3737.1991; Poschl J, 2011, ONCOGENE, V30, P4721, DOI 10.1038/onc.2011.173; Rachidi M, 2006, INT J DEV NEUROSCI, V24, P35, DOI 10.1016/j.ijdevneu.2005.11.015; Ramaswamy V, 2016, ACTA NEUROPATHOL, V131, P821, DOI 10.1007/s00401-016-1569-6; Reig G, 2007, DEV BIOL, V302, P367, DOI 10.1016/j.ydbio.2006.10.008; Rich JN, 1999, J BIOL CHEM, V274, P35053, DOI 10.1074/jbc.274.49.35053; Rutkowski S, 2010, J CLIN ONCOL, V28, P4961, DOI 10.1200/JCO.2010.30.2299; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Swartling FJ, 2010, GENE DEV, V24, P1059, DOI 10.1101/gad.1907510; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Uziel T, 2006, CELL CYCLE, V5, P363, DOI 10.4161/cc.5.4.2475; von Werder A, 2012, NAT PROTOC, V7, P1167, DOI 10.1038/nprot.2012.060; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; WIKSTRAND CJ, 1977, CANCER RES, V37, P4267; Xu JY, 2012, J NEURO-ONCOL, V107, P269, DOI 10.1007/s11060-011-0756-5; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003	68	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156907	10.1371/journal.pone.0156907	http://dx.doi.org/10.1371/journal.pone.0156907			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310018	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800018
J	Wang, Y; Justilien, V; Brennan, KI; Jamieson, L; Murray, NR; Fields, AP				Wang, Y.; Justilien, V.; Brennan, K. I.; Jamieson, L.; Murray, N. R.; Fields, A. P.			PKC iota regulates nuclear YAP1 localization and ovarian cancer tumorigenesis	ONCOGENE			English	Article							PROTEIN-KINASE-C; POOR-PROGNOSIS; ONCOGENE; OVERREPRESENTATION; OVEREXPRESSION; PROLIFERATION; EXPRESSION; ANGIOMOTIN; PHENOTYPE; EFFECTOR	Atypical protein kinase C iota (PKC iota) is an oncogene in lung and ovarian cancer. The PKC iota gene PRKCI is targeted for frequent tumorspecific copy number gain (CNG) in both lung squamous cell carcinoma (LSCC) and ovarian serous carcinoma (OSC). We recently demonstrated that in LSCC cells PRKCI CNG functions to drive transformed growth and tumorigenicity by activating PKC iota-dependent cell autonomous Hedgehog (Hh) signaling. Here, we assessed whether OSC cells harboring PRKCI CNG exhibit similar PKC iota-dependent Hh signaling. Surprisingly, we find that whereas PKC iota is required for the transformed growth of OSC cells harboring PRKCI CNG, these cells do not exhibit PKC iota-dependent Hh signaling or Hh-dependent proliferation. Rather, transformed growth of OSC cells is regulated by PKC iota-dependent nuclear localization of the oncogenic transcription factor, YAP1. Lentiviral shRNA-mediated knockdown (KD) of PKC iota leads to decreased nuclear YAP1 and increased YAP1 binding to angiomotin (AMOT), which sequesters YAP1 in the cytoplasm. Biochemical analysis reveals that PKC iota directly phosphorylates AMOT at a unique site, Thr750, whose phosphorylation inhibits YAP1 binding. Pharmacologic inhibition of PKC iota decreases YAP1 nuclear localization and blocks OSC tumor growth in vitro and in vivo. Immunohistochemical analysis reveals a strong positive correlation between tumor PKC iota expression and nuclear YAP1 in primary OSC tumor samples, indicating the clinical relevance of PKC iota-YAP1 signaling. Our results uncover a novel PKC iota-AMOT-YAP1 signaling axis that promotes OSC tumor growth, and provide a rationale for therapeutic targeting of this pathway for treatment of OSC.	[Wang, Y.; Justilien, V.; Brennan, K. I.; Jamieson, L.; Murray, N. R.; Fields, A. P.] Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Murray, NR; Fields, AP (corresponding author), Mayo Clin Florida, Dept Canc Biol, Griffin Canc Res Bldg,Rm 212,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	fields.alan@mayo.edu			Mayo Clinic Specialized Program in Research Excellence (SPORE) grant from the National Institutes of Health [CA136393]; Ovarian Cancer Research Fund; National Cancer Institute [R21 CA204938-01, R01 CA081436-18]; George Haub Family Career Development Award; NATIONAL CANCER INSTITUTE [R01CA081436, P50CA136393, R21CA204938] Funding Source: NIH RePORTER	Mayo Clinic Specialized Program in Research Excellence (SPORE) grant from the National Institutes of Health; Ovarian Cancer Research Fund; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); George Haub Family Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Kim Kalli and the Mayo Clinic Ovarian SPORE Tissue shared resource for ovarian cancer tissue microarrays, The Mayo Clinic Cytogenetics Core for FISH analysis, Ms Brandy Edenfield for tissue processing and immunohistochemical staining, and Kayla Lewis, Capella Weems and Dr Christelle Colin Cassin for technical assistance. This research was supported by the Mayo Clinic Specialized Program in Research Excellence (SPORE) grant CA136393 from the National Institutes of Health (APF is a Project Leader on this grant), a post-doctoral fellowship award from the Ovarian Cancer Research Fund to YW, National Cancer Institute grants R21 CA204938-01 (to VJ) and R01 CA081436-18 (to APF), and the George Haub Family Career Development Award (to VJ). APF is the Monica Flynn Jacoby Professor of Cancer Research, an endowment fund that provides partial support for his research program.	Algeciras-Schimnich A, 2010, CLIN CHEM, V56, P391, DOI 10.1373/clinchem.2009.134015; Ali SA, 2016, CANCER CELL, V29, P367, DOI 10.1016/j.ccell.2016.02.012; Archibald A, 2015, MOL BIOL CELL, V26, P3578, DOI 10.1091/mbc.E15-05-0265; Arnold N, 1996, GENE CHROMOSOME CANC, V16, P46, DOI 10.1002/(SICI)1098-2264(199605)16:1<46::AID-GCC7>3.0.CO;2-3; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Butler AM, 2015, ONCOTARGET, V6, P15297, DOI 10.18632/oncotarget.3812; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; Fields Alan P, 2003, Methods Mol Biol, V233, P519; Fields AP, 2008, ADV ENZYME REGUL, V48, P166, DOI 10.1016/j.advenzreg.2007.11.014; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Hsu YL, 2015, ONCOGENE, V34, P4056, DOI 10.1038/onc.2014.333; Jatoi A, 2015, ONCOLOGY-BASEL, V88, P208, DOI 10.1159/000369257; Jeong GO, 2013, CELL PHYSIOL BIOCHEM, V32, P253, DOI 10.1159/000354434; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Justilien V, 2011, J BIOL CHEM, V286, P8149, DOI 10.1074/jbc.M110.196113; Korkmaz T, 2016, CRIT REV ONCOL HEMAT, V98, P180, DOI 10.1016/j.critrevonc.2015.10.006; Llado V, 2015, CELL REP, V10, P740, DOI 10.1016/j.celrep.2015.01.007; Martin LP, 2009, SEMIN ONCOL, V36, P112, DOI 10.1053/j.seminoncol.2008.12.003; Moleirinho S, 2014, FEBS LETT, V588, P2693, DOI 10.1016/j.febslet.2014.02.006; Murray NR, 2011, J CELL PHYSIOL, V226, P879, DOI 10.1002/jcp.22463; Parker PJ, 2014, BIOCHEM PHARMACOL, V88, P1, DOI 10.1016/j.bcp.2013.10.023; Petrucelli N, 2010, GENET MED, V12, P245, DOI 10.1097/GIM.0b013e3181d38f2f; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Rho SB, 2009, BIOTECHNOL LETT, V31, P23, DOI 10.1007/s10529-008-9845-8; Shen HM, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0117-2; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sonoda G, 1997, GENE CHROMOSOME CANC, V20, P320; Sugita M, 2000, CANCER GENET CYTOGEN, V117, P9, DOI 10.1016/S0165-4608(99)00135-1; Wang Y, 2013, MOL CANCER RES, V11, P1624, DOI 10.1158/1541-7786.MCR-13-0371-T; Yi CL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004060; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8	39	32	37	2	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 26	2017	36	4					534	545		10.1038/onc.2016.224	http://dx.doi.org/10.1038/onc.2016.224			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8II	27321186	Green Accepted			2022-12-26	WOS:000394166700010
J	Sheng, R; Jung, DJ; Silkov, A; Kim, H; Singaram, I; Wang, ZG; Xin, Y; Kim, E; Park, MJ; Thiagarajan-Rosenkranz, P; Smrt, S; Honig, B; Baek, K; Ryu, S; Lorieau, J; Kim, YM; Cho, W				Sheng, Ren; Jung, Da-Jung; Silkov, Antonina; Kim, Hyunjin; Singaram, Indira; Wang, Zhi-Gang; Xin, Yao; Kim, Eui; Park, Mi-Jeong; Thiagarajan-Rosenkranz, Pallavi; Smrt, Sean; Honig, Barry; Baek, Kwanghee; Ryu, Sungho; Lorieau, Justin; Kim, You-Me; Cho, Wonhwa			Lipids Regulate Lck Protein Activity through Their Interactions with the Lck Src Homology 2 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; phosphoinositide; plasma membrane; Src homology 2 domain (SH2 domain); T-cell receptor (TCR); Lck	T-CELL-ACTIVATION; MEMBRANE-BINDING; FAMILY KINASES; SIGNALING PATHWAYS; LIVING CELLS; SH2 DOMAINS; C2 DOMAINS; DOCKING; SURFACE; SYSTEM	Lymphocyte-specific protein-tyrosine kinase (Lck) plays an essential role in T cell receptor (TCR) signaling and T cell development, but its activation mechanism is not fully understood. To explore the possibility that plasma membrane (PM) lipids control TCR signaling activities of Lck, we measured the membrane binding properties of its regulatory Src homology 2 (SH2) and Src homology 3 domains. The Lck SH2 domain binds anionic PM lipids with high affinity but with low specificity. Electrostatic potential calculation, NMR analysis, and mutational studies identified the lipid-binding site of the Lck SH2 domain that includes surface-exposed basic, aromatic, and hydrophobic residues but not the phospho-Tyr binding pocket. Mutation of lipid binding residues greatly reduced the interaction of Lck with the chain in the activated TCR signaling complex and its overall TCR signaling activities. These results suggest that PM lipids, including phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate, modulate interaction of Lck with its binding partners in the TCR signaling complex and its TCR signaling activities in a spatiotemporally specific manner via its SH2 domain.	[Sheng, Ren; Kim, Hyunjin; Singaram, Indira; Wang, Zhi-Gang; Xin, Yao; Thiagarajan-Rosenkranz, Pallavi; Smrt, Sean; Lorieau, Justin; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Jung, Da-Jung; Kim, Eui; Park, Mi-Jeong; Kim, You-Me] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea; [Ryu, Sungho; Kim, You-Me] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Silkov, Antonina; Honig, Barry] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 11032 USA; [Baek, Kwanghee; Cho, Wonhwa] Kyung Hee Univ, Dept Genet Engn, Yongin 446701, South Korea	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Columbia University; Howard Hughes Medical Institute; Kyung Hee University	Cho, W (corresponding author), Univ Illinois, Dept Chem, Chicago, IL 60607 USA.; Kim, YM (corresponding author), Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea.; Cho, W (corresponding author), Kyung Hee Univ, Dept Genet Engn, Yongin 446701, South Korea.	youmekim@postech.ac.kr; wcho@uic.edu	Lorieau, Justin/GXV-8916-2022; Baek, Kwanghee/N-2760-2018; Kim, You-Me/I-5553-2013; Xin, Yao/L-6259-2019; Singaram, Indira/AAB-8321-2021	Baek, Kwanghee/0000-0002-1364-1355; Kim, You-Me/0000-0001-8780-704X; Singaram, Indira/0000-0001-7508-7997; Park, Mi-Jeong/0000-0002-9592-4972; Jung, Da-Jung/0000-0003-4399-8029; Honig, Barry/0000-0002-1835-1031; Ryu, Sung Ho/0000-0003-0913-3048	National Institutes of Health [GM68849, GM110128, GM030518, GM094597, CA121852]; National Research Foundation of Korea [NRF-2013R1A1A2074573]; World Class University Program by the Korean Government [R31-2008-000-10105-0]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597, R01GM068849, R01GM110128, R01GM030518, R37GM030518] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012351, S10OD021764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); World Class University Program by the Korean Government; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants GM68849 and GM110128 (to W. C.) and GM030518, GM094597, and CA121852 (to B. H.), National Research Foundation of Korea Grant NRF-2013R1A1A2074573, and World Class University Program R31-2008-000-10105-0 by the Korean Government. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Chen Y, 2012, MOL CELL, V46, P226, DOI 10.1016/j.molcel.2012.02.012; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho Wonhwa, 2006, Sci STKE, V2006, ppe7, DOI 10.1126/stke.3212006pe7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Gamper CJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00312; Graves AP, 2008, J MOL BIOL, V377, P914, DOI 10.1016/j.jmb.2008.01.049; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Hong Yoojin, 2009, J Proteomics Bioinform, V2, P139; Hui EF, 2014, NAT STRUCT MOL BIOL, V21, P133, DOI 10.1038/nsmb.2762; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Kim H, 2013, J LIPID RES, V54, P3531, DOI 10.1194/jlr.D041376; Kim J, 2013, J IMMUNOL, V190, P5287, DOI 10.4049/jimmunol.1202767; Koyama-Honda I, 2005, BIOPHYS J, V88, P2126, DOI 10.1529/biophysj.104.048967; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Lo Surdo P, 1999, J BIOL CHEM, V274, P15678, DOI 10.1074/jbc.274.22.15678; Lorber DM, 1998, PROTEIN SCI, V7, P938; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Melowic HR, 2007, J BIOL CHEM, V282, P21467, DOI 10.1074/jbc.M700119200; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Park MJ, 2016, MOL CELL, V62, P7, DOI 10.1016/j.molcel.2016.01.027; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; RAMEH LE, 1995, CELL, V83, P821, DOI 10.1016/0092-8674(95)90195-7; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Scott MP, 2000, BIOCHEMISTRY-US, V39, P14531, DOI 10.1021/bi001850u; Sheng R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5393; Sheng R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2221; Shi XS, 2013, NATURE, V493, P111, DOI 10.1038/nature11699; Silkov A, 2011, J BIOL CHEM, V286, P34155, DOI 10.1074/jbc.M111.265611; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stahelin RV, 2001, BIOCHEM J, V359, P679, DOI 10.1042/0264-6021:3590679; Stephen TL, 2012, P NATL ACAD SCI USA, V109, P7415, DOI 10.1073/pnas.1119272109; Stirnweiss A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003607; Tokonzaba E, 2006, CHEM BIOL DRUG DES, V67, P230, DOI 10.1111/j.1747-0285.2006.00361.x; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wei BQQ, 2002, J MOL BIOL, V322, P339, DOI 10.1016/S0022-2836(02)00777-5; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yoon Y, 2011, NAT CHEM, V3, P868, DOI [10.1038/NCHEM.1163, 10.1038/nchem.1163]	57	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17639	17650		10.1074/jbc.M116.720284	http://dx.doi.org/10.1074/jbc.M116.720284			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27334919	Green Published, hybrid			2022-12-26	WOS:000383241300015
J	Kuhn, FJP; Kuhn, C; Winking, M; Hoffmann, DC; Luckhoff, A				Kuehn, Frank J. P.; Kuehn, Cornelia; Winking, Mathis; Hoffmann, Daniel C.; Lueckhoff, Andreas			ADP-Ribose Activates the TRPM2 Channel from the Sea Anemone Nematostella vectensis Independently of the NUDT9H Domain	PLOS ONE			English	Article							MULTIFUNCTIONAL ION-CHANNEL; OXIDATIVE STRESS; CATION CHANNEL; REVEALS; LTRPC2; PYROPHOSPHATASE; SUSCEPTIBILITY; PROTEINS; FAMILY; GENE	The human redox-sensitive Transient receptor potential melastatin type 2 (hTRPM2) channel contains the C-terminal Nudix hydrolase domain NUDT9H which most likely binds ADPribose. During oxidative stress, the intracellular release of ADP-ribose triggers the activation of hTRPM2. The TRPM2 orthologue from Nematostella vectensis (nv) is also stimulated by ADP-ribose but not by the oxidant hydrogen peroxide. For further clarification of the structure-function relationships of these two distantly related channel orthologues, we performed whole-cell as well as single channel patch-clamp recordings, Ca2+-imaging and Western blot analysis after heterologous expression of wild-type and mutated channels in HEK-293 cells. We demonstrate that the removal of the entire NUDT9H domain does not disturb the response of nvTRPM2 to ADP-ribose. The deletion, however, created channels that were activated by hydrogen peroxide, as did mutations within the NUDT9H domain of nvTRPM2 that presumably suppress its enzymatic function. The same findings were obtained with the nvTRPM2 channel when the NUDT9H domain was replaced by the corresponding sequences of the original hNUDT9 enzyme. Whenever the enzyme domain was mutated to presumably inactive variants, channel activation by hydrogen peroxide could be achieved. Moreover, we found strong evidences for ADPRase activity of the isolated NUDT9H domain of nvTRPM2 in co-expression experiments with the C-terminally truncated nvTRPM2 channel. Thus, there is a clear correlation between the loss of enzymatic activity and the capability of nvTRPM2 to respond to oxidative stress. In striking contrast, the channel function of the hTRPM2 orthologue, in particular its sensitivity to ADP-ribose, was abrogated by already small changes of the NUDT9H domain. These findings establish nvTRPM2 as a channel gated by ADP-ribose through a novel mechanism. We conclude that the endogenous NUDT9H domain does not directly affect ADP-ribose-dependent gating of the nvTRPM2 channel; instead it exerts an independent catalytic function which possibly controls the intracellular availability of ADP-ribose.	[Kuehn, Frank J. P.; Kuehn, Cornelia; Winking, Mathis; Hoffmann, Daniel C.; Lueckhoff, Andreas] Rhein Westfal TH Aachen, Fac Med, Inst Physiol, D-52057 Aachen, Germany	RWTH Aachen University	Kuhn, FJP (corresponding author), Rhein Westfal TH Aachen, Fac Med, Inst Physiol, D-52057 Aachen, Germany.	fkuehn@physiology.rwth-aachen.de	Kuehn, Frank JP/H-5889-2018		Deutsche Forschungsgemeinschaft [KU 2271/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de), grant number: KU 2271/4-1 to FK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Carloto A, 2006, BBA-GEN SUBJECTS, V1760, P1545, DOI 10.1016/j.bbagen.2006.06.003; Citarelli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-308; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Jang Y, 2015, J NEUROSCI, V35, P11811, DOI 10.1523/JNEUROSCI.5251-14.2015; Kahya MC, 2017, MOL NEUROBIOL, V54, P2345, DOI 10.1007/s12035-016-9727-3; Knowles H, 2013, IMMUNOL RES, V55, P241, DOI 10.1007/s12026-012-8373-8; Kozai D, 2014, ANTIOXID REDOX SIGN, V21, P971, DOI 10.1089/ars.2013.5616; Kuhn FJP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08032; Kuhn FJP, 2013, PFLUG ARCH EUR J PHY, V465, P1599, DOI 10.1007/s00424-013-1302-4; Kuhn FJP, 2010, J BIOL CHEM, V285, P26806, DOI 10.1074/jbc.M110.109975; Kuhn FJP, 2004, J BIOL CHEM, V279, P46431, DOI 10.1074/jbc.M407263200; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; Maue RA, 2007, J CELL PHYSIOL, V213, P618, DOI 10.1002/jcp.21259; Mei ZZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1022, DOI 10.1152/ajpcell.00606.2005; Ostapchenko VG, 2015, J NEUROSCI, V35, P15157, DOI 10.1523/JNEUROSCI.4081-14.2015; Peng GD, 2015, MOL PHYLOGENET EVOL, V84, P145, DOI 10.1016/j.ympev.2014.06.016; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2003, J BIOL CHEM, V278, P1794, DOI 10.1074/jbc.M205601200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reitzel AM, 2008, BIOL BULL-US, V214, P233, DOI 10.2307/25470666; Reitzel AM, 2013, MAR ECOL PROG SER, V484, P115, DOI 10.3354/meps10281; Ru Xiaochen, 2014, Shengli Xuebao, V66, P7; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schnitzler MMY, 2008, FASEB J, V22, P1540, DOI 10.1096/fj.07-9694com; Shen BW, 2003, J MOL BIOL, V332, P385, DOI 10.1016/S0022-2836(03)00954-9; Sullivan JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007311; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Tarrant AM, 2014, J EXP BIOL, V217, P1444, DOI 10.1242/jeb.093690; Toth B, 2015, J GEN PHYSIOL, V145, P419, DOI 10.1085/jgp.201511377; Toth B, 2014, P NATL ACAD SCI USA, V111, P16949, DOI 10.1073/pnas.1412449111; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200	37	21	21	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0158060	10.1371/journal.pone.0158060	http://dx.doi.org/10.1371/journal.pone.0158060			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333281	gold, Green Submitted, Green Published			2022-12-26	WOS:000378212800073
J	Lian, TC; Bonn, G; Han, YS; Choo, YC; Piau, WC				Lian, Tam Cai; Bonn, Gregory; Han, Yeoh Si; Choo, Yap Chin; Piau, Wong Chee			Physical Activity and Its Correlates among Adults in Malaysia: A Cross-Sectional Descriptive Study	PLOS ONE			English	Article							PREVALENCE; DETERMINANTS; VARIABLES; EXERCISE; HEALTH	Obesity and rates of non-communicable diseases linked to physical inactivity have increased dramatically in Malaysia over the past 20 years. Malaysia has also been identified as one of the least physically active countries in the world with over 60% of adults being essentially sedentary. This study examines the relationship of socio-demographic factors to physical activity among 770 adults from 3 Malaysian states. Physical activity levels were significantly related to ethnicity, gender, age, occupation and educational level. Controlling for inter-relationships among these variables; age, gender, Chinese ethnicity and education level were found to have unique effects on total physical activity, as well as moderate and vigorous exercise. As would be expected, younger people were more physically active, engaging more in both moderate and vigorous types of exercise and males were generally more active than females. Contrary to findings from many developed countries, however, more educated Malaysians were less likely to engage in all types of physical activity. Ethnic Chinese participants, and to a lesser degree Indians also consistently reported lower levels of activity. Possible intervention strategies are discussed that specifically target ethnic and cultural norms related to physical activity. Future research programs exploring barriers to participation and perceptions of physical activity, as well as programs to encourage active life styles among youths are also suggested.	[Lian, Tam Cai; Han, Yeoh Si; Choo, Yap Chin] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Dept Psychol, Bandar Sunway, Malaysia; [Bonn, Gregory] Japan Soc Promot Sci, Tokyo, Japan; [Bonn, Gregory] Nagoya Univ, Dept Educ & Human Dev, Nagoya, Aichi 4648601, Japan; [Bonn, Gregory] UCSI Univ, Dept Psychol, Kuala Lumpur, Malaysia; [Piau, Wong Chee] Monash Univ Malaysia, Dept Med, Jeffrey Cheah Med & Hlth Sci, Bandar Sunway, Malaysia	Monash University; Monash University Sunway; Japan Society for the Promotion of Science; Nagoya University; UCSI University; Monash University; Monash University Sunway	Bonn, G (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.; Bonn, G (corresponding author), Nagoya Univ, Dept Educ & Human Dev, Nagoya, Aichi 4648601, Japan.; Bonn, G (corresponding author), UCSI Univ, Dept Psychol, Kuala Lumpur, Malaysia.	gbbonn@hotmail.com	Bonn, Gregory/F-8992-2017		Fundamental Research Grant (FRGS) from Ministry of Education, Malaysia; Monash University Malaysia Tele-Medicine unit of the Tropical Medicine and Biology MultiDisciplinary Research Platform; Japan Society for the Promotion of Science; JSPS	Fundamental Research Grant (FRGS) from Ministry of Education, Malaysia; Monash University Malaysia Tele-Medicine unit of the Tropical Medicine and Biology MultiDisciplinary Research Platform; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Tam Cai Lian and Gregory Bonn received a Fundamental Research Grant (FRGS) from the Ministry of Education, Malaysia. Tam Cai Lian, Gregory Bonn, and Wong Chee Piau received funding from the Monash University Malaysia Tele-Medicine unit of the Tropical Medicine and Biology MultiDisciplinary Research Platform. Gregory Bonn received a Grant-in-Aid for International Researchers from the Japan Society for the Promotion of Science. Gregory Bonn, as an International Research Fellow of the Japan Society for the Promotion of Science, received a living stipend from JSPS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayiesah R., 2007, JUMMEC, V10, P29, DOI [DOI 10.22452/JUMMEC.V0L10N01.7, 10.22452/jummec.vol10no1.7]; Azevedo MR, 2007, INT J PUBLIC HEALTH, V52, P8, DOI 10.1007/s00038-006-5062-1; Azmi M Y Jr, 2009, Malays J Nutr, V15, P97; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Bauman AE, 2002, AM J PREV MED, V23, P5, DOI 10.1016/S0749-3797(02)00469-5; Burton NW, 2000, PREV MED, V31, P673, DOI 10.1006/pmed.2000.0763; CALDER BJ, 1982, J CONSUM RES, V9, P240, DOI 10.1086/208920; Cobb-Clark DA, 2012, 6789 IZA I STUD LAB; Courneya KS, 2006, PSYCHOL HEALTH, V21, P557, DOI 10.1080/14768320500422857; DENNISON BA, 1988, PEDIATRICS, V82, P324; DeVries LA, 1990, 28 INT CONV CONJ LAU; Ding D, 2011, AM J PREV MED, V41, P442, DOI 10.1016/j.amepre.2011.06.036; Engberg E, 2012, SPORTS MED, V42, P433, DOI 10.2165/11597610-000000000-00000; Godwin M, 2008, CAN FAM PHYSICIAN, V54, P76; Hallal PC, 2003, MED SCI SPORT EXER, V35, P1894, DOI 10.1249/01.MSS.0000093615.33774.0E; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hawkins MS, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-31; Ibrahim S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-275; IPH, 2008, NAT HLTH MORB SURV 2; Kaur J, 2015, ASIA-PAC J PUBLIC HE, V27, P314, DOI 10.1177/1010539513517257; King AC, 1998, ANN BEHAV MED, V20, P64, DOI 10.1007/BF02884450; Ministry of Health Malaysia Nation Coordinating Committee on Food and Nutrition, 2010, MAL DIET GUID; Pettee KK, 2006, MED SCI SPORT EXER, V38, P541, DOI 10.1249/01.mss.0000191346.95244.f7; Poh B K Jr, 2010, Malays J Nutr, V16, P13; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Rampal L, 2007, ASIA PAC J CLIN NUTR, V16, P561; Razak AM, 2010, J ASIA PACIFIC STUDI, V1, P364; Seiluri T, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-14; Shaw BA, 2008, J AGING HEALTH, V20, P767, DOI 10.1177/0898264308321081; Sherwood NE, 2000, ANNU REV NUTR, V20, P21, DOI 10.1146/annurev.nutr.20.1.21; Tam CL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01328; Teh CH, 2014, PUBLIC HEALTH, V128, P416, DOI 10.1016/j.puhe.2013.10.008; WALLSTON KA, 1978, HEALTH EDUC QUART, V6, P160, DOI 10.1177/109019817800600107; Wee E, 2013, J PHYS ACTIVITY SPOR, V1, P17; WHO, 2003, WHO TECH REP SER, V916, P1; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2010, WHO GLOB INF BAS IND; YAP CC, 2014, PSYCHOSOCIAL VARIABL, P319	38	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157730	10.1371/journal.pone.0157730	http://dx.doi.org/10.1371/journal.pone.0157730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP0WX	27332883	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212800046
J	Gilmore, RO; Thomas, AL; Fesi, J				Gilmore, Rick O.; Thomas, Amanda L.; Fesi, Jeremy			Children's Brain Responses to Optic Flow Vary by Pattern Type and Motion Speed	PLOS ONE			English	Article							TEMPORAL VISUAL AREA; CORTICAL RESPONSES; FUNCTIONAL-PROPERTIES; PHYSICAL ABILITIES; SENSITIVITY; PERCEPTION; SELECTIVITY; DIRECTION; INFANTS; MT	Structured patterns of global visual motion called optic flow provide crucial information about an observer's speed and direction of self-motion and about the geometry of the environment. Brain and behavioral responses to optic flow undergo considerable postnatal maturation, but relatively little brain imaging evidence describes the time course of development in motion processing systems in early to middle childhood, a time when psychophysical data suggest that there are changes in sensitivity. To fill this gap, electroen-cephalographic (EEG) responses were recorded in 4-to 8-year-old children who viewed three time-varying optic flow patterns (translation, rotation, and radial expansion/contraction) at three different speeds (2, 4, and 8 deg/s). Modulations of global motion coherence evoked coherent EEG responses at the first harmonic that differed by flow pattern and responses at the third harmonic and dot update rate that varied by speed. Pattern-related responses clustered over right lateral channels while speed-related responses clustered over midline channels. Both children and adults show widespread responses to modulations of motion coherence at the second harmonic that are not selective for pattern or speed. The results suggest that the developing brain segregates the processing of optic flow pattern from speed and that an adult-like pattern of neural responses to optic flow has begun to emerge by early to middle childhood.	[Gilmore, Rick O.; Thomas, Amanda L.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Fesi, Jeremy] CUNY City Coll, Dept Psychol, New York, NY 10031 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; City University of New York (CUNY) System; City College of New York (CUNY)	Gilmore, RO (corresponding author), Penn State Univ, Dept Psychol, University Pk, PA 16802 USA.	rogilmore@psu.edu		Gilmore, Rick/0000-0002-7676-3982	U.S. National Science Foundation [BCS-1147440]; Direct For Social, Behav & Economic Scie [1147440] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by the U.S. National Science Foundation under BCS-1147440.	Agyei SB, 2015, DEVELOPMENTAL SCI, V18, P436, DOI 10.1111/desc.12221; Ahlfors SP, 1999, J NEUROPHYSIOL, V82, P2545, DOI 10.1152/jn.1999.82.5.2545; Ahmed IJ, 2005, VISION RES, V45, P2129, DOI 10.1016/j.visres.2005.01.036; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Appelbaum LG, 2006, J NEUROSCI, V26, P11695, DOI 10.1523/JNEUROSCI.2741-06.2006; Atchley P, 1998, PSYCHOL AGING, V13, P297, DOI 10.1037/0882-7974.13.2.297; Bogfjellmo LG, 2014, J VISION, V14, DOI 10.1167/14.2.19; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; Braddick O, 2011, VISION RES, V51, P1588, DOI 10.1016/j.visres.2011.02.018; Britten KH, 2008, ANNU REV NEUROSCI, V31, P389, DOI 10.1146/annurev.neuro.29.051605.112953; Brosseau-Lachaine O, 2008, J VISION, V8, DOI 10.1167/8.4.5; Cai P, 2014, EXP BRAIN RES, V232, P4035, DOI 10.1007/s00221-014-4084-9; Connelly ML, 1998, ACCIDENT ANAL PREV, V30, P443, DOI 10.1016/S0001-4575(97)00109-7; Cottereau BR, 2014, J NEUROPHYSIOL, V111, P533, DOI 10.1152/jn.00549.2013; Crowell JA, 1998, NAT NEUROSCI, V1, P732, DOI 10.1038/3732; Culham J, 2001, ACTA PSYCHOL, V107, P69, DOI 10.1016/S0001-6918(01)00022-1; Cutting JE, 2002, J EXP PSYCHOL HUMAN, V28, P731, DOI 10.1037/0096-1523.28.3.731; de Hadad B.-S., 2015, FRONTIERS IN INTEGRA, V49; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Dukelow SP, 2001, J NEUROPHYSIOL, V86, P1991, DOI 10.1152/jn.2001.86.4.1991; DUPONT P, 1994, J NEUROPHYSIOL, V72, P1420, DOI 10.1152/jn.1994.72.3.1420; Ellemberg D, 2004, VISION RES, V44, P2403, DOI 10.1016/j.visres.2004.05.006; Falkenberg HK, 2014, VISION RES, V100, P8, DOI 10.1016/j.visres.2014.04.001; Ferber S, 2003, CEREB CORTEX, V13, P716, DOI 10.1093/cercor/13.7.716; Fesi JD, 2014, VISION RES, V100, P56, DOI 10.1016/j.visres.2014.04.004; Fesi JD, 2011, VISION RES, V51, P2110, DOI 10.1016/j.visres.2011.07.015; Fischer E, 2012, NEURON, V73, P1228, DOI 10.1016/j.neuron.2012.01.022; Gibson J. J., 1950, THE PERCEPTION OF TH, Vxii; Gilmore R. O., 2015, 2015 IEEE INTERNATIO; Gilmore RO, 2007, VISUAL NEUROSCI, V24, P845, DOI 10.1017/S0952523807070769; Goossens J, 2006, J NEUROSCI, V26, P5616, DOI 10.1523/JNEUROSCI.0730-06.2006; Gordon GE, 1999, DOC OPHTHALMOL, V99, P1, DOI 10.1023/A:1002171011644; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Hadad BS, 2011, DEVELOPMENTAL SCI, V14, P1330, DOI 10.1111/j.1467-7687.2011.01078.x; Hou C, 2009, VISION RES, V49, P2509, DOI 10.1016/j.visres.2009.08.007; Huk AC, 2002, J NEUROSCI, V22, P7195; Johnson M H, 1990, J Cogn Neurosci, V2, P81, DOI 10.1162/jocn.1990.2.2.81; Joshi MR, 2015, VISION RES, V110, P68, DOI 10.1016/j.visres.2015.03.006; Jouen F, 2000, INFANT BEHAV DEV, V23, P271, DOI 10.1016/S0163-6383(01)00044-3; Kiorpes L, 2004, VISUAL NEUROSCI, V21, P851, DOI 10.1017/S0952523804216054; KOENDERINK JJ, 1986, VISION RES, V26, P161, DOI 10.1016/0042-6989(86)90078-7; Koyama S, 2005, CURR BIOL, V15, P2027, DOI 10.1016/j.cub.2005.10.069; Kubova Z., 2014, CLINICAL NEUROPHYSIO, V125, pe36; Lefebvre L., 2010, J VISION, V9, P630; Manning C, 2012, VISION RES, V70, P27, DOI 10.1016/j.visres.2012.08.004; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Meier K, 2014, VISION RES, V95, P61, DOI 10.1016/j.visres.2013.12.007; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; Narasimhan S, 2012, VISION RES, V62, P102, DOI 10.1016/j.visres.2012.02.016; Nardini M, 2008, CURR BIOL, V18, P689, DOI 10.1016/j.cub.2008.04.021; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Parrish EE, 2005, VISION RES, V45, P827, DOI 10.1016/j.visres.2004.10.005; Peuskens H, 2001, J NEUROSCI, V21, P2451, DOI 10.1523/JNEUROSCI.21-07-02451.2001; Plumert JM, 1997, J EXP CHILD PSYCHOL, V67, P317, DOI 10.1006/jecp.1997.2411; PLUMERT JM, 1995, DEV PSYCHOL, V31, P866, DOI 10.1037/0012-1649.31.5.866; Plumert JM, 2004, CHILD DEV, V75, P1243, DOI 10.1111/j.1467-8624.2004.00736.x; Plumert JM, 2007, CURR DIR PSYCHOL SCI, V16, P255, DOI 10.1111/j.1467-8721.2007.00515.x; Plumert JM, 2014, CHILD DEV PERSPECT, V8, P207, DOI 10.1111/cdep.12089; R. Core Team, 2015, R A LANGUAGE AND ENV; Raudies F, 2012, J IEEE I C DEVELOP L; Raudies F, 2014, NEURAL COMPUT, V26, P2652, DOI 10.1162/NECO_a_00645; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Rosander K, 2007, VISION RES, V47, P1614, DOI 10.1016/j.visres.2007.03.004; ROYDEN CS, 1994, VISION RES, V34, P3197, DOI 10.1016/0042-6989(94)90084-1; Rushton SK, 1998, CURR BIOL, V8, P1191, DOI 10.1016/S0960-9822(07)00492-7; SAITO H, 1986, J NEUROSCI, V6, P145; Scherf KS, 2007, DEVELOPMENTAL SCI, V10, pF15, DOI 10.1111/j.1467-7687.2007.00595.x; Scherf KS, 2011, CEREB CORTEX, V21, P1963, DOI 10.1093/cercor/bhq269; Sekuler R., 2002, HANDBOOK OF EXPERIME; Shirai N, 2008, EXP BRAIN RES, V190, P201, DOI 10.1007/s00221-008-1461-2; Shirai N, 2008, EXP BRAIN RES, V185, P461, DOI 10.1007/s00221-007-1170-2; Shirai N, 2009, DEVELOPMENTAL SCI, V12, P946, DOI 10.1111/j.1467-7687.2009.00839.x; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Teller DY, 1997, INVEST OPHTH VIS SCI, V38, P2183; Tootell RBH, 1997, J NEUROSCI, V17, P7060; VANDENBERG AV, 1992, VISION RES, V32, P1285, DOI 10.1016/0042-6989(92)90223-6; VANESSEN DC, 1994, NEURON, V13, P1, DOI 10.1016/0896-6273(94)90455-3; VICTOR JD, 1991, ELECTROEN CLIN NEURO, V78, P378, DOI 10.1016/0013-4694(91)90099-P; von Pfostl V, 2009, NEUROIMAGE, V45, P1253, DOI 10.1016/j.neuroimage.2008.12.058; Wall MB, 2008, CURR BIOL, V18, P191, DOI 10.1016/j.cub.2007.12.053; Wann JP, 2011, PSYCHOL SCI, V22, P429, DOI 10.1177/0956797611400917; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WARREN WH, 1988, J EXP PSYCHOL HUMAN, V14, P646, DOI 10.1037/0096-1523.14.4.646; WARREN WH, 1990, J OPT SOC AM A, V7, P160, DOI 10.1364/JOSAA.7.000160; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Wattam-Bell J, 2010, CURR BIOL, V20, P411, DOI 10.1016/j.cub.2009.12.020; Wickham H., 2015, DPLYR A GRAMMAR OF D; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilkie R, 2003, J EXP PSYCHOL HUMAN, V29, P363, DOI 10.1037/0096-1523.29.2.363	89	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157911	10.1371/journal.pone.0157911	http://dx.doi.org/10.1371/journal.pone.0157911			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP0WU	27326860	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400062
J	Gudiksen, A; Schwartz, CL; Bertholdt, L; Joensen, E; Knudsen, JG; Pilegaard, H				Gudiksen, Anders; Schwartz, Camilla Lindgren; Bertholdt, Laerke; Joensen, Ella; Knudsen, Jakob G.; Pilegaard, Henriette			Lack of Skeletal Muscle IL-6 Affects Pyruvate Dehydrogenase Activity at Rest and during Prolonged Exercise	PLOS ONE			English	Article							PHENOL-CHLOROFORM EXTRACTION; FATTY-ACID OXIDATION; SINGLE-STEP METHOD; CARBOHYDRATE-METABOLISM; PROTEIN-KINASE; GLUCOSE-UPTAKE; PHOSPHORYLATION SITES; INSULIN SENSITIVITY; INDUCED INCREASE; GENE-EXPRESSION	Pyruvate dehydrogenase (PDH) plays a key role in the regulation of skeletal muscle substrate utilization. IL-6 is produced in skeletal muscle during exercise in a duration dependent manner and has been reported to increase whole body fatty acid oxidation, muscle glucose uptake and decrease PDHa activity in skeletal muscle of fed mice. The aim of the present study was to examine whether muscle IL-6 contributes to exercise-induced PDH regulation in skeletal muscle. Skeletal muscle-specific IL-6 knockout (IL-6 MKO) mice and floxed littermate controls (control) completed a single bout of treadmill exercise for 10, 60 or 120 min, with rested mice of each genotype serving as basal controls. The respiratory exchange ratio (RER) was overall higher (P<0.05) in IL-6 MKO than control mice during the 120 min of treadmill exercise, while RER decreased during exercise independent of genotype. AMPK and ACC phosphorylation also increased with exercise independent of genotype. PDHa activity was in control mice higher (P<0.05) at 10 and 60 min of exercise than at rest but remained unchanged in IL-6 MKO mice. In addition, PDHa activity was higher (P<0.05) in IL-6 MKO than control mice at rest and 60 min of exercise. Neither PDH phosphorylation nor acetylation could explain the genotype differences in PDHa activity. Together, this provides evidence that skeletal muscle IL-6 contributes to the regulation of PDH at rest and during prolonged exercise and suggests that muscle IL-6 normally dampens carbohydrate utilization during prolonged exercise via effects on PDH.	[Gudiksen, Anders; Schwartz, Camilla Lindgren; Bertholdt, Laerke; Joensen, Ella; Knudsen, Jakob G.; Pilegaard, Henriette] Univ Copenhagen, Dept Biol, Sect Cell Biol & Physiol, Copenhagen, Denmark	University of Copenhagen	Gudiksen, A (corresponding author), Univ Copenhagen, Dept Biol, Sect Cell Biol & Physiol, Copenhagen, Denmark.	anders.gudiksen@bio.ku.dk	Knudsen, Jakob G/Q-2227-2018; Pilegaard, Henriette/M-2315-2014	Knudsen, Jakob G/0000-0001-7237-8457; Pilegaard, Henriette/0000-0002-1071-0327; Schwartz, Camilla Lindgren/0000-0002-2352-7396	Lundbeckfonden [R93-2011-8974]; Danish Agency for Science, Technology and Innovation [DFF-1323-00317]; Lundbeck Foundation [R93-2011-8974] Funding Source: researchfish	Lundbeckfonden(Lundbeckfonden); Danish Agency for Science, Technology and Innovation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by Lundbeckfonden: R93-2011-8974, www.lundbeckfonden.com/; Danish Agency for Science, Technology and Innovation, DFF-1323-00317, http://ufm.dk/en/the-minister-and-the-ministry/organisation/the-danish-agency-for-science-technology-and-innovation/contact. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abroun S, 2015, CELL J, V17, P395; Adser H, 2011, ACTA PHYSIOL, V202, P165, DOI 10.1111/j.1748-1716.2011.02269.x; Benrick A, 2012, EXP PHYSIOL, V97, P1224, DOI 10.1113/expphysiol.2012.065508; Bienso RS, 2014, PFLUG ARCH EUR J PHY, V466, P1647, DOI 10.1007/s00424-013-1399-5; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Castellani L, 2015, J APPL PHYSIOL, V119, P1347, DOI 10.1152/japplphysiol.00551.2015; CEDERBLAD G, 1990, ANAL BIOCHEM, V185, P274, DOI 10.1016/0003-2697(90)90292-H; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Colbert LH, 2001, INT J SPORTS MED, V22, P261, DOI 10.1055/s-2001-13818; CONSTANTINTEODOSIU D, 1991, ANAL BIOCHEM, V198, P347, DOI 10.1016/0003-2697(91)90437-X; Coyle EF, 1997, AM J PHYSIOL-ENDOC M, V273, pE268, DOI 10.1152/ajpendo.1997.273.2.E268; Faldt J, 2004, ENDOCRINOLOGY, V145, P2680, DOI 10.1210/en.2003-1319; Fritsche L, 2010, DIABETOLOGIA, V53, P1732, DOI 10.1007/s00125-010-1754-4; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Harris RA, 2001, ADV ENZYME REGUL, V41, P269, DOI 10.1016/S0065-2571(00)00020-0; Helge JW, 2011, EXP PHYSIOL, V96, P590, DOI 10.1113/expphysiol.2010.056424; Helge JW, 2003, J PHYSIOL-LONDON, V546, P299, DOI 10.1113/jphysiol.2002.030437; HERMANSE.L, 1967, ACTA PHYSIOL SCAND, V71, P129, DOI 10.1111/j.1748-1716.1967.tb03719.x; Jing EX, 2013, DIABETES, V62, P3404, DOI 10.2337/db12-1650; Kaminski KA, 2012, ADV MED SCI-POLAND, V57, P94, DOI 10.2478/v10039-011-0059-2; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Kiilerich K, 2008, AM J PHYSIOL-ENDOC M, V294, pE36, DOI 10.1152/ajpendo.00352.2007; Kiilerich K, 2010, DIABETES, V59, P26, DOI 10.2337/db09-1032; Klein DK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1242, DOI 10.1152/ajpendo.00382.2007; Knudsen JG, 2015, OBESITY, V23, P1616, DOI 10.1002/oby.21139; Korotchkina LG, 2001, J BIOL CHEM, V276, P37223, DOI 10.1074/jbc.M103069200; Korotchkina LG, 2001, J BIOL CHEM, V276, P5731, DOI 10.1074/jbc.M007558200; Lauritzen HPMM, 2013, DIABETES, V62, P3081, DOI 10.2337/db12-1261; LOWRY CV, 1978, J BIOL CHEM, V253, P8269; Mourtzakis M, 2006, J APPL PHYSIOL, V100, P1822, DOI 10.1152/japplphysiol.00571.2005; O'Neill HM, 2013, J APPL PHYSIOL, V114, P1151, DOI 10.1152/japplphysiol.00946.2012; Ozden O, 2014, FREE RADICAL BIO MED, V76, P163, DOI 10.1016/j.freeradbiomed.2014.08.001; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; Patel MS, 2001, EXP MOL MED, V33, P191, DOI 10.1038/emm.2001.32; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Pilegaard H, 2006, DIABETES, V55, P3020, DOI 10.2337/db06-0152; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; PUTMAN CT, 1993, AM J PHYSIOL, V265, pE752, DOI 10.1152/ajpendo.1993.265.5.E752; Quintana A, 2013, BRAIN BEHAV IMMUN, V27, P162, DOI 10.1016/j.bbi.2012.10.011; RANDLE PJ, 1963, LANCET, V1, P785; Reilly SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7047; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Smith AC, 2005, J PHYSIOL-LONDON, V565, P537, DOI 10.1113/jphysiol.2004.081679; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; van Loon LJC, 2001, J PHYSIOL-LONDON, V536, P295, DOI 10.1111/j.1469-7793.2001.00295.x; WARD GR, 1982, CLIN SCI, V63, P87, DOI 10.1042/cs0630087; Watt MJ, 2004, J APPL PHYSIOL, V97, P1261, DOI 10.1152/japplphysiol.00132.2004; Watt MJ, 2002, J PHYSIOL-LONDON, V541, P969, DOI 10.1113/jphysiol.2002.018820; Wojtaszewski JFP, 2003, AM J PHYSIOL-ENDOC M, V284, pE813, DOI 10.1152/ajpendo.00436.2002; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; Wolsk E, 2010, AM J PHYSIOL-ENDOC M, V299, pE832, DOI 10.1152/ajpendo.00328.2010	53	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0156460	10.1371/journal.pone.0156460	http://dx.doi.org/10.1371/journal.pone.0156460			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327080	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400003
J	Toschi, P; Czernik, M; Zacchini, F; Fidanza, A; Loi, P; Ptak, GE				Toschi, Paola; Czernik, Marta; Zacchini, Federica; Fidanza, Antonella; Loi, Pasqualino; Ptak, Grazyna Ewa			Evidence of Placental Autophagy during Early Pregnancy after Transfer of In Vitro Produced (IVP) Sheep Embryos	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; POOR PLACENTATION; TROPHOBLAST; DECORIN; GROWTH; PREECLAMPSIA; DYSFUNCTION; INDUCTION; PROTEINS; HYPOXIA	Pregnancies obtained by Assisted Reproductive Technologies (ART) are associated with limited maternal nutrient uptake. Our previous studies shown that in vitro culture of sheep embryos is associated with vascularization defects in their placentae and consequent reduction of embryo growth. Autophagy is a pro-survival cellular mechanism triggered by nutrient insufficiency. Therefore, the goal of our present study was to determine if autophagy is involved in early placental development after transfer of in vitro produced (IVP) embryos. To do this, placentae obtained following transfer of IVP sheep embryos were compared with placentae obtained after natural mating (control-CTR). The placentae were collected on day 20 post-fertilization and post-mating, respectively, and were analyzed using molecular (qPCR), ultrastructural and histological/immunological approaches. Our results show drastically increased autophagy in IVP placentae: high levels of expression (p<0.05) of canonical markers of cellular autophagy and a high proportion of autophagic cells (35.08%; p<0.001) were observed. We conclude that high autophagic activity in IVP placentae can be a successful temporary counterbalance to the retarded vasculogenesis and the reduction of foetal growth observed in pregnancies after transfer of IVP embryos.	[Toschi, Paola; Czernik, Marta; Loi, Pasqualino; Ptak, Grazyna Ewa] Univ Teramo, Fac Vet Med, Piazza Aldo Moro 45, I-64100 Teramo, Italy; [Zacchini, Federica; Fidanza, Antonella; Ptak, Grazyna Ewa] Polish Acad Sci, Inst Genet & Anim Breeding, Jastrzebiec Ul Postepu 36A, PL-05552 Magdalenka, Poland; [Ptak, Grazyna Ewa] Natl Res Inst Anim Prod, 1 Krakowska St, PL-32083 Balice, Poland	University of Teramo; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; National Research Institute of Animal Production	Ptak, GE (corresponding author), Univ Teramo, Fac Vet Med, Piazza Aldo Moro 45, I-64100 Teramo, Italy.; Ptak, GE (corresponding author), Polish Acad Sci, Inst Genet & Anim Breeding, Jastrzebiec Ul Postepu 36A, PL-05552 Magdalenka, Poland.; Ptak, GE (corresponding author), Natl Res Inst Anim Prod, 1 Krakowska St, PL-32083 Balice, Poland.	grazyna.ptak@izoo.krakow.pl	Zacchini, Federica/GQY-5276-2022; Fidanza, Antonella/N-7598-2019	Zacchini, Federica/0000-0001-7942-2625; Fidanza, Antonella/0000-0002-1266-6454; CZERNIK, Marta Teresa/0000-0002-4535-4932	European Union's Horizon Research and Innovation Programme (Acronym ERAofART) [692185]; European Union [312097 FECUND]; MIUR/CNR Programme FIRB GA [B81J12002520001]	European Union's Horizon Research and Innovation Programme (Acronym ERAofART); European Union(European Commission); MIUR/CNR Programme FIRB GA	The research leading to these results received funding from the European Union's Horizon 2020 Research and Innovation Programme under grant agreement No. 692185 (Acronym ERAofART) to GEP and European Union Seventh Framework Programme for research, technological development and demonstration under grant agreement no 312097 FECUND, and from MIUR/CNR Programme FIRB GA no B81J12002520001 Acronym: GenHome. The authors PT, MC, AF, FZ, PL and GEP are participating in the COST action FA 1201 EPICONCEPT - Epigenetic and Periconception Environment.	Avagliano L, 2015, REPROD SCI, V22, P838, DOI 10.1177/1933719114565036; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bloise E, 2012, ENDOCRINOLOGY, V153, P3457, DOI 10.1210/en.2011-1921; Broad KD, 2011, P NATL ACAD SCI USA, V108, P15237, DOI 10.1073/pnas.1106022108; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chinnadurai G, 2008, ONCOGENE, V27, pS114, DOI 10.1038/onc.2009.49; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Curtis S, 2013, J MATERN-FETAL NEO M, V26, P339, DOI 10.3109/14767058.2012.733764; Delle Piane L, 2010, HUM REPROD, V25, P2039, DOI 10.1093/humrep/deq165; Dhont M, 1999, AM J OBSTET GYNECOL, V181, P688, DOI 10.1016/S0002-9378(99)70514-4; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; DOYLE P, 1992, HUM REPROD, V7, P425, DOI 10.1093/oxfordjournals.humrep.a137663; Fauque P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009218; Ferraretti AP, 2012, HUM REPROD, V27, P2571, DOI 10.1093/humrep/des255; Fidanza A, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.113902; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Goldman-Wohl D, 2013, PLACENTA, V34, P959, DOI 10.1016/j.placenta.2013.07.069; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hansen M, 2013, HUM REPROD UPDATE, V19, P330, DOI 10.1093/humupd/dmt006; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Hung TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083475; Hung TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040957; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Iacob D, 2008, ENDOCRINOLOGY, V149, P6187, DOI 10.1210/en.2008-0780; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kalkat M, 2013, AUTOPHAGY, V9, P2140, DOI 10.4161/auto.26452; Khan GA, 2011, MOL ENDOCRINOL, V25, P1431, DOI 10.1210/me.2010-0426; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Mazure NM, 2010, CURR OPIN CELL BIOL, V22, P177, DOI 10.1016/j.ceb.2009.11.015; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nakabayashi Y, 2015, J REPROD IMMUNOL; Nakashima A, 2013, AUTOPHAGY, V9, P303, DOI 10.4161/auto.22927; Neill T, 2013, AUTOPHAGY, V9, P1626, DOI 10.4161/auto.25881; Ness RB, 2006, AM J OBSTET GYNECOL, V195, P40, DOI 10.1016/j.ajog.2005.07.049; Oh SY, 2008, REPROD SCI, V15, P912, DOI 10.1177/1933719108319159; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Ptak GE, 2013, HUM REPROD, V28, P298, DOI 10.1093/humrep/des397; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Saito S, 2013, PLACENTA, V34, pS79, DOI 10.1016/j.placenta.2012.11.026; Saito S, 2014, J REPROD IMMUNOL, V101, P80, DOI 10.1016/j.jri.2013.06.002; Shevell T, 2005, OBSTET GYNECOL, V106, P1039, DOI 10.1097/01.AOG.0000183593.24583.7c; Signorelli P, 2011, PLACENTA, V32, P482, DOI 10.1016/j.placenta.2011.03.005; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Stringfellow D. A., 2010, MANUAL INT EMBRYO TR; Sui LL, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.124248; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Yamanaka-Tatematsu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076605; Zhang XD, 2009, J NEUROSCI RES, V87, P3600, DOI 10.1002/jnr.22152; Zhang Y, 2010, PLACENTA, V31, P251, DOI 10.1016/j.placenta.2010.01.005; Zhang Y, 2008, PROTEOMICS, V8, P4344, DOI 10.1002/pmic.200800294	55	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157594	10.1371/journal.pone.0157594	http://dx.doi.org/10.1371/journal.pone.0157594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27326761	Green Published, gold			2022-12-26	WOS:000378212400025
J	Akin, L; Macabeo, B; Caliskan, Z; Altinel, S; Satman, I				Akin, Levent; Macabeo, Berengere; Caliskan, Zafer; Altinel, Serdar; Satman, Ilhan			Cost-Effectiveness of Increasing Influenza Vaccination Coverage in Adults with Type 2 Diabetes in Turkey	PLOS ONE			English	Article							SEASONAL INFLUENZA; HEALTHY-ADULTS; RISK; PEOPLE; IMPACT; HOSPITALIZATIONS; METAANALYSES; POPULATION; INFECTIONS; PREVALENCE	Objective In Turkey, the prevalence of diabetes is high but the influenza vaccination coverage rate (VCR) is low (9.1% in 2014), despite vaccination being recommended and reimbursed. This study evaluated the cost-effectiveness of increasing the influenza VCR of adults with type 2 diabetes in Turkey to 20%. Methods A decision-analytic model was adapted to Turkey using data derived from published sources. Direct medical costs and indirect costs due to productivity loss were included in the societal perspective. The time horizon was set at 1 year to reflect the seasonality of influenza. Results Increasing the VCR for adults with type 2 diabetes to 20% is predicted to avert an additional 19,777 influenza cases, 2376 hospitalizations, and 236 deaths. Associated influenza costs avoided were estimated at more than 8.3 million Turkish Lira (TRY), while the cost of vaccination would be more than TRY 8.4 million. The incremental cost-effectiveness ratio was estimated at TRY 64/quality-adjusted life years, which is below the per capita gross domestic product of TRY 21,511 and therefore very cost-effective according to World Health Organization guidelines. Factors most influencing the incremental cost-effectiveness ratio were the excess hospitalization rate, inpatient cost, vaccine effectiveness against hospitalization, and influenza attack rate. Increasing the VCR to >20% was also estimated to be very cost-effective. Conclusions Increasing the VCR for adults with type 2 diabetes in Turkey to >= 20% would be very cost-effective.	[Akin, Levent] Hacettepe Univ, Fac Med, Dept Publ Hlth, Univ Mh, TR-06640 Ankara, Turkey; [Macabeo, Berengere] Sanofi Pasteur, 2 Ave Pont Pasteur, F-69007 Lyon, France; [Caliskan, Zafer] Hacettepe Univ, Dept Econ, TR-06800 Ankara, Turkey; [Altinel, Serdar] Sanofi Pasteur, Buyukdere Cad 193 K 3 Levent, TR-34394 Istanbul, Turkey; [Satman, Ilhan] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Div Endocrinol & Metab, Turgut Ozal Millet Cad,PK 33, TR-34093 Istanbul, Turkey	Hacettepe University; Sanofi-Aventis; Sanofi France; Hacettepe University; Sanofi-Aventis; Sanofi Turkey; Istanbul University	Macabeo, B (corresponding author), Sanofi Pasteur, 2 Ave Pont Pasteur, F-69007 Lyon, France.	Berengere.Macabeo@sanofipasteur.com	Satman, Ilhan/AAS-7044-2020; Ilhan, Satman/E-4585-2012	Satman, Ilhan/0000-0001-8613-1797; 	Sanofi Pasteur	Sanofi Pasteur	Financial support for the study and for medical writing was provided by Sanofi Pasteur. The funder participated in study design, data collection and analysis, the decision to publish, and preparation of the manuscript.	Aballea S, 2007, VALUE HEALTH, V10, P98, DOI 10.1111/j.1524-4733.2006.00157.x; [Anonymous], 2014, THE COST OF DIABETES; Avritscher EBC, 2007, CANCER-AM CANCER SOC, V109, P2357, DOI 10.1002/cncr.22670; Badur S, 2015, TURKIYEDE INFLUENZA; Beyer WEP, 2013, VACCINE, V31, P6030, DOI 10.1016/j.vaccine.2013.09.063; Brady B, 2001, 13 CAN COORD OFF HLT; Burls A, 2002, Health Technol Assess, V6, P1; Choosakulchart P, 2013, ASIAN BIOMED, V7, P425, DOI 10.5372/1905-7415.0703.196; Ciblak MA, 2013, VACCINE, V31, P518, DOI 10.1016/j.vaccine.2012.11.022; Colquhoun AJ, 1997, EPIDEMIOL INFECT, V119, P335, DOI 10.1017/S095026889700825X; Cooper NJ, 2003, BRIT MED J, V326, P1235, DOI 10.1136/bmj.326.7401.1235; Council of the European Union. Council recommendation, 2009, OFFICIAL J EUROPEA L, V348, P71; DiazGranados CA, 2012, VACCINE, V31, P49, DOI 10.1016/j.vaccine.2012.10.084; El-Madhun AS, 1998, VACCINE, V16, P156, DOI 10.1016/S0264-410X(97)88328-4; Expectancy WL, HLTH PROFILE TURKEY; FEERY BJ, 1983, DIABETES CARE, V6, P475, DOI 10.2337/diacare.6.5.475; International Diabetes Federation, 2013, IDF DIABETES ATLAS; International Monetary Fund, REP SEL COUNTR SUBJ; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub4; Lee BY, 2011, AM J KIDNEY DIS, V57, P724, DOI 10.1053/j.ajkd.2010.12.016; Looijmans-Van den Akker I, 2006, DIABETES CARE, V29, P1771, DOI 10.2337/dc05-2517; Loukine L, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-7; Mauskopf JA, 2000, PHARMACOECONOMICS, V17, P611, DOI 10.2165/00019053-200017060-00007; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Monto AS, 2010, VACCINE, V28, pD33, DOI 10.1016/j.vaccine.2010.08.027; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Narayan KMV, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P591; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; Nosyk B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027059; O'Brien BJ, 2003, VALUE HEALTH, V6, P116, DOI 10.1046/j.1524-4733.2003.00213.x; OECD, COSN PRIC MEI; Peasah SK, 2013, VACCINE, V31, P5339, DOI 10.1016/j.vaccine.2013.09.013; POZZILLI P, 1986, DIABETOLOGIA, V29, P850, DOI 10.1007/BF00870139; Preaud E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-813; Rothberg MB, 2003, J GEN INTERN MED, V18, P808, DOI 10.1046/j.1525-1497.2003.20822.x; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; SAGE Working Group, 2012, BACKGR PAP INFL VACC; Satman I, 2002, DIABETES CARE, V25, P1551, DOI 10.2337/diacare.25.9.1551; Satman I, 2013, HUM VACC IMMUNOTHER, V9, P2618, DOI 10.4161/hv.25826; Satman I, 2013, EUR J EPIDEMIOL, V28, P169, DOI 10.1007/s10654-013-9771-5; Schade C P, 2000, W V Med J, V96, P444; Schaffner W, 2007, CLIN DIABETES, V25, P145; Schanzer DL, 2008, VACCINE, V26, P4697, DOI 10.1016/j.vaccine.2008.06.087; Shafiee G, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-17; Smith Steven A, 2003, Diabetes Care, V26 Suppl 1, pS126; Sorensen S, 2003, AM DIAB ASS ANN M 20; Sozmen K, 2015, INT J PUBLIC HEALTH, V60, pS13, DOI 10.1007/s00038-014-0622-2; Suryaprasad A, 2013, INFLUENZA OTHER RESP, V7, P1361, DOI 10.1111/irv.12123; Turkish Statistical Institute, POP PROV DISTR CTR T; Turkish Statistical Institute, AV WORK HOURS MONTHL; Turner David, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7350; US Centers for Disease Control and Prevention, 2015, YOU HAV DIAB FLU SHO; WHO, 2003, MAKING CHOICES HLTH; WHO-CHOICE, 2015, HLTH SERV DEL COSTS; Wongsurakiat Phunsup, 2003, Journal of the Medical Association of Thailand, V86, P497; World Bank, PPP CONV FACT GDP LC; World Health Organization, 2003, PREV CONTR INFL PAND; Yoldascan E, 2010, J MED SYST, V34, P139, DOI 10.1007/s10916-008-9225-x	62	10	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157657	10.1371/journal.pone.0157657	http://dx.doi.org/10.1371/journal.pone.0157657			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322384	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212000037
J	Bereswill, S; Alutis, ME; Grundmann, U; Fischer, A; Gobel, UB; Heimesaat, MM				Bereswill, Stefan; Alutis, Marie E.; Grundmann, Ursula; Fischer, Andre; Goebel, Ulf B.; Heimesaat, Markus M.			Interleukin-18 Mediates Immune Responses to Campylobacter jejuni Infection in Gnotobiotic Mice	PLOS ONE			English	Article							TOXOPLASMA-GONDII; CELLS; BACTERIA; ACTIVATION; PROTECTION; INDUCTION; CYTOKINE; COLITIS	Background Human Campylobacter jejuni infections are progressively rising worldwide. Information about the molecular mechanisms underlying campylobacteriosis, however, are limited. In the present study we investigated whether cytokines such as IL-23, IL-22 and IL-18, which share pivotal functions in host immunity, were involved in mediating intestinal and systemic immunopathological responses upon C. jejuni infection. Methodology/Principal Findings To assure stable infection, gnotobiotic (i. e. secondary abiotic) IL-23p19(-/-), IL-22(-/-) and IL-18(-/-) mice were generated by broad-spectrum antibiotic treatment. Following peroral C. jejuni strain 81-176 infection, mice of all genotypes harbored comparably high pathogenic loads in their intestines. As compared to wildtype controls, however, IL-18(-/-) mice displayed less distinct C. jejuni induced sequelae as indicated by less pronounced large intestinal shrinkage and lower numbers of apoptotic cells in the colonic epithelial layer at day 8 postinfection (p.i.). Furthermore, lower colonic numbers of adaptive immune cells including regulatory T cells and B lymphocytes were accompanied by less distinct secretion of proinflammatory cytokines such as TNF and IFN-gamma and lower IL-17A mRNA expression levels in colonic ex vivo biopsies of infected IL-18(-/-) as compared to wildtype mice. Upon C. jejuni infection, colonic IL-23p19 expression was up-regulated in IL-18(-/-) mice only, whereas IL-22 mRNA levels were lower in uninfected and infected IL-23p19(-/-) as well as infected IL-18(-/-) as compared to respective wildtype control mice. Remarkably, not only intestinal, but also systemic infection-induced immune responses were less pronounced in IL-18(-/-)mice as indicated by lower TNF, IFN-gamma and IL-6 serum levels as compared to wildtype mice. Conclusion/Significance We here show for the first time that IL-18 is essentially involved in mediating C. jejuni infection in the gnotobiotic mouse model. Future studies need to further unravel the underlying regulatory mechanisms orchestrating pathogen-host interaction.	[Bereswill, Stefan; Alutis, Marie E.; Grundmann, Ursula; Fischer, Andre; Goebel, Ulf B.; Heimesaat, Markus M.] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Heimesaat, MM (corresponding author), Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany.	markus.heimesaat@charite.de		Heimesaat, Markus/0000-0001-6399-651X	German Research Foundation (DFG) [SFB633]; German Federal Ministery of Education and Research (BMBF)	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministery of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the German Research Foundation (DFG) to AF, SB and UBG (SFB633, TP A7), MMH (SFB633, TP B6), MEA and UG (SFB633, Immuco), and from the German Federal Ministery of Education and Research (BMBF) to SB (TP1.1). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alter T, 2011, BUNDESGESUNDHEITSBLA, V54, P728, DOI 10.1007/s00103-011-1289-y; Alutis ME, 2014, EUR J MICROBIOL IMMU, V4, P213, DOI [10.1556/EUJMI-D-14-00031, 10.1556/EuJMI-D-14-00031]; Alutis ME, 2015, EUR J MICROBIOL IMMU, V5, P256, DOI 10.1556/1886.2015.00033; Alutis ME, 2015, EUR J MICROBIOL IMMU, V5, P188, DOI 10.1556/1886.2015.00020; Atarashi K, 2010, VACCINE, V28, P8036, DOI 10.1016/j.vaccine.2010.09.026; Bahrami B, 2011, J APPL MICROBIOL, V110, P353, DOI 10.1111/j.1365-2672.2010.04889.x; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Blaschitz C, 2010, J CLIN IMMUNOL, V30, P196, DOI 10.1007/s10875-010-9368-7; Bouwman LI, 2014, J IMMUNOL, V193, P4548, DOI 10.4049/jimmunol.1400648; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; Eidenschenk C, 2014, CURR TOP MICROBIOL, V380, P213, DOI 10.1007/978-3-662-43492-5_10; Golz G, 2016, EUR J MICROBIOL IMMU, V6, P67, DOI 10.1556/1886.2016.00006; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Guerry P, 2008, TRENDS MICROBIOL, V16, P428, DOI 10.1016/j.tim.2008.07.002; Haag LM, 2012, EUR J MICROBIOL IMMU, V2, P2, DOI 10.1556/EuJMI.2.2012.1.2; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2016, EUR J MICROBIOL IMMU, V6, P137, DOI 10.1556/1886.2016.00009; Heimesaat MM, 2016, EUR J MICROBIOL IMMU, V6, P124, DOI 10.1556/1886.2016.00008; Heimesaat MM, 2016, EUR J MICROBIOL IMMU, V6, P56, DOI 10.1556/1886.2016.00005; Heimesaat MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090148; Kaakoush NO, 2015, INFECT IMMUN, V83, P832, DOI 10.1128/IAI.03012-14; Kinoshita M, 2006, CLIN EXP IMMUNOL, V143, P41, DOI 10.1111/j.1365-2249.2005.02973.x; Kist M, 2001, Contrib Microbiol, V8, P150; Lane JA, 2010, INT J FOOD MICROBIOL, V142, P1, DOI 10.1016/j.ijfoodmicro.2010.05.027; Malik A, 2014, MUCOSAL IMMUNOL, V7, P802, DOI 10.1038/mi.2013.97; Masanta WO, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/526860; Munoz M, 2015, IMMUNITY, V42, P321, DOI 10.1016/j.immuni.2015.01.011; Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Namin BM, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.26393; Oertli M, 2012, J CLIN INVEST, V122, P1082, DOI 10.1172/JCI61029; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; VANSPREEUWEL JP, 1985, GUT, V26, P945, DOI 10.1136/gut.26.9.945; Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138; WALKER RI, 1986, MICROBIOL REV, V50, P81, DOI 10.1128/MMBR.50.1.81-94.1986; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718	40	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0158020	10.1371/journal.pone.0158020	http://dx.doi.org/10.1371/journal.pone.0158020			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322540	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212000060
J	Blixt, FW; Johansson, SE; Johnson, L; Haanes, KA; Warfvinge, K; Edvinsson, L				Blixt, Frank W.; Johansson, Sara Ellinor; Johnson, Leif; Haanes, Kristian Agmund; Warfvinge, Karin; Edvinsson, Lars			Enhanced Endothelin-1 Mediated Vasoconstriction of the Ophthalmic Artery May Exacerbate Retinal Damage after Transient Global Cerebral Ischemia in Rat	PLOS ONE			English	Article							FOREBRAIN ISCHEMIA; UP-REGULATION; CELL-DEATH; RECEPTOR; ELECTRORETINOGRAPHY; PHOTORECEPTORS; ACTIVATION; RESPONSES; INSULT; MODELS	Cerebral vasculature is often the target of stroke studies. However, the vasculature supplying the eye might also be affected by ischemia. The aim of the present study was to investigate if the transient global cerebral ischemia (GCI) enhances vascular effect of endothelin-1 (ET-1) and 5-hydroxytryptamine/ serotonin (5-HT) on the ophthalmic artery in rats, leading to delayed retinal damage. This was preformed using myography on the ophthalmic artery, coupled with immunohistochemistry and electroretinogram (ERG) to assess the ischemic consequences on the retina. Results showed a significant increase of ET-1 mediated vasoconstriction at 48 hours post ischemia. The retina did not exhibit any morphological changes throughout the study. However, we found an increase of GFAP and vimentin expression at 72 hours and 7 days after ischemia, indicating Muller cell mediated gliosis. ERG revealed significantly decreased function at 72 hours, but recovered almost completely after 7 days. In conclusion, we propose that the increased contractile response via ET-1 receptors in the ophthalmic artery after 48 hours may elicit negative retinal consequences due to a second ischemic period. This may exacerbate retinal damage after ischemia as illustrated by the decreased retinal function and Muller cell activation. The ophthalmic artery and ET-1 mediated vasoconstriction may be a valid and novel therapeutic target after longer periods of ischemic insults.	[Blixt, Frank W.; Warfvinge, Karin; Edvinsson, Lars] Lund Univ, Div Expt Vasc Res, Dept Clin Sci, Lund, Sweden; [Johansson, Sara Ellinor; Haanes, Kristian Agmund; Warfvinge, Karin; Edvinsson, Lars] Rigshosp, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark; [Johnson, Leif] Rigshosp, Glostrup Res Inst, Dept Ophthalmol, Glostrup, Denmark	Lund University; Rigshospitalet; Rigshospitalet	Blixt, FW (corresponding author), Lund Univ, Div Expt Vasc Res, Dept Clin Sci, Lund, Sweden.	frank.blixt@med.lu.se	Haanes, Kristian Agmund/I-5881-2013	Haanes, Kristian Agmund/0000-0001-5182-8957; W Blixt, Frank/0000-0002-5293-8223; Edvinsson, Lars/0000-0002-1805-1346	Hjart-Lungfonden [20130271]; Vetenskapsradet	Hjart-Lungfonden; Vetenskapsradet(Swedish Research Council)	This work was supported by Hjart-Lungfonden award number 20130271 (www.hjart-lungfonden.se) and Vetenskapsradet (http://www.vr.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIGNAMI A, 1979, EXP EYE RES, V28, P63; Block F, 1997, NEUROSCI LETT, V232, P45, DOI 10.1016/S0304-3940(97)00575-2; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; BUCHI ER, 1992, EXP EYE RES, V55, P605, DOI 10.1016/S0014-4835(05)80173-3; Bui BV, 1999, DOC OPHTHALMOL, V99, P151, DOI 10.1023/A:1002721315955; Bui BV, 2004, J PHYSIOL-LONDON, V555, P153, DOI 10.1113/jphysiol.2003.052738; Charng J, 2011, INVEST OPHTH VIS SCI, V52, P8891, DOI 10.1167/iovs.11-7602; Chaychi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136056; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Edvinsson L, 2009, CURR VASC PHARMACOL, V7, P26, DOI 10.2174/157016109787354178; Edvinsson LIH, 2011, J CEREBR BLOOD F MET, V31, P1554, DOI 10.1038/jcbfm.2011.70; HAEFLIGER IO, 1992, INVEST OPHTH VIS SCI, V33, P2340; HOOD DC, 1990, VISUAL NEUROSCI, V5, P379, DOI 10.1017/S0952523800000468; Hossmann KA, 2008, NEUROPHARMACOLOGY, V55, P257, DOI 10.1016/j.neuropharm.2007.12.004; Jarajapu YPR, 2004, INVEST OPHTH VIS SCI, V45, P253, DOI 10.1167/iovs.03-0546; Johansson SE, 2015, ACTA PHYSIOL, V214, P376, DOI 10.1111/apha.12519; Johansson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041852; Lafuente MP, 2002, NEUROSCIENCE, V109, P157, DOI 10.1016/S0306-4522(01)00458-4; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; MACRAE IM, 1993, J CEREBR BLOOD F MET, V13, P276, DOI 10.1038/jcbfm.1993.34; Masuzawa K, 2006, EXP BIOL MED, V231, P1085; Minton AZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043199; Napper GA, 1999, VISUAL NEUROSCI, V16, P149, DOI 10.1017/S0952523899161108; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; Schnitzer J., 1988, Progress in Retinal Research, V7, P209, DOI 10.1016/0278-4327(88)90009-0; Skovsted GF, 2012, LIFE SCI, V91, P593, DOI 10.1016/j.lfs.2012.02.009; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; Terelak-Borys B, 2012, MED SCI MONITOR, V18, pRA138, DOI 10.12659/MSM.883260; Velten IM, 2001, BRIT J OPHTHALMOL, V85, P403, DOI 10.1136/bjo.85.4.403; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003; Zhao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065555; ZIV I, 1992, STROKE, V23, P1014, DOI 10.1161/01.STR.23.7.1014	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157669	10.1371/journal.pone.0157669	http://dx.doi.org/10.1371/journal.pone.0157669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322388	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212000038
J	Nouwen, N; Fardoux, J; Giraud, E				Nouwen, Nico; Fardoux, Joel; Giraud, Eric			NodD1 and NodD2 Are Not Required for the Symbiotic Interaction of Bradyrhizobium ORS285 with Nod-Factor-Independent Aeschynomene Legumes	PLOS ONE			English	Article							NODULATION GENES; PHOTOSYNTHETIC BRADYRHIZOBIA; STRAIN ORS285; FLAVONOIDS; JAPONICUM; STEM; LIPOCHITOOLIGOSACCHARIDES; TRANSCRIPTION; UPSTREAM; REVEALS	Photosynthetic Bradyrhizobium strain ORS285 forms nitrogen-fixing nodules on the roots and stems of tropical aquatic legumes of the Aeschynomene genus. Depending on the Aeschynomene species, this symbiotic interaction does or does not rely on the synthesis of Nod-factors (NFs). However, whether during the interaction of Bradyrhizobium ORS285 with NF-independent Aeschynomene species the nod genes are expressed and if the general regulator NodD plays a symbiotic role is unknown. Expression studies showed that in contrast to the interaction with the NF-dependent Aeschynomene species, A. afraspera, the Bradyrhizobium ORS285 nod genes are not induced upon contact with the NF-independent host plant A. indica. Mutational analysis of the two nodD genes present in ORS285, showed that deletion of nodD1 and nodD2 did not affect the symbiotic interaction between Bradyrhizobium ORS285 and A. indica whereas the deletions had an effect on the symbiotic interaction with A. afraspera plants. In addition, when the expression of nod genes was artificially induced by adding naringenin to the plant growth medium, the nodulation of A. indica by Bradyrhizobium ORS285 is delayed and resulted in lower nodule numbers.	[Nouwen, Nico; Fardoux, Joel; Giraud, Eric] IRD, UMR IRD SupAgro INRA CIRAD UM2, Lab Symbioses Trop & Mediterraneennes, Montpellier, France	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Nouwen, N (corresponding author), IRD, UMR IRD SupAgro INRA CIRAD UM2, Lab Symbioses Trop & Mediterraneennes, Montpellier, France.	nico.nouwen@ird.fr			French national research agency [ANR-BugsInaCell-13-BSV7-0013]	French national research agency(French National Research Agency (ANR))	This work was supported by the French national research agency (ANR-BugsInaCell-13-BSV7- 0013).; This work was supported by a grant from the French national research agency (ANR-BugsInaCell-13-BSV7-0013). We thank the National BioResource Project (NIG, Japan): E.coli for providing plasmids pHRP308, pHRP315 and pHP45-Cm used in this study.	Abdel-Lateif K, 2013, NEW PHYTOL, V199, P1012, DOI 10.1111/nph.12326; ALAZARD D, 1987, PLANT SOIL, V101, P141, DOI 10.1007/BF02371043; ALAZARD D, 1985, APPL ENVIRON MICROB, V50, P732, DOI 10.1128/AEM.50.3.732-734.1985; Bonaldi K, 2011, MOL PLANT MICROBE IN, V24, P1359, DOI 10.1094/MPMI-04-11-0093; Bonaldi K, 2010, MOL PLANT MICROBE IN, V23, P760, DOI 10.1094/MPMI-23-6-0760; Broughton WJ, 2000, J BACTERIOL, V182, P5641, DOI 10.1128/JB.182.20.5641-5652.2000; Chaintreuil C, 2001, FEMS MICROBIOL LETT, V194, P83, DOI 10.1111/j.1574-6968.2001.tb09450.x; Eaglesham ARJ, 1990, 1 PHOTOSYNTHETIC N2F, P805; EHRHARDT DW, 1992, SCIENCE, V256, P998, DOI 10.1126/science.10744524; Feng J, 2003, NUCLEIC ACIDS RES, V31, P3143, DOI 10.1093/nar/gkg411; FISHER RF, 1988, GENE DEV, V2, P282, DOI 10.1101/gad.2.3.282; Garcia M, 1996, MOL PLANT MICROBE IN, V9, P625, DOI 10.1094/MPMI-9-0625; Giraud E, 2004, PHOTOSYNTH RES, V82, P115, DOI 10.1007/s11120-004-1768-1; Giraud E, 2000, P NATL ACAD SCI USA, V97, P14795, DOI 10.1073/pnas.250484097; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Gough C, 2013, TRENDS PLANT SCI, V18, P566, DOI 10.1016/j.tplants.2013.06.001; GYORGYPAL Z, 1991, MOL GEN GENET, V226, P337, DOI 10.1007/BF00273624; HUNGRIA M, 1992, MOL PLANT MICROBE IN, V5, P199, DOI 10.1094/MPMI-5-199; Kobayashi H, 2004, MOL MICROBIOL, V51, P335, DOI 10.1046/j.1365-2958.2003.03841.x; Krause A, 2002, MOL PLANT MICROBE IN, V15, P1228, DOI 10.1094/MPMI.2002.15.12.1228; Limpens E, 2015, ANNU REV PHYTOPATHOL, V53, P311, DOI 10.1146/annurev-phyto-080614-120149; Loh JT, 2001, MOL MICROBIOL, V42, P37, DOI 10.1046/j.1365-2958.2001.02625.x; Molouba F, 1999, APPL ENVIRON MICROB, V65, P3084; Okazaki S, 2016, ISME J, V10, P64, DOI 10.1038/ismej.2015.103; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Renier A, 2011, MOL PLANT MICROBE IN, V24, P1440, DOI 10.1094/MPMI-05-11-0104	26	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157888	10.1371/journal.pone.0157888	http://dx.doi.org/10.1371/journal.pone.0157888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315080	Green Published, gold			2022-12-26	WOS:000378030000064
J	Vervoort, G; Leunissen, I; Firbank, M; Heremans, E; Nackaerts, E; Vandenberghe, W; Nieuwboer, A				Vervoort, Griet; Leunissen, Inge; Firbank, Michael; Heremans, Elke; Nackaerts, Evelien; Vandenberghe, Wim; Nieuwboer, Alice			Structural Brain Alterations in Motor Subtypes of Parkinson's Disease: Evidence from Probabilistic Tractography and Shape Analysis	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; MILD COGNITIVE IMPAIRMENT; GRAY-MATTER ATROPHY; POSTURAL INSTABILITY; TREMOR-DOMINANT; GAIT DISORDER; WHITE; DEMENTIA; CIRCUITS; HIPPOCAMPAL	Background and Objectives The postural instability and gait disorder (PIGD) and tremor dominant (TD) subtypes of Parkinson's disease (PD) show different patterns of alterations in functional connectivity (FC) between specific brain regions. This study aimed to investigate the relation between symptomatic heterogeneity in PD and structural alterations underlying these FC changes. Methods 68 PD patients classified as PIGD (n = 41) or TD (n = 19) and 19 age-matched controls underwent Magnetic Resonance Imaging (MRI). Diffusion-weighted images were used to assess fractional anisotropy (FA) and mean diffusivity (MD) at the whole-brain level using tract-based spatial statistics (TBSS). In addition, structural connectivity was assessed between regions that previously showed altered FC using probabilistic tractography. Anatomical images were used to determine shape and volume of the putamen, caudate and pallidum. Results TBSS revealed widespread FA reductions in PIGD compared to controls involving the superior longitudinal fasciculi and corpus callosum. No such differences were found in TD. Both PD subgroups had increased MD compared to controls in tracts connecting the left caudate with the bilateral ventral putamen. TD patients additionally showed increased MD compared to PIGD and controls in tracts connecting the right inferior parietal lobule with the right pre-motor and primary motor cortex, which previously showed altered FC. We also found grey matter atrophy in the rostrodorsal head of the caudate in PIGD compared to controls. Conclusion Microstructural changes in white matter tracts, particularly in those connecting striatal subareas, partly underlie FC alterations in PD subtypes. Caudate shape alterations further implicate the striatum in PIGD pathophysiology.	[Vervoort, Griet; Heremans, Elke; Nackaerts, Evelien; Nieuwboer, Alice] Katholieke Univ Leuven, Dept Rehabil Sci, Tervuursevest 101-1501, B-3001 Leuven, Belgium; [Leunissen, Inge] Katholieke Univ Leuven, Dept Kinesiol, Tervuursevest 101-1501, B-3001 Leuven, Belgium; [Firbank, Michael] Newcastle Univ, Inst Neurosci, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Firbank, Michael] Newcastle Univ, Inst Ageing, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Vandenberghe, Wim] Univ Hosp Leuven, Dept Neurol, Herestr 49, B-3000 Leuven, Belgium; [Vandenberghe, Wim] Katholieke Univ Leuven, Dept Neurosci, Herestr 49, B-3000 Leuven, Belgium	KU Leuven; KU Leuven; Newcastle University - UK; Newcastle University - UK; KU Leuven; University Hospital Leuven; KU Leuven	Vervoort, G (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, Tervuursevest 101-1501, B-3001 Leuven, Belgium.	griet.vervoort@faber.kuleuven.be	Firbank, Michael J/K-3335-2012; Nieuwboer, Alice/F-5643-2013	Firbank, Michael J/0000-0002-9536-0185; Nieuwboer, Alice/0000-0003-1193-6229; Leunissen, Inge/0000-0002-3977-3620; Nackaerts, Evelien/0000-0002-6580-4902	KU Leuven, Belgium [OT / 11/ 091]; King Baudouin foundation; Research Foundation Flanders [G.0906.11]	KU Leuven, Belgium(KU Leuven); King Baudouin foundation; Research Foundation Flanders(FWO)	Support for this study was provided through a grant from the Special Research Fund of KU Leuven, Belgium (contract OT / 11/ 091), Malou-Malou funds of the King Baudouin foundation and Research Foundation Flanders project G.0906.11.; We would like to thank all subjects for their motivated and enthusiastic participation in this study. Support for this study was provided through a grant from the Special Research Fund of KU Leuven, Belgium (contract OT / 11/ 091), Malou-Malou funds of the King Baudouin foundation and Research Foundation Flanders project G.0906.11. W.V. is a Senior Clinical Investigator of the Research Foundation Flanders. All authors report no conflict of interest.	Abe O, 2010, NEURORADIOLOGY, V52, P699, DOI 10.1007/s00234-010-0716-3; Agosta F, 2014, HUM BRAIN MAPP, V35, P1921, DOI 10.1002/hbm.22302; Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Alves G, 2006, MOVEMENT DISORD, V21, P1123, DOI 10.1002/mds.20897; Apostolova LG, 2010, MOVEMENT DISORD, V25, P687, DOI 10.1002/mds.22799; Bartels AL, 2006, MOVEMENT DISORD, V21, P1326, DOI 10.1002/mds.20952; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bell PT, 2015, HUM BRAIN MAPP, V36, P1278, DOI 10.1002/hbm.22701; Bohnen NI, 2011, BRAIN, V134, P2358, DOI 10.1093/brain/awr139; Brooks DJ, 2006, BIOL PSYCHIAT, V59, P908, DOI 10.1016/j.biopsych.2005.12.017; Burn DJ, 2012, MOVEMENT DISORD, V27, P379, DOI 10.1002/mds.24041; Burn DJ, 2006, J NEUROL NEUROSUR PS, V77, P585, DOI 10.1136/jnnp.2005.081711; Canu E., 2015, HUM BRAIN MAPP; Caspers S, 2011, NEUROIMAGE, V58, P362, DOI 10.1016/j.neuroimage.2011.06.027; Chan LL, 2014, PARKINSONISM RELAT D, V20, P53, DOI 10.1016/j.parkreldis.2013.09.017; Choi EY, 2012, J NEUROPHYSIOL, V108, P2242, DOI 10.1152/jn.00270.2012; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Eggers C, 2011, MOVEMENT DISORD, V26, P416, DOI 10.1002/mds.23468; Factor SA, 2011, J NEUROL NEUROSUR PS, V82, P564, DOI 10.1136/jnnp.2010.222042; Fling BW, 2013, BRAIN, V136, P2405, DOI 10.1093/brain/awt172; Focke NK, 2008, NEUROIMAGE, V40, P728, DOI 10.1016/j.neuroimage.2007.12.031; Garces P, 2015, HUM BRAIN MAPP; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Gu QQ, 2014, CAN J NEUROL SCI, V41, P763, DOI 10.1017/cjn.2014.34; Helmich RC, 2012, BRAIN, V135, P3206, DOI 10.1093/brain/aws023; Helmich RC, 2010, CEREB CORTEX, V20, P1175, DOI 10.1093/cercor/bhp178; Herman T, 2014, J NEUROLOGY; Herman T, 2014, MOVEMENT DISORD, V29, P134, DOI 10.1002/mds.25697; Herman T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055193; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Huang HQ, 2016, BRAIN CONNECT, V6, P99, DOI 10.1089/brain.2015.0382; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Lee E, 2014, PARKINSONISM RELAT D, V20, P1376, DOI 10.1016/j.parkreldis.2014.09.027; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lin CHJ, 2012, BRAIN CONNECT, V2, P56, DOI 10.1089/brain.2011.0059; Linder J, 2009, J NEUROL, V256, P1671, DOI 10.1007/s00415-009-5177-4; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Lord S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00249; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Martino J, 2014, CLIN ANAT, V27, P563, DOI 10.1002/ca.22321; Moccia M, 2014, J NEUROL, V261, P2112, DOI 10.1007/s00415-014-7459-8; Nyberg EM, 2015, PARKINSONISM RELAT D, V21, P536, DOI 10.1016/j.parkreldis.2015.03.008; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Prodoehl J, 2013, JAMA NEUROL, V70, P100, DOI 10.1001/jamaneurol.2013.582; Rosenberg-Katz K, 2013, NEUROLOGY, V80, P1476, DOI 10.1212/WNL.0b013e31828cfaa4; Rossi C, 2010, EUR J NEUROL, V17, P626, DOI 10.1111/j.1468-1331.2009.02898.x; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; Schweder PM, 2010, NEUROREPORT, V21, P914, DOI 10.1097/WNR.0b013e32833ce5f1; Shine JM, 2013, BRAIN, V136, P1204, DOI 10.1093/brain/awt049; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song IU, 2014, ACTA RADIOL, V55, P366, DOI 10.1177/0284185113498075; Spiegel J, 2007, J NEURAL TRANSM, V114, P331, DOI 10.1007/s00702-006-0518-2; Squarcina L, 2012, NEUROIMAGE, V63, P779, DOI 10.1016/j.neuroimage.2012.07.016; Stam CJ, 2015, INT J PSYCHOPHYSIOL; Stebbins GT, 2013, MOVEMENT DISORD, V28, P668, DOI 10.1002/mds.25383; Sterling NW, 2013, NEUROBIOL AGING, V34, P2510, DOI 10.1016/j.neurobiolaging.2013.05.017; Thenganatt MA, 2014, JAMA NEUROL, V71, P499, DOI 10.1001/jamaneurol.2013.6233; Vercruysse S, 2015, MOVEMENT DISORD, V30, P567, DOI 10.1002/mds.26130; Vervoort G, 2016, PARKINSONISM RELAT D, V24, P48, DOI 10.1016/j.parkreldis.2016.01.016; Vervoort G, 2015, BEHAV BRAIN RES, V287, P1, DOI 10.1016/j.bbr.2015.03.026; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wu T., 2014, CEREB CORTEX; Wu T, 2015, NEUROBIOL DIS, V82, P226, DOI 10.1016/j.nbd.2015.06.014; Wu T, 2012, NEUROSCI LETT, V524, P55, DOI 10.1016/j.neulet.2012.07.012; Zhang JQ, 2015, PARKINSONISM RELAT D, V21, P23, DOI 10.1016/j.parkreldis.2014.10.017	70	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157743	10.1371/journal.pone.0157743	http://dx.doi.org/10.1371/journal.pone.0157743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314952	Green Published, Green Submitted, gold			2022-12-26	WOS:000378030000049
J	Zhao, LQ; Wu, YR; Chen, S; Ren, YY; Chen, P; Niu, JM; Li, C; Sun, K				Zhao, Liqing; Wu, Yurong; Chen, Sun; Ren, Yunyun; Chen, Ping; Niu, Jianmei; Li, Cao; Sun, Kun			Feasibility Study on Prenatal Cardiac Screening Using Four-Dimensional Ultrasound with Spatiotemporal Image Correlation: A Multicenter Study	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; FETAL ECHOCARDIOGRAPHY; DIAGNOSIS; ACCURACY; TOOL	Objective This study aimed at investigating the feasibility of using the spatiotemporal image correlation (STIC) technology for prenatal cardiac screening, finding factors that influence the offline evaluation of reconstructed fetal heart, and establishing an optimal acquisition scheme. Methods The study included 452 gravidae presenting for routine screening at 3 maternity centers at 20-38 gestational weeks. The factors influencing the quality of STIC volume data were evaluated using t test, chi-square test, and logistic regression analysis. The predictive power was evaluated using the receiver operating characteristic (ROC) curve. Results Among the 452 fetuses enrolled, 353 (78.1%) were identified as successful and 99 (21.9%) as failure of evaluation of the reconstructed fetal heart. The total success rate of qualified STIC images was 78.1%. The display rates of reconstructed cardiac views were 86.5% (four-chamber view), 92.5% (left ventricular outflow tract view), 92.7% (right ventricular outflow tract view), 89.9% (three-vessel trachea view), 63.9% (aortic arch view), 81.4% (ductal arch view), 81% (short-axis view of great vessels), 80.1% (long-cava view), and 86.9% (abdominal view). A logistic regression analysis showed that more than 28 gestational weeks [OR = 0.39 (CI 95% 0.16, 0.19), P = 0.035], frequent fetal movements [OR = 0.37 (CI 95% 0.16, 0.87), P = 0.022], shadowing [OR = 0.36 (CI 95% 0.19, 0.72), P = 0.004], spine location at 10-2 o'clock [OR = 0.08 (CI 95% 0.02, 0.27), P = 0.0], and original cardiac view [OR = 0.51 (0.25, 0.89), P = 0.019] had a significant impact on the quality of STIC. The area under the ROC curve was 0.775. Conclusions Fetal cardiac-STIC seems a feasible tool for prenatal screening of congenital heart diseases. The influence factors on the quality of STIC images included the intensity of training, gestational age, fetal conditions and parameter settings. The optimal acquisition scheme may improve the application and widespread use of cardiac STIC.	[Zhao, Liqing; Wu, Yurong; Chen, Sun; Sun, Kun] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Div Pediat Cardiol, Shanghai 200030, Peoples R China; [Ren, Yunyun; Li, Cao] Fudan Univ, Obstet & Gynecol Hosp, Dept Med Ultrasound, Shanghai 200433, Peoples R China; [Chen, Ping] Shanghai First Matern & Infant Hosp, Dept Med Ultrasound, Shanghai, Peoples R China; [Niu, Jianmei] Int Peace Matern & Child Hlth Hosp, China Welf Inst, Dept Med Ultrasound, Shanghai, Peoples R China	Shanghai Jiao Tong University; Fudan University	Sun, K (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Div Pediat Cardiol, Shanghai 200030, Peoples R China.	sunkun@xinhuamed.com.cn			National Basic Research Program of China [2010CB529501]; Shanghai health system important disease joint research project [2013ZYJB0016]	National Basic Research Program of China(National Basic Research Program of China); Shanghai health system important disease joint research project	The research was funded by a grant (2010CB529501) from the National Basic Research Program of China and supported by Shanghai health system important disease joint research project (No. 2013ZYJB0016) (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all the patients for participating in this study. The research was funded by a grant (2010CB529501) from the National Basic Research Program of China and supported by Shanghai health system important disease joint research project (No. 2013ZYJB0016)(Sun Kun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed BI, 2014, J MATERN-FETAL NEO M, V27, P1163, DOI 10.3109/14767058.2013.847423; Araujo E, 2014, INT J WOMENS HEALTH, V6, P501, DOI 10.2147/IJWH.S47074; Bennasar M, 2010, ULTRASOUND OBST GYN, V36, P458, DOI 10.1002/uog.7720; Carvalho JS, 2013, ULTRASOUND OBST GYN, V41, P348, DOI 10.1002/uog.12403; DeVore GR, 2003, ULTRASOUND OBST GYN, V22, P380, DOI 10.1002/uog.217; Donofrio MT, 2014, CIRCULATION, V129, P2183, DOI 10.1161/01.cir.0000437597.44550.5d; Goncalves LF, 2006, ULTRASOUND OBST GYN, V27, P336, DOI 10.1002/uog.2724; Gupta N, 2014, EUR J PEDIATR, V173, P655, DOI 10.1007/s00431-013-2231-0; He YH, 2013, EXP THER MED, V5, P1637, DOI 10.3892/etm.2013.1060; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Ogge G, 2006, ULTRASOUND OBST GYN, V28, P779, DOI 10.1002/uog.3830; Paladini D, 2007, ULTRASOUND OBST GYN, V29, P605, DOI 10.1002/uog.4049; Randall P, 2005, BJOG-INT J OBSTET GY, V112, P24, DOI 10.1111/j.1471-0528.2004.00295.x; Tworetzky W, 2001, CIRCULATION, V103, P1269, DOI 10.1161/01.cir.103.9.1269; Uittenbogaard LB, 2008, ULTRASOUND OBST GYN, V31, P625, DOI 10.1002/uog.5351; Vinals F, 2005, ULTRASOUND OBST GYN, V25, P25, DOI 10.1002/uog.1796; Vinals F, 2003, ULTRASOUND OBST GYN, V22, P388, DOI 10.1002/uog.883; Yagel S, 2011, ULTRASOUND OBST GYN, V37, P432, DOI 10.1002/uog.8867; Yeu BK, 2008, FETAL DIAGN THER, V24, P241, DOI 10.1159/000151669	19	10	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157477	10.1371/journal.pone.0157477	http://dx.doi.org/10.1371/journal.pone.0157477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314236	gold, Green Submitted, Green Published			2022-12-26	WOS:000378030000031
J	Dikkers, MF; Westerman, MJ; Rubinstein, SM; van Tulder, MW; Anema, JR				Dikkers, Marije F.; Westerman, Marjan J.; Rubinstein, Sidney M.; van Tulder, Maurits W.; Anema, Johannes R.			Why Neck Pain Patients Are Not Referred to Manual Therapy: A Qualitative Study among Dutch Primary Care Stakeholders	PLOS ONE			English	Article							GENERAL-PRACTITIONER; CONSERVATIVE MANAGEMENT; PHYSICAL-THERAPY; CONTINUED CARE; LOW-BACK; COST; PHYSIOTHERAPY	Background Treatment of neck pain with manual therapy demonstrated to be more effective and cost-effective than general practitioner (GP) care or physiotherapy in a high quality RCT in the Netherlands in 2002. However, referral to manual therapy for neck pain is still relatively low. This study aims to explore the barriers and facilitators affecting the implementation of manual therapy in neck pain management in primary care. Methods An explorative study was conducted comprising semi-structured interviews with GPs (n = 13), physiotherapists (n = 10), manual therapists (n = 7) and their patients with neck pain (n = 27), and three focus groups with additional stakeholders (n = 10-12 per group). A thematic analysis approach was used. Results Different barriers and facilitators for referral were found for patients, GPs and physiotherapists on the individual level, but also in the interaction between stakeholders and their context. Individual perceptions such as knowledge and beliefs about manual therapy for neck pain either impeded or facilitated referral. Fear for complications associated with cervical manipulation was an important barrier for patients as well as GPs. For GPs and physiotherapists it was important whether they perceived it was part of their professional role to refer for manual therapy. Existing relations formed referral behavior, and the trust in a particular practitioner was a recurrent theme among GPs and physiotherapist as well as patients. The contextual factor availability of manual therapy played a role for all stakeholders. Conclusions Barriers and facilitators were found especially in individual perceptions on manual therapy for neck pain (e.g. knowledge and beliefs), the interaction between stakeholders (e.g. collaboration and trust) and the organizational context. Implementation strategies that focus on these different aspects seem to be likely to optimize referral rates and the use of manual therapy in primary care management of neck pain.	[Dikkers, Marije F.; Westerman, Marjan J.; Rubinstein, Sidney M.; van Tulder, Maurits W.] Vrije Univ Amsterdam, Dept Hlth Sci, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands; [Dikkers, Marije F.; Westerman, Marjan J.; Rubinstein, Sidney M.; van Tulder, Maurits W.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands; [Anema, Johannes R.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands; [Anema, Johannes R.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Rubinstein, SM (corresponding author), Vrije Univ Amsterdam, Dept Hlth Sci, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.; Rubinstein, SM (corresponding author), Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	s.m.rubinstein@vu.nl	van Tulder, Maurits/AAB-9785-2022	van Tulder, Maurits/0000-0002-7589-8471; Rubinstein, Sidney/0000-0002-4819-994X; Westerman, Marjan J./0000-0002-9827-6958	Netherlands Organization for Health Research and Development [171203011]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	This study is supported by a grant from the Netherlands Organization for Health Research and Development (project number 171203011) (www.zonmw.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aker PD, 1996, BMJ-BRIT MED J, V313, P1291; [Anonymous], 2004, GEN M CAP TOWN MARCH; Bogduk N, 1999, BEST PRACT RES CL RH, V13, P261, DOI 10.1053/berh.1999.0020; Borghouts JAJ, 1999, PAIN, V80, P629, DOI 10.1016/S0304-3959(98)00268-1; Bot SDM, 2005, ANN RHEUM DIS, V64, P118, DOI 10.1136/ard.2003.019349; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Fleuren M, 2004, INT J QUAL HEALTH C, V16, P107, DOI 10.1093/intqhc/mzh030; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Grol R, 2004, MED J AUSTRALIA, V180, pS57, DOI 10.5694/j.1326-5377.2004.tb05948.x; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Gross A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004249.pub4; Gross AR, 2007, J RHEUMATOL, V34, P1083; Hoving JL, 2006, CLIN J PAIN, V22, P370, DOI 10.1097/01.ajp.0000180185.79382.3f; Hoving JL, 2002, ANN INTERN MED, V136, P713, DOI 10.7326/0003-4819-136-10-200205210-00006; Hurwitz EL, 1996, SPINE, V21, P1746, DOI 10.1097/00007632-199608010-00007; Hurwitz EL, 2008, SPINE, V33, pS123, DOI 10.1097/BRS.0b013e3181644b1d; Korthals-de Bos IBC, 2003, BRIT MED J, V326, P911; Ouwens M, 2012, DE ZACHTE KANTEN VAN; Paulussen, 2010, TSG, V88, P51, DOI [DOI 10.1007/BF03089541, 10.1007/BF03089541]; Perreault K, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-160; Scherer M, 2010, EUR SPINE J, V19, P963, DOI 10.1007/s00586-010-1297-x; Schers H, 2001, Spine (Phila Pa 1976), V26, pE348, DOI 10.1097/00007632-200108010-00013; Skargren EI, 1997, SPINE, V22, P2167, DOI 10.1097/00007632-199709150-00015; Stirbu-Wagner I, 2012, LANDELIJK INFORM HUI; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Verberne LDM, JAARCIJFERS 2011 TRE; Vos C, 2007, BRIT J GEN PRACT, V57, P23; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wermeling M, 2011, FAM PRACT, V28, P300, DOI 10.1093/fampra/cmq109	29	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157465	10.1371/journal.pone.0157465	http://dx.doi.org/10.1371/journal.pone.0157465			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311067	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800077
J	Lenzi, EK; Novatski, A; Farago, PV; Almeida, MA; Zawadzki, SF; Neto, RM				Lenzi, E. K.; Novatski, A.; Farago, P. V.; Almeida, M. A.; Zawadzki, S. F.; Neto, R. Menechini			Diffusion Processes and Drug Release: Capsaicinoids - Loaded Poly (epsilon-caprolactone) Microparticles	PLOS ONE			English	Article							FRACTIONAL DIFFUSION; EQUATION; MODELS	We present a generalmodel based on fractional diffusion equation coupled with a kinetic equation through the boundary condition. It covers several scenarios that may be characterized by usual or anomalous diffusion or present relaxation processes on the surface with non-Debye characteristics. A particular case of this model is used to investigate the experimental data obtained from the drug release of the capsaicinoids-loaded Poly (epsilon-caprolactone) microparticles. These considerations lead us to a good agreement with experimental data and to the conjecture that the burst effect, i.e., an initial large bolus of drug is released before the release rate reaches a stable profile, may be related to an anomalous diffusion manifested by the system.	[Lenzi, E. K.; Novatski, A.; Neto, R. Menechini] Univ Estadual Ponta Grossa, Dept Fis, BR-84030900 Ponta Grossa, Brazil; [Farago, P. V.] Univ Estadual Ponta Grossa, Dept Ciencias Farmaceut, BR-84030900 Ponta Grossa, Brazil; [Almeida, M. A.] Univ Fed Curitiba, Dept Quim, BR-81531980 Curitiba, Parana, Brazil	Universidade Estadual de Ponta Grossa; Universidade Estadual de Ponta Grossa; Universidade Federal do Parana	Lenzi, EK (corresponding author), Univ Estadual Ponta Grossa, Dept Fis, BR-84030900 Ponta Grossa, Brazil.	eklenzi@uepg.br	Lenzi, Ervin Kaminski/N-1767-2019; Novatski, Andressa/D-5366-2013; zawadzki, sonia f/T-1546-2017	Lenzi, Ervin Kaminski/0000-0003-3853-1790; Novatski, Andressa/0000-0002-8327-6285; 	CNPQ [303642/2014-9, 456403/2014-0, 401997/2014-6]; Fundacao Araucaria [613 / 2014, 822/13]	CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	The authors thank CNPQ (grant numbers, 303642/2014-9 (EKL), 456403/2014-0 (PVF), and 401997/2014-6 (RM)) and Fundacao Araucaria (grant numbers, 613 / 2014 (AN) and 822/13 (AN)) for the partial financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MA, 2014, MAT SCI ENG C-MATER, V40, P345, DOI 10.1016/j.msec.2014.03.049; Barkai E, 2012, PHYS TODAY, V65, P29, DOI 10.1063/PT.3.1677; Benichou O, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.038102; Berg, 2018, RANDOM WALKS BIOL; Bressloff P. C., 2014, STOCHASTIC PROCESSES; Bressloff PC, 2013, REV MOD PHYS, V85, P135, DOI 10.1103/RevModPhys.85.135; Bueno-Orovio A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0352; Chechkin AV, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3593198; Chechkin AV, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.040105; Chechkin AV, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046129; Ciuchi F, 2012, J PHYS CHEM C, V116, P8773, DOI 10.1021/jp211097m; Condamin S, 2008, P NATL ACAD SCI USA, V105, P5675, DOI 10.1073/pnas.0712158105; Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1; Crank J., 1975, MATH DIFFUSION; Guimaraes VG, 2015, SOFT MATTER, V11, P1658, DOI 10.1039/c5sm00151j; Hayman M., 2008, CURR ANAESTH CRIT CA, V19, P338, DOI [10.1016/j.cacc.2008.07.003, DOI 10.1016/J.CACC.2008.07.003]; HIGUCHI T, 1961, J PHARM SCI, V50, P874, DOI 10.1002/jps.2600501018; Hofling F, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/4/046602; Iyiola OS, 2014, AIP ADV, V4, DOI 10.1063/1.4898331; Klafter J., 2012, FRACTIONAL DYNAMICS; KORSMEYER RW, 1981, J MEMBRANE SCI, V9, P211, DOI 10.1016/S0376-7388(00)80265-3; Langlands TAM, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051102; Mathai AM, 2010, H-FUNCTION: THEORY AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-0916-9; Metzler R, 2014, PHYS CHEM CHEM PHYS, V16, P24128, DOI 10.1039/c4cp03465a; OSHAUGHNESSY B, 1985, PHYS REV LETT, V54, P455, DOI 10.1103/PhysRevLett.54.455; Peng HL, 2010, FOOD CHEM, V121, P23, DOI 10.1016/j.foodchem.2009.11.085; Podlubny I., 1999, FRACTIONAL DIFFERENT, VVolume 198; SCHNEIDER WR, 1989, J MATH PHYS, V30, P134, DOI 10.1063/1.528578; Schumer R, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002141; Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0; Siepmann J, 2013, INT J PHARMACEUT, V453, P12, DOI 10.1016/j.ijpharm.2013.04.044; Tateishi AA, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011147; WANG TT, 1969, J POLYM SCI A2, V7, P2019, DOI 10.1002/pol.1969.160071204; Wyld H. W., 1976, MATH METHODS PHYS; Yin C, 2011, INT J PHARMACEUT, V418, P78, DOI 10.1016/j.ijpharm.2010.12.009; Zola RS, 2007, CHEM PHYS LETT, V438, P144, DOI 10.1016/j.cplett.2007.02.068	36	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157662	10.1371/journal.pone.0157662	http://dx.doi.org/10.1371/journal.pone.0157662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309358	gold, Green Published, Green Submitted			2022-12-26	WOS:000378029800118
J	Smedley, J; Macalister, R; Wangari, S; Gathuka, M; Ahrens, J; Iwayama, N; May, D; Bratt, D; O'Connor, M; Munson, P; Koday, M; Lifson, J; Fuller, DH				Smedley, Jeremy; Macalister, Rhonda; Wangari, Solomon; Gathuka, Mercy; Ahrens, Joel; Iwayama, Naoto; May, Drew; Bratt, Debbie; O'Connor, Megan; Munson, Paul; Koday, Michael; Lifson, Jeff; Fuller, Deborah Heydenburg			Laparoscopic Technique for Serial Collection of Para-Colonic, Left Colic, and Inferior Mesenteric Lymph Nodes in Macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; T-CELLS; IMMUNE RECONSTITUTION; SIV INFECTION; AIDS; RESERVOIR; ABSENCE; HIV-1; DEATH	Unlike peripheral lymph nodes (PLN), the mesenteric lymph nodes (MLN) draining the gastrointestinal (GI) tract are exposed to microbes and microbial products from the intestines and as such, are immunologically distinct. GI draining (MLN) have also been shown to be sites of early viral replication and likely impact early events that determine the course of HIV infection. They also are important reservoir sites that harbor latently-infected cells and from which the virus can emerge even after prolonged combination antiretroviral therapy (cART). Changes in the microbial flora and increased permeability of the GI epithelium associated with lentiviral infection can impact the gut associated lymphoid tissue (GALT) and induce changes to secondary lymphoid organs limiting immune reconstitution with cART. Nonhuman primate models for AIDS closely model HIV infection in humans and serial sampling of the GALT and associated secondary lymphoid organs in this model is crucial to gain a better understanding of the critical early events in infection, pathogenesis, and the role of immune responses or drugs in controlling virus at these sites. However, current techniques to sample GI draining (MLN) involve major surgery and/or necropsy, which have, to date, limited the ability to investigate mechanisms mediating the initiation, persistence and control of infection in this compartment. Here, we describe a minimally invasive laparoscopic technique for serial sampling of these sites that can be used with increased sampling frequency, yields greater cell numbers and immune cell subsets than current non-invasive techniques of the GALT and reduces the potential for surgical complications that could complicate interpretation of the results. This procedure has potential to facilitate studies of pathogenesis and evaluation of preventive and treatment interventions, reducing sampling variables that can influence experimental results, and improving animal welfare.	[Smedley, Jeremy; Wangari, Solomon; Ahrens, Joel; Iwayama, Naoto; May, Drew] Univ Washington, Div Primate Resources, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; [Macalister, Rhonda] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Gathuka, Mercy] Leidos Biomed Res Inc, Lab Anim Sci Program, Frederick Natl Lab, Frederick, MD USA; [Bratt, Debbie; O'Connor, Megan; Munson, Paul; Koday, Michael; Fuller, Deborah Heydenburg] Univ Washington, Div AIDS Res, Washington Natl Primate Res Ctr, Dept Microbiol, Seattle, WA 98195 USA; [Lifson, Jeff] Leidos Biomed Res Inc, AIDS & Canc Viruses Program, Frederick Natl Lab, Frederick, MD USA	University of Washington; University of Washington Seattle; Oregon Health & Science University; Oregon National Primate Research Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Smedley, J (corresponding author), Univ Washington, Div Primate Resources, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA.	jsmedley@uw.edu	Bratt, Debra/B-1106-2019	O'Connor, Megan/0000-0003-2127-5073; Fuller, Deborah/0000-0001-7315-2441; Smedley, Jeremy/0000-0003-3369-4662	NIH grants [P51 NIH P51 OD010425-54]; National Institute of Allergy and Infectious Disease [R01 AI104679-01]; National Cancer Institute [HHSN261200800001E]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the following NIH grants: P51 NIH P51 OD010425-54, National Institute of Allergy and Infectious Disease R01 AI104679-01 and in part with federal funds from the National Cancer Institute under contract [HHSN261200800001E]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CDC, 2013, HIV SURV REP, P25; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Cumont MC, 2007, CELL DEATH DIFFER, V14, P1747, DOI 10.1038/sj.cdd.4402192; ESTAQUIER J, 1994, P NATL ACAD SCI USA, V91, P9431, DOI 10.1073/pnas.91.20.9431; Estaquier J, 2008, M S-MED SCI, V24, P1055, DOI 10.1051/medsci/200824121055; Estes J, 2008, J INFECT DIS, V198, P456, DOI 10.1086/590112; Estes JD, 2007, J INFECT DIS, V195, P551, DOI 10.1086/510852; Estes JD, 2015, J INFECT DIS, V211, P744, DOI 10.1093/infdis/jiu519; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Hall HI, 2015, MMWR-MORBID MORTAL W, V64, P657; Hao XP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9020; Horiike M, 2012, VIROLOGY, V423, P107, DOI 10.1016/j.virol.2011.11.024; Klatt NR, 2012, MUCOSAL IMMUNOL, V5, P646, DOI 10.1038/mi.2012.38; Klatt NR, 2010, MUCOSAL IMMUNOL, V3, P387, DOI 10.1038/mi.2010.14; Macpherson AJ, 2006, J EXP MED, V203, P497, DOI 10.1084/jem.20060227; Miura Soichiro, 2012, Ann Vasc Dis, V5, P275, DOI 10.3400/avd.ra.12.00059; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Siliciano JM, 2015, J INFECT DIS, V212, P1345, DOI 10.1093/infdis/jiv219; Smedley J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092830	19	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157535	10.1371/journal.pone.0157535	http://dx.doi.org/10.1371/journal.pone.0157535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309717	Green Submitted, Green Published, gold			2022-12-26	WOS:000378029800094
J	Suetsugu, N; Higa, T; Gotoh, E; Wada, M				Suetsugu, Noriyuki; Higa, Takeshi; Gotoh, Eiji; Wada, Masamitsu			Light-Induced Movements of Chloroplasts and Nuclei Are Regulated in Both Cp-Actin-Filament-Dependent and -Independent Manners in Arabidopsis thaliana	PLOS ONE			English	Article							KINESIN-LIKE PROTEINS; ADIANTUM-CAPILLUS-VENERIS; BLUE-LIGHT; AVOIDANCE MOVEMENT; PLASTID MOVEMENT; PLASMA-MEMBRANE; PHOTORELOCATION MOVEMENT; PHYSCOMITRELLA-PATENS; OUTER-MEMBRANE; LEAF-CELLS	Light-induced chloroplast movement and attachment to the plasma membrane are dependent on actin filaments. In Arabidopsis thaliana, the short actin filaments on the chloroplast envelope, cp-actin filaments, are essential for chloroplast movement and positioning. Furthermore, cp-actin-filament-mediated chloroplast movement is necessary for the strong-light- induced nuclear avoidance response. The proteins CHLOROPLAST UNUSUAL POSITIONING 1 (CHUP1), KINESIN-LIKE PROTEIN FOR ACTIN-BASED CHLOROPLAST MOVEMENT 1 (KAC1) and KAC2 are required for the generation and/or maintenance of cp-actin filaments in Arabidopsis. In land plants, CHUP1 and KAC family proteins play pivotal roles in the proper movement of chloroplasts and their attachment to the plasma membrane. Here, we report similar but distinct phenotypes in chloroplast and nuclear photorelocation movements between chup1 and kac1kac2 mutants. Measurement of chloroplast photorelocation movement indicated that kac1kac2, but not chup1, exhibited a clear strong-light- induced increase in leaf transmittance changes. The chloroplast movement in kac1kac2 depended on phototropin 2, CHUP1 and two other regulators for cp-actin filaments, PLASTID MOVEMENT IMPAIRED 1 and THRUMIN 1. Furthermore, kac1kac2 retained a weak but significant nuclear avoidance response although chup1 displayed a severe defect in the nuclear avoidance response. The kac1kac2chup1 triple mutant was completely defective in both chloroplast and nuclear avoidance responses. These results indicate that CHUP1 and the KACs function somewhat independently, but interdependently mediate both chloroplast and nuclear photorelocation movements.	[Suetsugu, Noriyuki; Higa, Takeshi; Wada, Masamitsu] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Gotoh, Eiji] Kyushu Univ, Dept Agr, Fukuoka 812, Japan; [Suetsugu, Noriyuki] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Higa, Takeshi; Wada, Masamitsu] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Biol Sci, Tokyo 158, Japan	Kyushu University; Kyushu University; Kyoto University; Tokyo Metropolitan University	Wada, M (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.; Wada, M (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Biol Sci, Tokyo 158, Japan.	masamitsu.wada@gmail.com		Higa, Takeshi/0000-0002-3196-2160	Japan Society of Promotion of Science [20227001, 22657016, 23120523, 20870030]; Grants-in-Aid for Scientific Research [15K18713, 25251033] Funding Source: KAKEN	Japan Society of Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Japan Society of Promotion of Science [20227001, 22657016 and 23120523 to M.W., 20870030 to N.S.] (https://www.jsps.go.jp/english/index.html). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sam-Geun Kong for the assistance in measurement of chloroplast photorelocation movement and critical reading of the manuscript. We appreciate Atsuko Tsutsumi for technical assistance. This work was supported in part by the Japan Society of Promotion of Science [20227001, 22657016 and 23120523 to M.W., 20870030 to N.S.].	Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; DeBlasio SL, 2005, PLANT PHYSIOL, V139, P101, DOI 10.1104/pp.105.061887; GABRYS H, 1980, ACTA PHYSIOL PLANT, V4, P281; Higa T, 2014, J EXP BOT, V65, P2873, DOI 10.1093/jxb/ert414; Higa T, 2014, P NATL ACAD SCI USA, V111, P4327, DOI 10.1073/pnas.1317902111; Ichikawa S, 2011, PLANT CELL PHYSIOL, V52, P1422, DOI 10.1093/pcp/pcr087; Iwabuchi K, 2007, PLANT CELL PHYSIOL, V48, P1291, DOI 10.1093/pcp/pcm095; Iwabuchi K, 2010, PLANT PHYSIOL, V152, P1309, DOI 10.1104/pp.109.149526; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; Jonsson E, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.87, 10.1038/nplants.2015.87]; Kadota A, 2009, P NATL ACAD SCI USA, V106, P13106, DOI 10.1073/pnas.0906250106; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kasahara M, 2002, NATURE, V420, P829, DOI 10.1038/nature01213; Kodama Y, 2010, P NATL ACAD SCI USA, V107, P19591, DOI 10.1073/pnas.1007836107; Kong SG, 2013, PLANT CELL, V25, P572, DOI 10.1105/tpc.113.109694; Kong SG, 2013, PLANT CELL PHYSIOL, V54, P80, DOI 10.1093/pcp/pcs151; Lehmann P, 2011, PLANT SCI, V180, P650, DOI 10.1016/j.plantsci.2011.01.006; Luesse DR, 2006, PLANT PHYSIOL, V141, P1328, DOI 10.1104/pp.106.080333; Luesse DR, 2010, J EXP BOT, V61, P4387, DOI 10.1093/jxb/erq242; Oikawa K, 2003, PLANT CELL, V15, P2805, DOI 10.1105/tpc.016428; Oikawa K, 2008, PLANT PHYSIOL, V148, P829, DOI 10.1104/pp.108.123075; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Sato Y, 2001, J CELL SCI, V114, P269; Shen ZY, 2015, J INTEGR PLANT BIOL, V57, P106, DOI 10.1111/jipb.12303; Suetsugu N, 2005, PLANT PHYSIOL, V139, P151, DOI 10.1104/pp.105.067371; Suetsugu N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00561; Suetsugu N, 2015, PLANT PHYSIOL, V169, P1155, DOI 10.1104/pp.15.00214; Suetsugu N, 2013, AM J BOT, V100, P60, DOI 10.3732/ajb.1200308; Suetsugu N, 2012, ADVANCES IN PHOTOSYNTHESIS - FUNDAMENTAL ASPECTS, P215; Suetsugu N, 2012, PLANT CELL PHYSIOL, V53, P1854, DOI 10.1093/pcp/pcs133; Suetsugu N, 2010, PLANT SIGNAL BEHAV, V5, P1190, DOI 10.4161/psb.5.10.12802; Suetsugu N, 2010, P NATL ACAD SCI USA, V107, P8860, DOI 10.1073/pnas.0912773107; Tsuboi H, 2007, PLANT CELL PHYSIOL, V48, P892, DOI 10.1093/pcp/pcm057; Tsuboi H, 2012, J PLANT RES, V125, P417, DOI 10.1007/s10265-011-0444-8; Usami H, 2012, PLANTA, V236, P1889, DOI 10.1007/s00425-012-1735-6; Vanstraelen M, 2006, CURR BIOL, V16, P308, DOI 10.1016/j.cub.2005.12.035; Vanstraelen M, 2004, PLANT PHYSIOL, V135, P1417, DOI 10.1104/pp.104.044818; von Braun SS, 2008, PLANTA, V227, P1151, DOI 10.1007/s00425-007-0688-7; Wada M, 2004, CURR OPIN PLANT BIOL, V7, P626, DOI 10.1016/j.pbi.2004.09.005; Wada M, 2013, PLANT SCI CELL BIOL, DOI [10.1007/SpringerReference_3685532013-10-0107:42:21UTC, DOI 10.1007/SPRINGERREFERENCE_3685532013-10-0107:42:21UTC]; Wada M, 2011, METHODS MOL BIOL, V774, P87, DOI 10.1007/978-1-61779-234-2_6; Whippo CW, 2011, CURR BIOL, V21, P59, DOI 10.1016/j.cub.2010.11.059; WILLIAMSON RE, 1993, ANNU REV PLANT PHYS, V44, P181, DOI 10.1146/annurev.pp.44.060193.001145; Yamashita H, 2011, PLANTA, V233, P357, DOI 10.1007/s00425-010-1299-2	44	23	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157429	10.1371/journal.pone.0157429	http://dx.doi.org/10.1371/journal.pone.0157429			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310016	Green Published, gold			2022-12-26	WOS:000378029800070
J	Wang, HB; Han, XK; Gambhir, D; Becker, S; Kunz, E; Liu, AJ; Hartnett, ME				Wang, Haibo; Han, Xiaokun; Gambhir, Deeksha; Becker, Silke; Kunz, Eric; Liu, Angelina Jingtong; Hartnett, M. Elizabeth			Retinal Inhibition of CCR3 Induces Retinal Cell Death in a Murine Model of Choroidal Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; INTRAVITREAL NEOVASCULARIZATION; MULLER CELLS; RAT MODEL; VEGF; RETINOPATHY; MIGRATION; NEURONS	Inhibition of chemokine C-C motif receptor 3 (CCR3) signaling has been considered as treatment for neovascular age-related macular degeneration (AMD). However, CCR3 is expressed in neural retina from aged human donor eyes. Therefore, broad CCR3 inhibition may be harmful to the retina. We assessed the effects of CCR3 inhibition on retina and choroidal endothelial cells (CECs) that develop into choroidal neovascularization (CNV). In adult murine eyes, CCR3 colocalized with glutamine-synthetase labeled Muller cells. In a murine laser-induced CNV model, CCR3 immunolocalized not only to lectin-stained cells in CNV lesions but also to the retina. Compared to non-lasered controls, CCR3 mRNA was significantly increased in laser-treated retina. An intravitreal injection of a CCR3 inhibitor (CCR3i) significantly reduced CNV compared to DMSO or PBS controls. Both CCR3i and a neutralizing antibody to CCR3 increased TUNEL+ retinal cells overlying CNV, compared to controls. There was no difference in cleaved caspase-3 in laser-induced CNV lesions or in overlying retina between CCR3i-or control-treated eyes. Following CCR3i, apoptotic inducible factor (AIF) was significantly increased and anti-apoptotic factor BCL2 decreased in the retina; there were no differences in retinal vascular endothelial growth factor (VEGF). In cultured human Muller cells exposed to eotaxin (CCL11) and VEGF, CCR3i significantly increased TUNEL+ cells and AIF but decreased BCL2 and brain derived neurotrophic factor, without affecting caspase-3 activity or VEGF. CCR3i significantly decreased AIF in RPE/choroids and immunostaining of phosphorylated VEGF receptor 2 (p-VEGFR2) in CNV with a trend toward reduced VEGF. In cultured CECs treated with CCL11 and/or VEGF, CCR3i decreased p-VEGFR2 and increased BCL2 without increasing TUNEL+ cells and AIF. These findings suggest that inhibition of retinal CCR3 causes retinal cell death and that targeted inhibition of CCR3 in CECs may be a safer if CCR3 inhibition is considered as a therapy for neovascular AMD.	[Wang, Haibo; Han, Xiaokun; Gambhir, Deeksha; Becker, Silke; Kunz, Eric; Liu, Angelina Jingtong; Hartnett, M. Elizabeth] Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT USA; [Han, Xiaokun] China Med Univ, Affiliated Hosp 4, Dept Ophthalmol, Shenyang 110001, Peoples R China	Utah System of Higher Education; University of Utah; China Medical University	Hartnett, ME (corresponding author), Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT USA.	ME.Hartnett@hsc.utah.edu	Chopra, Deeksha Gambhir/K-7148-2014	Chopra, Deeksha Gambhir/0000-0003-0835-4703	National Eye Institute [R01EY015130, R01EY017011]; March of Dimes [6-FY13-75]; Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE [R01EY017011] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); March of Dimes(March of Dimes); Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute, R01EY015130 and R01EY017011 (https://nei.nih.gov) to MEH, the March of Dimes, 6-FY13-75 (http://www.marchofdimes.org) to MEH and the Knights Templar Eye Foundation (http://www.knightstemplar.org/ktef) to HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2011, INVEST OPHTH VIS SCI, V52, P2166, DOI 10.1167/iovs.11-7328; Bradley John, 2007, Angiogenesis, V10, P141, DOI 10.1007/s10456-007-9069-x; Chen Y, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-15029; Dias JRD, 2011, BRIT J OPHTHALMOL, V95, P1631, DOI 10.1136/bjo.2010.186361; Edwards MM, 2012, EXP EYE RES, V96, P147, DOI 10.1016/j.exer.2011.12.005; Edwards MM, 2015, EXP EYE RES; Falavarjani KG, 2013, EYE, V27, P787, DOI 10.1038/eye.2013.107; Fu SH, 2015, DIABETES, V64, P3554, DOI 10.2337/db15-0180; Geisen P, 2006, EXP EYE RES, V82, P608, DOI 10.1016/j.exer.2005.08.021; Ishibashi T, 1997, GRAEF ARCH CLIN EXP, V235, P159, DOI 10.1007/BF00941723; Jiang YC, 2014, INVEST OPHTH VIS SCI, V55, P824, DOI 10.1167/iovs.13-13755; Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; Lorenc VE, 2015, INVEST OPHTH VIS SCI, V56, P6948, DOI 10.1167/iovs.15-17496; Maloney S. C., 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P147, DOI 10.2174/187152507780363197; Mizutani T, 2013, INVEST OPHTH VIS SCI, V54, P1564, DOI 10.1167/iovs.11-9095; Monaghan-Benson E, 2010, AM J PATHOL, V177, P2091, DOI 10.2353/ajpath.2010.090878; Nagai N, 2015, AM J PATHOL, V185, P2534, DOI 10.1016/j.ajpath.2015.04.029; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Nussenblatt RB, 2007, AM J OPHTHALMOL, V144, P618, DOI 10.1016/j.ajo.2007.06.025; Ren F, 2014, J HAZARD MATER, V271, P283, DOI 10.1016/j.jhazmat.2014.02.026; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Sharma NK, 2012, DNA CELL BIOL, V31, P1618, DOI 10.1089/dna.2012.1786; Sullivan R, 2003, INVEST OPHTH VIS SCI, V44, P856, DOI 10.1167/iovs.02-0416; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Wang HB, 2013, AM J PATHOL, V183, P964, DOI 10.1016/j.ajpath.2013.05.011; Wang HB, 2011, INVEST OPHTH VIS SCI, V52, P8271, DOI 10.1167/iovs.11-8230	28	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157748	10.1371/journal.pone.0157748	http://dx.doi.org/10.1371/journal.pone.0157748			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309355	gold, Green Submitted, Green Published			2022-12-26	WOS:000378029800131
J	Wilf, M; Ramot, M; Furman-Haran, E; Arzi, A; Levkovitz, Y; Malach, R				Wilf, Meytal; Ramot, Michal; Furman-Haran, Edna; Arzi, Anat; Levkovitz, Yechiel; Malach, Rafael			Diminished Auditory Responses during NREM Sleep Correlate with the Hierarchy of Language Processing	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; EYE-MOVEMENT SLEEP; EVENT-RELATED POTENTIALS; DEFAULT-MODE NETWORK; BOLD SIGNAL; PERCEPTUAL AWARENESS; SPEECH-PERCEPTION; PRIMATE PRIMARY; VISUAL-CORTEX; BRAIN	Natural sleep provides a powerful model system for studying the neuronal correlates of awareness and state changes in the human brain. To quantitatively map the nature of sleep-induced modulations in sensory responses we presented participants with auditory stimuli possessing different levels of linguistic complexity. Ten participants were scanned using functional magnetic resonance imaging (fMRI) during the waking state and after falling asleep. Sleep staging was based on heart rate measures validated independently on 20 participants using concurrent EEG and heart rate measurements and the results were confirmed using permutation analysis. Participants were exposed to three types of auditory stimuli: scrambled sounds, meaningless word sentences and comprehensible sentences. During non-rapid eye movement (NREM) sleep, we found diminishing brain activation along the hierarchy of language processing, more pronounced in higher processing regions. Specifically, the auditory thalamus showed similar activation levels during sleep and waking states, primary auditory cortex remained activated but showed a significant reduction in auditory responses during sleep, and the high order language-related representation in inferior frontal gyrus (IFG) cortex showed a complete abolishment of responses during NREM sleep. In addition to an overall activation decrease in language processing regions in superior temporal gyrus and IFG, those areas manifested a loss of semantic selectivity during NREM sleep. Our results suggest that the decreased awareness to linguistic auditory stimuli during NREM sleep is linked to diminished activity in high order processing stations.	[Wilf, Meytal; Ramot, Michal; Arzi, Anat; Malach, Rafael] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Furman-Haran, Edna] Weizmann Inst Sci, Dept Biol Serv, IL-76100 Rehovot, Israel; [Levkovitz, Yechiel] Tel Aviv Univ, Sch Med, Shalvata Mental Hlth Care Ctr, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University	Wilf, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	meytalwilf@gmail.com		Arzi, Anat/0000-0003-1005-1752; Wilf, Meytal/0000-0002-4037-8505; Ramot, Michal/0000-0001-9716-6469	EU FP7 VERE, ICORE program [ISF 51/11]; EU-Flagship, Human Brain Project grants; Helen and Martin Kimmel award	EU FP7 VERE, ICORE program; EU-Flagship, Human Brain Project grants; Helen and Martin Kimmel award	This work was funded by the EU FP7 VERE, ICORE program (ISF 51/11), the EU-Flagship, Human Brain Project grants and the Helen and Martin Kimmel award to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzi A, 2010, CHEM SENSES, V35, P31, DOI 10.1093/chemse/bjp079; Bastuji H, 2002, INT J PSYCHOPHYSIOL, V46, P243, DOI 10.1016/S0167-8760(02)00116-2; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Bonnet MH, 2007, J CLIN SLEEP MED, V3, P133; Brualla J, 1998, EVOKED POTENTIAL, V108, P283, DOI 10.1016/S0168-5597(97)00102-0; Cappe C, 2009, CEREB CORTEX; CARSKADON MA, 2000, PRINCIPLES PRACTICE, P15; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Coenen AML, 2002, INT J PSYCHOPHYSIOL, V46, P163, DOI 10.1016/S0167-8760(02)00110-1; Czisch M, 2004, EUR J NEUROSCI, V20, P566, DOI 10.1111/j.1460-9568.2004.03518.x; Czisch M, 2002, NEUROIMAGE, V16, P251, DOI 10.1006/nimg.2002.1071; Czisch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006749; Daltrozzo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050997; Davis MH, 2007, P NATL ACAD SCI USA, V104, P16032, DOI 10.1073/pnas.0701309104; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Ebrahimi F, 2013, COMPUT METH PROG BIO, V112, P47, DOI 10.1016/j.cmpb.2013.06.007; Fisch L, 2009, NEURON, V64, P562, DOI 10.1016/j.neuron.2009.11.001; Freedman NS, 2001, AM J RESP CRIT CARE, V163, P451, DOI 10.1164/ajrccm.163.2.9912128; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Gutschalk A, 2008, PLOS BIOL, V6, P1156, DOI 10.1371/journal.pbio.0060138; Harpaz Y, 2009, CORTEX, V45, P1097, DOI 10.1016/j.cortex.2009.01.002; Hennevin E, 2007, NEUROBIOL LEARN MEM, V87, P416, DOI 10.1016/j.nlm.2006.10.006; Hesselmann G, 2011, NEUROIMAGE, V56, P1608, DOI 10.1016/j.neuroimage.2011.03.017; Hilton B A, 1976, J Adv Nurs, V1, P453, DOI 10.1111/j.1365-2648.1976.tb00932.x; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Iacovella V, 2011, MAGN RESON IMAGING, V29, P1338, DOI 10.1016/j.mri.2011.03.006; Issa EB, 2011, J NEUROSCI, V31, P2965, DOI 10.1523/JNEUROSCI.4920-10.2011; Issa EB, 2008, J NEUROSCI, V28, P14467, DOI 10.1523/JNEUROSCI.3086-08.2008; Jancke L, 1999, NEUROSCI LETT, V266, P125, DOI 10.1016/S0304-3940(99)00288-8; Kouider S, 2014, CURR BIOL, V24, P2208, DOI 10.1016/j.cub.2014.08.016; Larson-Prior LJ, 2011, PROG BRAIN RES, V193, P277, DOI 10.1016/B978-0-444-53839-0.00018-1; Laureys S, 2002, ACTA NEUROL BELG, V102, P176; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Ma T, 2005, P ANN INT IEEE EMBS, P996, DOI 10.1109/IEMBS.2005.1616585; Magnin M, 2010, P NATL ACAD SCI USA, V107, P3829, DOI 10.1073/pnas.0909710107; Maquet P, 2000, J SLEEP RES, V9, P207; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2012, ARCH ITAL BIOL, V150, P44, DOI 10.4449/aib.v150i2.1361; MORAY N, 1959, Q J EXP PSYCHOL, V11, P56, DOI 10.1080/17470215908416289; Nir Y, 2013, CEREB CORTEX; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Pal D, 2011, SPR SER COMPUT NEURO, V15, P1, DOI 10.1007/978-1-4614-0173-5_1; Penzel T, 2003, IEEE T BIO-MED ENG, V50, P1143, DOI 10.1109/TBME.2003.817636; Perrin F, 1999, CLIN NEUROPHYSIOL, V110, P2153, DOI 10.1016/S1388-2457(99)00177-7; Perrin F, 2002, NEUROREPORT; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Picchioni Dante, 2014, Sleep, V37, P387, DOI 10.5665/sleep.3422; Portas CM, 2000, NEURON, V28, P991, DOI 10.1016/S0896-6273(00)00169-0; Quiroga RQ, 2008, P NATL ACAD SCI USA, V105, P3599, DOI 10.1073/pnas.0707043105; Ramot M, 2013, J NEUROSCI, V33, P14715, DOI 10.1523/JNEUROSCI.0232-13.2013; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rodd JM, 2005, CEREB CORTEX, V15, P1261, DOI 10.1093/cercor/bhi009; Sabri M, 2008, NEUROIMAGE, V39, P1444, DOI 10.1016/j.neuroimage.2007.09.052; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; Schabus M, 2012, FRONTIERS NEUROLOGY, V3; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; SNYDER F, 1964, J APPL PHYSIOL, V19, P417, DOI 10.1152/jappl.1964.19.3.417; Spoormaker VI, 2010, J NEUROSCI, V30, P11379, DOI 10.1523/JNEUROSCI.2015-10.2010; STERIADE M, 1991, J NEUROSCI, V11, P3200; Sterzer P, 2009, TRENDS COGN SCI, V13, P310, DOI 10.1016/j.tics.2009.04.006; Strauss M, 2015, P NATL ACAD SCI USA, V112, pE1353, DOI 10.1073/pnas.1501026112; Dang-Vu TT, 2011, P NATL ACAD SCI USA, V108, P15438, DOI 10.1073/pnas.1112503108; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tononi G, 2008, ANN NY ACAD SCI, V1124, P239, DOI 10.1196/annals.1440.004; Tononi G, 2008, ANN NY ACAD SCI, V1129, P330, DOI 10.1196/annals.1417.024; van Buuren M, 2009, HUM BRAIN MAPP, V30, P3031, DOI 10.1002/hbm.20729; Xiao M, 2013, BIOMED SIGNAL PROCES, V8, P624, DOI 10.1016/j.bspc.2013.06.001	70	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157143	10.1371/journal.pone.0157143	http://dx.doi.org/10.1371/journal.pone.0157143			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310812	gold, Green Published, Green Submitted			2022-12-26	WOS:000378029800036
J	Katorcha, E; Srivastava, S; Klimova, N; Baskakov, IV				Katorcha, Elizaveta; Srivastava, Saurabh; Klimova, Nina; Baskakov, Ilia V.			Sialylation of Glycosylphosphatidylinositol (GPI) Anchors of Mammalian Prions Is Regulated in a Host-, Tissue-, and Cell-specific Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						brain; glycosylphosphatidylinositol (GPI anchor); prion; prion disease; sialic acid; myotube; sialylation; spleen	TRANSMISSIBLE MINK ENCEPHALOPATHY; FOLLICULAR DENDRITIC CELLS; CREUTZFELDT-JAKOB-DISEASE; SIALYLTRANSFERASE ACTIVITY; SIALIC-ACID; ECTO-SIALYLTRANSFERASE; INTERCELLULAR TRANSFER; MASS-SPECTROMETRY; LYMPHOID-TISSUES; PROTEIN	Prions or PrPSc are proteinaceous infectious agents that consist of misfolded, self-replicating states of the prion protein or PrPC. PrPC is posttranslationally modified with N-linked glycans and a sialylated glycosylphosphatidylinositol (GPI) anchor. Conformational conversion of PrPC gives rise to glycosylated and GPI-anchored PrPSc. The question of the sialylation status of GPIs within PrPSc has been controversial. Previous studies that examined scrapie brains reported that both sialo- and asialo-GPIs were present in PrPSc, with the majority being asialo-GPIs. In contrast, recent work that employed cultured cells claimed that only PrPC with sialylo-GPIs could be recruited into PrPSc, whereas PrPC with asialo-GPIs inhibited conversion. To resolve this controversy, we analyzed the sialylation status of GPIs within PrPSc generated in the brain, spleen, or cultured N2a or C2C12 myotube cells. We found that recruiting PrPC with both sialo- and asialo-GPIs is a common feature of PrPSc. The mixtures of sialo- and asialo-GPIs were observed in PrPSc universally regardless of prion strain as well as host, tissue, or type of cells that produced PrPSc. Remarkably, the proportion of sialo- versus asialo-GPIs was found to be controlled by host, tissue, and cell type but not prion strain. In summary, this study found no strain-specific preferences for selecting PrPC with sialo- versus asialo-GPIs. Instead, this work suggests that the sialylation status of GPIs within PrPSc is regulated in a cell-, tissue-, or host-specific manner and is likely to be determined by the specifics of GPI biosynthesis.	[Baskakov, Ilia V.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, 111 S Penn St, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Baskakov, IV (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, 111 S Penn St, Baltimore, MD 21201 USA.	baskakov@umaryland.edu	Srivastava, Saurabh/L-1188-2017	Srivastava, Saurabh/0000-0003-3159-7826	National Institutes of Health [R01 NS045585, R01 NS074998]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074998, R01NS045585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01 NS045585 and R01 NS074998 (to I.V.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; Baldwin MA, 2005, METHOD ENZYMOL, V405, P172, DOI 10.1016/S0076-6879(05)05008-1; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Bate C, 2016, J BIOL CHEM, V291, P160, DOI 10.1074/jbc.M115.672394; Bate C, 2012, J BIOL CHEM, V287, P7935, DOI 10.1074/jbc.M111.275743; Bate C, 2010, BIOCHEM J, V428, P95, DOI 10.1042/BJ20091469; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Breydo L, 2007, BIOCHEMISTRY-US, V46, P852, DOI 10.1021/bi061923v; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Crespo HJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00491; Dall'Olio F, 2014, BBA-GEN SUBJECTS, V1840, P2752, DOI 10.1016/j.bbagen.2014.06.006; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Ferguson MAJ, 2009, ESSENTIALS GLYCOBIOL, V2nd, P143; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Ghaemmaghami S, 2007, P NATL ACAD SCI USA, V104, P17971, DOI 10.1073/pnas.0708372104; Ghaemmaghami S, 2011, J MOL BIOL, V413, P527, DOI 10.1016/j.jmb.2011.07.021; Gross HJ, 1996, BLOOD, V87, P5113, DOI 10.1182/blood.V87.12.5113.bloodjournal87125113; Cabral MG, 2010, IMMUNOL LETT, V131, P89, DOI 10.1016/j.imlet.2010.02.009; Guillerme-Bosselut F, 2009, GLYCOBIOLOGY, V19, P879, DOI 10.1093/glycob/cwp062; Guo BB, 2016, J BIOL CHEM, V291, P5128, DOI 10.1074/jbc.M115.684258; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Harduin-Lepers Anne, 2012, Front Biosci (Elite Ed), V4, P499; Herbst A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003755; Jeffrey M, 2014, NEUROPATH APPL NEURO, V40, P296, DOI 10.1111/nan.12053; Katorcha E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143218; Katorcha E, 2015, SCI REP-UK, V5, DOI 10.1038/srep16912; Katorcha E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004366; Kaufmann M, 1999, INT IMMUNOL, V11, P731, DOI 10.1093/intimm/11.5.731; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; Klimova N, 2015, VIRUS RES, V207, P113, DOI 10.1016/j.virusres.2014.10.002; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Makarava N, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0248-5; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; McCulloch L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002402; Monaco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032382; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Morales R, 2016, SCI REP-UK, V6, DOI 10.1038/srep20526; Nasirikenari M, 2014, J BIOL CHEM, V289, P7178, DOI 10.1074/jbc.M113.508457; Noble GP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005017; Ostapchenko VG, 2010, J MOL BIOL, V400, P908, DOI 10.1016/j.jmb.2010.05.051; Pan T, 2001, J BIOL CHEM, V276, P37284, DOI 10.1074/jbc.M107358200; Patil SA, 2012, ANAL BIOCHEM, V425, P135, DOI 10.1016/j.ab.2012.03.009; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puig B, 2014, PRION, V8, P11, DOI 10.4161/pri.27892; Rifat S, 2008, J LEUKOCYTE BIOL, V84, P1075, DOI 10.1189/jlb.0706462; Rudd PM, 1999, P NATL ACAD SCI USA, V96, P13044, DOI 10.1073/pnas.96.23.13044; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Schwartz-Albiez R, 2004, GLYCOCONJUGATE J, V21, P451, DOI 10.1007/s10719-004-5535-5; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Srivastava S, 2015, P NATL ACAD SCI USA, V112, pE6654, DOI 10.1073/pnas.1517993112; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stimson E, 1999, BIOCHEMISTRY-US, V38, P4885, DOI 10.1021/bi982330q; Stohr J, 2011, P NATL ACAD SCI USA, V108, P21223, DOI 10.1073/pnas.1117827108; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Zanusso G, 2004, J BIOL CHEM, V279, P38936, DOI 10.1074/jbc.M405468200; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	77	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17009	17019		10.1074/jbc.M116.732040	http://dx.doi.org/10.1074/jbc.M116.732040			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27317661	Green Published, hybrid			2022-12-26	WOS:000382643800008
J	Blythe, DAJ; Kiraly, FJ				Blythe, Duncan A. J.; Kiraly, Franz J.			Prediction and Quantification of Individual Athletic Performance of Runners	PLOS ONE			English	Article							VO2 SLOW COMPONENT; RUNNING PERFORMANCE; CROSS-VALIDATION; WORLD RECORDS; EXERCISE; ENDURANCE; THRESHOLD; VELOCITY; HUMANS; POWER	We present a novel, quantitative view on the human athletic performance of individual runners. We obtain a predictor for running performance, a parsimonious model and a training state summary consisting of three numbers by application of modern validation techniques and recent advances in machine learning to the thepowerof10 database of British runners' performances (164,746 individuals, 1,417,432 performances). Our predictor achieves an average prediction error (out-of-sample) of e.g. 3.6 min on elite Marathon performances and 0.3 seconds on 100 metres performances, and a lower error than the state-of-the-art in performance prediction (30% improvement, RMSE) over a range of distances. We are also the first to report on a systematic comparison of predictors for running performance. Our model has three parameters per runner, and three components which are the same for all runners. The first component of the model corresponds to a power law with exponent dependent on the runner which achieves a better goodness-of-fit than known power laws in the study of running. Many documented phenomena in quantitative sports science, such as the form of scoring tables, the success of existing prediction methods including Riegel's formula, the Purdy points scheme, the power law for world records performances and the broken power law for world record speeds may be explained on the basis of our findings in a unified way. We provide strong evidence that the three parameters per runner are related to physiological and behavioural parameters, such as training state, event specialization and age, which allows us to derive novel physiological hypotheses relating to athletic performance. We conjecture on this basis that our findings will be vital in exercise physiology, race planning, the study of aging and training regime design.	[Blythe, Duncan A. J.] African Inst Math Sci, Bagamoyo, Tanzania; [Blythe, Duncan A. J.] Bernstein Ctr Computat Neurosci, Berlin, Germany; [Kiraly, Franz J.] UCL, Dept Stat Sci, London, England; [Blythe, Duncan A. J.] African Inst Math Sci, POB 176,Alpha Zulu,Chunguuni St Indian Str, Pwani, Tanzania; [Kiraly, Franz J.] UCL, Dept Stat Sci, Mortimer St, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Blythe, DAJ (corresponding author), African Inst Math Sci, Bagamoyo, Tanzania.; Blythe, DAJ (corresponding author), Bernstein Ctr Computat Neurosci, Berlin, Germany.; Kiraly, FJ (corresponding author), UCL, Dept Stat Sci, London, England.; Blythe, DAJ (corresponding author), African Inst Math Sci, POB 176,Alpha Zulu,Chunguuni St Indian Str, Pwani, Tanzania.; Kiraly, FJ (corresponding author), UCL, Dept Stat Sci, Mortimer St, London WC1E 6BT, England.	duncan@aims.ac.tz; f.kiraly@ucl.ac.uk			German Research Foundation [GRK 1589/1]; Mathematisches Forschungsinstitut Oberwolfach (MFO); FJK's Oberwolfach Leibniz Fellowship	German Research Foundation(German Research Foundation (DFG)); Mathematisches Forschungsinstitut Oberwolfach (MFO); FJK's Oberwolfach Leibniz Fellowship	DAJB was supported by a grant from the German Research Foundation, research training group GRK 1589/1 "Sensory Computation in Neural Systems." FJK was partially supported by Mathematisches Forschungsinstitut Oberwolfach (MFO). This research was partially carried out at MFO with the support of FJK's Oberwolfach Leibniz Fellowship.	Billat LV, 1996, SPORTS MED, V22, P157, DOI 10.2165/00007256-199622030-00003; Billat LV, 1996, SPORTS MED, V22, P90, DOI 10.2165/00007256-199622020-00004; Borrani F, 2001, J APPL PHYSIOL, V90, P2212, DOI 10.1152/jappl.2001.90.6.2212; Bosquet L, 2002, SPORTS MED, V32, P675, DOI 10.2165/00007256-200232110-00002; BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253; Browne MW, 2000, J MATH PSYCHOL, V44, P108, DOI 10.1006/jmps.1999.1279; Bundle MW, 2003, J APPL PHYSIOL, V95, P1955, DOI 10.1152/japplphysiol.00921.2002; Candes EJ, 2010, IEEE T INFORM THEORY, V56, P2053, DOI 10.1109/TIT.2010.2044061; Candes EJ, 2009, FOUND COMPUT MATH, V9, P717, DOI 10.1007/s10208-009-9045-5; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; di Prampero PE, 2003, EUR J APPL PHYSIOL, V90, P420, DOI 10.1007/s00421-003-0926-z; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; EFRON B, 1983, J AM STAT ASSOC, V78, P316, DOI 10.2307/2288636; Faude O, 2009, SPORTS MED, V39, P469, DOI 10.2165/00007256-200939060-00003; Garcia-Manso JM, 2005, J THEOR BIOL, V233, P191, DOI 10.1016/j.jtbi.2004.10.014; Henry FM, 1955, RES QUART, V26, P147, DOI 10.1080/10671188.1955.10612815; Hill AV, 1924, P R SOC LOND B-CONTA, V97, P84, DOI 10.1098/rspb.1924.0045; HOPPELER H, 1985, J APPL PHYSIOL, V59, P320, DOI 10.1152/jappl.1985.59.2.320; Katz L., 1994, RES SPORTS MED, V5, P95, DOI DOI 10.1080/154386294095; Keller JB, 1973, PHYS TODAY, P43, DOI 10.1063/1.3128231; Kennelly AE, 1906, P AM ACAD ARTS SCI J, P275; Kiraly  F., 2015, J MACHINE LEARNING R; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; LIETZKE MH, 1954, SCIENCE, V119, P333, DOI 10.1126/science.119.3089.333; Noakes TD, 1990, J SPORT SCI, V8, P35, DOI 10.1080/02640419008732129; PERONNET F, 1989, J APPL PHYSIOL, V67, P453, DOI 10.1152/jappl.1989.67.1.453; POOLE DC, 1994, MED SCI SPORT EXER, V26, P1354; PURDY JG, 1974, MED SCI SPORT EXER, V6, P287; Purdy JG, 1974, MED SCI SPORTS, V7, P111; Purdy JG, 1976, MED SCI SPORTS, V9, P212; Riegel PS, 1980, AM SCI, V69, P285; Riegel PS, 1977, RUNNERS WORLD MAGAZI; Rittweger J, 2009, P ROY SOC B-BIOL SCI, V276, P683, DOI 10.1098/rspb.2008.1319; Saltin B, 1977, ANN NY ACAD SCI, P3, DOI [10.1111/j.1749-6632.1977.tb38182.x, DOI 10.1111/J.1749-6632.1977.TB38182.X]; Savaglio S, 2000, NATURE, V404, P244, DOI 10.1038/35005165; van Schenau GJI, 1994, SPORTS MED, V17, P259, DOI [10.2165/00007256-199417040-00006, DOI 10.2165/00007256-199417040-00006]; Venables MC, 2005, J APPL PHYSIOL, V98, P160, DOI 10.1152/japplphysiol.00662.2003; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236	39	8	8	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157257	10.1371/journal.pone.0157257	http://dx.doi.org/10.1371/journal.pone.0157257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336162	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200013
J	Ho, R; Siddiqui, MM; George, AK; Frye, T; Kilchevsky, A; Fascelli, M; Shakir, NA; Chelluri, R; Abboud, SF; Walton-Diaz, A; Sankineni, S; Merino, MJ; Turkbey, B; Choyke, PL; Wood, BJ; Pinto, PA				Ho, Richard; Siddiqui, Mohummad M.; George, Arvin K.; Frye, Thomas; Kilchevsky, Amichai; Fascelli, Michele; Shakir, Nabeel A.; Chelluri, Raju; Abboud, Steven F.; Walton-Diaz, Annerleim; Sankineni, Sandeep; Merino, Maria J.; Turkbey, Baris; Choyke, Peter L.; Wood, Bradford J.; Pinto, Peter A.			Preoperative Multiparametric Magnetic Resonance Imaging Predicts Biochemical Recurrence in Prostate Cancer after Radical Prostatectomy	PLOS ONE			English	Article							ANTIGEN RECURRENCE; RISK; GUIDELINES; OUTCOMES; UTILITY; BIOPSY; MRI	Objectives To evaluate the utility of preoperative multiparametric magnetic resonance imaging (MP-MRI) in predicting biochemical recurrence (BCR) following radical prostatectomy (RP). Materials/Methods From March 2007 to January 2015, 421 consecutive patients with prostate cancer (PCa) underwent preoperative MP-MRI and RP. BCR-free survival rates were estimated using the Kaplan-Meier method. Cox proportional hazards models were used to identify clinical and imaging variables predictive of BCR. Logistic regression was performed to generate a nomogram to predict three-year BCR probability. Results Of the total cohort, 370 patients met inclusion criteria with 39 (10.5%) patients experiencing BCR. On multivariate analysis, preoperative prostate-specific antigen (PSA) (p = 0.01), biopsy Gleason score (p = 0.0008), MP-MRI suspicion score (p = 0.03), and extracapsular extension on MP-MRI (p = 0.03) were significantly associated with time to BCR. A nomogram integrating these factors to predict BCR at three years after RP demonstrated a c-index of 0.84, outperforming the predictive value of Gleason score and PSA alone (c-index 0.74, p = 0.02). Conclusion The addition of MP-MRI to standard clinical factors significantly improves prediction of BCR in a post-prostatectomy PCa cohort. This could serve as a valuable tool to support clinical decision-making in patients with moderate and high-risk cancers.	[Ho, Richard; Siddiqui, Mohummad M.; George, Arvin K.; Frye, Thomas; Kilchevsky, Amichai; Fascelli, Michele; Shakir, Nabeel A.; Chelluri, Raju; Abboud, Steven F.; Walton-Diaz, Annerleim; Pinto, Peter A.] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA; [Sankineni, Sandeep; Turkbey, Baris; Choyke, Peter L.] NCI, Mol Imaging Program, NIH, Bethesda, MD 20892 USA; [Merino, Maria J.] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Wood, Bradford J.] NCI, Ctr Intervent Oncol, NIH, Bethesda, MD 20892 USA; [Siddiqui, Mohummad M.] Univ Maryland, Dept Surg, Div Urol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore	Pinto, PA (corresponding author), NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA.	pintop@mail.nih.gov	Siddiqui, Mohummad/V-1196-2019; Wood, Bradford J/M-7995-2017; Shakir, Nabeel/ABI-6623-2020	Wood, Bradford J/0000-0002-4297-0051; Shakir, Nabeel/0000-0002-9066-3670; Ho, Richard/0000-0002-6792-3411	Center for Cancer Research; Center for Interventional Oncology; NIH; Intramural Research Program of the National Institutes of Health, National Cancer Institute; Pfizer Inc.; Doris Duke Charitable Foundation; Alexandria Real Estate Equities, Inc.; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [ZIDBC011242, ZIABC011081] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL040015] Funding Source: NIH RePORTER	Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Interventional Oncology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pfizer Inc.(Pfizer); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Alexandria Real Estate Equities, Inc.; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, the Center for Cancer Research, and the Center for Interventional Oncology. NIH and Philips Healthcare/Invivo Corp. have a cooperative research and development agreement. NIH and Philips share intellectual property in the field. This research was also made possible through the National Institutes of Health Medical Research Scholars Program, a public-private partnership supported jointly by the NIH and generous contributions to the Foundation for the NIH from Pfizer Inc., The Doris Duke Charitable Foundation, The Alexandria Real Estate Equities, Inc. and Mr. and Mrs. Joel S. Marcus, and the Howard Hughes Medical Institute, as well as other private donors. For a complete list, please visit the Foundation website at: http://fnih.org/what-we-do/current-education-and-training-programs/mrsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Cookson MS, 2007, J UROLOGY, V177, P540, DOI 10.1016/j.juro.2006.10.097; D'Amico AV, 2000, J UROLOGY, V164, P759, DOI 10.1016/S0022-5347(05)67297-7; D'Amico AV, 2000, J CLIN ONCOL, V18, P1164, DOI 10.1200/JCO.2000.18.6.1164; DAMICO AV, 1995, J UROLOGY, V154, P131, DOI 10.1016/S0022-5347(01)67248-3; Diaz M, 2015, EUR UROL, V67, P1168, DOI 10.1016/j.eururo.2014.06.025; Fascelli M, 2015, CURR UROL REP, V16, DOI 10.1007/s11934-015-0507-9; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; Freedland SJ, 2006, J UROLOGY, V176, P1404, DOI 10.1016/j.juro.2006.06.017; Fuchsjager MH, 2009, BJU INT, V104, P315, DOI 10.1111/j.1464-410X.2009.08406.x; Han M, 2003, J UROLOGY, V169, P517, DOI 10.1016/S0022-5347(05)63946-8; Hattori S, 2014, BJU INT, V113, P741, DOI 10.1111/bju.12329; Heenan SD, 2004, PROSTATE CANCER P D, V7, P282, DOI 10.1038/sj.pcan.4500767; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Kattan MW, 1998, JNCI-J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766; Nishida K, 2011, ACTA RADIOL, V52, P120, DOI 10.1258/ar.2010.100293; Panebianco V, 2013, EUR RADIOL, V23, P1745, DOI 10.1007/s00330-013-2768-3; Park JJ, 2014, AM J ROENTGENOL, V202, pW459, DOI 10.2214/AJR.13.11381; Pinto PA, 2011, J UROLOGY, V186, P1281, DOI 10.1016/j.juro.2011.05.078; Poulakis V, 2004, UROLOGY, V64, P1165, DOI 10.1016/j.urology.2004.06.030; Rais-Bahrami S, 2013, J UROLOGY, V190, P1721, DOI 10.1016/j.juro.2013.05.052; Shariat SF, 2008, CANCER-AM CANCER SOC, V113, P3075, DOI 10.1002/cncr.23908; Siddiqui MM, 2015, J UROLOGY, V193, P1943, DOI 10.1016/j.juro.2015.01.088; Siddiqui MM, 2015, JAMA-J AM MED ASSOC, V313, P390, DOI 10.1001/jama.2014.17942; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Swindle PW, 2003, UROL CLIN N AM, V30, P377, DOI 10.1016/S0094-0143(02)00176-3; Thompson IM, 2013, J UROLOGY, V190, P441, DOI 10.1016/j.juro.2013.05.032; Turkbey B, 2010, RADIOLOGY, V255, P89, DOI 10.1148/radiol.09090475; Ung JO, 2002, UROLOGY, V60, P458, DOI 10.1016/S0090-4295(02)01814-9; Walz J, 2009, J UROLOGY, V181, P601, DOI 10.1016/j.juro.2008.10.033; Yerram NK, 2012, BJU INT, V110, pE783, DOI 10.1111/j.1464-410X.2012.11646.x	31	25	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157313	10.1371/journal.pone.0157313	http://dx.doi.org/10.1371/journal.pone.0157313			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336392	Green Submitted, Green Published, gold			2022-12-26	WOS:000378389200015
J	Kim, KJ; Choi, HM; Yoon, YE; Kim, HL; Lee, SP; Kim, HK; Kim, YJ; Cho, GY; Zo, JH; Sohn, DW				Kim, Kyung-Jin; Choi, Hong-Mi; Yoon, Yeonyee E.; Kim, Hack-Lyoung; Lee, Seung-Pyo; Kim, Hyung-Kwan; Kim, Yong-Jin; Cho, Goo-Yeong; Zo, Joo-Hee; Sohn, Dae-Won			Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; LATE GADOLINIUM ENHANCEMENT; LEFT-VENTRICULAR HYPERTROPHY; ASSOCIATION TASK-FORCE; SPECKLE TRACKING; CLINICAL-SIGNIFICANCE; PRACTICE GUIDELINES; PROGNOSTIC VALUE; FIBRILLATION; ECHOCARDIOGRAPHY	Background Atrial fibrillation is the most common arrhythmia and is associated with adverse outcomes in hypertrophic cardiomyopathy (HCM). Although left atrial (LA) remodeling and dysfunction are known to associate with the development of atrial fibrillation in HCM, the changes of the LA in HCM patients remain unclear. This study aimed to evaluate the changes in LA size and mechanical function in HCM patients compared to control subjects and to determine the characteristics of HCM associated with LA remodeling and dysfunction. Methods Seventy-nine HCM patients (mean age, 54 +/- 11 years; 76% were men) were compared to 79 age-and sex-matched controls (mean age, 54 +/- 11 years; 76% were men) and 20 young healthy controls (mean age, 33 +/- 5 years; 45% were men). The LA diameter, volume, and mechanical function, including global strain (epsilon), were evaluated by 2D-speckle tracking echocardiography. The phenotype of HCM, maximal left ventricular (LV) wall thickness, LV mass, and presence and extent of late gadolinium enhancement (LGE) were evaluated with cardiac magnetic resonance imaging. Results HCM patients showed increased LA volume index, impaired reservoir function, and decreased LA e compared to the control subjects. When we divided the HCM group according to a maximal LA volume index (LAVI(max)) of 38.7 ml/m(2) or LA epsilon of 21%, no significant differences in the HCM phenotype and maximal LV wall thickness were observed for patients with LAVI(max) > 38.7 ml/m(2) or LA epsilon <= 21%. Conversely, the LV mass index was significantly higher both in patients with maximal LA volume index > 38.7 ml/m(2) and with LA epsilon <= 21% and was independently associated with LAVI(max) and LA epsilon. Although the LGE extent was increased in patients with LA epsilon <= 21%, it was not independently associated with either LAVI(max) or LA epsilon. Conclusions HCM patients showed progressed LA remodeling and dysfunction; the determinant of LA remodeling and dysfunction was LV mass index rather than LV myocardial fibrosis by LGE-magnetic resonance imaging.	[Kim, Kyung-Jin; Choi, Hong-Mi; Yoon, Yeonyee E.; Kim, Hack-Lyoung; Lee, Seung-Pyo; Kim, Hyung-Kwan; Kim, Yong-Jin; Cho, Goo-Yeong; Zo, Joo-Hee; Sohn, Dae-Won] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Kyung-Jin; Choi, Hong-Mi; Lee, Seung-Pyo; Kim, Hyung-Kwan; Kim, Yong-Jin; Sohn, Dae-Won] Seoul Natl Univ Hosp, Dept Internal Med, Ctr Cardiovasc, Seoul 110744, South Korea; [Yoon, Yeonyee E.; Cho, Goo-Yeong] Seoul Natl Univ, Div Cardiol, Dept Internal Med, Bundang Hosp, Seongnam Si, Gyeonggi Do, South Korea; [Kim, Hack-Lyoung; Zo, Joo-Hee] Seoul Natl Univ, Div Cardiol, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Yoon, YE (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.; Yoon, YE (corresponding author), Seoul Natl Univ, Div Cardiol, Dept Internal Med, Bundang Hosp, Seongnam Si, Gyeonggi Do, South Korea.	islandtea@gmail.com	Kim, Hyung-Kwan/R-8375-2019; Kim, Hack-Lyoung/AAL-5038-2020	Kim, Hack-Lyoung/0000-0002-6703-1472; Kim, Hyung-Kwan/0000-0001-7950-2131	Seoul National University Bundang Hospital [02-2013-028]	Seoul National University Bundang Hospital	This work was funded by a research grant (02-2013-028) from the Seoul National University Bundang Hospital (www.snubh.org). YEY received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caselli S, 2014, AM J CARDIOL, V114, P1383, DOI 10.1016/j.amjcard.2014.07.070; Chan RH, 2014, CIRCULATION, V130, P484, DOI 10.1161/CIRCULATIONAHA.113.007094; Cheitlin MD, 1997, CIRCULATION, V95, P1686; Choudhury L, 2002, J AM COLL CARDIOL, V40, P2156, DOI 10.1016/S0735-1097(02)02602-5; D'Andrea A, 2007, EUR HEART J, V28, P2738, DOI 10.1093/eurheartj/ehm443; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Green JJ, 2012, JACC-CARDIOVASC IMAG, V5, P370, DOI 10.1016/j.jcmg.2011.11.021; Harrigan CJ, 2011, RADIOLOGY, V258, P128, DOI 10.1148/radiol.10090526; Henein M, 2012, INT J CARDIOL, V155, P437, DOI 10.1016/j.ijcard.2011.10.007; Hwang HJ, 2009, J INTERV CARD ELECTR, V26, P127, DOI 10.1007/s10840-009-9410-y; KLUES HG, 1995, J AM COLL CARDIOL, V26, P1699, DOI 10.1016/0735-1097(95)00390-8; Maron BJ, 2014, AM J CARDIOL, V113, P1394, DOI 10.1016/j.amjcard.2013.12.045; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron BJ, 2002, J AM COLL CARDIOL, V39, P301, DOI 10.1016/S0735-1097(01)01727-2; Maron MS, 2008, CIRC-HEART FAIL, V1, P184, DOI 10.1161/CIRCHEARTFAILURE.108.768119; Olivotto I, 2001, CIRCULATION, V104, P2517, DOI 10.1161/hc4601.097997; Olivotto I, 2008, J AM COLL CARDIOL, V52, P559, DOI 10.1016/j.jacc.2008.04.047; Olivotto I, 2010, AM J CARDIOL, V106, P261, DOI 10.1016/j.amjcard.2010.03.020; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Rickers C, 2005, CIRCULATION, V112, P855, DOI 10.1161/CIRCULATIONAHA.104.507723; Rubinshtein R, 2010, CIRC-HEART FAIL, V3, P51, DOI 10.1161/CIRCHEARTFAILURE.109.854026; Saraiva RM, 2010, J AM SOC ECHOCARDIOG, V23, P172, DOI 10.1016/j.echo.2009.11.003; Shin MS, 2006, J AM SOC ECHOCARDIOG, V19, P796, DOI 10.1016/j.echo.2006.01.012; Siontis KC, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001002; Tigen K, 2014, ECHOCARDIOGR-J CARD, V31, P833, DOI 10.1111/echo.12482; To ACY, 2011, JACC-CARDIOVASC IMAG, V4, P1123, DOI 10.1016/j.jcmg.2011.06.022; Yang H, 2005, J AM SOC ECHOCARDIOG, V18, P1074, DOI 10.1016/j.echo.2005.06.011; Yoon YE, 2015, J AM SOC ECHOCARDIOG, V28, P709, DOI 10.1016/j.echo.2015.01.017; Yoon Yeonyee E, 2012, J Cardiovasc Ultrasound, V20, P140, DOI 10.4250/jcu.2012.20.3.140	29	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157433	10.1371/journal.pone.0157433	http://dx.doi.org/10.1371/journal.pone.0157433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336444	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200016
J	Sampaio, J; Machado, D; Gomes, AM; Machado, I; Santos, C; Lima, N; Carvalho, MJ; Cabrita, A; Rodrigues, A; Martins, M				Sampaio, Joana; Machado, Diana; Gomes, Ana Marta; Machado, Idalina; Santos, Cledir; Lima, Nelson; Carvalho, Maria Joao; Cabrita, Antonio; Rodrigues, Anabela; Martins, Margarida			Deciphering the Contribution of Biofilm to the Pathogenesis of Peritoneal Dialysis Infections: Characterization and Microbial Behaviour on Dialysis Fluids	PLOS ONE			English	Article							EXIT-SITE INFECTION; SUBSEQUENT PERITONITIS; CATHETERS; ASSOCIATION; PREVENTION; RATES	Infections are major complications in peritoneal dialysis (PD) with a multifactorial etiology that comprises patient, microbial and dialytic factors. This study aimed at investigating the contribution of microbial biofilms on PD catheters to recalcitrant infections and their interplay with PD related-factors. A prospective observational study was performed on 47 patients attending Centro Hospitalar of Porto and Vila Nova de Gaia/Espinho to whom the catheter was removed due to infectious (n = 16) and non-infectious causes (n = 31). Microbial density on the catheter was assessed by culture methods and the isolated microorganisms identified by matrix-assisted laser desorption/ionization time-of-flight intact cell mass spectrometry. The effect of conventional and three biocompatible PD solutions on 16 Coagulase Negative Staphylococci (CNS) and 10 Pseudomonas aeruginosa strains planktonic growth and biofilm formation was evaluated. Cultures were positive in 87.5% of the catheters removed due infectious and 90.3% removed due to non-infectious causes. However, microbial yields were higher on the cuffs of catheters removed due to infection vs. non-infection. Staphylococci (CNS and Staphylococcus aureus) and P. aeruginosa were the predominant species: 32% and 20% in the infection and 43.3% and 22.7% in the non-infection group, respectively. In general, PD solutions had a detrimental effect on planktonic CNS and P. aeruginosa strains growth. All strains formed biofilms in the presence of PD solutions. The solutions had a more detrimental effect on P. aeruginosa than CNS strains. No major differences were observed between conventional and biocompatible solutions, although in icodextrin solution biofilm biomass was lower than in bicarbonate/lactate solution. Overall, we show that microbial biofilm is universal in PD catheters with the subclinical menace of Staphylococci and P. aeruginosa. Cuffs colonization may significantly contribute to infection. PD solutions differentially impact microbial species. This knowledge is important for the development of infection diagnosis, treatment and preventive strategies.	[Sampaio, Joana; Machado, Diana; Martins, Margarida] Univ Minho, CEB Ctr Biol Engn, LIBRO, Campus Gualtar, Braga, Portugal; [Gomes, Ana Marta] Ctr Hosp Vila Nova de Gaia Espinho, Serv Nefrol, Rua Conceicao Femandes, Vila Nova De Gaia, Portugal; [Machado, Idalina] Univ Porto, Fac Engn, Dept Chem Engn, LEPABE, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Santos, Cledir] BIOREN UFRO Univ La Frontera, CIBAMA, Dept Chem Sci & Nat Resources, Temuco, Chile; [Lima, Nelson] Micoteca Univ Minho, CEB Ctr Biol Engn, Campus Gualtar, Braga, Portugal; [Carvalho, Maria Joao; Cabrita, Antonio; Rodrigues, Anabela] Ctr Hosp Porto, Serv Nefrol, Largo Prof Abel Salazar Porto, Porto, Portugal; [Rodrigues, Anabela] UP, UMIB, ICBAS, Porto, Portugal	Universidade do Minho; Universidade do Porto; Universidade do Porto	Martins, M (corresponding author), Univ Minho, CEB Ctr Biol Engn, LIBRO, Campus Gualtar, Braga, Portugal.; Rodrigues, A (corresponding author), Ctr Hosp Porto, Serv Nefrol, Largo Prof Abel Salazar Porto, Porto, Portugal.; Rodrigues, A (corresponding author), UP, UMIB, ICBAS, Porto, Portugal.	rodrigues.anabela2016@gmail.com; martins.margarida@gmail.com	Lima, Nelson/D-3651-2009; Santos, Cledir/H-5214-2012; Machado, Idalina/J-2892-2013; Santos, Cledir/AAO-8276-2020; Martins, Margarida/F-2313-2010; Soares Rodrigues, Anabela/K-5226-2013	Lima, Nelson/0000-0003-2185-0613; Santos, Cledir/0000-0003-4681-0941; Machado, Idalina/0000-0003-0546-4915; Santos, Cledir/0000-0003-4681-0941; Martins, Margarida/0000-0002-4979-7634; Soares Rodrigues, Anabela/0000-0001-8818-2141; Cabrita, Antonio/0000-0003-3794-9239	Sociedade Portuguesa de Nefrologia research grant; Fundacao para a Ciencia e Tecnologia post doc grant [SFRH/BPD/73663/2010]	Sociedade Portuguesa de Nefrologia research grant; Fundacao para a Ciencia e Tecnologia post doc grant	This work received support from a Sociedade Portuguesa de Nefrologia (http://www.spnefro.pt) research grant to AR and a Fundacao para a Ciencia e Tecnologia (http://www.fct.pt) post doc grant (SFRH/BPD/73663/2010) to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek Joo-Eun, 2004, Korean Journal of Internal Medicine, V19, P104; Barraclough KA, 2009, EXPERT REV ANTI-INFE, V7, P1185, DOI [10.1586/eri.09.100, 10.1586/ERI.09.100]; Bayston R, 1999, PERITON DIALYSIS INT, V19, P550; Broekhuizen CAN, 2008, CRIT CARE MED, V36, P2395, DOI 10.1097/CCM.0b013e3181818268; Burke M, 2011, AM J KIDNEY DIS, V58, P429, DOI 10.1053/j.ajkd.2011.03.022; Cho Y, 2014, T COCHRANE DATABASE, V3; Cho Y, 2014, AM J KIDNEY DIS, V64, P278, DOI 10.1053/j.ajkd.2014.02.025; DASGUPTA MK, 1992, INT BIODETER BIODEGR, V30, P167, DOI 10.1016/0964-8305(92)90061-R; Finkelstein ES, 2002, AM J KIDNEY DIS, V39, P1278, DOI 10.1053/ajkd.2002.33403; Garcia-Lopez E, 2012, NAT REV NEPHROL, V8, P224, DOI 10.1038/nrneph.2012.13; Hall-Stoodley L, 2012, FEMS IMMUNOL MED MIC, V65, P127, DOI 10.1111/j.1574-695X.2012.00968.x; Harrison JJ, 2010, NAT PROTOC, V5, P1236, DOI 10.1038/nprot.2010.71; Hoiby N, 2015, CLIN MICROBIOL INFEC, V21, pS1, DOI 10.1016/j.cmi.2014.10.024; Jones SM, 2011, AM J KIDNEY DIS, V57, P449, DOI 10.1053/j.ajkd.2010.10.053; Lan PG, 2014, CLIN J AM SOC NEPHRO, V9, P1091, DOI 10.2215/CJN.09730913; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Lin CY, 2013, J AM SOC NEPHROL, V24, P2002, DOI 10.1681/ASN.2013040332; Magnussen Eyd Tausen, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2015-212619; Martins M, 2013, BIOFOULING, V29, P1015, DOI 10.1080/08927014.2013.824566; McGuire AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119238; Mehrotra R, 2013, CLIN J AM SOC NEPHRO, V8, P126, DOI 10.2215/CJN.06910712; Nessim SJ, 2012, PERITON DIALYSIS INT, V32, P316, DOI 10.3747/pdi.2011.00058; Pihl M, 2013, PATHOG DIS, V67, P192, DOI 10.1111/2049-632X.12035; Ramanathan V, 2012, AM J KIDNEY DIS, V60, P976, DOI 10.1053/j.ajkd.2012.06.003; Rocha A, 2012, BLOOD PURIFICAT, V33, P284, DOI 10.1159/000337377; Rodrigues A, 2014, AM J INFECT CONTROL, V42, P1016, DOI 10.1016/j.ajic.2014.05.036; Szeto CC, 2001, KIDNEY INT, V59, P2309, DOI 10.1046/j.1523-1755.2001.00748.x; Szeto CC, 2008, CLIN J AM SOC NEPHRO, V3, P91, DOI 10.2215/CJN.03070707; Szeto CC, 2014, PERITON DIALYSIS INT, V34, P151, DOI 10.3747/pdi.2014.00007; Szeto CC, 2013, CLIN J AM SOC NEPHRO, V8, P1935, DOI 10.2215/CJN.02360213; Szeto CC, 2011, CLIN J AM SOC NEPHRO, V6, P827, DOI 10.2215/CJN.05370610; Szeto CC, 2009, AM J KIDNEY DIS, V54, P702, DOI 10.1053/j.ajkd.2009.04.032; Uppuluri P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005397; de Luijtgaarden MWM, 2016, NEPHROL DIAL TRANSPL, V31, P120, DOI 10.1093/ndt/gfv295; van Diepen ATN, 2013, PERITON DIALYSIS INT, V33, P604, DOI 10.3747/pdi.2012.00082; van Diepen ATN, 2012, CLIN J AM SOC NEPHRO, V7, P1266, DOI 10.2215/CJN.00980112; van Esch S, 2014, PERITON DIALYSIS INT, V34, P162, DOI 10.3747/pdi.2013.00275; Vargemezis V, 2001, NEPHROL DIAL TRANSPL, V16, P106, DOI 10.1093/ndt/16.suppl_6.106; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	40	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157870	10.1371/journal.pone.0157870	http://dx.doi.org/10.1371/journal.pone.0157870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336367	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200059
J	Wang, J; Xue, DX; Zhang, BD; Li, YL; Liu, BJ; Liu, JX				Wang, Juan; Xue, Dong-Xiu; Zhang, Bai-Dong; Li, Yu-Long; Liu, Bing-Jian; Liu, Jin-Xian			Genome-Wide SNP Discovery, Genotyping and Their Preliminary Applications for Population Genetic Inference in Spotted Sea Bass (Lateolabrax maculatus)	PLOS ONE			English	Article							WESTSLOPE CUTTHROAT TROUT; CONSERVATION GENETICS; ATLANTIC SALMON; EUROPEAN EEL; DIVERGENCE; JAPONICUS; JAPANESE; MARKERS; POLYMORPHISM; FISHERIES	Next-generation sequencing and the collection of genome-wide single-nucleotide polymorphisms (SNPs) allow identifying fine-scale population genetic structure and genomic regions under selection. The spotted sea bass (Lateolabrax maculatus) is a non-model species of ecological and commercial importance and widely distributed in northwestern Pacific. A total of 22 648 SNPs was discovered across the genome of L. maculatus by paired-end sequencing of restriction-site associated DNA (RAD-PE) for 30 individuals from two populations. The nucleotide diversity (Pi) for each population was 0.0028 +/- 0.0001 in Dandong and 0.0018 +/- 0.0001 in Beihai, respectively. Shallow but significant genetic differentiation was detected between the two populations analyzed by using both the whole data set (F-ST = 0.0550, P < 0.001) and the putatively neutral SNPs (F-ST = 0.0347, P < 0.001). However, the two populations were highly differentiated based on the putatively adaptive SNPs (F-ST = 0.6929, P < 0.001). Moreover, a total of 356 SNPs representing 298 unique loci were detected as outliers putatively under divergent selection by F-ST-based outlier tests as implemented in BAYESCAN and LOSITAN. Functional annotation of the contigs containing putatively adaptive SNPs yielded hits for 22 of 55 (40%) significant BLASTX matches. Candidate genes for local selection constituted a wide array of functions, including binding, catalytic and metabolic activities, etc. The analyses with the SNPs developed in the present study highlighted the importance of genome-wide genetic variation for inference of population structure and local adaptation in L. maculatus.	[Wang, Juan; Xue, Dong-Xiu; Zhang, Bai-Dong; Li, Yu-Long; Liu, Bing-Jian; Liu, Jin-Xian] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Shandong, Peoples R China; [Wang, Juan; Xue, Dong-Xiu; Zhang, Bai-Dong; Li, Yu-Long; Liu, Bing-Jian; Liu, Jin-Xian] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Zhang, Bai-Dong; Li, Yu-Long; Liu, Bing-Jian] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, JX (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Shandong, Peoples R China.; Liu, JX (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	jinxianliu@gmail.com	Zhang, Baidong/AAA-9633-2022	Li, Yulong/0000-0002-1852-9469	Joint Project of the National Natural Science Foundation of China and Shandong Province: Marine Ecology and Environmental Sciences [U1406403]; China Postdoctoral Science Foundation [2014M560585]; Strategic Priority Research Program of Chinese Academy of Sciences [XDA11020704]; 100 Talents Program of the Chinese Academy of Sciences	Joint Project of the National Natural Science Foundation of China and Shandong Province: Marine Ecology and Environmental Sciences; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	The study was supported by the Joint Project of the National Natural Science Foundation of China and Shandong Province: Marine Ecology and Environmental Sciences (U1406403) to JXL, China Postdoctoral Science Foundation to JW (2014M560585), the Strategic Priority Research Program of Chinese Academy of Sciences to JXL (XDA11020704), and 100 Talents Program of the Chinese Academy of Sciences to JXL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; An HS, 2013, GENES GENOM, V35, P671, DOI 10.1007/s13258-013-0135-z; Angeloni F, 2012, EVOL APPL, V5, P130, DOI 10.1111/j.1752-4571.2011.00217.x; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Avise JC, 2010, CONSERV GENET, V11, P665, DOI 10.1007/s10592-009-0006-y; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bi YH, 2012, MITOCHONDR DNA, V23, P371, DOI 10.3109/19401736.2012.696630; Bourret V, 2013, MOL ECOL, V22, P532, DOI 10.1111/mec.12003; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Chen D., 2001, J OCEAN U QINGDAO, V23, P81; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Fraser HB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002023; Freamo H, 2011, MOL ECOL RESOUR, V11, P254, DOI 10.1111/j.1755-0998.2010.02952.x; Fu YB, 2012, MOL ECOL RESOUR, V12, P492, DOI 10.1111/j.1755-0998.2011.03100.x; Gompert Z, 2010, MOL ECOL, V19, P2455, DOI 10.1111/j.1365-294X.2010.04666.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Guo BC, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0130-8; Hemmer-Hansen J, 2013, MOL ECOL, V22, P2653, DOI 10.1111/mec.12284; Hess JE, 2013, MOL ECOL, V22, P2898, DOI 10.1111/mec.12150; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hohenlohe PA, 2013, MOL ECOL, V22, P3002, DOI 10.1111/mec.12239; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hu ZM, 2007, PERIODICAL OCEAN U C, V3, P413; Ilut DC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/675158; Jack BHA, 2011, INT J BIOCHEM CELL B, V43, P693, DOI 10.1016/j.biocel.2011.01.017; Jiang X, 2008, J APPL ICHTHYOL, V24, P180, DOI 10.1111/j.1439-0426.2007.01016.x; KIM Y, 2001, MARINE FISHES KOREA, P222; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Larson WA, 2014, EVOL APPL, V7, P355, DOI 10.1111/eva.12128; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liao G., 1998, FISHERIES SCI TECHNO, V25, P130; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Liu JX, 2006, MOL PHYLOGENET EVOL, V39, P799, DOI 10.1016/j.ympev.2006.01.009; [刘明月 Liu Mingyue], 2010, [南京师大学报. 自然科学版, Journal of Nanjing Normal University. Natural Science], V33, P102; Matsuoka S., 1993, SUISANZOSHOKU, V41, P265; Maughan PJ, 2009, PLANT GENOME-US, V2, P260, DOI 10.3835/plantgenome2009.08.0022; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Neuditschko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048375; Niu SF, 2017, MITOCHONDRIAL DNA A, V28, P173, DOI 10.3109/19401736.2015.1115496; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pujolar JM, 2014, MOL ECOL, V23, P2514, DOI 10.1111/mec.12753; Pujolar JM, 2013, MOL ECOL RESOUR, V13, P706, DOI 10.1111/1755-0998.12117; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Russello MA, 2012, EVOL APPL, V5, P39, DOI 10.1111/j.1752-4571.2011.00206.x; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Savolainen O, 2013, NAT REV GENET, V14, P807, DOI 10.1038/nrg3522; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Shaklee JB, 1999, FISH RES, V43, P45, DOI 10.1016/S0165-7836(99)00066-1; Shimada Y, 2011, MOL BIOL EVOL, V28, P181, DOI 10.1093/molbev/msq181; Steinig EJ, 2016, MOL ECOL RESOUR, V16, P216, DOI 10.1111/1755-0998.12442; Thurstan RH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1013; UTTER F, 1993, FISHERIES, V18, P11, DOI 10.1577/1548-8446(1993)018&lt;0011:GMAMSF&gt;2.0.CO;2; Van Bers NEM, 2010, MOL ECOL, V19, P89, DOI 10.1111/j.1365-294X.2009.04486.x; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Vandamme SG, 2014, MOL ECOL, V23, P618, DOI 10.1111/mec.12628; Wang Y, 2003, J OCEAN U QINGDAO, V4, P531; Waples RS, 2008, FISHERIES, V33, P76; Willing EM, 2011, BIOINFORMATICS, V27, P2187, DOI 10.1093/bioinformatics/btr346; YOKOGAWA K, 1995, JPN J ICHTHYOL, V41, P437; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang BD, 2016, MOL ECOL RESOUR, V16, P755, DOI 10.1111/1755-0998.12476; Zhang J, 2014, CELL MOL IMMUNOL, V11, P245, DOI 10.1038/cmi.2013.65; Zhao Yan, 2011, Zoological Research, V32, P515, DOI 10.3724/SP.J.1141.2011.05515	76	12	13	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157809	10.1371/journal.pone.0157809	http://dx.doi.org/10.1371/journal.pone.0157809			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336696	gold, Green Published, Green Submitted			2022-12-26	WOS:000378389200052
J	Curtis, RC; Custis, JT; Ehrhart, NP; Ehrhart, EJ; Condon, KW; Gookin, SE; Donahue, SW				Curtis, Ryan C.; Custis, James T.; Ehrhart, Nicole P.; Ehrhart, E. J.; Condon, Keith W.; Gookin, Sara E.; Donahue, Seth W.			Combination Therapy with Zoledronic Acid and Parathyroid Hormone Improves Bone Architecture and Strength following a Clinically-Relevant Dose of Stereotactic Radiation Therapy for the Local Treatment of Canine Osteosarcoma in Athymic Rats	PLOS ONE			English	Article							APPENDICULAR OSTEOSARCOMA; PALLIATIVE RADIOTHERAPY; POSTMENOPAUSAL WOMEN; MINERAL DENSITY; OSTEOPOROSIS; DOGS; TERIPARATIDE; FRACTURE; PTH; BISPHOSPHONATES	Clinical studies using definitive-intent stereotactic radiation therapy (SRT) for the local treatment of canine osteosarcoma (OSA) have shown canine patients achieving similar median survival times as the current standard of care (amputation and adjuvant chemotherapy). Despite this, there remains an unacceptable high risk of pathologic fracture following radiation treatment. Zoledronic acid (ZA) and parathyroid hormone (PTH) are therapeutic candidates for decreasing this fracture risk post-irradiation. Due to differing mechanisms, we hypothesized that the combined treatment with ZA and PTH would significantly improve bone healing more than ZA or PTH treatment alone. Using an orthotopic model of canine osteosarcoma in athymic rats, we evaluated bone healing following clinically-relevant doses of radiation therapy (12 Gy x 3 fractions, 36 Gy total). Groups included 36 Gy SRT only, 36 Gy SRT plus ZA, 36 Gy SRT plus ZA and PTH, 36 Gy SRT plus PTH, and 36 Gy SRT plus localized PTH treatment. Our study showed significant increases in bone volume and increased polar moments of inertia (in the distal femoral metaphysis) 8 weeks after radiation in the combined (ZA/PTH) treatment group as compared to radiation treatment alone. Histomorphometric analysis revealed evidence of active mineralization at the study endpoint as well as successful tumor-cell kill across all treatment groups. This work provides further evidence for the expanding potential indications for ZA and PTH therapy, including post-irradiated bone disease due to osteosarcoma.	[Curtis, Ryan C.; Ehrhart, E. J.] Colorado State Univ, Coll Vet Med & Biomed Sci, Microbiol Immunol & Pathol Dept, Ft Collins, CO 80523 USA; [Custis, James T.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Ehrhart, Nicole P.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA; [Condon, Keith W.] Indiana Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Gookin, Sara E.; Donahue, Seth W.] Colorado State Univ, Dept Mech Engn, Coll Engn, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University; Indiana University System; Indiana University Bloomington; Colorado State University	Curtis, RC (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Microbiol Immunol & Pathol Dept, Ft Collins, CO 80523 USA.; Curtis, RC (corresponding author), Oklahoma State Univ, Ctr Vet Hlth Sci, 101 McElroy Hall Annex, Stillwater, OK 74078 USA.	Ryan.Curtis@okstate.edu			Cancer Supercluster Grant from Colorado State University's Flint Animal Cancer Center	Cancer Supercluster Grant from Colorado State University's Flint Animal Cancer Center	Supported by a Cancer Supercluster Grant from Colorado State University's Flint Animal Cancer Center.	Alcaraz M, 2013, CLIN TRANSL ONCOL, V15, P300, DOI 10.1007/s12094-012-0917-9; Andrews EB, 2012, J BONE MINER RES, V27, P2429, DOI 10.1002/jbmr.1768; Arrington SA, 2010, CALCIFIED TISSUE INT, V87, P263, DOI 10.1007/s00223-010-9390-z; Bagi CM, 2006, BONE, V38, P136, DOI 10.1016/j.bone.2005.07.028; Bielack S, 2008, ANN ONCOL, V19, P94, DOI 10.1093/annonc/mdn102; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Chandra A, 2013, BONE, V55, P449, DOI 10.1016/j.bone.2013.02.023; Donahue SW, 2006, J EXP BIOL, V209, P1630, DOI 10.1242/jeb.02185; Fan TM, 2008, J VET INTERN MED, V22, P380, DOI 10.1111/j.1939-1676.2008.0046.x; Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725; Gao Y, 2008, CELL METAB, V8, P132, DOI 10.1016/j.cmet.2008.07.001; Gasser J. A., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P53; Gnant M, 2012, CANCER TREAT REV, V38, P407, DOI 10.1016/j.ctrv.2011.09.003; Gray S.K., 2012, THESIS, P111; Gray SK, 2012, BONE, V51, P578, DOI 10.1016/j.bone.2012.05.003; Green EM, 2002, J AM ANIM HOSP ASSOC, V38, P445, DOI 10.5326/0380445; Greenspan SL, 2007, ANN INTERN MED, V146, P326, DOI 10.7326/0003-4819-146-5-200703060-00005; Jiang YB, 2003, J BONE MINER RES, V18, P1932, DOI 10.1359/jbmr.2003.18.11.1932; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Jing D., 2014, J BONE MINER RES; Kijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064615; Lane AE, 2012, AUST VET J, V90, P69, DOI 10.1111/j.1751-0813.2011.00878.x; Li YF, 2012, OSTEOPOROSIS INT, V23, P1463, DOI 10.1007/s00198-011-1751-6; Liptak JM, 2004, COMP CONT EDUC PRACT, V26, P172; Mayer MN, 2006, CAN VET J, V47, P707; Mueller F, 2007, ANTICANCER RES, V27, P155; Mueller F, 2005, IN VIVO, V19, P713; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; O'Donoghue LE, 2011, J VET DIAGN INVEST, V23, P780, DOI 10.1177/1040638711408064; POWERS BE, 1991, CANCER, V67, P126, DOI 10.1002/1097-0142(19910101)67:1<126::AID-CNCR2820670123>3.0.CO;2-7; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; Ramirez O, 1999, VET RADIOL ULTRASOUN, V40, P517, DOI 10.1111/j.1740-8261.1999.tb00385.x; Recker RR, 2009, BONE, V44, P113, DOI 10.1016/j.bone.2008.09.019; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Samadfam R, 2007, ENDOCRINOLOGY, V148, P2778, DOI 10.1210/en.2006-1475; Schwartz AL, 2013, AM J VET RES, V74, P452, DOI 10.2460/ajvr.74.3.452; Spugnini EP, 2009, J SMALL ANIM PRACT, V50, P44, DOI 10.1111/j.1748-5827.2008.00635.x; Vahle JL, 2002, TOXICOL PATHOL, V30, P312, DOI 10.1080/01926230252929882; Vahle JL, 2004, TOXICOL PATHOL, V32, P426, DOI 10.1080/01926230490462138; Vegger JB, 2014, BONE; Walter C U, 2005, Vet Comp Oncol, V3, P1, DOI 10.1111/j.1476-5810.2005.00062.x	41	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0158005	10.1371/journal.pone.0158005	http://dx.doi.org/10.1371/journal.pone.0158005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332712	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212800066
J	Lin, SY; Sun, XH; Hsiao, YH; Chang, SE; Li, GS; Hu, NJ				Lin, Sung-Yao; Sun, Xing-Han; Hsiao, Yu-Hsuan; Chang, Shao-En; Li, Guan-Syun; Hu, Nien-Jen			Fluorophore Absorption Size Exclusion Chromatography (FA-SEC): An Alternative Method for High-Throughput Detergent Screening of Membrane Proteins	PLOS ONE			English	Article							OVEREXPRESSION; PURIFICATION; FLUORESCENCE; OPTIMIZATION; EXPRESSION; HOMOLOG; ASSAY	Membrane proteins play key roles in many fundamental functions in cells including ATP synthesis, ion and molecule transporter, cell signalling and enzymatic reactions, accounting for similar to 30% genes of whole genomes. However, the hydrophobic nature of membrane proteins frequently hampers the progress of structure determination. Detergent screening is the critical step in obtaining stable detergent-solubilized membrane proteins and well-diffracting protein crystals. Fluorescence Detection Size Exclusion Chromatography (FSEC) has been developed to monitor the extraction efficiency and monodispersity of membrane proteins in detergent micelles. By tracing the FSEC profiles of GFP-fused membrane proteins, this method significantly enhances the throughput of detergent screening. However, current methods to acquire FSEC profiles require either an in-line fluorescence detector with the SEC equipment or an off-line spectrofluorometer microplate reader. Here, we introduce an alternative method detecting the absorption of GFP (FA-SEC) at 485 nm, thus making this methodology possible on conventional SEC equipment through the in-line absorbance spectrometer. The results demonstrate that absorption is in great correlation with fluorescence of GFP. The comparably weaker absorption signal can be improved by using a longer path-length flow cell. The FA-SEC profiles were congruent with the ones plotted by FSEC, suggesting FA-SEC could be a comparable and economical setup for detergent screening of membrane proteins.	[Lin, Sung-Yao; Sun, Xing-Han; Hsiao, Yu-Hsuan; Chang, Shao-En; Li, Guan-Syun; Hu, Nien-Jen] Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan	National Chung Hsing University	Hu, NJ (corresponding author), Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan.	njhu@nchu.edu.tw		Hu, Nien-Jen/0000-0002-0917-0677	Ministry of Science and Technology (TW) MOST [103-2311-B-005-007-MY3]; ATU plan, Ministry of Education, Taiwan, ROC	Ministry of Science and Technology (TW) MOST; ATU plan, Ministry of Education, Taiwan, ROC	Funded by Ministry of Science and Technology (TW) MOST 103-2311-B-005-007-MY3 https://www.most.gov.tw/en/public; ATU plan, Ministry of Education, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher WB, 2010, PROTEIN SCI, V19, P1830, DOI 10.1002/pro.460; Axford D, 2015, ACTA CRYSTALLOGR D, V71, P1228, DOI 10.1107/S139900471500423X; Backmark AE, 2013, PROTEIN SCI, V22, P1124, DOI 10.1002/pro.2297; Brooks CL, 2013, PROTEIN SCI, V22, P425, DOI 10.1002/pro.2223; Chen H, 2013, PROTEIN EXPRES PURIF, V88, P134, DOI 10.1016/j.pep.2012.12.003; Chen YH, 2010, NATURE, V467, P1074, DOI 10.1038/nature09487; DEISENHOFER J, 1989, SCIENCE, V245, P1463, DOI 10.1126/science.245.4925.1463; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hu Nien-Jen, 2015, Methods Mol Biol, V1261, P197, DOI 10.1007/978-1-4939-2230-7_11; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Mizutani K, 2011, PROTEIN EXPRES PURIF, V77, P1, DOI 10.1016/j.pep.2010.12.009; Mobius K, 2010, P NATL ACAD SCI USA, V107, P10436, DOI 10.1073/pnas.1000956107; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Parcej D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067112; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; TILLER GE, 1984, ANAL BIOCHEM, V141, P262, DOI 10.1016/0003-2697(84)90455-X; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904	22	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157923	10.1371/journal.pone.0157923	http://dx.doi.org/10.1371/journal.pone.0157923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332877	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212800057
J	Mercadante, S; Adile, C; Caruselli, A; Ferrera, P; Costanzi, A; Marchetti, P; Casuccio, A				Mercadante, Sebastiano; Adile, Claudio; Caruselli, Amanda; Ferrera, Patrizia; Costanzi, Andrea; Marchetti, Paolo; Casuccio, Alessandra			The Palliative-Supportive Care Unit in a Comprehensive Cancer Center as Crossroad for Patients' Oncological Pathway	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ASSESSMENT SCALE; OUTCOMES; IMPACT; MODEL; TEAM; LIFE	Aim The aim of this study was to assess how an admission to an acute palliative-supportive care unit (APSCU), may influence the therapeutic trajectory of advanced cancer patients. Methods A consecutive sample of advanced cancer patients admitted to APCU was assessed. The following parameters were collected: patients demographics, including age, gender, primary diagnosis, marital status, and educational level, performance status and reasons for and kind of admission, data about care-givers, recent anticancer treatments, being on/off treatment or uncertain, the previous care setting, who proposed the admission to APSCU. Physical and psychological symptoms were evaluated at admission and at time of discharge. The use of opioids was also recorded. Hospital staying was also recorded. At time of discharge the parameters were recorded and a follow-up was performed one month after discharge. Results 314 consecutive patients admitted to the APSCU were surveyed. Pain was the most frequent reason for admission. Changes of ESAS were highly significant, as well as the use of opioids and breakthrough pain medications (p <0.0005). A significant decrease of the number of "on therapy" patients was reported, and concomitantly a significant number of "off-therapy" patients increased. At one month follow-up, 38.9% patients were at home, 19.7% patients were receiving palliative home care, and 1.6% patients were in hospice. 68.5% of patients were still living. Conclusion Data of this study suggest that the APSCU may have a relevant role for managing the therapeutic trajectory of advanced cancer patients, limiting the risk of futile and aggressive treatment while providing an appropriate care setting.	[Mercadante, Sebastiano; Adile, Claudio; Ferrera, Patrizia] La Maddalena Canc Ctr, Anesthesia & Intens Care Unit, Palermo, Italy; [Mercadante, Sebastiano; Adile, Claudio; Ferrera, Patrizia] La Maddalena Canc Ctr, Support Palliat Care Unit, Palermo, Italy; [Caruselli, Amanda] SAMO, Home Care Program, Palermo, Italy; [Costanzi, Andrea; Marchetti, Paolo] Univ Rome, Hosp St Andrea, Dept Oncol, Rome, Italy; [Casuccio, Alessandra] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Palermo, Italy	Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; University of Palermo	Mercadante, S (corresponding author), La Maddalena Canc Ctr, Anesthesia & Intens Care Unit, Palermo, Italy.; Mercadante, S (corresponding author), La Maddalena Canc Ctr, Support Palliat Care Unit, Palermo, Italy.	terapiadeldolore@lamaddalenanet.it	Marchetti, Paolo/J-9890-2018; casuccio, alessandra/B-1730-2013	Marchetti, Paolo/0000-0002-9064-8761; casuccio, alessandra/0000-0002-5676-9535				Albanese TH, 2013, J PALLIAT MED, V16, P289, DOI 10.1089/jpm.2012.0243; Aprile G, 2013, SUPPORT CARE CANCER, V21, P397, DOI 10.1007/s00520-012-1524-6; Braiteh F, 2007, J PALLIAT MED, V10, P948, DOI 10.1089/jpm.2006.0257; Breitbart W, 1997, J PAIN SYMPTOM MANAG, V13, P128, DOI 10.1016/S0885-3924(96)00316-8; Breuer B, 2011, J CLIN ONCOL, V29, P4769, DOI 10.1200/JCO.2011.35.0561; Bruera E, 1991, J Palliat Care, V7, P6; Bruera E, 2010, J CLIN ONCOL, V28, P4013, DOI 10.1200/JCO.2010.29.5618; Cassel JB, 2015, J PAIN SYMPTOM MANAG, V50, P741, DOI 10.1016/j.jpainsymman.2015.06.013; Chang VT, 2000, CANCER, V88, P2164, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5; Cheng Wen-Wu, 2005, J Palliat Med, V8, P1025, DOI 10.1089/jpm.2005.8.1025; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Elsayem A, 2010, SUPPORT CARE CANCER, V18, P67, DOI 10.1007/s00520-009-0631-5; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Ferris FD, 2009, J CLIN ONCOL, V27, P3052, DOI 10.1200/JCO.2008.20.1558; Gade G, 2008, J PALLIAT MED, V11, P180, DOI 10.1089/jpm.2007.0055; Gardiner C, 2013, PALLIATIVE MED, V27, P76, DOI 10.1177/0269216312447592; Hui D, 2010, J PALLIAT MED, V13, P49, DOI 10.1089/jpm.2009.0166; Ko W, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-960; Lagman R, 2008, AM J HOSP PALLIAT ME, V25, P24, DOI 10.1177/1049909107307375; Mercadante S, 2008, PALLIATIVE MED, V22, P760, DOI 10.1177/0269216308094338; Mercadante S, 2010, MINERVA ANESTESIOL, V76, P1060; Mercadante S, 2003, SUPPORT CARE CANCER, V11, P114, DOI 10.1007/s00520-002-0403-y; Mercadante S, 2013, SUPPORT CARE CANCER, V21, P935, DOI 10.1007/s00520-012-1608-3; Mercadante S, 2011, J PAIN SYMPTOM MANAG, V42, P702, DOI 10.1016/j.jpainsymman.2011.01.014; Nathaniel JD, 2015, J PAIN SYMPTOM MANAG, V50, P147, DOI 10.1016/j.jpainsymman.2015.02.023; Nipp RD, 2005, BRIT J CANCER, V113, P6; Pantilat SZ, 2010, ARCH INTERN MED, V170, P2038, DOI 10.1001/archinternmed.2010.460; Paris J, 2014, J ONCOL PRACT, V10, P174, DOI 10.1200/JOP.2014.001429; Rigby A, 2008, CANCER-AM CANCER SOC, V113, P3267, DOI 10.1002/cncr.23909; Rocque GB, 2013, J ONCOL PRACT, V9, P51, DOI 10.1200/JOP.2012.000698; Saito AM, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-14; Shin SH, 2014, J PAIN SYMPTOM MANAG, V47, P1028, DOI 10.1016/j.jpainsymman.2013.07.015; Smith Thomas J, 2003, J Palliat Med, V6, P699, DOI 10.1089/109662103322515202; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Vasile E, 2014, SUPPORT CARE CANCER, V22, P867, DOI 10.1007/s00520-013-2108-9; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	36	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157300	10.1371/journal.pone.0157300	http://dx.doi.org/10.1371/journal.pone.0157300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332884	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212800024
J	Yang, CW; Chen, CL; Chou, WC; Lin, HC; Jong, YJ; Tsai, LK; Chuang, CY				Yang, Chung-Wei; Chen, Chien-Lin; Chou, Wei-Chun; Lin, Ho-Chen; Jong, Yuh-Jyh; Tsai, Li-Kai; Chuang, Chun-Yu			An Integrative Transcriptomic Analysis for Identifying Novel Target Genes Corresponding to Severity Spectrum in Spinal Muscular Atrophy	PLOS ONE			English	Article							CONGENITAL BONE-FRACTURES; MOTOR-NEURON; MOUSE MODEL; UBIQUITIN HOMEOSTASIS; SMN PROTEIN; EXPRESSION; DISEASE; SURVIVAL; GROWTH; HEART	Spinal muscular atrophy (SMA) is an inherited neuromuscular disease resulting from a recessive mutation in the SMN1 gene. This disease affects multiple organ systems with varying degrees of severity. Exploration of the molecular pathological changes occurring in different cell types in SMA is crucial for developing new therapies. This study collected 39 human microarray datasets from ArrayExpress and GEO databases to build an integrative transcriptomic analysis for recognizing novel SMA targets. The transcriptomic analysis was conducted through combining weighted correlation network analysis (WGCNA) for gene module detection, gene set enrichment analysis (GSEA) for functional categorization and filtration, and Cytoscape (visual interaction gene network analysis) for target gene identification. Seven novel target genes (Bmp4, Serpine1, Gata6, Ptgs2, Bcl2, IL6 and Cntn1) of SMA were revealed, and are all known in the regulation of TNF alpha for controlling neural, cardiac and bone development. Sequentially, the differentially expressed patterns of these 7 target genes in mouse tissues (e.g., spinal cord, heart, muscles and bone) were validated in SMA mice of different severities (pre-symptomatic, mildly symptomatic, and severely symptomatic). In severely symptomatic SMA mice, TNF alpha was up-regulated with attenuation of Bmp4 and increase of Serpine1 and Gata6 (a pathway in neural and cardiac development), but not in pre-symptomatic and mildly symptomatic SMA mice. The severely symptomatic SMA mice also had the elevated levels of Ptgs2 and Bcl2 (a pathway in skeletal development) as well as IL6 and Cntn1 (a pathway in nervous system development). Thus, the 7 genes identified in this study might serve as potential target genes for future investigations of disease pathogenesis and SMA therapy.	[Yang, Chung-Wei; Chou, Wei-Chun; Lin, Ho-Chen; Chuang, Chun-Yu] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Chen, Chien-Lin; Tsai, Li-Kai] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan; [Chen, Chien-Lin; Tsai, Li-Kai] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Jong, Yuh-Jyh] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan; [Jong, Yuh-Jyh] Kaohsiung Med Univ, Dept Pediat, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Jong, Yuh-Jyh] Kaohsiung Med Univ, Dept Clin Lab, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Jong, Yuh-Jyh] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Tsing Hua University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Yang Ming Chiao Tung University	Chuang, CY (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.; Tsai, LK (corresponding author), Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan.; Tsai, LK (corresponding author), Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan.	009502@ntuh.gov.tw; cychuang@mx.nthu.edu.tw	Chou, Wei-Chun/AAO-6532-2020	Chou, Wei-Chun/0000-0003-3355-6921; Tsai, Li-Kai/0000-0001-8420-6951; Jong, Yuh-Jyh/0000-0002-1735-1101	Taiwan Ministry of Science and Technology [MOST103-2221-E-007-006-MY3, MOST104-2314-B002-051-MY3]	Taiwan Ministry of Science and Technology	This work was supported by Taiwan Ministry of Science and Technology MOST103-2221-E-007-006-MY3 and MOST104-2314-B002-051-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2012, HUM MOL GENET, V21, P2745, DOI 10.1093/hmg/dds102; Ben-Shachar S, 2009, AM J MED GENET A, V149A, P515, DOI 10.1002/ajmg.a.32667; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brotto M, 2014, CURR OSTEOPOROS REP, V12, P135, DOI 10.1007/s11914-014-0209-0; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Chen WJ, 2012, CLIN CHIM ACTA, V413, P1855, DOI 10.1016/j.cca.2012.07.020; Corti S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004108; d'Errico P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082654; Davisson MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029538; Dolgin E, 2012, NAT MED, V18, P1602, DOI 10.1038/nm1112-1602; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Faravelli I, 2015, NAT REV NEUROL, V11, P351, DOI 10.1038/nrneurol.2015.77; Farooq F, 2011, J CLIN INVEST, V121, P3042, DOI 10.1172/JCI46276; Felderhoff-Mueser U, 2002, J CHILD NEUROL, V17, P718, DOI 10.1177/088307380201700915; Garrett CA, 2014, BRAIN, V137, P1883, DOI 10.1093/brain/awu097; Goines PE, 2013, NEUROTOXICOL TERATOL, V36, P67, DOI 10.1016/j.ntt.2012.07.006; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Han Jeong A., 2014, Genomics & Informatics, V12, P247, DOI 10.5808/GI.2014.12.4.247; He BS, 2015, NAT PROD RES, V29, P359, DOI 10.1080/14786419.2014.942301; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Huo Q, 2014, RNA BIOL, V11, P1430, DOI 10.1080/15476286.2014.996494; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Iwahashi H, 1997, NATURE, V390, P413, DOI 10.1038/37144; Jablonka S, 2006, HUM MOL GENET, V15, P511, DOI 10.1093/hmg/ddi467; Khawaja K, 2004, ARCH DIS CHILD, V89, P384, DOI 10.1136/adc.2003.028225; Krebs S, 2006, MAMM GENOME, V17, P67, DOI 10.1007/s00335-005-0102-3; Kuru S, 2009, NEUROPATHOLOGY, V29, P63, DOI 10.1111/j.1440-1789.2008.00910.x; Kutz Stacie M, 2012, Mol Med Ther, V1, P106; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061505; Li RN, 2013, LIFE SCI, V92, P747, DOI 10.1016/j.lfs.2013.02.014; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liu KG, 2015, GENET MOL RES, V14, P6852, DOI 10.4238/2015.June.18.28; Locatelli D, 2012, J BIOL CHEM, V287, P25782, DOI 10.1074/jbc.M112.362830; Maeda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106818; MAY WS, 1994, J BIOL CHEM, V269, P26865; McGovern VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132364; Meissner A, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001920; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Millino C, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-14; Mo KG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012922; Moriishi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027487; MU XC, 1995, J CELL PHYSIOL, V165, P647, DOI 10.1002/jcp.1041650324; Nemer G, 2003, DEV BIOL, V254, P131, DOI 10.1016/S0012-1606(02)00026-X; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Pal M, 2014, IMMUNOL CELL BIOL, V92, P331, DOI 10.1038/icb.2014.16; Powis RA, 2014, NEUROPATH APPL NEURO, V40, P873, DOI 10.1111/nan.12168; Prior TW, 2010, AM J MED GENET A, V152A, P1608, DOI 10.1002/ajmg.a.33474; Rudnik-Schoneborn S, 2008, J MED GENET, V45, P635, DOI 10.1136/jmg.2008.057950; Schlange T, 2000, MECH DEVELOP, V91, P259, DOI 10.1016/S0925-4773(99)00311-1; See K, 2014, HUM MOL GENET, V23, P1754, DOI 10.1093/hmg/ddt567; Shababi M, 2014, J ANAT, V224, P15, DOI 10.1111/joa.12083; Shanmugarajan S, 2007, J CHILD NEUROL, V22, P967, DOI 10.1177/0883073807305664; Tsai LK, 2014, MOL THER, V22, P1450, DOI 10.1038/mt.2014.84; Tsai LK, 2012, NEUROBIOL DIS, V45, P272, DOI 10.1016/j.nbd.2011.06.021; Vigelso A, 2015, J APPL PHYSIOL, V118, P386, DOI 10.1152/japplphysiol.00840.2014; Walters MJ, 2001, MECH DEVELOP, V100, P263, DOI 10.1016/S0925-4773(00)00535-9; Wertz MH, 2016, ANN NY ACAD SCI, V1366, P5, DOI 10.1111/nyas.12813; Wilson PA, 1997, DEVELOPMENT, V124, P3177; Wirth B, 2013, CURR OPIN GENET DEV, V23, P330, DOI 10.1016/j.gde.2013.03.003; Wishart TM, 2014, J CLIN INVEST, V124, P1821, DOI 10.1172/JCI71318; Xu SH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001286; Yamagata M, 2012, J NEUROSCI, V32, P14402, DOI 10.1523/JNEUROSCI.3193-12.2012; Yamamoto K, 2014, SEMIN THROMB HEMOST, V40, P652, DOI 10.1055/s-0034-1384635; Yamamoto T, 2014, BRAIN DEV-JPN, V36, P914, DOI 10.1016/j.braindev.2013.11.009; Yousef H, 2015, STEM CELLS, V33, P1577, DOI 10.1002/stem.1943; Zheleznyakova GY, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-96; Zuko A, 2013, EUR J PHARMACOL, V719, P63, DOI 10.1016/j.ejphar.2013.07.016	70	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157426	10.1371/journal.pone.0157426	http://dx.doi.org/10.1371/journal.pone.0157426			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27331400	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212800030
J	Sapsirisavat, V; Vongsutilers, V; Thammajaruk, N; Pussadee, K; Riyaten, P; Kerr, S; Avihingsanon, A; Phanuphak, P; Ruxrungtham, K				Sapsirisavat, Vorapot; Vongsutilers, Vorasit; Thammajaruk, Narukjaporn; Pussadee, Kanitta; Riyaten, Prakit; Kerr, Stephen; Avihingsanon, Anchalee; Phanuphak, Praphan; Ruxrungtham, Kiat		PEDA Study Team	Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study - PEDA Study	PLOS ONE			English	Article							ANTIMALARIAL-DRUGS; QUALITY; COUNTERFEIT; GUIDELINES; INFECTION; MEDICINES; THERAPY; AFRICA; SAFETY	Objectives Ensuring that medicines meet quality standards is mandatory for ensuring safety and efficacy. There have been occasional reports of substandard generic medicines, especially in resource-limiting settings where policies to control quality may be less rigorous. As HIV treatment in Thailand depends mostly on affordable generic antiretrovirals (ARV), we performed quality assurance testing of several generic ARV available from different sources in Thailand and a source from Vietnam. Methods We sampled Tenofovir 300mg, Efavirenz 600mg and Lopinavir/ritonavir 200/50mg from 10 primary hospitals randomly selected from those participating in the National AIDS Program, 2 non-government organization ARV clinics, and 3 private drug stores. Quality of ARV was analyzed by blinded investigators at the Faculty of Pharmaceutical Science, Chulalongkorn University. The analysis included an identification test for drug molecules, a chemical composition assay to quantitate the active ingredients, a uniformity of mass test and a dissolution test to assess in-vitro drug release. Comparisons were made against the standards described in the WHO international pharmacopeia. Results A total of 42 batches of ARV from 15 sources were sampled from January-March 2015. Among those generics, 23, 17, 1, and 1 were Thai-made, Indian-made, Vietnamese-made and Chinese-made, respectively. All sampled products, regardless of manufacturers or sources, met the International Pharmacopeia standards for composition assay, mass uniformity and dissolution. Although local regulations restrict ARV supply to hospitals and clinics, samples of ARV could be bought from private drug stores even without formal prescription. Conclusion Sampled generic ARVs distributed within Thailand and 1 Vietnamese pharmacy showed consistent quality. However some products were illegally supplied without prescription, highlighting the importance of dispensing ARV for treatment or prevention in facilities where continuity along the HIV treatment and care cascade is available.	[Sapsirisavat, Vorapot; Thammajaruk, Narukjaporn; Pussadee, Kanitta; Riyaten, Prakit; Kerr, Stephen; Avihingsanon, Anchalee; Phanuphak, Praphan; Ruxrungtham, Kiat] Thai Red Cross AIDS Res Ctr, HIV NAT, 104 Ratchadamri Rd, Bangkok 10330, Thailand; [Vongsutilers, Vorasit] Chulalongkorn Univ, Fac Pharmaceut Sci, Rama 4 Rd, Bangkok 10330, Thailand; [Kerr, Stephen] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, Trinity Bldg C,Pietersbergweg 17, NL-1105 BM Amsterdam, Netherlands; [Avihingsanon, Anchalee; Phanuphak, Praphan; Ruxrungtham, Kiat] Chulalongkorn Univ, Dept Med, Fac Med, 254 Phyathai Rd, Bangkok, Thailand	Thai Red Cross Society; Chulalongkorn University; University of Amsterdam; Academic Medical Center Amsterdam; Chulalongkorn University	Ruxrungtham, K (corresponding author), Thai Red Cross AIDS Res Ctr, HIV NAT, 104 Ratchadamri Rd, Bangkok 10330, Thailand.; Ruxrungtham, K (corresponding author), Chulalongkorn Univ, Dept Med, Fac Med, 254 Phyathai Rd, Bangkok, Thailand.	rkiatchula@gmail.com	Vongsutilers, Vorasit/E-9317-2018; Kerr, Stephen/J-6126-2012	Vongsutilers, Vorasit/0000-0002-5352-7506; Kerr, Stephen/0000-0002-1919-4525; Ruxrungtham, Kiat/0000-0001-7348-2352	Thailand fiscal Year Research Fund through Chulalongkorn University; National Health Security Office (NHSO), Thailand	Thailand fiscal Year Research Fund through Chulalongkorn University; National Health Security Office (NHSO), Thailand	This study was supported by the Thailand fiscal Year 2014 Research Fund through Chulalongkorn University, and the National Health Security Office (NHSO), Thailand. The funders did not have any role in the study design, collection of data, analysis and interpretation of the results, writing the manuscript and deciding to submit the manuscript. The corresponding author had full access to all the data in the study and had the final responsibility for the decision to submit the manuscript for publication.	[Anonymous], 2015, PREQ PROGR UN PROGR; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Hajjou M, 2015, AM J TROP MED HYG, V92, P68, DOI 10.4269/ajtmh.14-0535; Jang WY, 2012, INJURY, V43, P237, DOI 10.1016/j.injury.2011.10.020; Kurtz SP, 2015, 3 C ASS SOC SCI HUM; Kurtz SP, 2014, AIDS CARE, V26, P411, DOI 10.1080/09540121.2013.837139; Laurent C, 2007, AIDS, V21, P768, DOI 10.1097/QAD.0b013e328045c4d7; Lon CT, 2006, T ROY SOC TROP MED H, V100, P1019, DOI 10.1016/j.trstmh.2006.01.003; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Manosuthi W, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0053-z; Nagori BP, 2011, CURR MED RES OPIN, V27, P541, DOI 10.1185/03007995.2010.548374; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; New Generic drug, 2007, NEW GEN DRUG; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Newton PN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000052; Nsimba Stephen E D, 2008, East Afr J Public Health, V5, P205; Ramachandran G, 2004, AIDS, V18, P1482, DOI 10.1097/01.aids.0000131346.76289.27; Ramautarsing RA, 2013, ANTIVIR THER, V18, P249, DOI 10.3851/IMP2324; Surratt HL, 2013, AM J PUBLIC HEALTH, V103, P1026, DOI 10.2105/AJPH.2012.301092; The Joint United Nations Programme on HIV/AIDS, 2014, 2014 GLOB STAT; US Food and Drug Administration (FDA), DRUGS FDA GLOSS TERM; Wang T, 2015, J CLIN PHARM THER, V40, P68, DOI 10.1111/jcpt.12226; World Health Organization, 2014, QAS14590 WHO; World Health Organization, 2006, INT PHARM, Vfourth; World Health Organization, 2015, WHO LIST PREQ MED PR	25	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157039	10.1371/journal.pone.0157039	http://dx.doi.org/10.1371/journal.pone.0157039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322409	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212000008
J	Cheng, E; Zhang, X; Wilson, KS; Wang, DH; Park, JY; Huo, XF; Yu, CH; Zhang, QY; Spechler, SJ; Souza, RF				Cheng, Edaire; Zhang, Xi; Wilson, Kathleen S.; Wang, David H.; Park, Jason Y.; Huo, Xiaofang; Yu, Chunhua; Zhang, Qiuyang; Spechler, Stuart J.; Souza, Rhonda F.			JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE	PLOS ONE			English	Article							SQUAMOUS-CELLS; GENE-EXPRESSION; FLUTICASONE; CHILDREN; INTERLEUKIN-13; CYTOKINES; DIAGNOSIS; MOTILITY; THERAPY; DISEASE	Background Although most studies on treatments for eosinophilic esophagitis (EoE) have focused on effects in the epithelium, EoE is a transmural disease. Eosinophils that infiltrate the subepithelial layers of the esophagus lead to fibrosis and the serious complications of EoE, and current therapies have shown minimal effects on this fibrosis. We aimed to elucidate T helper (Th) 2 cytokine effects on esophageal fibroblasts and to explore potential fibroblast-targeted therapies for EoE. Methods We established telomerase-immortalized fibroblasts from human esophageal biopsies. We stimulated these esophageal fibroblasts with Th2 cytokines, and examined effects of omeprazole and inhibitors of the Janus kinase (JAK)-signal transducer and activator of transcription (STAT6) pathway (AS1517499, leflunomide, and ruxolitinib) on STAT6 phosphorylation, STAT6 nuclear translocation, and eotaxin-3 expression. We also measured the effects of these inhibitors in esophageal epithelial cells stimulated with Th2 cytokines. Results As in esophageal epithelial cells, Th2 cytokines increased STAT6 phosphorylation, STAT6 nuclear translocation, eotaxin-3 transcription and protein secretion in esophageal fibroblasts. Unlike in epithelial cells, however, omeprazole did not inhibit cytokine-stimulated eotaxin-3 expression in fibroblasts. In contrast, JAK-STAT6 pathway inhibitors decreased cytokine-stimulated eotaxin-3 expression in both fibroblasts and epithelial cells. Conclusions Omeprazole does not inhibit Th2 cytokine-stimulated eotaxin-3 expression by esophageal fibroblasts, suggesting that PPIs will have limited impact on subepithelial EoE processes such as fibrosis. JAK-STAT6 pathway inhibitors block Th2 cytokine-stimulated eotaxin-3 expression both in fibroblasts and in epithelial cells, suggesting a potential role for JAK-STAT inhibitors in treating both epithelial inflammation and subepithelial fibrosis in EoE.	[Cheng, Edaire; Zhang, Xi; Wang, David H.; Park, Jason Y.; Huo, Xiaofang; Yu, Chunhua; Zhang, Qiuyang; Spechler, Stuart J.; Souza, Rhonda F.] Vet Affairs North Texas Hlth Care Syst, Esophageal Dis Ctr, Dallas, TX USA; [Cheng, Edaire; Zhang, Xi; Wang, David H.; Park, Jason Y.; Huo, Xiaofang; Yu, Chunhua; Zhang, Qiuyang; Spechler, Stuart J.; Souza, Rhonda F.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Cheng, Edaire] Childrens Hlth Childrens Med Ctr, Dept Pediat, Dallas, TX USA; [Cheng, Edaire] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Cheng, Edaire; Zhang, Xi; Wang, David H.; Huo, Xiaofang; Yu, Chunhua; Zhang, Qiuyang; Spechler, Stuart J.; Souza, Rhonda F.] Vet Affairs N Texas Hlth Care Syst, Med Serv, Dallas, TX USA; [Cheng, Edaire; Zhang, Xi; Wang, David H.; Huo, Xiaofang; Yu, Chunhua; Zhang, Qiuyang; Spechler, Stuart J.; Souza, Rhonda F.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Wilson, Kathleen S.; Park, Jason Y.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Wilson, Kathleen S.; Park, Jason Y.] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Wang, David H.; Spechler, Stuart J.; Souza, Rhonda F.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Park, Jason Y.] Childrens Hlth Childrens Med Ctr, Dept Pathol, Dallas, TX USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cheng, E (corresponding author), Vet Affairs North Texas Hlth Care Syst, Esophageal Dis Ctr, Dallas, TX USA.; Cheng, E (corresponding author), Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.; Cheng, E (corresponding author), Childrens Hlth Childrens Med Ctr, Dept Pediat, Dallas, TX USA.; Cheng, E (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.; Cheng, E (corresponding author), Vet Affairs N Texas Hlth Care Syst, Med Serv, Dallas, TX USA.; Cheng, E (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	edaire.cheng@utsouthwestern.edu		Park, Jason/0000-0001-6797-4000	Office of Medical Research, Departments of Veterans Affairs; National Institutes of Health [K12-HD068369, K08-DK099383, R01-DK63621, R01-CA134571, R01-DK097340]; North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Foundation/AstraZeneca Award; American Gastroenterological Association Research Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097340, K08DK099383] Funding Source: NIH RePORTER	Office of Medical Research, Departments of Veterans Affairs; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Foundation/AstraZeneca Award; American Gastroenterological Association Research Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Office of Medical Research, Departments of Veterans Affairs (RFS, SJS, DHW), the National Institutes of Health K12-HD068369 (EC), K08-DK099383 (EC), R01-DK63621 (RFS, SJS), R01-CA134571 (RFS, SJS), R01-DK097340 (DHW), the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Foundation/AstraZeneca Award (EC) www.naspghan.org, and American Gastroenterological Association Research Scholar Award (EC) www.gastro.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Sultaneh SMA, 2011, DIGEST DIS SCI, V56, P97, DOI 10.1007/s10620-010-1259-5; Aceves SS, 2010, ALLERGY, V65, P109, DOI 10.1111/j.1398-9995.2009.02142.x; Akiho H, 2005, AM J PHYSIOL-GASTR L, V288, pG609, DOI 10.1152/ajpgi.00273.2004; Barch MJ, 1997, AGT CYTOGENETICS LAB; Beppu L, 2015, J PEDIATR GASTR NUTR, V61, P194, DOI 10.1097/MPG.0000000000000668; Blanchard C, 2005, INT J BIOCHEM CELL B, V37, P2559, DOI 10.1016/j.biocel.2005.06.010; Caldwell JM, 2010, J ALLERGY CLIN IMMUN, V125, P879, DOI 10.1016/j.jaci.2010.01.038; Cheng E, 2013, GUT, V62, P824, DOI 10.1136/gutjnl-2012-302250; Cheng E, 2012, AM J PHYSIOL-GASTR L, V303, pG1175, DOI 10.1152/ajpgi.00313.2012; Chiba Y, 2009, AM J RESP CELL MOL, V41, P516, DOI 10.1165/rcmb.2008-0163OC; Dellon ES, 2014, CLIN GASTROENTEROL H, V12, P2015, DOI 10.1016/j.cgh.2014.06.019; Dellon ES, 2014, GASTROINTEST ENDOSC, V79, P577, DOI 10.1016/j.gie.2013.10.027; Dellon ES, 2013, AM J GASTROENTEROL, V108, P1854, DOI 10.1038/ajg.2013.363; Fontillon M, 2012, AM J GASTROENTEROL, V107, P1762, DOI 10.1038/ajg.2012.226; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hirano I, 2014, GASTROENTEROL CLIN N, V43, P297, DOI 10.1016/j.gtc.2014.02.015; Jaiswal KR, 2007, DIS ESOPHAGUS, V20, P256, DOI 10.1111/j.1442-2050.2007.00683.x; Kagami S, 2005, CLIN EXP IMMUNOL, V141, P459, DOI 10.1111/j.1365-2249.2005.02875.x; Kalabis J, 2012, NAT PROTOC, V7, P235, DOI 10.1038/nprot.2011.437; Levine J, 2012, ANN ALLERG ASTHMA IM, V108, P363, DOI 10.1016/j.anai.2012.02.024; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Lieberman JA, 2012, ALLERGY, V67, P1299, DOI 10.1111/j.1398-9995.2012.02881.x; Lipka S, 2016, J CLIN GASTROENTEROL, V50, P134, DOI 10.1097/MCG.0000000000000297; Lucendo AJ, 2011, J ALLERGY CLIN IMMUN, V128, P1037, DOI 10.1016/j.jaci.2011.08.007; Moawad FJ, 2013, AM J GASTROENTEROL, V108, P366, DOI 10.1038/ajg.2012.443; Molina-Infante J, 2014, ALIMENT PHARM THER, V40, P955, DOI 10.1111/apt.12914; Molina-Infante J, 2016, GUT, V65, P524, DOI 10.1136/gutjnl-2015-310991; Molina-Infante J, 2011, CLIN GASTROENTEROL H, V9, P110, DOI 10.1016/j.cgh.2010.09.019; Morales CP, 2003, GUT, V52, P327, DOI 10.1136/gut.52.3.327; Nagashima S, 2007, BIOORGAN MED CHEM, V15, P1044, DOI 10.1016/j.bmc.2006.10.015; NEWBOLD RF, 1982, NATURE, V299, P633, DOI 10.1038/299633a0; Punwani N, 2015, BRIT J DERMATOL, V173, P989, DOI 10.1111/bjd.13994; Rajan J, 2016, J ALLERGY CLIN IMMUN, V137, P147, DOI 10.1016/j.jaci.2015.05.045; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Rieder F, 2014, GASTROENTEROLOGY, V146, P1266, DOI 10.1053/j.gastro.2014.01.051; Schoepfer AM, 2013, GASTROENTEROLOGY, V145, P1230, DOI 10.1053/j.gastro.2013.08.015; Straumann A, 2011, CLIN GASTROENTEROL H, V9, P400, DOI 10.1016/j.cgh.2011.01.017; Straumann A, 2010, GASTROENTEROLOGY, V139, P1526, DOI 10.1053/j.gastro.2010.07.048; Wen T, 2015, J ALLERGY CLIN IMMUN, V135, P187, DOI 10.1016/j.jaci.2014.08.043; Zhang HY, 2008, AM J PHYSIOL-GASTR L, V295, pG470, DOI 10.1152/ajpgi.90262.2008; Zhang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050037	41	41	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157376	10.1371/journal.pone.0157376	http://dx.doi.org/10.1371/journal.pone.0157376			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310888	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800063
J	Peng, CN; Wang, XQ; Xian, ZC; Liu, X; Huang, WH; Xu, PC; Wang, JY				Peng, Changnong; Wang, Xiaoqing; Xian, Zhanchao; Liu, Xin; Huang, Wenhua; Xu, Pengcheng; Wang, Jinyang			The Impact of the Geometric Characteristics on the Hemodynamics in the Stenotic Coronary Artery	PLOS ONE			English	Article							FRACTIONAL FLOW RESERVE; OPTIMAL MEDICAL THERAPY; SHEAR-STRESS; BLOOD-FLOW; COMPUTED-TOMOGRAPHY; CT ANGIOGRAPHY; LESIONS; DISEASE; REVASCULARIZATION; INTERVENTION	The alterations of the hemodynamics in the coronary arteries, which result from patient-specific geometric significances are complex. The effect of the stenosis on the blood flow alteration had been wildly reported, but the combinational contribution from geometric factors required a comprehensive investigation to provide patient-specific information for diagnosis and assisting in the decision on the further treatment strategies. In the present study, we investigated the correlation between hemodynamic parameters and individual geometric factors in the patient-specific coronary arteries. Computational fluid dynamic simulations were performed on 22 patient-specific 3-dimensional coronary artery models that were reconstructed based on computed tomography angiography images. Our results showed that the increasing severity of the stenosis is associated with the increased maximum wall shear stress at the stenosis region (r = 0.752, P < 0.001). In contrast, the length of the recirculation zone has a moderate association with the curvature of the lesion segment (r = 0.505, P = 0.019) and the length of the lesions (r = 0.527, P = 0.064). Moreover, bifurcation in the coronary arteries is significantly correlated with the occurrence of recirculation, whereas the severity of distal stenosis demonstrated an effect on the alteration of the flow in the upstream bifurcation. These findings could serve as an indication for treatment planning and assist in prognosis evaluation.	[Peng, Changnong; Wang, Xiaoqing; Xian, Zhanchao] Shenzhen Sun Yat Sen Cardiovasc Hosp, Dept Cardiol, Shenzhen 518112, Peoples R China; [Liu, Xin] Chinese Acad Sci, Shenzhen Inst Adv Technol, Res Ctr Biomed Informat Technol, Shenzhen 518055, Peoples R China; [Huang, Wenhua; Xu, Pengcheng; Wang, Jinyang] Southern Med Univ, Inst Clin Anat, Guangzhou 510515, Guangdong, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Southern Medical University - China	Liu, X (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Res Ctr Biomed Informat Technol, Shenzhen 518055, Peoples R China.; Huang, WH (corresponding author), Southern Med Univ, Inst Clin Anat, Guangzhou 510515, Guangdong, Peoples R China.	xingliu1024@sina.com; huangwenhua2009@139.com	huang, wenhua/AAO-5990-2020; Xu, Pengcheng/J-1429-2012; Wang, Jinyang/E-7780-2011	huang, wenhua/0000-0003-2382-9180; Xu, Pengcheng/0000-0001-8651-208X; Wang, Jinyang/0000-0003-0668-336X	Guangdong Image-guided Therapy Innovation Team [2011S013]; Shenzhen Innovation Funding [SGLH20150213143207911, JCYJ20140901003939025, SGLH20131010110119871, GJHZ20140415152115754, JCYJ20151030151431727, JCYJ20140414170821190, SGLH20150216172854731]; Shenzhen science and technology innovation Funding [CXZZ20140909004122087]; Science and Technology Project of Guangdong Province [2015B010125005]	Guangdong Image-guided Therapy Innovation Team; Shenzhen Innovation Funding; Shenzhen science and technology innovation Funding; Science and Technology Project of Guangdong Province	The work was supported by Guangdong Image-guided Therapy Innovation Team (2011S013), Shenzhen Innovation Funding (SGLH20150213143207911, JCYJ20140901003939025, SGLH20131010110119871, GJHZ20140415152115754, JCYJ20151030151431727, JCYJ20151030151431727, JCYJ20140414170821190, SGLH20150216172854731) and Shenzhen science and technology innovation Funding (CXZZ20140909004122087). It was also supported by the Science and Technology Project of Guangdong Province (2015B010125005).	Abbara Suhny, 2009, J Cardiovasc Comput Tomogr, V3, P190, DOI 10.1016/j.jcct.2009.03.004; Antoniadis AP, 2015, JACC-CARDIOVASC INTE, V8, P1281, DOI 10.1016/j.jcin.2015.06.015; Barlis Peter, 2015, EuroIntervention, V11, pe1, DOI 10.4244/EIJV11I5A111; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Choi G, 2014, JOURNAL OF THE AMERI, V64; Comsol Multiphysics User's Guide, 2014, 2014 COMSOL MULTIPHY; Einav S, 2004, ANN NY ACAD SCI, V1015, P351, DOI 10.1196/annals.1302.031; Fam JM, 2015, JACC CARDIOVASCULAR, V8, pS22; Frattolin J, 2015, COMPUT BIOL MED, V57, P130, DOI 10.1016/j.compbiomed.2014.11.014; Gaemperli O, 2007, EUR J NUCL MED MOL I, V34, P1162, DOI 10.1007/s00259-006-0307-z; Hacker M, 2007, EUR J NUCL MED MOL I, V34, P4, DOI 10.1007/s00259-006-0207-2; Hanson I., 2015, INTERVENTIONAL CARDI, P107; Iguchi T, 2013, CLIN CARDIOL, V36, P172, DOI 10.1002/clc.22076; Javadzadegan A, 2013, AM J PHYSIOL-HEART C, V304, pH559, DOI 10.1152/ajpheart.00428.2012; Johnston BM, 2006, J BIOMECH, V39, P1116, DOI 10.1016/j.jbiomech.2005.01.034; Kwon SS, 2014, PROG BIOPHYS MOL BIO, V116, P48, DOI 10.1016/j.pbiomolbio.2014.09.003; Li-Na P, 2012, QUANTITATIVE STUDY E, P245; Liu BY, 2007, MED ENG PHYS, V29, P868, DOI 10.1016/j.medengphy.2006.09.009; Min JK, 2015, JACC-CARDIOVASC IMAG, V8, P1209, DOI 10.1016/j.jcmg.2015.08.006; Morris PD, 2013, JACC-CARDIOVASC INTE, V6, P149, DOI 10.1016/j.jcin.2012.08.024; Muhlenbruch G, 2007, EUR RADIOL, V17, P603, DOI 10.1007/s00330-006-0429-5; Myers JG, 2001, ANN BIOMED ENG, V29, P109, DOI 10.1114/1.1349703; Naidu SS, 2012, CATHETER CARDIO INTE, V80, P456, DOI 10.1002/ccd.24311; Parodi O, 2012, IEEE T INF TECHNOL B, V16, P952, DOI 10.1109/TITB.2012.2201732; Rispler S, 2007, J AM COLL CARDIOL, V49, P1059, DOI 10.1016/j.jacc.2006.10.069; Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824; Sankaran S, 2012, ANN BIOMED ENG, V40, P2228, DOI 10.1007/s10439-012-0579-3; Schuijf JD, 2006, J AM COLL CARDIOL, V48, P2508, DOI 10.1016/j.jacc.2006.05.080; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Siebert U, 2014, HEART LUNG CIRC, V23, P527, DOI 10.1016/j.hlc.2013.12.009; Tardy Y, 1997, ARTERIOSCL THROM VAS, V17, P3102, DOI 10.1161/01.ATV.17.11.3102; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; Tian F.B., 2013, COMPUTERS BIOL MED; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Torii R, 2009, BRIT J RADIOL, V82, pS24, DOI 10.1259/bjr/62450556; Warboys CM, 2010, AM J PHYSIOL-HEART C, V298, pH1850, DOI 10.1152/ajpheart.00114.2010	37	15	15	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157490	10.1371/journal.pone.0157490	http://dx.doi.org/10.1371/journal.pone.0157490			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310014	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800083
J	Pereira, HABS; Dionizio, AS; Fernandes, MS; Araujo, TT; Cestari, TM; Buzalaf, CP; Iano, FG; Buzalaf, MAR				Barbosa Silva Pereira, Heloisa Aparecida; Dionizio, Aline Salgado; Fernandes, Mileni Silva; Araujo, Tamara Teodoro; Cestari, Tania Mary; Buzalaf, Camila Peres; Iano, Flavia Godoy; Rabelo Buzalaf, Marlia Afonso			Fluoride Intensifies Hypercaloric Diet-Induced ER Oxidative Stress and Alters Lipid Metabolism	PLOS ONE			English	Article							FATTY LIVER-DISEASE; MEDIATED CARDIOTOXICITY; ANTIOXIDANT STATUS; HEPATIC STEATOSIS; APOLIPOPROTEIN-E; DYSLIPIDEMIA; DAMAGE; ACCUMULATION; CHOLESTEROL; MECHANISMS	The role of fluoride (F) in oxidative stress is well reported, but its effects on the lipid metabolism has not been completely explored Background Here, we evaluated the relationship of diet and F-induced oxidative stress to lipid metabolism in the liver of rats eating normocaloric or hypercaloric diets for two time periods (20 or 60 days). Methods Seventy-two 21-day-old Wistar rats were divided into 2 groups (n = 36) based on the type of diet they were eating; each of these groups was then further divided into another two groups (n = 18) based on the time periods of either 20 or 60 days, for a total of four groups. Each of these was divided into 3 subgroups (n = 6 animals/subgroup), dependent on the dose of F administered in the drinking water (0 mg/L(control), 15 mg/L or 50 mg/L). After the experimental period, blood samples and the liver were collected. Plasma samples were analyzed for HDL, cholesterol and triglycerides. Western blots were performed to probe for GRP78, Erp29, SOD2, Apo-E and SREBP in hepatic tissues. Results As expected, the expression of target proteins involved in oxidative stress increased in the F-treated groups, especially in liver tissue obtained from animals eating a hypercaloric diet. Most changes in the lipid levels and pathological conditions were seen earlier in the time period, at day 20. The morphometric analyses showed a reduction in steatosis in groups on ahypercaloric diet and treated with 50 mg F/L compared to the control, while no changes were obtained in normocaloric-fed rats. Accordingly, plasma TG was reduced in the F-treated group. The reduced expression of Apo-E in a time- and diet-dependent pattern may account for the particular decrease in steatosis in hypercaloric-fed F-treated rats. Conclusions These results suggest that F changes liver lipid homeostasis, possibly because of the induction of oxidative stress, which seems to be higher in animals fed hypercaloric diets.	[Barbosa Silva Pereira, Heloisa Aparecida; Fernandes, Mileni Silva] Univ Fed Sao Carlos, Dept Genet & Evolut, Ctr Biol Sci & Hlth, Washington Luis, Km 235, BR-13560970 Sao Paulo, Brazil; [Dionizio, Aline Salgado; Araujo, Tamara Teodoro; Cestari, Tania Mary; Iano, Flavia Godoy; Rabelo Buzalaf, Marlia Afonso] Univ Sao Paulo, Dept Biol Sci, Bauru Dent Sch, Al Octavio Pinheiro Brisolla 9-75, BR-17012901 Sao Paulo, Brazil; [Buzalaf, Camila Peres] Univ Sagrado Coracao, Ctr Ciencias Saude, Rua Irma Arminda 10-50, BR-17011160 Sao Paulo, Brazil	Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade do Sagrado Coracao	Buzalaf, MAR (corresponding author), Univ Sao Paulo, Dept Biol Sci, Bauru Dent Sch, Al Octavio Pinheiro Brisolla 9-75, BR-17012901 Sao Paulo, Brazil.	mbuzalaf@fob.usp.br	Buzalaf, Marilia Afonso Rabelo/C-5228-2012; Dionizio, Aline/N-6464-2016; Cestari, Tania Mary/E-7060-2012; Buzalaf, Marilia Afonso Rabelo/AAU-2554-2021; Heloisa Aparecida Barbosa da Silva, Pereira/M-1766-2013; IANO, Flavia/ABB-4811-2020; Iano, Flavia G/G-6923-2012; Araujo, Tamara Teodoro TT/H-1439-2019; Fernandes, Mileni MS/F-7359-2015	Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Dionizio, Aline/0000-0002-8687-0124; Cestari, Tania Mary/0000-0003-1287-5974; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Heloisa Aparecida Barbosa da Silva, Pereira/0000-0002-1839-2546; IANO, Flavia/0000-0001-6124-8817; Araujo, Tamara Teodoro TT/0000-0002-7560-9051; 	FAPESP [2012/16860-5, 2011/17263-9]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (2012/16860-5) and FAPESP (2011/17263-9).	Afolabi OK, 2013, ARH HIG RADA TOKSIKO, V64, P521, DOI 10.2478/10004-1254-64-2013-2351; Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Barbier O, 2010, CHEM-BIOL INTERACT, V188, P319, DOI 10.1016/j.cbi.2010.07.011; Pereira HABD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075343; Birkner E, 2009, BIOL TRACE ELEM RES, V129, P137, DOI 10.1007/s12011-008-8306-5; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286; Chiba FY, 2015, FLUORIDE, V48, P205; Chlubek D, 2003, FLUORIDE, V36, P217; Dabrowska E, 2006, Adv Med Sci, V51 Suppl 1, P91; Daugherity EK, 2012, CELL CYCLE, V11, P1918, DOI 10.4161/cc.20259; de Oliveira CPMS, 2006, WORLD J GASTROENTERO, V12, P1905, DOI 10.3748/wjg.v12.i12.1905; Demmer J, 1997, FEBS LETT, V402, P145, DOI 10.1016/S0014-5793(96)01513-X; DUNIPACE AJ, 1995, J DENT RES, V74, P358, DOI 10.1177/00220345950740011201; Ferramosca A, 2014, WORLD J GASTROENTERO, V20, P1746, DOI 10.3748/wjg.v20.i7.1746; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Iano FG, 2014, J FLUORINE CHEM, V168, P212, DOI 10.1016/j.jfluchem.2014.09.029; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kim E, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/290104; Kockx M, 2012, BIOCHEM J, V447, P51, DOI 10.1042/BJ20111891; Koruk M, 2004, ANN CLIN LAB SCI, V34, P57; Leite AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106646; Lobo JGVM, 2015, J DENT RES, V94, P990, DOI 10.1177/0022034515581186; Luna LG, 1968, MANUAL HISTOLOGIC ST, V3; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Marti VK, 2014, ADV PHARMACOL SCI, V2014, DOI 10.1155/2014/532969; McDonagh MS, 2000, BRIT MED J, V321, P855, DOI 10.1136/bmj.321.7265.855; Miltonprabu S, 2015, J TRACE ELEM MED BIO, V29, P321, DOI 10.1016/j.jtemb.2014.08.015; Moura LP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-2; Nabavi SF, 2014, CURR NEUROVASC RES, V11, P390, DOI 10.2174/1567202611666140912114833; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Rugg-Gunn Andrew, 2013, Acta Med Acad, V42, P117, DOI 10.5644/ama2006-124.80; Shanthakumari D, 2004, TOXICOLOGY, V204, P219, DOI 10.1016/j.tox.2004.06.058; Sun LY, 2014, ENVIRON TOXICOL PHAR, V38, P1000, DOI 10.1016/j.etap.2014.10.010; Umarani V, 2015, TOXICOL MECH METHOD, V25, P143, DOI 10.3109/15376516.2014.1003359; Wayhs CA, 2012, METAB BRAIN DIS, V25, P297; Xiong XZ, 2007, ENVIRON RES, V103, P112, DOI 10.1016/j.envres.2006.05.008; Yan YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035709; Yang KT, 2014, FOOD CHEM, V160, P148, DOI 10.1016/j.foodchem.2014.03.052; Yilmaz Y, 2012, ALIMENT PHARM THER, V36, P345, DOI 10.1111/j.1365-2036.2012.05196.x; Zhou BH, 2015, CHEMOSPHERE, V139, P504, DOI 10.1016/j.chemosphere.2015.08.030; Zhu B, ZHONGHUA YI XUE ZA Z, V91, P3134	45	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158121	10.1371/journal.pone.0158121	http://dx.doi.org/10.1371/journal.pone.0158121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336443	gold, Green Submitted, Green Published			2022-12-26	WOS:000378389200115
J	Cuni-Sanchez, A; White, LJT; Calders, K; Jeffery, KJ; Abernethy, K; Burt, A; Disney, M; Gilpin, M; Gomez-Dans, JL; Lewis, SL				Cuni-Sanchez, Aida; White, Lee J. T.; Calders, Kim; Jeffery, Kathryn J.; Abernethy, Katharine; Burt, Andrew; Disney, Mathias; Gilpin, Martin; Gomez-Dans, Jose L.; Lewis, Simon L.			African Savanna-Forest Boundary Dynamics: A 20-Year Study	PLOS ONE			English	Article							ABOVEGROUND BIOMASS; CARBON SEQUESTRATION; VEGETATION STRUCTURE; WOODY ENCROACHMENT; CLIMATE; IMPACT; SOILS; DISTRIBUTIONS; VARIABILITY; WOODLANDS	Recent studies show widespread encroachment of forest into savannas with important consequences for the global carbon cycle and land-atmosphere interactions. However, little research has focused on in situ measurements of the successional sequence of savanna to forest in Africa. Using long-term inventory plots we quantify changes in vegetation structure, above-ground biomass (AGB) and biodiversity of trees >= 10 cm diameter over 20 years for five vegetation types: savanna; colonising forest (F1), monodominant Okoume forest (F2); young Marantaceae forest (F3); and mixed Marantaceae forest (F4) in Lope National Park, central Gabon, plus novel 3D terrestrial laser scanning (TLS) measurements to assess forest structure differences. Over 20 years no plot changed to a new stage in the putative succession, but F1 forests strongly moved towards the structure, AGB and diversity of F2 forests. Overall, savanna plots showed no detectable change in structure, AGB or diversity using this method, with zero trees >= 10 cm diameter in 1993 and 2013. F1 and F2 forests increased in AGB, mainly as a result of adding recruited stems (F1) and increased Basal Area (F2), whereas F3 and F4 forests did not change substantially in structure, AGB or diversity. Critically, the stability of the F3 stage implies that this stage may be maintained for long periods. Soil carbon was low, and did not show a successional gradient as for AGB and diversity. TLS vertical plant profiles showed distinctive differences amongst the vegetation types, indicating that this technique can improve ecological understanding. We highlight two points: (i) as forest colonises, changes in biodiversity are much slower than changes in forest structure or AGB; and (ii) all forest types store substantial quantities of carbon. Multi-decadal monitoring is likely to be required to assess the speed of transition between vegetation types.	[Cuni-Sanchez, Aida; Calders, Kim; Burt, Andrew; Disney, Mathias; Gomez-Dans, Jose L.; Lewis, Simon L.] UCL, Dept Geog, Gower St, London WC1E 6BT, England; [Cuni-Sanchez, Aida] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Univ Parken 15, DK-2100 Copenhagen, Denmark; [White, Lee J. T.; Jeffery, Kathryn J.] Agence Natl Parcs Nationaux, BP 20379, Libreville, Gabon; [White, Lee J. T.; Jeffery, Kathryn J.; Abernethy, Katharine] Inst Rech Ecol Trop, BP13354, Libreville, Gabon; [White, Lee J. T.; Jeffery, Kathryn J.; Abernethy, Katharine] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Calders, Kim] Natl Phys Lab, Climate & Opt Grp, Earth Observat, Hampton Rd, Teddington TW11 0LW, Middx, England; [Calders, Kim] Wageningen Univ, Lab Geoinformat Sci & Remote Sensing, NL-6700 AP Wageningen, Netherlands; [Disney, Mathias; Gomez-Dans, Jose L.] Univ Leicester, UK NERC Natl Ctr Earth Observat NCEO, Michael Atiyah Bldg,Univ Rd, Leicester LE1 7RH, Leics, England; [Gilpin, Martin; Lewis, Simon L.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England	University of London; University College London; University of Copenhagen; University of Stirling; National Physical Laboratory - UK; Wageningen University & Research; University of Leicester; University of Leeds	Cuni-Sanchez, A (corresponding author), UCL, Dept Geog, Gower St, London WC1E 6BT, England.; Cuni-Sanchez, A (corresponding author), Univ Copenhagen, Ctr Macroecol Evolut & Climate, Univ Parken 15, DK-2100 Copenhagen, Denmark.	aidacuni@hotmail.com	Jeffery, Kathryn J/G-2530-2013	Jeffery, Kathryn J/0000-0002-2632-0008; Abernethy, Katharine/0000-0002-0393-9342; Calders, Kim/0000-0002-4562-2538; Disney, Mathias/0000-0002-2407-4026; Lewis, Simon/0000-0002-8066-6851	Wildlife Conservation Society; EU; University of Stirling; ANPN via a OLAM Gabon; EU FP7 GEOCARBON project; EU ERC T-FORCES project; ANPN; UK Natural Environment Research Council; National Centre for Earth Observation (NCEO); Natural Environment Research Council [nceo020005, NE/D000300/1, nceo020002, 1201745, NE/N00373X/1] Funding Source: researchfish; NERC [NE/N00373X/1, nceo020002, nceo020005] Funding Source: UKRI	Wildlife Conservation Society; EU(European Commission); University of Stirling; ANPN via a OLAM Gabon; EU FP7 GEOCARBON project; EU ERC T-FORCES project; ANPN; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Centre for Earth Observation (NCEO); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Plot establishment was funded by the Wildlife Conservation Society, the EU-funded ECOFAC program, and the University of Stirling, and the current study was funded by ANPN via a grant from OLAM Gabon. S.L. Lewis was funded by the EU FP7 GEOCARBON project and EU ERC T-FORCES project. K.J. Jeffery and L.J.T. White were funded by ANPN. K. Abernethy was funded by University of Stirling, and M. Disney and A. Burt were funded in part by the UK Natural Environment Research Council, which, through the National Centre for Earth Observation (NCEO) provided some travel funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is part of an on-going study, undertaken by Gabon's National Park's Agency (ANPN) on behalf of the Climate Council of Gabon, to assess carbon stock changes in Gabon's forests. Plot establishment was funded by the Wildlife Conservation Society, the EU-funded ECOFAC program, and the University of Stirling, and the current study was funded by ANPN via a grant from OLAM Gabon. The plots are part of a network of long-term inventory plots established by researchers as part of the AfriTRON network. We thank the Government of Gabon, notably CENAREST (Centre National de Rechereche Scientifique et Technologique) and ANPN (Gabon's National Parks Agency), and CIRMF (the International Medical Research Centre in Franceville) for permission to undertake this study and for logistical support in the field. We are grateful for the substantial contribution to fieldwork made by C.A. Mandebet, K. Y. Mayossa, J. Gonzalez de Tanago, J. T. Dikangadissi, E. Dimoto, A. Siniboure, J. Dibakou, D. Mala, C. Pasilende and M. Fernandez, plus support given by J. Poulsen and Caroline Tutin. We also thank J. Armston for his help with the vertical plant profiles. S.L. Lewis was funded by the EU FP7 GEOCARBON project and EU ERC T-FORCES project. K.J. Jeffery and L.J.T. White were funded by ANPN. K. Abernethy was funded by University of Stirling, and M. Disney and A. Burt were funded in part by the UK Natural Environment Research Council, which, through the National Centre for Earth Observation (NCEO) provided some travel funds.	Archer S., 2001, GLOBAL BIOGEOCHEM CY, P115; BAILEY RL, 1980, CAN J FOREST RES, V10, P117, DOI 10.1139/x80-021; Bond WJ, 2012, PHILOS T R SOC B, V367, P601, DOI 10.1098/rstb.2011.0182; Bonnell TR, 2011, FOREST ECOL MANAG, V261, P855, DOI 10.1016/j.foreco.2010.12.016; Boulvert Y., 1990, PAYSAGES QUATERNAIRE, P353; Brunck F, 1990, MONOGRAPHIE CIRAD; Bucini G, 2007, GLOBAL ECOL BIOGEOGR, V16, P593, DOI 10.1111/j.1466-8238.2007.00325.x; Calders K, 2015, AGR FOREST METEOROL, V203, P158, DOI 10.1016/j.agrformet.2015.01.009; Calders K, 2015, METHODS ECOL EVOL, V6, P198, DOI 10.1111/2041-210X.12301; Calders K, 2014, AGR FOREST METEOROL, V194, P104, DOI 10.1016/j.agrformet.2014.03.022; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; Chiti T, BIOTROPICA IN PRESS; Chiti T, 2010, PLANT SOIL, V331, P453, DOI 10.1007/s11104-009-0265-x; Coetsee C, 2013, J TROP ECOL, V29, P49, DOI 10.1017/S0266467412000697; Coomes DA, 2003, ECOL LETT, V6, P980, DOI 10.1046/j.1461-0248.2003.00520.x; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Coomes DA, 2012, J ECOL, V100, P42, DOI 10.1111/j.1365-2745.2011.01920.x; De Wasseige C., 2009, FORETS BASSIN CONGO; Devos C, 2008, AM J PRIMATOL, V70, P439, DOI 10.1002/ajp.20514; Djomo AN, 2011, FOREST ECOL MANAG, V261, P1448, DOI 10.1016/j.foreco.2011.01.031; Dohrmann R, 2006, APPL CLAY SCI, V34, P38, DOI 10.1016/j.clay.2006.02.009; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Fuhr M, 2001, FOREST ECOL MANAG, V140, P117, DOI 10.1016/S0378-1127(00)00320-0; Gautam S, 2012, AFR J ECOL, V50, P414, DOI 10.1111/j.1365-2028.2012.01337.x; Giglio L, 2009, REMOTE SENS ENVIRON, V113, P408, DOI 10.1016/j.rse.2008.10.006; Gond V, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0309; Gottschalk P, 2012, BIOGEOSCIENCES, V9, P3151, DOI 10.5194/bg-9-3151-2012; Gourlet-Fleury S, 2013, FOREST ECOL MANAG, V304, P322, DOI 10.1016/j.foreco.2013.05.021; Gourlet-Fleury S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0302; Gourlet-Fleury S, 2011, J ECOL, V99, P981, DOI 10.1111/j.1365-2745.2011.01829.x; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hely C, 2006, GLOBAL ECOL BIOGEOGR, V15, P258, DOI 10.1111/j.1466-822x.2006.00235.x; ISRIC, 2002, 9 ISRIC; James R, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0298; Jeffery K.J., 2014, PARKS, V20, P35, DOI DOI 10.2305/IUCN.CH.2014.PARKS-20-1.KJJ.EN; Jupp DLB, 2009, TREE PHYSIOL, V29, P171, DOI 10.1093/treephys/tpn022; Lewis SL, 2015, SCIENCE, V349, P827, DOI 10.1126/science.aaa9932; Lewis SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0295; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lienou G, 2008, HYDROLOG SCI J, V53, P789, DOI 10.1623/hysj.53.4.789; Maley J, 1996, P ROYAL SOC EDINBURG, V104B, P31, DOI 10.1017/S0269727000006114; Martin AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023533; Mayaux P, 2004, J BIOGEOGR, V31, P861, DOI 10.1111/j.1365-2699.2004.01073.x; Mitchard ETA, 2012, BIOGEOSCIENCES, V9, P179, DOI 10.5194/bg-9-179-2012; Mitchard ETA, 2011, REMOTE SENS ENVIRON, V115, P2861, DOI 10.1016/j.rse.2010.02.022; Mitchard ETA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0406; Naito AT, 2011, PROG PHYS GEOG, V35, P423, DOI 10.1177/0309133311403538; Nana A, 2005, THESIS; Njomgang Rosaline, 2011, Tropicultura, V29, P176; Obiang NLE, 2014, FOREST ECOL MANAG, V313, P55, DOI 10.1016/j.foreco.2013.10.045; Oslisly R, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0304; Peh KSH, 2011, J ECOL, V99, P891, DOI 10.1111/j.1365-2745.2011.01827.x; Pfeifer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039337; PHILLIPS OL, 1994, SCIENCE, V263, P954, DOI 10.1126/science.263.5149.954; Poulter B, 2014, NATURE, V509, P600, DOI 10.1038/nature13376; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; Quesada CA, 2010, BIOGEOSCIENCES, V7, P1515, DOI 10.5194/bg-7-1515-2010; R Core Team, 2016, R FDN STAT COMP; Rowell D. L., 1994, Soil science: methods and applications.; Roy DP, 2008, REMOTE SENS ENVIRON, V112, P3690, DOI 10.1016/j.rse.2008.05.013; Saiz G, 2012, GLOBAL CHANGE BIOL, V18, P1670, DOI 10.1111/j.1365-2486.2012.02657.x; Talbot J, 2014, FOREST ECOL MANAG, V320, P30, DOI 10.1016/j.foreco.2014.02.021; Tiessen H., 1993, SOIL SAMPLING METHOD, P75, DOI [10.1201/9781420005271.ch25, DOI 10.1201/9781420005271.CH25]; Torello-Raventos M, 2013, PLANT ECOL DIVERS, V6, P101, DOI 10.1080/17550874.2012.762812; Tovar C, 2014, ECOGRAPHY, V37, P1139, DOI 10.1111/ecog.00697; UNEP, 2009, VIT FOR REP; United Nations, 2015, PAR AGR UN CLIM CHAN; Veenendaal EM, 2015, BIOGEOSCIENCES, V12, P2927, DOI 10.5194/bg-12-2927-2015; Walker B. H., 1981, FOREST SUCCESSION CO, P431; Watson RT, 2000, LAND USE LAND USE CH; White L. J. T., 2001, African rain forest ecology and conservation: an interdisciplinary perspective, P165; White L. J. T., 1997, GUIDE VEGETATION LOP; White L. J. T., 1995, VEGETATION STUDY FIN; WHITE LJT, 1995, AFR J ECOL, V33, P124, DOI 10.1111/j.1365-2028.1995.tb00788.x; Williams M, 2008, FOREST ECOL MANAG, V254, P145, DOI 10.1016/j.foreco.2007.07.033; Yerima BPK., 2005, INTRO SOIL SCI SOILS; Zanne A, 2009, SPECTRUM, DOI [10.5061/dryad.234, DOI 10.5061/DRYAD.234]; Zelazowski P, 2011, PHILOS T R SOC A, V369, P137, DOI 10.1098/rsta.2010.0238	81	36	36	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0156934	10.1371/journal.pone.0156934	http://dx.doi.org/10.1371/journal.pone.0156934			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336632	Green Published, gold			2022-12-26	WOS:000378389200007
J	Liep, J; Kilic, E; Meyer, HA; Busch, J; Jung, K; Rabien, A				Liep, Julia; Kilic, Ergin; Meyer, Hellmuth A.; Busch, Jonas; Jung, Klaus; Rabien, Anja			Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							LYSYL-OXIDASE; TUMOR-SUPPRESSOR; GENE-EXPRESSION; CANCER; MICRORNAS; METASTASIS; IDENTIFICATION; PROGRESSION; MIGRATION; MIRNAS	Background Due to the poor prognosis for advanced renal cell carcinoma (RCC), there is an urgent need for new therapeutic targets and for prognostic markers to identify high risk tumors. Micro-RNAs (miRNAs) are frequently dysregulated in tumors, play a crucial role during carcinogenesis and therefore might be promising new biomarkers. In previous studies, we identified miR-141-3p and miR-145-5p to be downregulated in clear cell RCC (ccRCC). Our objective was to investigate the functional association of these miRNAs, focusing on the cooperative regulation of new specific targets and their role in ccRCC progression. Methods The effect of miR-141-3p and miR-145-5p on cell migration was examined by overexpression in 786-O cells. New targets of both miRNAs were identified by miRWalk, validated in 786-O and ACHN cells and additionally characterized in ccRCC tissue on mRNA and protein level. Results In functional analysis, a tumor suppressive effect of miR-141-3p and miR-145-5p by decreasing migration and invasion of RCC cells could be shown. Furthermore, co-overexpression of the miRNAs seemed to result in an increased inhibition of cell migration. Both miRNAs were recognized as post-transcriptional regulators of the targets EAPP, HS6ST2, LOX, TGFB2 and VRK2. Additionally, they showed a cooperative effect again as demonstrated by a significantly increased inhibition of HS6ST2 and LOX expression after simultaneous overexpression of both miRNAs. In ccRCC tissue, LOX mRNA expression was strongly increased compared to normal tissue, allowing also to distinguish between non-metastatic and already metastasized primary tumors. Finally, in subsequent tissue microarray analysis LOX protein expression showed a prognostic relevance for the overall survival of ccRCC patients. Conclusion These results illustrate a jointly strengthening effect of the dysregulated miR-141-3p and miR-145-5p in various tumor associated processes. Focusing on the cooperative effect of miRNAs provides new opportunities for the development of therapeutic strategies and offers novel prognostic and diagnostic capabilities.	[Liep, Julia; Meyer, Hellmuth A.; Busch, Jonas; Jung, Klaus; Rabien, Anja] Charite, Dept Urol, D-13353 Berlin, Germany; [Liep, Julia; Jung, Klaus; Rabien, Anja] Berlin Inst Urol Res, Berlin, Germany; [Kilic, Ergin] Charite, Inst Pathol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rabien, A (corresponding author), Charite, Dept Urol, D-13353 Berlin, Germany.; Rabien, A (corresponding author), Berlin Inst Urol Res, Berlin, Germany.	Anja.Rabien@charite.de	Jung, Klaus/Z-2122-2018	Jung, Klaus/0000-0001-9797-5362; Rabien, Anja/0000-0003-0124-4878	Foundation of Urologic Research Berlin	Foundation of Urologic Research Berlin	This work was supported by the Foundation of Urologic Research Berlin (http://stiftung-urologie.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SA, 2004, VACCINE, V22, P3585, DOI 10.1016/j.vaccine.2004.03.041; Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Baker AM, 2013, CANCER RES, V73, P583, DOI 10.1158/0008-5472.CAN-12-2447; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Bostrom AK, 2013, BIOCHEM BIOPH RES CO, V435, P126, DOI 10.1016/j.bbrc.2013.04.054; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao Y, 2013, CANCER RES, V73, P4579, DOI 10.1158/0008-5472.CAN-13-0529; Chang L, 2015, ONCOL LETT, V9, P2317, DOI 10.3892/ol.2015.3028; Chen XY, 2014, CLIN CANCER RES, V20, P2617, DOI 10.1158/1078-0432.CCR-13-3224; Chiyomaru T, 2014, J BIOL CHEM, V289, P12550, DOI 10.1074/jbc.M113.488593; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; da Silva R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119781; Doberstein K, 2013, NEOPLASIA, V15, P218, DOI 10.1593/neo.121222; Duns G, 2013, GENE CHROMOSOME CANC, V52, P165, DOI 10.1002/gcc.22016; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fendler Annika, 2013, Critical Reviews in Oncogenesis, V18, P289; Fendler A, 2011, CLIN CHEM, V57, P954, DOI 10.1373/clinchem.2010.157727; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Fujiwara S, 2015, EXP HEMATOL ONCOL, V4, DOI 10.1186/s40164-015-0008-z; Gadducci A, 2014, GYNECOL ENDOCRINOL, V30, P266, DOI 10.3109/09513590.2013.871525; Giampuzzi M, 2003, BBA-PROTEINS PROTEOM, V1647, P245, DOI 10.1016/S1570-9639(03)00059-1; Goldie SJ, 2012, CANCER RES, V72, P3424, DOI 10.1158/0008-5472.CAN-12-0423; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Han ZY, 2015, ONCOTARGET, V6, P13149, DOI 10.18632/oncotarget.3693; Hatabe S, 2013, MOL CLIN ONCOL, V1, P845, DOI 10.3892/mco.2013.151; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Jansen MK, 2007, MATRIX BIOL, V26, P136, DOI 10.1016/j.matbio.2006.09.004; Jonasch E, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4797; Jung M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-47; Jung M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/clinchem.2009.141580; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Kim Y, 2015, HUM PATHOL, V46, P104, DOI 10.1016/j.humpath.2014.09.013; Kirschmann DA, 2002, CANCER RES, V62, P4478; Kothapalli D, 2012, CELL REP, V2, P1259, DOI 10.1016/j.celrep.2012.09.018; Li WD, 2003, J CELL BIOCHEM, V88, P152, DOI 10.1002/jcb.10304; Lu RJ, 2014, J CANCER RES CLIN, V140, P387, DOI 10.1007/s00432-013-1577-z; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Luo DY, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-57; Mayorca-Guiliani A, 2013, ONCOTARGETS THER, V6, P1729, DOI 10.2147/OTT.S38110; MELLO MLS, 1995, EXP CELL RES, V220, P374, DOI 10.1006/excr.1995.1328; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Monsalve DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.40; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Nellaiappan K, 2000, J CELL BIOCHEM, V79, P576, DOI 10.1002/1097-4644(20001215)79:4<576::AID-JCB60>3.0.CO;2-A; Ni R, 2015, ONCOTARGETS THER, V8, P2689, DOI [10.2147/OTT.S90998, 10.2147/OTT.S86093]; Novy M, 2005, MOL BIOL CELL, V16, P2181, DOI 10.1091/mbc.E04-11-0975; Ostenfeld MS, 2010, ONCOGENE, V29, P1073, DOI 10.1038/onc.2009.395; Papadopoulos EI, 2016, BIOL CHEM; Patard JJ, 2011, EUR UROL, V60, P684, DOI 10.1016/j.eururo.2011.06.017; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Payne SL, 2006, J CELL BIOCHEM, V98, P827, DOI 10.1002/jcb.20792; Perryman L, 2014, FUTURE ONCOL, V10, P1709, DOI [10.2217/FON.14.39, 10.2217/fon.14.39]; Rabien A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-258; Ratert N, 2013, J MOL DIAGN, V15, P695, DOI 10.1016/j.jmoldx.2013.05.008; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Silva-Santos RM, 2013, BRIT J CANCER, V109, P2646, DOI 10.1038/bjc.2013.552; Slaby O, 2012, GENE CHROMOSOME CANC, V51, P707, DOI 10.1002/gcc.21957; Song K, 2011, BIOCHEM J, V436, P271, DOI 10.1042/BJ20110297; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Tang K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10272; Tejero R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101899; Thomas JS, 2015, CRIT REV ONCOL HEMAT, V96, P527, DOI 10.1016/j.critrevonc.2015.07.009; Tsang FHC, 2015, FRONT MED-PRC, V9, P331, DOI 10.1007/s11684-015-0409-8; van der Mijn JC, 2014, DRUG RESIST UPDATE, V17, P77, DOI 10.1016/j.drup.2014.10.003; Vlachos IS, 2013, CLIN BIOCHEM, V46, P879, DOI 10.1016/j.clinbiochem.2013.03.006; Waaijer CJF, 2012, VIRCHOWS ARCH, V461, P475, DOI 10.1007/s00428-012-1300-5; Wach S, 2013, BRIT J CANCER, V109, P714, DOI 10.1038/bjc.2013.313; Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276; Wittekind C, 2002, CANCER-AM CANCER SOC, V94, P2511, DOI 10.1002/cncr.10492; Wotschofsky Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148746; Wotschofsky Z, 2012, INT J BIOL SCI, V8, P1363, DOI 10.7150/ijbs.5106; Wotschofsky Z, 2011, ANAL BIOCHEM, V417, P233, DOI 10.1016/j.ab.2011.06.009; Xu F, 2015, CLIN TRANSL ONCOL; Yoshino H, 2013, CANCER SCI, V104, P1567, DOI 10.1111/cas.12280; Yoshino H, 2013, J HUM GENET, V58, P508, DOI 10.1038/jhg.2013.31; Young AN, 2001, AM J PATHOL, V158, P1639, DOI 10.1016/S0002-9440(10)64120-X; Zaravinos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091646	82	51	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157801	10.1371/journal.pone.0157801	http://dx.doi.org/10.1371/journal.pone.0157801			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336447	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200049
J	Wu, C; Crowhurst, RN; Dennis, AB; Twort, VG; Liu, SL; Newcomb, RD; Ross, HA; Buckley, TR				Wu, Chen; Crowhurst, Ross N.; Dennis, Alice B.; Twort, Victoria G.; Liu, Shanlin; Newcomb, Richard D.; Ross, Howard A.; Buckley, Thomas R.			De Novo Transcriptome Analysis of the Common New Zealand Stick Insect Clitarchus hookeri (Phasmatodea) Reveals Genes Involved in Olfaction, Digestion and Sexual Reproduction	PLOS ONE			English	Article							ODORANT-BINDING PROTEIN; SEMINAL FLUID PROTEINS; PHYLOGENETIC PLACEMENT; SEQUENCE SIMILARITY; CHEMOSENSORY ORGANS; SOLUBLE-PROTEINS; RAPID EVOLUTION; PHEROMONE; RECEPTORS; EXPRESSION	Phasmatodea, more commonly known as stick insects, have been poorly studied at the molecular level for several key traits, such as components of the sensory system and regulators of reproduction and development, impeding a deeper understanding of their functional biology. Here, we employ de novo transcriptome analysis to identify genes with primary functions related to female odour reception, digestion, and male sexual traits in the New Zealand common stick insect Clitarchus hookeri (White). The female olfactory gene repertoire revealed ten odorant binding proteins with three recently duplicated, 12 chemosensory proteins, 16 odorant receptors, and 17 ionotropic receptors. The majority of these olfactory genes were over-expressed in female antennae and have the inferred function of odorant reception. Others that were predominantly expressed in male terminalia (n = 3) and female midgut (n = 1) suggest they have a role in sexual reproduction and digestion, respectively. Over-represented transcripts in the midgut were enriched with digestive enzyme gene families. Clitarchus hookeri is likely to harbour nine members of an endogenous cellulase family (glycoside hydrolase family 9), two of which appear to be specific to the C. hookeri lineage. All of these cellulase sequences fall into four main phasmid clades and show gene duplication events occurred early in the diversification of Phasmatodea. In addition, C. hookeri genome is likely to express gamma-proteobacteria pectinase transcripts that have recently been shown to be the result of horizontal transfer. We also predicted 711 male terminalia-enriched transcripts that are candidate accessory gland proteins, 28 of which were annotated to have molecular functions of peptidase activity and peptidase inhibitor activity, two groups being widely reported to regulate female reproduction through proteolytic cascades. Our study has yielded new insights into the genetic basis of odour detection, nutrient digestion, and male sexual traits in stick insects. The C. hookeri reference transcriptome, together with identified gene families, provides a comprehensive resource for studying the evolution of sensory perception, digestive systems, and reproductive success in phasmids.	[Wu, Chen; Twort, Victoria G.; Buckley, Thomas R.] Landcare Res, Auckland, New Zealand; [Wu, Chen; Twort, Victoria G.; Newcomb, Richard D.; Ross, Howard A.; Buckley, Thomas R.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Crowhurst, Ross N.; Newcomb, Richard D.] New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand; [Dennis, Alice B.] ETH, Inst Integrat Biol, Zurich, Switzerland; [Dennis, Alice B.] Swiss Fed Inst Aquat Sci & Technol, EAWAG, Dubendorf, Switzerland; [Liu, Shanlin] BGI Shenzhen, China Natl GeneBank, Shenzhen, Peoples R China	Landcare Research - New Zealand; University of Auckland; New Zealand Institute for Plant & Food Research Ltd; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Beijing Genomics Institute (BGI)	Wu, C (corresponding author), Landcare Res, Auckland, New Zealand.; Wu, C (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	wuc@landcareresearch.co.nz	Crowhurst, Ross N/N-8892-2017; Buckley, Thomas/H-1284-2012; Twort, Victoria/AAL-9807-2021; Liu, Shanlin/GNH-3256-2022; Liu, Shanlin/HGA-2841-2022; Buckley, Thomas/HGD-4732-2022; Wu, Chen/E-4603-2017; Newcomb, Richard/C-2067-2009	Crowhurst, Ross N/0000-0003-0608-2134; Buckley, Thomas/0000-0002-3076-4234; Twort, Victoria/0000-0002-5581-4154; Liu, Shanlin/0000-0001-8118-8313; Liu, Shanlin/0000-0001-8118-8313; Dennis, Alice/0000-0003-0948-9845; Wu, Chen/0000-0003-1499-9567; Newcomb, Richard/0000-0002-7307-9755	Massey University [RM13790/24947]; Allan Wilson Centre	Massey University; Allan Wilson Centre	This work was supported by award number Massey University RM13790/24947, Allan Wilson Centre (http://www.allanwilsoncentre.ac.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank New Zealand eScience Infrastructure (NeSI) for high-performance computing facilities; P. Maxwell, X. Cheng, K. Rutherford, J. Blasco, M. Feller, H. Liu, M. Zhang and Y. Wang for analytic help; S. Myers, K. King and M. McDonald for field assistance; L. Dunning for his contribution in the construction to the C. hookeri head and prothorax transcriptome; R. Howitt, J. Allwood, A. Ramon-Laca, and D. Park for laboratory support. We thank K. Meusemann, A. Donath, X. Zhou, K. Kjer, B. Misof, L. Podsiadlowski, B. Wipfler and the 1kite Polyneopetra subgroup (http://www.1kite.org/subprojects.html) for providing the leg RNA-Seq data and especially A. Donath for submission to and data release on NCBI. We also thank the Allan Wilson Centre for funding, collaboration and facility support. We thank J. Joe Hull and three anonymous reviewers for giving us valuable suggestions to strengthen this paper.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; BASSLER U, 1977, BIOL CYBERN, V25, P61, DOI 10.1007/BF00337264; Boes KE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002946; Bragg PE, 2001, PHASMIDS BORNEO; Buckley TR, 2014, ZOOTAXA, V3900, P451, DOI 10.11646/zootaxa.3900.4.1; Buckley TR, 2010, J BIOGEOGR, V37, P682, DOI 10.1111/j.1365-2699.2009.02239.x; Buckley TR, 2010, SYST ENTOMOL, V35, P207, DOI 10.1111/j.1365-3113.2009.00505.x; Buckley TR, 2009, P ROY SOC B-BIOL SCI, V276, P1055, DOI 10.1098/rspb.2008.1552; Calderon-Cortes N, 2012, ANNU REV ECOL EVOL S, V43, P45, DOI 10.1146/annurev-ecolsys-110411-160312; Callahan FE, 2000, INSECT BIOCHEM MOLEC, V30, P507, DOI 10.1016/S0965-1748(00)00027-8; Carney GE, 2003, GENETICS, V164, P173; Cazemier AE, 1997, COMP BIOCHEM PHYS A, V118, P101, DOI 10.1016/S0300-9629(96)00443-4; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Comeault AA, 2012, MOL ECOL RESOUR, V12, P549, DOI 10.1111/j.1755-0998.2012.03121.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corcoran JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128596; Damberger FF, 2013, P NATL ACAD SCI USA, V110, P18680, DOI 10.1073/pnas.1317706110; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davison A, 2005, MOL BIOL EVOL, V22, P1273, DOI 10.1093/molbev/msi107; Dennis AB, 2014, NZ ENTOMOL, V37, P35, DOI 10.1080/00779962.2013.784235; Dennis AB, 2015, SCI REP-UK, V5, DOI 10.1038/srep13965; Dunning LT, 2014, MOL ECOL, V23, P2712, DOI 10.1111/mec.12767; Dunning LT, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-215; Dunning LT, 2013, COMP BIOCHEM PHYS D, V8, P24, DOI 10.1016/j.cbd.2012.10.005; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Gompert Z, 2014, ECOL LETT, V17, P369, DOI 10.1111/ele.12238; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Guindon S, 2009, INFECT GENET EVOL, V9, P384; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirsch R, 2014, INSECT BIOCHEM MOLEC, V52, P33, DOI 10.1016/j.ibmb.2014.06.008; Koenig D, 2015, NAT REV GENET, V16, P285, DOI 10.1038/nrg3883; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; LaFlamme BA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002435; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leitch O, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1466-8; Leng N., 2013, BIOINFORMATICS; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li W, 2012, BIOINFORMATICS, V28, P2914, DOI 10.1093/bioinformatics/bts559; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lung O, 2002, GENETICS, V160, P211; Mameli M, 1996, INSECT BIOCHEM MOLEC, V26, P875, DOI 10.1016/S0965-1748(96)00055-0; Marchese S, 2000, INSECT BIOCHEM MOLEC, V30, P1091, DOI 10.1016/S0965-1748(00)00084-9; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Missbach C, 2014, ELIFE, V3, DOI 10.7554/eLife.02115; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Morgan-Richards M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154911; Morgan-Richards M, 2010, MOL ECOL, V19, P1227, DOI 10.1111/j.1365-294X.2010.04542.x; Myers SS, 2015, BEHAVIOUR, V152, P1325, DOI 10.1163/1568539X-00003281; Naz RK, 1999, BIOL REPROD, V60, P1402, DOI 10.1095/biolreprod60.6.1402; PAESEN GC, 1995, INSECT BIOCHEM MOLEC, V25, P401, DOI 10.1016/0965-1748(94)00085-V; Panhuis TM, 2006, PHILOS T R SOC B, V361, P261, DOI 10.1098/rstb.2005.1793; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pilpel N, 2008, INSECT BIOCHEM MOLEC, V38, P320, DOI 10.1016/j.ibmb.2007.11.010; Ram KR, 2009, P NATL ACAD SCI USA, V106, P15384, DOI 10.1073/pnas.0902923106; Rinker DC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-749; Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007; Sabeur K, 2008, MOL REPROD DEV, V75, P867, DOI 10.1002/mrd.20792; Salmon JT, 1991, THE STICK INSECTS OF; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schneider D, 1998, J COMP PHYSIOL A, V182, P153, DOI 10.1007/s003590050166; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Scully ED, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-850; Shelomi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26388; Shelomi M, 2016, INSECT BIOCHEM MOLEC, V71, P1, DOI 10.1016/j.ibmb.2016.02.003; Shelomi M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-917; Shelomi M, 2014, J INSECT PHYSIOL, V60, P25, DOI 10.1016/j.jinsphys.2013.10.007; Shelomi Matan, 2013, BMC Research Notes, V6, P0001, DOI 10.1186/1756-0500-6-368; Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; SMITH GM, 1994, BIOCHEM J, V304, P775, DOI 10.1042/bj3040775; Sonenshine DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024711; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Soria-Carrasco V, 2014, SCIENCE, V344, P738, DOI 10.1126/science.1252136; Sprockett DD, 2011, GENE, V479, P29, DOI 10.1016/j.gene.2011.02.009; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Terrapon N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4636; Thymianou S, 1998, INSECT MOL BIOL, V7, P345, DOI 10.1046/j.1365-2583.1998.740345.x; Trewick SA, 2005, ZOOL SCR, V34, P483, DOI 10.1111/j.1463-6409.2005.00204.x; Tuccini A, 1996, INSECT BIOCHEM MOLEC, V26, P19, DOI 10.1016/0965-1748(95)00051-8; Walker MJ, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-9; Wang X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6776; Watanabe H, 1998, NATURE, V394, P330, DOI 10.1038/28527; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhou SS, 2014, COMP BIOCHEM PHYS D, V9, P31, DOI 10.1016/j.cbd.2013.12.002	102	15	17	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157783	10.1371/journal.pone.0157783	http://dx.doi.org/10.1371/journal.pone.0157783			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336743	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200042
J	Muller, NCJ; Genzel, L; Konrad, BN; Pawlowski, M; Neville, D; Fernandez, G; Steiger, A; Dresler, M				Muller, Nils C. J.; Genzel, Lisa; Konrad, Boris N.; Pawlowski, Marcel; Neville, David; Fernandez, Guillen; Steiger, Axel; Dresler, Martin			Motor Skills Enhance Procedural Memory Formation and Protect against Age-Related Decline	PLOS ONE			English	Article							SCHEMA THEORY; PRIOR KNOWLEDGE; TIME-COURSE; SLEEP; CONSOLIDATION; PERFORMANCE; ACQUISITION; EXPERTISE; TASK; CONNECTIVITY	The ability to consolidate procedural memories declines with increasing age. Prior knowledge enhances learning and memory consolidation of novel but related information in various domains. Here, we present evidence that prior motor experience-in our case piano skills-increases procedural learning and has a protective effect against age-related decline for the consolidation of novel but related manual movements. In our main experiment, we tested 128 participants with a sequential finger-tapping motor task during two sessions 24 hours apart. We observed enhanced online learning speed and offline memory consolidation for piano players. Enhanced memory consolidation was driven by a strong effect in older participants, whereas younger participants did not benefit significantly from prior piano experience. In a follow up independent control experiment, this compensatory effect of piano experience was not visible after a brief offline period of 30 minutes, hence requiring an extended consolidation window potentially involving sleep. Through a further control experiment, we rejected the possibility that the decreased effect in younger participants was caused by training saturation. We discuss our results in the context of the neurobiological schema approach and suggest that prior experience has the potential to rescue memory consolidation from age-related cognitive decline.	[Muller, Nils C. J.; Konrad, Boris N.; Neville, David; Fernandez, Guillen; Dresler, Martin] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Genzel, Lisa] Univ Edinburgh, Ctr Cognit & Neural Syst, Edinburgh, Midlothian, Scotland; [Pawlowski, Marcel; Steiger, Axel; Dresler, Martin] Max Planck Inst Psychiat, Munich, Germany	Radboud University Nijmegen; University of Edinburgh; Max Planck Society	Muller, NCJ; Dresler, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.; Dresler, M (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	n.muller@donders.ru.nl; dresler@psych.mpg.de	Genzel, Lisa/B-5716-2017; Neville, David/W-6877-2018; Dresler, Martin/A-9507-2014; Fernandez, Guillen/B-3771-2009	Genzel, Lisa/0000-0001-9537-7959; Neville, David/0000-0002-1394-3863; Dresler, Martin/0000-0001-7441-3818; Fernandez, Guillen/0000-0002-5522-0604; Zeising, Marcel/0000-0001-7902-5582; Steiger, Axel/0000-0001-5977-5896	Research Talent grant of the Netherlands Organisation for Scientific Research (NWO); European Research Council [ERC ADG R0001075]; Society in Science Branco Weiss Fellowhsip; Veni grant of the Netherlands Organisation for Scientific Research (NWO)	Research Talent grant of the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); Society in Science Branco Weiss Fellowhsip; Veni grant of the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	NCJM was supported by a Research Talent grant of the Netherlands Organisation for Scientific Research (NWO). LG was supported by the European Research Council (ERC ADG R0001075) and a Society in Science Branco Weiss Fellowhsip. GF was supported by the European Research Council (ERC ADG R0001075). MD was supported by a Veni grant of the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Albouy G, 2015, NEUROIMAGE, V108, P423, DOI 10.1016/j.neuroimage.2014.12.049; Albouy G, 2013, HIPPOCAMPUS, V23, P985, DOI 10.1002/hipo.22183; Brown RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006683; Brown S, 2003, BEHAV RES METH INS C, V35, P11, DOI 10.3758/BF03195493; Burt C, 1933, BRIT J EDUC PSYCHOL, V3, P187; CARSON LM, 1979, J MOTOR BEHAV, V11, P247, DOI 10.1080/00222895.1979.10735193; Cattell R. B., 1973, MEASURING INTELLIGEN; Dresler M, 2010, EUR NEUROPSYCHOPHARM, V20, P553, DOI 10.1016/j.euroneuro.2010.02.002; Durrant SJ, 2015, NEUROBIOL LEARN MEM, V122, P41, DOI 10.1016/j.nlm.2015.02.011; Estes WK, 2005, PSYCHON B REV, V12, P403, DOI 10.3758/BF03193784; Fenn KM, 2015, PSYCHON B REV, V22, P791, DOI 10.3758/s13423-014-0731-1; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Fogel SM, 2014, HUM BRAIN MAPP, V35, P3625, DOI 10.1002/hbm.22426; Furuya S, 2014, NEUROSCIENCE, V275, P444, DOI 10.1016/j.neuroscience.2014.06.031; Genzel L, 2014, NEUROPSYCHOBIOLOGY, V70, P253, DOI 10.1159/000369022; Genzel L, 2015, BIOL PSYCHIAT, V77, P177, DOI 10.1016/j.biopsych.2014.06.004; Genzel L, 2012, PSYCHONEUROENDOCRINO, V37, P987, DOI 10.1016/j.psyneuen.2011.11.006; Genzel L, 2011, J PSYCHIATR RES, V45, P555, DOI 10.1016/j.jpsychires.2010.08.015; Ghosh VE, 2014, NEUROPSYCHOLOGIA, V53, P104, DOI 10.1016/j.neuropsychologia.2013.11.010; Hauptmann B, 2005, COGNITIVE BRAIN RES, V24, P181, DOI 10.1016/j.cogbrainres.2005.01.012; Henderson L, 2015, DEV PSYCHOL, V51, P406, DOI 10.1037/a0038786; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Krampe RT, 1996, J EXP PSYCHOL GEN, V125, P331, DOI 10.1037/0096-3445.125.4.331; Kumaran D, 2009, NEURON, V63, P889, DOI 10.1016/j.neuron.2009.07.030; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Manoach DS, 2004, BIOL PSYCHIAT, V56, P951, DOI 10.1016/j.biopsych.2004.09.012; Newell KM, 2003, RES Q EXERCISE SPORT, V74, P383, DOI 10.1080/02701367.2003.10609108; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; Ofen N, 2013, NEUROSCI BIOBEHAV R, V37, P2258, DOI 10.1016/j.neubiorev.2013.04.006; Pereira T, 2013, PERCEPT MOTOR SKILL, V117, P108, DOI 10.2466/23.25.PMS.117x14z0; Piaget Jean, 1929, CHILDS CONCEPTION WO; Ramanathan DS, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002263; Roig M, 2014, NEUROBIOL AGING, V35, P1892, DOI 10.1016/j.neurobiolaging.2014.02.022; SALTHOUSE TA, 1984, J EXP PSYCHOL GEN, V113, P345, DOI 10.1037/0096-3445.113.3.345; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Schmidt RA, 2003, RES Q EXERCISE SPORT, V74, P366, DOI 10.1080/02701367.2003.10609106; Smith CT, 2004, LEARN MEMORY, V11, P714, DOI 10.1101/lm.74904; Smith PJK, 1995, J SPORT SCI, V13, P455, DOI 10.1080/02640419508732262; Spencer RMC, 2007, LEARN MEMORY, V14, P480, DOI 10.1101/lm.569407; Taylor JL, 2007, NEUROLOGY, V68, P648, DOI 10.1212/01.wnl.0000255943.10045.c0; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Tse D, 2011, SCIENCE, V333, P891, DOI 10.1126/science.1205274; Tucker M, 2011, J AM GERIATR SOC, V59, P603, DOI 10.1111/j.1532-5415.2011.03324.x; Tucker MA, 2009, J SLEEP RES, V18, P304, DOI 10.1111/j.1365-2869.2009.00740.x; Tunovic S, 2014, J NEUROSCI, V34, P5302, DOI 10.1523/JNEUROSCI.3497-13.2014; Tzvi E, 2015, NEUROIMAGE, V122, P52, DOI 10.1016/j.neuroimage.2015.07.077; van Buuren M, 2014, J NEUROSCI, V34, P16662, DOI 10.1523/JNEUROSCI.2365-14.2014; van Kesteren MTR, 2014, J COGNITIVE NEUROSCI, V26, P2250, DOI 10.1162/jocn_a_00630; van Kesteren MTR, 2012, TRENDS NEUROSCI, V35, P211, DOI 10.1016/j.tins.2012.02.001; van Kesteren MTR, 2010, J NEUROSCI, V30, P15888, DOI 10.1523/JNEUROSCI.2674-10.2010; van Kesteren MTR, 2010, P NATL ACAD SCI USA, V107, P7550, DOI 10.1073/pnas.0914892107; Vieluf S, 2012, GEROPSYCH, V25, P199, DOI 10.1024/1662-9647/a000071; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wei&beta; R.H., 2006, CFT 20 R GRUNDINTELL; Wilson JK, 2012, NEUROBIOL AGING, V33, P991, DOI 10.1016/j.neurobiolaging.2011.06.029	57	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157770	10.1371/journal.pone.0157770	http://dx.doi.org/10.1371/journal.pone.0157770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP0WX	27333186	Green Published, gold			2022-12-26	WOS:000378212800048
J	Park, D; Song, G; Jo, Y; Won, J; Son, T; Cha, O; Kim, J; Jung, B; Park, H; Kim, CW; Seo, J				Park, Donghee; Song, Gillsoo; Jo, Yongjun; Won, Jongho; Son, Taeyoon; Cha, Ohrum; Kim, Jinho; Jung, Byungjo; Park, Hyunjin; Kim, Chul-Woo; Seo, Jongbum			Sonophoresis Using Ultrasound Contrast Agents: Dependence on Concentration	PLOS ONE			English	Article							LOW-FREQUENCY SONOPHORESIS; TRANSDERMAL DRUG-DELIVERY; CAVITATION; SKIN	Sonophoresis can increase skin permeability to various drugs in transdermal drug delivery. Cavitation is recognized as the predominant mechanism of sonophoresis. Recently, a new logical approach to enhance the efficiency of transdermal drug delivery was tried. It is to utilize the engineered microbubble and its resonant frequency for increase of cavitation activity. Actively-induced cavitation with low-intensity ultrasound (less than similar to 1 MPa) causes disordering of the lipid bilayers and the formation of aqueous channels by stable cavitation which indicates a continuous oscillation of bubbles. Furthermore, the mutual interactions of microbubble determined by concentration of added bubble are also thought to be an important factor for activity of stable cavitation, even in different characteristics of drug. In the present study, we addressed the dependence of ultrasound contrast agent concentration using two types of drug on the efficiency of transdermal drug delivery. Two types of experiment were designed to quantitatively evaluate the efficiency of transdermal drug delivery according to ultrasound contrast agent concentration. First, an experiment of optical clearing using a tissue optical clearing agent was designed to assess the efficiency of sonophoresis with ultrasound contrast agents. Second, a Franz diffusion cell with ferulic acid was used to quantitatively determine the amount of drug delivered to the skin sample by sonophoresis with ultrasound contrast agents. The maximum enhancement ratio of sonophoresis with a concentration of 1:1,000 was approximately 3.1 times greater than that in the ultrasound group without ultrasound contrast agent and approximately 7.5 times greater than that in the control group. These results support our hypothesis that sonophoresis becomes more effective in transdermal drug delivery due to the presence of engineered bubbles, and that the efficiency of transdermal drug delivery using sonophoresis with microbubbles depends on the concentration of microbubbles in case stable cavitation is predominant.	[Park, Donghee; Kim, Chul-Woo] Seoul Natl Univ, Coll Med, Dept Pathol, Tumor Immun Med Res Ctr,Canc Res Inst, Seoul 151, South Korea; [Song, Gillsoo; Won, Jongho; Son, Taeyoon; Cha, Ohrum; Kim, Jinho; Jung, Byungjo; Seo, Jongbum] Yonsei Univ, Dept Biomed Engn, Wonju, Gangwon Do, South Korea; [Jo, Yongjun] Gumi Elect & Informat Technol Res Inst, Gumi, Gyeongsangbuk D, South Korea; [Park, Hyunjin] Sungkyunkwan Univ, Sch Elect Elect Engn, Suwon, Gyeonggi Do, South Korea	Seoul National University (SNU); Yonsei University; Sungkyunkwan University (SKKU)	Seo, J (corresponding author), Yonsei Univ, Dept Biomed Engn, Wonju, Gangwon Do, South Korea.	jongbums@yonsei.ac.kr	Son, Taeyoon/Q-4816-2017; Park, Hyunjin/A-1164-2007	Park, Hyunjin/0000-0001-5681-8918	National Research Foundation of Korea (NRF) grant - the Ministry of Science, ICT & Future Planning (MSIP) [NRF-2013R1A2A2A 04016262, NRF-2014M3A6A3063636, 2012-0001190, 2010-00757]; Technology Innovation Program - Ministry of Trade, industry & Energy, Republic of Korea [10052749]	National Research Foundation of Korea (NRF) grant - the Ministry of Science, ICT & Future Planning (MSIP); Technology Innovation Program - Ministry of Trade, industry & Energy, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT & Future Planning (MSIP) (NRF-2013R1A2A2A 04016262), (NRF-2014M3A6A3063636), (2012-0001190), (2010-00757), and by Technology Innovation Program (10052749) funded By the Ministry of Trade, industry & Energy, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APFEL RE, 1982, BRIT J CANCER, V45, P140; Azagury A, 2014, ADV DRUG DEL REV; Azmin M, 2012, CURR PHARM DESIGN, V18, P2118, DOI 10.2174/138161212800099955; BOMMANNAN D, 1992, PHARMACEUT RES, V9, P1043, DOI 10.1023/A:1015806528336; Boucaud A, 2001, INT J PHARMACEUT, V228, P69, DOI 10.1016/S0378-5173(01)00820-1; Carvell KJ, 2011, ULTRASONICS, V51, P115, DOI 10.1016/j.ultras.2010.06.005; Chatterjee D, 2005, ULTRASOUND MED BIOL, V31, P781, DOI 10.1016/j.ultrasmedbio.2005.02.014; Chen BT, 2010, SENSOR ACTUAT B-CHEM, V145, P54, DOI 10.1016/j.snb.2009.11.013; de Jong N, 2009, MED BIOL ENG COMPUT, V47, P861, DOI 10.1007/s11517-009-0497-1; Faez T, 2011, ULTRASOUND MED BIOL, V37, P338, DOI 10.1016/j.ultrasmedbio.2010.11.014; Genina Elina A., 2008, Advances in Optical Technologies, V2, DOI 10.1155/2008/267867; Gupta J, 2009, ULTRASOUND MED BIOL, V35, P1405, DOI 10.1016/j.ultrasmedbio.2009.04.001; HOLLAND CK, 1990, J ACOUST SOC AM, V88, P2059, DOI 10.1121/1.400102; Le L, 2000, PHARMACEUT RES, V17, P1151, DOI 10.1023/A:1026426317413; Mason TJ, 2011, ULTRASON SONOCHEM, V18, P847, DOI 10.1016/j.ultsonch.2011.01.004; Meidan VM, 1998, INT J PHARMACEUT, V170, P157, DOI 10.1016/S0378-5173(98)00140-9; Miller AP, 2004, ULTRASOUND MED BIOL, V30, P425, DOI 10.1016/j.ultrasmedbio.2003.12.002; MITRAGOTRI S, 1995, SCIENCE, V269, P850, DOI 10.1126/science.7638603; Mitragotri S, 2004, ADV DRUG DELIVER REV, V56, P589, DOI 10.1016/j.addr.2003.10.024; Mitragotri S, 1996, PHARMACEUT RES, V13, P411, DOI 10.1023/A:1016096626810; Netzlaff F, 2006, ATLA-ALTERN LAB ANIM, V34, P499; Ogura M, 2008, ADV DRUG DELIVER REV, V60, P1218, DOI 10.1016/j.addr.2008.03.006; Olefsky JM, 2001, JAMA-J AM MED ASSOC, V285, P628, DOI 10.1001/jama.285.5.628; Overvelde M., 2010, ULTRASOUND CONTRAST; Pahade A., 2010, INT J PHARM SCI REV, V3, P24; Park D, 2010, OPEN BIOMEDICAL ENG, V4; Park D, 2014, ULTRASONICS, V54, P56, DOI 10.1016/j.ultras.2013.07.007; Park D, 2012, ULTRASOUND MED BIOL, V38, P642, DOI 10.1016/j.ultrasmedbio.2011.12.015; Park EJ, 2007, PHARM RES-DORDR, V24, P1396, DOI 10.1007/s11095-007-9306-4; Park J, 2013, MOLECULES, V18, P13078, DOI 10.3390/molecules181013078; Smith NB, 2007, INT J NANOMED, V2, P585; Tang H, 2002, PHARMACEUT RES, V19, P1160, DOI 10.1023/A:1019898109793; Tezel A, 2002, J PHARM SCI-US, V91, P444, DOI 10.1002/jps.10024; Tezel A, 2003, BIOPHYS J, V85, P3502, DOI 10.1016/S0006-3495(03)74770-5; Tuchin VV, 2007, IEEE J SEL TOP QUANT, V13, P1621, DOI 10.1109/JSTQE.2007.911313; Ueda H, 2009, BIOL PHARM BULL, V32, P916, DOI 10.1248/bpb.32.916; Van der Meer S, 2004, ULTR S 2004 IEEE; Wen X, 2010, J BIOPHOTONICS, V3, P44, DOI 10.1002/jbio.200910080; Xie JB, 2007, J PHARMACEUT BIOMED, V45, P450, DOI 10.1016/j.jpba.2007.07.011; Yoon J, 2010, LASER SURG MED, V42, P412, DOI 10.1002/lsm.20930; Zhao YZ, 2005, ULTRASOUND MED BIOL, V31, P537, DOI 10.1016/j.ultrasmedbio.2005.01.003; Zhong WJ, 2011, ULTRASOUND MED BIOL, V37, P2149, DOI 10.1016/j.ultrasmedbio.2011.09.012	42	19	20	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157707	10.1371/journal.pone.0157707	http://dx.doi.org/10.1371/journal.pone.0157707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322539	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212000040
J	Xia, XR; Dai, CJ; Zhu, XC; Liao, QM; Luo, X; Fu, YY; Wang, LX				Xia, Xiaoru; Dai, Caijun; Zhu, Xiaochun; Liao, Qiumei; Luo, Xu; Fu, Yangyang; Wang, Liangxing			Identification of a Novel NLRP12 Nonsense Mutation (Trp408X) in the Extremely Rare Disease FCAS by Exome Sequencing	PLOS ONE			English	Article							UNDIAGNOSED PERIODIC FEVERS; AUTOINFLAMMATORY DISORDERS; HEALTHY CONTROLS; F402L VARIANT; CUTTING EDGE; IMMUNODEFICIENCY; FAMILY; CIAS1; GENE	Familial cold autoinflammatory syndrome (FCAS) is an extremely rare autosomal dominant inherited disease. Although there are four genes that have been linked with FCAS, its molecular diagnosis has been challenging in a relatively large proportion of cases. In this study, we aimed to investigate the genetic defect of a recruited FCAS family using exome sequencing followed by in-depth bioinformatics analysis. As a result, a novel heterozygous stop-gain mutation (Trp408X) in NLRP12 was identified in autosomal dominant inherited FCAS with clinical features of recurrent fever and skin urticaria due to cold conditions. When combined with previous studies, all of the reported mutations were found to have occurred in a highly conserved region in the NACHT domain coding sequence in NLRP12 exon 3, suggesting that a screening strategy for FCAS should focus on this area of the gene. In conclusion, this study demonstrates the importance of exome sequencing for clinical diagnosis of genetic disorders and provides molecular insight into FCAS treatment and diagnosis.	[Xia, Xiaoru; Zhu, Xiaochun; Liao, Qiumei] Wenzhou Med Univ, Affiliated Hosp 1, Dept Rheumatol, Wenzhou, Peoples R China; [Dai, Caijun; Fu, Yangyang; Wang, Liangxing] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pneumol, Wenzhou, Peoples R China; [Luo, Xu] Wenzhou Med Univ, Affiliated Hosp 1, Dept Wounds & Burns, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Wang, LX (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Pneumol, Wenzhou, Peoples R China.	wzyxywlx@163.com			Natural Science Foundation of Zhejiang province, China [LY16H110002]	Natural Science Foundation of Zhejiang province, China(Natural Science Foundation of Zhejiang Province)	This work was supported by grants from Natural Science Foundation of Zhejiang province, China (LY16H110002).	Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; Arthur JC, 2010, J IMMUNOL, V185, P4515, DOI 10.4049/jimmunol.1002227; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Borghini S, 2011, ARTHRITIS RHEUM-US, V63, P830, DOI 10.1002/art.30170; Borte S, 2014, CLIN IMMUNOL, V154, P105, DOI 10.1016/j.clim.2014.07.003; Cai T, 2015, P NATL ACAD SCI USA, V112, P8064, DOI 10.1073/pnas.1502454112; Cruceanu C, 2013, GENOME, V56, P634, DOI 10.1139/gen-2013-0081; Cuisset L, 2011, ANN RHEUM DIS, V70, P495, DOI 10.1136/ard.2010.138420; de Jesus AA, 2013, CLIN IMMUNOL, V147, P155, DOI 10.1016/j.clim.2013.03.016; De Pieri C, 2014, CLIN EXP RHEUMATOL, V32, P993; De Pieri C, 2015, PEDIATR RHEUMATOL, V13, DOI 10.1186/s12969-015-0006-z; Goh Gerald, 2012, Genomics & Informatics, V10, P214, DOI 10.5808/GI.2012.10.4.214; Hoffman HM, 2003, HUM GENET, V112, P209, DOI 10.1007/s00439-002-0860-x; Hoffman HM, 2001, J ALLERGY CLIN IMMUN, V108, P615, DOI 10.1067/mai.2001.118790; Ida Hiroaki, 2015, Rinsho Byori, V63, P1207; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Jeru I, 2011, ARTHRITIS RHEUM-US, V63, P2142, DOI 10.1002/art.30378; Kapur Saloni, 2009, P T, V34, P138; Kitamura A, 2014, J EXP MED, V211, P2385, DOI 10.1084/jem.20141091; Li GX, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-25; Li JC, 2015, J MED GENET, V52, P275, DOI 10.1136/jmedgenet-2014-102656; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; MacDonald JA, 2013, IUBMB LIFE, V65, P851, DOI 10.1002/iub.1210; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Rabbani B, 2012, J HUM GENET, V57, P621, DOI 10.1038/jhg.2012.91; Rusmini M, 2016, ANN RHEUM DIS, V75, P1550, DOI 10.1136/annrheumdis-2015-207701; Shinar Y, 2012, ANN RHEUM DIS, V71, P1599, DOI 10.1136/annrheumdis-2011-201271; Tunca Mehmet, 2005, Current Drug Targets - Inflammation and Allergy, V4, P77, DOI 10.2174/1568010053622957; Vitale A, 2014, CLIN EXP RHEUMATOL, V32, P994; Vitale A, 2013, CLIN EXP RHEUMATOL, V31, pS155	30	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0156981	10.1371/journal.pone.0156981	http://dx.doi.org/10.1371/journal.pone.0156981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314497	Green Published, gold, Green Submitted			2022-12-26	WOS:000378030000006
J	Fahner, NA; Shokralla, S; Baird, DJ; Hajibabaei, M				Fahner, Nicole A.; Shokralla, Shadi; Baird, Donald J.; Hajibabaei, Mehrdad			Large-Scale Monitoring of Plants through Environmental DNA Metabarcoding of Soil: Recovery, Resolution, and Annotation of Four DNA Markers	PLOS ONE			English	Article							BARCODE; CHALLENGES; PATTERNS	In a rapidly changing world we need methods to efficiently assess biodiversity in order to monitor ecosystem trends. Ecological monitoring often uses plant community composition to infer quality of sites but conventional aboveground surveys only capture a snapshot of the actively growing plant diversity. Environmental DNA (eDNA) extracted from soil samples, however, can include taxa represented by both active and dormant tissues, seeds, pollen, and detritus. Analysis of this eDNA through DNA metabarcoding provides a more comprehensive view of plant diversity at a site from a single assessment but it is not clear which DNA markers are best used to capture this diversity. Sequence recovery, annotation, and sequence resolution among taxa were evaluated for four established DNA markers (matK, rbcL, ITS2, and the trnL P6 loop) in silico using database sequences and in situ using high throughput sequencing of 35 soil samples from a remote boreal wetland. Overall, ITS2 and rbcL are recommended for DNA metabarcoding of vascular plants from eDNA when not using customized or geographically restricted reference databases. We describe a new framework for evaluating DNA metabarcodes and, contrary to existing assumptions, we found that full length DNA barcode regions could outperform shorter markers for surveying plant diversity from soil samples. By using current DNA barcoding markers rbcL and ITS2 for plant metabarcoding, we can take advantage of existing resources such as the growing DNA barcode database. Our work establishes the value of standard DNA barcodes for soil plant eDNA analysis in ecological investigations and biomonitoring programs and supports the collaborative development of DNA barcoding and metabarcoding.	[Fahner, Nicole A.; Shokralla, Shadi; Hajibabaei, Mehrdad] Univ Guelph, Dept Integrat Biol & Biodivers, Inst Ontario, Guelph, ON N1G 2W1, Canada; [Baird, Donald J.] Environm Canada, Canadian Rivers Inst, Fredericton, NB, Canada; [Baird, Donald J.] Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada	University of Guelph; Environment & Climate Change Canada; University of New Brunswick	Hajibabaei, M (corresponding author), Univ Guelph, Dept Integrat Biol & Biodivers, Inst Ontario, Guelph, ON N1G 2W1, Canada.	mhajibab@uoguelph.ca			Ontario Genomics Institute; Genome Canada; NSERC; Environment Canada; Parks Canada	Ontario Genomics Institute; Genome Canada(Genome Canada); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada(CGIAR); Parks Canada	This work was supported by the Ontario Genomics Institute; Genome Canada, NSERC, Environment Canada, Parks Canada.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Deagle BE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0562; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elliott TL, 2014, MOL ECOL RESOUR, V14, P883, DOI 10.1111/1755-0998.12277; Epp LS, 2012, MOL ECOL, V21, P1821, DOI 10.1111/j.1365-294X.2012.05537.x; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Ficetola GF, 2016, MOL ECOL RESOUR, V16, P604, DOI 10.1111/1755-0998.12508; Gibson JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138432; Hajibabaei M, 2012, TRENDS GENET, V28, P535, DOI 10.1016/j.tig.2012.08.001; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hiiesalu I, 2012, MOL ECOL, V21, P2004, DOI 10.1111/j.1365-294X.2011.05390.x; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Kesanakurti PR, 2011, MOL ECOL, V20, P1289, DOI 10.1111/j.1365-294X.2010.04989.x; Lamb EG, 2016, PLANT SOIL, P1; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McClenaghan B, 2015, ECOL EVOL, V5, P3046, DOI 10.1002/ece3.1585; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Oksanen J., 2020, VEGAN COMMUNITY ECOL; R Core Team, 2021, R LANGUAGE ENV STAT; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Song JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043971; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timoney K.P., 2013, PEACE ATHABASCA DELT, P15; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Wilson MJ, 2013, AQUAT ECOSYST HEALTH, V16, P288, DOI 10.1080/14634988.2013.825194; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x; Young JM, 2014, FORENSIC SCI INT-GEN, V13, P176, DOI 10.1016/j.fsigen.2014.07.014; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	44	80	88	3	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157505	10.1371/journal.pone.0157505	http://dx.doi.org/10.1371/journal.pone.0157505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310720	Green Submitted, Green Published, gold			2022-12-26	WOS:000378029800088
J	Switzer, WM; Tang, SH; Zheng, HQ; Shankar, A; Sprinkle, PS; Sullivan, V; Granade, TC; Heneine, W				Switzer, William M.; Tang, Shaohua; Zheng, HaoQiang; Shankar, Anupama; Sprinkle, Patrick S.; Sullivan, Vickie; Granade, Timothy C.; Heneine, Walid			Dual Simian Foamy Virus/Human Immunodeficiency Virus Type 1 Infections in Persons from Cote d'Ivoire	PLOS ONE			English	Article							CROSS-SPECIES TRANSMISSION; MYELOPATHY/TROPICAL SPASTIC PARAPARESIS; TO-CHILD TRANSMISSION; HIGH PROVIRAL LOAD; NONHUMAN-PRIMATES; GENETIC DIVERSITY; IVORY-COAST; HIV-1; LEUKEMIA; HTLV-1	Zoonotic transmission of simian retroviruses in West-Central Africa occurring in primate hunters has resulted in pandemic spread of human immunodeficiency viruses (HIVs) and human T-lymphotropic viruses (HTLVs). While simian foamy virus (SFV) and simian T-lymphotropic virus (STLV)-like infection were reported in healthy persons exposed to nonhuman primates (NHPs) in West-Central Africa, less is known about the distribution of these viruses in Western Africa and in hospitalized populations. We serologically screened for SFV and STLV infection using 1,529 specimens collected between 1985 and 1997 from Cote d'Ivoire patients with high HIV prevalence. PCR amplification and analysis of SFV, STLV, and HIV/SIV sequences from PBMCs was used to investigate possible simian origin of infection. We confirmed SFV antibodies in three persons (0.2%), two of whom were HIV1- infected. SFV polymerase (pol) and LTR sequences were detected in PBMC DNA available for one HIV-infected person. Phylogenetic comparisons with new SFV sequences from African guenons showed infection likely originated from a Chlorocebus sabaeus monkey endemic to Cote d'Ivoire. 4.6% of persons were HTLV seropositive and PCR testing of PBMCs from 15 HTLV seroreactive persons identified nine with HTLV-1 and one with HTLV-2 LTR sequences. Phylogenetic analysis showed that two persons had STLV-1-like infections, seven were HTLV-1, and one was an HTLV-2 infection. 310/858 (53%), 8/858 (0.93%), and 18/858 (2.1%) were HIV-1, HIV-2, and HIV-positive but undifferentiated by serology, respectively. No SIV sequences were found in persons with HIV-2 antibodies (n = 1) or with undifferentiated HIV results (n = 7). We document SFV, STLV-1-like, and dual SFV/HIV infection in Cote d'Ivoire expanding the geographic range for zoonotic simian retrovirus transmission to West Africa. These findings highlight the need to define the public health consequences of these infections. Studying dual HIV-1/SFV infections in immunocompromised populations may provide a new opportunity to better understand SFV pathogenicity and transmissibility in humans.	[Switzer, William M.; Tang, Shaohua; Zheng, HaoQiang; Shankar, Anupama; Sprinkle, Patrick S.; Sullivan, Vickie; Granade, Timothy C.; Heneine, Walid] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Switzer, WM (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA.	bis3@cdc.gov						Abouya L, 1998, AIDS, V12, P505, DOI 10.1097/00002030-199805000-00012; ADJORLOLOJOHNSON G, 1994, JAMA-J AM MED ASSOC, V272, P462, DOI 10.1001/jama.272.6.462; Ahuka-Mundeke S, 2012, AIDS RES HUM RETROV, V28, P628, DOI [10.1089/aid.2011.0211, 10.1089/AID.2011.0211]; Ayouba A, 2013, AIDS, V27, P2488, DOI 10.1097/01.aids.0000432443.22684.50; Besson G, 2009, J CLIN MICROBIOL, V47, P1129, DOI 10.1128/JCM.02006-08; Best I, 2006, CLIN EXP IMMUNOL, V146, P226, DOI 10.1111/j.1365-2249.2006.03208.x; Betsem E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002306; Bi SG, 2012, FOLIA PRIMATOL, V83, P11, DOI 10.1159/000338752; BONIS J, 1994, J INFECT DIS, V169, P225, DOI 10.1093/infdis/169.1.225; Calattini S, 2007, EMERG INFECT DIS, V13, P1314, DOI 10.3201/eid1309.061162; Calvignac-Spencer S, 2012, EMERG INFECT DIS, V18, P830, DOI 10.3201/eid1805.111663; Choudhary A, 2013, VIRUSES-BASEL, V5, P1414, DOI 10.3390/v5061414; Courgnaud V, 2001, J VIROL, V75, P857, DOI 10.1128/JVI.75.2.857-866.2001; DECOCK KM, 1990, AIDS, V4, P443, DOI 10.1097/00002030-199005000-00010; DECOCK KM, 1991, BMJ-BRIT MED J, V302, P496, DOI 10.1136/bmj.302.6775.496; DECOCK KM, 1989, LANCET, V2, P408; DJOMAND G, 1995, J ACQ IMMUN DEF SYND, V10, P358; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Enose-Akahata Y, 2015, RETROVIROLOGY SUPPL, V12, DOI [10.1186/1742-4690-12-S1-O30, DOI 10.1186/1742-4690-12-S1-O30]; GAO F, 1994, J VIROL, V68, P7433, DOI 10.1128/JVI.68.11.7433-7447.1994; Goldberg TL, 2009, J VIROL, V83, P11318, DOI 10.1128/JVI.02616-08; Haus T, 2013, AM J PRIMATOL, V75, P350, DOI 10.1002/ajp.22113; Heneine W, 2006, TRANSFUSION, V46, P1276, DOI 10.1111/j.1537-2995.2006.00925.x; HUGON J, 1990, J NEUROL NEUROSUR PS, V53, P269, DOI 10.1136/jnnp.53.3.269; Hussain AI, 2003, VIROLOGY, V309, P248, DOI 10.1016/S0042-6822(03)00070-9; Johnson JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000638; Jones-Engel L, 2008, EMERG INFECT DIS, V14, P1200, DOI 10.3201/eid1408.071430; Kaplan JE, 1996, J ACQ IMMUN DEF SYND, V12, P193, DOI 10.1097/00042560-199606010-00014; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keele BF, 2009, NATURE, V460, P515, DOI 10.1038/nature08200; Kwaan N, 2006, J INFECT DIS, V194, P1557, DOI 10.1086/508899; LeBreton M, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.7; Leendertz SAJ, 2010, J VIROL, V84, P7427, DOI 10.1128/JVI.00697-10; Lezin A, 2005, J INFECT DIS, V191, P1830, DOI 10.1086/429962; Liegeois F, 2008, VIROLOGY, V371, P405, DOI 10.1016/j.virol.2007.09.037; Locatelli S, 2012, AIDS, V26, P659, DOI 10.1097/QAD.0b013e328350fb68; MCCARTHY TJ, 1990, LAB ANIM SCI, V40, P79; McNulty A, 2007, J CLIN MICROBIOL, V45, P517, DOI 10.1128/JCM.02016-06; Meertens L, 2001, VIROLOGY, V287, P275, DOI 10.1006/viro.2001.1018; Moens B, 2009, J CLIN MICROBIOL, V47, P3682, DOI 10.1128/JCM.00781-09; Mouinga-Ondeme A, 2012, J VIROL, V86, P1255, DOI 10.1128/JVI.06016-11; Murray SM, 2006, J MED PRIMATOL, V35, P225, DOI 10.1111/j.1600-0684.2006.00171.x; Murray SM, 2006, J VIROL, V80, P663, DOI 10.1128/JVI.80.2.663-670.2006; Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225; NKENGASONG JN, 1995, J MED VIROL, V47, P278, DOI 10.1002/jmv.1890470315; OUATTARA SA, 1989, J ACQ IMMUN DEF SYND, V2, P481; Peeters M, 2002, EMERG INFECT DIS, V8, P451, DOI 10.3201/eid0805.010522; Refisch J, 2005, BIOTROPICA, V37, P136, DOI 10.1111/j.1744-7429.2005.03174.x; Rua R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077072; Schiffer C, 2004, J VIROL, V78, P11405, DOI 10.1128/JVI.78.20.11405-11410.2004; Schweizer M, 1997, J VIROL, V71, P4821, DOI 10.1128/JVI.71.6.4821-4824.1997; Sela I, 2015, NUCLEIC ACIDS RES, V43, pW7, DOI 10.1093/nar/gkv318; Sharp Paul M, 2010, Philos Trans R Soc Lond B Biol Sci, V365, P2487, DOI 10.1098/rstb.2010.0031; Silva MTT, 2007, CLIN INFECT DIS, V44, P689, DOI 10.1086/510679; Sintasath DM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-97; Sintasath DM, 2009, EMERG INFECT DIS, V15, P175, DOI 10.3201/eid1502.080584; Smith KM, 2012, PLOS ONE, V7, P71, DOI 10.1371/journal.pone.0029505; Switzer W, 2011, RETROVIROLOGY, V8, pA233, DOI DOI 10.1186/1742-4690-8-S1-A233; Switzer W. M., 2011, MOL DETECTION HUMAN, V1, P131; Switzer WM, 2008, J INFECT DIS, V197, P1389, DOI 10.1086/587493; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Switzer WM, 2004, J VIROL, V78, P2780, DOI 10.1128/JVI.78.6.2780-2789.2004; SWITZER WM, 1995, J VIROL, V69, P621, DOI 10.1128/JVI.69.2.621-632.1995; Switzer WM, 2001, TRANSPLANTATION, V71, P959, DOI 10.1097/00007890-200104150-00022; Takenouchi N, 2003, J NEUROVIROL, V9, P29, DOI 10.1080/13550280390173418; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ureta-Vidal A, 1999, INT J CANCER, V82, P832, DOI 10.1002/(SICI)1097-0215(19990909)82:6&lt;832::AID-IJC11&gt;3.0.CO;2-P; VERDIER M, 1989, J INFECT DIS, V160, P363, DOI 10.1093/infdis/160.3.363; VERDIER M, 1990, J INFECT DIS, V161, P1309, DOI 10.1093/infdis/161.6.1309; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; Wolfe ND, 2006, EMERG INFECT DIS, P139; Woolhouse MEJ, 2002, TRENDS MICROBIOL, V10, pS3, DOI 10.1016/S0966-842X(02)02428-9; Yamano Y, 2002, BLOOD, V99, P88, DOI 10.1182/blood.V99.1.88	75	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157709	10.1371/journal.pone.0157709	http://dx.doi.org/10.1371/journal.pone.0157709			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310836	Green Published, gold			2022-12-26	WOS:000378029800128
J	Fleet, A; Lee, JPY; Tamachi, A; Javeed, I; Hamel, PA				Fleet, Andrew; Lee, Jennifer P. Y.; Tamachi, Aaliya; Javeed, Imaan; Hamel, Paul A.			Activities of the Cytoplasmic Domains of Patched-1 Modulate but Are Not Essential for the Regulation of Canonical Hedgehog Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; cilia; Hedgehog signaling pathway; oligomerization; sonic hedgehog (SHH); Patched-1; Smoothened	CELL-CYCLE PROGRESSION; TUMOR-SUPPRESSOR GENE; SONIC HEDGEHOG; MESENCHYMAL DYSPLASIA; DROSOPHILA SEGMENT; PRIMARY CILIUM; MAMMARY-GLAND; HUMAN HOMOLOG; RECEPTOR; PROTEIN	The Hedgehog (Hh) pathway is a highly conserved signaling cascade crucial for cell fate determination during embryogenesis. Response to the Hh ligands is mediated by the receptor Patched-1 (Ptch1), a 12-pass transmembrane glycoprotein. Despite its essential role in Hh signaling and its activity as a tumor suppressor, Ptch1 remains largely uncharacterized. We demonstrate here that Ptch1 binds to itself to form oligomeric structures. Oligomerization is mediated by two distinct, structurally disordered, intracellular domains spanning amino acids 584-734 (middle loop) and 1162-1432 (C terminus). However, oligomerization is not required for Ptch1-dependent regulation of the canonical Hh pathway operating through Smo. Expression of a mutant protein that deletes both regions represses the Hh pathway and responds to the addition of Hh ligand independent of its inability to bind other factors such as Smurf2. Additionally, deletion of the cytoplasmic middle loop domain generates a Ptch1 mutant that, despite binding to Hh ligand, constitutively suppresses Hh signaling and increases the length of primary cilia. Constitutive activity because of deletion of this region is reversed by further deletion of specific sequences in the cytoplasmic C-terminal domain. These data reveal an interaction between the cytoplasmic domains of Ptch1 and that these domains modulate Ptch1 activity but are not essential for regulation of the Hh pathway.	[Fleet, Andrew; Lee, Jennifer P. Y.; Tamachi, Aaliya; Javeed, Imaan; Hamel, Paul A.] Univ Toronto, Dept Lab Med & Pathobiol, Fac Med, 1 Kings Coll Cir, Toronto, ON M5S 1A8, Canada	University of Toronto	Hamel, PA (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Fac Med, 1 Kings Coll Cir, Toronto, ON M5S 1A8, Canada.	paul.hamel@utoronto.ca			Canadian Institutes of Health Research [MOP-97929]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-97929 (to P. A. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adolphe C, 2006, CANCER RES, V66, P2081, DOI 10.1158/0008-5472.CAN-05-2146; Adolphe C, 2014, J INVEST DERMATOL, V134, P1981, DOI 10.1038/jid.2014.63; Alfaro AC, 2014, DEVELOPMENT, V141, P3331, DOI 10.1242/dev.110056; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; Bhattacharya R, 2008, CLIN CANCER RES, V14, P7659, DOI 10.1158/1078-0432.CCR-08-1414; Braun S, 2012, CANCER BIOL THER, V13, P487, DOI 10.4161/cbt.19591; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chang H, 2012, DEV BIOL, V370, P187, DOI 10.1016/j.ydbio.2012.07.027; Chang H, 2010, INT J BIOCHEM CELL B, V42, P1462, DOI 10.1016/j.biocel.2010.04.016; Chen XLL, 2014, MOL CELL BIOL, V34, P3855, DOI 10.1128/MCB.00960-14; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 1998, DEVELOPMENT, V125, P4943; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Hahn H, 1996, J BIOL CHEM, V271, P12125, DOI 10.1074/jbc.271.21.12125; Harvey MC, 2014, J BIOL CHEM, V289, P10939, DOI 10.1074/jbc.M113.514844; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; HIDALGO A, 1990, DEVELOPMENT, V110, P291; Holtz AM, 2013, DEVELOPMENT, V140, P3423, DOI 10.1242/dev.095083; Huang SJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001721; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kim J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5622; Li Z, 2008, INT J BIOL SCI, V4, P29; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Makino S, 2001, DEV BIOL, V239, P95, DOI 10.1006/dbio.2001.0419; Milenkovic L, 1999, DEVELOPMENT, V126, P4431; Motoyama J, 1998, NAT GENET, V18, P104, DOI 10.1038/ng0298-104; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; Nieuwenhuis E, 2007, DEV BIOL, V308, P547, DOI 10.1016/j.ydbio.2007.06.016; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Okolowsky N, 2014, DEV BIOL, V391, P219, DOI 10.1016/j.ydbio.2014.04.007; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Smyth I, 1999, HUM MOL GENET, V8, P291, DOI 10.1093/hmg/8.2.291; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Sweet HO, 1996, J HERED, V87, P87, DOI 10.1093/oxfordjournals.jhered.a022981; Wakabayashi Y, 2007, NATURE, V445, P761, DOI 10.1038/nature05489; Wilson CW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-102; Wilson CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005182; Wolter M, 1997, CANCER RES, V57, P2581; Yue S, 2014, ELIFE, V3, DOI 10.7554/eLife.02555; Zaphiropoulos PG, 1999, CANCER RES, V59, P787; Zhulyn O, 2015, DEV BIOL, V397, P191, DOI 10.1016/j.ydbio.2014.10.023	48	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17557	17568		10.1074/jbc.M116.731745	http://dx.doi.org/10.1074/jbc.M116.731745			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27325696	hybrid, Green Published			2022-12-26	WOS:000383241300008
J	Koyama, A; Hashimoto, M; Tanaka, H; Fujise, N; Matsushita, M; Miyagawa, Y; Hatada, Y; Fukuhara, R; Hasegawa, N; Todani, S; Matsukuma, K; Kawano, M; Ikeda, M				Koyama, Asuka; Hashimoto, Mamoru; Tanaka, Hibiki; Fujise, Noboru; Matsushita, Masateru; Miyagawa, Yusuke; Hatada, Yutaka; Fukuhara, Ryuji; Hasegawa, Noriko; Todani, Shuji; Matsukuma, Kengo; Kawano, Michiyo; Ikeda, Manabu			Malnutrition in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Lobar Degeneration: Comparison Using Serum Albumin, Total Protein, and Hemoglobin Level	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; NEUROPSYCHIATRIC INVENTORY; NUTRITIONAL-STATUS; ASSOCIATION; MANAGEMENT; DIAGNOSIS; JAPANESE; HEALTH	Malnutrition among dementia patients is an important issue. However, the biochemical markers of malnutrition have not been well studied in this population. The purpose of this study was to compare biochemical blood markers among patients with Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and frontotemporal lobar degeneration (FTLD). A total of 339 dementia outpatients and their family caregivers participated in this study. Low serum albumin was 7.2 times more prevalent among patients with DLB and 10.1 times more prevalent among those with FTLD than among those with AD, with adjustment for age. Low hemoglobin was 9.1 times more common in female DLB patients than in female AD patients, with adjustment for age. The levels of biochemical markers were not significantly correlated with cognitive function. Family caregivers of patients with low total protein, low albumin, or low hemoglobin were asked if the patients had loss of weight or appetite; 96.4% reported no loss of weight or appetite. In conclusion, nutritional status was worse in patients with DLB and FTLD than in those with AD. A multidimensional approach, including blood testing, is needed to assess malnutrition in patients with dementia.	[Koyama, Asuka; Hashimoto, Mamoru; Tanaka, Hibiki; Fujise, Noboru; Matsushita, Masateru; Miyagawa, Yusuke; Hatada, Yutaka; Fukuhara, Ryuji; Hasegawa, Noriko; Todani, Shuji; Matsukuma, Kengo; Ikeda, Manabu] Kumamoto Univ, Fac Life Sci, Dept Neuropsych, Kumamoto, Japan; [Kawano, Michiyo] Shokei Univ, Fac Human Life Sci, Kumamoto, Japan	Kumamoto University	Koyama, A (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Neuropsych, Kumamoto, Japan.	asuka@fc.kuh.kumamoto-u.ac.jp		koyama, Asuka/0000-0002-4559-1460	Japan Society for the Promotion of Science (JSPS) (KAKENHI) [26780306]; Grants-in-Aid for Scientific Research [26461750] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant provided by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) Grant Number 26780306 (Grant-in-Aid for Young Scientists (B)), http://www.jsps.go.jp/english/e-grants/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagiakrishnan K, 2013, ARCH GERONTOL GERIAT, V56, P1, DOI 10.1016/j.archger.2012.04.011; Alzheimer's Disease International (Producer), 2014, NUTR DEM; APA, 1987, DIAGN STAT MAN MENT, V3rd; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Chen L-L, J CLIN NURS IN PRESS; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Droogsma E, 2013, J NUTR HEALTH AGING, V17, P606, DOI 10.1007/s12603-013-0032-9; Faxen-Irving G, 2014, DEMENT GER COGN D EX, V4, P65, DOI 10.1159/000360415; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Greene K A, 1991, J Arthroplasty, V6, P321, DOI 10.1016/S0883-5403(06)80183-X; Guigoz Y, 1996, NUTR REV, V54, pS59; Ikeda M, 2002, J NEUROL NEUROSUR PS, V73, P371, DOI 10.1136/jnnp.73.4.371; Kai K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133666; Malara A, 2014, CLIN INTERV AGING, V9, P105, DOI 10.2147/CIA.S54611; Matsumoto Naomi, 2006, Brain and Nerve (Tokyo), V58, P785; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Michelakos T, 2013, J AGING HEALTH, V25, P589, DOI 10.1177/0898264313482488; Moore E, 2012, INT PSYCHOGERIATR, V24, P541, DOI 10.1017/S1041610211002511; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Roque M, 2013, J NUTR HEALTH AGING, V17, P295, DOI 10.1007/s12603-012-0401-9; Rullier L, 2013, INT J GERIATR PSYCH, V28, P580, DOI 10.1002/gps.3862; Sagawa M, 2011, GERIATR GERONTOL INT, V11, P63, DOI 10.1111/j.1447-0594.2010.00641.x; Saka B, 2010, CLIN NUTR, V29, P745, DOI 10.1016/j.clnu.2010.04.006; Shinagawa S, 2009, INT PSYCHOGERIATR, V21, P520, DOI 10.1017/S1041610209008631; Taniguchi Y, 2014, J GERONTOL A-BIOL, V69, P1276, DOI 10.1093/gerona/glt286	27	16	18	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157053	10.1371/journal.pone.0157053	http://dx.doi.org/10.1371/journal.pone.0157053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336725	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200008
J	Mojica, EK; Watts, BD; Turrin, CL				Mojica, Elizabeth K.; Watts, Bryan D.; Turrin, Courtney L.			Utilization Probability Map for Migrating Bald Eagles in Northeastern North America: A Tool for Siting Wind Energy Facilities and Other Flight Hazards	PLOS ONE			English	Article							BIRD MORTALITY; GOLDEN EAGLES; COLLISION; RISK; MOVEMENT; RAPTORS; FARMS; SEX	Collisions with anthropogenic structures are a significant and well documented source of mortality for avian species worldwide. The bald eagle (Haliaeetus leucocephalus) is known to be vulnerable to collision with wind turbines and federal wind energy guidelines include an eagle risk assessment for new projects. To address the need for risk assessment, in this study, we 1) identified areas of northeastern North America utilized by migrating bald eagles, and 2) compared these with high wind-potential areas to identify potential risk of bald eagle collision with wind turbines. We captured and marked 17 resident and migrant bald eagles in the northern Chesapeake Bay between August 2007 and May 2009. We produced utilization distribution (UD) surfaces for 132 individual migration tracks using a dynamic Brownian bridge movement model and combined these to create a population wide UD surface with a 1 km cell size. We found eagle migration movements were concentrated within two main corridors along the Appalachian Mountains and the Atlantic Coast. Of the 3,123 wind turbines >= 100 m in height in the study area, 38% were located in UD 20, and 31% in UD 40. In the United States portion of the study area, commercially viable wind power classes overlapped with only 2% of the UD category 20 (i.e., the areas of highest use by migrating eagles) and 4% of UD category 40. This is encouraging because it suggests that wind energy development can still occur in the study area at sites that are most viable from a wind power perspective and are unlikely to cause significant mortality of migrating eagles. In siting new turbines, wind energy developers should avoid the high-use migration corridors (UD categories 20 & 40) and focus new wind energy projects on lower-risk areas (UD categories 60-100).	[Mojica, Elizabeth K.] Coll William & Mary, Ctr Conservat Biol, Williamsburg, VA USA; Virginia Commonwealth Univ, Williamsburg, VA USA; [Mojica, Elizabeth K.] EDM Int Inc, 4001 Automat Way, Ft Collins, CO USA; [Turrin, Courtney L.] Yale Univ, Dept Psychol, New Haven, CT USA	William & Mary; Virginia Commonwealth University; Yale University	Mojica, EK (corresponding author), Coll William & Mary, Ctr Conservat Biol, Williamsburg, VA USA.; Mojica, EK (corresponding author), EDM Int Inc, 4001 Automat Way, Ft Collins, CO USA.	lmojica@edmlink.com	Mojica, Elizabeth/GLS-6846-2022; Mojica, Elizabeth/K-7919-2019; Mojica, Elizabeth K/G-1504-2012	Mojica, Elizabeth/0000-0001-6941-4840; Mojica, Elizabeth K/0000-0001-6941-4840; turrin, cedric-olivier/0000-0001-7187-8070	American Wind Wildlife Institute [778361]; U.S. Fish and Wildlife Service [F14PX00564]; U.S. Army at Aberdeen Proving Ground [W91ZLK-05-D-0020]	American Wind Wildlife Institute; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); U.S. Army at Aberdeen Proving Ground	Funding for this project was provided by the American Wind Wildlife Institute, 778361 (https://awwi.org/); U.S. Fish and Wildlife Service, F14PX00564 (http://www.fws.gov/); and the U.S. Army at Aberdeen Proving Ground, W91ZLK-05-D-0020 (https://www.apg.army.mil/). The funders had no role in study design, data collection and analysis, or decision to publish. Funders provided comments during preparation of the manuscript.	American Wind Energy Association, 2014, US WIND IND 4 QUART; [Anonymous], 2013, EAGL CONS PLAN GUID; APLIC (Avian Power Line Interaction Committee), 2012, RED AV COLL POW LIN; Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Bevanger K, 1998, BIOL CONSERV, V86, P67, DOI 10.1016/S0006-3207(97)00176-6; BEVANGER K, 1994, IBIS, V136, P412, DOI 10.1111/j.1474-919X.1994.tb01116.x; BORTOLOTTI GR, 1984, J FIELD ORNITHOL, V55, P467; Brandes D, 2004, J RAPTOR RES, V38, P195; Bright J, 2008, BIOL CONSERV, V141, P2342, DOI 10.1016/j.biocon.2008.06.029; Canadian Wind Energy Association, 2008, WIND VIS 2025 POW CA; Canadian Wind Energy Association, 2014, CAN CURR INST CAP DE; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; de Lucas M, 2008, J APPL ECOL, V45, P1695, DOI 10.1111/j.1365-2664.2008.01549.x; Dennhardt AJ, 2015, ECOL MODEL, V303, P19, DOI 10.1016/j.ecolmodel.2015.02.010; Diffendorfer J. E., 2014, US GEOLOGICAL SURVEY; Drewitt AL, 2008, ANN NY ACAD SCI, V1134, P233, DOI 10.1196/annals.1439.015; Duerr AE, 2015, FUNCT ECOL, V29, P779, DOI 10.1111/1365-2435.12381; Environment Canada, 2000, CAN WIND EN ATL; Erickson W., 2002, SYNTHESIS COMP BASEL; Erickson Wallace P., 2005, U S Forest Service General Technical Report PSW, V191, P1029; ESRI, 2012, ARCMAP 10 1; Federal Aviation Administration, 2015, DIG OBST FIL THROUGH; Ferrer M, 2012, J APPL ECOL, V49, P38, DOI 10.1111/j.1365-2664.2011.02054.x; Fish Vermont and Department Wildlife, 2010, VERM BALD EAGL REC P; Friedmann H, 1950, BIRDS N MIDDLE AM 11, V50; GARCELON DK, 1985, J WILDLIFE MANAGE, V49, P595, DOI 10.2307/3801678; HUNT G., 2002, GOLDEN EAGLES PERILO; HUNT WG, 1992, J RAPTOR RES, V26, P19; Johnston NN, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00608-080212; Johnston NN, 2014, PLOS ONE, V9, DOI [10. 1371/ journal. pone. 0093030, DOI 10.1371/J0URNAL.P0NE.0093030]; Katzner TE, 2012, J APPL ECOL, V49, P1178, DOI 10.1111/j.1365-2664.2012.02185.x; Kerlinger P., 2000, AVIAN MORTALIT UNPUB; Kranstauber B., 2013, MOVE VISUALIZING ANA; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; Laing DK, 2005, J RAPTOR RES, V39, P11; Luzenski J, 2016, CONDOR, V118, P402, DOI 10.1650/CONDOR-15-55.1; MacDougall G., 1999, BALD EAGLE PRINCE ED; McClelland BR, 1994, WILDLIFE MONOGR, P125; Miller TA, 2014, CONSERV BIOL, V28, P745, DOI 10.1111/cobi.12227; Mojica EK, 2008, WILSON J ORNITHOL, V120, P304, DOI 10.1676/07-079.1; Mojica EK, 2009, J RAPTOR RES, V43, P57, DOI 10.3356/JRR-07-60.1; Nygard T, 2010, BRIT ORNITHOLOGISTS; Olendorff R. R., 1986, RAPTOR COLLISIONS UT; Pacific Northwest Laboratory, 1986, WIND EN RES ATL US; Pagel JE, 2013, J RAPTOR RES, V47, P311, DOI 10.3356/JRR-12-00019.1; Piorkowski MD, 2012, J WILDLIFE MANAGE, V76, P451, DOI 10.1002/jwmg.327; R Development Core Team, 2014, R LANG ENV STAT COMP; REN21, 2013, REN 2013 GLOB STAT R; Shaffer F, 2011, ORNITHOLOGIE, V35, P86; Short W., 2008, DOEGO1020082567; Smallwood KS, 2008, J WILDLIFE MANAGE, V72, P215, DOI 10.2193/2007-032; Smith JA, 2016, CONDOR, V118, P411, DOI 10.1650/CONDOR-15-61.1; Stocek R, 2003, TENDANCES CHEZ OISEA, V9, P21; Todd C, 2008, DELISTING BALD EAGLE; United States Department of Energy Wind Vision, 2015, NEW ERA WIND POW US; United States Fish and Wildlife Service, 2012, LAND BAS EN GUID; US Fish and Wildlife Service (USFWS), 2009, FIN ENV ASS PROP PER; Watts BD, 2007, WATERBIRDS, V30, P25, DOI 10.1675/1524-4695(2007)030[0025:SDATFO]2.0.CO;2; Watts BD, 2015, J WILDLIFE MANAGE, V79, P435, DOI 10.1002/jwmg.853	59	12	12	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157807	10.1371/journal.pone.0157807	http://dx.doi.org/10.1371/journal.pone.0157807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336482	gold, Green Published, Green Submitted			2022-12-26	WOS:000378389200050
J	Adami, F; Figueiredo, FWD; Paiva, LD; de Sa, TH; Santos, EFD; Martins, BL; Valenti, VE; de Abreu, LC				Adami, Fernando; dos Santos Figueiredo, Francisco Winter; Paiva, Laercio da Silva; de Sa, Thiago Herick; de Sousa Santos, Edige Felipe; Martins, Bruno Luis; Valenti, Vitor Engracia; de Abreu, Luiz Carlos			Mortality and Incidence of Hospital Admissions for Stroke among Brazilians Aged 15 to 49 Years between 2008 and 2012	PLOS ONE			English	Article							CASE-FATALITY RATES; DECLINE; SYSTEM; HEALTH	Introduction The objective was to analyze rates of stroke-related mortality and incidence of hospital admissions in Brazilians aged 15 to 49 years according to region and age group between 2008 and 2012. Methods Secondary analysis was performed in 2014 using data from the Hospital and Mortality Information Systems and the Brazilian Institute of Geography and Statistics. Stroke was defined by ICD, 10th revision (I60-I64). Crude and standardized mortality (WHO reference) and incidence of hospital admissions per 100,000 inhabitants, stratified by region and age group, were estimated. Absolute and relative frequencies; and linear regression were also used. The software used was Stata 11.0. Results There were 35,005 deaths and 131,344 hospital admissions for stroke in Brazilians aged 15-49 years old between 2008 and 2012. Mortality decreased from 7.54 (95% CI 7.53; 7.54) in 2008 to 6.32 (95% CI 6.31; 6.32) in 2012 (beta = -0.27, p = 0.013, r(2) = 0.90). During the same time, incidence of hospital admissions stabilized: 24.67 (95% CI 24.66; 24.67) in 2008 and 25.11 (95% CI 25.10; 25.11) in 2012 (beta = 0.09, p = 0.692, r(2) = 0.05). There was a reduction in mortality in all Brazilian regions and in the age group between 30 and 49 years. Incidence of hospitalizations decreased in the South, but no significant decrease was observed in any age group. Conclusion We observed a decrease in stroke-related mortality, particularly in individuals over 30 years old, and stability of the incidence of hospitalizations; and also regional variation in stroke-related hospital admission incidence and mortality among Brazilian young adults.	[Adami, Fernando; dos Santos Figueiredo, Francisco Winter; Paiva, Laercio da Silva; de Sousa Santos, Edige Felipe; Martins, Bruno Luis; de Abreu, Luiz Carlos] Fac Med ABC, Lab Epidemiol & Anal Dados, Dept Saude Coletividade, Santo Andre, SP, Brazil; [Adami, Fernando; dos Santos Figueiredo, Francisco Winter; Paiva, Laercio da Silva; de Sousa Santos, Edige Felipe; de Abreu, Luiz Carlos] Fac Med ABC, Lab Delineamento Estudos & Escrita Cient, Dept Saude Coletividade, Santo Andre, SP, Brazil; [de Sousa Santos, Edige Felipe] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, BR-01255 Sao Paulo, SP, Brazil; [de Sa, Thiago Herick] Univ Sao Paulo, Fac Saude Publ, Dept Nutr, Sao Paulo, SP, Brazil; [de Sousa Santos, Edige Felipe] Fac Leao Sampaio, Unidade Saude, Juazeiro De Norte, Ceara, Brazil; [Valenti, Vitor Engracia] Univ Estadual Paulista, Fac Filosofia & Ciencias, Dept Fonoaudiol, Marilia, SP, Brazil	Faculdade de Medicina do ABC; Faculdade de Medicina do ABC; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista	Adami, F (corresponding author), Fac Med ABC, Lab Epidemiol & Anal Dados, Dept Saude Coletividade, Santo Andre, SP, Brazil.; Adami, F (corresponding author), Fac Med ABC, Lab Delineamento Estudos & Escrita Cient, Dept Saude Coletividade, Santo Andre, SP, Brazil.	fernando.adami@fmabc.br	de Abreu, Luiz Carlos/AAL-8219-2021; Valenti, Vitor E/C-1968-2012; Paiva, Laércio S/B-3190-2015; Valenti, Vitor Engracia/Q-6355-2019; de Abreu, Luiz Carlos/B-7873-2012; Figueiredo, Winter/A-7152-2015; Adami, Fernando/D-3855-2012; Sa, Thiago Herick de/N-1952-2015	de Abreu, Luiz Carlos/0000-0002-7618-2109; Valenti, Vitor E/0000-0001-7477-3805; Paiva, Laércio S/0000-0003-3646-2621; de Abreu, Luiz Carlos/0000-0002-7618-2109; Figueiredo, Winter/0000-0002-9377-6443; Adami, Fernando/0000-0003-1918-3364; Sa, Thiago Herick de/0000-0002-9348-4483	Foundation for Research of the State of Sao Paulo - FAPESP [2013/08943-1]	Foundation for Research of the State of Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Foundation for Research of the State of Sao Paulo - FAPESP (reference number No: 2013/08943-1). The funders had the role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre C, 2006, STROKE, V37, P2784, DOI 10.1161/01.STR.0000244768.46566.73; Bensenor IM, 2015, ARQ NEURO-PSIQUIAT, V73, P746, DOI 10.1590/0004-282X20150115; Cabral NL, 2009, J NEUROL NEUROSUR PS, V80, P749, DOI 10.1136/jnnp.2008.164475; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Figueiroa BD, 2013, CAD SAUDE PUBLICA, V29, P475, DOI 10.1590/S0102-311X2013000300006; Garritano CR, 2012, ARQ BRAS CARDIOL, V98, P519, DOI 10.1590/S0066-782X2012005000041; George Mary G, 2011, Ann Neurol, V70, P713, DOI 10.1002/ana.22539; IPEA, ATL DES HUM BRAS; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; Lotufo Paulo Andrade, 2005, Sao Paulo Med. J., V123, P3; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Minelli C, 2007, STROKE, V38, P2906, DOI 10.1161/STROKEAHA.107.484139; Ministerio da Saude do Brasil, 2013, COORD GER INF MORT S, P0; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Putaala J, 2012, STROKE, V43, P2624, DOI 10.1161/STROKEAHA.112.662866; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Smajlovic D, 2015, VASC HEALTH RISK MAN, V11, P157, DOI 10.2147/VHRM.S53203; Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X; World Health Organization, 2007, INT CLASS DIS	21	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0152739	10.1371/journal.pone.0152739	http://dx.doi.org/10.1371/journal.pone.0152739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332892	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212800002
J	Heng, YJJ; Pennell, CE; McDonald, SW; Vinturache, AE; Xu, JX; Lee, MWF; Briollais, L; Lyon, AW; Slater, DM; Bocking, AD; de Koning, L; Olson, DM; Dolan, SM; Tough, SC; Lye, SJ				Heng, Yujing J.; Pennell, Craig E.; McDonald, Sheila W.; Vinturache, Angela E.; Xu, Jingxiong; Lee, Mary W. F.; Briollais, Laurent; Lyon, Andrew W.; Slater, Donna M.; Bocking, Alan D.; de Koning, Lawrence; Olson, David M.; Dolan, Siobhan M.; Tough, Suzanne C.; Lye, Stephen J.			Maternal Whole Blood Gene Expression at 18 and 28 Weeks of Gestation Associated with Spontaneous Preterm Birth in Asymptomatic Women	PLOS ONE			English	Article							HUMAN FETAL MEMBRANES; SHORT CERVIX; VAGINAL PROGESTERONE; LEUKOCYTE DENSITY; PERIPHERAL-BLOOD; PREGNANT-WOMEN; DOUBLE-BLIND; RISK; FIBRONECTIN; LABOR	The heterogeneity of spontaneous preterm birth (SPTB) requires an interdisciplinary approach to determine potential predictive risk factors of early delivery. The aim of this study was to investigate maternal whole blood gene expression profiles associated with spontaneous preterm birth (SPTB, <37 weeks) in asymptomatic pregnant women. The study population was a matched subgroup of women (51 SPTBs, 114 term delivery controls) who participated in the All Our Babies community based cohort in Calgary (n = 1878). Maternal blood at 17-23 (sampling time point 1, T-1) and 27-33 weeks of gestation (T-2) were collected. Total RNA was extracted and microarray was performed on 326 samples (165 women). Univariate analyses determined significant clinical factors and differential gene expression associated with SPTB. Thirteen genes were validated using qRT-PCR. Three multivariate logistic models were constructed to identify gene expression at T-1 (Model A), T-2 (Model B), and gene expression fold change from T-1 to T-2 (Model C) associated with SPTB. All models were adjusted for clinical factors. Model C can predict SPTB with 65% sensitivity and 88% specificity in asymptomatic women after adjusting for history of abortion and anaemia (occurring before T-2). Clinical data enhanced the sensitivity of the Models to predict SPTB. In conclusion, clinical factors and whole blood gene expression are associated with SPTB in asymptomatic women. An effective screening tool for SPTB during pregnancy would enable targeted preventive approaches and personalised antenatal care.	[Heng, Yujing J.; Xu, Jingxiong; Lee, Mary W. F.; Briollais, Laurent; Bocking, Alan D.; Lye, Stephen J.] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Dept Obstet & Gynaecol, Toronto, ON M5G 1X5, Canada; [Heng, Yujing J.; Xu, Jingxiong; Lee, Mary W. F.; Briollais, Laurent; Bocking, Alan D.; Lye, Stephen J.] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Dept Physiol, Toronto, ON M5G 1X5, Canada; [Heng, Yujing J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Crawley, WA, Australia; [McDonald, Sheila W.; Vinturache, Angela E.; Slater, Donna M.; de Koning, Lawrence; Tough, Suzanne C.] Univ Calgary, Dept Paediat, Cumming Sch Med, Calgary, AB T2N 1N4, Canada; [Vinturache, Angela E.; Slater, Donna M.] Univ Calgary, Dept Obstet & Gynaecol, Cumming Sch Med, Calgary, AB, Canada; [Vinturache, Angela E.; Slater, Donna M.] Univ Calgary, Dept Physiol & Pharmacol, Cumming Sch Med, Calgary, AB, Canada; [Xu, Jingxiong; Briollais, Laurent] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5G 1X5, Canada; [Lyon, Andrew W.] Univ Saskatchewan, St Pauls Hosp, Dept Pathol & Lab Med, Saskatoon Hlth Reg, Saskatoon, SK, Canada; [de Koning, Lawrence] Calgary Lab Serv, Calgary, AB, Canada; [de Koning, Lawrence; Tough, Suzanne C.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Olson, David M.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Olson, David M.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Olson, David M.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Dolan, Siobhan M.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth Reprod Genet, Bronx, NY 10467 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Western Australia; University of Calgary; University of Calgary; University of Calgary; University of Toronto; St. Paul's Hospital; University of Saskatchewan; University of Calgary; University of Calgary; University of Alberta; University of Alberta; University of Alberta; Yeshiva University; Albert Einstein College of Medicine	Heng, YJJ (corresponding author), Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Dept Obstet & Gynaecol, Toronto, ON M5G 1X5, Canada.; Heng, YJJ (corresponding author), Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Dept Physiol, Toronto, ON M5G 1X5, Canada.; Heng, YJJ (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA.	yheng@bidmc.harvard.edu	Briollais, Laurent/A-2941-2013; Pennell, Craig/ABD-6902-2020; Lye, Stephen J/E-7269-2013	Pennell, Craig/0000-0002-0937-6165; Lye, Stephen J/0000-0002-3305-4406; Heng, Yu Jing Jan/0000-0002-8930-817X; Dolan, Siobhan/0000-0001-8890-8045	Alberta Innovates Health Solutions [200700595]; Global Alliance to Prevent Prematurity and Stillbirth (GAPPS award) [12006]; Canadian Institutes of Health Fellowship; Calgary Laboratory Services	Alberta Innovates Health Solutions; Global Alliance to Prevent Prematurity and Stillbirth (GAPPS award); Canadian Institutes of Health Fellowship; Calgary Laboratory Services	This work was supported by Alberta Innovates Health Solutions (Interdisciplinary Team Grant #200700595) and Global Alliance to Prevent Prematurity and Stillbirth (GAPPS award #12006). YJH was supported by a Canadian Institutes of Health Fellowship. Calgary Laboratory Services provided support in the form of salary for LdK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DS, 2015, OBSTET GYNECOL, V125, P1168, DOI 10.1097/AOG.0000000000000754; Alfirevic Z, 2013, ULTRASOUND OBST GYN, V41, P146, DOI 10.1002/uog.12300; Baig SA, 2013, J PAK MED ASSOC, V63, P414; Berghella V, 2005, OBSTET GYNECOL, V106, P181, DOI 10.1097/01.AOG.0000168435.17200.53; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Care AG, 2014, ULTRASOUND OBST GYN, V43, P681, DOI 10.1002/uog.13241; da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; DeFranco EA, 2007, ULTRASOUND OBST GYN, V30, P697, DOI 10.1002/uog.5159; Dekker GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039154; Duhig KE, 2009, BJOG-INT J OBSTET GY, V116, P799, DOI 10.1111/j.1471-0528.2009.02137.x; Enquobahrie DA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-56; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Fortunato SJ, 2003, PLACENTA, V24, P922, DOI 10.1016/S0143-4004(03)00160-7; Friebe-Hoffmann U, 2001, AM J REPROD IMMUNOL, V46, P226, DOI 10.1034/j.1600-0897.2001.d01-6.x; Gilbert Nicole M, 2013, Glob Adv Health Med, V2, P59, DOI 10.7453/gahmj.2013.061; Goya M, 2012, LANCET, V379, P1800, DOI 10.1016/S0140-6736(12)60030-0; Gracie SK, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-87; Heng YJ, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00151; Heng YJJ, 2015, J PROTEOME RES, V14, P457, DOI 10.1021/pr500852p; Heng YJJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096901; Honest H, 2002, BMJ-BRIT MED J, V325, P301, DOI 10.1136/bmj.325.7359.301; Howson CP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S1; Hutzal CE, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.008; Institute of Medicine (US), 2007, PRETERM BIRTH CAUSES; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johansson AM, 2014, DEV PSYCHOBIOL; KENNARD EA, 1995, AM J REPROD IMMUNOL, V34, P65, DOI 10.1111/j.1600-0897.1995.tb00920.x; Kuhrt K, 2016, ULTRASOUND OBST GYN, V47, P104, DOI 10.1002/uog.14865; Leung BMY, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-149; Liggins G. C., 1989, CERVIX PREGNANCY LAB, P1; Makhlouf MA, 2014, AM J PERINAT, V31, P765, DOI 10.1055/s-0033-1358771; Martin JA, 2013, NAT VITAL STAT REP, V62; McDonald SW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S2; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Menon R, 2011, REPROD SCI, V18, P1046, DOI 10.1177/1933719111415548; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Osman I, 2006, J SOC GYNECOL INVEST, V13, P97, DOI 10.1016/j.jsgi.2005.12.002; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Pennell CE, 2007, AM J OBSTET GYNECOL, V196, P107, DOI 10.1016/j.ajog.2006.03.109; Public Health Agency of Canada, 2012, PER HLTH IND CAN 201; Raisanen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060660; Rauk PN, 2000, AM J REPROD IMMUNOL, V43, P152, DOI 10.1111/j.8755-8920.2000.430304.x; ROMERO R, 1989, PROSTAGLANDINS, V37, P13, DOI 10.1016/0090-6980(89)90028-2; Schmitz T, 2003, MOL HUM REPROD, V9, P1, DOI 10.1093/molehr/gag007; Simcox R, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.03.010; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Treyvaud K, 2014, J PEDIATR-US, V164, P515, DOI 10.1016/j.jpeds.2013.11.001; ULMSTEN U, 1982, OBSTET GYNECOL, V59, P336; van den Broek NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090128; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Watari M, 1999, AM J PATHOL, V154, P1755, DOI 10.1016/S0002-9440(10)65431-4; Word RA, 2007, SEMIN REPROD MED, V25, P69, DOI 10.1055/s-2006-956777; Yi SW, 2013, EUR J CLIN NUTR, V67, P337, DOI 10.1038/ejcn.2013.12; Yuan M, 2009, MOL HUM REPROD, V15, P713, DOI 10.1093/molehr/gap054	59	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0155191	10.1371/journal.pone.0155191	http://dx.doi.org/10.1371/journal.pone.0155191			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333071	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212800004
J	Karabulut, NP; Frishman, D				Karabulut, Nermin Pinar; Frishman, Dmitrij			Sequence- and Structure-Based Analysis of Tissue-Specific Phosphorylation Sites	PLOS ONE			English	Article							PROTEIN-PHOSPHORYLATION; PREDICTION; SUBSTRATE; DATABASE; IDENTIFICATION; FRAMEWORK; DISORDER; KINASES; MOTIFS; DOMAIN	Phosphorylation is the most widespread and well studied reversible posttranslational modification. Discovering tissue-specific preferences of phosphorylation sites is important as phosphorylation plays a role in regulating almost every cellular activity and disease state. Here we present a comprehensive analysis of global and tissue-specific sequence and structure properties of phosphorylation sites utilizing recent proteomics data. We identified tissue-specific motifs in both sequence and spatial environments of phosphorylation sites. Target site preferences of kinases across tissues indicate that, while many kinases mediate phosphorylation in all tissues, there are also kinases that exhibit more tissue-specific preferences which, notably, are not caused by tissue-specific kinase expression. We also demonstrate that many metabolic pathways are differentially regulated by phosphorylation in different tissues.	[Karabulut, Nermin Pinar; Frishman, Dmitrij] Tech Univ Munich, Dept Genome Oriented Bioinformat, Freising Weihenstephan, Germany; [Frishman, Dmitrij] German Res Ctr Environm Hlth GmbH, Inst Bioinformat & Syst Biol, Helmholtz Zentrum Munich, Neuherberg, Germany; [Frishman, Dmitrij] St Petersburg State Polytech Univ, St Petersburg, Russia	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Peter the Great St. Petersburg Polytechnic University	Frishman, D (corresponding author), Tech Univ Munich, Dept Genome Oriented Bioinformat, Freising Weihenstephan, Germany.; Frishman, D (corresponding author), German Res Ctr Environm Hlth GmbH, Inst Bioinformat & Syst Biol, Helmholtz Zentrum Munich, Neuherberg, Germany.; Frishman, D (corresponding author), St Petersburg State Polytech Univ, St Petersburg, Russia.	d.frishman@wzw.tum.de	Frishman, Dmitrij/AAT-7815-2020		TUM Graduate School's Thematic Graduate Center Regulation and Evolution of Cellular Systems (RECESS); German Research Foundation (DFG); Technische Universitat Munchen in the framework of the Open Access Publishing Program	TUM Graduate School's Thematic Graduate Center Regulation and Evolution of Cellular Systems (RECESS); German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen in the framework of the Open Access Publishing Program	This work was supported by TUM Graduate School's Thematic Graduate Center Regulation and Evolution of Cellular Systems (RECESS) at the Technische Universitaet Muenchen. Publication was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen in the framework of the Open Access Publishing Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; BAXA CA, 1989, BIOCHEMISTRY-US, V28, P8683, DOI 10.1021/bi00448a003; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Chen X, 2015, BIOINFORMATICS, V31, P194, DOI 10.1093/bioinformatics/btu598; Chen YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020025; Chen Z, 2012, BIOPHYS J, V103, P558, DOI 10.1016/j.bpj.2012.07.002; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1316s36, 10.1002/0471250953.bi1315s35]; Damle NP, 2014, BIOINFORMATICS, V30, P1730, DOI 10.1093/bioinformatics/btu112; Dang TH, 2008, BIOINFORMATICS, V24, P2857, DOI 10.1093/bioinformatics/btn546; Dou YC, 2014, AMINO ACIDS, V46, P1459, DOI 10.1007/s00726-014-1711-5; Durek P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-117; Fan WW, 2014, AMINO ACIDS, V46, P1069, DOI 10.1007/s00726-014-1669-3; Gao JJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S9; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hubbard S. J., 1993, NACCESS COMPUTER PRO; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Kaji H, 2012, J PROTEOME RES, V11, P4553, DOI 10.1021/pr300346c; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karabulut NP, 2015, J STRUCT BIOL, V191, P39, DOI 10.1016/j.jsb.2015.06.001; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kobe B, 2005, BBA-PROTEINS PROTEOM, V1754, P200, DOI 10.1016/j.bbapap.2005.07.036; Kreegipuu A, 1998, FEBS LETT, V430, P45, DOI 10.1016/S0014-5793(98)00503-1; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; Li TT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015411; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Lundby A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1871; Manni S, 2008, J BIOL CHEM, V283, P24145, DOI 10.1074/jbc.M802278200; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Roskoski R, 2015, PHARMACOL RES, V100, P1, DOI 10.1016/j.phrs.2015.07.010; Sadoul K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970382; Saunders NFW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-245; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Schwartz PA, 2011, BIOORG CHEM, V39, P192, DOI 10.1016/j.bioorg.2011.07.004; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Su MG, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S16-S2; Suo SB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04524; Suo SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049108; Team RDC, 2009, LANGUAGE ENV STAT CO; Tyanova S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002842; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; World Health Organization, MALARIA; Yao ZZ, 2014, BIOINFORMATICS, V30, P775, DOI 10.1093/bioinformatics/btt615; Zhao XA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002847	54	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157896	10.1371/journal.pone.0157896	http://dx.doi.org/10.1371/journal.pone.0157896			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332813	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212800056
J	Atsou, K; Crequit, P; Chouaid, C; Hejblum, G				Atsou, Kokuvi; Crequit, Perrine; Chouaid, Christos; Hejblum, Gilles			Simulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in France	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; ACUTE EXACERBATIONS; ECONOMIC-EVALUATION; COPD; PROGRAM; MANAGEMENT; COMMUNITY; SEVERITY; BENEFITS; SOCIETY	Background The medico-economic impact of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD) is poorly documented. Objective To estimate the effectiveness and cost-effectiveness of pulmonary rehabilitation in a hypothetical cohort of COPD patients. Methods We used a multi-state Markov model, adopting society's perspective. Simulated cohorts of French GOLD stage 2 to 4 COPD patients with and without pulmonary rehabilitation were compared in terms of life expectancy, quality-adjusted life years (QALY), disease-related costs, and the incremental cost-effectiveness ratio (ICER). Sensitivity analyses included variations of key model parameters. Principal Findings At the horizon of a COPD patient's remaining lifetime, pulmonary rehabilitation would result in mean gain of 0.8 QALY, with an over disease-related costs of 14 102 (sic) per patient. The ICER was 17 583 (sic)/QALY. Sensitivity analysis showed that pulmonary rehabilitation was cost-effective in every scenario ( ICER < 50 000 (sic)/QALY). Conclusions These results should provide a useful basis for COPD pulmonary rehabilitation programs.	[Atsou, Kokuvi; Crequit, Perrine; Hejblum, Gilles] Sorbonne Univ, INSERM, UMR S 1136, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Crequit, Perrine; Hejblum, Gilles] Univ Paris 06, Hop St Antoine, AP HP, Unite Sante Publ, Paris, France; [Chouaid, Christos] CHI Creteil, UPEC, Paris Est, GRC OncoTho,Serv Pneumol, Creteil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil	Chouaid, C (corresponding author), CHI Creteil, UPEC, Paris Est, GRC OncoTho,Serv Pneumol, Creteil, France.	christos.chouaid@chicreteil.fr	Hejblum, Gilles/N-6337-2017; Créquit, Perrine/P-2264-2017; christos, chouaid/R-4477-2018	Hejblum, Gilles/0000-0003-0127-1964; Créquit, Perrine/0000-0001-7836-0717; christos, chouaid/0000-0002-4290-5524	Organisation Pneumologique pour la Recherche et l'Amelioration des Soins (OPRAS)	Organisation Pneumologique pour la Recherche et l'Amelioration des Soins (OPRAS)	This work was supported by Organisation Pneumologique pour la Recherche et l'Amelioration des Soins (OPRAS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsou K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024870; Atsou K, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-7; Beaumont M, 2011, REV MAL RESPIR, V28, P297, DOI 10.1016/j.rmr.2010.09.034; Bratas O, 2010, Chron Respir Dis, V7, P229, DOI 10.1177/1479972310374343; Burns DK, 2016, APPL HEALTH ECON HEA, V14, P105, DOI 10.1007/s40258-015-0199-9; Cecins N, 2008, AUST HEALTH REV, V32, P415, DOI 10.1071/AH080415; Clini EM, 2009, RESP MED, V103, P1526, DOI 10.1016/j.rmed.2009.04.011; Coursier JM, 2006, REV MAL RESPIR, V267; Detournay B, 2004, VALUE HEALTH, V7, P168, DOI 10.1111/j.1524-4733.2004.72329.x; Dodd JW, 2011, THORAX, V66, P425, DOI 10.1136/thx.2010.156372; Esteban C, 2010, EUR RESPIR J, V36, P292, DOI 10.1183/09031936.00021409; Gillespie P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003479; Golmohammadi K, 2004, LUNG, V182, P187, DOI 10.1007/s00408-004-3110-2; Griffiths TL, 2001, THORAX, V56, P779, DOI 10.1136/thorax.56.10.779; Hoogendoorn M, 2010, EUR RESPIR J, V35, P79, DOI 10.1183/09031936.00043309; Hoogendoorn M, 2010, THORAX, V65, P711, DOI 10.1136/thx.2009.131631; Hui KP, 2003, CHEST, V124, P94, DOI 10.1378/chest.124.1.94; Jacobsen R, 2014, CLIN RESPIR J, V8, P321, DOI 10.1111/crj.12074; Lan CC, 2011, RESPIROLOGY, V16, P276, DOI 10.1111/j.1440-1843.2010.01895.x; Mannino DM, 2015, CHEST, V148, P138, DOI 10.1378/chest.14-2434; Mapel DW, 2000, ARCH INTERN MED, V160, P2653, DOI 10.1001/archinte.160.17.2653; Nielsen R, 2009, EUR RESPIR J, V34, P850, DOI 10.1183/09031936.00166108; Oba Y, 2007, MAYO CLIN PROC, V82, P575, DOI 10.4065/82.5.575; Peytremann-Bridevaux I, 2008, AM J MED, V121, P433, DOI 10.1016/j.amjmed.2008.02.009; Puhan M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005305.pub2; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; ReinaRosenbaum R, 1997, ARCH PHYS MED REHAB, V78, P240, DOI 10.1016/S0003-9993(97)90027-7; Roche N, 2009, REV MAL RESPIR, V26, P933, DOI 10.1016/S0761-8425(09)73328-5; Rochester CL, 2015, AM J RESP CRIT CARE, V192, P1373, DOI 10.1164/rccm.201510-1966ST; Rycroft CE, 2012, INT J CHRONIC OBSTR, V7, P457, DOI 10.2147/COPD.S32330; Seymour JM, 2010, THORAX, V65, P423, DOI 10.1136/thx.2009.124164; Singh SJ, 1998, RESP MED, V92, P1146, DOI 10.1016/S0954-6111(98)90410-3; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Spencer LM, 2010, EUR RESPIR J, V35, P571, DOI 10.1183/09031936.00073609; Stewart DG, 2001, ARCH PHYS MED REHAB, V82, P347, DOI 10.1053/apmr.2001.20838; Szende A, 2009, QUAL LIFE RES, V18, P267, DOI 10.1007/s11136-008-9429-z; Theander K, 2009, CLIN REHABIL, V23, P125, DOI 10.1177/0269215508096174; van Wetering CR, 2010, J AM MED DIR ASSOC, V11, P179, DOI 10.1016/j.jamda.2009.12.083; Vieira DSR, 2010, CURR OPIN PULM MED, V16, P134, DOI 10.1097/MCP.0b013e32833642f2; Waterhouse JC, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14060; Wilson AM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005921; Zoumot Z, 2014, THORAX, V69, P973, DOI 10.1136/thoraxjnl-2014-205667	42	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0156514	10.1371/journal.pone.0156514	http://dx.doi.org/10.1371/journal.pone.0156514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327159	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400004
J	Su, XB; Tian, XG; Jiang, ZX; Ma, Q; Liu, Q; Lu, XM; Zhou, R				Su, Xiaobo; Tian, Xingui; Jiang, Zaixue; Ma, Qiang; Liu, Qian; Lu, Xiaomei; Zhou, Rong			Human Adenovirus Serotype 3 Vector Packaged by a Rare Serotype 14 Hexon	PLOS ONE			English	Article							NEUTRALIZING ANTIBODIES TARGET; GENE-TRANSFER VECTOR; VACCINE VECTORS; HYPERVARIABLE REGIONS; DESMOSOMAL CADHERINS; NUCLEOTIDE-SEQUENCE; DESMOGLEIN 2; CONSTRUCTION; IMMUNITY; RECEPTOR	Recombinant adenovirus serotype 3 (rAd3), which infects cells through the receptor desmoglein 2 (DSG2), has been investigated as a vector for gene therapy or vaccination. However, pre-existing anti-vector immunity may limit the practical application of rAd3. In this study, we investigated the seroprevalence and neutralizing antibody (NAb) titers to Ad3 and alternate serotypes in normal healthy adults in southern China. Sera samples had a high seroprevalence (80.00%) against Ad3 and Ad7 (85.83%), compared with Ad14 (22.50%). Furthermore, 19.17% and 25.83% of samples had high-titer neutralizing antibodies to Ad3 and Ad7, respectively, compared with 3.33% against Ad14. We constructed a chimeric adenovirus, rAd3H14, designed to evade anti-vector immunity by replacing the enhanced green fluorescent protein (EGFP)-expressing hexon of the rAd3EGFP vector with a hexon from Ad14. The chimeric vector rAd3H14 was not neutralized in vitro efficiently by Ad3 NAbs using sera from mice and normal healthy human volunteers. Furthermore, in contrast to the unmodified vector rAd3EGFP, rAd3H14 induced robust antibody responses against EGFP in mice with high levels of pre-existing anti-Ad3 immunity. In conclusion, the chimeric vector rAd3H14 may be a useful alternative vector in adult populations with a high prevalence of Ad3 NAbs.	[Su, Xiaobo] Guangzhou Med Univ, Sch Basic Sci, Dept Med Genet & Cell Biol, Guangzhou 511436, Guangdong, Peoples R China; [Tian, Xingui; Zhou, Rong] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Affiliated Hosp 1, Guangzhou 510120, Guangdong, Peoples R China; [Jiang, Zaixue; Ma, Qiang; Liu, Qian; Lu, Xiaomei] Dongguan Childrens Hosp, Dongguan Inst Pediat, Dongguan 523325, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Zhou, R (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Affiliated Hosp 1, Guangzhou 510120, Guangdong, Peoples R China.	zhourong@gird.cn	Tian, Xingui/AAF-5709-2020; Tian, Xingui/AAC-3957-2021	Tian, Xingui/0000-0001-9761-6677	National Natural Science Foundation of China (NSFC) [31370194, 31570163]; Science and Technology Projects of Guangzhou [201504010032]; Dongguan City Key Program of Science and Technology [2014108101014]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Projects of Guangzhou; Dongguan City Key Program of Science and Technology	This work was supported by the National Natural Science Foundation of China (NSFC 31370194 and 31570163), Science and Technology Projects of Guangzhou (201504010032) and the Dongguan City Key Program of Science and Technology (2014108101014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (NSFC 31370194 and 31570163), Science and Technology Projects of Guangzhou (201504010032) and the Dongguan City Key Program of Science and Technology (2014108101014). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2009, J GENE MED, V11, P570, DOI 10.1002/jgm.1332; Appaiahgari MB, 2015, EXPERT OPIN BIOL TH, V15, P337, DOI 10.1517/14712598.2015.993374; Bangari DS, 2006, VACCINE, V24, P849, DOI 10.1016/j.vaccine.2005.08.101; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bradley RR, 2012, J VIROL, V86, P1267, DOI 10.1128/JVI.06165-11; Bradley RR, 2012, J VIROL, V86, P625, DOI 10.1128/JVI.06254-11; Bruder JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033920; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Capone S, 2013, EXPERT REV VACCINES, V12, P379, DOI [10.1586/erv.13.15, 10.1586/ERV.13.15]; Chitaev NA, 1997, J CELL BIOL, V138, P193, DOI 10.1083/jcb.138.1.193; CrawfordMiksza L, 1996, J VIROL, V70, P1836, DOI 10.1128/JVI.70.3.1836-1844.1996; Gall JGD, 1998, J VIROL, V72, P10260, DOI 10.1128/JVI.72.12.10260-10264.1998; Gao W, 2003, GENE THER, V10, P1941, DOI 10.1038/sj.gt.3302097; Hemminki O, 2011, CANCER GENE THER, V18, P288, DOI 10.1038/cgt.2010.79; Nan X, 2003, GENE THER, V10, P326, DOI 10.1038/sj.gt.3301903; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Pandey A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033428; Qiu HL, 2012, J VIROL, V86, P7964, DOI 10.1128/JVI.07076-11; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; Sakurai F, 2007, CURR GENE THER, V7, P229; SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103; Sirena D, 2005, VIROLOGY, V343, P283, DOI 10.1016/j.virol.2005.08.024; Stone D, 2005, J VIROL, V79, P5090, DOI 10.1128/JVI.79.8.5090-5104.2005; Stone Daniel, 2006, Biotechnol Genet Eng Rev, V22, P101; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Tian XG, 2011, VIRUS RES, V160, P214, DOI 10.1016/j.virusres.2011.06.017; Tuve S, 2006, J VIROL, V80, P12109, DOI 10.1128/JVI.01370-06; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Wang HJ, 2013, J VIROL, V87, P11346, DOI 10.1128/JVI.01825-13; Wang HJ, 2012, J VIROL, V86, P6286, DOI 10.1128/JVI.00205-12; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Wu HJ, 2002, J VIROL, V76, P12775, DOI 10.1128/JVI.76.24.12775-12782.2002; Youil R, 2002, HUM GENE THER, V13, P311, DOI 10.1089/10430340252769824; Yu B, 2013, VIROLOGY, V437, P118, DOI 10.1016/j.virol.2012.12.014; Yuan XH, 2009, VACCINE, V27, P5103, DOI 10.1016/j.vaccine.2009.06.041; Zaiss AK, 2009, J CELL BIOCHEM, V108, P778, DOI 10.1002/jcb.22328; Zhang QW, 2012, J VIROL, V86, P7019, DOI 10.1128/JVI.00814-12; Zhang QW, 2009, VACCINE, V27, P1145, DOI 10.1016/j.vaccine.2008.12.039; Zhong TH, 2012, ARCH VIROL, V157, P1709, DOI 10.1007/s00705-012-1364-1	41	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0156984	10.1371/journal.pone.0156984	http://dx.doi.org/10.1371/journal.pone.0156984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27328032	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400011
J	Marriott, AC; Dennis, M; Kane, JA; Gooch, KE; Hatch, G; Sharpe, S; Prevosto, C; Leeming, G; Zekeng, EG; Staples, KJ; Hall, G; Ryan, KA; Bate, S; Moyo, N; Whittaker, CJ; Hallis, B; Silman, NJ; Lalvani, A; Wilkinson, TM; Hiscox, JA; Stewart, JP; Carroll, MW				Marriott, Anthony C.; Dennis, Mike; Kane, Jennifer A.; Gooch, Karen E.; Hatch, Graham; Sharpe, Sally; Prevosto, Claudia; Leeming, Gail; Zekeng, Elsa-Gayle; Staples, Karl J.; Hall, Graham; Ryan, Kathryn A.; Bate, Simon; Moyo, Nathifa; Whittaker, Catherine J.; Hallis, Bassam; Silman, Nigel J.; Lalvani, Ajit; Wilkinson, Tom M.; Hiscox, Julian A.; Stewart, James P.; Carroll, Miles W.			Influenza A Virus Challenge Models in Cynomolgus Macaques Using the Authentic Inhaled Aerosol and Intra-Nasal Routes of Infection	PLOS ONE			English	Article							RESPIRATORY-TRACT; NONHUMAN-PRIMATES; AVIAN INFLUENZA; RESPONSES; HUMANS; PROTECTION; VACCINE; CELL; PATHOGENICITY; TRANSMISSION	Non-human primates are the animals closest to humans for use in influenza A virus challenge studies, in terms of their phylogenetic relatedness, physiology and immune systems. Previous studies have shown that cynomolgus macaques (Macaca fascicularis) are permissive for infection with H1N1pdm influenza virus. These studies have typically used combined challenge routes, with the majority being intra-tracheal delivery, and high doses of virus (> 107 infectious units). This paper describes the outcome of novel challenge routes (inhaled aerosol, intra-nasal instillation) and low to moderate doses (103 to 106 plaque forming units) of H1N1pdm virus in cynomolgus macaques. Evidence of virus replication and sero-conversion were detected in all four challenge groups, although the disease was subclinical. Intra-nasal challenge led to an infection confined to the nasal cavity. A low dose (103 plaque forming units) did not lead to detectable infectious virus shedding, but a 1000-fold higher dose led to virus shedding in all intra-nasal challenged animals. In contrast, aerosol and intra-tracheal challenge routes led to infections throughout the respiratory tract, although shedding from the nasal cavity was less reproducible between animals compared to the high-dose intra-nasal challenge group. Intra-tracheal and aerosol challenges induced a transient lymphopaenia, similar to that observed in influenza-infected humans, and greater virus-specific cellular immune responses in the blood were observed in these groups in comparison to the intra-nasal challenge groups. Activation of lung macrophages and innate immune response genes was detected at days 5 to 7 post-challenge. The kinetics of infection, both virological and immunological, were broadly in line with human influenza A virus infections. These more authentic infection models will be valuable in the determination of anti-influenza efficacy of novel entities against less severe (and thus more common) influenza infections.	[Marriott, Anthony C.; Dennis, Mike; Kane, Jennifer A.; Gooch, Karen E.; Hatch, Graham; Sharpe, Sally; Prevosto, Claudia; Hall, Graham; Ryan, Kathryn A.; Bate, Simon; Whittaker, Catherine J.; Hallis, Bassam; Silman, Nigel J.; Carroll, Miles W.] Publ Hlth England, Natl Infect Serv, Porton Down, Wilts, England; [Leeming, Gail; Zekeng, Elsa-Gayle; Moyo, Nathifa; Hiscox, Julian A.; Stewart, James P.] Univ Liverpool, Inst Infect & Global Hlth, Dept Infect Biol, Liverpool L69 3BX, Merseyside, England; [Staples, Karl J.; Wilkinson, Tom M.] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton, Hants, England; [Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Resp Infect, London, England; [Prevosto, Claudia] Guys Hosp, Kings Coll London, Res Oncol Dept, London SE1 9RT, England; [Bate, Simon] Def Sci & Technol Lab, Porton Down, Wilts, England	Public Health England; University of Liverpool; University of Southampton; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Defence Science & Technology Laboratory	Marriott, AC (corresponding author), Publ Hlth England, Natl Infect Serv, Porton Down, Wilts, England.	Anthony.marriott@phe.gov.uk		Ryan, Kathryn Ann/0000-0001-8608-1144; Staples, Karl/0000-0003-3844-6457; Hiscox, Julian/0000-0002-6582-0275; Marriott, Anthony/0000-0002-8862-9852; Moyo, Nathifa Adaoha/0000-0003-3203-9463; Wilkinson, Tom/0000-0003-1771-3851; Lalvani, Ajit/0000-0002-2396-246X; Stewart, James/0000-0002-8928-2037	Department of Health; Biotechnology and Biological Sciences Research Council [BB/K009664/1]; BBSRC [BB/K009664/1] Funding Source: UKRI; MRC [G0801620] Funding Source: UKRI; Medical Research Council [G0801620] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10155] Funding Source: researchfish	Department of Health; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Department of Health, grant in aid (AM), https://www.gov.uk/government/organisations/department-of-health; Biotechnology and Biological Sciences Research Council, BB/K009664/1 (JS), http://www.bbsrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Davis AS, 2015, ANTIVIR RES, V117, P75, DOI 10.1016/j.antiviral.2015.02.011; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Go JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-627; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Herfst S, 2010, VET PATHOL, V47, P1040, DOI 10.1177/0300985810374836; Huang KYA, 2014, J INFECT DIS, V209, P1354, DOI 10.1093/infdis/jit650; Huang YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002234; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Josset L, 2012, J VIROL, V86, P11115, DOI 10.1128/JVI.01571-12; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Killingley B, 2012, J INFECT DIS, V205, P35, DOI 10.1093/infdis/jir701; Kipar A, 2001, J COMP PATHOL, V125, P182, DOI 10.1053/jcpa.2001.0501; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Koopman G, 2016, J VIROL, V90, P1023, DOI 10.1128/JVI.02757-15; Kuiken T, 2003, VET PATHOL, V40, P304, DOI 10.1354/vp.40-3-304; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; Marriott AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094090; McClain MT, 2013, J CLIN VIROL, V58, P689, DOI 10.1016/j.jcv.2013.09.015; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Memoli MJ, 2015, CLIN INFECT DIS, V60, P693, DOI 10.1093/cid/ciu924; Merekoulias G, 2010, PLOS CURR, V2, DOI [10.1371/currents.rrn1154, DOI 10.1371/CURRENTS.RRN1154]; Mooij P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126132; O'Donnell CD, 2011, MICROBES INFECT, V13, P502, DOI 10.1016/j.micinf.2011.01.014; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Scherliess R, 2014, VACCINE, V32, P2231, DOI 10.1016/j.vaccine.2014.01.077; Short SJ, 2010, BIOL PSYCHIAT, V67, P965, DOI 10.1016/j.biopsych.2009.11.026; Siegers JY, 2014, J VIROL, V88, P4595, DOI 10.1128/JVI.03190-13; Skinner JA, 2014, CLIN VACCINE IMMUNOL, V21, P1668, DOI 10.1128/CVI.00547-14; Sridhar S, 2012, EUR J IMMUNOL, V42, P2913, DOI 10.1002/eji.201242504; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Staples KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121527; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; Stewart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001673; Teunis PFM, 2010, EPIDEMICS-NETH, V2, P215, DOI 10.1016/j.epidem.2010.10.001; Thompson KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056278; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Watson JM, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0240-5; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	46	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157887	10.1371/journal.pone.0157887	http://dx.doi.org/10.1371/journal.pone.0157887			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311020	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000378029800142
J	Roy, M; Pompella, A; Kubacki, J; Szade, J; Roy, RA; Hedzelek, W				Roy, Marco; Pompella, Alfonso; Kubacki, Jerzy; Szade, Jacek; Roy, Robert A.; Hedzelek, Wieslaw			Photofunctionalization of Titanium: An Alternative Explanation of Its Chemical-Physical Mechanism	PLOS ONE			English	Article							SURFACE INTERACTION; IMPLANT SURFACES; AMINO-ACIDS; ADSORPTION; ANATASE; TIO2(110); DYNAMICS; GLYCINE; MOLECULES; CYSTEINE	Objectives To demonstrate that titanium implant surfaces as little as 4 weeks from production are contaminated by atmospheric hydrocarbons. This phenomenon, also known as biological ageing can be reversed by UVC irradiation technically known as photofunctionalization. To propose a new model from our experimental evidence to explain how the changes in chemical structure of the surface will affect the adsorption of amino acids on the titanium surface enhancing osteointegration. Methods In our study XPS and AES were used to analyze the effects of UVC irradiation (photofunctionalization) in reversing biological ageing of titanium. SEM was used to analyze any possible effects on the topography of the surface. Results UVC irradiation was able to reverse biological ageing of titanium by greatly reducing the amount of carbon contamination present on the implant surface by up to 4 times, while the topography of the surface was not affected. UVC photon energy reduces surface H2O and increases TiOH with many -OH groups being produced. These groups explain the superhydrophilic effect from photofunctionalization when these groups come into contact with water. Significance Photofunctionalization has proven to be a valid method to reduce the amount of hydrocarbon contamination on titanium dental implants and improve biological results. The chemisorption mechanisms of amino acids, in our study, are dictated by the chemical structure and electric state present on the surface, but only in the presence of an also favourable geometrical composition at the atomical level.	[Roy, Marco; Hedzelek, Wieslaw] Poznan Univ Med Sci, Dept Prosthodont, Poznan, Poland; [Pompella, Alfonso] Univ Pisa, Sch Med, Dept Translat Res & New Technol Med & Surg, I-56100 Pisa, Italy; [Kubacki, Jerzy; Szade, Jacek] Silesian Univ, A Chelkowski Inst Phys, Katowice, Poland; [Kubacki, Jerzy; Szade, Jacek] Silesian Ctr Educ & Interdisciplinary Res, Chorzow, Poland	Poznan University of Medical Sciences; University of Pisa; University of Silesia in Katowice	Roy, M (corresponding author), Poznan Univ Med Sci, Dept Prosthodont, Poznan, Poland.	metalmark@hotmail.it	Kubacki, Jerzy/B-4280-2019; Szade, Jacek/W-6169-2018	Kubacki, Jerzy/0000-0001-9596-4539; Roy, Marco/0000-0002-1842-0551; Szade, Jacek/0000-0003-2083-4275				Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004; Att W, 2012, INT J ORAL MAX IMPL, V27, P753; Atta W, 2009, BIOMATERIALS, V30, P5352, DOI 10.1016/j.biomaterials.2009.06.040; Bengtsson N., 2011, APPL TITANIUM DIOXID, P5; Buddy Ratner AH, 2013, INTRO MAT MED; Carravetta V, 2006, J PHYS CHEM B, V110, P6160, DOI 10.1021/jp056760j; Carravetta V, 2009, THEOR CHEM ACC, V123, P299, DOI 10.1007/s00214-009-0513-4; Hayashi R, 2014, J DENT RES, V93, P698, DOI 10.1177/0022034514536578; Iwasa F, 2010, BIOMATERIALS, V31, P2717, DOI 10.1016/j.biomaterials.2009.12.024; Jackman MJ, 2015, J PHYS CHEM C, V119, P13682, DOI 10.1021/acs.jpcc.5b02732; John F., 1995, HDB XRAY PHOTOELECTR, P255; Kang BS, 2009, ACTA BIOMATER, V5, P2222, DOI 10.1016/j.actbio.2009.01.049; Kanie K, 2004, CHEM COMMUN, P1584, DOI 10.1039/b404220d; Kevin E., 1992, BIOMATERIALS, V13, P9; Koppen S, 2008, J PHYS CHEM C, V112, P13600, DOI 10.1021/jp803354z; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Li C, 2014, LANGMUIR, V30, P8819, DOI 10.1021/la5014973; Li C, 2012, J PHYS CHEM C, V116, P18318, DOI 10.1021/jp3060729; Monti S, 2008, LANGMUIR, V24, P3205, DOI 10.1021/la702956t; Monti S, 2015, J PHYS CHEM C, V119, P6703, DOI 10.1021/acs.jpcc.5b00932; Morra M, 2003, INT J ORAL MAX IMPL, V18, P40; Muir JMR, 2013, SURF SCI, V617, P60, DOI 10.1016/j.susc.2013.07.009; Pang CL, 2008, CHEM SOC REV, V37, P2328, DOI 10.1039/b719085a; Qiu TZ, 2006, J COLLOID INTERF SCI, V303, P229, DOI 10.1016/j.jcis.2006.07.053; Roy M., 2014, J STOMATOL CZAS STOM, V67, P682, DOI DOI 10.5604/00114553.1127421; Seah M. P., 1979, Surface and Interface Analysis, V1, P86, DOI 10.1002/sia.740010304; Steinemann SG, 1998, PERIODONTOL 2000, V17, P7, DOI 10.1111/j.1600-0757.1998.tb00119.x; Szieberth D, 2010, PHYS CHEM CHEM PHYS, V12, P11033, DOI 10.1039/c004155f; Thomas AG, 2012, CHEM SOC REV, V41, P4207, DOI 10.1039/c2cs35057b; Tonner R, 2010, CHEMPHYSCHEM, V11, P1053, DOI 10.1002/cphc.200900902; Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320	31	31	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157481	10.1371/journal.pone.0157481	http://dx.doi.org/10.1371/journal.pone.0157481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309723	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800081
J	Zhang, Y; Walter, R; Ng, P; Luong, PN; Dutt, S; Heuer, H; Rojas-Rodriguez, JC; Tsai, R; Litvan, I; Dickerson, BC; Tartaglia, MC; Rabinovici, G; Miller, BL; Rosen, HJ; Schuff, N; Boxer, AL				Zhang, Yu; Walter, Rudolph; Ng, Peter; Luong, Phi N.; Dutt, Shubir; Heuer, Hilary; Rojas-Rodriguez, Julio C.; Tsai, Richard; Litvan, Irene; Dickerson, Bradford C.; Tartaglia, Maria Carmela; Rabinovici, Gil; Miller, Bruce L.; Rosen, Howard J.; Schuff, Norbert; Boxer, Adam L.			Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study	PLOS ONE			English	Article							WHITE-MATTER; NEUROPATHOLOGIC CRITERIA; CEREBELLAR PEDUNCLE; CLINICAL-DIAGNOSIS; ALZHEIMERS-DISEASE; TASK-FORCE; MRI; ATROPHY; DISORDERS; RATES	Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) are both 4 microtubule binding repeat tauopathy related disorders. Clinical trials need new biomarkers to assess the effectiveness of tau-directed therapies. This study investigated the regional distribution of longitudinal diffusion tensor imaging changes, measured by fractional anisotropy, radial and axial diffusivity over 6 months median interval, in 23 normal control subjects, 35 patients with PSP, and 25 patients with CBS. A mixed-effects framework was used to test longitudinal changes within and between groups. Correlations between changes in diffusion variables and clinical progression were also tested. The study found that over a 6 month period and compared to controls, the most prominent changes in PSP were up to 3 +/- 1% higher rates of FA reduction predominantly in superior cerebellar peduncles, and up to 18 +/- 6% higher rates of diffusivity increases in caudate nuclei. The most prominent changes in CBS compared to controls were up to 4 +/- 1% higher rates of anisotropy reduction and 18 +/- 6% higher rates of diffusivity increase in basal ganglia and widespread white matter regions. Compared to PSP, CBS was mainly associated with up to 3 +/- 1% greater rates of anisotropy reduction around the central sulci, and 11 +/- 3% greater rates of diffusivity increase in superior fronto-occipital fascicules. Rates of diffusivity increases in the superior cerebellar peduncle correlated with rates of ocular motor decline in PSP patients. This study demonstrated that longitudinal diffusion tensor imaging measurement is a promising surrogate marker of disease progression in PSP and CBS over a relatively short period.	[Zhang, Yu; Walter, Rudolph; Ng, Peter; Schuff, Norbert] VA Med Ctr San Francisco, Ctr Imaging Neurodegenerat Dis, San Francisco, CA USA; [Zhang, Yu; Walter, Rudolph; Ng, Peter; Schuff, Norbert] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Luong, Phi N.; Dutt, Shubir; Heuer, Hilary; Rojas-Rodriguez, Julio C.; Tsai, Richard; Tartaglia, Maria Carmela; Rabinovici, Gil; Miller, Bruce L.; Rosen, Howard J.; Boxer, Adam L.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Litvan, Irene] Univ Calif San Diego, Movement Disorder Ctr, Dept Neurosci, San Diego, CA 92103 USA; [Dickerson, Bradford C.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Tartaglia, Maria Carmela] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Tartaglia, Maria Carmela] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; Harvard University; Massachusetts General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Zhang, Y (corresponding author), VA Med Ctr San Francisco, Ctr Imaging Neurodegenerat Dis, San Francisco, CA USA.; Zhang, Y (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	Yu.Zhang@ucsf.edu	Litvan, Irene/X-9319-2018; Rabinovici, Gil/AAA-2495-2020	Litvan, Irene/0000-0002-3485-3445; Zhang, Yu/0000-0001-8066-7275	National Institutes of Health [R01AG038791, R01AG032306]; Frontotemporal Lobar Degeneration Clinical Research Consortium [U54NS092089]; Tau Consortium; Veterans Affairs Medical Center, San Francisco, California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS092089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032306, K24AG045333, R01AG038791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frontotemporal Lobar Degeneration Clinical Research Consortium; Tau Consortium; Veterans Affairs Medical Center, San Francisco, California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by the National Institutes of Health grants (R01AG038791, R01AG032306); The Frontotemporal Lobar Degeneration Clinical Research Consortium (U54NS092089); Tau Consortium; and with resources of the Veterans Affairs Medical Center, San Francisco, California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MJ, 2013, NEUROLOGY, V80, P496, DOI 10.1212/WNL.0b013e31827f0fd1; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boeve BF, 2007, NEUROL CLIN, V25, P761, DOI 10.1016/j.ncl.2007.04.002; Borroni B, 2008, ARCH NEUROL-CHICAGO, V65, P796, DOI 10.1001/archneur.65.6.796; Adam L, 2013, ALZHEIMERS DEMENT, V9, P189, DOI 10.1016/j.jalz.2012.03.003; Canu E, 2011, MOVEMENT DISORD, V26, P1752, DOI 10.1002/mds.23739; Dickson Dennis W, 2008, Handb Clin Neurol, V89, P487, DOI 10.1016/S0072-9752(07)01245-6; Dickson DW, 2002, J NEUROPATH EXP NEUR, V61, P935, DOI 10.1093/jnen/61.11.935; Dutt S, 2015, NEUROLOGY, V84; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forman MS, 2002, AM J PATHOL, V160, P2045, DOI 10.1016/S0002-9440(10)61154-6; Golbe LI, 2007, BRAIN, V130, P1552, DOI 10.1093/brain/awm032; Ishizawa K, 2001, J NEUROPATH EXP NEUR, V60, P647, DOI 10.1093/jnen/60.6.647; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Josephs KA, 2013, MOVEMENT DISORD, V28, P1117, DOI 10.1002/mds.25437; Knake S, 2010, MOVEMENT DISORD, V25, P1232, DOI 10.1002/mds.23054; Lee SE, 2011, ANN NEUROL, V70, P327, DOI 10.1002/ana.22424; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Naylor MG, 2014, HUM BRAIN MAPP, V35, P831, DOI 10.1002/hbm.22217; OHTSUKA K, 1992, OPHTHALMOLOGICA, V204, P44, DOI 10.1159/000310265; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Padovani A, 2006, J NEUROL NEUROSUR PS, V77, P457, DOI 10.1136/jnnp.2005.075713; Paviour DC, 2006, BRAIN, V129, P1040, DOI 10.1093/brain/awl021; Paviour DC, 2007, J NEUROL, V254, P478, DOI 10.1007/s00415-006-0396-4; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Reginold W, 2014, PARKINSONISM RELAT D, V20, P222, DOI 10.1016/j.parkreldis.2013.10.002; Revesz T, 2003, MOVEMENT DISORD, V18, pS13, DOI 10.1002/mds.10558; Rizzo G, 2008, BRAIN, V131, P2690, DOI 10.1093/brain/awn195; Sajjadi SA, 2013, BRAIN, V136, P2253, DOI 10.1093/brain/awt118; Sakai K, 2006, ACTA NEUROPATHOL, V112, P341, DOI 10.1007/s00401-006-0093-5; Scaravilli T, 2005, MOVEMENT DISORD, V20, pS21, DOI 10.1002/mds.20536; Schuff N, 2015, MOVEMENT DISORD, V30, P1885, DOI 10.1002/mds.26325; Schwab R, 1969, 3 S PARK DIS RES; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sudmeyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041873; Tsuboi Y, 2003, NEUROLOGY, V60, P1766, DOI 10.1212/01.WNL.0000068011.21396.F4; Whitwell JL, 2007, BRAIN, V130, P1148, DOI 10.1093/brain/awm021; Whitwell JL, 2014, PARKINSONISM RELAT D, V20, P493, DOI 10.1016/j.parkreldis.2014.01.023; Whitwell JL, 2011, PARKINSONISM RELAT D, V17, P599, DOI 10.1016/j.parkreldis.2011.05.013; Williams DR, 2007, BRAIN, V130, P1566, DOI 10.1093/brain/awm104	50	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157218	10.1371/journal.pone.0157218	http://dx.doi.org/10.1371/journal.pone.0157218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310132	Green Published, gold			2022-12-26	WOS:000378029800045
J	Vanderperre, B; Cermakova, K; Escoffier, J; Kaba, M; Bender, T; Nef, S; Martinou, JC				Vanderperre, Benoit; Cermakova, Kristina; Escoffier, Jessica; Kaba, Mayis; Bender, Tom; Nef, Serge; Martinou, Jean-Claude			MPC1-like Is a Placental Mammal-specific Mitochondrial Pyruvate Carrier Subunit Expressed in Postmeiotic Male Germ Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLISM; PROTEIN; FUNCTIONALITY; ACETYLATION; GLUCONEOGENESIS; EVOLUTION; TRANSPORT; DEFECTS; LEADS	Selective transport of pyruvate across the inner mitochondrial membrane by the mitochondrial pyruvate carrier (MPC) is a fundamental step that couples cytosolic and mitochondrial metabolism. The recent molecular identification of the MPC complex has revealed two interacting subunits, MPC1 and MPC2. Although in yeast, an additional subunit, MPC3, can functionally replace MPC2, no alternative MPC subunits have been described in higher eukaryotes. Here, we report for the first time the existence of a novel MPC subunit termed MPC1-like (MPC1L), which is present uniquely in placental mammals. MPC1L shares high sequence, structural, and topological homology with MPC1. In addition, we provide several lines of evidence to show that MPC1L is functionally equivalent to MPC1: 1) when co-expressed with MPC2, it rescues pyruvate import in a MPC-deleted yeast strain; 2) in mammalian cells, it can associate with MPC2 to form a functional carrier as assessed by bioluminescence resonance energy transfer; 3) in MPC1 depleted mouse embryonic fibroblasts, MPC1L rescues the loss of pyruvate-driven respiration and stabilizes MPC2 expression; and 4) MPC1- and MPC1L-mediated pyruvate imports show similar efficiency. However, we show that MPC1L has a highly specific expression pattern and is localized almost exclusively in testis and more specifically in postmeiotic spermatids and sperm cells. This is in marked contrast to MPC1/MPC2, which are ubiquitously expressed throughout the organism. To date, the biological importance of this alternative MPC complex during spermatogenesis in placental mammals remains unknown. Nevertheless, these findings open up new avenues for investigating the structure-function relationship within the MPC complex.	[Vanderperre, Benoit; Cermakova, Kristina; Bender, Tom; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Escoffier, Jessica; Kaba, Mayis; Nef, Serge] Univ Geneva, Swiss Ctr Appl Human Toxicol, CH-1211 Geneva 4, Switzerland; [Escoffier, Jessica; Kaba, Mayis; Nef, Serge] Univ Geneva, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of Geneva	Martinou, JC (corresponding author), Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland.	jean-claude.martinou@unige.ch	Escoffier, jessica/E-9498-2017; Nef, Serge/AAV-6445-2020; Escoffier, jessica/T-9857-2019	Escoffier, jessica/0000-0001-8166-5845; Nef, Serge/0000-0001-5462-0676; Vanderperre, Benoit/0000-0002-2111-1071; martinou, Jean-claude/0000-0002-9847-2051; Cermakova, Kristina/0000-0002-9143-8766	Swiss National Science Foundation [310030B_160257/1]; Sinergia Grant [CRSII3_147637/1]; IGE3; State of Geneva; Swiss Centre for Applied Human Toxicology; Departement de l'Instruction Publique of the State of Geneva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sinergia Grant; IGE3; State of Geneva; Swiss Centre for Applied Human Toxicology; Departement de l'Instruction Publique of the State of Geneva	This work was supported in the Martinou lab by Swiss National Science Foundation Grant 310030B_160257/1, Sinergia Grant CRSII3_147637/1, IGE3, and the State of Geneva, and in the Nef lab by the Swiss Centre for Applied Human Toxicology and by the Departement de l'Instruction Publique of the State of Geneva (to S. N., M. K., and J. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Agathocleous M, 2013, TRENDS CELL BIOL, V23, P484, DOI 10.1016/j.tcb.2013.05.004; Agathocleous M, 2012, NAT CELL BIOL, V14, P859, DOI 10.1038/ncb2531; Amaral A, 2013, REPRODUCTION, V146, pR163, DOI 10.1530/REP-13-0178; Bender T, 2015, EMBO J, V34, P911, DOI 10.15252/embj.201490197; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Compan V, 2015, MOL CELL, V59, P491, DOI 10.1016/j.molcel.2015.06.035; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; EBOLI ML, 1977, BIOCHIM BIOPHYS ACTA, V460, P183, DOI 10.1016/0005-2728(77)90166-9; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Galdieri L, 2014, EUKARYOT CELL, V13, P1472, DOI 10.1128/EC.00189-14; Gallon F, 2006, FERTIL STERIL, V86, P1526, DOI 10.1016/j.fertnstert.2006.03.055; Gan HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2995; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Gray LR, 2015, CELL METAB, V22, P669, DOI 10.1016/j.cmet.2015.07.027; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Kim KS, 2001, BIOL REPROD, V64, P36, DOI 10.1095/biolreprod64.1.36; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lercher MJ, 2003, MOL BIOL EVOL, V20, P1113, DOI 10.1093/molbev/msg131; Liang L, 2015, BIOCHEM BIOPH RES CO, V468, P807, DOI 10.1016/j.bbrc.2015.11.036; Marchiq I, 2015, CANCER RES, V75, P171, DOI 10.1158/0008-5472.CAN-14-2260; McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; PARADIES G, 1983, CANCER RES, V43, P5068; Parra MT, 2003, J CELL SCI, V116, P961, DOI 10.1242/jcs.00330; Patterson JN, 2014, J BIOL CHEM, V289, P13335, DOI 10.1074/jbc.M113.521666; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Rato L, 2012, NAT REV UROL, V9, P330, DOI 10.1038/nrurol.2012.77; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; San Martin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085780; Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026; Schell JC, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-6; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Stouffs K, 2012, BBA-MOL BASIS DIS, V1822, P1864, DOI 10.1016/j.bbadis.2012.05.012; Vanderperre B, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006056; Vigueira PA, 2014, CELL REP, V7, P2042, DOI 10.1016/j.celrep.2014.05.017; Wang LM, 2016, ONCOTARGET, V7, P14673, DOI 10.18632/oncotarget.7405; Yannez AJ, 2007, J CELL PHYSIOL, V212, P807, DOI 10.1002/jcp.21077; Yang CD, 2014, J BIOL CHEM, V289, P6212, DOI 10.1074/jbc.M113.543637; Zhong YL, 2015, ONCOTARGET, V6, P37758, DOI 10.18632/oncotarget.5386	47	21	21	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16448	16461		10.1074/jbc.M116.733840	http://dx.doi.org/10.1074/jbc.M116.733840			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27317664	Green Published, hybrid			2022-12-26	WOS:000380826700004
J	Hemrova, L; Knappova, J; Munzbergova, Z				Hemrova, Lucie; Knappova, Jana; Munzbergova, Zuzana			Assessment of Habitat Suitability Is Affected by Plant-Soil Feedback: Comparison of Field and Garden Experiment	PLOS ONE			English	Article							DENSITY-DEPENDENCE; POPULATION-DYNAMICS; RAIN-FOREST; GRASSLAND; SEED; SPECIALIZATION; IDENTIFICATION; COMPETITION; LIMITATION; DIVERSITY	Background Field translocation experiments (i.e., the introduction of seeds or seedlings of different species into different localities) are commonly used to study habitat associations of species, as well as factors limiting species distributions and local abundances. Species planted or sown in sites where they naturally occur are expected to perform better or equally well compared to sites at which they do not occur or are rare. This, however, contrasts with the predictions of the Janzen-Connell hypothesis and commonly reported intraspecific negative plant-soil feedback. The few previous studies indicating poorer performance of plants at sites where they naturally occur did not explore the mechanisms behind this pattern. Aims and Methods In this study, we used field translocation experiments established using both seeds and seedlings to study the determinants of local abundance of four dominant species in grass-lands. To explore the possible effects of intraspecific negative plant-soil feedback on our results, we tested the effect of local species abundance on the performance of the plants in the field experiment. In addition, we set up a garden experiment to explore the intensity of intraspecific as well as interspecific feedback between the dominants used in the experiment. Key Results In some cases, the distribution and local abundances of the species were partly driven by habitat conditions at the sites, and species performed better at their own sites. However, the prevailing pattern was that the local dominants performed worse at sites where they naturally occur than at any other sites. Moreover, the success of plants in the field experiment was lower in the case of higher intraspecific abundance prior to experimental setup. In the garden feedback experiment, two of the species performed significantly worse in soils conditioned by their species than in soils conditioned by the other species. In addition, the performance of the plants was significantly correlated between the two experiments, suggesting that plant-soil feedback is a likely explanation of the patterns observed in the field. Conclusions All of the results indicate that intraspecific negative plant-soil feedback, either biotic or abiotic, may be a key factor determining the performance of the plants in our field translocation experiment. The possible effects of negative feedback should thus be considered when evaluating results of translocation experiments in future studies.	[Knappova, Jana; Munzbergova, Zuzana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Hemrova, Lucie; Knappova, Jana; Munzbergova, Zuzana] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Munzbergova, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.; Munzbergova, Z (corresponding author), Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic.	zuzmun@natur.cuni.cz	Hemrová, Lucie/H-1590-2014; Knappová, Jana/I-7197-2016; Münzbergová, Zuzana/F-6321-2013	Hemrová, Lucie/0000-0003-4058-9975; Knappová, Jana/0000-0002-8095-2583; Münzbergová, Zuzana/0000-0002-4026-6220	grant Agency of Czech Republic [16-09659S]; Czech Academy of Sciences [RVO 67985939]; Ministry of Education of the Czech Republic; European Social Fund (ESF) [CZ.1.07/2.3.00/30.0048]; national budget of the Czech Republic through the Operational Programme Education for Competitiveness (OPEC)	grant Agency of Czech Republic(Grant Agency of the Czech Republic); Czech Academy of Sciences(Czech Academy of Sciences); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Social Fund (ESF)(European Social Fund (ESF)); national budget of the Czech Republic through the Operational Programme Education for Competitiveness (OPEC)	The work was supported by the grant Agency of Czech Republic (www.gacr.cz, Grant no. 16-09659S to ZM) and partly by the Czech Academy of Sciences (www.cas.cz, RVO 67985939), and by Ministry of Education of the Czech Republic (www.msmt.cz). This article has been written during implementation of the project "Integration of the experimental and population biology using new methods of interdisciplinary issues - the way to excellence with young scientists", No. CZ.1.07/2.3.00/30.0048, which is funded by the European Social Fund (ESF) and the national budget of the Czech Republic through the Operational Programme Education for Competitiveness (OPEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar MR, 2001, J ECOL, V89, P40, DOI 10.1046/j.1365-2745.2001.00523.x; Albrecht MA, 2009, J ECOL, V97, P1037, DOI 10.1111/j.1365-2745.2009.01527.x; Anacker BL, 2014, ECOL LETT, V17, P1613, DOI 10.1111/ele.12378; Andersen KM, 2014, ECOLOGY, V95, P3399, DOI 10.1890/13-1688.1; Bagchi R, 2010, ECOL LETT, V13, P1262, DOI 10.1111/j.1461-0248.2010.01520.x; Baltzer JL, 2005, ECOLOGY, V86, P3063, DOI 10.1890/04-0598; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Brinkman EP, 2010, J ECOL, V98, P1063, DOI 10.1111/j.1365-2745.2010.01695.x; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Caughlin TT, 2014, ECOLOGY, V95, P952, DOI 10.1890/13-0580.1; Cerna L, 2015, PLOS ONE, V10, DOI [0.1371/ journal. pone. 0116992, DOI 10.1371/J0URNAL.P0NE.0116992]; Chylova T, 2008, PRESLIA, V80, P183; Connell JH, 1970, DYNAMICS POPULATIONS, P14; Dullinger S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021537; Ehrlen J, 2006, J ECOL, V94, P1224, DOI 10.1111/j.1365-2745.2006.01169.x; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Fridley JD, 2007, J ECOL, V95, P707, DOI 10.1111/j.1365-2745.2007.01236.x; Harrison S, 2010, ECOLOGY, V91, P2141, DOI 10.1890/09-0742.1; Heinze J, 2015, PERSPECT PLANT ECOL, V17, P227, DOI 10.1016/j.ppees.2015.03.002; Hemrova L, 2015, OIKOS, V124, P437, DOI 10.1111/oik.01130; Hemrova L, 2012, PRESLIA, V84, P925; Hendry RJ, 1996, ECOL MODEL, V84, P81, DOI 10.1016/0304-3800(94)00128-6; Herben T, 2007, J VEG SCI, V18, P55, DOI 10.1111/j.1654-1103.2007.tb02515.x; Husakova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097110; Ibanez I, 2014, ECOLOGY, V95, P364, DOI 10.1890/13-0685.1; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; JOHANSSON ME, 1991, OIKOS, V60, P27, DOI 10.2307/3544988; Johnson DJ, 2014, ECOLOGY, V95, P2493, DOI 10.1890/13-2098.1; Johnson DJ, 2012, SCIENCE, V336, P904, DOI 10.1126/science.1220269; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Keddy PA, 2007, PLANTS AND VEGETATION: ORIGINS, PROCESSES, CONSEQUENCES, P186; Klimesova J, 2009, J VEG SCI, V20, P511, DOI 10.1111/j.1654-1103.2009.01050.x; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Knappova J, 2015, AGR ECOSYST ENVIRON, V200, P200, DOI 10.1016/j.agee.2014.11.008; Knappova J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065879; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Leps J, 2003, MULTIVARIATE ANAL EC; Munzbergova Z, 2007, ANN BOT-LONDON, V100, P1259, DOI 10.1093/aob/mcm204; MacDougall AS, 2011, P ROY SOC B-BIOL SCI, V278, P2939, DOI 10.1098/rspb.2010.2730; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Moore KA, 2006, ECOL LETT, V9, P797, DOI 10.1111/j.1461-0248.2006.00923.x; Munzbergova Z, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00206.1; Munzbergova Z, 2005, OECOLOGIA, V145, P1, DOI 10.1007/s00442-005-0052-1; Munzbergova Z, 2005, AM J BOT, V92, P1987, DOI 10.3732/ajb.92.12.1987; Munzbergova Z, 2004, J ECOL, V92, P854, DOI 10.1111/j.0022-0477.2004.00919.x; Olff H, 2000, OECOLOGIA, V125, P45, DOI 10.1007/PL00008890; PACALA SW, 1990, ECOL MONOGR, V60, P113, DOI 10.2307/1943028; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Palmiotto PA, 2004, J ECOL, V92, P609, DOI 10.1111/j.0022-0477.2004.00894.x; Pankova H, 2008, OECOLOGIA, V157, P211, DOI 10.1007/s00442-008-1064-4; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Reinhart KO, 2012, ECOLOGY, V93, P2377, DOI 10.1890/12-0486.1; Seifert B, 2010, BIOL CONSERV, V143, P1202, DOI 10.1016/j.biocon.2010.02.028; Speek TAA, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv021; Stropp J, 2014, PLANT ECOL DIVERS, V7, P255, DOI 10.1080/17550874.2013.773103; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; Terborgh J, 2012, AM NAT, V179, P303, DOI 10.1086/664183; Tutin TG, 2001, FLORA EUROPAEA, P2392; van Dam NM, 2010, J CHEM ECOL, V36, P1006, DOI 10.1007/s10886-010-9844-9; van der Putten WH, 2013, J ECOL, V101, P265, DOI 10.1111/1365-2745.12054; VANDERPUTTEN WH, 1993, NATURE, V362, P53; Vitova A, 2011, PLANT ECOL, V212, P1231, DOI 10.1007/s11258-011-9900-8; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	67	14	14	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157800	10.1371/journal.pone.0157800	http://dx.doi.org/10.1371/journal.pone.0157800			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336400	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200048
J	Chang, CC; Chang, WF; Xu, J; Cheng, AS; Chang, CC; Nagy, ZP; Yang, CC; Ding, ST; Sung, LY				Chang, Ching-Chien; Chang, Wei-Fang; Xu, Jie; Cheng, An-Sheng; Chang, Chia-Chun; Nagy, Zsolt Peter; Yang, Cho-Chen; Ding, Shih-Torng; Sung, Li-Ying			Production of Live Offspring from Vitrified-Warmed Oocytes Collected at Metaphase I Stage	PLOS ONE			English	Article							INTRACYTOPLASMIC SPERM INJECTION; GERMINAL VESICLE STAGE; IMMATURE HUMAN OOCYTES; VITRO MATURED OOCYTES; FERTILITY PRESERVATION; VITRIFICATION; CRYOPRESERVATION; MATURATION; EMBRYOS; FERTILIZATION	Vitrification of matured oocytes is widely adopted in human clinics and animal research laboratories. Cryopreservation of immature oocytes, particularly those at metaphase I (MI), remains a challenge. In the present work, mouse MI oocytes denuded of cumulus cells were vitrified and warmed (V/W) either prior to (V/W-BEFORE-IVM, n = 562) or after (V/W-AFTER-IVM, n = 664) in vitro maturation (IVM). Derivative metaphase II (MII) oocytes were then used for intracytoplasmic sperm injection (ICSI). In the control groups, in vivo matured MII oocytes were used freshly (FRESH-MII, n = 517) or after V/W (MII-V/W, n = 617). In vitro and in vivo developmental competencies were compared among groups. Satisfactory blastocyst rates were achieved in V/W-BEFORE-IVM (27.5%) and V/W-AFTER-IVM (32.4%) groups, albeit as expected still lower than those from fresh-MII (56.1%) or MII-V/W(45.6%) oocytes. Similarly, the term development rates from V/W-BEFORE-IVM and V/W-AFTER-IVM were 12.4% and 16.7% respectively, acceptable but lower than those of the fresh-MII (41.2%) and MII-V/W (23.3%) groups. These data demonstrate that oocytes collected at MI stage are amenable to V/W, which can be performed before or after IVM with acceptable development rates including production of healthy pups. These findings provide useful knowledge to researchers and clinical practitioners for preservation and use of the otherwise discarded MI oocytes.	[Chang, Ching-Chien; Nagy, Zsolt Peter] Reprod Biol Associates, Atlanta, GA USA; [Chang, Wei-Fang; Chang, Chia-Chun; Ding, Shih-Torng; Sung, Li-Ying] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Xu, Jie] Univ Michigan, Med Ctr, Ctr Adv Models Translat Sci & Therapeut, Ann Arbor, MI USA; [Cheng, An-Sheng] Yupintang Tradit Chinese Med Fdn, Dept Med Plant Dev, Kaohsiung, Taiwan; [Yang, Cho-Chen] Natl Chiayi Univ, Dept Anim Sci, Chiayi 60004, Taiwan; [Ding, Shih-Torng] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10764, Taiwan; [Sung, Li-Ying] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Sung, Li-Ying] Natl Taiwan Univ, Anim Resource Ctr, Taipei 10764, Taiwan	National Taiwan University; University of Michigan System; University of Michigan; National Chiayi University; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University	Sung, LY (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan.; Sung, LY (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.; Sung, LY (corresponding author), Natl Taiwan Univ, Anim Resource Ctr, Taipei 10764, Taiwan.	liyingsung@ntu.edu.tw		SUNG, LI-YING/0000-0003-1221-2476; Chang, Chia Chun/0000-0001-7942-6300	Yupintan Traditional Chinese Medicine Foundation (Kaohsiung, Taiwan, R.O.C.); National Taiwan University, Taiwan, R.O.C. [NTU-CDG-105R7885, 103R4000]	Yupintan Traditional Chinese Medicine Foundation (Kaohsiung, Taiwan, R.O.C.); National Taiwan University, Taiwan, R.O.C.(National Taiwan University)	This study was supported by grants from Yupintan Traditional Chinese Medicine Foundation (Kaohsiung, Taiwan, R.O.C.) and the National Taiwan University, Taiwan, R.O.C., Grant # NTU-CDG-105R7885 to LYS and 103R4000 to WFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKA SG, 1995, HUM REPROD, V10, P1816, DOI 10.1093/oxfordjournals.humrep.a136182; Boiso I, 2002, HUM REPROD, V17, P1885, DOI 10.1093/humrep/17.7.1885; Cao YX, 2009, SEMIN REPROD MED, V27, P456, DOI 10.1055/s-0029-1241055; Cao YX, 2009, REPROD BIOMED ONLINE, V19, P369, DOI 10.1016/S1472-6483(10)60170-8; Casillas F, 2015, CRYOBIOLOGY, V71, P299, DOI 10.1016/j.cryobiol.2015.08.003; Cha KY, 1998, HUM REPROD UPDATE, V4, P103, DOI 10.1093/humupd/4.2.103; Chang CC, 2013, FERTIL STERIL, V99, P1891, DOI 10.1016/j.fertnstert.2013.02.008; Chang CC, 2008, REPROD BIOMED ONLINE, V17, P684, DOI 10.1016/S1472-6483(10)60316-1; Chian RC, 2009, FERTIL STERIL, V91, P372, DOI 10.1016/j.fertnstert.2007.11.088; Cobo A, 2008, FERTIL STERIL, V89, P1657, DOI 10.1016/j.fertnstert.2007.05.050; Combelles CMH, 2012, INT J DEV BIOL, V56, P919, DOI 10.1387/ijdb.120132cc; Edgar DH, 2012, HUM REPROD UPDATE, V18, P536, DOI 10.1093/humupd/dms016; Goud A, 2000, FERTIL STERIL, V74, P487, DOI 10.1016/S0015-0282(00)00672-5; Hutt KJ, 2007, REPROD BIOMED ONLINE, V14, P758, DOI 10.1016/S1472-6483(10)60679-7; KENNEDY JF, 1969, SCIENCE, V164, P1292, DOI 10.1126/science.164.3885.1292; Kishigami S, 2004, BIOL REPROD, V70, P1863, DOI 10.1095/biolreprod.103.025171; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1; Lane M, 1999, NAT BIOTECHNOL, V17, P1234, DOI 10.1038/70795; Lee JA, 2014, CURR OPIN OBSTET GYN, V26, P168, DOI 10.1097/GCO.0000000000000062; Matsumoto H, 2001, CRYOBIOLOGY, V42, P139, DOI 10.1006/cryo.2001.2309; Nagy ZP, 2009, FERTIL STERIL, V92, P520, DOI 10.1016/j.fertnstert.2008.06.005; Nogueira D, 2006, FERTIL STERIL, V85, P578, DOI 10.1016/j.fertnstert.2005.08.033; Plancha CE, 2005, REPROD BIOMED ONLINE, V10, P478, DOI 10.1016/S1472-6483(10)60824-3; Rienzi L, 2012, HUM REPROD, V27, P1606, DOI 10.1093/humrep/des088; Ruppert-Lingham CJ, 2003, HUM REPROD, V18, P392, DOI 10.1093/humrep/deg071; SCHROEDER AC, 1984, DEV BIOL, V102, P493, DOI 10.1016/0012-1606(84)90215-X; Smith GD, 2010, FERTIL STERIL, V94, P2088, DOI 10.1016/j.fertnstert.2009.12.065; Smitz JEJ, 2004, GYNECOL OBSTET INVES, V57, P18; Spricigo JFW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130164; Sung LY, 2010, CELL REPROGRAM, V12, P203, DOI 10.1089/cell.2009.0072; Tominaga K, 2004, J REPROD DEVELOP, V50, P29, DOI 10.1262/jrd.50.29; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;53::AID-MRD6&gt;3.0.CO;2-V; Versieren K, 2011, FERTIL STERIL, V96, P624, DOI 10.1016/j.fertnstert.2011.06.060; Wang HY, 2012, CRYOBIOLOGY, V65, P79, DOI 10.1016/j.cryobiol.2012.06.001; Yazdanpanah F, 2013, ARCH GYNECOL OBSTET, V288, P439, DOI 10.1007/s00404-013-2777-0	35	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157785	10.1371/journal.pone.0157785	http://dx.doi.org/10.1371/journal.pone.0157785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333297	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212800050
J	Gavito, AL; Bautista, D; Suarez, J; Badran, S; Arco, R; Pavon, FJ; Serrano, A; Rivera, P; Decara, J; Cuesta, AL; Rodriguez-de-Fonseca, F; Baixeras, E				Luisa Gavito, Ana; Bautista, Dolores; Suarez, Juan; Badran, Samir; Arco, Rocio; Javier Pavon, Francisco; Serrano, Antonia; Rivera, Patricia; Decara, Juan; Cuesta, Antonio Luis; Rodriguez-de-Fonseca, Fernando; Baixeras, Elena			Chronic IL-6 Administration Desensitizes IL-6 Response in Liver, Causes Hyperleptinemia and Aggravates Steatosis in Diet-Induced-Obese Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SUBCUTANEOUS ADIPOSE-TISSUE; ACTIVATED RECEPTOR-ALPHA; HEPATIC STEATOSIS; FATTY LIVER; INTERLEUKIN-6 CONCENTRATIONS; INSULIN SENSITIVITY; SIGNAL-TRANSDUCTION; CYTOKINE; SOCS3	High-fat diet-induced obesity (DIO) is associated with fatty liver and elevated IL-6 circulating levels. IL-6 administration in rodents has yielded contradictory results regarding its effects on steatosis progression. In some models of fatty liver disease, high doses of human IL-6 ameliorate the liver steatosis, whereas restoration of IL-6 in DIO IL-6(-/-) mice up-regulates hepatic lipogenic enzymes and aggravates steatosis. We further examined the effects of chronic low doses of murine IL-6 on hepatic lipid metabolism in WT mice in DIO. IL-6 was delivered twice daily in C57BL/6J DIO mice for 15 days. The status and expression of IL-6 signalling mediators and targets were investigated in relation to the steatosis and lipid content in blood and in liver. IL-6 administration in DIO mice markedly raised circulating levels of lipids, glucose and leptin, elevated fat liver content and aggravated steatosis. Under IL-6 treatment there was hepatic Stat3 activation and increased gene expression of Socs3 and Tnf-alpha whereas the gene expression of endogenous IL-6, IL-6-receptor, Stat3, Cpt1 and the enzymes involved in lipogenesis was suppressed. These data further implicate IL-6 in fatty liver disease modulation in the context of DIO, and indicate that continuous stimulation with IL-6 attenuates the IL-6-receptor response, which is associated with high serum levels of leptin, glucose and lipids, the lowering levels of lipogenic and Cpt1 hepatic enzymes and with increased Tnf-alpha hepatic expression, a scenario evoking that observed in IL-6(-/-) mice exposed to DIO and in obese Zucker rats.	[Luisa Gavito, Ana; Suarez, Juan; Arco, Rocio; Javier Pavon, Francisco; Serrano, Antonia; Rivera, Patricia; Decara, Juan; Rodriguez-de-Fonseca, Fernando; Baixeras, Elena] Hosp Reg Univ Malaga, IBIMA, Lab Invest, Malaga 29010, Spain; [Luisa Gavito, Ana; Suarez, Juan; Arco, Rocio; Javier Pavon, Francisco; Serrano, Antonia; Rivera, Patricia; Decara, Juan; Rodriguez-de-Fonseca, Fernando; Baixeras, Elena] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid 28029, Spain; [Luisa Gavito, Ana; Suarez, Juan; Arco, Rocio; Javier Pavon, Francisco; Serrano, Antonia; Rivera, Patricia; Decara, Juan; Rodriguez-de-Fonseca, Fernando; Baixeras, Elena] Hosp Reg Univ Malaga, Unidad Gest Clin Salud Mental, Malaga 29010, Spain; [Bautista, Dolores] Hosp Reg Univ Malaga, Unidad Gest Clin Anat Patol, Malaga 29010, Spain; [Badran, Samir] Univ Coll South Denmark, DK-6705 Esbjerg, Denmark; [Cuesta, Antonio Luis] Univ Copenhagen, Panum Inst, Dept Biomed Sci, Danish Diabet Acad, DK-2200 Copenhagen, Denmark	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Copenhagen	Baixeras, E (corresponding author), Hosp Reg Univ Malaga, IBIMA, Lab Invest, Malaga 29010, Spain.; Baixeras, E (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid 28029, Spain.; Baixeras, E (corresponding author), Hosp Reg Univ Malaga, Unidad Gest Clin Salud Mental, Malaga 29010, Spain.	elena.baixeras@ibima.eu	Suarez, Juan/I-5188-2015; Pavón Morón, Francisco Javier/AAG-9721-2020; Decara Del Olmo, Juan Manuel/I-1931-2015	Suarez, Juan/0000-0001-5254-9802; Pavón Morón, Francisco Javier/0000-0002-5256-8904; Badran, Samir/0000-0002-5314-6789; BAIXERAS, ELENA/0000-0001-6955-2434; Arco Gonzalez, Rocio/0000-0002-5618-5687; RODRIGUEZ DE FONSECA, FERNANDO/0000-0002-4516-5795; Decara Del Olmo, Juan Manuel/0000-0002-9868-015X	Instituto de Salud Carlos III, Red de Trastornos Adictivos UE-FEDER [RD12/0028/0001]; Ministerio de Economia y Competitividad [PI13/02261]; Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional sobre Drogas [049/2009, 049/2013]; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia [CTS-433]; Consejeria de Salud y Bienestar Social, Junta Andalucia [PI0552, PI0228-2013, PI0823-2012]; National System of Health, Instituto de Salud Carlos III [CP12/03109, CP14/00212, CP14/00173]; Program of the Instituto de Salud Carlos III; Andalusian "Progreso y Salud" Foundation, Spain	Instituto de Salud Carlos III, Red de Trastornos Adictivos UE-FEDER(Instituto de Salud Carlos III); Ministerio de Economia y Competitividad(Spanish Government); Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional sobre Drogas; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia(Junta de Andalucia); Consejeria de Salud y Bienestar Social, Junta Andalucia; National System of Health, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Program of the Instituto de Salud Carlos III(Instituto de Salud Carlos III); Andalusian "Progreso y Salud" Foundation, Spain	The present study was financially supported through funding from the Instituto de Salud Carlos III, Red de Trastornos Adictivos UE-FEDER 2012 (RD12/0028/0001); Ministerio de Economia y Competitividad(PI13/02261); Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional sobre Drogas 049/2009 and 049/2013; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia (CTS-433); Consejeria de Salud y Bienestar Social, Junta Andalucia (PI0552, PI0228-2013 and PI0823-2012). Samir Badran received an Erasmus+ mobility grant EU funds (code ID: DK ESBEJRG19). Juan Suarez, Antonia Serrano and F. Javier Pavon received a "MiguelServet" research contract and grant from the National System of Health, Instituto de Salud Carlos III, (grants number CP12/03109, CP14/00212, CP14/00173, respectively). Elena Baixeras received an I3SNS contract from Program of the Instituto de Salud Carlos III and Andalusian "Progreso y Salud" Foundation, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADERKA D, 1989, J IMMUNOL, V143, P3517; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Bauer S, 2011, METABOLIC SYNDROME, V1, P1; BRASS EP, 1994, BIOCHEM J, V301, P193, DOI 10.1042/bj3010193; Brass Eric P., 1995, Am J Ther, V2, P706, DOI 10.1097/00045391-199509000-00019; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Decara JM, 2015, DIS MODEL MECH, V8, P1213, DOI 10.1242/dmm.019919; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE182, DOI 10.1152/ajpendo.00189.2003; DiSanto E, 1997, CYTOKINE, V9, P300, DOI 10.1006/cyto.1996.0169; Ehlting C, 2007, J IMMUNOL, V178, P2813, DOI 10.4049/jimmunol.178.5.2813; El-Assal O, 2004, CELL MOL IMMUNOL, V1, P205; Fischer P, 2004, BIOCHEM J, V378, P449, DOI 10.1042/BJ20030893; Gavito AL, 2016, BRIT J PHARMACOL, V173, P1070, DOI 10.1111/bph.13423; Glund S, 2008, ACTA PHYSIOL, V192, P37, DOI 10.1111/j.1748-1716.2007.01779.x; GREENBERG AS, 1992, CANCER RES, V52, P4113; Greenhalgh CJ, 2001, J LEUKOCYTE BIOL, V70, P348; Hashizume M, 2011, ARTHRITIS, DOI 10.1155/2011/765624; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HILL DB, 1992, J LAB CLIN MED, V119, P547; Hong F, 2004, HEPATOLOGY, V40, P933, DOI 10.1002/hep.20400; Hong F, 2002, ONCOGENE, V21, P32, DOI 10.1038/sj.onc.1205016; Kelly M, 2009, DIABETES, V58, P1953, DOI 10.2337/db08-1293; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; KHORUTS A, 1991, HEPATOLOGY, V13, P267, DOI 10.1016/0270-9139(91)92439-F; Kinoshita Shinichi, 2008, Kobe J Med Sci, V54, pE200; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; Kroy DC, 2010, HEPATOLOGY, V51, P463, DOI 10.1002/hep.23322; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Nieto-Vazquez I, 2008, DIABETES, V57, P3211, DOI 10.2337/db07-1062; NONOGAKI K, 1995, ENDOCRINOLOGY, V136, P2143, DOI 10.1210/en.136.5.2143; Norris CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096053; PEARCE J, 1983, P NUTR SOC, V42, P263, DOI 10.1079/PNS19830031; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Serrano A, 2012, AM J PHYSIOL-ENDOC M, V302, pE817, DOI 10.1152/ajpendo.00468.2011; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Streetz KL, 2003, HEPATOLOGY, V38, P218, DOI 10.1053/jhep.2003.50268; Tsigos C, 1997, J CLIN ENDOCR METAB, V82, P4167, DOI 10.1210/jc.82.12.4167; Vida M, 2015, DIS MODEL MECH, V8, P721, DOI 10.1242/dmm.019166; Vida M, 2013, LIVER INT, V33, P1019, DOI 10.1111/liv.12156; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wang YX, 2013, P NATL ACAD SCI USA, V110, P16975, DOI 10.1073/pnas.1315862110; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Yamaguchi K, 2010, LAB INVEST, V90, P1169, DOI 10.1038/labinvest.2010.75	53	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157956	10.1371/journal.pone.0157956	http://dx.doi.org/10.1371/journal.pone.0157956			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333268	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212800060
J	Nozaki, Y; Nakamoto, T				Nozaki, Yuji; Nakamoto, Takamichi			Odor Impression Prediction from Mass Spectra	PLOS ONE			English	Article							REGRESSION; SYSTEM	The sense of smell arises from the perception of odors from chemicals. However, the relationship between the impression of odor and the numerous physicochemical parameters has yet to be understood owing to its complexity. As such, there is no established general method for predicting the impression of odor of a chemical only from its physicochemical properties. In this study, we designed a novel predictive model based on an artificial neural network with a deep structure for predicting odor impression utilizing the mass spectra of chemicals, and we conducted a series of computational analyses to evaluate its performance. Feature vectors extracted from the original high-dimensional space using two auto-encoders equipped with both input and output layers in the model are used to build a mapping function from the feature space of mass spectra to the feature space of sensory data. The results of predictions obtained by the proposed new method have notable accuracy (R congruent to 0.76) in comparison with a conventional method (R congruent to 0.61).	[Nozaki, Yuji; Nakamoto, Takamichi] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan; [Nakamoto, Takamichi] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Nakamoto, T (corresponding author), Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan.; Nakamoto, T (corresponding author), Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan.	nakamoto.t.ab@m.titech.ac.jp			Kayanomori Foundation of Informational Science Advancement	Kayanomori Foundation of Informational Science Advancement	This work was supported by the Kayanomori Foundation of Informational Science Advancement.; This research was partially supported by Kayanomori Foundation of Informational Science Advancement. We are also grateful to Mr. Perez and Mr. Chakraborty for their comments on an earlier version of this manuscript.	Bellman R., 1957, DYNAMIC PROGRAMMING; Braun H, 1993, DIRECT ADAPTIVE METH; CAIN WS, 1979, SCIENCE, V203, P467, DOI 10.1126/science.760202; Castro JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073289; Cottrell GW, 2008, ADV COGNITIVE SCI, V3, P208; DRAVNIEKS A, 1984, JAPCA J AIR WASTE MA, V34, P752, DOI 10.1080/00022470.1984.10465810; Dravnieks A., 1985, ATLAS ODOR CHARACTER; Fahlman, 1988, EMPIRICAL STUDY LEAR; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Hanaki S, 1996, SENSOR ACTUAT A-PHYS, V57, P65, DOI 10.1016/S0924-4247(97)80096-9; Heymann H, 1986, SENSORY EVALUATION F; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2007, TRENDS COGN SCI, V11, P428, DOI 10.1016/j.tics.2007.09.004; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hochreiter S, 1998, INT J UNCERTAIN FUZZ, V6, P107, DOI 10.1142/S0218488598000094; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Lee JA, 2007, INFORM SCI STAT, P1; Menini A, 2004, NEWS PHYSIOL SCI, V19, P101, DOI 10.1152/nips.1507.2003; Nakamoto T, 2012, IEEE SENS J, V12, P3225, DOI 10.1109/JSEN.2012.2190506; OHLOFF G, 1986, EXPERIENTIA, V42, P271, DOI 10.1007/BF01942507; Sell CS, 2004, CHEM BIODIVERS, V1, P1899, DOI 10.1002/cbdv.200490146; Somboon P, 2009, SENSOR ACTUAT B-CHEM, V141, P141, DOI 10.1016/j.snb.2009.06.005; Srebro N, 2005, LECT NOTES COMPUT SC, V3559, P545, DOI 10.1007/11503415_37; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Triller A, 2008, CHEM BIODIVERS, V5, P862, DOI 10.1002/cbdv.200890101; Vinaixa M, 2005, SENSOR ACTUAT B-CHEM, V106, P67, DOI 10.1016/j.snb.2004.05.038; YOKOYAMA K, 1993, ANAL CHEM, V65, P673, DOI 10.1021/ac00054a004	28	18	19	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157030	10.1371/journal.pone.0157030	http://dx.doi.org/10.1371/journal.pone.0157030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27326765	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212400013
J	Zhang, J; Yuan, HW; Li, M; Li, YJ; Wang, Y; Ma, XJ; Zhang, Y; Tan, F; Wu, RL				Zhang, Jian; Yuan, Huwei; Li, Min; Li, Yujuan; Wang, Ying; Ma, Xiangjian; Zhang, Yuan; Tan, Feng; Wu, Rongling			A High-Density Genetic Map of Tetraploid Salix matsudana Using Specific Length Amplified Fragment Sequencing (SLAF-seq)	PLOS ONE			English	Article							SHRUB WILLOW; QTL ANALYSIS; LINKAGE; POLYMORPHISM; SEGREGATION; IRRIGATION; TOLERANCE; VIMINALIS; EVOLUTION; DISCOVERY	As a salt-tolerant arbor tree species, Salix matsudana plays an important role in afforestation and greening in the coastal areas of China. To select superior Salix varieties that adapt to wide saline areas, it is of paramount importance to understand and identify the mechanisms of salt-tolerance at the level of the whole genome. Here, we describe a high-density genetic linkage map of S. matsudana that represents a good coverage of the Salix genome. An intraspecific F-1 hybrid population was established by crossing the salt-sensitive "Yanjiang" variety as the female parent with the salt-tolerant "9901" variety as the male parent. This population, along with its parents, was genotyped by specific length amplified fragment sequencing (SLAF-seq), leading to 277,333 high-quality SLAF markers. By marker analysis, we found that both the parents and offspring were tetraploid. The mean sequencing depth was 53.20-fold for "Yanjiang", 47.41-fold for "9901", and 11.02-fold for the offspring. Of the SLAF markers detected, 42,321 are polymorphic with sufficient quality for map construction. The final genetic map was constructed using 6,737 SLAF markers, covering 38 linkage groups (LGs). The genetic map spanned 5,497.45 cM in length, with an average distance of 0.82 cM. As a first high-density genetic map of S. matsudana constructed from salt tolerance-varying varieties, this study will provide a foundation for mapping quantitative trait loci that modulate salt tolerance and resistance in Salix and provide important references for molecular breeding of this important forest tree.	[Zhang, Jian; Wu, Rongling] Beijing Forestry Univ, Coll Biol Sci & Technol, Ctr Computat Biol, Beijing, Peoples R China; [Yuan, Huwei] Beijing Forestry Univ, Natl Engn Lab Forest Tree Breeding, Key Lab Genet & Breeding Forest Trees & Ornamenta, Minist Educ,Coll Biol Sci & Technol, Beijing, Peoples R China; [Zhang, Jian; Li, Min; Li, Yujuan; Wang, Ying; Ma, Xiangjian; Zhang, Yuan; Tan, Feng] Jiangsu Riverine Inst Agr Sci, Rugao, Jiangsu, Peoples R China; [Wu, Rongling] Penn State Univ, Ctr Stat Genet, Hershey, PA USA	Beijing Forestry University; Beijing Forestry University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Wu, RL (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Ctr Computat Biol, Beijing, Peoples R China.; Wu, RL (corresponding author), Penn State Univ, Ctr Stat Genet, Hershey, PA USA.	rwu@bjfu.edu.cn	Li, yu/HHZ-5236-2022; li, yu/HGL-9518-2022		Fund for Independent Innovation of Agricultural Sciences and Technology in Jiangsu Province [CX (14)5094]; Fund for 333 Engineering Project in Jiangsu Province [BRA2015125]; Fund for the 12th Six Peak Talent Project in Jiangsu Province [2015-NY-042]; Fund for 226 Engineering Project in Nantong City [2014008]	Fund for Independent Innovation of Agricultural Sciences and Technology in Jiangsu Province; Fund for 333 Engineering Project in Jiangsu Province; Fund for the 12th Six Peak Talent Project in Jiangsu Province; Fund for 226 Engineering Project in Nantong City	This work was supported by "the Fund for Independent Innovation of Agricultural Sciences and Technology in Jiangsu Province (No. CX (14)5094)", "the Fund for 333 Engineering Project in Jiangsu Province (No. BRA2015125)", "the Fund for the 12th Six Peak Talent Project in Jiangsu Province (No. 2015-NY-042)", and "the Fund for 226 Engineering Project in Nantong City (No. 2014008)".	Ahman I., 1994, Norwegian Journal of Agricultural Sciences, P47; Aronsson P, 2010, ENVIRON POLLUT, V158, P795, DOI 10.1016/j.envpol.2009.10.003; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barcaccia G, 2003, HEREDITY, V90, P169, DOI 10.1038/sj.hdy.6800213; Berlin S, 2011, G3-GENES GENOM GENET, V1, P387, DOI 10.1534/g3.111.000539; Berlin S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-129; Dai XG, 2014, CELL RES, V24, P1274, DOI 10.1038/cr.2014.83; Dimitriou I, 2006, BIORESOURCE TECHNOL, V97, P150, DOI 10.1016/j.biortech.2005.02.004; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; GULLBERG U, 1993, FOREST CHRON, V69, P721, DOI 10.5558/tfc69721-6; Hangs RD, 2011, CAN J PLANT SCI, V91, P509, DOI [10.4141/CJPS10135, 10.4141/cjps10135]; HEDLEY DW, 1983, J HISTOCHEM CYTOCHEM, V31, P1333, DOI 10.1177/31.11.6619538; Kumar S., 2012, INT J COMP APP IRAFI, V5, P1; Li B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1086; Li M, 2014, CURR GENOMICS, V15, P341, DOI 10.2174/138920291505141106102544; Lindegaard K. N., 1997, Aspects of Applied Biology, P155; Ma J, 2015, PLOS ONE, V10; MacAlpine W. J., 2008, Aspects of Applied Biology, P173; Mirck J, 2012, BIOMASS BIOENERG, V39, P427, DOI 10.1016/j.biombioe.2012.01.039; Phillips D, 2015, NEW PHYTOL, V208, P421, DOI 10.1111/nph.13548; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Qi ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104871; Serapiglia MJ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-74; Stolarska A, 2008, ENVIRON PROT ENG, V34, P97; SUDA Y, 1968, BRITTONIA, V20, P191, DOI 10.2307/2805440; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Tsarouhas V, 2002, THEOR APPL GENET, V105, P277, DOI 10.1007/s00122-002-0918-0; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Wang Y, 2013, ISR J PLANT SCI, V61, P73, DOI 10.1080/07929978.2014.977548; Wu RL, 2002, GENET RES, V79, P85, DOI 10.1017/S0016672301005389; Wu RL, 2001, GENETICS, V159, P869; Xu XW, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00768; Yang XX, 2013, BRIEF BIOINFORM, V14, P96, DOI 10.1093/bib/bbs011; Zhou J, 2012, MOL BIOL REP, V39, P8645, DOI 10.1007/s11033-012-1719-4	34	16	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157777	10.1371/journal.pone.0157777	http://dx.doi.org/10.1371/journal.pone.0157777			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327501	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212400043
J	Cao, BB; Yan, HF; Guo, MM; Xie, H; Wu, Y; Gu, Q; Xiao, JX; Shang, J; Yang, YL; Xiong, H; Niu, ZP; Wu, XR; Jiang, YW; Wang, JM				Cao, Binbin; Yan, Huifang; Guo, Mangmang; Xie, Han; Wu, Ye; Gu, Qiang; Xiao, Jiangxi; Shang, Jing; Yang, Yanling; Xiong, Hui; Niu, Zhengping; Wu, Xiru; Jiang, Yuwu; Wang, Jingmin			Ten Novel Mutations in Chinese Patients with Megalencephalic Leukoencephalopathy with Subcortical Cysts and a Long-Term Follow-Up Research	PLOS ONE			English	Article							GENETIC-HETEROGENEITY; MLC1; LEUKODYSTROPHY; PROTEIN	Objective Megalencephalic leukoencephalopathy with subcortical cysts (MLC, OMIM 604004) is a rare neurological deterioration disease. We aimed to clarify clinical and genetic features of Chinese MLC patients. Methods Clinical information and peripheral venous blood of 20 patients and their families were collected, Sanger-sequencing and Multiple Ligation-dependent Probe Amplification were performed to make genetic analysis. Splicing-site mutation was confirmed with RT-PCR. UPD was detected by haplotype analysis. Follow-up study was performed through telephone for 27 patients. Results Out of 20 patients, macrocephaly, classic MRI features, motor development delay and cognitive impairment were detected in 20(100%), 20(100%), 17(85%) and 4(20%) patients, respectively. 20(100%) were clinically diagnosed with MLC. 19(95%) were genetically diagnosed with 10 novel mutations in MLC1, MLC1 and GlialCAM mutations were identified in 15 and 4 patients, respectively. Deletion mutation from exon4 to exon9 and a homozygous point mutation due to maternal UPD of chromosome22 in MLC1 were found firstly. c. 598-2A>C in MLC1 leads to the skip of exon8. c. 772-1G>C in MLC1 accounting for 15.5%(9/ 58) alleles in Chinese patients might be a founder or a hot-spot mutation. Out of 27 patients in the follow-up study, head circumference was ranged from 56cm to 61cm in patients older than 5yeas old, with a median of 57cm. Motor development delay and cognitive impairment were detected in 22(81.5%) and 5(18.5%) patients, respectively. Motor and cognitive deterioration was found in 5 (18.5%) and 2 patients (7.4%), respectively. Improvements and MRI recovery were first found in Chinese patients. Rate of seizures (45.5%), transient motor retrogress (45.5%) and unconsciousness (13.6%) after head trauma was much higher than that after fever (18.2%, 9.1%, 0%, respectively). Significance It's a clinical and genetic analysis and a follow-up study for largest sample of Chinese MLC patients, identifying 10 novel mutations, expanding mutation spectrums and discovering clinical features of Chinese MLC patients.	[Cao, Binbin; Yan, Huifang; Guo, Mangmang; Xie, Han; Wu, Ye; Gu, Qiang; Shang, Jing; Yang, Yanling; Xiong, Hui; Wu, Xiru; Jiang, Yuwu; Wang, Jingmin] Peking Univ, Hosp 1, Dept Pediat, Beijing 100034, Peoples R China; [Guo, Mangmang] Capital Med Univ, Beijing Tian Tan Hosp, Dept Pediat, Beijing 100050, Peoples R China; [Xiao, Jiangxi] Peking Univ, Hosp 1, Dept Radiol, Beijing 100034, Peoples R China; [Shang, Jing] Shanxi Dayi Hosp, Dept Neurol, Taiyuan 030000, Shanxi Province, Peoples R China; [Niu, Zhengping] Shanxi Med Univ, Hosp 1, Dept Neurol, Taiyuan 030001, Shanxi Province, Peoples R China	Peking University; Capital Medical University; Peking University; Shanxi Medical University	Jiang, YW; Wang, JM (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100034, Peoples R China.	jiangyw@263.net; wang66jm@163.com	han, xie/AAO-9359-2021; jiang, yu/HGU-0029-2022; /AAD-1783-2020		National Key Research Project [12-5, 2012BAI09B04]; National Natural Science Foundation of China [30973227]; Beijing key laboratory of molecular diagnosis and study on pediatric genetic diseases [Z141107004414036]	National Key Research Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing key laboratory of molecular diagnosis and study on pediatric genetic diseases	This research was supported by grants from National Key Research Project "12-5" (No: 2012BAI09B04), National Natural Science Foundation of China (No: 30973227), Beijing key laboratory of molecular diagnosis and study on pediatric genetic diseases (No: Z141107004414036).	Arnedo T, 2014, NEUROGENETICS, V15, P41, DOI 10.1007/s10048-013-0381-x; Blattner R, 2003, NEUROPEDIATRICS, V34, P215; Boor PKI, 2006, HUM MUTAT, V27, P505, DOI 10.1002/humu.20332; Bugiani M, 2003, NEUROPEDIATRICS, V34, P211; Caminsky Natasha, 2014, F1000Res, V3, P282, DOI 10.12688/f1000research.5654.1; Gorospe JR, 2004, NEUROLOGY, V62, P878, DOI 10.1212/01.WNL.0000115106.88813.5B; Guo Mang-mang, 2012, Zhonghua Er Ke Za Zhi, V50, P895; Kariminejad A, 2015, EUR J MED GENET, V58, P71, DOI 10.1016/j.ejmg.2014.12.004; Leegwater PAJ, 2001, AM J HUM GENET, V68, P831, DOI 10.1086/319519; Lopez-Hernandez T, 2011, AM J HUM GENET, V88, P422, DOI 10.1016/j.ajhg.2011.02.009; Mancini C, 2012, NEUROGENETICS, V13, P205, DOI 10.1007/s10048-012-0331-z; Niida Y, 2012, J HUM GENET, V57, P687, DOI 10.1038/jhg.2012.97; Pascual-Castroviejo I, 2005, NEUROLOGIA, V20, P33; Patrono C, 2003, NEUROLOGY, V61, P534, DOI 10.1212/01.WNL.0000076184.21183.CA; Robinson WP, 2000, BIOESSAYS, V22, P452; Roy Ujjawal, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2015-209831; Saijo H, 2003, BRAIN DEV-JPN, V25, P362, DOI 10.1016/S0387-7604(03)00006-8; Scheper GC, 2010, GENET TEST MOL BIOMA, V14, P255, DOI 10.1089/gtmb.2009.0148; Shi W, 2006, CHIN J EVID BASED PE, V2, P122; Singhal BS, 1996, PEDIATR NEUROL, V14, P291, DOI 10.1016/0887-8994(96)00048-3; Teijido O, 2004, HUM MOL GENET, V13, P2581, DOI 10.1093/hmg/ddh291; van der Knaap MS, 2012, LANCET NEUROL, V11, P973, DOI 10.1016/S1474-4422(12)70192-8; VANDERKNAAP MS, 1995, ANN NEUROL, V37, P324, DOI 10.1002/ana.410370308; Wang JM, 2011, J HUM GENET, V56, P138, DOI 10.1038/jhg.2010.146; Wang JM, 2010, BRAIN DEV-JPN, V32, P236, DOI 10.1016/j.braindev.2009.03.013; WEI Hong-en, 2006, J APPL CLIN PEDIAT, V21, P1497; Wu Wei-qing, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P616, DOI 10.3760/cma.j.issn.1003-9406.2011.06.004; Yalcinkaya C, 2003, SEIZURE-EUR J EPILEP, V12, P388, DOI 10.1016/S1059-1311(02)00350-3; Zhang HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118001; Zhu L., 2015, WORLD J TRADIT CHIN, V1, P1	30	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157258	10.1371/journal.pone.0157258	http://dx.doi.org/10.1371/journal.pone.0157258			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322623	gold, Green Submitted, Green Published			2022-12-26	WOS:000378212000011
J	Rabier, CE; Barre, P; Asp, T; Charmet, G; Mangin, B				Rabier, Charles-Elie; Barre, Philippe; Asp, Torben; Charmet, Gilles; Mangin, Brigitte			On the Accuracy of Genomic Selection	PLOS ONE			English	Article							DIMENSIONAL LINEAR-MODELS; COMMON SNPS EXPLAIN; LOLIUM-PERENNE L.; WIDE ASSOCIATION; MISSING HERITABILITY; GENETIC ARCHITECTURE; QUANTITATIVE TRAITS; LARGE PROPORTION; PLANT HEIGHT; DAIRY-CATTLE	Genomic selection is focused on prediction of breeding values of selection candidates by means of high density of markers. It relies on the assumption that all quantitative trait loci (QTLs) tend to be in strong linkage disequilibrium (LD) with at least one marker. In this context, we present theoretical results regarding the accuracy of genomic selection, i.e., the correlation between predicted and true breeding values. Typically, for individuals (so-called test individuals), breeding values are predicted by means of markers, using marker effects estimated by fitting a ridge regression model to a set of training individuals. We present a theoretical expression for the accuracy; this expression is suitable for any configurations of LD between QTLs and markers. We also introduce a new accuracy proxy that is free of the QTL parameters and easily computable; it outperforms the proxies suggested in the literature, in particular, those based on an estimated effective number of independent loci (Me). The theoretical formula, the new proxy, and existing proxies were compared for simulated data, and the results point to the validity of our approach. The calculations were also illustrated on a new perennial ryegrass set (367 individuals) genotyped for 24,957 single nucleotide polymorphisms (SNPs). In this case, most of the proxies studied yielded similar results because of the lack of markers for coverage of the entire genome (2.7 Gb).	[Rabier, Charles-Elie] Univ Toulouse, INRA, MIAT, Castanet Tolosan, France; [Barre, Philippe] INRA, Unite Rech Pluridisciplinaire Prairies & Plantes, UR4, Lusignan, France; [Asp, Torben] Aarhus Univ, Dept Mol Biol & Genet, Slagelse, Denmark; [Charmet, Gilles] UMR INRA UBP, GDEC, Clermont Ferrand, France; [Mangin, Brigitte] Univ Toulouse, INRA, CNRS, LIPM, Castanet Tolosan, France	INRAE; INRAE; Aarhus University; INRAE; Universite Clermont Auvergne (UCA); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Rabier, CE (corresponding author), Univ Toulouse, INRA, MIAT, Castanet Tolosan, France.; Mangin, B (corresponding author), Univ Toulouse, INRA, CNRS, LIPM, Castanet Tolosan, France.	cerabier@insa-toulouse.fr; Brigitte.Mangin@toulouse.inra.fr			CROPDL project, INRA Meta-program SELGEN	CROPDL project, INRA Meta-program SELGEN	This work was supported by the CROPDL project, which is a part of the INRA Meta-program SELGEN (http://www.selgen.inra.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the CROPDL project, which is a part of the INRA Meta-program SELGEN.	Albrecht T, 2011, THEOR APPL GENET, V123, P339, DOI 10.1007/s00122-011-1587-7; Asoro FG, 2011, PLANT GENOME-US, V4, P132, DOI 10.3835/plantgenome2011.02.0007; Auzanneau J, 2007, THEOR APPL GENET, V115, P837, DOI 10.1007/s00122-007-0612-3; Azais JM, 2014, STATISTICS-ABINGDON, V48, P787, DOI 10.1080/02331888.2012.760093; Barre P, 2006, AGRON J, V98, P978, DOI 10.2134/agronj2005.0213; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Boichard D, 2012, ANIM PROD SCI, V52, P115, DOI 10.1071/AN11119; Brard S, 2015, J ANIM BREED GENET, V132, P207, DOI [10.1111/jbg.12123, 10.1111/jbg.1212]; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Buhlmann P, 2013, BERNOULLI, V19, P1212, DOI 10.3150/12-BEJSP11; Burstin J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1266-1; Byrne S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057438; Chen ZH, 2005, STAT SINICA, V15, P909; Cierco C, 1998, STATISTICS, V31, P261, DOI 10.1080/02331889808802639; CORBEIL RR, 1976, TECHNOMETRICS, V18, P31, DOI 10.2307/1267913; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; de los Campos G, 2010, GENET RES, V92, P295, DOI 10.1017/S0016672310000285; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Falconer D.S., 1960, INTRO QUANTITATIVE G, P1, DOI [10.2307/2985722, DOI 10.2307/2985722]; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Gianola D, 2006, GENETICS, V173, P1761, DOI 10.1534/genetics.105.049510; Gianola D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091693; Goddard ME, 2011, J ANIM BREED GENET, V128, P409, DOI 10.1111/j.1439-0388.2011.00964.x; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2013, GENETICS, V194, P597, DOI 10.1534/genetics.113.152207; Haldane JBS, 1919, J GENET, V8, P299; Hayes B., 2007, QTL MAPPING MAS GENO; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes B, 2010, GENOME, V53, P876, DOI 10.1139/G10-076; Hayes BJ, 2013, PLANT BREEDING, V132, P133, DOI 10.1111/pbr.12037; Hazard L, 1995, GRASS FORAGE SCI, V50, P241, DOI 10.1111/j.1365-2494.1995.tb02319.x; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HORST GL, 1978, CROP SCI, V18, P715, DOI 10.2135/cropsci1978.0011183X001800050005x; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Karkkainen HP, 2012, GENETICS, V191, P969, DOI 10.1534/genetics.112.139014; Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036674; LANDER ES, 1989, GENETICS, V121, P185; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li ZT, 2012, THEOR APPL GENET, V125, P419, DOI 10.1007/s00122-012-1892-9; Lian L, 2014, CROP SCI, V54, P1514, DOI 10.2135/cropsci2013.12.0856; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Mangin B, 2012, HEREDITY, V108, P285, DOI 10.1038/hdy.2011.73; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meuwissen THE, 2001, GENETICS, V157, P1819; Pauly L, 2012, THEOR APPL GENET, V124, P1139, DOI 10.1007/s00122-011-1775-5; Perez-Enciso M, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0117-5; Pszczola M, 2012, J DAIRY SCI, V95, P389, DOI 10.3168/jds.2011-4338; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rincent R, 2012, GENETICS, V192, P715, DOI 10.1534/genetics.112.141473; Schulz-Streeck T, 2012, CROP SCI, V52, P2453, DOI 10.2135/cropsci2012.03.0160; Shao J, 2012, ANN STAT, V40, P812, DOI 10.1214/12-AOS982; Shinozuka H, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-101; Smarda P, 2008, ANN BOT-LONDON, V101, P421, DOI 10.1093/aob/mcm307; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Technow, 2014, R PACKAGE HYPRED SIM; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Wu R., 2007, STAT GENETICS QUANTI; Wurschum T, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-85; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao Y, 2014, HEREDITY, V112, P638, DOI 10.1038/hdy.2014.1	76	26	29	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0156086	10.1371/journal.pone.0156086	http://dx.doi.org/10.1371/journal.pone.0156086			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322178	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212000005
J	Cheng, L; Zhang, S; Hu, Y				Cheng, Liang; Zhang, Shuo; Hu, Yang			BLAT2DOLite: An Online System for Identifying Significant Relationships between Genetic Sequences and Diseases	PLOS ONE			English	Article							ONTOLOGY; GENOME; BLAST; CORE	The significantly related diseases of sequences could play an important role in understanding the functions of these sequences. In this paper, we introduced BLAT2DOLite, an online system for annotating human genes and diseases and identifying the significant relationships between sequences and diseases. Currently, BLAT2DOLite integrates Entrez Gene database and Disease Ontology Lite (DOLite), which contain loci of gene and relationships between genes and diseases. It utilizes hypergeometric test to calculate P-values between genes and diseases of DOLite. The system can be accessed from: http://123.59.132.21:8080/BLAT2DOLite. The corresponding web service is described in: http://123.59.132.21:8080/BLAT2DOLite/BLAT2DOLiteIDMappingPort?wsdl.	[Cheng, Liang] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China; [Zhang, Shuo] Harbin Univ Commerce, Sch Management, Harbin 150028, Peoples R China; [Hu, Yang] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China	Harbin Medical University; Harbin University of Commerce; Harbin Institute of Technology	Cheng, L (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China.; Hu, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China.	liangcheng@hrbmu.edu.cn; huyang@hit.edu.cn	Cheng, Liang/ABY-7421-2022	Hu, Yang/0000-0002-4508-5365; Cheng, Liang/0000-0002-6665-6710	National Natural Science Foundation of China [61502125]; Heilongjiang Postdoctoral Fund [LBH-Z15179]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Postdoctoral Fund	This work was supported by the National Natural Science Foundation of China (Grant No. 61502125) and Heilongjiang Postdoctoral Fund (NO: LBH-Z15179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Bioinformatics UG, 2011, GRCH37 HG19 ASS; Cheng X, 2012, BMC GENOMICS, V13, P1; Danilov A, 2013, ONCOTARGET, V4, P1507, DOI 10.18632/oncotarget.1272; Du P, 2009, BIOINFORMATICS, V25, pI63, DOI 10.1093/bioinformatics/btp193; Feng G, 2012, METHODS MOL BIOL, V802, P101, DOI 10.1007/978-1-61779-400-1_7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Janjic V, 2012, MOL BIOSYST, V8, P2614, DOI 10.1039/c2mb25230a; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281, DOI 10.1055/s-0038-1634945; Liu YS, 2017, IEEE ACM T COMPUT BI, V14, P905, DOI 10.1109/TCBB.2016.2550432; Lu ZY, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P269; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Meystre S, 2005, STUD HEALTH TECHNOL, V116, P823; Nair J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094328; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Sarajlic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071537; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Shah NH, 2004, BIOINFORMATICS, V20, P1196, DOI 10.1093/bioinformatics/bth056; Shashni B, 2013, J DRUG TARGET, V21, P161, DOI 10.3109/1061186X.2012.736998; Sqalli MH, 2012, UCLOUD SIMULATED HYB, P170; Sullivan J, 2013, SCI REPORTS, V3; Vaughan-Nichols SJ, 2002, WEB SERVICES HYPE, P18; Vazquez-Naya JM, 2010, CURR PHARM DESIGN, V16, P2724; Xiang Y, 2012, IEEE ACM T COMPUT BI, V9, P294, DOI 10.1109/TCBB.2011.58; Yang JL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-18; Yu GC, 2015, BIOINFORMATICS, V31, P608, DOI 10.1093/bioinformatics/btu684; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937; Zou Q, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/810514; Zou Q, 2015, BIOINFORMATICS, V31, P2475, DOI 10.1093/bioinformatics/btv177	35	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157274	10.1371/journal.pone.0157274	http://dx.doi.org/10.1371/journal.pone.0157274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315278	Green Published, Green Submitted, gold			2022-12-26	WOS:000378030000016
J	Cantarino, SG; Pinto, JMD; Fabiao, JADAD; Garcia, AMC; Abellan, MV; Rodrigues, MA				Gomez Cantarino, Sagrario; de Matos Pinto, Jose Manuel; Amaro de Oliveira Fabiao, Joana Alice da Silva; Carrobles Garcia, Ana Maria; Velasco Abellan, Minerva; Rodrigues, Manuel Alves			The Importance of Religiosity/Spirituality in the Sexuality of Pregnant and Postpartum Women	PLOS ONE			English	Article							RELIGION; SPIRITUALITY; SEX	In this article, we decided to study the representation of the Spanish pregnant and postpartum women and the importance of religiosity/spirituality and the social context for them. We analyzed the influence of religion on the woman within her social context. Objective: to understand how pregnant and postpartum women experience their sexuality according to their religious beliefs and the opinion of others from a socially learned perspective. Method: qualitative study using ethnography. This study aims at understanding reality from the women's point of view, acknowledging that the points of view are constructed through interaction with others, through cultural and historical norms that influence the lives of individuals. Results: The findings indicate a difference in the religious beliefs and sexual behaviors of these women, which is more marked in urban than rural areas. Mothers have an influence on their daughters, conditioning their behavior. Conclusion We conclude that the process of change is underway. However, some paradoxes still persist concerning the sexual roles to be adopted, as well as some contradictions between sexual behaviors and the statements on religion. Within the scope of our study, we can confirm that pregnant and postpartum women are more or less pressured by the religious and social norms conveyed by their mothers, mainly in rural settings. From an external point of view, to be sexually free goes against the maternal and social expectations. However, the internal representation, marked by religion, that has been experienced over the years does not change the narratives of sexual experiences, assigning women to traditional role. This role brings conflict more or less assumed by women.	[Gomez Cantarino, Sagrario; Velasco Abellan, Minerva] Univ Castilla La Mancha, Escuela Enfermeria & Fisioterapia, Dept Enfermeria Fisioterapia & Terapia Ocupac, Campus Toledo, Toledo, Spain; [de Matos Pinto, Jose Manuel; Amaro de Oliveira Fabiao, Joana Alice da Silva; Rodrigues, Manuel Alves] Nursing Sch Coimbra, Hlth Sci Res Unit Nursing, Coimbra, Portugal; [Carrobles Garcia, Ana Maria] Univ Castilla La Mancha, Escuela Enfermeria & Fisioterapia, Dept Enfermeria Fisioterapia & Terapia Ocupac, Campus Talavera Reina, Toledo, Spain	Universidad de Castilla-La Mancha; Nursing School of Coimbra; Universidad de Castilla-La Mancha	Cantarino, SG (corresponding author), Univ Castilla La Mancha, Escuela Enfermeria & Fisioterapia, Dept Enfermeria Fisioterapia & Terapia Ocupac, Campus Toledo, Toledo, Spain.	sagrario.gomez@uclm.es	Cantarino, Sagrario Gómez/AAP-3845-2021	Cantarino, Sagrario Gómez/0000-0002-9640-0409	FISCAM (Foundation for Health Research in Castilla la Mancha) [PI-2009/73, 78]	FISCAM (Foundation for Health Research in Castilla la Mancha)	The study was funded by FISCAM (Foundation for Health Research in Castilla la Mancha) on the April 16th, 2009, Call (DOCM No. 78 of April 24th, 2009) File Number: PI-2009/73.	Barkan SE, 2006, J SCI STUD RELIG, V45, P407, DOI 10.1111/j.1468-5906.2006.00315.x; Baumeister RF, 2001, PERS SOC PSYCHOL REV, V5, P242, DOI 10.1207/S15327957PSPR0503_5; Bridges SK, 2007, J SEX MARITAL THER, V33, P41, DOI 10.1080/00926230600998466; Byers ES, 2005, J SEX RES, V42, P113, DOI 10.1080/00224490509552264; Carrillo Pineda Marcela, 2011, Index Enferm, V20, P96, DOI 10.4321/s1132-12962011000100020; Chozas J., 2006, REV FILOS, P81; Creswell J. W., 2007, QUALITATIVE INQUIRY; Di Virgilio M. M., 2007, REV ARGENTINA SOCIOL, V5, P90; Garnier G, 1975, SEXUALIDAD MUJER EMB, P13; Gomez S., 2012, THESIS; Guba EG., 1994, HDB QUALITATIVE RES, P105; Hardy SA, 2003, ADOLESCENT RELIG SEX, P97; Hernandez Collazo Y, 2010, HACIA PSICOLOGIA PUE, P174; Hill PC, 2000, J THEOR SOC BEHAV, V30, P51, DOI 10.1111/1468-5914.00119; Johnstone, 2015, RELIG SOC; Koenig HG, 2008, MED RELIG HLTH WHERE; Leininger M, 2005, ASUNTOS CRITICOS INV, P112; Leyva JM, 2010, THESIS; Lucca Irizarry N, 2003, INVESTIGACION CUALIT; Marks MJ, 2005, SEX ROLES, V52, P175, DOI 10.1007/s11199-005-1293-5; Medina J. L., 2005, DESEO CUIDAR VOLUNTA; Miller WR, 2003, AM PSYCHOL, V58, P24, DOI 10.1037/0003-066X.58.1.24; Moran JM, 2012, REFLEXIONES TORNO DE, P13; Murray SH, 2012, J SEX MARITAL THER, V38, P28, DOI 10.1080/0092623X.2011.569637; Murray SH., 2012, CANADIAN J HUMAN SEX, V21, P101; O'Sullivan L.F., 2008, CAN J HUM SEX, V17, P109; O'Sullivan LF, 2008, J ADOLESCENT HEALTH, V42, P207, DOI 10.1016/j.jadohealth.2008.01.002; Pargament KI, 2005, J SOC ISSUES, V61, P665, DOI 10.1111/j.1540-4560.2005.00426.x; Rodriguez T., 2007, REPRESENTACIONES SOC, P157; Ruiz J. I., 2009, METODOLOGIA INVESTIG, V5; Santos R.S., 2020, THESIS; Servicio de salud de Castilla La Mancha, 2010, SESCAM CIFRAS; Sofiati F, 2010, ANPUH, V8, P227; Sprecher S, 2002, J SEX RES, V39, P190, DOI 10.1080/00224490209552141; Strauss A, 2002, BASES INVESSTIGACION; Zinnbauer BJ, 1999, J PERS, V67, P889, DOI 10.1111/1467-6494.00077	36	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156809	10.1371/journal.pone.0156809	http://dx.doi.org/10.1371/journal.pone.0156809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27309528	gold, Green Published, Green Submitted			2022-12-26	WOS:000378029800015
J	Lin, BR; Le, DJ; Chen, YB; Wang, QW; Chung, DD; Frausto, RF; Croasdale, C; Yee, RW; Hejtmancik, FJ; Aldave, AJ				Lin, Benjamin R.; Le, Derek J.; Chen, Yabin; Wang, Qiwei; Chung, D. Doug; Frausto, Ricardo F.; Croasdale, Christopher; Yee, Richard W.; Hejtmancik, Fielding J.; Aldave, Anthony J.			Whole Exome Sequencing and Segregation Analysis Confirms That a Mutation in COL17A1 Is the Cause of Epithelial Recurrent Erosion Dystrophy in a Large Dominant Pedigree Previously Mapped to Chromosome 10q23-q24	PLOS ONE			English	Article							BEHNKE CORNEAL-DYSTROPHY; INDIVIDUAL PHENOTYPIC VARIANCES; GENE; PREDICTION; EXCLUSION; COLLAGEN; FAMILY; CDB2; XVII	Purpose To report identification of a COL17A1 mutation in a family with a corneal dystrophy previously mapped to chromosome 10q23-q24. Methods Whole-exome sequencing was performed on DNA samples from five affected family members and two unrelated, unaffected individuals. Identified variants were filtered for those that were: located in the linked interval on chromosome 10q23-q24; novel or rare (minor allele frequency <= 0.01); heterozygous; present in all affected individuals and not in controls; and present in genes that encode proteins expressed in human corneal epithelial cells (reads per kilobase per million >= 1). Sanger sequencing of identified variants (SNVs) was performed in additional family members. In silico analysis was used to predict the functional impact of non-synonymous variants. Results Three SNVs located in two genes were identified that met the filtering criteria: one rare synonymous c.3156C>T variant in the collagen, type XVII, alpha I (COL17A1) gene; and two rare variants, one synonymous and one missense, in the dynamin binding protein (DNMBP) gene. Sanger sequencing of additional family members determined that only the COL17A1 variant segregates with the affected phenotype. In silico analysis predicts that the missense variant in DNMBP would be tolerated. Conclusions The corneal dystrophy mapped to chromosome 10q23-q24 is associated with the c.3156C>T variant in COL17A1. As this variant has recently been identified in five other families with early onset recurrent corneal erosions, and has been shown in vitro to introduce a cryptic splice donor site, this dystrophy is likely caused by aberrant splicing of COL17A1 and should be classified as epithelial recurrent erosion dystrophy.	[Lin, Benjamin R.; Le, Derek J.; Chung, D. Doug; Frausto, Ricardo F.; Aldave, Anthony J.] Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA; [Chen, Yabin; Wang, Qiwei; Hejtmancik, Fielding J.] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Croasdale, Christopher] Davis Duehr Dean Clin, Madison, WI USA; [Yee, Richard W.] Cross Ophthalmol Associates, Houston, TX USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Aldave, AJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA.	aldave@jsei.ucla.edu	Chen, Yabin/N-3845-2015; Frausto, Ricardo/AAE-3146-2021	Frausto, Ricardo/0000-0003-3064-6745; Lin, Benjamin/0000-0002-6035-2468	National Eye Institute [R01EY022082, Z01EY000272]; National Institute of Health [P30 EY000331]; Research to Prevent Blindness (Stein Eye Institute); NATIONAL EYE INSTITUTE [R01EY022082] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (Stein Eye Institute)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by the following: National Eye Institute Grants R01EY022082 (A.J.A.) and Z01EY000272 (F.J.H.), https://nei.nih.gov/; National Institute of Health grant P30 EY000331 (core grant to Stein Eye Institute), http://www.nih.gov/; unrestricted grant from Research to Prevent Blindness (Stein Eye Institute), no grant #, https://www.rpbusa.org/rpb/?. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aldave AJ, 2005, MOL VIS, V11, P713; Bucklers M, 1949, KLIN MONATSBL AUGENH, V114, P386; Dighiero P, 2000, OPHTHALMOLOGY, V107, P1353, DOI 10.1016/S0161-6420(00)00149-4; Evans CJ, 2015, ANN HUM GENET, V79, P1, DOI 10.1111/ahg.12090; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Jonsson F, 2015, HUM MUTAT, V36, P463, DOI 10.1002/humu.22764; Kodaganur SG, 2013, MOL VIS, V19, P1694; Lisch W, 2013, CORNEA, V32, pE192, DOI 10.1097/ICO.0b013e3182a73865; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mort M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r19; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; Nakamura H, 2012, CORNEA, V31, P1217, DOI 10.1097/ICO.0b013e3181c32efd; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Okada M, 1998, AM J OPHTHALMOL, V126, P535, DOI 10.1016/S0002-9394(98)00135-4; Oliver VF, 2016, OPHTHALMOLOGY, V123, P709, DOI 10.1016/j.ophtha.2015.12.008; Reis W, 1917, DEUT MED WOCHENSCHR, V43, P575; Ridgway AEA, 2000, INVEST OPHTH VIS SCI, V41, P3286; Sullivan LS, 2003, CURR EYE RES, V27, P223, DOI 10.1076/ceyr.27.4.223.16595; Thiel H J, 1967, Klin Monbl Augenheilkd, V150, P862; Vincent AL, 2009, MOL VIS, V15, P1700; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; Weiss JS, 2015, CORNEA, V34, P117, DOI 10.1097/ICO.0000000000000307; Yee RW, 1997, GENOMICS, V46, P152, DOI 10.1006/geno.1997.5028	24	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157418	10.1371/journal.pone.0157418	http://dx.doi.org/10.1371/journal.pone.0157418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309958	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800069
J	Natarajan, S; Kim, HT; Thamilarasan, SK; Veerappan, K; Park, JI; Nou, IS				Natarajan, Sathishkumar; Kim, Hoy-Taek; Thamilarasan, Senthil Kumar; Veerappan, Karpagam; Park, Jong-In; Nou, Ill-Sup			Whole Genome Re-Sequencing and Characterization of Powdery Mildew Disease-Associated Allelic Variation in Melon	PLOS ONE			English	Article							MOLECULAR MARKERS; VIRUS-RESISTANCE; CUCUMIS-SATIVUS; MOSAIC-VIRUS; RACE 2; GENE; INHERITANCE; L.; GENERATION; SINGLE	Powdery mildew is one of the most common fungal diseases in the world. This disease frequently affects melon (Cucumis melo L.) and other Cucurbitaceous family crops in both open field and greenhouse cultivation. One of the goals of genomics is to identify the polymorphic loci responsible for variation in phenotypic traits. In this study, powdery mildew disease assessment scores were calculated for four melon accessions, 'SCNU1154', 'Edisto47', 'MR-1', and 'PMR5'. To investigate the genetic variation of these accessions, whole genome re-sequencing using the Illumina HiSeq 2000 platform was performed. A total of 754,759,704 quality-filtered reads were generated, with an average of 82.64% coverage relative to the reference genome. Comparisons of the sequences for the melon accessions revealed around 7.4 million single nucleotide polymorphisms (SNPs), 1.9 million InDels, and 182,398 putative structural variations (SVs). Functional enrichment analysis of detected variations classified them into biological process, cellular component and molecular function categories. Further, a disease-associated QTL map was constructed for 390 SNPs and 45 InDels identified as related to defense-response genes. Among them 112 SNPs and 12 InDels were observed in powdery mildew responsive chromosomes. Accordingly, this whole genome re-sequencing study identified SNPs and InDels associated with defense genes that will serve as candidate polymorphisms in the search for sources of resistance against powdery mildew disease and could accelerate marker-assisted breeding in melon.	[Natarajan, Sathishkumar; Kim, Hoy-Taek; Thamilarasan, Senthil Kumar; Veerappan, Karpagam; Park, Jong-In; Nou, Ill-Sup] Sunchon Natl Univ, Dept Hort, Sunchon 540950, Jeonnam, South Korea	Sunchon National University	Nou, IS (corresponding author), Sunchon Natl Univ, Dept Hort, Sunchon 540950, Jeonnam, South Korea.	nis@sunchon.ac.kr	Thamilarasan, Senthil Kumar/AAX-5643-2021	Thamilarasan, Senthil Kumar/0000-0003-3691-5838; Natarajan, Sathishkumar/0000-0002-9001-8495; Veerappan, Karpagam/0000-0002-9910-6715	Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA); Korea Forest Service (KFS) [213003-04-4-SB110]; Export Promotion Technology Development Program [312065-05-4-HD030]; Golden Seed Project (Center for Horticultural Seed Development); Ministry of Agriculture, Food and Rural Affairs (MAFRA)	Ministry of Oceans and Fisheries (MOF)(Ministry of Oceans & Fisheries (MOF), Republic of Korea); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Korea Forest Service (KFS)(Korea Forest Service); Export Promotion Technology Development Program; Golden Seed Project (Center for Horticultural Seed Development); Ministry of Agriculture, Food and Rural Affairs (MAFRA)(Ministry of Agriculture, Food & Rural Affairs (MAFRA), Republic of Korea)	This research was supported by Golden Seed Project (Center for Horticultural Seed Development, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA) and Korea Forest Service (KFS): 213003-04-4-SB110. Export Promotion Technology Development Program (Grant No. 312065-05-4-HD030), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BaudraccoArnas S, 1996, THEOR APPL GENET, V93, P57, DOI 10.1007/BF00225727; BOHN GW, 1964, PHYTOPATHOLOGY, V54, P587; Brotman Y, 2005, THEOR APPL GENET, V110, P337, DOI 10.1007/s00122-004-1845-z; Causse M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-791; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clepet C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-252; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dahmani-Mardas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015776; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Dogimont C, 1997, EUPHYTICA, V96, P391, DOI 10.1023/A:1003069703294; Dogimont C, 2011, GENE LIST FOR MELON; EPINAT C, 1993, EUPHYTICA, V65, P135, DOI 10.1007/BF00022575; Esteras C, 2013, THEOR APPL GENET, V126, P1285, DOI 10.1007/s00122-013-2053-5; Esteva J, 1988, RESISTANCE YELLOWING; Fukino N, 2004, BREEDING SCI, V54, P141, DOI 10.1270/jsbbs.54.141; Garcia-Mas J, 2000, THEOR APPL GENET, V101, P860, DOI 10.1007/s001220051553; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Gonzalez VM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-246; Gonzalez VM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1131; Gonzalez VM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-782; Gonzalez VM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-339; Gumpf D, 1979, PHYTOPATHOLOGY; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; HARWOOD RR, 1968, J HERED, V59, P213, DOI 10.1093/oxfordjournals.jhered.a107695; HARWOOD RR, 1968, J HERED, V59, P126, DOI 10.1093/oxfordjournals.jhered.a107663; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Iovieno P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2325-3; Jagger I, 1938, PHYTOPATHOLOGY, V28, P761; Jahn M, 2002, POWDERY MILDEWS: A COMPREHENSIVE TREATISE, P239; JEFFREY C, 1980, BOT J LINN SOC, V81, P233, DOI 10.1111/j.1095-8339.1980.tb01676.x; Jewel H, EXPRESSION PROFILING; Joobeur T, 2004, PLANT J, V39, P283, DOI 10.1111/j.1365-313X.2004.02134.x; KENIGSBUCH D, 1989, PLANT DIS, V73, P206, DOI 10.1094/PD-73-0206; Kim Hoy-taek, 2016, Journal of Plant Biotechnology, V43, P58, DOI 10.5010/JPB.2016.43.1.58; Kong Q, 2014, SCREENING SUITABLE R; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lebeda A., 2006, Cucurbitaceae 2006, Asheville, North Carolina, USA, 17-21 September 2006, P444; Lebeda A, 2015, EUROPEAN J PLANT PAT, P1; Leida C, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0183-2; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu LZ, 2010, HORTSCIENCE, V45, P1407, DOI 10.21273/HORTSCI.45.9.1407; Nunes EWLP, 2015, CROP BREED APPL BIOT, V15, P181, DOI 10.1590/1984-70332015v15n3n31; Lopesz-Sese AI, 2000, HORTSCIENCE, V35, P110, DOI 10.21273/HORTSCI.35.1.110; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Mascarell-Creus A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-467; McCreight JD, 2008, HORTSCIENCE, V43, P122, DOI 10.21273/HORTSCI.43.1.122; McCreight JD, 1991, POTENTIAL SOURCES RE, V14, P51; McGrath MT, 2001, PLANT DIS, V85, P236, DOI 10.1094/PDIS.2001.85.3.236; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Monforte AJ, 2003, PLANT BREEDING, V122, P153, DOI 10.1046/j.1439-0523.2003.00848.x; Morishita M, 2003, JARQ-JPN AGR RES Q, V37, P7, DOI 10.6090/jarq.37.7; Ning XF, 2014, EUPHYTICA, V195, P345, DOI 10.1007/s10681-013-1000-5; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pech JC, 2008, PLANT SCI, V175, P114, DOI 10.1016/j.plantsci.2008.01.003; PITRAT M, 1984, EUPHYTICA, V33, P57, DOI 10.1007/BF00022750; Pitrat M, 1991, J HEREDITY, V82; Pitrat Michel, 2008, V1, P283; Quiot-Douine L, 1988, EUCARPIA M CUC GEN B; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477; Salari M., 2012, African Journal of Biotechnology, V11, P15324; Sanseverino W, 2013, NUCLEIC ACIDS RES, V41, pD1167, DOI 10.1093/nar/gks1183; Saxena RK, 2014, BRIEF FUNCT GENOMICS, V13, P296, DOI 10.1093/bfgp/elu016; Sebastian P, 2010, P NATL ACAD SCI USA, V107, P14269, DOI 10.1073/pnas.1005338107; Silberstein L, 1999, SCI HORTIC-AMSTERDAM, V79, P101, DOI 10.1016/S0304-4238(98)00199-X; Sitterly WR, 1978, POWDERY MILDEWS, P359; Sugiyama M, 2007, J JPN SOC HORTIC SCI, V76, P316, DOI 10.2503/jjshs.76.316; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Webb R, 1979, HORTSCIENCE USA; Xu XY, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0240-6; Zhang BC, 2010, P NATL ACAD SCI USA, V107, P13532, DOI 10.1073/pnas.0910558107	73	22	24	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157524	10.1371/journal.pone.0157524	http://dx.doi.org/10.1371/journal.pone.0157524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311063	Green Submitted, Green Published, gold			2022-12-26	WOS:000378029800090
J	Schroder, M; Melum, GR; Landsverk, OJB; Bujko, A; Yaqub, S; Gran, E; Aamodt, H; Baekkevold, ES; Jahnsen, FL; Richter, L				Schroder, Martine; Melum, Guro Reinholt; Landsverk, Ole J. B.; Bujko, Anna; Yaqub, Sheraz; Gran, Einar; Aamodt, Henrik; Baekkevold, Espen S.; Jahnsen, Frode L.; Richter, Lisa			CD1c-Expression by Monocytes - Implications for the Use of Commercial CD1c(+) Dendritic Cell Isolation Kits	PLOS ONE			English	Article							HUMAN TISSUES; CUTTING EDGE; BLOOD; SUBSETS; DISTINCT; RESPONSES; MACROPHAGES; EXPRESSION; POLARIZATION; INDUCTION	Conventional dendritic cells (cDCs) comprise a heterogeneous population of cells that are important regulators of immunity and homeostasis. CD1c(+) cDCs are present in human blood and tissues, and found to efficiently activate naive CD4(+) T cells. While CD1c is thought to specifically identify this subset of human cDCs, we show here that also classical and intermediate monocytes express CD1c. Accordingly, the commercial CD1c (BDCA-1) Dendritic Cell Isolation Kit isolates two distinct cell populations from blood: CD1c(+) CD14 cDCs and CD1c(+) CD14(+) monocytes. CD1c(+) cDCs and CD1c(+) monocytes exhibited strikingly different properties, including their differential regulation of surface marker expression, their levels of cytokine production, and their ability to stimulate naive CD4(+) T cells. These results demonstrate that a commercial CD1c (BDCA-1) Dendritic Cell Isolation Kit isolates two functionally different cell populations, which has important implications for the interpretation of previously generated data using this kit to characterize CD1c(+) cDCs.	[Schroder, Martine; Melum, Guro Reinholt; Landsverk, Ole J. B.; Bujko, Anna; Baekkevold, Espen S.; Jahnsen, Frode L.; Richter, Lisa] Oslo Univ Hosp, Dept Pathol, N-0450 Oslo, Norway; [Schroder, Martine; Landsverk, Ole J. B.; Bujko, Anna; Baekkevold, Espen S.; Jahnsen, Frode L.; Richter, Lisa] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Yaqub, Sheraz] Oslo Univ Hosp, Dept Gastrointestinal Surg, N-0450 Oslo, Norway; [Gran, Einar] Lovisenberg Diakonale Hosp, Dept Otolaryngol, Oslo, Norway; [Aamodt, Henrik] Oslo Univ Hosp, Dept Cardiothorac Surg, N-0450 Oslo, Norway; [Aamodt, Henrik] Oslo Univ Hosp, Dept Pathol, Tumor Immunol Grp, N-0450 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Richter, L (corresponding author), Oslo Univ Hosp, Dept Pathol, N-0450 Oslo, Norway.; Richter, L (corresponding author), Univ Oslo, Ctr Immune Regulat, Oslo, Norway.	lisamgr@medisin.uio.no	Yaqub, Sheraz/AAC-3906-2019; Richter, Lisa/AAJ-8014-2021; Landsverk, Ole Jørgen Bjarnason/J-1975-2019	Yaqub, Sheraz/0000-0002-5696-2319; Richter, Lisa/0000-0002-0769-619X; Landsverk, Ole Jørgen Bjarnason/0000-0002-1367-2397; Bujko, Anna/0000-0001-8693-9227	Research Council of Norway through its Centres of Excellence funding scheme [179573/V40]; South Eastern Norway Regional Health Authority [1012105]	Research Council of Norway through its Centres of Excellence funding scheme; South Eastern Norway Regional Health Authority	This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179573/V40 (LR FLJ); and by a grant from the South Eastern Norway Regional Health Authority, project number 1012105 (LR GRM OJBL FLJ ESB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Kathrine Hagelsteen, Kjersti Thorvaldsen Hagen and Aaste Aursjo for excellent technical assistance, and the Flowcytometry Core Facility at Oslo University Hospital, Rikshopitalet. This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179573/V40; and by grant from the South Eastern Norway Regional Health Authority, project number 1012105.	[Anonymous], 2008, CD1C BDCA 1 DENDR CE; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Beitnes ACR, 2011, SCAND J IMMUNOL, V74, P186, DOI 10.1111/j.1365-3083.2011.02549.x; Beitnes ACR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033556; Bigley V, 2015, J LEUKOCYTE BIOL, V97, P627, DOI 10.1189/jlb.1HI0714-351R; Bine S, 2012, CLIN EXP IMMUNOL, V169, P10, DOI 10.1111/j.1365-2249.2012.04586.x; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chow KV, 2016, J IMMUNOL, V196, P624, DOI 10.4049/jimmunol.1501202; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; DALE I, 1985, AM J CLIN PATHOL, V84, P24, DOI 10.1093/ajcp/84.1.24; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Faivre V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047209; Franks HA, 2014, INT J CANCER, V134, P575, DOI 10.1002/ijc.28398; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gingras MC, 2002, MOL IMMUNOL, V38, P817, DOI 10.1016/S0161-5890(02)00004-4; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Horlock C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r30; Jongbloed SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1864; Karlsson A, 2007, CLIN VACCINE IMMUNOL, V14, P328, DOI 10.1128/CVI.00349-06; Kassianos AJ, 2013, AM J PHYSIOL-RENAL, V305, pF1391, DOI 10.1152/ajprenal.00318.2013; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Mann ER, 2016, GUT, V65, P256, DOI 10.1136/gutjnl-2014-307916; Mann ER, 2012, INFLAMM BOWEL DIS, V18, P1275, DOI 10.1002/ibd.21893; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Melum GR, 2015, MUCOSAL DENDRITIC CE; Melum GR, 2014, J ALLERGY CLIN IMMUN, V134, P613, DOI 10.1016/j.jaci.2014.05.010; Milne P, 2015, BLOOD, V125, P470, DOI 10.1182/blood-2014-08-593582; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Penna G, 2001, J IMMUNOL, V167, P1862, DOI 10.4049/jimmunol.167.4.1862; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; Selenko-Gebauer N, 2003, J IMMUNOL, V170, P3637, DOI 10.4049/jimmunol.170.7.3637; STASHENKO P, 1982, INFECT IMMUN, V38, P938, DOI 10.1128/IAI.38.3.938-947.1982; Vittorakis S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/231036; Watchmaker PB, 2014, NAT IMMUNOL, V15, P98, DOI 10.1038/ni.2768; Wilkinson R, 2006, PROSTATE, V66, P180, DOI 10.1002/pros.20333	46	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157387	10.1371/journal.pone.0157387	http://dx.doi.org/10.1371/journal.pone.0157387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311059	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800064
J	Vinyoles, M; Del Valle-Perez, B; Curto, J; Padilla, M; Villarroel, A; Yang, J; de Herreros, AG; Dunach, M				Vinyoles, M.; Del Valle-Perez, B.; Curto, J.; Padilla, M.; Villarroel, A.; Yang, J.; de Herreros, A. G.; Dunach, M.			Activation of CK1 epsilon by PP2A/PR61 epsilon is required for the initiation of Wnt signaling	ONCOGENE			English	Article							PROTEIN PHOSPHATASE 2A; CASEIN KINASE 1; BETA-CATENIN; LRP6 PHOSPHORYLATION; REGULATORY SUBUNIT; TRANSCRIPTIONAL ACTIVITY; COMPLEX; P120-CATENIN; BINDING; DOMAIN	Canonical Wnt signaling induces the stabilization of beta-catenin, its translocation to the nucleus and the activation of target promoters. This pathway is initiated by the binding of Wnt ligands to the Frizzled receptor, the association of the LRP5/6 coreceptor and the formation of a complex comprising Dvl-2, Axin and protein kinases CK1 alpha, epsilon, gamma and GSK3. Among these, activation of CK1 epsilon, constitutively bound to LRP5/6 through p120-catenin, is required for the association of the rest of the components. We describe here that CK1 epsilon is activated by the PP2A/PR61 epsilon phosphatase. Binding of Wnt ligands promotes the interaction of LRP5/6-associated CK1 epsilon with Frizzled-bound PR61 epsilon regulatory subunit, facilitating the access of PP2A catalytic subunit to CK1 epsilon and its activation, what enables the recruitment of Dvl-2 to the receptor complex and the initiation of the Wnt pathway. Our results uncover the mechanism of activation of the canonical Wnt pathway by its ligands.	[Vinyoles, M.; Del Valle-Perez, B.; Curto, J.; Padilla, M.; Villarroel, A.; Dunach, M.] Univ Autonoma Barcelona, Fac Med, CEB, Dept Bioquim & Biol Mol, E-08193 Bellaterra, Spain; [Vinyoles, M.; de Herreros, A. G.] Inst Hosp Mar Invest Med IMIM, Programa Recerca Canc, Barcelona, Spain; [Yang, J.] Univ Illinois, Coll Vet Med, Dept Comparat Biosci, Urbana, IL USA; [de Herreros, A. G.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain	Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Illinois System; University of Illinois Urbana-Champaign; Pompeu Fabra University	Dunach, M (corresponding author), Univ Autonoma Barcelona, Fac Med, CEB, Dept Bioquim & Biol Mol, E-08193 Bellaterra, Spain.; de Herreros, AG (corresponding author), IMIM, Parc Recerca Biomed Barcelona,C Doctor Aiguader, E-08003 Barcelona, Spain.	agarcia@imim.es; mireia.dunach@uab.es	Dunach, Mireia/E-3604-2015; Vinyoles, Meritxell/AAA-5302-2019	Dunach, Mireia/0000-0001-9844-5603; 	Ministerio de Economia y Competitividad [BFU2012-31554, BFU2015-65153-R, SAF2013-48849-C2-R1]; Fundacio La Marato de TV3 [120130]; ICREA Academia from Generalitat de Catalunya [2014SGR-32]; ISCIII/FEDER [RD12/0036/005]; FPI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111816, R35GM131810] Funding Source: NIH RePORTER	Ministerio de Economia y Competitividad(Spanish Government); Fundacio La Marato de TV3; ICREA Academia from Generalitat de Catalunya(ICREA); ISCIII/FEDER(Spanish Government); FPI(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs Gonzalez-Sancho, C Niehrs, A Bigas and A Kikuchi for providing reagents and N Ontiveros for excellent technical assistance. This work was funded by grants from the Ministerio de Economia y Competitividad (BFU2012-31554 and BFU2015-65153-R, both MINECO/FEDER, to MD and SAF2013-48849-C2-R1 to AGH) and Fundacio La Marato de TV3 (120130) to MD and AGH. Support from ICREA Academia, 2014SGR-32 from Generalitat de Catalunya and ISCIII/FEDER (RD12/0036/005) is also appreciated. MV was a recipient of a predoctoral fellowship from FPI.	Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Casagolda D, 2010, J CELL SCI, V123, P2621, DOI 10.1242/jcs.067512; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; Cruciat CM, 2014, CURR OPIN CELL BIOL, V31, P46, DOI 10.1016/j.ceb.2014.08.003; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; del Valle-Perez B, 2011, J CELL SCI, V124, P2298, DOI 10.1242/jcs.082693; del Valle-Perez B, 2011, MOL CELL BIOL, V31, P2877, DOI 10.1128/MCB.01466-10; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Jin Z, 2009, J BIOL CHEM, V284, P7190, DOI 10.1074/jbc.M807907200; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Li XH, 2001, EMBO J, V20, P4122, DOI 10.1093/emboj/20.15.4122; Liang J, 2011, MOL CELL BIOL, V31, P2577, DOI 10.1128/MCB.05103-11; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Ratcliffe MJ, 2000, J BIOL CHEM, V275, P35680, DOI 10.1074/jbc.C000639200; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Solanas G, 2008, J CELL SCI, V121, P2224, DOI 10.1242/jcs.021667; Swiatek W, 2004, J BIOL CHEM, V279, P13011, DOI 10.1074/jbc.M304682200; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Valls G, 2012, J CELL SCI, V125, P5288, DOI 10.1242/jcs.101030; Vinyoles M, 2014, MOL CELL, V53, P444, DOI 10.1016/j.molcel.2013.12.010; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yang J, 2003, DEVELOPMENT, V130, P5569, DOI 10.1242/dev.00762; Yu J, 2014, BIOSCIENCE REP, V34; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698	45	12	12	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 19	2017	36	3					429	438		10.1038/onc.2016.209	http://dx.doi.org/10.1038/onc.2016.209			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IB	27321178	Green Accepted			2022-12-26	WOS:000394166000012
J	Imbrici, P; Altamura, C; Camerino, GM; Mangiatordi, GF; Conte, E; Maggi, L; Brugnoni, R; Musaraj, K; Caloiero, R; Alberga, D; Marsano, RM; Ricci, G; Siciliano, G; Nicolotti, O; Mora, M; Bernasconi, P; Desaphy, JF; Mantegazza, R; Camerino, DC				Imbrici, Paola; Altamura, Concetta; Camerino, Giulia Maria; Mangiatordi, Giuseppe Felice; Conte, Elena; Maggi, Lorenzo; Brugnoni, Raffaella; Musaraj, Kejla; Caloiero, Roberta; Alberga, Domenico; Marsano, Rene Massimiliano; Ricci, Giulia; Siciliano, Gabriele; Nicolotti, Orazio; Mora, Marina; Bernasconi, Pia; Desaphy, Jean-Francois; Mantegazza, Renato; Camerino, Diana Conte			Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies	FASEB JOURNAL			English	Article						chloride channel; gene expression; molecular dynamics; patch-clamp; skeletal muscle	CHLORIDE CHANNEL; MOLECULAR-DYNAMICS; CLCN1 MUTATIONS; FUNCTIONAL-CHARACTERIZATION; MUSCLE CHANNELOPATHIES; GENE; DISEASE; PHENOTYPE; INSIGHTS; MECHANISMS	Myotonia congenita is an inherited disease that is characterized by impaired muscle relaxation after contraction caused by loss-of-function mutations in the skeletal muscle ClC-1 channel. We report a novel ClC-1 mutation, T335N, that is associated with a mild phenotype in 1 patient, located in the extracellular I-J loop. The purpose of this study was to provide a solid correlation between T335N dysfunction and clinical symptoms in the affected patient as well as to offer hints for drug development. Our multidisciplinary approach includes patch-clamp electrophysiology on T335N and ClC-1 wild-type channels expressed in tsA201 cells, Western blot and quantitative PCR analyses on muscle biopsies from patient and unaffected individuals, and molecular dynamics simulations using a homology model of the ClC-1 dimer. T335N channels display reduced chloride currents as a result of gating alterations rather than altered surface expression. Molecular dynamics simulations suggest that the I-J loop might be involved in conformational changes that occur at the dimer interface, thus affecting gating. Finally, the gene expression profile of T335N carrier showed a diverse expression of K+ channel genes, compared with control individuals, as potentially contributing to the phenotype. This experimental paradigm satisfactorily explained myotonia in the patient. Furthermore, it could be relevant to the study and therapy of any channelopathy.-Imbrici, P., Altamura, C., Camerino, G. M., Mangiatordi, G. F., Conte, E., Maggi, L., Brugnoni, R., Musaraj, K., Caloiero, R., Alberga, D., Marsano, R. M., Ricci, G., Siciliano, G., Nicolotti, O., Mora, M., Bernasconi, P., Desaphy, J.-F., Mantegazza, R., Camerino, D. C. Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies.	[Imbrici, Paola; Altamura, Concetta; Camerino, Giulia Maria; Mangiatordi, Giuseppe Felice; Conte, Elena; Musaraj, Kejla; Caloiero, Roberta; Nicolotti, Orazio; Camerino, Diana Conte] Ist Nazl Fis Nucl, Dept Pharm, Drug Sci, Bari, Italy; [Alberga, Domenico] Ist Nazl Fis Nucl, Dept Phys M Merlin, Bari, Italy; Ctr Tecnol Innovat Rilevaz & Elaboraz Segnale, Bari, Italy; [Marsano, Rene Massimiliano] Univ Bari Aldo Moro, Dept Biol, Bari, Italy; [Desaphy, Jean-Francois] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Bari, Italy; [Maggi, Lorenzo; Brugnoni, Raffaella; Mora, Marina; Bernasconi, Pia; Mantegazza, Renato] Fdn Ist Neurol Carlo Besta, Ist Ricovero & Cura Carattere Sci, Div Neurol, Neuroimmunol & Neuromuscular Dis Unit, Milan, Italy; [Ricci, Giulia; Siciliano, Gabriele] Univ Pisa, Dept Clin & Expt Med, Neurol Sect, Pisa, Italy	Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; University of Pisa	Imbrici, P (corresponding author), Univ Bari Aldo Moro, Dept Pharm, Drug Sci, Via Orabona 4, I-70125 Bari, Italy.		Bernasconi, Pia/AAB-7590-2019; Conte, Elena/AAF-4055-2019; Maggi, Lorenzo/K-3578-2018; Brugnoni, Raffaella/AAN-8039-2021; Desaphy, Jean-Francois/T-6191-2019; Alberga, Domenico/K-3272-2019; Conte, Elena/AAV-3153-2020; Marsano, René Massimiliano/B-9640-2012; Mantegazza, Renato/AAB-7569-2019; imbrici, paola/J-6855-2018; Mangiatordi, Giuseppe Felice/AAH-9527-2020; Mora, Marina/J-2883-2018	Conte, Elena/0000-0001-8571-5125; Maggi, Lorenzo/0000-0002-0932-5173; Brugnoni, Raffaella/0000-0003-1365-4508; Desaphy, Jean-Francois/0000-0001-8816-9369; Alberga, Domenico/0000-0002-9475-9602; Marsano, René Massimiliano/0000-0001-8450-1010; Mantegazza, Renato/0000-0002-9810-5737; imbrici, paola/0000-0001-9140-5350; Mangiatordi, Giuseppe Felice/0000-0003-4042-2841; Bernasconi, Pia/0000-0003-0869-2104; Camerino, Giulia Maria/0000-0003-1410-6327; Mora, Marina/0000-0002-5765-2320	Italian Health Ministry [GR-2009-1580433]; Telethon-Italy [GGP14096]	Italian Health Ministry(Ministry of Health, Italy); Telethon-Italy(Fondazione Telethon)	This work was supported by the Italian Health Ministry (Grant GR-2009-1580433 to P.I.) and Telethon-Italy (Grant GGP14096 to D.C.). The authors thank Brett Bennetts (St Vincent's Institute of Medical Research, Fitzroy, VIC, Australia) and Michael Parker (Department of Biochemistry and Molecular Biology, The University of Melbourne, Parkville, VIC, Australia) for kindly providing the homology model of hClC-1 that is based on the crystallographic coordinates of CmClC. The authors declare no competing financial interests.	Accardi A, 2000, J GEN PHYSIOL, V116, P433, DOI 10.1085/jgp.116.3.433; ADELMAN SA, 1976, J CHEM PHYS, V64, P2375, DOI 10.1063/1.432526; Alberga D, 2014, BBA-BIOMEMBRANES, V1838, P3052, DOI 10.1016/j.bbamem.2014.08.015; [Anonymous], 2013, SCHROD REL 2013 2 MA; Bennetts B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3507; Brugnoni R, 2013, J HUM GENET, V58, P581, DOI 10.1038/jhg.2013.58; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cederholm JM, 2010, INT J BIOCHEM CELL B, V42, P1182, DOI 10.1016/j.biocel.2010.04.004; Colding-Jorgensen E, 2005, MUSCLE NERVE, V32, P19, DOI 10.1002/mus.20295; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Desaphy JF, 2013, EXP NEUROL, V248, P530, DOI 10.1016/j.expneurol.2013.07.018; Duno M, 2004, EUR J HUM GENET, V12, P738, DOI 10.1038/sj.ejhg.5201218; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; FAHLKE C, 1995, NEURON, V15, P463, DOI 10.1016/0896-6273(95)90050-0; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Fialho D, 2007, BRAIN, V130, P3265, DOI 10.1093/brain/awm248; Furby A, 2014, NEUROMUSCULAR DISORD, V24, P953, DOI 10.1016/j.nmd.2014.06.439; GEORGE AL, 1993, NAT GENET, V3, P305, DOI 10.1038/ng0493-305; Gradogna A, 2014, BBA-BIOMEMBRANES, V1838, P2745, DOI 10.1016/j.bbamem.2014.07.021; Ha K, 2014, MOL CELLS, V37, P202, DOI 10.14348/molcells.2014.2267; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imbrici P, 2015, J PHYSIOL-LONDON, V593, P4181, DOI 10.1113/JP270358; Imbrici P, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00156; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kearney JA, 2011, CURR OPIN GENET DEV, V21, P349, DOI 10.1016/j.gde.2010.12.007; Kullmann DM, 2010, J PHYSIOL-LONDON, V588, P1823, DOI 10.1113/jphysiol.2010.190652; Lo Monaco M, 2015, CLIN NEUROPHYSIOL, V126, P399, DOI 10.1016/j.clinph.2014.06.008; Lossin C, 2008, ADV GENET, V63, P25, DOI 10.1016/S0065-2660(08)01002-X; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Mangiatordi GF, 2015, BBA-BIOMEMBRANES, V1848, P1462, DOI 10.1016/j.bbamem.2015.03.019; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Papponen H, 2005, EXP NEUROL, V191, P163, DOI 10.1016/j.expneurol.2004.07.018; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Portaro S, 2015, NEUROMOL MED, V17, P285, DOI 10.1007/s12017-015-8356-8; Pusch M, 2002, HUM MUTAT, V19, P423, DOI 10.1002/humu.10063; Raheem O, 2012, NEUROLOGY, V79, P2194, DOI 10.1212/WNL.0b013e31827595e2; Ryan A, 2002, J PHYSIOL-LONDON, V545, P345, DOI 10.1113/jphysiol.2002.027037; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Skalova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082549; Stolting G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00378; Suetterlin K, 2014, CURR OPIN NEUROL, V27, P583, DOI 10.1097/WCO.0000000000000127; Suetterlin KJ, 2015, JAMA NEUROL, V72, P1531, DOI 10.1001/jamaneurol.2015.2338; Swaggart KA, 2014, EXP PHYSIOL, V99, P621, DOI 10.1113/expphysiol.2013.075887; Tricarico D, 2004, FASEB J, V18, P760, DOI 10.1096/fj.03-0722fje; Trivedi JR, 2014, EXP NEUROL, V253, P28, DOI 10.1016/j.expneurol.2013.12.005; Ulzi G, 2012, J NEUROL SCI, V318, P65, DOI 10.1016/j.jns.2012.03.024; Weinberger S, 2012, J PHYSIOL-LONDON, V590, P3449, DOI 10.1113/jphysiol.2012.232785; Wu FF, 2002, BRAIN, V125, P2392, DOI 10.1093/brain/awf246; Zhang J, 2000, J BIOL CHEM, V275, P2999, DOI 10.1074/jbc.275.4.2999	51	17	17	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3285	3295		10.1096/fj.201500079R	http://dx.doi.org/10.1096/fj.201500079R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27324117	Green Published, hybrid			2022-12-26	WOS:000384329800003
J	Hamlin, AN; Basford, JE; Jaeschke, A; Hui, DY				Hamlin, Allyson N.; Basford, Joshua E.; Jaeschke, Anja; Hui, David Y.			LRP1 Protein Deficiency Exacerbates Palmitate-induced Steatosis and Toxicity in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-1; MOLECULAR-MECHANISMS; VASCULAR WALL; FATTY-ACIDS; AUTOPHAGY; APOPTOSIS; METABOLISM; DISEASE; STORAGE; GENE	LRP1 (LDL receptor-related protein-1) is a ubiquitous receptor with both cell signaling and ligand endocytosis properties. In the liver, LRP1 serves as a chylomicron remnant receptor and also participates in the transport of extracellular cathepsin D to the lysosome for prosaposin activation. The current study showed that in comparison with wild type mice, hepatocyte-specific LRP1 knock-out (hLrp1(-/-)) mice were more susceptible to fasting-induced lipid accumulation in the liver. Primary hepatocytes isolated from hLrp1(-/-) mice also accumulated more intracellular lipids and experienced higher levels of endoplasmic reticulum (ER) stress after palmitate treatment compared with similarly treated hLrp1(+/+) hepatocytes. Palmitate-treated hLrp1(-/-) hepatocytes displayed similar LC3-II levels, but the levels of p62 were elevated in comparison with palmitate-treated hLrp1(+/+) hepatocytes, suggesting that the elevated lipid accumulation in LRP1-defective hepatocytes was not due to defects in autophagosome formation but was due to impairment of lipophagic lipid hydrolysis in the lysosome. Additional studies showed increased palmitate-induced oxidative stress, mitochondrial and lysosomal permeability, and cell death in hLrp1(-/-) hepatocytes. Importantly, the elevated cell death and ER stress observed in hLrp1(-/-) hepatocytes were abrogated by E64D treatment, whereas inhibiting ER stress diminished cell death but not lysosomal permeabilization. Taken together, these results documented that LRP1 deficiency in hepatocytes promotes lipid accumulation and lipotoxicity through lysosomal-mitochondrial permeabilization and ER stress that ultimately result in cell death. Hence, LRP1 dysfunction may be a major risk factor in fatty liver disease progression.	[Hamlin, Allyson N.] Univ Cincinnati, Coll Med, Metab Dis Res Ctr, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45237 USA; [Basford, Joshua E.; Jaeschke, Anja; Hui, David Y.] Univ Cincinnati, Coll Med, Metab Dis Res Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Hui, DY (corresponding author), Univ Cincinnati, Coll Med, Metab Dis Res Ctr, Dept Pathol ML0507, 2120 E Galbraith Rd, Cincinnati, OH 45267 USA.	huidy@ucmail.uc.edu			National Institutes of Health [RO1 DK074932]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant RO1 DK074932 (to D. Y. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Basford J. E., 2009, THROMB VASC BIOL, V29, P1772; Basford JE, 2011, J BIOL CHEM, V286, P13079, DOI 10.1074/jbc.M111.229369; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Cai N, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-28; Caldwell Stephen H, 2004, Clin Liver Dis, V8, P595, DOI 10.1016/j.cld.2004.04.009; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Chatterjee TK, 2014, DIABETES, V63, P176, DOI 10.2337/db13-1148; Czaja MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC973, DOI 10.1152/ajpcell.00527.2009; Day CP, 2011, CLIN MED, V11, P176, DOI 10.7861/clinmedicine.11-2-176; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dong HQ, 2011, TRENDS ENDOCRIN MET, V22, P234, DOI 10.1016/j.tem.2011.02.003; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Hu L, 2006, ARTERIOSCL THROM VAS, V26, P2710, DOI 10.1161/01.ATV.0000249641.96896.e6; Huang X, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-22; Kneeman JM, 2012, THER ADV GASTROENTER, V5, P199, DOI 10.1177/1756283X11430859; Leamy AK, 2013, PROG LIPID RES, V52, P165, DOI 10.1016/j.plipres.2012.10.004; Li ZZ, 2008, HEPATOLOGY, V47, P1495, DOI 10.1002/hep.22183; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Masson O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007422; Moller L, 2008, CLIN SCI, V114, P547, DOI 10.1042/CS20070217; Overton CD, 2007, CIRC RES, V100, P670, DOI 10.1161/01.RES.0000260204.40510.aa; Quiroga AD, 2012, BBA-MOL CELL BIOL L, V1821, P762, DOI 10.1016/j.bbalip.2011.09.007; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; ROBBINS E, 1963, J CELL BIOL, V18, P237, DOI 10.1083/jcb.18.2.237; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Steinberg D, 1963, Biochem Soc Symp, V24, P111; Sun Y, 2013, AUTOPHAGY, V9, P1115, DOI 10.4161/auto.24919; Tatti M, 2013, AUTOPHAGY, V9, P241, DOI 10.4161/auto.22557; Tatti M, 2012, HUM MOL GENET, V21, P5159, DOI 10.1093/hmg/dds367; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; Wang YJ, 2010, HEPATOLOGY, V52, P266, DOI 10.1002/hep.23645; Yahiro K, 2012, J BIOL CHEM, V287, P31104, DOI 10.1074/jbc.M112.387498; Yancey PG, 2010, ARTERIOSCL THROM VAS, V30, P787, DOI 10.1161/ATVBAHA.109.202051; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006922	41	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16610	16619		10.1074/jbc.M116.717744	http://dx.doi.org/10.1074/jbc.M116.717744			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27317662	hybrid, Green Published			2022-12-26	WOS:000380826700020
J	Rego, S; Heal, TJ; Pidwill, GR; Till, M; Robson, A; Lamont, RJ; Sessions, RB; Jenkinson, HF; Race, PR; Nobbs, AH				Rego, Sara; Heal, Timothy J.; Pidwill, Grace R.; Till, Marisa; Robson, Alice; Lamont, Richard J.; Sessions, Richard B.; Jenkinson, Howard F.; Race, Paul R.; Nobbs, Angela H.			Structural and Functional Analysis of Cell Wall-anchored Polypeptide Adhesin BspA in Streptococcus agalactiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; C-TERMINAL DOMAIN; GROUP-A STREPTOCOCCUS; RICH REPEAT PROTEINS; MUTANS ANTIGEN-I/II; CRYSTAL-STRUCTURE; BIOFILM FORMATION; CANDIDA-ALBICANS; PORPHYROMONAS-GINGIVALIS	Streptococcus agalactiae (group B Streptococcus, GBS) is the predominant cause of early-onset infectious disease in neonates and is responsible for life-threatening infections in elderly and immunocompromised individuals. Clinical manifestations of GBS infection include sepsis, pneumonia, and meningitis. Here, we describe BspA, a deviant antigen I/II family polypeptide that confers adhesive properties linked to pathogenesis in GBS. Heterologous expression of BspA on the surface of the non-adherent bacterium Lactococcus lactis confers adherence to scavenger receptor gp340, human vaginal epithelium, and to the fungus Candida albicans. Complementary crystallographic and biophysical characterization of BspA reveal a novel beta-sandwich adhesion domain and unique asparagine-dependent super-helical stalk. Collectively, these findings establish a new bacterial adhesin structure that has in effect been hijacked by a pathogenic Streptococcus species to provide competitive advantage in human mucosal infections.	[Rego, Sara; Pidwill, Grace R.; Jenkinson, Howard F.; Nobbs, Angela H.] Univ Bristol, Sch Oral & Dent Sci, Lower Maudlin St, Bristol BS1 2LY, Avon, England; [Rego, Sara; Heal, Timothy J.; Till, Marisa; Robson, Alice; Sessions, Richard B.; Race, Paul R.] Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Heal, Timothy J.] Univ Bristol, Bristol Ctr Funct Nanomat, Bristol BS8 1TL, Avon, England; [Till, Marisa; Sessions, Richard B.; Race, Paul R.] Univ Bristol, BrisSynBio Synthet Biol Res Ctr, Bristol BS8 1TQ, Avon, England; [Lamont, Richard J.] Univ Louisville, Dept Oral Immunol & Infect Dis, Louisville, KY 40202 USA	University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of Louisville	Nobbs, AH (corresponding author), Univ Bristol, Sch Oral & Dent Sci, Lower Maudlin St, Bristol BS1 2LY, Avon, England.; Race, PR (corresponding author), Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.	paul.race@bristol.ac.uk	Jenkinson, Howard/AAD-9282-2022; Jenkinson, Howard/ABI-1842-2020; Nobbs, Angela/AAS-3926-2020	Pidwill, Grace/0000-0002-5193-3631; Robson, Alice/0000-0003-3338-2626; Jenkinson, Howard/0000-0002-9195-7945; Sessions, Richard/0000-0003-0320-0895; Nobbs, Angela/0000-0003-3813-4410	Biotechnology and Biological Sciences Research Council Grant [BB/I006478/I]; National Institutes of Health [DE016690, DE012505]; Royal Society University Research Fellowship Award [UF080534]; BBSRC [BB/I006478/1, BB/L01386X/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016690, R01DE012505] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I006478/1, BB/L01386X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society University Research Fellowship Award; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded in part by Biotechnology and Biological Sciences Research Council Grant BB/I006478/I (to P. R. R.), National Institutes of Health Grants DE016690 (to H. F. J. and R. J. L.) and DE012505 (to R. J. L.), and Royal Society University Research Fellowship Award UF080534 (to P. R. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Al-Okla S, 1999, CELL MICROBIOL, V1, P157, DOI 10.1046/j.1462-5822.1999.00016.x; Back CR, 2015, MOL ORAL MICROBIOL, V30, P411, DOI 10.1111/omi.12106; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bamford CV, 2009, INFECT IMMUN, V77, P3696, DOI 10.1128/IAI.00438-09; Baron MJ, 2004, J BIOL CHEM, V279, P24714, DOI 10.1074/jbc.M402164200; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bayo M., 2002, International Microbiology, V5, P87, DOI 10.1007/s10123-002-0064-1; Berner R, 2002, CURR OPIN INFECT DIS, V15, P307, DOI 10.1097/00001432-200206000-00015; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Brady LJ, 2010, MOL MICROBIOL, V77, P276, DOI 10.1111/j.1365-2958.2010.07212.x; Brittan JL, 2015, MICROBES INFECT, V17, P360, DOI 10.1016/j.micinf.2014.12.013; Brochet M, 2008, J BACTERIOL, V190, P6913, DOI 10.1128/JB.00824-08; Chuzeville S, 2015, MICROB PATHOGENESIS, V88, P1, DOI 10.1016/j.micpath.2015.07.018; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Cools P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148052; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Egland PG, 2001, INFECT IMMUN, V69, P7512, DOI 10.1128/IAI.69.12.7512-7516.2001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forsgren N, 2010, J MOL BIOL, V397, P740, DOI 10.1016/j.jmb.2010.01.065; Forsgren N, 2009, PROTEIN SCI, V18, P1896, DOI 10.1002/pro.200; Franklin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062433; Giglio KM, 2013, J BACTERIOL, V195, P3277, DOI 10.1128/JB.00374-13; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Hall M, 2014, FEBS OPEN BIO, V4, P283, DOI 10.1016/j.fob.2014.02.012; Heim KP, 2014, P NATL ACAD SCI USA, V111, P15746, DOI 10.1073/pnas.1413018111; Hirt H, 2000, J BACTERIOL, V182, P2299, DOI 10.1128/JB.182.8.2299-2306.2000; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jakubovics NS, 2005, MOL MICROBIOL, V55, P1591, DOI 10.1111/j.1365-2958.2005.04495.x; JENKINSON HF, 1990, INFECT IMMUN, V58, P1429, DOI 10.1128/IAI.58.5.1429-1436.1990; JENKINSON HF, 1990, INFECT IMMUN, V58, P3689, DOI 10.1128/IAI.58.11.3689-3697.1990; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelly CG, 2000, EXPERT OPIN INV DRUG, V9, P1711, DOI 10.1517/13543784.9.8.1711; KOLENBRANDER PE, 1993, FASEB J, V7, P406, DOI 10.1096/fasebj.7.5.8462782; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lamont RJ, 2002, MICROBIOL-SGM, V148, P1627, DOI 10.1099/00221287-148-6-1627; Larson MR, 2011, J BIOL CHEM, V286, P21657, DOI 10.1074/jbc.M111.231100; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; Le Doare K, 2013, VACCINE, V31, pD7, DOI 10.1016/j.vaccine.2013.01.009; Ligtenberg AJM, 2007, BIOL CHEM, V388, P1275, DOI 10.1515/BC.2007.158; Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005; Maddocks SE, 2011, MOL MICROBIOL, V81, P1034, DOI 10.1111/j.1365-2958.2011.07749.x; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McIntosh-Smith S, 2015, INT J HIGH PERFORM C, V29, P119, DOI 10.1177/1094342014528252; Monif G R, 1998, Infect Dis Obstet Gynecol, V6, P52, DOI 10.1155/S1064744998000131; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nobbs AH, 2007, CELL MICROBIOL, V9, P65, DOI 10.1111/j.1462-5822.2006.00768.x; Nylander A, 2011, ACTA CRYSTALLOGR F, V67, P23, DOI 10.1107/S174430911004443X; Park Y, 2005, INFECT IMMUN, V73, P3983, DOI 10.1128/IAI.73.7.3983-3989.2005; Purushotham S, 2014, J BIOL CHEM, V289, P21877, DOI 10.1074/jbc.M114.565507; Sheen TR, 2011, J BACTERIOL, V193, P6834, DOI 10.1128/JB.00094-11; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Silverman RJ, 2010, INFECT IMMUN, V78, P4644, DOI 10.1128/IAI.00685-10; Sitkiewicz I, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-65; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stoddard E, 2007, J IMMUNOL, V179, P3126, DOI 10.4049/jimmunol.179.5.3126; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Troffer-Charlier N, 2002, J MOL BIOL, V318, P179, DOI 10.1016/S0022-2836(02)00025-6; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Verstraelen H, 2013, CURR OPIN INFECT DIS, V26, P86, DOI 10.1097/QCO.0b013e32835c20cd; Wang NY, 2014, J INFECT DIS, V210, P982, DOI 10.1093/infdis/jiu151; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang S, 2006, INFECT IMMUN, V74, P4200, DOI 10.1128/IAI.00493-06	70	27	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					15985	16000		10.1074/jbc.M116.726562	http://dx.doi.org/10.1074/jbc.M116.726562			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27311712	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000380585400006
J	Treglown, L; Palaiou, K; Zarola, A; Furnham, A				Treglown, Luke; Palaiou, Kat; Zarola, Anthony; Furnham, Adrian			The Dark Side of Resilience and Burnout: A Moderation-Mediation Model	PLOS ONE			English	Article							SELF-ENHANCEMENT; PERSONALITY; PREVALENCE	This study tested whether specific dark-side traits may be beneficial in manifesting and maintaining Resilience, whilst others are vulnerability factors for Burnout. Four hundred and fifty-one (50 female) ambulance personnel completed three questionnaires as a part of a selection and development assessment. The study utilised the Hogan Development survey as a measure of dark side personality, the Copenhagen Burnout Inventory to assess work-related burnout, and the Resilience Scale-14 to measure resilience levels. Those high on Excitable and Cautious but low on Bold and Reserved were linked to an increased vulnerability to Burnout. Also those high on Bold and Diligent yet low on the Excitable, Cautious, and Imaginative scales were more resilient. Structural Equation Modelling revealed that resilience plays both a mediating and moderating role on personality and burnout. Theoretical implications suggest future research assessing the predictive capacity of psychological variables on burnout should account the indirect effect of resilience.	[Treglown, Luke; Palaiou, Kat; Furnham, Adrian] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Zarola, Anthony] Zeal Solut, Nottingham, England; [Furnham, Adrian] Norwegian Business Sch BI, Nydalveien, Olso, Norway	University of London; University College London; BI Norwegian Business School	Furnham, A (corresponding author), UCL, Res Dept Clin Educ & Hlth Psychol, London, England.; Furnham, A (corresponding author), Norwegian Business Sch BI, Nydalveien, Olso, Norway.	a.furnham@ucl.ac.uk	Furnham, Adrian/ABB-2072-2020					Abiola Tajudeen, 2011, BMC Res Notes, V4, P509, DOI 10.1186/1756-0500-4-509; Adriaenssens J, 2015, INT J NURS STUD, V52, P649, DOI 10.1016/j.ijnurstu.2014.11.004; Ahern NR, 2006, COMPR CHILD ADOLES N, V29, P103, DOI 10.1080/01460860600677643; Avanzi L, 2014, ANXIETY STRESS COPIN, V27, P455, DOI 10.1080/10615806.2013.866230; Batey M, 2008, PERS INDIV DIFFER, V45, P816, DOI 10.1016/j.paid.2008.08.014; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bianchi R, 2014, SCAND J PSYCHOL, V55, P357, DOI 10.1111/sjop.12119; Bonanno GA, 2005, J PERS SOC PSYCHOL, V88, P984, DOI 10.1037/0022-3514.88.6.984; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Borritz M., 2001, COPENHAGEN BURNOUT I; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Cheung GW, 2008, ORGAN RES METHODS, V11, P296, DOI 10.1177/1094428107300343; Damasio BF, 2011, J NURS MEAS, V19, P131, DOI 10.1891/1061-3749.19.3.131; De Fruyt F, 2013, EUR J PERSONALITY, V27, P555, DOI 10.1002/per.1911; Demerouti E, 2010, J OCCUP HEALTH PSYCH, V15, P209, DOI 10.1037/a0019408; Denckla CA, 2015, PERS INDIV DIFFER, V82, P148, DOI 10.1016/j.paid.2015.03.008; Dunn LB, 2008, ACAD PSYCHIATR, V32, P44, DOI 10.1176/appi.ap.32.1.44; Fico J, 2000, INTERPERSONAL COMPAS; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Fox G., 2001, MENTAL MEASUREMENTS; Girtler N, 2010, CLIN EXP RHEUMATOL, V28, P669; Gupta S, 2010, PSYCHOL TRAUMA-US, V2, P83, DOI 10.1037/a0018959; Harms PD, 2015, APPL PSYCHOL-INT REV, V64, P15, DOI 10.1111/apps.12042; Hasui CH., 2009, OPEN FAM STUD J, V10, P15; Hogan J., 2011, APA HDB IND ORG PSYC, P555, DOI DOI 10.1037/12171-015; Hogan R, 2005, REV GEN PSYCHOL, V9, P169, DOI 10.1037/1089-2680.9.2.169; Hogan R, 2001, INT J SELECT ASSESS, V9, P40, DOI 10.1111/1468-2389.00162; Hogan R., 1997, HOGAN DEV SURVEY MAN; Homey K, 1997, NEUROSIS HUMAN GROWT; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; Hox J.J., 1999, FAMILY SCI REV, V11, P354, DOI DOI 10.1080/10705510903008345; HU LT, 1998, STRUCTURAL EQUATION, P76; Kaiser RB, 2015, APPL PSYCHOL-INT REV, V64, P55, DOI 10.1111/apps.12024; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Kristensen TS, 2005, WORK STRESS, V19, P192, DOI 10.1080/02678370500297720; LITTLE TD, 2007, MODELING CONTEXTUAL, P207, DOI DOI 10.1198/TECH.2006.S369; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Maslach C, 1998, THEORIES OF ORGANIZATIONAL STRESS, P68; Maslach C., 2008, TRUTH BURNOUT ORG CA; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Nishi Daisuke, 2010, BMC Res Notes, V3, P310, DOI 10.1186/1756-0500-3-310; Oliveira A, 2015, PROCD SOC BEHV, V165, P260, DOI 10.1016/j.sbspro.2014.12.630; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Paulhus DL, 2014, CURR DIR PSYCHOL SCI, V23, P421, DOI 10.1177/0963721414547737; Pinheiro M. R., 2013, EUROPEAN J SOCIAL BE, V2, P178, DOI DOI 10.15405/FUTUREACADEMY/EJSBS(2301-2218).2012.2.5; Pritzker S, 2014, CHILD YOUTH SERV REV, V44, P328, DOI 10.1016/j.childyouth.2014.06.022; Robins RW, 2001, J PERS SOC PSYCHOL, V80, P340, DOI 10.1037//0022-3514.80.2.340; Schaufeli W.B., 1996, MASLACH BURNOUT INVE; Schaufeli WB, 2009, CAREER DEV INT, V14, P204, DOI 10.1108/13620430910966406; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Thoresen CJ, 2003, PSYCHOL BULL, V129, P914, DOI 10.1037/0033-2909.129.6.914; Wagnild G., 2011, RESILIENCE SCALE USE; Wagnild G M, 1993, J Nurs Meas, V1, P165; Wagnild G, 2009, J NURS MEAS, V17, P105, DOI 10.1891/1061-3749.17.2.105; Windle G, 2011, GERONTOLOGIST, V51, P331; Winwood PC, 2013, J OCCUP ENVIRON MED, V55, P1205, DOI 10.1097/JOM.0b013e3182a2a60a	58	28	28	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0156279	10.1371/journal.pone.0156279	http://dx.doi.org/10.1371/journal.pone.0156279			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP3JL	27336304	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200003
J	Oleszkiewicz, A; Walliczek-Dworschak, U; Klotze, P; Gerber, F; Croy, I; Hummel, T				Oleszkiewicz, Anna; Walliczek-Dworschak, Ute; Kloetze, Paula; Gerber, Friederike; Croy, Ilona; Hummel, Thomas			Developmental Changes in Adolescents' Olfactory Performance and Significance of Olfaction	PLOS ONE			English	Article							ODOR IDENTIFICATION; SEX-DIFFERENCES; NORMATIVE DATA; DISCRIMINATION; THRESHOLDS; AGE; EXPERIENCE; RESPONSES; FLUENCY; LIFE	Aim of the current work was to examine developmental changes in adolescents' olfactory performance and personal significance of olfaction. In the first study olfactory identification abilities of 76 participants (31 males and 45 females aged between 10 and 18 years; M = 13.8, SD = 2.3) was evaluated with the Sniffin Stick identification test, presented in a cued and in an uncued manner. Verbal fluency was additionally examined for control purpose. In the second study 131 participants (46 males and 85 females aged between 10 and 18 years; (M = 14.4, SD = 2.2) filled in the importance of olfaction questionnaire. Odor identification abilities increased significantly with age and were significantly higher in girls as compared to boys. These effects were especially pronounced in the uncued task and partly related to verbal fluency. In line, the personal significance of olfaction increased with age and was generally higher among female compared to male participants.	[Oleszkiewicz, Anna; Walliczek-Dworschak, Ute; Kloetze, Paula; Gerber, Friederike; Croy, Ilona; Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Interdisciplinary Ctr Smell & Taste, Dresden, Germany; [Oleszkiewicz, Anna] Univ Wroclaw, Inst Psychol, PL-50138 Wroclaw, Poland; [Walliczek-Dworschak, Ute] Univ Marburg, Dept Otorhinolaryngol, Marburg, Germany; [Croy, Ilona] Tech Univ Dresden, Dept Psychotherapy & Psychosomat Med, Dresden, Germany	Technische Universitat Dresden; University of Wroclaw; Philipps University Marburg; Technische Universitat Dresden	Oleszkiewicz, A (corresponding author), Tech Univ Dresden, Dept Otorhinolaryngol, Interdisciplinary Ctr Smell & Taste, Dresden, Germany.; Oleszkiewicz, A (corresponding author), Univ Wroclaw, Inst Psychol, PL-50138 Wroclaw, Poland.	ania.oleszkiewicz@gmail.com		Croy, Ilona/0000-0002-0361-5559; Oleszkiewicz, Anna/0000-0003-2217-1858	Else Kroner-Fresenius Stiftung [2015_A71]	Else Kroner-Fresenius Stiftung	The Else Kroner-Fresenius Stiftung supported this study (grant number 2015_A71). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam MDE, 2006, INFANT BEHAV DEV, V29, P308, DOI 10.1016/j.infbeh.2005.12.008; Bryan J, 1997, PSYCHOL AGING, V12, P473, DOI 10.1037/0882-7974.12.3.473; Chopra A, 2008, NEUROIMAGE, V40, P1257, DOI 10.1016/j.neuroimage.2008.01.015; Croy I, 2011, ARCH OTOLARYNGOL, V137, P377, DOI 10.1001/archoto.2011.32; Croy I, 2010, EUR ARCH OTO-RHINO-L, V267, P67, DOI 10.1007/s00405-009-1054-0; Dalton P, 2011, LARYNGOSCOPE, V121, P1843, DOI 10.1002/lary.21928; DORRIES KM, 1989, DEV PSYCHOBIOL, V22, P423, DOI 10.1002/dev.420220502; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; Doucet S, 2007, DEV PSYCHOBIOL, V49, P129, DOI 10.1002/dev.20210; Engen E, 1997, ENFANCE PERSEE PORTA, V50, P125; ENGEN T, 1963, J COMP PHYSIOL PSYCH, V56, P73, DOI 10.1037/h0043633; Ferdenzi C, 2008, INT J BEHAV DEV, V32, P422, DOI 10.1177/0165025408093661; Ferdenzi C, 2010, J CHEM ECOL, V36, P847, DOI 10.1007/s10886-010-9827-x; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; Herz Rachel., 2004, SENSE SMELL I RES ED; Hudson R, 1999, J COMP PHYSIOL A, V185, P297, DOI 10.1007/s003590050390; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 2005, HORM BEHAV, V47, P306, DOI 10.1016/j.yhbeh.2004.10.007; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2001, ANN OTO RHINOL LARYN, V110, P976, DOI 10.1177/000348940111001015; Hurks PPM, 2006, J CLIN EXP NEUROPSYC, V28, P684, DOI 10.1080/13803390590954191; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Larsson M, 2000, J GERONTOL B-PSYCHOL, V55, pP304, DOI 10.1093/geronb/55.5.P304; Larsson M, 2003, ACTA PSYCHOL, V112, P89, DOI 10.1016/S0001-6918(02)00092-6; Lehrner JP, 1999, CHEM SENSES, V24, P337, DOI 10.1093/chemse/24.3.337; LYTTON H, 1991, PSYCHOL BULL, V109, P267, DOI 10.1037/0033-2909.109.2.267; Martin GN., 2001, N AM J PSYCHOL, V3, P491; Monnery-Patris S, 2009, Dev Psychobiol, V51, P268, DOI 10.1002/dev.20363; Oberg C, 2002, J INT NEUROPSYCH SOC, V8, P691, DOI 10.1017/S1355617702801424; Oleszkiewicz A, 2015, EUR ARCH OTO-RHINO-L, V273, P1; Rattaz C, 2005, J DEV BEHAV PEDIATR, V26, P86, DOI 10.1097/00004703-200504000-00003; Romantshik O, 2007, ACTA PAEDIATR, V96, P372, DOI 10.1111/j.1651-2227.2006.00106.x; SCHAAL B, 1988, CHEM SENSES, V13, P145, DOI 10.1093/chemse/13.2.145; SCHAAL B, 1995, BIOL NEONATE, V67, P397; Schaal B, 2004, CLIN PERINATOL, V31, P261, DOI 10.1016/j.clp.2004.04.003; SCHAAL B, 1980, REPROD NUTR DEV, V20, P843, DOI 10.1051/rnd:19800510; Schaal B, 2000, CHEM SENSES, V25, P729, DOI 10.1093/chemse/25.6.729; Sorokowska A, 2015, EUR ARCH OTO-RHINO-L, V272, P1937, DOI 10.1007/s00405-014-3263-4; Soussignan R, 1997, PHYSIOL BEHAV, V62, P745, DOI 10.1016/S0031-9384(97)00187-X; Varendi H, 2001, ACTA PAEDIATR, V90, P372, DOI 10.1080/080352501750126131	41	26	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157560	10.1371/journal.pone.0157560	http://dx.doi.org/10.1371/journal.pone.0157560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332887	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212800035
J	Suzuki-Kemuriyama, N; Matsuzaka, T; Kuba, M; Ohno, H; Han, S; Takeuchi, Y; Isaka, M; Kobayashi, K; Iwasaki, H; Yatoh, S; Suzuki, H; Miyajima, K; Nakae, D; Yahagi, N; Nakagawa, Y; Sone, H; Yamada, N; Shimano, H				Suzuki-Kemuriyama, Noriko; Matsuzaka, Takashi; Kuba, Motoko; Ohno, Hiroshi; Han, Song-iee; Takeuchi, Yoshinori; Isaka, Masaaki; Kobayashi, Kazuto; Iwasaki, Hitoshi; Yatoh, Shigeru; Suzuki, Hiroaki; Miyajima, Katsuhiro; Nakae, Dai; Yahagi, Naoya; Nakagawa, Yoshimi; Sone, Hirohito; Yamada, Nobuhiro; Shimano, Hitoshi			Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1; HEPATIC STEATOSIS; OXIDATIVE STRESS; CRUCIAL ROLE; STEATOHEPATITIS; INFLAMMATION; N-3; OBESITY; PROSTAGLANDINS; TRIGLYCERIDES	Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndrome, can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver cirrhosis and cancer. Recent studies have shown the benefits of consuming n-3 polyunsaturated fatty acids (PUFAs) for the treatment of NAFLD. In the present study, we investigated and compared the effects of the major n-3 PUFAs-eicosapentaenoic acid (EPA, C20:5) and docosahexaenoic acid (DHA, C22:6)-in preventing atherogenic high-fat (AHF) diet-induced NAFLD. Mice were fed the AHF diet supplemented with or without EPA or DHA for four weeks. Both EPA and DHA reduced the pathological features of AHF dietinduced NASH pathologies such as hepatic lobular inflammation and elevated serum transaminase activity. Intriguingly, EPA had a greater hepatic triacylglycerol (TG)-reducing effect than DHA. In contrast, DHA had a greater suppressive effect than EPA on AHF diet-induced hepatic inflammation and ROS generation, but no difference in fibrosis. Both EPA and DHA could be effective for treatment of NAFLD and NASH. Meanwhile, the two major n-3 polyunsaturated fatty acids might differ in a relative contribution to pathological intermediate steps towards liver fibrosis.	[Suzuki-Kemuriyama, Noriko; Matsuzaka, Takashi; Kuba, Motoko; Ohno, Hiroshi; Han, Song-iee; Takeuchi, Yoshinori; Isaka, Masaaki; Kobayashi, Kazuto; Iwasaki, Hitoshi; Yatoh, Shigeru; Suzuki, Hiroaki; Yahagi, Naoya; Nakagawa, Yoshimi; Yamada, Nobuhiro; Shimano, Hitoshi] Univ Tsukuba, Dept Internal Med Endocrinol & Metab, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan; [Suzuki-Kemuriyama, Noriko; Miyajima, Katsuhiro; Nakae, Dai] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci & Food Safety, Setagaya Ku, 1-1-1 Sakuragaoka, Tokyo 1568502, Japan; [Nakagawa, Yoshimi; Shimano, Hitoshi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan; [Sone, Hirohito] Niigata Univ, Dept Internal Med, Fac Med, 1-754 Asahimachi, Niigata 9518510, Japan; [Shimano, Hitoshi] Japan Agcy Med Res & Dev AMED, AMED CREST, Chiyoda Ku, 1-7-1 Ohte Machi, Tokyo 1000004, Japan	University of Tsukuba; Tokyo University of Agriculture; University of Tsukuba; Niigata University	Shimano, H (corresponding author), Univ Tsukuba, Dept Internal Med Endocrinol & Metab, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.; Shimano, H (corresponding author), Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.; Shimano, H (corresponding author), Japan Agcy Med Res & Dev AMED, AMED CREST, Chiyoda Ku, 1-7-1 Ohte Machi, Tokyo 1000004, Japan.	hshimano@md.tsukuba.ac.jp	Sone, Hirohito/ABC-9346-2021; Shimano, Hitoshi/AAI-5648-2020; Shimano, Hitoshi/V-1761-2019; Yahagi, Naoya/D-2360-2014	Sone, Hirohito/0000-0003-1263-2817; Shimano, Hitoshi/0000-0002-5562-5572; Yahagi, Naoya/0000-0002-1823-1865	Ministry of Science, Education, Culture, and Technology of Japan [22117502, 15H03093]; Mochida Pharmaceutical Co. Ltd.	Ministry of Science, Education, Culture, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Pharmaceutical Co. Ltd.	This work was supported by Grants-in-Aid for Scientific Research 22117502 (to H.S.), 15H03093 (to T.M.), and Program to Disseminate Tenure Tracking System (to T.M.) from the Ministry of Science, Education, Culture, and Technology of Japan. This work was also supported in part by Mochida Pharmaceutical Co. Ltd., who also provided highly purified EPA ethyl ester. Co-author Hiroyuki Kawano and Masanori Nakakuki are employed by Mochida Pharmaceutical Co. Ltd. Mochida Pharmaceutical Co. Ltd. provided support in the form of salary for Hiroyuki Kawano and Masanori Nakakuki, but had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BM, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-33; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Argo CK, 2009, CLIN LIVER DIS, V13, P511, DOI 10.1016/j.cld.2009.07.005; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Buzzetti E, 2016, MULTIPLE HIT PATHOGE; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; Delarue J, 2016, MOL NUTR FOOD RES, V60, P147, DOI 10.1002/mnfr.201500346; Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322; Everhart JE, 2010, HEPATOLOGY, V51, P1491, DOI 10.1002/hep.23659; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Ishikado A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069415; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Jump DB, 2016, P NUTR SOC, V75, P1, DOI 10.1017/S002966511500244X; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kuba M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17604; KUEHL FA, 1980, SCIENCE, V210, P978, DOI 10.1126/science.6254151; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Levy JR, 2004, HEPATOLOGY, V39, P608, DOI 10.1002/hep.20093; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Loria P, 2014, ATHEROSCLEROSIS, V232, P99, DOI 10.1016/j.atherosclerosis.2013.10.030; MALMSTEN CL, 1986, AM J MED, V80, P11, DOI 10.1016/0002-9343(86)90073-2; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Nogueira MA, 2016, CLIN NUTR, V35, P578, DOI 10.1016/j.clnu.2015.05.001; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Pawar A, 2003, J BIOL CHEM, V278, P35931, DOI 10.1074/jbc.M306238200; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Sanyal AJ, 2014, GASTROENTEROLOGY, V147, P377, DOI 10.1053/j.gastro.2014.04.046; Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Scorletti E, 2013, ANNU REV NUTR, V33, P231, DOI 10.1146/annurev-nutr-071812-161230; Scorletti E, 2014, HEPATOLOGY, V60, P1211, DOI 10.1002/hep.27289; Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028; Shearer GC, 2012, BBA-MOL CELL BIOL L, V1821, P843, DOI 10.1016/j.bbalip.2011.10.011; Takeuchi Y, 2010, J BIOL CHEM, V285, P11681, DOI 10.1074/jbc.M109.096107; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200; Watanabe S, 2013, J TOXICOL SCI, V38, P379, DOI 10.2131/jts.38.379; Yahagi N, 1999, J BIOL CHEM, V274, P35840, DOI 10.1074/jbc.274.50.35840; Yamada K, 2015, LIVER INT, V35, P582, DOI 10.1111/liv.12685; Zambo V, 2013, WORLD J HEPATOL, V5, P550, DOI 10.4254/wjh.v5.i10.550; Zhang JY, 2016, CURR OPIN CLIN NUTR, V19, P103, DOI 10.1097/MCO.0000000000000254	54	45	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157580	10.1371/journal.pone.0157580	http://dx.doi.org/10.1371/journal.pone.0157580			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333187	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212800037
J	Bisterfeld, C; Classen, T; Kuberl, I; Henssen, B; Metz, A; Gohlke, H; Pietruszka, J				Bisterfeld, Carolin; Classen, Thomas; Kueberl, Irene; Henssen, Birgit; Metz, Alexander; Gohlke, Holger; Pietruszka, Joerg			Redesigning Aldolase Stereoselectivity by Homologous Grafting	PLOS ONE			English	Article							STEREOCHEMICALLY COMPLEMENTARY BIOCATALYSTS; THDP-DEPENDENT ENZYMES; DIRECTED EVOLUTION; ENGINEERING STEREOSELECTIVITY; SUBSTRATE-SPECIFICITY; LIQUID-CHROMATOGRAPHY; BUILDING-BLOCKS; BINDING-SITE; PROTEIN; MUTAGENESIS	The 2-deoxy-D-ribose-5-phosphate aldolase (DERA) offers access to highly desirable building blocks for organic synthesis by catalyzing a stereoselective C-C bond formation between acetaldehyde and certain electrophilic aldehydes. DERA's potential is particularly highlighted by the ability to catalyze sequential, highly enantioselective aldol reactions. However, its synthetic use is limited by the absence of an enantiocomplementary enzyme. Here, we introduce the concept of homologous grafting to identify stereoselectivity-determining amino acid positions in DERA. We identified such positions by structural analysis of the homologous aldolases 2-keto-3-deoxy-6-phosphogluconate aldolase (KDPG) and the enantiocomplementary enzyme 2-keto-3-deoxy-6-phosphogalactonate aldolase (KDPGal). Mutation of these positions led to a slightly inversed enantiopreference of both aldolases to the same extent. By transferring these sequence motifs onto DERA we achieved the intended change in enantioselectivity.	[Bisterfeld, Carolin; Kueberl, Irene; Henssen, Birgit; Pietruszka, Joerg] Univ Dusseldorf, Forschungszentrum Julich, Inst Bioorgan Chem, D-52426 Julich, Germany; [Classen, Thomas; Pietruszka, Joerg] Forschungszentrum Julich, Inst Bio & Geosci IBG Biotechnol 1, D-52425 Julich, Germany; [Metz, Alexander; Gohlke, Holger] Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Pietruszka, J (corresponding author), Univ Dusseldorf, Forschungszentrum Julich, Inst Bioorgan Chem, D-52426 Julich, Germany.; Pietruszka, J (corresponding author), Forschungszentrum Julich, Inst Bio & Geosci IBG Biotechnol 1, D-52425 Julich, Germany.	j.pietruszka@fz-juelich.de	Classen, Thomas/K-8706-2013; Classen, Thomas/P-1380-2019; Pietruszka, Jörg/G-5731-2013	Classen, Thomas/0000-0002-3259-964X; Classen, Thomas/0000-0002-3259-964X; Pietruszka, Jörg/0000-0002-9819-889X	Ministry of Innovation, Science and Research of the German federal state of North Rhine-Westphalia (NRW); Heinrich Heine University Dusseldorf (HHU); Deutsche Forschungsgemeinschaft; Forschungszentrum Julich GmbH	Ministry of Innovation, Science and Research of the German federal state of North Rhine-Westphalia (NRW); Heinrich Heine University Dusseldorf (HHU); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungszentrum Julich GmbH	The authors gratefully acknowledge the Ministry of Innovation, Science and Research of the German federal state of North Rhine-Westphalia (NRW) and the Heinrich Heine University Dusseldorf (HHU; scholarship within the CLIB-Graduate Cluster Industrial Biotechnology for I.K., the NRW-Forschungsschule BioStruct for C.B. and T.C.), the Deutsche Forschungsgemeinschaft, and the Forschungszentrum Julich GmbH for the support of the authors' projects.	Allard J, 2001, P NATL ACAD SCI USA, V98, P3679, DOI 10.1073/pnas.071380898; Baerga-Ortiz A, 2006, CHEM BIOL, V13, P277, DOI 10.1016/j.chembiol.2006.01.004; Baker P, 2012, J AM CHEM SOC, V134, P507, DOI 10.1021/ja208754r; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bisterfeld C, 2016, SYNLETT, V27, P11, DOI 10.1055/s-0035-1560723; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen-Goodspeed M, 2001, BIOCHEMISTRY-US, V40, P1332, DOI 10.1021/bi001549d; Cheriyan M, 2012, BIOCHEMISTRY-US, V51, P1658, DOI 10.1021/bi201899b; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeSantis G, 2003, BIOORGAN MED CHEM, V11, P43, DOI 10.1016/S0968-0896(02)00429-7; Dick M, 2016, CHEM SCI; Dick M, 2016, SCI REP-UK, V6, DOI 10.1038/srep17908; Donaldson JM, 2013, P NATL ACAD SCI USA, V110, P17456, DOI 10.1073/pnas.1307309110; Douglas CC, 2004, BIOCHEMISTRY-US, V43, P10435, DOI 10.1021/bi049359g; Dyballa N., 2009, J VISUALIZED EXPT; Follo C, 2008, BIOTECHNOL APPL BIOC, V49, P175, DOI 10.1042/BA20070045; Fong S, 2000, CHEM BIOL, V7, P873, DOI 10.1016/S1074-5521(00)00035-1; GIJSEN HJM, 1994, J AM CHEM SOC, V116, P8422, DOI 10.1021/ja00097a082; Gocke D, 2008, CHEMBIOCHEM, V9, P406, DOI 10.1002/cbic.200700598; Greenberg WA, 2004, P NATL ACAD SCI USA, V101, P5788, DOI 10.1073/pnas.0307563101; Hailes HC, 2013, FEBS J, V280, P6374, DOI 10.1111/febs.12496; Hall M, 2008, ADV SYNTH CATAL, V350, P411, DOI 10.1002/adsc.200700458; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jennewein Stefan, 2006, Biotechnology Journal, V1, P537, DOI 10.1002/biot.200600020; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kazlauskas RJ, 2009, NAT CHEM BIOL, V5, P526, DOI 10.1038/nchembio0809-526; Kullartz I, 2012, J BIOTECHNOL, V161, P174, DOI 10.1016/j.jbiotec.2011.12.018; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lin H, 2012, J BIOTECHNOL, V161, P235, DOI 10.1016/j.jbiotec.2012.06.028; Liu J., 2002, ANGEW CHEM, V114, P1462; Liu JJ, 2004, TETRAHEDRON LETT, V45, P2439, DOI 10.1016/j.tetlet.2004.01.110; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moore SD, 2002, J VIROL, V76, P10245, DOI 10.1128/JVI.76.20.10245-10255.2002; Mugford PF, 2008, ANGEW CHEM INT EDIT, V47, P8782, DOI 10.1002/anie.200705159; Mulhardt C., 2008, EXPT MOLEKULARBIOLOG; Muller M, 2005, ANGEW CHEM INT EDIT, V44, P362, DOI 10.1002/anie.200460852; Patel JM, 2009, J MOL CATAL B-ENZYM, V61, P123, DOI 10.1016/j.molcatb.2009.07.004; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pilz J, 2000, J CHROMATOGR B, V742, P315, DOI 10.1016/S0378-4347(00)00174-2; Pleiss J, 2014, CHEMCATCHEM, V6, P944, DOI 10.1002/cctc.201300950; Reyda S, 2003, J MOL BIOL, V325, P963, DOI 10.1016/S0022-2836(02)01337-2; Royer SF, 2010, J AM CHEM SOC, V132, P11753, DOI 10.1021/ja104412a; Ruethlein E, 2015, ADV SYNTH CATAL, V357, P1775, DOI 10.1002/adsc.201500149; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Smith MEB, 2008, ADV SYNTH CATAL, V350, P2631, DOI 10.1002/adsc.200800489; Sun ZT, 2015, ANGEW CHEM INT EDIT, V54, P12410, DOI 10.1002/anie.201501809; Pazmino DET, 2007, ADV SYNTH CATAL, V349, P1361, DOI 10.1002/adsc.200700045; van Leeuwen SM, 2004, J CHROMATOGR A, V1058, P107, DOI 10.1016/j.chroma.2004.08.149; Wada M, 2003, BIOORGAN MED CHEM, V11, P2091, DOI 10.1016/S0968-0896(03)00052-X; Walters MJ, 2008, BIOORGAN MED CHEM, V16, P710, DOI 10.1016/j.bmc.2007.10.043; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Williams GJ, 2006, J AM CHEM SOC, V128, P16238, DOI 10.1021/ja065233q; Wolberg M, 2008, ADV SYNTH CATAL, V350, P1751, DOI 10.1002/adsc.200800224; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Zweiner C, 2002, ANAL BIOANAL CHEM, V372, P615, DOI 10.1007/s00216-002-1233-y	60	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0156525	10.1371/journal.pone.0156525	http://dx.doi.org/10.1371/journal.pone.0156525			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327271	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400005
J	Coleman, CI; Tangirala, M; Evers, T				Coleman, Craig I.; Tangirala, Muralikrishna; Evers, Thomas			Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States	PLOS ONE			English	Article							MEDICATION PERSISTENCE; THERAPY; SCORE	A retrospective cohort analysis of the US MarketScan claims databases was performed to compare persistence and discontinuation rates between the vitamin K antagonist warfarin and the non-vitamin K antagonist oral anticoagulants rivaroxaban and dabigatran in patients with non-valvular atrial fibrillation. The analysis included adult patients with non-valvular atrial fibrillation newly initiated on rivaroxaban, dabigatran, or warfarin between November 1, 2011 and December 31, 2013, with a baseline CHA2DS2-VASc score >= 2, two or more non-valvular atrial fibrillation diagnosis codes (427.31), and >= 6 months' continuous medical and pharmacy benefit enrollment before oral anticoagulant initiation. Propensity score matching was performed to match patients receiving rivaroxaban with those receiving dabigatran (1: 1) and warfarin (1: 1). Patients were followed until the first event of inpatient death, end of continuous enrollment, or end of study period. Medication persistence was defined as absence of a refill gap of > 60 days. Discontinuation was defined as no additional refill for > 90 days and through to end of follow-up. Hazard ratios (HRs) of oral anticoagulant persistence and discontinuation were estimated using Cox proportional hazard models. In total, 3,2634 patients were included (n = 10878/oral anticoagulant group). Rivaroxaban was associated with better persistence than both dabigatran (HR 0.64, 95% confidence interval [CI] 0.62-0.67) and warfarin (HR 0.62, 95% CI 0.59-0.64) and lower discontinuation than dabigatran (HR 0.61, 95% CI 0.58-0.64) and warfarin (HR 0.65, 95% CI 0.62-0.68). Real world analysis of oral anticoagulant use may reveal whether the relatively high persistence/ low discontinuation demonstrated for rivaroxaban translates into lower rates of stroke.	[Coleman, Craig I.] Univ Connecticut, Sch Pharm, Storrs, CT USA; [Tangirala, Muralikrishna] Bayer HealthCare Pharmaceut, Whippany, NJ USA; [Evers, Thomas] Bayer Pharma AG, Wuppertal, Germany	University of Connecticut; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals	Coleman, CI (corresponding author), Univ Connecticut, Sch Pharm, Storrs, CT USA.	craig.coleman@hhchealth.org		Coleman, Craig/0000-0003-4868-7158	Bayer HealthCare Pharmaceuticals; Janssen Scientific Affairs, LLC	Bayer HealthCare Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals); Janssen Scientific Affairs, LLC	Funding for this study was provided by Bayer HealthCare Pharmaceuticals who provided support in the form of salaries for author MT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section. Bayer Pharma AG provided support in the form of salaries for author TE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section. This study was also funded by Janssen Scientific Affairs, LLC. who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bayer HealthCare, 2011, FDA APPR BAYERS XAR; Beyer-Westendorf J, 2016, EUROPACE, V18, P1150, DOI 10.1093/europace/euv421; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coleman CI, 2013, J INVEST MED, V61, P878, DOI [10.231/JIM.0b013e31828df1bf, 10.2310/JIM.0b013e31828df1bf]; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Danielson E., 2015, HLTH RES DATA REAL W; Douxfils J, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000515; Gomes T, 2012, ARCH INTERN MED, V172, P1687, DOI 10.1001/archinternmed.2012.4485; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Laliberte F, 2014, CURR MED RES OPIN, V30, P1317, DOI 10.1185/03007995.2014.907140; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Nelson WW, 2015, CURR MED RES OPIN, V31, P1831, DOI 10.1185/03007995.2015.1074064; Nelson WW, 2014, CURR MED RES OPIN, V30, P2461, DOI 10.1185/03007995.2014.933577; Patel AA, 2013, CLIN THER, V35, P1794, DOI 10.1016/j.clinthera.2013.09.010; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Zalesak M, 2013, CIRC-CARDIOVASC QUAL, V6, P567, DOI 10.1161/CIRCOUTCOMES.113.000192	19	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157769	10.1371/journal.pone.0157769	http://dx.doi.org/10.1371/journal.pone.0157769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327275	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212400041
J	Lou, XY; Li, X; Li, AX; Pu, MY; Shoaib, M; Liu, DC; Sun, JZ; Zhang, AM; Yang, WL				Lou, XueYuan; Li, Xin; Li, AiXia; Pu, MingYu; Shoaib, Muhammad; Liu, DongCheng; Sun, JiaZhu; Zhang, AiMin; Yang, WenLong			Molecular Characterization of Three GIBBERELLIN-INSENSITIVE DWARF2 Homologous Genes in Common Wheat	PLOS ONE			English	Article							F-BOX PROTEINS; SCF E3 COMPLEX; EXPRESSION ANALYSIS; GREEN-REVOLUTION; GIBBERELLIN RECEPTOR; RESPONSE MUTANT; PLANT-GROWTH; ARABIDOPSIS; RICE; SLEEPY1	F-box protein is a core component of the ubiquitin E3 ligase SCF complex and is involved in the gibberellin (GA) signaling pathway. To elucidate the molecular mechanism of GA signaling in wheat, three homologous GIBBERELLIN-INSENSITIVE DWARF2 genes, TaGID2s, were isolated from the Chinese Spring wheat variety. A subcellular localization assay in onion epidermal cells and Arabidopsis mesophyll protoplasts showed that TaGID2s are localized in the nuclei. The expression profiles using quantitative real-time polymerase chain reaction showed that TaGID2s were downregulated by GA(3). The interaction between TaGID2s and TSK1 (homologous to ASK1) in yeast indicated that TaGID2s might function as a component of an E3 ubiquitin-ligase SCF complex. Yeast two-hybrid assays showed that a GA-independent interaction occurred between three TaGID2s and RHT-A1a, RHT-B1a, and RHT-D1a. Furthermore, TaGID2s interact with most RHT-1s, such as RHT-B1h, RHT-B1i, RHT-D1e, RHT-D1f, etc., but cannot interact with RHT-B1b or RHT-B1e, which have a stop codon in the DELLA motif, resulting in a lack of a GRAS domain. In addition, RHT-B1k has a frame-shift mutation in the VHIID motif leading to loss of the LHRII motif in the GRAS domain and RHT-D1h has a missense mutation in the LHRII motif. These results indicate that TaGID2s, novel positive regulators of the GA response, recognize RHT-1s in the LHRII motif resulting in poly-ubiquitination and degradation of the DELLA protein.	[Lou, XueYuan; Li, Xin; Li, AiXia; Pu, MingYu; Shoaib, Muhammad; Liu, DongCheng; Sun, JiaZhu; Zhang, AiMin; Yang, WenLong] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China; [Lou, XueYuan; Li, AiXia; Pu, MingYu] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Zhang, AiMin] Henan Agr Univ, Collaborat Innovat Ctr Grain Crops Henan, Zhengzhou 450002, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Henan Agricultural University	Zhang, AM; Yang, WL (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China.; Zhang, AM (corresponding author), Henan Agr Univ, Collaborat Innovat Ctr Grain Crops Henan, Zhengzhou 450002, Peoples R China.	amzhang@genetics.ac.cn; wlyang@genetics.ac.cn			National Basic Research Program of China [2014CB138100]; CAS Strategic Priority Program [XDA08010104]	National Basic Research Program of China(National Basic Research Program of China); CAS Strategic Priority Program	The work was supported by the following: National Basic Research Program of China (2014CB138100), http://program.most.gov.cn/; and CAS Strategic Priority Program (XDA08010104), http://www.cas.cn/xxgkml/zgkxyyb/kxyj/xdzx/.	Aldrich C., 1993, PLANT MOL BIOL REP, V11, P128, DOI [10.1007/BF02670471, DOI 10.1007/BF02670471]; Ariizumi T, 2011, PLANT PHYSIOL, V155, P765, DOI 10.1104/pp.110.166272; Ashikari M, 2003, J PLANT GROWTH REGUL, V22, P141, DOI 10.1007/s00344-003-0033-8; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Evans LT., 1993, CROP EVOLUTION ADAPT; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gale MD, 1985, PROGR PLANT BREEDING, P1, DOI DOI 10.1016/B978-0-407-00780-2.50005-9; Gomi K, 2004, PLANT J, V37, P626, DOI 10.1111/j.1365-313X.2003.01990.x; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Hirano K, 2010, PLANT CELL, V22, P2680, DOI 10.1105/tpc.110.075549; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jiang C, 2007, CURR OPIN PLANT BIOL, V10, P461, DOI 10.1016/j.pbi.2007.08.011; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; KUMAR A, 1995, P NATL ACAD SCI USA, V92, P3343, DOI 10.1073/pnas.92.8.3343; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Li AX, 2013, J INTEGR PLANT BIOL, V55, P1026, DOI 10.1111/jipb.12103; Li AX, 2013, J PLANT PHYSIOL, V170, P432, DOI 10.1016/j.jplph.2012.11.010; Li AX, 2012, MOL BREEDING, V30, P1443, DOI 10.1007/s11032-012-9730-y; Li CJ, 2006, FUNCT PLANT BIOL, V33, P381, DOI 10.1071/FP06026; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Oh SK, 2008, NEW PHYTOL, V177, P977, DOI 10.1111/j.1469-8137.2007.02310.x; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; PHINNEY BO, 1983, CHEM PHYSL GIBBERELL, P19; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Richards DE, 2001, ANNU REV PLANT PHYS, V52, P67, DOI 10.1146/annurev.arplant.52.1.67; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Shimada A, 2008, NATURE, V456, P520, DOI 10.1038/nature07546; Steber CM, 1998, GENETICS, V149, P509; Steber CM, 2001, PLANT PHYSIOL, V125, P763, DOI 10.1104/pp.125.2.763; Strader LC, 2004, P NATL ACAD SCI USA, V101, P12771, DOI 10.1073/pnas.0404287101; Sun TP, 2010, PLANT PHYSIOL, V154, P567, DOI 10.1104/pp.110.161554; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yano K, 2015, PLANT PHYSIOL, V167, P531, DOI 10.1104/pp.114.247940; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	44	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157642	10.1371/journal.pone.0157642	http://dx.doi.org/10.1371/journal.pone.0157642			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327160	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212400028
J	He, YJ; Mao, SS; Gao, YL; Zhu, LY; Wu, DM; Cui, YX; Li, JN; Qian, W				He, Yajun; Mao, Shaoshuai; Gao, Yulong; Zhu, Liying; Wu, Daoming; Cui, Yixin; Li, Jiana; Qian, Wei			Genome-Wide Identification and Expression Analysis of WRKY Transcription Factors under Multiple Stresses in Brassica napus	PLOS ONE			English	Article							GENE FAMILY; ABIOTIC STRESSES; DUPLICATED GENES; ARABIDOPSIS; EVOLUTION; RESISTANCE; RICE; SUPERFAMILY; EXPANSION; CABBAGE	WRKY transcription factors play important roles in responses to environmental stress stimuli. Using a genome-wide domain analysis, we identified 287 WRKY genes with 343 WRKY domains in the sequenced genome of Brassica napus, 139 in the A sub-genome and 148 in the C sub-genome. These genes were classified into eight groups based on phylogenetic analysis. In the 343 WRKY domains, a total of 26 members showed divergence in the WRKY domain, and 21 belonged to group I. This finding suggested that WRKY genes in group I are more active and variable compared with genes in other groups. Using genome-wide identification and analysis of the WRKY gene family in Brassica napus, we observed genome duplication, chromosomal/segmental duplications and tandem duplication. All of these duplications contributed to the expansion of the WRKY gene family. The duplicate segments that were detected indicated that genome duplication events occurred in the two diploid progenitors B. rapa and B. olearecea before they combined to form B. napus. Analysis of the public microarray database and EST database for B. napus indicated that 74 WRKY genes were induced or preferentially expressed under stress conditions. According to the public QTL data, we identified 77 WRKY genes in 31 QTL regions related to various stress tolerance. We further evaluated the expression of 26 BnaWRKY genes under multiple stresses by qRT-PCR. Most of the genes were induced by low temperature, salinity and drought stress, indicating that the WRKYs play important roles in B. napus stress responses. Further, three BnaWRKY genes were strongly responsive to the three multiple stresses simultaneously, which suggests that these 3 WRKY may have multi-functional roles in stress tolerance and can potentially be used in breeding new rapeseed cultivars. We also found six tandem repeat pairs exhibiting similar expression profiles under the various stress conditions, and three pairs were mapped in the stress related QTL regions, indicating tandem duplicate WRKYs in the adaptive responses to environmental stimuli during the evolution process. Our results provide a framework for future studies regarding the function of WRKY genes in response to stress in B. napus.	[He, Yajun; Mao, Shaoshuai; Zhu, Liying; Wu, Daoming; Cui, Yixin; Li, Jiana; Qian, Wei] Southwest Univ, Coll Agron & Biotechnol, Chongqing 400716, Peoples R China; [Gao, Yulong] Yunnan Acad Tobacco Agr Sci, Yuxi 653100, Peoples R China	Southwest University - China; China National Tobacco Corporation	Qian, W (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing 400716, Peoples R China.	qianwei666@hotmail.com			National Natural Science Foundation of China [U1302266, 31301351]; National Basic Research Program of China (973 Program) [SQ2015CB150201]; Project of Technology Development and Application of Chongqing [cstc2014yykfA80008]; Fundamental Research Funds for the Central Universities [XDJK2016B031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Project of Technology Development and Application of Chongqing; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was financially supported in part by the National Natural Science Foundation of China (U1302266, 31301351), the National Basic Research Program of China (973 Program, SQ2015CB150201), the Project of Technology Development and Application of Chongqing (cstc2014yykfA80008), and the Fundamental Research Funds for the Central Universities (XDJK2016B031).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asghari A, 2009, INT J PLANT PROD, V3; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Banerjee Aditya, 2015, ScientificWorldJournal, V2015, P807560, DOI 10.1155/2015/807560; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cai CP, 2014, CROP J, V2, P87, DOI 10.1016/j.cj.2014.03.001; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chapman BA, 2006, P NATL ACAD SCI USA, V103, P2730, DOI 10.1073/pnas.0507782103; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Delourme R, 2008, THEOR APPL GENET, V117, P1055, DOI 10.1007/s00122-008-0844-x; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Ermolaeva MD, 2003, PLANT MOL BIOL, V51, P859, DOI 10.1023/A:1023001130337; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Gu X, 2003, TRENDS GENET, V19, P354, DOI 10.1016/S0168-9525(03)00139-2; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Jiang YQ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-25; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Kayum MA, 2015, MOL GENET GENOMICS, V290, P79, DOI 10.1007/s00438-014-0898-1; Kifuji Y, 2013, EUPHYTICA, V190, P289, DOI 10.1007/s10681-012-0847-1; Ku HM, 2000, P NATL ACAD SCI USA, V97, P9121, DOI 10.1073/pnas.160271297; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mei JQ, 2013, THEOR APPL GENET, V126, P549, DOI 10.1007/s00122-012-2000-x; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pu ZJ, 2012, MOL BREEDING, V30, P809, DOI 10.1007/s11032-011-9665-8; Qiu YP, 2004, CHINESE SCI BULL, V49, P2159, DOI 10.1360/982004-183; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomita H, 2013, MOL BREEDING, V32, P889, DOI 10.1007/s11032-013-9918-9; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang M, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.16; Wei KF, 2012, DNA RES, V19, P153, DOI 10.1093/dnares/dsr048; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wu HL, 2008, PROG NAT SCI-MATER, V18, P697, DOI 10.1016/j.pnsc.2007.12.006; Wu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067740; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Yamasaki K, 2013, TRENDS PLANT SCI, V18, P267, DOI 10.1016/j.tplants.2012.09.001; Yang B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-68; Yao QY, 2015, GENE, V557, P35, DOI 10.1016/j.gene.2014.12.005; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x; [邹智 Zou Zhi], 2013, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V35, P36	45	68	78	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157558	10.1371/journal.pone.0157558	http://dx.doi.org/10.1371/journal.pone.0157558			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322342	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212000026
J	Keith, RJ; Al Rifai, M; Carruba, C; De Jarnett, N; McEvoy, JW; Bhatnagar, A; Blaha, MJ; Defilippis, AP				Keith, Rachel J.; Al Rifai, Mahmoud; Carruba, Christopher; De Jarnett, Natasha; McEvoy, John W.; Bhatnagar, Aruni; Blaha, Michael J.; Defilippis, Andrew P.			Tobacco Use, Insulin Resistance, and Risk of Type 2 Diabetes: Results from the Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							CIGARETTE-SMOKING; PUBLICATION BIAS; CARDIOVASCULAR-DISEASE; FAT DISTRIBUTION; METAANALYSIS; GLUCOSE; MEN; POPULATION; EXPOSURE; MELLITUS	Introduction Tobacco use is associated with insulin resistance and incident diabetes. Given the racial/ethnic differences in smoking patterns and incident type 2 diabetes our objective was to evaluate the association between tobacco use and insulin resistance (IR) as well as incident type 2 diabetes mellitus in a contemporary multiethnic cohort. Methods and Results We studied 5,931 Multi-Ethnic Study of Atherosclerosis (MESA) participants who at baseline were free of type 2 diabetes (fasting glucose >= 7.0 mmol/l (126 mg/dl) and/or use of insulin or oral hypoglycemic medications) categorized by self-reported tobacco status and reclassified by urinary cotinine (available in 58% of participants) as never, current or former tobacco users. The association between tobacco use, IR (fasting plasma glucose, insulin, and the homeostatic model assessment of insulin resistance (HOMA-IR)) and incident diabetes over 10 years was evaluated using multivariable linear regression and Cox proportional hazards models, respectively. Mean age of the participants was 62 (+/- 10) years, 46% were male, 41% Caucasian, 12% Chinese, 26% African American and 21% Hispanic/Latino. IR biomarkers did not significantly differ between current, former, and never cigarette users (P > 0.10) but showed limited unadjusted differences for users of cigar, pipe and smokeless tobacco (All P <0.05). Fully adjusted models showed no association between dose or intensity of tobacco exposure and any index of IR. When stratified into participants that quit smoking vs. those who continued smoking during the 10-year study there was no difference in serum glucose levels or frequency of diabetes. In fully adjusted models, there was no significant difference in diabetes risk between former or current cigarette smokers compared to never smokers [HR (95% CI) 1.02 (0.77,1.37) and 0.81 (0.52,1.26) respectively]. Conclusion In a contemporary multi-ethnic cohort, there was no independent association between tobacco use and IR or incident type 2 diabetes. The role smoking plays in causing diabetes may be more complicated than originally thought and warrants more in-depth large contemporary multi-ethnic studies.	[Keith, Rachel J.; De Jarnett, Natasha; Bhatnagar, Aruni; Defilippis, Andrew P.] Univ Louisville, Sch Med, Diabet & Obes Ctr, Louisville, KY 40292 USA; [Keith, Rachel J.; Bhatnagar, Aruni; Defilippis, Andrew P.] Univ Louisville, Sch Med, Dept Med, Div Cardiol, Louisville, KY 40292 USA; [Keith, Rachel J.; Al Rifai, Mahmoud; De Jarnett, Natasha; Bhatnagar, Aruni; Blaha, Michael J.; Defilippis, Andrew P.] Amer Heart Assoc, Tobacco Regulatory & Addict Ctr, Louisville, KY 40222 USA; [Al Rifai, Mahmoud; McEvoy, John W.; Blaha, Michael J.; Defilippis, Andrew P.] John Hopkins Med, Ciccarone Ctr Prevent Heart Dis, Baltimore, MD USA; [Carruba, Christopher] Univ Colorado, Dept Med, Aurora, CO USA	University of Louisville; University of Louisville; Johns Hopkins University; Johns Hopkins Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus	Keith, RJ (corresponding author), Univ Louisville, Sch Med, Diabet & Obes Ctr, Louisville, KY 40292 USA.; Keith, RJ (corresponding author), Univ Louisville, Sch Med, Dept Med, Div Cardiol, Louisville, KY 40292 USA.; Keith, RJ (corresponding author), Amer Heart Assoc, Tobacco Regulatory & Addict Ctr, Louisville, KY 40222 USA.	Rachel.keith@lousiville.edu		Keith, Rachel/0000-0003-3877-0636	National Heart, Blood, and Lung Institute (NHLBI) [HL071739, N01-HC-95159, N01-HC-95169]; AHA Tobacco Regulation and Addiction Center (A-TRAC); FDA Center for Tobacco Products (CTP) [HL120163]; MESA Lung [HL077612]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077612, U54HL120163, P50HL120163] Funding Source: NIH RePORTER	National Heart, Blood, and Lung Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHA Tobacco Regulation and Addiction Center (A-TRAC); FDA Center for Tobacco Products (CTP)(United States Department of Health & Human Services); MESA Lung; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Blood, and Lung Institute (NHLBI) (HL071739, N01-HC-95159 through, and N01-HC-95169), the AHA Tobacco Regulation and Addiction Center (A-TRAC), and FDA Center for Tobacco Products (CTP) (HL120163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research reported in this publication was supported by the AHA Tobacco Regulation and Addiction Center (A-TRAC) and FDA Center for Tobacco Products (CTP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration. The authors thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org. Exam 1 and 5 Urinary Cotinine measurements are available to the MESA study courtesy of MESA Lung contract HL077612.	Axelsson T, 2001, J INTERN MED, V249, P539, DOI 10.1046/j.1365-2796.2001.00840.x; BARRETTCONNOR E, 1989, ANN INTERN MED, V111, P783, DOI 10.7326/0003-4819-111-10-783; Benowitz NL, 1999, ENVIRON HEALTH PERSP, V107, P349, DOI 10.2307/3434427; Berlin I, 2008, DIABETES METAB, V34, P307, DOI 10.1016/j.diabet.2008.01.008; Beziaud F, 2004, DIABETES METAB, V30, P161, DOI 10.1016/S1262-3636(07)70102-7; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Canoy D, 2005, OBES RES, V13, P1466, DOI 10.1038/oby.2005.177; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Cugati S, 2007, MED J AUSTRALIA, V186, P131, DOI 10.5694/j.1326-5377.2007.tb00836.x; Dhar P, 2004, J PHARMACEUT BIOMED, V35, P155, DOI 10.1016/j.jpba.2004.01.009; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eliasson B, 2003, PROG CARDIOVASC DIS, V45, P405, DOI 10.1053/pcad.2003.00103; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; Foy CG, 2005, DIABETES CARE, V28, P2501, DOI 10.2337/diacare.28.10.2501; Fukami T, 2007, DRUG METAB DISPOS, V35, P515, DOI 10.1124/dmd.106.013557; Haffner SM, 1996, DIABETES, V45, P742, DOI 10.2337/diabetes.45.6.742; Haussmann HJ, 2012, CHEM RES TOXICOL, V25, P794, DOI 10.1021/tx200536w; Henley SJ, 2005, CANCER CAUSE CONTROL, V16, P347, DOI 10.1007/s10552-004-5519-6; Henninger J, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0048-8; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, pb880, DOI DOI 10.1136/bmj.b880; HOFFMANN D, 1994, J TOXICOL ENV HEALTH, V41, P1, DOI 10.1080/15287399409531825; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; Hu H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141260; Kurian AK, 2007, ETHNIC DIS, V17, P143; Levin G, 2010, AM J EPIDEMIOL, V172, P1144, DOI 10.1093/aje/kwq266; MADSBAD S, 1980, DIABETES CARE, V3, P41, DOI 10.2337/diacare.3.1.41; McCulloch P, 2002, J INVEST MED, V50, P284, DOI 10.2310/6650.2002.33059; McEvoy JW, 2015, ARTERIOSCL THROM VAS, V35, P1002, DOI 10.1161/ATVBAHA.114.304960; McEvoy JW, 2015, ARTERIOSCL THROM VAS, V35, P700, DOI 10.1161/ATVBAHA.114.304562; Mickens L, 2010, ADDICT BEHAV, V35, P383, DOI 10.1016/j.addbeh.2009.12.014; Misakian AL, 1998, JAMA-J AM MED ASSOC, V280, P250, DOI 10.1001/jama.280.3.250; Montori VM, 2000, MAYO CLIN PROC, V75, P1284, DOI 10.4065/75.12.1284; Mustonen TK, 2005, NICOTINE TOB RES, V7, P581, DOI 10.1080/14622200500185199; Nagaya T, 2008, ANN EPIDEMIOL, V18, P113, DOI 10.1016/j.annepidem.2007.07.107; Nakajima M, 2006, CLIN PHARMACOL THER, V80, P282, DOI 10.1016/j.clpt.2006.05.012; Onat A, 2007, ATHEROSCLEROSIS, V193, P380, DOI 10.1016/j.atherosclerosis.2006.07.002; Ostenson CG, 2012, SCAND J PUBLIC HEALT, V40, P730, DOI 10.1177/1403494812459814; Palaniappan LP, 2002, DIABETES CARE, V25, P1351, DOI 10.2337/diacare.25.8.1351; Pan A, 2015, LANCET DIABETES ENDO, V3, P958, DOI 10.1016/S2213-8587(15)00316-2; Persson PG, 2000, J INTERN MED, V248, P103, DOI 10.1046/j.1365-2796.2000.00708.x; Sarkar Mohamadi, 2012, Drug Metab Lett, V6, P198; Seet RCS, 2012, ATHEROSCLEROSIS, V224, P195, DOI 10.1016/j.atherosclerosis.2012.06.060; Services U.S.D.o.H.a.H, 2014, HLTH CONSMOK 50 YE; Soulimane S, 2014, DIABETOLOGIA, V57, P30, DOI 10.1007/s00125-013-3058-y; Stepanov I, 2008, NICOTINE TOB RES, V10, P1773, DOI 10.1080/14622200802443544; Twig G, 2014, DIABETES CARE, V37, P2989, DOI 10.2337/dc14-0869; Wang LY, 2014, ARTERIOSCL THROM VAS, V34, P219, DOI 10.1161/ATVBAHA.113.302706; Wannamethee SG, 2005, EUR HEART J, V26, P1765, DOI 10.1093/eurheartj/ehi183; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Xia Y, 2011, BIOMARKERS, V16, P112, DOI 10.3109/1354750X.2010.533288; Zinser Michael C, 2011, Am J Health Promot, V25, peS1, DOI 10.4278/ajhp.100616-QUAN-200	52	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157592	10.1371/journal.pone.0157592	http://dx.doi.org/10.1371/journal.pone.0157592			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322410	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212000029
J	Mehryan, SAM; Kashkooli, FM; Soltani, M; Raahemifar, K				Mehryan, S. A. M.; Kashkooli, Farshad Moradi; Soltani, M.; Raahemifar, Kaamran			Fluid Flow and Heat Transfer Analysis of a Nanofluid Containing Motile Gyrotactic Micro-Organisms Passing a Nonlinear Stretching Vertical Sheet in the Presence of a Non-Uniform Magnetic Field; Numerical Approach	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; NATURAL-CONVECTION; MASS-TRANSFER; POROUS-MEDIA; FLAT-PLATE; SUSPENSION; BIOCONVECTION; SURFACE; NANOPARTICLES; SUCTION	The behavior of a water-based nanofluid containing motile gyrotactic micro-organisms passing an isothermal nonlinear stretching sheet in the presence of a non-uniform magnetic field is studied numerically. The governing partial differential equations including continuity, momentums, energy, concentration of the nanoparticles, and density of motile micro-organisms are converted into a system of the ordinary differential equations via a set of similarity transformations. New set of equations are discretized using the finite difference method and have been linearized by employing the Newton's linearization technique. The tri-diagonal system of algebraic equations from discretization is solved using the well-known Thomas algorithm. The numerical results for profiles of velocity, temperature, nanoparticles concentration and density of motile micro-organisms as well as the local skin friction coefficient C-fx, the local Nusselt number Nu(x), the local Sherwood number Sh(x) and the local density number of the motile microorganism Nn(x) are expressed graphically and described in detail. This investigation shows the density number of the motile micro-organisms enhances with rise of M, Gr/Re-2, Pe and Omega but it decreases with augment of Rb and n. Also, Sherwood number augments with an increase of M and Gr/Re-2, while decreases with n, Rb, Nb and Nr. To show the validity of the current results, a comparison between the present results and the existing literature has been carried out.	[Mehryan, S. A. M.; Kashkooli, Farshad Moradi; Soltani, M.] KNT Univ Technol, Dept Mech Engn, Tehran, Iran; [Soltani, M.] Johns Hopkins Univ, Sch Med, Div Nucl Med, Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Raahemifar, Kaamran] Ryerson Univ, Elect & Comp Engn Dept, Toronto, ON, Canada	Johns Hopkins University; Toronto Metropolitan University	Soltani, M (corresponding author), KNT Univ Technol, Dept Mech Engn, Tehran, Iran.; Soltani, M (corresponding author), Johns Hopkins Univ, Sch Med, Div Nucl Med, Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	msoltani@jhu.edu	Moradi Kashkooli, Farshad/ABD-7574-2021; Moradi Kashkooli, Farshad/GXW-0169-2022	Moradi Kashkooli, Farshad/0000-0003-4338-8538				Akbar NS, 2016, J MAGN MAGN MATER, V410, P72, DOI 10.1016/j.jmmm.2016.02.075; Alloui Z, 2007, INT J HEAT MASS TRAN, V50, P1435, DOI 10.1016/j.ijheatmasstransfer.2006.09.008; Aman F, 2010, HEAT MASS TRANSFER, V46, P615, DOI 10.1007/s00231-010-0606-6; Aminossadati SM, 2011, INT J NONLIN MECH, V46, P1373, DOI 10.1016/j.ijnonlinmec.2011.07.013; Avramenko AA, 2010, INT J NUMER METHOD H, V20, P111, DOI 10.1108/09615531011008154; Avramenko AA, 2004, INT COMMUN HEAT MASS, V31, P1057, DOI 10.1016/j.icheatmasstransfer.2004.08.003; Awais M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129814; Aziz A, 2012, INT J THERM SCI, V56, P48, DOI 10.1016/j.ijthermalsci.2012.01.011; Aziz A, 2012, INT J THERM SCI, V52, P83, DOI 10.1016/j.ijthermalsci.2011.10.001; Behseresht A, 2014, CHEM ENG RES DES, V92, P447, DOI 10.1016/j.cherd.2013.08.028; Chamkha AJ, 2011, CHEM ENG COMMUN, V198, P425, DOI 10.1080/00986445.2010.520232; CHEN CK, 1988, J MATH ANAL APPL, V135, P568, DOI 10.1016/0022-247X(88)90172-2; CHIAM TC, 1995, INT J ENG SCI, V33, P429, DOI 10.1016/0020-7225(94)00066-S; Choi SUS., 1995, ASME PUBLICATIONS FE, P99; ERICKSON LE, 1966, IND ENG CHEM FUND, V5, P19, DOI 10.1021/i160017a004; Ferdows M, 2013, INT J HEAT MASS TRAN, V56, P181, DOI 10.1016/j.ijheatmasstransfer.2012.09.020; Freidoonimehr N, 2016, J BRAZ SOC MECH SCI, V38, P1999, DOI 10.1007/s40430-015-0456-8; Gbadeyan JA., 2011, AUST J BASIC APPL SC, V5, P1323; Ghalambaz M, 2015, CAN J PHYS, V93, P725, DOI 10.1139/cjp-2014-0370; Ghalambaz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126486; Goyal M, 2014, MICROFLUID NANOFLUID, V17, P591, DOI 10.1007/s10404-013-1326-2; HELMY KA, 1994, ACTA MECH, V102, P25, DOI 10.1007/BF01178515; Hill NA, 2005, FLUID DYN RES, V37, P1, DOI 10.1016/j.fluiddyn.2005.03.002; Ibrahim W, 2013, COMPUT FLUIDS, V75, P1, DOI 10.1016/j.compfluid.2013.01.014; Khan MS, 2013, PROCEDIA ENGINEER, V56, P316, DOI 10.1016/j.proeng.2013.03.125; Khan WA, 2015, EUR PHYS J PLUS, V130, DOI 10.1140/epjp/i2015-15086-4; Khan WA, 2014, INT J HEAT MASS TRAN, V74, P285, DOI 10.1016/j.ijheatmasstransfer.2014.03.026; Khan WA, 2014, INT J THERM SCI, V81, P118, DOI 10.1016/j.ijthermalsci.2014.03.009; Khan WA, 2013, TRANSPORT POROUS MED, V97, P241, DOI 10.1007/s11242-012-0120-z; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Kuznetsov AV, 2011, INT J THERM SCI, V50, P712, DOI 10.1016/j.ijthermalsci.2011.01.003; Kuznetsov AV, 2010, INT COMMUN HEAT MASS, V37, P1421, DOI 10.1016/j.icheatmasstransfer.2010.08.015; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; Kuznetsov AV, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-100; Kuznetsov AV, 2006, EUR J MECH B-FLUID, V25, P223, DOI 10.1016/j.euromechflu.2005.06.003; Mabood F, 2016, EUR PHYS J PLUS, V131, DOI 10.1140/epjp/i2016-16003-1; Mabood F, 2015, J MAGN MAGN MATER, V374, P569, DOI 10.1016/j.jmmm.2014.09.013; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Mutuku WN, 2014, COMPUT FLUIDS, V95, P88, DOI 10.1016/j.compfluid.2014.02.026; Nadeem S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069811; Noghrehabadi A, 2014, J MECH, V30, P265, DOI 10.1017/jmech.2013.61; Noghrehabadi A, 2013, HEAT MASS TRANSFER, V49, P1357, DOI 10.1007/s00231-013-1179-y; Noghrehabadi A, 2013, APPL MATH MECH-ENGL, V34, P669, DOI 10.1007/s10483-013-1699-6; Noghrehabadi A, 2012, J THERMOPHYS HEAT TR, V26, P686, DOI 10.2514/1.T3866; Noghrehabadi A, 2012, INT J THERM SCI, V54, P253, DOI 10.1016/j.ijthermalsci.2011.11.017; Nourazar SS, 2011, J APPL MATH, DOI 10.1155/2011/876437; Qasim M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059393; Rana P, 2012, COMMUN NONLINEAR SCI, V17, P212, DOI 10.1016/j.cnsns.2011.05.009; Rashidi MM, 2014, MECCANICA, V49, P469, DOI 10.1007/s11012-013-9805-9; SAKIADIS BC, 1961, AICHE J, V7, P221, DOI 10.1002/aic.690070211; Uddin MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049499; Vajravelu K, 2011, INT J THERM SCI, V50, P843, DOI 10.1016/j.ijthermalsci.2011.01.008; Zaraki A, 2015, ADV POWDER TECHNOL, V26, P935, DOI 10.1016/j.apt.2015.03.012; Zargartalebi H, 2015, ADV POWDER TECHNOL, V26, P819, DOI 10.1016/j.apt.2015.02.008	54	40	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157598	10.1371/journal.pone.0157598	http://dx.doi.org/10.1371/journal.pone.0157598			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322536	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212000030
J	Pearson, SF; Knapp, SM				Pearson, Scott F.; Knapp, Shannon M.			Considering Spatial Scale and Reproductive Consequences of Habitat Selection when Managing Grasslands for a Threatened Species	PLOS ONE			English	Article							NEST-SITE SELECTION; POPULATION-GROWTH; PARENTAL ACTIVITY; PREDATION; PRAIRIE; COLONIZATION; LANDSCAPE; SURVIVAL; SUCCESS; MANAGEMENT	Habitat selection that has fitness consequences has important implications for conservation activities. For example, habitat characteristics that influence nest success in birds can be manipulated to improve habitat quality with the goal of ultimately improving reproductive success. We examined habitat selection by the threatened streaked horned lark (Eremophila alpestris strigata) at both the breeding-site (territory) and nest-site scales. Larks were selective at both spatial scales but with contrasting selection. At the territory scale, male larks selected sparsely vegetated grasslands with relatively short vegetation. At the nestsite scale, female larks selected sites within territories with higher vegetation density and more perennial forbs. These nest-site scale choices had reproductive consequences, with greater nest success in areas with higher densities of perennial forbs. We experimentally manipulated lark habitat structure in an attempt to mimic the habitat conditions selected by larks by using late summer prescribed fires. After the burn, changes in vegetation structure were in the direction preferred by larks but habitat effects attenuated by the following year. Our results highlight the importance of evaluating habitat selection at spatial scales appropriate to the species of interest, especially when attempting to improve habitat quality for rare and declining species. They also highlight the importance of conducting restoration activities in a research context. For example, because the sparsely vegetated conditions created by fire attenuate, there may be value in examining more frequent burns or hotter fires as the next management and research action. We hope the design outlined in this study will serve as an integrated research and management example for conserving grassland birds generally.	[Pearson, Scott F.] Washington Dept Fish & Wildlife, Wildlife Res Div, 1111 Washington St SE, Olympia, WA 98501 USA; [Knapp, Shannon M.] Univ Arizona, Stat Consulting Lab, Inst Bio5, 1657 E Helen St, Tucson, AZ 85721 USA	Washington Department of Fish & Wildlife (WDFW); University of Arizona	Pearson, SF (corresponding author), Washington Dept Fish & Wildlife, Wildlife Res Div, 1111 Washington St SE, Olympia, WA 98501 USA.	scott.pearson@dfw.wa.gov		Pearson, Scott/0000-0003-4960-3956	Center for Natural Lands Management [CNLM WA-C-2014-029-0]; Nature Conservancy [WAFO-98-04105, WAFO-96-032305]; U.S. Fish and Wildlife Service Washington Field Office recovery funds [13410-1-J023 - $58,697]; Washington Department of Transportation [GCA3226 - $10,000]; Washington Department of Fish and Wildlife; Washington Department of Natural Resources; US Fish and Wildlife Service western Washington field office; Joint Base Lewis-McChord	Center for Natural Lands Management; Nature Conservancy; U.S. Fish and Wildlife Service Washington Field Office recovery funds; Washington Department of Transportation; Washington Department of Fish and Wildlife; Washington Department of Natural Resources; US Fish and Wildlife Service western Washington field office; Joint Base Lewis-McChord	This work was funded by the following grants to Scott Pearson: Center for Natural Lands Management (CNLM WA-C-2014-029-0 DOD JBLM Ecosystem response Monitoring: Streaked Horned Lark Nesting Habitat $18,278), The Nature Conservancy (WAFO-98-04105 FT Lewis STHL FY05 - $33,630, TNC WAFO-96-032305 McChord larks - $10,249.22), U.S. Fish and Wildlife Service Washington Field Office recovery funds (13410-1-J023 - $58,697), Washington Department of Transportation (GCA3226 - $10,000), and funds from Washington Department of Fish and Wildlife and Washington Department of Natural Resources.; We thank the US Fish and Wildlife Service western Washington field office and Joint Base Lewis-McChord for funding-with a special thanks to Kim Flotlin with the Service, and Jim Lynch and Dave Clouse with Joint Base. The Center of Natural lands management helped to coordinate this work, especially Hannah Anderson and Gary Slater. Thank you to Dave Hays and Peter Dunwiddie for providing input on the effects of fire on local grasslands. Without the field and data management help of Mark Hopey and Hannah Anderson in particular, this work would not have been possible-thank you! We thank Joint Base Lewis-McChord, Port of Olympia, Port of Shelton, Washington Departments of Natural Resources and State Parks, and Oregon Division of State Lands for granting access to our study sites. We thank the Joint Base Lewis-McChord fire crew for conducting our prescribed burns.	Altman B, 2011, NORTHWEST SCI, V85, P194, DOI 10.3955/046.085.0210; Anders AD, 2005, CONSERV BIOL, V19, P66, DOI 10.1111/j.1523-1739.2005.00543.x; [Anonymous], 2013, MEASUREMENTS TERREST; Archer S., 2003, WOODY PLANT ENCROACH; Barbour M.G., 1988, N AM TERRESTRIAL VEG; Beason Robert C., 1995, Birds of North America, V195, P1; Borgmann KL, 2015, WILSON J ORNITHOL, V127, P646, DOI 10.1676/14-162.1; Borgmann KL, 2004, ECOL APPL, V14, P1757, DOI 10.1890/03-5129; Bowles J. H., 1906, Auk Cambridge N Ser, V23; Bowles JH, 1898, OSPREY, V3, P53; BOWMAN GB, 1980, J WILDLIFE MANAGE, V44, P806, DOI 10.2307/3808308; BOYD R, 1986, Canadian Journal of Anthropology, V5, P65; Boyd R., 1999, INDIANS FIRE LAND PA; BURLEIGH THOMAS D., 1929, AUK, V46, P502; Burnham K. P., 2002, MODEL SELECTION AND; Camfield AF, 2011, AVIAN CONSERV ECOL, V6, DOI 10.5751/ACE-00467-060204; Camfield AF, 2010, J AVIAN BIOL, V41, P273, DOI 10.1111/j.1600-048X.2009.04816.x; Chalfoun AD, 2007, J APPL ECOL, V44, P983, DOI 10.1111/j.1365-2664.2007.01352.x; Chandler R, 2011, J STAT SOFTWARE; Chappell CB, 2001, CONSERVATION WASHING, P124; Cooper J, 2003, COSEWIC STATUS REPOR; Crawford R. C., 1997, ECOLOGY CONSERVATION, P11; Davis SK, 1999, STUD AVIAN BIOL-SER, P211; Drovetski SV, 2005, CONSERV GENET, V6, P875, DOI 10.1007/s10592-005-9074-9; DuBOIS A. DAWES, 1935, CONDOR, V37, P56, DOI 10.2307/1363878; Dunwiddie P., 2006, DAVIDSONIA, V17, P51; Dunwiddie PW, 2002, MANAGEMENT AND RESTO; Engineers USACo, 1988, LOW COL RIV FLOOD CO; Engineers USACo, 1948, REV REP COL RIV TRIB; Fieberg J, 2001, ECOL LETT, V4, P244, DOI 10.1046/j.1461-0248.2001.00202.x; Floberg J., 2004, WILLAMETTE VALLEY PU; Foster JR, 2003, NORTHWEST SCI, V77, P283; Gelfenbaum G, 1999, COLUMBIA RIVER LITTO; Hamman ST, 2011, NORTHWEST SCI, V85, P317, DOI 10.3955/046.085.0218; Hartman CA, 2003, CONDOR, V105, P158, DOI 10.1650/0010-5422(2003)105[158:OAMOHL]2.0.CO;2; HERKERT JR, 1994, NAT AREA J, V14, P128; Herman DM, 2015, CONDOR, V117, P473, DOI 10.1650/CONDOR-15-18.1; Johnson OB, 1880, AM NAT, V14, P485; JOHNSON RG, 1990, J WILDLIFE MANAGE, V54, P106, DOI 10.2307/3808909; Knutson MG, 2006, CONDOR, V108, P301, DOI 10.1650/0010-5422(2006)108[301:AAOBHQ]2.0.CO;2; Larson MA, 2002, J WILDLIFE MANAGE, V66, P361, DOI 10.2307/3803169; Maguire GS, 2009, WILDLIFE RES, V36, P702, DOI 10.1071/WR09123; Martin T.E., 1992, Current Ornithology, V9, P163; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1988, CONDOR, V90, P51, DOI 10.2307/1368432; Mason NA, 2014, AUK, V131, P162, DOI 10.1642/AUK-13-181.1; Misenhelter MD, 2000, ECOLOGY, V81, P2892, DOI 10.2307/177349; Morlan JC, 2000, SUMMARY CURRENT STAT, P45; Morris W.G., 1934, OR HIST Q, V35, P313; Muchai M, 2005, J AVIAN BIOL, V36, P110, DOI 10.1111/j.0908-8857.2005.03312.x; Newton I., 1998, POPULATION LIMITATIO; ORIANS GH, 1991, AM NAT, V137, pS29, DOI 10.1086/285138; Pearson SF, 2012, J FIELD ORNITHOL, V83, P315, DOI 10.1111/j.1557-9263.2012.00381.x; Pearson SF, 2015, STREAKED HORNED LARK; Peter D, 2006, RESTOR ECOL, V14, P605, DOI 10.1111/j.1526-100X.2006.00172.x; Peter DH, 2014, NORTHWEST SCI, V88, P186, DOI 10.3955/046.088.0303; Ricklefs R.E., 1969, ANAL NESTING MORTALI; Rogers RE, 2000, STATUS MICROHABITAT; Rohrbaugh RW, 1999, STUD AVIAN BIOL-SER, P165; Rook EJ, 2011, NORTHWEST SCI, V85, P288, DOI 10.3955/046.085.0216; Rotella J. J., 2004, Animal Biodiversity and Conservation, V27, P187; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Schultz CB, 1998, RESTOR ECOL, V6, P244, DOI 10.1046/j.1526-100X.1998.00637.x; Shaffer TL, 2004, AUK, V121, P526, DOI 10.1642/0004-8038(2004)121[0526:AUATAN]2.0.CO;2; SKUTCH AF, 1949, IBIS, V91, P430, DOI 10.1111/j.1474-919X.1949.tb02293.x; Smith RK, 2011, BIOL CONSERV, V144, P1, DOI 10.1016/j.biocon.2010.05.008; Smith RK, 2010, CONSERV BIOL, V24, P820, DOI 10.1111/j.1523-1739.2009.01421.x; Stephens SE, 2005, ECOL APPL, V15, P2137, DOI 10.1890/04-1162; Stephens SE, 2003, INFLUENCE LANDSCAPE; Stinson DW, 2005, WASHINGTON STATE STA; Union AO, 1957, CHECK LIST N AM BIRD; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Warren SD, 2008, J WILDLIFE MANAGE, V72, P738, DOI 10.2193/2007-160; Willson MF, 2001, CONSERV BIOL, V15, P447, DOI 10.1046/j.1523-1739.2001.015002447.x; Winter M, 2005, J WILDLIFE MANAGE, V69, P185, DOI 10.2193/0022-541X(2005)069&lt;0185:VIVEOD&gt;2.0.CO;2; Wisdom MJ, 2000, ECOLOGY, V81, P628, DOI 10.1890/0012-9658(2000)081[0628:LSSAEV]2.0.CO;2	76	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0156330	10.1371/journal.pone.0156330	http://dx.doi.org/10.1371/journal.pone.0156330			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322196	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212000006
J	Pinho, R; Guedes, LC; Soreq, L; Lobo, PP; Mestre, T; Coelho, M; Rosa, MM; Goncalves, N; Wales, P; Mendes, T; Gerhardt, E; Fahlbusch, C; Bonifati, V; Bonin, M; Miltenberger-Miltenyi, G; Borovecki, F; Soreq, H; Ferreira, JJ; Outeiro, TF				Pinho, Raquel; Guedes, Leonor C.; Soreq, Lilach; Lobo, Patricia P.; Mestre, Tiago; Coelho, Miguel; Rosa, Mario M.; Goncalves, Nilza; Wales, Pauline; Mendes, Tiago; Gerhardt, Ellen; Fahlbusch, Christiane; Bonifati, Vincenzo; Bonin, Michael; Miltenberger-Miltenyi, Gabriel; Borovecki, Fran; Soreq, Hermona; Ferreira, Joaquim J.; Outeiro, Tiago F.			Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles	PLOS ONE			English	Article							ESSENTIAL TRANSCRIPTIONAL REGULATOR; DNA-DAMAGE; MICROARRAY ANALYSIS; CLINICAL-DIAGNOSIS; ALPHA-SYNUCLEIN; MODELS; REPAIR; CELLS; NUB1; NEURODEGENERATION	The prognosis of neurodegenerative disorders is clinically challenging due to the inexistence of established biomarkers for predicting disease progression. Here, we performed an exploratory cross-sectional, case-control study aimed at determining whether gene expression differences in peripheral blood may be used as a signature of Parkinson's disease (PD) progression, thereby shedding light into potential molecular mechanisms underlying disease development. We compared transcriptional profiles in the blood from 34 PD patients who developed postural instability within ten years with those of 33 patients who did not develop postural instability within this time frame. Our study identified >200 differentially expressed genes between the two groups. The expression of several of the genes identified was previously found deregulated in animal models of PD and in PD patients. Relevant genes were selected for validation by real-time PCR in a subset of patients. The genes validated were linked to nucleic acid metabolism, mitochondria, immune response and intracellular-transport. Interestingly, we also found deregulation of these genes in a dopaminergic cell model of PD, a simple paradigm that can now be used to further dissect the role of these molecular players on dopaminergic cell loss. Altogether, our study provides preliminary evidence that expression changes in specific groups of genes and pathways, detected in peripheral blood samples, may be correlated with differential PD progression. Our exploratory study suggests that peripheral gene expression profiling may prove valuable for assisting in prediction of PD prognosis, and identifies novel culprits possibly involved in dopaminergic cell death. Given the exploratory nature of our study, further investigations using independent, well-characterized cohorts will be essential in order to validate our candidates as predictors of PD prognosis and to definitively confirm the value of gene expression analysis in aiding patient stratification and therapeutic intervention.	[Pinho, Raquel; Wales, Pauline; Gerhardt, Ellen; Fahlbusch, Christiane; Outeiro, Tiago F.] Univ Med Ctr Gottingen, Ctr Nanoscale Microscopy & Mol Physiol Brain, Dept NeuroDegenerat & Restorat Res, Gottingen, Niedersachsen, Germany; [Pinho, Raquel] Univ Porto, Fac Med, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Guedes, Leonor C.; Lobo, Patricia P.; Mestre, Tiago; Coelho, Miguel; Rosa, Mario M.; Goncalves, Nilza; Mendes, Tiago; Miltenberger-Miltenyi, Gabriel; Ferreira, Joaquim J.] Univ Lisbon, Fac Med, Inst Mol Med, Clin Pharmacol Unit, P-1699 Lisbon, Portugal; [Soreq, Lilach] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Bonifati, Vincenzo] Erasmus MC, Dept Clin Genet, Rotterdam, South Holland, Netherlands; [Bonin, Michael] Eberhard Karls Univ Tubingen, Inst Med Genet & Appl Gen, Baden, Switzerland; [Borovecki, Fran] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Dept Funct Gen,Ctr Translat & Clin Res, Zagreb 41000, Croatia; [Soreq, Hermona] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Soreq, Hermona] Inst Life Sci, Dept Biol Chem, Jerusalem, Israel; [Outeiro, Tiago F.] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, P-1200 Lisbon, Portugal	University of Gottingen; Universidade do Porto; Universidade de Lisboa; University of London; University College London; Erasmus University Rotterdam; Erasmus MC; University of Zagreb; Hebrew University of Jerusalem; Universidade Nova de Lisboa	Outeiro, TF (corresponding author), Univ Med Ctr Gottingen, Ctr Nanoscale Microscopy & Mol Physiol Brain, Dept NeuroDegenerat & Restorat Res, Gottingen, Niedersachsen, Germany.; Ferreira, JJ (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, Clin Pharmacol Unit, P-1699 Lisbon, Portugal.; Outeiro, TF (corresponding author), Univ Nova Lisboa, Fac Ciencias Med, CEDOC, P-1200 Lisbon, Portugal.	joaquimjferreira@gmail.com; touteir@gwdg.de	Outeiro, Tiago F/C-1067-2008; Ferreira, Joaquim/AAA-1837-2020; Soreq, Lilach/AAY-7139-2020; Miltenberger-Miltenyi, Gabriel/B-4993-2018; Outeiro, Tiago/L-7351-2019; Outeiro, Tiago/M-8106-2019	Outeiro, Tiago F/0000-0003-1679-1727; Miltenberger-Miltenyi, Gabriel/0000-0003-0224-1281; Outeiro, Tiago/0000-0003-1679-1727; Bouca-Machado, Raquel/0000-0003-3756-2763; Mendes, Tiago/0000-0002-6194-7295; Soreq, Hermona/0000-0002-0955-526X; Correia Guedes, Leonor/0000-0002-8422-0494	Fundacao para a Ciencia e Tecnologia (FCT) [PIC/IC/82760/2007]; FCT [SFRH/BD/80884/2011]; DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain; Parkinson Fonds, Germany; European Community's Seventh Framework Programme (FP7) [241791]; Marie Curie Intra-European Fellowship (IEF) within the European Union's Seventh Framework Programme [PRANA-GPF-330430]; Stichting ParkinsonFonds (The Netherlands); Parkinson&quot;s UK [K-1206] Funding Source: researchfish; Fundação para a Ciência e a Tecnologia [PIC/IC/82760/2007] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG)); Parkinson Fonds, Germany; European Community's Seventh Framework Programme (FP7)(European Commission); Marie Curie Intra-European Fellowship (IEF) within the European Union's Seventh Framework Programme; Stichting ParkinsonFonds (The Netherlands)(Netherlands Government); Parkinson&quot;s UK(Parkinson&apos;s UK); Fundação para a Ciência e a Tecnologia	This project was supported by Fundacao para a Ciencia e Tecnologia (FCT grant PIC/IC/82760/2007). RP is supported by a PhD fellowship from FCT (SFRH/BD/80884/2011). TFO was supported by an EMBO Installation Grant, and is currently supported by the DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain, and by a Grant from Parkinson Fonds, Germany. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-20013) under grant agreement No. 241791 European Project on Mendelian Forms of PD (MEFOPA). LS is funded by a Marie Curie Intra-European Fellowship (IEF) within the European Union's Seventh Framework Programme (PRANA-GPF-330430). VB is supported by the Stichting ParkinsonFonds (The Netherlands).	Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Bendor J, 2010, EMBO J, V29, P2813, DOI 10.1038/emboj.2010.154; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Conn KJ, 2003, NEUROCHEM RES, V28, P1873, DOI 10.1023/A:1026179926780; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dumitriu A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002794; Evans JR, 2011, J NEUROL NEUROSUR PS, V82, P1112, DOI 10.1136/jnnp.2011.240366; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; Francisconi S, 2005, BRAIN RES REV, V48, P347, DOI 10.1016/j.brainresrev.2004.12.023; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Gotovac K, 2014, MOL DIAGN THER, V18, P17, DOI 10.1007/s40291-013-0058-z; Harvey SH, 2004, MOL CELL BIOL, V24, P662, DOI 10.1128/MCB.24.2.662-674.2004; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; Hely MA, 1999, J NEUROL NEUROSUR PS, V67, P300, DOI 10.1136/jnnp.67.3.300; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jackson Brian C., 2010, Human Genomics, V4, P345; Jenner P, 2003, NEUROLOGY, V61, pS4, DOI 10.1212/WNL.61.6_suppl_3.S4; Jeppesen DK, 2011, PROG NEUROBIOL, V94, P166, DOI 10.1016/j.pneurobio.2011.04.013; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kempster PA, 2007, BRAIN, V130, P2123, DOI 10.1093/brain/awm142; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Krimbou L, 2006, CURR OPIN LIPIDOL, V17, P258, DOI 10.1097/01.mol.0000226117.43178.7c; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Locascio JJ, 2015, BRAIN, V138, P2659, DOI 10.1093/brain/awv202; Mena NP, 2011, BIOCHEM BIOPH RES CO, V409, P241, DOI 10.1016/j.bbrc.2011.04.137; Newman EJ, 2009, MOVEMENT DISORD, V24, P2379, DOI 10.1002/mds.22829; Parenti R, 2007, EUR J NEUROSCI, V26, P2444, DOI 10.1111/j.1460-9568.2007.05864.x; Richet E, 2012, HUM MOL GENET, V21, P5254, DOI 10.1093/hmg/dds376; Rolig RL, 2000, TRENDS NEUROSCI, V23, P417, DOI 10.1016/S0166-2236(00)01625-8; Rozen S, 2000, Methods Mol Biol, V132, P365; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Scholz D, 2011, J NEUROCHEM, V119, P957, DOI 10.1111/j.1471-4159.2011.07255.x; Schrag A, 2002, J NEUROL NEUROSUR PS, V73, P529, DOI 10.1136/jnnp.73.5.529; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shtilbans A, 2012, CURR OPIN NEUROL, V25, P460, DOI 10.1097/WCO.0b013e3283550c0d; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soreq L, 2008, J NEUROIMMUNOL, V201, P227, DOI 10.1016/j.jneuroim.2008.06.019; Soreq L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003517; Soreq L, 2012, NEURODEGENER DIS, V10, P203, DOI 10.1159/000332598; Soreq L, 2012, J CELL MOL MED, V16, P1496, DOI 10.1111/j.1582-4934.2011.01444.x; Soreq L, 2012, NEUROBIOL DIS, V45, P1018, DOI 10.1016/j.nbd.2011.12.021; Tanji K, 2006, AM J PATHOL, V169, P553, DOI 10.2353/ajpath.2006.051067; Tanji K, 2011, J NEUROPATH EXP NEUR, V70, P879, DOI 10.1097/NEN.0b013e3182303745; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Uberti D, 2003, TOXICOL LETT, V139, P99, DOI 10.1016/S0378-4274(02)00423-X; Williams-Gray CH, 2013, J NEUROL NEUROSUR PS, V84, P1258, DOI 10.1136/jnnp-2013-305277; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	56	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157852	10.1371/journal.pone.0157852	http://dx.doi.org/10.1371/journal.pone.0157852			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322389	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000378212000048
J	Dbara, S; Haworth, M; Emiliani, G; Ben Mimoun, M; Gomez-Cadenas, A; Centritto, M				Dbara, Soumaya; Haworth, Matthew; Emiliani, Giovani; Ben Mimoun, Mehdi; Gomez-Cadenas, Aurelio; Centritto, Mauro			Partial Root-Zone Drying of Olive (Olea europaea var. 'Chetoui') Induces Reduced Yield under Field Conditions	PLOS ONE			English	Article							REGULATED DEFICIT IRRIGATION; LEAF GAS-EXCHANGE; WATER-USE; ABSCISIC-ACID; STOMATAL CONTROL; PROLINE ACCUMULATION; DIFFUSIONAL LIMITATIONS; PHOTOSYNTHETIC CAPACITY; MESOPHYLL CONDUCTANCE; HYDRAULIC CONTROL	The productivity of olive trees in arid and semi-arid environments is closely linked to irrigation. It is necessary to improve the efficiency of irrigation techniques to optimise the amount of olive fruit produced in relation to the volume of water used. Partial root-zone drying (PRD) is a water saving irrigation technique that theoretically allows the production of a root-to shoot signal that modifies the physiology of the above-ground parts of the plant; specifically reducing stomatal conductance (g(s)) and improving water use efficiency (WUE). Partial root zone drying has been successfully applied under field conditions to woody and non-woody crops; yet the few previous trials with olive trees have produced contrasting results. Thirty year-old olive trees (Olea europaea 'var. Chetoui') in a Tunisian grove were exposed to four treatments from May to October for three-years: 'control' plants received 100% of the potential evapotranspirative demand (ETc) applied to the whole root-zone; 'PRD100' were supplied with an identical volume of water to the control plants alternated between halves of the root-zone every ten-days; 'PRD50' were given 50% of ETc to half of the root-system, and; 'rain-fed' plants received no supplementary irrigation. Allowing part of the root-zone to dry resulted in reduced vegetative growth and lower yield: PRD100 decreased yield by similar to 47% during productive years. During the less productive years of the alternate bearing cycle, irrigation had no effect on yield; this suggests that withholding of water during 'off-years' may enhance the effectiveness of irrigation over a two-year cycle. The amount and quality of oil within the olive fruit was unaffected by the irrigation treatment. Photosynthesis declined in the PRD50 and rain-fed trees due to greater diffusive limitations and reduced biochemical uptake of CO2. Stomatal conductance and the foliar concentration of abscisic acid (ABA) were not altered by PRD100 irrigation, which may indicate the absence of a hormonal root to-shoot signal. Rain-fed and PRD50 treatments induced increased stem water potential and increased foliar concentrations of ABA, proline and soluble sugars. The stomata of the olive trees were relatively insensitive to super-ambient increases in [CO2] and higher [ABA]. These characteristics of 'hydro-passive' stomatal behaviour indicate that the 'Chetoui' variety of olive tree used in this study lacks the physiological responses required for the successful exploitation of PRD techniques to increase yield and water productivity. Alternative irrigation techniques such as partial deficit irrigation may be more suitable for 'Chetour' olive production.	[Dbara, Soumaya] Ctr Reg Rech Hort & Agr Biol, BP57, Chott Mariem 4042, Tunisia; [Haworth, Matthew; Emiliani, Giovani; Centritto, Mauro] CNR, IVALSA, Natl Res Council, Trees & Timber Inst, Via Madonna Piano 10, I-50019 Sesto Fiorentino, FI, Italy; [Ben Mimoun, Mehdi] Inst Natl Agron Tunisie, 43 Ave Charles Nicolle, Tunis 1082, Tunisia; [Gomez-Cadenas, Aurelio] Univ Jaume 1, Dept Ciencias Agr & Medio Nat, Campus Riu Sec, E-12071 Castellon de La Plana, Spain	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Valorizzazione del Legno e delle Specie Arboree (IVALSA-CNR); Universite de Carthage; Universitat Jaume I	Centritto, M (corresponding author), CNR, IVALSA, Natl Res Council, Trees & Timber Inst, Via Madonna Piano 10, I-50019 Sesto Fiorentino, FI, Italy.	mauro.centritto@cnr.it	Haworth, Matthew/B-7817-2013; Gomez-Cadenas, Aurelio/K-6084-2012; Mimoun, Mehdi Ben/AAI-9156-2020; Emiliani, Giovanni/G-5023-2016	Gomez-Cadenas, Aurelio/0000-0002-4598-2664; Mimoun, Mehdi Ben/0000-0002-3379-8229; Emiliani, Giovanni/0000-0002-1264-8002; Haworth, Matthew/0000-0002-3225-6620	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN "PRO-ROOT"; Progetto Premiale "Aqua"; Marie Curie IEF [2010-275626]	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN "PRO-ROOT"; Progetto Premiale "Aqua"; Marie Curie IEF(European Commission)	MC acknowledges funding from the Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN 2010-2011 "PRO-ROOT" and Progetto Premiale 2012 "Aqua". MH acknowledges funding from a Marie Curie IEF (2010-275626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN 2010-2011 "PRO-ROOT" and Progetto Premiale 2012 "Aqua". MH acknowledges funding from a Marie Curie IEF (2010-275626). We are grateful to Dr Mohamed Ghrab (Olive Tree Institute) for technical assistance and scientific discussion. The comments of Georgios Koubouris (Hellenic Agricultural Organization) and two anonymous reviewers significantly improved this manuscript.	Aganchich B, 2008, GRASAS ACEITES, V59, P225; Aganchich B, 2007, PLANT BIOSYST, V141, P252, DOI 10.1080/11263500701401893; Aganchich B., 2013, Journal of Agricultural Science and Technology, B, V3, P344; Aganchich B, 2009, TREE PHYSIOL, V29, P685, DOI 10.1093/treephys/tpp012; Allen RG, 2006, AGR WATER MANAGE, V81, P1, DOI 10.1016/j.agwat.2005.03.007; Antolin MC, 2006, AUST J GRAPE WINE R, V12, P13, DOI 10.1111/j.1755-0238.2006.tb00039.x; Aparicio R., 2013, HDB OLIVE OIL ANAL P, P590; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BLUM A, 1976, CROP SCI, V16, P428, DOI 10.2135/cropsci1976.0011183X001600030030x; BOYER JS, 1970, PLANT PHYSIOL, V46, P233, DOI 10.1104/pp.46.2.233; Brodribb TJ, 2011, SCIENCE, V331, P582, DOI 10.1126/science.1197985; Centritto M, 2005, AGR ECOSYST ENVIRON, V106, P303, DOI 10.1016/j.agee.2004.10.016; Centritto M, 2003, PLANT CELL ENVIRON, V26, P585, DOI 10.1046/j.1365-3040.2003.00993.x; Centritto M, 2009, J EXP BOT, V60, P2325, DOI 10.1093/jxb/erp123; Connor DJ, 2005, AUST J AGR RES, V56, P1181, DOI 10.1071/AR05169; Cowan I. R., 1977, Advances in Botanical Research, V4, P117, DOI 10.1016/S0065-2296(08)60370-5; Davies WJ, 2002, NEW PHYTOL, V153, P449, DOI 10.1046/j.0028-646X.2001.00345.x; DAVIES WJ, 1991, ANNU REV PLANT PHYS, V42, P55, DOI 10.1146/annurev.pp.42.060191.000415; Diaz-Espejo A, 2007, PLANT CELL ENVIRON, V30, P922, DOI 10.1111/j.1365-3040.2007.001686.x; dos Santos MR, 2014, REV BRAS ENG AGR AMB, V18, P899, DOI 10.1590/1807-1929/agriambi.v18n09p899-907; Dry P, 1999, 3 INT S IRR HORT CRO, P537; Dry P. R., 1998, Australian Journal of Grape and Wine Research, V4, P140, DOI 10.1111/j.1755-0238.1998.tb00143.x; Duarte F, 2008, J ENVIRON MANAGE, V89, P86, DOI 10.1016/j.jenvman.2007.05.024; EC. European Commission, 2012, DIR GEN AGR RUR DEV; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Fernandez JE, 2006, PLANT SOIL, V284, P273, DOI 10.1007/s11104-006-0045-9; Fernandez JE, 1997, PLANT SOIL, V190, P179, DOI 10.1023/A:1004293026973; Fernandez JE, 2003, AGRONOMIE, V23, P545, DOI 10.1051/agro:2003031; Fernandez-Escobar R, 1999, SCI HORTIC-AMSTERDAM, V82, P25, DOI 10.1016/S0304-4238(99)00045-X; Flexas J, 2013, PHOTOSYNTH RES, V117, P45, DOI 10.1007/s11120-013-9844-z; Fuchs EE, 1996, PLANT CELL ENVIRON, V19, P1091, DOI 10.1111/j.1365-3040.1996.tb00216.x; Galan C, 2008, AGRON J, V100, P98, DOI 10.2134/agronj2006.0345; Ghrab M, 2013, AGR WATER MANAGE, V123, P1, DOI 10.1016/j.agwat.2013.03.007; Giday H, 2014, J EXP BOT, V65, P4361, DOI 10.1093/jxb/eru216; Gomez-Cadenas A, 2002, PHYTOCHEM ANALYSIS, V13, P228, DOI 10.1002/pca.640; Greven M, 2009, AGR WATER MANAGE, V96, P1525, DOI 10.1016/j.agwat.2009.06.002; Grierson CS, 2011, NEW PHYTOL, V192, P6, DOI 10.1111/j.1469-8137.2011.03859.x; Gucci R, 2007, J HORTIC SCI BIOTECH, V82, P648, DOI 10.1080/14620316.2007.11512286; Guerfel M, 2009, SCI HORTIC-AMSTERDAM, V119, P257, DOI 10.1016/j.scienta.2008.08.006; Gutierrez F, 2001, J SCI FOOD AGR, V81, P1463, DOI 10.1002/jsfa.958; HARLEY PC, 1992, PLANT PHYSIOL, V98, P1429, DOI 10.1104/pp.98.4.1429; Haworth M, 2015, AM J BOT, V102, P677, DOI 10.3732/ajb.1400508; Haworth M, 2013, OECOLOGIA, V171, P71, DOI 10.1007/s00442-012-2406-9; Holbrook NM, 2002, J EXP BOT, V53, P1503, DOI 10.1093/jexbot/53.373.1503; Hutton R., 2000, Farmers' Newsletter, Horticulture, P47; Hutton RJ, 2007, AUST J EXP AGR, V47, P71, DOI 10.1071/EA05233; Iniesta F, 2009, EUR J AGRON, V30, P258, DOI 10.1016/j.eja.2008.12.004; Kalua CM, 2007, FOOD CHEM, V100, P273, DOI 10.1016/j.foodchem.2005.09.059; Killi D, 2014, INT BIODETER BIODEGR, V94, P48, DOI 10.1016/j.ibiod.2014.06.019; Koyama K, 2009, AM NAT, V173, P640, DOI 10.1086/597604; Laisk A.K., 1977, KINETICS PHOTOSYNTHE; Lauteri M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109054; Lavee S, 2007, SCI HORTIC-AMSTERDAM, V112, P156, DOI 10.1016/j.scienta.2006.12.017; Leib BG, 2006, IRRIGATION SCI, V24, P85, DOI 10.1007/s00271-005-0013-9; Liu FL, 2005, AUST J AGR RES, V56, P1245, DOI 10.1071/AR05062; Liu FL, 2006, J EXP BOT, V57, P3727, DOI 10.1093/jxb/erl131; LONG SP, 1991, PLANT CELL ENVIRON, V14, P729, DOI 10.1111/j.1365-3040.1991.tb01439.x; Mailer RJ, 2005, OLIVE HARVEST HARVES; Marino G, 2014, ENVIRON EXP BOT, V99, P43, DOI 10.1016/j.envexpbot.2013.10.008; McAdam SAM, 2011, J EXP BOT, V62, P195, DOI 10.1093/jxb/erq260; Mizokami Y, 2015, PLANT CELL ENVIRON, V38, P388, DOI 10.1111/pce.12394; Morales-Sillero A, 2013, AGR WATER MANAGE, V123, P79, DOI 10.1016/j.agwat.2013.03.008; Moriana A, 2003, J AM SOC HORTIC SCI, V128, P425, DOI 10.21273/JASHS.128.3.0425; Morison JIL, 2008, PHILOS T R SOC B, V363, P639, DOI 10.1098/rstb.2007.2175; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Panigrahi P, 2013, IRRIG DRAIN, V62, P67, DOI 10.1002/ird.1719; Panigrahi P, 2013, INT J PLANT PROD, V7, P33; Parvizi H, 2014, AGR WATER MANAGE, V146, P45, DOI 10.1016/j.agwat.2014.07.005; Patakas A, 2002, PLANT SCI, V163, P361, DOI 10.1016/S0168-9452(02)00140-1; Quiroga S, 2009, AGR SYST, V101, P91, DOI 10.1016/j.agsy.2009.03.006; References IOC, 2014, INT OL COUNC WORLD O; Reuveni J, 1997, ANN BOT-LONDON, V80, P539, DOI 10.1006/anbo.1997.0489; Robyt JF, 1987, BIOCH TECHNIQUES THE, p[xvi, 407]; Ruehr NK, 2009, NEW PHYTOL, V184, P950, DOI 10.1111/j.1469-8137.2009.03044.x; Sahin U, 2014, CHIL J AGR RES, V74, P302, DOI 10.4067/S0718-58392014000300008; Salvador MD, 2001, FOOD CHEM, V73, P45, DOI 10.1016/S0308-8146(00)00276-4; Sampathkumar T, 2014, EXP AGR, V50, P407, DOI 10.1017/S0014479713000598; Schofield P, 2001, ANIM FEED SCI TECH, V91, P21, DOI 10.1016/S0377-8401(01)00228-0; Sezen SM, 2011, IRRIG DRAIN, V60, P499, DOI 10.1002/ird.607; SIDDIQUE KHM, 1989, FIELD CROP RES, V21, P59, DOI 10.1016/0378-4290(89)90041-5; Sofo A, 2004, PHYSIOL PLANTARUM, V121, P58, DOI 10.1111/j.0031-9317.2004.00294.x; Sun PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105165; Talluto G, 2008, AUST J AGR RES, V59, P785, DOI 10.1071/AR07458; TARDIEU F, 1992, PLANT PHYSIOL, V98, P540, DOI 10.1104/pp.98.2.540; Tattini M, 1997, PLANT SOIL, V197, P87, DOI 10.1023/A:1004241628878; Tazoe Y, 2015, PLANT CELL ENVIRON, V38, P385, DOI 10.1111/pce.12437; Tomimatsu H, 2012, OECOLOGIA, V169, P869, DOI 10.1007/s00442-012-2256-5; TREJO CL, 1991, J EXP BOT, V42, P1507, DOI 10.1093/jxb/42.12.1507; TSIMIDOU M, 1992, FOOD CHEM, V45, P141, DOI 10.1016/0308-8146(92)90025-W; Uceda M, 1975, EPOCAS RECOLECCION E; VERNON LP, 1960, ANAL CHEM, V32, P1144, DOI 10.1021/ac60165a029; Wahbi S, 2005, AGR ECOSYST ENVIRON, V106, P289, DOI 10.1016/j.agee.2004.10.015; Wilkinson S, 1997, PLANT PHYSIOL, V113, P559, DOI 10.1104/pp.113.2.559; Wolf JP, 1968, MANUAL ANAL CORPS GR; WWAP U, 2012, WORLD WAT ASS PROGR; Yao C, 2001, PLANT CELL ENVIRON, V24, P227, DOI 10.1111/j.1365-3040.2001.00667.x; Yin XY, 2011, J EXP BOT, V62, P3489, DOI 10.1093/jxb/err038	98	26	26	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157089	10.1371/journal.pone.0157089	http://dx.doi.org/10.1371/journal.pone.0157089			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315081	Green Published, gold, Green Submitted			2022-12-26	WOS:000378030000012
J	Selvey, LA; Slimings, C; Joske, DJL; Riley, TV				Selvey, Linda A.; Slimings, Claudia; Joske, David J. L.; Riley, Thomas V.			Clostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage Study	PLOS ONE			English	Article							CELL TRANSPLANT RECIPIENTS; PCR RIBOTYPE 027; RISK-FACTORS; DISEASE; OUTCOMES; AUSTRALIA; DIARRHEA; EPIDEMIOLOGY; VANCOMYCIN; MORBIDITY	Objectives Identify risk factors for Clostridium difficile infection (CDI) and assess CDI outcomes among Australian patients with a haematological malignancy. Methods A retrospective cohort study involving all patients admitted to hospitals in Western Australia with a haematological malignancy from July 2011 to June 2012. Hospital admission data were linked with all hospital investigated CDI case data. Potential risk factors were assessed by logistic regression. The risk of death within 60 and 90 days of CDI was assessed by Cox Proportional Hazards regression. Results There were 2085 patients of whom 65 had at least one CDI. Twenty percent of CDI cases were either community-acquired, indeterminate source or had only single-day admissions in the 28 days prior to CDI. Using logistic regression, having acute lymphocytic leukaemia, neutropenia and having had bacterial pneumonia or another bacterial infection were associated with CDI. CDI was associated with an increased risk of death within 60 and 90 days post CDI, but only two deaths had CDI recorded as an antecedent factor. Ribotyping information was available for 33 of the 65 CDIs. There were 19 different ribotypes identified. Conclusions Neutropenia was strongly associated with CDI. While having CDI is a risk factor for death, in many cases it may not be a direct contributor to death but may reflect patients having higher morbidity. A wide variety of C. difficile ribotypes were found and community-acquired infection may be under-estimated in these patients.	[Selvey, Linda A.] Curtin Univ, Sch Publ Hlth, GPO Box U1987, Perth, WA 6845, Australia; [Slimings, Claudia; Riley, Thomas V.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Joske, David J. L.] Sir Charles Gairdner Hosp, Dept Haematol, Nedlands, WA 6009, Australia; [Joske, David J. L.] Univ Western Australia, Sch Med, Perth, WA 6009, Australia; [Riley, Thomas V.] PathWest Lab Med, Dept Microbiol, Nedlands, WA, Australia	Curtin University; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Selvey, LA (corresponding author), Curtin Univ, Sch Publ Hlth, GPO Box U1987, Perth, WA 6845, Australia.	linda.selvey@curtin.edu.au	Selvey, Linda/B-8473-2017; Slimings, Claudia/AAE-6550-2019	Selvey, Linda/0000-0001-8493-0974; Slimings, Claudia/0000-0001-7988-1186	Sanofi Pasteur	Sanofi Pasteur	Sanofi Pasteur funded the data linkage component of the study. The funders had no role in the study design, data collection and analysis or decision to publish. The funders did review the manuscript prior to publication. www.sanofipasteur.us.	Alonso CD, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0414-0; Apostolopoulou E, 2011, EUR J ONCOL NURS, V15, P404, DOI 10.1016/j.ejon.2010.11.002; Arango JI, 2006, BONE MARROW TRANSPL, V37, P517, DOI 10.1038/sj.bmt.1705269; Arthur C, 2012, 54TH AMERICAN SOCIET; Australian Commission on Safety and Quality in Healthcare, 2013, IMPL GUID SURV CLOST; Australian Institute of Health and Welfare, 2016, METEOR MET ONL REG; Bradstock KF, 2005, BLOOD, V105, P481, DOI 10.1182/blood-2004-01-0326; Callejas-Diaz A, 2014, CURR HEMATOL MALIG R, V9, P85, DOI 10.1007/s11899-013-0193-y; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chopra T, 2010, EXPERT REV ANTI-INFE, V8, P1113, DOI [10.1586/eri.10.95, 10.1586/ERI.10.95]; Clements ACA, 2010, LANCET INFECT DIS, V10, P395, DOI 10.1016/S1473-3099(10)70080-3; Dial S, 2006, CAN MED ASSOC J, V175, P745, DOI 10.1503/cmaj.060284; Gifford AH, 2006, EUR J CLIN MICROBIOL, V25, P751, DOI 10.1007/s10096-006-0220-1; Gorschluter M, 2001, CLIN INFECT DIS, V33, P786, DOI 10.1086/322616; Gu SL, 2015, J MED MICROBIOL, V64, P209, DOI 10.1099/jmm.0.000028; Guddati AK, 2014, INT J HEMATOL, V99, P758, DOI 10.1007/s12185-014-1577-z; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Kamboj M, 2014, BIOL BLOOD MARROW TR, V20, P1626, DOI 10.1016/j.bbmt.2014.06.025; Kuijper E.J., 2008, EUROSURVEILLANCE, V13, P1; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Luo RH, 2015, INFECT CONT HOSP EP, V36, P794, DOI 10.1017/ice.2015.54; McCann R, 2014, HEALTHCARE INFECT SU; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; Moorin RE, 2010, EMERG INFECT DIS, V16, P1440, DOI 10.3201/eid1609.081665; ONeill GL, 1996, ANAEROBE, V2, P205, DOI 10.1006/anae.1996.0028; Parmar SR, 2014, J ONCOL PHARM PRACT, V20, P172, DOI 10.1177/1078155213490004; Peterson A, 2014, HEALTHCARE INFECT SU; RAMPLING A, 1985, J CLIN PATHOL, V38, P445, DOI 10.1136/jcp.38.4.445; Richards M, 2011, MED J AUSTRALIA, V194, P369, DOI 10.5694/j.1326-5377.2011.tb03012.x; Riley TV, 2009, MED J AUSTRALIA, V190, P706, DOI 10.5694/j.1326-5377.2009.tb02644.x; Schalk E, 2010, ANN HEMATOL, V89, P9, DOI 10.1007/s00277-009-0772-0; Slimings C, 2014, MED J AUSTRALIA, V200, P272, DOI 10.5694/mja13.11153; Stagg V, 2006, CHARLSON STATA MODUL; Trifilio SM, 2013, BIOL BLOOD MARROW TR, V19, P405, DOI 10.1016/j.bbmt.2012.10.030; Vehreschild MJ, 2014, BIOL BLOOD MARROW TR; Yoon YK, 2014, SUPPORT CARE CANCER, V22, P2039, DOI 10.1007/s00520-014-2174-7; Zacharioudakis Ioannis M, 2014, Biol Blood Marrow Transplant, V20, P1650, DOI 10.1016/j.bbmt.2014.06.001	37	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157839	10.1371/journal.pone.0157839	http://dx.doi.org/10.1371/journal.pone.0157839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314498	Green Published, gold, Green Submitted			2022-12-26	WOS:000378030000058
J	Veluchamy, JP; Spanholtz, J; Tordoir, M; Thijssen, VL; Heideman, DAM; Verheul, HMW; de Gruijl, TD; van der Vliet, HJ				Veluchamy, John Pradeep; Spanholtz, Jan; Tordoir, Marleen; Thijssen, Victor L.; Heideman, Danielle A. M.; Verheul, Henk M. W.; de Gruijl, Tanja D.; van der Vliet, Hans J.			Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DEPENDENT CELLULAR CYTOTOXICITY; GROWTH-FACTOR RECEPTOR; ANTI-EGFR THERAPY; MONOCLONAL-ANTIBODY; KRAS MUTATIONS; COLON-CANCER; LUNG-CANCER; HLA-E; POLYMORPHISMS	The ability of Natural Killer (NK) cells to kill tumor targets has been extensively studied in various hematological malignancies. However, NK cell therapy directed against solid tumors is still in early development. Epidermal Growth Factor Receptor (EGFR) targeted therapies using monoclonal antibodies (mAbs) such as cetuximab and panitumumab are widely used for the treatment of metastatic colorectal cancer (mCRC). Still, the clinical efficacy of this treatment is hampered by mutations in RAS gene, allowing tumors to escape from anti-EGFR mAb therapy. It is well established that NK cells kill tumor cells by natural cytotoxicity and can in addition be activated upon binding of IgG(1) mAbs through Fc receptors (CD16/Fc gamma RIIIa) on their surface, thereby mediating antibody dependent cellular cytotoxicity (ADCC). In the current study, activated Peripheral Blood NK cells (PBNK) were combined with anti-EGFR mAbs to study their effect on the killing of EGFR(+/-) cancer cell lines, including those with RAS mutations. In vitro cytotoxicity experiments using colon cancer primary tumors and cell lines COLO320, Caco-2, SW620, SW480 and HT-29, demonstrated that PBNK cells are cytotoxic for a range of tumor cells, regardless of EGFR, RAS or BRAF status and at low E:T ratios. Cetuximab enhanced the cytotoxic activity of NK cells on EGFR(+) tumor cells (either RAS(wt), RAS(mut) or BRAF(mut)) in a CD16 dependent manner, whereas it could not increase the killing of EGFR(-) COLO320. Our study provides a rationale to strengthen NK cell immunotherapy through a combination with cetuximab for RAS and BRAF mutant mCRC patients.	[Veluchamy, John Pradeep; Thijssen, Victor L.; Verheul, Henk M. W.; de Gruijl, Tanja D.; van der Vliet, Hans J.] Vrije Univ Amsterdam, Ctr Canc, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Heideman, Danielle A. M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Veluchamy, John Pradeep; Spanholtz, Jan; Tordoir, Marleen] Glycostem Therapeut, Oss, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van der Vliet, HJ (corresponding author), Vrije Univ Amsterdam, Ctr Canc, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands.	jj.vandervliet@vumc.nl	Verheul, Henk/V-6462-2019; Verheul, Henk M.W./J-9775-2013; Thijssen, Victor LJL/B-2792-2009	Verheul, Henk/0000-0001-5981-922X; Thijssen, Victor LJL/0000-0002-6146-1842; Veluchamy, John/0000-0002-5681-1860; Spanholtz, Jan/0000-0001-7152-6956; van der Vliet, Hans/0000-0001-7846-8613	Marie Curie FP7 NATURIMMUN Network; Glycostem; Marie Curie FP7 ITN NATURIMMUN network	Marie Curie FP7 NATURIMMUN Network; Glycostem; Marie Curie FP7 ITN NATURIMMUN network	This work was supported by the Marie Curie FP7 NATURIMMUN Network (http://www.naturimmun.eu/) to JV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (Glycostem) provided support in the form of salaries for authors: JS, JV, MT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contribution' section.; The authors thank all voluntary blood donors, Charlotte Huijts and Roeland Lameris of VUmc Cancer Center Amsterdam for their help in collecting blood and Martijn Bogaarts for technical assistance. This work was financially supported by Marie Curie FP7 ITN NATURIMMUN network.	Abdullah N, 1999, CANCER IMMUNOL IMMUN, V48, P517, DOI 10.1007/s002620050600; Arai S, 2008, CYTOTHERAPY, V10, P625, DOI 10.1080/14653240802301872; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Binyamin L, 2008, J IMMUNOL, V180, P6392, DOI 10.4049/jimmunol.180.9.6392; Calemma R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-232; Capdevila J, 2009, CANCER TREAT REV, V35, P354, DOI 10.1016/j.ctrv.2009.02.001; Carrega P, 2008, CANCER-AM CANCER SOC, V112, P863, DOI 10.1002/cncr.23239; Cheng M, 2013, CELL MOL IMMUNOL, V10, P230, DOI 10.1038/cmi.2013.10; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Er TK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/591867; Geller MA, 2011, IMMUNOTHERAPY-UK, V3, P1445, DOI [10.2217/IMT.11.131, 10.2217/imt.11.131]; Gulubova M, 2009, APMIS, V117, P870, DOI 10.1111/j.1600-0463.2009.02547.x; Heideman DAM, 2009, CELL ONCOL, V31, P329, DOI 10.3233/CLO-2009-0489; Heideman DAM, 2012, J MOL DIAGN, V14, P247, DOI 10.1016/j.jmoldx.2012.01.011; Jeong WJ, 2014, WORLD J GASTROENTERO, V20, P9862, DOI 10.3748/wjg.v20.i29.9862; Kjersem JB, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-340; Koehl U, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00118; Kurai J, 2007, CLIN CANCER RES, V13, P1552, DOI 10.1158/1078-0432.CCR-06-1726; Kuss I, 2004, CLIN CANCER RES, V10, P3755, DOI 10.1158/1078-0432.CCR-04-0054; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Levy EM, 2008, INT J ONCOL, V32, P633, DOI 10.3892/ijo.32.3.633; Lindenberg JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070237; Lo Monaco E, 2011, NEOPLASIA, V13, P822, DOI 10.1593/neo.101684; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Levy EM, 2009, INNATE IMMUN-LONDON, V15, P91, DOI 10.1177/1753425908101404; Mellor JD, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-1; Menon AG, 2002, LAB INVEST, V82, P1725, DOI 10.1097/01.LAB.0000043124.75633.ED; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Paz-Ares LG, 2011, J CLIN ONCOL, V29, P3783, DOI 10.1200/JCO.2011.34.8888; Pietra G, 2009, INT IMMUNOL, V21, P793, DOI 10.1093/intimm/dxp047; Roberti MP, 2012, BREAST CANCER RES TR, V136, P659, DOI 10.1007/s10549-012-2287-y; Sconocchia G, 2009, NEOPLASIA, V11, P662, DOI 10.1593/neo.09296; Seidel UJE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00076; Shaib W, 2013, J GASTROINTEST ONCOL, V4, P308, DOI 10.3978/j.issn.2078-6891.2013.029; Spanholtz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020740; Spanholtz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009221; Spano JP, 2005, ANN ONCOL, V16, P102, DOI 10.1093/annonc/mdi006; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; VANDENINGH HF, 1987, BRIT J CANCER, V55, P125, DOI 10.1038/bjc.1987.26; Vermorken JB, 1999, LANCET, V353, P345, DOI 10.1016/S0140-6736(98)07186-4; Vincent MD, 2012, CURR ONCOL, V19, pS33, DOI 10.3747/co.19.1149	47	59	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157830	10.1371/journal.pone.0157830	http://dx.doi.org/10.1371/journal.pone.0157830			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314237	Green Submitted, Green Published, gold			2022-12-26	WOS:000378030000057
J	Brzoska, AJ; Jensen, SO; Barton, DA; Davies, DS; Overall, RL; Skurray, RA; Firth, N				Brzoska, Anthony J.; Jensen, Slade O.; Barton, Deborah A.; Davies, Danielle S.; Overall, Robyn L.; Skurray, Ronald A.; Firth, Neville			Dynamic Filament Formation by a Divergent Bacterial Actin-Like ParM Protein	PLOS ONE			English	Article							PLASMID-DNA-SEGREGATION; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; IN-VITRO; PSK41; EXPRESSION; SYSTEM; CYTOSKELETON; INSTABILITY	Actin-like proteins (Alps) are a diverse family of proteins whose genes are abundant in the chromosomes and mobile genetic elements of many bacteria. The low-copy-number staphylococcal multiresistance plasmid pSK41 encodes ParM, an Alp involved in efficient plasmid partitioning. pSK41 ParM has previously been shown to form filaments in vitro that are structurally dissimilar to those formed by other bacterial Alps. The mechanistic implications of these differences are not known. In order to gain insights into the properties and behavior of the pSK41 ParM Alp in vivo, we reconstituted the parMRC system in the ectopic rodshaped host, E. coli, which is larger and more genetically amenable than the native host, Staphylococcus aureus. Fluorescence microscopy showed a functional fusion protein, ParM-YFP, formed straight filaments in vivo when expressed in isolation. Strikingly, however, in the presence of ParR and parC, ParM-YFP adopted a dramatically different structure, instead forming axial curved filaments. Time-lapse imaging and selective photobleaching experiments revealed that, in the presence of all components of the parMRC system, ParM-YFP filaments were dynamic in nature. Finally, molecular dissection of the parMRC operon revealed that all components of the system are essential for the generation of dynamic filaments.	[Brzoska, Anthony J.; Jensen, Slade O.; Barton, Deborah A.; Davies, Danielle S.; Overall, Robyn L.; Skurray, Ronald A.; Firth, Neville] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia; [Jensen, Slade O.] Univ Western Sydney, Ingham Inst Appl Med Res, Sch Med, Sydney, NSW 1871, Australia	University of Sydney; Ingham Institute for Applied Medical Research; Western Sydney University	Brzoska, AJ (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.	anthony.brzoska@sydney.edu.au	Barton, Deborah/C-8124-2013	Firth, Neville/0000-0002-5791-7691; Jensen, Slade/0000-0003-4489-589X	National Health and Medical Research Council of Australia [307620, APP1030003]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia Project grants 307620 and APP1030003 to NF and RS (https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Health and Medical Research Council of Australia Project grants 307620 and APP1030003.	Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; Berg T, 1998, J BACTERIOL, V180, P4350, DOI 10.1128/JB.180.17.4350-4359.1998; Brzoska AJ, 2013, APPL ENVIRON MICROB, V79, P3133, DOI 10.1128/AEM.00144-13; CHANG ACY, 1978, NATURE, V275, P617, DOI 10.1038/275617a0; Derman AI, 2012, J BACTERIOL, V194, P2715, DOI 10.1128/JB.06550-11; Derman AI, 2009, MOL MICROBIOL, V73, P534, DOI 10.1111/j.1365-2958.2009.06771.x; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Gayathri P, 2012, SCIENCE, V338, P1334, DOI 10.1126/science.1229091; Godfrin-Estevenon AM, 2002, MOL MICROBIOL, V43, P39, DOI 10.1046/j.1365-2958.2002.02735.x; Ingerson-Mahar M, 2012, FEMS MICROBIOL REV, V36, P256, DOI 10.1111/j.1574-6976.2011.00316.x; Kwong SM, 2010, MICROBIOL-SGM, V156, P975, DOI 10.1099/mic.0.038323-0; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; LeBard RJ, 2008, FEMS MICROBIOL LETT, V284, P58, DOI 10.1111/j.1574-6968.2008.01190.x; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Ni L, 2009, NUCLEIC ACIDS RES, V37, P6970, DOI 10.1093/nar/gkp756; Pilhofer M, 2013, CURR OPIN CELL BIOL, V25, P125, DOI 10.1016/j.ceb.2012.10.019; Polka JK, 2014, P NATL ACAD SCI USA, V111, P2176, DOI 10.1073/pnas.1304127111; Polka JK, 2009, J BACTERIOL, V191, P6219, DOI 10.1128/JB.00676-09; Popp D, 2012, J BIOL CHEM, V287, P21121, DOI 10.1074/jbc.M112.341016; Popp D, 2011, MOL MICROBIOL, V80, P300, DOI 10.1111/j.1365-2958.2011.07599.x; Popp D, 2010, J BIOL CHEM, V285, P10130, DOI 10.1074/jbc.M109.071613; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Salje J, 2009, SCIENCE, V323, P509, DOI 10.1126/science.1164346; Sambrook J., 2001, MOL CLONING LAB MANU; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; Weaver KE, 2009, PLASMID, V61, P94, DOI 10.1016/j.plasmid.2008.11.004; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Yamaichi Y, 2000, P NATL ACAD SCI USA, V97, P14656, DOI 10.1073/pnas.97.26.14656; Zhu WM, 2013, ANTIMICROB AGENTS CH, V57, P212, DOI 10.1128/AAC.01587-12	36	2	2	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156944	10.1371/journal.pone.0156944	http://dx.doi.org/10.1371/journal.pone.0156944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310470	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800021
J	Jeong, M; Lee, EW; Seong, D; Seo, J; Kim, JH; Grootjans, S; Kim, SY; Vandenabeele, P; Song, J				Jeong, M.; Lee, E-W; Seong, D.; Seo, J.; Kim, J-H; Grootjans, S.; Kim, S-Y; Vandenabeele, P.; Song, J.			USP8 suppresses death receptor-mediated apoptosis by enhancing FLIPL stability	ONCOGENE			English	Article							FLICE-INHIBITORY PROTEIN; TUMOR-NECROSIS-FACTOR; CELL LUNG-CANCER; SIGNALING COMPLEX; C-FLIP; CASPASE-8 ACTIVATION; CFLIP ISOFORMS; TRAIL; DEGRADATION; PATHWAY	FLICE-like inhibitory protein (FLIP) is a critical regulator of death receptor-mediated apoptosis. Here, we found ubiquitin-specific peptidase 8 (USP8) to be a novel deubiquitylase of the long isoform of FLIP (FLIPL). USP8 directly deubiquitylates and stabilizes FLIPL, but not the short isoform. USP8 depletion induces FLIPL destabilization, promoting anti-Fas-, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)- and tumor necrosis factor alpha-induced extrinsic apoptosis by facilitating death-inducing signaling complex or TNFR1 complex II formation, which results in the activation of caspase-8 and caspase-3. USP8 mRNA levels are elevated in melanoma and cervical cancers, and the protein levels of USP8 and FLIPL are positively correlated in these cancer cell lines. Xenograft analyses using ME-180 cervical cancer cells showed that USP8 depletion attenuated tumor growth upon TRAIL injection. Taken together, our data indicate that USP8 functions as a novel deubiquitylase of FLIPL and inhibits extrinsic apoptosis by stabilizing FLIPL.	[Jeong, M.; Lee, E-W; Seong, D.; Seo, J.; Kim, J-H; Song, J.] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Yonsei Ro 50, Seoul 120749, South Korea; [Grootjans, S.; Vandenabeele, P.] VIB, Inflammat Res Ctr, Zwijnaarde Ghent, Belgium; [Grootjans, S.; Vandenabeele, P.] Univ Ghent, Dept Biomed Mol Biol, Zwijnaarde Ghent, Belgium; [Kim, S-Y] Natl Canc Ctr, Canc Cell & Mol Biol Branch, Div Canc Biol, Res Inst, Goyang, South Korea	Yonsei University; Flanders Institute for Biotechnology (VIB); Ghent University; National Cancer Center - Korea (NCC)	Song, J (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Yonsei Ro 50, Seoul 120749, South Korea.	jso678@yonsei.ac.kr	Lee, Eun-Woo/AAP-9603-2020; Vandenabeele, Peter/C-8597-2009; Vandenabeele, Peter/AAD-5793-2022; Grootjans, Sasker/N-3262-2013	Vandenabeele, Peter/0000-0002-6669-8822; Grootjans, Sasker/0000-0002-8385-2545; Song, Jaewhan/0000-0001-8152-9210; Lee, Eun-Woo/0000-0002-5156-0003	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2015R1A3A2066581]; Ministry of Education [2012R1A6A3A04040105]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; Ministry of Education	This work was supported by a grant from the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT and Future Planning (NRF-2015R1A3A2066581) (to J Song) and by the Ministry of Education (2012R1A6A3A04040105) (to E-WL).	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Byun S, 2013, CLIN CANCER RES, V19, P3894, DOI 10.1158/1078-0432.CCR-12-3696; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chanvorachote P, 2005, J BIOL CHEM, V280, P42044, DOI 10.1074/jbc.M510080200; den Hollander MW, 2013, CANCER LETT, V332, P194, DOI 10.1016/j.canlet.2012.04.007; Dickens LS, 2012, MOL CELL, V47, P291, DOI 10.1016/j.molcel.2012.05.004; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; French LE, 2003, CELL DEATH DIFFER, V10, P117, DOI 10.1038/sj.cdd.4401185; Fukazawa T, 2001, ONCOGENE, V20, P5225, DOI 10.1038/sj.onc.1204673; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; Goltsev YV, 1997, J BIOL CHEM, V272, P19641, DOI 10.1074/jbc.272.32.19641; Guedat P, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S14; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Hughes MA, 2016, MOL CELL, V61, P834, DOI 10.1016/j.molcel.2016.02.023; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kaunisto A, 2009, CELL DEATH DIFFER, V16, P1215, DOI 10.1038/cdd.2009.35; Kavuri SM, 2011, J BIOL CHEM, V286, P16631, DOI 10.1074/jbc.M110.148585; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Lee EW, 2015, CELL DEATH DIFFER, V22, P1463, DOI 10.1038/cdd.2014.234; Mahmood Z, 2010, EXP CELL RES, V316, P887, DOI 10.1016/j.yexcr.2009.12.011; Maksimovic-Ivanic D, 2012, IMMUNOL RES, V52, P157, DOI 10.1007/s12026-012-8284-8; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Oh YM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04980; Panka DJ, 2001, J BIOL CHEM, V276, P6893, DOI 10.1074/jbc.C000569200; Panner A, 2010, CANCER RES, V70, P5046, DOI 10.1158/0008-5472.CAN-09-3979; Perez D, 2003, J VIROL, V77, P2651, DOI 10.1128/JVI.77.4.2651-2662.2003; Pop C, 2011, BIOCHEM J, V433, P447, DOI 10.1042/BJ20101738; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Shirley S, 2013, CANCER LETT, V332, P141, DOI 10.1016/j.canlet.2010.10.009; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Soria JC, 2011, J CLIN ONCOL, V29, P4442, DOI 10.1200/JCO.2011.37.2623; Soria JC, 2010, J CLIN ONCOL, V28, P1527, DOI 10.1200/JCO.2009.25.4847; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; Stuckey DW, 2013, TRENDS MOL MED, V19, P685, DOI 10.1016/j.molmed.2013.08.007; Symons A, 2006, TRENDS IMMUNOL, V27, P40, DOI 10.1016/j.it.2005.11.007; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Vandenabeele P, 2012, CELL DEATH DIFFER, V19, P1093, DOI 10.1038/cdd.2012.65; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Wajant H, 2003, ESSAYS BIOCHEM, V39, P53, DOI 10.1042/bse0390053; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Weinlich R, 2011, TRENDS CELL BIOL, V21, P630, DOI 10.1016/j.tcb.2011.09.002; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yerbes R, 2012, CELL DEATH DIFFER, V19, P1908, DOI 10.1038/cdd.2012.78; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299	64	36	36	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 26	2017	36	4					458	470		10.1038/onc.2016.215	http://dx.doi.org/10.1038/onc.2016.215			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8II	27321185				2022-12-26	WOS:000394166700003
J	Napoli, E; Song, G; Schneider, A; Hagerman, R; Eldeeb, MA; Azarang, A; Tassone, F; Giulivi, C				Napoli, Eleonora; Song, Gyu; Schneider, Andrea; Hagerman, Randi; Eldeeb, Marwa Abd Al Azaim; Azarang, Atoosa; Tassone, Flora; Giulivi, Cecilia			Warburg effect linked to cognitive-executive deficits in FMR1 premutation	FASEB JOURNAL			English	Article						fragile X; mitochondria; proteomics; triplet nucleotide diseases; neurological disorder	INNATE IMMUNE-RESPONSES; LARGE GENE LISTS; TREMOR/ATAXIA SYNDROME; MITOCHONDRIAL DYSFUNCTION; PARKINSONS-DISEASE; MESSENGER-RNA; UNCOUPLING PROTEINS; ALZHEIMERS-DISEASE; STATISTICAL-MODEL; DELETION SYNDROME	A 55-200 CGG repeat expansion in the 5 '-UTR of the fragile X mental retardation 1 (FMR1) gene is known as a premutation. Some carriers are affected by the neurodegenerative disorder fragile X-associated tremor/ataxia syndrome (FXTAS), primary ovarian insufficiency, and neurobehavioral impairments. Based on the mitochondrial dysfunction observed in fibroblasts and brain samples from carriers, as well as in neurons and brains from a mouse model of the premutation, we evaluated the presence of the Warburg effect in peripheral blood mononuclear cells (PBMCs) from 30 premutation carriers with either a rebalance of the metabolism [increasing glycolysis while decreasing oxidative phosphorylation (oxphos)] or a metabolic amplification (increasing glycolysis while maintaining/increasing oxphos). Deficits in oxphosmore pronounced in FXTAS-affected subjects-were accompanied by a shift toward glycolysis, suggesting increased glycolysis despite aerobic conditions. Differential proteomics extended these findings, unveiling a decreased antioxidant response, translation, and disrupted extracellular matrix and cytoskeleton organization with activation of prosenescence pathways. Lower bioenergetics segregated with increased incidence of low executive function, tremors, below-average IQ, and FXTAS. The combination of functional and proteomic data unveiled new mechanisms related to energy production in the premutation, showing the potential of being applicable to other psychiatric disorders to identify endophenotype-specific responses relevant to neurobiology.-Napoli, E., Song, G., Schneider, A., Hagerman, R., Eldeeb, M. A. A. A., Azarang, A., Tassone, F., Giulivi, C. Warburg effect linked to cognitive-executive deficits in FMR1 premutation.	[Napoli, Eleonora; Song, Gyu; Giulivi, Cecilia] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Tassone, Flora] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Schneider, Andrea; Hagerman, Randi; Eldeeb, Marwa Abd Al Azaim; Azarang, Atoosa; Tassone, Flora] Univ Calif Davis, Med Invest Neurodev Disorders MIND Inst, Davis, CA 95616 USA; [Schneider, Andrea; Hagerman, Randi; Giulivi, Cecilia] Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Giulivi, C (corresponding author), Univ Calif Davis, Dept Mol Biosci, Vet Med 3B 3009, 1089 Vet Med Dr, Davis, CA 95616 USA.	cgiulivi@ucdavis.edu	Giulivi, Cecilia/ABB-7809-2020; Napoli, Eleonora/AAQ-6079-2021; Schneider, Andrea/Y-5200-2019; Giulivi, Cecilia/AAV-6774-2021	Giulivi, Cecilia/0000-0003-1033-7435; Napoli, Eleonora/0000-0001-8808-4242; Schneider, Andrea/0000-0002-4674-7244; 	U.S. National Institutes for Health (NIH) National Institute of Environmental Health Sciences [ES12691, ES020392]; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD036071]; Simons Foundation [271406]; MIND Institute Intellectual and Developmental Disabilities Research Center [U54 HD079125]; Health and Human Administration of Developmental Disabilities [90DD0596]; Novartis; Roche/Genentech; Alcobra; Neuren; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079125, R01HD036071] Funding Source: NIH RePORTER; National Center on Birth Defects and Developmental Disabilities [U50DD000596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020392, R01ES012691] Funding Source: NIH RePORTER	U.S. National Institutes for Health (NIH) National Institute of Environmental Health Sciences; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Simons Foundation; MIND Institute Intellectual and Developmental Disabilities Research Center; Health and Human Administration of Developmental Disabilities; Novartis(Novartis); Roche/Genentech(Roche HoldingGenentech); Alcobra; Neuren; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center on Birth Defects and Developmental Disabilities(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank all families that provided the samples, making the study possible. The study was funded by U.S. National Institutes for Health (NIH) National Institute of Environmental Health Sciences Grants ES12691 and ES020392; the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant HD036071; Simons Foundation Grant 271406; MIND Institute Intellectual and Developmental Disabilities Research Center Grant U54 HD079125; and Health and Human Administration of Developmental Disabilities Grant 90DD0596. R.H. has received funding from Novartis, Roche/Genentech, Alcobra, and Neuren for treatment trials in FXS, autism, and Down syndrome, and has also consulted with Novartis and Roche/Genentech regarding treatment for FXS.	Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Armstrong DL, 2015, J BIOL CHEM, V290, P12595, DOI 10.1074/jbc.M115.639021; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Arocena DG, 2005, HUM MOL GENET, V14, P3661, DOI 10.1093/hmg/ddi394; Blandini F, 2013, J NEUROIMMUNE PHARM, V8, P189, DOI 10.1007/s11481-013-9435-y; Boisse L, 2004, J NEUROSCI, V24, P4928, DOI 10.1523/JNEUROSCI.1077-04.2004; Capkova M, 2002, INT J OBESITY, V26, P1110, DOI 10.1038/sj.ijo.0802055; Caron M, 2007, CELL DEATH DIFFER, V14, P1759, DOI 10.1038/sj.cdd.4402197; Carvalho AF, 2014, CNS NEUROL DISORD-DR, V13, P1819; Catherman AD, 2013, MOL CELL PROTEOMICS, V12, P3465, DOI 10.1074/mcp.M113.030114; Chen Y, 2012, J BIOL CHEM, V287, P27227, DOI 10.1074/jbc.M112.340315; CHRETIEN D, 1994, CLIN CHIM ACTA, V228, P53, DOI 10.1016/0009-8981(94)90056-6; Cloonan SM, 2012, CURR OPIN IMMUNOL, V24, P32, DOI 10.1016/j.coi.2011.11.001; Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x; Da Pozzo E, 2012, CURR MOL MED, V12, P426; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; De Matteis MA, 2005, BBA-MOL CELL RES, V1744, P396, DOI 10.1016/j.bbamcr.2005.04.013; Dhull DK, 2012, J MOL NEUROSCI, V46, P223, DOI 10.1007/s12031-011-9583-6; Dioguardi CC, 2016, MOL HUM REPROD, V22, P384, DOI 10.1093/molehr/gaw023; Ellis S, 2005, FASEB J, V19, P1519, DOI 10.1096/fj.04-3569fje; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001; Fossati G, 2003, J IMMUNOL, V170, P1964, DOI 10.4049/jimmunol.170.4.1964; Friedman JR, 2015, ELIFE, V4, DOI 10.7554/eLife.07739; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Garcia-Arocena D, 2010, HUM MOL GENET, V19, pR83, DOI 10.1093/hmg/ddq166; Gibson GE, 2010, BBA-MOL BASIS DIS, V1802, P122, DOI 10.1016/j.bbadis.2009.08.010; Giulivi C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/609602; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Glatt SJ, 2012, J AM ACAD CHILD PSY, V51, P934, DOI 10.1016/j.jaac.2012.07.007; GRIGSBY J, 2000, J CLIN GEROPSYCHOLOG, V6, P259, DOI DOI 10.1023/A:1009582728548; Hagerman PJ, 2015, ANN NY ACAD SCI, V1338, P58, DOI 10.1111/nyas.12693; Hagerman R, 2013, LANCET NEUROL, V12, P786, DOI 10.1016/S1474-4422(13)70125-X; Hammond G, 2004, CURR TOP MICROBIOL, V282, P177; Harikrishnareddy D, 2015, REV NEUROSCIENCE, V26, P161, DOI 10.1515/revneuro-2014-0057; Hmadcha A, 1998, J LAB CLIN MED, V131, P170, DOI 10.1016/S0022-2143(98)90160-3; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Jacome ASV, 2015, PROTEOMICS, V15, P2519, DOI 10.1002/pmic.201400617; Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321; Jasinska AJ, 2009, HUM MOL GENET, V18, P4415, DOI 10.1093/hmg/ddp397; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kaplan ES, 2012, J NEUROCHEM, V123, P613, DOI 10.1111/j.1471-4159.2012.07936.x; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khalifeh S, 2016, CELL MOL NEUROBIOL, V36, P553, DOI 10.1007/s10571-015-0236-0; Klegeris A, 2007, CURR OPIN NEUROL, V20, P351, DOI 10.1097/WCO.0b013e3280adc943; Klingenberg M, 2001, BBA-BIOENERGETICS, V1504, P128, DOI 10.1016/S0005-2728(00)00242-5; Kong SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049475; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Laughton JD, 2000, NEUROSCIENCE, V96, P619, DOI 10.1016/S0306-4522(99)00580-1; Lin CC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00785; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Loomis EW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004294; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Luckhart S, 2015, CURR OPIN IMMUNOL, V36, P73, DOI 10.1016/j.coi.2015.07.002; Luckhart S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003180; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; MARKERT CL, 1975, SCIENCE, V189, P102, DOI 10.1126/science.1138367; Meechan DW, 2011, INT J DEV NEUROSCI, V29, P283, DOI 10.1016/j.ijdevneu.2010.08.005; Napoli E, 2016, CEREBELLUM, V15, P552, DOI 10.1007/s12311-016-0779-8; Napoli E, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00159; Napoli E, 2015, J BIOL CHEM, V290, P23240, DOI 10.1074/jbc.M115.672360; Napoli E, 2013, HUM MOL GENET, V22, P989, DOI 10.1093/hmg/dds503; Napoli E, 2011, HUM MOL GENET, V20, P3079, DOI 10.1093/hmg/ddr211; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Padmos RC, 2008, ARCH GEN PSYCHIAT, V65, P395, DOI 10.1001/archpsyc.65.4.395; Pastoris O, 2000, EXP GERONTOL, V35, P95, DOI 10.1016/S0531-5565(99)00077-7; Pellegrino MW, 2014, NATURE, V516, P414, DOI 10.1038/nature13818; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Ross-Inta C, 2010, BIOCHEM J, V429, P545, DOI 10.1042/BJ20091960; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Sanchis D, 1998, J BIOL CHEM, V273, P34611, DOI 10.1074/jbc.273.51.34611; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Sekar S, 2015, NEUROBIOL AGING, V36, P583, DOI 10.1016/j.neurobiolaging.2014.09.027; Sellier C, 2013, CELL REP, V3, P869, DOI 10.1016/j.celrep.2013.02.004; Sellier C, 2010, EMBO J, V29, P1248, DOI 10.1038/emboj.2010.21; Shanks N, 2000, P NATL ACAD SCI USA, V97, P5645, DOI 10.1073/pnas.090571897; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Sparaco M, 2006, CEPHALALGIA, V26, P361, DOI 10.1111/j.1468-2982.2005.01059.x; Spencer SJ, 2005, BEHAV BRAIN RES, V164, P231, DOI 10.1016/j.bbr.2005.06.032; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Tabb DL, 2008, J PROTEOME RES, V7, P45, DOI 10.1021/pr700728t; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Todd PK, 2013, NEURON, V79, P402, DOI 10.1016/j.neuron.2013.07.008; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; WARBURG O, 1956, SCIENCE, V124, P269; Washizuka S, 2009, NEUROSCI RES, V63, P199, DOI 10.1016/j.neures.2008.12.004; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617	97	23	23	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3334	3351		10.1096/fj.201600315R	http://dx.doi.org/10.1096/fj.201600315R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27335370	Green Published			2022-12-26	WOS:000384329800007
J	Zheng, DL; Sabbagh, JJ; Blair, LJ; Darling, AL; Wen, XQ; Dickey, CA				Zheng, Dali; Sabbagh, Jonathan J.; Blair, Laura J.; Darling, April L.; Wen, Xiaoqi; Dickey, Chad A.			MicroRNA-511 Binds to FKBP5 mRNA, Which Encodes a Chaperone Protein, and Regulates Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						depression; glucocorticoid; microRNA (miRNA); neurodifferentiation; stress; FKBP5	LARGE GENE LISTS; GLUCOCORTICOID-RECEPTOR; FK506-BINDING PROTEIN-51; DEPRESSION; STRESS; TAU; POLYMORPHISMS; DYSREGULATION; EXPRESSION; VECTORS	Single nucleotide polymorphisms in the FKBP5 gene increase the expression of the FKBP51 protein and have been associated with increased risk for neuropsychiatric disorders such as major depression and post-traumatic stress disorder. Moreover, levels of FKBP51 are increased with aging and in Alzheimer disease, potentially contributing to disease pathogenesis. However, aside from its glucocorticoid responsiveness, little is known about what regulates FKBP5. In recent years, non-coding RNAs, and in particular microRNAs, have been shown to modulate disease-related genes and processes. The current study sought to investigate which miRNAs could target and functionally regulate FKBP5. Following in silico data mining and initial target expression validation, miR-511 was found to suppress FKBP5 mRNA and protein levels. Using luciferase p-miR-Report constructs and RNA pulldown assays, we confirmed that miR-511 bound directly to the 3-UTR of FKBP5, validating the predicted gene-microRNA interaction. miR-511 suppressed glucocorticoid-induced up-regulation of FKBP51 in cells and primary neurons, demonstrating functional, disease-relevant control of the protein. Consistent with a regulator of FKBP5, miR-511 expression in the mouse brain decreased with age but increased following chronic glucocorticoid treatment. Analysis of the predicted target genes of miR-511 revealed that neurogenesis, neuronal development, and neuronal differentiation were likely controlled by these genes. Accordingly, miR-511 increased neuronal differentiation in cells and enhanced neuronal development in primary neurons. Collectively, these findings show that miR-511 is a functional regulator of FKBP5 and can contribute to neuronal differentiation.	[Zheng, Dali; Sabbagh, Jonathan J.; Blair, Laura J.; Darling, April L.; Wen, Xiaoqi; Dickey, Chad A.] Univ S Florida, Byrd Alzheimers Res Inst, Dept Mol Med, Tampa, FL 33613 USA	State University System of Florida; University of South Florida	Dickey, CA (corresponding author), Univ S Florida, Dept Mol Med, 4001 E Fletcher Ave, Tampa, FL 33613 USA.	cdickey@health.usf.edu	Zheng, Dali/J-2973-2019	Zheng, Dali/0000-0003-2345-4040; Blair, Laura/0000-0002-4981-5564	National Institutes of Mental Health [R01 MH103848]; National Institutes of Neurological Disease and Stroke [NS073899]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH103848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073899] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Neurological Disease and Stroke; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Mental Health Grant R01 MH103848 and National Institutes of Neurological Disease and Stroke R01 Grant NS073899. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abisambra JF, 2013, J NEUROSCI, V33, P9498, DOI 10.1523/JNEUROSCI.5397-12.2013; Balakathiresan NS, 2014, J PSYCHIATR RES, V57, P65, DOI 10.1016/j.jpsychires.2014.05.020; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Blair LJ, 2013, J CLIN INVEST, V123, P4158, DOI 10.1172/JCI69003; Burgos K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094839; Camkurt MA, 2015, J PSYCHIATR RES, V69, P67, DOI 10.1016/j.jpsychires.2015.07.023; Daily K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-495; Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888; Denny WB, 2005, ENDOCRINOLOGY, V146, P3194, DOI 10.1210/en.2005-0027; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Dwivedi Y, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.175; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Femminella GD, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00040; Gillespie CF, 2005, PSYCHOSOM MED, V67, pS26, DOI 10.1097/01.psy.0000163456.22154.d2; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hartmann J, 2012, NEUROPHARMACOLOGY, V62, P332, DOI 10.1016/j.neuropharm.2011.07.041; Hassan T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1466; He Y, 2012, DNA CELL BIOL, V31, P1499, DOI 10.1089/dna.2012.1660; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Issler O, 2014, NEURON, V83, P344, DOI 10.1016/j.neuron.2014.05.042; Iwakawa HO, 2015, TRENDS CELL BIOL, V25, P651, DOI 10.1016/j.tcb.2015.07.011; Katnik C, 2006, J PHARMACOL EXP THER, V319, P1355, DOI 10.1124/jpet.106.107557; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mah C, 2003, HUM GENE THER, V14, P143, DOI 10.1089/104303403321070838; O'Leary JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024840; Paakinaho V, 2010, MOL ENDOCRINOL, V24, P511, DOI 10.1210/me.2009-0443; Puimege L, 2015, EMBO MOL MED, V7, P1004, DOI 10.15252/emmm.201405010; Sabbagh JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107241; Schmidt MV, 2012, CHEMMEDCHEM, V7, P1351, DOI 10.1002/cmdc.201200137; Smalheiser NR, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00006; Smalheiser NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033201; Smalheiser NR, 2011, INT J NEUROPSYCHOPH, V14, P1315, DOI 10.1017/S1461145710001628; Song MF, 2015, J AFFECT DISORDERS, V178, P25, DOI 10.1016/j.jad.2015.02.022; Wan YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121975; Wang X, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0099-8; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	42	31	32	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17897	17906		10.1074/jbc.M116.727941	http://dx.doi.org/10.1074/jbc.M116.727941			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27334923	hybrid, Green Published			2022-12-26	WOS:000383241300033
J	Tseng, CL; Hung, YJ; Chen, ZY; Fang, HW; Chen, KH				Tseng, Ching-Li; Hung, Ya-Jung; Chen, Zhi-Yu; Fang, Hsu-Wei; Chen, Ko-Hua			Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; OCULAR DRUG-DELIVERY; BENZALKONIUM CHLORIDE; SODIUM HYALURONATE; ANIMAL-MODELS; IN-VITRO; SURFACE; DISEASE; SYMPTOMS; EFFICACY	Dry eye syndrome (DES) is a common eye disease. Artificial tears (AT) are used to treat DES, but they are not effective. In this study, we assessed the anti-inflammatory effect of AT containing epigallocatechin gallate (EGCG) and hyaluronic acid (HA) on DES. Human corneal epithelial cells (HCECs) were used in the WST-8 assay to determine the safe dose of EGCG. Lipopolysaccharide-stimulated HCECs showing inflammation were treated with EGCG/HA. The expression of IL-1 beta, IL-6, IL-8, and TNF-alpha was assessed by real-time PCR and AT physical properties such as the viscosity, osmolarity, and pH were examined. AT containing EGCG and HA were topically administered in a rabbit DES model established by treatment with 0.1% benzalkonium chloride (BAC). Tear secretion was assessed and fluorescein, H&E, and TUNEL staining were performed. Inflammatory cytokine levels in the corneas were also examined. The non-toxic optimal concentration of EGCG used for the treatment of HCECs in vitro was 10 mu g/mL. The expression of several inflammatory genes, including IL-1 beta, IL-6, IL-8, and TNF-alpha, was significantly inhibited in inflamed HCECs treated with 10 mu g/mL EGCG and 0.1% (w/v) HA (E10/HA) compared to that in inflamed HCECs treated with either EGCG or HA alone. AT containing E10/HA mimic human tears, with similar osmolarity and viscosity and a neutral pH. Fluorescence examination of the ocular surface of mouse eyes showed that HA increased drug retention on the ocular surface. Topical treatment of DES rabbits with AT plus E10/HA increased tear secretion, reduced corneal epithelial damage, and maintained the epithelial layers and stromal structure. Moreover, the corneas of the E10/HA-treated rabbits showed fewer apoptotic cells, lower inflammation, and decreased IL-6, IL-8, and TNF-alpha levels. In conclusion, we showed that AT plus E10/HA had anti-inflammatory and mucoadhesive properties when used as topical eye drops and were effective for treating DES in rabbits.	[Tseng, Ching-Li; Chen, Zhi-Yu] Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, 250 Wu Hsing St, Taipei 110, Taiwan; [Hung, Ya-Jung; Fang, Hsu-Wei] Natl Taipei Univ Technol, Dept Chem Engn & Biotechnol, 1 Sect 3,Chung Hsiao E Rd, Taipei 106, Taiwan; [Fang, Hsu-Wei] Natl Hlth Res Inst, Inst Biomed Engn & Nanomed Res, 35 Keyan Rd, Zhunan Town 350, Miaoli County, Taiwan; [Chen, Ko-Hua] Taipei Vet Gen Hosp, Dept Ophthalmol, 201 Sec 2,Shipai Rd, Taipei 112, Taiwan; [Chen, Ko-Hua] Taipei Med Univ, Coll Med, Sch Med, Dept Ophthalmol, 250 Wu Hsing St, Taipei 110, Taiwan	Taipei Medical University; National Taipei University of Technology; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; Taipei Medical University	Tseng, CL (corresponding author), Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, 250 Wu Hsing St, Taipei 110, Taiwan.	chingli@tmu.edu.tw		Tseng, Ching-Li/0000-0001-9446-4030	Ministry of Science and Technology (MOST), Taiwan [MOST 102-2221-E-038 -007]; National Health Research Institute (NHRI), Taiwan [NHRI-EX103-10334EI]; Innovation grant of Southern Taiwan Science Park [CZ-01-01-01-105]	Ministry of Science and Technology (MOST), Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute (NHRI), Taiwan(National Health Research Institutes - Taiwan); Innovation grant of Southern Taiwan Science Park	This work was supported by grants from Ministry of Science and Technology (MOST), Taiwan under grant number at MOST 102-2221-E-038 -007; and an integrated research grant in health and medical sciences from National Health Research Institute (NHRI), Taiwan at grant number of NHRI-EX103-10334EI awarded to CL Tseng. An Innovation grant of Southern Taiwan Science Park at grant number of CZ-01-01-01-105 was awarded to HW Fang.	ABELSON MB, 1981, ARCH OPHTHALMOL-CHIC, V99, P301; Barabino S, 2005, INVEST OPHTH VIS SCI, V46, P2766, DOI 10.1167/iovs.04-1326; Barabino S, 2004, INVEST OPHTH VIS SCI, V45, P1641, DOI 10.1167/iovs.03-1055; Baudouin C, 2008, OPHTHALMOLOGY, V115, P109, DOI 10.1016/j.ophtha.2007.01.036; Benelli U, 2010, CONTACT LENS ANTERIO, V33, P61, DOI 10.1016/j.clae.2010.01.003; Brignole F, 2005, GRAEF ARCH CLIN EXP, V243, P531, DOI 10.1007/s00417-004-1040-6; BURSTEIN NL, 1980, INVEST OPHTH VIS SCI, V19, P308; Cavet ME, 2011, MOL VIS, V17, P533; de la Fuente M, 2008, INVEST OPHTH VIS SCI, V49, P2016, DOI 10.1167/iovs.07-1077; Doughty MJ, 2009, OPHTHAL PHYSL OPT, V29, P573, DOI 10.1111/j.1475-1313.2009.00683.x; Erdinest N, 2012, INVEST OPHTH VIS SCI, V53, P4396, DOI 10.1167/iovs.12-9724; Fukuda M, 1998, ASIA PACIFIC J OPHTH, V10, P20; Gillespie K, 2008, LIFE SCI, V83, P581, DOI 10.1016/j.lfs.2008.08.011; Hargittai I, 2008, STRUCT CHEM, V19, P697, DOI 10.1007/s11224-008-9370-3; Hessen Michelle, 2014, J Ophthalmic Vis Res, V9, P240; JEAN MD, 2000, CURR EYE RES, V20, P85; Kalt W, 2010, J AGR FOOD CHEM, V58, P4001, DOI 10.1021/jf903038r; Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; Kwon YS, 2011, INVEST OPHTH VIS SCI, V52, P3765; Larrosa M, 2008, FREE RADICAL RES, V42, P903, DOI 10.1080/10715760802510077; LEE H, 2010, ARVO ANN M MAY 2 6 F; Lemp MA, 2007, OCUL SURF, V5, P75; Li C, 2012, ANN SURG ONCOL, V7, P7, DOI DOI 10.1504/IJHPCN.2012.046371; Li N, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-50; Lin ZR, 2011, MOL VIS, V17, P257; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; McDonald CC, 2002, EYE, V16, P601, DOI 10.1038/sj.eye.6700169; Mitsui Y, 2008, J ORTHOP RES, V26, P1032, DOI 10.1002/jor.20558; Nagarwal RC, 2009, J CONTROL RELEASE, V136, P2, DOI 10.1016/j.jconrel.2008.12.018; Pisella PJ, 2002, BRIT J OPHTHALMOL, V86, P418, DOI 10.1136/bjo.86.4.418; Short BG, 2008, TOXICOL PATHOL, V36, P49, DOI 10.1177/0192623307310955; Smith J, 2004, PHARM RES-DORDR, V21, P43, DOI 10.1023/B:PHAM.0000012150.60180.e3; Tiffany JM, 2003, EYE, V17, P923, DOI 10.1038/sj.eye.6700566; Tseng CL, 2015, TRANSFUS APHER SCI, V53, P95, DOI 10.1016/j.transci.2015.05.016; Uematsu M, 2007, OPHTHAL RES, V39, P308, DOI 10.1159/000109986; Wilson G, 1995, J Am Optom Assoc, V66, P435; Wilson SE, 2007, OPHTHALMOLOGY, V114, P76, DOI 10.1016/j.ophtha.2006.05.077; WILSON WS, 1975, BRIT J OPHTHALMOL, V59, P667, DOI 10.1136/bjo.59.11.667; Xiong C, 2008, INVEST OPHTH VIS SCI, V49, P1850, DOI 10.1167/iovs.07-0720; Yeh S, 2003, INVEST OPHTH VIS SCI, V44, P124, DOI 10.1167/iovs.02-0581; Yoon KC, 2007, INVEST OPHTH VIS SCI, V48, P2561, DOI 10.1167/iovs.07-0002; Zhang Z, 2014, INVEST OPHTH VIS SCI, V13, P2963; Zheng XD, 2013, CORNEA, V32, P1260, DOI 10.1097/ICO.0b013e31829cfd44	44	29	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157982	10.1371/journal.pone.0157982	http://dx.doi.org/10.1371/journal.pone.0157982			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336157	Green Submitted, gold, Green Published			2022-12-26	WOS:000378389200079
J	Feng, XM; Zheng, WY; Zhang, HM; Shi, WY; Li, Y; Cui, BJ; Wang, HY				Feng, Xian-Min; Zheng, Wen-Yu; Zhang, Hong-Mei; Shi, Wen-Yan; Li, Yao; Cui, Bai-Ji; Wang, Hui-Yan			Vaccination with Bivalent DNA Vaccine of alpha 1-Giardin and CWP2 Delivered by Attenuated Salmonella typhimurium Reduces Trophozoites and Cysts in the Feces of Mice Infected with Giardia lamblia	PLOS ONE			English	Article							ANTIGENIC VARIATION; ALPHA-1 GIARDIN; WALL PROTEIN-2; ANNEXIN; TRANSMISSION; MECHANISMS; GENE	Background Giardia lamblia is one of the most common infectious protozoans in human that may cause diarrhea in travelers. Searching for antigens that induced effectively protective immunity has become a key point in the development of vaccine against giardiasis. Methodology/Principal Findings Mice vaccinated with G. lamblia trophozozite-specific alpha 1-giardin DNA vaccine delivered orally by attenuated Salmonella typhimurium SL7027 elicited 74.2% trophozoite reduction, but only 28% reduction in cyst shedding compared with PBS buffer control. Oral vaccination with Salmonella-delivered cyst-specific CWP2 DNA produced 89% reduction in cysts shedding in feces of vaccinated mice. Significantly, the mice vaccinated with Salmonella-delivered bivalent a1-giardin and CWP2 DNA vaccines produced significant reduction in both trophozoite (79%) and cyst (93%) in feces of vaccinated mice. This parasite reduction is associated with the strong local mucosal IgA secretion and the IgG2a-dominant systemic immune responses in vaccinated mice. Conclusions The results demonstrate that bivalent vaccines targeting a1-giardin and CWP2 can protect mice against the colonization of Giardia trophozoite and block the transformation of cyst in host at the same time, and can be used to prevent Giardia infection and block the transmission of giardiasis.	[Feng, Xian-Min; Zhang, Hong-Mei; Shi, Wen-Yan; Li, Yao; Cui, Bai-Ji; Wang, Hui-Yan] Jilin Med Univ, Dept Pathogen Biol, Jilin, Peoples R China; [Zheng, Wen-Yu] Ctr Hosp Jilin City, Jilin, Peoples R China	Jilin Medical University	Feng, XM (corresponding author), Jilin Med Univ, Dept Pathogen Biol, Jilin, Peoples R China.	fengxianmin28@163.com	SHI, wen/GPW-9531-2022		 [81301450];  [31572262]	; 	This work was supported by grant no: 81301450 and 31572262 (Feng XM), http://www.nsfc.gov.cn/.	Abdul-Wahid A, 2007, VACCINE, V25, P8372, DOI 10.1016/j.vaccine.2007.10.012; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Bartelt Luther A, 2015, F1000Prime Rep, V7, P62, DOI 10.12703/P7-62; Bond A, 2015, J GASTROINTEST LIVER, V24, P281, DOI 10.15403/jgld.2014.1121.243.abo; Chen JS, 2012, VACCINE, V30, P5310, DOI 10.1016/j.vaccine.2012.06.052; Corthesy B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00185; Curtiss R, 2002, J CLIN INVEST, V110, P1061, DOI 10.1172/JCI200216941; Davis-Hayman SR, 2003, INT J PARASITOL, V33, P1005, DOI 10.1016/S0020-7519(03)00177-2; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Gottig N, 2006, J BIOL CHEM, V281, P18156, DOI 10.1074/jbc.M602081200; Halle S, 2007, INFECT IMMUN, V75, P1577, DOI 10.1128/IAI.01392-06; Huang LY, 2014, FISH SHELLFISH IMMUN, V38, P34, DOI 10.1016/j.fsi.2014.02.017; Jenikova G, 2011, VACCINE, V29, P9529, DOI 10.1016/j.vaccine.2011.09.126; Jepson MA, 2001, MICROBES INFECT, V3, P1183, DOI 10.1016/S1286-4579(01)01478-2; Karanis P, 2007, J WATER HEALTH, V5, P1, DOI 10.2166/wh.2006.002; Kinnear CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141356; Lee P, 2006, MICROBIOL-SGM, V152, P1981, DOI 10.1099/mic.0.28877-0; Lee P, 2009, MICROBES INFECT, V11, P20, DOI 10.1016/j.micinf.2008.10.002; Li LD, 2012, EXP PARASITOL, V132, P465, DOI 10.1016/j.exppara.2012.09.014; Li W, 2013, MBIO, V4, DOI 10.1128/mBio.00321-13; Lu SQ, 1996, J PARASITOL, V82, P659, DOI 10.2307/3283799; NASH TE, 1990, MOL BIOCHEM PARASIT, V42, P125, DOI 10.1016/0166-6851(90)90120-B; Olson ME, 2000, PARASITOL TODAY, V16, P213, DOI 10.1016/S0169-4758(99)01623-3; Prucca CG, 2011, ANNU REV MICROBIOL, V65, P611, DOI 10.1146/annurev-micro-090110-102940; Prucca CG, 2008, NATURE, V456, P750, DOI 10.1038/nature07585; Rivero FD, 2010, NAT MED, V16, P551, DOI 10.1038/nm.2141; Weeratunga SK, 2012, J MOL BIOL, V423, P169, DOI 10.1016/j.jmb.2012.06.041; Wei CJ, 2010, EXP PARASITOL, V126, P489, DOI 10.1016/j.exppara.2010.05.028; Weiland MEL, 2005, INT J PARASITOL, V35, P617, DOI 10.1016/j.ijpara.2004.12.009; Weiland MEL, 2003, INT J PARASITOL, V33, P1341, DOI 10.1016/S0020-7519(03)00201-7; Yang YP, 2010, VACCINE, V28, P2735, DOI 10.1016/j.vaccine.2010.01.026; Zhang D, 2016, J VIROL METHODS, V227, P6, DOI 10.1016/j.jviromet.2015.08.011	32	5	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157872	10.1371/journal.pone.0157872	http://dx.doi.org/10.1371/journal.pone.0157872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332547	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212800054
J	Fuchs, SP; Martinez-Navio, JM; Gao, GP; Desrosiers, RC				Fuchs, Sebastian P.; Martinez-Navio, Jose M.; Gao, Guangping; Desrosiers, Ronald C.			Recombinant AAV Vectors for Enhanced Expression of Authentic IgG	PLOS ONE			English	Article							ADENOASSOCIATED VIRAL VECTORS; HIGH-EFFICIENCY TRANSDUCTION; MEDIATED GENE-TRANSFER; TRANSGENE EXPRESSION; NEUTRALIZING ACTIVITY; REGULATED EXPRESSION; PACKAGING CAPACITY; THERAPEUTIC LEVELS; CLINICAL-TRIAL; HEMOPHILIA-B	Adeno-associated virus (AAV) has become a vector of choice for the treatment of a variety of genetic diseases that require safe and long-term delivery of a missing protein. Muscle-directed gene transfer for delivery of protective antibodies against AIDS viruses and other pathogens has been used experimentally in mice and monkeys. Here we examined a number of variations to AAV vector design for the ability to produce authentic immunoglobulin G (IgG) molecules. Expression of rhesus IgG from a single single-stranded AAV (ssAAV) vector (one vector approach) was compared to expression from two self-complementary AAV (scAAV) vectors, one for heavy chain and one for light chain (two vector approach). Both the one vector and the two vector approaches yielded considerable levels of expressed full length IgG. A number of modifications to the ssAAV expression system were then examined for their ability to increase the efficiency of IgG expression. Inclusion of a furin cleavage sequence with a linker peptide just upstream of the 2A self-cleaving sequence from foot-and- mouth disease virus (F2A) increased IgG expression approximately 2 fold. Inclusion of these sequences also helped to ensure a proper sequence at the C-terminal end of the heavy chain. Inclusion of the post-transcriptional regulatory element from woodchuck hepatitis virus (WPRE) further increased IgG expression 1.5-2.0 fold. IgG1 versions of the two rhesus IgGs that were examined consistently expressed better than the IgG2 forms. In contrast to what has been reported for AAV2-mediated expression of other proteins, introduction of capsid mutations Y445F and Y731F did not increase ssAAV1-mediated expression of IgG as determined by transduction experiments in cell culture. Our findings provide a rational basis for AAV vector design for expression of authentic IgG.	[Fuchs, Sebastian P.; Martinez-Navio, Jose M.; Desrosiers, Ronald C.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Fuchs, Sebastian P.] Univ Erlangen Nurnberg, Inst Klin & Mol Virol, Loschgestr 7, Erlangen, Germany; [Gao, Guangping] Univ Massachusetts, Sch Med, Gene Therapy Ctr, Worcester, MA USA	University of Miami; University of Erlangen Nuremberg; University of Massachusetts System; University of Massachusetts Worcester	Desrosiers, RC (corresponding author), Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.	r.desrosiers@med.miami.edu		Martinez-Navio, Jose/0000-0003-0560-5407	National Institutes of Health (NIH) [P01 AI100263, R01 AI098446, U19 AI095985]; Miami Center for AIDS Research - National Institutes of Health [P30AI073961]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098446, P30AI073961] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miami Center for AIDS Research - National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by National Institutes of Health (NIH) grants P01 AI100263, R01 AI098446, and U19 AI095985 (to RCD). The authors also acknowledge support from the Miami Center for AIDS Research (to JMMN) at the University of Miami Miller School of Medicine funded by grant (P30AI073961) from the National Institutes of Health.	Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; Bowles DE, 2012, MOL THER, V20, P443, DOI 10.1038/mt.2011.237; Brantly ML, 2009, P NATL ACAD SCI USA, V106, P16363, DOI 10.1073/pnas.0904514106; Bryant LM, 2013, HUM GENE THER CL DEV, V24, P55, DOI 10.1089/humc.2013.087; Cai B, 2011, BIOTECHNOL BIOENG, V108, P404, DOI 10.1002/bit.22933; Choi JH, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-17; Fang JM, 2007, MOL THER, V15, P1153, DOI 10.1038/sj.mt.6300142; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Flotte T, 1996, HUM GENE THER, V7, P1145, DOI 10.1089/hum.1996.7.9-1145; Flotte TR, 2011, HUM GENE THER, V22, P1239, DOI 10.1089/hum.2011.053; Fuchs SP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005090; Gao GP, 2006, J VIROL, V80, P6192, DOI 10.1128/JVI.00526-06; Gardner MR, 2015, NATURE, V519, P87, DOI 10.1038/nature14264; Gaudet D, 2013, GENE THER, V20, P361, DOI 10.1038/gt.2012.43; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hakim CH, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.2; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Johnson WE, 2003, J VIROL, V77, P9993, DOI 10.1128/JVI.77.18.9993-10003.2003; Kingsman SM, 2005, GENE THER, V12, P3, DOI 10.1038/sj.gt.3302417; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Lewis AD, 2002, J VIROL, V76, P8769, DOI 10.1128/JVI.76.17.8769-8775.2002; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Markusic DM, 2010, MOL THER, V18, P2048, DOI 10.1038/mt.2010.172; Martinez-Navio J.M., 2015, MOL THER; McCarty DM, 2003, GENE THER, V10, P2112, DOI 10.1038/sj.gt.3302134; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Qiao CP, 2010, HUM GENE THER, V21, P1343, DOI 10.1089/hum.2010.003; Ratner D, 2012, CURR PROTOC MICROBIO; Rivera VM, 2005, BLOOD, V105, P1424, DOI 10.1182/blood-2004-06-2501; Samulski RJ, 2014, ANNU REV VIROL, V1, P427, DOI 10.1146/annurev-virology-031413-085355; Saunders KO, 2015, J VIROL; Schambach A, 2006, GENE THER, V13, P641, DOI 10.1038/sj.gt.3302698; Scott LJ, 2015, DRUGS, V75, P175, DOI 10.1007/s40265-014-0339-9; Ura T, 2014, VACCINES, V2, P624, DOI 10.3390/vaccines2030624; Vannucci L, 2013, NEW MICROBIOL, V36, P1; Wang D, 2014, EXPERT OPIN DRUG DEL, V11, P345, DOI 10.1517/17425247.2014.871258; Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133; West AP, 2012, J VIROL, V86, P195, DOI 10.1128/JVI.05848-11; Wu JQ, 2007, HUM GENE THER, V18, P171, DOI 10.1089/hum.2006.088; Wu Z, 2008, MOL THER, V16, P280, DOI 10.1038/sj.mt.6300355; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	52	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0158009	10.1371/journal.pone.0158009	http://dx.doi.org/10.1371/journal.pone.0158009			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332822	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212800067
J	Ko, YE; Cho, B; Kim, SS; Song, SY; Choi, EK; Ahn, SD; Yi, B				Ko, Young Eun; Cho, Byungchul; Kim, Su Ssan; Song, Si Yeol; Choi, Eun Kyung; Ahn, Seung Do; Yi, Byongyong			Improving Delivery Accuracy of Stereotactic Body Radiotherapy to a Moving Tumor Using Simplified Volumetric Modulated Arc Therapy	PLOS ONE			English	Article							PERIPHERAL LUNG-TUMORS; RADIATION-THERAPY; SBRT; CANCER; PROTOCOL; MOTION; TRIAL	Purpose To develop a simplified volumetric modulated arc therapy (VMAT) technique for more accurate dose delivery in thoracic stereotactic body radiation therapy (SBRT). Methods and Materials For each of the 22 lung SBRT cases treated with respiratory-gated VMAT, a dose rate modulated arc therapy (DrMAT) plan was retrospectively generated. A dynamic conformal arc therapy plan with 33 adjoining coplanar arcs was designed and their beam weights were optimized by an inverse planning process. All sub-arc beams were converted into a series of control points with varying MLC segment and dose rates and merged into an arc beam for a DrMAT plan. The plan quality of original VMAT and DrMAT was compared in terms of target coverage, compactness of dose distribution, and dose sparing of organs at risk. To assess the delivery accuracy, the VMAT and DrMAT plans were delivered to a motion phantom programmed with the corresponding patients' respiratory signal; results were compared using film dosimetry with gamma analysis. Results The plan quality of DrMAT was equivalent to that of VMAT in terms of target coverage, dose compactness, and dose sparing for the normal lung. In dose sparing for other critical organs, DrMAT was less effective than VMAT for the spinal cord, heart, and esophagus while being well within the limits specified by the Radiation Therapy Oncology Group. Delivery accuracy of DrMAT to a moving target was similar to that of VMAT using a gamma criterion of 2%/2mm but was significantly better using a 2%/1mm criterion, implying the superiority of DrMAT over VMAT in SBRT for thoracic/abdominal tumors with respiratory movement. Conclusion We developed a DrMAT technique for SBRT that produces plans of a quality similar to that achieved with VMAT but with better delivery accuracy. This technique is well-suited for small tumors with motion uncertainty.	[Ko, Young Eun] Ulsan Univ Hosp, Dept Radiat Oncol, Ulsan, South Korea; [Cho, Byungchul; Kim, Su Ssan; Song, Si Yeol; Choi, Eun Kyung; Ahn, Seung Do] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Yi, Byongyong] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA	University of Ulsan; Ulsan University Hospital; University of Ulsan; Asan Medical Center; University System of Maryland; University of Maryland Baltimore	Cho, B (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea.	bcho@amc.seoul.kr			Radiation Technology R&D program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [2013M2A2A7043506]	Radiation Technology R&D program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning	This work was supported by the Radiation Technology R&D program (2013M2A2A7043506) through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning.	[Anonymous], 2009, EXT BEAM PLANN REF G; Bezjak A, 2016, INT J RADIAT ONCOL, V94, P5, DOI 10.1016/j.ijrobp.2015.10.040; Bouilhol G, 2013, PHYS MEDICA, V29, P333, DOI 10.1016/j.ejmp.2012.04.006; Brock J, 2012, CLIN ONCOL-UK, V24, P68, DOI 10.1016/j.clon.2011.02.003; Cai J, 2014, MED PHYS, V41, DOI 10.1118/1.4856175; Dagoglu RN, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.3_suppl.451; Fakiris AJ, 2009, INT J RADIAT ONCOL, V75, P677, DOI 10.1016/j.ijrobp.2008.11.042; Feuvret L, 2006, INT J RADIAT ONCOL, V64, P333, DOI 10.1016/j.ijrobp.2005.09.028; Herman TD, 2010, J APPL CLIN MED PHYS, V11, P158, DOI 10.1120/jacmp.v11i1.3133; Huang BT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127501; Kavanagh BD, 2006, ACTA ONCOL, V45, P848, DOI 10.1080/02841860600904870; Kim SS, 2013, LUNG CANCER, V79, P161, DOI 10.1016/j.lungcan.2012.10.011; Lewis D, 2012, MED PHYS, V39, P6339, DOI 10.1118/1.4754797; Marrazzo L, 2015, PHYS MEDICA, V31, P1035, DOI 10.1016/j.ejmp.2015.08.010; Merrow Caitlin E, 2012, J Appl Clin Med Phys, V14, P4110, DOI 10.1120/jacmp.v14i1.4110; Nyman J, 2006, LUNG CANCER-J IASLC, V51, P97, DOI 10.1016/j.lungcan.2005.08.011; Ong CL, 2010, RADIOTHER ONCOL, V97, P437, DOI 10.1016/j.radonc.2010.09.027; Purdie TG, 2007, INT J RADIAT ONCOL, V68, P243, DOI 10.1016/j.ijrobp.2006.12.022; Rao M, 2012, INT J RADIAT ONCOL, V83, pE251, DOI 10.1016/j.ijrobp.2011.12.001; Rauschenbach BM, 2014, J APPL CLIN MED PHYS, V15, P147, DOI 10.1120/jacmp.v15i5.4898; Ross CC, 2011, PRACT RADIAT ONCOL, V1, P126, DOI 10.1016/j.prro.2010.11.002; Saito T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112824; Shi CY, 2015, MED DOSIM, V40, P26, DOI 10.1016/j.meddos.2014.07.002; Smith Ashley, 2014, [PROGRESS in MEDICAL PHYSICS, 의학물리], V25, P288, DOI 10.14316/pmp.2014.25.4.288; Tang G, 2009, PHYS MED BIOL, V54, P6439, DOI 10.1088/0031-9155/54/21/001; Timmerman RD, 2009, INT J RADIAT ONCOL, V75, pS3, DOI 10.1016/j.ijrobp.2009.07.033; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Videtic GM, 2013, INT J RADIAT ONCOL, V87, pS3, DOI 10.1016/j.ijrobp.2013.06.016; Wong JW, 1999, INT J RADIAT ONCOL, V44, P911, DOI 10.1016/S0360-3016(99)00056-5; Yu CX, 1998, PHYS MED BIOL, V43, P91, DOI 10.1088/0031-9155/43/1/006; Zhang GG, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-152; Zhang HH, 2013, PHYS MED BIOL, V58, P7117, DOI 10.1088/0031-9155/58/20/7117	32	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0158053	10.1371/journal.pone.0158053	http://dx.doi.org/10.1371/journal.pone.0158053			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333199	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212800072
J	Morisaki, N; Fujiwara, T; Horikawa, R				Morisaki, Naho; Fujiwara, Takeo; Horikawa, Reiko			The Impact of Parental Personality on Birth Outcomes: A Prospective Cohort Study	PLOS ONE			English	Article							CHARACTER INVENTORY TCI; PRETERM BIRTH; GESTATIONAL-AGE; TEMPERAMENT; DEPRESSION; PREDICTORS; INFANTS; STRESS; WEIGHT; GROWTH	Objective To investigate the effect of parental personality on birth outcomes. Design Prospective cohort study. Setting 727 pregnant women and 579 spouses receiving antenatal care at a single-center in rural Tokyo, Japan during 2010-2013. Methods We measured the association between maternal effect of parental personality traits assessed by the Cloninger's Temperament and Character Inventory on birth outcomes, using multiple regression and adjusting for demographics. Results Maternal self-transcendence personality was inversely associated with gestational age [-0.26 (95% confidence interval (CI): -0.51 to -0.01) weeks per unit] and positively associated with preterm birth [odds ratio (OR) 2.60 (95% CI: 1.00 to 6.75) per unit], while paternal self-transcendence personality was positively associated with gestational age [0.31 (95% CI: 0.07 to 0.55) weeks per unit]. Maternal reward dependence was positively associated with fetal growth [0.30 (95% CI: 0.02 to 0.59) per unit]. Other maternal and paternal personality traits associated with adverse maternal behavior, such as novelty seeking, harm avoidance and self-directedness, were not associated with birth outcomes. Conclusion We found that specific parental personality traits can be associated with birth outcomes.	[Morisaki, Naho; Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Social Med, Setagaya Ku, 2-10-1 Okura, Tokyo, Japan; [Fujiwara, Takeo] Tokyo Med & Dent Univ, Dept Global Hlth Promot, Bunkyo Ku, 1-5-45 Yushima, Tokyo, Japan; [Horikawa, Reiko] Natl Res Ctr Child Hlth & Dev, Dept Endocrinol, Setagaya Ku, 2-10-1 Okura, Tokyo, Japan	National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU); National Center for Child Health & Development - Japan	Fujiwara, T (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Social Med, Setagaya Ku, 2-10-1 Okura, Tokyo, Japan.; Fujiwara, T (corresponding author), Tokyo Med & Dent Univ, Dept Global Hlth Promot, Bunkyo Ku, 1-5-45 Yushima, Tokyo, Japan.	fujiwara.hlth@tmd.ac.jp		Morisaki, Naho/0000-0001-6151-4513	Ministry of Health, Labor and Welfare [H22-jisedai-ippan-008]; Japan Agency for Medical Research [AMED-6013]; Research Development Grant for Child Health and Development from National Center for Child Health and Development [25-4]	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research; Research Development Grant for Child Health and Development from National Center for Child Health and Development	This study was partially supported by grants from the Ministry of Health, Labor and Welfare (http://www.mhlw.go.jp/) (H22-jisedai-ippan-008 to RH), the Japan Agency for Medical Research (http://www.amed.go.jp/) (AMED-6013 to TF), and the Research Development Grant for Child Health and Development from the National Center for Child Health and Development (25-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol CL, 2012, NAT REV NEPHROL, V8, P265, DOI 10.1038/nrneph.2012.38; Andriola E, 2011, DEPRESS RES TREAT, V2011, DOI [10.1155/2011/356428, DOI 10.1155/2011/356428]; Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3; Bayman E, 2014, ARCH DIS CHILD FETAL; Been JV, 2014, LANCET, V383, P1549, DOI 10.1016/S0140-6736(14)60082-9; Catov JM, 2011, AM J CLIN NUTR, V94, P906, DOI 10.3945/ajcn.111.012393; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Crump C, 2011, AM J EPIDEMIOL, V173, P797, DOI 10.1093/aje/kwq440; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; Dean SV, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S3; Elovainio M, 2004, J AFFECT DISORDERS, V83, P227, DOI 10.1016/j.jad.2004.06.005; Etter JF, 2010, NICOTINE TOB RES, V12, P919, DOI 10.1093/ntr/ntq116; Hansenne M, 1999, J PSYCHIATR RES, V33, P31, DOI 10.1016/S0022-3956(98)00036-3; Kampman O, 2011, J AFFECT DISORDERS, V135, P20, DOI 10.1016/j.jad.2010.12.021; Kijima N, 2000, PSYCHOL REP, V86, P1050, DOI 10.2466/PR0.86.3.1050-1058; Minatani Mariko, 2013, Depress Res Treat, V2013, P140169, DOI 10.1155/2013/140169; Monk C, 2012, DEV PSYCHOPATHOL, V24, P1361, DOI 10.1017/S0954579412000764; Naito M, 2000, J CLIN PSYCHOL, V56, P1579, DOI 10.1002/1097-4679(200012)56:12<1579::AID-8>3.0.CO;2-K; Odberg MD, 2010, ARCH DIS CHILD-FETAL, V95, pF201, DOI 10.1136/adc.2009.160614; Parkinson JRC, 2013, PEDIATRICS, V131, pE1240, DOI 10.1542/peds.2012-2177; Pomerleau C S, 1992, J Subst Abuse, V4, P143, DOI 10.1016/0899-3289(92)90014-O; Rotteveel J, 2008, PEDIATRICS, V122, P313, DOI 10.1542/peds.2007-2012; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; Serretti A, 2009, INT CLIN PSYCHOPHARM, V24, P1, DOI 10.1097/YIC.0b013e32831db2d7; Shapiro GD, 2013, J PERINAT MED, V41, P631, DOI 10.1515/jpm-2012-0295; SVRAKIC DM, 1993, ARCH GEN PSYCHIAT, V50, P991; Swamy GK, 2008, JAMA-J AM MED ASSOC, V299, P1429, DOI 10.1001/jama.299.12.1429; Takeuchi M, 2011, COMPR PSYCHIAT, V52, P109, DOI 10.1016/j.comppsych.2010.04.002; Tanaka EJ, 1997, PSYCHOL REP, V80, P251, DOI 10.2466/PR0.80.1.251-254; Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561; Uehara R, 2011, J EPIDEMIOL, V21, P217, DOI 10.2188/jea.JE20100123; Wadhwa PD, 2011, CLIN PERINATOL, V38, P351, DOI 10.1016/j.clp.2011.06.007	34	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157080	10.1371/journal.pone.0157080	http://dx.doi.org/10.1371/journal.pone.0157080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP0WX	27331908	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212800020
J	Yang, S; Du, WG; Shi, PZ; Ju, SG; Liu, SJ; Zhou, CH; Chen, P; Zhang, Q; Fan, HL				Yang, Song; Du, Wenguang; Shi, Pengzheng; Ju Shangguan; Liu, Shoujun; Zhou, Changhai; Chen, Peng; Zhang, Qian; Fan, Huiling			Mechanistic and Kinetic Analysis of Na2SO4-Modified Laterite Decomposition by Thermogravimetry Coupled with Mass Spectrometry	PLOS ONE			English	Article							SODIUM-SULFATE; SOLID-STATE; PRECONCENTRATION STRATEGIES; THERMAL-DECOMPOSITION; NICKEL; REDUCTION; PYROLYSIS; ORE; GASIFICATION; DOLOMITE	Nickel laterites cannot be effectively used in physical methods because of their poor crystallinity and fine grain size. Na2SO4 is the most efficient additive for grade enrichment and Ni recovery. However, how Na2SO4 affects the selective reduction of laterite ores has not been clearly investigated. This study investigated the decomposition of laterite with and without the addition of Na2SO4 in an argon atmosphere using thermogravimetry coupled with mass spectrometry (TG-MS). Approximately 25 mg of samples with 20 wt% Na2SO4 was pyrolyzed under a 100 ml/min Ar flow at a heating rate of 10 degrees C/min from room temperature to 1300 degrees C. The kinetic study was based on derivative thermogravimetric (DTG) curves. The evolution of the pyrolysis gas composition was detected by mass spectrometry, and the decomposition products were analyzed by X-ray diffraction (XRD). The decomposition behavior of laterite with the addition of Na2SO4 was similar to that of pure laterite below 800 degrees C during the first three stages. However, in the fourth stage, the dolomite decomposed at 897 degrees C, which is approximately 200 degrees C lower than the decomposition of pure laterite. In the last stage, the laterite decomposed and emitted SO2 in the presence of Na2SO4 with an activation energy of 91.37 kJ/mol. The decomposition of laterite with and without the addition of Na2SO4 can be described by one first-order reaction. Moreover, the use of Na2SO4 as the modification agent can reduce the activation energy of laterite decomposition; thus, the reaction rate can be accelerated, and the reaction temperature can be markedly reduced.	[Yang, Song; Du, Wenguang; Shi, Pengzheng; Ju Shangguan; Zhang, Qian; Fan, Huiling] Taiyuan Univ Technol, Inst Chem Engn Coal, Minist Educ & Shanxi Prov, Key Lab Coal Sci & Technol, Taiyuan 030024, Peoples R China; [Liu, Shoujun; Zhou, Changhai; Chen, Peng] Taiyuan Univ Technol, Coll Chem & Chem Engn, Taiyuan 030024, Peoples R China	Taiyuan University of Technology; Taiyuan University of Technology	Ju, SG (corresponding author), Taiyuan Univ Technol, Inst Chem Engn Coal, Minist Educ & Shanxi Prov, Key Lab Coal Sci & Technol, Taiyuan 030024, Peoples R China.	shanggj62@163.com			National Natural Science Foundation of China [21276172]; Taiyuan Green Coal-based Clean Fuel Co., Ltd. (China)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taiyuan Green Coal-based Clean Fuel Co., Ltd. (China)	This work was financially supported by the National Natural Science Foundation of China (No. 21276172) and sponsored by the Taiyuan Green Coal-based Clean Fuel Co., Ltd. (China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANDAKUMARAN P, 1982, THERMOCHIM ACTA, V59, P319, DOI 10.1016/0040-6031(82)87155-4; Bingham PA, 2007, J NON-CRYST SOLIDS, V353, P2479, DOI 10.1016/j.jnoncrysol.2007.03.017; Cai JH, 2012, ENERG FUEL, V26, P5550, DOI 10.1021/ef3011965; Cai JQ, 2008, FUEL PROCESS TECHNOL, V89, P21, DOI 10.1016/j.fuproc.2007.06.006; Conesa JA, 2015, J ANAL APPL PYROL, V113, P680, DOI 10.1016/j.jaap.2015.04.019; CUBICCIOTTI D, 1977, J ELECTROCHEM SOC, V124, P933, DOI 10.1149/1.2133456; Francis A, 2007, J MATER PROCESS TECH, V181, P213, DOI 10.1016/j.jmatprotec.2006.03.025; Freyer D, 1998, EUR J SOL STATE INOR, V35, P595, DOI 10.1016/S0992-4361(99)80001-0; Ghaffari M, 2012, THERMOCHIM ACTA, V549, P81, DOI 10.1016/j.tca.2012.09.021; Hidayat T, 2008, MINER ENG, V21, P157, DOI 10.1016/j.mineng.2007.09.004; Jaber JO, 1999, APPL ENERG, V63, P269, DOI 10.1016/S0306-2619(99)00033-1; JACOBSON NS, 1989, OXID MET, V31, P91, DOI 10.1007/BF00665488; Jang KO, 2014, MINER ENG, V60, P14, DOI 10.1016/j.mineng.2014.01.021; Jiang M, 2013, INT J MINER PROCESS, V123, P32, DOI 10.1016/j.minpro.2013.04.005; Katzagiannakis N., 2014, GEOMATERIALS, V4, P105; Kaupp G, 2003, TETRAHEDRON, V59, P3753, DOI 10.1016/S0040-4020(03)00554-4; Khataee A, 2015, J IND ENG CHEM, V26, P129, DOI 10.1016/j.jiec.2014.11.024; Li B, 2011, MINER ENG, V24, P1556, DOI 10.1016/j.mineng.2011.08.006; Li GH, 2012, MINER ENG, V32, P19, DOI 10.1016/j.mineng.2012.03.012; Liu W, 2016, POWDER TECHNOL, V287, P373, DOI 10.1016/j.powtec.2015.10.024; Lu J, 2013, MINER ENG, V49, P154, DOI 10.1016/j.mineng.2013.05.023; Mabuda AI, 2016, RENEW SUST ENERG REV, V53, P1656, DOI 10.1016/j.rser.2015.07.038; Mitchell SL, 2015, J COMPUT APPL MATH, V281, P58, DOI 10.1016/j.cam.2014.11.051; MOBIN M, 1991, J LESS-COMMON MET, V170, P243, DOI 10.1016/0022-5088(91)90325-X; Norgate T, 2011, MINER ENG, V24, P698, DOI 10.1016/j.mineng.2010.10.002; O'Neill HSC, 2002, CHEM GEOL, V186, P151, DOI 10.1016/S0009-2541(01)00414-4; Ozawa T., 1970, J THERM ANAL CALORIM, V2, P301, DOI DOI 10.1007/BF01911411; Park JO, 2015, MINER ENG, V71, P205, DOI 10.1016/j.mineng.2014.11.011; Quast K, 2015, MINER ENG, V79, P261, DOI 10.1016/j.mineng.2015.03.017; Quast K, 2015, MINER ENG, V79, P269, DOI 10.1016/j.mineng.2015.03.016; Rat'ko AI, 2011, INORG MATER+, V47, P1372, DOI 10.1134/S0020168511120156; Reck BK, 2008, ENVIRON SCI TECHNOL, V42, P3394, DOI 10.1021/es072108l; Vyazovkin S, 1998, INT REV PHYS CHEM, V17, P407, DOI 10.1080/014423598230108; Yoshida M, 2015, J ENVIRON CHEM ENG, V3, P1614, DOI 10.1016/j.jece.2015.05.016; Zhang Q, 2014, APPL ENERG, V132, P426, DOI 10.1016/j.apenergy.2014.07.014; Zhu DQ, 2012, T NONFERR METAL SOC, V22, P907, DOI 10.1016/S1003-6326(11)61264-8	36	7	8	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157369	10.1371/journal.pone.0157369	http://dx.doi.org/10.1371/journal.pone.0157369			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333072	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212800027
J	Dong, XZ; Sun, XR; Sun, L; Maxim, PG; Xing, L; Huang, Y; Li, WW; Wan, HL; Zhao, XG; Xing, LG; Yu, JM				Dong, Xinzhe; Sun, Xiaorong; Sun, Lu; Maxim, Peter G.; Xing, Lei; Huang, Yong; Li, Wenwu; Wan, Honglin; Zhao, Xianguang; Xing, Ligang; Yu, Jinming			Early Change in Metabolic Tumor Heterogeneity during Chemoradiotherapy and Its Prognostic Value for Patients with Locally Advanced Non-Small Cell Lung Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; TEXTURE ANALYSIS; F-18-FDG PET/CT; FDG-PET; RESPONSE EVALUATION; SURVIVAL; FEATURES; RADIOTHERAPY; PREDICTION	Introduction To observe the early change of metabolic tumor heterogeneity during chemoradiotherapy and to determine its prognostic value for patients with locally advanced non-small cell lung cancer (NSCLC). Methods From January 2007 to March 2010, 58 patients with NSCLC were included who were received 18F-fluorodeoxyglucose (F-18-FDG) PET/CT before and following 40 Gy radiotherapy with the concurrent cisplatin-based chemotherapy (CCRT). Primary tumor FDG uptake heterogeneity was determined using global and local scale textural features extracted from standardized uptake value (SUV) histogram analysis (coefficient of variation [COV], skewness, kurtosis, area under the curve of the cumulative SUV histogram [AUC-CSH]) and normalized gray-level co-occurrence matrix (contrast, dissimilarity, entropy, homogeneity). SUVmax and metabolic tumor volume (MTV) were also evaluated. Correlations were analyzed between parameters on baseline or during treatments with tumor response, progression-free survival (PFS), and overall survival (OS). Results Compared with non-responders, responders showed significantly greater pre-treatment COV, contrast and MTV (AUC = 0.781, 0.804, 0.686, respectively). Receiver-operating-characteristic curve analysis showed that early change of tumor textural analysis serves as a response predictor with higher sensitivity (73.2%similar to 92.1%) and specificity (80.0%similar to 83.6%) than baseline parameters. Change in AUC-CSH and dissimilarity during CCRT could also predict response with optimal cut-off values (33.0% and 28.7%, respectively). The patients with greater changes in contrast and AUC-CSH had significantly higher 5-year OS (P = 0.008, P = 0.034) and PFS (P = 0.007, P = 0.039). In multivariate analysis, only change in contrast was found as the independent prognostic factor of PFS (HR 0.476, P = 0.021) and OS (HR 0.519, P = 0.015). Conclusions The metabolic tumor heterogeneity change during CCRT characterized by global and local scale textural features may be valuable for predicting treatment response and survival for patients with locally advanced NSCLC.	[Dong, Xinzhe; Zhao, Xianguang; Xing, Ligang; Yu, Jinming] Shandong Univ, Dept Radiat Oncol, Shandong Canc Hosp, Jinan, Shandong, Peoples R China; [Dong, Xinzhe; Zhao, Xianguang; Xing, Ligang; Yu, Jinming] Shandong Canc Hosp & Inst, Key Lab Radiat Oncol Shandong Prov, Jinan, Shandong, Peoples R China; [Sun, Xiaorong; Huang, Yong; Li, Wenwu] Shandong Canc Hosp & Inst, Dept Radiol, Jinan, Shandong, Peoples R China; [Sun, Lu] Jinan Univ, Jinan, Shandong, Peoples R China; [Maxim, Peter G.; Xing, Lei] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; [Maxim, Peter G.; Xing, Lei] Stanford Univ, Sch Med, Inst Canc, Stanford, CA 94305 USA; [Wan, Honglin] Shandong Normal Univ, Coll Phys & Elect Sci, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Stanford University; Stanford University; Shandong Normal University	Zhao, XG; Xing, LG (corresponding author), Shandong Univ, Dept Radiat Oncol, Shandong Canc Hosp, Jinan, Shandong, Peoples R China.; Zhao, XG; Xing, LG (corresponding author), Shandong Canc Hosp & Inst, Key Lab Radiat Oncol Shandong Prov, Jinan, Shandong, Peoples R China.	stanfordbonnie@outlook.com; xinglg@medmail.com.cn		Xing, Lei/0000-0003-2536-5359	National Health and Family Planning Commission Institutes of the People's Republic of China [201402011]; National Natural Science Foundation of China [81272502, L1322016]; Shandong Natural Science Foundation [ZR2014YL033, ZR2009CL023]; Educational fund from the China Scholarship Council [201406220074]	National Health and Family Planning Commission Institutes of the People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Natural Science Foundation(Natural Science Foundation of Shandong Province); Educational fund from the China Scholarship Council	This work was supported in part by the grant from National Health and Family Planning Commission Institutes of the People's Republic of China (201402011 [http://www.nhfpc.gov.cn] to Ligang Xing), National Natural Science Foundation of China (81272502 and L1322016 [http://www.nsfc.gov.cn] to Ligang Xing), Shandong Natural Science Foundation (ZR2014YL033 and ZR2009CL023 [http://www.sdnsf.gov.cn/portal/] to Ligang Xing) and the Educational fund from the China Scholarship Council (201406220074 [http://www.csc.edu.cn] to XD).	Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Ben-Haim S, 2009, J NUCL MED, V50, P88, DOI 10.2967/jnumed.108.054205; Berghmans T, 2008, J THORAC ONCOL, V3, P6, DOI 10.1097/JTO.0b013e31815e6d6b; Bradley JD, 2015, LANCET ONCOL, V16, P187, DOI 10.1016/S1470-2045(14)71207-0; Bundschuh RA, 2014, J NUCL MED, V55, P891, DOI 10.2967/jnumed.113.127340; Bussink J, 2011, NAT REV CLIN ONCOL, V8, P233, DOI 10.1038/nrclinonc.2010.218; Chicklore S, 2013, EUR J NUCL MED MOL I, V40, P133, DOI 10.1007/s00259-012-2247-0; Cook GJR, 2015, RADIOLOGY, V276, P883, DOI 10.1148/radiol.2015141309; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; Coudert B, 2014, LANCET ONCOL, V15, P1493, DOI 10.1016/S1470-2045(14)70475-9; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; Desseroit MC, 2016, EUR J NUCL MED MOL I, V43, P1477, DOI 10.1007/s00259-016-3325-5; Dong XZ, 2015, J MED IMAG RADIAT ON, V59, P338, DOI 10.1111/1754-9485.12289; Dong XZ, 2013, NUCL MED COMMUN, V34, P40, DOI 10.1097/MNM.0b013e32835ae50c; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Fried DV, 2016, RADIOLOGY, V278, P214, DOI 10.1148/radiol.2015142920; Fried DV, 2014, INT J RADIAT ONCOL, V90, P834, DOI 10.1016/j.ijrobp.2014.07.020; Ganeshan B, 2013, RADIOLOGY, V266, P326, DOI 10.1148/radiol.12112428; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Henriksson E, 2007, ANTICANCER RES, V27, P2155; Hoang JK, 2008, J CLIN ONCOL, V26, P1459, DOI 10.1200/JCO.2007.14.3628; Huang W, 2014, J NUCL MED, V55, P1584, DOI 10.2967/jnumed.114.142919; Kang SR, 2014, NUCL MED MOLEC IMAG, V48, P16, DOI 10.1007/s13139-013-0231-7; Kunkel M, 2003, CANCER, V97, P1015, DOI 10.1002/cncr.11159; Lovinfosse P, 2016, EUR J NUCL MED MOL I, V43, P1453, DOI 10.1007/s00259-016-3314-8; Machtay M, 2013, J CLIN ONCOL, V31, P3823, DOI 10.1200/JCO.2012.47.5947; Miller TR, 2003, J NUCL MED, V44, P192; Ohri N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv004; Orlhac F, 2014, J NUCL MED, V55, P414, DOI 10.2967/jnumed.113.129858; Pyka T, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0407-7; Soussan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094017; Swinnen LJ, 2015, BRIT J HAEMATOL, V170, P56, DOI 10.1111/bjh.13389; Tixier F, 2014, J NUCL MED, V55, P1235, DOI 10.2967/jnumed.113.133389; Tixier F, 2012, J NUCL MED, V53, P693, DOI 10.2967/jnumed.111.099127; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Usmanij EA, 2013, J NUCL MED, V54, P1528, DOI 10.2967/jnumed.112.116921; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; Yang F, 2013, EUR J NUCL MED MOL I, V40, P716, DOI 10.1007/s00259-012-2332-4; Yu JM, 2009, INT J RADIAT ONCOL, V75, P1468, DOI 10.1016/j.ijrobp.2009.01.019	40	47	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157836	10.1371/journal.pone.0157836	http://dx.doi.org/10.1371/journal.pone.0157836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322376	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212000047
J	Hora, B; Keating, SM; Chen, Y; Sanchez, AM; Sabino, E; Hunt, G; Ledwaba, J; Hackett, J; Swanson, P; Hewlett, I; Ragupathy, V; Vemula, SV; Zeng, PB; Tee, KK; Chow, WZ; Ji, HZ; Sandstrom, P; Denny, TN; Busch, MP; Gao, F				Hora, Bhavna; Keating, Sheila M.; Chen, Yue; Sanchez, Ana M.; Sabino, Ester; Hunt, Gillian; Ledwaba, Johanna; Hackett, John, Jr.; Swanson, Priscilla; Hewlett, Indira; Ragupathy, Viswanath; Vemula, Sai Vikram; Zeng, Peibin; Tee, Kok-Keng; Chow, Wei Zhen; Ji, Hezhao; Sandstrom, Paul; Denny, Thomas N.; Busch, Michael P.; Gao, Feng		REDS-iii; EQAPOL Programs	Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NON-B SUBTYPES; DRUG-RESISTANCE; IMMUNOLOGICAL RESPONSE; ANTIRETROVIRAL THERAPY; RECOMBINANT FORMS; APTIMA HIV-1; VIRAL LOAD; IDENTIFICATION; QUANTIFICATION	HIV-1 subtypes and drug resistance are routinely tested by many international surveillance groups. However, results from different sites often vary. A systematic comparison of results from multiple sites is needed to determine whether a standardized protocol is required for consistent and accurate data analysis. A panel of well-characterized HIV-1 isolates (N = 50) from the External Quality Assurance Program Oversight Laboratory (EQAPOL) was assembled for evaluation at seven international sites. This virus panel included seven subtypes, six circulating recombinant forms (CRFs), nine unique recombinant forms (URFs) and three group O viruses. Seven viruses contained 10 major drug resistance mutations (DRMs). HIV-1 isolates were prepared at a concentration of 10(7) copies/ml and compiled into blinded panels. Subtypes and DRMs were determined with partial or full pol gene sequences by conventional Sanger sequencing and/or Next Generation Sequencing (NGS). Subtype and DRM results were reported and decoded for comparison with full-length genome sequences generated by EQAPOL. The partial pol gene was amplified by RT-PCR and sequenced for 89.4%-100% of group M viruses at six sites. Subtyping results of majority of the viruses (83%-97.9%) were correctly determined for the partial pol sequences. All 10 major DRMs in seven isolates were detected at these six sites. The complete pol gene sequence was also obtained by NGS at one site. However, this method missed six group M viruses and sequences contained host chromosome fragments. Three group O viruses were only characterized with additional group O-specific RT-PCR primers employed by one site. These results indicate that PCR protocols and subtyping tools should be standardized to efficiently amplify diverse viruses and more consistently assign virus genotypes, which is critical for accurate global subtype and drug resistance surveillance. Targeted NGS analysis of partial pol sequences can serve as an alternative approach, especially for detection of low-abundance DRMs.	[Hora, Bhavna; Chen, Yue; Sanchez, Ana M.; Denny, Thomas N.; Gao, Feng] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Hora, Bhavna; Chen, Yue; Sanchez, Ana M.; Denny, Thomas N.; Gao, Feng] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Keating, Sheila M.; Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA; [Keating, Sheila M.; Busch, Michael P.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Sabino, Ester] Inst Trop Med, Sao Paulo, Brazil; [Hunt, Gillian; Ledwaba, Johanna] Natl Inst Communicable Dis, Johannesburg, South Africa; [Hackett, John, Jr.; Swanson, Priscilla] Abbott Labs, Infect Dis Res, Abbott Pk, IL 60064 USA; [Hewlett, Indira; Ragupathy, Viswanath; Vemula, Sai Vikram] Food & Drug Adm, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Zeng, Peibin] Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Peoples R China; [Tee, Kok-Keng; Chow, Wei Zhen] Univ Malaya, Fac Med, Dept Med Microbiol, Ctr Excellence Res AIDS, Kuala Lumpur, Malaysia; [Ji, Hezhao; Sandstrom, Paul] Publ Hlth Agcy Canada, JC Wilt Infect Dis Res Ctr, Natl HIV & Retrovirol Labs, Winnipeg, MB, Canada	Duke University; Duke University; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; National Institute for Communicable Diseases (NICD); Abbott Laboratories; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; Universiti Malaya; Public Health Agency of Canada	Gao, F (corresponding author), Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA.; Gao, F (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.; Busch, MP (corresponding author), Blood Syst Res Inst, San Francisco, CA USA.; Busch, MP (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	mbusch@bloodsystems.org; fgao@duke.edu	Tee, Kok Keng/A-8148-2008; Ragupathy, Viswanath/ABA-3444-2021; Sabino, Ester C/F-7750-2010	Tee, Kok Keng/0000-0002-7923-5448; Sabino, Ester C/0000-0003-2623-5126; Keating, Sheila/0000-0002-8324-3694; Ji, Hezhao/0000-0002-5451-6294; Ledwaba, Johanna/0000-0003-4727-1601	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for External Quality Assurance Program Oversight Laboratory (EQAPOL) [HHSN272201000045C, HHSN272200800014C]; National Heart, Lung, and Blood Institute (NHLBI), NIH [HHSN268201100001I, HHSN268201100007I, HSN268201100008I, HHSN268201100009I]; Global HIV panel project [DAIDS IAA - Y1-HB-5026-01];  [UM.C/625/1/HIR/MOE/CHAN/02/02]	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for External Quality Assurance Program Oversight Laboratory (EQAPOL); National Heart, Lung, and Blood Institute (NHLBI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Global HIV panel project; 	This study was supported by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for External Quality Assurance Program Oversight Laboratory (EQAPOL) (HHSN272201000045C and HHSN272200800014C), the National Heart, Lung, and Blood Institute (NHLBI), NIH for funding for the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) (HHSN268201100001I, HHSN268201100007I, HSN268201100008I and HHSN268201100009I), Global HIV panel project (DAIDS IAA - Y1-HB-5026-01) and the High Impact Research grant for KKT (UM.C/625/1/HIR/MOE/CHAN/02/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Abbott Laboratories did not play a role in the study design, decision to publish or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials.	Aldrich C, 2012, TRENDS MOL MED, V18, P691, DOI 10.1016/j.molmed.2012.06.004; Alencar CS, 2013, JAIDS-J ACQ IMM DEF, V63, P387, DOI 10.1097/QAI.0b013e31828ff979; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Berg Michael G, 2016, J Clin Microbiol, V54, P868, DOI 10.1128/JCM.02479-15; Bourlet T, 2011, J CLIN MICROBIOL, V49, P292, DOI 10.1128/JCM.01688-10; Chudy M, 2012, TRANSFUSION, V52, P431, DOI 10.1111/j.1537-2995.2011.03281.x; Delwart E, 2012, J INFECT DIS, V205, P875, DOI 10.1093/infdis/jir862; Fernandez-Garcia A, 2010, AIDS RES HUM RETROV, V26, P827, DOI 10.1089/aid.2009.0311; Foley B., 2013, HIV SEQUENCE COMPEND; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Geretti AM, 2009, CLIN INFECT DIS, V48, P1296, DOI 10.1086/598502; Hemelaar J, 2013, J INFECTION, V66, P391, DOI 10.1016/j.jinf.2012.10.026; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Ji H., 2015, 8 INT AIDS SOC C HIV; Kantor R, 2006, CURR OPIN INFECT DIS, V19, P594, DOI 10.1097/QCO.0b013e3280109122; Klein Marina B, 2014, CMAJ Open, V2, pE318, DOI 10.9778/cmajo.20140017; Kleinman S, 2014, TRANSFUSION, V54, P942, DOI 10.1111/trf.12468; Luk KC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141723; Martinez-Cajas JL, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-11; Martinez-Cajas JL, 2008, AIDS REV, V10, P212; Mor O, 2015, J CLIN MICROBIOL, V53, P3458, DOI 10.1128/JCM.01806-15; Muller B, 2013, TRANSFUSION, V53, P2422, DOI 10.1111/trf.12298; Nair SV, 2016, J CLIN VIROL, V77, P46, DOI 10.1016/j.jcv.2016.02.002; Paraskevis D, 2013, AIDS RES HUM RETROV, V29, P461, DOI [10.1089/aid.2012.0143, 10.1089/AID.2012.0143]; Pasquier C, 2001, J VIROL METHODS, V94, P45, DOI 10.1016/S0166-0934(01)00272-5; Peeters M, 2010, CLIN MICROBIOL INFEC, V16, P1525, DOI 10.1111/j.1469-0691.2010.03300.x; Perez L, 2006, AIDS RES HUM RETROV, V22, P724, DOI 10.1089/aid.2006.22.724; Pessoa R, 2015, TRANSFUSION, V55, P980, DOI 10.1111/trf.12936; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Sanchez AM, 2014, J IMMUNOL METHODS, V409, P117, DOI 10.1016/j.jim.2014.01.004; Santos AF, 2010, VIRUSES-BASEL, V2, P503, DOI 10.3390/v2020503; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Shapland EB, 2015, ACS SYNTH BIOL, V4, P860, DOI 10.1021/sb500362n; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Sierra M, 2007, JAIDS-J ACQ IMM DEF, V45, P151, DOI 10.1097/QAI.0b013e318046ea47; Singh K, 2014, VIRUSES-BASEL, V6, P3535, DOI 10.3390/v6093535; Sutherland KA, 2015, J ANTIMICROB CHEMOTH, V70, P243, DOI 10.1093/jac/dku365; Tatem AJ, 2012, AIDS, V26, P2351, DOI 10.1097/QAD.0b013e328359a904; Touloumi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071174; Vallari A, 2011, J VIROL, V85, P1403, DOI 10.1128/JVI.02005-10; Vidal N, 2006, AIDS RES HUM RETROV, V22, P182, DOI 10.1089/aid.2006.22.182	43	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157340	10.1371/journal.pone.0157340	http://dx.doi.org/10.1371/journal.pone.0157340			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314585	gold, Green Published, Green Submitted			2022-12-26	WOS:000378030000020
J	Laspas, P; Culmann, PD; Grus, FH; Prokosch-Willing, V; Poplawksi, A; Pfeiffer, N; Hoffmann, EM				Laspas, Panagiotis; Culmann, Philipp David; Grus, Franz Hermann; Prokosch-Willing, Verena; Poplawksi, Alicia; Pfeiffer, Norbert; Hoffmann, Esther Maria			A New Method for Revision of Encapsulated Blebs after Trabeculectomy: Combination of Standard Bleb Needling with Transconjunctival Scleral Flap Sutures Prevents Early Postoperative Hypotony	PLOS ONE			English	Article							LONG-TERM OUTCOMES; MITOMYCIN-C; MACULOPATHY; MORPHOLOGY; INJECTION; EFFICACY; SAFETY	Purpose A simple needling procedure is the standard method for restoring the function of an encapsulated bleb after trabeculectomy. However, postoperative hypotony represents a possible hazard. This study describes a new surgical approach for treating encapsulated blebs with reduced risk of early postoperative hypotony: bleb needling combined with transconjunctival sutures tightening the scleral flap directly. Methods The study included two groups of 23 patients with failing bleb following trabeculectomy: "Group 1" underwent simple needling revision of the filtering bleb and served as a control group, while "Group 2" received needling revision with additional transconjunctival scleral flap sutures, if intraoperatively the intraocular pressure was estimated to be very low. Intraocular pressure (IOP), postoperative management and complications were analyzed over a follow-up period of 4 weeks postoperatively. Results were compared using t-test or Mann-Whitney U-tests. Results Adverse effects occurred with a higher frequency after sole needling of the bleb (5 cases of choroidal effusion and 1 case of choroidal hemorrhage) than after the combined method with additional scleral sutures (1 case of choroidal effusion). The IOP on the first postoperative day was significantly lower in group 1, with 9.43 +/- 9.01 mm Hg vs. 16.43 +/- 8.35 mm Hg in group 2 (P = 0.01). Ten patients with ocular hypotony (IOD of 5 mmHg or lower) were found in group 1 and only two in group 2. One week and one month after surgery the intraocular pressure was similar in both groups (P>0.05). Conclusions This new needling technique with additional transconjunctival scleral flap sutures appears to reduce postoperative hypotony, and may thus protect from further complications, such as subchoroidal hemorrhage.	[Laspas, Panagiotis; Culmann, Philipp David; Grus, Franz Hermann; Prokosch-Willing, Verena; Poplawksi, Alicia; Pfeiffer, Norbert; Hoffmann, Esther Maria] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Laspas, P (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany.	panoslaspas@gmail.com	Hoffmann, Esther/AAY-3575-2020; Hoffmann, Esther/AAO-5968-2021; Pfeiffer, Norbert/AAO-7586-2020; Poplawski, Alicia/U-4910-2019	Hoffmann, Esther/0000-0002-0949-4268; Schulze, Alicia/0000-0003-2527-0763				Anand N, 2009, J GLAUCOMA, V18, P513, DOI 10.1097/IJG.0b013e3181911271; Azuara-Blanco A, 1998, SURV OPHTHALMOL, V43, P93, DOI 10.1016/S0039-6257(98)00025-3; Cohen SM, 1995, OPHTHALMIC SURG LAS, V26, P435; De Fendi LI, 2013, CLIN EXP OPHTHALMOL, V41, P798, DOI 10.1111/ceo.12097; Dinah C, 2010, BRIT J OPHTHALMOL, V94, P392, DOI 10.1136/bjo.2009.164160; Eha J, 2013, AM J OPHTHALMOL, V155, P864, DOI 10.1016/j.ajo.2012.12.004; Errico D, 2011, CLIN OPHTHALMOL, V5, P1679, DOI 10.2147/OPTH.S25611; Green E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001132.pub2; Kawai M, 2014, CASE REP OPHTHALM, V5, P297, DOI 10.1159/000368159; Koukkoulli A, 2015, GRAEF ARCH CLIN EXP, V253, P99, DOI 10.1007/s00417-014-2810-4; Letartre L, 2009, CAN J OPHTHALMOL, V44, P567, DOI 10.3129/i09-123; Maestrini HA, 2011, OPHTHALMOLOGY, V118, P755, DOI 10.1016/j.ophtha.2010.08.020; NUYTS RMMA, 1994, AM J OPHTHALMOL, V118, P322, DOI 10.1016/S0002-9394(14)72956-3; Occleston NL, 1997, INVEST OPHTH VIS SCI, V38, P1998; Radhakrishnan S, 2009, OPHTHALMOLOGY, V116, P1713, DOI 10.1016/j.ophtha.2009.04.003; Rotchford AP, 2008, OPHTHALMOLOGY, V115, P1148, DOI 10.1016/j.ophtha.2007.10.023; Rulli E, 2013, JAMA OPHTHALMOL, V131, P1573, DOI 10.1001/jamaophthalmol.2013.5059; Schwenn O, 2001, J GLAUCOMA, V10, P85, DOI 10.1097/00061198-200104000-00003; Shafi F, 2011, CAN J OPHTHALMOL, V46, P537, DOI 10.1016/j.jcjo.2011.09.005; SHERWOOD MB, 1987, ARCH OPHTHALMOL-CHIC, V105, P1517, DOI 10.1001/archopht.1987.01060110063032	20	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157320	10.1371/journal.pone.0157320	http://dx.doi.org/10.1371/journal.pone.0157320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314495	Green Published, Green Submitted, gold			2022-12-26	WOS:000378030000019
J	Recha-Sancho, L; Semino, CE				Recha-Sancho, Lourdes; Semino, Carlos E.			Chondroitin Sulfate- and Decorin-Based Self-Assembling Scaffolds for Cartilage Tissue Engineering	PLOS ONE			English	Article							MOUSE EMBRYONIC FIBROBLASTS; MESENCHYMAL STEM-CELLS; IN-VITRO; CHONDROCYTES; HYDROGEL; MATRIX; REPAIR; DEFECTS; BONE; DIFFERENTIATION	Cartilage injury and degenerative tissue progression remain poorly understood by the medical community. Therefore, various tissue engineering strategies aim to recover areas of damaged cartilage by using non-traditional approaches. To this end, the use of biomimetic scaffolds for recreating the complex in vivo cartilage microenvironment has become of increasing interest in the field. In the present study, we report the development of two novel biomaterials for cartilage tissue engineering (CTE) with bioactive motifs, aiming to emulate the native cartilage extracellular matrix (ECM). We employed a simple mixture of the self-assembling peptide RAD16-I with either Chondroitin Sulfate (CS) or Decorin molecules, taking advantage of the versatility of RAD16-I. After evaluating the structural stability of the bi-component scaffolds at a physiological pH, we characterized these materials using two different in vitro assessments: re-differentiation of human articular chondrocytes (AC) and induction of human adipose derived stem cells (ADSC) to a chondrogenic commitment. Interestingly, differences in cellular morphology and viability were observed between cell types and culture conditions (control and chondrogenic). In addition, both cell types underwent a chondrogenic commitment under inductive media conditions, and this did not occur under control conditions. Remarkably, the synthesis of important ECM constituents of mature cartilage, such as type II collagen and proteoglycans, was confirmed by gene and protein expression analyses and toluidine blue staining. Furthermore, the viscoelastic behavior of ADSC constructs after 4 weeks of culture was more similar to that of native articular cartilage than to that of AC constructs. Altogether, this comparative study between two cell types demonstrates the versatility of our novel biomaterials and suggests a potential 3D culture system suitable for promoting chondrogenic differentiation.	[Recha-Sancho, Lourdes; Semino, Carlos E.] Ramon Llull Univ, IQS Sch Engn, Dept Bioengn, Tissue Engn Lab, Barcelona, Spain	Universitat Ramon Llull; Institut Quimic de Sarria	Semino, CE (corresponding author), Ramon Llull Univ, IQS Sch Engn, Dept Bioengn, Tissue Engn Lab, Barcelona, Spain.	carlos.semino@iqs.url.edu	Semino, Carlos/AAF-2298-2019		AO Foundation in Acute Cartilage Injury Collaborative Research Program (ACI CRP) under the project "Bioactive and biomimetic scaffolds for cartilage regeneration" (BIOCART); "Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement" of Catalan Government; Fons Socials Europeus [2015FI_B2 00109]	AO Foundation in Acute Cartilage Injury Collaborative Research Program (ACI CRP) under the project "Bioactive and biomimetic scaffolds for cartilage regeneration" (BIOCART); "Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement" of Catalan Government; Fons Socials Europeus	This research was supported by funding from the AO Foundation in Acute Cartilage Injury Collaborative Research Program (ACI CRP) under the project "Bioactive and biomimetic scaffolds for cartilage regeneration" (BIOCART). The authors thank "Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement" of Catalan Government and "Fons Socials Europeus" for the pre-doctoral fellowship 2015FI_B2 00109 to Lourdes Recha Sancho.; This research was supported by funding from the AO Foundation in Acute Cartilage Injury Collaborative Research Program(ACI CRP) under the project "Bioactive and biomimetic scaffolds for cartilage regeneration" (BIOCART). We thank "Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement" of Catalan Government and "Fons Socials Europeus" for the pre-doctoral fellowship 2015FI_B2 00109 to Lourdes Recha Sancho. We also thank the Materials Science Laboratory of the IQS-School of Engineering for kindly helping us with the DMA analysis and Scientific and Technological Centers of Barcelona University for SEM services. Additionally, we thank Maria Pilar Armengol from the Genomic Unit of the IGTP for her help with quantitative PCR.	Alemany-Ribes M, 2014, ADV DRUG DELIVER REV, V79-80, P40, DOI 10.1016/j.addr.2014.06.004; Alemany-Ribes M, 2013, TISSUE ENG PT A, V19, P1665, DOI [10.1089/ten.TEA.2012.0661, 10.1089/ten.tea.2012.0661]; Baghaban Eslaminejad Mohamadreza, 2014, World J Stem Cells, V6, P344, DOI 10.4252/wjsc.v6.i3.344; Bauge C, 2014, AGING DIS, V5, P394, DOI 10.14336/AD.2014.0500394; Bobick BE, 2009, BIRTH DEFECTS RES C, V87, P351, DOI 10.1002/bdrc.20167; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Bussmann B.M., 2013, J TISSUE ENG REGEN M; Cals FLJ, 2012, J TISSUE ENG REGEN M, V6, P68, DOI 10.1002/term.399; Castells-Sala C, 2012, IEEE ENG MED BIO, P5658, DOI 10.1109/EMBC.2012.6347278; Castells-sala C, 2013, BIOCHIPS TISSUE CHIP, DOI [10.4172/2153-0777.S2-004, DOI 10.4172/2153-0777.S2-004]; Chen WC, 2011, J BIOSCI BIOENG, V111, P226, DOI 10.1016/j.jbiosc.2010.10.002; Chiang HS, 2009, J FORMOS MED ASSOC, V108, P87, DOI 10.1016/S0929-6646(09)60039-5; Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008; Fernandez-Muinos T, 2015, ACTA BIOMATER, V16, P35, DOI 10.1016/j.actbio.2015.01.008; Fernandez-Muinos T, 2014, TISSUE ENG PT A, V20, P1145, DOI 10.1089/ten.tea.2013.0369; Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215; Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012; Genove E, 2009, J CELL MOL MED, V13, P3387, DOI 10.1111/j.1582-4934.2009.00970.x; Girotto D, 2003, BIOMATERIALS, V24, P3265, DOI 10.1016/S0142-9612(03)00160-1; Grad S, 2006, EFFECTS SIMPLE COMPL, P12; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hubka KM, 2014, TISSUE ENG PART B-RE, V20, P641, DOI [10.1089/ten.teb.2014.0034, 10.1089/ten.TEB.2014.0034]; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Jeng L, 2011, PRINCIPLES OF REGENERATIVE MEDICINE, 2ND EDITION, P761, DOI 10.1016/B978-0-12-381422-7.10042-2; Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18; Keeney M, 2011, CURR OPIN BIOTECH, V22, P734, DOI 10.1016/j.copbio.2011.04.003; Kim M, 2011, BIOMATERIALS, V32, P7883, DOI 10.1016/j.biomaterials.2011.07.015; Kopesky PW, 2010, SELF ASSEMBLING PEPT, P16; LaPorta TF, 2012, ORTHOP CLIN N AM, V43, P245, DOI 10.1016/j.ocl.2012.02.002; Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016; LEFEBVRE V, 1990, BIOCHIM BIOPHYS ACTA, V1051, P266, DOI 10.1016/0167-4889(90)90132-W; Mari-Buye N, 2013, TISSUE ENG PT A, V19, P870, DOI [10.1089/ten.tea.2012.0077, 10.1089/ten.TEA.2012.0077]; Merceron C, 2008, JOINT BONE SPINE, V75, P672, DOI 10.1016/j.jbspin.2008.07.007; Miot S, 2005, BIOMATERIALS, V26, P2479, DOI 10.1016/j.biomaterials.2004.06.048; Mullen LM, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5325-y; Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quinatana L, 2009, TISSUE ENG PT A, V15, P45, DOI 10.1089/ten.tea.2007.0296; Recha-Sancho L, 2016, J BIOMED MATER RES P; Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#; Seidler DG, 2008, IUBMB LIFE, V60, P729, DOI 10.1002/iub.115; Semino CE, 2008, J DENT RES, V87, P606, DOI 10.1177/154405910808700710; Semino CE, 2003, J BIOMED BIOTECHNOL, P164, DOI 10.1155/S1110724303208019; Semino CE, 2004, TISSUE ENG PART, V10; Sieminski AL, 2007, CELL BIOCHEM BIOPHYS, V49, P73, DOI 10.1007/s12013-007-0046-1; Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241; Tiedemann K, 2005, GLYCOBIOLOGY, V15, P1277, DOI 10.1093/glycob/cwj027; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806; Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002; Vater C, 2011, ACTA BIOMATER, V7, P463, DOI 10.1016/j.actbio.2010.07.037; Wu Jonathan, 2010, Journal of Nanobiotechnology, V8, P29, DOI 10.1186/1477-3155-8-29	53	25	26	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157603	10.1371/journal.pone.0157603	http://dx.doi.org/10.1371/journal.pone.0157603			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315119	Green Published, Green Submitted, gold			2022-12-26	WOS:000378030000040
J	Custodio, IDD; Marinho, ED; Gontijo, CA; Pereira, TSS; Paiva, CE; Maia, YCD				Dias Custodio, Isis Danyelle; Marinho, Eduarda da Costa; Gontijo, Cristiana Araujo; Silva Pereira, Taisa Sabrina; Paiva, Carlos Eduardo; de Paiva Maia, Yara Cristina			Impact of Chemotherapy on Diet and Nutritional Status of Women with Breast Cancer: A Prospective Study	PLOS ONE			English	Article							HEALTHY EATING INDEX; PHYSICAL-ACTIVITY; ENERGY-INTAKE; WEIGHT CHANGE; QUALITY; INFLAMMATION; OBESITY; SURVIVORS; RISK; GAIN	Certain food groups are often rejected during chemotherapy (CT) due to the side effects of treatment, which may interfere with adequate diet and nutritional status. The aim of this study was to evaluate the treatment impact on the diet and nutritional status of women with breast cancer (BC). In this prospective longitudinal study, conducted in 2014-2015, 55 women diagnosed with BC, with a mean age 51.5 +/- 10.1 years, were followed and data were collected at three different times. Anthropometric and dietary assessments were performed, the latter by applying nine 24h dietary recalls, by using the Brazilian Healthy Eating Index Revised (BHEI-R), and calculating the prevalence of inadequacy by the EAR cut-off point method. Regarding the BHEI-R analysis, the majority of women had a "diet requires modification', both at the beginning (T0, 58.2%, n = 32) and during treatment (T1, 54.5%, n = 30). However, after the end of the CT, the greater percentage of patients (T2, 49.1%, n = 27) were classified as having an "inadequate diet", since the Total Fruit consumption as well as the Dark Green and Orange Vegetable and Legume consumption decreased significantly during treatment (p = 0.043 and p = 0.026, respectively). There was a significant reduction in the intake of macro and micronutrients, with a high prevalence of inadequacy, of up to 100%, for calcium, iron, phosphorus, magnesium, niacin, riboflavin, thiamin, vitamin B6, vitamin C and zinc. Assessment of the nutritional status indicated that 56% (n = 31) of patients were overweight at these three different times. Weight, BMI and Waist Circumference increased significantly, indicating a worse nutritional status, and there was a correlation between poor diet quality and higher values for BMI, Waist-Hip Ratio and Waist-to-Height Ratio. Chemotherapy interferes in the patients' diet generating a negative impact on the quality and intake of micro and macronutrients, as well as an impact on their nutritional status, with an increase in anthropometric measurements.	[Dias Custodio, Isis Danyelle; Marinho, Eduarda da Costa; Gontijo, Cristiana Araujo; de Paiva Maia, Yara Cristina] Univ Fed Uberlandia, Grad Program Hlth Sci, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil; [Silva Pereira, Taisa Sabrina] Univ Fed Espirito Santo, Grad Program Publ Hlth, Vitoria, ES, Brazil; [Paiva, Carlos Eduardo] Barretos Canc Hosp, Dept Clin Oncol, Grad Program Oncol, Palliat Care & Qual Life Res Grp GPQual,Pio Fdn 1, Barretos, SP, Brazil	Universidade Federal de Uberlandia; Universidade Federal do Espirito Santo; Hospital de Cancer de Barretos	Maia, YCD (corresponding author), Univ Fed Uberlandia, Grad Program Hlth Sci, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	yara.maia@ufu.br	Maia, Yara/AAT-8314-2020; Pereira, Taísa Sabrina Silva/AAB-3715-2021; Gontijo, Cristiana Araújo/AAP-8315-2020; Paiva, Carlos E/F-4810-2012; Gontijo, Cristiana/AAI-2118-2019	Pereira, Taísa Sabrina Silva/0000-0002-5922-7424; Gontijo, Cristiana Araújo/0000-0002-0957-273X; Paiva Maia, Yara Cristina de/0000-0001-9169-5028; Paiva, Carlos Eduardo/0000-0002-7934-1451; Custodio, Isis Danyelle Dias/0000-0003-2741-5110	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil (CNPq) [449938/2014-0]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Fundacao PIO XII	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao PIO XII	This study received financial support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil (CNPq Grant number: 449938/2014-0), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and to Fundacao PIO XII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches MV, 2011, EUR J CANCER PREV, V20, P403, DOI 10.1097/CEJ.0b013e328347618e; Ahmed Syed Danish Haseen, 2015, Asian Pac J Cancer Prev, V16, P4945; Ambrosi C, 2011, REV BRAS GINECOL OBS, V33, P207, DOI 10.1590/S0100-72032011000800007; [Anonymous], 1995, PHYS STAT US INT ANT; [Anonymous], 2011, TAB BRAS COMP AL; Arnold M, 2015, LANCET ONCOL, V16, P36, DOI 10.1016/S1470-2045(14)71123-4; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Aune D, 2012, BREAST CANCER RES TR, V134, P479, DOI 10.1007/s10549-012-2118-1; Azim HA, 2011, ANN ONCOL, V22, P1939, DOI 10.1093/annonc/mdq683; Beasley JM, 2011, BREAST CANCER RES TR, V128, P229, DOI 10.1007/s10549-010-1323-z; BEATON GH, 1994, AM J CLIN NUTR, V59, p253S, DOI 10.1093/ajcn/59.1.253S; Bell KE, 2014, CLIN NUTR, V33, P550, DOI 10.1016/j.clnu.2013.08.001; Boltong A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103512; Brasil. Ministerio da Saude (MS), 2015, VIG BRAS 2014 VIG FA; Brasil. Ministerio da Saude. Secretaria de Atsencao a Saude. Coordenacao-Geral da Politica de Alimentacao e Nutricao, 2006, GUIA AL POP BRAS PRO; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Ceccatto V, 2014, NUTR HOSP, V30, P1101, DOI 10.3305/nh.2014.30.5.7439; Chen XL, 2011, NUTR CANCER, V63, P538, DOI 10.1080/01635581.2011.539316; de Andrade SC, 2013, REV SAUDE PUBL, V47, P675, DOI 10.1590/S0034-8910.2013047004267; Eilat-Adar S, 2013, NUTRIENTS, V5, P3646, DOI 10.3390/nu5093646; Fabian CJ, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0571-6; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fisberg Regina Mara, 2004, Rev. Nutr., V17, P301, DOI 10.1590/S1415-52732004000300003; Food and Agriculture Organization [FAO], 2010, FAO FOOD NUTR PAPER; George SM, 2014, CANCER EPIDEM BIOMAR, V23, P575, DOI 10.1158/1055-9965.EPI-13-1162; George SM, 2011, CANCER CAUSE CONTROL, V22, P589, DOI 10.1007/s10552-011-9732-9; George SM, 2010, CANCER EPIDEM BIOMAR, V19, P2220, DOI 10.1158/1055-9965.EPI-10-0464; Guenther PM, 2007, DEV EVALUATION HLTH, P1; Howe LR, 2013, CLIN CANCER RES, V19, P6074, DOI 10.1158/1078-0432.CCR-12-2603; INCA, 2015, EST 2016 INC CANC BR; IOM, 1997, DIET REF INT TABL AP; Irwin ML, 2004, MED SCI SPORT EXER, V36, P1484, DOI 10.1249/01.MSS.0000074670.03001.98; Izano MA, 2013, NUTR CANCER, V65, P820, DOI 10.1080/01635581.2013.804939; Karimi Z, 2014, PUBLIC HEALTH NUTR, V17, P1098, DOI 10.1017/S1368980013001018; KENNEDY ET, 1995, J AM DIET ASSOC, V95, P1103, DOI 10.1016/S0002-8223(95)00300-2; Kim EHJ, 2011, NUTR CANCER, V63, P381, DOI 10.1080/01635581.2011.535963; Kottschade L, 2016, SUPPORT CARE CANCER, V24, P2661, DOI 10.1007/s00520-016-3080-y; Kwan ML, 2009, J CLIN ONCOL, V27, P919, DOI 10.1200/JCO.2008.19.4035; Kwok A, 2015, SUPPORT CARE CANCER, V23, P1561, DOI 10.1007/s00520-014-2496-5; LIPSCHITZ DA, 1994, PRIMARY CARE, V21, P55; Milliron BJ, 2014, J ACAD NUTR DIET, V114, P932, DOI 10.1016/j.jand.2013.08.015; Mourouti N, 2015, INT J FOOD SCI NUTR, V66, P1, DOI 10.3109/09637486.2014.950207; Nusser SM, 1996, J AM STAT ASSOC, V91, P1440, DOI 10.2307/2291570; Nusser SM, 1995, 6 IOW STAT U CTR AGR, P1; Patnaik JL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2901; Patterson RE, 2011, J NUTR, V141, P201, DOI 10.3945/jn.110.128777; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Previdelli AN, 2011, REV SAUDE PUBL, V45, P794, DOI 10.1590/S0034-89102011005000035; Qiu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036497; Rockenbach G, 2011, NUTR HOSP, V26, P737, DOI [10.1590/S0212-16112011000400011, 10.3305/nh.2011.26.4.5067]; San Felipe MJR, 2013, NUTR HOSP, V28, P1829, DOI [10.3305/nh.2013.28.6.6981, 10.3305/nutr hosp.v28in06.6981]; Shivappa N, 2015, BRIT J CANCER, V113, P1099, DOI 10.1038/bjc.2015.304; Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1689, DOI 10.1017/S1368980013002115; Tredan O, 2010, CLIN NUTR, V29, P187, DOI 10.1016/j.clnu.2009.08.003; *USDA, 2005, DIET GUID AM; Vance V, 2011, OBES REV, V12, P282, DOI 10.1111/j.1467-789X.2010.00805.x; Vance V, 2014, APPL PHYSIOL NUTR ME, V39, P707, DOI 10.1139/apnm-2013-0400; Velentzis LS, 2011, BREAST CANCER RES TR, V128, P473, DOI 10.1007/s10549-010-1238-8; Wayne SJ, 2006, BREAST CANCER RES TR, V96, P227, DOI 10.1007/s10549-005-9018-6; WCRF World Cancer Research Fund, 2014, DIET NUTR PHYS ACT B; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Yaw YH, 2014, ASIAN PAC J CANCER P, V15, P39, DOI 10.7314/APJCP.2014.15.1.39; Zuniga K. E., 2015, EUR J NUTR, P1	66	43	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157113	10.1371/journal.pone.0157113	http://dx.doi.org/10.1371/journal.pone.0157113			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310615	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800035
J	Karamitros, T; Harrison, I; Piorkowska, R; Katzourakis, A; Magiorkinis, G; Mbisa, JL				Karamitros, Timokratis; Harrison, Ian; Piorkowska, Renata; Katzourakis, Aris; Magiorkinis, Gkikas; Mbisa, Jean Lutamyo			De Novo Assembly of Human Herpes Virus Type 1 (HHV-1) Genome, Mining of Non-Canonical Structures and Detection of Novel Drug-Resistance Mutations Using Short- and Long-Read Next Generation Sequencing Technologies	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; COMPLETE DNA-SEQUENCE; SIMPLEX-VIRUS; THYMIDINE KINASE; GENITAL HERPES; VARIABILITY; ALIGNMENT; REPEAT; EVOLUTION; MUTANTS	Human herpesvirus type 1 (HHV-1) has a large double-stranded DNA genome of approximately 152 kbp that is structurally complex and GC-rich. This makes the assembly of HHV-1 whole genomes from short-read sequencing data technically challenging. To improve the assembly of HHV-1 genomes we have employed a hybrid genome assembly protocol using data from two sequencing technologies: the short-read Roche 454 and the long-read Oxford Nanopore MinlON sequencers. We sequenced 18 HHV-1 cell culture-isolated clinical specimens collected from immunocompromised patients undergoing antiviral therapy. The susceptibility of the samples to several antivirals was determined by plaque reduction assay. Hybrid genome assembly resulted in a decrease in the number of contigs in 6 out of 7 samples and an increase in N(G) 50 and N(G) 75 of all 7 samples sequenced by both technologies. The approach also enhanced the detection of non-canonical contigs including a rearrangement between the unique (UL) and repeat (T/IRL) sequence regions of one sample that was not detectable by assembly of 454 reads alone. We detected several known and novel resistance-associated mutations in UL23 and UL30 genes. Genome-wide genetic variability ranged from <1% to 53% of amino acids in each gene exhibiting at least one substitution within the pool of samples. The UL23 gene had one of the highest genetic variabilities at 35.2% in keeping with its role in development of drug resistance. The assembly of accurate, full-length HHV-1 genomes will be useful in determining genetic determinants of drug resistance, virulence, pathogenesis and viral evolution. The numerous, complex repeat regions of the HHV-1 genome currently remain a barrier towards this goal.	[Karamitros, Timokratis; Katzourakis, Aris; Magiorkinis, Gkikas] Univ Oxford, Dept Zool, S Parks Rd, Oxford, England; [Harrison, Ian; Piorkowska, Renata; Magiorkinis, Gkikas; Mbisa, Jean Lutamyo] Publ Hlth England, Natl Infect Serv, Virus Reference Dept, London, England	University of Oxford; Public Health England	Magiorkinis, G (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford, England.; Magiorkinis, G; Mbisa, JL (corresponding author), Publ Hlth England, Natl Infect Serv, Virus Reference Dept, London, England.	gkikas.magiorkinis@zoo.ox.ac.uk; tamyo.mbisa@phe.gov.uk	Karamitros, Timokratis/ABE-3880-2021	Karamitros, Timokratis/0000-0003-0841-9159; Katzourakis, Aris/0000-0003-3328-6204; Mbisa, Jean/0000-0002-0348-9679	Public Health England (PHE) Pump-Priming & Small Initiatives Fund; Medical Research Council (MRC) grant [MR/K010565/1]; MRC [MR/K010565/1] Funding Source: UKRI; Medical Research Council [MR/K010565/1] Funding Source: researchfish	Public Health England (PHE) Pump-Priming & Small Initiatives Fund; Medical Research Council (MRC) grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was partly supported by a Public Health England (PHE) Pump-Priming & Small Initiatives Fund to JLM and by a Medical Research Council (MRC) grant [MR/K010565/1] to GM. The views expressed are those of the authors and not necessarily those of PHE, the Department of Health or MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrei G, 2013, CURR OPIN INFECT DIS, V26, P551, DOI 10.1097/QCO.0000000000000015; Andrei G, 2013, J INFECT DIS, V207, P1295, DOI 10.1093/infdis/jit019; Ashton PM, 2015, NAT BIOTECHNOL, V33, P296, DOI 10.1038/nbt.3103; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chayavichitsilp P, 2009, PEDIATR REV, V30, P119, DOI 10.1542/pir.30-4-119; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; CHOU J, 1985, CELL, V41, P803, DOI 10.1016/S0092-8674(85)80061-1; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Colgrove RC, 2016, VIROLOGY, V487, P215, DOI 10.1016/j.virol.2015.09.026; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Frith MC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-80; Garceau R, 2012, CAN J INFECT DIS MED, V23; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Harmenberg J, 2010, ACTA DERM-VENEREOL, V90, P122, DOI 10.2340/00015555-0806; JENKINS FJ, 1986, J VIROL, V59, P494, DOI 10.1128/JVI.59.2.494-499.1986; JENKINS FJ, 1990, INTERVIROLOGY, V31, P129, DOI 10.1159/000150147; Johnston C, 2011, J CLIN INVEST, V121, P4600, DOI 10.1172/JCI57148; Kolb AW, 2011, INVEST OPHTH VIS SCI, V52, P9061, DOI 10.1167/iovs.11-7812; Kortekangas-Savolainen O, 2014, SEX TRANSM DIS, V41, P268, DOI 10.1097/OLQ.0000000000000101; Labetoulle M, 2005, OPHTHALMOLOGY, V112, P888, DOI 10.1016/j.ophtha.2004.11.052; LARDER BA, 1985, VIROLOGY, V146, P262, DOI 10.1016/0042-6822(85)90009-1; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Macdonald SJ, 2012, J VIROL, V86, P9540, DOI 10.1128/JVI.01469-12; Macdonald SJ, 2012, J VIROL, V86, P6371, DOI 10.1128/JVI.00646-12; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Mahiet C, 2012, J VIROL, V86, P8592, DOI 10.1128/JVI.00223-12; Mbisa J.L., 2013, ANTIVIRAL RESISTANCE; MCGEOCH DJ, 1986, NUCLEIC ACIDS RES, V14, P1727, DOI 10.1093/nar/14.4.1727; MCGEOCH DJ, 1988, J GEN VIROL, V69, P1531, DOI 10.1099/0022-1317-69-7-1531; Morfin F, 2003, J CLIN VIROL, V26, P29, DOI 10.1016/S1386-6532(02)00263-9; Norberg P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022527; Pielberg Gerli, 2007, V373, P147; Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10; Quick J, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-22; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; SAKAOKA H, 1987, J GEN VIROL, V68, P749, DOI 10.1099/0022-1317-68-3-749; SAKAOKA H, 1995, J MED VIROL, V46, P387, DOI 10.1002/jmv.1890460416; Samra Z, 2003, SEX TRANSM DIS, V30, P794, DOI 10.1097/01.OLQ.0000079517.04451.79; Sauerbrei Andreas, 2010, Virulence, V1, P555, DOI 10.4161/viru.1.6.13806; Schubert A, 2014, ANTIVIR RES, V107, P16, DOI 10.1016/j.antiviral.2014.03.015; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; SMILEY JR, 1990, J VIROL, V64, P5036, DOI 10.1128/JVI.64.10.5036-5050.1990; Szpara ML, 2014, J VIROL, V88, P1209, DOI 10.1128/JVI.01987-13; Szpara ML, 2010, J VIROL, V84, P5303, DOI 10.1128/JVI.00312-10; Takahashi G, 2013, J GEN VIROL, V94, P726, DOI 10.1099/vir.0.044834-0; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Ushijima Y, 2007, MICROBES INFECT, V9, P142, DOI 10.1016/j.micinf.2006.10.019; Warren RL, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0076-3; Watson G, 2012, VIROLOGY, V433, P528, DOI 10.1016/j.virol.2012.08.043; Watson M, 2015, BIOINFORMATICS, V31, P114, DOI 10.1093/bioinformatics/btu590; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Wyles DL, 2005, CLIN INFECT DIS, V41, P676, DOI 10.1086/432477	58	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157600	10.1371/journal.pone.0157600	http://dx.doi.org/10.1371/journal.pone.0157600			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309375	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800105
J	Velez, AM; Khajuria, C; Wang, H; Narva, KE; Siegfried, BD				Velez, Ana Maria; Khajuria, Chitvan; Wang, Haichuan; Narva, Kenneth E.; Siegfried, Blair D.			Knockdown of RNA Interference Pathway Genes in Western Corn Rootworms (Diabrotica virgifera virgifera Le Conte) Demonstrates a Possible Mechanism of Resistance to Lethal dsRNA	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DISTINCT ROLES; ARGONAUTE; INSECTS; DICER-2; GENOME	RNA interference (RNAi) is being developed as a potential tool for insect pest management. Increased understanding of the RNAi pathway in target insect pests will provide information to use this technology effectively and to inform decisions related to resistant management strategies for RNAi based traits. Dicer 2 (Dcr2), an endonuclease responsible for formation of small interfering RNA's and Argonaute 2 (Ago2), an essential catalytic component of the RNA-induced silencing complex (RISC) have both been associated with the RNAi pathway in a number of different insect species including the western corn rootworm, Diabrotica virgifera virgifera (Coleoptera: Chrysomelidae). We identified both genes from a transcriptome library generated from different tissues and developmental stages of the western corn rootworm, an important target pest for transgenic plants expressing dsRNA targeting essential genes. The expression of these genes was suppressed by more than 90% after injecting gene specific dsRNA into adult rootworms. The injected beetles were then fed vATPase A dsRNA which has previously been demonstrated to cause mortality in western corn rootworm adults. The suppression of both RNAi pathway genes resulted in reduced mortality after subsequent exposure to lethal concentrations of vATPase A dsRNA as well as increased vATPase A expression relative to control treatments. Injections with dsRNA for a non-lethal target sequence (Laccase 2) did not affect mortality or expression caused by vATPase A dsRNA indicating that the results observed with Argo and Dicer dsRNA were not caused by simple competition among different dsRNA's. These results confirm that both genes play an important role in the RNAi pathway for western corn rootworms and indicate that selection pressures that potentially affect the expression of these genes may provide a basis for future studies to understand potential mechanisms of resistance.	[Velez, Ana Maria; Khajuria, Chitvan; Wang, Haichuan] Univ Nebraska, Dept Entomol, 103 Entomology Hall, Lincoln, NE 68583 USA; [Narva, Kenneth E.] Dow AgroSci, 9330 Zionsville Rd, Indianapolis, IN 46268 USA; [Siegfried, Blair D.] Univ Florida, Dept Entomol & Nematol, POB 110260, Gainesville, FL 32611 USA	University of Nebraska System; University of Nebraska Lincoln; Dow Chemical Company; State University System of Florida; University of Florida	Siegfried, BD (corresponding author), Univ Florida, Dept Entomol & Nematol, POB 110260, Gainesville, FL 32611 USA.	bsiegfried1@ufl.edu		Velez, Ana Maria/0000-0002-8329-6243; Narva, Kenneth/0000-0001-8094-6418	University of Nebraska; Dow AgroSciences	University of Nebraska; Dow AgroSciences	This study was funded through an Industry Partnership Grant between University of Nebraska and Dow AgroSciences. Dow Agrosciences provided the salary for author KN who participated in study design and manuscript preparation. Dow AgroSciences had no role in the data collection and analysis or in the decision to publish.	Alves AP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14122; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Eyun SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094052; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gassmann AJ, 2012, J INVERTEBR PATHOL, V110, P287, DOI 10.1016/j.jip.2012.04.006; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Miller SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047431; Miyata K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101661; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Rangasamy M, 2012, PEST MANAG SCI, V68, P587, DOI 10.1002/ps.2301; SAS-Institute, 2011, SAS US MAN VERS 9 3; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Siegfried BD., 2012, GENE CONTAINMENT; Song JJ, 2006, CURR OPIN STRUC BIOL, V16, P5, DOI 10.1016/j.sbi.2006.01.010; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Tuschl T, 2001, CHEMBIOCHEM, V2, P239, DOI 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.0.CO;2-R; Zhang XY, 2013, INSECT SCI, V20, P61, DOI 10.1111/j.1744-7917.2012.01539.x	28	27	28	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157520	10.1371/journal.pone.0157520	http://dx.doi.org/10.1371/journal.pone.0157520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310918	Green Published, gold			2022-12-26	WOS:000378029800089
J	Verloigne, M; Cardon, G; De Craemer, M; D'Haese, S; De Bourdeaudhuij, I				Verloigne, Maite; Cardon, Greet; De Craemer, Marieke; D'Haese, Sara; De Bourdeaudhuij, Ilse			Mediating Effects of Self-Efficacy, Benefits and Barriers on the Association between Peer and Parental Factors and Physical Activity among Adolescent Girls with a Lower Educational Level	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; SOCIAL SUPPORT; FEMALE ADOLESCENTS; PERCEIVED BARRIERS; HEALTH; BEHAVIORS; YOUTH; PARTICIPATION; PERCEPTIONS; FITNESS	Background The prevalence of physical activity among lower educated adolescent girls is low, suggesting it is important to have insights into the complex processes that may underlie their physical activity levels. Therefore, this study aimed to examine the mediating effects of self-efficacy, perceived benefits and barriers on the associations between peer and parental variables and physical activity among lower educated adolescent girls. Methods In total, 226 girls (mean age 16.0 +/- 1.0 years; 53% technical education; 47% vocational education) from a convenience sample of 6 secondary schools in Flanders, Belgium, completed a questionnaire on their total physical activity level and related peer and parental variables (i.e. modeling of physical activity, co-participation in physical activities and encouragement to be active) and personal variables (i.e. self-efficacy to be active, and specific perceived benefits of physical activity and specific barriers to be active). Mediating effects were tested using MacKinnon's product-of-coefficients test based on multilevel linear regression analyses. Results Higher peer and parental modeling, co-participation and encouragement were significantly related to a higher physical activity level among adolescent girls (p<0.05). Self-efficacy, the perceived benefits of having fun, being around friends or meeting new people, and not being bored and the perceived barrier of not liking physical activity mediated several associations between peer and parental variables and girls' physical activity, with some of the mediated proportions exceeding 60%. Conclusions This study contributed to a better understanding of the complexity of how parental and peer factors work together with personal factors to influence the physical activity levels of adolescent girls with a lower educational level. Interventions should involve both peers and parents, as they may influence girls' physical activity both directly and indirectly through the internalisation of several personal variables, such as self-efficacy to be active and the perceived benefit of having fun.	[Verloigne, Maite; Cardon, Greet; De Craemer, Marieke; D'Haese, Sara; De Bourdeaudhuij, Ilse] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sports Sci, B-9000 Ghent, Belgium; [Verloigne, Maite; D'Haese, Sara] Res Fdn FWO, Brussels, Belgium	Ghent University	Verloigne, M (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sports Sci, B-9000 Ghent, Belgium.; Verloigne, M (corresponding author), Res Fdn FWO, Brussels, Belgium.	maite.verloigne@ugent.be	De Craemer, Marieke/P-6072-2016; De+Bourdeaudhuij, Ilse/AAC-5528-2019; De Craemer, Marieke/Z-3050-2019	De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; De Craemer, Marieke/0000-0002-5220-7850; Cardon, Greet/0000-0003-4983-6557	Fund for Scientific Research Flanders (FWO) [FWO13/PDO/191, FWO12/ASP/102]	Fund for Scientific Research Flanders (FWO)(FWO)	MV and SDH are supported by a grant from the Fund for Scientific Research Flanders (FWO) (grant numbers: MV: FWO13/PDO/191; SDH: FWO12/ASP/102; www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio M, 2002, BRIT J SPORT MED, V36, P360, DOI 10.1136/bjsm.36.5.360; Arredondo EM, 2014, FAM COMMUNITY HEALTH, V37, P6, DOI 10.1097/FCH.0000000000000015; Beets MW, 2010, HEALTH EDUC BEHAV, V37, P621, DOI 10.1177/1090198110363884; Beets MW, 2006, AM J HEALTH BEHAV, V30, P278, DOI 10.5993/AJHB.30.3.6; Biddle SJH, 2005, J PHYS ACT HEALTH, V2, P423, DOI [DOI 10.1123/JPAH.2.4.423, 10.1123/jpah.2.4.423]; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Camacho-Minano MJ, 2011, HEALTH EDUC RES, V26, P1025, DOI 10.1093/her/cyr040; Cheng KY, 2003, J SPORT MED PHYS FIT, V43, P523; Craggs C, 2011, AM J PREV MED, V40, P645, DOI 10.1016/j.amepre.2011.02.025; De Bourdeaudhuij I, 2002, PREV MED, V34, P279, DOI 10.1006/pmed.2001.0979; De Meester F, 2013, SOC SCI MED, V81, P1, DOI 10.1016/j.socscimed.2013.01.013; Deforche B, 2004, PATIENT EDUC COUNS, V55, P407, DOI 10.1016/j.pec.2003.07.012; Deforche B, 2010, PREV MED, V50, pS24, DOI 10.1016/j.ypmed.2009.08.017; Dishman RK, 2010, J PEDIATR PSYCHOL, V35, P188, DOI 10.1093/jpepsy/jsp042; Dwyer JJM, 2006, ADOLESCENCE, V41, P75; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-50; Elstad JI, 2010, SOC THEOR HEALTH, V8, P134, DOI 10.1057/sth.2009.26; Fortier MS, 2007, PSYCHOL SPORT EXERC, V8, P741, DOI 10.1016/j.psychsport.2006.10.006; Franzini L, 2009, AM J PUBLIC HEALTH, V99, P271, DOI 10.2105/AJPH.2007.128702; Graham DJ, 2014, J PHYS ACT HEALTH, V11, P51, DOI 10.1123/jpah.2011-0239; Haerens L, 2008, EUR J CLIN NUTR, V62, P51, DOI 10.1038/sj.ejcn.1602681; Haug E, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-47; Hsu YW, 2011, J PHYS ACT HEALTH, V8, P210, DOI 10.1123/jpah.8.2.210; Jago R, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-83; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kargarfard M, 2012, PREV MED, V54, P219, DOI 10.1016/j.ypmed.2012.01.010; Kirby J, 2011, J PHYS ACT HEALTH, V8, P785, DOI 10.1123/jpah.8.6.785; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Kremers SPJ, 2010, PATIENT EDUC COUNS, V79, P291, DOI 10.1016/j.pec.2010.03.002; Lubans DR, 2012, ARCH PEDIAT ADOL MED, V166, P821, DOI 10.1001/archpediatrics.2012.41; Lytle LA, 2009, ANN BEHAV MED, V38, P124, DOI 10.1007/s12160-009-9127-2; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Madsen KA, 2009, J PEDIATR-US, V154, P278, DOI 10.1016/j.jpeds.2008.07.044; Mommerency G., 1994, RES REPORT; Morgan A, 2012, HLTH BEHAV SCH AGED; Motl RW, 2007, J PEDIATR PSYCHOL, V32, P6, DOI 10.1093/jpepsy/jsl001; Pender N.J., 1996, HLTH PROMOTION NURSI; Peterson MS, 2013, HEALTH PSYCHOL, V32, P666, DOI 10.1037/a0029129; Philippaerts RM, 2006, INT J SPORTS MED, V27, P131, DOI 10.1055/s-2005-837619; Ransdell LB, 2003, MED SCI SPORT EXER, V35, P286, DOI 10.1249/01.MSS.0000048836.67270.1F; Robbins LB, 2003, J MIDWIFERY WOM HEAL, V48, P206, DOI 10.1016/S1526-9523(03)00054-0; Ruiz-Canela M, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-2; Sallis JF, 2008, HLTH BEHAV HLTH ED T, P464; Sebire SJ, 2014, J PHYS ACT HEALTH, V11, P734, DOI 10.1123/jpah.2012-0034; Sharma SV, 2009, J PHYS ACT HEALTH, V6, P606, DOI 10.1123/jpah.6.5.606; Shaw C., 2011, GUIDELINES RES CHILD; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Spittaels H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-149; Springer AE, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-8; Srof BJ, 2006, NURS SCI QUART, V19, P366, DOI 10.1177/0894318406292831; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Vereecken CA, 2004, J ADOLESCENT HEALTH, V34, P330, DOI 10.1016/j.jadohealth.2003.07.011; Vissers D, 2008, J NUTR EDUC BEHAV, V40, P65, DOI 10.1016/j.jneb.2007.06.010; Voorhees CC, 2005, AM J HEALTH BEHAV, V29, P183, DOI 10.5993/AJHB.29.2.9; Whitehead S, 2008, EUR PHYS EDUC REV, V14, P243, DOI 10.1177/1356336X08090708; Zaragoza J, 2011, J SPORT MED PHYS FIT, V51, P128	57	17	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157216	10.1371/journal.pone.0157216	http://dx.doi.org/10.1371/journal.pone.0157216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27309847	gold, Green Published, Green Submitted			2022-12-26	WOS:000378029800043
J	Jorgensen, EM; Alderman, MH; Taylor, HS				Jorgensen, Elisa M.; Alderman, Myles H., III; Taylor, Hugh S.			Preferential epigenetic programming of estrogen response after in utero xenoestrogen (bisphenol-A) exposure	FASEB JOURNAL			English	Article						endocrine disruptor; methylation; ER binding; uterus	MAMMARY-GLAND; ENDOCRINE DISRUPTORS; REPRODUCTIVE HEALTH; GENE-EXPRESSION; AMNIOTIC-FLUID; BREAST-CANCER; RECEPTOR; HYPERMETHYLATION; MECHANISM; ALTERS	Bisphenol-A (BPA) is an environmentally ubiquitous estrogen-like endocrine-disrupting compound. Exposure to BPA in utero has been linked to female reproductive disorders, including endometrial hyperplasia and breast cancer. Estrogens are an etiological factor in many of these conditions. We sought to determine whether in utero exposure to BPA altered the global CpG methylation pattern of the uterine genome, subsequent gene expression, and estrogen response. Pregnant mice were exposed to an environmentally relevant dose of BPA or DMSO control. Uterine DNA and RNA were examined by using methylated DNA immunoprecipitation methylation microarray, expression microarray, and quantitative PCR. In utero BPA exposure altered the global CpG methylation profile of the uterine genome and subsequent gene expression. The effect on gene expression was not apparent until sexual maturation, which suggested that estrogen response was the primary alteration. Indeed, prenatal BPA exposure preferentially altered adult estrogen-responsive gene expression. Changes in estrogen response were accompanied by altered methylation that preferentially affected estrogen receptor- (ER)-binding genes. The majority of genes that demonstrated both altered expression and ER binding had decreased methylation. BPA selectively altered the normal developmental programming of estrogen-responsive genes via modification of the genes that bind ER. Gene-environment interactions driven by early life xenoestrogen exposure likely contributes to increased risk of estrogen-related disease in adults.Jorgensen, E. M., Alderman, M. H., III, Taylor, H. S. Preferential epigenetic programming of estrogen response after in utero xenoestrogen (bisphenol-A) exposure.	[Jorgensen, Elisa M.; Alderman, Myles H., III; Taylor, Hugh S.] Yale Univ, Sch Med, 333 Cedar St,POB 208063, New Haven, CT 06520 USA	Yale University	Taylor, HS (corresponding author), Yale Univ, Sch Med, 333 Cedar St,POB 208063, New Haven, CT 06520 USA.	hugh.taylor@yale.edu		Alderman III, Myles/0000-0001-8515-1462; Jorgensen, Elisa/0000-0002-6405-867X	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD076422]; NIH National Institute of Environmental Health Sciences [R01-ES010610]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076422] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010610] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Aiping Lin (Department of Biostatistics, Yale University) and Xiaoqing Yu (Department of Public Health, Yale University) for assistance with data analysis. This work was supported by U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant R01-HD076422; and NIH National Institute of Environmental Health Sciences Grant R01-ES010610. Author contributions: E. M. Jorgensen, M. H. Alderman, and H. S. Taylor designed the research, analyzed data, and wrote the paper. E. M. Jorgensen and M. H. Alderman performed the research. The authors declare no conflicts of interest.	Adewale HB, 2009, BIOL REPROD, V81, P690, DOI 10.1095/biolreprod.109.078261; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bromer JG, 2010, FASEB J, V24, P2273, DOI 10.1096/fj.09-140533; Bromer JG, 2009, ENDOCRINOLOGY, V150, P3376, DOI 10.1210/en.2009-0071; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Crain DA, 2008, FERTIL STERIL, V90, P911, DOI 10.1016/j.fertnstert.2008.08.067; Delmas AL, 2011, CARCINOGENESIS, V32, P1625, DOI 10.1093/carcin/bgr193; Doherty Leo F., 2010, Hormones & Cancer, V1, P146, DOI 10.1007/s12672-010-0015-9; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Engel SM, 2006, REPROD TOXICOL, V21, P110, DOI 10.1016/j.reprotox.2005.07.007; FOLKMAN J, 1971, NEW ENGL J MED, V285, P404, DOI 10.1056/NEJM197108122850711; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; Haghnegahdar H, 2000, J LEUKOCYTE BIOL, V67, P53, DOI 10.1002/jlb.67.1.53; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; Hiroi H, 1999, ENDOCR J, V46, P773, DOI 10.1507/endocrj.46.773; Holder AM, 2013, BREAST CANCER RES TR, V137, P319, DOI 10.1007/s10549-012-2354-4; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lakind JS, 2008, J EXPO SCI ENV EPID, V18, P608, DOI 10.1038/jes.2008.20; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maffini MV, 2006, MOL CELL ENDOCRINOL, V254, P179, DOI 10.1016/j.mce.2006.04.033; Markey CM, 2005, BIOL REPROD, V72, P1344, DOI 10.1095/biolreprod.104.036301; Markey CM, 2001, BIOL REPROD, V65, P1215, DOI 10.1093/biolreprod/65.4.1215; Mileva G, 2014, INT J ENV RES PUB HE, V11, P7537, DOI 10.3390/ijerph110707537; Munoz-de-Toro M, 2005, ENDOCRINOLOGY, V146, P4138, DOI 10.1210/en.2005-0340; Newbold RR, 2009, ENVIRON HEALTH PERSP, V117, P879, DOI 10.1289/ehp.0800045; Peretz J, 2014, ENVIRON HEALTH PERSP, V122, P775, DOI 10.1289/ehp.1307728; Peruzzi D, 2009, CLIN CANCER RES, V15, P4104, DOI 10.1158/1078-0432.CCR-08-3226; Rackow BW, 2008, FERTIL STERIL, V89, P1234, DOI [10.1016/j.fertnstert.2007.04.060, 10.1016/j.fertnstert.2007.12.030]; Santoro M, 2004, CELL MOL LIFE SCI, V61, P2954, DOI 10.1007/s00018-004-4276-8; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Sheehan DM, 2000, P SOC EXP BIOL MED, V224, P57, DOI 10.1046/j.1525-1373.2000.22401.x; Takahashi O, 2000, ENVIRON HEALTH PERSP, V108, P931, DOI 10.2307/3435050; Yamada H, 2002, REPROD TOXICOL, V16, P735, DOI 10.1016/S0890-6238(02)00051-5; Yu NF, 2008, CURR MED CHEM, V15, P1350, DOI 10.2174/092986708784567653	37	37	38	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3194	3201		10.1096/fj.201500089R	http://dx.doi.org/10.1096/fj.201500089R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27312807	Green Published			2022-12-26	WOS:000382816300019
J	Holzer, G; Morishita, Y; Fini, JB; Lorin, T; Gillet, B; Hughes, S; Tohme, M; Deleage, G; Demeneix, B; Arvan, P; Laudet, V				Holzer, Guillaume; Morishita, Yoshiaki; Fini, Jean-Baptiste; Lorin, Thibault; Gillet, Benjamin; Hughes, Sandrine; Tohme, Marie; Deleage, Gilbert; Demeneix, Barbara; Arvan, Peter; Laudet, Vincent			Thyroglobulin Represents a Novel Molecular Architecture of Vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; THYROID-HORMONE FORMATION; AMINO-ACID-SEQUENCE; BOVINE THYROGLOBULIN; COMPLEMENTARY-DNA; AMPHIBIAN METAMORPHOSIS; EVOLUTION; PROTEIN; ENDOSTYLE; LAMPREY	Thyroid hormones modulate not only multiple functions in vertebrates (energy metabolism, central nervous system function, seasonal changes in physiology, and behavior) but also in some non-vertebrates where they control critical post-embryonic developmental transitions such as metamorphosis. Despite their obvious biological importance, the thyroid hormone precursor protein, thyroglobulin (Tg), has been experimentally investigated only in mammals. This may bias our view of how thyroid hormones are produced in other organisms. In this study we searched genomic databases and found Tg orthologs in all vertebrates including the sea lamprey (Petromyzon marinus). We cloned a full-size Tg coding sequence from western clawed frog (Xenopus tropicalis) and zebrafish (Danio rerio). Comparisons between the representative mammal, amphibian, teleost fish, and basal vertebrate indicate that all of the different domains of Tg, as well as Tg regional structure, are conserved throughout the vertebrates. Indeed, in Xenopus, zebrafish, and lamprey Tgs, key residues, including the hormonogenic tyrosines and the disulfide bond-forming cysteines critical for Tg function, are well conserved despite overall divergence of amino acid sequences. We uncovered upstream sequences that include start codons of zebrafish and Xenopus Tgs and experimentally proved that these are full-length secreted proteins, which are specifically recognized by antibodies against rat Tg. By contrast, we have not been able to find any orthologs of Tg among non-vertebrate species. Thus, Tg appears to be a novel protein elaborated as a single event at the base of vertebrates and virtually unchanged thereafter.	[Holzer, Guillaume; Lorin, Thibault; Gillet, Benjamin; Hughes, Sandrine; Tohme, Marie; Laudet, Vincent] Univ Lyon 1, Inst Genom Fonct Lyon, Ecole Normale Super Lyon, CNRS,UMR 5242, 46 Allee Italie, F-69364 Lyon 07, France; [Morishita, Yoshiaki; Arvan, Peter] Univ Michigan, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Demeneix, Barbara] Museum Natl Hist Nat, Evolut Regulat Endocriniennes, Dept Regulat Dev & Divers Mol, CNRS,UMR 7221, 7 Rue Cuvier, F-75231 Paris 05, France; [Deleage, Gilbert] Univ Lyon 1, Lab Biol Tissulaire & Ingn Therapeut, Inst Biol & Chim Prot, CNRS,UMR 5086, 7 Passage Vercors, F-69367 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Arvan, P (corresponding author), Brehm Tower,Rm 5112,1000 Wall St, Ann Arbor, MI 48105 USA.; Laudet, V (corresponding author), Observ Oceanol Banyuls Sur Mer, 1 Ave Fontaule, F-66650 Banyuls Sur Mer, France.	parvan@umich.edu; vincent.laudet@obs-banyuls.fr	Morishita, Yoshiaki/AAX-6552-2021; Gillet, Benjamin/ABD-6704-2020; Morishita, Yoshiaki/GWQ-6726-2022; Deléage, Gilbert/F-7163-2010	Morishita, Yoshiaki/0000-0003-4733-7981; Deléage, Gilbert/0000-0003-1939-1614; FINI, Jean-Baptiste/0000-0002-5620-2600; Laudet, Vincent/0000-0003-4022-4175; Holzer, Guillaume/0000-0002-5778-8500	National Institutes of Health [R01 DK40344]; Ecole Normale Superieure de Lyon (ENS); CNRS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040344, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ecole Normale Superieure de Lyon (ENS); CNRS(Centre National de la Recherche Scientifique (CNRS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK40344 (to P. A.). We also thank the Ecole Normale Superieure de Lyon (ENS) and CNRS for financial support. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Arvan P, 1997, THYROID, V7, P89, DOI 10.1089/thy.1997.7.89; Baisse B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-166; BARRINGTON EJW, 1958, J MAR BIOL ASSOC UK, V37, P117, DOI 10.1017/S0025315400014879; Belkadi A, 2012, THYROID RES, V5, DOI 10.1186/1756-6614-5-3; BERG G, 1975, BIOCHIM BIOPHYS ACTA, V386, P422, DOI 10.1016/0005-2795(75)90285-8; Brix K, 1996, ENDOCRINOLOGY, V137, P1963, DOI 10.1210/en.137.5.1963; Brown DD, 1997, P NATL ACAD SCI USA, V94, P13011, DOI 10.1073/pnas.94.24.13011; Brown DD, 2007, DEV BIOL, V306, P20, DOI 10.1016/j.ydbio.2007.03.021; Cortesi F, 2015, P NATL ACAD SCI USA, V112, P1493, DOI 10.1073/pnas.1417803112; Dardente H, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00019; Di Jeso B, 2016, ENDOCR REV, V37, P2, DOI 10.1210/er.2015-1090; Dunn AD, 1998, J BIOL CHEM, V273, P25223, DOI 10.1074/jbc.273.39.25223; DUNN JT, 1975, J BIOL CHEM, V250, P5801; Dunn JT, 1999, BIOCHIMIE, V81, P505, DOI 10.1016/S0300-9084(99)80102-3; DUNN JT, 1987, J BIOL CHEM, V262, P16948; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faber J, 1994, NORMAL TABLE XENOPUS; Fini JB, 2012, ENDOCRINOLOGY, V153, P5068, DOI 10.1210/en.2012-1463; FORMISANO S, 1983, ARCH BIOCHEM BIOPHYS, V227, P351, DOI 10.1016/0003-9861(83)90463-0; Frishman D, 1996, PROTEIN ENG, V9, P133, DOI 10.1093/protein/9.2.133; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gibert Y, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2764; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hiruta J, 2005, DEV DYNAM, V233, P1031, DOI 10.1002/dvdy.20401; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Holzer G, 2015, CURR BIOL, V25, pR344, DOI 10.1016/j.cub.2015.02.026; KIM PS, 1991, J BIOL CHEM, V266, P12412; Kim PS, 2000, MOL ENDOCRINOL, V14, P1944, DOI 10.1210/me.14.12.1944; Kimura S, 1996, TRENDS ENDOCRIN MET, V7, P247, DOI 10.1016/S1043-2760(96)00115-4; Kluge B, 2005, DEV GENES EVOL, V215, P32, DOI 10.1007/s00427-004-0450-0; KREJCI E, 1991, P NATL ACAD SCI USA, V88, P6647, DOI 10.1073/pnas.88.15.6647; LAMAS L, 1989, J BIOL CHEM, V264, P13541; Laudet V, 2011, CURR BIOL, V21, pR726, DOI 10.1016/j.cub.2011.07.030; Lee JY, 2007, DOMEST ANIM ENDOCRIN, V32, P178, DOI 10.1016/j.domaniend.2006.02.005; Lee J, 2011, J BIOL CHEM, V286, P26327, DOI 10.1074/jbc.M111.242099; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; Little AG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-26; MALTHIERY Y, 1987, EUR J BIOCHEM, V165, P491, DOI 10.1111/j.1432-1033.1987.tb11466.x; MERCKEN L, 1985, NATURE, V316, P647, DOI 10.1038/316647a0; Miller AEM, 2013, J EXP BIOL, V216, P915, DOI 10.1242/jeb.077958; MONACO F, 1981, COMP BIOCHEM PHYS B, V70, P341, DOI 10.1016/0305-0491(81)90054-7; MONACO F, 1978, COMP BIOCHEM PHYS B, V60, P87, DOI 10.1016/0305-0491(78)90033-0; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; NEUENSCHWANDER P, 1972, Z ZELLFORSCH MIK ANA, V130, P553, DOI 10.1007/BF00307007; Novinec M, 2006, MOL BIOL EVOL, V23, P744, DOI 10.1093/molbev/msj082; Ogasawara M, 2001, GENESIS, V30, P51, DOI 10.1002/gene.1032; OHMIYA Y, 1990, J BIOL CHEM, V265, P9066; PALUMBO G, 1990, J BIOL CHEM, V265, P8887; Paris M, 2008, CURR BIOL, V18, P825, DOI 10.1016/j.cub.2008.04.078; Paris M, 2008, DEV GENES EVOL, V218, P667, DOI 10.1007/s00427-008-0255-7; Park YN, 2004, J BIOL CHEM, V279, P17085, DOI 10.1074/jbc.M314042200; Patricolo E, 2001, J EXP ZOOL, V290, P426, DOI 10.1002/jez.1084; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ris-Stalpers C, 2010, MOL CELL ENDOCRINOL, V322, P38, DOI 10.1016/j.mce.2010.02.008; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Rubio IGS, 2009, CURR OPIN ENDOCRINOL, V16, P373, DOI 10.1097/MED.0b013e32832ff218; Shen XX, 2011, MOL BIOL EVOL, V28, P3237, DOI 10.1093/molbev/msr148; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; Sommerfeld D, 2009, FUTURE GENER COMP SY, V25, P337, DOI 10.1016/j.future.2008.05.010; SUZUKI S, 1973, GEN COMP ENDOCR, V21, P451, DOI 10.1016/0016-6480(73)90104-4; Tata JR, 2013, BBA-GEN SUBJECTS, V1830, P3860, DOI 10.1016/j.bbagen.2012.02.017; van de Graaf SAR, 2001, J ENDOCRINOL, V170, P307, DOI 10.1677/joe.0.1700307; VANHERLE AJ, 1979, NEW ENGL J MED, V301, P307, DOI 10.1056/NEJM197908093010605; VANHERLE AJ, 1979, NEW ENGL J MED, V301, P239, DOI 10.1056/NEJM197908023010504; Williams GR, 2014, ENDOCRINOLOGY, V155, P2747, DOI 10.1210/en.2014-1527; WRIGHT GM, 1980, GEN COMP ENDOCR, V42, P187, DOI 10.1016/0016-6480(80)90187-2; Wu H, 2009, BIOCHEM BIOPH RES CO, V389, P269, DOI 10.1016/j.bbrc.2009.08.129; Yang SX, 1996, ARCH BIOCHEM BIOPHYS, V327, P61, DOI 10.1006/abbi.1996.0093; Youson JH, 1997, AM ZOOL, V37, P441	73	27	27	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16553	16566		10.1074/jbc.M116.719047	http://dx.doi.org/10.1074/jbc.M116.719047			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27311711	Green Published, hybrid			2022-12-26	WOS:000380826700015
J	Del Prete, D; Rice, RC; Rajadhyaksha, AM; D'Adamio, L				Del Prete, Dolores; Rice, Richard C.; Rajadhyaksha, Anjali M.; D'Adamio, Luciano			Amyloid Precursor Protein (APP) May Act as a Substrate and a Recognition Unit for CRL4(CRBN) and Stub1 E3 Ligases Facilitating Ubiquitination of Proteins Involved in Presynaptic Functions and Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid precursor protein (APP); E3 ubiquitin ligase; neurodegenerative disease; ubiquitylation (ubiquitination); CRL4CRBN; Cereblon; Intellectual disability	JNK-INTERACTING PROTEIN-1; LINKED MENTAL-RETARDATION; A-BETA-PP; PHOSPHOTYROSINE-BINDING DOMAIN; ALZHEIMERS-DISEASE BRAIN; ONSET PARKINSON-DISEASE; GAMMA-SECRETASE COMPLEX; C-TERMINAL FRAGMENTS; INTRACELLULAR DOMAIN; INTELLECTUAL DISABILITY	The amyloid precursor protein (APP), whose mutations cause Alzheimer disease, plays an important in vivo role and facilitates transmitter release. Because the APP cytosolic region (ACR) is essential for these functions, we have characterized its brain interactome. We found that the ACR interacts with proteins that regulate the ubiquitin-proteasome system, predominantly with the E3 ubiquitin-protein ligases Stub1, which binds the NH2 terminus of the ACR, and CRL4(CRBN), which is formed by Cul4a/b, Ddb1, and Crbn, and interacts with the COOH terminus of the ACR via Crbn. APP shares essential functions with APP-like protein-2 (APLP2) but not APP-like protein-1 (APLP1). Noteworthy, APLP2, but not APLP1, interacts with Stub1 and CRL4(CRBN), pointing to a functional pathway shared only by APP and APLP2. In vitro ubiquitination/ubiquitome analysis indicates that these E3 ligases are enzymatically active and ubiquitinate the ACR residues Lys(649/650/651/676/688). Deletion of Crbn reduces ubiquitination of Lys(676) suggesting that Lys(676) is physiologically ubiquitinated by CRL4(CRBN). The ACR facilitated in vitro ubiquitination of presynaptic proteins that regulate exocytosis, suggesting a mechanism by which APP tunes transmitter release. Other dementia-related proteins, namely Tau and apoE, interact with and are ubiquitinated via the ACR in vitro. This, and the evidence that CRBN and CUL4B are linked to intellectual disability, prompts us to hypothesize a pathogenic mechanism, in which APP acts as a modulator of E3 ubiquitin-protein ligase(s), shared by distinct neuronal disorders. The well described accumulation of ubiquitinated protein inclusions in neurodegenerative diseases and the link between the ubiquitin-proteasome system and neurodegeneration make this concept plausible.	[Del Prete, Dolores; D'Adamio, Luciano] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Rice, Richard C.; Rajadhyaksha, Anjali M.] Weill Cornell Med Coll, Dept Pediat, Div Pediat Neurol, New York, NY 10065 USA; [Rajadhyaksha, Anjali M.] Weill Cornell Med Coll, Weill Cornell Autism Res Program, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA	Yeshiva University; Albert Einstein College of Medicine; Cornell University; Cornell University	D'Adamio, L (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA.	luciano.dadamio@einstein.yu.edu		D'Adamio, Luciano/0000-0002-9820-4882; D'Adamio, Luciano/0000-0002-2204-9441	National Institutes of Health from NIA [R01AG033007, R01AG041531, R21AG048971, R01AG052286]; Hartwell Foundation; BrightFocus; NATIONAL INSTITUTE ON AGING [R01AG052286, R01AG033007, R21AG048971, R01AG041531] Funding Source: NIH RePORTER	National Institutes of Health from NIA; Hartwell Foundation; BrightFocus(BrightFocus Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01AG033007, R01AG041531, R21AG048971, and R01AG052286 from NIA (to L. D.), The Hartwell Foundation (to A. M. R.), and The BrightFocus (to D. D. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Annaert W, 2000, ANN NY ACAD SCI, V920, P158; Badura-Stronka M, 2010, CLIN GENET, V77, P141, DOI 10.1111/j.1399-0004.2009.01331.x; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Baizabal-Carvallo JF, 2016, NAT REV NEUROL, V12, P175, DOI 10.1038/nrneurol.2016.14; Barbagallo APM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018006; Barbagallo APM, 2011, J BIOL CHEM, V286, P8717, DOI 10.1074/jbc.C111.219873; Barbagallo APM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015503; Baulac S, 2003, NEUROBIOL DIS, V14, P194, DOI 10.1016/S0969-9961(03)00123-2; Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Bertrand E, 2001, MOL CELL NEUROSCI, V18, P503, DOI 10.1006/mcne.2001.1030; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Borchelt DR, 2002, NEUROBIOL AGING, V23, P171, DOI 10.1016/S0197-4580(01)00280-9; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Bourassa CV, 2012, AM J HUM GENET, V91, P548, DOI 10.1016/j.ajhg.2012.07.018; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Checler F, 2007, CURR ALZHEIMER RES, V4, P423, DOI 10.2174/156720507781788945; Ciarlo E, 2013, DIS MODEL MECH, V6, P424, DOI 10.1242/dmm.009761; Clark LN, 2006, ARCH NEUROL-CHICAGO, V63, P548, DOI 10.1001/archneur.63.4.548; Clark LN, 2004, MOVEMENT DISORD, V19, P796, DOI 10.1002/mds.20131; Cordoba M, 2014, NEUROLOGY, V83, P287, DOI 10.1212/WNL.0000000000000600; Coyne ES, 2016, F1000RES, V5, DOI [10.12688/f1000research.7220.1, DOI 10.12688/F1000RESEARCH.7220.1]; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Dahlmann B, 2016, ARCH BIOCHEM BIOPHYS, V591, P132, DOI 10.1016/j.abb.2015.12.012; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; De Strooper B, 2012, NATURE, V488, P38, DOI 10.1038/488038a; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Del Prete D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108576; Depondt C, 2014, NEUROLOGY, V82, P1749, DOI 10.1212/WNL.0000000000000416; Dijkhuizen T, 2006, AM J MED GENET A, V140A, P2482, DOI 10.1002/ajmg.a.31487; Dlamini N, 2013, NEUROMUSCULAR DISORD, V23, P391, DOI 10.1016/j.nmd.2013.02.001; Duilio A, 1998, BIOCHEM J, V330, P513, DOI 10.1042/bj3300513; Egashira N, 2005, BRAIN RES, V1059, P7, DOI 10.1016/j.brainres.2005.08.004; Fanutza T, 2015, ELIFE, V4, DOI 10.7554/eLife.09743; Finsterer J, 2014, EUR J MED GENET, V57, P103, DOI 10.1016/j.ejmg.2014.01.002; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Garcia CC, 2004, J MED GENET, V41, P183, DOI 10.1136/jmg.2003.013680; Garringer HJ, 2010, BRAIN STRUCT FUNCT, V214, P235, DOI 10.1007/s00429-009-0221-9; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Ghersi E, 2004, J BIOL CHEM, V279, P49105, DOI 10.1074/jbc.M405329200; Ghersi E, 2004, J ALZHEIMERS DIS, V6, P67; Hamid R, 2007, J NEUROCHEM, V102, P1264, DOI 10.1111/j.1471-4159.2007.04627.x; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hartmann MD, 2014, J STRUCT BIOL, V188, P225, DOI 10.1016/j.jsb.2014.10.010; Heber S, 2000, J NEUROSCI, V20, P7951; Hedrich K, 2004, NEUROLOGY, V62, P389, DOI 10.1212/01.WNL.0000113022.51739.88; Heimdal K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0146-0; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Herrmann DN, 2014, AM J HUM GENET, V95, P332, DOI 10.1016/j.ajhg.2014.08.007; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Homan CC, 2014, AM J HUM GENET, V94, P470, DOI 10.1016/j.ajhg.2014.02.004; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Iqbal Z, 2015, AM J HUM GENET, V96, P386, DOI 10.1016/j.ajhg.2015.01.010; Islam K, 1997, AM J PATHOL, V151, P265; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Klein CJ, 2014, NEUROLOGY, V82, P873, DOI 10.1212/WNL.0000000000000206; Klevanski M, 2015, J NEUROSCI, V35, P16018, DOI 10.1523/JNEUROSCI.2009-15.2015; Kohli BM, 2012, J PROTEOME RES, V11, P4075, DOI 10.1021/pr300123g; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; Lee DY, 2012, BIOL CHEM, V393, P441, DOI 10.1515/hsz-2012-0120; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Li HM, 2010, J BIOL CHEM, V285, P30598, DOI 10.1074/jbc.M110.137729; Li M, 2015, NEUROBIOL AGING, V36, P2725, DOI 10.1016/j.neurobiolaging.2015.06.021; Lim KL, 2007, EXPERT REV PROTEOMIC, V4, P769, DOI 10.1586/14789450.4.6.769; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Liu WM, 2015, TOXICOL APPL PHARM, V287, P98, DOI 10.1016/j.taap.2015.05.003; Lombino F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057120; Londin ER, 2014, AM J MED GENET A, V164, P2294, DOI 10.1002/ajmg.a.36629; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Lu PJ, 1999, NATURE, V399, P784; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Matrone C, 2012, AGING CELL, V11, P1084, DOI 10.1111/acel.12009; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Matsuda S, 2009, J BIOL CHEM, V284, P15815, DOI 10.1074/jbc.M109.006403; McLoughlin DM, 1996, FEBS LETT, V397, P197; Morel E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3250; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Norstrom EM, 2010, J NEUROSCI, V30, P15677, DOI 10.1523/JNEUROSCI.4464-10.2010; Noviello C, 2003, J BIOL CHEM, V278, P31843, DOI 10.1074/jbc.M304133200; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Passer BJ, 1999, J BIOL CHEM, V274, P24007, DOI 10.1074/jbc.274.34.24007; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Pellegrini L, 1999, J BIOL CHEM, V274, P21011, DOI 10.1074/jbc.274.30.21011; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Rajadhyaksha AM, 2012, BEHAV BRAIN RES, V226, P428, DOI 10.1016/j.bbr.2011.09.039; Riederer BM, 2011, EXP BIOL MED, V236, P268, DOI 10.1258/ebm.2010.010327; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Russo C, 2005, BRAIN RES REV, V48, P257, DOI 10.1016/j.brainresrev.2004.12.016; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; Sabbagh JJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00003; Saccone V, 2008, HUM MUTAT, V29, P240, DOI 10.1002/humu.20633; Sang YZ, 2015, ONCOTARGET, V6, P42590, DOI 10.18632/oncotarget.6052; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scheinfeld MH, 2003, J BIOL CHEM, V278, P42058, DOI 10.1074/jbc.M304853200; Scheinfeld MH, 2002, J BIOL CHEM, V277, P44195, DOI 10.1074/jbc.M208110200; Scheinfeld MH, 2002, J BIOL CHEM, V277, P3767, DOI 10.1074/jbc.M108357200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; Schoser BGH, 2005, ANN NEUROL, V57, P591, DOI 10.1002/ana.20441; Schwechheimer C, 2004, BBA-MOL CELL RES, V1695, P45, DOI 10.1016/j.bbamcr.2004.09.023; Sell GL, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00322; Shen XM, 2014, NEUROLOGY, V83, P2247, DOI 10.1212/WNL.0000000000001079; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081884; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Skaar JR, 2014, NAT REV DRUG DISCOV, V13, P889, DOI 10.1038/nrd4432; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tamayev R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-28; Tanzi R. E., 2012, COLD SPRING HARB PER, V2; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; Thomas SN, 2009, METHODS MOL BIOL, V566, P109, DOI 10.1007/978-1-59745-562-6_8; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Weidemann A, 1999, J BIOL CHEM, V274, P5823, DOI 10.1074/jbc.274.9.5823; Wenner C, 2001, BIOCHEM BIOPH RES CO, V282, P608, DOI 10.1006/bbrc.2001.4611; Yang G, 2005, NEUROSCI LETT, V384, P66, DOI 10.1016/j.neulet.2005.04.040; Zhou DW, 2009, J ALZHEIMERS DIS, V16, P301, DOI 10.3233/JAD-2009-0970; Zhou DW, 2004, J BIOL CHEM, V279, P25374, DOI 10.1074/jbc.M400488200; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489	142	49	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17209	17227		10.1074/jbc.M116.733626	http://dx.doi.org/10.1074/jbc.M116.733626			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27325702	Green Published, hybrid			2022-12-26	WOS:000382643800024
J	Cevik, O; Baykal, AT; Sener, A				Cevik, Ozge; Baykal, Ahmet Tarik; Sener, Azize			Platelets Proteomic Profiles of Acute Ischemic Stroke Patients	PLOS ONE			English	Article							ALPHA(1)-MICROGLOBULIN/BIKUNIN PRECURSOR AMBP; RICH GLYCOPROTEIN BINDING; LEUKEMIA PATIENTS; ACTIVATION; COMPLEMENT; THROMBOSPONDIN-1; QUANTIFICATION; VITRONECTIN; MECHANISMS; THROMBOSIS	Platelets play a crucial role in the pathogenesis of stroke and antiplatelet agents exist for its treatment and prevention. Through the use of LC-MS based protein expression profiling, platelets from stroke patients were analyzed and then correlated with the proteomic analyses results in the context of this disease. This study was based on patients who post ischemic stroke were admitted to hospital and had venous blood drawn within 24 hrs of the incidence. Label-free protein expression analyses of the platelets' tryptic digest was performed in triplicate on a UPLC-ESI-qTOF-MS/MS system and ProteinLynx Global Server (v2.5, Waters) was used for tandem mass data extraction. The peptide sequences were searched against the reviewed homo sapiens database (www.uniprot.org) and the quantitation of protein variation was achieved through Progenesis LC-MS software (V4.0, Nonlinear Dynamics). These Label-free differential proteomics analysis of platelets ensured that 500 proteins were identified and 83 of these proteins were found to be statistically significant. The differentially expressed proteins are involved in various processes such as inflammatory response, cellular movement, immune cell trafficking, cell-to-cell signaling and interaction, hematological system development and function and nucleic acid metabolism. The expressions of myeloperoxidase, arachidonate 12-Lipoxygenase and histidine-rich glycoprotein are involved in cellular metabolic processes, crk-like protein and ras homolog gene family member A involved in cell signaling with vitronectin, thrombospondin 1, Integrin alpha 2b, and integrin beta 3 involved in cell adhesion. Apolipoprotein H, immunoglobulin heavy constant gamma 1 and immunoglobulin heavy constant gamma 3 are involved in structural, apolipoprotein A-I, and alpha-1-microglobulin/bikunin precursor is involved in transport, complement component 3 and clusterin is involved in immunity proteins as has been discussed. Our data provides an insight into the proteins that are involved in the platelets' activation response during ischemic stroke. It could be argued that this study lays the foundation for future mechanistic studies.	[Cevik, Ozge] Cumhuriyet Univ, Dept Biochem, Fac Pharm, Sivas, Turkey; [Baykal, Ahmet Tarik] Acibadem Univ, Sch Med, Dept Med Biochem, Istanbul, Turkey; [Cevik, Ozge; Sener, Azize] Marmara Univ, Dept Biochem, Fac Pharm, Istanbul, Turkey	Cumhuriyet University; Acibadem University; Marmara University	Cevik, O (corresponding author), Cumhuriyet Univ, Dept Biochem, Fac Pharm, Sivas, Turkey.; Cevik, O (corresponding author), Marmara Univ, Dept Biochem, Fac Pharm, Istanbul, Turkey.	drozgecevik@gmail.com	Baykal, Ahmet T/C-3948-2013; Cevik, Ozge/Z-2790-2019; Cevik, Ozge/F-1326-2014	Baykal, Ahmet T/0000-0002-8814-7351; Cevik, Ozge/0000-0002-9325-3757	Marmara University Research Unit Grants [SAG-C-DRP-010710-0216]	Marmara University Research Unit Grants	This research was supported by Marmara University Research Unit Grants SAG-C-DRP-010710-0216. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCH E, 1990, J CLIN INVEST, V85, P1372, DOI 10.1172/JCI114581; Aslan JE, 2013, J THROMB HAEMOST, V11, P35, DOI 10.1111/jth.12051; Attali G, 2004, EUR J IMMUNOL, V34, P3236, DOI 10.1002/eji.200425011; Berger JS, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/234316; Best D, 2001, BRIT J HAEMATOL, V112, P609, DOI 10.1046/j.1365-2141.2001.02624.x; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Bostanci N, 2010, J PROTEOME RES, V9, P2191, DOI 10.1021/pr900941z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branchford BR, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.4159.4159; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Cevik O, 2013, MOL BIOL REP, V40, P6721, DOI 10.1007/s11033-013-2787-9; Cheng FY, 2009, J PROTEOME RES, V8, P82, DOI 10.1021/pr800649s; D'Aguanno S, 2011, J PROTEOME RES, V10, P416, DOI 10.1021/pr100457n; del Zoppo GJ, 1998, NEUROLOGY, V51, pS9, DOI 10.1212/WNL.51.3_Suppl_3.S9; Depta JP, 2015, ANNU REV PHARMACOL, V55, P373, DOI 10.1146/annurev-pharmtox-010814-124438; Eitzman DT, 2000, BLOOD, V95, P577, DOI 10.1182/blood.V95.2.577; Ekmekci OB, 2006, CLIN CHIM ACTA, V368, P77, DOI 10.1016/j.cca.2005.12.015; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Fateh-Moghadam S, 2007, THROMB HAEMOSTASIS, V97, P974, DOI 10.1160/TH06-12-0725; Fishelson Z, 2001, MOL IMMUNOL, V38, P207, DOI 10.1016/S0161-5890(01)00055-4; Furlan JC, 2016, J NEUROL SCI, V362, P198, DOI 10.1016/j.jns.2016.01.044; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Gorudko IV, 2013, BIOL OPEN, V2, P916, DOI 10.1242/bio.20135314; Gyulkhandanyan AV, 2013, BRIT J HAEMATOL, V161, P245, DOI 10.1111/bjh.12237; Hagemeyer CE, 2010, CURR PHARM DESIGN, V16, P4119; Hamad OA, 2010, J IMMUNOL, V184, P2686, DOI 10.4049/jimmunol.0902810; Hong KS, 2014, J CLIN NEUROL, V10, P189, DOI 10.3988/jcn.2014.10.3.189; Horne MK, 2001, THROMB HAEMOSTASIS, V85, P890; Huang H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0748-8; Igci M, 2010, SCAND J UROL NEPHROL, V44, P413, DOI 10.3109/00365599.2010.497768; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Kleinschnitz C, 2009, BLOOD, V113, P3600, DOI 10.1182/blood-2008-09-180695; Lee SY, 2008, J CLIN NEUROL, V4, P148, DOI 10.3988/jcn.2008.4.4.148; LEFKOVITS J, 1995, NEW ENGL J MED, V332, P1553, DOI 10.1056/NEJM199506083322306; Leng LJ, 1998, BLOOD, V91, P4206, DOI 10.1182/blood.V91.11.4206.411k30_4206_4215; LERCH PG, 1988, BRIT J HAEMATOL, V70, P219, DOI 10.1111/j.1365-2141.1988.tb02467.x; Lim YA, 2008, PLATELETS, V19, P328, DOI 10.1080/09537100802129867; Lin TN, 2003, STROKE, V34, P177, DOI 10.1161/01.STR.0000047100.84604.BA; Morrell CN, 2007, AM J TRANSPLANT, V7, P2447, DOI 10.1111/j.1600-6143.2007.01958.x; Nardi M, 2004, J CLIN INVEST, V113, P973, DOI 10.1172/JCI200420726; Nieswandt B, 2011, J THROMB HAEMOST, V9, P92, DOI 10.1111/j.1538-7836.2011.04361.x; Niu PP, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009013; Nyby MD, 1996, J PHARMACOL EXP THER, V278, P503; Oda A, 1996, BLOOD, V88, P4304; Pan B, 2013, MOL BIOL REP, V40, P27, DOI 10.1007/s11033-012-1944-x; Parguina AF, 2011, ARTERIOSCL THROM VAS, V31, P2957, DOI 10.1161/ATVBAHA.111.235713; Pleines I, 2012, BLOOD, V119, P1054, DOI 10.1182/blood-2011-08-372193; Prochazkova R, 2007, TRANSFUS APHER SCI, V37, P115, DOI 10.1016/j.transci.2007.03.015; Reed GL, 2000, BLOOD, V96, P3334; Ringvall M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014526; Sener A, 2009, FOLIA BIOL-PRAGUE, V55, P45; Serhatli M, 2014, J PROTEOME RES, V13, P5071, DOI 10.1021/pr5006586; Shannan B, 2006, J MOL HISTOL, V37, P183, DOI 10.1007/s10735-006-9052-7; Shulga Olga, 2011, Front Neurol, V2, P36, DOI 10.3389/fneur.2011.00036; Sibon I, 2004, NEUROLOGY, V62, P1187, DOI 10.1212/01.WNL.0000118288.04483.02; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Smith NM, 1999, VASC MED, V4, P165, DOI 10.1177/1358836X9900400307; Starlinger P, 2010, J THROMB HAEMOST, V8, P1809, DOI 10.1111/j.1538-7836.2010.03908.x; Tang L, 2014, J THROMB HAEMOST, V12, P1616, DOI 10.1111/jth.12679; Topol EJ, 1999, LANCET, V353, P227, DOI 10.1016/S0140-6736(98)11086-3; TSCHOPP J, 1993, BLOOD, V82, P118, DOI 10.1182/blood.V82.1.118.bloodjournal821118; Tyagi S, 2002, ARCH BIOCHEM BIOPHYS, V399, P66, DOI 10.1006/abbi.2001.2745; Vissers JPC, 2007, MOL CELL PROTEOMICS, V6, P755, DOI 10.1074/mcp.M600303-MCP200; Voit S, 2003, FEBS LETT, V544, P240, DOI 10.1016/S0014-5793(03)00472-1; Wang L, 2004, J THROMB HAEMOST, V2, P1436, DOI 10.1111/j.1538-7836.2004.00854.x; Wasinger VC, 2016, MOL CELL PROTEOMICS, V15, P256, DOI 10.1074/mcp.M115.055095; Wu YP, 2004, BLOOD, V104, P1034, DOI 10.1182/blood-2003-12-4293; Yago T, 1999, J IMMUNOL, V163, P367	68	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158287	10.1371/journal.pone.0158287	http://dx.doi.org/10.1371/journal.pone.0158287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336623	gold, Green Published, Green Submitted			2022-12-26	WOS:000378389200128
J	Choi, KH; Park, JK; Son, D; Hwang, JY; Lee, DK; Ka, H; Park, J; Lee, CK				Choi, Kwang-Hwan; Park, Jin-Kyu; Son, Dongchan; Hwang, Jae Yeon; Lee, Dong-Kyung; Ka, Hakhyun; Park, Joonghoon; Lee, Chang-Kyu			Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig	PLOS ONE			English	Article							SOMATIC-CELLS; IPS CELLS; NAIVE; STATE; INDUCTION; DERIVATION; NANOG; FIBROBLASTS; MAINTENANCE; CIRCUITRY	Cellular reprogramming of committed cells into a pluripotent state can be induced by ectopic expression of genes such as OCT4, SOX2, KLF4, and MYC. Reprogrammed cells can be maintained by activating endogenous pluripotent networks without transgene expression. Although various research groups have attempted to generate pig induced pluripotent stem cells (iPSCs), authentic iPSCs have not be obtained, instead showing dependence on transgene expression. In this study, iPSCs were derived from porcine fetal fibroblasts via drug-inducible vectors carrying human transcription factors (OCT4, SOX2, KLF4, and MYC). Therefore, this study investigated characteristics of iPSCs and reprogramming mechanisms in pig. The iPSCs were stably maintained over an extended period with potential in vitro differentiation into three germ layers. In addition, the pluripotent state of iPSCs was regulated by modulating culture conditions. They showed naive-or primed-like pluripotent states in LIF or bFGF supplemented culture conditions, respectively. However, iPSCs could not be maintained without ectopic expression of transgenes. The cultured iPSCs expressed endogenous transcription factors such as OCT4 and SOX2, but not NANOG (a known gateway to complete reprogramming). Endogenous genes related to mesenchymal-to-epithelial transition (DPPA2, CDH1, EPCAM, and OCLN) were not sufficiently reactivated, as measured by qPCR. DNA methylation analysis for promoters of OCT4, NANOG, and XIST showed that epigenetic reprogramming did not occur in female iPSCs. Based on our results, expression of exogenous genes could not sufficiently activate the essential endogenous genes and remodel the epigenetic milieu to achieve faithful pluripotency in pig. Accordingly, investigating iPSCs could help us improve and develop reprogramming methods by understanding reprogramming mechanisms in pig.	[Choi, Kwang-Hwan; Son, Dongchan; Hwang, Jae Yeon; Lee, Dong-Kyung; Lee, Chang-Kyu] Seoul Natl Univ, Dept Agr Biotechnol, Anim Biotechnol Major, Seoul, South Korea; [Choi, Kwang-Hwan; Son, Dongchan; Hwang, Jae Yeon; Lee, Dong-Kyung; Lee, Chang-Kyu] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Park, Jin-Kyu] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Park, Jin-Kyu] Univ Missouri, Bond Life Sci Ctr, Columbia, MO USA; [Ka, Hakhyun] Yonsei Univ, Dept Biol Resources & Technol, Wonju, South Korea; [Park, Joonghoon] LG Life Sci, R&D Pk, Daejeon, South Korea; [Lee, Chang-Kyu] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeong Chang, Kangwon Do, South Korea; [Hwang, Jae Yeon] Kangwon Natl Univ, Dept Anim Life Sci, Chunchon, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Yonsei University; LG Life Sciences Ltd; Seoul National University (SNU); Kangwon National University	Lee, CK (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Anim Biotechnol Major, Seoul, South Korea.; Lee, CK (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.; Lee, CK (corresponding author), Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeong Chang, Kangwon Do, South Korea.	leeck@snu.ac.kr		Choi, Kwang-Hwan/0000-0003-3919-7413; Hwang, Jae Yeon/0000-0002-6493-4182	Next-generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ0113002015]; BK21 plus program through the National Research Foundation (NRF), the Ministry of Education of Korea; LG Life Sciences	Next-generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; BK21 plus program through the National Research Foundation (NRF), the Ministry of Education of Korea; LG Life Sciences	This work was supported by the Next-generation BioGreen 21 Program (PJ0113002015), Rural Development Administration, Republic of Korea and also supported by BK21 plus program through the National Research Foundation (NRF), the Ministry of Education of Korea. The funder, LG Life Sciences, provided support in the form of salaries for author [JP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberio R, 2012, REPROD DOMEST ANIM, V47, P98, DOI 10.1111/j.1439-0531.2012.02062.x; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen JK, 2010, J BIOL CHEM, V285, P31066, DOI 10.1074/jbc.M110.139436; Choi KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072184; Du J, 2010, J BIOCHEM, V147, P265, DOI 10.1093/jb/mvp161; Du XG, 2015, STEM CELLS, V33, P3228, DOI 10.1002/stem.2089; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Hall VJ, 2012, CELL REPROGRAM, V14, P204, DOI 10.1089/cell.2011.0089; Hall VJ, 2009, DEV DYNAM, V238, P2014, DOI 10.1002/dvdy.22027; Hall VJ, 2014, STEM CELLS DEV, V23, P2030, DOI 10.1089/scd.2013.0502; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kwon DJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/140639; Lai SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146562; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liu SC, 2015, DEV DYNAM, V244, P619, DOI 10.1002/dvdy.24248; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Montserrat N, 2012, CELL TRANSPLANT, V21, P815, DOI 10.3727/096368911X601019; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okada M, 2011, BBA-GEN SUBJECTS, V1810, P226, DOI 10.1016/j.bbagen.2010.10.004; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052481; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shi GL, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt39; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468; Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Valamehr B, 2014, STEM CELL REP, V2, P366, DOI 10.1016/j.stemcr.2014.01.014; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Wei C, 2015, REPRODUCTION, V149, P485, DOI 10.1530/REP-14-0410; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; West FD, 2011, STEM CELLS, V29, P1640, DOI 10.1002/stem.713; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang SQ, 2015, STEM CELL REV REP, V11, P24, DOI 10.1007/s12015-014-9552-x; Zhang W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124562; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085089	67	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158046	10.1371/journal.pone.0158046	http://dx.doi.org/10.1371/journal.pone.0158046			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336671	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200096
J	Turlure, C; Schtickzelle, N; Van Dyck, H; Seymoure, B; Rutowski, R				Turlure, Camille; Schtickzelle, Nicolas; Van Dyck, Hans; Seymoure, Brett; Rutowski, Ronald			Flight Morphology, Compound Eye Structure and Dispersal in the Bog and the Cranberry Fritillary Butterflies: An Inter- and Intraspecific Comparison	PLOS ONE			English	Article							MOVEMENT ECOLOGY PARADIGM; LANDSCAPE FRAGMENTATION; QUANTITATIVE-ANALYSIS; SEXUAL-DIMORPHISM; WING KINEMATICS; VISUAL-FIELD; PERFORMANCE; LEPIDOPTERA; BEHAVIOR; STRATEGIES	Understanding dispersal is of prime importance in conservation and population biology. Individual traits related to motion and navigation during dispersal may differ: (1) among species differing in habitat distribution, which in turn, may lead to interspecific differences in the potential for and costs of dispersal, (2) among populations of a species that experiences different levels of habitat fragmentation; (3) among individuals differing in their dispersal strategy and (4) between the sexes due to sexual differences in behaviour and dispersal tendencies. In butterflies, the visual system plays a central role in dispersal, but exactly how the visual system is related to dispersal has received far less attention than flight morphology. We studied two butterfly species to explore the relationships between flight and eye morphology, and dispersal. We predicted interspecific, intraspecific and intersexual differences for both flight and eye morphology relative to i) species-specific habitat distribution, ii) variation in dispersal strategy within each species and iii) behavioural differences between sexes. However, we did not investigate for potential population differences. We found: (1) sexual differences that presumably reflect different demands on both male and female visual and flight systems, (2) a higher wing loading (i.e. a proxy for flight performance), larger eyes and larger facet sizes in the frontal and lateral region of the eye (i.e. better navigation capacities) in the species inhabiting naturally fragmented habitat compared to the species inhabiting rather continuous habitat, and (3) larger facets in the frontal region in dispersers compared to residents within a species. Hence, dispersers may have similar locomotory capacity but potentially better navigation capacity. Dispersal ecology and evolution have attracted much attention, but there are still significant gaps in our understanding of the mechanisms of dispersal. Unfortunately, for many species we lack detailed information on the role of behavioural, morphological and physiological traits for dispersal. Our novel study supports the existence of inter-and intra-specific evolutionary responses in both motion and navigation capacities (i.e. flight and eye morphology) linked to dispersal.	[Turlure, Camille; Schtickzelle, Nicolas; Van Dyck, Hans] Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, Louvain La Neuve, Belgium; [Seymoure, Brett; Rutowski, Ronald] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Universite Catholique Louvain; Arizona State University; Arizona State University-Tempe	Turlure, C (corresponding author), Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, Louvain La Neuve, Belgium.	camille.turlure@uclouvain.be			F.R.S-FNRS [2012/V 3/5/380 - IB/JN - 14913]; ARC [10-15/031]	F.R.S-FNRS(Fonds de la Recherche Scientifique - FNRS); ARC(Australian Research Council)	CT is postdoctoral fellow and NS research associate of the F.R.S.-FNRS, and they acknowledge its financial support. CT received a travelling grant from the F.R.S-FNRS (2012/V 3/5/380 - IB/JN - 14913) to learn the eye dissection techniques at Arizona State University (RR lab). NS and HVD were supported by research grant ARC 10-15/031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almbro M, 2012, J INSECT BEHAV, V25, P441, DOI 10.1007/s10905-011-9309-1; Altizer S, 2010, EVOLUTION, V64, P1018, DOI 10.1111/j.1558-5646.2010.00946.x; [Anonymous], 2020, ECONOMIST 0326; Baguette M, 2003, ECOGRAPHY, V26, P153, DOI 10.1034/j.1600-0587.2003.03364.x; Baguette M, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0013-6; Baguette M, 2013, BIOL REV, V88, P310, DOI 10.1111/brv.12000; Barker JSF, 1995, J EVOLUTION BIOL, V8, P689, DOI 10.1046/j.1420-9101.1995.8060689.x; Berwaerts K, 2002, FUNCT ECOL, V16, P484, DOI 10.1046/j.1365-2435.2002.00650.x; Berwaerts K, 2006, BIOL J LINN SOC, V89, P675, DOI 10.1111/j.1095-8312.2006.00699.x; BETTS CR, 1988, J EXP BIOL, V138, P271; Blanchet S, 2010, EVOL APPL, V3, P291, DOI 10.1111/j.1752-4571.2009.00110.x; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burton BG, 2001, J NEUROPHYSIOL, V86, P950, DOI 10.1152/jn.2001.86.2.950; DANTHANARAYANA W, 1976, OECOLOGIA, V26, P121, DOI 10.1007/BF00582890; Ducatez S, 2012, ECOL ENTOMOL, V37, P377, DOI 10.1111/j.1365-2311.2012.01375.x; Duthie AB, 2015, AM NAT, V186, P151, DOI 10.1086/681621; Garcia-Barros Enrique, 2009, P29; Greggor AL, 2014, TRENDS ECOL EVOL, V29, P489, DOI 10.1016/j.tree.2014.06.004; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Hanski I, 2005, EMBO REP, V6, P388, DOI 10.1038/sj.embor.7400398; HARRISON RG, 1980, ANNU REV ECOL SYST, V11, P95, DOI 10.1146/annurev.es.11.110180.000523; Hill JK, 1999, OECOLOGIA, V121, P165, DOI 10.1007/s004420050918; Holyoak M, 2008, P NATL ACAD SCI USA, V105, P19060, DOI 10.1073/pnas.0800483105; Hornstein EP, 2000, P ROY SOC B-BIOL SCI, V267, P2111, DOI 10.1098/rspb.2000.1257; Horridge A, 2006, INVERTEBRATE VISION, P494; Kery M, 2002, J WILDLIFE MANAGE, V66, P330, DOI 10.2307/3803165; Kinoshita M, 2015, J COMP NEUROL, V523, P162, DOI 10.1002/cne.23674; LAND MF, 1985, J COMP PHYSIOL A, V156, P525, DOI 10.1007/BF00613976; Land MF, 2006, INVERTEBRATE VISION, P167; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Lehmann FO, 1998, J EXP BIOL, V201, P385; LEVIN SA, 1984, THEOR POPUL BIOL, V26, P165, DOI 10.1016/0040-5809(84)90028-5; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Merlin C, 2012, CURR OPIN NEUROBIOL, V22, P353, DOI 10.1016/j.conb.2011.11.009; Merlin C, 2009, SCIENCE, V325, P1700, DOI 10.1126/science.1176221; Merry JW, 2006, J INSECT PHYSIOL, V52, P240, DOI 10.1016/j.jinsphys.2005.11.002; Meylan S, 2009, J EXP ZOOL PART A, V311A, P377, DOI 10.1002/jez.533; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Neve G, 1996, J APPL ECOL, V33, P14, DOI 10.2307/2405011; Niitepold K, 2009, ECOLOGY, V90, P2223, DOI 10.1890/08-1498.1; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Niven JE, 2007, PLOS BIOL, V5, P828, DOI 10.1371/journal.pbio.0050116; Nordstrom K, 2008, CURR BIOL, V18, P661, DOI 10.1016/j.cub.2008.03.061; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PROKOPY RJ, 1983, ANNU REV ENTOMOL, V28, P337, DOI 10.1146/annurev.en.28.010183.002005; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Rutowski RL, 2000, J ZOOL, V252, P187, DOI 10.1111/j.1469-7998.2000.tb00614.x; Rutowski RL, 2002, J COMP PHYSIOL A, V188, P1, DOI 10.1007/s00359-001-0273-7; Rutowski Ronald L., 2003, P9; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schtickzelle N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-4; Shreeve Tim, 2009, P171; Srygley RB, 2000, BIOL J LINN SOC, V70, P707, DOI 10.1111/j.1095-8312.2000.tb00225.x; Stevens VM, 2012, ECOL LETT, V15, P74, DOI 10.1111/j.1461-0248.2011.01709.x; Turlure C, 2010, J INSECT CONSERV; Turlure C, 2011, BEHAV ECOL, V22, P967, DOI 10.1093/beheco/arr077; Turlure C, 2010, LANDSCAPE ECOL, V25, P95, DOI 10.1007/s10980-009-9403-3; Van Dyck H, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P357; Weber JM, 2009, J EXP BIOL, V212, P593, DOI 10.1242/jeb.015024; WICKMAN PO, 1992, EVOLUTION, V46, P1525, DOI 10.1111/j.1558-5646.1992.tb01142.x; Yagi N., 1963, COMPOUND EYE LEPIDOP; Ziemba K.S., 2000, PSYCHE, V103, P25; Zuur Alain F., 2009, P1	66	23	23	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158073	10.1371/journal.pone.0158073	http://dx.doi.org/10.1371/journal.pone.0158073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336590	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200105
J	Huber, SKR; Luimstra, JJ; Van Beek, J; Hoppes, R; Jacobi, RHJ; Hendriks, M; Kapteijn, K; Ouwerkerk, C; Rodenko, B; Ovaa, H; de Jonge, J				Huber, Sietske K. Rosendahl; Luimstra, Jolien J.; van Beek, Josine; Hoppes, Rieuwert; Jacobi, Ronald H. J.; Hendriks, Marion; Kapteijn, Kim; Ouwerkerk, Casper; Rodenko, Boris; Ovaa, Huib; de Jonge, Jorgen			Chemical Modification of Influenza CD8+T-Cell Epitopes Enhances Their Immunogenicity Regardless of Immunodominance	PLOS ONE			English	Article							MHC CLASS-I; PEPTIDE-BINDING; ANCHOR SUBSTITUTIONS; CTL RESPONSE; AMINO-ACID; A VIRUS; COMPLEX; PROTECTION; LIGANDS; IMMUNITY	T cells are essential players in the defense against infection. By targeting the MHC class I antigen-presenting pathway with peptide-based vaccines, antigen-specific T cells can be induced. However, low immunogenicity of peptides poses a challenge. Here, we set out to increase immunogenicity of influenza-specific CD8(+) T cell epitopes. By substituting amino acids in wild type sequences with non-proteogenic amino acids, affinity for MHC can be increased, which may ultimately enhance cytotoxic CD8(+) T cell responses. Since preventive vaccines against viruses should induce a broad immune response, we used this method to optimize influenza-specific epitopes of varying dominance. For this purpose, HLA-A*0201 epitopes GILGFVFTL, FMYSDFHFI and NMLSTVLGV were selected in order of decreasing MHC-affinity and dominance. For all epitopes, we designed chemically enhanced altered peptide ligands (CPLs) that exhibited greater binding affinity than their WT counterparts; even binding scores of the high affinity GILGFVFTL epitope could be improved. When HLA-A*0201 transgenic mice were vaccinated with selected CPLs, at least 2 out of 4 CPLs of each epitope showed an increase in IFN-gamma responses of splenocytes. Moreover, modification of the low affinity epitope NMLSTVLGV led to an increase in the number of mice that responded. By optimizing three additional influenza epitopes specific for HLA-A*0301, we show that this strategy can be extended to other alleles. Thus, enhancing binding affinity of peptides provides a valuable tool to improve the immunogenicity and range of preventive T cell-targeted peptide vaccines.	[Huber, Sietske K. Rosendahl; van Beek, Josine; Jacobi, Ronald H. J.; Hendriks, Marion; de Jonge, Jorgen] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Cib, NL-3720 BA Bilthoven, Netherlands; [Luimstra, Jolien J.; Hoppes, Rieuwert; Kapteijn, Kim; Ouwerkerk, Casper; Rodenko, Boris; Ovaa, Huib] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Luimstra, Jolien J.; Ovaa, Huib] ICI, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands Cancer Institute	de Jonge, J (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Cib, NL-3720 BA Bilthoven, Netherlands.	jorgen.de.jonge@rivm.nl	; ovaa, huib/M-2334-2016	Luimstra, Jolien/0000-0001-9742-929X; ovaa, huib/0000-0002-0068-054X; de Jonge, Jorgen/0000-0003-3167-2435	Center for Translational Molecular Medicine (CTMM) under grant Ampvacs [2010016, 041-301]; Institute for Chemical Immunology, an NWO Gravitation project - Ministry of Education, Culture and Science of the government of the Netherlands [ICI-00002]	Center for Translational Molecular Medicine (CTMM) under grant Ampvacs; Institute for Chemical Immunology, an NWO Gravitation project - Ministry of Education, Culture and Science of the government of the Netherlands	This project was funded by the Center for Translational Molecular Medicine (CTMM) under grant Ampvacs (Contractnumber 2010016 and project number 041-301). URL for CTMM: www.ctmm.nl. This work was supported by the Institute for Chemical Immunology, an NWO Gravitation project funded by the Ministry of Education, Culture and Science of the government of the Netherlands under number ICI-00002. URL to website nwo: www.nwo.nl. Authors who received funding: SRH, JvB, JdJ, JL, HO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian Png Eak Hock, 2002, BMC Struct Biol, V2, P2, DOI 10.1186/1472-6807-2-2; Amore A, 2013, CHEMBIOCHEM, V14, P123, DOI 10.1002/cbic.201200540; Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; Bakker AH, 2008, P NATL ACAD SCI USA, V105, P3825, DOI 10.1073/pnas.0709717105; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; BUTCHKO GM, 1978, J IMMUNOL, V121, P2381; Choo JAL, 2014, ANGEW CHEM INT EDIT, V53, P13390, DOI 10.1002/anie.201406295; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Denkberg G, 2002, J IMMUNOL, V169, P4399, DOI 10.4049/jimmunol.169.8.4399; EFFROS RB, 1977, J EXP MED, V145, P557, DOI 10.1084/jem.145.3.557; Francis JN, 2015, VACCINE, V33, P396, DOI 10.1016/j.vaccine.2014.06.006; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; Gonzalez PA, 2005, P NATL ACAD SCI USA, V102, P4824, DOI 10.1073/pnas.0500922102; Guo HL, 2011, J VIROL, V85, P448, DOI 10.1128/JVI.01812-10; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hickman HD, 2013, EUR J IMMUNOL, V43, P2814, DOI 10.1002/eji.201344095; Hoppes R, 2014, J IMMUNOL, V193, P4803, DOI 10.4049/jimmunol.1400800; Houser K, 2015, CELL HOST MICROBE, V17, P295, DOI 10.1016/j.chom.2015.02.012; Huber SKR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127969; Huber SR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00171; Ichihashi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024626; Iskander J, 2013, EMERG INFECT DIS, V19, P879, DOI 10.3201/eid1906.121478; Johansen TE, 1997, SCAND J IMMUNOL, V46, P137, DOI 10.1046/j.1365-3083.1997.d01-102.x; Joseph MA, 2007, MOL IMMUNOL, V44, P322, DOI 10.1016/j.molimm.2006.02.027; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Keskin DB, 2015, P NATL ACAD SCI USA, V112, P2151, DOI 10.1073/pnas.1423482112; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Lee YT, 2014, CLIN EXP VACCINE RES, V3, P12, DOI 10.7774/cevr.2014.3.1.12; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Matsui M, 2010, BIOCHEM BIOPH RES CO, V391, P1494, DOI 10.1016/j.bbrc.2009.12.100; McMahon RM, 2011, ACTA CRYSTALLOGR D, V67, P447, DOI 10.1107/S0907444911007888; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Pleguezuelos O, 2012, VACCINE, V30, P4655, DOI 10.1016/j.vaccine.2012.04.089; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Rodenko B, 2009, J AM CHEM SOC, V131, P12305, DOI 10.1021/ja9037565; Rognan D, 1999, J MED CHEM, V42, P4650, DOI 10.1021/jm9910775; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; Scheibenbogen C, 1997, CLIN CANCER RES, V3, P221; Schueler-Furman O, 2000, PROTEIN SCI, V9, P1838, DOI 10.1110/ps.9.9.1838; Sette A, 1998, CURR OPIN IMMUNOL, V10, P478, DOI 10.1016/S0952-7915(98)80124-6; Sharma AK, 2001, J BIOL CHEM, V276, P21443, DOI 10.1074/jbc.M010791200; Slansky JE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000482; Soema PC, 2015, PHARM RES-DORDR, V32, P1505, DOI 10.1007/s11095-014-1556-3; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Tan ACL, 2013, IMMUNOL CELL BIOL, V91, P96, DOI 10.1038/icb.2012.54; Tan ACL, 2011, J IMMUNOL, V187, P1895, DOI 10.4049/jimmunol.1100664; TENG JMC, 1994, MOL IMMUNOL, V31, P459, DOI 10.1016/0161-5890(94)90065-5; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Toebes Mireille, 2009, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1816s87; Trujillo JA, 2014, J IMMUNOL, V192, P5245, DOI 10.4049/jimmunol.1400111; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; World Health Organization, 2014, FACT SHEET INFL SEAS; Yanover C, 2011, P NATL ACAD SCI USA, V108, P6981, DOI 10.1073/pnas.1018165108	61	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0156462	10.1371/journal.pone.0156462	http://dx.doi.org/10.1371/journal.pone.0156462			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333291	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212800007
J	Sayqal, A; Xu, Y; Trivedi, DK; AlMasoud, N; Ellis, DI; Rattray, NJW; Goodacre, R				Sayqal, Ali; Xu, Yun; Trivedi, Drupad K.; AlMasoud, Najla; Ellis, David I.; Rattray, Nicholas J. W.; Goodacre, Royston			Metabolomics Analysis Reveals the Participation of Efflux Pumps and Ornithine in the Response of Pseudomonas putida DOT-T1E Cells to Challenge with Propranolol	PLOS ONE			English	Article							POTENT ENVIRONMENTAL-POLLUTANTS; PERSONAL CARE PRODUCTS; MASS-SPECTROMETRY; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PHYSIOLOGICAL-RESPONSES; MULTIDRUG TRANSPORTERS; LIQUID-CHROMATOGRAPHY; HUMAN PHARMACEUTICALS; GAS-CHROMATOGRAPHY	Efflux pumps are critically important membrane components that play a crucial role in strain tolerance in Pseudomonas putida to antibiotics and aromatic hydrocarbons that result in these toxicants being expelled from the bacteria. Here, the effect of propranolol on P. putida was examined by sudden addition of 0.2, 0.4 and 0.6 mg mL(-1) of this beta-blocker to several strains of P. putida, including the wild type DOT-T1E and the efflux pump knockout mutants DOT-T1E-PS28 and DOT-T1E-18. Bacterial viability measurements reveal that the efflux pump TtgABC plays a more important role than the TtgGHI pump in strain tolerance to propranolol. Mid-infrared (MIR) spectroscopy was then used as a rapid, high-throughput screening tool to investigate any phenotypic changes resulting from exposure to varying levels of propranolol. Multivariate statistical analysis of these MIR data revealed gradient trends in resultant ordination scores plots, which were related to the concentration of propranolol. MIR illustrated phenotypic changes associated with the presence of this drug within the cell that could be assigned to significant changes that occurred within the bacterial protein components. To complement this phenotypic fingerprinting approach metabolic profiling was performed using gas chromatography mass spectrometry (GC-MS) to identify metabolites of interest during the growth of bacteria following toxic perturbation with the same concentration levels of propranolol. Metabolic profiling revealed that ornithine, which was only produced by P. putida cells in the presence of propranolol, presents itself as a major metabolic feature that has important functions in propranolol stress tolerance mechanisms within this highly significant and environmentally relevant species of bacteria.	[Sayqal, Ali; Xu, Yun; Trivedi, Drupad K.; AlMasoud, Najla; Ellis, David I.; Rattray, Nicholas J. W.; Goodacre, Royston] Univ Manchester, Manchester Inst Biotechnol, Sch Chem, Manchester M1 7DN, Lancs, England	University of Manchester	Goodacre, R (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Sch Chem, Manchester M1 7DN, Lancs, England.	roy.goodacre@manchester.ac.uk	Goodacre, Roy/J-1600-2012; Xu, Yun/ABG-2114-2021; Ellis, David Ian/D-8603-2016; Rattray, Nicholas/AAX-7283-2021; Trivedi, Drupad/I-3904-2017; Goodacre, Roy/AAO-3194-2021	Goodacre, Roy/0000-0003-2230-645X; Xu, Yun/0000-0003-3228-5111; Ellis, David Ian/0000-0002-7633-7019; Trivedi, Drupad/0000-0001-7969-0195; Goodacre, Roy/0000-0003-2230-645X; Rattray, Nicholas/0000-0002-3528-6905	Umm Al-Qura University in Saudi Arabia; Saudi Ministry of higher education and Princess Nora bint Abdul Rahman University; Cancer Research UK; UK BBSRC [BBS/S/N/2004/11499, BBS/S/N/2005/12339]; Biotechnology and Biological Sciences Research Council [BB/M017702/1] Funding Source: researchfish; BBSRC [BB/M017702/1] Funding Source: UKRI	Umm Al-Qura University in Saudi Arabia; Saudi Ministry of higher education and Princess Nora bint Abdul Rahman University; Cancer Research UK(Cancer Research UK); UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AS thanks Umm Al-Qura University in Saudi Arabia for funding. NM thanks The Saudi Ministry of higher education and Princess Nora bint Abdul Rahman University for funding. YX and DKT thank the Cancer Research UK for funding (including an Experimental Cancer Medicine Centre award). RG thanks UK BBSRC for funding (BBS/S/N/2004/11499 and BBS/S/N/2005/12339).	Abbott DA, 2009, FEMS YEAST RES, V9, P1123, DOI 10.1111/j.1567-1364.2009.00537.x; Allwood JW, 2015, METABOLOMICS, V11, P438, DOI 10.1007/s11306-014-0674-6; Vences-Guzman MA, 2015, ENVIRON MICROBIOL, V17, P1487, DOI 10.1111/1462-2920.12562; Anton J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064701; Molina-Henares MA, 2010, ENVIRON MICROBIOL, V12, P1468, DOI 10.1111/j.1462-2920.2010.02166.x; Ashton D, 2004, SCI TOTAL ENVIRON, V333, P167, DOI 10.1016/j.scitotenv.2004.04.062; Baker MJ, 2016, CHEM SOC REV, V45, P1803, DOI 10.1039/c5cs00585j; Baker MJ, 2014, NAT PROTOC, V9, P1771, DOI 10.1038/nprot.2014.110; Begley P, 2009, ANAL CHEM, V81, P7038, DOI 10.1021/ac9011599; Bino RJ, 2004, TRENDS PLANT SCI, V9, P418, DOI 10.1016/j.tplants.2004.07.004; Breton R, 2003, QSAR COMB SCI, V22, P399, DOI 10.1002/qsar.200390030; Brito-Echeverria J, 2011, EXTREMOPHILES, V15, P379, DOI 10.1007/s00792-011-0366-3; Carlsson C, 2006, SCI TOTAL ENVIRON, V364, P67, DOI 10.1016/j.scitotenv.2005.06.035; Carlsson C, 2006, SCI TOTAL ENVIRON, V364, P88, DOI 10.1016/j.scitotenv.2005.06.036; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Dunn WB, 2015, METABOLOMICS, V11, P9, DOI 10.1007/s11306-014-0707-1; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j; Duque E, 2007, J BACTERIOL, V189, P207, DOI 10.1128/JB.00950-06; Eaton RW, 1996, J BACTERIOL, V178, P1351, DOI 10.1128/jb.178.5.1351-1362.1996; Ellis DI, 2007, PHARMACOGENOMICS, V8, P1243, DOI 10.2217/14622416.8.9.1243; Ellis DI, 2006, ANALYST, V131, P875, DOI 10.1039/b602376m; Ellis DI, 2012, CURR OPIN BIOTECH, V23, P22, DOI 10.1016/j.copbio.2011.10.014; Ellis DI, 2003, METABOLIC PROFILING: ITS ROLE IN BIOMARKER DISCOVERY AND GENE FUNCTION ANALYSIS, P111; Escher BI, 2005, ENVIRON SCI TECHNOL, V39, P3090, DOI 10.1021/es048590e; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Garcia V, 2010, ENV MICROBIOL REP, V2, P389, DOI 10.1111/j.1758-2229.2009.00093.x; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; Halling-Sorensen B, 1998, CHEMOSPHERE, V36, P357, DOI 10.1016/S0045-6535(97)00354-8; HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69; Huggett DB, 2002, ARCH ENVIRON CON TOX, V43, P229, DOI 10.1007/s00244-002-1182-7; Isken S, 1999, APPL ENVIRON MICROB, V65, P2631; Johnning A, 2013, APPL ENVIRON MICROB, V79, P7256, DOI 10.1128/AEM.02141-13; Johnson HE, 2003, PHYTOCHEMISTRY, V62, P919, DOI 10.1016/S0031-9422(02)00722-7; Jones OAH, 2002, WATER RES, V36, P5013, DOI 10.1016/S0043-1354(02)00227-0; Kell DB, 2004, BIOESSAYS, V26, P99, DOI 10.1002/bies.10385; KEWELOH H, 1990, APPL MICROBIOL BIOT, V33, P66; Kim DH, 2014, MOL BIOSYST, V10, P398, DOI 10.1039/c3mb70423h; Kol S, 2010, APPL ENVIRON MICROB, V76, P2574, DOI 10.1128/AEM.01992-09; Li XZ, 1998, J BACTERIOL, V180, P2987, DOI 10.1128/JB.180.11.2987-2991.1998; Liu MM, 2012, ENVIRON SCI TECHNOL, V46, P7551, DOI 10.1021/es301145m; MACFIE HJH, 1978, J GEN MICROBIOL, V104, P67, DOI 10.1099/00221287-104-1-67; Marathe NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077310; Martens H, 2003, ANAL CHEM, V75, P394, DOI 10.1021/ac020194w; Mashego MR, 2007, BIOTECHNOL LETT, V29, P1, DOI 10.1007/s10529-006-9218-0; Molina-Santiago C, 2014, ENVIRON MICROBIOL, V16, P1267, DOI 10.1111/1462-2920.12368; Mosqueda G, 2000, J BACTERIOL, V182, P937, DOI 10.1128/JB.182.4.937-943.2000; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Pandey J, 2009, FEMS MICROBIOL REV, V33, P324, DOI 10.1111/j.1574-6976.2008.00133.x; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; POULIQUEN H, 1992, MAR ECOL PROG SER, V89, P93, DOI 10.3354/meps089093; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Ramos JL, 1998, J BACTERIOL, V180, P3323, DOI 10.1128/JB.180.13.3323-3329.1998; RAMOS JL, 1995, J BACTERIOL, V177, P3911, DOI 10.1128/jb.177.14.3911-3916.1995; Ramos JL, 1997, J BIOL CHEM, V272, P3887, DOI 10.1074/jbc.272.7.3887; Roca A, 2008, MICROB BIOTECHNOL, V1, P158, DOI 10.1111/j.1751-7915.2007.00014.x; Rojas A, 2004, APPL ENVIRON MICROB, V70, P3637, DOI 10.1128/aem.70.6.3637-3643.2004; Rojas A, 2001, J BACTERIOL, V183, P3967, DOI 10.1128/JB.183.13.3967-3973.2001; Rojo F, 2010, FEMS MICROBIOL REV, V34, P658, DOI 10.1111/j.1574-6976.2010.00218.x; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Segura A, 2005, J BACTERIOL, V187, P5937, DOI 10.1128/JB.187.17.5937-5945.2005; Seiler JP, 2002, TOXICOL LETT, V131, P105, DOI 10.1016/S0378-4274(02)00045-0; Smilde AK, 2003, J CHEMOMETR, V17, P323, DOI 10.1002/cem.811; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Teran W, 2003, ANTIMICROB AGENTS CH, V47, P3067, DOI 10.1128/AAC.47.10.3067-3072.2003; Thacker PD, 2005, ENVIRON SCI TECHNOL, V39, p193A; Thomas KV, 2004, MAR POLLUT BULL, V49, P436, DOI 10.1016/j.marpolbul.2004.02.028; van der Werf MJ, 2008, MOL BIOSYST, V4, P315, DOI 10.1039/b717340g; Villas-Boas SG, 2005, MASS SPECTROM REV, V24, P613, DOI 10.1002/mas.20032; Volkers RJM, 2009, EXTREMOPHILES, V13, P283, DOI 10.1007/s00792-008-0216-0; Wedge DC, 2011, ANAL CHEM, V83, P6689, DOI 10.1021/ac2012224; Westerhoff HV, 2009, J MATH BIOL, V58, P7, DOI 10.1007/s00285-008-0160-8; Wijte D, 2011, J PROTEOME RES, V10, P394, DOI 10.1021/pr100401n; Winder CL, 2008, ANAL CHEM, V80, P2939, DOI 10.1021/ac7023409; Winder CL, 2006, MICROBIOL-SGM, V152, P2757, DOI 10.1099/mic.0.28986-0; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Xu Y, 2012, METABOLOMICS, V8, pS37, DOI 10.1007/s11306-011-0361-9; Zhang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026041	84	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0156509	10.1371/journal.pone.0156509	http://dx.doi.org/10.1371/journal.pone.0156509			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27331395	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000378212800008
J	Hilton, B; Gopal, S; Xu, LF; Mazumder, S; Musich, PR; Cho, BP; Zou, Y				Hilton, Benjamin; Gopal, Sathyaraj; Xu, Lifang; Mazumder, Sharmistha; Musich, Phillip R.; Cho, Bongsup P.; Zou, Yue			Dissociation Dynamics of XPC-RAD23B from Damaged DNA Is a Determining Factor of NER Efficiency	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; SURFACE-PLASMON RESONANCE; ESCHERICHIA-COLI; XERODERMA-PIGMENTOSUM; CONFORMATIONAL HETEROGENEITY; SEQUENCE CONTEXT; AROMATIC-AMINES; UVRABC NUCLEASE; NARI SEQUENCE; F-19 NMR	XPC-RAD23B (XPC) plays a critical role in human nucleotide excision repair (hNER) as this complex recognizes DNA adducts to initiate NER. To determine the mutagenic potential of structurally different bulky DNA damages, various studies have been conducted to define the correlation of XPC-DNA damage equilibrium binding affinity with NER efficiency. However, little is known about the effects of XPC-DNA damage recognition kinetics on hNER. Although association of XPC is important, our current work shows that the XPC-DNA dissociation rate also plays a pivotal role in achieving NER efficiency. We characterized for the first time the binding of XPC to mono-versus di-AAF-modified sequences by using the real time monitoring surface plasmon resonance technique. Strikingly, the half-life (t(1/2) or the retention time of XPC in association with damaged DNA) shares an inverse relationship with NER efficiency. This is particularly true when XPC remained bound to clustered adducts for a much longer period of time as compared to mono-adducts. Our results suggest that XPC dissociation from the damage site could become a rate-limiting step in NER of certain types of DNA adducts, leading to repression of NER.	[Hilton, Benjamin; Mazumder, Sharmistha; Musich, Phillip R.; Zou, Yue] E Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA; [Gopal, Sathyaraj; Xu, Lifang; Cho, Bongsup P.] Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA	East Tennessee State University; University of Rhode Island	Zou, Y (corresponding author), E Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA.; Cho, BP (corresponding author), Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA.	bcho@uri.edu; zouy@etsu.edu	Zou, Yue/ABA-8429-2020	Musich, Phillip/0000-0001-8816-4242	National Institutes of Health [CA86927, CA098296]; NATIONAL CANCER INSTITUTE [R01CA086927, R01CA098296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM112168, P20GM103430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (Grants CA86927 to YZ and CA098296 to BPC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KE, 1997, CARCINOGENESIS, V18, P1085, DOI 10.1093/carcin/18.5.1085; Bergink S, 2012, J CELL BIOL, V196, P681, DOI 10.1083/jcb.201107050; Bradshaw JM, 2015, NAT CHEM BIOL, V11, P525, DOI [10.1038/NCHEMBIO.1817, 10.1038/nchembio.1817]; Chen XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6849; Cho BP, 1999, BIOCHEMISTRY-US, V38, P7572, DOI 10.1021/bi990182d; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; HEFLICH RH, 1994, MUTAT RES-REV GENET, V318, P73, DOI 10.1016/0165-1110(94)90025-6; Hilton B, 2014, BIOSCIENCE REP, V34, P831, DOI 10.1042/BSR20140158; Jaciuk M, 2011, NAT STRUCT MOL BIOL, V18, P191, DOI 10.1038/nsmb.1973; Jain V, 2014, BIOCHEMISTRY-US, V53, P4059, DOI 10.1021/bi5003212; Jain V, 2013, CHEM RES TOXICOL, V26, P1251, DOI 10.1021/tx400186v; Jain V, 2013, NUCLEIC ACIDS RES, V41, P869, DOI 10.1093/nar/gks1077; Jain V, 2012, NUCLEIC ACIDS RES, V40, P3939, DOI 10.1093/nar/gkr1307; Juricek L, 2015, ARCH TOXICOL, V89, P2403, DOI 10.1007/s00204-014-1367-7; Kalam MA, 2005, CHEM RES TOXICOL, V18, P1187, DOI 10.1021/tx050119r; Kortt AA, 1997, J MOL RECOGNIT, V10, P148, DOI 10.1002/(SICI)1099-1352(199705/06)10:3<148::AID-JMR360>3.0.CO;2-F; Lee YC, 2014, DNA REPAIR, V19, P55, DOI 10.1016/j.dnarep.2014.03.026; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Liu YY, 2011, DNA REPAIR, V10, P1145, DOI 10.1016/j.dnarep.2011.08.012; Luch A, 2005, NAT REV CANCER, V5, P113, DOI 10.1038/nrc1546; Luijsterburg MS, 2010, J CELL BIOL, V189, P445, DOI 10.1083/jcb.200909175; Malta E, 2006, J BIOL CHEM, V281, P2184, DOI 10.1074/jbc.M508901200; Mekhovich O, 1998, BIOCHEMISTRY-US, V37, P571, DOI 10.1021/bi971544p; MELCHIOR WB, 1994, CARCINOGENESIS, V15, P889, DOI 10.1093/carcin/15.5.889; Meneni SR, 2007, BIOCHEMISTRY-US, V46, P11263, DOI 10.1021/bi700858s; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Missura M, 2001, EMBO J, V20, P3554, DOI 10.1093/emboj/20.13.3554; MU D, 1994, NUCLEIC ACIDS RES, V22, P4869, DOI 10.1093/nar/22.23.4869; Mu H, 2012, NUCLEIC ACIDS RES, V40, P9675, DOI 10.1093/nar/gks788; Neumann HG, 2007, CRIT REV TOXICOL, V37, P211, DOI 10.1080/10408440601028603; Pakotiprapha D, 2008, MOL CELL, V29, P122, DOI 10.1016/j.molcel.2007.10.026; Pakotiprapha D, 2012, NAT STRUCT MOL BIOL, V19, P291, DOI 10.1038/nsmb.2240; Patnaik S, 2010, CHEM RES TOXICOL, V23, P1650, DOI 10.1021/tx100341u; Poirier MC, 2012, DISCOV MED, V14, P283; Puumalainen MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4695; Ray A, 2013, DNA REPAIR, V12, P273, DOI 10.1016/j.dnarep.2013.01.003; Reardon JT, 1996, J BIOL CHEM, V271, P19451, DOI 10.1074/jbc.271.32.19451; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; SEEBERG E, 1990, P NATL ACAD SCI USA, V87, P191, DOI 10.1073/pnas.87.1.191; Shell SM, 2013, DNA REPAIR, V12, P947, DOI 10.1016/j.dnarep.2013.08.013; Shikazono N, 2006, NUCLEIC ACIDS RES, V34, P3722, DOI 10.1093/nar/gkl503; Shivji MKK, 1999, METH MOL B, V113, P373; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2009, MOL CELL, V36, P642, DOI 10.1016/j.molcel.2009.09.035; Trego KS, 2006, BIOCHEMISTRY-US, V45, P1961, DOI 10.1021/bi051936t; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Vaidyanathan VG, 2012, CHEM RES TOXICOL, V25, P1568, DOI 10.1021/tx300289d; Vaidyanathan VG, 2013, NATURE PROTOCOL EXCH, DOI [10.1038/protex.2013.054, DOI 10.1038/PROTEX.2013.054]; VANHOUTEN B, 1990, MICROBIOL REV, V54, P18, DOI 10.1128/MMBR.54.1.18-51.1990; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wagner K, 2010, DNA REPAIR, V9, P1176, DOI 10.1016/j.dnarep.2010.08.008; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Walkup GK, 2015, NAT CHEM BIOL, V11, P416, DOI 10.1038/nchembio.1796; Wood RD, 1999, BIOCHIMIE, V81, P39, DOI 10.1016/S0300-9084(99)80036-4; Xu LF, 2014, CHEM RES TOXICOL, V27, P1796, DOI 10.1021/tx500252z; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q; Yeo JE, 2012, CHEM RES TOXICOL, V25, P2462, DOI 10.1021/tx3003033; You JS, 2003, J BIOL CHEM, V278, P7476, DOI 10.1074/jbc.M210603200; Zou Y, 1998, J MOL BIOL, V281, P107, DOI 10.1006/jmbi.1998.1903; Zou Y, 1999, EMBO J, V18, P4889, DOI 10.1093/emboj/18.17.4889; Zou Y, 2003, BIOCHEMISTRY-US, V42, P12654, DOI 10.1021/bi034446e; Zou Y, 2001, BIOCHEMISTRY-US, V40, P2923, DOI 10.1021/bi001504c; ZOU Y, 1994, BIOCHEMISTRY-US, V33, P5404, DOI 10.1021/bi00184a007; Zou Y, 2004, BIOCHEMISTRY-US, V43, P4196, DOI 10.1021/bi035992a; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	67	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157784	10.1371/journal.pone.0157784	http://dx.doi.org/10.1371/journal.pone.0157784			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327897	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212400046
J	Anand, T; Talluri, TR; Kumar, D; Garrels, W; Mukherjee, A; Debowski, K; Behr, R; Kues, WA				Anand, Taruna; Talluri, Thirumala R.; Kumar, Dharmendra; Garrels, Wiebke; Mukherjee, Ayan; Debowski, Katharina; Behr, Ruediger; Kues, Wilfried A.			Differentiation of Induced Pluripotent Stem Cells to Lentoid Bodies Expressing a Lens Cell-Specific Fluorescent Reporter	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; CATARACT-CAUSING ALLELE; A-CRYSTALLIN GENE; SLEEPING-BEAUTY; GERMLINE TRANSGENESIS; CONGENITAL CATARACT; MUTATION ANALYSIS; EPITHELIAL-CELLS; CRYAA; MICROINJECTION	Curative approaches for eye cataracts and other eye abnormalities, such as myopia and hyperopia currently suffer from a lack of appropriate models. Here, we present a new approach for in vitro growth of lentoid bodies from induced pluripotent stem (iPS) cells as a tool for ophthalmological research. We generated a transgenic mouse line with lens-specific expression of a fluorescent reporter driven by the alphaA crystallin promoter. Fetal fibroblasts were isolated from transgenic fetuses, reprogrammed to iPS cells, and differentiated to lentoid bodies exploiting the specific fluorescence of the lens cell-specific reporter. The employment of cell type-specific reporters for establishing and optimizing differentiation in vitro seems to be an efficient and generally applicable approach for developing differentiation protocols for desired cell populations.	[Anand, Taruna; Talluri, Thirumala R.; Kumar, Dharmendra; Mukherjee, Ayan; Kues, Wilfried A.] Friedrich Loeffler Inst, Inst Nutztiergenet, Neustadt, Germany; [Anand, Taruna; Talluri, Thirumala R.] ICAR Natl Res Ctr Equines, Hisar, Haryana, India; [Kumar, Dharmendra] ICAR Cent Inst Res Buffalos, Hisar, Haryana, India; [Garrels, Wiebke] Hannover Med Sch, Hannover, Germany; [Debowski, Katharina; Behr, Ruediger] German Primate Ctr, Gottingen, Germany	Friedrich Loeffler Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines; Indian Council of Agricultural Research (ICAR); ICAR - Central Institute for Research on Buffaloes; Hannover Medical School; Deutsches Primatenzentrum (DPZ)	Kues, WA (corresponding author), Friedrich Loeffler Inst, Inst Nutztiergenet, Neustadt, Germany.	wilfried.kues@fli.bund.de	Mukherjee, Ayan/AAG-6345-2021; Kues, Wilfried/AAX-2466-2020	Mukherjee, Ayan/0000-0003-2389-6594; Kues, Wilfried/0000-0002-0850-8103	Deutsche Forschungsgemeinschaft [KU 1586/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (KU 1586/2-1) to WAK, a NAIP India Fellowship to TA, a DBT CREST Fellowship to DK, and the Indian Council of Agricultural Research (ICAR) International Fellowships to TRT and AM The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Beby F, 2007, ARCH OPHTHALMOL-CHIC, V125, P213, DOI 10.1001/archopht.125.2.213; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Brandl C, 2014, NEUROMOL MED, V16, P551, DOI 10.1007/s12017-014-8308-8; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Cornett JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029486; Cvekl A, 2007, PROG RETIN EYE RES, V26, P555, DOI 10.1016/j.preteyeres.2007.07.002; DAMJANOV I, 1984, CELL DIFFER DEV, V15, P133, DOI 10.1016/0045-6039(84)90065-4; Dong LM, 2009, ARCH OPHTHALMOL-CHIC, V127, P1412, DOI 10.1001/archophthalmol.2009.152; Garrels W, 2015, BIOTECHNOL J, V11, P178, DOI [10.1002/biot.201500218, DOI 10.1002/BI0T.201500218]; Garrels W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023573; Grabundzija I, 2013, NUCLEIC ACIDS RES, V41, P1829, DOI 10.1093/nar/gks1305; Graw J, 2006, GRAEF ARCH CLIN EXP, V244, P912, DOI 10.1007/s00417-005-0234-x; Hansen L, 2007, INVEST OPHTH VIS SCI, V48, P3937, DOI 10.1167/iovs.07-0013; Hayashi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045435; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Hirano M, 2003, DEV DYNAM, V228, P664, DOI 10.1002/dvdy.10425; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Iqbal K, 2009, BIOTECHNIQUES, V47, P959, DOI 10.2144/000113270; Ivics Z, 2014, NAT PROTOC, V9, P810, DOI 10.1038/nprot.2014.010; Ivics Z, 2014, NAT PROTOC, V9, P773, DOI 10.1038/nprot.2014.008; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Khan AO, 2007, AM J OPHTHALMOL, V144, P949, DOI 10.1016/j.ajo.2007.08.005; Kues WA, 2013, STEM CELLS DEV, V22, P124, DOI 10.1089/scd.2012.0382; LEE VMY, 1986, J NEUROSCI, V6, P514; Long QM, 1997, DEVELOPMENT, V124, P4105; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Maeda T, 2013, J BIOL CHEM, V288, P34484, DOI 10.1074/jbc.M113.518571; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Mikhailova A, 2014, STEM CELL REP, V2, P219, DOI 10.1016/j.stemcr.2013.12.014; Pauli S, 2007, MOL VIS, V13, P962; Qiu XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032612; ROSSANT J, 1982, J EMBRYOL EXP MORPH, V70, P99; Sakaguchi M, 2014, MOL BIOTECHNOL, V56, P621, DOI 10.1007/s12033-014-9738-0; Santana A, 2009, MOL VIS, V15, P793; Santhiya S, 2006, MOL VIS, V12, P768; Shalom-Feuerstein R, 2013, P NATL ACAD SCI USA, V110, P2152, DOI 10.1073/pnas.1201753109; Streit A, 2004, DEV BIOL, V276, P1, DOI 10.1016/j.ydbio.2004.08.037; Talluri TR, 2015, CELL REPROGRAM, V17, P131, DOI 10.1089/cell.2014.0080; Talluri TR, 2014, BIOCHEM BIOPH RES CO, V450, P581, DOI 10.1016/j.bbrc.2014.06.014; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wang J, 2008, PROTEOMIC STUDIES ST; Wolf L, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-88; Xi JH, 2003, J CELL SCI, V116, P1073, DOI 10.1242/jcs.00325; Xi JH, 2008, J BIOL CHEM, V283, P5801, DOI 10.1074/jbc.M708704200; Yang CB, 2010, FASEB J, V24, P3274, DOI 10.1096/fj.10-157255; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108	50	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157570	10.1371/journal.pone.0157570	http://dx.doi.org/10.1371/journal.pone.0157570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322380	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212000027
J	Fan, B; Guan, J; Wang, XM; Cong, YL				Fan, Bing; Guan, Jie; Wang, Xiumei; Cong, Yulong			Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model	PLOS ONE			English	Article							GALLERIA-MELLONELLA MODEL; IN-VIVO EFFICACY; FIELD GEL-ELECTROPHORESIS; TRACT-INFECTION; VITRO SYNERGY; MOUSE MODEL; CARBAPENEM; THERAPY; PNEUMONIA; METAANALYSIS	Few effective therapeutic options are available for treating severe infections caused by extensively drug-resistant Acinetobacter baumannii (XDR-AB). Using a murine thigh-infection model, we examined the in vivo efficacy of colistin in combination with meropenem, tige-cycline, fosfomycin, fusidic acid, rifampin, or sulbactam against 12 XDR-AB strains. Colistin, tigecycline, rifampin, and sulbactam monotherapy significantly decreased bacterial counts in murine thigh infections compared with those observed in control mice receiving no treatment. Colistin was the most effective agent tested, displaying bactericidal activity against 91.7% of strains at 48 h post-treatment. With strains showing a relatively low minimum inhibitory concentration (MIC) for meropenem (MIC <= 32 mg/L), combination therapy with colistin plus meropenem caused synergistic inhibition at both 24 h and 48 h post-treatment. However, when the meropenem MIC was >= 64 mg/L, meropenem did not significantly alter the efficacy of colistin. The addition of rifampin and fusidic acid significantly improved the efficacy of colistin, showing a synergistic effect in 100% and 58.3% of strains after 24 h of treatment, respectively, while the addition of tigecycline, fosfomycin, or sulbactam did not show obvious synergistic activity. No clear differences in activities were observed between colistin-rifampin and colistin-fusidic acid combination therapy with most strains. Overall, our in vivo study showed that administering colistin in combination with rifampin or fusidic acid is more efficacious in treating XDR-AB infections than other combinations. The colistin-meropenem combination may be another appropriate option if the MIC is <= 32 mg/L. Further clinical studies are urgently needed to confirm the relevance of these findings.	[Fan, Bing; Cong, Yulong] Chinese Peoples Liberat Army Gen Hosp, Clin Lab South Bldg, Beijing 100853, Peoples R China; [Fan, Bing] Gen Hosp Chinese Peoples Armed Police Forces, Clin Lab Clin Dist 2, Beijing 100039, Peoples R China; [Guan, Jie] Peking Univ, Hosp 1, Dept Clin Lab, Beijing 100034, Peoples R China; [Wang, Xiumei] Gen Hosp Chinese Peoples Armed Police Forces, Dept Clin Lab, Beijing 100039, Peoples R China	Chinese People's Liberation Army General Hospital; Peking University	Cong, YL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Clin Lab South Bldg, Beijing 100853, Peoples R China.	congyulongpla301@163.com						Barthold SW, 2010, ANTIMICROB AGENTS CH, V54, P643, DOI 10.1128/AAC.00788-09; BELLAHSENE A, 1980, INFECT IMMUN, V29, P873; Biswas S, 2012, EXPERT REV ANTI-INFE, V10, P917, DOI [10.1586/eri.12.78, 10.1586/ERI.12.78]; Cheng A, 2015, CRIT CARE MED, V43, P1194, DOI 10.1097/CCM.0000000000000933; Chuang YC, 2011, CLIN INFECT DIS, V52, P352, DOI 10.1093/cid/ciq154; Clinical and Laboratory Standards Institute, 2014, CLSI DOCUMENT M100 S; Clinical and Laboratory Standards Institute, 2012, CLSI DOCUMENT M07 A9; Dinc G, 2013, CHEMOTHERAPY, V59, P325, DOI 10.1159/000356755; Durante-Mangoni E, 2013, CLIN INFECT DIS, V57, P349, DOI 10.1093/cid/cit253; Galani I, 2014, INT J ANTIMICROB AG, V43, P370, DOI 10.1016/j.ijantimicag.2013.12.010; Gordon NC, 2010, ANTIMICROB AGENTS CH, V54, P5316, DOI 10.1128/AAC.00922-10; GOUBY A, 1992, J CLIN MICROBIOL, V30, P1588, DOI 10.1128/JCM.30.6.1588-1591.1992; Hornsey M, 2011, ANTIMICROB AGENTS CH, V55, P3534, DOI 10.1128/AAC.00230-11; Hornsey M, 2013, INT J ANTIMICROB AG, V41, P285, DOI 10.1016/j.ijantimicag.2012.11.013; Lee HJ, 2013, ANTIMICROB AGENTS CH, V57, P3738, DOI 10.1128/AAC.00703-13; Lefort A, 2014, INT J ANTIMICROB AG, V43, P366, DOI 10.1016/j.ijantimicag.2013.12.001; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Michail G, 2013, ANTIMICROB AGENTS CH, V57, P6028, DOI 10.1128/AAC.00891-13; Montero A, 2002, ANTIMICROB AGENTS CH, V46, P1946, DOI 10.1128/AAC.46.6.1946-1952.2002; Morinaga Y, 2008, J ANTIMICROB CHEMOTH, V62, P1326, DOI 10.1093/jac/dkn411; Ni WT, 2015, INT J ANTIMICROB AG, V45, P8, DOI 10.1016/j.ijantimicag.2014.10.002; Pachon-Ibanez ME, 2010, ANTIMICROB AGENTS CH, V54, P1165, DOI 10.1128/AAC.00367-09; Paul M, 2014, J ANTIMICROB CHEMOTH, V69, P2305, DOI 10.1093/jac/dku168; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Phee LM, 2015, ANTIMICROB AGENTS CH, V59, P4544, DOI 10.1128/AAC.00753-15; Pogue JM, 2013, EXPERT REV ANTI-INFE, V11, P881, DOI 10.1586/14787210.2013.827881; Song JY, 2007, J ANTIMICROB CHEMOTH, V60, P317, DOI 10.1093/jac/dkm136; Song JY, 2009, INT J ANTIMICROB AG, V33, P33, DOI 10.1016/j.ijantimicag.2008.07.008; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Vila J, 2012, EXPERT OPIN PHARMACO, V13, P2319, DOI 10.1517/14656566.2012.729820; Wareham DW, 2011, J ANTIMICROB CHEMOTH, V66, P1047, DOI 10.1093/jac/dkr069; Yang HF, 2015, INT J ANTIMICROB AG, V45, P188, DOI 10.1016/j.ijantimicag.2014.10.012; Yilmaz EM, 2012, INT J ANTIMICROB AG, V40, P332, DOI 10.1016/j.ijantimicag.2012.06.003; Zusman O, 2013, ANTIMICROB AGENTS CH, V57, P5104, DOI 10.1128/AAC.01230-13	36	47	51	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157757	10.1371/journal.pone.0157757	http://dx.doi.org/10.1371/journal.pone.0157757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315107	Green Submitted, gold, Green Published			2022-12-26	WOS:000378030000051
J	Gonzalez-Pena, D; Nixon, SE; Southey, BR; Lawson, MA; McCusker, RH; Hernandez, AG; Dantzer, R; Kelley, KW; Rodriguez-Zas, SL				Gonzalez-Pena, Dianelys; Nixon, Scott E.; Southey, Bruce R.; Lawson, Marcus A.; McCusker, Robert H.; Hernandez, Alvaro G.; Dantzer, Robert; Kelley, Keith W.; Rodriguez-Zas, Sandra L.			Differential Transcriptome Networks between IDO1-Knockout and Wild-Type Mice in Brain Microglia and Macrophages	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; INDOLEAMINE 2,3-DIOXYGENASE; ANALYSIS REVEALS; MYELOID CELLS; MOUSE MODEL; T-CELLS; PROTEIN; IDENTIFICATION; RNA	Microglia in the brain and macrophages in peripheral organs are cell types responsible for immune response to challenges. Indoleamine 2,3-dioxygenase 1 (IDO1) is an immunomodulatory enzyme of the tryptophan pathway that is expressed in the brain. The higher activity of IDO1 in response to immune challenge has been implicated in behavioral disorders. The impact of IDO1 depletion on the microglia transcriptome has not been studied. An investigation of the transcript networks in the brain microglia from IDO1-knockout (IDO1-KO) mice was undertaken, relative to peripheral macrophages and to wild-type (WT) mice under unchallenged conditions. Over 105 transcript isoforms were differentially expressed between WT and IDO1-KO within cell type. Within microglia, Saa3 and Irg1 were over-expressed in IDO1-KO relative to WT. Within macrophages, Csf3 and Sele were over-expressed in IDO1-KO relative to WT. Among the genes differentially expressed between strains, enriched biological processes included ion homeostasis and ensheathment of neurons within microglia, and cytokine and chemokine expression within macrophages. Over 11,110 transcript isoforms were differentially expressed between microglia and macrophages and of these, over 10,800 transcripts overlapped between strains. Enriched biological processes among the genes over- and under-expressed in microglia relative to macrophages included cell adhesion and apoptosis, respectively. Detected only in microglia or macrophages were 421 and 43 transcript isoforms, respectively. Alternative splicing between cell types based on differential transcript isoform abundance was detected in 210 genes including Phf11d, H2afy, and Abr. Across strains, networks depicted a predominance of genes under-expressed in microglia relative to macrophages that may be a precursor for the different response of both cell types to challenges. The detected transcriptome differences enhance the understanding of the role of IDO1 in the microglia transcriptome under unchallenged conditions.	[Gonzalez-Pena, Dianelys; Nixon, Scott E.; Southey, Bruce R.; Lawson, Marcus A.; McCusker, Robert H.; Kelley, Keith W.; Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Hernandez, Alvaro G.] Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA; [Dantzer, Robert] Univ Illinois, Roy J Carver Biotechnol Ctr, High Throughput Sequencing & Genotyping Unit, Urbana, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Stat, Champaign, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Carle Woese Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; UTMD Anderson Cancer Center; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL USA.; Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Stat, Champaign, IL USA.; Rodriguez-Zas, SL (corresponding author), Univ Illinois, Carle Woese Inst Genom Biol, Urbana, IL USA.	rodrgzzs@illinois.edu	Peña, Dianelys Gonzalez/AAF-4021-2019	Peña, Dianelys Gonzalez/0000-0003-4846-7569; Southey, Bruce/0000-0002-8959-7709; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Dantzer, Robert/0000-0001-9399-6107	NIH [R21 MH 096030, R01 MH 090127, R01 SUB UT 00000712, R01 MH083767]; USDA NIFA grant [ILLU-538-632, ILLU-538-909]; NIH National Institute of Drug Abuse [5P30DA018310]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA NIFA grant; NIH National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The support of NIH grant numbers: R21 MH 096030 to SRZ, R01 MH 090127 to RHM, R01 SUB UT 00000712 to KWK, R01 MH083767 to MAL, USDA NIFA grant numbers ILLU-538-632 to SRZ and ILLU-538-909 to SRZ, and 5P30DA018310 NIH National Institute of Drug Abuse to Bruce Southey to BRS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Akhtar MN, 2012, J PROTEOME RES, V11; Balch SG, 2002, EUR J IMMUNOGENET, V29, P61, DOI 10.1046/j.1365-2370.2002.00266.x; Ball HJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00485; Beardsley DI, 2003, EXP CELL RES, V290, P402, DOI 10.1016/S0014-4827(03)00353-7; Bell-Temin H, 2012, PROTEOMICS, V12, P246, DOI 10.1002/pmic.201100398; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bsibsi M, 2010, J IMMUNOL, V184, P6929, DOI 10.4049/jimmunol.0902419; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Caetano-Anolles K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116828; Chang MY, 2014, CANCER BIOL THER, V12, P1050; Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Cho YJ, 2007, MOL CELL BIOL, V27, P899, DOI 10.1128/MCB.00756-06; Cunnick JM, 2009, MOL CELL BIOL, V29, P5742, DOI 10.1128/MCB.00357-09; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Das A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121117; Delfino KR, 2011, CANCER GENOM PROTEOM, V8, P173; Delfino KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058608; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Dobos N, 2012, J ALZHEIMERS DIS, V28, P905, DOI 10.3233/JAD-2011-111097; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Finelli D, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.08.001; FORD AL, 1995, J IMMUNOL, V154, P4309; Foulkes T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000086; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goldmann O, 2007, INFECT IMMUN, V75, P4148, DOI 10.1128/IAI.00181-07; Gomes-Leal W, 2012, BRAIN BEHAV, V2, P345, DOI 10.1002/brb3.51; Gonzalez-Pena D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150858; Gow DJ, 2014, MOL THER, V22, P1580, DOI 10.1038/mt.2014.112; He JQ, 2008, EUR RESPIR J, V32, P25, DOI 10.1183/09031936.00040307; HEISTERKAMP N, 1989, NUCLEIC ACIDS RES, V17, P8821, DOI 10.1093/nar/17.21.8821; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hobson GM, 2002, ANN NEUROL, V52, P477, DOI 10.1002/ana.10320; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066546; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Jiang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059229; Karlstetter M, 2010, J IMMUNOL, V185, P3379, DOI 10.4049/jimmunol.0903300; Keum S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003807; Kim H, 2012, J CLIN INVEST, V122, P2940, DOI 10.1172/JCI61884; Kim JM, 2006, DNA RES, V13, P275, DOI 10.1093/dnares/dsl016; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Kolodziej L, 2013, TRANSGENIC RES, V22, P1049, DOI 10.1007/s11248-013-9696-5; KONIG G, 1992, J BIOL CHEM, V267, P10804; Kota RS, 2006, BIOCHEM BIOPH RES CO, V342, P1137, DOI 10.1016/j.bbrc.2006.02.087; Krappa R, 1999, P NATL ACAD SCI USA, V96, P4633, DOI 10.1073/pnas.96.8.4633; Kuhn H, 1996, PROG LIPID RES, V35, P203, DOI 10.1016/S0163-7827(96)00008-2; Lauridsen JB, 2011, NEUROSCI RES, V70, P269, DOI 10.1016/j.neures.2011.03.011; Linnartz B, 2012, CELL TISSUE RES, V349, P215, DOI 10.1007/s00441-012-1342-7; Linnartz-Gerlach B, 2014, NEUROSCIENCE, V275, P113, DOI 10.1016/j.neuroscience.2014.05.061; Liu J, 2007, J PROTEOME RES, V6, P3614, DOI 10.1021/pr0701512; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Loniewski KJ, 2007, MOL IMMUNOL, V44, P3715, DOI 10.1016/j.molimm.2007.04.002; Madeddu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127336; Magee DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032034; Markart P, 2004, BIOCHEM J, V380, P385, DOI 10.1042/BJ20031810; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; McDonald JG, 2010, J LEUKOCYTE BIOL, V88, P1071, DOI 10.1189/jlb.0710418; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; Mellor AL, 2003, J IMMUNOL, V171, P1652, DOI 10.4049/jimmunol.171.4.1652; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Moog U, 2011, J MED GENET, V48, P741, DOI 10.1136/jmedgenet-2011-100218; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Nakagawa T, 1997, P NATL ACAD SCI USA, V94, P9654, DOI 10.1073/pnas.94.18.9654; Nikodemova M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-147; Nixon SE, 2015, J BIOINF COMPUT BIOL, V13, DOI 10.1142/S0219720015500109; Oskolkova OV, 2010, J IMMUNOL, V185, P7706, DOI 10.4049/jimmunol.0903594; Otto EA, 2009, J MED GENET, V46, P663, DOI 10.1136/jmg.2009.066613; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Prendergast GC, 2008, ONCOGENE, V27, P3889, DOI 10.1038/onc.2008.35; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Reno C, 1997, BIOTECHNIQUES, V22, P1082, DOI 10.2144/97226bm16; Rodriguez-Zas SL, 2015, BRAIN BEHAV IMMUN, V44, P176, DOI 10.1016/j.bbi.2014.09.018; Sadasivan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124047; Sadeque A, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-59; Serao NVL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078530; Serao NVL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-94; Serao NVL, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-49; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siddiqui S, 2013, CELL IMMUNOL, V281, P159, DOI 10.1016/j.cellimm.2013.03.001; Smith ME, 1998, J NEUROSCI RES, V54, P68, DOI 10.1002/(SICI)1097-4547(19981001)54:1<68::AID-JNR8>3.0.CO;2-F; Solga AC, 2015, GLIA, V63, P531, DOI 10.1002/glia.22754; Sosa RA, 2013, J IMMUNOL, V191, P5848, DOI 10.4049/jimmunol.1300771; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Stamova B, 2012, INTERNATIONAL MEETIN; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swearingen KE, 2010, J PROTEOME RES, V9, P2412, DOI 10.1021/pr901124u; Szulzewsky F., 2015, THESIS; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; Taylor JMW, 2010, CARDIOVASC RES, V86, P526, DOI 10.1093/cvr/cvq015; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Weisser SB, 2011, EUR J IMMUNOL, V41, P1742, DOI 10.1002/eji.201041105; Williams WM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-127; Winter J, 2004, HUM GENET, V114, P541, DOI 10.1007/s00439-004-1114-x; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628; Yool D, 2002, GLIA, V39, P256, DOI 10.1002/glia.10103; Yutsudo N, 2013, NEUROPSYCHOPHARMACOL, V38, P895, DOI 10.1038/npp.2012.260; Zavala C, 2014, PROCEEDINGS OF THE 6, P93; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhang Y., 2014, MEDIAT INFLAMM, V2014, P11, DOI DOI 10.3171/2014.11.JNS14770; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhao PS, 2013, INFECT GENET EVOL, V20, P257, DOI 10.1016/j.meegid.2013.09.016; Zhu XL, 2014, NAT NEUROSCI, V17, P773, DOI 10.1038/nn.3713	113	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157727	10.1371/journal.pone.0157727	http://dx.doi.org/10.1371/journal.pone.0157727			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314674	Green Submitted, Green Published, gold			2022-12-26	WOS:000378030000047
J	Johnson, FA; Fackler, PL; Boomer, GS; Zimmerman, GS; Williams, BK; Nichols, JD; Dorazio, RM				Johnson, Fred A.; Fackler, Paul L.; Boomer, G. Scott; Zimmerman, Guthrie S.; Williams, Byron K.; Nichols, James D.; Dorazio, Robert M.			State-Dependent Resource Harvesting with Lagged Information about System States	PLOS ONE			English	Article							ADAPTIVE-MANAGEMENT FRAMEWORK; OPTIMAL FIRE MANAGEMENT; ENVIRONMENTAL-MANAGEMENT; UNCERTAINTY; OPTIMIZATION; CONSERVATION; PERSISTENCE; POPULATION; STRATEGIES; HABITAT	Markov decision processes (MDPs), which involve a temporal sequence of actions conditioned on the state of the managed system, are increasingly being applied in natural resource management. This study focuses on the modification of a traditional MDP to account for those cases in which an action must be chosen after a significant time lag in observing system state, but just prior to a new observation. In order to calculate an optimal decision policy under these conditions, possible actions must be conditioned on the previous observed system state and action taken. We show how to solve these problems when the state transition structure is known and when it is uncertain. Our focus is on the latter case, and we show how actions must be conditioned not only on the previous system state and action, but on the probabilities associated with alternative models of system dynamics. To demonstrate this framework, we calculated and simulated optimal, adaptive policies for MDPs with lagged states for the problem of deciding annual harvest regulations for mallards (Anas platyrhynchos) in the United States. In this particular example, changes in harvest policy induced by the use of lagged information about system state were sufficient to maintain expected management performance (e.g. population size, harvest) even in the face of an uncertain system state at the time of a decision.	[Johnson, Fred A.; Dorazio, Robert M.] US Geol Survey, Wetland & Aquat Res Ctr, Gainesville, FL USA; [Fackler, Paul L.] N Carolina State Univ, Dept Agr & Resource Econ, Raleigh, NC 27695 USA; [Boomer, G. Scott] US Fish & Wildlife Serv, Div Migratory Bird Management, Laurel, MD USA; [Zimmerman, Guthrie S.] US Fish & Wildlife Serv, Div Migratory Bird Management, Sacramento, CA USA; [Williams, Byron K.] Wildlife Soc, Bethesda, MD USA; [Nichols, James D.] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA	United States Department of the Interior; United States Geological Survey; University of North Carolina; North Carolina State University; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey	Johnson, FA (corresponding author), US Geol Survey, Wetland & Aquat Res Ctr, Gainesville, FL USA.	fjohnson@usgs.gov	Johnson, Fred/GLU-6494-2022; Nichols, James/AAF-7336-2020; Nichols, James/AAG-1500-2019		U.S. Fish and Wildlife Service	U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	Funding for this study was provided by the U.S. Fish and Wildlife Service (through an interagency agreement). URL:http://www.fws.gov/birds/index.php. The funder (Ken Richkus) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CR, 2011, J ENVIRON MANAGE, V92, P1339, DOI 10.1016/j.jenvman.2010.11.019; Anderson D. R., 1976, FISH WILDLIFE SERVIC, V128; ANDERSON DR, 1975, ECOLOGY, V56, P1281, DOI 10.2307/1934697; Bogich T, 2008, ECOL APPL, V18, P748, DOI 10.1890/07-0642.1; Breininger D, 2014, LAND, V3, P874, DOI 10.3390/land3030874; Chades I., 2014, P AAAI C ART INT, V26, DOI [10.1609/aaai.v26i1.8171, DOI 10.1609/AAAI.V26I1.8171]; Chades I, 2008, P NATL ACAD SCI USA, V105, P13936, DOI 10.1073/pnas.0805265105; Chades I, 2011, P NATL ACAD SCI USA, V108, P8323, DOI 10.1073/pnas.1016846108; Convertino M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02922; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Dujardin Y, 2015, P 24 INT JOINT C ART; Fackler P, 2014, J ENVIRON MANAGE, V133, P27, DOI 10.1016/j.jenvman.2013.11.004; Fackler PL, 2013, INT REV ENVIRON RESO, V7, P109, DOI 10.1561/101.00000058; Fackler PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102434; Fackler PL, 2014, RESOUR ENERGY ECON, V37, P226, DOI 10.1016/j.reseneeco.2013.12.005; Gregory R, 2006, ECOL APPL, V16, P2411, DOI 10.1890/1051-0761(2006)016[2411:DAMCFA]2.0.CO;2; Johnson F.A., 2015, ADAPTIVE MANAGEMENT, P61; Johnson FA, 2010, ANAL MANAGEMENT MIGR; Johnson FA, 2015, WILDLIFE SOC B, V39, P9, DOI 10.1002/wsb.518; Johnson FA, 2014, ECOL MODEL, V273, P186, DOI 10.1016/j.ecolmodel.2013.10.031; Johnson FA, 2011, J FISH WILDL MANAG, V2, P234, DOI 10.3996/012011-JFWM-003; Johnson FA, 2011, J ENVIRON MANAGE, V92, P1385, DOI 10.1016/j.jenvman.2010.10.064; Linkov I, 2006, ENVIRON INT, V32, P1072, DOI 10.1016/j.envint.2006.06.013; Linkov I, 2006, INTEGR ENVIRON ASSES, V2, P92, DOI 10.1002/ieam.5630020116; Loh WY, 2011, WIRES DATA MIN KNOWL, V1, P14, DOI 10.1002/widm.8; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Marescot L, 2013, METHODS ECOL EVOL, V4, P872, DOI 10.1111/2041-210X.12082; Martin J, 2011, CONSERV BIOL, V25, P316, DOI 10.1111/j.1523-1739.2010.01644.x; McCarthy MA, 2001, J APPL ECOL, V38, P585, DOI 10.1046/j.1365-2664.2001.00617.x; McCarthy MA, 2007, CONSERV BIOL, V21, P956, DOI 10.1111/j.1523-1739.2007.00677.x; McDonald-Madden E, 2008, ECOL LETT, V11, P1169, DOI 10.1111/j.1461-0248.2008.01226.x; McDonald-Madden E, 2011, NAT CLIM CHANGE, V1, P261, DOI 10.1038/NCLIMATE1170; McDonald-Madden E, 2011, ECOL APPL, V21, P844, DOI 10.1890/09-2075.1; McFadden JE, 2011, J ENVIRON MANAGE, V92, P1354, DOI 10.1016/j.jenvman.2010.10.038; McGowan CP, 2015, BIOL CONSERV, V191, P759, DOI 10.1016/j.biocon.2015.08.038; Miranda M. J., 2002, APPL COMPUTATIONAL E; Moilanen A, 2007, BIOL CONSERV, V136, P470, DOI 10.1016/j.biocon.2006.12.019; Moore CT, 2006, FOREST SCI, V52, P155; Nicol S, 2013, IJCAI 23 INT JOINT C; Nicol S, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2984; Nicol S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028993; Possingham H., 1997, ECOLOGICAL BASIS CON, P298; Puterman ML., 2014, MARKOV DECISION PROC; Regan TJ, 2011, J APPL ECOL, V48, P76, DOI 10.1111/j.1365-2664.2010.01915.x; Richards SA, 1999, ECOL APPL, V9, P880, DOI 10.1890/1051-0761(1999)009[0880:OFMFMC]2.0.CO;2; Rist L, 2013, ENVIRON CONSERV, V40, P5, DOI 10.1017/S0376892912000240; Ross S.M., 1983, INTRO STOCHASTIC DYN; Rout TM, 2014, J APPL ECOL, V51, P804, DOI 10.1111/1365-2664.12234; Schreiber E.S.G., 2004, ECOL MANAG RESTOR, V5, P177, DOI [DOI 10.1111/J.1442-8903.2004.00206.X, 10.1111/j.1442-8903.2004.00206.x]; Southwell DM, 2016, ECOL APPL, V26, P279, DOI 10.1890/14-2430; Tenhumberg B, 2004, CONSERV BIOL, V18, P1304, DOI 10.1111/j.1523-1739.2004.00246.x; U.S. Fish and Wildlife Service, 2010, ISS ANN REG PERM HUN, P296; Walters C., 1986, ADAPTIVE MANAGEMENT; WALTERS CJ, 1990, ECOLOGY, V71, P2060, DOI 10.2307/1938620; WALTERS CJ, 1978, ANNU REV ECOL SYST, V9, P157, DOI 10.1146/annurev.es.09.110178.001105; Westgate MJ, 2013, BIOL CONSERV, V158, P128, DOI 10.1016/j.biocon.2012.08.016; Williams B. K., 2009, ADAPTIVE MANAGEMENT; Williams B.K., 1989, NAT RESOUR MODEL, V3, P137, DOI DOI 10.1111/j.1939-7445.1989.tb00074.x; Williams BK, 1996, ECOL MODEL, V93, P101, DOI 10.1016/0304-3800(95)00217-0; Williams BK, 2001, ENVIRON ECOL STAT, V8, P269, DOI 10.1023/A:1011395725123; Williams BK, 1996, J WILDLIFE MANAGE, V60, P223, DOI 10.2307/3802220; Williams BK, 2015, ECOL EVOL, V5, P466, DOI 10.1002/ece3.1363; Williams BK, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/025004; Williams BK, 2011, ECOL MODEL, V222, P1092, DOI 10.1016/j.ecolmodel.2010.12.015; Williams BK, 2011, J ENVIRON MANAGE, V92, P1346, DOI 10.1016/j.jenvman.2010.10.041; Williams BK, 2009, ECOL MODEL, V220, P830, DOI 10.1016/j.ecolmodel.2008.12.023	66	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157373	10.1371/journal.pone.0157373	http://dx.doi.org/10.1371/journal.pone.0157373			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314852	gold, Green Submitted, Green Published			2022-12-26	WOS:000378030000022
J	Marrone, G; Mellgren, A; Eriksson, LE; Svedhem, V				Marrone, Gaetano; Mellgren, Asa; Eriksson, Lars E.; Svedhem, Veronica			High Concordance between Self-Reported Adherence, Treatment Outcome and Satisfaction with Care Using a Nine-Item Health Questionnaire in InfCareHIV	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; QUALITY-OF-LIFE; HIV-INFECTED PATIENTS; MEDICATION ADHERENCE; PEOPLE; ART; NONADHERENCE; METAANALYSIS; PROGRESSION; MORTALITY	Background In this cross-sectional study we present an integrated analysis of a self-reported Health Questionnaire and socio-demographic and treatment outcome data from the national Swedish HIV cohort, InfCareHIV. Objectives To evaluate the Health Questionnaire and identify the main determinants of adherence. Methods A total of 2,846 patients answered a nine-item disease-specific Health Questionnaire between 2012 and 2014, corresponding to 44% of all active patients in the national InfCareHIV cohort. The questionnaire assessed patient related outcome measures (PROMs) regarding health and antiretroviral treatment (ART) and patient related experience measures (PREMs) regarding involvement in care and satisfaction with the care provider. Result We found the Health Questionnaire to be valid and reliable when used in ordinary clinical practice. There was a high concordance between self-reported adherence to ART in the past seven days and treatment outcome, with 94% of patients who reported optimal adherence having a viral load <50 copies/ml. The main determinants of optimal adherence were heterosexual transmission path, being born in Sweden, being male, not reporting experience of ART side effects and being fully satisfied with care. Conclusion The nine-item Health Questionnaire can identify patients at risk of treatment failure, those in need of clinical assessment of adverse events and those with impaired physical health.	[Marrone, Gaetano] Karolinska Univ Hosp, Dept Infect Dis & Clin Virol, Stockholm, Sweden; [Marrone, Gaetano] Karolinska Inst, Dept Publ Hlth Sci, Solna, Sweden; [Mellgren, Asa] South Alvsborg Hosp, Clin Infect Dis, Boras, Sweden; [Eriksson, Lars E.] Karolinska Inst, Dept Learning Informat Management & Eth, Solna, Sweden; [Eriksson, Lars E.; Svedhem, Veronica] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Eriksson, Lars E.] City Univ London, Sch Hlth Sci, London EC1V 0HB, England; [Svedhem, Veronica] Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; City University London; Karolinska Institutet	Svedhem, V (corresponding author), Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden.; Svedhem, V (corresponding author), Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden.	veronica.svedhem-johansson@karolinska.se		Marrone, Gaetano/0000-0002-2991-1663; Mellgren, Asa/0000-0002-1202-3504	Stockholm County Council; Gilead Nordic Fellow program; Swedish Association of Local Authorities and Regions	Stockholm County Council(Stockholm County Council); Gilead Nordic Fellow program; Swedish Association of Local Authorities and Regions	This work was supported by the Stockholm County Council (www.sll.se), Gilead Nordic Fellow program (www.Gilead.com), and the Swedish Association of Local Authorities and Regions (www.kvalitetsregister.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006; Andrade ASA, 2013, JAIDS-J ACQ IMM DEF, V62, P282, DOI 10.1097/QAI.0b013e31827ed678; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Brannstrom J, 2015, HIV MED; Bulgiba A, 2013, PREV MED, V57, pS34, DOI 10.1016/j.ypmed.2013.01.002; Silva ACDE, 2014, REV LAT-AM ENFERM, V22, P994, DOI 10.1590/0104-1169.3534.2508; Degroote S, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18643; Eriksson LE, 2000, J ADV NURS, V32, P1213, DOI 10.1046/j.1365-2648.2000.01592.x; Ettenhofer ML, 2010, NEUROLOGY, V74, P1217, DOI 10.1212/WNL.0b013e3181d8c1ca; Fayers Peter MD, 2007, ASSESSMENT ANAL INTE; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Gisslen M, 2016, SWEDISH HIV TREATMEN; Haggblom A, 2016, THE LANCET IN PRESS; Haubrich RH, 1999, AIDS, V13, P1099, DOI 10.1097/00002030-199906180-00014; Hill A, 2013, J INFECT DIS, V207, pS78, DOI 10.1093/infdis/jit112; Langebeek N, 2014, BMC MED, V12, DOI [10.1186/s12916-014-0142-1, 10.1186/PREACCEPT-1453408941291432]; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Miners A, 2014, LANCET HIV, V1, pE32, DOI 10.1016/S2352-3018(14)70018-9; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Nieuwkerk PT, 2005, JAIDS-J ACQ IMM DEF, V38, P445, DOI 10.1097/01.qai.0000147522.34369.12; Protopopescu C, 2009, J ANTIMICROB CHEMOTH, V64, P599, DOI 10.1093/jac/dkp232; Rydstrom LL, 2016, AIDS CARE, V28, P665, DOI 10.1080/09540121.2015.1120267; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Sodergard B, 2006, J CLIN PHARM THER, V31, P605, DOI 10.1111/j.1365-2710.2006.00782.x; Tadesse WT, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-32; Villes V, 2007, ANTIVIR THER, V12, P1067; Wagner GJ, 2000, AIDS CARE, V12, P405, DOI 10.1080/09540120050123800	28	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156916	10.1371/journal.pone.0156916	http://dx.doi.org/10.1371/journal.pone.0156916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310201	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000378029800019
J	Montero-Marin, J; Zubiaga, F; Cereceda, M; Demarzo, MMP; Trenc, P; Garcia-Campayo, J				Montero-Marin, Jesus; Zubiaga, Fernando; Cereceda, Maria; Piva Demarzo, Marcelo Marcos; Trenc, Patricia; Garcia-Campayo, Javier			Burnout Subtypes and Absence of Self-Compassion in Primary Healthcare Professionals: A Cross-Sectional Study	PLOS ONE			English	Article							LEAST-SQUARES ESTIMATION; WORK ENGAGEMENT; PHYSICIAN BURNOUT; NEGATIVE AFFECT; PANAS SCALES; RISK-FACTORS; JOB DEMANDS; SATISFACTION; VALIDATION; WORKAHOLISM	Background Primary healthcare professionals report high levels of distress and burnout. A new model of burnout has been developed to differentiate three clinical subtypes: 'frenetic', 'underchallenged' and 'worn-out'. The aim of this study was to confirm the validity and reliability of the burnout subtype model in Spanish primary healthcare professionals, and to assess the explanatory power of the self-compassion construct as a possible protective factor. Method The study employed a cross-sectional design. A sample of n = 440 Spanish primary healthcare professionals (214 general practitioners, 184 nurses, 42 medical residents) completed the Burnout Clinical Subtype Questionnaire (BCSQ-36), the Maslach Burnout Inventory General Survey (MBI-GS), the Self-Compassion Scale (SCS), the Utrecht Work Engagement Scale (UWES) and the Positive and Negative Affect Schedule (PANAS). The factor structure of the BCSQ-36 was estimated using confirmatory factor analysis (CFA) by the unweighted least squares method from polychoric correlations. Internal consistency (R) was assessed by squaring the correlation between the latent true variable and the observed variables. The relationships between the BCSQ-36 and the other constructs were analysed using Spearman's r and multiple linear regression models. Results The structure of the BCSQ-36 fit the data well, with adequate CFA indices for all the burnout subtypes. Reliability was adequate for all the scales and sub-scales (R >= 0.75). Self-judgement was the self-compassion factor that explained the frenetic subtype (Beta = 0.36; p<0.001); isolation explained the underchallenged (Beta = 0.16; p = 0.010); and over-identification the worn-out (Beta = 0.25; p = 0.001). Other significant associations were observed between the different burnout subtypes and the dimensions of the MBI-GS, UWES and PANAS. Conclusions The typological definition of burnout through the BCSQ-36 showed good structure and appropriate internal consistence in Spanish primary healthcare professionals. The negative self-compassion dimensions seem to play a relevant role in explaining the burnout profiles in this population, and they should be considered when designing specific treatments and interventions tailored to the specific vulnerability of each subtype.	[Montero-Marin, Jesus] Univ Zaragoza, Fac Hlth & Sport Sci, Zaragoza, Spain; [Montero-Marin, Jesus; Zubiaga, Fernando; Cereceda, Maria; Trenc, Patricia; Garcia-Campayo, Javier] Primary Care Prevent & Hlth Promot Res Network Re, Zaragoza, Spain; [Montero-Marin, Jesus; Zubiaga, Fernando; Cereceda, Maria; Trenc, Patricia; Garcia-Campayo, Javier] CIBERSAM, Ctr Invest Biomed Red Salud Mental, Oviedo, Spain; [Piva Demarzo, Marcelo Marcos] Univ Fed Sao Paulo, UNIFESP, Dept Prevent Med, Mente Aberta Brazilian Ctr Mindfulness & Hlth Pr, Sao Paulo, Brazil; [Garcia-Campayo, Javier] Miguel Servet Hosp, Zaragoza, Spain; [Garcia-Campayo, Javier] Univ Zaragoza, Zaragoza, Spain	University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Universidade Federal de Sao Paulo (UNIFESP); Miguel Servet University Hospital; University of Zaragoza	Garcia-Campayo, J (corresponding author), Primary Care Prevent & Hlth Promot Res Network Re, Zaragoza, Spain.; Garcia-Campayo, J (corresponding author), CIBERSAM, Ctr Invest Biomed Red Salud Mental, Oviedo, Spain.; Garcia-Campayo, J (corresponding author), Miguel Servet Hosp, Zaragoza, Spain.; Garcia-Campayo, J (corresponding author), Univ Zaragoza, Zaragoza, Spain.	jgarcamp@gmail.com	Demarzo, Marcelo/A-7021-2010; Montero-Marin, Jesus/ABG-8919-2020	Demarzo, Marcelo/0000-0002-7447-1839; Montero-Marin, Jesus/0000-0001-5677-1662; Garcia-Campayo, Javier/0000-0002-3797-4218	Research Network on Preventative Activities and Health Promotion (REDIAPP); Aragon Health Sciences Institute, Zaragoza, Spain	Research Network on Preventative Activities and Health Promotion (REDIAPP); Aragon Health Sciences Institute, Zaragoza, Spain	This study was supported by the Research Network on Preventative Activities and Health Promotion (REDIAPP) and the Aragon Health Sciences Institute, Zaragoza, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2010, J PSYCHOSOM RES, V69, P51, DOI 10.1016/j.jpsychores.2010.01.002; Al-Sareai NS, 2013, E MEDITERR HEALTH J, V19, P426, DOI 10.26719/2013.19.5.426; Andreassen CS, 2011, STRESS HEALTH, V27, pE209, DOI 10.1002/smi.1366; [Anonymous], 1998, THE; Atanes ACM, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0823-0; Bakker AB, 2005, J OCCUP HEALTH PSYCH, V10, P170, DOI 10.1037/1076-8998.10.2.170; Boellinghaus I, 2014, MINDFULNESS, V5, P129, DOI 10.1007/s12671-012-0158-6; BOLLEN KA, 1986, PSYCHOMETRIKA, V51, P375, DOI 10.1007/BF02294061; Breso E., 2007, SINDROME ESTAR QUEMA; Briggs NE, 2003, MULTIVAR BEHAV RES, V38, P25, DOI 10.1207/S15327906MBR3801_2; Byrne B, 2001, STUCTURAL EQUATION M; DECKARD GJ, 1992, J INFECT DIS, V165, P224, DOI 10.1093/infdis/165.2.224; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Demerouti E, 2001, SCAND J WORK ENV HEA, V27, P279, DOI 10.5271/sjweh.615; Demerouti E, 2010, J OCCUP HEALTH PSYCH, V15, P209, DOI 10.1037/a0019408; Dolan ED, 2015, J GEN INTERN MED, V30, P582, DOI 10.1007/s11606-014-3112-6; Farber B.A, 1990, PSYCHOTHERAPY PRIVAT, V8, P35, DOI [DOI 10.1300/J294V08N01_07, 10.1300/J294v08n01_07]; Farber BA, 2000, J CLIN PSYCHOL, V56, P589, DOI 10.1002/(SICI)1097-4679(200005)56:5<589::AID-JCLP1>3.0.CO;2-S; Fortney L, 2013, ANN FAM MED, V11, P412, DOI 10.1370/afm.1511; FREUDENBERGER HJ, 1974, J SOC ISSUES, V30, P159, DOI 10.1111/j.1540-4560.1974.tb00706.x; Gabbe SG, 2002, AM J OBSTET GYNECOL, V186, P601, DOI 10.1067/mob.2002.122391; Garcia-Campayo J, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-4; Gazelle G, 2015, J GEN INTERN MED, V30, P508, DOI 10.1007/s11606-014-3144-y; Girón Manuel, 2002, Rev. Esp. Salud Publica, V76, P561, DOI 10.1590/s1135-57272002000500016; Goetz JL, 2010, PSYCHOL BULL, V136, P351, DOI 10.1037/a0018807; Goldberg R, 1996, ACAD EMERG MED, V3, P1156, DOI 10.1111/j.1553-2712.1996.tb03379.x; Graham JM, 2006, EDUC PSYCHOL MEAS, V66, P930, DOI 10.1177/0013164406288165; Heffernan M, 2010, INT J NURS PRACT, V16, P366, DOI 10.1111/j.1440-172X.2010.01853.x; Heras-Mosteiro J, 2016, INT J HEALTH SERV, V46, P283, DOI 10.1177/0020731415625251; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hyman SA, 2011, ANESTHESIOLOGY, V114, P194, DOI 10.1097/ALN.0b013e318201ce9a; Kemper KJ, 2015, J ALTERN COMPLEM MED, V21, P496, DOI 10.1089/acm.2014.0281; King G, 2003, INT STUDIES PERSPECT, V4, P100, DOI DOI 10.1111/1528-3577.04105; KNOL DL, 1991, MULTIVAR BEHAV RES, V26, P457, DOI 10.1207/s15327906mbr2603_5; Krasner MS, 2009, JAMA-J AM MED ASSOC, V302, P1284, DOI 10.1001/jama.2009.1384; Kubota K, 2010, IND HEALTH, V48, P864, DOI 10.2486/indhealth.MS1139; Lama D., 2001, OPEN HEART PRACTICIN; Lamothe M, 2016, COMPLEMENT THER MED, V24, P19, DOI 10.1016/j.ctim.2015.11.001; Lee CT, 2012, MULTIVAR BEHAV RES, V47, P314, DOI 10.1080/00273171.2012.658340; Levy J, 2006, MODELIZACION CON EST, P21; Linzer M, 2001, AM J MED, V111, P170, DOI 10.1016/S0002-9343(01)00814-2; MARDIA KV, 1974, SANKHYA SER B, V36, P115; Martinez-Gonzalez M, 2006, BIOESTADISTICA AMIGA, P851; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C., 1996, MASLACH BURNOUT INVE; Mazzetti G, 2016, EUR JPSYCHOL ASSESS; Montero-Marin J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01895; Montero-Marin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089090; Montero-Marin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087071; Montero-Marin J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-922; Montero-Marin J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-74; Montero-Marin J, 2011, BMC MED EDUC, V11, DOI [10.1186/1472-6920-11-103, 10.1186/1471-244X-11-49]; Montero-Marin J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-302; Montero-Marin Jesus, 2009, J Occup Med Toxicol, V4, P31, DOI 10.1186/1745-6673-4-31; Muris P., 2016, CLIN PSYCHOL PSYCHOT; MUTHEN B, 1992, BRIT J MATH STAT PSY, V45, P19, DOI 10.1111/j.2044-8317.1992.tb00975.x; Navarro-Gonzalez D, 2015, Semergen, V41, P191, DOI 10.1016/j.semerg.2014.03.008; Neff K, 2003, SELF IDENTITY, V2, P85, DOI 10.1080/15298860390129863; Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035; Ng TWH, 2007, J ORGAN BEHAV, V28, P111, DOI 10.1002/job.424; PARRY CDH, 1991, APPL PSYCH MEAS, V15, P35, DOI 10.1177/014662169101500105; Raab K, 2014, J HEALTH CARE CHAPL, V20, P95, DOI 10.1080/08854726.2014.913876; Rabatin J, 2015, J PRIM CARE COMMUNIT; Rao N, 2016, J EVID BASED COMPLEM; Raykov T, 1997, APPL PSYCH MEAS, V21, P173, DOI 10.1177/01466216970212006; Reijseger G., 2016, J BUS PSYCHOL; Richter A, 2015, INT ARCH OCC ENV HEA, V88, P103, DOI 10.1007/s00420-014-0941-x; Russett B, 2003, INT STUDIES PERSPECT, V4, P88; Sandin B, 1999, PSICOTHEMA, V11, P37; Schaufeli W.B., 2002, J HAPPINESS STUD, V3, P72, DOI [10.1023/A:1015630930326, DOI 10.1023/A:1015630930326]; Schaufeli WB, 2008, APPL PSYCHOL-INT REV, V57, P173, DOI 10.1111/j.1464-0597.2007.00285.x; Schaufeli WB, 2009, CAREER DEV INT, V14, P204, DOI 10.1108/13620430910966406; Schutte N, 2000, J OCCUP ORGAN PSYCH, V73, P53, DOI 10.1348/096317900166877; Shanafelt TD, 2014, J CLIN ONCOL, V32, P678, DOI 10.1200/JCO.2013.51.8480; Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd; Shimazu A, 2015, INT J BEHAV MED, V22, P18, DOI 10.1007/s12529-014-9410-x; Slocum-Gori S, 2013, PALLIATIVE MED, V27, P172, DOI 10.1177/0269216311431311; Thomas MR, 2007, J GEN INTERN MED, V22, P177, DOI 10.1007/s11606-006-0039-6; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Williams ES, 2007, HEALTH CARE MANAGE R, V32, P203, DOI 10.1097/01.HMR.0000281626.28363.59	82	49	49	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157499	10.1371/journal.pone.0157499	http://dx.doi.org/10.1371/journal.pone.0157499			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310426	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800086
J	Nam, VT; van Kuijk, M; Anten, NPR				Vu Thanh Nam; van Kuijk, Marijke; Anten, Niels P. R.			Allometric Equations for Aboveground and Belowground Biomass Estimations in an Evergreen Forest in Vietnam	PLOS ONE			English	Article							LIFE-HISTORY VARIATION; WOOD SPECIFIC-GRAVITY; SECONDARY FORESTS; TREE ALLOMETRY; DENSITY	Allometric regression models are widely used to estimate tropical forest biomass, but balancing model accuracy with efficiency of implementation remains a major challenge. In addition, while numerous models exist for aboveground mass, very few exist for roots. We developed allometric equations for aboveground biomass (AGB) and root biomass (RB) based on 300 (of 45 species) and 40 (of 25 species) sample trees respectively, in an evergreen forest in Vietnam. The biomass estimations from these local models were compared to regional and pan-tropical models. For AGB we also compared local models that distinguish functional types to an aggregated model, to assess the degree of specificity needed in local models. Besides diameter at breast height (DBH) and tree height (H), wood density (WD) was found to be an important parameter in AGB models. Existing pan-tropical models resulted in up to 27% higher estimates of AGB, and overestimated RB by nearly 150%, indicating the greater accuracy of local models at the plot level. Our functional group aggregated local model which combined data for all species, was as accurate in estimating AGB as functional type specific models, indicating that a local aggregated model is the best choice for predicting plot level AGB in tropical forests. Finally our study presents the first allometric biomass models for aboveground and root biomass in forests in Vietnam.	[Vu Thanh Nam; van Kuijk, Marijke] Univ Utrecht, Dept Biol, Utrecht, Netherlands; [Vu Thanh Nam] Vietnam Adm Forestry, Hanoi, Vietnam; [Anten, Niels P. R.] Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands; [Vu Thanh Nam] Bach Ma Natl Pk, Phu Loc Dist, Thua Thien Hue, Vietnam	Utrecht University; Wageningen University & Research	Nam, VT (corresponding author), Univ Utrecht, Dept Biol, Utrecht, Netherlands.; Nam, VT (corresponding author), Vietnam Adm Forestry, Hanoi, Vietnam.; Nam, VT (corresponding author), Bach Ma Natl Pk, Phu Loc Dist, Thua Thien Hue, Vietnam.	Nam@vnforest.gov.vn			Tropenbos International	Tropenbos International	This work was supported by Tropenbos International. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Anten NPR, 2010, AM NAT, V175, P250, DOI 10.1086/649581; Ban DV, 2010, J FOREST SCI RES I V, V1, P7; Basuki TM, 2009, FOREST ECOL MANAG, V257, P1684, DOI 10.1016/j.foreco.2009.01.027; BROWN S, 1989, FOREST SCI, V35, P881; Brown S, 1997, ESTIMATING BIOMASS B, V134, P55; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J., 2005, MEASURING WOOD DENSI; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Djomo AN, 2010, FOREST ECOL MANAG, V260, P1873, DOI 10.1016/j.foreco.2010.08.034; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; Fayolle A, 2013, FOREST ECOL MANAG, V305, P29, DOI 10.1016/j.foreco.2013.05.036; Feldpausch TR, 2011, BIOGEOSCIENCES, V8, P1081, DOI 10.5194/bg-8-1081-2011; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Henry M, 2010, FOREST ECOL MANAG, V260, P375, DOI [10.1016/j.foreco.2010.1007.1040, DOI 10.1016/J.FORECO.2010.1007.1040]; Iida Y, 2012, FUNCT ECOL, V26, P274, DOI 10.1111/j.1365-2435.2011.01921.x; IPCC, 2003, GOOD PRACTICE GUIDAN; Ishihara MI, 2015, ECOL APPL, V25, P1433, DOI 10.1890/14-0175.1; Kenzo T, 2009, J FOREST RES-JPN, V14, P365, DOI 10.1007/s10310-009-0149-1; Kenzo T, 2009, J TROP ECOL, V25, P371, DOI 10.1017/S0266467409006129; Ketterings QM, 2001, FOREST ECOL MANAG, V146, P199, DOI 10.1016/S0378-1127(00)00460-6; King DA, 2006, J ECOL, V94, P670, DOI 10.1111/j.1365-2745.2006.01112.x; Lung NN, 2011, FINAL REPORT FOREST; MARD, 2000, NAM FOR PLANTS VIETN; Ministry of Agriculture and Rural Development (MARD), 2004, 102004QDBNN MARD; Muller-Landau HC, 2004, BIOTROPICA, V36, P20, DOI 10.1111/j.1744-7429.2004.tb00292.x; Nelson BW, 1999, FOREST ECOL MANAG, V117, P149, DOI 10.1016/S0378-1127(98)00475-7; Niiyama K, 2010, J TROP ECOL, V26, P271, DOI 10.1017/S0266467410000040; Lima AJN, 2012, FOREST ECOL MANAG, V277, P163, DOI 10.1016/j.foreco.2012.04.028; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; SPRUGEL DG, 1983, ECOLOGY, V64, P209, DOI 10.2307/1937343; van Breugel M, 2011, FOREST ECOL MANAG, V262, P1648, DOI 10.1016/j.foreco.2011.07.018; van Gelder HA, 2006, NEW PHYTOL, V171, P367, DOI 10.1111/j.1469-8137.2006.01757.x; Vieilledent G, 2012, ECOL APPL, V22, P572, DOI 10.1890/11-0039.1; Wiemann MC, 2002, WOOD FIBER SCI, V34, P96	38	33	34	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156827	10.1371/journal.pone.0156827	http://dx.doi.org/10.1371/journal.pone.0156827			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309718	Green Submitted, gold, Green Published			2022-12-26	WOS:000378029800016
J	Zhai, Q; Huang, B; Dong, H; Zhao, QP; Zhu, SH; Liang, ST; Li, S; Yang, SH; Han, HY				Zhai, Qi; Huang, Bing; Dong, Hui; Zhao, Qiping; Zhu, Shunhai; Liang, Siting; Li, Sha; Yang, Sihan; Han, Hongyu			Molecular Characterization and Immune Protection of a New Conserved Hypothetical Protein of Eimeria tenella	PLOS ONE			English	Article							APICAL ORGANELLES; HOST-CELL; COCCIDIOSIS; CD8; IDENTIFICATION; RESISTANCE; INVASION; BIOLOGY; MAXIMA; SERUM	The genome sequences of Eimeria tenella have been sequenced, but >70% of these genes are currently categorized as having an unknown function or annotated as conserved hypothetical proteins, and few of them have been studied. In the present study, a conserved hypothetical protein gene of E. tenella, designated EtCHP559, was cloned using rapid amplification of cDNA 5'-ends (5'RACE) based on the expressed sequence tag (EST). The 1746-bp full-length cDNA of EtCHP559 contained a 1224-bp open reading frame (ORF) that encoded a 407-amino acid polypeptide with the predicted molecular weight of 46.04 kDa. Real-time quantitative PCR analysis revealed that EtCHP559 was expressed at higher levels in sporozoites than in the other developmental stages (unsporulated oocysts, sporulated oocysts and second generation merozoites). The ORF was inserted into pCold-TF to produce recombinant EtCHP559. Using western blotting, the recombinant protein was successfully recognized by rabbit serum against E. tenella sporozoites. Immunolocalization by using EtCHP559 antibody showed that EtCHP559 was mainly distributed on the parasite surface in free sporozoites and became concentrated in the anterior region after sporozoites were incubated in complete medium. The EtCHP559 became uniformly dispersed in immature and mature schizonts. Inhibition of EtCHP559 function using anti-rEtCHP559 polyclonal antibody reduced the ability of E. tenella sporozoites to invade host cells by >70%. Animal challenge experiments demonstrated that the recombinant EtCHP559 significantly increased the average body weight gain, reduced the oocyst outputs, alleviated cecal lesions of the infected chickens, and resulted in anticoccidial index >160 against E. tenella. These results suggest that EtCHP559 plays an important role in sporozoite invasion and could be an effective candidate for the development of a new vaccine against E. tenella.	[Zhai, Qi; Huang, Bing; Dong, Hui; Zhao, Qiping; Zhu, Shunhai; Liang, Siting; Li, Sha; Yang, Sihan; Han, Hongyu] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr, Shanghai, Peoples R China; [Huang, Bing] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Han, HY (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr, Shanghai, Peoples R China.	hhysh@shvri.ac.cn			National Science Foundation of China [31201699, 31572266, 31272557]; Central Public Welfare Research Institutions and Basic Scientific Research Business Expenses [2015JB10]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central Public Welfare Research Institutions and Basic Scientific Research Business Expenses	This work was supported by grants from National Science Foundation of China (No. 31201699, No. 31572266, No. 31272557) and Central Public Welfare Research Institutions and Basic Scientific Research Business Expenses (No. 2015JB10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0; Blake DP, 2015, VET PARASITOL, V212, P68, DOI 10.1016/j.vetpar.2015.05.007; Chapman HD, 2013, ADV PARASIT, V83, P93, DOI 10.1016/B978-0-12-407705-8.00002-1; Chen PP, 2015, EXP PARASITOL, V155, P1, DOI 10.1016/j.exppara.2015.04.020; del Cacho E, 2007, J PARASITOL, V93, P328, DOI 10.1645/GE-992R.1; del Cacho E, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-25; Dubremetz JF, 1998, INT J PARASITOL, V28, P1007, DOI 10.1016/S0020-7519(98)00076-9; Han HY, 2013, PARASITOLOGY, V140, P746, DOI 10.1017/S0031182012002107; Han HY, 2010, J PARASITOL, V96, P95, DOI 10.1645/GE-2221.1; Han HY, 2015, EXP PARASITOL, V154, P118, DOI 10.1016/j.exppara.2015.04.002; Han HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099914; HARPAZ R, 1992, J CLIN INVEST, V90, P515, DOI 10.1172/JCI115889; HUANG B, 1993, SHANGHAI J ANIM HUSB, V3, P18; Huang JW, 2015, AVIAN PATHOL, V44, P392, DOI 10.1080/03079457.2015.1071780; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jahn D, 2009, PARASITOL RES, V105, P655, DOI 10.1007/s00436-009-1437-6; Jiang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041115; Jiang LL, 2012, PARASITOL RES, V110, P865, DOI 10.1007/s00436-011-2568-0; JOHNSON J, 1970, EXP PARASITOL, V28, P30, DOI 10.1016/0014-4894(70)90063-9; Lal K, 2009, PROTEOMICS, V9, P4566, DOI 10.1002/pmic.200900305; Li GQ, 2004, VET PARASITOL, V119, P261, DOI 10.1016/j.vetpar.2003.12.009; Lillehoj HS, 2005, AVIAN DIS, V49, P112, DOI 10.1637/7249-073004R; Lillehoj HS, 2004, POULTRY SCI, V83, P611, DOI 10.1093/ps/83.4.611; Ltd MSDC, 1998, CONTR COCC MSD TECHN, P2; MCMANUS EC, 1968, J PARASITOL, V54, P1190, DOI 10.2307/3276989; Nam HW, 2009, KOREAN J PARASITOL, V47, pS29, DOI 10.3347/kjp.2009.47.S.S29; Orditura M, 1998, INT J MOL MED, V2, P75; Peroval M, 2006, INT J PARASITOL, V36, P1205, DOI 10.1016/j.ijpara.2006.04.006; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Reid AJ, 2014, GENOME RES, V24, P1676, DOI 10.1101/gr.168955.113; Rodriguez P, 2012, MED MICROBIOL IMMUN, V201, P157, DOI 10.1007/s00430-011-0217-y; ROSE ME, 1983, PARASITE IMMUNOL, V5, P479, DOI 10.1111/j.1365-3024.1983.tb00762.x; Rothwell L, 2004, J IMMUNOL, V173, P2675, DOI 10.4049/jimmunol.173.4.2675; Saini P, 2014, PROTEIN EXPRES PURIF, V104, P71, DOI 10.1016/j.pep.2014.09.004; Sharma Sourabh, 2015, J Parasit Dis, V39, P147, DOI 10.1007/s12639-013-0302-9; Shirley MW, 2007, VACCINE, V25, P5540, DOI 10.1016/j.vaccine.2006.12.030; Shirley MW, 2005, ADV PARASIT, V60, P285, DOI 10.1016/S0065-308X(05)60005-X; Tabares E, 2004, MOL BIOCHEM PARASIT, V135, P123, DOI 10.1016/j.molbiopara.2004.01.013; Talebi A, 2005, EXP PARASITOL, V110, P342, DOI 10.1016/j.exppara.2005.03.026; Tomley F, 1997, METHODS, V13, P171, DOI 10.1006/meth.1997.0509; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; Wang CC, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-29; Willsie SK, 1996, J LEUKOCYTE BIOL, V59, P813, DOI 10.1002/jlb.59.6.813; Zajkowska J, 2001, INFECTION, V29, P71, DOI 10.1007/s15010-001-1078-x; Zhang J, 2014, VET PARASITOL, V205, P62, DOI 10.1016/j.vetpar.2014.06.029; Zhang L, 2013, EXP PARASITOL, V133, P121, DOI 10.1016/j.exppara.2012.11.009; Zhang ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115411; Zhou BH, 2010, EXP PARASITOL, V125, P264, DOI 10.1016/j.exppara.2010.01.022	49	15	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157678	10.1371/journal.pone.0157678	http://dx.doi.org/10.1371/journal.pone.0157678			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309852	Green Submitted, gold, Green Published			2022-12-26	WOS:000378029800121
J	Haas, LT; Strittmatter, SM				Haas, Laura T.; Strittmatter, Stephen M.			Oligomers of Amyloid Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid; Ca2+; calmodulin-dependent protein kinase II (CaMKII); metabotropic glutamate receptor (mGluR); prion; homer; pyk2	TRANSGENIC MOUSE MODEL; OPERATED CALCIUM-ENTRY; SYNAPTIC PLASTICITY; BETA OLIGOMERS; A-BETA; MEMORY IMPAIRMENT; HOMER-PROTEINS; MICE; FYN; NEURONS	The dysfunction and loss of synapses in Alzheimer disease are central to dementia symptoms. We have recently demonstrated that pathological Amyloid oligomer (Ao) regulates the association between intracellular protein mediators and the synaptic receptor complex composed of cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5). Here we sought to determine whether Ao alters the physiological signaling of the PrPC-mGluR5 complex upon glutamate activation. We provide evidence that acute exposure to Ao as well as chronic expression of familial Alzheimer disease mutant transgenes in model mice prevents protein-protein interaction changes of the complex induced by the glutamate analog 3,5-dihydroxyphenylglycine. We further show that 3,5-dihydroxyphenylglycine triggers the phosphorylation and activation of protein-tyrosine kinase 2- (PTK2B, also referred to as Pyk2) and of calcium/calmodulin-dependent protein kinase II in wild-type brain slices but not in Alzheimer disease transgenic brain slices or wild-type slices incubated with Ao. This study further distinguishes two separate Ao-dependent signaling cascades, one dependent on extracellular Ca2+ and Fyn kinase activation and the other dependent on the release of Ca2+ from intracellular stores. Thus, Ao triggers multiple distinct PrPC-mGluR5-dependent events implicated in neurodegeneration and dementia. We propose that targeting the PrPC-mGluR5 complex will reverse aberrant Ao-triggered states of the complex to allow physiological fluctuations of glutamate signaling.	[Haas, Laura T.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, 333 Cedar St, New Haven, CT 06536 USA; [Haas, Laura T.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurosci, Cellular Neurosci Neurodegenerat & Repair Program, 333 Cedar St, New Haven, CT 06536 USA; [Haas, Laura T.] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, D-72074 Tubingen, Germany	Yale University; Yale University; Eberhard Karls University of Tubingen	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, BCMM 436,295 Congress Ave, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092	National Institutes of Health; BrightFocus Foundation; Alzheimer's Association; Falk Medical Research Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034924, P50AG047270, RF1AG053000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BrightFocus Foundation(BrightFocus Foundation); Alzheimer's Association(Alzheimer's Association); Falk Medical Research Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health, BrightFocus Foundation, Alzheimer's Association, and the Falk Medical Research Trust (to S. M. S.). S. M. S. is a co-founder of Axerion Therapeutics, seeking to develop PrP-based therapeutics for Alzheimer disease. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Giuffrida R, 2005, J NEUROSCI, V25, P8908, DOI 10.1523/JNEUROSCI.0932-05.2005; Gruszczynska-Biegala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019285; Haas LT, 2016, BRAIN, V139, P526, DOI 10.1093/brain/awv356; Haas LT, 2014, J BIOL CHEM, V289, P28460, DOI 10.1074/jbc.M114.584342; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heidinger V, 2002, J NEUROSCI, V22, P5452; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Jin DZ, 2013, J NEUROCHEM, V127, P620, DOI 10.1111/jnc.12434; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kaufman AC, 2015, ANN NEUROL, V77, P953, DOI 10.1002/ana.24394; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khondoker M, 2015, J ALZHEIMERS DIS, V45, P851, DOI 10.3233/JAD-142214; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Kostylev MA, 2015, J BIOL CHEM, V290, P17415, DOI 10.1074/jbc.M115.643577; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Nicodemo AA, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-4; Nygaard HB, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0119-0; Nygaard HB, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt238; Park JH, 2006, J NEUROSCI, V26, P13279, DOI 10.1523/JNEUROSCI.4504-06.2006; Pignatelli M, 2014, J NEUROSCI, V34, P4558, DOI 10.1523/JNEUROSCI.1846-13.2014; Raka F, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0111-4; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; SCHULMAN H, 1978, NATURE, V271, P478, DOI 10.1038/271478a0; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sun SY, 2014, NEURON, V82, P79, DOI 10.1016/j.neuron.2014.02.019; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Wang X, 2015, J ALZHEIMERS DIS, V43, P649, DOI 10.3233/JAD-140729; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Zhang H, 2015, J NEUROSCI, V35, P13275, DOI 10.1523/JNEUROSCI.1034-15.2015	50	55	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17112	17121		10.1074/jbc.M116.720664	http://dx.doi.org/10.1074/jbc.M116.720664			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27325698	hybrid, Green Published			2022-12-26	WOS:000382643800017
J	Caceres, NC; Weber, MD; Melo, GL; Meloro, C; Sponchiado, J; Carvalho, RD; Bubadue, JD				Caceres, Nilton Carlos; Weber, Marcelo de Moraes; Melo, Geruza Leal; Meloro, Carlo; Sponchiado, Jonas; Carvalho, Renan dos Santos; Bubadue, Jamile de Moura			Which Factors Determine Spatial Segregation in the South American Opossums (Didelphis aurita and D-albiventris)? An Ecological Niche Modelling and Geometric Morphometrics Approach	PLOS ONE			English	Article							BLACK-EARED OPOSSUM; CHARACTER DISPLACEMENT; ECOGEOGRAPHICAL VARIATION; SPECIES DISTRIBUTIONS; SKULL SHAPE; AREA; DIFFERENTIATION; PATTERNS; RELEASE; PREDICT	Didelphis albiventris and D. aurita are Neotropical marsupials that share a unique evolutionary history and both are largely distributed throughout South America, being primarily allopatric throughout their ranges. In the Araucaria moist forest of Southern Brazil these species are sympatric and they might potentially compete having similar ecology. For this reason, they are ideal biological models to address questions about ecological character displacement and how closely related species might share their geographic space. Little is known about how two morphologically similar species of marsupials may affect each other through competition, if by competitive exclusion and competitive release. We combined ecological niche modeling and geometric morphometrics to explore the possible effects of competition on their distributional ranges and skull morphology. Ecological niche modeling was used to predict their potential distribution and this method enabled us to identify a case of biotic exclusion where the habit generalist D. albiventris is excluded by the presence of the specialist D. aurita. The morphometric analyses show that a degree of shape discrimination occurs between the species, strengthened by allometric differences, which possibly allowed them to occupy marginally different feeding niches supplemented by behavioral shift in contact areas. Overlap in skull morphology is shown between sympatric and allopatric specimens and a significant, but weak, shift in shape occurs only in D. aurita in sympatric areas. This could be a residual evidence of a higher past competition between both species, when contact zones were possibly larger than today. Therefore, the specialist D. aurita acts a biotic barrier to D. albiventris when niche diversity is not available for coexistence. On the other hand, when there is niche diversification (e.g. habitat mosaic), both species are capable to coexist with a minimal competitive effect on the morphology of D. aurita.	[Caceres, Nilton Carlos; Melo, Geruza Leal; Sponchiado, Jonas; Carvalho, Renan dos Santos; Bubadue, Jamile de Moura] Univ Fed Santa Maria, Dept Ecol & Evolucao, Lab Ecol & Biogeog, BR-97119900 Santa Maria, RS, Brazil; [Weber, Marcelo de Moraes] Univ Fed Goias, Inst Ciencias Biol, Lab Ecol Teor & Sintese, Goiania, Go, Brazil; [Melo, Geruza Leal] Univ Fed Mato Grosso do Sul, CCBS, Programa Posgrad Ecol & Conservacao, Campo Grande, Brazil; [Meloro, Carlo] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 5UX, Merseyside, England; [Sponchiado, Jonas; Bubadue, Jamile de Moura] Univ Fed Santa Maria, CCNE, Programa Posgrad Biodiversidade Anim, BR-97119900 Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Goias; Universidade Federal de Mato Grosso do Sul; Liverpool John Moores University; Universidade Federal de Santa Maria (UFSM)	Caceres, NC; Bubadue, JD (corresponding author), Univ Fed Santa Maria, Dept Ecol & Evolucao, Lab Ecol & Biogeog, BR-97119900 Santa Maria, RS, Brazil.; Bubadue, JD (corresponding author), Univ Fed Santa Maria, CCNE, Programa Posgrad Biodiversidade Anim, BR-97119900 Santa Maria, RS, Brazil.	niltoncaceres@gmail.com; jamilebubadue@gmail.com	Weber, Marcelo M/I-4813-2015; Sponchiado, Jonas/E-4501-2013; Melo, Geruza Leal/P-7449-2016; Bubadué, Jamile/G-5378-2015; Cáceres, Nilton C./H-6899-2012; Sponchiado, Jonas/AAT-3039-2021; Meloro, Carlo/U-4527-2019	Weber, Marcelo M/0000-0002-1205-1169; Sponchiado, Jonas/0000-0002-1267-1763; Melo, Geruza Leal/0000-0002-2384-3786; Bubadué, Jamile/0000-0001-7069-996X; Cáceres, Nilton C./0000-0003-4904-0604; Sponchiado, Jonas/0000-0002-1267-1763; Meloro, Carlo/0000-0003-0175-1706	British Research Council [127432108]; 'Conselho Nacional de Desenvolvimento Cientifico e Tecnologico' (CNPq) in Brazil [308957/2010-5]; CNPq; 'Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior' (CAPES)	British Research Council; 'Conselho Nacional de Desenvolvimento Cientifico e Tecnologico' (CNPq) in Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 'Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior' (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The contribution of Carlo Meloro to this research was supported by the British Research Council Travel grant (ref: 127432108). The senior author (Nilton Caceres) was supported by the 'Conselho Nacional de Desenvolvimento Cientifico e Tecnologico' (CNPq) in Brazil (PQ Researcher Fellow process number 308957/2010-5). Author Marcelo de Moraes Weber was supported by CNPq and Geruza Melo, Jonas Sponchiado, Renan Carvalho and Jamile Bubadue by 'Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior' (CAPES) with a scholarship.; Our thanks to curators and staff of the Museu de Ciencias Naturais da Fundacao Zoobotanica do Rio Grande do Sul (MCN) (M.M. de A. Jardim), Museu de Ciencias e Tecnologia da PUCRS (MCP) (C.S. Fontana), Museu Nacional (MN) (J.A. de Oliveira and S.M. Vaz), Museu de Historia Natural Capao da Imbuia (MNHNCI) (V. Abilhoa and S.C. Pereira), Colecao Cientifica do Laboratorio de Mamiferos Aquaticos da UFSC (LAMAQ) (M.E. Graipel) and Museu de Zoologia da Universidade de Sao Paulo (MZUSP) (M. De Vivo and J.G. Barros) for the authorization and support to specimens access. The contribution of Carlo Meloro to this research was supported by the British Research Council Travel grant (ref: 127432108). The senior author (Nilton Caceres) was supported by the 'Conselho Nacional de Desenvolvimento Cientifico e Tecnologico' (CNPq) in Brazil (PQ Researcher Fellow process number 308957/2010-5). Author Marcelo de Moraes Weber was supported by CNPq and Geruza Melo, Jonas Sponchiado, Renan Carvalho and Jamile Bubadue by 'Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior' (CAPES) with a scholarship.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Adams DC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-72; AIELLOLAMMENS MA, 2015, ECOGRAPHY, V38, P1; Sanches VQA, 2012, BIOTA NEOTROP, V12, P50, DOI 10.1590/S1676-06032012000400004; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Anderson RP, 2002, OIKOS, V98, P3, DOI 10.1034/j.1600-0706.2002.t01-1-980116.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Broennimann O., 2015, ECOSPAT SPATIAL ECOL; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Bubadue JM, 2015, EVOL BIOL; CACERES NC, 2007, CIENCIA AMBIENTE, V35, P167; Caceres N, 2014, J BIOGEOGR, V41, P501, DOI 10.1111/jbi.12203; Caceres Nilton C., 2013, Open Ecology Journal, V6, P10; Cáceres Nilton Carlos, 2003, Rev. Bras. Zool., V20, P315, DOI 10.1590/S0101-81752003000200023; Caceres Nilton Carlos, 2000, Ciencia e Cultura (Sao Paulo), V52, P171; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; CERQUEIRA R, 1985, J BIOGEOGR, V12, P135, DOI 10.2307/2844837; Cerqueira R, 2000, MAMMALIA, V64, P319, DOI 10.1515/mamm.2000.64.3.319; Costa Leonora Pires, 2006, P321; Davies TJ, 2007, ECOL LETT, V10, P146, DOI 10.1111/j.1461-0248.2006.01005.x; Dayan T, 1998, MAMMAL REV, V28, P99, DOI 10.1046/j.1365-2907.1998.00029.x; de la Sancha NU, 2014, MAMMALIA, V78, P437, DOI 10.1515/mammalia-2013-0100; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Drake JM, 2006, J APPL ECOL, V43, P424, DOI 10.1111/j.1365-2664.2006.01141.x; Dudik M, 2004, LECT NOTES COMPUT SC, V3120, P472, DOI 10.1007/978-3-540-27819-1_33; Eisenberg JF, 1999, MAMMALS NEOTTROPICS; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Feer F, 1997, NEOTROPICAL RAINFORE; Franklin J, 2009, MAPPING SPECIES DIST; Gannon WL, 2006, J MAMMAL, V87, P171, DOI 10.1644/05-MAMM-A-140R1.1; Gutierrez EE, 2014, ECOGRAPHY, V37, P741, DOI 10.1111/ecog.00620; Herrmann G., 2012, ANNOTATED CHECKLIST, V2nd; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jansa Sharon A., 2000, Journal of Mammalian Evolution, V7, P43, DOI 10.1023/A:1009465716811; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Lemos B, 2002, J MAMMAL, V83, P354, DOI 10.1644/1545-1542(2002)083<0354:MDITWE>2.0.CO;2; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loy A, 1998, ACTA ZOOL ACAD SCI H, V44, P151; Machado FD, 2009, BIOL J LINN SOC, V98, P77; Martinez PA, 2013, J ANIM ECOL, V82, P997, DOI 10.1111/1365-2656.12076; Meloro C, 2014, ZOOL ANZ, V253, P345, DOI 10.1016/j.jcz.2013.11.002; Mendel SM, 2008, J MAMMAL, V89, P159, DOI 10.1644/06-MAMM-A-263.1; Munguia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034420; Munoz MES, 2011, GEOINFORMATICA, V15, P111, DOI DOI 10.1007/s10707-009-0090-7; Nabout JC, 2010, BRAZ J BIOL, V70, P911, DOI 10.1590/S1519-69842010000500001; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Putman R.J., 1984, PRINCIPLES ECOLOGY; R Development Core Team, 2014, R LANG ENV STAT COMP; Rohlf FJ, 2015, HYSTRIX, V26, P9, DOI 10.4404/hystrix-26.1-11264; Rohlf FJ., 2000, HYSTRIX IT J MAMM, V11, P1, DOI DOI 10.4404/HYSTRIX-11.1-4134; Russo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110894; Cerboncini RAS, 2011, MAMMALIA, V75, P287, DOI 10.1515/MAMM.2011.024; Tocchio LJ, 2015, ZOOL SCR, V44, P1, DOI 10.1111/zsc.12082; VANVALKENBURGH B, 1994, ECOLOGY, V75, P1567; Veloso H.P., 1991, CLASSIFICACAO VEGETA; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Weber MD, 2014, GLOBAL ECOL BIOGEOGR, V23, P1177, DOI 10.1111/geb.12198; YOMTOV Y, 1991, OIKOS, V60, P173, DOI 10.2307/3544863	63	21	21	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157723	10.1371/journal.pone.0157723	http://dx.doi.org/10.1371/journal.pone.0157723			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336371	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000378389200037
J	Arribas, J; Cajuso, T; Rodio, A; Marcos, R; Leonardi, A; Velazquez, A				Arribas, Jessica; Cajuso, Tatiana; Rodio, Angela; Marcos, Ricard; Leonardi, Antonio; Velazquez, Antonia			NF-kappa B Mediates the Expression of TBX15 in Cancer Cells	PLOS ONE			English	Article							DNA METHYLATION; GENE; DIFFERENTIATION; ROLES	TBX15 is a T-box transcription factor essential for development, also proposed as a marker in prostate cancer; and, recently, its antiapoptotic function indicates a role in carcinogenesis. Regulation of TBX15 is uncovered. In this study, we investigated the regulation of TBX15 expression in human cancer cells, by analyzing the regulatory function of a 5'-distal conserved region of TBX15. Bisulfite sequencing showed high methylation of the CpG island contained in this region that was not correlated with TBX15 mRNA levels, in the cancer cell lines analyzed; however, after 5-aza-dC treatment of TPC-1 cells an increase of TBX15 expression was observed. We also found a significant response of TBX15 to TNF-alpha activation of the NF-kappa B pathway using five cancer cell lines, and similar results were obtained when NF-kappa B was activated with PMA/ionomycin. Next, by luciferase reporter assays, we identified the TBX15 regulatory region containing two functional NF-kappa B binding sites with response to NF-kappa Bp65, mapping on the -3302 and -3059 positions of the TBX15 gene. Moreover, a direct interaction of NF-kappa Bp65 with one of the two NF-kappa B binding sites was indicated by ChIP assays. In summary, we provide novel data showing that NF-kappa B signaling up-regulates TBX15 expression in cancer cells. Furthermore, the link between TBX15 and NF-kappa B found in this study may be important to understand cancer and development processes.	[Arribas, Jessica; Cajuso, Tatiana; Marcos, Ricard; Velazquez, Antonia] Univ Autonoma Barcelona, Fac Biociencies, Dept Genet & Microbiol, Grp Mutagenesi,Unitat Genet, E-08193 Barcelona, Spain; [Marcos, Ricard; Velazquez, Antonia] Inst Salud Carlos III SCIII, CIBER Epidemiol & Salud Publ, Madrid, Spain; [Rodio, Angela; Leonardi, Antonio] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Naples, Italy	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Naples Federico II	Arribas, J (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, Dept Genet & Microbiol, Grp Mutagenesi,Unitat Genet, E-08193 Barcelona, Spain.	j.arribas.arranz@gmail.com	Marcos, Ricard/G-9671-2015; leonardi, antonio/A-2887-2009; Arribas, Jéssica/AAT-9717-2020	Marcos, Ricard/0000-0001-7891-357X; leonardi, antonio/0000-0001-8636-9623; Arribas, Jéssica/0000-0002-3390-276X; Cajuso, Tatiana/0000-0002-6354-5572	Universitat Autonoma de Barcelona; Spanish Ministry of Education and Science [SAF2007-6338]; Generalitat de Catalunya (CIRIT) [2009SGR-725]	Universitat Autonoma de Barcelona; Spanish Ministry of Education and Science(Spanish Government); Generalitat de Catalunya (CIRIT)(Generalitat de Catalunya)	JA was supported by a predoctoral fellowship (PIF) from the Universitat Autonoma de Barcelona. This research was supported by grant support: Spanish Ministry of Education and Science (project SAF2007-6338) and the Generalitat de Catalunya (CIRIT; 2009SGR-725).	Arribas J, 2015, APOPTOSIS, V20, P1338, DOI 10.1007/s10495-015-1155-8; Baida A, 2008, CANCER EPIDEM BIOMAR, V17, P1499, DOI 10.1158/1055-9965.EPI-07-0235; Bushdid PB, 1998, NATURE, V392, P615, DOI 10.1038/33435; Candille SI, 2004, PLOS BIOL, V2, P30, DOI 10.1371/journal.pbio.0020003; Chelbi ST, 2011, EPIGENETICS-US, V6, P247, DOI 10.4161/epi.6.2.13791; Dikoglu E, 2013, AM J MED GENET A, V161, P3161, DOI 10.1002/ajmg.a.36173; Escarcega RO, 2007, CLIN ONCOL-UK, V19, P154, DOI 10.1016/j.clon.2006.11.013; Gburcik V, 2012, AM J PHYSIOL-ENDOC M, V303, pE1053, DOI 10.1152/ajpendo.00104.2012; Gesta S, 2011, P NATL ACAD SCI USA, V108, P2771, DOI 10.1073/pnas.1019704108; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jiang MH, 2010, LAB INVEST, V90, P282, DOI 10.1038/labinvest.2009.132; Joyce D, 2001, CYTOKINE GROWTH F R, V12, P73, DOI 10.1016/S1359-6101(00)00018-6; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kron K, 2012, CLIN CANCER RES, V18, P2896, DOI 10.1158/1078-0432.CCR-11-2901; Kuijper S, 2005, DEVELOPMENT, V132, P1601, DOI 10.1242/dev.01735; Lausch E, 2008, AM J HUM GENET, V83, P649, DOI 10.1016/j.ajhg.2008.10.011; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Pacifico F, 2004, J BIOL CHEM, V279, P54610, DOI 10.1074/jbc.M403492200; Pacifico F, 2006, BIOCHEM PHARMACOL, V72, P1142, DOI 10.1016/j.bcp.2006.07.032; Pacifico F, 2010, MOL CELL ENDOCRINOL, V321, P29, DOI 10.1016/j.mce.2009.10.010; Papaioannou VE, 2014, DEVELOPMENT, V141, P3819, DOI 10.1242/dev.104471; Peres Jade, 2010, Genes Cancer, V1, P272, DOI 10.1177/1947601910365160; Singh MK, 2005, MECH DEVELOP, V122, P131, DOI 10.1016/j.mod.2004.10.011; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Yu J, 2010, ONCOGENE, V29, P6464, DOI 10.1038/onc.2010.370	27	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157761	10.1371/journal.pone.0157761	http://dx.doi.org/10.1371/journal.pone.0157761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327083	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212400039
J	Takacs, P; Vital, Z; Ferincz, A; Staszny, A				Takacs, Peter; Vital, Zoltan; Ferincz, Arpad; Staszny, Adam			Repeatability, Reproducibility, Separative Power and Subjectivity of Different Fish Morphometric Analysis Methods	PLOS ONE			English	Article							GEOMETRIC MORPHOMETRICS; MEASUREMENT ERROR; MORPHOLOGICAL VARIATION; SEXUAL-DIMORPHISM; OTOLITH SHAPE; POPULATIONS; TELEOSTEI; LENGTH; TRUSS; LAKE	We compared the repeatability, reproducibility (intra-and inter-measurer similarity), separative power and subjectivity (measurer effect on results) of four morphometric methods frequently used in ichthyological research, the "traditional" caliper-based (TRA) and trussnetwork (TRU) distance methods and two geometric methods that compare landmark coordinates on the body (GMB) and scales (GMS). In each case, measurements were performed three times by three measurers on the same specimen of three common cyprinid species (roach Rutilus rutilus (Linnaeus, 1758), bleak Alburnus alburnus (Linnaeus, 1758) and Prussian carp Carassius gibelio (Bloch, 1782)) collected from three closely-situated sites in the Lake Balaton catchment (Hungary) in 2014. TRA measurements were made on conserved specimens using a digital caliper, while TRU, GMB and GMS measurements were undertaken on digital images of the bodies and scales. In most cases, intra-measurer repeatability was similar. While all four methods were able to differentiate the source populations, significant differences were observed in their repeatability, reproducibility and subjectivity. GMB displayed highest overall repeatability and reproducibility and was least burdened by measurer effect. While GMS showed similar repeatability to GMB when fish scales had a characteristic shape, it showed significantly lower reproducability (compared with its repeatability) for each species than the other methods. TRU showed similar repeatability as the GMS. TRA was the least applicable method as measurements were obtained from the fish itself, resulting in poor repeatability and reproducibility. Although all four methods showed some degree of subjectivity, TRA was the only method where population-level detachment was entirely overwritten by measurer effect. Based on these results, we recommend a) avoidance of aggregating different measurer's datasets when using TRA and GMS methods; and b) use of image-based methods for morphometric surveys. Automation of the morphometric workflow would also reduce any measurer effect and eliminate measurement and data-input errors.	[Takacs, Peter; Vital, Zoltan] Balaton Limnol Inst, Ctr Ecol Res, MTA, Tihany, Hungary; [Ferincz, Arpad; Staszny, Adam] Szent Istvan Univ, Dept Aquaculture, Godollo, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Balaton Limnological Research Institute; Hungarian University of Agriculture & Life Sciences	Takacs, P (corresponding author), Balaton Limnol Inst, Ctr Ecol Res, MTA, Tihany, Hungary.	takacs.peter@okologia.mta.hu	Vitál, Zoltán/M-8322-2019; Takács, Péter/A-8082-2016; Staszny, Ádám/AAM-2193-2020; Vitál, Zoltán/GXF-7227-2022	Takács, Péter/0000-0001-5247-7597; Staszny, Ádám/0000-0002-6166-8333; Ferincz, Arpad/0000-0003-2420-0245; VITAL, Zoltan/0000-0001-7832-082X	Hungarian Scientific Research Fund [OTKA PD115801]; Horizon 2020 - the framework Programme for Research and Innovation-Tools for Assessment and Planning of Aquaculture Sustainability (TAPAS) [678396]; Research Centre of Excellence-project (Szent Istvan University) [9878-3/2016/FEKUT]; Bolyai Fellowship of the Hungarian Academy of Sciences	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Horizon 2020 - the framework Programme for Research and Innovation-Tools for Assessment and Planning of Aquaculture Sustainability (TAPAS); Research Centre of Excellence-project (Szent Istvan University); Bolyai Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	PT is supported by the Hungarian Scientific Research Fund-grant no.: OTKA PD115801 (website: http://nyilvanos.otka-palyazat.hu/index.php? menuid= 930&num= 115801). AS and AF are supported by "Horizon 2020 - the framework Programme for Research and Innovation (2014-2020)- Project No.: 678396-Tools for Assessment and Planning of Aquaculture Sustainability (TAPAS)" (website: http://tapas-h2020.eu) and "Research Centre of Excellence-project no: 9878-3/2016/FEKUT (Funder: Szent Istvan University)" (website: http://ofi.hu/sites/default/files/attachments/d_kutato_karok_ final.pdf). Moreover AF was supported by the Bolyai Fellowship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams GL, 2004, AM J ORTHOD DENTOFAC, V126, P397, DOI 10.1016/j.ajodo.2004.03.023; Aguera A, 2011, FISH RES, V110, P465, DOI 10.1016/j.fishres.2011.06.003; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arechavala-Lopez P, 2012, HYDROBIOLOGIA, V679, P217, DOI 10.1007/s10750-011-0886-y; Arnqvist G, 1998, ACTA ZOOL ACAD SCI H, V44, P73; BAILEY RC, 1990, SYST ZOOL, V39, P124, DOI 10.2307/2992450; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Berinkey L, 1966, HALAK PISCES FAUNA H, V132; Bertin E, 2011, ASTR SOC P, V442, P435; Bookstein FL, 1985, SPECIAL PUBLICATION; Cadrin SX, 1999, FISH RES, V43, P129, DOI 10.1016/S0165-7836(99)00070-3; Cales Paul, 2015, J Pathol Inform, V6, P20, DOI 10.4103/2153-3539.157782; Carpenter KE, 1996, NATO ADV SCI INST SE, V284, P103; CHINN S, 1991, THORAX, V46, P454, DOI 10.1136/thx.46.6.454; CREECH S, 1992, J FISH BIOL, V41, P341, DOI 10.1111/j.1095-8649.1992.tb02663.x; Darwin C, ORIGINS SPECIES MEAN, P247; DISTEFANO RJ, 1994, T AM FISH SOC, V123, P817, DOI 10.1577/1548-8659(1994)123<0817:RPOFPO>2.3.CO;2; Doadrio I, 2002, FOLIA ZOOL, V51, P67; Dujardin Jean-Pierre Al, 2010, BMC Res Notes, V3, P266, DOI 10.1186/1756-0500-3-266; ELLIOTT NG, 1995, J FISH BIOL, V46, P202, DOI 10.1111/j.1095-8649.1995.tb05962.x; Essner Richard L. Jr., 2014, Transactions of the Illinois State Academy of Science, V107, P27; Franklin D, 2012, INT J LEGAL MED, V126, P549, DOI 10.1007/s00414-012-0684-8; Ginter CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034481; Gomez GF, 2014, ACTA TROP, V135, P75, DOI 10.1016/j.actatropica.2014.03.020; Gomez-Robles A, 2007, J HUM EVOL, V53, P272, DOI 10.1016/j.jhevol.2007.02.002; Gonzalez-Castro M, 2012, ZOOL STUD, V51, P1515; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heckemann RA, 2011, NEUROIMAGE, V56, P2024, DOI 10.1016/j.neuroimage.2011.03.014; Helm B, 2000, ANIM BEHAV, V60, P899, DOI 10.1006/anbe.2000.1534; Herler J, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-4; Howe JC, 2002, FISH RES, V56, P1, DOI 10.1016/S0165-7836(01)00312-5; Huber HR, 2011, J ARCHAEOL SCI, V38, P136, DOI 10.1016/j.jas.2010.08.020; Ibanez AL, 2007, CAN J FISH AQUAT SCI, V64, P1091, DOI 10.1139/F07-075; Ibanez AL, 2011, FISH RES, V109, P54, DOI 10.1016/j.fishres.2011.01.016; Jorgensen HBH, 2008, CAN J FISH AQUAT SCI, V65, P389, DOI 10.1139/F07-177; Kitano J, 2007, COPEIA, P336, DOI 10.1643/0045-8511(2007)7[336:SDITEM]2.0.CO;2; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kocovsky PM, 2009, T AM FISH SOC, V138, P487, DOI 10.1577/T08-091.1; LEE JC, 1982, SYST ZOOL, V31, P266, DOI 10.2307/2413232; Lehtinen RM, 2012, COPEIA, P648, DOI 10.1643/CH-11-128; LINDSEY CC, 1963, J FISH RES BOARD CAN, V20, P749, DOI 10.1139/f63-050; Linnaeus C, 1788, SYSTEMA NATURAE REGN, V1; LYNNERUP N, 1993, COMPUT BIOL MED, V23, P143, DOI 10.1016/0010-4825(93)90145-Q; Maderbacher M, 2008, J ZOOL SYST EVOL RES, V46, P153, DOI 10.1111/j.1439-0469.2007.00447.x; MANTEL N, 1967, CANCER RES, V27, P209; Martinon-Torres M, 2006, J HUM EVOL, V50, P523, DOI 10.1016/j.jhevol.2005.12.004; Nowak Michal, 2011, Archives of Polish Fisheries, V19, P37; Parsons KJ, 2003, ENVIRON BIOL FISH, V67, P417, DOI 10.1023/A:1025895317253; Petrtyl M, 2014, TURK J VET ANIM SCI, V38, P88, DOI 10.3906/vet-1209-9; Pinheiro A, 2005, FISH RES, V73, P67, DOI 10.1016/j.fishres.2005.01.004; Ponton D, 2006, J MORPHOL, V267, P750, DOI 10.1002/jmor.10439; Rabinovich S, 1995, MEASUREMENT ERRORS T, V1; Rasband WS, 2012, ASTROPHYSICS SOURCE, V1, P6013; ROHLF FJ, 1990, ANNU REV ECOL SYST, V21, P299, DOI 10.1146/annurev.es.21.110190.001503; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 1998, SYST BIOL, V47, P147, DOI 10.1080/106351598261094; Rohlf FJ, 2010, TPSUTIL FILE UTILITY; Rohlf FJ, 2010, TPSDIG2 DIGITIZE LAN; Roitberg ES, 2011, AMPHIBIA-REPTILIA, V32, P477, DOI 10.1163/156853811X601636; Sajina AM, 2011, FISH RES, V108, P100, DOI 10.1016/j.fishres.2010.12.006; Slezak P, 2011, PHYSIOL RES, V60, P203; Staszny A, 2013, ACTA BIOL HUNG, V64, P462, DOI 10.1556/ABiol.64.2013.4.6; Staszny A, 2012, ACTA ZOOL ACAD SCI H, V58, P19; STRAUSS RE, 1982, SYST ZOOL, V31, P113, DOI 10.2307/2413032; Szlachciak J, 2015, BIOLOGIA, V70, P121, DOI 10.1515/biolog-2015-0016; Takacs P, 2012, ANN LIMNOL-INT J LIM, V48, P53; Trapani J, 2003, ENVIRON BIOL FISH, V68, P357, DOI 10.1023/B:EBFI.0000005763.96260.2a; Turan C, 2004, ICES J MAR SCI, V61, P774, DOI 10.1016/j.icesjms.2004.05.001; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Viscosi V, 2009, PLANT BIOSYST, V143, P564, DOI 10.1080/11263500902723129; Walford LA, 1950, BIOMETRIC COMP YELLO; YEZERINAC SM, 1992, SYST BIOL, V41, P471, DOI 10.2307/2992588; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	75	24	26	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157890	10.1371/journal.pone.0157890	http://dx.doi.org/10.1371/journal.pone.0157890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DP0WU	27327896	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000378212400058
J	Yamanashi, J; Takayanagi, H; Isaji, A; Asami, R; Iryu, Y				Yamanashi, Junpei; Takayanagi, Hideko; Isaji, Ayaka; Asami, Ryuji; Iryu, Yasufumi			Carbon and Oxygen Isotope Records from Tridacna derasa Shells: Toward Establishing a Reliable Proxy for Sea Surface Environments	PLOS ONE			English	Article							INTERDECADAL CLIMATE VARIABILITY; CORAL-REEF ENVIRONMENT; STABLE-ISOTOPES; ARCTICA-ISLANDICA; GIANT CLAMS; INTRASPECIFIC VARIATIONS; GIGAS BIVALVES; RYUKYU ISLANDS; TRACE-ELEMENTS; PINNA-NOBILIS	We report the carbon (delta C-13) and oxygen (delta O-18) isotope records of three modern Tridacna derasa shells from Ishigaki-jima, southwestern Japan. The high-resolution delta C-13 profiles of samples from the inner shell layer on cross-sections fall within similar narrow ranges and display no regular variations or trends, such as an ontogenetic trend or abrupt short-term drops likely to be related to reproductive activity. This suggests that the calcification site of this species is not likely affected by photosynthetic CO2 uptake or CO2 incorporation during respiration. The delta O-18 profiles show distinct seasonal cycles. The intraspecific variability in the delta O-18 values is small in parts of the shell precipitated in the adult stage, but is not negligible in the juvenile and senescent stages. The differences in the monthly and seasonally resolved delta O-18 values among shells are less than 0.51 parts per thousand and 0.76 parts per thousand, respectively. The shell delta O-18 values are nearly identical or close to the delta O-18 values for aragonite precipitated in oxygen isotope equilibrium with ambient seawater (delta O-18(EA)). The largest differences between the shell delta O-18 and delta O-18(EA) values calculated from the monthly and seasonally resolved data correspond to an overestimate of the seawater temperature by as much as 1.7 degrees C and 2.3 degrees C, respectively. However, these differences are smaller in the adult stage (<0.25%) than in the other stages. This small difference allows an accurate reconstruction of the seawater temperature with an error of <1.1 degrees C. Consequently, we recommend that multiple shell records be obtained because of the non-negligible intraspecific variations in their delta O-18 values. Growth banding, composed of alternating narrow white bands and wide light-grey bands, is discernible on cross-sections of the inner shell layer. The delta O-18(shell) data indicate that they were formed in winter and the other seasons, respectively.	[Yamanashi, Junpei; Takayanagi, Hideko; Iryu, Yasufumi] Tohoku Univ, Grad Sch Sci, Inst Geol & Paleontol, Sendai, Miyagi 980, Japan; [Isaji, Ayaka] Nagoya Univ, Dept Earth & Planetary Sci, Grad Sch Environm Studies, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Asami, Ryuji] Univ Ryukyus, Fac Sci, Dept Earth Sci, 1 Senbaru, Nishihara, Okinawa 90301, Japan	Tohoku University; Nagoya University; University of the Ryukyus	Yamanashi, J; Iryu, Y (corresponding author), Tohoku Univ, Grad Sch Sci, Inst Geol & Paleontol, Sendai, Miyagi 980, Japan.	seedfaise50@yahoo.co.jp; iryu@m.tohoku.ac.jp	Takayanagi, Hideko/AAE-4381-2019; Iryu, Yasufumi/N-1782-2019	Iryu, Yasufumi/0000-0002-6099-0662; Takayanagi, Hideko/0000-0003-3212-9506	KAKENHI from the Japan Society for the Promotion of Science (JSPS) [21340152, 26302008]; Grants-in-Aid for Scientific Research [26302008] Funding Source: KAKEN	KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI (Grant-in-Aid for Scientific Research; http://www.jsps.go.jp/english/e-grants/index.html) (grant numbers 21340152 and 26302008 to YI) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2009, ISOT ENVIRON HEALT S, V45, P247, DOI 10.1080/10256010903083847; AHARON P, 1986, PALAEOGEOGR PALAEOCL, V56, P337, DOI 10.1016/0031-0182(86)90101-X; AHARON P, 1991, CORAL REEFS, V10, P71, DOI 10.1007/BF00571826; Amante C., 2009, NGDC24 NOAA NESDIS; Asami R, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002555; Asami R, 2015, ISL ARC, V24, P61, DOI 10.1111/iar.12076; Aubert A, 2009, CORAL REEFS, V28, P989, DOI 10.1007/s00338-009-0538-0; Auclair AC, 2003, CHEM GEOL, V202, P59, DOI 10.1016/S0009-2541(03)00233-X; Batenburg SJ, 2011, PALAEOGEOGR PALAEOCL, V306, P75, DOI 10.1016/j.palaeo.2011.03.031; Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070; Bohm F, 2000, GEOCHIM COSMOCHIM AC, V64, P1695, DOI 10.1016/S0016-7037(99)00408-1; Brand U, 2003, CHEM GEOL, V198, P305, DOI 10.1016/S0009-2541(03)00032-9; Bruguiere JG, 1797, TABLEAU ENCY METHODI; Calvo E, 2007, PALAEOGEOGR PALAEOCL, V248, P190, DOI 10.1016/j.palaeo.2006.12.003; Carre M, 2005, PALAEOGEOGR PALAEOCL, V228, P4, DOI 10.1016/j.palaeo.2005.03.045; Chauvaud L, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000890; Cusack M, 2012, CHEM GEOL, V334, P139, DOI 10.1016/j.chemgeo.2012.10.021; Elliot M, 2009, PALAEOGEOGR PALAEOCL, V280, P132, DOI 10.1016/j.palaeo.2009.06.007; EMILIANI C, 1955, J GEOL, V63, P538, DOI 10.1086/626295; EPSTEIN S, 1953, GEOL SOC AM BULL, V64, P1315, DOI 10.1130/0016-7606(1953)64[1315:RCITS]2.0.CO;2; FANKBONER PV, 1971, NATURE, V230, P579, DOI 10.1038/230579a0; Felis T, 2009, GEOLOGY, V37, P527, DOI 10.1130/G25581A.1; Gagan MK, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002215; Gillikin DP, 2006, ORG GEOCHEM, V37, P1371, DOI 10.1016/j.orggeochem.2006.03.008; GROSSMAN EL, 1984, GEOCHIM COSMOCHIM AC, V48, P1505, DOI 10.1016/0016-7037(84)90406-X; Hean RL, 2003, ECOL MODEL, V163, P87, DOI 10.1016/S0304-3800(02)00400-3; Huelsken T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080858; JONES DS, 1986, SCIENCE, V231, P46, DOI 10.1126/science.231.4733.46; Keller N, 2002, MAR BIOL, V140, P9, DOI 10.1007/s002270100660; Kennedy H, 2001, MAR BIOL, V139, P1115; Kim ST, 1997, GEOCHIM COSMOCHIM AC, V61, P3461, DOI 10.1016/S0016-7037(97)00169-5; Kitamura A, 2011, VELIGER, V51, P59; Ku TL, 1986, ORG GEOCHEM, V37, P1371, DOI [10.1016/168-9622(86)90057-6, DOI 10.1016/168-9622(86)90057-6]; LAMARCK J.B.M. DE, 1819, HIST NATURELLE ANIMA; Linsley BK, 2004, CLIM DYNAM, V22, P1, DOI 10.1007/s00382-003-0364-y; Loomis W. F., 1961, BIOL HYDRA SOME OTHE, P269; Lorrain A, 2004, GEOCHIM COSMOCHIM AC, V68, P3509, DOI 10.1016/j.gca.2004.01.025; Maier E, 2010, PALAEOGEOGR PALAEOCL, V291, P228, DOI 10.1016/j.palaeo.2010.02.032; McConnaughey TA, 1997, GEOCHIM COSMOCHIM AC, V61, P611, DOI 10.1016/S0016-7037(96)00361-4; McConnaughey TA, 2008, GEO-MAR LETT, V28, P287, DOI 10.1007/s00367-008-0116-4; Okai T., 2004, GEOCHEMISTRY, V38, P281; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Parkinson D, 2005, CHEM GEOL, V219, P193, DOI 10.1016/j.chemgeo.2005.02.002; PATZOLD J, 1991, CORAL REEFS, V10, P65, DOI 10.1007/BF00571825; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Richardson CA, 1999, MAR BIOL, V133, P205, DOI 10.1007/s002270050459; Roding P.F., 1798, ANNOS PROTO PHYS HAM; Rohlf FJ, 1994, BIOMETRY PRINCIPAL P; Rollion-Bard C, 2003, CORAL REEFS, V22, P405, DOI 10.1007/s00338-003-0347-9; ROMANEK C S, 1989, Palaios, V4, P402, DOI 10.2307/3514585; ROMANEK CS, 1992, GEOCHIM COSMOCHIM AC, V56, P419, DOI 10.1016/0016-7037(92)90142-6; ROMANEK CS, 1987, MAR BIOL, V94, P385, DOI 10.1007/BF00428244; ROSEWATER JOSEPH, 1965, INDO PACIFIC MOLLUSCA, V1, P347; Sano Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1763; Schone BR, 2013, GLOBAL PLANET CHANGE, V111, P199, DOI 10.1016/j.gloplacha.2013.09.013; Schone BR, 2011, PALAEOGEOGR PALAEOCL, V302, P31, DOI 10.1016/j.palaeo.2010.02.002; Schone B. R., 2004, QUATERNARY SCI REV, V23, P1803, DOI DOI 10.1016/J.QUASCIREV.2004.02.017; Schone BR, 2005, PALAEOGEOGR PALAEOCL, V228, P130, DOI 10.1016/j.palaeo.2005.03.049; Schone BR, 2004, PALAEOGEOGR PALAEOCL, V212, P215, DOI 10.1016/j.palaeo.2004.05.024; SHACKLETON N, 1967, NATURE, V215, P15, DOI 10.1038/215015a0; SIMKISS K, 1964, BIOL REV, V39, P487, DOI 10.1111/j.1469-185X.1964.tb01166.x; Takayanagi H, 2015, GEOCHIM COSMOCHIM AC, V170, P301, DOI 10.1016/j.gca.2015.08.006; Takayanagi H, 2013, GEOCHIM COSMOCHIM AC, V115, P115, DOI 10.1016/j.gca.2013.03.026; Takayanagi H, 2012, GEOCHEM J, V46, P77; Vander Putten E, 2000, GEOCHIM COSMOCHIM AC, V64, P997; Watanabe T, 1999, J GEOPHYS RES-OCEANS, V104, P20667, DOI 10.1029/1999JC900097; Watanabe T, 2004, PALAEOGEOGR PALAEOCL, V212, P343, DOI 10.1016/j.palaeo.2004.07.001; Welsh K, 2011, EARTH PLANET SC LETT, V307, P266, DOI 10.1016/j.epsl.2011.05.032; Yamamoto K, 2013, PALEONTOL RES, V17, P12, DOI 10.2517/1342-8144-17.1.12; Yamamoto K, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047134; Yamamoto K, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003190; Yamamoto K, 2010, PALAEOGEOGR PALAEOCL, V291, P348, DOI 10.1016/j.palaeo.2010.03.006; Yan H, 2013, GEOCHIM COSMOCHIM AC, V112, P52, DOI 10.1016/j.gca.2013.03.007; ZHANG J, 1995, GEOCHIM COSMOCHIM AC, V59, P107, DOI 10.1016/0016-7037(95)91550-D	74	12	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157659	10.1371/journal.pone.0157659	http://dx.doi.org/10.1371/journal.pone.0157659			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327430	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212400030
J	Song, N; Zhang, H; Li, H; Cai, WZ				Song, Nan; Zhang, Hao; Li, Hu; Cai, Wanzhi			All 37 Mitochondrial Genes of Aphid Aphis craccivora Obtained from Transcriptome Sequencing: Implications for the Evolution of Aphids	PLOS ONE			English	Article							INSECTA HEMIPTERA APHIDIDAE; GENOME SEQUENCE; SOFTWARE PACKAGE; PHYLOGENY; HOMOPTERA; DNA; AUCHENORRHYNCHA; SYSTEMATICS; SELECTION	The availability of mitochondrial genome data for Aphididae, one of the economically important insect pest families, in public databases is limited. The advent of next generation sequencing technology provides the potential to generate mitochondrial genome data for many species timely and cost-effectively. In this report, we used transcriptome sequencing technology to determine all the 37 mitochondrial genes of the cowpea aphid, Aphis craccivora. This method avoids the necessity of finding suitable primers for long PCRs or primer-walking amplicons, and is proved to be effective in obtaining the whole set of mitochondrial gene data for insects with difficulty in sequencing mitochondrial genome by PCR-based strategies. Phylogenetic analyses of aphid mitochondrial genome data show clustering based on tribe level, and strongly support the monophyly of the family Aphididae. Within the monophyletic Aphidini, three samples from Aphis grouped together. In another major clade of Aphididae, Pterocomma pilosum was recovered as a potential sister-group of Cavariella salicicola, as part of Macrosiphini.	[Song, Nan] Henan Agr Univ, Coll Plant Protect, Zhengzhou, Peoples R China; [Zhang, Hao] Henan Vocat & Technol Coll Commun, Zhengzhou, Peoples R China; [Li, Hu; Cai, Wanzhi] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China	Henan Agricultural University; China Agricultural University	Song, N (corresponding author), Henan Agr Univ, Coll Plant Protect, Zhengzhou, Peoples R China.	songnan@henau.edu.cn		Li, Hu/0000-0001-8590-1753	National Natural Science Foundation of China [31402002]; Key scientific research projects of Henan Province, China [14B210036, 16A210029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key scientific research projects of Henan Province, China	This research is supported by grants from the National Natural Science Foundation of China (No. 31402002), and Key scientific research projects of Henan Province, China (No. 14B210036, No. 16A210029).	Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P352, DOI 10.1016/j.ympev.2013.05.002; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Blackman R.L., 2000, APHIDS WORLDS CROPS, V2nd; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Cameron SL, 2014, SYST ENTOMOL, V39, P400, DOI 10.1111/syen.12071; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; CAMPBELL BC, 1995, SYST ENTOMOL, V20, P175, DOI 10.1111/j.1365-3113.1995.tb00090.x; Chen K, 1998, CHINESE J OIL CROP S, V21, P64; Chen K, 1998, CHINESE J OIL CROP S, V21, P55; Coceano P. G., 1998, Phytopathologia Mediterranea, V37, P111; Cryan JR, 2012, SYST ENTOMOL, V37, P7, DOI 10.1111/j.1365-3113.2011.00611.x; Dixon AF G, 1998, APHID ECOLOGY; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Forero D, 2008, REV COLOMB ENTOMOL, V34, P1; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heie O.E., 1987, World Crop Pests, V2A, P367; HEIE OE, 1990, ACTA PHYTOPATHOL HUN, V25, P253; Holland BR, 2003, SYST BIOL, V52, P229, DOI 10.1080/10635150390192771; Ilharco F.A., 1987, World Crop Pests, V2A, P51; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109140; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-156; Mc Gavin GC, 1993, BUGS OF THE WORLD; Miller M.A., 2010, P GAT COMP ENV WORKS; MORAN NA, 1988, AM NAT, V132, P681, DOI 10.1086/284882; Moretti S, 2008, NUCLEIC ACIDS RES, V36, pW10, DOI 10.1093/nar/gkn278; Nabholz B, 2010, MOL PHYLOGENET EVOL, V57, P466, DOI 10.1016/j.ympev.2010.06.009; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; Novakova E, 2013, MOL PHYLOGENET EVOL, V68, P42, DOI 10.1016/j.ympev.2013.03.016; Ortiz-Rivas B, 2004, MOL PHYLOGENET EVOL, V30, P24, DOI 10.1016/S1055-7903(03)00155-6; Ortiz-Rivas B, 2010, MOL PHYLOGENET EVOL, V55, P305, DOI 10.1016/j.ympev.2009.12.005; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Remaudiere G., 1997, CATALOGUE APHIDIDAE; Rufener L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001091; Sano M, 2011, SYST ENTOMOL, V36, P607, DOI 10.1111/j.1365-3113.2011.00589.x; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Shaposhnikov G., 1998, P481; Simon S, 2013, MOL PHYLOGENET EVOL, V69, P393, DOI 10.1016/j.ympev.2013.03.033; SMITH AB, 1994, BIOL J LINN SOC, V51, P279, DOI 10.1111/j.1095-8312.1994.tb00962.x; Smith DR, 2013, BRIEF FUNCT GENOMICS, V12, P454, DOI 10.1093/bfgp/els066; Song N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048778; Song N, 2009, ACTA BIOCH BIOPH SIN, V41, P206, DOI 10.1093/abbs/gmp003; STACKEBRANDT E, 1994, SYST APPL MICROBIOL, V17, P39, DOI 10.1016/S0723-2020(11)80029-9; Stewart JB, 2005, GENOME, V48, P46, DOI 10.1139/G04-090; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; TZAGOLOFF A, 1986, ANNU REV BIOCHEM, V55, P249, DOI 10.1146/annurev.bi.55.070186.001341; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035; Von Dohlen CD, 2000, BIOL J LINN SOC, V71, P689, DOI 10.1006/bijl.2000.0470; VONDOHLEN CD, 1995, J MOL EVOL, V41, P211, DOI 10.1007/BF00170675; Wang Y, 2015, INT J MOL SCI, V16, P30091, DOI 10.3390/ijms161226219; Wang Y, 2014, INSECT SCI, V21, P278, DOI 10.1111/1744-7917.12112; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077511; Ware JL, 2008, SYST ENTOMOL, V33, P429, DOI 10.1111/j.1365-3113.2008.00424.x; WHEELER WC, 1990, CLADISTICS, V6, P363, DOI 10.1111/j.1096-0031.1990.tb00550.x; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang B, 2016, MITOCHONDRIAL DNA A, V27, P945, DOI 10.3109/19401736.2014.926498; Zhang B, 2014, GENE, V533, P253, DOI 10.1016/j.gene.2013.09.064; Zhang KJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-417; Zhang S, 2016, MITOCHONDRIAL DNA A, V27, P854, DOI 10.3109/19401736.2014.919474	72	13	13	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157857	10.1371/journal.pone.0157857	http://dx.doi.org/10.1371/journal.pone.0157857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314587	Green Published, gold, Green Submitted			2022-12-26	WOS:000378030000059
J	Wallach, J; Kang, H; Colestock, T; Morris, H; Bortolotto, ZA; Collingridge, GL; Lodge, D; Halberstadt, AL; Brandt, SD; Adejare, A				Wallach, Jason; Kang, Heather; Colestock, Tristan; Morris, Hamilton; Bortolotto, Zuner A.; Collingridge, Graham L.; Lodge, David; Halberstadt, Adam L.; Brandt, Simon D.; Adejare, Adeboye			Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues	PLOS ONE			English	Article							METHYL-D-ASPARTATE; PREPULSE INHIBITION; ACOUSTIC STARTLE; CHANNEL COMPLEX; SIGMA-RECEPTORS; PHENCYCLIDINE; MK-801; ANTAGONISTS; KETAMINE; MODULATE	1,2-Diarylethylamines including lanicemine, lefetamine, and remacemide have clinical relevance in a range of therapeutic areas including pain management, epilepsy, neurodegenerative disease and depression. More recently 1,2-diarylethylamines have been sold as 'legal highs' in a number of different forms including powders and tablets. These compounds are sold to circumvent governmental legislation regulating psychoactive drugs. Examples include the opioid MT-45 and the dissociative agents diphenidine (DPH) and 2-methoxydiphenidine (2-MXP). A number of fatal and non-fatal overdoses have been linked to abuse of these compounds. As with many 'legal highs', little is known about their pharmacology. To obtain a better understanding, the effects of DPH, 2-MXP and its 3-and 4-MeO-isomers, and 2-Cl-diphenidine (2-Cl-DPH) were investigated using binding studies at 46 central nervous system receptors including the N-methyl-D-aspartate receptor (NMDAR), serotonin, dopamine, norepinephrine, histamine, and sigma receptors as well as the reuptake transporters for serotonin, dopamine and norepinephrine. Reuptake inhibition potencies were measured at serotonin, norepinephrine and dopamine transporters. NMDAR antagonism was established in vitro using NMDAR-induced field excitatory postsynaptic potential (fEPSP) experiments. Finally, DPH and 2-MXP were investigated using tests of pre-pulse inhibition of startle (PPI) in rats to determine whether they reduce sensorimotor gating, an effect observed with known dissociative drugs such as phencyclidine (PCP) and ketamine. The results suggest that these 1,2-diarylethylamines are relatively selective NMDAR antagonists with weak off-target inhibitory effects on dopamine and norepinephrine reuptake. DPH and 2-MXP significantly inhibited PPI. DPH showed greater potency than 2-MXP, acting with a median effective dose (ED50) of 9.5 mg/kg, which is less potent than values reported for other commonly abused dissociative drugs such as PCP and ketamine.	[Wallach, Jason; Colestock, Tristan; Morris, Hamilton; Adejare, Adeboye] Univ Sci, Pharmaceut Sci, Philadelphia Coll Pharm, Philadelphia, PA USA; [Kang, Heather] Univ Bristol, Ctr Synapt Plast, Sch Clin Sci, Bristol, Avon, England; [Bortolotto, Zuner A.; Collingridge, Graham L.; Lodge, David] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Ctr Synapt Plast, Bristol, Avon, England; [Collingridge, Graham L.] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Collingridge, Graham L.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Halberstadt, Adam L.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Brandt, Simon D.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Byrom St, Liverpool L3 5UX, Merseyside, England	University of Bristol; University of Bristol; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of California System; University of California San Diego; Liverpool John Moores University	Wallach, J (corresponding author), Univ Sci, Pharmaceut Sci, Philadelphia Coll Pharm, Philadelphia, PA USA.	jwallach@mail.usciences.edu	collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015; Wallach, Jason/AAK-3776-2020; Halberstadt, Adam L/J-9328-2015	Collingridge, Graham L/0000-0002-9572-5359; Brandt, Simon D./0000-0001-8632-5372; Wallach, Jason/0000-0002-2467-5761	USA NIH NIMH Psychoactive Drug Screening Program; NIMH [MH100644]; NIDA [DA002925]; MRC [MR/K023098/1] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH100644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002925] Funding Source: NIH RePORTER; Medical Research Council [MR/K023098/1] Funding Source: researchfish	USA NIH NIMH Psychoactive Drug Screening Program; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors gratefully acknowledge support of the USA NIH NIMH Psychoactive Drug Screening Program for the screening of the compounds in receptors and the monoamine transporter assays. Dr. Halberstadt was supported by NIMH (MH100644) and NIDA (DA002925).	Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; [Anonymous], 2012, ACMD REP METH; Berger ML, 2009, BIOORGAN MED CHEM, V17, P3456, DOI 10.1016/j.bmc.2009.03.025; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Ceolin L, 2012, NEUROCHEM INT, V61, P517, DOI 10.1016/j.neuint.2012.02.035; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; DEMONTIS MG, 1985, PHARMACOL RES COMMUN, V17, P471, DOI 10.1016/0031-6989(85)90082-7; Elliott SP, 2015, J ANAL TOXICOL, V39, P287, DOI 10.1093/jat/bkv006; Fray MJ, 2006, BIOORG MED CHEM LETT, V16, P4345, DOI 10.1016/j.bmcl.2006.05.051; Fray MJ, 2010, BIOORG MED CHEM LETT, V20, P3788, DOI 10.1016/j.bmcl.2010.04.052; Geyer M A, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0807s03; Gray NM, 1989, Patent, Patent No. [EP346791A1, 346791]; Guitart X, 2004, PSYCHOPHARMACOLOGY, V174, P301, DOI 10.1007/s00213-004-1920-9; Halberstadt AL, 2016, PSYCHOPHARM IN PRESS; Helander A, 2014, CLIN TOXICOL, V52, P901, DOI 10.3109/15563650.2014.943908; Helander A, 2015, CLIN TOXICO IN PRESS; JANIRI L, 1994, DRUG ALCOHOL DEPEN, V36, P139, DOI 10.1016/0376-8716(94)90096-5; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Lodge D, 2015, BRIT J PHARMACOL, V172, P4254, DOI 10.1111/bph.13222; MANSBACH RS, 1991, PSYCHOPHARMACOLOGY, V105, P162, DOI 10.1007/BF02244303; MANSBACH RS, 1989, NEUROPSYCHOPHARMACOL, V2, P299, DOI 10.1016/0893-133X(89)90035-3; McLaughlin G, 2016, DRUG TEST ANAL, V8, P99, DOI 10.1002/dta.1800; MONNET FP, 1995, P NATL ACAD SCI USA, V92, P3774, DOI 10.1073/pnas.92.9.3774; Morris H, 2014, DRUG TEST ANAL, V6, P614, DOI 10.1002/dta.1620; NATSUKA K, 1987, J MED CHEM, V30, P1779, DOI 10.1021/jm00393a017; NOZAKI M, 1983, LIFE SCI, V33, P431, DOI 10.1016/0024-3205(83)90534-9; Palmer GC, 1997, EXCITATORY AMINO ACI, P109; Pochwat B, 2014, EXPERT OPIN INV DRUG, V23, P1181, DOI 10.1517/13543784.2014.918951; Reynolds I J, 2001, Curr Protoc Pharmacol, VChapter 1, DOI 10.1002/0471141755.ph0120s11; Reynolds LJ, 1999, METH MOL B, V128, P93; Roth B, 2013, PSYCHOACTIVE DRUG SC; Roth BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059334; Sanacora G, 2014, MOL PSYCHIATR, V19, P978, DOI 10.1038/mp.2013.130; TRICKLEBANK MD, 1989, EUR J PHARMACOL, V167, P127, DOI 10.1016/0014-2999(89)90754-1; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P9, DOI 10.1007/s11419-013-0194-5; Vilner BJ, 2000, J PHARMACOL EXP THER, V292, P900; Volianskis A, 2013, J PHYSIOL-LONDON, V591, P955, DOI 10.1113/jphysiol.2012.247296; Vollenweider FX, 2001, BRAIN RES BULL, V56, P495, DOI 10.1016/S0361-9230(01)00646-3; Wallach J. V., 2014, THESIS; Wallach J, 2015, DRUG TEST ANAL, V7, P358, DOI 10.1002/dta.1689; Wiley JL, 2003, PSYCHOPHARMACOLOGY, V165, P378, DOI 10.1007/s00213-002-1297-6; Wink CSD, 2016, DRUG TEST ANAL, V8, P1005, DOI 10.1002/dta.1946; WONG EHF, 1988, J NEUROCHEM, V50, P274, DOI 10.1111/j.1471-4159.1988.tb13260.x; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; WOODRUFF GN, 1987, NEUROPHARMACOLOGY, V26, P903, DOI 10.1016/0028-3908(87)90068-2; YAMAMOTO H, 1995, J NEUROSCI, V15, P731	49	48	48	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157021	10.1371/journal.pone.0157021	http://dx.doi.org/10.1371/journal.pone.0157021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314670	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000378030000008
J	Gaume, X; Place, C; Delage, H; Mongelard, F; Monier, K; Bouvet, P				Gaume, Xavier; Place, Christophe; Delage, Helene; Mongelard, Fabien; Monier, Karine; Bouvet, Philippe			Expression of Nucleolin Affects Microtubule Dynamics	PLOS ONE			English	Article							BINDING-PROTEIN; LIPID-RAFT; NUCLEOPHOSMIN/B23; CENTROSOME; GROWTH; CYCLE; INSTABILITY; INTERPLAY; TARGET; LEADS	Nucleolin is present in diverse cellular compartments and is involved in a variety of cellular processes from nucleolar structure and function to intracellular trafficking, cell adhesion and migration. Recently, nucleolin has been localized at the mature centriole where it is involved in microtubule nucleation and anchoring. Although this new function of nucleolin linked to microtubule regulation has been identified, the global effects of nucleolin on microtubule dynamics have not been addressed yet. In the present study, we analyzed the roles of nucleolin protein levels on global microtubule dynamics by tracking the EB3 microtubule plus end binding protein in live cells. We have found that during microtubule growth phases, nucleolin affects both the speed and life time of polymerization and by analyzing catastrophe events, we showed that nucleolin reduces catastrophe frequency. This new property of nucleolin was then confirmed in a cold induced microtubule depolymerization experiment in which we have found that cold resistant microtubules were totally destabilized in nucleolin depleted cells. Altogether, our data demonstrate a new function of nucleolin on microtubule stabilization, thus bringing novel insights into understanding the multifunctional properties of nucleolin in healthy and cancer cells.	[Gaume, Xavier; Delage, Helene; Mongelard, Fabien; Monier, Karine; Bouvet, Philippe] Univ Lyon, Ecole Normale Super Lyon, UMR INSERM CNRS 5286 1052,Ctr Leon Berard, Canc Cell Plast Dept,Ctr Rech Cancerol Lyon, Lyon, France; [Place, Christophe] Univ Lyon, Ecole Normale Super Lyon, Univ Claude Bernard, CNRS,Lab Phys, F-69342 Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Monier, K; Bouvet, P (corresponding author), Univ Lyon, Ecole Normale Super Lyon, UMR INSERM CNRS 5286 1052,Ctr Leon Berard, Canc Cell Plast Dept,Ctr Rech Cancerol Lyon, Lyon, France.	Karine.monier@ens-lyon.fr; pbouvet@ens-lyon.fr	Monier, Karine/AAP-4806-2021; , Bouvet/AAC-8779-2020	Bouvet, Philippe/0000-0003-4524-2233; Mongelard, Fabien/0000-0002-5929-6120	Agence Nationale de la Recherche [ANR-07-BLAN-0062-01]; Association pour la Recherche sur le Cancer [ECL2010R01122]; Ligue contre le Cancer (Rhone); FINOVI; CNRS; Ecole Normale Superieure de Lyon	Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue contre le Cancer (Rhone); FINOVI; CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic)	This project was funded thanks to the Agence Nationale de la Recherche [ANR-07-BLAN-0062-01], the Association pour la Recherche sur le Cancer n_ECL2010R01122, Ligue contre le Cancer (Rhone), FINOVI, the CNRS and Ecole Normale Superieure de Lyon.	Akhmanova A, 2013, CURR OPIN CELL BIOL, V25, P3, DOI 10.1016/j.ceb.2012.12.003; Amin MA, 2008, BIOCHEM J, V415, P345, DOI 10.1042/BJ20081411; Applegate KT, 2011, J STRUCT BIOL, V176, P168, DOI 10.1016/j.jsb.2011.07.009; Berger CM, 2015, BIOCHIMIE        APR; Bi JJ, 2013, MOL CELLS, V36, P507, DOI 10.1007/s10059-013-0149-z; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Chen XG, 2011, MOL THER, V19, P93, DOI 10.1038/mt.2010.214; Cheung YK, 1997, STAT SINICA, V7, P805; de Forges H, 2012, INT J BIOCHEM CELL B, V44, P266, DOI 10.1016/j.biocel.2011.11.009; DERENZINI M, 1995, LAB INVEST, V73, P497; Fumoto K, 2009, EMBO REP, V10, P606, DOI 10.1038/embor.2009.45; Gaume X, 2015, CELL CYCLE, V14, P902, DOI 10.1080/15384101.2014.1000197; Gaume X, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/187624; Giannakakou P, 2000, J NATL CANCER I, V92, P182, DOI 10.1093/jnci/92.3.182; Greco A, 2012, J VIROL, V86, P1449, DOI 10.1128/JVI.06194-11; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hollander BA, 1999, CELL MOTIL CYTOSKEL, V43, P114, DOI 10.1002/(SICI)1097-0169(1999)43:2<114::AID-CM3>3.3.CO;2-D; Honore S, 2005, CELL MOL LIFE SCI, V62, P3039, DOI 10.1007/s00018-005-5330-x; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; Koutsioumpa M, 2014, RECENT PAT ANTI-CANC, V9, DOI 10.2174/1574892808666131119095953; Koutsioumpa M, 2013, J BIOL CHEM, V288, P343, DOI 10.1074/jbc.M112.387076; Larrucea S, 1998, J BIOL CHEM, V273, P31718, DOI 10.1074/jbc.273.48.31718; Larrucea S, 1999, BIOCHEM BIOPH RES CO, V266, P51, DOI 10.1006/bbrc.1999.1766; Li N, 2009, BIOCHEM BIOPH RES CO, V384, P76, DOI 10.1016/j.bbrc.2009.04.077; Li YP, 1996, EUR J BIOCHEM, V237, P153, DOI 10.1111/j.1432-1033.1996.0153n.x; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; Matov A, 2010, NAT METHODS, V7, P761, DOI 10.1038/nmeth.1493; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07; Neukirchen D, 2011, SEMIN CELL DEV BIOL, V22, P825, DOI 10.1016/j.semcdb.2011.08.007; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Reyes-Reyes EM, 2008, EXP CELL RES, V314, P2212, DOI 10.1016/j.yexcr.2008.03.016; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Shinmura K, 2005, FEBS LETT, V579, P6621, DOI 10.1016/j.febslet.2005.10.057; Smole Z, 2014, CANCER RES, V74, P353, DOI 10.1158/0008-5472.CAN-13-1334; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Stehbens S, 2012, J CELL BIOL, V198, P481, DOI 10.1083/jcb.201206050; Stepanova T, 2003, J NEUROSCI, V23, P2655; Stepanova V, 2008, BLOOD, V112, P100, DOI 10.1182/blood-2007-07-104455; Syred HM, 2013, MOL CELL PROTEOMICS, V12, P3135, DOI 10.1074/mcp.M113.028563; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Wang GX, 2010, J BIOL CHEM, V285, P19060, DOI 10.1074/jbc.M110.100396	45	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157534	10.1371/journal.pone.0157534	http://dx.doi.org/10.1371/journal.pone.0157534			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309529	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800093
J	Maddipati, KR; Romero, R; Chaiworapongsa, T; Chaemsaithong, P; Zhou, SL; Xu, ZH; Tarca, AL; Kusanovic, JP; Gomez, R; Chaiyasit, N; Honn, KV				Maddipati, Krishna Rao; Romero, Roberto; Chaiworapongsa, Tinnakorn; Chaemsaithong, Piya; Zhou, Sen-Lin; Xu, Zhonghui; Tarca, Adi L.; Kusanovic, Juan Pedro; Gomez, Ricardo; Chaiyasit, Noppadol; Honn, Kenneth V.			Lipidomic analysis of patients with microbial invasion of the amniotic cavity reveals up-regulation of leukotriene B-4	FASEB JOURNAL			English	Article						infection; inflammation; clinical chorioamnionitis; amniotic fluid; 5-lipoxygenase	TUMOR-NECROSIS-FACTOR; PRETERM LABOR; CLINICAL CHORIOAMNIONITIS; INTRAAMNIOTIC INFLAMMATION; CONCENTRATIONS INCREASE; FLUID CONCENTRATIONS; HUMAN-NEUTROPHILS; TERM; PROSTAGLANDINS; INFECTION	Bioactive lipids derived from the metabolism of polyunsaturated fatty acids are important mediators of the inflammatory response. Labor per se is considered a sterile inflammatory process. Intra-amniotic inflammation (IAI) due to microorganisms (i.e., intra-amniotic infection) or danger signals (i.e., sterile IAI) has been implicated in the pathogenesis of preterm labor and clinical chorioamnionitis at term. Early and accurate diagnosis of microbial invasion of the amniotic cavity (MIAC) requires analysis of amniotic fluid (AF). It is possible that IAI caused by microorganisms is associated with a stereotypic lipidomic profile, and that analysis of AF may help in the identification of patients with this condition. To test this hypothesis, we analyzed the fatty acyl lipidome of AF by liquid chromatography-mass spectrometry from patients in spontaneous labor at term and preterm gestations. We report that the AF concentrations of proinflammatory lipid mediators of the 5-lipoxygenase pathway are significantly higher in MIAC than in cases of sterile IAI. These results suggest that the concentrations of 5-lipoxygenase metabolites of arachidonic acid, 5-hydroxyeicosatetraenoic acid, and leukotriene B-4 in particular could serve as potential biomarkers of MIAC. This finding could have important implications for the rapid identification of patients who may benefit from anti-microbial treatment.-Maddipati, K. R., Romero, R., Chaiworapongsa ,T., Chaemsaithong, P., Zhou, S.-L., Xu, Z., Tarca, A. L., Kusanovic, J. P., Gomez, R., Chaiyasit, N., Honn, K. V. Lipidomic analysis of patients with microbial invasion of the amniotic cavity reveals up-regulation of leukotriene B-4.	[Maddipati, Krishna Rao; Zhou, Sen-Lin; Honn, Kenneth V.] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Maddipati, Krishna Rao; Zhou, Sen-Lin] Wayne State Univ, Sch Med, Lipid Core Facil, Detroit, MI USA; [Chaiworapongsa, Tinnakorn; Chaemsaithong, Piya; Tarca, Adi L.; Chaiyasit, Noppadol] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Romero, Roberto; Chaiworapongsa, Tinnakorn; Chaemsaithong, Piya; Xu, Zhonghui; Tarca, Adi L.; Kusanovic, Juan Pedro; Chaiyasit, Noppadol] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Div Intramural Res, Natl Inst Hlth,Dept Hlth & Human Serv, Bethesda, MD USA; [Romero, Roberto] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Romero, Roberto] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA; [Tarca, Adi L.] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Romero, Roberto] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Kusanovic, Juan Pedro] Hosp Dr Sotero del Rio, Dept Obstet & Gynecol, Ctr Res & Innovat Maternal Fetal Med CIMAF, Santiago, Chile; [Kusanovic, Juan Pedro; Gomez, Ricardo] Pontificia Univ Catolica Chile, Div Obstet & Gynecol, Santiago, Chile; [Gomez, Ricardo] Hosp Clin La Florida, Res & Acad Innovat, Ctr Perinatal Diag CEDIP, Santiago, Chile	Wayne State University; Wayne State University; Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Michigan System; University of Michigan; Wayne State University; Wayne State University; Michigan State University; Universidad de Chile; Pontificia Universidad Catolica de Chile	Maddipati, KR (corresponding author), Wayne State Univ, Dept Pathol, 435 Chem Bldg,410 W Warren Ave, Detroit, MI 48202 USA.	maddipati@wayne.edu	Maddipati, Krishna Rao/G-1859-2011; Kusanovic, Juan Pedro/AAM-5782-2020; Xu, Zhonghui/F-3353-2018; Maddipati, Krishna Rao/H-3569-2019; Kusanovic, Juan Pedro/R-8616-2019; Romero, Roberto/A-5268-2019	Maddipati, Krishna Rao/0000-0003-1445-791X; Kusanovic, Juan Pedro/0000-0003-0640-2070; Xu, Zhonghui/0000-0002-6469-9178; Maddipati, Krishna Rao/0000-0003-1445-791X; Gomez, Ricardo/0000-0001-9267-304X; Romero, Roberto/0000-0002-4448-5121; chaemsaithong, piya/0000-0003-1750-9834; Chaemsaithong, piya/0000-0002-5398-6868	Perinatology Research Branch, Division of Intramural Research Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, U.S. National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS); NICHD/NIH/DHHS [HHSN275201300006C]; National Center for Research Resources [S10RR027926]; Wayne State University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027926] Funding Source: NIH RePORTER	Perinatology Research Branch, Division of Intramural Research Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, U.S. National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS); NICHD/NIH/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Wayne State University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported, in part, by the Perinatology Research Branch, Division of Intramural Research Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, U.S. National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS); and, in part, with Federal funds from NICHD/NIH/DHHS Contract No. HHSN275201300006C; and, in part, by the National Center for Research Resources Grant S10RR027926 and the Perinatal Virtual Discovery Grant from Wayne State University (to K.R.M.). The authors declare no conflicts of interest.	ANDERSEN HF, 1990, AM J OBSTET GYNECOL, V163, P859, DOI 10.1016/0002-9378(90)91084-P; ANDREWS WW, 1995, AM J OBSTET GYNECOL, V173, P606, DOI 10.1016/0002-9378(95)90290-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERRYMAN GK, 1987, LIFE SCI, V41, P1611, DOI 10.1016/0024-3205(87)90728-4; Bowers RC, 2000, J BIOL CHEM, V275, P29931, DOI 10.1074/jbc.C000502200; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Chaemsaithong P, 2015, J MATERN-FETAL NEO M, V28, P1510, DOI 10.3109/14767058.2014.961417; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Cobo T, 2014, AM J OBSTET GYNECOL, V211, P708, DOI 10.1016/j.ajog.2014.06.060; Combs CA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.032; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Eshoo MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036825; Esplin M S, 2003, J Matern Fetal Neonatal Med, V14, P51, DOI 10.1080/713605933; FORDHUTCHINSON AW, 1990, CRIT REV IMMUNOL, V10, P1; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gervasi MT, 2012, J PERINAT MED, V40, P329, DOI 10.1515/jpm-2012-0034; Gibb W, 1998, ANN MED, V30, P235, DOI 10.3109/07853899809005850; GIBBS RS, 1988, OBSTET GYNECOL, V72, P823, DOI 10.1097/00006250-198812000-00001; GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N; Gomez-Lopez N, 2009, J REPROD IMMUNOL, V80, P122, DOI 10.1016/j.jri.2009.01.002; Gomez-Lopez N, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.010; Grant GE, 2009, PROSTAG OTH LIPID M, V89, P98, DOI 10.1016/j.prostaglandins.2009.05.002; GRAVETT MG, 1986, OBSTET GYNECOL, V67, P229, DOI 10.1097/00006250-198602000-00013; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Henningsen A, 2011, CENSREG CENSORED REG; Hevko JM, 2002, J BIOL CHEM, V277, P7037, DOI 10.1074/jbc.M108942200; Hsu CD, 1998, AM J PERINAT, V15, P683, DOI 10.1055/s-2007-999302; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Jones CE, 2003, MOL PHARMACOL, V63, P471, DOI 10.1124/mol.63.3.471; KARIM SMM, 1971, P ROY SOC MED, V64, P10, DOI 10.1177/003591577106400105; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; KUMLIN M, 1990, BIOCHEM BIOPH RES CO, V170, P23, DOI 10.1016/0006-291X(90)91235-K; Lee J, 2016, J MATERN-FETAL NEO M, V29, P707, DOI 10.3109/14767058.2015.1020293; Lee SE, 2008, J MATERN-FETAL NEO M, V21, P89, DOI 10.1080/14767050701830514; Lee SE, 2009, J MATERN-FETAL NEO M, V22, P880, DOI 10.1080/14767050902994648; LEE TH, 1989, CLIN SCI, V77, P195, DOI 10.1042/cs0770195; Liggins G. C, 1981, CERVIX PREGNANCY LAB, P1; Maddipati KR, 2014, FASEB J, V28, P4835, DOI 10.1096/fj.14-254383; Maddipati KR, 2011, PROSTAG OTH LIPID M, V94, P59, DOI 10.1016/j.prostaglandins.2011.01.003; Maymon E, 1999, AM J OBSTET GYNECOL, V181, P1142, DOI 10.1016/S0002-9378(99)70097-9; Menon R, 2011, OBSTET GYNECOL, V118, P121, DOI 10.1097/AOG.0b013e3182204eaa; Mercer BM, 1997, JAMA-J AM MED ASSOC, V278, P989, DOI 10.1001/jama.278.12.989; Metzgar D, 2013, J CLIN MICROBIOL, V51, P2670, DOI 10.1128/JCM.00966-13; Mitchell MD, 2005, J CLIN ENDOCR METAB, V90, P4244, DOI 10.1210/jc.2004-2496; MITCHELL MD, 1995, REPROD FERT DEVELOP, V7, P623, DOI 10.1071/RD9950623; MITCHELL MD, 1981, J REPROD FERTIL, V62, P305; Nakamura M, 2011, CHEM REV, V111, P6231, DOI 10.1021/cr100392s; NIEDER J, 1983, PROSTA LEUKOTR MED, V12, P289, DOI 10.1016/0262-1746(83)90007-0; O'Flaherty JT, 1998, J BIOL CHEM, V273, P32535, DOI 10.1074/jbc.273.49.32535; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Papayianni A, 1996, J IMMUNOL, V156, P2264; Patel P, 2009, J PHARMACOL EXP THER, V329, P335, DOI 10.1124/jpet.108.143453; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; ROMERO R, 1987, AM J OBSTET GYNECOL, V157, P1454, DOI 10.1016/S0002-9378(87)80243-0; ROMERO R, 1990, AM J OBSTET GYNECOL, V163, P968, DOI 10.1016/0002-9378(90)91106-M; ROMERO R, 1992, CIBA F SYMP, V167, P205; ROMERO R, 1988, AM J OBSTET GYNECOL, V159, P114, DOI 10.1016/0002-9378(88)90503-0; ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P821, DOI 10.1016/0002-9378(91)90423-O; ROMERO R, 1994, PROSTAG LEUKOTR ESS, V50, P97, DOI 10.1016/0952-3278(94)90154-6; ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P1576, DOI 10.1016/0002-9378(92)91636-O; ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P813, DOI 10.1016/0002-9378(91)90422-N; ROMERO R, 1989, AM J OBSTET GYNECOL, V160, P1117, DOI 10.1016/0002-9378(89)90172-5; Romero R, 1996, PROSTAG LEUKOTR ESS, V54, P187, DOI 10.1016/S0952-3278(96)90015-0; ROMERO R, 1992, AM J REPROD IMMUNOL, V27, P117, DOI 10.1111/j.1600-0897.1992.tb00737.x; ROMERO R, 1994, AM J OBSTET GYNECOL, V171, P1613, DOI 10.1016/0002-9378(94)90412-X; Romero R, 2016, J PERINAT MED, V44, P33, DOI 10.1515/jpm-2015-0119; Romero R, 2016, J PERINAT MED, V44, P53, DOI 10.1515/jpm-2015-0121; Romero R, 2016, J PERINAT MED, V44, P5, DOI 10.1515/jpm-2015-0045; Romero R, 2016, J PERINAT MED, V44, P23, DOI 10.1515/jpm-2015-0044; Romero R, 2015, J MATERN-FETAL NEO M, V28, P1394, DOI 10.3109/14767058.2014.958463; Romero R, 2015, J PERINAT MED, V43, P19, DOI 10.1515/jpm-2014-0249; Romero R, 2014, AM J REPROD IMMUNOL, V72, P458, DOI 10.1111/aji.12296; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2014, AM J REPROD IMMUNOL, V71, P330, DOI 10.1111/aji.12189; SAITO S, 1993, CYTOKINE, V5, P81, DOI 10.1016/1043-4666(93)90027-3; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2008, PROSTAG LEUKOTR ESS, V79, P157, DOI 10.1016/j.plefa.2008.09.012; Serhan CN, 2005, PROSTAG LEUKOTR ESS, V73, P141, DOI 10.1016/j.plefa.2005.05.002; SERHAN CN, 1994, BBA-LIPID LIPID MET, V1212, P1, DOI 10.1016/0005-2760(94)90185-6; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shin JH, 2013, J CLIN MICROBIOL, V51, P136, DOI 10.1128/JCM.01907-12; Shynlova O, 2008, J IMMUNOL, V181, P1470, DOI 10.4049/jimmunol.181.2.1470; STRICKLAND DM, 1983, SCIENCE, V220, P521, DOI 10.1126/science.6573023; VANDERELST CW, 1991, OBSTET GYNECOL, V77, P672; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680; Zarini S, 2009, P NATL ACAD SCI USA, V106, P8296, DOI 10.1073/pnas.0903851106	90	33	34	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3296	3307		10.1096/fj.201600583R	http://dx.doi.org/10.1096/fj.201600583R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27312808	Green Published, Green Submitted			2022-12-26	WOS:000384329800004
J	Jiao, XD; Kabir, F; Irum, B; Khan, AO; Wang, QW; Li, D; Khan, AA; Husnain, T; Akram, J; Riazuddin, S; Hejtmancik, JF; Riazuddin, SA				Jiao, Xiaodong; Kabir, Firoz; Irum, Bushra; Khan, Arif O.; Wang, Qiwei; Li, David; Khan, Asma A.; Husnain, Tayyab; Akram, Javed; Riazuddin, Sheikh; Hejtmancik, J. Fielding; Riazuddin, S. Amer			A Common Ancestral Mutation in CRYBB3 Identified in Multiple Consanguineous Families with Congenital Cataracts	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE CATARACT; PAKISTANI FAMILIES; NONSENSE MUTATION; LOCUS; GENE; LENS; BLINDNESS; PROTEINS; MAPS	Purpose This study was performed to investigate the genetic determinants of autosomal recessive congenital cataracts in large consanguineous families. Methods Affected individuals underwent a detailed ophthalmological examination and slit-lamp photographs of the cataractous lenses were obtained. An aliquot of blood was collected from all participating family members and genomic DNA was extracted from white blood cells. Initially, a genome-wide scan was performed with genomic DNAs of family PKCC025 followed by exclusion analysis of our familial cohort of congenital cataracts. Protein-coding exons of CRYBB1, CRYBB2, CRYBB3, and CRYBA4 were sequenced bidirectionally. A haplotype was constructed with SNPs flanking the causal mutation for affected individuals in all four families, while the probability that the four familial cases have a common founder was estimated using EM and CHM-based algorithms. The expression of Crybb3 in the developing murine lens was investigated using TaqMan assays. Results The clinical and ophthalmological examinations suggested that all affected individuals had nuclear cataracts. Genome-wide linkage analysis localized the causal phenotype in family PKCC025 to chromosome 22q with statistically significant two-point logarithm of odds (LOD) scores. Subsequently, we localized three additional families, PKCC063, PKCC131, and PKCC168 to chromosome 22q. Bidirectional Sanger sequencing identified a missense variation: c.493G>C (p.Gly165Arg) in CRYBB3 that segregated with the disease phenotype in all four familial cases. This variation was not found in ethnically matched control chromosomes, the NHLBI exome variant server, or the 1000 Genomes or dbSNP databases. Interestingly, all four families harbor a unique disease haplotype that strongly suggests a common founder of the causal mutation (p<1.64E-10). We observed expression of Crybb3 in the mouse lens as early as embryonic day 15 (E15), and expression remained relatively steady throughout development. Conclusion Here, we report a common ancestral mutation in CRYBB3 associated with autosomal recessive congenital cataracts identified in four familial cases of Pakistani origin.	[Jiao, Xiaodong; Wang, Qiwei; Li, David; Hejtmancik, J. Fielding] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Kabir, Firoz; Irum, Bushra; Riazuddin, S. Amer] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Irum, Bushra; Khan, Asma A.; Husnain, Tayyab; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan; [Khan, Arif O.] King Khalid Eye Specialist Hosp, Riyadh 12329, Saudi Arabia; [Akram, Javed; Riazuddin, Sheikh] Univ Hlth Sci, Allama Iqbal Med Coll, Lahore 54550, Pakistan; [Akram, Javed; Riazuddin, Sheikh] Shaheed Zulfiqar Ali Bhutto Med Univ, Natl Ctr Genet Dis, Islamabad, Pakistan	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Johns Hopkins University; Johns Hopkins Medicine; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; King Khaled Eye Specialist Hospital; University of Health Science - Pakistan	Riazuddin, SA (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA.	riazuddin@jhmi.edu	Khan, Asma Al/AAH-5277-2021; Husnain, Tayyab/AAE-9033-2019		National Eye Institute grant [1R01EY022714]; Knights Templar Eye Foundation grant; King Khaled Eye Specialist Hospital-Johns Hopkins University collaboration grant; National Academy of Sciences, Washington DC USA; Higher Education Commission, Islamabad Pakistan; NATIONAL EYE INSTITUTE [R01EY022714, ZIAEY000281] Funding Source: NIH RePORTER	National Eye Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Knights Templar Eye Foundation grant; King Khaled Eye Specialist Hospital-Johns Hopkins University collaboration grant; National Academy of Sciences, Washington DC USA; Higher Education Commission, Islamabad Pakistan(Higher Education Commission of Pakistan); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by the National Eye Institute grant 1R01EY022714 (SAR), the Knights Templar Eye Foundation grant (SAR), King Khaled Eye Specialist Hospital-Johns Hopkins University collaboration grant (SAR), the National Academy of Sciences, Washington DC USA, and the Higher Education Commission, Islamabad Pakistan.; The authors are grateful to all members for their participation in this study. This study was supported in part by the National Eye Institute grant 1R01EY022714 (SAR), the Knights Templar Eye Foundation grant (SAR), King Khaled Eye Specialist Hospital-Johns Hopkins University collaboration grant (SAR), the National Academy of Sciences, Washington DC USA, and the Higher Education Commission, Islamabad Pakistan.	Abu Safieh L, 2009, MOL VIS, V15, P980; Aldahmesh MA, 2012, HUM MUTAT, V33, P960, DOI 10.1002/humu.22071; Apple DJ, 2000, SURV OPHTHALMOL, V45, pS5; Butt T, 2007, MOL VIS, V13, P1635; Chen JJ, 2011, AM J HUM GENET, V88, P827, DOI 10.1016/j.ajhg.2011.05.008; Cohen D, 2007, INVEST OPHTH VIS SCI, V48, P2208, DOI 10.1167/iovs.06-1019; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Francis PJ, 2000, J MED GENET, V37, P481, DOI 10.1136/jmg.37.7.481; Hansen L, 2009, INVEST OPHTH VIS SCI, V50, P3291, DOI 10.1167/iovs.08-3149; Hawse J, 2003, MOL VIS, V9, P515; Heon E, 2001, AM J HUM GENET, V68, P772, DOI 10.1086/318798; HULSEBOS TJM, 1995, GENOMICS, V25, P574, DOI 10.1016/0888-7543(95)80062-Q; Kaul H, 2010, MOL VIS, V16, P511; Kaul H, 2010, MOL VIS, V16, P240; Khan SY, 2015, INVEST OPHTH VIS SCI, V56, P4919, DOI 10.1167/iovs.14-16253; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Naeem MA, 2015, MOL VIS, V21, P1261; Ponnam SPG, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050138; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Pras E, 2004, INVEST OPHTH VIS SCI, V45, P1940, DOI 10.1167/iovs.03-1117; Pras E, 2002, AM J HUM GENET, V70, P1363, DOI 10.1086/340318; Pras E, 2001, ISR MED ASSOC J, V3, P559; Ramachandran RD, 2007, HUM GENET, V121, P475, DOI 10.1007/s00439-006-0319-6; Reis LM, 2013, HUM GENET, V132, P761, DOI 10.1007/s00439-013-1289-0; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P623, DOI 10.1167/iovs.04-0955; ROBINSON GC, 1987, AM J DIS CHILD, V141, P1321, DOI 10.1001/archpedi.1987.04460120087041; Sabir N, 2010, MOL VIS, V16, P2911; Sabir N, 2010, MOL VIS, V16, P2634; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Shiels A, 2007, ARCH OPHTHALMOL-CHIC, V125, P165, DOI 10.1001/archopht.125.2.165; Smaoui N, 2004, INVEST OPHTH VIS SCI, V45, P2716, DOI 10.1167/iovs.03-1370; Yasmeen A, 2010, MOL VIS, V16, P682; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650	36	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157005	10.1371/journal.pone.0157005	http://dx.doi.org/10.1371/journal.pone.0157005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27326458	gold, Green Submitted, Green Published			2022-12-26	WOS:000378212400012
J	Modulevsky, DJ; Cuerrier, CM; Pelling, AE				Modulevsky, Daniel J.; Cuerrier, Charles M.; Pelling, Andrew E.			Biocompatibility of Subcutaneously Implanted Plant-Derived Cellulose Biomaterials	PLOS ONE			English	Article							IN-VIVO BIOCOMPATIBILITY; 3D CELL-CULTURE; MECHANICAL-PROPERTIES; BACTERIAL CELLULOSE; RESORBABLE BIOMATERIALS; REGENERATIVE MEDICINE; ELECTROSPUN SCAFFOLDS; DECELLULARIZED MATRIX; EXTRACELLULAR-MATRIX; BLOOD COMPATIBILITY	There is intense interest in developing novel biomaterials which support the invasion and proliferation of living cells for potential applications in tissue engineering and regenerative medicine. Decellularization of existing tissues have formed the basis of one major approach to producing 3D scaffolds for such purposes. In this study, we utilize the native hypanthium tissue of apples and a simple preparation methodology to create implantable cellulose scaffolds. To examine biocompatibility, scaffolds were subcutaneously implanted in wild-type, immunocompetent mice (males and females; 6-9 weeks old). Following the implantation, the scaffolds were resected at 1, 4 and 8 weeks and processed for histological analysis (H&E, Masson's Trichrome, anti-CD31 and anti-CD45 antibodies). Histological analysis revealed a characteristic foreign body response to the scaffold 1 week post-implantation. However, the immune response was observed to gradually disappear by 8 weeks post-implantation. By 8 weeks, there was no immune response in the surrounding dermis tissue and active fibroblast migration within the cellulose scaffold was observed. This was concomitant with the deposition of a new collagen extracellular matrix. Furthermore, active blood vessel formation within the scaffold was observed throughout the period of study indicating the pro-angiogenic properties of the native scaffolds. Finally, while the scaffolds retain much of their original shape they do undergo a slow deformation over the 8-week length of the study. Taken together, our results demonstrate that native cellulose scaffolds are biocompatible and exhibit promising potential as a surgical biomaterial.	[Modulevsky, Daniel J.; Cuerrier, Charles M.; Pelling, Andrew E.] Univ Ottawa, Ctr Interdisciplinary NanoPhys, Ottawa, ON, Canada; [Modulevsky, Daniel J.; Pelling, Andrew E.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Cuerrier, Charles M.; Pelling, Andrew E.] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; [Pelling, Andrew E.] Univ Ottawa, Inst Sci Soc & Policy, Ottawa, ON, Canada; [Pelling, Andrew E.] Univ Western Australia, Sch Anat Physiol & Human Biol, SymbioticA, Perth, WA 6009, Australia	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; University of Western Australia	Pelling, AE (corresponding author), Univ Ottawa, Ctr Interdisciplinary NanoPhys, Ottawa, ON, Canada.; Pelling, AE (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.; Pelling, AE (corresponding author), Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.; Pelling, AE (corresponding author), Univ Ottawa, Inst Sci Soc & Policy, Ottawa, ON, Canada.; Pelling, AE (corresponding author), Univ Western Australia, Sch Anat Physiol & Human Biol, SymbioticA, Perth, WA 6009, Australia.	a@pellinglab.net			Natural Sciences and Engineering Resource Council (NSERC) Discovery Grant [RGPIN-2014-04978]; University of Ottawa Faculty Development Fund; "Fonds de Recherche du Quebec - Sante" (FRQS); Canada Research Chairs Program [950-229071]	Natural Sciences and Engineering Resource Council (NSERC) Discovery Grant; University of Ottawa Faculty Development Fund; "Fonds de Recherche du Quebec - Sante" (FRQS)(Fonds de la Recherche en Sante du Quebec); Canada Research Chairs Program(Canada Research Chairs)	This study was funded by a Natural Sciences and Engineering Resource Council (NSERC) Discovery Grant (#RGPIN-2014-04978) and the University of Ottawa Faculty Development Fund. D.J.M. was supported by a graduate student fellowship from the "Fonds de Recherche du Quebec - Sante" (FRQS). C.M.C. was supported by a postdoctoral training award from the "Fonds de Recherche du Quebec - Sante" (FRQS). A.E.P. would like to acknowledge generous support from the Canada Research Chairs Program (#950-229071). The funders had no role in study design, datacollection and analysis, decision to publish, or preparation of the manuscript.	Abou Neel EA, 2014, J DENT, V42, P915, DOI 10.1016/j.jdent.2014.05.008; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Andrade FK, 2013, J BIOACT COMPAT POL, V28, P97, DOI 10.1177/0883911512467643; Andrade FK, 2011, J BIOMED MATER RES A, V98A, P554, DOI 10.1002/jbm.a.33148; [Anonymous], WHY ORG EYE TISS DON; [Anonymous], 2011, COMPR BIOM ONL VERS, V1; Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7; Anseth KS, 2012, DYNAMIC MICROENVIRON, V4, P1; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026; Badylak SF, 2011, ANN REV; Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043; Bae H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003688; Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f; Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007; Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032; Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001; Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067; Baptista PM, 2009, IEEE ENG MED BIO, P6526, DOI 10.1109/IEMBS.2009.5333145; BEGUIN P, 1994, FEMS MICROBIOL REV, V13, P25, DOI 10.1016/0168-6445(94)90099-X; Behravesh E, 1999, CLIN ORTHOP RELAT R, pS118; Bhardwaj N, 2015, MACROMOL BIOSCI, V15, P153, DOI 10.1002/mabi.201400335; Bhattacharya M, 2012, J CONTROL RELEASE, V164, P291, DOI 10.1016/j.jconrel.2012.06.039; Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056; Bohner M, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70014-6; Brown EE, 2013, BIOMACROMOLECULES, V14, P1063, DOI 10.1021/bm3019467; Campoli G, 2013, MATER DESIGN, V49, P957, DOI 10.1016/j.matdes.2013.01.071; Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023; Cervantes TM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0413; Chang HI, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P569; Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003; Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001; Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d; de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054; Derda R, 2009, P NATL ACAD SCI USA, V106, P18457, DOI 10.1073/pnas.0910666106; Dong WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18266; Dugan JM, 2013, NANOMEDICINE-UK, V8, P287, DOI [10.2217/NNM.12.211, 10.2217/nnm.12.211]; Dugan JM, 2013, ACTA BIOMATER, V9, P4707, DOI 10.1016/j.actbio.2012.08.050; Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024; Tischer PCSF, 2010, BIOMACROMOLECULES, V11, P1217, DOI 10.1021/bm901383a; Gibson LJ, 2012, J R SOC INTERFACE, V9, P2749, DOI 10.1098/rsif.2012.0341; Gottenbos B, 2002, J MATER SCI-MATER M, V13, P717, DOI 10.1023/A:1016175502756; Gu L, 2016, NAT REV CANCER, V16, P56, DOI 10.1038/nrc.2015.3; Guillaume O, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-015-5648-3; Guyette JP, 2016, CIRC RES, V118, P56, DOI 10.1161/CIRCRESAHA.115.306874; Hattori N, 2014, MOVEMENT DISORD, V29, P185, DOI 10.1002/mds.25740; Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570; Hsu SH, 2015, WOUND REPAIR REGEN, V23, P57, DOI 10.1111/wrr.12239; ISHIHARA K, 1995, J BIOMED MATER RES, V29, P181, DOI 10.1002/jbm.820290207; ISHIHARA K, 1992, BIOMATERIALS, V13, P145, DOI 10.1016/0142-9612(92)90062-S; Isogai N, 2004, TISSUE ENG, V10, P673, DOI 10.1089/1076327041348527; Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005; Kar M, 2016, BIOMATERIALS, V77, P186, DOI 10.1016/j.biomaterials.2015.11.018; Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1; Lee Daniel K, 2007, J Foot Ankle Surg, V46, P451, DOI 10.1053/j.jfas.2007.05.007; Lee J-S, 2014, BIOFABRICATION, V6; Lemons J E, 1986, J Arthroplasty, V1, P143; Liao HT, 2015, PLAST RECONSTR SURG, V135, p313E, DOI 10.1097/PRS.0000000000001105; Lin N, 2014, EUR POLYM J, V59, P302, DOI 10.1016/j.eurpolymj.2014.07.025; Lu Y, 2014, TAPPI J, V13, P47; Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024; Mannoor MS, 2013, NANO LETT, V13, P2634, DOI 10.1021/nl4007744; Mao AS, 2015, P NATL ACAD SCI USA, V112, P14452, DOI 10.1073/pnas.1508520112; Maurer MM, 2015, MATERIALS, V8, P2794, DOI 10.3390/ma8052794; McBane JE, 2011, BIOMATERIALS, V32, P6034, DOI 10.1016/j.biomaterials.2011.04.048; Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047; Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179; MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110; Modulevsky DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097835; MOTEGI K, 1984, J MAXILLOFAC SURG, V12, P21, DOI 10.1016/S0301-0503(84)80205-2; Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI [10.1089/ten.tea.2009.0602, 10.1089/ten.TEA.2009.0602]; Neumeister MW, 2006, PLAST RECONSTR SURG, V117, P116, DOI 10.1097/01.prs.0000195071.01699.ce; Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020; Nimeskern L, 2013, J MECH BEHAV BIOMED, V22, P12, DOI 10.1016/j.jmbbm.2013.03.005; O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X; Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003; Orlando G, 2011, TRANSPLANTATION, V91, P1310, DOI 10.1097/TP.0b013e318219ebb5; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Page H, 2013, CELL TISSUE RES, V352, P123, DOI 10.1007/s00441-012-1441-5; Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717; Pertile RAN, 2012, J BIOMAT SCI-POLYM E, V23, P1339, DOI 10.1163/092050611X581516; Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/nmat2441, 10.1038/NMAT2441]; Pomerantseva I, 2016, TISSUE ENG PT A, V22, P197, DOI [10.1089/ten.tea.2015.0173, 10.1089/ten.TEA.2015.0173]; Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446; Rai R, 2011, MAT SCI ENG R, V72, P29, DOI 10.1016/j.mser.2010.11.002; Ratner B.D., 2004, BIOMATERIALS SCI INT; Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9; Raya-Rivera AM, 2014, LANCET, V384, P329, DOI 10.1016/S0140-6736(14)60542-0; Ren X, 2015, NAT BIOTECHNOL, V33, P1097, DOI 10.1038/nbt.3354; Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175; Saini M, 2015, WORLD J CLIN CASES, V3, P52, DOI 10.12998/wjcc.v3.i1.52; Salzberg CA, 2006, ANN PLAS SURG, V57, P1, DOI 10.1097/01.sap.0000214873.13102.9f; Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079; Schumann DA, 2009, CELLULOSE, V16, P877, DOI 10.1007/s10570-008-9264-y; Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5; Shue Li, 2012, Biomatter, V2, P271, DOI 10.4161/biom.22948; Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6; Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; Soto-Gutierrez A, 2011, TISSUE ENG PART C-ME, V17, P677, DOI 10.1089/ten.tec.2010.0698; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; Sterling JA, 2014, CURR OSTEOPOROS REP, V12, P48, DOI 10.1007/s11914-014-0187-2; Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Torres FG, 2012, J FUNCT BIOMATER, V3, P864, DOI 10.3390/jfb3040864; Trindade R, 2016, CLIN IMPLANT DENT R, V18, P192, DOI 10.1111/cid.12274; Wang X, 2013, ADV BIOMATERIALS SCI, P111; WATANABE K, 1993, CYTOTECHNOLOGY, V13, P107, DOI 10.1007/BF00749937; Xiao X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09409; Xu JW, 2005, PLAST RECONSTR SURG, V115, P1633, DOI 10.1097/01.PRS.0000161465.21513.5D; Zhao RG, 2011, ACTA BIOMATER, V7, P1220, DOI 10.1016/j.actbio.2010.11.004; Zhou LB, 2011, TISSUE ENG PT A, V17, P1573, DOI 10.1089/ten.tea.2010.0627	117	106	110	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157894	10.1371/journal.pone.0157894	http://dx.doi.org/10.1371/journal.pone.0157894			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27328066	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212400059
J	Wang, YJ; Shi, YB; Yu, XY; Liu, YJ				Wang, Yajie; Shi, Yunbo; Yu, Xiaoyu; Liu, Yongjie			Intelligent Photovoltaic Systems by Combining the Improved Perturbation Method of Observation and Sun Location Tracking	PLOS ONE			English	Article							EQUIVALENT-CIRCUIT MODELS	Currently, tracking in photovoltaic (PV) systems suffers from some problems such as high energy consumption, poor anti-interference performance, and large tracking errors. This paper presents a solar PV tracking system on the basis of an improved perturbation and observation method, which maximizes photoelectric conversion efficiency. According to the projection principle, we design a sensor module with a light-intensity-detection module for environmental light-intensity measurement. The effect of environmental factors on the system operation is reduced, and intelligent identification of the weather is realized. This system adopts the discrete-type tracking method to reduce power consumption. A mechanical structure with a level-pitch double-degree-of-freedom is designed, and attitude correction is performed by closed-loop control. A worm-and-gear mechanism is added, and the reliability, stability, and precision of the system are improved. Finally, the perturbation and observation method designed and improved by this study was tested by simulated experiments. The experiments verified that the photoelectric sensor resolution can reach 0.344 degrees, the tracking error is less than 2.5 degrees, the largest improvement in the charge efficiency can reach 44.5%, and the system steadily and reliably works.	[Wang, Yajie; Shi, Yunbo; Yu, Xiaoyu; Liu, Yongjie] Harbin Univ Sci & Technol, Higher Educ Key Lab Measuring & Control Technol &, Sch Measurement Control Technol & Commun Engn, Harbin, Peoples R China	Harbin University of Science & Technology	Shi, YB (corresponding author), Harbin Univ Sci & Technol, Higher Educ Key Lab Measuring & Control Technol &, Sch Measurement Control Technol & Commun Engn, Harbin, Peoples R China.	shiyunbo@126.com						[卞新高 Bian Xingao], 2010, [太阳能学报, Acta Energiae Solaris Sinica], V31, P1298; [蔡国伟 Cai Guowei], 2012, [电网技术, Power System Technology], V36, P65; Cao Wei-hua, 2010, Journal of Zhejiang University, V44, P1260, DOI 10.3785/j.issn.1008-973X.2010.07.005; Chen Shuyong, 2011, Proceedings of the CSEE, V31, P6; [杜春旭 Du Chunxu], 2011, [太阳能学报, Acta Energiae Solaris Sinica], V32, P1640; Femia N, 2009, IEEE T IND ELECTRON, V56, P4473, DOI 10.1109/TIE.2009.2029589; Hohm DP, 2003, PROG PHOTOVOLTAICS, V11, P47, DOI 10.1002/pip.459; Hu XS, 2011, J CENT SOUTH UNIV T, V18, P1525, DOI 10.1007/s11771-011-0869-1; Hu XS, 2014, IEEE T INTELL TRANSP, V15, P1193, DOI 10.1109/TITS.2013.2294675; Hu XS, 2012, J POWER SOURCES, V198, P359, DOI 10.1016/j.jpowsour.2011.10.013; Jiao Yang, 2010, Power System Technology, V34, P198; Liu Li-qun, 2009, Journal of South China University of Technology, V37, P140; Neil SD, 2010, ELECTR POW SYST RES, P296; Rodriguez C, 2007, IEEE T CIRCUITS-I, V54, P2054, DOI 10.1109/TCSI.2007.902537; Yang B, 2010, IEEE T POWER ELECTR, V25, P992, DOI 10.1109/TPEL.2009.2036432; [杨晓光 Yang Xiaoguang], 2010, [电工技术学报, Transactions of China Electrotechnical Society], V25, P130; [于荣金 Yu Rongjin], 2009, [光学学报, Acta Optica Sinica], V29, P1751; Zhang L, 2015, J POWER SOURCES, V287, P129, DOI 10.1016/j.jpowsour.2015.04.043; Zhang L, 2015, J POWER SOURCES, V274, P899, DOI 10.1016/j.jpowsour.2014.10.170; Zhao Jing-bo, 2008, Power System Technology, V32, P93	20	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0156858	10.1371/journal.pone.0156858	http://dx.doi.org/10.1371/journal.pone.0156858			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327657	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212400009
J	Tanislav, C; Guenduez, D; Liebetrau, C; Giese, AK; Eichler, S; Sieweke, N; Speth, M; Bauer, T; Hamm, C; Rolfs, A				Tanislav, Christian; Guenduez, Dursun; Liebetrau, Christoph; Giese, Anne Kathrin; Eichler, Sabrina; Sieweke, Nicole; Speth, Maria; Bauer, Timm; Hamm, Christian; Rolfs, Arndt			Cardiac Troponin I: A Valuable Biomarker Indicating the Cardiac Involvement in Fabry Disease	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; LEFT-VENTRICULAR MASS; ENZYME-REPLACEMENT THERAPY; HEMODIALYSIS-PATIENTS; RENAL-FUNCTION; DIAGNOSIS; ASSAY; RECOMMENDATIONS; ELEVATION; OUTCOMES	Objectives Assessment of the clinical severity of Fabry disease (FD), an X-linked, rare, progressive disorder based on a genetic defect in alpha-galactosidase is challenging, especially regarding cardiac involvement. The aim of the study was to evaluate the diagnostic value of cardiac troponin I (cTnI) in discriminating FD patients with cardiac involvement in a large FD patient cohort. Methods cTnI levels were measured with a contemporary sensitive assay in plasma samples taken routinely from FD patients. The assay was calibrated to measure cTnI levels >= 0.01 ng/ml. Elevated cTnI values (cut-off >= 0.04 ng/ml) were correlated with clinical data. Results cTnI was assessed in 62 FD patients (median age: 47 years, males: 36%). Elevated cTnI levels were detected in 23 (37%) patients. Patients with a cTnI elevation were older (median 55 years versus 36 years, p<0.001). Elevated cTnI levels were associated with the presence of a LVH (16/23 versus 1/39; OR 65.81, CI: 6.747-641.859; p<0.001). In almost all patients with a left ventricular hypertrophy (LVH) elevated cTnI levels were detected (16/17, 94%). Absolute cTnI levels in patients with LVH were higher than in those without (median 0.23 ng/ml versus 0.02 ng/ml; p<0.001). A cTnI level <0.04ng/ml had a high negative predictive value regarding the presence of a LVH (38/39, 97%). In a control group of non-FD patients (n = 17) with LVH (due to hypertension) none showed cTnI levels >= 0.01 ng/ml. Conclusions Elevated cTnI levels are common in FD patients, reflecting cardiac involvement. FD patients might benefit from a continuous cTnI monitoring.	[Tanislav, Christian; Sieweke, Nicole] Univ Giessen, Dept Neurol, D-35390 Giessen, Germany; [Guenduez, Dursun; Bauer, Timm; Hamm, Christian] Univ Giessen, Dept Cardiol & Angiol, D-35390 Giessen, Germany; [Liebetrau, Christoph; Hamm, Christian] Kerckhoff Heart & Thorax Ctr, Dept Cardiol, Bad Nauheim, Germany; [Liebetrau, Christoph; Hamm, Christian] German Ctr Cardiovascular Res DZHK, Partner Site RheinMain, Frankfurt, Germany; [Giese, Anne Kathrin; Eichler, Sabrina; Rolfs, Arndt] Univ Rostock, Albrecht Kossel Inst Neuroregenerat, D-18055 Rostock, Germany; [Eichler, Sabrina; Rolfs, Arndt] Centogene, Rostock, Germany; [Speth, Maria] Univ Giessen, Dept Clin Chem, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Kerckhoff Clinic; German Centre for Cardiovascular Research; University of Rostock; CENTOGENE AG; Justus Liebig University Giessen	Tanislav, C (corresponding author), Univ Giessen, Dept Neurol, D-35390 Giessen, Germany.; Guenduez, D (corresponding author), Univ Giessen, Dept Cardiol & Angiol, D-35390 Giessen, Germany.	christian.tanislav@neuro.med.uni-giessen.de; dursun.guenduez@med.uni-giessen.de	Hamm, Christian W./I-3155-2017	Hamm, Christian W./0000-0001-6763-4161; Giese, A.K./0000-0002-8500-2376				Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Biegstraaten M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0253-6; Brunet P, 2008, INT J CARDIOL, V129, P205, DOI 10.1016/j.ijcard.2007.07.004; Chimenti C, 2008, CIRC-HEART FAIL, V1, P161, DOI 10.1161/CIRCHEARTFAILURE.108.769729; Cramer G, 2014, AM J CARDIOL, V113, P1240, DOI 10.1016/j.amjcard.2013.12.033; Dixit S, 2000, ARCH INTERN MED, V160, P3153, DOI 10.1001/archinte.160.20.3153; Ellis K, 2001, SOUTHERN MED J, V94, P993; Fauler G, 2005, RAPID COMMUN MASS SP, V19, P1499, DOI 10.1002/rcm.1948; Feriozzi S, 2007, J NEPHROL, V20, P437; Feustel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091757; Germain DP, 2013, GENET MED, V15, P958, DOI 10.1038/gim.2013.53; Hamm CW, 2002, CIRCULATION, V106, P2871, DOI 10.1161/01.CIR.0000044342.50593.63; Higgins JP, 2003, CLIN INVEST MED, V26, P133; Hulkova H, 1999, Cas Lek Cesk, V138, P660; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Korff S, 2006, HEART, V92, P987, DOI 10.1136/hrt.2005.071282; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Legaz-Arrese A, 2011, EUR J APPL PHYSIOL, V111, P2961, DOI 10.1007/s00421-011-1922-3; Lim W, 2006, AM J CRIT CARE, V15, P280; Linhart A, 2000, AM HEART J, V139, P1101, DOI 10.1067/mhj.2000.105105; Lippi G, 2008, ARCH PATHOL LAB MED, V132, P72, DOI 10.1043/1543-2165(2008)132[72:IOSTAU]2.0.CO;2; Mallamaci F, 2002, AM J KIDNEY DIS, V40, P68, DOI 10.1053/ajkd.2002.33914; Masson S, 2012, CIRCULATION, V125, P280, DOI 10.1161/CIRCULATIONAHA.111.044149; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; Mehta AB, 2009, INT J CLIN PHARM TH, V47, pS66; Niemann M, 2014, CIRC-CARDIOVASC GENE, V7, P8, DOI 10.1161/CIRCGENETICS.113.000249; O'Mahony C, 2010, PROG CARDIOVASC DIS, V52, P326, DOI 10.1016/j.pcad.2009.11.002; Omland T, 2013, J AM COLL CARDIOL, V61, P1240, DOI 10.1016/j.jacc.2012.12.026; Rolfs A, 2013, STROKE, V44, P340, DOI 10.1161/STROKEAHA.112.663708; Sieweke N, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-58; Takenaka T, 2008, J CARDIOL, V51, P50, DOI 10.1016/j.jjcc.2007.12.001; Tanislav C, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-6; Tutarel O, 2011, KIDNEY BLOOD PRESS R, V34, P41, DOI 10.1159/000322614; Van Lente F, 1999, J AM COLL CARDIOL, V33, P471, DOI 10.1016/S0735-1097(98)00592-0; Weber M, 2011, AM HEART J, V162, P81, DOI [10.1016/j.ahj.2011.04.007, 10.1016/j.ahj.2011.07.029]; Weidemann F, 2013, J INTERN MED, V274, P331, DOI 10.1111/joim.12077; Yousef Z, 2013, EUR HEART J, V34, P802, DOI 10.1093/eurheartj/ehs166	37	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157640	10.1371/journal.pone.0157640	http://dx.doi.org/10.1371/journal.pone.0157640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322070	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212000034
J	Apostolov, A; Litim-Mecheri, I; Oravecz, A; Goepp, M; Kirstetter, P; Marchal, P; Ittel, A; Mauvieux, L; Chan, S; Kastner, P				Apostolov, Apostol; Litim-Mecheri, Isma; Oravecz, Attila; Goepp, Marie; Kirstetter, Peggy; Marchal, Patricia; Ittel, Antoine; Mauvieux, Laurent; Chan, Susan; Kastner, Philippe			Sumoylation Inhibits the Growth Suppressive Properties of Ikaros	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; DNA-BINDING PROTEINS; SUMO-1 MODIFICATION; TRANSCRIPTIONAL ACTIVITY; CELL-LINE; T-CELLS; ACTIVATION; PHOSPHORYLATION; LOCALIZATION; TRANSITION	The Ikaros transcription factor is a tumor suppressor that is also important for lymphocyte development. How post-translational modifications influence Ikaros function remains partially understood. We show that Ikaros undergoes sumoylation in developing T cells that correspond to mono-, bi- or poly-sumoylation by SUMO1 and/or SUMO2/3 on three lysine residues (K58, K240 and K425). Sumoylation occurs in the nucleus and requires DNA binding by Ikaros. Sumoylated Ikaros is less effective than unsumoylated forms at inhibiting the expansion of murine leukemic cells, and Ikaros sumoylation is abundant in human B-cell acute lymphoblastic leukemic cells, but not in healthy peripheral blood leukocytes. Our results suggest that sumoylation may be important in modulating the tumor suppressor function of Ikaros.	[Apostolov, Apostol; Litim-Mecheri, Isma; Oravecz, Attila; Goepp, Marie; Kirstetter, Peggy; Marchal, Patricia; Chan, Susan; Kastner, Philippe] Univ Strasbourg, CNRS UMR 7104, INSERM U964, IGBMC, F-67404 Illkirch Graffenstaden, France; [Ittel, Antoine; Mauvieux, Laurent] Hop Univ Strasbourg, Hematol Lab, Strasbourg, France; [Ittel, Antoine; Mauvieux, Laurent] Univ Strasbourg, Fac Med Strasbourg, Federat Med Translat Strasbourg, Inst Hematol & Immunol,Lab Hematol Cellulaire,EA, Strasbourg, France; [Kastner, Philippe] Univ Strasbourg, Fac Med, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kastner, P (corresponding author), Univ Strasbourg, CNRS UMR 7104, INSERM U964, IGBMC, F-67404 Illkirch Graffenstaden, France.; Kastner, P (corresponding author), Univ Strasbourg, Fac Med, Strasbourg, France.	scpk@igbmc.fr	Kirstetter, Peggy/I-9582-2016	Kirstetter, Peggy/0000-0001-7592-8004; APOSTOLOV, Apostol/0000-0002-8825-582X; Goepp, Marie/0000-0003-1659-5689; ITTEL, Antoine/0000-0001-5067-575X; Mauvieux, Laurent/0000-0002-9043-1845	Agence Nationale de la Recherche [ANR-11-BSV3-018]; Ligue Nationale contre le Cancer (equipe labellisee); Conference de Coordination Inter-Regionale du Grand-Est of the Ligue contre le Cancer [173AC.2012]; INSERM, CNRS, University of Strasbourg; Ministry of Research and Technology; Fondation ARC; Institut National du Cancer; Fondation pour la Recherche Medicale;  [ANR-10-LABX-0030-INRT]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue Nationale contre le Cancer (equipe labellisee)(Ligue nationale contre le cancer); Conference de Coordination Inter-Regionale du Grand-Est of the Ligue contre le Cancer; INSERM, CNRS, University of Strasbourg; Ministry of Research and Technology(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Fondation ARC; Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); 	This work was supported by the Agence Nationale de la Recherche (ANR-11-BSV3-018), the Ligue Nationale contre le Cancer (equipe labellisee 2006-2012 and 2015-2017), the Conference de Coordination Inter-Regionale du Grand-Est of the Ligue contre le Cancer (#173AC.2012 to PK) and institutional funds from INSERM, CNRS, University of Strasbourg and the ANR-10-LABX-0030-INRT grant. A.A. received a pre-doctoral fellowship from the Ministry of Research and Technology. I.L-M. received a post-doctoral fellowship from the Fondation ARC. A.O. received post-doctoral fellowships from the Institut National du Cancer and the Fondation pour la Recherche Medicale.	Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Druker J, 2013, MOL CELL BIOL, V33, P2116, DOI 10.1128/MCB.01470-12; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; FINDLEY HW, 1982, BLOOD, V60, P1305; Geimer Le Lay AS, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004545; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; GRAMATZKI M, 1985, CANCER, V55, P77, DOI 10.1002/1097-0142(19850101)55:1<77::AID-CNCR2820550113>3.0.CO;2-A; Gurel Z, 2008, J BIOL CHEM, V283, P8291, DOI 10.1074/jbc.M707906200; Kastner P, 2013, AM J BLOOD RES, V3, P1; Kathrein KL, 2005, MOL CELL BIOL, V25, P1645, DOI 10.1128/MCB.25.5.1645-1654.2005; Ke QD, 2008, TOXICOL APPL PHARM, V228, P190, DOI 10.1016/j.taap.2007.12.015; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kim KI, 2002, J CELL PHYSIOL, V191, P257, DOI 10.1002/jcp.10100; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Myatt SS, 2014, ONCOGENE, V33, P4316, DOI 10.1038/onc.2013.546; Neyret-Kahn H, 2013, GENOME RES, V23, P1563, DOI 10.1101/gr.154872.113; OKABE M, 1987, BLOOD, V69, P990; Oravecz A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9823; Popescu M, 2009, J BIOL CHEM, V284, P13869, DOI 10.1074/jbc.M900209200; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rosonina E, 2012, GENE DEV, V26, P350, DOI 10.1101/gad.184689.111; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Uckun FM, 2012, P NATL ACAD SCI USA, V109, P18072, DOI 10.1073/pnas.1209828109; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204	30	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157767	10.1371/journal.pone.0157767	http://dx.doi.org/10.1371/journal.pone.0157767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315244	Green Published, Green Submitted, gold			2022-12-26	WOS:000378030000053
J	Schubring-Giese, M; Leemburg, S; Luft, AR; Hosp, JA				Schubring-Giese, Maximilian; Leemburg, Susan; Luft, Andreas Rudiger; Hosp, Jonas Aurel			Protein Synthesis Inhibition in the Peri-Infarct Cortex Slows Motor Recovery in Rats	PLOS ONE			English	Article							ISCHEMIC BRAIN-INJURY; STROKE; PLASTICITY; REORGANIZATION; STIMULATION; MAINTENANCE; MECHANISMS; ANISOMYCIN; DEPENDS; MODELS	Neuroplasticity and reorganization of brain motor networks are thought to enable recovery of motor function after ischemic stroke. Especially in the cortex surrounding the ischemic scar (i.e., peri-infarct cortex), evidence for lasting reorganization has been found at the level of neurons and networks. This reorganization depends on expression of specific genes and subsequent protein synthesis. To test the functional relevance of the peri-infarct cortex for recovery we assessed the effect of protein synthesis inhibition within this region after experimental stroke. Long-Evans rats were trained to perform a skilled-reaching task (SRT) until they reached plateau performance. A photothrombotic stroke was induced in the forelimb representation of the primary motor cortex (M1) contralateral to the trained paw. The SRT was re-trained after stroke while the protein synthesis inhibitor anisomycin (ANI) or saline were injected into the peri-infarct cortex through implanted cannulas. ANI injections reduced protein synthesis within the peri-infarct cortex by 69% and significantly impaired recovery of reaching performance through re-training. Improvement of motor performance within a single training session remained intact, while improvement between training sessions was impaired. ANI injections did not affect infarct size. Thus, protein synthesis inhibition within the peri-infarct cortex impairs recovery of motor deficits after ischemic stroke by interfering with consolidation of motor memory between training sessions but not short-term improvements within one session.	[Schubring-Giese, Maximilian; Leemburg, Susan; Luft, Andreas Rudiger; Hosp, Jonas Aurel] Univ & Univ Hosp Zurich, Dept Neurol, Div Vasc Neurol & Rehabil, Zurich, Switzerland; [Luft, Andreas Rudiger] Cereneo Ctr Neurol & Rehabil, Vitznau, Switzerland; [Luft, Andreas Rudiger] Johns Hopkins Univ, Dept Neurol, 1550 Orleans St, Baltimore, MD 21231 USA	University of Zurich; University Zurich Hospital; Johns Hopkins University	Luft, AR (corresponding author), Univ & Univ Hosp Zurich, Dept Neurol, Div Vasc Neurol & Rehabil, Zurich, Switzerland.; Luft, AR (corresponding author), Cereneo Ctr Neurol & Rehabil, Vitznau, Switzerland.; Luft, AR (corresponding author), Johns Hopkins Univ, Dept Neurol, 1550 Orleans St, Baltimore, MD 21231 USA.	andreas.luft@uzh.ch		/0000-0002-7949-4044	Swiss National Science Foundation (SNF, NCCR Neuro); P & K Puhringer Foundation	Swiss National Science Foundation (SNF, NCCR Neuro)(Swiss National Science Foundation (SNSF)); P & K Puhringer Foundation	Funding came from the Swiss National Science Foundation (SNF, NCCR Neuro) and the P & K Puhringer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Alvarez J, 2000, PROG NEUROBIOL, V62, P1, DOI 10.1016/S0301-0082(99)00062-3; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P299, DOI 10.1016/S0166-4328(02)00045-1; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Biernaskie J, 2005, EUR J NEUROSCI, V21, P989, DOI 10.1111/j.1460-9568.2005.03899.x; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; BISBY MA, 1992, MOL NEUROBIOL, V6, P107, DOI 10.1007/BF02780547; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Brown CE, 2010, J CEREBR BLOOD F MET, V30, P783, DOI 10.1038/jcbfm.2009.241; Buitrago MM, 2004, BEHAV BRAIN RES, V155, P249, DOI 10.1016/j.bbr.2004.04.025; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Carr J., 1987, A MOTOR RELEARNING P; Cramer SC, 2006, STROKE, V37, P111, DOI 10.1161/01.STR.0000195135.70379.1f; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Eisner-Janowicz I, 2008, J NEUROPHYSIOL, V100, P1498, DOI 10.1152/jn.90447.2008; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Hagemann G, 1998, ANN NEUROL, V44, P255, DOI 10.1002/ana.410440217; Hong SS, 2007, BRAIN RES, V1149, P76, DOI 10.1016/j.brainres.2007.02.062; Hosp JA, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/871296; Kawai R, 2015, NEURON, V86, P800, DOI 10.1016/j.neuron.2015.03.024; Lehane C, 2013, J PHARMACOL EXP THER, V347, P781, DOI 10.1124/jpet.113.205989; Luft AR, 2004, LEARN MEMORY, V11, P379, DOI 10.1101/lm.72604; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Molina-Luna K, 2007, J NEUROSCI METH, V161, P118, DOI 10.1016/j.jneumeth.2006.10.025; Monfils MH, 2005, NEUROSCIENTIST, V11, P471, DOI 10.1177/1073858405278015; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schubring-Giese M, 2007, EXP BRAIN RES, V181, P359, DOI 10.1007/s00221-007-0930-3; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Smith JB, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00004; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502; Zeiler SR, 2013, CURR OPIN NEUROL, V26, P609, DOI 10.1097/WCO.0000000000000025; Zeiler SR, 2013, STROKE, V44, P483, DOI 10.1161/STROKEAHA.112.676940; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157859	10.1371/journal.pone.0157859	http://dx.doi.org/10.1371/journal.pone.0157859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314672	Green Accepted, gold, Green Published			2022-12-26	WOS:000378030000060
J	Alwan, N; Esmaeili, HR; Krupp, F				Alwan, Nisreen; Esmaeili, Hamid-Reza; Krupp, Friedhelm			Molecular Phylogeny and Zoogeography of the Capoeta damascina Species Complex (Pisces: Teleostei: Cyprinidae)	PLOS ONE			English	Article							RIVER; FISH; SEQUENCE; CARP; DNA	Capoeta damascina was earlier considered by many authors as one of the most common freshwater fish species found throughout the Levant, Mesopotamia, Turkey, and Iran. However, owing to a high variation in morphological characters among and within its various populations, 17 nominal species were described, several of which were regarded as valid by subsequent revising authors. Capoeta damascina proved to be a complex of closely related species, which had been poorly studied. The current study aims at defining C. damascina and the C. damascina species complex. It investigates phylogenetic relationships among the various members of the C. damascina complex, based on mitochondrial and nuclear DNA sequences. Phylogenetic relationships were projected against paleogeographical events to interpret the geographic distribution of the taxa under consideration in relation to the area's geological history. Samples were obtained from throughout the geographic range and were subjected to genetic analyses, using two molecular markers targeting the mitochondrial cytochrome oxidase I (n = 103) and the two adjacent divergence regions (D1-D2) of the nuclear 28S rRNA genes (n = 65). Six closely related species were recognized within the C. damascina complex, constituting two main lineages: A western lineage represented by C. caelestis, C. damascina, and C. umbla and an eastern lineage represented by C. buhsei, C. coadi, and C. saadii. The results indicate that speciation of these taxa is rather a recent event. Dispersal occurred during the Pleistocene, resulting in present-day distribution patterns. A coherent picture of the phylogenetic relationships and evolutionary history of the C. damascina species complex is drawn, explaining the current patterns of distribution as a result of paleogeographic events and ecological adaptations.	[Alwan, Nisreen; Krupp, Friedhelm] Senckenberg Res Inst, D-60325 Frankfurt, Germany; [Alwan, Nisreen; Krupp, Friedhelm] Museum Nat, D-60325 Frankfurt, Germany; [Alwan, Nisreen] Modern Univ Business & Sci, Sch Hlth Sci, POB 113-7501, Beirut, Lebanon; [Esmaeili, Hamid-Reza] Shiraz Univ, Dept Biol, Coll Sci, Shiraz 71454, Iran; [Krupp, Friedhelm] Qatar Museums Author, Qatar Nat Hist Museum, POB 2777, Doha, Qatar	Senckenberg Gesellschaft fur Naturforschung (SGN); Shiraz University; Qatar Museums	Alwan, N (corresponding author), Senckenberg Res Inst, D-60325 Frankfurt, Germany.; Alwan, N (corresponding author), Museum Nat, D-60325 Frankfurt, Germany.; Alwan, N (corresponding author), Modern Univ Business & Sci, Sch Hlth Sci, POB 113-7501, Beirut, Lebanon.	alwan.nisreen@gmail.com	Esmaeili, Hamid Reza/AAT-7368-2020	Esmaeili, Hamid Reza/0000-0002-9736-397X; Alwan, Nisreen/0000-0002-3307-4730	Shiraz University [SU-909789]; German Academic Exchange Service (DAAD)	Shiraz University; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The research work in Iran was funded by Shiraz University (SU-909789) and by the German Academic Exchange Service (DAAD) and was approved by the Ethics Committee of Biology Department (SU-909789). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the German Academic Exchange Service (DAAD) for supporting all field research in the Levant and Iran carried out for this study in the framework of the project "Establishment of a Middle Eastern Biodiversity Network". Many thanks are also due to our colleagues at the Grunelius-Mollgaard Laboratory for Molecular Evolution Research and the LOEWE Biodiversity and Climate Research Centre (BiK-F), Germany for support and granting access to their facilities. We would like to thank Kai Borkenhagen, Florian Wicker, Nadia Manasfi, Mehdi Ghanbari Fardi, Abbas Kazemi, Mohammed Abdel Sater, Masoumeh Malek, Alireza Sari, Michel Bariche, Zuhair Amr, and Adwan Shehab for vital support during field research. The first author wishes to thank Michel Bariche and Jorg Freyhof for providing samples, and the latter as well as Kai Borkenhagen, Tilman Alpermann and Florian Wicker for stimulating valuable discussions throughout the course of this work.	Abdoli A, 2000, INLAND WATER FISHES; Alwan N, 2011, THESIS; Alwan NH, 2016, ZOOKEYS, P155, DOI 10.3897/zookeys.572.7377; AMERY HA, 1993, GEOGR REV, V83, P229, DOI 10.2307/215726; Banarescu P. M, 1999, FRESHWATER FISHES 1; Banister K.K., 1980, Monographiae Biologicae, V38, P95; Barrois T., 1894, Revue Biologique du Nord de la France, Vvi, P224; Berberian M, 1999, B SEISMOL SOC AM, V89, P120; BIANCO P G, 1982, Cybium, V6, P75; Bobek H., 1963, CHANGES CLIMATE, P403; Bobek H., 1959, FEATURES FORMATION G; BUTZER KW, 1961, HISTORY LAND USE ARI, P31; CHANG YS, 1994, J MOL EVOL, V38, P138, DOI 10.1007/BF00166161; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coad B.W., 1987, Beihefte zum Tuebinger Atlas des Vorderen Orients Reihe A Naturwissenschaften, P213; Coad B.W., 1991, Syllogeus, P1; Coad B.W., 1996, Publicaciones Especiales Instituto Espanol de Oceanografia, V21, P63; Coad B.W., 2010, FRESHWATER FISHES IR; Coad B. W., 2008, FISHES TEHRAN PROVIN; Coad Brian W., 1995, Acta Scientiarum Naturalium Academiae Scientiarum Bohemicae Brno, V29, P1; Cuvier G, 1842, HIST NATURELLE POISS, V16, P1; Cuvier G, 1844, HIST NATURELLE POISO, V17, P1; de Vaumas E., 1957, B SOC GEOGR EGYPT, V30, P97; Durand JD, 2002, MOL PHYLOGENET EVOL, V22, P91, DOI 10.1006/mpev.2001.1040; Esmaeili H. R., 2010, ZOOSYSTEMATICA ROSSICA, V19, P361; Esmaeili Hamid Reza, 2016, FishTaxa-Journal of Fish Taxonomy, V1, P35, DOI 10.7508/jft.2016.01.005; Gruvel A., 1931, ETATS SYRIE RICHESSE; Hanko B., 1924, Annales Historico Naturales Musei Nationalis Hungarici, V21, P137; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heckel J.J., 1849, REISEN EUROPA ASIEN, V2, P255; Heckel JJ., 1843, ABBILDUNGEN BESCHREI; Horowitz A, 1979, QUATERNARY ISRAEL, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KARAMAN M S, 1969, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V66, P17; Kassler P, 1973, PERSIAN GULF, P11, DOI DOI 10.1007/978-3-642-65545-6_2; KESSLER KF, 1877, T ARALO KASPIISKOI E, V4, P1; Kinzelbach R., 1987, P S FAUN ZOOG MIDDL, P41; Kinzelbach R, 1980, NAT MUS, V110, P9; Krinsley DB, 1970, GEOMORPHOLOGICAL PAL, P1; Krupp F., 1987, Beihefte zum Tuebinger Atlas des Vorderen Orients Reihe A Naturwissenschaften, P229; Krupp F., 1985, THESIS; Kucuk F, 2009, ZOOL MIDDLE EAST, V47, P71; Levin BA, 2012, MOL PHYLOGENET EVOL, V62, P542, DOI 10.1016/j.ympev.2011.09.004; MIR S, 1988, J FISH BIOL, V32, P931, DOI 10.1111/j.1095-8649.1988.tb05436.x; Mitchell R. C., 1959, GEOL RUNDSCH, V46, P476; Nylander JAA, 2004, MRMODELTEST V2 2 PRO, P1; Ozulug M, 2008, ICHTHYOL EXPLOR FRES, V19, P289; PIETSCHMANN VIKTOR, 1933, AKAD WISS WIEN MATH NAT KL ANZ, V70, P21; Por F.D, 1989, LEGACY TETHYS AQUATI, P1; Rozen S, 2000, Methods Mol Biol, V132, P365; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Schoter C, 2009, ICHTHYOL EXPLOR FRES, V20, P229; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; STEINITZ H., 1957, BULL RES COUNC ISRAEL SECT B BIOL AND MED, V6, P176; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAKIN M, 1972, NATURE, V235, P147, DOI 10.1038/235147a0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsigenopoulos CS, 2003, BIOL J LINN SOC, V80, P207, DOI 10.1046/j.1095-8312.2003.00237.x; Turan Cemal, 2008, Acta Zoologica Cracoviensia Ser. A - Vertebrata, V51A, P1, DOI 10.3409/azc.51a_1-2.1-14; Turan D, 2006, ICHTHYOL EXPLOR FRES, V17, P147; Turan D, 2008, ICHTHYOL EXPLOR FRES, V19, P263; Vera MI, 1997, COMP BIOCHEM PHYS B, V118, P777, DOI 10.1016/S0305-0491(97)00271-X; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Weulersse J., 1940, ORONTE ETUDE FLEUVE, P1; Wolfart R., 1967, GEOLOGIE SYRIEN LIBA, P1; Wolfart R, 1987, P S  FAUN ZOOG MIDDL, P9	68	12	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156434	10.1371/journal.pone.0156434	http://dx.doi.org/10.1371/journal.pone.0156434			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309854	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800004
J	Liu, BZ; Tao, L; Chen, YZ; Li, XZ; Dong, YL; Ma, YJ; Li, SG; Li, F; Zhang, WJ				Liu, Bin Zheng; Tao, Lin; Chen, Yun Zhao; Li, Xu Zhe; Dong, Yu Ling; Ma, Ya Jing; Li, Shu Gang; Li, Feng; Zhang, Wen Jie			Preoperative Body Mass Index, Blood Albumin and Triglycerides Predict Survival for Patients with Gastric Cancer	PLOS ONE			English	Article							LONG-TERM SURVIVAL; METABOLIC SYNDROME; PROSPECTIVE COHORT; OBESITY PARADOX; SERUM-ALBUMIN; OUTCOMES; RISK; MORTALITY; RATIO	Background Gastric cancer (GC) is common and its prognosis is often poor due to difficulties in early diagnosis and optimal treatment strategies. TNM staging system is useful in predicting prognosis but only possible after surgery. Therefore, it is desirable to investigate prognostic factors/markers that may predict prognosis before surgery by which helps appropriate management decisions preoperatively. Methods A total of 320 GC patients were consecutively recruited from 2004 to 2013 and followed up for 127 months (10.6 years) after surgery. These patients' were examined for body mass index (BMI) and blood levels of albumin, triglyceride, total cholesterol, low density lipoprotein cholesterol (LDL-C), and high density lipoprotein cholesterol (HDL-C). Kaplan-Meier method and log rank test were used to analyze long-term survival using the above potential risk markers. We first employed medians of these variables to reveal maximal potentials of the above prognostic predictors. Results Three major findings were obtained: (1) Preoperative BMI was positively correlated with albumin (r = 0.144, P<0.05) and triglyceride (r = 0.365, P<0.01), but negatively correlated with TNM staging (r = -0.265, P<0.05). Preoperative albumin levels were positively correlated with triglyceride (r = 0.173, P<0.05) but again, negatively correlated with TNM staging (r = -0.137, P<0.05); (2) Poor survival was observed in GC patients with lower levels of BMI (P = 0.028), albumin (P = 0.004), and triglyceride (P = 0.043), respectively. Receiver operating characteristic (ROC) curve analyses suggested BMI, albumin and triglyceride to have survival-predictor powers similar to TNM system; and (3) Cox multi-factorial analyses demonstrated that age (P = 0.049), BMI (P = 0.016), cell differentiation (P = 0.001), and TNM staging (P = 0.011) were independent overall survival-predictors for GC patients. Conclusions Preoperative BMI, albumin, and triglyceride levels are capable of predicting survival for GC patients superior to postoperative TNM system in terms of timing for management. As potential survival-predictors, preoperative tests of BMI, albumin and triglyceride, combined with clinical imaging, may help personalized management for GC patients including planning surgical strategy, optimal radio-chemotherapy and appropriate follow-up intervals after surgery.	[Liu, Bin Zheng; Tao, Lin; Chen, Yun Zhao; Li, Xu Zhe; Dong, Yu Ling; Li, Feng; Zhang, Wen Jie] Shihezi Univ, Sch Med, Affiliated Univ Hosp 1, Dept Pathol, Shihezi, Xinjiang, Peoples R China; [Liu, Bin Zheng; Tao, Lin; Chen, Yun Zhao; Li, Xu Zhe; Dong, Yu Ling; Zhang, Wen Jie] Shihezi Univ, Sch Med, Key Labs Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China; [Ma, Ya Jing] Shihezi Univ, Sch Med, Affiliated Univ Hosp 1, Clin Lab, Shihezi, Xinjiang, Peoples R China; [Li, Shu Gang] Shihezi Univ, Sch Med, Dept Prevent Med, Shihezi, Xinjiang, Peoples R China; [Li, Shu Gang] Capital Med Univ, Beijing Chaoyang Hosp, Dept Pathol, Beijing, Peoples R China; [Liu, Bin Zheng] Jiande First Peoples Hosp, Dept Pathol, Hangzhou, Jiangsu, Peoples R China	Shihezi University; Shihezi University; Shihezi University; Shihezi University; Capital Medical University	Zhang, WJ (corresponding author), Shihezi Univ, Sch Med, Affiliated Univ Hosp 1, Dept Pathol, Shihezi, Xinjiang, Peoples R China.; Zhang, WJ (corresponding author), Shihezi Univ, Sch Med, Key Labs Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China.	zhangwj82@yahoo.com			Xinjiang Uyghur Autonomous Region [XJGRI2015056]; Oasis Scholar Fund of Shihezi University [LZXZ201023]; National Natural Science Foundation of China [81360358, 81460362]	Xinjiang Uyghur Autonomous Region; Oasis Scholar Fund of Shihezi University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from Xinjiang Uyghur Autonomous Region (Xinjiang Graduate Student Innovation Program (No. XJGRI2015056), the Oasis Scholar Fund of Shihezi University (No. LZXZ201023), and the National Natural Science Foundation of China (Nos. 81360358, 81460362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Arnold M, 2015, LANCET ONCOL, V16, P36, DOI 10.1016/S1470-2045(14)71123-4; Arques S, 2011, J CARD FAIL, V17, P451, DOI 10.1016/j.cardfail.2011.02.010; Azab B, 2013, INT J COLORECTAL DIS, V28, P1629, DOI 10.1007/s00384-013-1748-z; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Bickenbach KA, 2013, ANN SURG ONCOL, V20, P780, DOI 10.1245/s10434-012-2653-3; Chen HN, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001769; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen Wen, 2016, Computer Aided Engineering, V25, P1, DOI 10.13340/j.cae.2016.03.001; Cong L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090262; Crumley ABC, 2010, WORLD J SURG, V34, P2393, DOI 10.1007/s00268-010-0641-y; Cui Jingli, 2014, Zhonghua Wai Ke Za Zhi, V52, P409; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; Dawood S, 2008, CLIN CANCER RES, V14, P1718, DOI 10.1158/1078-0432.CCR-07-1479; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; HANLEY JA, 1988, RADIOLOGY, V168, P568, DOI 10.1148/radiology.168.2.3393683; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Kawut SM, 2005, AM J CARDIOL, V95, P199, DOI 10.1016/j.amjcard.2004.09.006; Lianos GD, 2014, FUTURE ONCOL, V10, P249, DOI [10.2217/FON.13.188, 10.2217/fon.13.188]; Lindkvist B, 2013, CANCER CAUSE CONTROL, V24, P107, DOI 10.1007/s10552-012-0096-6; Martin RM, 2009, CANCER CAUSE CONTROL, V20, P1181, DOI 10.1007/s10552-009-9319-x; Medical Administration Department of Ministry of Health P.R.C, 2006, PRC NAT GUID CLIN LA; Mullen JT, 2009, ANN SURG, V250, P166, DOI 10.1097/SLA.0b013e3181ad8935; O'Brien JM, 2006, CRIT CARE MED, V34, P738, DOI 10.1097/01.CCM.0000202207.87891.FC; Okamura T, 2004, J CLIN EPIDEMIOL, V57, P1188, DOI 10.1016/j.jclinepi.2004.02.019; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pasini F, 2011, ANTICANCER RES, V31, P3543; Schindl M, 2005, ARCH SURG-CHICAGO, V140, P183, DOI 10.1001/archsurg.140.2.183; Sinicrope FA, 2010, CLIN CANCER RES, V16, P1884, DOI 10.1158/1078-0432.CCR-09-2636; Tateishi R, 2005, GUT, V54, P419, DOI 10.1136/gut.2003.035055; Thrumurthy SG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6367; Tokunaga M, 2009, ANN SURG ONCOL, V16, P3245, DOI 10.1245/s10434-009-0645-8; Ulmer H, 2009, BRIT J CANCER, V101, P1202, DOI 10.1038/sj.bjc.6605264; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Wu N, 2015, NUTR CANCER, V67, P481, DOI 10.1080/01635581.2015.1004726; Yasunaga H, 2013, BRIT J SURG, V100, P1335, DOI 10.1002/bjs.9221; Zhao DQ, 2014, HEPATO-GASTROENTEROL, V61, P1154, DOI 10.5754/hge13576; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	40	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157401	10.1371/journal.pone.0157401	http://dx.doi.org/10.1371/journal.pone.0157401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309531	gold, Green Submitted, Green Published			2022-12-26	WOS:000378029800067
J	Yang, H; Ni, HM; Guo, FL; Ding, YF; Shi, YH; Lahiri, P; Frohlich, LF; Rulicke, T; Smole, C; Schmidt, VC; Zatloukal, K; Cui, Y; Komatsu, M; Fan, J; Ding, WX				Yang, Hua; Ni, Hong-Min; Guo, Fengli; Ding, Yifeng; Shi, Ying-Hong; Lahiri, Pooja; Froehlich, Leopold F.; Ruelicke, Thomas; Smole, Claudia; Schmidt, Volker C.; Zatloukal, Kurt; Cui, Yue; Komatsu, Masaaki; Fan, Jia; Ding, Wen-Xing			Sequestosome 1/p62 Protein Is Associated with Autophagic Removal of Excess Hepatic Endoplasmic Reticulum in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE AUTOPHAGY; P62/SQSTM1; MITOPHAGY; MITOCHONDRIA; REDUCTASE; RECEPTOR; PARKIN; LIVER; UBIQUITINATION; PEROXISOMES	Xenobiotics exposure increases endoplasmic reticulum (ER) proliferation and cytochrome P-450 (CYP) induction to sustain metabolic requirements. Whether autophagy is essential for the removal of excess ER and CYP and whether an autophagy receptor is involved in this process in mammals remains elusive. In this study, we show that autophagy is induced in mouse livers after withdrawal of the hepatic mitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene (TCPOBOP). Although isolated autophagosomes, autolysosomes, and lysosomes from mouse livers after withdrawal of TCPOBOP contained ER proteins, those in control mouse livers did not, Liver-specific Atg5 knockout mice had higher basal hepatic ER content that was further increased and sustained after withdrawal of TCPOBOP compared with wild type mice. In addition to regulating ER degradation, our results also suggest that autophagy plays a role in regulating the homeostasis of hepatic CYP because blocking autophagy led to increased CYP2B10 accumulation either at the basal level or following TCPOBOP withdrawal. Furthermore, we found that the autophagy receptor protein sequestosome 1 (SQSTM1)/p62 is associated with the ER. After withdrawal of TCPOBOP, p62 knockout mice had increased ER content in the liver compared with wild-type mice. These results suggest that p62 may act as an autophagy receptor for the autophagic removal of excess ER in the mouse liver. Taken together, our results indicate that autophagy is important for the removal of excess ER and hepatic CYP enzymes in mouse livers, a process associated with the autophagy receptor protein p62.	[Yang, Hua; Shi, Ying-Hong; Fan, Jia] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Dept Liver Surg, 108 Fenglin Rd, Shanghai 20032, Peoples R China; [Yang, Hua; Ni, Hong-Min; Ding, Yifeng; Ding, Wen-Xing] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, MS 1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Guo, Fengli] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Lahiri, Pooja; Smole, Claudia; Zatloukal, Kurt] Med Univ Graz, Inst Pathol, A-8036 Graz, Austria; [Froehlich, Leopold F.] Univ Munster, Dept Craniomaxillofacial Surg, Albert Schweitzer Campus 1, D-48149 Munster, Germany; [Ruelicke, Thomas] Univ Vet Med, Inst Lab Anim Sci & Biomodels Austria, A-1210 Vienna, Austria; [Cui, Yue] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98159 USA; [Komatsu, Masaaki] Niigata Univ, Sch Med, Dept Biochem, Chuo Ku, Niigata 9518510, Japan	Fudan University; University of Kansas; University of Kansas Medical Center; Stowers Institute for Medical Research; Medical University of Graz; University of Munster; University of Veterinary Medicine Vienna; University of Washington; University of Washington Seattle; Niigata University	Fan, J (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Dept Liver Surg, 108 Fenglin Rd, Shanghai 20032, Peoples R China.; Ding, WX (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, MS 1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	wxding@kumc.edu	Lahiri, Pooja/AAE-6663-2019; Komatsu, Masaaki/B-8321-2011; Shi, Ying-Hong/B-7063-2017	Komatsu, Masaaki/0000-0001-7672-7722; Lahiri, Pooja/0000-0002-6305-9451	National Institutes of Health COBRE Grant [9P20GM104936]; National Institutes of Health [S10RR027564]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940, S10RR027564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936, P20GM103549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020518, R37AA020518] Funding Source: NIH RePORTER	National Institutes of Health COBRE Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We wish to acknowledge the Electron Microscopy Research Laboratory (EMRL) facility for assistance with electron microscopy. The EMRL is supported in part by National Institutes of Health COBRE Grant 9P20GM104936. The JEOL JEM-14.00 transmission electron microscope used in the study was purchased with funds from National Institutes of Health Grant S10RR027564. We thank Dr, Noboru Mizushima (University of Tokyo, Japan) for providing reagents and Dr. Ana Maria Cuervo (Albeit Einstein College of Medicine) for providing guidance on the isolation of lysosomes. Y. D. was a summer intern from Blue Valley North High School in Kansas.	Aleksunes LM, 2012, DRUG METAB DISPOS, V40, P1366, DOI 10.1124/dmd.112.045112; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Correia MA, 2005, ANNU REV PHARMACOL, V45, P439, DOI 10.1146/annurev.pharmtox.45.120403.100127; Cribb AE, 2005, DRUG METAB REV, V37, P405, DOI 10.1080/03602530500205135; Deosaran E, 2013, J CELL SCI, V126, P939, DOI 10.1242/jcs.114819; Ding WX, 2012, J BIOL CHEM, V287, P42379, DOI 10.1074/jbc.M112.413682; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Ding WX, 2009, MOL CANCER THER, V8, P2036, DOI 10.1158/1535-7163.MCT-08-1169; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; FELDMAN D, 1980, J HISTOCHEM CYTOCHEM, V28, P997, DOI 10.1177/28.9.7410819; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Koning AJ, 1996, MOL BIOL CELL, V7, P769, DOI 10.1091/mbc.7.5.769; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Leneuve P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng021; LUM PY, 1995, J CELL BIOL, V131, P81, DOI 10.1083/jcb.131.1.81; Manley S, 2013, EXP BIOL MED, V238, P525, DOI 10.1177/1535370213489446; MASAKI R, 1987, J CELL BIOL, V104, P1207, DOI 10.1083/jcb.104.5.1207; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Ni HM, 2016, J HEPATOL, V65, P354, DOI 10.1016/j.jhep.2016.04.025; Ni HM, 2014, J HEPATOL, V61, P617, DOI 10.1016/j.jhep.2014.04.043; Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Park C, 2013, CELL BIOCHEM BIOPHYS, V67, P3, DOI 10.1007/s12013-013-9623-7; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112	41	42	43	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18663	18674		10.1074/jbc.M116.739821	http://dx.doi.org/10.1074/jbc.M116.739821			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27325701	hybrid, Green Published			2022-12-26	WOS:000383242300006
J	Erbil, S; Oral, O; Mitou, G; Kig, C; Durmaz-Timucin, E; Guven-Maiorov, E; Gulacti, F; Gokce, G; Dengjel, J; Sezerman, OU; Gozuacik, D				Erbil, Secil; Oral, Ozlem; Mitou, Geraldine; Kig, Cenk; Durmaz-Timucin, Emel; Guven-Maiorov, Emine; Gulacti, Ferah; Gokce, Gokcen; Dengjel, Jorn; Sezerman, Osman Ugur; Gozuacik, Devrim			RACK1 Is an Interaction Partner of ATG5 and a Novel Regulator of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; PROTEIN; COMPLEX; MTOR; PHOSPHORYLATION; IDENTIFICATION; MECHANISMS; PROTEOMICS; CONJUGATE; FIELDS	Autophagy is biological mechanism allowing recycling of long-lived proteins, abnormal protein aggregates, and damaged organelles under cellular stress conditions. Following sequestration in double-or multimembrane autophagic vesicles, the cargo is delivered to lysosomes for degradation. ATG5 is a key component of an E3-like ATG12-ATG5-ATG16 protein complex that catalyzes conjugation of the MAP1LC3 protein to lipids, thus controlling autophagic vesicle formation and expansion. Accumulating data indicate that ATG5 is a convergence point for autophagy regulation. Here, we describe the scaffold protein RACK1 (receptor activated C-kinase 1, GNB2L1) as a novel ATG5 interactor and an autophagy protein. Using several independent techniques, we showed that RACK1 interacted with ATG5. Importantly, classical autophagy inducers (starvation or mammalian target of rapamycin blockage) stimulated RACK1-ATG5 interaction. Knockdown of RACK1 or prevention of its binding to ATG5 using mutagenesis blocked autophagy activation. Therefore, the scaffold protein RACK1 is a new ATG5-interacting protein and an important and novel component of the autophagy pathways.	[Erbil, Secil; Oral, Ozlem; Mitou, Geraldine; Kig, Cenk; Durmaz-Timucin, Emel; Gulacti, Ferah; Gokce, Gokcen; Gozuacik, Devrim] Sabanci Univ, Mol Biol Genet & Bioengn Program, TR-34956 Istanbul, Turkey; [Guven-Maiorov, Emine] Koc Univ, Dept Chem & Biol Engn, TR-34450 Istanbul, Turkey; [Guven-Maiorov, Emine] Koc Univ, Ctr Computat Biol & Bioinformat, TR-34450 Istanbul, Turkey; [Dengjel, Jorn] Univ Fribourg, Dept Biol, Chemin Musee 10, CH-1700 Fribourg, Switzerland; [Sezerman, Osman Ugur] Acibadem Univ, Sch Med, Dept Biostat & Med Informat, TR-34752 Istanbul, Turkey; [Oral, Ozlem] Sabanci Univ, Nanotechnol Res & Applicat Ctr, TR-34956 Istanbul, Turkey; [Mitou, Geraldine] Inserm UMR1037 CRCT, F-31000 Toulouse, France; [Guven-Maiorov, Emine] NCI, Ctr Canc Res, NIH, Bldg 542,Rm 603, Frederick, MD 21702 USA; [Gulacti, Ferah] Duzce Ataturk Publ Hosp, Aziziye Str, TR-81010 Duzce, Turkey; [Gokce, Gokcen] Santa Farma Drug Co, Borucicegi Str 16, TR-34382 Istanbul, Turkey	Sabanci University; Koc University; Koc University; University of Fribourg; Acibadem University; Sabanci University; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duzce Ataturk State Hospital; Santa Farma Ilac	Gozuacik, D (corresponding author), Sabanci Univ, Mol Biol Genet & Bioengn Program, TR-34956 Istanbul, Turkey.	dgozuacik@sabanciuniv.edu	Dengjel, Joern/AAI-3682-2020; kig, cenk/ABI-4009-2020; Timucin, Emel/AHE-5258-2022; Timucin, Emel/N-7446-2017; SEZERMAN, OSMAN U/X-6441-2018; Devrim, Gozuacik/C-3330-2008	kig, cenk/0000-0002-6318-5001; Timucin, Emel/0000-0003-0048-0668; Timucin, Emel/0000-0003-0048-0668; Devrim, Gozuacik/0000-0001-7739-2346; Erbil Bilir, Secil/0000-0001-5250-1972; Dengjel, Joern/0000-0002-9453-4614; Guven Maiorov, Emine/0000-0002-7388-9811	Scientific and Technological Research Council of Turkey (TUBITAK) [107T153]; Sabanci University; Swiss National Science Foundation [31003A-166482/1]; TUBITAK [BIDEB 2211]; IKU Prof. Onder Oztunali Science Award; TGC Sedat Simavi Health Sciences Award; Elginkan Foundation Technology Award	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Sabanci University(Sabanci University); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); IKU Prof. Onder Oztunali Science Award; TGC Sedat Simavi Health Sciences Award; Elginkan Foundation Technology Award	This work was supported in part by Scientific and Technological Research Council of Turkey (TUBITAK) 1001 Grant 107T153, the Sabanci University (to D. G.), and Swiss National Science Foundation Grant 31003A-166482/1 (to J. D.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a TUBITAK BIDEB 2211 Scholarship for Ph.D. studies.r Recipient of IKU Prof. Onder Oztunali Science Award, TGC Sedat Simavi Health Sciences Award, and Elginkan Foundation Technology Award. To whom correspondence should be addressed. Tel.: 90-216-4839617; E-mail: dgozuacik@sabanciuniv.edu.	Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chantranupong L, 2015, CELL, V161, P67, DOI 10.1016/j.cell.2015.02.041; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; Dengjel J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014035; Dengjel J, 2010, METHODS MOL BIOL, V658, P267, DOI 10.1007/978-1-60761-780-8_16; Erdi B, 2012, AUTOPHAGY, V8, P1124, DOI 10.4161/auto.20069; Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Ishibashi K, 2011, AUTOPHAGY, V7, P1500, DOI 10.4161/auto.7.12.18025; Itah Z, 2013, EXP BIOL MED, V238, P1242, DOI 10.1177/1535370213503273; Jastrzebski K, 2011, CELL SIGNAL, V23, P1338, DOI 10.1016/j.cellsig.2011.03.016; JORGENSEN WL, 1983, J AM CHEM SOC, V105, P1407, DOI 10.1021/ja00344a001; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Korkmaz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082556; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li JJ, 2015, ONCOGENE, V34, P1890, DOI 10.1038/onc.2014.127; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Nanes BA, 2015, BIOTECHNIQUES, V59, P269, DOI 10.2144/000114351; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Oral O, 2015, ANN BIOMED ENG, V43, P2816, DOI 10.1007/s10439-015-1331-6; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shibutani ST, 2014, CELL RES, V24, P58, DOI 10.1038/cr.2013.159; Tooze Sharon A, 2015, Methods Mol Biol, V1270, P155, DOI 10.1007/978-1-4939-2309-0_12; Walker S, 2008, AUTOPHAGY, V4, P1093, DOI 10.4161/auto.7141; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhao YW, 2015, CELL REP, V13, P1407, DOI 10.1016/j.celrep.2015.10.011; Zhu JJ, 2016, LIFE SCI, V151, P115, DOI 10.1016/j.lfs.2016.02.014	39	35	36	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16753	16765		10.1074/jbc.M115.708081	http://dx.doi.org/10.1074/jbc.M115.708081			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27325703	Green Published, hybrid			2022-12-26	WOS:000380826700032
J	Chang, CY; Chang, CP; Chakraborty, S; Wang, SW; Tseng, YK; Wang, CC				Chang, Chih-Yao; Chang, Chia-Pei; Chakraborty, Shruti; Wang, Shao-Win; Tseng, Yi-Kuan; Wang, Chien-Chia			Modulating the Structure and Function of an Aminoacyl-tRNA Synthetase Cofactor by Biotinylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; biotin; post-translational modification (PTM); protein synthesis; transfer RNA (tRNA)	ACETYL-COA-CARBOXYLASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; IN-VIVO; HOLOCARBOXYLASE SYNTHETASE; PROTEIN ARC1P; GENE ENCODES; YEAST; BIOTIN; MITOCHONDRIAL	Arc1p is a yeast-specific tRNA-binding protein that forms a ternary complex with glutamyl-tRNA synthetase (GluRS(c)) and methionyl-tRNA synthetase (MetRS) in the cytoplasm to regulate their catalytic activities and subcellular distributions. Despite Arc1p not being involved in any known biotin-dependent reaction, it is a natural target of biotin modification. Results presented herein show that biotin modification had no obvious effect on the growth-supporting activity, subcellular distribution, tRNA binding, or interactions of Arc1p with GluRS(c) and MetRS. Nevertheless, biotinylation of Arc1p was temperature dependent; raising the growth temperature from 30 to 37 degrees C drastically reduced its biotinylation level. As a result, Arc1p purified from a yeast culture that had been grown overnight at 37 degrees C was essentially biotin free. Non-biotinylated Arc1p was more heat stable, more flexible in structure, and more effective than its biotinylated counterpart in promoting glutamylation activity of the otherwise inactive GluRS(c) at 37 degrees C in vitro. Our study suggests that the structure and function of Arc1p can be modulated via biotinylation in response to temperature changes.	[Chang, Chih-Yao; Chang, Chia-Pei; Wang, Chien-Chia] Natl Cent Univ, Dept Life Sci, Taoyuan 32001, Taiwan; [Tseng, Yi-Kuan] Natl Cent Univ, Grad Inst Stat, Taoyuan 32001, Taiwan; [Chakraborty, Shruti] Univ Calcutta, Dept Biotechnol, Kolkata 700019, India; [Wang, Shao-Win] Natl Hlth Res Inst, Div Mol & Genom Med, Miaoli 35053, Taiwan	National Central University; National Central University; University of Calcutta; National Health Research Institutes - Taiwan	Wang, CC (corresponding author), Natl Cent Univ, Dept Life Sci, Taoyuan 32001, Taiwan.	dukewang@cc.ncu.edu.tw		Wang, Chien-Chia/0000-0002-7104-1307	Ministry of Science and Technology (Taipei, Taiwan) [MOST 103-2311-B-008-003-MY3, MOST 103-2923-B-008-001-MY3, NSC 102-2311-B-008-004-MY3]	Ministry of Science and Technology (Taipei, Taiwan)	This work was supported by Grants MOST 103-2311-B-008-003-MY3, MOST 103-2923-B-008-001-MY3, and NSC 102-2311-B-008-004-MY3 (to C. C. W.) from the Ministry of Science and Technology (Taipei, Taiwan). The authors declare that they have no conflicts of interest with the contents of this article.	BURBAUM JJ, 1991, J BIOL CHEM, V266, P16965; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chang CP, 2012, NUCLEIC ACIDS RES, V40, P314, DOI 10.1093/nar/gkr724; Chang Chia-Pei, 2008, J Biol Chem, V283, P30699, DOI 10.1074/jbc.M805339200; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; Chapman-Smith A, 1999, BIOMOL ENG, V16, P119, DOI 10.1016/S1050-3862(99)00046-7; CHATTON B, 1988, J BIOL CHEM, V263, P52; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; Dassanayake RP, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0651-6; Frechin M, 2014, MOL CELL, V56, P763, DOI 10.1016/j.molcel.2014.10.015; Frechin M, 2009, GENE DEV, V23, P1119, DOI 10.1101/gad.518109; Frugier M, 2000, EMBO J, V19, P2371, DOI 10.1093/emboj/19.10.2371; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Godinic V, 2007, FEBS J, V274, P2788, DOI 10.1111/j.1742-4658.2007.05812.x; Graindorge JS, 2005, BIOCHEMISTRY-US, V44, P1344, DOI 10.1021/bi049024z; Grant TD, 2012, NUCLEIC ACIDS RES, V40, P3723, DOI 10.1093/nar/gkr1223; Hasim S, 2013, FEMS YEAST RES, V13, P529, DOI 10.1111/1567-1364.12056; Hoja U, 1998, EUR J BIOCHEM, V254, P520, DOI 10.1046/j.1432-1327.1998.2540520.x; Huang HY, 2006, MOL MICROBIOL, V60, P189, DOI 10.1111/j.1365-2958.2006.05083.x; Karanasios E, 2010, FEBS LETT, V584, P3842, DOI 10.1016/j.febslet.2010.08.023; Kim HS, 2004, J BIOL CHEM, V279, P42445, DOI 10.1074/jbc.M407137200; Kuroishi T, 2011, MOL GENET METAB, V104, P537, DOI 10.1016/j.ymgme.2011.08.030; Ladror US, 1998, PROTEIN SCI, V7, P2595, DOI 10.1002/pro.5560071213; LEONDELRIO A, 1995, P NATL ACAD SCI USA, V92, P4626, DOI 10.1073/pnas.92.10.4626; Liao CC, 2012, NUCLEIC ACIDS RES, V40, P9171, DOI 10.1093/nar/gks689; Lin CH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-85; Mirande M, 2010, FEBS LETT, V584, P443, DOI 10.1016/j.febslet.2009.11.027; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; Pick H, 2014, BBA-GENE REGUL MECH, V1839, P644, DOI 10.1016/j.bbagrm.2014.04.016; Polyak SW, 1999, J BIOL CHEM, V274, P32847, DOI 10.1074/jbc.274.46.32847; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; SUMPER M, 1972, EUR J BIOCHEM, V29, P237, DOI 10.1111/j.1432-1033.1972.tb01980.x; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Tissot G, 1998, EUR J BIOCHEM, V258, P586, DOI 10.1046/j.1432-1327.1998.2580586.x; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; Wang CC, 1999, J BIOL CHEM, V274, P16508, DOI 10.1074/jbc.274.23.16508; Yao X, 1997, BIOCHEMISTRY-US, V36, P15089, DOI 10.1021/bi971485f; Zempleni J, 2009, BIOFACTORS, V35, P36, DOI 10.1002/biof.8	38	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17102	17111		10.1074/jbc.M116.734343	http://dx.doi.org/10.1074/jbc.M116.734343			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27330079	Green Published, hybrid			2022-12-26	WOS:000382643800016
J	Elks, CM; Zhao, P; Grant, RW; Hang, H; Bailey, JL; Burk, DH; McNulty, MA; Mynatt, RL; Stephens, JM				Elks, Carrie M.; Zhao, Peng; Grant, Ryan W.; Hang, Hardy; Bailey, Jennifer L.; Burk, David H.; McNulty, Margaret A.; Mynatt, Randall L.; Stephens, Jacqueline M.			Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; adipose tissue; inflammation; insulin resistance; obesity; STATs; oncostatin M	CILIARY NEUROTROPHIC FACTOR; M RECEPTOR-BETA; MATRIX METALLOPROTEINASES; ACTIVATOR INHIBITOR-1; METABOLIC-DISORDERS; GROWTH-REGULATOR; OBESITY; ACCUMULATION; PROLIFERATION; ADIPOGENESIS	Oncostatin M (OSM) is a multifunctional gp130 cytokine. Although OSM is produced in adipose tissue, it is not produced by adipocytes. OSM expression is significantly induced in adipose tissue from obese mice and humans. The OSM-specific receptor, OSM receptor (OSMR), is expressed in adipocytes, but its function remains largely unknown. To better understand the effects of OSM in adipose tissue, we knocked down Osmr expression in adipocytes in vitro using siRNA. In vivo, we generated a mouse line lacking Osmr in adiponectin-expressing cells (OSMRFKO mice). The effects of OSM on gene expression were also assessed in vitro and in vivo. OSM exerts proinflammatory effects on cultured adipocytes that are partially rescued by Osmr knockdown. Osm expression is significantly increased in adipose tissue T cells of high fat-fed mice. In addition, adipocyte Osmr expression is increased following high fat feeding. OSMRFKO mice exhibit increased insulin resistance and adipose tissue inflammation and have increased lean mass, femoral length, and bone volume. Also, OSMRFKO mice exhibit increased expression of Osm, the T cell markers Cd4 and Cd8, and the macrophage markers F4/80 and Cd11c. Interestingly, the same proinflammatory genes induced by OSM in adipocytes are induced in the adipose tissue of the OSMRFKO mouse, suggesting that increased expression of proinflammatory genes in adipose tissue arises both from adipocytes and other cell types. These findings suggest that adipocyte OSMR signaling is involved in the regulation of adipose tissue homeostasis and that, in obesity, OSMR ablation may exacerbate insulin resistance by promoting adipose tissue inflammation.	[Elks, Carrie M.; Bailey, Jennifer L.] Louisiana State Univ, Pennington Biomed Res Ctr, Matrix Biol Lab, Baton Rouge, LA 70808 USA; [Hang, Hardy; Stephens, Jacqueline M.] Louisiana State Univ, Pennington Biomed Res Ctr, Adipocyte Biol Lab, Baton Rouge, LA 70808 USA; [Burk, David H.] Louisiana State Univ, Pennington Biomed Res Ctr, Cell Biol & Bioimaging Core, Baton Rouge, LA 70808 USA; [Mynatt, Randall L.] Louisiana State Univ, Pennington Biomed Res Ctr, Transgen Core, Baton Rouge, LA 70808 USA; [Zhao, Peng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Grant, Ryan W.] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA; [McNulty, Margaret A.] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA; [Stephens, Jacqueline M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of California System; University of California San Diego; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Stephens, JM (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	jsteph1@lsu.edu	Elks, Carrie Marie/N-1961-2017; Mynatt, Randall L/N-1980-2017; Zhao, Peng/G-3562-2019; Stephens, Jacqueline M/R-5217-2018; Burk, David/D-2056-2009	Mynatt, Randall L/0000-0003-4399-0019; McNulty, Margaret/0000-0001-6638-253X; Hang, Hardy/0000-0003-0794-3514; Grant, Ryan/0000-0002-8940-4196; Stephens, Jacqueline/0000-0002-3796-9531	National Institutes of Health [R01DK052968]; National Institutes of Health Nutrition Obesity Research Centers [P30DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052968, P30DK057521, P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Nutrition Obesity Research Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant R01DK052968 (to J. M. S.) and National Institutes of Health Nutrition Obesity Research Centers Grant P30DK072476 entitled "Nutritional Programming: Environmental and Molecular Interactions." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albasanz-Puig A, 2011, ATHEROSCLEROSIS, V216, P292, DOI 10.1016/j.atherosclerosis.2011.02.003; Alessi MC, 2007, CURR OPIN LIPIDOL, V18, P240, DOI 10.1097/MOL.0b013e32814e6d29; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Bamber B, 1998, J MOL MED-JMM, V76, P61, DOI 10.1007/s109-1998-8105-3; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; BROWN TJ, 1987, J IMMUNOL, V139, P2977; Chan SSY, 2005, J CLIN ENDOCR METAB, V90, P6588, DOI 10.1210/jc.2005-0595; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Elks CM, 2015, OBESITY, V23, P573, DOI 10.1002/oby.20926; Ettinger MP, 2003, JAMA-J AM MED ASSOC, V289, P1826, DOI 10.1001/jama.289.14.1826; Fasnacht N, 2008, SEMIN CELL DEV BIOL, V19, P379, DOI 10.1016/j.semcdb.2008.07.001; Febbraio MA, 2007, J CLIN INVEST, V117, P841, DOI 10.1172/JCI30453; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Giannandrea M, 2014, DIS MODEL MECH, V7, P193, DOI 10.1242/dmm.012062; Gloaguen I, 1997, P NATL ACAD SCI USA, V94, P6456, DOI 10.1073/pnas.94.12.6456; Grant Ryan, 2013, Methods Mol Biol, V1040, P195, DOI 10.1007/978-1-62703-523-1_15; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Henkel J, 2011, LAB INVEST, V91, P1107, DOI 10.1038/labinvest.2011.47; Hui W, 1997, ANN RHEUM DIS, V56, P184, DOI 10.1136/ard.56.3.184; Kahles F, 2014, MOL METAB, V3, P384, DOI 10.1016/j.molmet.2014.03.004; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Komori T, 2015, DIABETOLOGIA, V58, P1868, DOI 10.1007/s00125-015-3613-9; Komori T, 2014, J BIOL CHEM, V289, P13821, DOI 10.1074/jbc.M113.542399; Komori T, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.461905; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Lawler HM, 2016, J CLIN ENDOCR METAB, V101, P1422, DOI 10.1210/jc.2015-4125; MALIK N, 1989, MOL CELL BIOL, V9, P2847, DOI 10.1128/MCB.9.7.2847; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Meissburger B, 2011, DIABETOLOGIA, V54, P1468, DOI 10.1007/s00125-011-2093-9; Miyaoka Y, 2006, J BIOL CHEM, V281, P37913, DOI 10.1074/jbc.M606089200; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Nakamura K, 2004, HEPATOLOGY, V39, P635, DOI 10.1002/hep.20086; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Okaya A, 2005, AM J PATHOL, V166, P709, DOI 10.1016/S0002-9440(10)62292-4; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Rega G, 2005, CIRCULATION, V111, P1938, DOI 10.1161/01.CIR.0000161823.55935.BE; Sanchez-Infantes D, 2014, J CLIN ENDOCR METAB, V99, pE217, DOI 10.1210/jc.2013-3555; Schnittker D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/317503; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Silha JV, 2002, AM J PHYSIOL-ENDOC M, V283, pE937, DOI 10.1152/ajpendo.00014.2002; Tamura S, 2002, MECH DEVELOP, V115, P127, DOI 10.1016/S0925-4773(02)00081-3; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Vollmer S, 2009, HEPATOLOGY, V50, P253, DOI 10.1002/hep.22928; Wallace PM, 1999, J IMMUNOL, V162, P5547; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; White UA, 2008, J BIOL CHEM, V283, P22505, DOI 10.1074/jbc.M710462200; White UA, 2011, OBESITY, V19, P903, DOI 10.1038/oby.2010.293; Wicks SE, 2015, P NATL ACAD SCI USA, V112, pE3300, DOI 10.1073/pnas.1418560112; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739	53	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17066	17076		10.1074/jbc.M116.739110	http://dx.doi.org/10.1074/jbc.M116.739110			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27325693	hybrid, Green Published			2022-12-26	WOS:000382643800013
J	Friederich, U; Billings, SA; Hardie, RC; Juusola, M; Coca, D				Friederich, Uwe; Billings, Stephen A.; Hardie, Roger C.; Juusola, Mikko; Coca, Daniel			Fly Photoreceptors Encode Phase Congruency	PLOS ONE			English	Article							INFORMATION-TRANSMISSION; NATURALISTIC STIMULI; FREQUENCY-RESPONSE; RECEPTIVE-FIELDS; VISUAL-ACUITY; SPATIAL PHASE; STATISTICS; IMAGES; DISCRIMINATION; REPRESENTATION	More than five decades ago it was postulated that sensory neurons detect and selectively enhance behaviourally relevant features of natural signals. Although we now know that sensory neurons are tuned to efficiently encode natural stimuli, until now it was not clear what statistical features of the stimuli they encode and how. Here we reverse-engineer the neural code of Drosophila photoreceptors and show for the first time that photoreceptors exploit nonlinear dynamics to selectively enhance and encode phase-related features of temporal stimuli, such as local phase congruency, which are invariant to changes in illumination and contrast. We demonstrate that to mitigate for the inherent sensitivity to noise of the local phase congruency measure, the nonlinear coding mechanisms of the fly photoreceptors are tuned to suppress random phase signals, which explains why photoreceptor responses to naturalistic stimuli are significantly different from their responses to white noise stimuli.	[Friederich, Uwe; Billings, Stephen A.; Coca, Daniel] Univ Sheffield, Dept Automat Control & Syst Engn, Mappin St, Sheffield S1 3JD, S Yorkshire, England; [Hardie, Roger C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England; [Juusola, Mikko] Univ Sheffield, Dept Biomed Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Cambridge; University of Sheffield	Coca, D (corresponding author), Univ Sheffield, Dept Automat Control & Syst Engn, Mappin St, Sheffield S1 3JD, S Yorkshire, England.	d.coca@sheffield.ac.uk	Juusola, Mikko/E-6948-2011	Juusola, Mikko/0000-0002-4428-5330; Hardie, Roger/0000-0001-5531-3264	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H013849, BB/M025527/1, BB/F012071/1, BB/D001900/1]; Engineering and Physical Sciences Research Council [EP/H00453X]; European Research Council [226037 NSYS]; BBSRC [BB/D001900/1, BB/M009564/1, BB/F012071/1, BB/M025527/1, BB/H013849/1] Funding Source: UKRI; EPSRC [EP/D032741/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D001900/1, BB/F012071/1, BB/H013849/1, BB/M009564/1, BB/M025527/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [GR/T17731/01, EP/C528212/1, GR/S08893/01, EP/D032741/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	DC, UF, SAB and MJ gratefully acknowledge that this work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/H013849. The authors gratefully acknowledge additional support from BBSRC (BB/M025527/1: DC; BB/F012071/1 and BB/D001900/1: MJ), Engineering and Physical Sciences Research Council (EP/H00453X: SAB and DC) and the European Research Council Advanced Investigator Grant (226037 NSYS: SAB). The authors declare no competing financial interests.	Asyali MH, 2005, IEEE T BIO-MED ENG, V52, P229, DOI 10.1109/TBME.2004.840187; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Billings SA, 2013, NONLINEAR SYSTEM IDENTIFICATION: NARMAX METHODS IN THE TIME, FREQUENCY, AND SPATIO-TEMPORAL DOMAINS, P1, DOI 10.1002/9781118535561; BILLINGS SA, 1989, MECH SYST SIGNAL PR, V3, P341, DOI 10.1016/0888-3270(89)90042-3; BILLINGS SA, 1990, INT J CONTROL, V52, P863, DOI 10.1080/00207179008953572; Brinkworth RSA, 2008, J VISION, V8, DOI 10.1167/8.11.8; BURG MG, 1993, EMBO J, V12, P911, DOI 10.1002/j.1460-2075.1993.tb05732.x; Burton BG, 2003, J EXP BIOL, V206, P3963, DOI 10.1242/jeb.00600; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; CHEN S, 1989, INT J CONTROL, V49, P1013, DOI 10.1080/00207178908559683; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; FRENCH AS, 1993, BIOPHYS J, V65, P832, DOI 10.1016/S0006-3495(93)81116-0; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Henriksson L, 2009, J NEUROSCI, V29, P14342, DOI 10.1523/JNEUROSCI.3136-09.2009; JONES JCP, 1989, INT J CONTROL, V50, P1925, DOI 10.1080/00207178908953474; Juusola M, 1997, J NEUROPHYSIOL, V77, P1487, DOI 10.1152/jn.1997.77.3.1487; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; Kovesi P., 1999, VIDERE J COMPUT VIS, V1, P1; Lang ZQ, 2007, AUTOMATICA, V43, P805, DOI 10.1016/j.automatica.2006.11.013; Marr D., 2010, VISION COMPUTATIONAL; Mathieson K, 2012, NAT PHOTONICS, V6, P391, DOI [10.1038/NPHOTON.2012.104, 10.1038/nphoton.2012.104]; Mechler F, 2002, J NEUROSCI, V22, P6129; Melzig J, 1996, J COMP PHYSIOL A, V179, P763, DOI 10.1007/BF00207355; MORRONE MC, 1988, PROC R SOC SER B-BIO, V235, P221, DOI 10.1098/rspb.1988.0073; MORRONE MC, 1987, PATTERN RECOGN LETT, V6, P303, DOI 10.1016/0167-8655(87)90013-4; Niven JE, 2007, PLOS BIOL, V5, P828, DOI 10.1371/journal.pbio.0050116; Oka S, 2007, VISION RES, V47, P2212, DOI 10.1016/j.visres.2007.03.020; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; OPPENHEIM AV, 1981, P IEEE, V69, P529, DOI 10.1109/PROC.1981.12022; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Rucci M, 2007, NATURE, V447, P851, DOI 10.1038/nature05866; Schneider DM, 2011, J NEUROSCI, V31, P11867, DOI 10.1523/JNEUROSCI.5790-10.2011; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; SHAW SR, 1984, J EXP BIOL, V112, P225; Simoncelli EP, 2001, NATURAL IMAGE STATIS; SRINIVASAN MV, 1977, J COMP PHYSIOL, V115, P101, DOI 10.1007/BF00667788; SRINIVASAN MV, 1975, VISION RES, V15, P515, DOI 10.1016/0042-6989(75)90029-2; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Thomson MGA, 1999, NETWORK-COMP NEURAL, V10, P123, DOI 10.1088/0954-898X/10/2/302; Tkacik G, 2010, P NATL ACAD SCI USA, V107, P18149, DOI 10.1073/pnas.0914916107; van Hateren JH, 2006, J COMP PHYSIOL A, V192, P187, DOI 10.1007/s00359-005-0060-y; van Hateren JH, 2001, VISION RES, V41, P1851, DOI 10.1016/S0042-6989(01)00052-9; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; VICTOR JD, 1979, J GEN PHYSIOL, V74, P275, DOI 10.1085/jgp.74.2.275; Victor JD, 2009, J NEUROPHYSIOL, V102, P3414, DOI 10.1152/jn.00086.2009; Wainwright MJ, 2002, NEURAL INF PROCESS S, P203; Wardill TJ, 2012, SCIENCE, V336, P925, DOI 10.1126/science.1215317; Zheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004307; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	56	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157993	10.1371/journal.pone.0157993	http://dx.doi.org/10.1371/journal.pone.0157993			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336733	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000378389200084
J	Montelli, S; Peruffo, A; Patarnello, T; Cozzi, B; Negrisolo, E				Montelli, Stefano; Peruffo, Antonella; Patarnello, Tomaso; Cozzi, Bruno; Negrisolo, Enrico			Back to Water: Signature of Adaptive Evolution in Cetacean Mitochondrial tRNAs	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; KILLER WHALE ECOTYPES; PHYLOGENETIC ANALYSES; GENOME; GENE; DIVERSIFICATION; CETARTIODACTYLA; SUBSTITUTION; DIVERGENCE; DIVERSITY	The mitochondrion is the power plant of the eukaryotic cell, and tRNAs are the fundamental components of its translational machinery. In the present paper, the evolution of mitochondrial tRNAs was investigated in the Cetacea, a clade of Cetartiodactyla that retuned to water and thus had to adapt its metabolism to a different medium than that of its mainland ancestors. Our analysis focussed on identifying the factors that influenced the evolution of Cetacea tRNA double-helix elements, which play a pivotal role in the formation of the secondary and tertiary structures of each tRNA and consequently manipulate the whole translation machinery of the mitochondrion. Our analyses showed that the substitution pathways in the stems of different tRNAs were influenced by various factors, determining a molecular evolution that was unique to each of the 22 tRNAs. Our data suggested that the composition, AT-skew, and GC-skew of the tRNA stems were the main factors influencing the substitution process. In particular, the range of variation and the fluctuation of these parameters affected the fate of single tRNAs. Strong heterogeneity was observed among the different species of Cetacea. Finally, it appears that the evolution of mitochondrial tRNAs was also shaped by the environments in which the Cetacean taxa differentiated. This latter effect was particularly evident in toothed whales that either live in freshwater or are deep divers.	[Montelli, Stefano; Peruffo, Antonella; Patarnello, Tomaso; Cozzi, Bruno; Negrisolo, Enrico] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy	University of Padua	Negrisolo, E (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy.	enrico.negrisolo@unipd.it	Cozzi, Bruno/H-9618-2019	Cozzi, Bruno/0000-0002-7531-7040; Peruffo, Antonella/0000-0003-0454-9087				Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Agnarsson I, 2008, MOL PHYLOGENET EVOL, V48, P964, DOI 10.1016/j.ympev.2008.05.046; Ai WM, 2014, FEBS LETT, V588, P450, DOI 10.1016/j.febslet.2013.12.005; Alexander A, 2013, GENOME BIOL EVOL, V5, P113, DOI 10.1093/gbe/evs126; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARNASON U, 1993, J MOL EVOL, V37, P312; Arnason U, 2004, GENE, V333, P27, DOI 10.1016/j.gene.2004.02.010; Arnason U, 2000, J MOL EVOL, V50, P569, DOI 10.1007/s002390010060; Babbucci M, 2014, GENOME BIOL EVOL, V6, P3326, DOI 10.1093/gbe/evu265; Best PB, 2007, WHALES AND DOLPHINS, P36; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cabria MT, 2006, GENE, V375, P1, DOI 10.1016/j.gene.2006.01.038; Cameron SL, 2008, GENOME, V51, P800, DOI 10.1139/G08-066; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen Z, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-314; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; de Bruyn PJN, 2013, BIOL REV, V88, P62, DOI 10.1111/j.1469-185X.2012.00239.x; Dornburg A, 2012, MOL BIOL EVOL, V29, P721, DOI 10.1093/molbev/msr228; Duchene S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027138; FEARNLEY IM, 1987, BIOCHEMISTRY-US, V26, P8247, DOI 10.1021/bi00399a034; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2004, INFERRING PHYLOGENIE; Foote AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024980; Foote AD, 2011, BIOL LETTERS, V7, P116, DOI 10.1098/rsbl.2010.0638; Fordyce RE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2645; Gatesy J, 2013, MOL PHYLOGENET EVOL, V66, P479, DOI 10.1016/j.ympev.2012.10.012; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hassanin A, 2009, J MOL EVOL, V68, P293, DOI 10.1007/s00239-009-9208-7; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Leduc RG, 2008, BIOL LETTERS, V4, P426, DOI 10.1098/rsbl.2008.0168; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo YJ, 2008, MITOCHONDRION, V8, P352, DOI 10.1016/j.mito.2008.07.005; Maddison W.P., 2015, MESQUITE A MODULAR S; Marx FG, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140434; McGowen MR, 2014, TRENDS ECOL EVOL, V29, P336, DOI 10.1016/j.tree.2014.04.001; McGowen MR, 2011, MOL PHYLOGENET EVOL, V60, P345, DOI 10.1016/j.ympev.2011.05.003; McGowen MR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-98; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; Meer MV, 2010, NATURE, V464, P279, DOI 10.1038/nature08691; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Moura AE, 2013, SYST BIOL, V62, P865, DOI 10.1093/sysbio/syt051; Negrisolo E, 2004, MOL BIOL EVOL, V21, P770, DOI 10.1093/molbev/msh078; Negrisolo E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-221; Nery MF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-869; Ortiz RM, 2001, J EXP BIOL, V204, P1831; PATWARY MU, 1994, J SHELLFISH RES, V13, P547; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Perrin WF, 2015, WORLD CETACEA DATABA; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Sasaki T, 2005, SYST BIOL, V54, P77, DOI 10.1080/10635150590905939; Sasaki T, 2006, MOL PHYLOGENET EVOL, V41, P40, DOI 10.1016/j.ympev.2006.03.032; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; SMITH AE, 1968, J MOL BIOL, V38, P241, DOI 10.1016/0022-2836(68)90409-9; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson KF, 2016, MITOCHONDRIAL DNA A, V27, P128, DOI 10.3109/19401736.2013.878908; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Uhen MD, 2007, ANAT REC, V290, P514, DOI 10.1002/ar.20545; VALVERDE JR, 1994, P NATL ACAD SCI USA, V91, P5368, DOI 10.1073/pnas.91.12.5368; Vilstrup JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-65; Wang Z, 2009, MOL BIOL EVOL, V26, P613, DOI 10.1093/molbev/msn282; Williams TM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7055; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xiong Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-20; Yan H, 2005, MOL PHYLOGENET EVOL, V37, P743, DOI 10.1016/j.ympev.2005.06.009; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yim HS, 2014, NAT GENET, V46, P88, DOI 10.1038/ng.2835; Zhou XM, 2011, MOL PHYLOGENET EVOL, V61, P255, DOI 10.1016/j.ympev.2011.02.009; ZUKER M, 1991, NUCLEIC ACIDS RES, V19, P2707, DOI 10.1093/nar/19.10.2707	81	11	11	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158129	10.1371/journal.pone.0158129	http://dx.doi.org/10.1371/journal.pone.0158129			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336480	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200116
J	Splendiani, A; Fioravanti, T; Giovannotti, M; Negri, A; Ruggeri, P; Olivieri, L; Cerioni, PN; Lorenzoni, M; Barucchi, VC				Splendiani, Andrea; Fioravanti, Tatiana; Giovannotti, Massimo; Negri, Alessandra; Ruggeri, Paolo; Olivieri, Luigi; Cerioni, Paola Nisi; Lorenzoni, Massimo; Barucchi, Vincenzo Caputo			The Effects of Paleoclimatic Events on Mediterranean Trout: Preliminary Evidences from Ancient DNA	PLOS ONE			English	Article							SALMO-TRUTTA POPULATIONS; FRESH-WATER FISH; BROWN TROUT; CLIMATE-CHANGE; ARCHAEOLOGICAL REMAINS; EVOLUTIONARY HISTORY; AGE CALIBRATION; CLUSTAL-W; MITOCHONDRIAL; BIODIVERSITY	In this pilot study for the first time, ancient DNA has been extracted from bone remains of Salmo trutta. These samples were from a stratigraphic succession located in a coastal cave of Calabria (southern Italy) inhabited by humans from upper Palaeolithic to historical times. Seven pairs of primers were used to PCR-amplify and sequence from 128 to 410 bp of the mtDNA control region of eleven samples. Three haplotypes were observed: two (ADcs-1 and MEcs-1) already described in rivers from the Italian peninsula; one (ATcs-33) belonging to the southern Atlantic clade of the AT Salmo trutta mtDNA lineage (sensu Bernatchez). The prehistoric occurrence of this latter haplotype in the water courses of the Italian peninsula has been detected for the first time in this study. Finally, we observed a correspondence between frequency of trout remains and variation in haplotype diversity that we related with ecological and demographic changes resulting from a period of rapid cooling known as the Younger Dryas.	[Splendiani, Andrea; Fioravanti, Tatiana; Giovannotti, Massimo; Negri, Alessandra; Ruggeri, Paolo; Olivieri, Luigi; Cerioni, Paola Nisi; Barucchi, Vincenzo Caputo] Univ Politecn Marche, DiSVA, Via Brecce Bianche, I-60131 Ancona, Italy; [Lorenzoni, Massimo] Univ Perugia, Dipartimento Chim Biol & Biotecnol, Via Elce di Sotto, I-06123 Perugia, Italy; [Barucchi, Vincenzo Caputo] Ist Italiano Paleontol Umana, Convitto Nazl Regina Margherita, Piazza Ruggero Bonghi 2, I-03012 Anagni, Italy	Marche Polytechnic University; University of Perugia	Barucchi, VC (corresponding author), Univ Politecn Marche, DiSVA, Via Brecce Bianche, I-60131 Ancona, Italy.; Barucchi, VC (corresponding author), Ist Italiano Paleontol Umana, Convitto Nazl Regina Margherita, Piazza Ruggero Bonghi 2, I-03012 Anagni, Italy.	v.caputo@univpm.it	Negri, Alessandra/D-4085-2011; Giovannotti, Massimo/AAZ-3563-2020; lorenzoni, massimo/G-7610-2014	Negri, Alessandra/0000-0002-8133-3936; lorenzoni, massimo/0000-0002-8548-9487; Ruggeri, Paolo/0000-0002-5433-508X; Giovannotti, Massimo/0000-0001-7622-3583; NISI CERIONI, Paola/0000-0001-5074-9843	Universita Politecnica delle Marche [2014/472, 2015/342]; SAPROPEL AND THE MEDITERRANEAN CLIMATE [85 RFO2014]; funds (Ricerca Scientifica d'Ateneo)	Universita Politecnica delle Marche; SAPROPEL AND THE MEDITERRANEAN CLIMATE; funds (Ricerca Scientifica d'Ateneo)	This work was financed by: 1) Universita Politecnica delle Marche (grant number 2014/472 "Divergenza genetica e speciazione in vertebrati ectotermi"awarded to Vincenzo Caputo Barucchi) http://www.univpm.it/Entra/Engine/RAServePG.php/P/250010010603/T/Universita-Politecnica-delleMarche; 2) Universita Politecnica delle Marche grant number 2015/342 "Aspetti dell'evoluzione del genoma in Vertebrati ectotermi (Pesci ossei, Rettili squamati)"awarded to Massimo Giovannotti (Ricerca scientifica d'ateneo 2015; and 3) Prog n. 85 RFO2014 "SAPROPEL AND THE MEDITERRANEAN CLIMATE" awarded to Alessandra Negri.; We are grateful to Fabio Parenti (Istituto Italiano di Paleontologia Umana) for his help during sample selection. We also wish to thank Franca Saccucci (Dipartimento di Scienze Cliniche Specialistiche ed Odontostomatologiche, Universita Politecnica delle Marche) for making the Laboratory of Human Genetics available for us to perform the genetic analyses on archaeological samples. This research was supported by funds (Ricerca Scientifica d'Ateneo) provided by Universita Politecnica delle Marche (Ancona, Italy) to Vincenzo Caputo Barucchi, Alessandra Negri and Massimo Giovannotti.	ALESSIO M, 1966, RADIOCARBON, V8, P401, DOI 10.1017/S0033822200000242; ALESSIO M, 1967, RADIOCARBON, V9, P346, DOI 10.1017/S003382220000062X; Almodovar A, 2012, GLOBAL CHANGE BIOL, V18, P1549, DOI 10.1111/j.1365-2486.2011.02608.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1994, QUANTITATIVE ECOLOGY; Arndt A, 2003, J ARCHAEOL SCI, V30, P1095, DOI 10.1016/S0305-4403(02)00204-2; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bernatchez L, 2001, EVOLUTION, V55, P351, DOI 10.1111/j.0014-3820.2001.tb01300.x; Blanchet S, 2012, MOL ECOL, V21, P2311, DOI 10.1111/j.1365-294X.2012.05563.x; Campos PF, 2010, MOL ECOL, V19, P4863, DOI 10.1111/j.1365-294X.2010.04826.x; CARDINI L, 1970, B PALETNOLOGIA ITALI, V79, P31; Clavero M, 2010, DIVERS DISTRIB, V16, P744, DOI 10.1111/j.1472-4642.2010.00680.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Consuegra S, 2002, MOL ECOL, V11, P2037, DOI 10.1046/j.1365-294X.2002.01592.x; Cooper A, 2000, SCIENCE, V289, P1139; Cortey M, 2004, MOL PHYLOGENET EVOL, V33, P831, DOI 10.1016/j.ympev.2004.08.012; Cortey M, 2009, BIOL J LINN SOC, V97, P904, DOI 10.1111/j.1095-8312.2009.01220.x; Dalen L, 2007, P NATL ACAD SCI USA, V104, P6726, DOI 10.1073/pnas.0701341104; de Bruyn M, 2011, TRENDS ECOL EVOL, V26, P405, DOI 10.1016/j.tree.2011.03.021; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Durante S., 1978, Quaternaria, V20, P117; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Filipe AF, 2013, DIVERS DISTRIB, V19, P1059, DOI 10.1111/ddi.12086; Fisher TG, 2002, QUATERNARY SCI REV, V21, P873, DOI 10.1016/S0277-3791(01)00148-2; Foote AD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2714; Fruciano C, 2014, BIOL J LINN SOC, V112, P387, DOI 10.1111/bij.12279; Hagelberg E, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0371; Halffman CM, 2015, P NATL ACAD SCI USA, V112, P12344, DOI 10.1073/pnas.1509747112; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hughen KA, 2004, RADIOCARBON, V46, P1059, DOI 10.1017/S0033822200033002; Jonsson N, 2011, CLIMATIC EFFECTS ATL, P473; Knapp M, 2012, ANN ANAT, V194, P3, DOI 10.1016/j.aanat.2011.03.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Leonard JA, 2008, MOL ECOL, V17, P4186, DOI 10.1111/j.1365-294X.2008.03891.x; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; Mannino MA, 2011, J ARCHAEOL SCI, V38, P3094, DOI 10.1016/j.jas.2011.07.009; Munoz M, 1997, J QUATERNARY SCI, V12, P111, DOI 10.1002/(SICI)1099-1417(199703/04)12:2<111::AID-JQS294>3.0.CO;2-P; Nelson JS., 2016, FISHES WORLD, DOI DOI 10.1002/9781119174844.FMATTER; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Pages M, 2009, CONSERV GENET, V10, P217, DOI 10.1007/s10592-008-9549-6; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Russ H, 2009, ENVIRON ARCHAEOL, V14, P155, DOI 10.1179/146141009X12481709928364; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Scarciglia F, 2009, MEDITERRANEE, V112, P137; Snoj A, 2002, J BIOGEOGR, V29, P1179, DOI 10.1046/j.1365-2699.2002.00735.x; Snoj A, 2011, MOL PHYLOGENET EVOL, V61, P203, DOI 10.1016/j.ympev.2011.05.011; Speller CF, 2005, J ARCHAEOL SCI, V32, P1378, DOI 10.1016/j.jas.2005.03.016; Suarez J, 2001, HEREDITY, V87, P198, DOI 10.1046/j.1365-2540.2001.00905.x; Tagliacozzo A, 2005, PREISTORIA ALPINA, V40, P187; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turrero P, 2012, MOL ECOL, V21, P2318, DOI 10.1111/j.1365-294X.2012.05508.x; Turrero P, 2013, PALAIOS, V28, P228, DOI 10.2110/palo.2012.p12-114r; Van Neer W., 2007, ANTHR PRAEHISTORICA, V118, P5; Waples RS, 2008, EVOL APPL, V1, P189, DOI 10.1111/j.1752-4571.2008.00023.x; Weninger B, 2008, J HUM EVOL, V55, P772, DOI 10.1016/j.jhevol.2008.08.017; Xenopoulos MA, 2005, GLOBAL CHANGE BIOL, V11, P1557, DOI 10.1111/j.1365-2486.2005.001008.x; Yang DYY, 2004, J ARCHAEOL SCI, V31, P619, DOI 10.1016/j.jas.2003.10.008	61	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157975	10.1371/journal.pone.0157975	http://dx.doi.org/10.1371/journal.pone.0157975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27331397	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212800063
J	Vegvari, C; Cauet, E; Hadjichrysanthou, C; Lawrence, E; Weverling, GJ; de Wolf, F; Anderson, RM				Vegvari, Carolin; Cauet, Emilie; Hadjichrysanthou, Christoforos; Lawrence, Emma; Weverling, Gerrit-Jan; de Wolf, Frank; Anderson, Roy M.			Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral Infections	PLOS ONE			English	Article							EXPERIMENTAL HUMAN INFLUENZA; A VIRUS-INFECTION; CHALLENGE; DISEASE; HUMANS; OSELTAMIVIR; PERFORMANCE; ASSAYS; CELLS; PCR	Background About 90% of drugs fail in clinical development. The question is whether trials fail because of insufficient efficacy of the new treatment, or rather because of poor trial design that is unable to detect the true efficacy. The variance of the measured endpoints is a major, largely underestimated source of uncertainty in clinical trial design, particularly in acute viral infections. We use a clinical trial simulator to demonstrate how a thorough consideration of the variability inherent in clinical trials of novel therapies for acute viral infections can improve trial design. Methods and Findings We developed a clinical trial simulator to analyse the impact of three different types of variation on the outcome of a challenge study of influenza treatments for infected patients, including individual patient variability in the response to the drug, the variance of the measurement procedure, and the variance of the lower limit of quantification of endpoint measurements. In addition, we investigated the impact of protocol variation on clinical trial outcome. We found that the greatest source of variance was inter-individual variability in the natural course of infection. Running a larger phase II study can save up to $38 million, if an unlikely to succeed phase III trial is avoided. In addition, low-sensitivity viral load assays can lead to falsely negative trial outcomes. Conclusions Due to high inter-individual variability in natural infection, the most important variable in clinical trial design for challenge studies of potential novel influenza treatments is the number of participants. 100 participants are preferable over 50. Using more sensitive viral load assays increases the probability of a positive trial outcome, but may in some circumstances lead to false positive outcomes. Clinical trial simulations are powerful tools to identify the most important sources of variance in clinical trials and thereby help improve trial design.	[Vegvari, Carolin; Cauet, Emilie; Hadjichrysanthou, Christoforos; Lawrence, Emma; de Wolf, Frank; Anderson, Roy M.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England; [Weverling, Gerrit-Jan; de Wolf, Frank] Janssen Prevent Ctr, Leiden, Netherlands	Imperial College London	Vegvari, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England.	c.vegvari@imperial.ac.uk	Cauët, Emilie L. M./H-5849-2012	Cauët, Emilie L. M./0000-0002-2923-245X; Anderson, Roy/0000-0002-9528-3175	Janssen Prevention Center	Janssen Prevention Center	The study was sponsored by the Janssen Prevention Center. RMA received the funding. The funder provided support in the form of salaries for authors CV, EC, CH, EL, GJW, FDW, RA, but did not have any additional role in the study design, data collection and analysis. FDW and GJW approved the final manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We would like to thank Hoffman La Roche for providing access to their data for this analysis and the Janssen Prevention Center for funding this research.	Air GM, 2015, CURR OPIN VIROL, V11, P113, DOI 10.1016/j.coviro.2015.03.006; [Anonymous], 2014, R LANG ENV STAT COMP; Atmar RL, 1996, J CLIN MICROBIOL, V34, P2604, DOI 10.1128/JCM.34.10.2604-2606.1996; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Canini L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003568; Canini L, 2011, J VIROL, V85, P2764, DOI 10.1128/JVI.01318-10; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Economist T., 2014, THE ECONOMIST; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Hadjichrysanthou C, PLOS COMPUTATI UNPUB; Handel A, 2009, J THEOR BIOL, V256, P117, DOI 10.1016/j.jtbi.2008.09.021; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Heldt FS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003372; Horby P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033180; Hurt AC, 2009, INFLUENZA OTHER RESP, V3, P171, DOI 10.1111/j.1750-2659.2009.00086.x; Ison MG, 2010, J INFECT DIS, V201, P1654, DOI 10.1086/652498; Lowenstein PR, 2009, CURR GENE THER, V9, P368, DOI 10.2174/156652309789753392; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mullard A, 2014, NAT REV DRUG DISCOV, V13, P873, DOI 10.1038/nrd4487; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Petrie SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064098; Pleguezuelos O, 2015, CLIN VACCINE IMMUNOL; Practice BTP, 2015, BIOPH IND SPONS CLIN; Quinones-Parra S, 2014, P NATL ACAD SCI USA, V111, P1049, DOI 10.1073/pnas.1322229111; Rubenfeld Gordon D, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS58, DOI 10.1513/AnnalsATS.201409-414MG; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; TCSDD TCftSoDD, 2014, COST DEV WIN MARK AP; To KKW, 2015, CURR OPIN VIROL, V14, P7, DOI 10.1016/j.coviro.2015.04.010; Trammell RA, 2012, MICROBES INFECT, V14, P50, DOI 10.1016/j.micinf.2011.08.008; Vegvari C, EBIOMEDICIN IN PRESS; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wulff Niels H, 2012, J Clin Bioinforma, V2, P5, DOI 10.1186/2043-9113-2-5; ZINKERNAGEL RM, 1978, IMMUNOL REV, V42, P224, DOI 10.1111/j.1600-065X.1978.tb00264.x	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0156622	10.1371/journal.pone.0156622	http://dx.doi.org/10.1371/journal.pone.0156622			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332704	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212800011
J	Wyrwicka, A; Urbaniak, M				Wyrwicka, Anna; Urbaniak, Magdalena			The Different Physiological and Antioxidative Responses of Zucchini and Cucumber to Sewage Sludge Application	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; INDUCED OXIDATIVE STRESS; POLYCYCLIC AROMATIC-HYDROCARBONS; DIOXIN-LIKE COMPOUNDS; DIBENZO-P-DIOXINS; PEPO SSP PEPO; CUCURBITA-PEPO; HEAVY-METALS; ACID-RAIN; WEATHERED P,P'-DDE	The present study investigates the effect of soil amended with sewage sludge on oxidative changes in zucchini and cucumber plants (Cucurbitaceae) and the consequent activation of their antioxidative systems and detoxification mechanisms. The plants were grown in pots containing soil amended with three concentrations of sewage sludge (1.8 g, 5.4 g and 10.8 g per pot), while controls were potted with vegetable soil. The activities of three antioxidative enzymes, ascorbate peroxidase (APx), catalase (CAT) and guaiacol peroxidase (POx), were assessed, as well as of the detoxifying enzyme S-glutathione transferase (GST). Lipid peroxidation was evaluated by measuring the extent of oxidative damage; a-tocopherol content, the main lipophilic antioxidant, was also measured. Visible symptoms of leaf blade damage after sewage sludge application occurred only on the zucchini plants. The zucchini and cucumber plants showed a range of enzymatic antioxidant responses to sewage sludge application. While APx and POx activities increased significantly with increasing sludge concentration in the zucchini plants, they decreased in the cucumber plants. Moreover, although the activity of these enzymes increased gradually with increasing doses of sewage sludge, these levels fell at the highest dose. An inverse relationship between peroxidases activity and CAT activity was observed in both investigated plant species. In contrast, although GST activity increased progressively with sludge concentration in both the zucchini and cucumber leaves, the increase in GST activity was greater in the zucchini plants, being visible at the lowest dose used. The results indicate that signs of sewage sludge toxicity were greater in zucchini than cucumber, and its defense reactions were mainly associated with increases in APx, POx and GST activity.	[Wyrwicka, Anna] Univ Lodz, Fac Biol & Environm Protect, Dept Plant Physiol & Biochem, PL-90131 Lodz, Poland; [Urbaniak, Magdalena] Univ Lodz, Fac Biol & Environm Protect, Dept Appl Ecol, PL-90131 Lodz, Poland; [Urbaniak, Magdalena] Polish Acad Sci, European Reg Ctr Ecohydrol, Lodz, Poland	University of Lodz; University of Lodz; Polish Academy of Sciences; European Regional Centre for Ecohydrology of the Polish Academy of Sciences	Wyrwicka, A (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Plant Physiol & Biochem, PL-90131 Lodz, Poland.	wyrwicka@biol.uni.lodz.pl	Wyrwicka, Anna/M-2708-2019	Urbaniak, Magdalena/0000-0001-5118-4530; Wyrwicka, Anna/0000-0001-5216-2608	Ministry of Science and Higher Education programme under the name "luventus Plus" [0492/IP1/2015/73]	Ministry of Science and Higher Education programme under the name "luventus Plus"	The project was funded by the Ministry of Science and Higher Education programme under the name "Iuventus Plus" for the years 2015-2017 granted on the basis of the decision number 0492/IP1/2015/73, MU (http://www.nauka.gov.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolin MC, 2005, FIELD CROP RES, V94, P224, DOI 10.1016/j.fcr.2005.01.009; Aslund MLW, 2010, ENVIRON POLLUT, V158, P508, DOI 10.1016/j.envpol.2009.08.030; Bartosz G, 1997, ACTA PHYSIOL PLANT, V19, P47, DOI 10.1007/s11738-997-0022-9; Boo YC, 1999, J PLANT PHYSIOL, V155, P255, DOI 10.1016/S0176-1617(99)80016-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIGGS GG, 1982, PESTIC SCI, V13, P495, DOI 10.1002/ps.2780130506; Antolin MC, 2010, ECOTOX ENVIRON SAFE, V73, P436, DOI 10.1016/j.ecoenv.2009.08.022; Antolin MC, 2010, ENVIRON EXP BOT, V68, P75, DOI 10.1016/j.envexpbot.2009.11.001; Marti MC, 2009, J HAZARD MATER, V171, P879, DOI 10.1016/j.jhazmat.2009.06.083; Clostre F, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2153-0; Cunningham SD, 1996, ADV AGRON, V56, P55, DOI 10.1016/S0065-2113(08)60179-0; Dai QJ, 1997, PHYSIOL PLANTARUM, V101, P301, DOI 10.1034/j.1399-3054.1997.1010207.x; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Edwards R, 2004, ECOL STU AN, V170, P17; Engwall M, 2000, CHEMOSPHERE, V40, P1189, DOI 10.1016/S0045-6535(99)00368-9; FEIERABEND J, 1983, PHYSIOL PLANTARUM, V57, P346, DOI 10.1111/j.1399-3054.1983.tb02298.x; Ferrat L, 2003, AQUAT TOXICOL, V65, P187, DOI 10.1016/S0166-445X(03)00133-4; Gabara B, 2003, PLANT SCI, V164, P507, DOI 10.1016/S0168-9452(02)00447-8; Gent MPN, 2007, ENVIRON TOXICOL CHEM, V26, P2467, DOI 10.1897/06-257.1; Gerhardt KE, 2009, PLANT SCI, V176, P20, DOI 10.1016/j.plantsci.2008.09.014; Gonçalves Jamile F., 2009, Braz. J. Plant Physiol., V21, P175, DOI 10.1590/S1677-04202009000300002; Greenwood SJ, 2011, ENVIRON SCI TECHNOL, V45, P6511, DOI 10.1021/es200598u; Gworek B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109548; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hamoutene D, 1996, B ENVIRON CONTAM TOX, V56, P327, DOI 10.1007/s001289900048; Hanano A, 2014, CHEMOSPHERE, V104, P76, DOI 10.1016/j.chemosphere.2013.10.060; HATZINGER PB, 1995, ENVIRON SCI TECHNOL, V29, P537, DOI 10.1021/es00002a033; Hernandez J, 1999, NEW PHYTOL, V141, P241, DOI 10.1046/j.1469-8137.1999.00341.x; HULSTER A, 1994, ENVIRON SCI TECHNOL, V28, P1110, DOI 10.1021/es00055a021; Inui H, 2008, CHEMOSPHERE, V73, P1602, DOI 10.1016/j.chemosphere.2008.08.013; Ivanov VB, 2003, RUSS J PLANT PHYSL+, V50, P398, DOI 10.1023/A:1023838707715; Jimenez A, 1997, PLANT PHYSIOL, V114, P275, DOI 10.1104/pp.114.1.275; Kang HM, 2001, PHYSIOL PLANTARUM, V113, P548, DOI 10.1034/j.1399-3054.2001.1130414.x; Karolewski P, 1995, EUR J FOREST PATHOL, V25, P297; Lakhdar A, 2009, COMMUN SOIL SCI PLAN, V40, P3524, DOI 10.1080/00103620903326040; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Liao CJ, 2015, ECOTOX ENVIRON SAFE, V112, P1, DOI 10.1016/j.ecoenv.2014.10.025; Liu H, 2009, PLANT SCI, V176, P375, DOI 10.1016/j.plantsci.2008.12.002; Low JE, 2011, ENVIRON POLLUT, V159, P769, DOI 10.1016/j.envpol.2010.11.015; Low JE, 2010, J ENVIRON QUAL, V39, P245, DOI 10.2134/jeq2009.0169; Ludwikow A, 2004, CELL MOL BIOL LETT, V9, P829; Lyubenova L, 2009, ENVIRON SCI POLLUT R, V16, P573, DOI 10.1007/s11356-009-0175-8; Macek T, 2000, BIOTECHNOL ADV, V18, P23, DOI 10.1016/S0734-9750(99)00034-8; MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Matsuo S, 2011, J PESTIC SCI, V36, P363, DOI 10.1584/jpestics.G11-03; Mattina MI, 2004, ENVIRON TOXICOL CHEM, V23, P2756, DOI 10.1897/03-570; Mattina MI, 2003, ENVIRON POLLUT, V124, P375, DOI 10.1016/S0269-7491(03)00060-5; Mattina MJI, 1999, ENVIRON SCI TECHNOL, V33, P2425, DOI 10.1021/es990012o; Mattina MJI, 2000, J AGR FOOD CHEM, V48, P1909, DOI 10.1021/jf990566a; Menone ML, 2005, CHEMOSPHERE, V60, P79, DOI 10.1016/j.chemosphere.2004.11.094; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mitton FM, 2016, PESTIC BIOCHEM PHYS, V130, P17, DOI 10.1016/j.pestbp.2015.12.005; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Parrish ZD, 2006, CHEMOSPHERE, V64, P609, DOI 10.1016/j.chemosphere.2005.11.003; Pascal S, 1999, PHYSIOL PLANTARUM, V106, P17, DOI 10.1034/j.1399-3054.1999.106103.x; Paskova V, 2006, ENVIRON TOXICOL CHEM, V25, P3238, DOI 10.1897/06-162R.1; Ranvier S, 2000, BOT MAR, V43, P161, DOI 10.1515/BOT.2000.017; Reddy AM, 2005, CHEMOSPHERE, V60, P97, DOI 10.1016/j.chemosphere.2004.11.092; Reed G, 1975, ENZYMES IN FOOD PROC; ROY S, 1995, CHEMOSPHERE, V30, P1489, DOI 10.1016/0045-6535(95)00043-8; Rutherford AW, 2001, TRENDS BIOCHEM SCI, V26, P648, DOI 10.1016/S0968-0004(01)01953-3; Schafer FQ, 2002, BIOL CHEM, V383, P671, DOI 10.1515/BC.2002.069; Schutzendubel A, 2002, PLANT PHYSIOL BIOCH, V40, P577, DOI 10.1016/S0981-9428(02)01411-0; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; TANAKA K, 1982, PLANT CELL PHYSIOL, V23, P1009; Tang J, 1998, ENVIRON TOXICOL CHEM, V17, P1085, DOI [10.1897/1551-5028(1998)017&lt;1085:UABOAB&gt;2.3.CO;2, 10.1002/etc.5620170614]; Tausz M, 2000, PHYTON-ANN REI BOT A, V40, P111; Tayefi-Nasrabadi H, 2011, AFR J BIOTECHNOL, V10, P751; TAYLOR SL, 1976, LIPIDS, V11, P530, DOI 10.1007/BF02532898; Tejada M, 2014, COMMUN SOIL SCI PLAN, V45, P570, DOI 10.1080/00103624.2013.874017; Velikova V, 2000, PLANT SCI, V151, P59, DOI 10.1016/S0168-9452(99)00197-1; Wan L, 2005, SCI CHINA SER C, V48, P33; Waqas M, 2014, CHEMOSPHERE, V105, P53, DOI 10.1016/j.chemosphere.2013.11.064; White JC, 2010, ENVIRON SCI TECHNOL, V44, P5165, DOI 10.1021/es100706t; White JC, 2005, MICROCHEM J, V81, P148, DOI 10.1016/j.microc.2005.01.010; White JC, 2003, ENVIRON SCI TECHNOL, V37, P4368, DOI 10.1021/es034357p; White JC, 2002, CHEMOSPHERE, V49, P143, DOI 10.1016/S0045-6535(02)00277-1; WILLEKENS H, 1995, MOL BREEDING, V1, P207, DOI 10.1007/BF02277422; Wyrwicka A, 2006, ENVIRON EXP BOT, V56, P198, DOI 10.1016/j.envexpbot.2005.02.003; Wyrwicka Anna, 2014, Ecohydrology & Hydrobiology, V14, P75, DOI 10.1016/j.ecohyd.2014.01.003; Wyrwicka A, 2014, ACTA PHYSIOL PLANT, V36, P837, DOI 10.1007/s11738-013-1462-z; Xu J, 2012, PLANTA, V235, P399, DOI 10.1007/s00425-011-1498-5; YAGI K, 1982, LIPID PEROXIDES BIOL, P223; Zhang HJ, 2009, CHEMOSPHERE, V76, P740, DOI 10.1016/j.chemosphere.2009.05.030; Zhu ZJ, 2004, PLANT SCI, V167, P527, DOI 10.1016/j.plantsci.2004.04.020	89	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157782	10.1371/journal.pone.0157782	http://dx.doi.org/10.1371/journal.pone.0157782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327659	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400045
J	Klein-Theyer, A; Horwath-Winter, J; Rabensteiner, DF; Schwantzer, G; Wultsch, G; Aminfar, H; Heidinger, A; Boldin, I				Klein-Theyer, Angelika; Horwath-Winter, Jutta; Rabensteiner, Dieter Franz; Schwantzer, Gerold; Wultsch, Georg; Aminfar, Haleh; Heidinger, Andrea; Boldin, Ingrid			The Impact of Visual Guided Order Picking on Ocular Comfort, Ocular Surface and Tear Function	PLOS ONE			English	Article							COMPUTER VISION SYNDROME; BLINK RATE; DRY EYE; DISPLAY; SYMPTOMS	Purpose We investigated the effects of a visual picking system on ocular comfort, the ocular surface and tear function compared to those of a voice guided picking solution. Design Prospective, observational, cohort study. Method Setting: Institutional. Study Population: A total of 25 young asymptomatic volunteers performed commissioning over 10 hours on two consecutive days. Main Outcome Measures: The operators were guided in the picking process by two different picking solutions, either visually or by voice while their subjective symptoms and ocular surface and tear function parameters were recorded. Results The visual analogue scale (VAS) values, according to subjective dry eye symptoms, in the visual condition were significantly higher at the end of the commissioning than the baseline measurements. In the voice condition, the VAS values remained stable during the commissioning. The tear break-up time (BUT) values declined significantly in the visual condition (pre-task: 16.6 sec and post-task: 9.6 sec) in the right eyes, that were exposed to the displays, the left eyes in the visual condition showed only a minor decline, whereas the BUT values in the voice condition remained constant (right eyes) or even increased (left eyes) over the time. No significant differences in the tear meniscus height values before and after the commissioning were observed in either condition. Conclusion In our study, the use of visually guided picking solutions was correlated with post-task subjective symptoms and tear film instability.	[Klein-Theyer, Angelika; Horwath-Winter, Jutta; Rabensteiner, Dieter Franz; Aminfar, Haleh; Heidinger, Andrea; Boldin, Ingrid] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Schwantzer, Gerold] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Wultsch, Georg] Med Univ Graz, AMEZ Graz Occupat Hlth Ctr, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Klein-Theyer, A (corresponding author), Med Univ Graz, Dept Ophthalmol, Graz, Austria.	angelika.klein@medunigraz.at	Schwantzer, Gerold/A-3209-2012	Schwantzer, Gerold/0000-0003-3349-1101				Abelson MB, 2010, REV OPHTHALMOL, V17, P92; Acosta MC, 1999, EXP EYE RES, V68, P663, DOI 10.1006/exer.1998.0656; Blehm C, 2005, SURV OPHTHALMOL, V50, P253, DOI 10.1016/j.survophthal.2005.02.008; Cardona G, 2011, CURR EYE RES, V36, P190, DOI 10.3109/02713683.2010.544442; Cole BL, 1996, OPTOMETRY VISION SCI, V73, P512, DOI 10.1097/00006324-199608000-00001; Goto E, 2001, CORNEA, V20, P807, DOI 10.1097/00003226-200111000-00006; Himebaugh NL, 2009, OPTOMETRY VISION SCI, V86, P106, DOI 10.1097/OPX.0b013e318194e962; Iwakiri Kazuyuki, 2004, Sangyo Eiseigaku Zasshi, V46, P201, DOI 10.1539/sangyoeisei.46.201; Miyake-Kashima M, 2005, CORNEA, V24, P567, DOI 10.1097/01.ico.0000151564.24989.38; Mocci F, 2001, OCCUP ENVIRON MED, V58, P267, DOI 10.1136/oem.58.4.267; OCULUS Inc, KERATOGRAPH 5M; PATEL S, 1991, OPTOMETRY VISION SCI, V68, P888, DOI 10.1097/00006324-199111000-00010; Portello JK, 2012, OPHTHAL PHYSL OPT, V32, P375, DOI 10.1111/j.1475-1313.2012.00925.x; Rosenfield M, 2011, OPHTHAL PHYSL OPT, V31, P502, DOI 10.1111/j.1475-1313.2011.00834.x; Salibello C, 1995, J Am Optom Assoc, V66, P479; Schlote T, 2004, GRAEF ARCH CLIN EXP, V242, P306, DOI 10.1007/s00417-003-0845-z; Shima M, 1993, Nihon Eiseigaku Zasshi, V47, P1032; Studeli T, 2001, BERICHT ZUM 47 ARBEI, P111; Taino G, 2006, G Ital Med Lav Ergon, V28, P487; Teoh SC, 2012, J OPTOMET, V5, P56; Tsubota K, 1999, BRIT J OPHTHALMOL, V83, P390, DOI 10.1136/bjo.83.4.390; Uchino M, 2013, AM J OPHTHALMOL, V156, P759, DOI 10.1016/j.ajo.2013.05.040; Vincent SJ, 2015, OPHTHAL PHYSL OPT, V35, P552, DOI 10.1111/opo.12225	23	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157564	10.1371/journal.pone.0157564	http://dx.doi.org/10.1371/journal.pone.0157564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314855	gold, Green Published, Green Submitted			2022-12-26	WOS:000378030000035
J	Lee, SY; Kim, JH; Seo, TK; No, JS; Kim, H; Kim, WK; Choi, HG; Kang, SH; Song, JW				Lee, Sook-Young; Kim, Jeong-Hoon; Seo, Tae-Kun; No, Jin Sun; Kim, Hankyeom; Kim, Won-Keun; Choi, Han-Gu; Kang, Sung-Ho; Song, Jin-Won			Genetic and Molecular Epidemiological Characterization of a Novel Adenovirus in Antarctic Penguins Collected between 2008 and 2013	PLOS ONE			English	Article							COMPLETE DNA-SEQUENCE; AVIAN ADENOVIRUS; GENOME ANALYSIS; CHINSTRAP PENGUINS; ORGANIZATION; ADELIE; IDENTIFICATION; COMPLETION; INFECTION; LINEAGE	Antarctica is considered a relatively uncontaminated region with regard to the infectious diseases because of its extreme environment, and isolated geography. For the genetic characterization and molecular epidemiology of the newly found penguin adenovirus in Antarctica, entire genome sequencing and annual survey of penguin adenovirus were conducted. The entire genome sequences of penguin adenoviruses were completed for two Chinstrap penguins (Pygoscelis antarctica) and two Gentoo penguins (Pygoscelis papua). The whole genome lengths and G+ C content of penguin adenoviruses were found to be 24,63024,662 bp and 35.5-35.6%, respectively. Notably, the presence of putative sialidase gene was not identified in penguin adenoviruses by Rapid Amplification of cDNA Ends (RACEPCR) as well as consensus specific PCR. The penguin adenoviruses were demonstrated to be a new species within the genus Siadenovirus, with a distance of 29.9-39.3%(amino acid, 32.1-47.9%) in DNA polymerase gene, and showed the closest relationship with turkey adenovirus 3 (TAdV-3) in phylogenetic analysis. During the 2008-2013 study period, the penguin adenoviruses were annually detected in 22 of 78 penguins (28.2%), and the molecular epidemiological study of the penguin adenovirus indicates a predominant infection in Chinstrap penguin population (12/30, 40%). Interestingly, the genome of penguin adenovirus could be detected in several internal samples, except the lymph node and brain. In conclusion, an analysis of the entire adenoviral genomes from Antarctic penguins was conducted, and the penguin adenoviruses, containing unique genetic character, were identified as a new species within the genus Siadenovirus. Moreover, it was annually detected in Antarctic penguins, suggesting its circulation within the penguin population.	[Lee, Sook-Young; No, Jin Sun; Kim, Won-Keun; Song, Jin-Won] Korea Univ, Coll Med, Dept Microbiol, Seoul 136705, South Korea; [Kim, Jeong-Hoon; Seo, Tae-Kun; Choi, Han-Gu] Korea Polar Res Inst, Div Life Sci, Inchon, South Korea; [Kim, Hankyeom] Korea Univ, Guro Hosp, Coll Med, Dept Pathol, Seoul, South Korea; [Kang, Sung-Ho] Korea Polar Res Inst, Div Polar Ocean Environm, Inchon, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Korea University; Korea University Medicine (KU Medicine); Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Song, JW (corresponding author), Korea Univ, Coll Med, Dept Microbiol, Seoul 136705, South Korea.	jwsong@korea.ac.kr	Song, Jin/HHS-8731-2022		Korea Polar Research Institute, Korea [PC12010, PE15020]; Polar Academic Program	Korea Polar Research Institute, Korea(Korea Polar Research Institute of Marine Research Placement (KOPRI)); Polar Academic Program	This work was supported by grants PC12010 (Polar Academic Program) and PE15020 provided by the Korea Polar Research Institute, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jin Woo Jung, Min-Goo Lee, Kyeong Hoon Cho, and Yeong Woong Kim for assistance in sample collection. This work was supported by Polar Academic Program and Korea Polar Research Institute, Korea.	Aggarwal N, 2000, INTERVIROLOGY, V43, P6, DOI 10.1159/000025016; Beach NM, 2009, J GEN VIROL, V90, P1978, DOI 10.1099/vir.0.010090-0; Benko M, 2014, ICTV OFFICIAL TAXONO; Berk AJ, 2007, FIELDS VIROLOGY, P2355; Chiocca S, 1996, J VIROL, V70, P2939, DOI 10.1128/JVI.70.5.2939-2949.1996; Chown SL, 2012, SCIENCE, V337, P158, DOI 10.1126/science.1222821; Dan A, 1998, J GEN VIROL, V79, P1453; DAVISON AJ, 1993, J MOL BIOL, V234, P1308, DOI 10.1006/jmbi.1993.1687; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; Davison AJ, 2000, J GEN VIROL, V81, P2431, DOI 10.1099/0022-1317-81-10-2431; Farkas SL, 2008, VIRUS RES, V132, P132, DOI 10.1016/j.virusres.2007.11.009; Grimaldi WW, 2015, POLAR BIOL, V38, P591, DOI 10.1007/s00300-014-1632-5; Harrach B, 1995, VIRUS TAXONOMY, V9, P125; Hess M, 1997, VIROLOGY, V238, P145, DOI 10.1006/viro.1997.8815; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Hurt AC, 2014, MBIO, V5, DOI 10.1128/mBio.01098-14; Joseph HM, 2014, VET MICROBIOL, V172, P35, DOI 10.1016/j.vetmic.2014.04.006; Katoh H, 2009, VIRUS RES, V144, P294, DOI 10.1016/j.virusres.2009.04.012; Kerry K., 1998, DIS ANTARCTIC WILDLI, V18, P89; Kohl C, 2012, J VIROL, V86, P1888, DOI 10.1128/JVI.05974-11; Kovacs ER, 2011, INFECT GENET EVOL, V11, P1058, DOI 10.1016/j.meegid.2011.03.021; Kovacs ER, 2010, J VIROL METHODS, V163, P262, DOI 10.1016/j.jviromet.2009.10.007; Kovacs GM, 2004, J GEN VIROL, V85, P2799, DOI 10.1099/vir.0.80225-0; Kovacs GM, 2003, VIRUS RES, V98, P27, DOI 10.1016/j.virusres.2003.08.010; Lee SY, 2014, VIRUSES-BASEL, V6, P2052, DOI 10.3390/v6052052; Meissner JD, 1997, VIRUS RES, V51, P53, DOI 10.1016/S0168-1702(97)00079-8; Miller AK, 2010, CONDOR, V112, P683, DOI 10.1525/cond.2010.090221; Morrison MD, 1997, J GEN VIROL, V78, P873, DOI 10.1099/0022-1317-78-4-873; Park YM, 2012, VIROLOGY, V422, P144, DOI 10.1016/j.virol.2011.10.008; Pitcovski J, 1998, VIROLOGY, V249, P307, DOI 10.1006/viro.1998.9336; Rivera S, 2009, J VET DIAGN INVEST, V21, P415, DOI 10.1177/104063870902100402; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rusvai M, 2000, VIRUS RES, V70, P25, DOI 10.1016/S0168-1702(00)00201-X; Singh AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139339; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TRIVELPIECE WZ, 1987, ECOLOGY, V68, P351, DOI 10.2307/1939266; Varsani A, 2015, J GEN VIROL, V96, P851, DOI 10.1099/vir.0.000038; Varsani A, 2014, J GEN VIROL, V95, P1352, DOI 10.1099/vir.0.064436-0; Wellehan JFX, 2009, AVIAN PATHOL, V38, P413, DOI 10.1080/03079450903183660	39	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157032	10.1371/journal.pone.0157032	http://dx.doi.org/10.1371/journal.pone.0157032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309961	Green Submitted, gold, Green Published			2022-12-26	WOS:000378029800030
J	Orang'o, EO; Wachira, J; Asirwa, FC; Busakhala, N; Naanyu, V; Kisuya, J; Otieno, G; Keter, A; Mwangi, A; Inui, T				Orang'o, Elkanah Omenge; Wachira, Juddy; Asirwa, Fredrick Chite; Busakhala, Naftali; Naanyu, Violet; Kisuya, Job; Otieno, Grieven; Keter, Alfred; Mwangi, Ann; Inui, Thomas			Factors Associated with Uptake of Visual Inspection with Acetic Acid (VIA) for Cervical Cancer Screening in Western Kenya	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; INFECTED WOMEN; SINGLE-VISIT; PREVENTION; ACCEPTABILITY; INDIA; FEASIBILITY; VACCINATION; THAILAND; LESIONS	Purpose Cervical cancer screening has been successful in reducing the rates of cervical cancer in developed countries, but this disease remains the leading cause of cancer deaths among women in sub-Saharan Africa. We sought to understand factors associated with limited uptake of screening services in our cervical cancer-screening program in Western Kenya. Participants and Methods Using items from a previously validated cancer awareness questionnaire repurposed for use in cervical cancer and culturally adapted for use in Kenya, we interviewed 2,505 women aged 18-55 years receiving care in gynecology clinics or seeking other services in 4 health facilities in Western Kenya between April 2014 and September 2014. We used logistic regression modeling to assess factors associated with uptake (or non-uptake), associated odds ratios (ORs) and the 95% confidence intervals (95% CI). Results Only two hundred and seventy-three women out of 2505 (11%) accepted VIA cervical cancer screening. Knowledge of just how women are screened for cervical cancer was significantly associated with reduced uptake of cervical cancer screening (OR: 0.53; CI 0.380.73) as was fear that screening would reveal a cancer (OR 0.70; CI 0.63-0.77), and reliance on prayer with the onset of illness (OR 0.43; CI 0.26-0.71). Participants who thought that one should get cervical cancer screening even if there were no symptoms were more than twice as likely to accept cervical cancer screening (OR 2.21; 95% CI 1.24-3.93). Older patients, patients living with HIV and women who do not know if bleeding immediately after sex might be a sign of cervical cancer were also more likely to accept screening (OR 1.03, CI 1.02-1.04; OR 1.78, CI 1.01-3.14; OR 2.39, CI 1.31-4.39, respectively). Conclusions In our population, a high percent of women knew that it is appropriate for all women to get cervical cancer screening, but only a small proportion of women actually got screening. There may be an opportunity to design educational materials for this population that will not only encourage participation in cervical cancer screening but also remediate misconceptions. The discussion illustrates how our findings could be used in such an effort.	[Orang'o, Elkanah Omenge; Wachira, Juddy; Asirwa, Fredrick Chite; Busakhala, Naftali; Naanyu, Violet; Kisuya, Job; Otieno, Grieven; Keter, Alfred; Mwangi, Ann; Inui, Thomas] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya; [Orang'o, Elkanah Omenge] Moi Univ, Coll Hlth Sci, Sch Med, Dept Reprod Hlth, Eldoret, Kenya; [Busakhala, Naftali] Moi Univ, Coll Hlth Sci, Sch Med, Dept Pharmacol Oncol, Eldoret, Kenya; [Naanyu, Violet; Mwangi, Ann] Moi Univ, Coll Hlth Sci, Sch Med, Dept Behav Sci, Eldoret, Kenya; [Asirwa, Fredrick Chite; Inui, Thomas] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46204 USA; [Asirwa, Fredrick Chite; Inui, Thomas] Regenstrief Inst Inc, Indianapolis, IN USA	Moi University; Moi University; Moi University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Orang'o, EO (corresponding author), Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya.; Orang'o, EO (corresponding author), Moi Univ, Coll Hlth Sci, Sch Med, Dept Reprod Hlth, Eldoret, Kenya.	bworango@mu.ac.ke	Naanyu, Violet/AAL-6106-2020; Asirwa, Fredrick Chite/AAS-3461-2021; Naanyu, Violet/GNM-8783-2022	Naanyu, Violet/0000-0003-0182-1719; Naanyu, Violet/0000-0003-0182-1719; Orango, Elkanah Omenge/0000-0003-1551-244X; Otieno, Grieven/0000-0002-3053-1369; Kisuya, Job/0000-0003-4988-7266	Walther Cancer Foundation, Inc. [IU 0110.01]	Walther Cancer Foundation, Inc.	This study was supported by a grant (IU 0110.01) from the Walther Cancer Foundation, Inc. (http://www.walther.org/) to Indiana University. Their respective universities supported all authors in the Walther Cancer research team, and no individuals employed or contracted by the Walther Cancer Foundation played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, OBSTET GYNECOL, V127, pe1, DOI [10.1097/AOG.0000000000001263, DOI 10.1097/AOG.0000000000001263]; Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Brewster WR, 2005, JAMA-J AM MED ASSOC, V294, P2182, DOI 10.1001/jama.294.17.2182; Cox DS, 2010, HEALTH PSYCHOL, V29, P29, DOI 10.1037/a0016942; De Vuyst H, 2005, INT J GYNECOL OBSTET, V89, P120, DOI 10.1016/j.ijgo.2005.01.035; Delmas MC, 2000, AIDS, V14, P1775, DOI 10.1097/00002030-200008180-00013; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Gaffikin L, 2003, LANCET, V361, P814, DOI 10.1016/S0140-6736(03)12707-9; Gorin SNS, 2011, ADV THER, V28, P615, DOI 10.1007/s12325-011-0045-x; Huh WK, 2009, OBSTET GYNECOL, V114, P139, DOI 10.1097/AOG.0b013e3181ab6878; Jia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067005; Katharine W, 1997, SOC SCI MED, V45, P283; Kavanagh AM, 1997, BRIT MED J, V314, P1388; Leung SSK, 2010, INT J WOMENS HEALTH, V2, P221; Mabeya H, 2012, J LOW GENIT TRACT DI, V16, P92, DOI 10.1097/LGT.0b013e3182320f0c; Mangoma J F, 2006, Afr J Reprod Health, V10, P91; Moreira Edson Duarte Jr, 2006, J Pediatr Adolesc Gynecol, V19, P81, DOI 10.1016/j.jpag.2006.01.003; Mutyaba T, 2007, INFLUENCES UPTAKE RE; Mwanahamuntu MH, 2009, AIDS, V23, pN1, DOI 10.1097/QAD.0b013e3283236e11; Rositch AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040766; Sanghvi H, 2008, REPROD HEALTH MATTER, V16, P67, DOI 10.1016/S0968-8080(08)32401-X; Sankaranarayanan R, 2007, BRIT J CANCER, V96, P738, DOI 10.1038/sj.bjc.6603633; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Urasa M, 2011, AFR HEALTH SCI, V11, P48; Vetter KM, 2007, J WOMENS HEALTH, V16, P1258, DOI 10.1089/jwh.2007.0493; WHO, 2008, EP FACT SHEET HIV AI; Wong LP, 2011, INT J BEHAV MED, V18, P105, DOI 10.1007/s12529-010-9104-y; World Health Organization, 2009, HPV VACC POS PAP; World Health Organization, 2004, GLOB BURD DIS REP KE	30	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157217	10.1371/journal.pone.0157217	http://dx.doi.org/10.1371/journal.pone.0157217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310005	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800044
J	Choko, AT; Taegtmeyer, M; MacPherson, P; Cocker, D; Khundi, M; Thindwa, D; Sambakunsi, RS; Kumwenda, MK; Chiumya, K; Malema, O; Makombe, SD; Webb, EL; Corbett, EL				Choko, Augustine T.; Taegtmeyer, Miriam; MacPherson, Peter; Cocker, Derek; Khundi, McEwen; Thindwa, Deus; Sambakunsi, Rodrick S.; Kumwenda, Moses K.; Chiumya, Kondwani; Malema, Owen; Makombe, Simon D.; Webb, Emily L.; Corbett, Elizabeth L.			Initial Accuracy of HIV Rapid Test Kits Stored in Suboptimal Conditions and Validity of Delayed Reading of Oral Fluid Tests	PLOS ONE			English	Article							ALGORITHM; HIV-1/2; ASSAYS	Objectives To evaluate the effect of storing commonly used rapid diagnostic tests above manufacturer-recommended temperature (at 37 degrees C), and the accuracy of delayed reading of oral fluid kits with relevance to HIV self-testing programmes. Design A quality assurance study of OraQuick (OraSure), Determine HIV 1/2 (TM) (Alere) and UniGold (TM) (Recombigen (R)). Methods Consecutive adults (>= 18y) attending Ndirande Health Centre in urban Blantyre, Malawi in January to April 2012 underwent HIV testing with two of each of the three rapid diagnostic test kits stored for 28 days at either 18 degrees C (optimally-stored) or at 37 degrees C (pre-incubated). Used OraQuick test kits were stored in a laboratory for delayed day 1 and subsequent monthly re-reading was undertaken for one year. Results Of 378 individuals who underwent parallel testing, 5 (1.3%) were dropped from the final analysis due to discordant or missing reference standard results (optimally-stored Determine and Uni-Gold). Compared to the diagnostic reference standard, OraQuick had a sensitivity of 97.2% (95% CI: 93.6-99.6). There were 7 false negative results among all test kits stored at 37 degrees C and three false negatives among optimally stored kits. Excellent agreement between pre-incubated tests and optimally-stored tests with Kappa values of 1.00 for Determine and Uni-Gold; and 0.97 (95% CI: 0.95; 1.00) for OraQuick were observed. There was high visual stability on re-reading of OraQuick, with only 1/375 pre-incubated and 1/371 optimally-stored OraQuick kits changing from the initial result over 12 months. Conclusion Erroneous results observed during HIV testing in low income settings are likely to be due to factors other than suboptimal storage conditions. Re-reading returned OraQuick kits may offer a convenient and accurate quality assurance approach, including in HIV self-testing programmes.	[Choko, Augustine T.; Khundi, McEwen; Thindwa, Deus; Sambakunsi, Rodrick S.; Kumwenda, Moses K.; Chiumya, Kondwani; Corbett, Elizabeth L.] Malawi Liverpool Wellcome Trust, TB & HIV Theme, Blantyre, Malawi; [Taegtmeyer, Miriam; Cocker, Derek] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Malema, Owen] Minist Hlth, Blantyre Dist Hlth Off, Blantyre, Malawi; [Makombe, Simon D.] Minist Hlth, Dept HIV, Lilongwe, Malawi; [Webb, Emily L.; Corbett, Elizabeth L.] London Sch Hyg & Trop Med, London WC1, England; [Corbett, Elizabeth L.] Coll Med, Blantyre, Malawi; [MacPherson, Peter] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [MacPherson, Peter] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Res, Liverpool L3 5QA, Merseyside, England	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; University of Malawi; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool	Choko, AT (corresponding author), Malawi Liverpool Wellcome Trust, TB & HIV Theme, Blantyre, Malawi.	augutc@gmail.com	MacPherson, Peter/AHD-2477-2022	MacPherson, Peter/0000-0002-0329-9613; Kumwenda, Moses Kelly/0000-0003-3091-7330; cocker, derek/0000-0002-6670-2713; Khundi, McEwen/0000-0003-2718-7576; Corbett, Elizabeth/0000-0002-3552-3181; Choko, Augustine/0000-0001-6095-9430; Thindwa, Deus/0000-0003-4845-7862; Taegtmeyer, Miriam/0000-0002-5377-2536	Wellcome Trust, UK [WT091769]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Wellcome Trust, UK(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Wellcome Trust, UK (grant number WT091769; URL: http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choko AT, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001873; Crucitti T, 2011, CLIN VACCINE IMMUNOL, V18, P1480, DOI 10.1128/CVI.05069-11; Jaspard M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101148; Johnson C, 2015, ANNEX 14 A REPORT ON; Kshatriya R, 2008, J CLIN MICROBIOL, V46, P3482, DOI 10.1128/JCM.00665-08; Learmonth KM, 2008, J CLIN MICROBIOL, V46, P1692, DOI 10.1128/JCM.01761-07; Mao A, 2010, JAIDS-J ACQ IMM DEF, V55, P641, DOI 10.1097/QAI.0b013e3181f5b291; Pascoe SJS, 2009, AIDS PATIENT CARE ST, V23, P571, DOI 10.1089/apc.2008.0225; Pavie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011581; Shanks L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0769-3; Shanks L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059906; Staveteig S, 2013, DHS COMPARATIVE REPO, V30; Strategic Evaluation ADCS, 2010, ANALYSIS OF POCT VCT; Wesolowski LG, 2006, AIDS, V20, P1661, DOI 10.1097/01.aids.0000238413.13442.ed; World Health Organization, 2014, MARCH 2014 SUPPLEMEN; World Health Organization, 2015, CONSOLIDATED GUIDELI	16	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158107	10.1371/journal.pone.0158107	http://dx.doi.org/10.1371/journal.pone.0158107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336161	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000378389200112
J	Andradi-Brown, DA; Gress, E; Wright, G; Exton, DA; Rogers, AD				Andradi-Brown, Dominic A.; Gress, Erika; Wright, Georgina; Exton, Dan A.; Rogers, Alex D.			Reef Fish Community Biomass and Trophic Structure Changes across Shallow to Upper-Mesophotic Reefs in the Mesoamerican Barrier Reef, Caribbean	PLOS ONE			English	Article							CORAL ECOSYSTEMS; DEPTH GRADIENT; HABITAT USE; FORE-REEF; ABUNDANCE; ASSEMBLAGES; DIVERSITY; SEA; ARCHIPELAGO; SUBMARINE	Mesophotic coral ecosystems (MCEs; reefs 30-150m depth) are of increased research interest because of their potential role as depth refuges from many shallow reef threats. Yet few studies have identified patterns in fish species composition and trophic group structure between MCEs and their shallow counterparts. Here we explore reef fish species and biomass distributions across shallow to upper-MCE Caribbean reef gradients (5-40m) around Utila, Honduras, using a diver-operated stereo-video system. Broadly, we found reef fish species richness, abundance and biomass declining with depth. At the trophic group level we identified declines in herbivores (both total and relative community biomass) with depth, mostly driven by declines in parrotfish (Scaridae). Piscivores increased as a proportion of the community with increased depth while, in contrast to previous studies, we found no change in relative planktivorous reef fish biomass across the depth gradient. In addition, we also found evidence of ontogenetic migrations in the blue tang (Acanthurus coeruleus), striped parrotfish (Scarus iserti), blue chromis (Chromis cyanea), creole wrasse (Clepticus parrae), bluehead wrasse (Thalassoma bifasciatum) and yellowtail snapper (Ocyurus chrysurus), with a higher proportion of larger individuals at mesophotic and near-mesophotic depths than on shallow reefs. Our results highlight the importance of using biomass measures when considering fish community changes across depth gradients, with biomass generating different results to simple abundance counts.	[Andradi-Brown, Dominic A.; Rogers, Alex D.] Univ Oxford, Dept Zool, Tinbergen Bldg,South Parks Rd, Oxford OX1 3PS, England; [Andradi-Brown, Dominic A.; Gress, Erika; Wright, Georgina; Exton, Dan A.] Operat Wallacea, Wallace House, Spilsby PE23 4EX, Lincs, England	University of Oxford	Andradi-Brown, DA (corresponding author), Univ Oxford, Dept Zool, Tinbergen Bldg,South Parks Rd, Oxford OX1 3PS, England.; Andradi-Brown, DA (corresponding author), Operat Wallacea, Wallace House, Spilsby PE23 4EX, Lincs, England.	dominic.andradi-brown@zoo.ox.ac.uk	Exton, Dan/L-5695-2019	Exton, Dan/0000-0001-8885-5828; Gress, Erika/0000-0002-4662-4017	Fisheries Society of the British Isles PhD studentship; Operation Wallacea	Fisheries Society of the British Isles PhD studentship; Operation Wallacea	DAAB was funded by a Fisheries Society of the British Isles (www.fsbi.org.uk) PhD studentship. Operation Wallacea (www.opwall.com) provided fieldwork support for all authors. Operation Wallacea provided support in the form of salaries for authors DAAB, EG, GW and DAE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson MJ, 2008, PERMANOVA PRIMER GUI; Andradi-Brown D, 2016, MESOPHOTIC CORAL ECO, P67, DOI DOI 10.1007/S10530-011-0005-Z; [Anonymous], REEF FISH IDENTIFICA; [Anonymous], 2013, KERNSMOOTH FUNCTIONS; Aponte NE, 2001, DEEP-SEA RES PT I, V48, P2185, DOI 10.1016/S0967-0637(01)00011-5; Armstrong RA, 2012, ELSEV INSIGHT, P365, DOI 10.1016/B978-0-12-385140-6.00024-4; Bausell R.Barker., 2002, POWER ANAL EXPT RES; Bejarano I, 2014, CORAL REEFS, V33, P313, DOI 10.1007/s00338-014-1125-6; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bowman A.W., 2014, R PACKAGE SM NONPARA; Bridge T, 2012, CORAL REEFS, V31, P1057, DOI 10.1007/s00338-012-0916-x; Bridge TCL, 2013, NAT CLIM CHANGE, V3, P528, DOI 10.1038/nclimate1879; Brokovich E, 2007, ENVIRON BIOL FISH, V80, P1, DOI 10.1007/s10641-006-9160-y; Brokovich E, 2010, MAR ECOL PROG SER, V399, P69, DOI 10.3354/meps08354; Brokovich E, 2008, MAR ECOL PROG SER, V371, P253, DOI 10.3354/meps07591; Brolund TM, 2004, J MAR BIOL ASSOC UK, V84, P671, DOI 10.1017/S0025315404009737h; Dahlgren CP, 2000, ECOLOGY, V81, P2227; de la Moriniere EC, 2002, ESTUAR COAST SHELF S, V55, P309, DOI 10.1006/ecss.2001.0907; English S., 1997, SURVEY MANUAL TROPIC; Feitoza BM, 2005, B MAR SCI, V76, P725; Ferreira CEL, 2006, J FISH BIOL, V69, P1533, DOI 10.1111/j.1095-8649.2006.01220.x; Garcia-Sais JR, 2010, CORAL REEFS, V29, P277, DOI 10.1007/s00338-009-0582-9; GILMORE RG, 1992, B MAR SCI, V51, P83; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Grol MGG, 2014, MAR ECOL PROG SER, V502, P229, DOI 10.3354/meps10682; Harris PT, 2013, ICES J MAR SCI, V70, P284, DOI 10.1093/icesjms/fss165; Harvey E, 2004, MAR FRESHWATER RES, V55, P573, DOI 10.1071/MF03130; Harvey E, 2001, FISH B-NOAA, V99, P63; Holmes TH, 2013, LIMNOL OCEANOGR-METH, V11, P337, DOI 10.4319/lom.2013.11.337; ITZKOWITZ M, 1991, Northeast Gulf Science, V12, P25; JOHNSON WS, 1988, ENVIRON BIOL FISH, V23, P225, DOI 10.1007/BF00004913; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kulbicki Michel, 2015, P104; Langlois TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045973; Leichter JJ, 2008, MAR ECOL PROG SER, V356, P123, DOI 10.3354/meps07230; Lesser MP, 2011, BIOL INVASIONS, V13, P1855, DOI 10.1007/s10530-011-0005-z; Liddell WD, 2000, P 9 INT COR REEF S, V2, P1053; LUCKHURST BE, 1977, CAN J ZOOL, V55, P681, DOI 10.1139/z77-089; MACPHERSON E, 1991, MAR ECOL PROG SER, V71, P103, DOI 10.3354/meps071103; Menza C, 2008, REV BIOL TROP, V56, P11; Micheli F, 2014, BIOL CONSERV, V171, P186, DOI 10.1016/j.biocon.2013.12.029; MORRISON D, 1988, ECOLOGY, V69, P1367, DOI 10.2307/1941634; Nemeth M, 2009, CARIBB J SCI, V45, P247; Nugues MM, 2008, CORAL REEFS, V27, P389, DOI 10.1007/s00338-007-0346-3; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Papastamatiou YP, 2015, MAR ECOL PROG SER, V521, P155, DOI 10.3354/meps11110; PARKER R O JR, 1986, Northeast Gulf Science, V8, P31; Pereira GH, 2011, BRAZ J OCEANOGR, V59, P201, DOI 10.1590/S1679-87592011000300001; Pinheiro HT, 2016, CORAL REEFS, V35, P139, DOI 10.1007/s00338-015-1381-0; Puglise KA, 2009, MES COR EC RES STRAT, P24; R Core Team, 2021, R LANGUAGE ENV STAT; Rosa MR, 2016, CORAL REEFS, V35, P113, DOI 10.1007/s00338-015-1368-x; Rotjan RD, 2006, J EXP MAR BIOL ECOL, V335, P292, DOI 10.1016/j.jembe.2006.03.015; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Shedrawi G, 2014, CORAL REEFS, V33, P579, DOI 10.1007/s00338-014-1160-3; STRASBURG D6, 1968, J CONSEIL, V31, P410; THRESHER RE, 1986, B MAR SCI, V38, P253; VANSTEVENINCK EDD, 1986, MAR ECOL PROG SER, V34, P87; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Weaver DC, 2001, BSR20010008 USGS US, P92; WERNER EE, 1983, ECOLOGY, V64, P1525, DOI 10.2307/1937507; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508	63	45	45	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0156641	10.1371/journal.pone.0156641	http://dx.doi.org/10.1371/journal.pone.0156641			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332811	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212800012
J	Patel, SH; Morreale, SJ; Saba, VS; Panagopoulou, A; Margaritoulis, D; Spotila, JR				Patel, Samir H.; Morreale, Stephen J.; Saba, Vincent S.; Panagopoulou, Aliki; Margaritoulis, Dimitris; Spotila, James R.			Climate Impacts on Sea Turtle Breeding Phenology in Greece and Associated Foraging Habitats in the Wider Mediterranean Region	PLOS ONE			English	Article							CARETTA-CARETTA; LOGGERHEAD TURTLES; LEATHERBACK TURTLES; POPULATION-DYNAMICS; POSIDONIA-OCEANICA; SURFACE TEMPERATURE; REPRODUCTIVE OUTPUT; SATELLITE TRACKING; SAND TEMPERATURE; LAGANAS BAY	Sea turtles are vulnerable to climate change impacts in both their terrestrial (nesting beach) and oceanic habitats. From 1982 to 2012, air and sea surface temperatures at major high use foraging and nesting regions (n = 5) of loggerhead turtles (Caretta caretta) nesting in Greece have steadily increased. Here, we update the established relationships between sea surface temperature and nesting data from Zakynthos (latitude: 37.7 degrees N), a major nesting beach, while also expanding these analyses to include precipitation and air temperature and additional nesting data from two other key beaches in Greece: Kyparissia Bay (latitude: 37.3 degrees N) and Rethymno, Crete (latitude: 35.4 degrees N). We confirmed that nesting phenology at Zakynthos has continued to be impacted by breeding season temperature; however, temperature has no consistent relationship with nest numbers, which are declining on Zakynthos and Crete but increasing at Kyparissia. Then using statistically downscaled outputs of 14 climate models assessed by the Intergovernmental Panel on Climate Change (IPCC), we projected future shifts in nesting for these populations. Based on the climate models, we projected that temperature at the key foraging and breeding sites (Adriatic Sea, Aegean Sea, Crete, Gulf of Gabes and Zakynthos/Kyparissia Bay; overall latitudinal range:33.0 degrees-45.8 degrees N) for loggerhead turtles nesting in Greece will rise by 3-5 degrees C by 2100. Our calculations indicate that the projected rise in air and ocean temperature at Zakynthos could cause the nesting season in this major rookery to shift to an earlier date by as much as 50-74 days by 2100. Although an earlier onset of the nesting season may provide minor relief for nest success as temperatures rise, the overall climatic changes to the various important habitats will most likely have an overall negative impact on this population.	[Patel, Samir H.; Panagopoulou, Aliki; Spotila, James R.] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA; [Morreale, Stephen J.] Cornell Univ, Dept Nat Resources, Ithaca, NY 14850 USA; [Saba, Vincent S.] NOAA NMFS NEFSC, Geophys Fluid Dynam Lab, Princeton Univ Forrestal Campus, Princeton, NJ USA; [Panagopoulou, Aliki; Margaritoulis, Dimitris] ARCHELON, Sea Turtle Protect Soc Greece, Athens 10432, Greece	Drexel University; Cornell University; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University	Patel, SH (corresponding author), Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA.	shp42@drexel.edu	Saba, Vincent/A-3799-2010	Saba, Vincent/0000-0002-2974-4826; Patel, Samir/0000-0003-0846-1795; Patel, Samir/0000-0002-2177-5038	Betz Chair of Environmental Science at Drexel University; Leatherback Trust, Monterrey Bay, CA	Betz Chair of Environmental Science at Drexel University; Leatherback Trust, Monterrey Bay, CA	This project was funded by The Betz Chair of Environmental Science at Drexel University and by The Leatherback Trust, Monterrey Bay, CA. The funders contributed in an advisory role, but were not directly part of collecting and analyzing data.	Ackerman Ralph A., 1997, P83; Backof TF, 2013, THESIS; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Borum J., 2004, EUR SEAGRASSES INTRO, V1; Broderick AC, 2001, P ROY SOC B-BIOL SCI, V268, P1481, DOI 10.1098/rspb.2001.1695; Cardona L, 2014, MAR ECOL PROG SER, V497, P229, DOI 10.3354/meps10595; Casale P, 2005, HERPETOL J, V15, P145; Casale P., 2015, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2015-4.RLTS.T83644804A83646294.EN; Casale P., 2010, SEA TURTLES MEDITERR; Casale P, 2006, MAR ECOL PROG SER, V324, P281, DOI 10.3354/meps324281; Casale P, 2014, SCI MAR, V78, P303, DOI 10.3989/scimar.03988.30E; Casale P, 2008, MAR ECOL PROG SER, V372, P265, DOI 10.3354/meps07702; Chaloupka M, 2001, BIOL CONSERV, V101, P263, DOI 10.1016/S0006-3207(00)00199-3; Chaloupka M, 2008, J EXP MAR BIOL ECOL, V356, P136, DOI 10.1016/j.jembe.2007.12.009; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; El Lakhrach H, 2012, MEDITERR MAR SCI, V13, P12, DOI 10.12681/mms.19; Fossette S, 2012, FUNCT ECOL, V26, P324, DOI 10.1111/j.1365-2435.2011.01960.x; Fuller WJ, 2013, MAR ECOL PROG SER, V488, P267, DOI 10.3354/meps10419; Godley BJ, 2001, J EXP MAR BIOL ECOL, V263, P45, DOI 10.1016/S0022-0981(01)00269-6; Godley BJ, 2001, MAR ECOL PROG SER, V210, P195, DOI 10.3354/meps210195; Godley BJ, 1997, J MOLLUS STUD, V63, P474, DOI 10.1093/mollus/63.3.474; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Hays GC, 2000, J THEOR BIOL, V206, P221, DOI 10.1006/jtbi.2000.2116; Hays GC, 2003, GLOBAL CHANGE BIOL, V9, P642, DOI 10.1046/j.1365-2486.2003.00606.x; Hays GC, 2002, J THERM BIOL, V27, P429, DOI 10.1016/S0306-4565(02)00012-8; Hays GC, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00043; Honarvar S, 2011, J EXP MAR BIOL ECOL, V409, P339, DOI 10.1016/j.jembe.2011.09.015; Houghton JDR, 2000, J MAR BIOL ASSOC UK, V80, P761, DOI 10.1017/S002531540000271X; Houghton JDR, 2001, NATURWISSENSCHAFTEN, V88, P133, DOI 10.1007/s001140100212; Jorda G, 2012, NAT CLIM CHANGE, V2, P821, DOI [10.1038/NCLIMATE1533, 10.1038/nclimate1533]; Kaska Y, 2006, NATURWISSENSCHAFTEN, V93, P338, DOI 10.1007/s00114-006-0110-5; Katselidis KA, 2012, ANIM CONSERV, V15, P508, DOI 10.1111/j.1469-1795.2012.00543.x; Katselidis KA, 2014, J EXP MAR BIOL ECOL, V450, P47, DOI 10.1016/j.jembe.2013.10.017; Laloe JO, 2016, J EXP MAR BIOL ECOL, V474, P92, DOI 10.1016/j.jembe.2015.09.015; Lazar B, 2011, MAR ECOL-EVOL PERSP, V32, P65, DOI 10.1111/j.1439-0485.2010.00402.x; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Limpus C, 2000, ATMOS OCEAN SCI LIB, V21, P399; Lolavar A, 2015, ENDANGER SPECIES RES, V28, P235, DOI 10.3354/esr00684; Marba N, 2005, ESTUARIES, V28, P53, DOI 10.1007/BF02732753; Marba N, 1996, MAR ECOL PROG SER, V137, P203, DOI 10.3354/meps137203; Marba N, 2010, GLOBAL CHANGE BIOL, V16, P2366, DOI 10.1111/j.1365-2486.2009.02130.x; Margaritoulis D, 2005, CHELONIAN CONSERV BI, V4, P916; Margaritoulis D., 2011, Marine Turtle Newsletter, P2; Margaritoulis D., 2003, LOGGERHEAD SEA TURTL, P175; Margaritoulis D, 2009, P 2 MED C MAR TURTL, P116; Margaritoulis Dimitris, 2001, Zoology in the Middle East, V24, P75; Margaritoulis Dimitris, 2011, Marine Turtle Newsletter, P12; Matsuzawa Y, 2002, MAR BIOL, V140, P639, DOI 10.1007/s00227-001-0724-2; Mazaris AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2397; Mazaris AD, 2009, J EXP MAR BIOL ECOL, V379, P23, DOI 10.1016/j.jembe.2009.07.026; Mazaris AD, 2008, J EXP MAR BIOL ECOL, V367, P219, DOI 10.1016/j.jembe.2008.09.025; MILLER J.D., 2003, LOGGERHEAD SEA TURTL, P125, DOI DOI 10.1086/431100; Moran KL, 1999, MAR ECOL PROG SER, V189, P251, DOI 10.3354/meps189251; MORREALE SJ, 1982, SCIENCE, V216, P1245, DOI 10.1126/science.7079758; Mrosovsky N, 2002, CAN J ZOOL, V80, P2118, DOI 10.1139/Z02-204; Panagopoulou A, 2015, THESIS; Patel SH, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00358.1; Patel SH, 2015, MAR ECOL PROG SER, V535, P231, DOI 10.3354/meps11433; Pike DA, 2006, J HERPETOL, V40, P91, DOI 10.1670/100-05N.1; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Rees Alan F., 2004, Testudo, V6, P23; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Robinson NJ, 2014, ENDANGER SPECIES RES, V24, P197, DOI 10.3354/esr00604; Saba VS, 2008, DEEP-SEA RES PT I, V55, P646, DOI 10.1016/j.dsr.2008.02.006; Saba VS, 2007, J APPL ECOL, V44, P395, DOI 10.1111/j.1365-2664.2007.01276.x; Saba VS, 2012, NAT CLIM CHANGE, V2, P814, DOI 10.1038/NCLIMATE1582; Tomillo PS, 2015, GLOBAL CHANGE BIOL, V21, P2980, DOI 10.1111/gcb.12918; Tomillo PS, 2014, BIOL CONSERV, V176, P71, DOI 10.1016/j.biocon.2014.05.011; Schofield G, 2013, DIVERS DISTRIB, V19, P834, DOI 10.1111/ddi.12077; Schofield G, 2013, BIOL CONSERV, V161, P101, DOI 10.1016/j.biocon.2013.03.004; Schofield G, 2010, BIOL CONSERV, V143, P722, DOI 10.1016/j.biocon.2009.12.011; Schofield G, 2009, J ANIM ECOL, V78, P14, DOI 10.1111/j.1365-2656.2008.01454.x; Segura LN, 2010, HERPETOL CONSERV BIO, V5, P196; SPOTILA JR, 1985, COPEIA, P694, DOI 10.2307/1444763; STANDORA EA, 1985, COPEIA, P711, DOI 10.2307/1444765; Suss JS, 2013, THESIS; Tomillo PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037602; Wallace BP, 2004, PHYSIOL BIOCHEM ZOOL, V77, P423, DOI 10.1086/420951; Wallace BP, 2006, MAR ECOL PROG SER, V318, P263, DOI 10.3354/meps318263; Weishampel JF, 2004, GLOBAL CHANGE BIOL, V10, P1424, DOI 10.1111/j.1529-8817.2003.00817.x; Witt MJ, 2010, J EXP BIOL, V213, P901, DOI 10.1242/jeb.038133; Zbinden Judith A., 2007, Endangered Species Research, V3, P305, DOI 10.3354/esr00058; Zbinden JA, 2011, MAR ECOL PROG SER, V421, P291, DOI 10.3354/meps08871	84	28	28	4	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157170	10.1371/journal.pone.0157170	http://dx.doi.org/10.1371/journal.pone.0157170			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332550	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212800021
J	Grimshaw, CE; Jennings, A; Kamran, R; Ueno, H; Nishigaki, N; Kosaka, T; Tani, A; Sano, H; Kinugawa, Y; Koumura, E; Shi, LH; Takeuchi, K				Grimshaw, Charles E.; Jennings, Andy; Kamran, Ruhi; Ueno, Hikaru; Nishigaki, Nobuhiro; Kosaka, Takuo; Tani, Akiyoshi; Sano, Hiroki; Kinugawa, Yoshinobu; Koumura, Emiko; Shi, Lihong; Takeuchi, Koji			Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism	PLOS ONE			English	Article							DOUBLE-BLIND; IV; ALOGLIPTIN; COMPLEX; POTENT; DISCOVERY; PROFILES; RATS	Trelagliptin (SYR-472), a novel dipeptidyl peptidase-4 inhibitor, shows sustained efficacy by once-weekly dosing in type 2 diabetes patients. In this study, we characterized in vitro properties of trelagliptin, which exhibited approximately 4-and 12-fold more potent inhibition against human dipeptidyl peptidase-4 than alogliptin and sitagliptin, respectively, and >10,000-fold selectivity over related proteases including dipeptidyl peptidase-8 and dipeptidyl peptidase-9. Kinetic analysis revealed reversible, competitive and slow-binding inhibition of dipeptidyl peptidase-4 by trelagliptin (t(1/2) for dissociation approximate to 30 minutes). X-ray diffraction data indicated a non-covalent interaction between dipeptidyl peptidase and trelagliptin. Taken together, potent dipeptidyl peptidase inhibitionmay partially contribute to sustained efficacy of trelagliptin.	[Grimshaw, Charles E.; Kamran, Ruhi; Shi, Lihong] Takeda Calif Inc, Enzymol & Biophys Chem, San Diego, CA 92121 USA; [Jennings, Andy] Takeda Calif Inc, Computat Sci & Crystallog, San Diego, CA USA; [Ueno, Hikaru; Nishigaki, Nobuhiro; Takeuchi, Koji] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cardiovasc & Metab Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Kosaka, Takuo; Tani, Akiyoshi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Biomol Res Labs, Fujisawa, Kanagawa, Japan; [Sano, Hiroki; Kinugawa, Yoshinobu; Koumura, Emiko] Takeda Pharmaceut Co Ltd, Takeda Dev Ctr Japan, Osaka, Japan; [Shi, Lihong] Celgene Quanticel Res, San Diego, CA USA	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Grimshaw, CE (corresponding author), Takeda Calif Inc, Enzymol & Biophys Chem, San Diego, CA 92121 USA.	ched.grimshaw@takeda.com	Nishigaki, Nobuhiro/AAZ-3584-2021	Nishigaki, Nobuhiro/0000-0002-7524-1429; Ueno, Hikaru/0000-0002-5595-8342	global Takeda Pharmaceutical Company Limited; Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the U.S. Department of Energy at Lawrence Berkeley National Laboratory [DE-AC03-76SF00098]	global Takeda Pharmaceutical Company Limited; Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the U.S. Department of Energy at Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	During the time this work was conducted, each of the co-authors was an employee of the global Takeda Pharmaceutical Company Limited or one of its wholly owned affiliates, which provided support in the form of salaries for authors [CEG, AJ, RK, HU, NN, TK, AT, HS, YK, EK, LS, and KT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors wish to thank Dr. Yusuke Moritoh for preparing human, dog and rat plasma. We wish to thank Dr. Kathleen Aertgeerts and Dr. Jason Yano for their contributions to the DPP-4 crystal structures. The X-ray crystallography data reported here are based on research conducted at the Advanced Light Source (ALS). ALS is supported by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the U.S. Department of Energy under Contract No. DE-AC03-76SF00098 at the Lawrence Berkeley National Laboratory. We thank the staff at ALS for their excellent support in the use of the synchrotron beamlines.	Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; Brandt I, 2005, BIOCHEM PHARMACOL, V70, P134, DOI 10.1016/j.bcp.2005.04.009; Burkey BF, 2008, DIABETES OBES METAB, V10, P1057, DOI 10.1111/j.1463-1326.2008.00860.x; Ceriello A, 2014, EXPERT OPIN DRUG SAF, V13, pS57, DOI 10.1517/14740338.2014.944862; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Covington P, 2008, CLIN THER, V30, P499, DOI 10.1016/j.clinthera.2008.03.004; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Feng J, 2007, J MED CHEM, V50, P2297, DOI 10.1021/jm070104l; Hosfield D, 2003, J STRUCT BIOL, V142, P207, DOI 10.1016/S1047-8477(03)00051-0; Inagaki N, 2015, LANCET DIABETES ENDO, V3, P191, DOI 10.1016/S2213-8587(14)70251-7; Inagaki N, 2014, LANCET DIABETES ENDO, V2, P125, DOI 10.1016/S2213-8587(13)70149-9; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; Kim YB, 2006, ARCH BIOCHEM BIOPHYS, V445, P9, DOI 10.1016/j.abb.2005.11.010; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Lee B, 2008, EUR J PHARMACOL, V589, P306, DOI 10.1016/j.ejphar.2008.04.047; MANTLE D, 1991, CLIN CHIM ACTA, V196, P135, DOI 10.1016/0009-8981(91)90066-L; Matsuno K, 2012, J JAPAN DIABETES SOC, pS; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Metzler WJ, 2008, PROTEIN SCI, V17, P240, DOI 10.1110/ps.073253208; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Nonaka N, 1997, J ANTIBIOT, V50, P646, DOI 10.7164/antibiotics.50.646; Oefner C, 2003, ACTA CRYSTALLOGR D, V59, P1206, DOI 10.1107/S0907444903010059; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schnapp G, 2014, DIABETES, V63, pA271; TOIDE K, 1995, J NEUROCHEM, V65, P234; Wu JJ, 2009, BIOCHEM PHARMACOL, V78, P203, DOI 10.1016/j.bcp.2009.03.032; Zhang ZY, 2011, J MED CHEM, V54, P510, DOI 10.1021/jm101016w	28	33	33	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157509	10.1371/journal.pone.0157509	http://dx.doi.org/10.1371/journal.pone.0157509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27328054	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212400023
J	Lee, YY; Yang, CK; Weng, YM; Chuang, CH; Yu, W; Chen, JC; Li, WC				Lee, Yi-Yen; Yang, Chih-Kai; Weng, Yi-Ming; Chuang, Chung-Hsun; Yu, Wei; Chen, Jih-Chang; Li, Wen-Cheng			All Components of Metabolic Syndrome Are Associated with Microalbuminuria in a Chinese Population	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; URINARY ALBUMIN EXCRETION; 3RD NATIONAL-HEALTH; GENERAL-POPULATION; COLLABORATIVE METAANALYSIS; CARDIOVASCULAR-DISEASE; NONDIABETIC SUBJECTS; US POPULATION; RISK-FACTORS	Background and Aim Albuminuria is a well-known predictor of poor renal and cardiovascular outcomes and associated with increased risk of all-cause mortality. The study aimed to evaluate the associations between metabolic characteristics and the presence of albuminuria. Methods This cross-sectional study included 18,384 adult Chinese who participated in health examinations during 2013-2014. Differences in clinical characteristics were compared for micro-albuminuria (MAU) and albuminuria, and between genders. Potential risk factors associated with the risk of developing MAU and albuminuria were analyzed using univariate logistic regression. Multiple logistic regression was applied to further identify the independent associations between different levels of risk factors and the presence of MAU and albuminuria. The area under the ROC curve (AUC) was used to determine the discriminatory ability of metabolic risk factors in detecting albuminuria. Results There were significant gender differences in clinical characteristics according to albuminuria status. Risk for the presence of albuminuria was significantly associated with age, male gender, waist circumference (WC), waist-to-height ratio (WHtR), hypertension, fasting plasma glucose (FPG), and triglycerides to high-density lipoprotein cholesterol ratio (TG/HDL-C) in univariate logistic regression. Multiple logistic regression analysis indicated that the factors significantly associated with the presence of MAU were WC > 90cm, WHtR at 0.6-0.7, hypertension, FPG > 6.1 mmole/L, and TG/HDL-C ratio > 1.6. The optimal cutoffs for risk factors of metabolic syndrome (MetS) to predict albuminuria in males and females were: WC, 90.8 vs. 80.0 cm; WHtR, 0.53 vs. 0.52; MAP, 97.9 vs. 91.9 mmHg; FPG, 5.40 vs. 5.28 mmole/L; and TG/HDL-C, 1.13 vs. 1.08. Conclusion MetS and all its components were associated with the presence of MAU in a health checkup population in China. Gender specific and optimal cutoffs for MetS components associated with the presence of MAU were determined.	[Lee, Yi-Yen] Taipei Vet Gen Hosp, Neurol Inst, Div Pediat Neurosurg, Taipei, Taiwan; [Lee, Yi-Yen] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Yang, Chih-Kai; Weng, Yi-Ming; Chuang, Chung-Hsun; Li, Wen-Cheng] Xiamen Chang Gung Hosp, Dept Emergency Med, Xiamen, Peoples R China; [Weng, Yi-Ming; Chuang, Chung-Hsun; Chen, Jih-Chang; Li, Wen-Cheng] Chang Gung Mem Hosp Linkou, Dept Emergency Med, Taoyuan, Taiwan; [Yu, Wei] Xiamen Chang Gung Hosp, Dept Hlth Management, Xiamen, Peoples R China; [Weng, Yi-Ming; Chen, Jih-Chang] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University	Li, WC (corresponding author), Xiamen Chang Gung Hosp, Dept Emergency Med, Xiamen, Peoples R China.; Li, WC (corresponding author), Chang Gung Mem Hosp Linkou, Dept Emergency Med, Taoyuan, Taiwan.	620313@adm.cgmh.org.tw	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454				Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Atkins RC, 2004, KIDNEY INT, V66, pS22, DOI 10.1111/j.1523-1755.2004.09206.x; Batlle D, 2012, KIDNEY INT, V81, P520, DOI 10.1038/ki.2011.381; Bonnet F, 2006, J HYPERTENS, V24, P1157, DOI 10.1097/01.hjh.0000226206.03560.ac; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chen BD, 2010, CLIN CHIM ACTA, V411, P705, DOI 10.1016/j.cca.2010.01.038; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Choi HS, 2006, NEPHRON CLIN PRACT, V104, pC85, DOI 10.1159/000093995; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Costacou T, 2007, AM J KIDNEY DIS, V50, P721, DOI 10.1053/j.ajkd.2007.08.005; de Jong PE, 2003, NEPHROL DIAL TRANSPL, V18, P10, DOI 10.1093/ndt/18.1.10; de Zeeuw D, 2006, J AM SOC NEPHROL, V17, P2100, DOI 10.1681/ASN.2006050517; Esteghamati A, 2010, ACTA DIABETOL, V47, P125, DOI 10.1007/s00592-009-0131-6; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Gobal F, 2011, J AM COLL CARDIOL, V57, P2303, DOI 10.1016/j.jacc.2011.02.027; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Hao Z, 2007, INTERNAL MED, V46, P341, DOI 10.2169/internalmedicine.46.6056; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Imai Enyu, 2007, Clin Exp Nephrol, V11, P156, DOI 10.1007/s10157-007-0463-x; Jensen JS, 1995, CLIN CHIM ACTA, V243, P95, DOI 10.1016/0009-8981(95)06155-X; Jiang LP, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-118; Jones CA, 2002, AM J KIDNEY DIS, V39, P445, DOI 10.1053/ajkd.2002.31388; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Klausen KP, 2007, J INTERN MED, V262, P470, DOI 10.1111/j.1365-2796.2007.01839.x; Lee Hyun-Ok, 2015, Korean J Fam Med, V36, P60, DOI 10.4082/kjfm.2015.36.2.60; Lee JE, 2007, NEPHRON CLIN PRACT, V106, P98, DOI 10.1159/000102996; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Lin CC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/841497; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Marin R, 2006, J AM SOC NEPHROL, V17, pS178, DOI 10.1681/ASN.2006080912; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Meigs JB, 2002, DIABETES CARE, V25, P977, DOI 10.2337/diacare.25.6.977; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Nazim J, 2014, ENDOKRYNOL POL, V65, P83, DOI 10.5603/EP.2014.0012; Ochodnicky P, 2006, J CARDIOVASC PHARM, V47, pS151, DOI 10.1097/00005344-200606001-00009; Palaniappan L, 2003, AM J HYPERTENS, V16, P952, DOI 10.1016/S0895-7061(03)01009-4; Ritz E, 2010, DIABETOLOGIA, V53, P49, DOI 10.1007/s00125-009-1577-3; Tanaka Satoru, 2013, BMC Res Notes, V6, P256, DOI 10.1186/1756-0500-6-256; Valmadrid CT, 2000, ARCH INTERN MED, V160, P1093, DOI 10.1001/archinte.160.8.1093; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Vyssoulis G, 2010, J CLIN HYPERTENS, V12, P597, DOI 10.1111/j.1751-7176.2010.00306.x; Wang JJ, 2005, DIABETES CARE, V28, P448, DOI 10.2337/diacare.28.2.448; Wang TZ, 2013, J INTEGR MED-JIM, V11, P175, DOI 10.3736/jintegrmed2013032; Won JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083273; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; YUDKIN JS, 1988, LANCET, V2, P530; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065597	47	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157303	10.1371/journal.pone.0157303	http://dx.doi.org/10.1371/journal.pone.0157303			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327443	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212400018
J	Manzano, S; Armengol, M; Price, AJ; Hulley, PA; Gill, HS; Doblare, M; Doweidar, MH				Manzano, Sara; Armengol, Monica; Price, Andrew J.; Hulley, Philippa A.; Gill, Harinderjit S.; Doblare, Manuel; Doweidar, Mohamed H.			Inhomogeneous Response of Articular Cartilage: A Three-Dimensional Multiphasic Heterogeneous Study	PLOS ONE			English	Article							MODEL; COMPRESSION; BEHAVIOR; COLLAGEN; MODULUS; BONE	Articular cartilage exhibits complex mechano-electrochemical behaviour due to its anisotropy, inhomogeneity and material non-linearity. In this work, the thickness and radial dependence of cartilage properties are incorporated into a 3D mechano-electrochemical model to explore the relevance of heterogeneity in the behaviour of the tissue. The model considers four essential phenomena: (i) osmotic pressure, (ii) convective and diffusive processes, (iii) chemical expansion and (iv) three-dimensional through-the-thickness heterogeneity of the tissue. The need to consider heterogeneity in computational simulations of cartilage behaviour and in manufacturing biomaterials mimicking this tissue is discussed. To this end, healthy tibial plateaus from pigs were mechanically and biochemically tested in-vitro. Heterogeneous properties were included in the mechano-electrochemical computational model to simulate tissue swelling. The simulation results demonstrated that swelling of the heterogeneous samples was significantly lower than swelling under homogeneous and isotropic conditions. Furthermore, there was a significant reduction in the flux of water and ions in the former samples. In conclusion, the computational model presented here can be considered as a valuable tool for predicting how the variation of cartilage properties affects its behaviour, opening up possibilities for exploring the requirements of cartilage-mimicking biomaterials for tissue engineering. Besides, the model also allows the establishment of behavioural patterns of swelling and of water and ion fluxes in articular cartilage.	[Manzano, Sara; Doblare, Manuel; Doweidar, Mohamed H.] Univ Zaragoza, Sch Engn & Architecture EINA, Dept Mech Engn, E-50009 Zaragoza, Spain; [Manzano, Sara; Doblare, Manuel; Doweidar, Mohamed H.] Univ Zaragoza, Aragon Inst Engn Res I3A, E-50009 Zaragoza, Spain; [Manzano, Sara; Doblare, Manuel; Doweidar, Mohamed H.] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona, Spain; [Armengol, Monica] Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England; [Armengol, Monica; Price, Andrew J.; Hulley, Philippa A.; Gill, Harinderjit S.] Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Gill, Harinderjit S.] Univ Bath, Dept Mech Engn, Bath BA2 7AY, Avon, England	University of Zaragoza; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Oxford; Nuffield Orthopaedic Centre; University of Oxford; University of Bath	Doweidar, MH (corresponding author), Univ Zaragoza, Sch Engn & Architecture EINA, Dept Mech Engn, E-50009 Zaragoza, Spain.; Doweidar, MH (corresponding author), Univ Zaragoza, Aragon Inst Engn Res I3A, E-50009 Zaragoza, Spain.; Doweidar, MH (corresponding author), Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona, Spain.	mohamed@unizar.es	Gill, Richie H. S./A-9808-2011; Hulley, Philippa A/A-8538-2011; Doweidar, Mohamed H./F-2140-2016; Doweidar, Mohamed H./HGF-0661-2022	Gill, Richie H. S./0000-0002-7740-2062; Hulley, Philippa A/0000-0002-4994-2264; Doweidar, Mohamed H./0000-0003-0088-7222; 	Spanish Ministry of Economy and Competitiveness (MINECO) [MAT2013-46467-C4-3-R]; Spanish Ministry of Economy and Competitiveness (MINECO), FPU graduate research program [AP2010/2557]; Government of Aragon (DGA); Centro de Investigacion Biomedica en Red en Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN); Nuffield Orthopaedic Centre NIHR Biomedical Research Unit funding; Orthopaedic Research of UK (ORUK); Spanish Ministry of Economy and Competitiveness [MINECO MAT2013-46467-C4-3-R]; Spanish Ministry of Economy and Competitiveness (FPU graduate research program) [AP2010/2557]; Instituto de Salud Carlos III; European Regional Development Fund	Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Spanish Ministry of Economy and Competitiveness (MINECO), FPU graduate research program; Government of Aragon (DGA)(Gobierno de Aragon); Centro de Investigacion Biomedica en Red en Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN); Nuffield Orthopaedic Centre NIHR Biomedical Research Unit funding; Orthopaedic Research of UK (ORUK); Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Economy and Competitiveness (FPU graduate research program); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund(European Commission)	This work was supported by The Spanish Ministry of Economy and Competitiveness (MINECO), https://sede.micinn.gob.es/, MAT2013-46467-C4-3-R, to MHD; The Spanish Ministry of Economy and Competitiveness (MINECO), https://sede.micinn.gob.es/, FPU graduate research program AP2010/2557, to SM; The Government of Aragon (DGA), to MHD; Centro de Investigacion Biomedica en Red en Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN), http://www.ciber-bbn.es/es/quienes-somos, to MHD; and the Nuffield Orthopaedic Centre NIHR Biomedical Research Unit funding and Orthopaedic Research of UK (ORUK), http://www.ndorms.ox.ac.uk/about/contact-us, to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors gratefully acknowledge the financial support from the Spanish Ministry of Economy and Competitiveness (MINECO MAT2013-46467-C4-3-R and FPU graduate research program AP2010/2557), the Government of Aragon (DGA) and the Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN). CIBER-BBN is financed by the Instituto de Salud Carlos III with the assistance from the European Regional Development Fund. The authors also acknowledge Nuffield Orthopaedic Centre NIHR Biomedical Research Unit funding and Orthopaedic Research of UK (ORUK).	Albro MB, 2016, BIOMATERIALS, V77, P173, DOI 10.1016/j.biomaterials.2015.10.018; ARMSTRONG CG, 1984, J BIOMECH ENG-T ASME, V106, P165, DOI 10.1115/1.3138475; Babalola OM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128672; Broom ND, 1998, BIOMATERIALS, V19, P1179, DOI 10.1016/S0142-9612(98)00017-9; Calvo E, 2004, OSTEOARTHR CARTILAGE, V12, P878, DOI 10.1016/j.joca.2004.07.007; Campos DFD, 2012, CARTILAGE, V3, P205, DOI 10.1177/1947603512444722; Federico S, 2005, J BIOMECH, V38, P2008, DOI 10.1016/j.jbiomech.2004.09.020; FIELD JS, 1993, J MATER RES, V8, P297, DOI 10.1557/JMR.1993.0297; Guo H, 2014, J BIOMECH; Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454; Garcia JJ, 2006, J BIOMECH, V39, P2991, DOI 10.1016/j.jbiomech.2005.10.017; Jurvelin J S, 2003, Proc Inst Mech Eng H, V217, P215, DOI 10.1243/095441103765212712; Korhonen RK, 2002, MED ENG PHYS, V24, P99, DOI 10.1016/S1350-4533(01)00123-0; LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880; Li LP, 2000, J BIOMECH, V33, P1533, DOI 10.1016/S0021-9290(00)00153-6; Manzano S, 2015, COMPUT METH PROG BIO, V122, P491, DOI 10.1016/j.cmpb.2015.09.018; Manzano S, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1090; Manzano S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/179070; MAROUDAS A, 1977, ANN RHEUM DIS, V36, P399, DOI 10.1136/ard.36.5.399; Martin JA, 2002, BIOGERONTOLOGY, V3, P257, DOI 10.1023/A:1020185404126; Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309; PHARR GM, 1992, J MATER RES, V7, P613, DOI 10.1557/JMR.1992.0613; Rasanen LP, 2013, J ORTHOP RES, V31, P10, DOI 10.1002/jor.22175; Richard F, 2013, J MECH BEHAV BIOMED, V24, P41, DOI 10.1016/j.jmbbm.2013.04.012; Schinagl RM, 1997, J ORTHOPAED RES, V15, P499, DOI 10.1002/jor.1100150404; Summers GC, 2008, BIORHEOLOGY, V45, P365, DOI 10.3233/BIR-2008-0495; Sun DN, 1999, INT J NUMER METH ENG, V45, P1375, DOI 10.1002/(SICI)1097-0207(19990810)45:10<1375::AID-NME635>3.0.CO;2-7; Tomkoria S, 2004, MED ENG PHYS, V26, P815, DOI 10.1016/j.medengphy.2004.07.006; Wang CCB, 2001, J BIOMECH, V34, P75, DOI 10.1016/S0021-9290(00)00137-8; Wang Q., 2013, POWERTECH POWERTECH, P1; Wang T, 2013, OSTEOARTHR CARTILAGE, V21, P574, DOI 10.1016/j.joca.2013.01.002; Watson PJ, 1996, OSTEOARTHR CARTILAGE, V4, P197, DOI 10.1016/S1063-4584(96)80016-1; Wilson W, 2005, MED ENG PHYS, V27, P810, DOI 10.1016/j.medengphy.2005.03.004; Zadpoor AA, 2015, MAT SCI ENG C-MATER, V48, P150, DOI 10.1016/j.msec.2014.11.067; Zhang Jun, 2011, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V25, P687; Zheng SK, 2011, MAGN RESON MED, V65, P656, DOI 10.1002/mrm.22648	36	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157967	10.1371/journal.pone.0157967	http://dx.doi.org/10.1371/journal.pone.0157967			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327166	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400064
J	Ahmed, AA; Pedersen, C; Thordal-Christensen, H				Ahmed, Ali Abdurehim; Pedersen, Carsten; Thordal-Christensen, Hans			The Barley Powdery Mildew Effector Candidates CSEP0081 and CSEP0254 Promote Fungal Infection Success	PLOS ONE			English	Article							DEFENSE; GENES; TRAFFICKING; RESISTANCE; PATHOGEN; IMMUNITY; SYSTEM; PLANTS; RNA	Effectors play significant roles in the success of pathogens. Recent advances in genome sequencing have revealed arrays of effectors and effector candidates from a wide range of plant pathogens. Yet, the vast majority of them remain uncharacterized. Among the similar to 500 Candidate Secreted Effector Proteins (CSEPs) predicted from the barley powdery mildew fungal genome, only a few have been studied and shown to have a function in virulence. Here, we provide evidence that CSEP0081 and CSEP0254 contribute to infection by the fungus. This was studied using Host-Induced Gene Silencing (HIGS), where independent silencing of the transcripts for these CSEPs significantly reduced the fungal penetration and haustoria formation rate. Both CSEPs are likely required during and after the formation of haustoria, in which their transcripts were found to be differentially expressed, rather than in epiphytic tissue. When expressed in barley leaf epidermal cells, both CSEPs appears to move freely between the cytosol and the nucleus, suggesting that their host targets locate in these cellular compartments. Collectively, our data suggest that, in addition to the previously reported effectors, the barley powdery mildew fungus utilizes these two CSEPs as virulence factors to enhance infection.	[Ahmed, Ali Abdurehim; Pedersen, Carsten; Thordal-Christensen, Hans] Univ Copenhagen, Dept Plant & Environm Sci, Sect Plant & Soil Sci, Frederiksberg, Denmark; [Ahmed, Ali Abdurehim] Univ Calif Davis, UC Davis Genome Ctr, Davis, CA 95616 USA	University of Copenhagen; University of California System; University of California Davis	Thordal-Christensen, H (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Sect Plant & Soil Sci, Frederiksberg, Denmark.	htc@plen.ku.dk	Pedersen, Carsten/F-6797-2014; Thordal-Christensen, Hans/F-6281-2014	Pedersen, Carsten/0000-0002-9520-2232; Thordal-Christensen, Hans/0000-0001-8813-0157	Danish Strategic Research Council [10-093504]; Danish Council for Independent Research/Technology and Production Sciences [10-082292]; Department of Plant and Environmental Sciences, University of Copenhagen	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research/Technology and Production Sciences(Det Frie Forskningsrad (DFF)); Department of Plant and Environmental Sciences, University of Copenhagen	This work was supported by the Danish Strategic Research Council, 10-093504, http://strategiskforskning.dk/en/about-the-danish-strategicresearch-council, HTC; The Danish Council for Independent Research/Technology and Production Sciences, 10-082292, HTC; The Department of Plant and Environmental Sciences, University of Copenhagen, http://plen.ku.dk/english/, HTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar GB, 2016, PLANT PATHOL, V65, P953, DOI 10.1111/ppa.12476; Ahmed A. A., 2016, PLANT PATHOGEN RESIS, P23; Ahmed AA, 2015, PLANT PHYSIOL, V168, P321, DOI 10.1104/pp.15.00278; Bindschedler LV, 2011, METHODS, V54, P432, DOI 10.1016/j.ymeth.2011.03.006; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P483, DOI 10.1016/j.pbi.2012.03.008; Caillaud MC, 2012, PLANT J, V69, P252, DOI 10.1111/j.1365-313X.2011.04787.x; Chen GYJ, 2000, J PHYTOPATHOL, V148, P57, DOI 10.1111/j.1439-0434.2000.tb04625.x; Cook DE, 2015, ANNU REV PHYTOPATHOL, V53, P541, DOI 10.1146/annurev-phyto-080614-120114; de Wit PJGM, 2007, CELL MOL LIFE SCI, V64, P2726, DOI 10.1007/s00018-007-7284-7; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Deslandes L, 2011, PLANT SIGNAL BEHAV, V6, P42, DOI 10.4161/psb.6.1.13978; Douchkov D, 2005, MOL PLANT MICROBE IN, V18, P755, DOI 10.1094/MPMI-18-0755; Ghag SB, 2014, PLANT BIOTECHNOL J, V12, P541, DOI 10.1111/pbi.12158; Godfrey D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-317; Hacquard S, 2013, P NATL ACAD SCI USA, V110, pE2219, DOI 10.1073/pnas.1306807110; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Knip M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004602; Koch A, 2013, P NATL ACAD SCI USA, V110, P19324, DOI 10.1073/pnas.1306373110; Nowara D, 2010, PLANT CELL, V22, P3130, DOI 10.1105/tpc.110.077040; Pedersen C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-694; Pliego C, 2013, MOL PLANT MICROBE IN, V26, P633, DOI 10.1094/MPMI-01-13-0005-R; Quentin M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00053; Rivas S, 2012, PLANT PHYSIOL, V158, P87, DOI 10.1104/pp.111.186163; Schmidt SM, 2014, MOL PLANT PATHOL, V15, P535, DOI 10.1111/mpp.12110; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Stuart LM, 2013, NAT REV IMMUNOL, V13, P199, DOI 10.1038/nri3398; Whigham E, 2015, MOL PLANT MICROBE IN, V28, P968, DOI 10.1094/MPMI-02-15-0027-FI; Wiermer M, 2007, CELL MICROBIOL, V9, P1880, DOI 10.1111/j.1462-5822.2007.00962.x; Yin CT, 2011, MOL PLANT MICROBE IN, V24, P554, DOI 10.1094/MPMI-10-10-0229; Zhang WJ, 2012, MOL PLANT PATHOL, V13, P1110, DOI 10.1111/j.1364-3703.2012.00820.x	32	26	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157586	10.1371/journal.pone.0157586	http://dx.doi.org/10.1371/journal.pone.0157586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322386	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212000028
J	Julia, C; Mejean, C; Peneau, S; Buscail, C; Alles, B; Fezeu, L; Touvier, M; Hercberg, S; Kesse-Guyot, E				Julia, Chantal; Mejean, Caroline; Peneau, Sandrine; Buscail, Camille; Alles, Benjamin; Fezeu, Leopold; Touvier, Mathilde; Hercberg, Serge; Kesse-Guyot, Emmanuelle			The 5-CNL Front-of-Pack Nutrition Label Appears an Effective Tool to Achieve Food Substitutions towards Healthier Diets across Dietary Profiles	PLOS ONE			English	Article							TOTAL-ENERGY-INTAKE; NATIONAL NUTRITION; CLUSTER-ANALYSIS; BRITISH ADULTS; FRENCH ADULTS; NUTRIENT; PATTERNS; QUALITY; SYSTEM; SIMULATION	Background Front-of-pack (FOP) nutrition labels are considered helpful tools to help consumers making healthier food choices, thus improving their diet. In France, the implementation of a FOP nutrition label-the 5-Colour Nutrition Label (5-CNL)-is currently under consideration. Our objective was to investigate dietary profiles in a French adult population using the 5-CNL, and to assess its potential impact in improving the diet through substitution of foods. Methods and Findings Subjects included in the NutriNet-Sante cohort, who had completed three 24-h dietary records were included in this cross-sectional analysis. Mutually exclusive clusters of individuals were identified using the percentage of energy derived from foods of each of the 5-CNL colours as input variables. Three scenarios of substitution of foods for healthier alternative using the 5-CNL were tested. Food group and dietary intakes, socio-demographic and lifestyle data were compared across clusters using ANOVAs or Chi-square tests, as appropriate. We identified three mutually exclusive dietary profiles: 'Healthy' (N = 28 095, 29.3% of the sample), with high consumption of fruit, vegetables, whole cereals and fish; 'Western' (N = 33 386, 34.8%); with high consumption of sweetened beverages, breakfast cereal, cheese, fatty and sugary foods; 'Traditional' (N = 34 461, 35.1%), with high consumption of potatoes, bread, meat and dairy desserts. Overall, substitutions strategies led to an increase in the number of subjects reaching the recommended intakes in energy, macro and micronutrients. Increases were particularly high in the 'Western' pattern for lipids and saturates intakes: from 16.2% reaching the recommended amount for lipids (13.5% for saturates) to 60.6% and 85.7% respectively. Conclusion The use of the 5-CNL as an indicator of food choice meaningfully characterizes clusters of dietary habits and appears as an effective tool to help improving the nutritional quality of the diet.	[Julia, Chantal; Mejean, Caroline; Peneau, Sandrine; Buscail, Camille; Alles, Benjamin; Fezeu, Leopold; Touvier, Mathilde; Hercberg, Serge; Kesse-Guyot, Emmanuelle] Univ Paris 13, INSERM, U1153,Inra,U1125,Cnam,COMUE Sorbonne Paris Cite, EREN,Ctr Epidemiol & Biostat,Sorbonne Paris Cite, F-93017 Bobigny, France; [Julia, Chantal; Hercberg, Serge] Hop Avicenne, AP HP, Dept Sante Publ, F-93017 Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Julia, C (corresponding author), Univ Paris 13, INSERM, U1153,Inra,U1125,Cnam,COMUE Sorbonne Paris Cite, EREN,Ctr Epidemiol & Biostat,Sorbonne Paris Cite, F-93017 Bobigny, France.; Julia, C (corresponding author), Hop Avicenne, AP HP, Dept Sante Publ, F-93017 Bobigny, France.	c.julia@eren.smbh.univ-paris13.fr	Kesse-Guyot, Emmanuelle/ABH-7347-2020; Alles, Benjamin/F-1006-2017; HERCBERG, Serge/B-4429-2008; Fezeu, Leopold/F-2804-2017; Peneau, Sandrine/F-2701-2017; Kesse-Guyot, Emmanuelle/F-2692-2017; Chantal, Julia/F-2805-2017; Serge, Hercberg/F-3038-2017; Touvier, Mathilde/E-8817-2017; Kesse-Guyot, Emmanuelle/K-4689-2012; Buscail, Camille/J-7682-2016; Mejean, Caroline/F-2792-2017	Alles, Benjamin/0000-0002-7970-171X; HERCBERG, Serge/0000-0002-3168-1350; Fezeu, Leopold/0000-0002-7589-3179; Peneau, Sandrine/0000-0002-3463-0989; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Chantal, Julia/0000-0003-2006-5269; Serge, Hercberg/0000-0002-3168-1350; Touvier, Mathilde/0000-0002-8322-8857; Buscail, Camille/0000-0002-6120-6497; Mejean, Caroline/0000-0001-6467-5056	French Ministry of Health; Institut de Veille Sanitaire; Institut National de la Sante et de la Recherche Medicale; Institut National de la Recherche Agronomique; Conservatoire National des Arts et Metiers; Institut National de Prevention et d'Education pour la Sante; Fondation pour la Recherche Medicale; Paris 13 University	French Ministry of Health; Institut de Veille Sanitaire; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique; Conservatoire National des Arts et Metiers; Institut National de Prevention et d'Education pour la Sante; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Paris 13 University	The NutriNet-Sante Study is supported by the French Ministry of Health, the Institut de Veille Sanitaire, the Institut National de la Sante et de la Recherche Medicale, the Institut National de la Recherche Agronomique, the Conservatoire National des Arts et Metiers, the Institut National de Prevention et d'Education pour la Sante and the Fondation pour la Recherche Medicale and Paris 13 University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Study sponsors had no part in study design, collection, analysis, and interpretation of data and the writing of the article and the decision to submit it for publication. Researchers are independant from funders and sponsors. All researchers had access to all the data.	AFSSA, 2007, APP PROT CONS QUAL B; American Heart Association, 2015, AM HEART ASS HEART C; Anses, 2015, EV FAIS CALC SCOR NU; Asp NG, 2007, NUTR RES, V51, P2007; Azais-Braesco V, 2006, PUBLIC HEALTH NUTR, V9, P613, DOI 10.1079/PHN2006966; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Chiuve SE, 2011, AM J PREV MED, V40, P505, DOI 10.1016/j.amepre.2010.11.022; Commonwealth of Australia, 2015, HLTH STAR RAT SYST J; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de la Sant ~e Publique HC, 2015, AV REL INF QUAL NUTR; Estaquio C, 2009, J AM DIET ASSOC, V109, P1031, DOI 10.1016/j.jada.2009.03.012; Etude Nutrinet-Sante, 2013, TABL COMP AL ET NUTR; Hercberg S, 2013, PROPOSITIONS NOUVEL; Hercberg S, 2002, MANUEL PHOTOS ESTIMA; Hercberg S, 2008, INT J PUBLIC HEALTH, V53, P68, DOI 10.1007/s00038-008-7016-2; Hercberg S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-242; INPES, 2010, REDUIRE LES INEGALIT; INSEE. (Institut National De La Statistique et des Etudes Economiques), 2014, METH; Inserm, 2013, IN SOC SANT EXP COLL; Julia C, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0090-4; Julia C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1522-y; Julia C, 2014, J NUTR, V144, P2009, DOI 10.3945/jn.114.199679; Julia C, 2014, BRIT J NUTR, V112, P1699, DOI 10.1017/S0007114514002761; Katz DL, 2010, AM J CLIN NUTR, V91, p1102S, DOI 10.3945/ajcn.2010.28450E; Kesse-Guyot E, 2009, EUR J CLIN NUTR, V63, P521, DOI 10.1038/sj.ejcn.1602978; Lichtenstein AH, 2014, AM J CLIN NUTR, V99, P454, DOI 10.3945/ajcn.113.071407; Maillot M, 2011, AM J CLIN NUTR, V94, P1127, DOI 10.3945/ajcn.111.016501; Maillot M, 2009, J NUTR, V139, P1721, DOI 10.3945/jn.109.107318; Ministere du Travail de l'Emploi et de la Sante, 2011, PROGR NAT NUTR SANT; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Organisation for Economic Co-operation and Development, 2008, PROM SUST CONS GOOD; Pryer JA, 2001, J EPIDEMIOL COMMUN H, V55, P29, DOI 10.1136/jech.55.1.29; Rayner L, 2005, NUTR PROFILES DEV FI; Rayner M, 2009, UK OFCOM NUTR PROFIL; Reedy J, 2011, AM J PREV MED, V40, P581, DOI 10.1016/j.amepre.2011.02.010; Scarborough P, 2010, EUR J CLIN NUTR, V64, P553, DOI 10.1038/ejcn.2010.31; Schickenberg B, 2009, BRIT J NUTR, V102, P478, DOI 10.1017/S0007114508190298; Thomson JL, 2011, J NUTR, V141, P2191, DOI 10.3945/jn.111.144659; Touraine M., 2015, 2302 MIN AFF SOC SAN; Touvier M, 2011, BRIT J NUTR, V105, P1055, DOI 10.1017/S0007114510004617; Townsend MS, 2010, AM J CLIN NUTR, V91, p1109S, DOI 10.3945/ajcn.2010.28450F; Van Kleef E, 2015, CRIT REV FOOD SCI, V55, P291, DOI 10.1080/10408398.2011.653018; Verger EO, 2014, J NUTR, V144, P929, DOI 10.3945/jn.113.188284; Villegas R, 2004, PUBLIC HEALTH NUTR, V7, P1017, DOI 10.1079/PHN2004638; Vyth EL, 2012, EUR J CLIN NUTR, V66, P510, DOI 10.1038/ejcn.2011.193; Vyth EL, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-65; Vyth EL, 2009, J HEALTH COMMUN, V14, P631, DOI 10.1080/10810730903204247; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; World Health Organization, 2000, WHO TECHN REP SER, V894; World Health Organization, 2004, GLOB STRAT DIET PHYS	50	13	13	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157545	10.1371/journal.pone.0157545	http://dx.doi.org/10.1371/journal.pone.0157545			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322033	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212000024
J	Wang, LS; Li, SS; Chen, RZ; Liu, SY; Chen, JC				Wang, Liansheng; Li, Shusheng; Chen, Rongzhen; Liu, Sze-Yu; Chen, Jyh-Cheng			An Automatic Segmentation and Classification Framework Based on PCNN Model for Single Tooth in MicroCT Images	PLOS ONE			English	Article							VERTICAL ROOT FRACTURE; ENDODONTICALLY TREATED TEETH; VARIATIONAL LEVEL SET; ACTIVE CONTOURS; PATTERN	Accurate segmentation and classification of different anatomical structures of teeth from medical images plays an essential role in many clinical applications. Usually, the anatomical structures of teeth are manually labelled by experienced clinical doctors, which is time consuming. However, automatic segmentation and classification is a challenging task because the anatomical structures and surroundings of the tooth in medical images are rather complex. Therefore, in this paper, we propose an effective framework which is designed to segment the tooth with a Selective Binary and Gaussian Filtering Regularized Level Set (GFRLS) method improved by fully utilizing three dimensional (3D) information, and classify the tooth by employing unsupervised learning Pulse Coupled Neural Networks (PCNN) model. In order to evaluate the proposed method, the experiments are conducted on the different datasets of mandibular molars and the experimental results show that our method can achieve better accuracy and robustness compared to other four state of the art clustering methods.	[Wang, Liansheng; Li, Shusheng; Chen, Rongzhen] Xiamen Univ, Dept Comp Sci, Xiamen 361005, Peoples R China; [Liu, Sze-Yu; Chen, Jyh-Cheng] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan	Xiamen University; National Yang Ming Chiao Tung University	Wang, LS (corresponding author), Xiamen Univ, Dept Comp Sci, Xiamen 361005, Peoples R China.	lswang@xmu.edu.cn	Wang, Liansheng/HGA-8949-2022	Wang, Liansheng/0000-0002-2096-454X	National Natural Science Foundation of China [61301010]; Natural Science Foundation of Fujian Province [2014J05080]; Research Fund for the Doctoral Program of Higher Education [20130121120045]; Fundamental Research Funds for the Central Universities [2013SH005, 20720150110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (Grant No. 61301010), the Natural Science Foundation of Fujian Province (Grant No. 2014J05080), Research Fund for the Doctoral Program of Higher Education (20130121120045), and by the Fundamental Research Funds for the Central Universities (Grant No. 2013SH005, 20720150110).	Caselles V, 1997, INT J COMPUT VISION, V22, P61, DOI 10.1023/A:1007979827043; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Eckhorn R, 1990, NEURAL COMPUT, V2, P293, DOI 10.1162/neco.1990.2.3.293; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Farda NM, 2012, INT J ADV RES COMPUT, V1; Ghebremedhin M, 2015, SPIE BIOS; JOHNSON JL, 1993, OPT LETT, V18, P1253, DOI 10.1364/OL.18.001253; Johnson JL, 1999, IEEE T NEURAL NETWOR, V10, P480, DOI 10.1109/72.761706; Jones M L, 2001, J Orthod, V28, P29; Juloski J, 2014, DENT MATER, V30, P1304, DOI 10.1016/j.dental.2014.09.004; Kannan SR, 2012, EXPERT SYST APPL, V39, P6292, DOI 10.1016/j.eswa.2011.11.063; Karygianni L, 2014, CLIN ORAL INVEST, V18, P2015, DOI 10.1007/s00784-013-1182-1; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Konno H, 2005, IIE TRANS, V37, P893, DOI 10.1080/07408170591007786; Lertchirakarn V, 2003, J ENDODONT, V29, P529, DOI 10.1097/00004770-200308000-00009; Li S, 2006, COMPUT MED IMAG GRAP, V30, P65, DOI 10.1016/j.compmedimag.2005.10.007; Li S, 2007, PATTERN RECOGN, V40, P2861, DOI 10.1016/j.patcog.2007.01.012; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Lindblad T., 1998, IMAGE PROCESSING USI; Lustig JP, 2000, ORAL SURG ORAL MED O, V90, P224, DOI 10.1067/moe.2000.107445; McNicholas PD, 2010, COMPUT STAT DATA AN, V54, P711, DOI 10.1016/j.csda.2009.02.011; MUMFORD D, 1989, COMMUN PUR APPL MATH, V42, P577, DOI 10.1002/cpa.3160420503; Muresan RC, 2003, NEUROCOMPUTING, V51, P487, DOI 10.1016/S0925-2312(02)00727-0; Ozer SY, 2011, J ENDODONT, V37, P97, DOI 10.1016/j.joen.2010.09.002; Ranganath H. S., 1995, Proceedings IEEE Southeastcon '95. Visualize the Future (Cat. No.95CH35793), P37, DOI 10.1109/SECON.1995.513053; Robinson JP, 2012, J DENT, V40, P999, DOI 10.1016/j.jdent.2012.08.007; Tamse A, 2006, ORAL SURG ORAL MED O, V101, P797, DOI 10.1016/j.tripleo.2005.09.014; Tamse A., 2008, INGLES ENDODONTICS, P676; Wang ZB, 2010, PATTERN RECOGN, V43, P2003, DOI 10.1016/j.patcog.2010.01.011; YANG SF, 1995, J ENDODONT, V21, P337, DOI 10.1016/S0099-2399(06)81013-7; Zhang KH, 2010, IMAGE VISION COMPUT, V28, P668, DOI 10.1016/j.imavis.2009.10.009; ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096; Zou Q, 2016, NEUROCOMPUTING, V173, P346, DOI 10.1016/j.neucom.2014.12.123; Zou Q, 2014, BRIEF BIOINFORM, V15, P637, DOI 10.1093/bib/bbs088	34	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157694	10.1371/journal.pone.0157694	http://dx.doi.org/10.1371/journal.pone.0157694			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322421	gold, Green Submitted, Green Published			2022-12-26	WOS:000378212000039
J	Konrat, K; Schwebke, I; Laue, M; Dittmann, C; Levin, K; Andrich, R; Arvand, M; Schaudinn, C				Konrat, Katharina; Schwebke, Ingeborg; Laue, Michael; Dittmann, Christin; Levin, Katja; Andrich, Ricarda; Arvand, Mardjan; Schaudinn, Christoph			The Bead Assay for Biofilms: A Quick, Easy and Robust Method for Testing Disinfectants	PLOS ONE			English	Article							MICROBIAL BIOFILMS; RESISTANCE	Bacteria live primarily in microbial communities (biofilms), where they exhibit considerably higher biocide tolerance than their planktonic counterparts. Current standardized efficacy testing protocols of disinfectants, however, employ predominantly planktonic bacteria. In order to test the efficacy of biocides on biofilms in a standardized manner, a new assay was developed and optimized for easy-handling, quickness, low running costs, and above allrepeatability. In this assay, 5 mm glass-or polytetrafluoroethylene beads in 24 well microtiter plates served as substrate for Pseudomonas aeruginosa biofilms. After optimizing result-relevant steps, the actual performance of the assay was explored by treating P. aeruginosa biofilms with glutaraldehyde, isopropanol, or peracetic acid in predefined concentrations. The aspired 5 log(10) reduction in CFU counts was achieved by glutaraldehyde at 5% (30 min), and by peracetic acid at 0.3% (10 min). In contrast, 80% isopropanol (30 min) failed to meet the reduction goal. However, the main accomplishment of this study was to unveil the potential of the array itself; most noteworthy here, a reliable repeatability of the results. The new bead assay for biofilms is a robust, quick and cost-effective method for assessing the efficacy of biocides against biofilms.	[Konrat, Katharina; Schwebke, Ingeborg; Levin, Katja; Andrich, Ricarda; Arvand, Mardjan] Div Appl Infect Control, Berlin, Germany; [Konrat, Katharina; Schwebke, Ingeborg; Levin, Katja; Andrich, Ricarda; Arvand, Mardjan] Hosp Hyg, Robert Koch Inst, Berlin, Germany; [Konrat, Katharina; Laue, Michael; Dittmann, Christin; Schaudinn, Christoph] Robert Koch Inst, Adv Light & Electron Microscopy, Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Schaudinn, C (corresponding author), Robert Koch Inst, Adv Light & Electron Microscopy, Berlin, Germany.	schaudinnc@rki.de						Allan N, 2011, SCI MICROBIAL PATHOG, P864; Angeloni S, 2004, AM J GASTROENTEROL, V99, P280, DOI 10.1111/j.1572-0241.2004.04056.x; [Anonymous], 2006, DIN EN 14561 2006 08; [Anonymous], 2014, DIN EN 13727 2014 03; ASTM, 2012, E2799 12; Bardouniotis E, 2001, FEMS MICROBIOL LETT, V203, P263, DOI 10.1111/j.1574-6968.2001.tb10851.x; BARMAN AA, 1981, CARDIOVASC DIS, V8, P555; Buckingham-Meyer K, 2007, J MICROBIOL METH, V70, P236, DOI 10.1016/j.mimet.2007.04.010; Carson L, 2009, GREEN CHEM, V11, P492, DOI 10.1039/b821842k; Cholodny N, 1924, BER DEUT BOT GES, VXLII, P35; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; FRASER VJ, 1993, INFECT CONT HOSP EP, V14, P383, DOI 10.2307/30148320; Harrison JJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-53; Harrison JJ, 2010, NAT PROTOC, V5, P1236, DOI 10.1038/nprot.2010.71; International A, 2007, STAND TEST METH EV D, P1444; Krankenhaushygiene DGf, 1994, HYGMED, V19, P477; Liu Y, 2002, WATER RES, V36, P1653, DOI 10.1016/S0043-1354(01)00379-7; LOH A, 1993, EUR J VASCULAR SURG, V7, P26, DOI 10.1016/S0950-821X(05)80539-0; Parker AE, 2014, J MICROBIOL METH, V102, P55, DOI 10.1016/j.mimet.2014.04.013; Schulte S, 2006, CHEM-ING-TECH, V78, P1683, DOI 10.1002/cite.200600088; Tote K, 2010, APPL ENVIRON MICROB, V76, P3135, DOI 10.1128/AEM.02095-09; Vikram A, 2015, ANTIMICROB AGENTS CH, V59, P3433, DOI 10.1128/AAC.05152-14; Webster P, 2006, J HISTOCHEM CYTOCHEM, V54, P829, DOI 10.1369/jhc.6A6922.2006	23	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157663	10.1371/journal.pone.0157663	http://dx.doi.org/10.1371/journal.pone.0157663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315246	Green Published, gold, Green Submitted			2022-12-26	WOS:000378030000042
J	Lindemann, U; Mohr, C; Machann, J; Blatzonis, K; Rapp, K; Becker, C				Lindemann, Ulrich; Mohr, Christian; Machann, Juergen; Blatzonis, Konstantinos; Rapp, Kilian; Becker, Clemens			Association between Thigh Muscle Volume and Leg Muscle Power in Older Women	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; FUNCTIONAL-CAPACITY; SARCOPENIA; ADULTS; STRENGTH; VALIDITY; MASS; RELIABILITY; PREVALENCE; MYOSTATIN	The construct of sarcopenia is still discussed with regard to best appropriate measures of muscle volume and muscle function. The aim of this post-hoc analysis of a cross-sectional experimental study was to investigate and describe the hierarchy of the association between thigh muscle volume and measurements of functional performance in older women. Thigh muscle volume of 68 independently living older women (mean age 77.6 years) was measured via magnetic resonance imaging. Isometric strength was assessed for leg extension in a movement laboratory in sitting position with the knee flexed at 90 degrees and for hand grip. Maximum and habitual gait speed was measured on an electronic walk way. Leg muscle power was measured during single leg push and during sit-to-stand performance. Thigh muscle volume was associated with sit-to-stand performance power (r = 0.628), leg push power (r = 0.550), isometric quadriceps strength (r = 0.442), hand grip strength (r = 0.367), fast gait speed (r = 0.291), habitual gait speed (r = 0.256), body mass index (r = 0.411) and age (r = -0.392). Muscle power showed the highest association with thigh muscle volume in healthy older women. Sit-to-stand performance power showed an even higher association with thigh muscle volume compared to single leg push power.	[Lindemann, Ulrich; Mohr, Christian; Rapp, Kilian; Becker, Clemens] Robert Bosch Krankenhaus, Dept Clin Gerontol & Rehabil, Stuttgart, Germany; [Machann, Juergen] Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis IDM, Tubingen, Germany; [Machann, Juergen] Univ Tubingen, Dept Diagnost & Intervent Radiol, Sect Expt Radiol, Tubingen, Germany; [Blatzonis, Konstantinos] Robert Bosch Krankenhaus, Dept Radiol & Nucl Med, Stuttgart, Germany	Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Bosch; Robert Bosch Krankenhaus	Lindemann, U (corresponding author), Robert Bosch Krankenhaus, Dept Clin Gerontol & Rehabil, Stuttgart, Germany.	ulrich.lindemann@rbk.de	Rapp, Kilian/AAJ-3370-2020; Becker, Clemens/ABI-5405-2020	Rapp, Kilian/0000-0003-1625-2571; 	German Research Council [BE 2338/2-1]	German Research Council(German Research Foundation (DFG))	This work was supported by the German Research Council (www.dfg.de) [BE 2338/2-1]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSEY EJ, 1990, EUR J APPL PHYSIOL, V60, P385, DOI 10.1007/BF00713504; Bean JF, 2003, J GERONTOL A-BIOL, V58, P728; Becker C, 2015, LANCET DIABETES ENDO, V3, P948, DOI 10.1016/S2213-8587(15)00298-3; Bernabei R, 2014, CLIN CASES MINER BON, V11, P201, DOI 10.11138/ccmbm/2014.11.3.201; Bowen TS, 2015, J CACHEXIA SARCOPENI, V6, P197, DOI 10.1002/jcsm.12043; Cawthon PM, 2015, J CLIN DENSITOM, V18, P467, DOI 10.1016/j.jocd.2015.05.063; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Cutlip RG, 2000, GAIT POSTURE, V12, P134, DOI 10.1016/S0966-6362(00)00062-X; Delmonico MJ, 2008, EUR J CLIN NUTR, V62, P1372, DOI 10.1038/sj.ejcn.1602880; Gray M, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-145; Groll DL, 2005, J CLIN EPIDEMIOL, V58, P595, DOI 10.1016/j.jclinepi.2004.10.018; Harridge S, 2000, OXFORD TXB GERIATRIC; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Leenders M, 2013, J AM MED DIR ASSOC, V14, P585, DOI 10.1016/j.jamda.2013.02.006; Lindemann U, 2008, GAIT POSTURE, V27, P91, DOI 10.1016/j.gaitpost.2007.02.005; Lindemann U, 2015, PHYSIOTHERAPY, V101, P298, DOI 10.1016/j.physio.2014.12.005; Lindemann U, 2014, AGE AGEING, V43, P571, DOI 10.1093/ageing/afu057; Maden-Wilkinson TM, 2013, J MUSCULOSKEL NEURON, V13, P320; Morley JE, 2014, J CACHEXIA SARCOPENI, V5, P253, DOI 10.1007/s13539-014-0161-y; Morley JE, 2012, FAM PRACT, V29, pi44, DOI 10.1093/fampra/cmr063; Nayak S, 2015, OSTEOPOROSIS INT, V26, P1543, DOI 10.1007/s00198-015-3025-1; O'Brien TD, 2009, EXP PHYSIOL, V94, P731, DOI 10.1113/expphysiol.2008.045062; Scherbakov N, 2013, INT J CARDIOL, V170, P89, DOI 10.1016/j.ijcard.2013.10.031; Villani AM, 2013, J CACHEXIA SARCOPENI, V4, P209, DOI 10.1007/s13539-013-0108-8; White TA, 2014, GERONTOLOGY, V60, P289, DOI 10.1159/000356740; Wilhelm EN, 2014, AGE, V36, P1113, DOI 10.1007/s11357-014-9625-4; Zhang W, 2014, SENSORS-BASEL, V14, P8705, DOI 10.3390/s140508705; Zijlstra W, 2010, GAIT POSTURE, V31, P272, DOI 10.1016/j.gaitpost.2009.11.003	30	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157885	10.1371/journal.pone.0157885	http://dx.doi.org/10.1371/journal.pone.0157885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315060	Green Submitted, Green Published, gold			2022-12-26	WOS:000378030000063
J	Music, N; Reber, AJ; Kim, JH; York, IA				Music, Nedzad; Reber, Adrian J.; Kim, Jin Hyang; York, Ian A.			Peripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza Virus	PLOS ONE			English	Article							CD8(+) T-CELLS; PANDEMIC INFLUENZA; MOUSE MODEL; INFLAMMATION; PATHOGENESIS; CD4(+); TRANSMISSION; IMMUNITY; RECEPTOR; DEATH	In order to better understand inflammation associated with influenza virus infection, we measured cell trafficking, via flow cytometry, to various tissues in the ferret model following infection with an A(H3N2) human seasonal influenza virus (A/Perth/16/2009). Changes in immune cells were observed in the blood, bronchoalveolar lavage fluid, and spleen, as well as lymph nodes associated with the site of infection or distant from the respiratory system. Nevertheless clinical symptoms were mild, with circulating leukocytes exhibiting rapid, dynamic, and profound changes in response to infection. Each of the biological compartments examined responded differently to influenza infection. Two days after infection, when infected ferrets showed peak fever, a marked, transient lymphopenia and granulocytosis were apparent in all infected animals. Both draining and distal lymph nodes demonstrated significant accumulation of T cells, B cells, and granulocytes at days 2 and 5 post-infection. CD8+ T cells significantly increased in spleen at days 2 and 5 post-infection; CD4+ T cells, B cells and granulocytes significantly increased at day 5. We interpret our findings as showing that lymphocytes exit the peripheral blood and differentially home to lymph nodes and tissues based on cell type and proximity to the site of infection. Monitoring leukocyte homing and trafficking will aid in providing a more detailed view of the inflammatory impact of influenza virus infection.	[Music, Nedzad; Reber, Adrian J.; Kim, Jin Hyang; York, Ian A.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Music, Nedzad] Battelle Mem Inst, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	York, IA (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA.	ite1@cdc.gov	York, Ian/X-9351-2019	York, Ian/0000-0002-3478-3344	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The source of funding for this work was the Centers for Disease Control and Prevention. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Belser JA, 2013, VIROLOGY, V438, P56, DOI 10.1016/j.virol.2013.01.012; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Brown C, 2006, LAB ANIMAL, V35, P23, DOI 10.1038/laban0206-23; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Chaussee MS, 2011, VACCINE, V29, P3773, DOI 10.1016/j.vaccine.2011.03.031; Clark NM, 2011, SEMIN RESP CRIT CARE, V32, P373, DOI 10.1055/s-0031-1283278; Damjanovic D, 2012, CLIN IMMUNOL, V144, P57, DOI 10.1016/j.clim.2012.05.005; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Dondi E, 2004, J IMMUNOL, V173, P3740, DOI 10.4049/jimmunol.173.6.3740; Feng YL, 2015, J CLIN PATHOL, V68, P57, DOI 10.1136/jclinpath-2014-202441; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Houser KV, 2013, J VIROL, V87, P13480, DOI 10.1128/JVI.02434-13; Huang SSH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027512; Hufford MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046581; Ibrahim HM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/148725; Kreijtz JHCM, 2011, VIRUS RES, V162, P19, DOI 10.1016/j.virusres.2011.09.022; Kuiken T, 2012, CURR OPIN VIROL, V2, P276, DOI 10.1016/j.coviro.2012.02.013; Li C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107966; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Music N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100926; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Okamba FR, 2010, VACCINE, V28, P4802, DOI 10.1016/j.vaccine.2010.04.089; Peiris JSM, 2010, CURR OPIN IMMUNOL, V22, P475, DOI 10.1016/j.coi.2010.06.003; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; REED L. J., 1938, AMER JOUR HYG, V27, P493; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; Russell S M, 1977, Dev Biol Stand, V39, P397; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shrestha S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0233; Shrestha S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005982; Soghoian DZ, 2010, EXPERT REV VACCINES, V9, P1453, DOI 10.1586/ERV.10.132; Sun J, 2011, NAT IMMUNOL, V12, P327, DOI 10.1038/ni.1996; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Tate MD, 2012, IMMUNOL CELL BIOL, V90, P197, DOI 10.1038/icb.2011.26; van Domselaar R, 2011, REV MED VIROL, V21, P301, DOI 10.1002/rmv.697; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; White GE, 2013, PHARMACOL REV, V65, P47, DOI 10.1124/pr.111.005074; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Wu HL, 2011, J IMMUNOL, V187, P4474, DOI 10.4049/jimmunol.1101443; Ye SY, 2015, J VIROL, V89, P2672, DOI 10.1128/JVI.03529-14	57	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157903	10.1371/journal.pone.0157903	http://dx.doi.org/10.1371/journal.pone.0157903			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315117	gold, Green Submitted, Green Published			2022-12-26	WOS:000378030000065
J	Thomson, FJ; Auld, TD; Ramp, D; Kingsford, RT				Thomson, Fiona J.; Auld, Tony D.; Ramp, Daniel; Kingsford, Richard T.			A Switch in Keystone Seed-Dispersing Ant Genera between Two Elevations for a Myrmecochorous Plant, Acacia terminalis	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; SOIL TEMPERATURES; FUNCTIONAL-GROUPS; REMOVAL; VEGETATION; AUSTRALIA; PREDATION; COMMUNITIES; DISTURBANCE; MUTUALISM	The dispersal capacity of plant species that rely on animals to disperse their seeds (biotic dispersal) can alter with changes to the populations of their keystone dispersal vectors. Knowledge on how biotic dispersal systems vary across landscapes allows better understanding of factors driving plant persistence. Myrmecochory, seed dispersal by ants, is a common method of biotic dispersal for many plant species throughout the world. We tested if the seed dispersal system of Acacia terminalis (Fabaceae), a known myrmecochore, differed between two elevations in the Greater Blue Mountains World Heritage Area, in southeastern Australia. We compared ant assemblages, seed removal rates of ants and other vertebrates (bird and mammal) and the dominant seed-dispersing ant genera. At low elevations (c.200 ma.s.l) seed removal was predominantly by ants, however, at high elevation sites (c.700 ma.s.l) vertebrate seed dispersers or seed predators were present, removing over 60% of seeds from experimental depots when ants were excluded. We found a switch in the keystone seed-dispersing ant genera from Rhytidoponera at low elevations sites to Aphaenogaster at high elevation sites. This resulted in more seeds being removed faster at low elevation sites compared to high elevation sites, however long-term seed removal rates were equal between elevations. Differences in the keystone seed removalist, and the addition of an alternate dispersal vector or seed predator at high elevations, will result in different dispersal and establishment patterns for A. terminalis at different elevations. These differences in dispersal concur with other global studies that report myrmecochorous dispersal systems alter with elevation.	[Thomson, Fiona J.] Landcare Res Manaaki Whenua, Lincoln, New Zealand; [Thomson, Fiona J.; Ramp, Daniel; Kingsford, Richard T.] Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Ecosyst Sci, Sydney, NSW, Australia; [Thomson, Fiona J.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Auld, Tony D.] Off Environm & Heritage, Sydney, NSW, Australia; [Ramp, Daniel] Univ Technol Sydney, Sch Life Sci, Ctr Compassionate Conservat, Sydney, NSW 2007, Australia	Landcare Research - New Zealand; University of New South Wales Sydney; University of New South Wales Sydney; Office of Environment & Heritage - New South Wales; University of Technology Sydney	Thomson, FJ (corresponding author), Landcare Res Manaaki Whenua, Lincoln, New Zealand.; Thomson, FJ (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Ecosyst Sci, Sydney, NSW, Australia.; Thomson, FJ (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	ThomsonF@landcareresearch.co.nz	Ramp, Daniel/C-3692-2008	Ramp, Daniel/0000-0003-3202-9898; Auld, Tony/0000-0002-8766-2829; Kingsford, Richard/0000-0001-6565-4134	Australian Research Council [LP0774833]; Landcare Research from the Ministry of Business, Innovation and Employment, New Zealand; ARC [LP0774833]; Landcare Research	Australian Research Council(Australian Research Council); Landcare Research from the Ministry of Business, Innovation and Employment, New Zealand; ARC(Australian Research Council); Landcare Research	Fiona J. Thomson received funding from the Australian Research Council (http://www.arc.gov.au/) Linkage project, (LP0774833) Managing for Ecosystem Change in the Greater Blue Mountains World Heritage Area project for this work. Fiona J. Thomson also received core funding to rewrite this manuscript from Landcare Research (http://www.landcareresearch.co.nz) from the Ministry of Business, Innovation and Employment (http://www.mbie.govt.nz/), New Zealand.; Thanks to our field assistants, including Tom Mullaney. Also thanks to David J. Eldridge, Terry B. Koen and Sarah Richardson for statistical advice, and Peter Bellingham and the anonymous reviewers for comments on the manuscript. This work was part of the ARC Linkage project, (LP0774833) Managing for Ecosystem Change in the Greater Blue Mountains World Heritage Area project. We thank the industry partners: Office of Environment and Heritage NSW, Hawkesbury Nepean Catchment Management Authority, Blue Mountains City Council and New South Wales Department of Primary Industry. We also thank our research collaborators on this project; the University of Wollongong, the University of Western Sydney and the Greater Blue Mountains World Heritage Institute. Lastly, we thank Landcare Research for providing funding and time to rewrite the manuscript.	ANDERSEN AN, 1988, AUST J ECOL, V13, P285, DOI 10.1111/j.1442-9993.1988.tb00976.x; Andersen AN, 1997, J BIOGEOGR, V24, P433, DOI 10.1111/j.1365-2699.1997.00137.x; ANDERSEN AN, 1995, J BIOGEOGR, V22, P15, DOI 10.2307/2846070; Andersen AN, 1998, AUST J ECOL, V23, P483, DOI 10.1111/j.1442-9993.1998.tb00756.x; ANDERSEN AN, 1988, AUST J ECOL, V13, P469, DOI 10.1111/j.1442-9993.1988.tb00995.x; Auld TD, 1999, PLANT ECOL, V144, P201, DOI 10.1023/A:1009817132378; Auld TD, 1996, AUST J ECOL, V21, P106, DOI 10.1111/j.1442-9993.1996.tb00589.x; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Beaumont KP, 2013, OECOLOGIA, V172, P791, DOI 10.1007/s00442-012-2534-2; Benson D. H., 1992, Cunninghamia, V2, P541; BERG RY, 1975, AUST J BOT, V23, P475, DOI 10.1071/BT9750475; Botes A, 2006, J BIOGEOGR, V33, P71, DOI 10.1111/j.1365-2699.2005.01336.x; BRIESE DT, 1981, AUST J ECOL, V6, P1, DOI 10.1111/j.1442-9993.1981.tb01269.x; Calvino-Cancela M, 2008, DIVERS DISTRIB, V14, P11, DOI 10.1111/j.1472-4642.2007.00402.x; Christian CE, 2001, NATURE, V413, P635, DOI 10.1038/35098093; Clarke K. R, 2006, PRIMER V5 USER MANUA; DRAKE WE, 1981, AUST J BOT, V29, P293, DOI 10.1071/BT9810293; Edwards W, 2006, J ECOL, V94, P687, DOI 10.1111/j.1365-2745.2006.01116.x; Fenner M, 1985, SEED ECOLOGY; Gibb H, 2003, OIKOS, V103, P469, DOI 10.1034/j.1600-0706.2003.12652.x; Gomez C, 2013, ECOGRAPHY, V36, P1193, DOI 10.1111/j.1600-0587.2013.00289.x; Gove AD, 2007, OECOLOGIA, V153, P687, DOI 10.1007/s00442-007-0756-5; Hammil K, 2010, VEGETATION FIRE CLIM; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HUGHES L, 1992, ECOLOGY, V73, P1285, DOI 10.2307/1940676; HUGHES L, 1990, ECOLOGY, V71, P138, DOI 10.2307/1940254; HUGHES L, 1992, ECOLOGY, V73, P1300, DOI 10.2307/1940677; Lengyel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005480; Lomov B, 2009, AUSTRAL ECOL, V34, P751, DOI 10.1111/j.1442-9993.2009.01981.x; Lubertazzi D, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14118; MAJER JD, 1985, AUST J BOT, V33, P611, DOI 10.1071/BT9850611; McConkey KR, 2012, BIOL CONSERV, V146, P1, DOI 10.1016/j.biocon.2011.09.018; Menke SB, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00234.1; MOSSOP MK, 1989, AUST J ECOL, V14, P367, DOI 10.1111/j.1442-9993.1989.tb01445.x; Munoz AA, 2002, ARCT ANTARCT ALP RES, V34, P178, DOI 10.2307/1552469; Ness JH, 2009, OIKOS, V118, P1793, DOI 10.1111/j.1600-0706.2009.17430.x; Ness JH, 2004, ECOLOGY, V85, P1244, DOI 10.1890/03-0364; Ness JH, 2004, BIOL INVASIONS, V6, P445, DOI 10.1023/B:BINV.0000041556.88920.dd; New South Wales National Parks and Wildlife Service, 1998, GREAT BLUE MOUNT AR; Ooi MKJ, 2009, GLOBAL CHANGE BIOL, V15, P2375, DOI 10.1111/j.1365-2486.2009.01887.x; Reymond A, 2013, ECOL ENTOMOL, V38, P364, DOI 10.1111/een.12027; RICE B, 1986, ECOLOGY, V67, P1270, DOI 10.2307/1938682; RICE B, 1981, AUST J ECOL, V6, P291, DOI 10.1111/j.1442-9993.1981.tb01579.x; Robinson L., 2003, FIELD GUIDE NATIVE P; Shattuck S. O., 1999, AUSTR ANTS THEIR BIO; Stuble KL, 2014, PEERJ, V2, DOI 10.7717/peerj.286; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Trakhtenbrot A, 2005, DIVERS DISTRIB, V11, P173, DOI 10.1111/j.1366-9516.2005.00156.x; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Warren RJ, 2010, J ECOL, V98, P1178, DOI 10.1111/j.1365-2745.2010.01694.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Zelikova TJ, 2008, ACTA OECOL, V34, P155, DOI 10.1016/j.actao.2008.05.002	53	10	10	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157632	10.1371/journal.pone.0157632	http://dx.doi.org/10.1371/journal.pone.0157632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310262	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800111
J	Werner, A; Herzog, B; Frey, S; Poggeler, S				Werner, Antonia; Herzog, Britta; Frey, Stefan; Poeggeler, Stefanie			Autophagy-Associated Protein SmATG12 Is Required for Fruiting-Body Formation in the Filamentous Ascomycete Sordaria macrospora	PLOS ONE			English	Article							ATG12-ATG5 CONJUGATE; ASCOSPORE GERMINATION; SEXUAL DEVELOPMENT; VEGETATIVE GROWTH; LC3 LIPIDATION; GENES SMATG8; YEAST; MEMBRANE; MUTANTS; MECHANISM	In filamentous fungi, autophagy functions as a catabolic mechanism to overcome starvation and to control diverse developmental processes under normal nutritional conditions. Autophagy involves the formation of double-membrane vesicles, termed autophagosomes that engulf cellular components and bring about their degradation via fusion with vacuoles. Two ubiquitin-like (UBL) conjugation systems are essential for the expansion of the autophagosomal membrane: the UBL protein ATG8 is conjugated to the lipid phosphatidylethanolamine and the UBL protein ATG12 is coupled to ATG5. We recently showed that in the homothallic ascomycete Sordaria macrospora autophagy-related genes encoding components of the conjugation systems are required for fruiting-body development and/or are essential for viability. In the present work, we cloned and characterized the S. macrospora (Sm)atg12 gene. Two-hybrid analysis revealed that SmATG12 can interact with SmATG7 and SmATG3. To examine its role in S. macrospora, we replaced the open reading frame of Smatg12 with a hygromycin resistance cassette and generated a homokaryotic Delta Smatg12 knockout strain, which displayed slower vegetative growth under nutrient starvation conditions and was unable to form fruiting bodies. In the hyphae of S. macrospora EGFP-labeled SmATG12 was detected in the cytoplasm and as punctate structures presumed to be phagophores or phagophore assembly sites. Delivery of EGFP-labelled SmATG8 to the vacuole was entirely dependent on SmATG12.	[Werner, Antonia; Herzog, Britta; Frey, Stefan; Poeggeler, Stefanie] Univ Gottingen, Inst Microbiol & Genet, Dept Genet Eukaryot Microorganisms, D-37073 Gottingen, Germany; [Poeggeler, Stefanie] Univ Gottingen, Gottingen Ctr Mol Biosci GZMB, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Poggeler, S (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Genet Eukaryot Microorganisms, D-37073 Gottingen, Germany.; Poggeler, S (corresponding author), Univ Gottingen, Gottingen Ctr Mol Biosci GZMB, D-37073 Gottingen, Germany.	spoegge@gwdg.de			Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (Deutsche Forschungsgemeinschaft) [GSC 226/1, GSC 226/2]; Open Access Publication Funds of the Gottingen University	Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (Deutsche Forschungsgemeinschaft); Open Access Publication Funds of the Gottingen University	AW and SF were partly supported by the Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (Deutsche Forschungsgemeinschaft Grants GSC 226/1, GSC 226/2). The authors acknowledge support by the Open Access Publication Funds of the Gottingen University.; We thank Gertrud Stahlhut for excellent technical assistance. We are very grateful to Prof. Dr. Michael Thumm (Department of Cellular Biochemistry, UMG, Georg-August University Gottingen) for kindly providing the API antibody and plasmid pRS315-GFP-ATG8. AW and SF were partly supported by the Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (DFG Grants GSC 226/1, GSC 226/2). The authors acknowledge support by the Open Access Publication Funds of the Gottingen University.	Amberg DC., 2005, METHODS YEAST GENETI; Avin-Wittenberg T, 2012, PROTOPLASMA, V249, P285, DOI 10.1007/s00709-011-0296-z; Becker D M, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1307s27; Bloemendal S, 2012, MOL MICROBIOL, V84, P310, DOI 10.1111/j.1365-2958.2012.08024.x; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; CARROLL AM, 1994, FUNGAL GENET NEWSLET, V41, P22, DOI DOI 10.4148/1941-4765.1367; Chinnici JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110603; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Chung T, 2010, PLANT J, V62, P483, DOI 10.1111/j.1365-313X.2010.04166.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Elleuche S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005177; Engh I, 2010, EUR J CELL BIOL, V89, P864, DOI 10.1016/j.ejcb.2010.07.002; Esser K, 1992, CRYPTOGAMS CYANAOBAC; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hanada T, 2005, AUTOPHAGY, V1, P110, DOI 10.4161/auto.1.2.1858; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; James P, 1996, GENETICS, V144, P1425; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Josefsen L, 2012, AUTOPHAGY, V8, P326, DOI 10.4161/auto.18705; Kaufmann A, 2014, CELL, V156, P469, DOI 10.1016/j.cell.2013.12.022; Kershaw MJ, 2009, P NATL ACAD SCI USA, V106, P15967, DOI 10.1073/pnas.0901477106; Kim SH, 2015, EXP PARASITOL, V159, P46, DOI 10.1016/j.exppara.2015.08.013; Kitamura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042977; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klix V, 2010, EUKARYOT CELL, V9, P894, DOI 10.1128/EC.00019-10; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Li FQ, 2015, PLANT CELL, V27, P1389, DOI 10.1105/tpc.15.00158; Lord KM, 2011, FUNGAL GENET BIOL, V48, P388, DOI 10.1016/j.fgb.2010.11.009; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Metlagel Z, 2013, P NATL ACAD SCI USA, V110, P18844, DOI 10.1073/pnas.1314755110; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Mukaiyama H, 2009, MICROBIOL-SGM, V155, P3816, DOI 10.1099/mic.0.034389-0; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Murrow L, 2015, NAT CELL BIOL, V17, P300, DOI 10.1038/ncb3112; Nakatogawa H, 2013, ESSAYS BIOCHEM, V55, P39, DOI [10.1042/bse0550039, 10.1042/BSE0550039]; Noda NN, 2013, EMBO REP, V14, P206, DOI 10.1038/embor.2012.208; Nolting N, 2009, FUNGAL GENET BIOL, V46, P531, DOI 10.1016/j.fgb.2009.03.008; Nowrousian M, 1999, MOL CELL BIOL, V19, P450; Nowrousian M, 2012, G3-GENES GENOM GENET, V2, P261, DOI 10.1534/g3.111.001479; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Otomo C, 2013, NAT STRUCT MOL BIOL, V20, P59, DOI 10.1038/nsmb.2431; Poggeler S, 2006, MOL GENET GENOMICS, V275, P492, DOI 10.1007/s00438-006-0107-y; Poggeler S, 2006, GENE, V378, P1, DOI 10.1016/j.gene.2006.03.020; Poggeler S, 1997, J MICROBIOL METH, V29, P49, DOI 10.1016/S0167-7012(97)00018-3; Poggeler S, 2003, CURR GENET, V43, P54, DOI 10.1007/s00294-003-0370-y; Poggeler S., 2008, FUNGAL GENET REP, V55, P8, DOI [10.4148/1941-4765.1083, DOI 10.4148/1941-4765.1083]; Poggeler S., 2018, PHYSL GENETICS, V15, P325, DOI [10.1007/978-3-319-71740-1_1, DOI 10.1007/978-3-319-71740-1_1, DOI 10.1007/3-540-28135-5_16]; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Sambrook J., 2001, MOL CLONING LAB MANU; Shintani T, 1999, EMBO J, V18, P5234, DOI 10.1093/emboj/18.19.5234; Shoji JY, 2014, CURR OPIN MICROBIOL, V20, P1, DOI 10.1016/j.mib.2014.03.002; Shoji Jun-ya, 2011, Fungal Biology Reviews, V25, P79, DOI 10.1016/j.fbr.2011.04.001; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2013, J CELL SCI, V126, P2534, DOI 10.1242/jcs.122960; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Teichert I., 2014, ADV GENET, V87, P201; Teichert I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-511; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Tucker CL, 2009, GENETICS, V182, P1377, DOI 10.1534/genetics.109.103069; Voigt O, 2014, MICROBIOL RES, V169, P128, DOI 10.1016/j.micres.2013.07.012; Voigt O, 2013, FUNGAL GENET BIOL, V61, P50, DOI 10.1016/j.fgb.2013.09.006; Voigt O, 2013, APPL MICROBIOL BIOT, V97, P9277, DOI 10.1007/s00253-013-5221-2; Voigt O, 2013, AUTOPHAGY, V9, P33, DOI 10.4161/auto.22398; Yamazaki-Sato H, 2003, FEBS LETT, V551, P71, DOI 10.1016/S0014-5793(03)00899-8	88	9	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157960	10.1371/journal.pone.0157960	http://dx.doi.org/10.1371/journal.pone.0157960			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309377	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800144
J	Witso, IL; Rukke, HV; Benneche, T; Scheie, AA				Witso, Ingun Lund; Rukke, Hakon Valen; Benneche, Tore; Scheie, Anne Aamdal			Thiophenone Attenuates Enteropathogenic Escherichia coli O103:H2 Virulence by Interfering with AI-2 Signaling	PLOS ONE			English	Article							BIOFILM FORMATION; SALMONELLA-TYPHIMURIUM; HOST COMMUNICATION; VIBRIO-HARVEYI; SENSOR KINASE; EPINEPHRINE; EXPRESSION; SYSTEM; NOREPINEPHRINE; AUTOINDUCER-2	Interference with bacterial quorum sensing communication provides an anti-virulence strategy to control pathogenic bacteria. Here, using the Enteropathogenic E. coli (EPEC) O103:H2, we showed for the first time that thiophenone TF101 reduced expression of lsrB; the gene encoding the AI-2 receptor. Combined results of transcriptional and phenotypic analyses suggested that TF101 interfere with AI-2 signalling, possibly by competing with AI-2 for binding to LsrB. This is supported by in silico docking prediction of thiophenone TF101 in the LsrB pocket. Transcriptional analyses furthermore showed that thiophenone TF101 interfered with expression of the virulence genes eae and fimH. In addition, TF101 reduced AI-2 induced E. coli adhesion to colorectal adenocarcinoma cells. TF101, on the other hand, did not affect epinephrine or norepinephrine enhanced E. coli adhesion. Overall, our results showed that thiophenone TF101 interfered with virulence expression in E. coli O103:H2, suggestedly by interfering with AI-2 mediated quorum sensing. We thus conclude that thiophenone TF101 might represent a promising future anti-virulence agent in the fight against pathogenic E. coli.	[Witso, Ingun Lund; Scheie, Anne Aamdal] Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway; [Rukke, Hakon Valen] Nord Inst Dent Mat NIOM, Oslo, Norway; [Benneche, Tore] Univ Oslo, Fac Math & Nat Sci, Dept Chem, Oslo, Norway	University of Oslo; University of Oslo	Witso, IL (corresponding author), Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway.	ingunwitso@gmail.com		Valen, Hakon/0000-0002-9038-4153	Faculty of Dentistry, University of Oslo	Faculty of Dentistry, University of Oslo	This work was funded by the Faculty of Dentistry, University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON P, 1991, INFECT IMMUN, V59, P2915, DOI 10.1128/IAI.59.9.2915-2921.1991; Bansal T, 2008, APPL MICROBIOL BIOT, V78, P811, DOI 10.1007/s00253-008-1359-8; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Benneche T, 2011, RSC ADV, V1, P323, DOI 10.1039/c1ra00254f; Brito PH, 2013, GENOME BIOL EVOL, V5, P16, DOI 10.1093/gbe/evs122; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Defoirdt T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041788; Elhadidy M, 2014, FOODBORNE PATHOG DIS, V11, P874, DOI 10.1089/fpd.2014.1780; Freestone PP, 2002, SHOCK, V18, P465, DOI 10.1097/00024382-200211000-00014; Freestone PPE, 1999, FEMS MICROBIOL LETT, V172, P53, DOI 10.1111/j.1574-6968.1999.tb13449.x; Freestone PPE, 2008, TRENDS MICROBIOL, V16, P55, DOI 10.1016/j.tim.2007.11.005; Hancock V, 2007, FEMS MICROBIOL LETT, V267, P30, DOI 10.1111/j.1574-6968.2006.00507.x; Hernandes RT, 2009, FEMS MICROBIOL LETT, V297, P137, DOI 10.1111/j.1574-6968.2009.01664.x; Hughes DT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000553; Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karavolos MH, 2013, MOL MICROBIOL, V87, P455, DOI 10.1111/mmi.12110; Kendall MM, 2007, INFECT IMMUN, V75, P4875, DOI 10.1128/IAI.00550-07; Kjelleberg S., 2001, MICROBIOL TODAY, V28, P134; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Lee KM, 2011, FEMS MICROBIOL LETT, V321, P67, DOI 10.1111/j.1574-6968.2011.02311.x; Lonn-Stensrud J, 2007, ORAL MICROBIOL IMMUN, V22, P340, DOI 10.1111/j.1399-302X.2007.00367.x; Lonn-Stensrud J, 2010, SCI TECHNOLOGY MICRO, P155; Lonn-Stensrud J, 2012, FEMS IMMUNOL MED MIC, V65, P326, DOI 10.1111/j.1574-695X.2012.00964.x; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Nesse LL, 2014, APPL ENVIRON MICROB, V80, P2042, DOI 10.1128/AEM.03331-13; Pacheco AR, 2009, CURR OPIN MICROBIOL, V12, P192, DOI 10.1016/j.mib.2009.01.006; Pereira CS, 2012, MOL MICROBIOL, V84, P93, DOI 10.1111/j.1365-2958.2012.08010.x; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Ren DC, 2004, BIOTECHNOL BIOENG, V88, P630, DOI 10.1002/bit.20259; Ren DC, 2001, ENVIRON MICROBIOL, V3, P731, DOI 10.1046/j.1462-2920.2001.00249.x; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Sekse C, 2013, APPL ENVIRON MICROB, V79, P7502, DOI 10.1128/AEM.01825-13; Sircili MP, 2004, INFECT IMMUN, V72, P2329, DOI 10.1128/IAI.72.4.2329-2337.2004; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Sperandio V, 2001, J BACTERIOL, V183, P5187, DOI 10.1128/JB.183.17.5187-5197.2001; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Stevens MP, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0007-2013; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Vattem DA, 2007, FITOTERAPIA, V78, P302, DOI 10.1016/j.fitote.2007.03.009; Vestby LK, 2014, J APPL MICROBIOL, V116, P258, DOI 10.1111/jam.12355; Vieira MAM, 2001, J INFECT DIS, V183, P762, DOI 10.1086/318821; Witso IL, 2014, PATHOG DIS, V70, P297, DOI 10.1111/2049-632X.12128; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005; Xue T, 2009, CELL RES, V19, P1258, DOI 10.1038/cr.2009.91; Yang K, 2014, CELL BIOCHEM BIOPHYS, V70, P391, DOI 10.1007/s12013-014-9924-5	51	4	4	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157334	10.1371/journal.pone.0157334	http://dx.doi.org/10.1371/journal.pone.0157334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309855	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800056
J	Yuan, HW; Niu, SH; El-Kassaby, YA; Li, Y; Li, W				Yuan, Huwei; Niu, Shihui; El-Kassaby, Yousry A.; Li, Yue; Li, Wei			Simple Genetic Distance-Optimized Field Deployments for Clonal Seed Orchards Based on Microsatellite Markers: As a Case of Chinese Pine Seed Orchard	PLOS ONE			English	Article							NATURAL-POPULATIONS; UNEQUAL DEPLOYMENT; PARENTAGE ANALYSIS; PATERNITY ANALYSIS; SELECTION; TABULIFORMIS; PARAMETERS; DESIGN	Chinese pine seed orchards are in a period of transition from first-generation to advanced-generations. How to effectively select populations for second-generation seed orchards and significantly increase genetic gain through rational deployment have become major issues. In this study, we examined open-and control-pollinated progeny of the first-generation Chinese pine seed orchards in Zhengning (Gansu Province, China) and Xixian (Shanxi Province, China) to address issues related to phenotypic selection for high volume growth, genetic diversity analysis and genetic distance-based phylogenetic analysis of the selections by simple sequence repeats (SSRs), and phylogenetic relationship-based field deployment for advanced-generation orchards. In total, 40, 28, 20, and 13 superior individuals were selected from the large-scale no-pedigree open-pollinated progeny of Zhengning (ZN-NP), open-pollinated families of Zhengning (ZN-OP), open-pollinated families of Xixian (XX-OP), and control-pollinated families of Xixian, with mean volume dominance ratios of 0.83, 0.15, 0.25, and 0.20, respectively. Phylogenetic relationship analysis of the ZN-NP and XX-OP populations showed that the 40 superior individuals in the ZN-NP selected population belonged to 23 families and could be further divided into five phylogenetic groups, and that families in the same group were closely related. Similarly, 20 families in the XX-OP population were related to varying degrees. Based on these results, we found that second-generation Chinese pine seed orchards in Zhengning and Xixian should adopt a grouped, unbalanced, complete, fixed block design and an unbalanced, incomplete, fixed block design, respectively. This study will provide practical references for applying molecular markers to establishing advanced-generation seed orchards.	[Yuan, Huwei; Niu, Shihui; Li, Yue; Li, Wei] Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Forest Tree Breeding,Minist Educ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China; [El-Kassaby, Yousry A.] Univ British Columbia, Fac Forestry, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada	Beijing Forestry University; University of British Columbia	Li, Y (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Forest Tree Breeding,Minist Educ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China.	liyue@bjfu.edu.cn; bjfuliwei@bjfu.edu.cn	El-Kassaby, Yousry A/K-9856-2016; Niu, Shihui/HCH-9336-2022	El-Kassaby, Yousry A/0000-0002-4887-8977; Niu, Shihui/0000-0002-6296-9373	Fundamental Research Funds for the Central Universities [2015ZCQ-SW-02]; Special Fund for Forestry Scientific Research in the Public Interest [201104022]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Fund for Forestry Scientific Research in the Public Interest	This work was supported by "the Fundamental Research Funds for the Central Universities (No. 2015ZCQ-SW-02)" and "Special Fund for Forestry Scientific Research in the Public Interest (No. 201104022)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlinder J, 2014, TREE GENET GENOMES, V10, P27, DOI 10.1007/s11295-013-0659-z; BELL GD, 1978, SILVAE GENET, V27, P223; Burczyk J, 1997, ANN SCI FOREST, V54, P129, DOI 10.1051/forest:19970201; CHEN B. W, 1992, J BEIJING FORESTRY U, V14, P7; Chen KM, 2008, MOL ECOL, V17, P4276, DOI 10.1111/j.1365-294X.2008.03911.x; El-Kassaby YA, 2014, TREE GENET GENOMES, V10, P555, DOI 10.1007/s11295-014-0703-7; El-Kassaby YA, 2012, NEW FOREST, V43, P631, DOI 10.1007/s11056-012-9338-4; El-Kassaby YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025737; El-Kassaby YA, 2009, GENET RES, V91, P111, DOI 10.1017/S001667230900007X; Fang P, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1300057; Gomes F, 2016, J FOR RES, V24, P227; Grattapaglia D, 2004, THEOR APPL GENET, V109, P192, DOI 10.1007/s00122-004-1617-9; GRIFFIN AR, 1985, THEOR APPL GENET, V71, P334, DOI 10.1007/BF00252077; Hodge GR, 1993, NEW FOREST, V7, P213; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Kang KyuSuk, 1999, Forest Genetics, V6, P191; Klapste J, 2014, TREE GENET GENOMES, V10, P241, DOI 10.1007/s11295-013-0673-1; Korecky J, 2013, TREE GENET GENOMES, V9, P1227, DOI 10.1007/s11295-013-0630-z; Li W, 2012, SILVAE GENET, V61, P133, DOI 10.1515/sg-2012-0017; Li W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016945, 10.1371/journal.pone.0021082]; Lindgren D, 2009, FORESTRY, V82, P17, DOI 10.1093/forestry/cpn033; Lu YQ, 2015, J FORESTRY RES, V26, P963, DOI 10.1007/s11676-015-0093-1; Luikart G, 1999, TRENDS ECOL EVOL, V14, P253, DOI 10.1016/S0169-5347(99)01632-8; Massah N, 2010, J HERED, V101, P154, DOI 10.1093/jhered/esp102; Moriguchi Y, 2011, TREE GENET GENOMES, V7, P1089, DOI 10.1007/s11295-011-0397-z; NAMKOONG G, 1966, FOREST SCI, V12, P8; Ndez JSF, 2009, CONSERV GENET, V10, P45; Neff BD, 2000, MOL ECOL, V9, P515, DOI 10.1046/j.1365-294x.2000.00889.x; Ng CH, 2012, J FOREST RES-JPN, V17, P479, DOI 10.1007/s10310-011-0318-x; Nielsen R, 2001, GENETICS, V157, P1673; PENA SDJ, 1994, TRENDS GENET, V10, P204, DOI 10.1016/0168-9525(94)90257-7; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Shimono A, 2011, TREE GENET GENOMES, V7, P499, DOI 10.1007/s11295-010-0351-5; Wang JL, 2012, MOL ECOL, V21, P100, DOI 10.1111/j.1365-294X.2011.05373.x; Wang SS, 1985, J BEIJING FOR U, V7, P72; Wang XR, 2010, TREE GENET GENOMES, V6, P227, DOI 10.1007/s11295-009-0243-8; WANG XR, 1989, J BEIJING FORESTRY U, V11, P60; Weng YH, 2012, TREE GENET GENOMES, V8, P77, DOI 10.1007/s11295-011-0422-2; Weng YH, 2010, TREE GENET GENOMES, V6, P367, DOI 10.1007/s11295-009-0255-4; Wu C.Y., 1995, VEGETATION CHINA; Xu H., 1993, CHINESE PINE; Yuan HW, 2016, J FORESTRY RES, V27, P1003, DOI 10.1007/s11676-016-0238-x; Yuan HW, 2014, SILVAE GENET, V63, P41, DOI 10.1515/sg-2014-0007; Zhang DongMei, 2007, Journal of Beijing Forestry University, V29, P13; Zhang HuaXin, 2002, Scientia Silvae Sinicae, V38, P129; Zhao P, 2013, NEW FOREST, V44, P357, DOI 10.1007/s11056-012-9343-7	46	2	5	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157646	10.1371/journal.pone.0157646	http://dx.doi.org/10.1371/journal.pone.0157646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310437	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800112
J	Galiani, S; Waithe, D; Reglinski, K; Cruz-Zaragoza, LD; Garcia, E; Clausen, MP; Schliebs, W; Erdmann, R; Eggeling, C				Galiani, Silvia; Waithe, Dominic; Reglinski, Katharina; Cruz-Zaragoza, Luis Daniel; Garcia, Esther; Clausen, Mathias P.; Schliebs, Wolfgang; Erdmann, Ralf; Eggeling, Christian			Super-resolution Microscopy Reveals Compartmentalization of Peroxisomal Membrane Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; membrane trafficking; microscopy; peroxisome; protein import; STED microscopy; super-resolution optical microscopy	RECEPTOR PEX5; STRUCTURAL BASIS; PTS1 RECEPTOR; IMPORT; BIOGENESIS; DISORDERS; DIVISION; PROLIFERATION; ELONGATION; METABOLISM	Membrane-associated events during peroxisomal protein import processes play an essential role in peroxisome functionality. Many details of these processes are not known due to missing spatial resolution of technologies capable of investigating peroxisomes directly in the cell. Here, we present the use of super-resolution optical stimulated emission depletion microscopy to investigate with sub-60-nm resolution the heterogeneous spatial organization of the peroxisomal proteins PEX5, PEX14, and PEX11 around actively importing peroxisomes, showing distinct differences between these peroxins. Moreover, imported protein sterol carrier protein 2 (SCP2) occupies only a subregion of larger peroxisomes, highlighting the heterogeneous distribution of proteins even within the peroxisome. Finally, our data reveal subpopulations of peroxisomes showing only weak colocalization between PEX14 and PEX5 or PEX11 but at the same time a clear compartmentalized organization. This compartmentalization, which was less evident in cases of strong colocalization, indicates dynamic protein reorganization linked to changes occurring in the peroxisomes. Through the use of multicolor stimulated emission depletion microscopy, we have been able to characterize peroxisomes and their constituents to a yet unseen level of detail while maintaining a highly statistical approach, paving the way for equally complex biological studies in the future.	[Galiani, Silvia; Reglinski, Katharina; Clausen, Mathias P.; Eggeling, Christian] Univ Oxford, Med Res Council Human Immunol Unit, Headley Way, Oxford OX3 9DS, England; [Waithe, Dominic; Garcia, Esther; Eggeling, Christian] Univ Oxford, Weatherall Inst Mol Med, Wolfson Imaging Ctr, Headley Way, Oxford OX3 9DS, England; [Cruz-Zaragoza, Luis Daniel; Schliebs, Wolfgang; Erdmann, Ralf] Ruhr Univ Bochum, Inst Physiol Chem, Syst Biochem, Univ Str 150, D-44801 Bochum, Germany; [Clausen, Mathias P.] Univ Southern Denmark, Dept Phys Chem & Pharm, MEMPHYS, Ctr Biomembrane Phys, Campusvej 55, DK-5230 Odense, Denmark	University of Oxford; University of Oxford; Ruhr University Bochum; University of Southern Denmark	Eggeling, C (corresponding author), Univ Oxford, Med Res Council Human Immunol Unit, Headley Way, Oxford OX3 9DS, England.; Eggeling, C (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Wolfson Imaging Ctr, Headley Way, Oxford OX3 9DS, England.	christian.eggeling@rdm.ox.ac.uk	Garcia, Esther/AAH-3794-2020; Clausen, Mathias P./AAE-6487-2020	Garcia, Esther/0000-0002-6424-5379; Clausen, Mathias P./0000-0003-1196-6241; Reglinski, Katharina/0000-0001-8994-067X; Cruz-Zaragoza, Luis Daniel/0000-0001-9568-0245; Waithe, Dominic/0000-0003-2685-4226; Schliebs, Wolfgang/0000-0003-2762-3403	Deutsche Forschungsgemeinschaft [1905]; Wolfson Foundation, Medical Research Council (MRC) [MC_UU_12010, G0902418, MC_UU_12025]; MRC/Biotechnology and Biological Sciences Research Council/Engineering and Physical Sciences Research Council Grant [MR/K01577X/1]; Wellcome Trust [104924/14/Z/14]; Biotechnology and Biological Sciences Research Council [BB/L00433X/1] Funding Source: researchfish; Medical Research Council [G0902418, MC_UU_12010/9, MR/K01577X/1] Funding Source: researchfish; MRC [G0902418, MC_UU_12010/9, MR/K01577X/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wolfson Foundation, Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC/Biotechnology and Biological Sciences Research Council/Engineering and Physical Sciences Research Council Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the Deutsche Forschungsgemeinschaft (Research unit 1905 "Structure and function of the peroxisomal translocon"), the Wolfson Foundation, Medical Research Council (MRC) Grants MC_UU_12010/Unit Programs G0902418 and MC_UU_12025, MRC/Biotechnology and Biological Sciences Research Council/Engineering and Physical Sciences Research Council Grant MR/K01577X/1, and Wellcome Trust Grant 104924/14/Z/14. The authors declare that they have no conflicts of interest with the contents of this article.	Bharti P, 2011, J CELL SCI, V124, P1759, DOI 10.1242/jcs.079368; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Cizmowski C, 2011, HYBRIDOMA, V30, P387, DOI 10.1089/hyb.2011.0038; Clausen M. P., 2013, NANOBIOIMAGING, V1, P1; Delille HK, 2010, J CELL SCI, V123, P2750, DOI 10.1242/jcs.062109; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Gabaldon T, 2010, PHILOS T R SOC B, V365, P765, DOI 10.1098/rstb.2009.0240; Gottfert F, 2013, BIOPHYS J, V105, pL1, DOI 10.1016/j.bpj.2013.05.029; Gould TJ, 2012, OPT EXPRESS, V20, P20998, DOI 10.1364/OE.20.020998; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Islinger M, 2012, HISTOCHEM CELL BIOL, V137, P547, DOI 10.1007/s00418-012-0941-4; Koch A, 2004, J CELL SCI, V117, P3995, DOI 10.1242/jcs.01268; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Kunau W, 2006, BBA-MOL CELL RES, V1763, P1363, DOI 10.1016/j.bbamcr.2006.09.021; Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322; Leon S, 2006, J CELL BIOL, V172, P67, DOI 10.1083/jcb.200508096; Li XL, 2002, J CELL BIOL, V156, P643, DOI 10.1083/jcb.200112028; Marshall PA, 1996, J CELL BIOL, V135, P123, DOI 10.1083/jcb.135.1.123; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Nagotu S, 2012, BBA-MOL BASIS DIS, V1822, P1326, DOI 10.1016/j.bbadis.2012.05.010; Neufeld C, 2009, EMBO J, V28, P745, DOI 10.1038/emboj.2009.7; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Saidowsky J, 2001, J BIOL CHEM, V276, P34524, DOI 10.1074/jbc.M104647200; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Schrader M, 2016, BBA-MOL CELL RES, V1863, P971, DOI 10.1016/j.bbamcr.2015.09.024; Schrader M, 2012, HISTOCHEM CELL BIOL, V138, P541, DOI 10.1007/s00418-012-1010-8; Shai N, 2016, BBA-MOL CELL RES, V1863, P1061, DOI 10.1016/j.bbamcr.2015.09.016; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; Tam YYC, 2003, MOL BIOL CELL, V14, P4089, DOI 10.1091/mbc.E03-03-0150; Waterham HR, 2016, BBA-MOL CELL RES, V1863, P922, DOI 10.1016/j.bbamcr.2015.11.015; Will GK, 1999, MOL CELL BIOL, V19, P2265; Wurm CA, 2011, P NATL ACAD SCI USA, V108, P13546, DOI 10.1073/pnas.1107553108; YAMAMOTO K, 1987, J CELL BIOL, V105, P713, DOI 10.1083/jcb.105.2.713	39	44	44	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					16948	16962		10.1074/jbc.M116.734038	http://dx.doi.org/10.1074/jbc.M116.734038			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27311714	Green Published, hybrid			2022-12-26	WOS:000382643800003
J	Herrema, H; Zhou, YJ; Zhang, DY; Lee, J; Hernandez, MAS; Shulman, GI; Ozcan, U				Herrema, Hilde; Zhou, Yingjiang; Zhang, Dongyan; Lee, Justin; Hernandez, Mario Andres Salazar; Shulman, Gerald I.; Ozcan, Umut			XBP1s Is an Anti-lipogenic Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); insulin resistance; liver; obesity; unfolded protein response (UPR)	FATTY LIVER-DISEASE; HEPATIC INSULIN-RESISTANCE; ENDOPLASMIC-RETICULUM STRESS; ER STRESS; GLUCOSE-HOMEOSTASIS; UNITED-STATES; REGULATORY SUBUNITS; OBESE SUBJECTS; MICE; STEATOSIS	Endoplasmic reticulum (ER) stress has been shown to contribute to various metabolic diseases, including non-alcoholic fatty liver disease and type 2 diabetes. Reduction of ER stress by treatment with chemical chaperones or overexpression of ER chaperone proteins alleviates hepatic steatosis. Nonetheless, X-box binding protein 1s (XBP1s), a key transcription factor that reduces ER stress, has been proposed as a lipogenic transcription factor. In this report, we document that XBP1s leads to suppression of lipogenic gene expression and reduction of hepatic triglyceride and diacylglycerol content in livers of diet-induced obese and genetically obese and insulin-resistant ob/ob mice. Furthermore, we also show that PKCE activity, which correlates with fatty liver and which causes insulin resistance, was significantly reduced in diet-induced obese mice. Finally, we have shown that XBP1s reduces the hepatic fatty acid synthesis rate and enhances macrolipophagy, an initiating step in lipolysis. Our results reveal that XBP1s reduces hepatic lipogenic gene expression and improves hepatosteatosis in mouse models of obesity and insulin resistance, which leads us to conclude that XBP1s has anti-lipogenic properties in the liver.	[Herrema, Hilde; Zhou, Yingjiang; Lee, Justin; Hernandez, Mario Andres Salazar; Ozcan, Umut] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Zhang, Dongyan; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06519 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Herrema, H; Ozcan, U (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA.	hilde.herrema@childrens.harvard.edu; umut.ozcan@childrens.harvard.edu	Salazar, Mario/GSN-2646-2022; Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Herrema, Hilde/0000-0002-0112-6348	Department of Medicine, Boston Children's Hospital; National Institutes of Health [R01DK081009, R01DK098496, R01 DK-40936, U24 DK-059635]; American Diabetes Association Career Development Grant [7-09-CD-10]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, R01DK081009, U24DK059635, R01DK098496] Funding Source: NIH RePORTER	Department of Medicine, Boston Children's Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Career Development Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funds from the Department of Medicine, Boston Children's Hospital (to U. O.); National Institutes of Health Grants R01DK081009 and R01DK098496 (to U. O.), R01 DK-40936, and U24 DK-059635; and by American Diabetes Association Career Development Grant 7-09-CD-10. U. O. is a scientific founder, shareholder, and member of the scientific advisory board and board of directors of ERX Pharmaceuticals, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Deng YF, 2013, J CLIN INVEST, V123, P455, DOI 10.1172/JCI62819; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; HARWOOD HJ, 1993, J LIPID RES, V34, P377; Jornayvaz FR, 2011, P NATL ACAD SCI USA, V108, P5748, DOI 10.1073/pnas.1103451108; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Lee JS, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep126; Magkos F, 2012, GASTROENTEROLOGY, V142, P1444, DOI 10.1053/j.gastro.2012.03.003; Neeland IJ, 2012, JAMA-J AM MED ASSOC, V308, P1150, DOI 10.1001/2012.jama.11132; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Papackova Z, 2012, PHYSIOL RES, V61, pS67, DOI 10.33549/physiolres.932394; Park SW, 2014, CELL METAB, V20, P73, DOI 10.1016/j.cmet.2014.04.006; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Raddatz K, 2011, DIABETOLOGIA, V54, P1447, DOI 10.1007/s00125-011-2073-0; Ratziu V, 2015, J HEPATOL, V62, pS65, DOI 10.1016/j.jhep.2015.02.041; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Shao ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4528; Sharma S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025269; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Smits MM, 2013, J GASTROEN HEPATOL, V28, P664, DOI 10.1111/jgh.12106; Tolman KG, 2007, DIABETES CARE, V30, P734, DOI 10.2337/dc06-1539; Upadhyay J, 2014, NEW ENGL J MED, V371, P285, DOI 10.1056/NEJMc1406009; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293; Zoppini G, 2014, AM J GASTROENTEROL, V109, P1020, DOI 10.1038/ajg.2014.132	51	48	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17394	17404		10.1074/jbc.M116.728949	http://dx.doi.org/10.1074/jbc.M116.728949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27325692	Green Published, hybrid			2022-12-26	WOS:000382643800038
J	Khatlani, T; Pradhan, S; Da, Q; Shaw, T; Buchman, VL; Cruz, MA; Vijayan, KV				Khatlani, Tanvir; Pradhan, Subhashree; Da, Qi; Shaw, Tanner; Buchman, Vladimir L.; Cruz, Miguel A.; Vijayan, K. Vinod			A Novel Interaction of the Catalytic Subunit of Protein Phosphatase 2A with the Adaptor Protein CIN85 Suppresses Phosphatase Activity and Facilitates Platelet Outside-in (IIb3) Integrin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; adhesion; fibrinogen; integrin; platelet; protein phosphatase 2A	CHRONIC LYMPHOCYTIC-LEUKEMIA; OKADAIC ACID; PI 3-KINASE; ALPHA(IIB)BETA(3); ADHESION; ISOFORMS; PP2A; AGGREGATION; EXPRESSION; RUK/CIN85	The transduction of signals generated by protein kinases and phosphatases are critical for the ability of integrin (IIb3) to support stable platelet adhesion and thrombus formation. Unlike kinases, it remains unclear how serine/threonine phosphatases engage the signaling networks that are initiated following integrin ligation. Because protein-protein interactions form the backbone of signal transduction, we searched for proteins that interact with the catalytic subunit of protein phosphatase 2A (PP2Ac). In a yeast two-hybrid study, we identified a novel interaction between PP2Ac and an adaptor protein CIN85 (Cbl-interacting protein of 85 kDa). Truncation and alanine mutagenesis studies revealed that PP2Ac binds to the P3 block ((396)PAIPPKKPRP(405)) of the proline-rich region in CIN85. The interaction of purified PP2Ac with CIN85 suppressed phosphatase activity. Human embryonal kidney 293 (IIb3) cells overexpressing a CIN85 P3 mutant, which cannot support PP2Ac binding, displayed decreased adhesion to immobilized fibrinogen. Platelets contain the approximate to 85 kDa CIN85 protein along with the PP2Ac-CIN85 complex. A myristylated cell-permeable peptide derived from residues 395-407 of CIN85 protein (P3 peptide) disrupted the platelet PP2Ac-CIN85 complex and decreased (IIb3) signaling dependent functions such as platelet spreading on fibrinogen and thrombin-mediated fibrin clot retraction. In a phospho-profiling study P3 peptide treated platelets also displayed decreased phosphorylation of several signaling proteins including Src and GSK3. Taken together, these data support a role for the novel PP2Ac-CIN85 complex in supporting integrin-dependent platelet function by dampening the phosphatase activity.	[Khatlani, Tanvir; Pradhan, Subhashree; Da, Qi; Shaw, Tanner; Cruz, Miguel A.; Vijayan, K. Vinod] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Cruz, Miguel A.; Vijayan, K. Vinod] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Cruz, Miguel A.; Vijayan, K. Vinod] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Cruz, Miguel A.; Vijayan, K. Vinod] Baylor Coll Med, Houston, TX 77030 USA; MEDVAMC, CTRID, Houston, TX 77030 USA; [Buchman, Vladimir L.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Cardiff University	Vijayan, KV (corresponding author), Baylor Coll Med, Cardiovasc Res Sect, Rm 146,Bldg 109,2002 Holcombe Blvd, Houston, TX 77030 USA.; Vijayan, KV (corresponding author), MEDVAMC, Rm 146,Bldg 109,2002 Holcombe Blvd, Houston, TX 77030 USA.	vvijayan@bcm.edu	Buchman, Vladimir L/A-4814-2010	Buchman, Vladimir L/0000-0002-7631-8352	National Institutes of Health [HL081613, GM112806]; American Heart Association [13 GRNT17260021]; Mary R. Gibson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Mary R. Gibson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL081613 and GM112806 and American Heart Association Grant 13 GRNT17260021. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Mary R. Gibson Foundation.	Alrehani N, 2013, THROMB HAEMOSTASIS, V109, P118, DOI 10.1160/TH12-04-0237; Borinstein SC, 2000, CELL SIGNAL, V12, P769, DOI 10.1016/S0898-6568(00)00129-7; Borthwick EB, 2004, J MOL BIOL, V343, P1135, DOI 10.1016/j.jmb.2004.08.075; Buchman VL, 2002, GENE, V295, P13, DOI 10.1016/S0378-1119(02)00821-1; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Christensen DJ, 2011, BLOOD, V118, P4150, DOI 10.1182/blood-2011-04-351072; Ciccone M, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00021; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; Estevez B, 2015, ARTERIOSCL THROM VAS, V35, P24, DOI 10.1161/ATVBAHA.114.303411; Finniss S, 2004, BIOCHEM BIOPH RES CO, V325, P174, DOI 10.1016/j.bbrc.2004.10.007; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; Gushiken FC, 2008, J BIOL CHEM, V283, P12862, DOI 10.1074/jbc.M708804200; Haesen D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00347; Havrylov S, 2010, TRAFFIC, V11, P721, DOI 10.1111/j.1600-0854.2010.01061.x; HOYT CH, 1995, BIOCHEMISTRY-US, V34, P9565, DOI 10.1021/bi00029a033; Jiang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2663; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Lambrecht C, 2013, METHODS MOL BIOL, V1053, P283, DOI 10.1007/978-1-62703-562-0_17; Lerea KM, 1999, J BIOL CHEM, V274, P1914, DOI 10.1074/jbc.274.4.1914; Li M, 1998, METH MOL B, V93, P59; Liu Q, 2008, BLOOD, V111, P275, DOI 10.1182/blood-2006-10-053884; Mauco G, 1997, CELL SIGNAL, V9, P117, DOI 10.1016/S0898-6568(96)00119-2; Mayevska O., 2006, Experimental Oncology, V28, P275; McConnell JL, 2007, ONCOGENE, V26, P6021, DOI 10.1038/sj.onc.1210406; McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140; Narita T, 2001, CYTOGENET CELL GENET, V93, P133, DOI 10.1159/000056966; NISHIKAWA M, 1994, CELL SIGNAL, V6, P59, DOI 10.1016/0898-6568(94)90061-2; Pradhan S, 2010, J BIOL CHEM, V285, P29059, DOI 10.1074/jbc.M109.085167; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Shattil SJ, 2009, J THROMB HAEMOST, V7, P210, DOI 10.1111/j.1538-7836.2009.03397.x; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shen B, 2013, NATURE, V503, P131, DOI 10.1038/nature12613; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Simon LM, 2014, BLOOD, V123, pE37, DOI 10.1182/blood-2013-12-544692; Stalker TJ, 2014, CURR OPIN HEMATOL, V21, P410, DOI 10.1097/MOH.0000000000000070; Switzer CH, 2011, ONCOGENE, V30, P2504, DOI 10.1038/onc.2010.622; Vijayan KV, 2000, J CLIN INVEST, V105, P793, DOI 10.1172/JCI6982	39	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17360	17368		10.1074/jbc.M115.704296	http://dx.doi.org/10.1074/jbc.M115.704296			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27334924	Green Published, hybrid			2022-12-26	WOS:000382643800035
J	Ullrich, F; Reincke, SM; Voss, FK; Stauber, T; Jentsch, TJ				Ullrich, Florian; Reincke, S. Momsen; Voss, Felizia K.; Stauber, Tobias; Jentsch, Thomas J.			Inactivation and Anion Selectivity of Volume-regulated Anion Channels (VRACs) Depend on C-terminal Residues of the First Extracellular Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anion transport; chloride channel; electrophysiology; gating; ion channel; structure-function; ICl; swell; VSOAC; VSOR	CELL-CELL COMMUNICATION; LEUCINE-RICH REPEAT; ESSENTIAL COMPONENT; MAMMALIAN-CELLS; K+ CHANNELS; IDENTIFICATION; CONDUCTANCE; MECHANISMS; PROTEIN; DRUGS	Canonical volume-regulated anion channels (VRACs) are crucial for cell volume regulation and have many other important roles, including tumor drug resistance and release of neurotransmitters. Although VRAC-mediated swelling-activated chloride currents (I-Cl,I-vol) have been studied for decades, exploration of the structure-function relationship of VRAC has become possible only after the recent discovery that VRACs are formed by differently composed heteromers of LRRC8 proteins. Inactivation of I-Cl,I-vol at positive potentials, a typical hallmark of VRACs, strongly varies between native cell types. Exploiting the large differences in inactivation between different LRRC8 heteromers, we now used chimeras assembled from isoforms LRRC8C and LRRC8E to uncover a highly conserved extracellular region preceding the second LRRC8 transmembrane domain as a major determinant of I-Cl,I-vol inactivation. Point mutations identified two amino acids (Lys-98 and Asp-100 in LRRC8A and equivalent residues in LRRC8C and -E), which upon charge reversal strongly altered the kinetics and voltage dependence of inactivation. Importantly, charge reversal at the first position also reduced the iodide > chloride permeability of I-Cl,I-vol. This change in selectivity was stronger when both the obligatory LRRC8A subunit and the other co-expressed isoform (LRR8C or -E) carried such mutations. Hence, the C-terminal part of the first extracellular loop not only determines VRAC inactivation but might also participate in forming its outer pore. Inactivation of VRACs may involve a closure of the extracellular mouth of the permeation pathway.	[Ullrich, Florian; Reincke, S. Momsen; Voss, Felizia K.; Stauber, Tobias; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Ullrich, Florian; Reincke, S. Momsen; Voss, Felizia K.; Stauber, Tobias; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Ullrich, Florian] Free Univ Berlin, Grad Program, D-14195 Berlin, Germany; [Jentsch, Thomas J.] Charite, Neurocure, D-10117 Berlin, Germany; [Stauber, Tobias] Free Univ Berlin, Inst Chem & Biochem, Thielallee 63, D-14195 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Jentsch, TJ (corresponding author), FMP MDC, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de	Ullrich, Florian/AAA-6043-2019; Stauber, Tobias/E-4005-2010	Ullrich, Florian/0000-0002-1153-2040; Stauber, Tobias/0000-0003-0727-6109; Jentsch, Thomas/0000-0002-3509-2553; Reincke, Momsen/0000-0002-8132-3527	European Research Council (ERC) [294435]; DFG (Exc) [257]	European Research Council (ERC)(European Research Council (ERC)); DFG (Exc)(German Research Foundation (DFG))	This work was supported by European Research Council (ERC) Advanced Grant (FP/2007-2013) 294435 "Cytovolion" and the DFG (Exc 257 "Neurocure") (to T. J. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Abascal F, 2012, BIOESSAYS, V34, P551, DOI 10.1002/bies.201100173; Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jackson PS, 1996, KIDNEY INT, V49, P1695, DOI 10.1038/ki.1996.250; JACKSON PS, 1995, J GEN PHYSIOL, V105, P661, DOI 10.1085/jgp.105.5.661; Jentsch TJ, 2016, NAT REV MOL CELL BIO, V17, P293, DOI 10.1038/nrm.2016.29; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Kumar L, 2014, J EXP MED, V211, P929, DOI 10.1084/jem.20131379; Lee CC, 2014, J BIOL CHEM, V289, P17124, DOI 10.1074/jbc.M114.571257; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; OKADA Y, 1994, JPN J PHYSIOL, V44, P403, DOI 10.2170/jjphysiol.44.403; Okada Y, 2009, J PHYSIOL-LONDON, V587, P2141, DOI 10.1113/jphysiol.2008.165076; Pasantes-Morales H, 2006, AM J MED, V119, pS4, DOI 10.1016/j.amjmed.2006.05.002; Pedersen SF, 2015, ACTA PHYSIOL, V213, P868, DOI 10.1111/apha.12450; Planells-Cases R, 2015, EMBO J, V34, P2993, DOI 10.15252/embj.201592409; Qiu F, 2012, PURINERG SIGNAL, V8, P81, DOI 10.1007/s11302-011-9263-6; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Syeda R, 2016, CELL, V164, P499, DOI 10.1016/j.cell.2015.12.031; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Voets T, 1997, J GEN PHYSIOL, V110, P313, DOI 10.1085/jgp.110.3.313; Voets T, 2015, EMBO J, V34, P2985, DOI 10.15252/embj.201593357; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wang JJ, 2010, J GEN PHYSIOL, V136, P515, DOI 10.1085/jgp.201010440	29	43	43	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17040	17048		10.1074/jbc.M116.739342	http://dx.doi.org/10.1074/jbc.M116.739342			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27325695	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000382643800011
J	Brocklehurst, N; Reisz, RR; Fernandez, V; Frobisch, J				Brocklehurst, Neil; Reisz, Robert R.; Fernandez, Vincent; Frobisch, Jorg			A Re-Description of 'Mycterosaurus' smithae, an Early Permian Eothyridid, and Its Impact on the Phylogeny of Pelycosaurian-Grade Synapsids	PLOS ONE			English	Article							TEXAS; EUPELYCOSAURIA; OSTEOLOGY; REPTILES; ANATOMY; ROMERI; GENUS	'Mycterosaurus' smithae, from the Cisuralian (early Permian) of Colorado, was first described in 1965 as a second species of the genus Mycterosaurus. While the type species of this genus, M. longiceps, has been shown by multiple cladistic analyses to belong to the basal synapsid family Varanopidae, 'M.' smithae has been largely ignored since its original description. Additional preparation and synchrotron scanning has revealed new significant information that supports the assignment of this species to a new genus: Vaughnictis gen. nov. Vaughnictis lacks many of the characteristics of mycterosaurines and varanopids in general: it lacks the slender femur, the linguo-labially compressed and strongly recurved teeth, and the lateral boss on the postorbital characteristic of this family. Instead, it possesses coronoid teeth, a large supratemporal, and a large pineal foramen positioned midway along the length of the parietal, features that support its assignment to Eothyrididae. Moreover, the postcranium shares many characters with the eothyridid Oedaleops. An expanded version of a recently published phylogenetic analysis of pelycosaurian-grade synapsids positions Vaughnictis as the sister taxon of Eothyris within the clade Eothyrididae. The addition of data on the postcranium of eothyridids and the inclusion of the recently-described basal caseid Eocasea confirms the recently-disputed position of caseasaurs as the most basal synapsids. As the parsimony analysis produced low support values and a lack of resolution due to missing data, additional analyses were undertaken using Bayesian and Implied Weights methods, which produced better resolution and relationships with higher support values. While the results are similar, alternative positions for the enigmatic Moscovian age (Carboniferous) synapsid Echinerpeton are suggested by Bayesian analysis; the parsimony analysis found it to be an ophiacodontid, while the Bayesian and Implied Weights analysis found it to be the sister to the Sphenacomorpha.	[Brocklehurst, Neil; Frobisch, Jorg] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Invalidenstr 43, D-10115 Berlin, Germany; [Reisz, Robert R.] Univ Toronto, Dept Biol, 3359 Mississauga Rd, Mississauga, ON L5L 1C6, Canada; [Fernandez, Vincent] European Synchrotron Radiat Facil, 71 Ave Martyrs, F-38000 Grenoble, France; [Frobisch, Jorg] Humboldt Univ, Inst Biol, Invalidenstr 110, D-10115 Berlin, Germany	Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Toronto; University Toronto Mississauga; European Synchrotron Radiation Facility (ESRF); Humboldt University of Berlin	Brocklehurst, N (corresponding author), Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Invalidenstr 43, D-10115 Berlin, Germany.	neil.brocklehurst@mfn-berlin.de		Fernandez, Vincent/0000-0002-8315-1458	Sofja Kovalevskaja Award; Alexander von Humboldt Foundation; DFG grant [FR 2457/5-1]; NSERC Discovery Grant	Sofja Kovalevskaja Award; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); DFG grant(German Research Foundation (DFG)); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a Sofja Kovalevskaja Award, which is awarded by the Alexander von Humboldt Foundation and donated by the German Federal Ministry for Education and Research, and by DFG grant FR 2457/5-1, both awarded to Jorg Frobisch, and an NSERC Discovery Grant awarded to Robert R. Reisz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baars D. L., 1974, GHOST RANCH NEW MEXI, P167; Baars D.L., 1962, AAPG BULL, V46, P149; Benson RBJ, 2012, J SYST PALAEONTOL, V10, P601, DOI 10.1080/14772019.2011.631042; BERMAN D S, 1982, Annals of Carnegie Museum, V51, P423; Botha-Brink J, 2009, J VERTEBR PALEONTOL, V29, P389, DOI 10.1671/039.029.0209; Brocklehurst N, 2014, PALAEOGEOGR PALAEOCL, V399, P114, DOI 10.1016/j.palaeo.2014.02.006; Brocklehurst N, 2013, PALEOBIOLOGY, V39, P470, DOI 10.1666/12049; Campione NE, 2010, J VERTEBR PALEONTOL, V30, P724, DOI 10.1080/02724631003762914; Evans Susan E., 2008, Contributions to Herpetology, V23, P1; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2001, CLADISTICS, V17, pS26, DOI 10.1111/j.1096-0031.2001.tb00102.x; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GOW CE, 1972, J ZOOL, V167, P219; Kluge AG, 1997, ZOOL SCR, V26, P349, DOI 10.1111/j.1463-6409.1997.tb00424.x; Kluge AG, 1997, CLADISTICS, V13, P81, DOI 10.1111/j.1096-0031.1997.tb00242.x; Kluge Arnold G., 2005, P15; Langston Jr W., 1965, B TEX MEM MUS, V9, P5; LAURIN M, 1991, ZOOL J LINN SOC-LOND, V101, P59, DOI 10.1111/j.1096-3642.1991.tb00886.x; Lee MSY, 2012, BIOL LETTERS, V8, P299, DOI 10.1098/rsbl.2011.0884; Lewis G. E., 1965, Professional Papers US Geological Survey, VNo. 503-C, P1; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Lucas SG, 2006, SPECIAL PUBLICATION, V265; Lucas SG, 2013, INT J COAL GEOL, V119, P79, DOI 10.1016/j.coal.2013.04.007; Maddin HC, 2006, J VERTEBR PALEONTOL, V26, P957, DOI 10.1671/0272-4634(2006)26[957:AEPVVS]2.0.CO;2; Maddin HC, 2008, J VERTEBR PALEONTOL, V28, P160, DOI 10.1671/0272-4634(2008)28[160:CAOETS]2.0.CO;2; Mahler D. Luke, 2006, Fieldiana Zoology, P1; Mirone A, 2014, NUCL INSTRUM METH B, V324, P41, DOI 10.1016/j.nimb.2013.09.030; Muller J, 2006, SYSTEMATIC BIOL, V55, P503, DOI 10.1080/10635150600755396; Muller J, 2005, J VERTEBR PALEONTOL, V25, P561, DOI 10.1671/0272-4634(2005)025[0561:AECRAE]2.0.CO;2; OLSON EVERETT CLAIRE, 1954, FIELDIANA GEOL, V10, P193; Osborn H F, 1903, Science, V17, P275, DOI 10.1126/science.17.424.275-b; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Pol D, 2009, CLADISTICS, V25, P515, DOI 10.1111/j.1096-0031.2009.00258.x; Price LI, 1940, SPECIAL PUBLICATIONS, V28; Reisz R.R., 1997, OKLA GEOL NOTES, V57, P160; Reisz RR, 2014, J VERTEBR PALEONTOL, V34, P1033, DOI 10.1080/02724634.2013.829844; Reisz RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094518; Reisz RR, 2010, J VERTEBR PALEONTOL, V30, P1628, DOI 10.1080/02724634.2010.501441; Reisz RR, 2009, J VERTEBR PALEONTOL, V29, P39, DOI 10.1671/039.029.0112; REISZ RR, 1977, SCIENCE, V196, P1091, DOI 10.1126/science.196.4294.1091; Reisz RR, 2001, ANN CARNEGIE MUS, V70, P113; Reisz RR, 1998, J VERTEBR PALEONTOL, V18, P602, DOI 10.1080/02724634.1998.10011087; Romano M, 2015, PALAEONTOLOGY, V58, P1109, DOI 10.1111/pala.12197; Romer A. S., 1937, Proceedings of the New England Zoological Club, V16, P89; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sigogneau-Russell D., 1974, B MUSEUM NATL HIST N, V230, P145; Spencer MR, 2013, CLADISTICS, V29, P663, DOI 10.1111/cla.12018; Spindler F, 2016, ACTA PALAEO IN PRESS, V61; Stovall JW, 1937, AM J SCI, V34, P308; Sumida SS, 2014, VERTEBR PALEOBIOL PA, P7, DOI 10.1007/978-94-007-6841-3_2; Wellnhofer P, 1986, HANBUCH PALEOHERPETO; Williston SW, 1912, J MORPHOL, V23, P637, DOI 10.1002/jmor.1050230404; Williston SW, 1915, AM J SCI, V39, P575; Wright AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109210	56	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0156810	10.1371/journal.pone.0156810	http://dx.doi.org/10.1371/journal.pone.0156810			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333277	Green Submitted, Green Published, gold			2022-12-26	WOS:000378212800016
J	Kang, YB; Pan, QH; Wang, XT; He, MF				Kang, Yibin; Pan, Qiuhui; Wang, Xueting; He, Mingfeng			A Five-Species Jungle Game	PLOS ONE			English	Article							SPECIES COEXISTENCE; COMPETITION; DYNAMICS; PROMOTES; PATTERN; BIODIVERSITY; ALLELOPATHY; EVOLUTION	In this paper, we investigate the five-species Jungle game in the framework of evolutionary game theory. We address the coexistence and biodiversity of the system using mean-field theory and Monte Carlo simulations. Then, we find that the inhibition from the bottom-level species to the top-level species can be critical factors that affect biodiversity, no matter how it is distributed, whether homogeneously well mixed or structured. We also find that predators' different preferences for food affect species' coexistence.	[Kang, Yibin; Pan, Qiuhui; Wang, Xueting; He, Mingfeng] Dalian Univ Technol, Sch Math Sci, Dalian 116024, Peoples R China; [Pan, Qiuhui] Dalian Univ Technol, Sch Innovat Expt, Dalian 116024, Peoples R China	Dalian University of Technology; Dalian University of Technology	He, MF (corresponding author), Dalian Univ Technol, Sch Math Sci, Dalian 116024, Peoples R China.	mfhe@dlut.edu.cn						Avelino PP, 2014, PHYS LETT A, V378, P393, DOI 10.1016/j.physleta.2013.11.041; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; Cameron DD, 2009, J ECOL, V97, P1311, DOI 10.1111/j.1365-2745.2009.01568.x; Cheng HY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07486; Claussen JC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058104; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; Dobrinevski A, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012721; Durney CH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051108; Durrett R, 1998, THEOR POPUL BIOL, V53, P30, DOI 10.1006/tpbi.1997.1338; Durrett R, 1997, J THEOR BIOL, V185, P165, DOI 10.1006/jtbi.1996.0292; Feng SS, 2013, PHYSICA A, V392, P4675, DOI 10.1016/j.physa.2013.05.033; Gilg O, 2003, SCIENCE, V302, P866, DOI 10.1126/science.1087509; Guill C, 2011, J THEOR BIOL, V276, P16, DOI 10.1016/j.jtbi.2011.01.036; Imhof LA, 2007, J THEOR BIOL, V247, P574, DOI 10.1016/j.jtbi.2007.03.027; Intoy B, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/08/P08011; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; Kang YB, 2013, PHYSICA A, V392, P2652, DOI 10.1016/j.physa.2012.10.011; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; Knebel J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.168106; Laird RA, 2009, J THEOR BIOL, V256, P90, DOI 10.1016/j.jtbi.2008.09.017; Lankau RA, 2007, SCIENCE, V317, P1561, DOI 10.1126/science.1147455; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Li L, 2016, APPL MATH MODEL, V40, P4765, DOI 10.1016/j.apm.2015.12.003; Li L, 2015, APPL MATH COMPUT, V258, P342, DOI 10.1016/j.amc.2015.02.006; Li YM, 2012, PHYSICA A, V391, P125, DOI 10.1016/j.physa.2011.08.019; Nahum JR, 2011, P NATL ACAD SCI USA, V108, P10831, DOI 10.1073/pnas.1100296108; Neumann GF, 2010, BIOSYSTEMS, V99, P155, DOI 10.1016/j.biosystems.2009.10.007; Reichenbach T, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051907; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; SILVERTOWN J, 1992, J ECOL, V80, P527, DOI 10.2307/2260696; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Stouffer DB, 2012, SCIENCE, V335, P1489, DOI 10.1126/science.1216556; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1097, DOI 10.1007/s11071-012-0330-5; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1631, DOI 10.1007/s11071-012-0374-6; Szabo G, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041919; Szabo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051921; Szolnoki A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0735; TAYLOR DR, 1990, AM NAT, V136, P305, DOI 10.1086/285100; Vukov J, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022123	44	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157938	10.1371/journal.pone.0157938	http://dx.doi.org/10.1371/journal.pone.0157938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332995	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212800058
J	Wang, XF; Song, Y; Liu, YS; Sun, YC; Wang, YG; Wang, Y; Lyu, PJ				Wang, Xiao-Fei; Song, Yang; Liu, Yun-Song; Sun, Yu-chun; Wang, Yu-guang; Wang, Yong; Lyu, Pei-Jun			Osteogenic Differentiation of Three-Dimensional Bioprinted Constructs Consisting of Human Adipose-Derived Stem Cells In Vitro and In Vivo	PLOS ONE			English	Article							TISSUE; SCAFFOLDS; HYDROGELS; REGENERATION; LADEN; BIOFABRICATION; ALGINATE	Here, we aimed to investigate osteogenic differentiation of human adipose-derived stem cells (hASCs) in three-dimensional (3D) bioprinted tissue constructs in vitro and in vivo. A 3D Bio-plotter dispensing system was used for building 3D constructs. Cell viability was determined using live/dead cell staining. After 7 and 14 days of culture, real-time quantitative polymerase chain reaction (PCR) was performed to analyze the expression of osteogenesis-related genes (RUNX2, OSX, and OCN). Western blotting for RUNX2 and immunofluorescent staining for OCN and RUNX2 were also performed. At 8 weeks after surgery, osteoids secreted by osteogenically differentiated cells were assessed by hematoxylin-eosin (H&E) staining, Masson trichrome staining, and OCN immunohistochemical staining. Results from live/dead cell staining showed that most of the cells remained alive, with a cell viability of 89%, on day 1 after printing. In vitro osteogenic induction of the 3D construct showed that the expression levels of RUNX2, OSX, and OCN were significantly increased on days 7 and 14 after printing in cells cultured in osteogenic medium (OM) compared with that in normal proliferation medium (PM). Fluorescence microscopy and western blotting showed that the expression of osteogenesis-related proteins was significantly higher in cells cultured in OM than in cells cultured in PM. In vivo studies demonstrated obvious bone matrix formation in the 3D bioprinted constructs. These results indicated that 3D bioprinted constructs consisting of hASCs had the ability to promote mineralized matrix formation and that hASCs could be used in 3D bioprinted constructs for the repair of large bone tissue defects.	[Wang, Yong; Lyu, Pei-Jun] Peking Univ, Sch & Hosp Stomatol, Fac Prosthodont, Ctr Digital Dent, Beijing 100081, Peoples R China; Minist Hlth, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing 100081, Peoples R China; Minist Hlth, Res Ctr Engn & Technol Digital Dent, Beijing 100081, Peoples R China	Peking University	Wang, Y; Lyu, PJ (corresponding author), Peking Univ, Sch & Hosp Stomatol, Fac Prosthodont, Ctr Digital Dent, Beijing 100081, Peoples R China.	kqcadc@bjmu.edu.cn; kqlpj@bjmu.edu.cn	, 孙玉春/AAX-5280-2020		Project of the Chinese Ministry of Education, China [113002A]	Project of the Chinese Ministry of Education, China	This manuscript was supported by the Project of the Chinese Ministry of Education, China (113002A). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyewickreme A, 2009, INTEGR BIOL-UK, V1, P260, DOI 10.1039/b819889f; Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069; Barron JA, 2004, APPL PHYS A, V79, P4; Billiet T, 2014, BIOMATERIALS, V35, P49, DOI 10.1016/j.biomaterials.2013.09.078; Cecchini MP, 2014, ANAT HISTOL EMBRYOL, V43, P239, DOI 10.1111/ahe.12074; Fedorovich NE, 2008, TISSUE ENG PT A, V14, P127, DOI 10.1089/ten.a.2007.0158; Fedorovich NE, 2012, TISSUE ENG PART C-ME, V18, P33, DOI [10.1089/ten.tec.2011.0060, 10.1089/ten.TEC.2011.0060]; Ferris CJ, 2013, APPL MICROBIOL BIOT, V97, P4243, DOI 10.1007/s00253-013-4853-6; Gao GF, 2014, BIOTECHNOL J, V9, P1304, DOI 10.1002/biot.201400305; Gotz C, 2015, OR SURG OR MED OR PA, V120, P315, DOI 10.1016/j.oooo.2015.05.022; Gruene M, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/1/015005; Guillemot F, 2010, ACTA BIOMATER, V6, P2494, DOI 10.1016/j.actbio.2009.09.029; Inzana JA, 2014, BIOMATERIALS, V35, P4026, DOI 10.1016/j.biomaterials.2014.01.064; Jia J, 2014, ACTA BIOMATER, V10, P4323, DOI 10.1016/j.actbio.2014.06.034; Koroleva A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118164; Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4; Lee CH, 2014, TISSUE ENG PT A, V20, P1342, DOI [10.1089/ten.tea.2013.0386, 10.1089/ten.TEA.2013.0386]; Lindborg BA, 2015, TISSUE ENG PT A, V21, P1952, DOI [10.1089/ten.TEA.2014.0335, 10.1089/ten.tea.2014.0335]; Liu Yu-Qiang, 2014, J Anal Methods Chem, V2014, P617367, DOI 10.1155/2014/617367; Liu YS, 2014, BIOMATERIALS, V35, P4489, DOI 10.1016/j.biomaterials.2014.02.025; Liu YS, 2008, BIOMATERIALS, V29, P3338, DOI 10.1016/j.biomaterials.2008.04.037; Lu S, 2014, BIOMATERIALS, V35, P8829, DOI 10.1016/j.biomaterials.2014.07.006; Mandrycky C, 2015, BIOTECHNOLOGY ADV; Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7; Mironov V, 2007, J MATER CHEM, V17, P2054, DOI 10.1039/b617903g; Mironov V, 2006, TISSUE ENG, V12, P631, DOI 10.1089/ten.2006.12.631; Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023; Murphy KC, 2014, CELL TISSUE RES, V357, P91, DOI 10.1007/s00441-014-1830-z; Murphy SV, 2013, J BIOMED MATER RES A, V101, P272, DOI 10.1002/jbm.a.34326; Neufurth M, 2014, BIOMATERIALS, V35, P8810, DOI 10.1016/j.biomaterials.2014.07.002; Ouyang LL, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015010; Phillippi JA, 2008, STEM CELLS, V26, P127, DOI 10.1634/stemcells.2007-0520; Tasoglu S, 2013, TRENDS BIOTECHNOL, V31, P10, DOI 10.1016/j.tibtech.2012.10.005; Torres AL, 2013, MAT SCI ENG C-MATER, V33, P4460, DOI 10.1016/j.msec.2013.07.003; Yilgor P, 2008, MACROMOL SYMP, V269, P92, DOI 10.1002/masy.200850911; Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102	36	34	35	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157214	10.1371/journal.pone.0157214	http://dx.doi.org/10.1371/journal.pone.0157214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27332814	gold, Green Submitted, Green Published			2022-12-26	WOS:000378212800023
J	Yates, KL; Mellin, C; Caley, MJ; Radford, BT; Meeuwig, JJ				Yates, Katherine L.; Mellin, Camille; Caley, M. Julian; Radford, Ben T.; Meeuwig, Jessica J.			Models of Marine Fish Biodiversity: Assessing Predictors from Three Habitat Classification Schemes	PLOS ONE			English	Article							SPECIES RICHNESS; REGRESSION TREES; CONSERVATION; ASSEMBLAGES; ABUNDANCE; FISHERIES; PATTERNS; IMPACTS; SHELF	Prioritising biodiversity conservation requires knowledge of where biodiversity occurs. Such knowledge, however, is often lacking. New technologies for collecting biological and physical data coupled with advances in modelling techniques could help address these gaps and facilitate improved management outcomes. Here we examined the utility of environmental data, obtained using different methods, for developing models of both uni- and multivariate biodiversity metrics. We tested which biodiversity metrics could be predicted best and evaluated the performance of predictor variables generated from three types of habitat data: acoustic multibeam sonar imagery, predicted habitat classification, and direct observer habitat classification. We used boosted regression trees (BRT) to model metrics of fish species richness, abundance and biomass, and multivariate regression trees (MRT) to model biomass and abundance of fish functional groups. We compared model performance using different sets of predictors and estimated the relative influence of individual predictors. Models of total species richness and total abundance performed best; those developed for endemic species performed worst. Abundance models performed substantially better than corresponding biomass models. In general, BRT and MRTs developed using predicted habitat classifications performed less well than those using multibeam data. The most influential individual predictor was the abiotic categorical variable from direct observer habitat classification and models that incorporated predictors from direct observer habitat classification consistently outperformed those that did not. Our results show that while remotely sensed data can offer considerable utility for predictive modelling, the addition of direct observer habitat classification data can substantially improve model performance. Thus it appears that there are aspects of marine habitats that are important for modelling metrics of fish biodiversity that are not fully captured by remotely sensed data. As such, the use of remotely sensed data to model biodiversity represents a compromise between model performance and data availability.	[Yates, Katherine L.; Mellin, Camille; Caley, M. Julian] Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia; [Yates, Katherine L.] Univ Salford, Sch Environm & Life Sci, Manchester, Lancs, England; [Mellin, Camille] Univ Adelaide, Sch Biol Sci, Global Change Ecol Lab, Adelaide, SA, Australia; [Radford, Ben T.] UWA Oceans Inst, Australian Inst Marine Sci, Crawley, WA, Australia; [Meeuwig, Jessica J.] Univ Western Australia, Ctr Marine Futures, Oceans Inst, Crawley, WA, Australia; [Meeuwig, Jessica J.] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia	Australian Institute of Marine Science; University of Manchester; University of Salford; University of Adelaide; Australian Institute of Marine Science; University of Western Australia; University of Western Australia; University of Western Australia	Yates, KL (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.; Yates, KL (corresponding author), Univ Salford, Sch Environm & Life Sci, Manchester, Lancs, England.	k.l.yates@Salford.ac.uk	Yates, Katherine Lucy/I-7725-2019; Mellin, Camille/AAB-1768-2019; Mellin, Camille/X-9161-2019	Yates, Katherine Lucy/0000-0001-8429-2941; Mellin, Camille/0000-0002-7369-2349; Meeuwig, Jessica/0000-0003-1169-8785	Natural Heritage Trust II; Australian Research Council grant [DE140100701]; Marine Biodiversity Hub	Natural Heritage Trust II; Australian Research Council grant(Australian Research Council); Marine Biodiversity Hub	No specific funding was obtained for this piece of research. However, the original data collection was funded by the Natural Heritage Trust II (as part of a different project) and CM is funded by an Australian Research Council grant (DE140100701).; This work was done under the auspices of the Marine Biodiversity Hub. Our thanks to Dr K van Niel, for her contribution to the Marine Futures Project, and to three anonymous reviewers for their constructive and insightful comments.	Beaumont NJ, 2007, MAR POLLUT BULL, V54, P253, DOI 10.1016/j.marpolbul.2006.12.003; Breiman L., 1984, CLASSIFICATION REGRE; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; Cheung WWL, 2007, MAR ECOL PROG SER, V333, P1, DOI 10.3354/meps333001; De Falco G, 2010, CONT SHELF RES, V30, P1941, DOI 10.1016/j.csr.2010.09.006; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Ferrier S, 2006, ECOGRAPHY COP, V2, P121; Fisher R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026556; Fisher R, 2011, CONSERV LETT, V4, P64, DOI 10.1111/j.1755-263X.2010.00146.x; FROESE R, 2008, FISHBASE; Giakoumi S, 2011, BIOL CONSERV, V144, P753, DOI 10.1016/j.biocon.2010.11.006; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; GWA, 2014, ROTTN ISL MAN PLAN 2; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Harman N, 2003, MAR FRESHWATER RES, V54, P177, DOI 10.1071/MF02040; Hinz H, 2013, FISH FISH, V14, P110, DOI 10.1111/j.1467-2979.2012.00475.x; Huang Z, 2012, INT J GEOGR INF SCI, V26, P283, DOI 10.1080/13658816.2011.590139; Hughes DJ, 1998, ZOSTERA BIOTOPES; HUTCHINS JB, 1994, B MAR SCI, V54, P245; Jimenez H, 2012, CORAL REEFS, V31, P89, DOI 10.1007/s00338-011-0820-9; Kimmerera W, 2005, T AM FISH SOC, P134; Knudby A, 2010, REMOTE SENS ENVIRON, V114, P1230, DOI 10.1016/j.rse.2010.01.007; Langlois TJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P886, DOI 10.1111/j.1466-8238.2011.00734.x; Leathwick J, 2008, CONSERV LETT, V1, P91, DOI 10.1111/j.1755-263X.2008.00012.x; Letessier T.B., 2013, METHODS OCEANOGR, V8, P41, DOI [10.1016/j.mio.2013.11.003, DOI 10.1016/J.MIO.2013.11.003]; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mellin C, 2012, ECOL APPL, V22, P792, DOI 10.1890/11-2105.1; Mellin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020141; Mellin C, 2009, MAR POLLUT BULL, V58, P11, DOI 10.1016/j.marpolbul.2008.10.010; MOLLES MC, 1978, ECOL MONOGR, V48, P289, DOI 10.2307/2937232; Mulhearn PJ, 2001, DSTOTN0381 AER MAR R; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Pittman SJ, 2007, ECOL MODEL, V204, P9, DOI 10.1016/j.ecolmodel.2006.12.017; Pittman SJ, 2009, J COASTAL RES, V25, P27, DOI [10.2112/SI53-004.1, 10.2112/S153-004.1]; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Radford B, 2008, WA MARINE FUTURES BE; Richmond S, 2014, ESTUAR COAST SHELF S, V138, P79, DOI 10.1016/j.ecss.2013.12.012; SeaGIS, 2008, PHOTOMEASURE EVENTME; Sequeira A, 2016, J APPL ECOL IN PRESS; Sumner NR, 2008, 177 FISH RES DIV W A; Sutcliffe PR, 2014, ECOGRAPHY, V37, P162, DOI 10.1111/j.1600-0587.2013.00102.x; Sutcliffe PR, 2012, ECOL APPL, V22, P1762, DOI 10.1890/11-0990.1; van Rein H, 2011, ESTUAR COAST SHELF S, V93, P336, DOI 10.1016/j.ecss.2011.04.011; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Wise BS, 2007, 2003052 FRDC; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yates KL, 2015, ICES J MAR SCI, V72, P587, DOI 10.1093/icesjms/fsu122; Yates KL, 2015, J ENVIRON MANAGE, V152, P201, DOI 10.1016/j.jenvman.2015.01.045; Yates KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068424	56	11	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0155634	10.1371/journal.pone.0155634	http://dx.doi.org/10.1371/journal.pone.0155634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333202	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212800005
J	Kallo, G; Emri, M; Varga, Z; Ujhelyi, B; Tozser, J; Csutak, A; Csosz, E				Kallo, Gergo; Emri, Miklos; Varga, Zsofia; Ujhelyi, Bernadett; Tozser, Jozsef; Csutak, Adrienne; Csosz, Eva			Changes in the Chemical Barrier Composition of Tears in Alzheimer's Disease Reveal Potential Tear Diagnostic Biomarkers	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; PROTEOMICS; PROTEINS; FLUID; SWEAT; BETA; QUANTIFICATION; DEFENSE; PACKAGE	Alzheimer's disease (AD) is one of the most common neurodegenerative diseases, with increasing prevalence affecting millions of people worldwide. Currently, only autopsy is able to confirm the diagnosis with a 100% certainty, therefore, biomarkers from body fluids obtained by non-invasive means provide an attractive alternative for the diagnosis of Alzheimer's disease. Global changes of the protein profile were examined by quantitative proteomics; firstly, electrophoresis and LC-MS/MS were used, thereafter, SRM-based targeted proteomics method was developed and applied to examine quantitative changes of tear proteins. Alterations in the tear flow rate, total tear protein concentration and composition of the chemical barrier specific to AD were demonstrated, and the combination of lipocalin-1, dermcidin, lysozyme-C and lacritin was shown to be a potential biomarker, with an 81% sensitivity and 77% specificity.	[Kallo, Gergo; Tozser, Jozsef; Csosz, Eva] Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Egyet Ter 1, H-4032 Debrecen, Hungary; [Emri, Miklos] Univ Debrecen, Fac Med, Dept Nucl Med, Egyet Ter 1, H-4032 Debrecen, Hungary; [Varga, Zsofia] Univ Debrecen, Fac Med, Dept Psychiat, Egyet Ter 1, H-4032 Debrecen, Hungary; [Ujhelyi, Bernadett; Csutak, Adrienne] Univ Debrecen, Dept Ophthalmol, Fac Med, Egyet Ter 1, H-4032 Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Csosz, E (corresponding author), Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Egyet Ter 1, H-4032 Debrecen, Hungary.	cseva@med.unideb.hu	Emri, Miklós/AAK-3515-2020; Tozser, Jozsef/A-7840-2008	Emri, Miklós/0000-0001-9884-9202; Tozser, Jozsef/0000-0003-0274-0056; Csosz, Eva/0000-0003-4373-2175	National Brain Research Program [KTIA_13_NAP-A-II/3]; Astellas Pharma Ltd.; Janos Bolyai and Lajos Szodoray Postdoctoral Fellowships;  [TAMOP 4.2.4.A/2-11-1-2012-0001];  [TAMOP 4.2.2.A-11/1/KONV-2012-0045];  [TAMOP-4.2.2.D-15/1/KONV-2015-0016];  [TAMOP-4.2.2.B-15/1/KONV-2015-0001]	National Brain Research Program; Astellas Pharma Ltd.(Astellas Pharmaceuticals); Janos Bolyai and Lajos Szodoray Postdoctoral Fellowships; ; ; ; 	This work was supported by the New Szechenyi Plan TAMOP 4.2.4.A/2-11-1-2012-0001 to GK, New Szechenyi Plan TAMOP 4.2.2.A-11/1/KONV-2012-0045 to: GK AC EC, New Szechenyi Plan TAMOP-4.2.2.D-15/1/KONV-2015-0016 to: JT EC GK, New Szechenyi Plan TAMOP-4.2.2.B-15/1/KONV-2015-0001 to GK, National Brain Research Program KTIA_13_NAP-A-II/3 to ME, Astellas Pharma Ltd. Fellowship to GK, Janos Bolyai and Lajos Szodoray Postdoctoral Fellowships to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by TAMOP-4.2.2.D-15/1/KONV-2015-0016, TAMOP 4.2.4.A/2-11-1-2012-0001, TAMOP-4.2.2.B-15/1/KONV-2015-0001, TAMOP 4.2.2.A-11/1/KONV-2012-0045 and National Brain Research Program KTIA_13_NAP-A-II/3. Adrienne Csutak is receiver of Janos Bolyai and Lajos Szodoray Postdoctoral Fellowships. We thank Dr. Mohamed Mahdi for the English proofreading.; Gergo Kallo was supported by Astellas Pharma Ltd. in form of support for chemicals and consumables which does not alter our adherence to PLOS ONE policies on sharing data and materials.	An HJ, 2005, J PROTEOME RES, V4, P1981, DOI 10.1021/pr0501620; [Anonymous], DIAGN STAT MAN MENT; Armstrong RA, 2009, J OPTOM, V2, P103, DOI [10.3921/joptom.2009.103, DOI 10.3921/JOPTOM.2009.103]; Bali J, 2010, ANN INDIAN ACAD NEUR, V13, P89, DOI 10.4103/0972-2327.74251; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BERTA A, 1983, AM J OPHTHALMOL, V96, P115, DOI 10.1016/0002-9394(83)90473-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Comoglu SS, 2013, NEUROSCI LETT, V553, P63, DOI 10.1016/j.neulet.2013.08.019; Crews L, 2009, NEUROTOX RES, V16, P306, DOI 10.1007/s12640-009-9073-6; Csosz E, 2015, J EUR ACAD DERMATOL, V29, P2024, DOI 10.1111/jdv.13221; Csosz E, 2012, J PROTEOMICS, V75, P2196, DOI 10.1016/j.jprot.2012.01.019; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FULLARD RJ, 1990, INVEST OPHTH VIS SCI, V31, P1119; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; HAECKEL R, 1993, ANN BIOL CLIN-PARIS, V51, P903; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Herber S, 2001, ELECTROPHORESIS, V22, P1838, DOI 10.1002/1522-2683(200105)22:9<1838::AID-ELPS1838>3.0.CO;2-7; Hochberg Y, 2015, UNGUARDED USE GREATL, V57, P289; Kallo G, 2015, RAPID COMMUN MASS SP, V29, P1623, DOI 10.1002/rcm.7259; Kim DH, 2014, GENE, V545, P185, DOI 10.1016/j.gene.2014.05.031; Korolainen MA, 2006, NEUROBIOL AGING, V27, P42, DOI 10.1016/j.neurobiolaging.2004.11.010; Korolainen MA, 2007, CLIN CHEM, V53, P657, DOI 10.1373/clinchem.2006.078014; Korolainen MA, 2010, J NEUROCHEM, V112, P1386, DOI 10.1111/j.1471-4159.2009.06558.x; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Laske C, 2015, ALZHEIMERS DEMENT, V11, P561, DOI 10.1016/j.jalz.2014.06.004; Love S, 2004, J NEUROL NEUROSUR PS, V75, P1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; Mumcu G, 2012, ARCH ORAL BIOL, V57, P642, DOI 10.1016/j.archoralbio.2011.11.003; Ornek N, 2015, CURR EYE RES, V40, P423, DOI 10.3109/02713683.2014.930154; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Podtelezhnikov AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029610; Prvulovic D, 2011, CLIN CHEM LAB MED, V49, P367, DOI 10.1515/CCLM.2011.087; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Rieg S, 2005, J IMMUNOL, V174, P8003, DOI 10.4049/jimmunol.174.12.8003; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schittek B, 2012, J INNATE IMMUN, V4, P349, DOI 10.1159/000336844; SHULTZ EK, 1995, CLIN CHEM, V41, P1248; Sperandio B, 2015, SEMIN IMMUNOL, V27, P111, DOI 10.1016/j.smim.2015.03.011; Sugi K, 1996, AM J GASTROENTEROL, V91, P927; Takuma K, 2005, J PHARMACOL SCI, V97, P312, DOI 10.1254/jphs.CPJ04006X; ULLRICH A, 1994, J BIOL CHEM, V269, P18401; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Zhou L, 2012, J PROTEOMICS, V75, P3877, DOI 10.1016/j.jprot.2012.04.053; Zhou L, 2009, J PROTEOME RES, V8, P4889, DOI 10.1021/pr900686s	48	74	75	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0158000	10.1371/journal.pone.0158000	http://dx.doi.org/10.1371/journal.pone.0158000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327445	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000378212400066
J	Di Rosa, V; Lopez-Olmeda, JF; Burguillo, A; Frigato, E; Bertolucci, C; Piferrer, F; Sanchez-Vazquez, FJ				Di Rosa, Viviana; Fernando Lopez-Olmeda, Jose; Burguillo, Ana; Frigato, Elena; Bertolucci, Cristiano; Piferrer, Francesc; Javier Sanchez-Vazquez, Francisco			Daily Rhythms of the Expression of Key Genes Involved in Steroidogenesis and Gonadal Function in Zebrafish	PLOS ONE			English	Article							BASS DICENTRARCHUS-LABRAX; SEXUALLY DIMORPHIC EXPRESSION; FOLLICLE-STIMULATING-HORMONE; DEPENDENT SEX DETERMINATION; DAILY SPAWNING RHYTHMS; LOCOMOTOR-ACTIVITY; DANIO-RERIO; CIRCADIAN-RHYTHMS; PLASMA-LEVELS; REPRODUCTIVE-CYCLE	Fish present daily and seasonal rhythms in spawning and plasmatic levels of steroids that control reproduction. However, the existence of the rhythms of expression of the genes that underlie the endocrine mechanisms responsible for processes such as steroidogenesis and reproduction in fish have still been poorly explored to date. Here we investigated the daily pattern of the expression of key genes involved in sex steroid production that ultimately set the sex ratio in fish. Adult zebrafish were maintained under a 12: 12 h light-dark cycle at a constant temperature of 27 degrees C and were sampled every 4 h during a 24-hour cycle. The expression of key genes in the gonads and brains of female and male individuals were analyzed. In gonads, the expression of aromatase (cyp19a1a, ovarian aromatase) and the antimullerian hormone (amh, testis) was rhythmic, with almost opposite acrophases: ZT 5: 13 h (in the light phase) and ZT 15: 39 h (at night), respectively. The expression of foxl2 (forkhead box L2) was also rhythmic in the ovary (acrophase located at ZT 5: 02 h) and the expression of dmrt1 (doublesex and mab-3-related transcription factor 1) was rhythmic in testes (acrophase at ZT 18: 36 h). In the brain, cyp19a1b (brain aromatase) and cyp11b (11beta-hydroxylase) presented daily differences, especially in males, where the expression peaked at night. These results provide the first evidence for marked time-of-theday- dependent differences in the expression of the genes involved in sex ratio control, which should be considered when investigating processes such as reproduction, sex differentiation and steroidogenesis in fish.	[Di Rosa, Viviana; Fernando Lopez-Olmeda, Jose; Burguillo, Ana; Javier Sanchez-Vazquez, Francisco] Univ Murcia, Fac Biol, Dept Physiol, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain; [Frigato, Elena; Bertolucci, Cristiano] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Piferrer, Francesc] CSIC, Inst Ciencias Mar, Barcelona, Spain	University of Murcia; University of Ferrara; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Sanchez-Vazquez, FJ (corresponding author), Univ Murcia, Fac Biol, Dept Physiol, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain.	javisan@um.es	Bertolucci, Cristiano/H-1916-2015; Lopez-Olmeda, Jose Fernando/K-3848-2014; Piferrer, Francesc/A-5634-2012	Bertolucci, Cristiano/0000-0003-0252-3107; Lopez-Olmeda, Jose Fernando/0000-0003-4920-5704; Piferrer, Francesc/0000-0003-0903-4736	Spanish Ministry of Economic Affairs and Competitiveness (MINECO) [AGL2010-22139-C03-01, AGL2013-49027-C3-1-R]; FEDER fund; Agencia de Ciencia y Tecnologia de la Region de Murcia (Fundacion Seneca) [18963/JLI/13]; MINECO (Juan de la Cierva Program)	Spanish Ministry of Economic Affairs and Competitiveness (MINECO); FEDER fund; Agencia de Ciencia y Tecnologia de la Region de Murcia (Fundacion Seneca); MINECO (Juan de la Cierva Program)	This research was funded by Spanish Ministry of Economic Affairs and Competitiveness (MINECO) by project "Cronosolea" AGL2010-22139-C03-01 and "Solembryo" AGL2013-49027-C3-1-R, cofunded with FEDER fund; and by Project 18963/JLI/13 granted by the Agencia de Ciencia y Tecnologia de la Region de Murcia (Fundacion Seneca) and a research fellowship granted by MINECO (Juan de la Cierva Program) to JFLO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida K, 1995, P 5 INT S REPR PHYS, P161; Baroiller JF, 1999, CELL MOL LIFE SCI, V55, P910, DOI 10.1007/s000180050344; Baroiller JF, 2001, COMP BIOCHEM PHYS C, V130, P399, DOI 10.1016/S1532-0456(01)00267-8; Bayarri MJ, 2004, GEN COMP ENDOCR, V136, P72, DOI 10.1016/j.ygcen.2003.12.004; BAYNES SM, 1985, GEN COMP ENDOCR, V57, P150, DOI 10.1016/0016-6480(85)90211-4; Blanco-Vives B, 2009, PHYSIOL BEHAV, V98, P268, DOI 10.1016/j.physbeh.2009.05.015; Blazquez M, 2005, MOL CELL ENDOCRINOL, V237, P37, DOI 10.1016/j.mce.2005.04.001; Blazquez M, 1998, J EXP ZOOL, V281, P207, DOI 10.1002/(SICI)1097-010X(19980615)281:3&lt;207::AID-JEZ6&gt;3.0.CO;2-R; Blazquez M, 2009, J EXP ZOOL PART B, V312B, P686, DOI 10.1002/jez.b.21286; Bromage NR, 1987, P 3 INT S REPR PHYS, P303; CARRAGHER JF, 1993, AQUACULTURE, V109, P375, DOI 10.1016/0044-8486(93)90176-Y; Colombo L., 1998, Cahiers Options Mediterraneennes, V34, P77; Conley A, 2001, REPRODUCTION, V121, P685, DOI 10.1530/rep.0.1210685; del Pozo A, 2011, CHRONOBIOL INT, V28, P39, DOI 10.3109/07420528.2010.530728; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Falcon J, 2007, TRENDS ENDOCRIN MET, V18, P81, DOI 10.1016/j.tem.2007.01.002; Lopez-Olmeda JF, 2009, CHRONOBIOL INT, V26, P200, DOI 10.1080/07420520902765928; Gonzalez A, 2003, GEN COMP ENDOCR, V132, P223, DOI 10.1016/S0016-6480(03)00086-8; Gothilf Y, 1997, BIOL REPROD, V57, P1145, DOI 10.1095/biolreprod57.5.1145; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; Guo YQ, 2005, BIOCHEM BIOPH RES CO, V330, P950, DOI 10.1016/j.bbrc.2005.03.066; Hurd MW, 1998, PHYSIOL BEHAV, V65, P465, DOI 10.1016/S0031-9384(98)00183-8; Ijiri S, 2008, BIOL REPROD, V78, P333, DOI 10.1095/biolreprod.107.064246; Jorgensen A, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-25; KOBAYASHI M, 1988, GEN COMP ENDOCR, V72, P264, DOI 10.1016/0016-6480(88)90209-2; LAMBA VJ, 1983, GEN COMP ENDOCR, V50, P205, DOI 10.1016/0016-6480(83)90221-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Olmeda JF, 2011, J THERM BIOL, V36, P91, DOI 10.1016/j.jtherbio.2010.12.005; Lopez-Olmeda JF, 2006, CHRONOBIOL INT, V23, P537, DOI 10.1080/07420520600651065; Mananos EL, 1997, FISH PHYSIOL BIOCHEM, V16, P211, DOI 10.1023/A:1007777816306; MATSUYAMA M, 1990, FISH PHYSIOL BIOCHEM, V8, P329, DOI 10.1007/BF00003428; Matsuyama M, 1998, ENVIRON BIOL FISH, V52, P281, DOI 10.1023/A:1007424103444; Meseguer C, 2008, CHRONOBIOL INT, V25, P666, DOI 10.1080/07420520802380018; Ohta K, 2008, J EXP ZOOL PART A, V309A, P534, DOI 10.1002/jez.485; Oliveira C, 2009, J FISH BIOL, V75, P61, DOI 10.1111/j.1095-8649.2009.02263.x; Oliveira C, 2009, COMP BIOCHEM PHYS A, V152, P168, DOI 10.1016/j.cbpa.2008.09.012; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Patil JG, 2008, GEN COMP ENDOCR, V158, P131, DOI 10.1016/j.ygcen.2008.05.016; Pavlidis M, 2000, J EXP ZOOL, V287, P225, DOI 10.1002/1097-010X(20000801)287:3&lt;225::AID-JEZ4&gt;3.0.CO;2-D; Piferrer F, 2001, AQUACULTURE, V197, P229, DOI 10.1016/S0044-8486(01)00589-0; PRAT F, 1990, GEN COMP ENDOCR, V78, P361, DOI 10.1016/0016-6480(90)90026-I; Sawyer SJ, 2006, GEN COMP ENDOCR, V147, P108, DOI 10.1016/j.ygcen.2005.12.010; Schaefer J, 2006, J FISH BIOL, V69, P722, DOI 10.1111/j.1095-8649.2006.01145.x; Sfakianakis DG, 2012, J BIOL RES-THESSALON, V17, P68; So WK, 2005, BIOL REPROD, V72, P1382, DOI 10.1095/biolreprod.104.038216; Taranger GL, 1998, AQUACULTURE, V162, P85, DOI 10.1016/S0044-8486(98)00168-9; Tomy S, 2007, J NEUROENDOCRINOL, V19, P643, DOI 10.1111/j.1365-2826.2007.01572.x; Tranger GL, 1995, P 5 INT S REPR PHYS, P200; Vanhauwaert S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109091; Villamizar N, 2012, AQUACULTURE, V354, P117, DOI 10.1016/j.aquaculture.2012.03.028; Villamizar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052153; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; Wang DS, 2010, ENDOCRINOLOGY, V151, P1331, DOI 10.1210/en.2009-0999; Wang XG, 2007, DEV DYNAM, V236, P1329, DOI 10.1002/dvdy.21129; Wang Y, 2004, BIOL REPROD, V71, P2056, DOI 10.1095/biolreprod.104.032649; Yamada H, 2002, ZOOL SCI, V19, P891, DOI 10.2108/zsj.19.891; Yamaguchi T, 2007, BIOCHEM BIOPH RES CO, V359, P935, DOI 10.1016/j.bbrc.2007.05.208	58	14	15	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157716	10.1371/journal.pone.0157716	http://dx.doi.org/10.1371/journal.pone.0157716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322588	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212000041
J	Khan, M; Hashim; Alshomrani, AS				Khan, Masood; Hashim; Alshomrani, Ali Saleh			MHD Stagnation-Point Flow of a Carreau Fluid and Heat Transfer in the Presence of Convective Boundary Conditions	PLOS ONE			English	Article							PARTIAL SLIP; LAYER-FLOW; MOTION	In the present investigation we analyze the impact of magnetic field on the stagnation- point flow of a generalized Newtonian Carreau fluid. The convective surface boundary conditions are considered to investigate the thermal boundary layer. The leading partial differential equations of the current problem are altered to a set of ordinary differential equations by picking local similarity transformations. The developed non-linear ordinary differential equations are then numerically integrated via Runge-Kutta Fehlberg method after changing into initial value problems. This investigation explores that the momentum and thermal boundary layers are significantly influenced by various pertinent parameters like the Hartmann number M, velocity shear ratio parameter a, Weissenberg number We, power law index n, Biot number. and Prandtl number Pr. The analysis further reveals that the fluid velocity as well as the skin friction is raised by the velocity shear ratio parameter. Moreover, strong values of the Hartmann number correspond to thinning of the momentum boundary layer thickness while quite the opposite is true for the thermal boundary layer thickness. Additionally, it is seen that the numerical computations are in splendid consent with previously reported studies.	[Khan, Masood; Hashim] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan; [Alshomrani, Ali Saleh] King Abdulaziz Univ, Fac Sci, Dept Math, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Hashim (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan.	hashim_alik@yahoo.com	ALSHOMRANI, ALI SALEH/Q-4236-2017; KHAN, Masood/AAA-7384-2020; Hashim, Hashim/AFD-8127-2022	ALSHOMRANI, ALI SALEH/0000-0001-9222-8915; KHAN, Masood/0000-0003-4404-1456; Hashim, Hashim/0000-0003-3663-8682				Ali N, 2007, APPL MATH COMPUT, V193, P535, DOI 10.1016/j.amc.2007.04.010; ANDERSSON HI, 1992, ACTA MECH, V95, P227, DOI 10.1007/BF01170814; BIRD R.B., 1987, FLUID MECH-SOV RES, V1; BOGER DV, 1977, NATURE, V265, P126, DOI 10.1038/265126a0; CHHABRA RP, 1980, RHEOL ACTA, V19, P187, DOI 10.1007/BF01521930; CHIAM TC, 1994, J PHYS SOC JPN, V63, P2443, DOI 10.1143/JPSJ.63.2443; Eckert ERG, 1942, BERECHNUNG WARMEUBER, P416; Fang TG, 2009, COMMUN NONLINEAR SCI, V14, P2853, DOI 10.1016/j.cnsns.2008.10.005; Hakeem AKA, 2014, AIN SHAMS ENG J, V5, P913, DOI 10.1016/j.asej.2014.02.006; Hayat T, 2009, NONLINEAR ANAL-REAL, V10, P1514, DOI 10.1016/j.nonrwa.2008.01.019; Hiemenz K., 1911, DINGLERS POLYTECH J, V326, P391; Ishak A, 2006, MECCANICA, V41, P509, DOI 10.1007/s11012-006-0009-4; Khan M, 2015, AIP ADV, V5, DOI 10.1063/1.4932627; Khan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125683; Khan M, 2013, MECCANICA, V48, P2391, DOI 10.1007/s11012-013-9755-2; Khellaf K, 2000, J NON-NEWTON FLUID, V89, P45, DOI 10.1016/S0377-0257(99)00030-0; Mahapatra TR, 2002, HEAT MASS TRANSFER, V38, P517, DOI [10.1007/s002310100215, 10.1007/S002310100215]; Mahapatra TR, 2001, ACTA MECH, V152, P191, DOI 10.1007/BF01176953; Makinde OD, 2016, INT J HEAT MASS TRAN, V93, P595, DOI 10.1016/j.ijheatmasstransfer.2015.10.050; Martins RR, 2008, LAT AM APPL RES, V38, P321; Nadeem S, 2015, J MAGN MAGN MATER, V378, P457, DOI 10.1016/j.jmmm.2014.11.043; Nazar R, 2004, INT J ENG SCI, V42, P1241, DOI 10.1016/j.ijengsci.2003.12.002; Pavlov K. B., 1974, MAGN GIDRODIN, V4, P146; Postelnicu A, 2011, APPL MATH COMPUT, V217, P4359, DOI 10.1016/j.amc.2010.09.037; Sobh AM, 2009, CAN J PHYS, V87, P957, DOI 10.1139/P09-027	25	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157180	10.1371/journal.pone.0157180	http://dx.doi.org/10.1371/journal.pone.0157180			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322600	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212000010
J	Singh, A; Breja, P; Khurana, JP; Khurana, P				Singh, Akanksha; Breja, Priyanka; Khurana, Jitendra P.; Khurana, Paramjit			Wheat Brassinosteroid-Insensitive1 (TaBRI1) Interacts with Members of TaSERK Gene Family and Cause Early Flowering and Seed Yield Enhancement in Arabidopsis	PLOS ONE			English	Article							SOMATIC-EMBRYOGENESIS; SIGNAL-TRANSDUCTION; STEROID-HORMONE; MEMBRANE-RECEPTOR; PLANT-GROWTH; KINASE; BRI1; EXPRESSION; ELONGATION; PROTEINS	Brassinosteroids (BRs) hormones are important for plant growth, development and immune responses. They are sensed by the transmembrane receptor kinase Brassinosteroid-Insensitive 1 (BRI1) when they bind to its extracellular Leu-rich repeat (LRR) domain. We cloned and characterized the TaBRI1 from T. aestivum and raised overexpression transgenics in Arabidopsis to decipher its functional role. TaBRI1 protein consists of a putative signal peptide followed by 25 leucine rich repeats (LRR), a transmembrane domain and a C-terminal kinase domain. The analysis determined the interaction of TaBRI1 with five members of the wheat Somatic Embryogenesis Receptor Kinase (TaSERKs) gene family (TaSERK1, TaSERK2, TaSERK3, TaSERK4 and TaSERK5), at the plasma membrane. Furthermore, overexpression of TaBRI1 in Arabidopsis leads to the early flowering, increased silique size and seed yield. Root growth analysis of TaBRI1 overexpressing transgenic plants showed hypersensitivity to epi-brassinolide (epi-BL) hormone in a dose-dependent manner. Interestingly, transgenic Arabidopsis plants show thermotolerance phenotype at the seedling stages as revealed by chlorophyll content, photosystem II activity and membrane stability. The transcriptome profiling on the basis of microarray analysis indicates up-regulation of several genes related to brassinosteroid signaling pathway, abiotic stress response, defense response and transcription factors. These studies predict the possible role of TaBRI1 gene in plant growth and development imparting tolerance to thermal stress.	[Singh, Akanksha; Breja, Priyanka; Khurana, Jitendra P.; Khurana, Paramjit] Univ Delhi, Dept Plant Mol Biol, South Campus,Benito Juarez Rd, New Delhi 110021, India	University of Delhi	Khurana, P (corresponding author), Univ Delhi, Dept Plant Mol Biol, South Campus,Benito Juarez Rd, New Delhi 110021, India.	param@genomeindia.org			Department of Biotechnology, the Ministry of Science and Technology, Government of India; Department of Biotechnology, Government of India; Council for Scientific and Industrial Research	Department of Biotechnology, the Ministry of Science and Technology, Government of India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was financially supported by the Department of Biotechnology, the Ministry of Science and Technology, Government of India. AS thanks the Council for Scientific and Industrial Research for a JRF and SRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by the Department of Biotechnology, Government of India. AS thanks the Council for Scientific and Industrial Research for a JRF and SRF.	Albrecht C, 2008, PLANT PHYSIOL, V148, P611, DOI 10.1104/pp.108.123216; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Belkhadir Y, 2006, SCIENCE, V314, P1410, DOI 10.1126/science.1134040; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; Bucherl CA, 2013, PLANT PHYSIOL, V162, P1911, DOI 10.1104/pp.113.220152; Checker VG, 2013, PLANT CELL REP, V32, P1729, DOI 10.1007/s00299-013-1483-5; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Chono M, 2003, PLANT PHYSIOL, V133, P1209, DOI 10.1104/pp.103.026195; CHORY J, 1991, PLANT CELL, V3, P445, DOI 10.1105/tpc.3.5.445; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Clouse SD, 2008, P NATL ACAD SCI USA, V105, P7345, DOI 10.1073/pnas.0803552105; Clouse SD, 2011, PLANT CELL, V23, P1219, DOI 10.1105/tpc.111.084475; Domagalska MA, 2007, DEVELOPMENT, V134, P2841, DOI 10.1242/dev.02866; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Kim MH, 2013, PLANT CELL PHYSIOL, V54, P1620, DOI 10.1093/pcp/pct106; Kim SY, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1086; Kim TW, 2007, PLANT CELL ENVIRON, V30, P679, DOI 10.1111/j.1365-3040.2007.01659.x; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Lee LY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-24; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Liu N, 2007, PLANTA, V226, P827, DOI 10.1007/s00425-007-0529-8; Lu SX, 2011, PLANT PHYSIOL, V155, P906, DOI 10.1104/pp.110.167015; MANDAVA NB, 1988, ANNU REV PLANT PHYS, V39, P23, DOI 10.1146/annurev.arplant.39.1.23; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Montoya T, 2002, PLANT CELL, V14, P3163, DOI 10.1105/tpc.006379; Morinaka Y, 2006, PLANT PHYSIOL, V141, P924, DOI 10.1104/pp.106.077081; Mouchel CF, 2004, GENE DEV, V18, P700, DOI 10.1101/gad.1187704; Mussig C, 2006, PLANT BIOLOGY, V8, P291, DOI 10.1055/s-2005-873043; Mussig C, 2003, PLANT PHYSIOL, V133, P1261, DOI 10.1104/pp.103.028662; Nomura T, 2003, PLANT J, V36, P291, DOI 10.1046/j.1365-313X.2003.01863.x; Pfalz M, 2009, PLANT CELL, V21, P985, DOI 10.1105/tpc.108.063115; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Sairam RK, 2002, PLANT SCI, V163, P1037, DOI 10.1016/S0168-9452(02)00278-9; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Sharma I, 2013, PLANT PHYSIOL BIOCH, V69, P17, DOI 10.1016/j.plaphy.2013.04.013; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Singla B, 2007, PLANT MOL BIOL, V65, P677, DOI 10.1007/s11103-007-9234-z; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; Somerville C.R., 1982, METHODS CHLOROPLAST, P129; Sun Y, 2004, PLANT MOL BIOL, V54, P221, DOI 10.1023/B:PLAN.0000028788.96381.47; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Wang M, 2014, INT J MOL SCI, V15, P3871, DOI 10.3390/ijms15033871; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2012, ANNU REV GENET, V46, P701, DOI 10.1146/annurev-genet-102209-163450; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Withers JC, 2013, AM J BOT, V100, P183, DOI 10.3732/ajb.1200436; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Yu XF, 2008, P NATL ACAD SCI USA, V105, P7618, DOI 10.1073/pnas.0802254105; Zhu JY, 2013, DEVELOPMENT, V140, P1615, DOI 10.1242/dev.060590	62	59	60	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0153273	10.1371/journal.pone.0153273	http://dx.doi.org/10.1371/journal.pone.0153273			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322749	Green Submitted, gold, Green Published			2022-12-26	WOS:000378212000001
J	Fall, A; Dia, N; Cisse, EHAK; Kiori, DE; Sarr, FD; Sy, S; Goudiaby, D; Richard, V; Niang, MN				Fall, Amary; Dia, Ndongo; Cisse, El Hadj Abdel Kader; Kiori, Davy E.; Sarr, Fatoumata Diene; Sy, Sara; Goudiaby, Debora; Richard, Vincent; Niang, Mbayame Ndiaye			Epidemiology and Molecular Characterization of Human Respiratory Syncytial Virus in Senegal after Four Consecutive Years of Surveillance, 2012-2015	PLOS ONE			English	Article							INFLUENZA-LIKE ILLNESS; GENETIC DIVERSITY; VIRAL ETIOLOGY; SUBGROUP-A; INFECTION	Background The burden of respiratory syncytial virus (RSV) infection remains poorly defined in Africa. To address this, we carried out a descriptive and retrospective pilot study, with a focus on the epidemiology of RSV in Senegal after 4 years of surveillance. Methodology and Results From January 2012 to October 2015 swabs were collected from consenting ILI outpatients. Viral detection was performed using RV16 kit enabling direct subtyping of RSV-A and B. For the molecular characterization of HRSV, the second hypervariable region of the Glycoprotein (G) gene was targeted for sequencing. We enrolled 5338 patients with 2803 children younger than five years of age (52.5%). 610 (11.4%) were positive for RSV infection: 276 (45.2%) were group A infections, 334 (54.8%) were group B infections and 21 (3.4%) were A/B co-infections. RSV detection rate is significantly higher (P < 0.0001) in children below 5 years. We noted that the annual distribution of RSV varied substantially by season and for the predominant subtype. Globally, results show a clear circulation pattern in the second half of each year; between June and September and possibly extended into November. The majority of RSV-A strains from Senegal clustered with strains that were previously assigned NA1 and novel ON1 genotype sequences. RSV-B sequences from Senegal clustered with the BA9 genotype. At the amino acid level, RSV-A strains from Senegal show proximity with the genotype ON1 characterized by a 72 nt insertion in G, resulting in 24 extra amino acids of which 23 are duplications of as 261-283. Conclusion Globally our results show a clear circulation pattern of RSV in the second half of each year, between June and September and possibly extending into November, with children under 5 being more susceptible. Molecular studies identified the novel strains ON1 and BA9 as the major genotypes circulating in Senegal between 2012 and 2015.	[Fall, Amary; Dia, Ndongo; Cisse, El Hadj Abdel Kader; Kiori, Davy E.; Sy, Sara; Goudiaby, Debora; Niang, Mbayame Ndiaye] Inst Pasteur, Unite Virol Med, Dakar, Senegal; [Sarr, Fatoumata Diene; Richard, Vincent] Inst Pasteur, Unite Epidemiol Malad Infect, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Dia, N; Niang, MN (corresponding author), Inst Pasteur, Unite Virol Med, Dakar, Senegal.	ndia@pasteur.sn; niang@pasteur.sn	Fall, Amary/AAR-8776-2021	Fall, Amary/0000-0002-6890-7915; Vincent, RICHARD/0000-0002-6961-1753	Department of Health and Human Service (DHSS) via International Network of Pasteur Institutes; Pasteur Institute of Dakar	Department of Health and Human Service (DHSS) via International Network of Pasteur Institutes; Pasteur Institute of Dakar	This work was supported by the Department of Health and Human Service (DHSS) via the International Network of Pasteur Institutes and the Pasteur Institute of Dakar.	Arnott A, 2011, J CLIN MICROBIOL, V49, P3504, DOI 10.1128/JCM.01131-11; Ramirez JB, 2014, REV PANAM SALUD PUBL, V36, P101; Bellei N, 2008, J MED VIROL, V80, P1824, DOI 10.1002/jmv.21295; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Dia N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093227; Duvvuri VR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14268; Emukule GO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105543; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Fowlkes A, 2014, J INFECT DIS, V209, P1715, DOI 10.1093/infdis/jit806; Goto-Sugai K, 2010, JPN J INFECT DIS, V63, P393; Gupta R., 2004, RESEARCHGATE; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Homaira N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147982; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Lekana-Douki SE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-373; McIntosh K, 1990, VIROLOGY, V1, P1045; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Njouom R, 2012, J INFECT DIS, V206, pS29, DOI 10.1093/infdis/jis573; Noh JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064295; Otomaru H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123755; Panayiotou C, 2014, EPIDEMIOL INFECT, V142, P2406, DOI 10.1017/S0950268814000028; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Saha S, 2015, J GLOB HEALTH, V5, P233, DOI 10.7189/jogh.05.020419; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Uduman S. A., 1996, Journal of Communicable Diseases, V28, P245; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	33	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157163	10.1371/journal.pone.0157163	http://dx.doi.org/10.1371/journal.pone.0157163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315120	Green Published, Green Submitted, gold			2022-12-26	WOS:000378030000013
J	Faverial, J; Cornet, D; Paul, J; Sierra, J				Faverial, Julie; Cornet, Denis; Paul, Jacky; Sierra, Jorge			Multivariate Analysis of the Determinants of the End-Product Quality of Manure-Based Composts and Vermicomposts Using Bayesian Network Modelling	PLOS ONE			English	Article							STRUCTURE DISCOVERY; WASTES; BIODEGRADATION; PHOSPHORUS; CARBON; SOIL	Previous studies indicated that the quality of tropical composts is poorer than that of composts produced in temperate regions. The aim of this study was to test the type of manure, the use of co-composting with green waste, and the stabilization method for their ability to improve compost quality in the tropics. We produced 68 composts and vermicomposts that were analysed for their C, lignin and NPK contents throughout the composting process. Bayesian networks were used to assess the mechanisms controlling compost quality. The concentration effect, for C and lignin, and the initial blend quality, for NPK content, were the main factors affecting compost quality. Cattle manure composts presented the highest C and lignin contents, and poultry litter composts exhibited the highest NPK content. Co-composting improved quality by enhancing the concentration effect, which reduced the impact of C and nutrient losses. Vermicomposting did not improve compost quality; co-composting without earthworms thus appears to be a suitable stabilization method under the conditions of this study because it produced high quality composts and is easier to implement.	[Faverial, Julie; Paul, Jacky; Sierra, Jorge] INRA, ASTRO UR1321, Agrosyst Tropicaux, Petit Bourg, Guadeloupe, France; [Cornet, Denis] CIRAD, UMR AGAP, Montpellier, France	INRAE; CIRAD; Universite de Montpellier	Sierra, J (corresponding author), INRA, ASTRO UR1321, Agrosyst Tropicaux, Petit Bourg, Guadeloupe, France.	jorge.sierra@antilles.inra.fr	Cornet, Denis/N-3589-2019; Denis, Cornet JM/L-7477-2015	Cornet, Denis/0000-0001-9297-2680; Denis, Cornet JM/0000-0001-9297-2680; Sierra, Jorge/0000-0001-6973-7148	Regional Council of Guadeloupe; Animal Genetics Division of the French National Institute for Agricultural Research (INRA); Environment and Agronomy Division of the French National Institute for Agricultural Research (INRA); European Regional Development Fund (FEDER); Departmental Council of Guadeloupe	Regional Council of Guadeloupe; Animal Genetics Division of the French National Institute for Agricultural Research (INRA); Environment and Agronomy Division of the French National Institute for Agricultural Research (INRA); European Regional Development Fund (FEDER)(European Commission); Departmental Council of Guadeloupe	The contribution of the first author benefited from a Ph.D. fellowship co-financed by the Regional Council of Guadeloupe and the Animal Genetics and Environment and Agronomy Divisions of the French National Institute for Agricultural Research (INRA). This study was financed by the European Regional Development Fund (FEDER), the Departmental Council of Guadeloupe and the Regional Council of Guadeloupe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFNOR, 2005, 44162 AFNOR XPU; [Anonymous], 2011, BIOAUGMENTATION BIOS, V28, P107; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Castillo LE, 2006, SCI TOTAL ENVIRON, V367, P418, DOI 10.1016/j.scitotenv.2006.02.052; Cornet D, 2016, EUR J AGRON, V75, P80, DOI 10.1016/j.eja.2016.01.009; de Nijs PJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06682; Eckelman MJ, 2014, J IND ECOL, V18, P306, DOI 10.1111/jiec.12113; Evanylo G, 2008, AGR ECOSYST ENVIRON, V127, P50, DOI 10.1016/j.agee.2008.02.014; Francou C, 2008, BIORESOURCE TECHNOL, V99, P8926, DOI 10.1016/j.biortech.2008.04.071; Friedman N, 2003, MACH LEARN, V50, P95, DOI 10.1023/A:1020249912095; Gagnon B, 2012, CAN J SOIL SCI, V92, P711, DOI [10.4141/CJSS2012-032, 10.4141/cjss2012-032]; GARG VK, 2008, CURRENT DEV SOLID ST, P468, DOI DOI 10.1007/978-0-387-75213-6_20; Jensen FV, 2007, BAYESIAN NETWORKS DE; Jouquet P, 2010, APPL SOIL ECOL, V46, P125, DOI 10.1016/j.apsoil.2010.07.002; Kabore TWT, 2010, BIORESOURCE TECHNOL, V101, P1002, DOI 10.1016/j.biortech.2009.08.101; Kumar PR, 2009, CLEAN TECHNOL ENVIR, V11, P473, DOI 10.1007/s10098-009-0204-9; Larney FJ, 2007, BIORESOURCE TECHNOL, V98, P3221, DOI 10.1016/j.biortech.2006.07.005; Leconte MC, 2009, WASTE MANAGE, V29, P2446, DOI 10.1016/j.wasman.2009.04.006; Lewis FI, 2011, PREV VET MED, V100, P109, DOI 10.1016/j.prevetmed.2011.02.003; Lewis FI, 2012, AM J EPIDEMIOL, V176, P1051, DOI 10.1093/aje/kws183; Lobell DB, 2013, AGR FOREST METEOROL, V170, P58, DOI 10.1016/j.agrformet.2012.05.013; Mandonnet N, 2012, ANIMAL, V6, P705, DOI 10.1017/S1751731112000523; Neher DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079512; Parkinson R, 2004, BIORESOURCE TECHNOL, V91, P171, DOI 10.1016/S0960-8524(03)00174-3; Plummer M., 2003, P 3 INT WORKSH DISTR; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Regional Council of Guadeloupe, 2010, VAL EN BIOM GUAD ET; Sierra J, 2015, AGR ECOSYST ENVIRON, V213, P252, DOI 10.1016/j.agee.2015.08.015; Sierra J, 2013, SOIL RES, V51, P142, DOI 10.1071/SR13031; Sim EYS, 2010, J SCI FOOD AGR, V90, P2153, DOI 10.1002/jsfa.4127; Singh YK, 2009, RESOUR CONSERV RECY, V53, P386, DOI 10.1016/j.resconrec.2009.02.004; Stloukal P, 2015, WASTE MANAGE, V42, P31, DOI 10.1016/j.wasman.2015.04.006; Tuomela M, 2000, BIORESOURCE TECHNOL, V72, P169, DOI 10.1016/S0960-8524(99)00104-2; Wang K, 2015, J HAZARD MATER, V300, P745, DOI 10.1016/j.jhazmat.2015.08.016	35	4	4	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157884	10.1371/journal.pone.0157884	http://dx.doi.org/10.1371/journal.pone.0157884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314950	Green Published, Green Submitted, gold			2022-12-26	WOS:000378030000062
J	Bernal, ICPD; Lillebaek, T; Pedersen, MK; Martinez-Martinez, L; Folkvardsen, DB; Aguero, J; Rasmussen, EM				Perez del Molino Bernal, Inmaculada C.; Lillebaek, Troels; Pedersen, Mathias K.; Martinez-Martinez, Luis; Folkvardsen, Dorte B.; Agueero, Jesus; Michael Rasmussen, E.			Genomic Diversity of Mycobacterium tuberculosis Complex Strains in Cantabria (Spain), a Moderate TB Incidence Setting	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; PULMONARY TUBERCULOSIS; CLUSTERED TUBERCULOSIS; MIRU-VNTRPLUS; TRANSMISSION; DATABASE; COUNTRY; 4-YEAR; RISK	Background Tuberculosis (TB) control strategies are focused mainly on prevention, early diagnosis, compliance to treatment and contact tracing. The objectives of this study were to explore the frequency and risk factors of recent transmission of clinical isolates of Mycobacterium tuberculosis complex (MTBC) in Cantabria in Northern Spain from 2012 through 2013 and to analyze their clonal complexity for better understanding of the transmission dynamics in a moderate TB incidence setting. Methods DNA from 85 out of 87 isolates from bacteriologically confirmed cases of MTBC infection were extracted directly from frozen stocks and genotyped using the mycobacterial interspersed repetitive units-variable number tandem repeat (MIRU-VNTR) method. The MIRU-VNTRpIus database tool was used to identify clusters and lineages and to build a neighbor joining (NJ) phylogenetic tree. In addition, data were compared to the SITVIT2 database at the Pasteur Institute of Guadeloupe. Results The rate of recent transmission was calculated to 24%. Clustering was associated with being Spanish-born. A high prevalence of isolates of the Euro-American lineage was found. In addition, MIRU-VNTR profiles of the studied isolates corresponded to previously found MIRU-VNTR types in other countries, including Spain, Belgium, Great Britain, USA, Croatia, South Africa and The Netherlands. Six of the strains analyzed represented clonal variants. Conclusion Transmission of MTBC is well controlled in Cantabria. The majority of TB patients were born in Spain. The population structure of MTBC in Cantabria has a low diversity of major clonal lineages with the Euro-American lineage predominating.	[Perez del Molino Bernal, Inmaculada C.; Martinez-Martinez, Luis; Agueero, Jesus] Univ Hosp Marques Valdecilla, Microbiol Serv, Santander, Spain; [Perez del Molino Bernal, Inmaculada C.; Lillebaek, Troels; Pedersen, Mathias K.; Folkvardsen, Dorte B.; Michael Rasmussen, E.] Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark; [Perez del Molino Bernal, Inmaculada C.; Martinez-Martinez, Luis; Agueero, Jesus] Valdecilla Biomed Res Inst IDIVAL, Santander, Spain; [Martinez-Martinez, Luis; Agueero, Jesus] Univ Cantabria, Sch Med, Dept Mol Biol, E-39005 Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Statens Serum Institut; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Bernal, ICPD (corresponding author), Univ Hosp Marques Valdecilla, Microbiol Serv, Santander, Spain.; Bernal, ICPD (corresponding author), Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark.; Bernal, ICPD (corresponding author), Valdecilla Biomed Res Inst IDIVAL, Santander, Spain.	inmperez@humv.es	Martínez, Luis Martínez/U-1801-2017	Martínez, Luis Martínez/0000-0002-6091-4045; , Inmaculada/0000-0001-5315-3690; Lillebaek, Troels/0000-0002-2601-2718	Valdecilla Biomedical Research Institut (IDIVAL), Santander, Spain [CVE-2013-7667]	Valdecilla Biomedical Research Institut (IDIVAL), Santander, Spain	This study was supported by a grant from Valdecilla Biomedical Research Institut (IDIVAL), Santander, Spain (grant: CVE-2013-7667). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Lucerna MA, 2011, ENFERM INFEC MICR CL, V29, P174, DOI 10.1016/j.eimc.2010.06.010; [Anonymous], 2007, HIST CANT, VI, P213; [Anonymous], 2013, INFORME EPIDEMIOLOGI; [Anonymous], 2008, TUBERCULOSIS GENOTYP; Borgdorff MW, 2011, AM J EPIDEMIOL, V174, P243, DOI 10.1093/aje/kwr061; Braden CR, 2001, CLIN INFECT DIS, V33, pE42, DOI 10.1086/322635; Chaoui I, 2014, INFECT GENET EVOL, V21, P463, DOI 10.1016/j.meegid.2013.05.023; Cohen T, 2011, J CLIN MICROBIOL, V49, P385, DOI 10.1128/JCM.01378-10; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; Dahle UR, 2001, J CLIN MICROBIOL, V39, P1802, DOI 10.1128/JCM.39.5.1802-1807.2001; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Fallico L, 2014, INFECT GENET EVOL, V26, P58, DOI 10.1016/j.meegid.2014.05.004; Fitzgibbon MM, 2013, EURO SURVEILL, V18; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Garcia de Viedma D, 2005, J CLIN MICROBIOL, V43, P5660, DOI 10.1128/JCM.43.11.5660-5664.2005; Garcia de Viedma D, 2005, J CLIN MICROBIOL, V43, P1797, DOI 10.1128/JCM.43.4.1797-1806.2005; Kamper-Jorgensen Z, 2012, J CLIN MICROBIOL, V50, P2660, DOI 10.1128/JCM.06358-11; Kato-Maeda M, 2011, FUTURE MICROBIOL, V6, P203, DOI 10.2217/FMB.10.165; Lillebaek T, 2001, J CLIN MICROBIOL, V39, P855, DOI 10.1128/JCM.39.3.855-861.2001; Lopez Calleja AI, 2007, INT J TUBERC LUNG D, V11, P1080; Lopez Calleja AI, 2009, BMC PULM MED, V9, P3, DOI [10.1186/1471-2466-9-3, DOI 10.1186/1471-2466-9-3]; Navarro Y, 2011, J CLIN MICROBIOL, V49, P4131, DOI 10.1128/JCM.05203-11; Pena MJ, 2003, THORAX, V58, P618, DOI 10.1136/thorax.58.7.618; Perez-Lago L, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.015; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; Perez-Lago L, 2011, J CLIN MICROBIOL, V49, P3771, DOI 10.1128/JCM.01285-11; Pfyffer GE, 1998, EUR RESPIR J, V11, P804, DOI 10.1183/09031936.98.11040804; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Roetzer A, 2011, J CLIN MICROBIOL, V49, P4173, DOI 10.1128/JCM.05293-11; Sanchez-Castanon M, 2009, INT J TUBERC LUNG D, V13, P480; Shamputa IC, 2004, J CLIN MICROBIOL, V42, P5528, DOI 10.1128/JCM.42.12.5528-5536.2004; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; van Deutekom H, 2004, AM J RESP CRIT CARE, V169, P806, DOI 10.1164/rccm.200306-856OC; Vasconcellos SEG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107747; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157266	10.1371/journal.pone.0157266	http://dx.doi.org/10.1371/journal.pone.0157266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315243	Green Published, gold			2022-12-26	WOS:000378030000015
J	Comstock, SS; Maleki, SJ; Teuber, SS				Comstock, Sarah S.; Maleki, Soheila J.; Teuber, Suzanne S.			Boiling and Frying Peanuts Decreases Soluble Peanut (Arachis Hypogaea) Allergens Ara h 1 and Ara h 2 But Does Not Generate Hypoallergenic Peanuts	PLOS ONE			English	Article							CROSS-REACTIVITY; ATOPIC-DERMATITIS; COOKING METHODS; PHAGE DISPLAY; IGE-BINDING; CASHEW NUT; IDENTIFICATION; PROTEINS; CHALLENGE; TOLERANCE	Peanut allergy continues to be a problem in most developed countries of the world. We sought a processing method that would alter allergenic peanut proteins, such that allergen recognition by IgE from allergic individuals would be significantly reduced or eliminated. Such a method would render accidental exposures to trace amounts of peanuts safer. A combination of boiling and frying decreased recovery of Ara h 1 and Ara h 2 at their expected MWs. In contrast, treatment with high pressures under varying temperatures had no effect on protein extraction profiles. Antibodies specific for Ara h 1, Ara h 2, and Ara h 6 bound proteins extracted from raw samples but not in boiled/fried samples. However, pre-incubation of serum with boiled/fried extract removed most raw peanut-reactive IgE from solution, including IgE directed to Ara h 1 and 2. Thus, this method of processing is unlikely to generate a peanut product tolerated by peanut allergic patients. Importantly, variability in individual patients' IgE repertoires may mean that some patients' IgE would bind fewer polypeptides in the sequentially processed seed.	[Comstock, Sarah S.; Teuber, Suzanne S.] Univ Calif Davis, Dept Internal Med, Div Rheumatol Allergy & Clin Immunol, Sch Med, Davis, CA 95616 USA; [Maleki, Soheila J.] USDA ARS SRRC, New Orleans, LA USA; [Comstock, Sarah S.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA	University of California System; University of California Davis; United States Department of Agriculture (USDA); Michigan State University	Comstock, SS (corresponding author), Univ Calif Davis, Dept Internal Med, Div Rheumatol Allergy & Clin Immunol, Sch Med, Davis, CA 95616 USA.; Comstock, SS (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	comsto37@msu.edu			Masterfoods Inc.; University of California, Davis	Masterfoods Inc.; University of California, Davis(University of California System)	This research was partially supported by Masterfoods Inc. (SST). The remaining funding was provided by the University of California, Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asarnoj A, 2012, J ALLERGY CLIN IMMUN, V130, P468, DOI 10.1016/j.jaci.2012.05.019; Astier C, 2006, J ALLERGY CLIN IMMUN, V118, P250, DOI 10.1016/j.jaci.2006.04.053; Beyer KB, 2001, J ALLERGY CLIN IMMUN, V107, P1077, DOI 10.1067/mai.2001.115480; Blom WM, 2013, J ALLERGY CLIN IMMUN, V131, P172, DOI 10.1016/j.jaci.2012.10.034; Bublin M, 2013, J ALLERGY CLIN IMMUN, V132, P118, DOI 10.1016/j.jaci.2013.01.022; Burbank AJ, 2016, IMMUNOL ALLERGY CLIN, V36, P55, DOI 10.1016/j.iac.2015.08.007; BURKS AW, 1992, J ALLERGY CLIN IMMUN, V90, P962, DOI 10.1016/0091-6749(92)90469-I; BURKS AW, 1991, J ALLERGY CLIN IMMUN, V88, P172, DOI 10.1016/0091-6749(91)90325-I; Chung SY, 2001, J AGR FOOD CHEM, V49, P3911, DOI 10.1021/jf001186o; Chung SY, 1999, J AGR FOOD CHEM, V47, P5227, DOI 10.1021/jf9904416; Comstock SS, 2004, CLIN EXP ALLERGY, V34, P1583, DOI 10.1111/j.1365-2222.2004.02049.x; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Flinterman AE, 2006, J ALLERGY CLIN IMMUN, V117, P448, DOI 10.1016/j.jaci.2005.11.035; Hildebrandt S, 2010, J ALLERGY CAIRO 2010, V2010; Hourihane JO, 1997, BRIT MED J, V314, P1084, DOI 10.1136/bmj.314.7087.1084; Hu CQ, 2011, J SCI FOOD AGR, V91, P1304, DOI 10.1002/jsfa.4318; Kim J, 2013, ANN ALLERG ASTHMA IM, V110, P34, DOI 10.1016/j.anai.2012.10.011; Kleber-Janke T, 1999, INT ARCH ALLERGY IMM, V119, P265, DOI 10.1159/000024203; Kleber-Janke T, 2001, J CHROMATOGR B, V756, P295, DOI 10.1016/S0378-4347(01)00088-3; Kobayashi S, 2012, BIOSCI BIOTECH BIOCH, V76, P1182, DOI 10.1271/bbb.120063; Koppelman SJ, 1999, J BIOL CHEM, V274, P4770, DOI 10.1074/jbc.274.8.4770; Koppelman SJ, 2005, CLIN EXP ALLERGY, V35, P490, DOI 10.1111/j.1365-2222.2005.02204.x; Koppelman SJ, 2004, CLIN EXP ALLERGY, V34, P583, DOI 10.1111/j.1365-2222.2004.1923.x; Koppelman SJ, 2003, ALLERGY, V58, P1144, DOI 10.1034/j.1398-9995.2003.00259.x; Koppelman SJ, 2001, ALLERGY, V56, P132, DOI 10.1034/j.1398-9995.2001.056002132.x; Kopper RA, 2005, INT ARCH ALLERGY IMM, V136, P16, DOI 10.1159/000082580; Krause S, 2009, J ALLERGY CLIN IMMUN, V124, P771, DOI 10.1016/j.jaci.2009.06.008; Lauer I, 2009, CLIN EXP ALLERGY, V39, P1427, DOI 10.1111/j.1365-2222.2009.03312.x; Maleki SJ, 2000, J ALLERGY CLIN IMMUN, V106, P763, DOI 10.1067/mai.2000.109620; Maleki SJ, 2010, ANN ALLERG ASTHMA IM, V105, P451, DOI 10.1016/j.anai.2010.09.025; Mittag D, 2004, J ALLERGY CLIN IMMUN, V114, P1410, DOI 10.1016/j.jaci.2004.09.014; Mondoulet L, 2005, J AGR FOOD CHEM, V53, P4547, DOI 10.1021/jf050091p; Nesbit JB, 2012, MOL NUTR FOOD RES, V56, P1739, DOI 10.1002/mnfr.201100815; Petersen A, 2015, J ALLERGY CLIN IMMUN, V136, P1295, DOI 10.1016/j.jaci.2015.04.010; Poms RE, 2004, MOL NUTR FOOD RES, V48, P459, DOI 10.1002/mnfr.200400052; Pons L, 2002, ALLERGY, V57, P88, DOI 10.1034/j.1398-9995.57.s72.16.x; Santos AF, 2016, CLIN TRANSL ALLERGY, V6, DOI 10.1186/s13601-016-0098-7; Schmitt D. A., 2004, Journal of Allergy and Clinical Immunology, V113, pS155, DOI 10.1016/j.jaci.2003.12.566; Schmitt DA, 2010, J AGR FOOD CHEM, V58, P1138, DOI 10.1021/jf902694j; Schwager C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123419; Su M, 2004, J SCI FOOD AGR, V84, P1119, DOI 10.1002/jsfa.1748; Taylor SL, 2014, FOOD CHEM TOXICOL, V63, P9, DOI 10.1016/j.fct.2013.10.032; Teuber SS, 2002, J AGR FOOD CHEM, V50, P6543, DOI 10.1021/jf025757j; Turner PJ, 2014, J ALLERGY CLIN IMMUN, V134, P751, DOI 10.1016/j.jaci.2014.06.016; Vissers YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023998; Wensing M, 2002, J ALLERGY CLIN IMMUN, V110, P915, DOI 10.1067/mai.2002.129235; Yu JM, 2011, FOOD CHEM, V127, P1014, DOI 10.1016/j.foodchem.2011.01.074	47	18	19	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157849	10.1371/journal.pone.0157849	http://dx.doi.org/10.1371/journal.pone.0157849			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310538	gold, Green Published, Green Submitted			2022-12-26	WOS:000378029800139
J	Guo, J; Hirasaki, N; Miyata, Y; Tanaka, K; Tanaka, T; Wu, X; Tahara, Y; Toko, K; Matsui, T				Guo, Jian; Hirasaki, Naoto; Miyata, Yuji; Tanaka, Kazunari; Tanaka, Takashi; Wu, Xiao; Tahara, Yusuke; Toko, Kiyoshi; Matsui, Toshiro			Evaluating the Reduced Hydrophobic Taste Sensor Response of Dipeptides by Theasinensin A by Using NMR and Quantum Mechanical Analyses	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; SPRAGUE-DAWLEY RATS; AMINO-ACIDS; PROTEIN HYDROLYSATE; FERMENTED TEA; CYCLODEXTRIN; ABSORPTION; PEPTIDES; PHOSPHOLIPIDS; INHIBITION	The current study demonstrated that theasinensin A (TSA) had a potential to form the complex with hydrophobic Trp-containing dipeptides, and to reduce their membrane potential by artificial-lipid membrane taste sensor. At a 1: 3 molar ratio of the 6 Trp-containing dipeptides together with TSA, we observed a significant chemical shift of the protons of the dipeptides (Delta delta) to a high magnetic field, when analyzed using H-1-nuclear-magnetic resonance (NMR) spectroscopy. The Delta delta values were correlated with the hydrophobicity (log P) of the dipeptides and significant correlations were obtained (P = 0.022, R-2 = 0.77); e.g., Trp-Leu with the highest log P value of 1.623 among the tested dipeptides showed the highest Delta delta value of 0.105 ppm for the H7 proton of Trp-Leu, while less chemical shifts were observed in theasinensin B and epigallocatechin-3-O-gallate. Diffusion-ordered NMR spectroscopy revealed that the diffusion coefficient of 3 mM of Trp-Leu (7.6 x 10(-11) m(2)/s) at a pulse field gradient in the range 0.05-0.3 T/m decreased in the presence of 3 mM TSA (6.6 x 10(-11) m(2)/s), suggesting that Trp-Leu forms a complex with TSA. Quantum mechanical calculations and rotating frame nuclear Overhauser effect-NMR spectroscopy provided configuration information on the geometry of the complex that Trp-Leu formed with TSA (1:1 complex) with a Delta G energy of -8.7 kJ/mol. A sensor analysis using artificial-lipid membranes demonstrated that the changes in membrane potential of 1 mM Trp-Leu (21.8 +/- 1.3 mV) and Leu-Trp (5.3 +/- 0.9 mV) were significantly (P < 0.001) reduced by 1 mM TSA (Trp-Leu, 13.1 +/- 2.4 mV; Leu-Trp, 3.5 +/- 0.5 mV; TSA alone, 0.2 +/- 0.01 mV), indicating the effective suppression of hydrophobicity of dipeptides by TSA-formed complex.	[Guo, Jian; Hirasaki, Naoto; Matsui, Toshiro] Kyushu Univ, Graduated Sch, Fac Agr, Dept Biosci & Biotechnol,Div Bioresource & Bioenv, 6-10-1 Hakozaki, Fukuoka 8128581, Japan; [Miyata, Yuji] Higashisonogi Tea Res Stn, Nagasaki Agr & Forestry Tech Dev Ctr, 1414 Nakano Go, Nagasaki 8593801, Japan; [Tanaka, Kazunari] Nagasaki Univ, Dept Nutr, 1-1-1 Manabino, Nagasaki 8512195, Japan; [Tanaka, Takashi] Nagasaki Univ, Grad Sch Biochem Sci, 1-14 Bukyo Machi, Nagasaki 8528521, Japan; [Wu, Xiao; Tahara, Yusuke; Toko, Kiyoshi] Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan; [Toko, Kiyoshi; Matsui, Toshiro] Kyushu Univ, Res & Dev Ctr Taste & Odor Sensing, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan	Kyushu University; Nagasaki University; Nagasaki University; Kyushu University; Kyushu University	Matsui, T (corresponding author), Kyushu Univ, Graduated Sch, Fac Agr, Dept Biosci & Biotechnol,Div Bioresource & Bioenv, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.; Matsui, T (corresponding author), Kyushu Univ, Res & Dev Ctr Taste & Odor Sensing, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	tmatsui@agr.kyushu-u.ac.jp	Yusuke, Tahara/AAR-4156-2020; Tahara, Yusuke/H-3865-2011	Yusuke, Tahara/0000-0003-1216-4419; 	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry in Japan	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry in Japan	This work was supported by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry in Japan.	Akitomi H, 2013, SENSOR ACTUAT B-CHEM, V179, P276, DOI 10.1016/j.snb.2012.09.014; Binello A, 2004, FLAVOUR FRAG J, V19, P394, DOI 10.1002/ffj.1434; Calton GJ, 2002, Modifying undesirable tastes, Patent No. [US 2002/0187180, 20020187180]; Cameron KS, 2001, J ORG CHEM, V66, P6891, DOI 10.1021/jo010081x; Cao RG, 2015, PHARM RES-DORDR, V32, P2301, DOI 10.1007/s11095-015-1621-6; Cao R, 2015, FOOD CHEM, V171, P8, DOI 10.1016/j.foodchem.2014.08.105; Cao R, 2014, ANAL SCI, V30, P383, DOI 10.2116/analsci.30.383; Cho SJ, 2007, J AGR FOOD CHEM, V55, P10599, DOI 10.1021/jf071903f; Durand J, 2008, MAGN RESON CHEM, V46, P739, DOI 10.1002/mrc.2244; Eckert M, 2007, FOOD TECHNOL-CHICAGO, V61, P20; Figueiras A, 2007, PHARM RES-DORDR, V24, P377, DOI 10.1007/s11095-006-9161-8; Hara D., 2014, SENSOR LETT, V12, P1172, DOI [10. 1166/sl. 2014. 3182, DOI 10.1166/SL.2014.3182]; HARA H, 1984, J NUTR, V114, P1122, DOI 10.1093/jn/114.6.1122; He Q, 2006, FOOD CHEM, V95, P250, DOI 10.1016/j.foodchem.2004.11.055; Jullian C, 2007, BIOORGAN MED CHEM, V15, P3217, DOI 10.1016/j.bmc.2007.02.035; Kato H, 1986, DEV FOOD FLAVOURS, P158; Katsuragi Y, 1997, PHARMACEUT RES, V14, P720, DOI 10.1023/A:1012138103223; Kobayashi Y, 2010, SENSORS-BASEL, V10, P3411, DOI 10.3390/s100403411; Kohl S, 2013, J AGR FOOD CHEM, V61, P53, DOI 10.1021/jf303146h; Kumrungsee T, 2014, BBA-GEN SUBJECTS, V1840, P3073, DOI 10.1016/j.bbagen.2014.07.020; Ley JP, 2008, CHEMOSENS PERCEPT, V1, P58, DOI 10.1007/s12078-008-9008-2; LINDE GA, 2009, FOOD RES INT, V42, P814, DOI DOI 10.1016/j.foodres.2009.03.016; Linde GA, 2010, FOOD RES INT, V43, P187, DOI 10.1016/j.foodres.2009.09.025; Maehashi K, 2009, CELL MOL LIFE SCI, V66, P1661, DOI 10.1007/s00018-009-8755-9; Maehashi K, 2008, BIOCHEM BIOPH RES CO, V365, P851, DOI 10.1016/j.bbrc.2007.11.070; Matsui T, 2010, BRIT J NUTR, V103, P309, DOI 10.1017/S0007114509991814; Miyata Y, 2013, J AGR FOOD CHEM, V61, P9366, DOI 10.1021/jf400123y; Miyata Y, 2011, FOOD SCI TECHNOL RES, V17, P585, DOI 10.3136/fstr.17.585; Murase K, 2000, JP patent, Patent No. [0021390, WO0021390]; Pszczola DE, 2004, FOOD TECHNOL-CHICAGO, V58, P56; Qiu J, 2012, J AGR FOOD CHEM, V60, P8036, DOI 10.1021/jf302242n; Roberts PR, 1999, DIGESTION, V60, P332, DOI 10.1159/000007679; Shii T, 2011, CHEM PHARM BULL, V59, P1183, DOI 10.1248/cpb.59.1183; Shii T, 2011, J AGR FOOD CHEM, V59, P7253, DOI 10.1021/jf201499n; Sohi H, 2004, DRUG DEV IND PHARM, V30, P429, DOI 10.1081/DDC-120037477; Tahara Y, 2013, IEEE SENS J, V13, P3001, DOI 10.1109/JSEN.2013.2263125; Toko K, 1997, SENSOR MATER, V9, P171; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Wroblewski K, 2001, EUR J BIOCHEM, V268, P4384, DOI 10.1046/j.1432-1327.2001.02350.x; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011	40	2	2	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157315	10.1371/journal.pone.0157315	http://dx.doi.org/10.1371/journal.pone.0157315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309380	Green Submitted, Green Published, gold			2022-12-26	WOS:000378029800053
J	Huls, A; Kramer, U; Stolz, S; Hennig, F; Hoffmann, B; Ickstadt, K; Vierkotter, A; Schikowski, T				Huels, Anke; Kraemer, Ursula; Stolz, Sabine; Hennig, Frauke; Hoffmann, Barbara; Ickstadt, Katja; Vierkoetter, Andrea; Schikowski, Tamara			Applicability of the Global Lung Initiative 2012 Reference Values for Spirometry for Longitudinal Data of Elderly Women	PLOS ONE			English	Article							AIR-POLLUTION EXPOSURE; DECLINE; AGE; EQUATIONS; SAMPLE; ADULTS	Background and Objectives Lung function depends nonlinearly on age and height, so that the use of age and height specific reference values is required. The widely used age and height specific GLI (Global Lung Initiative) z-scores derived from cross-sectional data, however, have not been proven for validity in an elderly population or for longitudinal data. Therefore, we aimed to test their validity in a population of elderly women followed prospectively for more than 20 years. Methods We used spirometric data (forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) and FEV1/FVC) from the SALIA cohort of German women (baseline: 1985-1994 (aged 55 years), follow-up: 2008/2009 and 2012/2013). We calculated GLI-z-scores for baseline and follow-up examination separately (cross-sectional evaluation) and individual differences in z-scores between baseline and follow-up (longitudinal evaluation) for healthy never-smoking women. Results GLI reference values for FEV1, FVC and FEV1/FVC were cross-sectionally and longitudinally equivalent with our SALIA data. The mean change in z-scores between baseline and follow-up was 0.33 for FEV1, 0.38 for FVC and -0.10 for FEV1/FVC. Conclusions In conclusion, GLI z-scores fit cross-sectionally and longitudinally with FEV1, FVC and FEV1/FVC measured in women from Germany which indicates that they can be used in longitudinal association analyses.	[Huels, Anke; Kraemer, Ursula; Stolz, Sabine; Hennig, Frauke; Hoffmann, Barbara; Vierkoetter, Andrea; Schikowski, Tamara] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Hoffmann, Barbara] Univ Dusseldorf, Fac Med, Deanery Med, Dusseldorf, Germany; [Ickstadt, Katja] TU Dortmund Univ, Fac Stat, Dortmund, Germany	Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf; Dortmund University of Technology	Huls, A (corresponding author), IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany.	Anke.Huels@IUF-Duesseldorf.de	Huels, Anke/J-8743-2019	Huels, Anke/0000-0002-6005-417X	Deutsche Forschungsgemeinschaft (DFG) [HE-4510/2-1, KR 1938/3-1, LU 691/4-1]; Ministry of the Environment of the state North Rhine-Westphalia (Dusseldorf, Germany); Federal Ministry of the Environment (Berlin, Germany); DGUV (German statutory accident assurance) [VT 266.1]; European Community [211250]; German Federal Ministry of Education and Research (BMBF); Research Commission of the Medical Faculty of the Heinrich-Heine University of Dusseldorf [12/2011]; Open Access fund of the Leibniz Association	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry of the Environment of the state North Rhine-Westphalia (Dusseldorf, Germany); Federal Ministry of the Environment (Berlin, Germany); DGUV (German statutory accident assurance); European Community(European Commission); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Research Commission of the Medical Faculty of the Heinrich-Heine University of Dusseldorf; Open Access fund of the Leibniz Association	This work was supported by the Deutsche Forschungsgemeinschaft (DFG; HE-4510/2-1, KR 1938/3-1, LU 691/4-1), by the Ministry of the Environment of the state North Rhine-Westphalia, (Dusseldorf, Germany), by the Federal Ministry of the Environment (Berlin, Germany); DGUV (German statutory accident assurance) VT 266.1, by the European Community's Seventh Framework Program (FP7/2007-2011) under grant agreement number 211250, by the German Federal Ministry of Education and Research (BMBF) and by the Research Commission of the Medical Faculty of the Heinrich-Heine University of Dusseldorf (12/2011). The publication of this article was funded by the Open Access fund of the Leibniz Association.; This work was supported by the Deutsche Forschungsgemeinschaft (DFG; HE-4510/2-1, KR 1938/3-1, LU 691/4-1), by the Ministry of the Environment of the state North Rhine-Westphalia (Dusseldorf Germany), by the Federal Ministry of the Environment (Berlin, Germany); DGUV (German statutory accident assurance) VT 266.1, by the European Community's Seventh Framework Program (FP7/2007-2011) under grant agreement number 211250, by the German Federal Ministry of Education and Research (BMBF) and by the Research Commission of the Medical Faculty of the Heinrich-Heine University of Dusseldorf (12/2011). The publication of this article was funded by the Open Access fund of the Leibniz Association.	Adam M, 2015, EUR RESPIR J, V45, P38, DOI 10.1183/09031936.00130014; [Anonymous], 1979, AM REV RESPIR DIS, V119, P831; [Anonymous], 2010, TESTING STAT HYPOTHE, DOI DOI 10.1201/EBK1439808184; Backman H, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0022-2; Ben Saad H, 2013, RESP MED, V107, P2000, DOI 10.1016/j.rmed.2013.10.015; BURROWS B, 1986, AM REV RESPIR DIS, V133, P974; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Hall GL, 2012, RESPIROLOGY, V17, P1150, DOI 10.1111/j.1440-1843.2012.02232.x; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Kainu A, 2016, CLIN PHYSIOL FUNCT I, V36, P346, DOI 10.1111/cpf.12237; Kerstjens HAM, 1997, THORAX, V52, P820, DOI 10.1136/thx.52.9.820; Koch B, 2011, RESP MED, V105, P352, DOI 10.1016/j.rmed.2010.10.014; LOUIS TA, 1986, J CHRON DIS, V39, P831, DOI 10.1016/0021-9681(86)90085-8; Marsh S, 2007, RESPIROLOGY, V12, P367, DOI 10.1111/j.1440-1843.2007.01071.x; Miller MR, 2014, EUR RESPIR J, V43, P1338, DOI 10.1183/09031936.00100313; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Muller-Brandes C, 2014, EUR RESPIR J, V43, P1347, DOI 10.1183/09031936.00058813; Quanjer PH, 2011, EUR RESPIR J, V37, P658, DOI 10.1183/09031936.00110010; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Quanjer PH, 2008, AM J RESP CRIT CARE, V178, P1262, DOI 10.1164/rccm.200805-700OC; R Development Core Team, 2014, R LANG ENV STAT COMP; Robinson AP, 2004, ECOL MODEL, V176, P349, DOI 10.1016/j.ecolmodel.2004.01.013; Schikowski T, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-152; Schikowski T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-113; Schikowski T, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-20; SCHUIRMANN DL, 1981, BIOMETRICS, V37, P617; Thompson BR, 2011, RESPIROLOGY, V16, P912, DOI 10.1111/j.1440-1843.2011.01970.x; Vossoughi M, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-5; WARE JH, 1990, AM J EPIDEMIOL, V132, P685, DOI 10.1093/oxfordjournals.aje.a115710; WESTLAKE WJ, 1981, BIOMETRICS, V37, P591	31	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157569	10.1371/journal.pone.0157569	http://dx.doi.org/10.1371/journal.pone.0157569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310365	gold, Green Submitted, Green Published			2022-12-26	WOS:000378029800099
J	Lee, WJ; Chen, LK; Liang, CK; Peng, LN; Chiou, ST; Chou, P				Lee, Wei-Ju; Chen, Liang-Kung; Liang, Chih-Kuang; Peng, Li-Ning; Chiou, Shu-Ti; Chou, Pesus			Soluble ICAM-1, Independent of IL-6, Is Associated with Prevalent Frailty in Community-Dwelling Elderly Taiwanese People	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; INFLAMMATORY MARKERS; PHYSICAL PERFORMANCE; INTERLEUKIN-6; PREDICTORS; HEALTH; ADULTS; MASS	Background Activation of inflammatory pathway with elevation of inflammatory biomarkers such as Interleukin 6 (IL-6) has been considered a pathophysiological feature of frailty. In recent years, the association between Intercellular adhesive molecule -1 (ICAM-1) and vascular inflammatory was established. Provocation of inflammatory cascades from ICAM-1 is potential IL-6 related, although the association between the inflammatory process and frailty is little to known. The study was intended to evaluate the relationship between serum ICAM-1, IL-6 and frailty. Materials and Methods Data was derived from a representative national sampling cohort in Taiwan. The cross-sectional study included nine-hundred-forty-six community-dwelling people aged 53 and older. Frailty was defined as having three or more components (including, muscle shrinkage, slowness, weakness, exhaustion, and low activity) Serum IL-6 and ICAM-1 levels were measured using standard enzyme-linked immunosorbent assays. Results Soluble ICAM-1 (sICAM-1) levels were stepwise increased in non-frail, pre-frail and frail elderly people (the median levels were 255 vs. 265 vs. 285 ng/ml, respectively p<0.001). A multivariate multinomial logistic regression, which was adjusted for age, sex, smoking, education, BMI, and chronic disease number, was utilized to determine that the probability of being frail due to increased log (ICAM-1) and log (IL-6) standard deviation levels were 1.44 (95% CI 1.09-1.91) and 1.54 (95% CI 1.07-2.20), respectively. Conclusion sICAM-1 was significantly associated with frailty, independent of IL-6. This implied that leukocyte migration and inflammation cascade activation might contribute to frailty, in addition to monocyte/macrophage-mediated immuno-inflammation.	[Lee, Wei-Ju; Chen, Liang-Kung; Liang, Chih-Kuang; Peng, Li-Ning] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei 112, Taiwan; [Lee, Wei-Ju; Peng, Li-Ning; Chiou, Shu-Ti; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Wei-Ju] Taipei Vet Gen Hosp, Yuanshan Branch, Dept Family Med, Yilan, Taiwan; [Chen, Liang-Kung; Peng, Li-Ning] Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, Taipei, Taiwan; [Liang, Chih-Kuang] Kaohsiung Vet Gen Hosp, Ctr Geriatr & Gerontol, Kaoshiung City, Taiwan; [Chiou, Shu-Ti] Minist Hlth & Welf, Hlth Promot Adm, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Kaohsiung Veterans General Hospital	Chou, P (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	pschou@ym.edu.tw	Liang, Chih-Kuang/AAJ-5235-2020; Lee, Wei-Ju/AAK-1549-2021	Liang, Chih-Kuang/0000-0003-1604-1600; Lee, Wei-Ju/0000-0003-4326-333X; Chen, Liang-Kung/0000-0002-2387-8508	Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital; Ministry of Science and Technology of Taiwan [MOST 103-2633-B-400-002, MOST 105-3011-B-010-001]	Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, as well as the Ministry of Science and Technology of Taiwan (MOST 103-2633-B-400-002 and MOST 105-3011-B-010-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors express their gratitude to the Health Promotion Administration staff, the Ministry of Health and Welfare, Taiwan for data collection and to all of the participants for their assistance. This study was supported by the Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, as well as the Ministry of Science and Technology of Taiwan (MOST 103-2633-B-400-002 and MOST 105-3011-B-010-001).	Afilalo J, 2014, J AM COLL CARDIOL, V63, P747, DOI 10.1016/j.jacc.2013.09.070; Barron E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127550; Boey KW, 1999, INT J GERIATR PSYCH, V14, P608, DOI 10.1002/(SICI)1099-1166(199908)14:8<608::AID-GPS991>3.0.CO;2-Z; Cesari M, 2004, J GERONTOL A-BIOL, V59, P242; Chen CY, 2010, ARCH GERONTOL GERIAT, V50, pS43, DOI 10.1016/S0167-4943(10)70012-1; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Hasegawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088150; Hofer S, 2009, CRIT CARE, V13, DOI 10.1186/cc7923; Hubbard RE, 2010, J GERONTOL A-BIOL, V65, P377, DOI 10.1093/gerona/glp186; Joyce BT, 2015, CANC EPIDEMIOL BIOMA; Kim JC, 2013, J AM SOC NEPHROL, V24, P337, DOI 10.1681/ASN.2012010047; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; LEEUWENBERG JFM, 1992, IMMUNOLOGY, V77, P543; Leng S, 2002, J AM GERIATR SOC, V50, P1268, DOI 10.1046/j.1532-5415.2002.50315.x; Leng SX, 2007, J AM GERIATR SOC, V55, P864, DOI 10.1111/j.1532-5415.2007.01186.x; MCCABE SM, 1993, CELL IMMUNOL, V150, P364, DOI 10.1006/cimm.1993.1204; Nguyen QM, 2010, ANN EPIDEMIOL, V20, P53, DOI 10.1016/j.annepidem.2009.10.001; Puts MTE, 2005, CLIN ENDOCRINOL, V63, P403, DOI 10.1111/j.1365-2265.2005.02355.x; Qu Ning-ning, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P265; Qu T, 2009, CYTOKINE, V46, P319, DOI 10.1016/j.cyto.2009.02.015; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Rouhl RPW, 2012, NEUROBIOL AGING, V33, P1800, DOI 10.1016/j.neurobiolaging.2011.04.008; Santos MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044668; Schmal H, 1998, J IMMUNOL, V161, P3685; Sherman DG, 2001, NEUROLOGY, V57, P1428, DOI 10.1212/wnl.57.8.1428; Taguchi O, 1997, INTERNAL MED, V36, P14, DOI 10.2169/internalmedicine.36.14; Theou O, 2015, AGEING RES REV, V21, P78, DOI 10.1016/j.arr.2015.04.001; Theou O, 2013, J AM GERIATR SOC, V61, P1537, DOI 10.1111/jgs.12420; Tiainen K, 2012, EXP GERONTOL, V47, P109, DOI 10.1016/j.exger.2011.11.002; Vemuganti R, 2004, STROKE, V35, P179, DOI 10.1161/01.STR.0000106479.53235.3E; Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326; Wallet MA, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0106-z; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; Weinstein M., 2014, SOCIAL ENV BIOMARKER	34	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157877	10.1371/journal.pone.0157877	http://dx.doi.org/10.1371/journal.pone.0157877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310835	Green Published, Green Submitted, gold			2022-12-26	WOS:000378029800141
J	Liebick, M; Schlager, C; Oppermann, M				Liebick, Marcel; Schlaeger, Christian; Oppermann, Martin			Analysis of Chemokine Receptor Trafficking by Site-Specific Biotinylation	PLOS ONE			English	Article							5 CCR5 PHOSPHORYLATION; CELL-SURFACE PROTEINS; CONSTITUTIVE INTERNALIZATION; ENDOCYTIC PATHWAY; CANCER; CXCR4; GPCR; MECHANISMS; EXPRESSION; AGONIST	Chemokine receptors undergo internalization and desensitization in response to ligand activation. Internalized receptors are either preferentially directed towards recycling pathways (e.g. CCR5) or sorted for proteasomal degradation (e.g. CXCR4). Here we describe a method for the analysis of receptor internalization and recycling based on specific Bir A-mediated biotinylation of an acceptor peptide coupled to the receptor, which allows a more detailed analysis of receptor trafficking compared to classical antibody-based detection methods. Studies on constitutive internalization of the chemokine receptors CXCR4 (12.1% +/- 0.99% receptor internalization/h) and CCR5 (13.7% +/- 0.68%/h) reveals modulation of these processes by inverse (TAK779; 10.9% +/- 0.95%/h) or partial agonists (Met-CCL5; 15.6% +/- 0.5%/h). These results suggest an actively driven internalization process. We also demonstrate the advantages of specific biotinylation compared to classical antibody detection during agonist-induced receptor internalization, which may be used for immunofluorescence analysis as well. Site-specific biotinylation may be applicable to studies on trafficking of transmembrane proteins, in general.	[Liebick, Marcel; Schlaeger, Christian; Oppermann, Martin] Univ Gottingen, Dept Cellular & Mol Immunol, D-37073 Gottingen, Germany	University of Gottingen	Liebick, M (corresponding author), Univ Gottingen, Dept Cellular & Mol Immunol, D-37073 Gottingen, Germany.	marcel.liebick@med.uni-goettingen.de			Deutsche Forschungsgemeinschaft [DFG Op42-10]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft (DFG Op42-10) (http://www.dfg.de/) (recipient: MO).	Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec; Alvarez-Curto E, 2011, MOL PHARMACOL, V80, P1033, DOI 10.1124/mol.111.074674; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Anselmo A, 2014, CYTOM PART A, V85, P292, DOI 10.1002/cyto.a.22439; Arancibia-Carcamo I. L., 2006, DYNAMIC SYNAPSE MOL; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Carrodus NL, 2014, JOVE-J VIS EXP, DOI 10.3791/51139; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Cull MG, 2000, METHOD ENZYMOL, V326, P430; Duffy S, 1998, ANAL BIOCHEM, V262, P122, DOI 10.1006/abio.1998.2770; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Escola JM, 2010, J BIOL CHEM, V285, P41772, DOI 10.1074/jbc.M110.153460; Ferain T, 2011, J PHARMACOL EXP THER, V337, P655, DOI 10.1124/jpet.111.179622; Fisher GW, 2010, J BIOMOL SCREEN, V15, P703, DOI 10.1177/1087057110370892; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Garcia-Perez J, 2011, J BIOL CHEM, V286, P4978, DOI 10.1074/jbc.M110.168955; Garippa RT, 2006, METHOD ENZYMOL, V414, P99, DOI 10.1016/S0076-6879(06)14007-0; George N, 2004, J AM CHEM SOC, V126, P8896, DOI 10.1021/ja048396s; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gilliland CT, 2013, J BIOL CHEM, V288, P32194, DOI 10.1074/jbc.M113.503797; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GRADY EF, 1995, MOL BIOL CELL, V6, P509, DOI 10.1091/mbc.6.5.509; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Hammer MM, 2007, FASEB J, V21, P3827, DOI 10.1096/fj.07-8777com; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hoffmann C, 2008, BRIT J PHARMACOL, V153, pS358, DOI 10.1038/sj.bjp.0707615; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Kakinuma T, 2006, J LEUKOCYTE BIOL, V79, P639, DOI 10.1189/jlb.1105633; Kershaw T, 2009, METHOD ENZYMOL, V460, P357, DOI 10.1016/S0076-6879(09)05218-5; Kiss DL, 2009, CELL MOL BIOL LETT, V14, P537, DOI 10.2478/s11658-009-0017-1; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Lam VM, 2013, TRAFFIC, V14, P778, DOI 10.1111/tra.12073; Laporte SA, 2002, J BIOL CHEM, V277, P9247, DOI 10.1074/jbc.M108490200; Levoye A, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00167; Li YF, 2012, PROTEIN EXPRES PURIF, V82, P162, DOI 10.1016/j.pep.2011.12.008; Longden J, 2008, BRIT J PHARMACOL, V153, P1513, DOI 10.1038/sj.bjp.0707691; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2014, CURR OPIN CELL BIOL, V27, P72, DOI 10.1016/j.ceb.2013.11.011; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Miller WE, 2003, J BIOL CHEM, V278, P21663, DOI 10.1074/jbc.M303219200; MOORE RH, 1995, J CELL SCI, V108, P2983; Mueller A, 2004, EUR J BIOCHEM, V271, P243, DOI 10.1046/j.1432-1033.2003.03918.x; Mueller A, 2002, BLOOD, V99, P785, DOI 10.1182/blood.V99.3.785; Murdoch C, 2000, BLOOD, V95, P3032; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Pollok-Kopp B, 2003, J BIOL CHEM, V278, P2190, DOI 10.1074/jbc.M209844200; Robers MB, 2015, ANAL BIOCHEM, V489, P1, DOI 10.1016/j.ab.2015.08.005; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Sarvaiya PJ, 2013, ONCOTARGET, V4, P2171, DOI 10.18632/oncotarget.1426; Signoret N, 2004, TRAFFIC, V5, P529, DOI 10.1111/j.1600-0854.2004.00200.x; Signoret N, 2000, METH MOL B, V138, P197; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Snyder JC, 2013, J BIOL CHEM, V288, P10286, DOI 10.1074/jbc.M112.447540; Sorkin A, 2010, CURR PROTOC CELL BIO, V15, P1; Steel E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093646; Tamamis P, 2014, SCI REP-UK, V4, DOI 10.1038/srep05447; Tamamis P, 2014, J CHEM INF MODEL, V54, P1174, DOI 10.1021/ci500069y; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Trivedi RR, 2012, BIOCHEM BIOPH RES CO, V427, P185, DOI 10.1016/j.bbrc.2012.09.040; Weitzenfeld P, 2014, CANCER LETT, V352, P36, DOI 10.1016/j.canlet.2013.10.006; Woehler Andrew, 2009, Curr Mol Pharmacol, V2, P237; Yokoyama Wayne M, 2013, Curr Protoc Immunol, V102, DOI 10.1002/0471142735.im0205s102; Zhang R, 2012, ACTA PHARMACOL SIN, V33, P372, DOI 10.1038/aps.2011.173; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015	86	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157502	10.1371/journal.pone.0157502	http://dx.doi.org/10.1371/journal.pone.0157502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310579	Green Submitted, Green Published, gold			2022-12-26	WOS:000378029800087
J	Xu, L; Zhou, XY; Wang, WS; Wang, YJ; Yin, YB; van der Laan, LJW; Sprengers, D; Metselaar, HJ; Peppelenbosch, MP; Pan, QW				Xu, Lei; Zhou, Xinying; Wang, Wenshi; Wang, Yijin; Yin, Yuebang; van der Laan, Luc J. W.; Sprengers, Dave; Metselaar, Herold J.; Peppelenbosch, Maikel P.; Pan, Qiuwei			IFN regulatory factor 1 restricts hepatitis E virus replication by activating STAT1 to induce antiviral IFN-stimulated genes	FASEB JOURNAL			English	Article						innate immunity; ribavirin; transcription	C-VIRUS; IN-VITRO; INTERFERON; INFECTION; RIBAVIRIN; PROTEINS; ALPHA; IDENTIFICATION; EXPRESSION; MECHANISM	IFN regulatory factor 1 (IRF1) is one of the most important IFN-stimulated genes (ISGs) in cellular antiviral immunity. Although hepatitis E virus (HEV) is a leading cause of acute hepatitis worldwide, how ISGs counteract HEV infection is largely unknown. This study was conducted to investigate the effect of IRF1 on HEV replication. Multiple cell lines were used in 2 models that harbor HEV. In different HEV cell culture systems, IRF1 effectively inhibited HEV replication. IRF1 did not trigger IFN production, and chromatin immunoprecipitation sequencing data analysis revealed that IRF1 bound to the promoter region of signal transducers and activators of transcription 1 (STAT1). Functional assay confirmed that IRF1 could drive the transcription of STAT1, resulting in elevation of total and phosphorylated STAT1 proteins and further activating the transcription of a panel of downstream antiviral ISGs. By pharmacological inhibitors and RNAi-mediated gene-silencing approaches, we revealed that antiviral function of IRF1 is dependent on the JAK-STAT cascade. Furthermore, induction of ISGs and the anti-HEV effect of IRF1 overlapped that of IFN, but was potentiated by ribavirin. We demonstrated that IRF1 effectively inhibits HEV replication through the activation of the JAK-STAT pathway, and the subsequent transcription of antiviral ISGs, but independent of IFN production.-Xu, L., Zhou, X., Wang, W., Wang, Y., Yin, Y., van der Laan, L. J. W., Sprengers, D., Metselaar, H. J., Peppelenbosch, M. P., Pan, Q. IFN regulatory factor 1 restricts hepatitis E virus replication by activating STAT1 to induce antiviral IFN-stimulated genes.	[Xu, Lei; Zhou, Xinying; Wang, Wenshi; Wang, Yijin; Yin, Yuebang; Sprengers, Dave; Metselaar, Herold J.; Peppelenbosch, Maikel P.; Pan, Qiuwei] Erasmus MC Univ Med Ctr, Postgrad Sch Mol Med, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [van der Laan, Luc J. W.] Erasmus MC Univ Med Ctr, Postgrad Sch Mol Med, Dept Surg, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Pan, QW (corresponding author), Erasmus MC, Dept Gastroenterol & Hepatol, Room Na-617,S Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	q.pan@erasmusmc.nl	Peppelenbosch, Maikel P./U-5304-2019; Wang, Yijin/AAA-8753-2022; wang, yijin/GRS-5538-2022; Zhou, Xinying/AAH-7382-2019; Wang, Yijin/HCH-6264-2022	Wang, Yijin/0000-0002-3700-1766; Peppelenbosch, Maikel/0000-0001-9112-6028; van der Laan, Luc/0000-0002-0651-5334; Pan, Qiuwei/0000-0001-9982-6184	European Association for the Study of the Liver (EASL), Sheila Sherlock Fellowship; Netherlands Organization for Scientific Research (NWO/ZonMw) Veni Grant [916-13-032]; Dutch Digestive Foundation (MLDS) Career Development Grant (CDG) [1304]; Daniel den Hoed Foundation Centennial Award Fellowship, an Erasmus MC Medical Research Advisory Committee (MRace) grant; China Scholarship Council [201306300027, 201206150075, 201303250056, 201207720007, 201307720045]	European Association for the Study of the Liver (EASL), Sheila Sherlock Fellowship; Netherlands Organization for Scientific Research (NWO/ZonMw) Veni Grant; Dutch Digestive Foundation (MLDS) Career Development Grant (CDG); Daniel den Hoed Foundation Centennial Award Fellowship, an Erasmus MC Medical Research Advisory Committee (MRace) grant; China Scholarship Council(China Scholarship Council)	The authors thank Dr. Charles M. Rice (Rockefeller University, New York, NY, USA) for generously providing the overexpressing lentiviral vector; Dr. Suzanne U. Emerson (National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA) for generously providing the plasmids to generate subgenomic and full-length HEV genomic RNA; Prof. Ralf Bartenschlager and Dr. Volker Lohmann (University of Heidelberg, Heidelberg, Germany) for providing the HCV replicon cells, and Dr. Steve Ralph (Griffith University, Southpost, QLD, Australia) for generously providing the full- length STAT1 promoter luciferase plasmids. This research was supported by the European Association for the Study of the Liver (EASL), Sheila Sherlock Fellowship (to Q.P.); The Netherlands Organization for Scientific Research (NWO/ZonMw) Veni Grant 916-13-032) (to Q.P.); the Dutch Digestive Foundation (MLDS) Career Development Grant (CDG) 1304 (to Q.P.); an Daniel den Hoed Foundation Centennial Award Fellowship (to Q.P.), an Erasmus MC Medical Research Advisory Committee (MRace) grant (to Q.P.) and the China Scholarship Council Ph.D. Fellowships Grants 201306300027 (to L.X.), 201206150075 (to X.Z.), 201303250056 (to W.W.), 201207720007 (to Y.W.), and 201307720045 (to Y.Y.). The authors declare no conflicts of interest.	Behrendt P, 2014, J HEPATOL, V61, P1418, DOI 10.1016/j.jhep.2014.08.047; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Dalton HR, 2012, NAT REV GASTRO HEPAT, V9, P430, DOI 10.1038/nrgastro.2012.121; Debing Y, 2014, GASTROENTEROLOGY, V147, P1008, DOI 10.1053/j.gastro.2014.08.040; Debing Y, 2014, ANTIMICROB AGENTS CH, V58, P267, DOI 10.1128/AAC.01795-13; Dong C, 2012, HEPATOLOGY, V55, P1324, DOI 10.1002/hep.25530; Engelen E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8155; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Frese M, 2003, J GEN VIROL, V84, P1253, DOI 10.1099/vir.0.18997-0; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Frontini M, 2009, NUCLEIC ACIDS RES, V37, P1073, DOI 10.1093/nar/gkn1051; FUJITA T, 1989, P NATL ACAD SCI USA, V86, P9936, DOI 10.1073/pnas.86.24.9936; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Melchjorsen J, 2013, VIRUSES-BASEL, V5, P470, DOI 10.3390/v5020470; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Pan QW, 2012, HEPATOLOGY, V55, P1673, DOI 10.1002/hep.25562; Pan QW, 2009, J MOL MED, V87, P713, DOI 10.1007/s00109-009-0470-3; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Shukla P, 2012, J VIROL, V86, P5697, DOI 10.1128/JVI.00146-12; Shukla P, 2011, P NATL ACAD SCI USA, V108, P2438, DOI 10.1073/pnas.1018878108; Thomas E, 2011, HEPATOLOGY, V53, P32, DOI 10.1002/hep.23985; Todt D, 2016, ANTIMICROB AGENTS CH, V60, P2132, DOI 10.1128/AAC.02427-15; van Ton AMP, 2015, J VIRAL HEPATITIS, V22, P965, DOI 10.1111/jvh.12403; Xie MR, 2015, J VIROL, V89, P3049, DOI 10.1128/JVI.03416-14; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou X, 2016, J VIRAL HEPATITIS, V23, P294, DOI 10.1111/jvh.12491; Zhou XY, 2014, J HEPATOL, V61, P746, DOI 10.1016/j.jhep.2014.05.026; Zhou XY, 2013, REV MED VIROL, V23, P295, DOI 10.1002/rmv.1751	40	41	41	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3352	3367		10.1096/fj.201600356R	http://dx.doi.org/10.1096/fj.201600356R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27328944				2022-12-26	WOS:000384329800008
J	Lorinczi, E; Helliwell, M; Finch, A; Stansfeld, PJ; Davies, NW; Mahaut-Smith, M; Muskett, FW; Mitcheson, JS				Lorinczi, Eva; Helliwell, Matthew; Finch, Alina; Stansfeld, Phillip J.; Davies, Noel W.; Mahaut-Smith, Martyn; Muskett, Frederick W.; Mitcheson, John S.			Calmodulin Regulates Human Ether a Go-Go 1 (hEAG1) Potassium Channels through Interactions of the Eag Domain with the Cyclic Nucleotide Binding Homology Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium imaging; calmodulin (CaM); electrophysiology; gating; potassium channel	C-TERMINAL REGION; ION CHANNELS; CELL-CYCLE; HERG; RAT; DEACTIVATION; PIP2; DETERMINANTS; INHIBITION; EXPRESSION	The ether a go-go family of voltage-gated potassium channels is structurally distinct. The N terminus contains an eag domain (eagD) that contains a Per-Arnt-Sim (PAS) domain that is preceded by a conserved sequence of 25-27 amino acids known as the PAS-cap. The C terminus contains a region with homology to cyclic nucleotide binding domains (cNBHD), which is directly linked to the channel pore. The human EAG1 (hEAG1) channel is remarkably sensitive to inhibition by intracellular calcium (Ca-i(2+)) through binding of Ca2+-calmodulin to three sites adjacent to the eagD and cNBHD. Here, we show that the eagD and cNBHD interact to modulate Ca2+-calmodulin as well as voltage-dependent gating. Sustained elevation of Ca-i(2+) resulted in an initial profound inhibition of hEAG1 currents, which was followed by a phase when current amplitudes partially recovered, but activation gating was slowed and shifted to depolarized potentials. Deletion of either the eagD or cNBHD abolished the inhibition by Ca-i(2+). However, deletion of just the PAS-cap resulted in a >15-fold potentiation in response to elevated Ca-i(2+). Mutations of residues at the interface between the eagD and cNBHD have been linked to human cancer. Glu-600 on the cNBHD, when substituted with residues with a larger volume, resulted in hEAG1 currents that were profoundly potentiated by Ca-i(2+) in a manner similar to the PAS-cap mutant. These findings provide the first evidence that eagD and cNBHD interactions are regulating Ca2+-dependent gating and indicate that the binding of the PAS-cap with the cNBHD is required for the closure of the channels upon CaM binding.	[Lorinczi, Eva; Helliwell, Matthew; Finch, Alina; Davies, Noel W.; Mahaut-Smith, Martyn; Muskett, Frederick W.; Mitcheson, John S.] Univ Leicester, Dept Mol & Cell Biol, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England; [Helliwell, Matthew] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS5 1TD, Avon, England; [Stansfeld, Phillip J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Leicester; University of Bristol; University of Oxford	Mitcheson, JS (corresponding author), Univ Leicester, Dept Mol & Cell Biol, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	jm109@le.ac.uk	Stansfeld, Phillip James/AAA-9228-2020; Stansfeld, Phill/C-6213-2011	Stansfeld, Phillip James/0000-0001-8800-7669; Stansfeld, Phill/0000-0001-8800-7669; Finch, Alina/0000-0002-5021-2111; Mitcheson, John/0000-0002-2683-2839	British Heart Foundation [PG/11/38/28886]; Biotechnology and Biological Sciences Research Council, United Kingdom [BB/K000128/1]; Biotechnology and Biological Sciences Research Council [BB/K000128/1] Funding Source: researchfish; BBSRC [BB/K000128/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by British Heart Foundation Project Grant PG/11/38/28886 and the Biotechnology and Biological Sciences Research Council, United Kingdom, Grant BB/K000128/1. The authors declare that they have no conflicts of interest with the contents of this article.	Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chuang CC, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-23; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Darby N.J., 1993, PROTEIN STRUCTURE; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; Garg V, 2012, J GEN PHYSIOL, V140, P307, DOI 10.1085/jgp.201210826; Gavrilova-Ruch O, 2002, J MEMBRANE BIOL, V188, P137, DOI 10.1007/s00232-001-0181-3; Gianulis EC, 2013, J GEN PHYSIOL, V142, P351, DOI 10.1085/jgp.201310995; Gomez-Varela D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008858; Goncalves JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010873; Gustina AS, 2013, J GEN PHYSIOL, V141, P229, DOI 10.1085/jgp.201210870; Gustina AS, 2012, CELL SIGNAL, V24, P1592, DOI 10.1016/j.cellsig.2012.04.004; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Han B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23417; Huang X, 2012, GENE DEV, V26, P1780, DOI 10.1101/gad.193789.112; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Kovalevskaya NV, 2013, PFLUG ARCH EUR J PHY, V465, P1507, DOI 10.1007/s00424-013-1278-0; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; Martin S, 2008, NEUROSCIENCE, V155, P833, DOI 10.1016/j.neuroscience.2008.05.019; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Meyer R, 1998, J PHYSIOL-LONDON, V508, P49, DOI 10.1111/j.1469-7793.1998.049br.x; Mortensen LS, 2015, J PHYSIOL-LONDON, V593, P181, DOI 10.1113/jphysiol.2014.281600; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Ng CA, 2014, J BIOL CHEM, V289, P25822, DOI 10.1074/jbc.M114.558379; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 1998, J CELL BIOL, V143, P767, DOI 10.1083/jcb.143.3.767; Pardo LA, 2008, CANCER RES, V68, P1611, DOI 10.1158/0008-5472.CAN-07-5710; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Perry M, 2006, MOL PHARMACOL, V69, P509, DOI 10.1124/mol.105.016741; Perry M, 2004, MOL PHARMACOL, V66, P240, DOI 10.1124/mol.104.000117; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez A, 2016, EMBO REP, V17, P708, DOI 10.15252/embr.201541082; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Stansfeld CE, 1996, P NATL ACAD SCI USA, V93, P9910, DOI 10.1073/pnas.93.18.9910; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Terlau H, 1997, J PHYSIOL-LONDON, V502, P537, DOI 10.1111/j.1469-7793.1997.537bj.x; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Weber WM, 1999, BBA-BIOMEMBRANES, V1421, P213, DOI 10.1016/S0005-2736(99)00135-2; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhang M, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500008; Zhang M, 2014, NAT CHEM BIOL, V10, P753, DOI [10.1038/NCHEMBIO.1592, 10.1038/nchembio.1592]; Zhang T, 2010, HUM MUTAT, V31, pE1801, DOI 10.1002/humu.21341; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x	58	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17907	17918		10.1074/jbc.M116.733576	http://dx.doi.org/10.1074/jbc.M116.733576			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27325704	Green Published, hybrid			2022-12-26	WOS:000383241300034
J	Ramachandran, A; Nandakumar, D; Deshpande, AP; Lucas, TP; R-Bhojappa, R; Tang, GQ; Raney, K; Yin, YW; Patel, SS				Ramachandran, Aparna; Nandakumar, Divya; Deshpande, Aishwarya P.; Lucas, Thomas P.; R-Bhojappa, Ramanagouda; Tang, Guo-Qing; Raney, Kevin; Yin, Y. Whitney; Patel, Smita S.			The Yeast Mitochondrial RNA Polymerase and Transcriptio Factor Complex Catalyzes Efficient Priming of DNA Synthesis on Single-stranded DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-T7 DEOXYRIBONUCLEIC-ACID; STALLED REPLICATION FORKS; BINDING-PROTEIN; SACCHAROMYCES-CEREVISIAE; PURIFIED PROTEINS; INITIATION SITES; PRIMARY ORIGIN; HUMAN PRIMPOL; WILD-TYPE; IN-VITRO	Primases use single-stranded (ss) DNAs as templates to synthesize short oligoribonucleotide primers that initiate lagging strand DNA synthesis or reprime DNA synthesis after replication fork collapse, but the origin of this activity in the mitochondria remains unclear. Herein, we show that the Saccharomyces cerevisiae mitochondrial RNA polymerase (Rpo41) and its transcription factor (Mtf1) is an efficient primase that initiates DNA synthesis on ssDNA coated with the yeast mitochondrial ssDNA-binding protein, Rim1. Both Rpo41 and Rpo41-Mtf1 can synthesize short and long RNAs on ssDNA template and prime DNA synthesis by the yeast mitochondrial DNA polymerase Mip1. However, the ssDNA-binding protein Rim1 severely inhibits the RNA synthesis activity of Rpo41, but not the Rpo41-Mtf1 complex, which continues to prime DNA synthesis efficiently in the presence of Rim1. We show that RNAs as short as 10-12 nt serve as primers for DNA synthesis. Characterization of the RNA-DNA products shows that Rpo41 and Rpo41-Mtf1 have slightly different priming specificity. However, both prefer to initiate with ATP from short priming sequences such as 3'-TCC, TTC, and TTT, and the consensus sequence is 3'-Pu(Py)(2-3). Based on our studies, we propose that Rpo41-Mtf1 is an attractive candidate for serving as the primase to initiate lagging strand DNA synthesis during normal replication and/or to restart stalled replication from downstream ssDNA.	[Ramachandran, Aparna; Nandakumar, Divya; Deshpande, Aishwarya P.; Tang, Guo-Qing; Patel, Smita S.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Nandakumar, Divya] Robert Wood Johnson Med Sch, Grad Sch Biomed Sci, Piscataway, NJ USA; [Lucas, Thomas P.; Yin, Y. Whitney] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Sealy Ctr Struct Biol, Galveston, TX 77555 USA; [R-Bhojappa, Ramanagouda; Raney, Kevin] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Texas System; University of Texas Medical Branch Galveston; University of Arkansas System; University of Arkansas Medical Sciences	Patel, SS (corresponding author), Rutgers, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ USA.	patelss@rutgers.edu	Ramanagoudr Bhojappa, Ramanagouda/ABG-3444-2021; Nandakumar, Divya/K-6250-2014	Ramanagoudr Bhojappa, Ramanagouda/0000-0002-3122-3827; Nandakumar, Divya/0000-0001-7672-0213	National Institutes of Health [R37 GM51966, RO1 GM 083703, RO1 GM 110591, RO1 GM098922]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083703, R01GM110591, R37GM051966, R35GM118086, R01GM098922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (R37 GM51966, to S. S. P.; RO1 GM 083703 and RO1 GM 110591, to Y. W. Y.; and RO1 GM098922, to K. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], SCI; BALDACCI G, 1982, EMBO J, V1, P987, DOI 10.1002/j.1460-2075.1982.tb01282.x; BALDACCI G, 1984, EMBO J, V3, P2115, DOI 10.1002/j.1460-2075.1984.tb02099.x; Basu RS, 2014, J BIOL CHEM, V289, P24549, DOI 10.1074/jbc.M114.584037; Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035; Biswas TK, 1999, BIOCHEMISTRY-US, V38, P9693, DOI 10.1021/bi982804l; Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105; DAVEY SK, 1990, J BIOL CHEM, V265, P3611; DEZAMAROCZY M, 1984, GENE, V32, P439, DOI 10.1016/0378-1119(84)90019-2; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; FULLER CW, 1985, J BIOL CHEM, V260, P3197; FULLER CW, 1985, J BIOL CHEM, V260, P3185; Fuste JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Gerhold JM, 2014, J BIOL CHEM, V289, P22659, DOI 10.1074/jbc.M114.552828; Gerhold JM, 2010, MOL CELL, V39, P851, DOI 10.1016/j.molcel.2010.09.002; Ghosh S, 2010, J BIOL CHEM, V285, P18103, DOI 10.1074/jbc.M110.107656; Ghosh S, 2009, J BIOL CHEM, V284, P30339, DOI 10.1074/jbc.M109.024059; Graves T, 1998, NUCLEIC ACIDS RES, V26, P1309, DOI 10.1093/nar/26.5.1309; Guilliam TA, 2015, NUCLEIC ACIDS RES, V43, P1056, DOI 10.1093/nar/gku1321; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Helleday T, 2013, NAT STRUCT MOL BIOL, V20, P1348, DOI 10.1038/nsmb.2727; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; HOLMES AM, 1985, J BIOL CHEM, V260, P840; Im JS, 2013, EMBO REP, V14, P1032, DOI 10.1038/embor.2013.171; Keen BA, 2014, NUCLEIC ACIDS RES, V42, P5830, DOI 10.1093/nar/gku214; Lee DY, 1998, J BIOL CHEM, V273, P30614, DOI 10.1074/jbc.273.46.30614; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; Matsunaga M, 2004, PROTEIN EXPRES PURIF, V35, P126, DOI 10.1016/j.pep.2003.12.022; Mouron S, 2013, NAT STRUCT MOL BIOL, V20, P1383, DOI 10.1038/nsmb.2719; Nilsen Timothy W, 2014, Cold Spring Harb Protoc, V2014, P677, DOI 10.1101/pdb.prot080788; PARKER WB, 1987, MOL PHARMACOL, V31, P146; Ramanagoudr-Bhojappa R, 2013, NUCLEIC ACIDS RES, V41, P1029, DOI 10.1093/nar/gks1088; Sanchez-Sandoval E, 2015, MITOCHONDRION, V24, P22, DOI 10.1016/j.mito.2015.06.004; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; Turk EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078105; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; VISHWANATHA JK, 1986, NUCLEIC ACIDS RES, V14, P7305, DOI 10.1093/nar/14.18.7305; Wan L, 2013, EMBO REP, V14, P1104, DOI 10.1038/embor.2013.159; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; XU BJ, 1995, MOL CELL BIOL, V15, P580, DOI 10.1128/MCB.15.1.580; Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x; YAMAGUCHI M, 1985, MOL CELL BIOL, V5, P1170, DOI 10.1128/MCB.5.5.1170; Yang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136879	46	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16828	16839		10.1074/jbc.M116.740282	http://dx.doi.org/10.1074/jbc.M116.740282			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27311715	hybrid, Green Published			2022-12-26	WOS:000380826700038
J	Dorgham, K; Dejou, C; Piesse, C; Gorochov, G; Pene, J; Yssel, H				Dorgham, Karim; Dejou, Cecile; Piesse, Christophe; Gorochov, Guy; Pene, Jerome; Yssel, Hans			Identification of the Single Immunodominant Region of the Native Human CC Chemokine Receptor 6 Recognized by Mouse Monoclonal Antibodies	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; DENDRITIC CELLS; T-CELLS; LIGAND-BINDING; EXPRESSION; HYPERSENSITIVITY; RESPONSIVENESS; RECRUITMENT; HOMEOSTASIS; ACTIVATION	Chemokines and their receptors play an important role in cell trafficking and recruitment. The CCR6 chemokine receptor, selectively expressed on leukocyte populations, has been shown to play a deleterious role in the pathogenesis of various chronic inflammatory diseases and, as such, may constitute a prime target in the development of immunotherapeutic treatment. However, to date no neutralizing mouse monoclonal antibodies (mAbs) specific for this chemokine receptor have been reported, whereas information on small molecules capable of interfering with the interaction of CCR6 and its ligands is scant. Here, we report the failure to generate neutralizing mouse mAbs specific for human (hu)CCR6. Immunization of mice with peptides mimicking extracellular domains, potentially involved in CCR6 function, failed to induce Abs reactive with the native receptor. Although the use of NIH-3T3 cells expressing huCCR6 resulted in the isolation of mAbs specific for this receptor, they were not able to block the interaction between huCCR6 and huCCL20. Investigation of the anti-huCCR6 mAbs generated in the present study, as well as those commercially available, show that all mAbs invariably recognize a unique, non-neutralizing, immunodominant region in the first part of its N-terminal domain. Together, these results indicate that the generation of potential neutralizing anti-huCCR6 mAbs in the mouse is unlikely to succeed and that alternative techniques, such as the use of other animal species for immunization, might constitute a better approach to generate such a potentially therapeutic tool for the treatment of inflammatory disease.	[Dorgham, Karim; Gorochov, Guy; Yssel, Hans] Univ Paris 06, Sorbonne Univ, INSERM, U1135,UMRS 1135,Ctr Immunol & Malad Infect Cimi P, F-75013 Paris, France; [Dejou, Cecile] Inst Rech Canc, F-34090 Montpellier, France; [Piesse, Christophe] Univ Paris 06, Sorbonne Univ, IBPS FR 3631, Serv Synth Peptid, F-75005 Paris, France; [Gorochov, Guy] Grp Hosp Pitie Salpetriere, AP HP, Dept Immunol, F-75013 Paris, France; [Pene, Jerome] INSERM, U1183, Inst Regenerat Med & Biotherapy, F-34295 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Yssel, H (corresponding author), Univ Paris 06, Sorbonne Univ, INSERM, U1135,UMRS 1135,Ctr Immunol & Malad Infect Cimi P, F-75013 Paris, France.	hans.yssel@inserm.fr	Dorgham, karim/A-2241-2016; Gorochov, Guy/P-2911-2017; Yssel, Hans/AFV-2907-2022; Tharaux, Pierre-Louis/A-9155-2009	Dorgham, karim/0000-0001-9539-3203; Yssel, Hans/0000-0001-7454-1836; Tharaux, Pierre-Louis/0000-0002-6062-5905; Gorochov, Guy/0000-0003-2097-9677	Agence Nationale de la Recherche [ANR-13-BSV1-0021-02]; Fondation pour l'Aide a la Recherche sur la Sclerose en Plaques; Fondation pour la Recherche Medicale [DIM081013833]; Fondation Arthritis	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour l'Aide a la Recherche sur la Sclerose en Plaques(Fondation pour la Recherche Medicale); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Arthritis	The study was funded by grants from the Agence Nationale de la Recherche (ANR-13-BSV1-0021-02; http://www.agence-nationale-recherche.fr/), Fondation pour l'Aide a la Recherche sur la Sclerose en Plaques (https://www.arsep.org/), Fondation pour la Recherche Medicale DIM081013833 (https://www.frm.org/) and the Fondation Arthritis (www.fondationarthritis.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Ai LS, 2004, J BIOMED SCI, V11, P818, DOI 10.1159/000081829; Ai LS, 2002, BIOCHEMISTRY-US, V41, P8332, DOI 10.1021/bi025855y; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; [Anonymous], 2012, Drug Discov Today Technol, V9, pe227, DOI 10.1016/j.ddtec.2012.05.003; Baba M, 1997, J BIOL CHEM, V272, P14893, DOI 10.1074/jbc.272.23.14893; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Carramolino L, 1999, J LEUKOCYTE BIOL, V66, P837, DOI 10.1002/jlb.66.5.837; CHEN TR, 1977, EXP CELL RES, V104, P255, DOI 10.1016/0014-4827(77)90089-1; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Dorgham K, 2005, AIDS RES HUM RETROV, V21, P82, DOI 10.1089/aid.2005.21.82; Dufour A, 2013, BLOOD, V121, P3650, DOI 10.1182/blood-2012-10-458695; Elgueta R, 2015, J IMMUNOL, V194, P505, DOI 10.4049/jimmunol.1401553; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Ghannam S, 2011, J IMMUNOL, V186, P1411, DOI 10.4049/jimmunol.1000597; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hornbeck P, 2001, Curr Protoc Immunol, VChapter 2, DOI [10.1002/0471142735.im0202s01, 10.1002/0471142735.im0203s00, 10.1002/0471142735.im0201s01]; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Krzysiek R, 2000, BLOOD, V96, P2338, DOI 10.1182/blood.V96.7.2338.h8002338_2338_2345; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Lechner A, 2007, MICROBES INFECT, V9, P291, DOI 10.1016/j.micinf.2006.12.002; Liao F, 1999, J IMMUNOL, V162, P186; Liston A, 2009, J IMMUNOL, V182, P3121, DOI 10.4049/jimmunol.0713169; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Minamiya Y, 2011, TUMOR BIOL, V32, P197, DOI 10.1007/s13277-010-0113-x; Misumi S, 2003, J BIOL CHEM, V278, P32335, DOI 10.1074/jbc.M301209200; Misumi S, 2001, J VIROL, V75, P11614, DOI 10.1128/JVI.75.23.11614-11620.2001; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Raja Z, 2013, PLOS ONE, V8, DOI [10.1371/ journal. pone. 0070782, DOI 10.1371/J0URNAL.P0NE.0070782]; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rubbert-Roth A, 2010, RHEUMATOLOGY, V49, P1683, DOI 10.1093/rheumatology/keq116; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Salim SY, 2009, AM J PATHOL, V174, P82, DOI 10.2353/ajpath.2009.080273; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Varona R, 1998, FEBS LETT, V440, P188, DOI 10.1016/S0014-5793(98)01450-1; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Weisser M, 2014, BLOOD, V124, P420, DOI 10.1182/blood-2013-12-538975; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yokoyama Wayne M, 2013, Curr Protoc Immunol, V102, DOI 10.1002/0471142735.im0205s102; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2; Yssel Hans, 2002, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0719s47	56	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0157740	10.1371/journal.pone.0157740	http://dx.doi.org/10.1371/journal.pone.0157740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336468	Green Published, gold, Green Submitted			2022-12-26	WOS:000378389200038
J	Mundiyanapurath, S; Ringleb, PA; Diatschuk, S; Hansen, MB; Mouridsen, K; Ostergaard, L; Wick, W; Bendszus, M; Radbruch, A				Mundiyanapurath, Sibu; Ringleb, Peter Arthur; Diatschuk, Sascha; Hansen, Mikkel Bo; Mouridsen, Kim; Ostergaard, Leif; Wick, Wolfgang; Bendszus, Martin; Radbruch, Alexander			Capillary Transit Time Heterogeneity Is Associated with Modified Rankin Scale Score at Discharge in Patients with Bilateral High Grade Internal Carotid Artery Stenosis	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; HIGH-RESOLUTION MEASUREMENT; TRACER BOLUS PASSAGES; ISCHEMIC-STROKE; HYPOPERFUSION; DIFFUSION; REPERFUSION; MODEL; MRI	Background and Purpose Perfusion weighted imaging (PWI) is inherently unreliable in patients with severe perfusion abnormalities. We compared the diagnostic accuracy of a novel index of microvascular flow-patterns, so-called capillary transit time heterogeneity (CTH) to that of the commonly used delay parameter T-max in patients with bilateral high grade internal carotid artery stenosis (ICAS). Methods Consecutive patients with bilateral ICAS >= 70%(NASCET) who underwent PWI were retrospectively examined. Maps of CTH and T-max were analyzed with a volumetric approach using several thresholds. Predictors of favorable outcome (modified Rankin scale at discharge 0-2) were identified using univariate and receiver operating characteristic (ROC) curve analysis. Results Eighteen patients were included. CTH >= 30s differentiated best between patients with favorable and unfavorable outcome when both hemispheres were taken into account (sensitivity 83%, specificity 73%, area under the curve [AUC] 0.833 [confidence interval (CI) 0.635; 1.000]; p = 0.027). The best discrimination using T-max was achieved with a threshold of >= 4s (sensitivity 83%, specificity 64%, AUC 0.803 [CI 0.585; 1.000]; p = 0.044). The highest AUC was found for left sided volume with CTH >= 15s (sensitivity 83%, specificity 91%, AUC 0.924 [CI 0.791; 1.000]; p = 0.005). Conclusion The study suggests that CTH is superior to T-max in discriminating ICAS patients with favorable from non-favorable outcome. This finding may reflect the simultaneous involvement of large vessels and microvessels in ICAS and underscore the need to diagnose and manage both aspects of the disease.	[Mundiyanapurath, Sibu; Ringleb, Peter Arthur; Wick, Wolfgang] Univ Heidelberg Hosp, Dept Neurol, Heidelberg, Germany; [Diatschuk, Sascha; Radbruch, Alexander] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany; [Hansen, Mikkel Bo; Mouridsen, Kim; Ostergaard, Leif] Aarhus Univ, Inst Clin Med, Ctr Funct Integrat Neurosci, Aarhus, Denmark; [Hansen, Mikkel Bo; Mouridsen, Kim; Ostergaard, Leif] Aarhus Univ, Inst Clin Med, MINDLab, Aarhus, Denmark; [Ostergaard, Leif] Aarhus Univ Hosp, Dept Neuroradiol, DK-8000 Aarhus, Denmark; [Wick, Wolfgang] German Canc Consortium DKTK, CCU Neurooncol, Heidelberg, Germany; [Wick, Wolfgang] German Canc Res Ctr, Heidelberg, Germany; [Bendszus, Martin; Radbruch, Alexander] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Aarhus University; Aarhus University; Aarhus University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Radbruch, A (corresponding author), German Canc Res Ctr, Dept Radiol, Heidelberg, Germany.; Radbruch, A (corresponding author), Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany.	a.radbruch@dkfz.de	Wick, Wolfgang/AAA-2545-2020; Radbruch, Alexander/ABA-6277-2021; Ostergaard, Lars/AAA-3020-2020; Østergaard, Leif/A-9281-2008; Hansen, Mikkel B/A-5899-2009	Wick, Wolfgang/0000-0002-6171-634X; Ostergaard, Lars/0000-0003-2459-0511; Østergaard, Leif/0000-0003-2930-6997; Hansen, Mikkel B/0000-0002-8619-1519; Ostergaard, Lars/0000-0002-7619-605X; Mundiyanapurath, Sibu/0000-0003-4637-4641; Radbruch, Alexander/0000-0001-6238-6525				Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Calamante F, 2010, STROKE, V41, P1169, DOI 10.1161/STROKEAHA.110.580670; Caplan LR, 1998, ARCH NEUROL-CHICAGO, V55, P1475, DOI 10.1001/archneur.55.11.1475; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; Foerch C, 2005, LANCET, V366, P392, DOI 10.1016/S0140-6736(05)67024-9; Hedna VS, 2013, J CLIN NEUROL, V9, P97, DOI 10.3988/jcn.2013.9.2.97; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; Mouridsen K, 2006, MAGN RESON MED, V55, P524, DOI 10.1002/mrm.20759; Mouridsen K, 2006, NEUROIMAGE, V33, P570, DOI 10.1016/j.neuroimage.2006.06.015; Mouridsen K, 2014, J CEREBR BLOOD F MET, V34, P1511, DOI 10.1038/jcbfm.2014.111; Mundiyanapurath S, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0576-5; Mundiyanapurath S, 2016, EUR J RADIOL, V85, P534, DOI 10.1016/j.ejrad.2015.12.020; Neumann-Haefelin T, 2000, STROKE, V31, P1311, DOI 10.1161/01.STR.31.6.1311; Ostergaard L, 2000, STROKE, V31, P1097, DOI 10.1161/01.STR.31.5.1097; Ostergaard L, 1996, MAGNET RESON MED, V36, P726, DOI 10.1002/mrm.1910360511; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Ostergaard L, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0557-x; Ostergaard L, 2013, J CEREBR BLOOD F MET, V33, P635, DOI 10.1038/jcbfm.2013.18; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Rochon J, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-81; Selwaness M, 2014, STROKE, V45, P3226, DOI 10.1161/STROKEAHA.114.005202; Shih LC, 2003, STROKE, V34, P1425, DOI 10.1161/01.STR.0000072998.70087.E9; Sorensen AG, 1999, RADIOLOGY, V210, P519, DOI 10.1148/radiology.210.2.r99fe06519; Srinivasan VJ, 2015, J CEREBR BLOOD F MET, V35, P1552, DOI 10.1038/jcbfm.2015.175; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Wirth M, 2016, J CEREB BLOOD FLOW M; Wu O, 2003, MAGNET RESON MED, V50, P164, DOI 10.1002/mrm.10522; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	32	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2016	11	6							e0158148	10.1371/journal.pone.0158148	http://dx.doi.org/10.1371/journal.pone.0158148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP3JL	27336668	Green Published, Green Submitted, gold			2022-12-26	WOS:000378389200118
J	Charnchai, P; Jantama, SS; Prasitpuriprecha, C; Kanchanatawee, S; Jantama, K				Charnchai, Pattra; Jantama, Sirima Suvarnakuta; Prasitpuriprecha, Chutinun; Kanchanatawee, Sunthorn; Jantama, Kaemwich			Effects of the Food Manufacturing Chain on the Viability and Functionality of Bifidobacterium animalis through Simulated Gastrointestinal Conditions	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; CLARIFIED APPLE JUICE; PROBIOTIC BACTERIA; LACTOBACILLUS STRAINS; ANTIBIOTIC-RESISTANCE; TOLERANCE; STABILITY; SURVIVAL; STORAGE; OLIGOFRUCTOSE	The viability and functionality of probiotics may be influenced by industrial production processes resulting in a decrease in probiotic efficiency that benefit the health of humans. This study aimed to investigate the probiotic characteristics of Bifidobacterium strains isolated from fecal samples of healthy Thai infants. In the present work, three local strains (BF014, BF052, and BH053) belonging to Bifidobacterium animalis showed a great resistance against conditions simulating the gastrointestinal tract. Among these, B. animalis BF052 possessed considerable probiotic properties, including high acid and bile tolerance, strong adhesion capability to Caco-2 cells, and inhibitory activity against pathogens including Salmonella typhimurium and Vibrio cholerae. This strain also exhibited a high survival rate compared to commercial strains during storage in a wide variety of products, including pasteurized milk, soy milk, drinking yogurt, and orange juice. The impact of food processing processes as well as the freeze-drying process, storage of freeze-dried powders, and incorporation of freeze-dried cells in food matrix on probiotic properties was also determined. The stability of the probiotic properties of the BF052 strain was not affected by food processing chain, especially its resistance in the simulated gastrointestinal conditions and its adherence ability to Caco-2 cells. It indicates that it satisfies the criteria as a potential probiotic and may be used as an effective probiotic starter in food applications.	[Charnchai, Pattra; Kanchanatawee, Sunthorn; Jantama, Kaemwich] Suranaree Univ Technol, Sch Biotechnol, Inst Agr Technol, Metab Engn Res Unit, 111 Univ Ave, Muang Dist 30000, Nakhon Ratchasi, Thailand; [Jantama, Sirima Suvarnakuta; Prasitpuriprecha, Chutinun] Ubon Ratchathani Univ, Fac Pharmaceut Sci, Div Biopharm, Warinchamrap 34190, Ubon Ratchathan, Thailand	Suranaree University of Technology; Ubon Ratchathani University	Jantama, K (corresponding author), Suranaree Univ Technol, Sch Biotechnol, Inst Agr Technol, Metab Engn Res Unit, 111 Univ Ave, Muang Dist 30000, Nakhon Ratchasi, Thailand.	kaemwich@sut.ac.th	jantama, kaemwich/K-6880-2017	jantama, kaemwich/0000-0002-5405-6304	Thailand Research Fund (TRF) under the Royal Golden Jubilee PhD Program [PHD/0076/2552]	Thailand Research Fund (TRF) under the Royal Golden Jubilee PhD Program(Thailand Research Fund (TRF))	This work was financially supported by the Thailand Research Fund (TRF) under the Royal Golden Jubilee PhD Program (Grant No. PHD/0076/2552). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleya S, 2011, INT J FOOD MICROBIOL, V149, P28, DOI 10.1016/j.ijfoodmicro.2010.10.036; Bujnakova D, 2014, ANAEROBE, V29, P118, DOI 10.1016/j.anaerobe.2013.10.009; Carvalho AS, 2004, INT DAIRY J, V14, P835, DOI 10.1016/j.idairyj.2004.02.001; Chaikham P, 2015, FOOD BIOSCI, V12, P61, DOI 10.1016/j.fbio.2015.07.006; Collado MC, 2006, J FOOD PROTECT, V69, P1675, DOI 10.4315/0362-028X-69.7.1675; D'Aimmo MR, 2007, INT J FOOD MICROBIOL, V115, P35, DOI 10.1016/j.ijfoodmicro.2006.10.003; du Toit E, 2013, INT J FOOD MICROBIOL, V165, P51, DOI 10.1016/j.ijfoodmicro.2013.04.022; Farnworth ER, 2007, INT J FOOD MICROBIOL, V116, P174, DOI 10.1016/j.ijfoodmicro.2006.12.015; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Garcia-Ruiz A, 2014, FOOD MICROBIOL, V44, P220, DOI 10.1016/j.fm.2014.06.015; Gonzalez-Rodriguez I, 2013, FEMS MICROBIOL LETT, V340, P1, DOI 10.1111/1574-6968.12056; Gueimonde M, 2004, FOOD RES INT, V37, P839, DOI 10.1016/j.foodres.2004.04.006; Gueimonde M, 2007, INT J FOOD MICROBIOL, V113, P228, DOI 10.1016/j.ijfoodmicro.2006.05.017; Heller KJ, 2001, AM J CLIN NUTR, V73, p374S, DOI 10.1093/ajcn/73.2.374s; Huang LJ, 2006, J IND MICROBIOL BIOT, V33, P55, DOI 10.1007/s10295-005-0041-8; IBRAHIM SA, 1993, J FOOD PROTECT, V56, P713, DOI 10.4315/0362-028X-56.8.713; Jankovic I, 2010, CURR OPIN BIOTECH, V21, P175, DOI 10.1016/j.copbio.2010.03.009; Kaewnopparat S, 2013, ANAEROBE, V22, P6, DOI 10.1016/j.anaerobe.2013.04.009; Khoramnia A, 2011, ANIM SCI J, V82, P127, DOI 10.1111/j.1740-0929.2010.00804.x; Kos B, 2000, FOOD TECHNOL BIOTECH, V38, P121; Laparra JM, 2009, LETT APPL MICROBIOL, V49, P695, DOI 10.1111/j.1472-765X.2009.02729.x; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Liu GR, 2016, FOOD CONTROL, V62, P309, DOI 10.1016/j.foodcont.2015.10.033; Lopez P, 2012, FOOD RES INT, V46, P99, DOI 10.1016/j.foodres.2011.11.020; Madureira AR, 2011, FOOD RES INT, V44, P465, DOI 10.1016/j.foodres.2010.09.010; Madureira AR, 2005, INT DAIRY J, V15, P921, DOI 10.1016/j.idairyj.2004.08.025; Maragkoudakis PA, 2006, INT DAIRY J, V16, P189, DOI 10.1016/j.idairyj.2005.02.009; Mattila-Sandholm T, 2002, INT DAIRY J, V12, P173, DOI 10.1016/S0958-6946(01)00099-1; Matto J, 2006, INT DAIRY J, V16, P1029, DOI 10.1016/j.idairyj.2005.10.014; Nami Y, 2014, ANAEROBE, V28, P29, DOI 10.1016/j.anaerobe.2014.04.012; Nualkaekul S, 2011, FOOD CHEM, V129, P1037, DOI 10.1016/j.foodchem.2011.05.071; O'Toole Paul W, 2008, Interdiscip Perspect Infect Dis, V2008, P175285, DOI 10.1155/2008/175285; Pennacchia C, 2006, MEAT SCI, V73, P90, DOI 10.1016/j.meatsci.2005.10.019; Peres CM, 2014, LWT-FOOD SCI TECHNOL, V59, P234, DOI 10.1016/j.lwt.2014.03.003; Pimentel TC, 2015, LWT-FOOD SCI TECHNOL, V63, P415, DOI 10.1016/j.lwt.2015.03.009; Pimentel TC, 2015, LWT-FOOD SCI TECHNOL, V62, P838, DOI 10.1016/j.lwt.2014.08.001; Saarela M, 2000, J BIOTECHNOL, V84, P197, DOI 10.1016/S0168-1656(00)00375-8; Saarela M, 2011, LWT-FOOD SCI TECHNOL, V44, P1012, DOI 10.1016/j.lwt.2010.11.004; Saarela M, 2006, INT DAIRY J, V16, P1477, DOI 10.1016/j.idairyj.2005.12.007; Ammor MS, 2007, FOOD MICROBIOL, V24, P559, DOI 10.1016/j.fm.2006.11.001; Sanchez B, 2013, PHARMACOL RES, V69, P127, DOI 10.1016/j.phrs.2012.11.004; Sanchez B, 2010, INT DAIRY J, V20, P800, DOI 10.1016/j.idairyj.2010.06.004; Santivarangkna C, 2008, FOOD MICROBIOL, V25, P429, DOI 10.1016/j.fm.2007.12.004; Shamekhi F, 2013, FOLIA MICROBIOL, V58, P91, DOI 10.1007/s12223-012-0183-9; Sharma P, 2014, FOOD RES INT, V57, P176, DOI 10.1016/j.foodres.2014.01.025; Sheehan VM, 2007, INNOV FOOD SCI EMERG, V8, P279, DOI 10.1016/j.ifset.2007.01.007; Solieri L, 2014, FOOD MICROBIOL, V38, P240, DOI 10.1016/j.fm.2013.10.003; Sousa S, 2015, FOOD BIOPROD PROCESS, V93, P90, DOI 10.1016/j.fbp.2013.11.007; Strompfova V, 2014, ANAEROBE, V29, P108, DOI 10.1016/j.anaerobe.2013.10.007; Ventura M, 2007, INT J FOOD MICROBIOL, V120, P2, DOI 10.1016/j.ijfoodmicro.2007.06.011; Vinderola G, 2012, FOOD MICROBIOL, V30, P274, DOI 10.1016/j.fm.2011.12.004; Wang CY, 2010, ANAEROBE, V16, P578, DOI 10.1016/j.anaerobe.2010.10.003; Wang YC, 2004, INT J FOOD MICROBIOL, V93, P209, DOI 10.1016/j.ijfoodmicro.2003.12.001; Zhao G, 2005, J APPL MICROBIOL, V99, P333, DOI 10.1111/j.1365-2672.2005.02587.x	54	13	14	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2016	11	6							e0157958	10.1371/journal.pone.0157958	http://dx.doi.org/10.1371/journal.pone.0157958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WX	27333286	Green Published, Green Submitted, gold			2022-12-26	WOS:000378212800061
J	Thomsen, MCF; Ahrenfeldt, J; Cisneros, JLB; Jurtz, V; Larsen, MV; Hasman, H; Aarestrup, FM; Lund, O				Thomsen, Martin Christen Frolund; Ahrenfeldt, Johanne; Cisneros, Jose Luis Bellod; Jurtz, Vanessa; Larsen, Mette Voldby; Hasman, Henrik; Aarestrup, Frank Moller; Lund, Ole			A Bacterial Analysis Platform: An Integrated System for Analysing Bacterial Whole Genome Sequencing Data for Clinical Diagnostics and Surveillance	PLOS ONE			English	Article							ESCHERICHIA-COLI; OUTBREAK	Recent advances in whole genome sequencing have made the technology available for routine use in microbiological laboratories. However, a major obstacle for using this technology is the availability of simple and automatic bioinformatics tools. Based on previously published and already available web-based tools we developed a single pipeline for batch uploading of whole genome sequencing data from multiple bacterial isolates. The pipeline will automatically identify the bacterial species and, if applicable, assemble the genome, identify the multilocus sequence type, plasmids, virulence genes and antimicrobial resistance genes. A short printable report for each sample will be provided and an Excel spreadsheet containing all the metadata and a summary of the results for all submitted samples can be downloaded. The pipeline was benchmarked using datasets previously used to test the individual services. The reported results enable a rapid overview of the major results, and comparing that to the previously found results showed that the platform is reliable and able to correctly predict the species and find most of the expected genes automatically. In conclusion, a combined bioinformatics platform was developed and made publicly available, providing easy-to-use automated analysis of bacterial whole genome sequencing data. The platform may be of immediate relevance as a guide for investigators using whole genome sequencing for clinical diagnostics and surveillance. The platform is freely available at: https://cge.cbs.dtu.dk/services/CGEpipeline-1.1 and it is the intention that it will continue to be expanded with new features as these become available.	[Thomsen, Martin Christen Frolund; Ahrenfeldt, Johanne; Cisneros, Jose Luis Bellod; Jurtz, Vanessa; Larsen, Mette Voldby; Lund, Ole] Tech Univ Denmark, Dept Syst Biol, Kemitorvet Bldg 208, DK-2800 Lyngby, Denmark; [Hasman, Henrik; Aarestrup, Frank Moller] Tech Univ Denmark, Natl Food Inst, Soltofts Plads Bldg 221, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Thomsen, MCF (corresponding author), Tech Univ Denmark, Dept Syst Biol, Kemitorvet Bldg 208, DK-2800 Lyngby, Denmark.	mcft@cbs.dtu.dk	Lund, Ole/F-4437-2014; Ahrenfeldt, Johanne/GQZ-6257-2022	Lund, Ole/0000-0003-1108-0491; Hasman, Henrik/0000-0001-6314-2709; Ahrenfeldt, Johanne/0000-0001-9175-0373; Aarestrup, Frank/0000-0002-7116-2723	Danish Council for Strategic Research [09-067103]; European Union's Horizon 2020 research and innovation programme [643476]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); European Union's Horizon 2020 research and innovation programme	This work was supported by the Danish Council for Strategic Research (grant 09-067103) to the Center for Genomic Epidemiology (www.genomicepidemiology.org) and has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement no 643476 to the COMPARE project (www.compare-europe.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup Frank M, 2012, Emerg Infect Dis, V18, pe1, DOI 10.3201/eid/1811.120453; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Cosentino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077302; den Bakker HC, 2014, EMERG INFECT DIS, V20, P1306, DOI 10.3201/eid2008.131399; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Hasman H, 2014, J CLIN MICROBIOL, V52, P139, DOI 10.1128/JCM.02452-13; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Larsen MV, 2014, J CLIN MICROBIOL, V52, P1529, DOI 10.1128/JCM.02981-13; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Leekitcharoenphon P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S6; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Teixeira LM, 2011, MANUAL CLIN MICROBIO, V2, P350, DOI DOI 10.1128/9781555816728; Torok ME, 2013, J CLIN MICROBIOL, V51, P611, DOI 10.1128/JCM.02279-12; Wyres KL, 2014, PATHOGENS, V3, P437, DOI 10.3390/pathogens3020437; Zankari E, 2013, J ANTIMICROB CHEMOTH, V68, P771, DOI 10.1093/jac/dks496; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang SK, 2015, J CLIN MICROBIOL, V53, P1685, DOI 10.1128/JCM.00323-15	25	117	121	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157718	10.1371/journal.pone.0157718	http://dx.doi.org/10.1371/journal.pone.0157718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327771	Green Published, gold, Green Submitted			2022-12-26	WOS:000378212400034
J	Yang, JM; Sung, MS; Ji, YS; Heo, H; Park, SW				Yang, Jee Myung; Sung, Mi Sun; Ji, Yong Sok; Heo, Hwan; Park, Sang Woo			Analysis of Clinical Factors Associated with Retinal Morphological Changes in Patients with Primary Sjogren's Syndrome	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; CONGENITAL HEART-BLOCK; INNER PLEXIFORM LAYER; MACULAR GANGLION-CELL; LONG-TERM; T-CELLS; CLASSIFICATION CRITERIA; LUPUS-ERYTHEMATOSUS; MULTIPLE-SCLEROSIS	Purpose To investigate clinical factors associated with abnormal retinal morphologies in patients with primary Sjogren's syndrome (pSS). Methods One-hundred-thirty patients with pSS who underwent immunoserological tests, minor salivary gland biopsies, and optical coherence tomography examinations were retrospectively analyzed. Risk factors for abnormally reduced peripapillary retinal nerve fiber layer (pRNFL) and macular ganglion cell-inner plexiform layer (mGCIPL) thicknesses were evaluated, as well as the correlation between clinical factors and pRNFL and mGCIPL thicknesses. Results Anti-Sjogren's syndrome type B (SSB) antibody positivity (P = 0.048) was identified as a risk factor associated with abnormally reduced pRNFL thickness, and anti-SSB positivity (P = 0.005) and erythrocyte sedimentation rate (ESR) level (P = 0.031) were identified as risk factors associated with an abnormally reduced mGCIPL thickness as revealed by multivariate logistic regression analysis. There was a significant negative correlation between anti-SSB antibody levels and the thickness of pRNFL and mGCIPL. The thicknesses of pRNFL and mGCIPL were significantly reduced in anti-SSB-positive eyes when compared to anti-SSB-negative eyes (P < 0.05). However, histopathologic grading was not associated with the pRNFL and mGCIPL thicknesses. Conclusion Anti-SSB antibody positivity and ESR levels may be useful for predicting an abnormally reduced pRNFL or mGCIPL thickness in patients with pSS. Our results may provide clinical evidence to substantiate the association between aberrant autoimmunity and inner retinal changes in patients with pSS.	[Yang, Jee Myung; Sung, Mi Sun; Ji, Yong Sok; Heo, Hwan; Park, Sang Woo] Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Gwangju, South Korea; [Yang, Jee Myung] Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Park, Sang Woo] Chonnam Natl Univ, Ctr Creat Biomed Scientists, Gwangju, South Korea	Chonnam National University; Korea Advanced Institute of Science & Technology (KAIST); Chonnam National University	Park, SW (corresponding author), Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Gwangju, South Korea.; Park, SW (corresponding author), Chonnam Natl Univ, Ctr Creat Biomed Scientists, Gwangju, South Korea.	exo70@naver.com		Yang, Jee Myung/0000-0001-5729-2233				Albrecht P, 2015, NEUROLOGY, V85, P521, DOI 10.1212/WNL.0000000000001832; Asmussen K, 1996, J INTERN MED, V239, P475, DOI 10.1046/j.1365-2796.1996.418817000.x; ATKINSON JC, 1992, ARTHRITIS RHEUM, V35, P1368, DOI 10.1002/art.1780351119; Bonanomi MTBC, 2006, CLIN EXP OPHTHALMOL, V34, P130, DOI 10.1111/j.1442-9071.2006.01167.x; Buyon JP, 2003, SEMIN ARTHRITIS RHEU, V33, P140, DOI 10.1016/j.semarthrit.2003.09.002; Carubbi F, 2015, LUPUS, V24, P315, DOI 10.1177/0961203314554251; Casado A, 2014, GRAEF ARCH CLIN EXP, V252, P1653, DOI 10.1007/s00417-014-2773-5; Castro C, 2010, J ALLERGY CLIN IMMUN, V125, pS238, DOI 10.1016/j.jaci.2009.09.041; Clancy RM, 2006, J CLIN INVEST, V116, P2413, DOI 10.1172/JCI27803; DROSOS AA, 1990, ANN MED INTERNE, V141, P421; Esen F, 2016, J GLAUCOMA; Gaipl US, 2007, J AUTOIMMUN, V28, P114, DOI 10.1016/j.jaut.2007.02.005; Gan XX, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/340751; Garcia-Martin E, 2014, OPHTHALMOLOGY, V121, P573, DOI 10.1016/j.ophtha.2013.09.035; GERLI R, 1988, CLIN EXP IMMUNOL, V73, P226; GERLI R, 1989, CHEST, V95, P811, DOI 10.1378/chest.95.4.811; Gerli R, 1997, BRIT J RHEUMATOL, V36, P969; GERLI R, 1990, J CLIN INVEST, V86, P1870, DOI 10.1172/JCI114918; Gramlich OW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057557; Grus F, 2008, SEMIN IMMUNOPATHOL, V30, P121, DOI 10.1007/s00281-008-0105-8; Grus FH, 2008, J GLAUCOMA, V17, P79, DOI 10.1097/IJG.0b013e318156a592; HALLBERG A, 1990, ACTA OPHTHALMOL, V68, P125; HARLEY JB, 1986, ARTHRITIS RHEUM, V29, P196, DOI 10.1002/art.1780290207; Hernandez-Molina G, 2011, AUTOIMMUN REV, V10, P123, DOI 10.1016/j.autrev.2010.09.001; Kang Eun Min, 2015, Korean J Ophthalmol, V29, P263, DOI 10.3341/kjo.2015.29.4.263; Kim JH, 2014, INVEST OPHTH VIS SCI, V55, P4801, DOI 10.1167/iovs.13-13052; Kim KE, 2015, OPHTHALMOLOGY, V122, P502, DOI 10.1016/j.ophtha.2014.09.031; Knier B, 2015, J AUTOIMMUN, V56, P34, DOI 10.1016/j.jaut.2014.09.003; Locht H, 2005, AUTOIMMUN REV, V4, P276, DOI 10.1016/j.autrev.2004.12.002; Lucas M, 2003, J IMMUNOL, V171, P2610, DOI 10.4049/jimmunol.171.5.2610; Melles RB, 2014, JAMA OPHTHALMOL, V132, P1453, DOI 10.1001/jamaophthalmol.2014.3459; Moon H, 2015, BRIT J OPHTHALMOL, V99, P329, DOI 10.1136/bjophthalmol-2014-305361; Murdoch IE, 1998, BRIT J OPHTHALMOL, V82, P971, DOI 10.1136/bjo.82.8.971; Oray M, 2015, AM J OPHTHALMOL, V159, P475, DOI 10.1016/j.ajo.2014.11.029; Pagana TJ, 2014, MOSBYS MANUAL DIAGNO, P98; Plant GT, 2008, CURR OPIN NEUROL, V21, P16, DOI 10.1097/WCO.0b013e3282f419ca; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Reichelt J, 2008, CURR EYE RES, V33, P253, DOI 10.1080/02713680701871157; Reksten TR, 2009, RHEUMATOLOGY, V48, P1102, DOI 10.1093/rheumatology/kep149; Ringelstein M, 2015, NEUROLOGY, V85, P610, DOI 10.1212/WNL.0000000000001852; Risselada AP, 2014, ANN RHEUM DIS, V73, P1537, DOI 10.1136/annrheumdis-2013-204634; ROSENTHAL AR, 1978, INVEST OPHTH VIS SCI, V17, P1158; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Shon Kilhwan, 2014, Korean J Ophthalmol, V28, P314, DOI 10.3341/kjo.2014.28.4.314; Szabo K, 2013, CLIN IMMUNOL, V147, P95, DOI 10.1016/j.clim.2013.02.024; Theander E, 2011, ANN RHEUM DIS, V70, P1363, DOI 10.1136/ard.2010.144782; Tran HB, 2002, ARTHRITIS RHEUM-US, V46, P1572, DOI 10.1002/art.10316; Ucar D, 2015, GRAEF ARCH CLIN EXP, V253, P1181, DOI 10.1007/s00417-015-3040-0; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Vitali C, 2007, ARTHRITIS RHEUM-US, V56, P2223, DOI 10.1002/art.22658; Wax MB, 2009, EXP EYE RES, V88, P825, DOI 10.1016/j.exer.2009.02.005; Yang JM, 2014, JPN J OPHTHALMOL, V58, P359, DOI 10.1007/s10384-014-0327-3; Yoshimi R, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/606195	53	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2016	11	6							e0157995	10.1371/journal.pone.0157995	http://dx.doi.org/10.1371/journal.pone.0157995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WU	27327297	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212400065
J	Jones, MA; DeWolf, S; Vacharathit, V; Yim, M; Spencer, S; Bamezai, AK				Jones, Morgan A.; DeWolf, Sean; Vacharathit, Vimvara; Yim, Michelle; Spencer, Stacey; Bamezai, Anil K.			Investigating B Cell Development, Natural and Primary Antibody Responses in Ly-6A/Sca-1 Deficient Mice	PLOS ONE			English	Article							COMMON LYMPHOID PROGENITORS; HEMATOPOIETIC STEM-CELL; MOUSE BONE-MARROW; T-CELLS; IMMUNE-RESPONSES; MULTIGENE FAMILY; DENDRITIC CELL; UP-REGULATION; IN-VIVO; LY-6	Ly-6A/Stem cell antigen-1 (Ly-6A/Sca-1) is a glycosylphosphatidylinositol-anchored protein expressed on many cell types including hematopoietic stem cells (HSCs) and early lymphoid-specific progenitors. Ly-6A/Sca-1 is expressed on CD4(+) T cells and plays a role in regulating cellular responses to foreign antigens. The role of Ly-6A/Sca-1 in primary antibody responses has not been defined. To investigate whether Ly-6A/Sca-1 functions in humoral immunity, we first injected Ly-6A/Sca-1-deficient and wild-type control mice with chicken ovalbumin (c-Ova) protein mixed with an adjuvant. We then assessed the ability of the mice to generate a primary antibody response against cOva. We further examined the development of B cells and circulating antibody isotypes in non-immunized Ly-6A/Sca-1 deficient mice to determine if Ly6A/Sca-1 functions in development irrespective of antigen-specific immune activation. Ly-6A/Sca-1/Sca-1-deficient mice did not show any significant changes in the number of B lymphocytes in the bone marrow and peripheral lymphoid tissues. Interestingly, Ly-6A/Sca-1/Sca-1(-/-) mice have significantly elevated serum levels of IgA with lambda light chains compared to wild type controls. B cell clusters with high reactivity to anti-IgA lambda monoclonal antibody were detected in the lamina propria of the gut, though this was not observed in the bone marrow and peripheral lymphoid tissues. Despite these differences, the Ly-6A/Sca-1 deficient mice generated a similar primary antibody response when compared to the wild-type mice. In summary, we conclude that the primary antibody response to cOva antigen is similar in Ly-6A/Sca-1deficient and sufficient mice. In addition, we report significantly higher expression of the immunoglobulin lambda light chain by B cells in lamina propria of Ly-6A/Sca-1deficient mice when compared to the wild-type control.	[Jones, Morgan A.; DeWolf, Sean; Vacharathit, Vimvara; Yim, Michelle; Spencer, Stacey; Bamezai, Anil K.] Villanova Univ, Dept Biol, 800 E Lancaster Ave, Villanova, PA 19085 USA; [Jones, Morgan A.] Univ Michigan Hlth Syst, Dept Internal Med, Phys Scientist Training Program, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [DeWolf, Sean] Univ Calif San Diego, MD Program, 200 W Arbor Dr, San Diego, CA 92103 USA; [Vacharathit, Vimvara] Johns Hopkins Univ, PhD Program Immunol, Baltimore, MD 21218 USA; [Yim, Michelle] Western Univ Hlth Sci, Coll Osteopath Med Pacific, 309 E 2nd St, Pomona, CA 91766 USA; [Spencer, Stacey] Johnson & Johnson, Janssen R&D, PA 920 Route 202, Raritan, NJ 08869 USA	Villanova University; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Johns Hopkins University; Western University of Health Sciences; Johnson & Johnson; Johnson & Johnson USA	Bamezai, AK (corresponding author), Villanova Univ, Dept Biol, 800 E Lancaster Ave, Villanova, PA 19085 USA.	anil.bamezai@villanova.edu	Vacharathit, Vimvara/ABH-9086-2020	Bamezai, Anil/0000-0002-2447-7706; Vacharathit, Vimvara/0000-0002-5173-8238				Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Altuwaijri S, 2009, MOL ENDOCRINOL, V23, P444, DOI 10.1210/me.2008-0106; BAMEZAI A, 1995, P NATL ACAD SCI USA, V92, P4294, DOI 10.1073/pnas.92.10.4294; BAMEZAI A, 1995, J IMMUNOL, V154, P4233; Bamezai A, 2004, ARCH IMMUNOL THER EX, V52, P255; Carter LL, 1998, J IMMUNOTHER, V21, P181, DOI 10.1097/00002371-199805000-00003; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Chou JH, 2001, GENETICS, V157, P211; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; CROFT M, 1991, J IMMUNOL, V147, P3679; Crotty S, 2015, NAT REV IMMUNOL, V15, P185, DOI 10.1038/nri3803; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; DUMONT FJ, 1987, EUR J IMMUNOL, V17, P1183, DOI 10.1002/eji.1830170816; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Hardy RR, 2006, J IMMUNOL, V177, P2749, DOI 10.4049/jimmunol.177.5.2749; Harman BC, 2008, J IMMUNOL, V181, P7514, DOI 10.4049/jimmunol.181.11.7514; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Henderson SC, 2002, J IMMUNOL, V168, P118, DOI 10.4049/jimmunol.168.1.118; Hijazi A, 2009, DEVELOPMENT, V136, P2199, DOI 10.1242/dev.033845; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Khodadoust MM, 1999, J IMMUNOL, V163, P811; KINCADE PW, 1994, IMMUNOL TODAY, V15, P539, DOI 10.1016/0167-5699(94)90211-9; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kouro T, 2002, BLOOD, V100, P3672, DOI 10.1182/blood-2002-02-0653; Kumar R, 2008, J IMMUNOL, V181, P7507, DOI 10.4049/jimmunol.181.11.7507; Long KK, 2011, FASEB J, V25, P1156, DOI 10.1096/fj.10-170308; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; MASUZAWA T, 1994, J CLIN INVEST, V94, P1090, DOI 10.1172/JCI117424; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; McHeyzer-Williams LJ, 2004, IMMUNITY, V20, P231, DOI 10.1016/S1074-7613(04)00028-7; Okumura R, 2016, NATURE, V532, P117, DOI 10.1038/nature17406; Pflugh DL, 2002, J IMMUNOL, V169, P5130, DOI 10.4049/jimmunol.169.9.5130; ROCK KL, 1986, J EXP MED, V163, P315, DOI 10.1084/jem.163.2.315; ROCK KL, 1989, IMMUNOL REV, V111, P195, DOI 10.1111/j.1600-065X.1989.tb00547.x; Serwold T, 2009, BLOOD, V113, P807, DOI 10.1182/blood-2008-08-173682; SHEVACH EM, 1989, IMMUNOL TODAY, V10, P195, DOI 10.1016/0167-5699(89)90324-1; Smithson G, 1998, J IMMUNOL, V161, P27; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stanford WL, 1997, J EXP MED, V186, P705, DOI 10.1084/jem.186.5.705; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Upadhyay G, 2011, P NATL ACAD SCI USA, V108, P7820, DOI 10.1073/pnas.1103441108; Welner RS, 2008, NAT REV IMMUNOL, V8, P95, DOI 10.1038/nri2234; WILLIAMS AF, 1988, IMMUNOGENETICS, V27, P265, DOI 10.1007/BF00376121	54	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2016	11	6							e0157271	10.1371/journal.pone.0157271	http://dx.doi.org/10.1371/journal.pone.0157271			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP0WR	27322740	gold, Green Published, Green Submitted			2022-12-26	WOS:000378212000012
J	Mahani, MAN; Haghgoo, HA; Azizi, S; Ahmadabadi, MN				Mahani, Mohammad-Ali Nikouei; Haghgoo, Hojjat Allah; Azizi, Solmaz; Ahmadabadi, Majid Nili			Attention Cueing and Activity Equally Reduce False Alarm Rate in Visual-Auditory Associative Learning through Improving Memory	PLOS ONE			English	Article							CONTINUOUS PERFORMANCE-TEST; OBJECT; RECOGNITION; INTEGRATION	In our daily life, we continually exploit already learned multisensory associations and form new ones when facing novel situations. Improving our associative learning results in higher cognitive capabilities. We experimentally and computationally studied the learning performance of healthy subjects in a visual-auditory sensory associative learning task across active learning, attention cueing learning, and passive learning modes. According to our results, the learning mode had no significant effect on learning association of congruent pairs. In addition, subjects' performance in learning congruent samples was not correlated with their vigilance score. Nevertheless, vigilance score was significantly correlated with the learning performance of the non-congruent pairs. Moreover, in the last block of the passive learning mode, subjects significantly made more mistakes in taking non-congruent pairs as associated and consciously reported lower confidence. These results indicate that attention and activity equally enhanced visual-auditory associative learning for non-congruent pairs, while false alarm rate in the passive learning mode did not decrease after the second block. We investigated the cause of higher false alarm rate in the passive learning mode by using a computational model, composed of a reinforcement learning module and a memory-decay module. The results suggest that the higher rate of memory decay is the source of making more mistakes and reporting lower confidence in non-congruent pairs in the passive learning mode.	[Mahani, Mohammad-Ali Nikouei; Ahmadabadi, Majid Nili] Univ Tehran, Sch Elect & Comp Engn, Cognit Robot Lab, Tehran, Iran; [Mahani, Mohammad-Ali Nikouei; Ahmadabadi, Majid Nili] Inst Res Fundamental Sci, Sch Cognit Sci, Tehran, Iran; [Mahani, Mohammad-Ali Nikouei] Univ Tubingen, Dept Psychol, Cognit & Percept, Tubingen, Germany; [Haghgoo, Hojjat Allah; Azizi, Solmaz] Univ Social Welf & Rehabil Sci, Occupat Therapy Dept, Tehran, Iran	University of Tehran; Eberhard Karls University of Tubingen	Mahani, MAN (corresponding author), Univ Tehran, Sch Elect & Comp Engn, Cognit Robot Lab, Tehran, Iran.; Mahani, MAN (corresponding author), Inst Res Fundamental Sci, Sch Cognit Sci, Tehran, Iran.; Mahani, MAN (corresponding author), Univ Tubingen, Dept Psychol, Cognit & Percept, Tubingen, Germany.	ma@mahani.info	Haghgoo, Hojjat/AAD-7124-2021; Haghgoo, Hojjat Allah/J-5327-2017; Haghgoo, Hojjat/P-8698-2018	Haghgoo, Hojjat/0000-0001-6136-2417; Nikouei Mahani, Mohammad-Ali/0000-0002-6718-3361				[Anonymous], 2014, COMMUN; [Anonymous], 2014, FRONT PSYCHOL, V5, P1, DOI [10.3389/fpsyg.2014.01095, DOI 10.3389/FPSYG.2014.01095]; Arble E, 2014, ARCH CLIN NEUROPSYCH, V29, P300, DOI 10.1093/arclin/acu006; Beets IAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037687; Busse L, 2005, P NATL ACAD SCI USA, V102, P18751, DOI 10.1073/pnas.0507704102; Butler AJ, 2012, J COGNITIVE NEUROSCI, V25, P1, DOI [10.1162/jo00284, DOI 10.1162/JO00284]; Butler AJ, 2011, J COGNITIVE NEUROSCI, V23, P3515, DOI 10.1162/jocn_a_00015; Chen TW, 2015, EUR J NEUROSCI, V41, P264, DOI 10.1111/ejn.12764; Cohen RA, NEUROPSYCHOLOGY ATTE; Ebbinghaus H, 1913, CONTRIBUTION EXPT PS; Gohil K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09485; James KH, 2001, CAN J EXP PSYCHOL, V55, P111, DOI 10.1037/h0087358; James KH, 2002, BEHAV RES METH INS C, V34, P383, DOI 10.3758/BF03195466; Kafaligonul H, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00026; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; Parks CM, 2009, P NATL ACAD SCI USA, V106, P11515, DOI 10.1073/pnas.0905505106; Richard S., REINFORCEMENT LEARNI; Sasaoka T, 2010, PERCEPTION, V39, P289, DOI 10.1068/p5721; Schomaker J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00918; Spiegel DP, 2015, SCI REP-UK, V5, DOI 10.1038/srep10802; Talsma D, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00019; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Tinius TP, 2003, ARCH CLIN NEUROPSYCH, V18, P439, DOI 10.1016/S0887-6177(02)00144-0; Trewartha KM, 2015, BEHAV BRAIN RES, V279, P234, DOI 10.1016/j.bbr.2014.11.043; Voss JL, 2011, NAT NEUROSCI, V14, P115, DOI 10.1038/nn.2693	25	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157680	10.1371/journal.pone.0157680	http://dx.doi.org/10.1371/journal.pone.0157680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JQ	27314235	Green Submitted, gold, Green Published			2022-12-26	WOS:000378030000044
J	Gusella, GL; Teixeira, A; Aberg, J; Uversky, VN; Mosoian, A				Gusella, G. Luca; Teixeira, Avelino; Aberg, Judith; Uversky, Vladimir N.; Mosoian, Arevik			Prothymosin-alpha Variants Elicit Anti-HIV-1 Response via TLR4 Dependent and Independent Pathways	PLOS ONE			English	Article							INTRINSIC DISORDER; TUMOR-CELLS; WEB SERVER; PROTEIN; SEQUENCE; GENE; DIFFERENTIATION; EXPRESSION; PREDICTION; INHIBITOR	Background Prothymosin a (ProT alpha) (isoform 2: iso2) is a widely distributed, small acidic protein with intracellular and extracellular-associated functions. Recently, we identified two new ProT alpha variants with potent anti-HIV activity from CD8(+) T cells and cervicovaginal lavage. The first is a splice variant of the ProT alpha gene known as isoB and the second is the product of ProT alpha pseudogene 7 (p7). Similarly to iso2, the anti-HIV activity of both variants is mediated by type I IFN. Here we tested whether the immunomodulatory activity of isoB and p7 are also TLR4 dependent and determined their kinetic of release in response to HIV-1 infection. Methods Type I, type III, TNF-alpha and IL-6 mRNA inducing activity was determined in macrophages from wild type and TLR4 knockout mice treated with recombinant ProT alpha variants. Supernatants from mock and HIV infected cells were analyzed by mass spectrometry in positive and negative modes for the presence of ProT alpha variants. In silico structural and functional analysis of ProT alpha variants were performed. Results We show that both isoB and p7 upregulate IFN-beta, IFN-lambda 1, IL-6, TNF-alpha and RANTES mRNAs in primary human macrophages. The potent stimulation of IFN-beta by the recombinant ProT alpha variants in human macrophages is dependent on the TLR4 pathway, whereas the induction of TNF-alpha and IL-6 may also occur independently of TLR4, suggesting the interaction of ProT alpha variants with other signaling molecules/receptors. In silico analyses confirmed that the novel isoB and p7 variants are intrinsically disordered proteins, which lack the NLS and mass spectrometry showed release of ProT alpha variants within minutes post HIV-1 infection. These features are consistent with the function of ProT alpha variants as damage associate molecular patterns (DAMPs). Conclusions Our findings indicate that ProTa variants strongly inhibit viral replication mainly, but not exclusively, through TLR4 signaling and that they are released within minutes of viral infection suggesting that they may function as DAMPs.	[Gusella, G. Luca; Teixeira, Avelino; Aberg, Judith; Mosoian, Arevik] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Uversky, Vladimir N.] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL USA; [Uversky, Vladimir N.] Univ S Florida, USF Hlth Byrd Alzheimers Res Inst, Morsani Coll Med, Tampa, FL USA; [Uversky, Vladimir N.] King Abdulaziz Univ, Fac Sci, Dept Biol, POB 80203, Jeddah 21589, Saudi Arabia; [Uversky, Vladimir N.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia	Icahn School of Medicine at Mount Sinai; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; King Abdulaziz University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Mosoian, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.	arevik.mosoian@mssm.edu	Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857	Campbell Foundation; Lehman Brother Foundation; Dorothy Rodbell Cohen Cancer Research Program	Campbell Foundation; Lehman Brother Foundation; Dorothy Rodbell Cohen Cancer Research Program	This work was supported by grants from the Campbell Foundation, Lehman Brother Foundation, and Dorothy Rodbell Cohen Cancer Research Program (AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos SM, 2011, CANCER IMMUNOL IMMUN, V60, P671, DOI 10.1007/s00262-011-0984-8; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bowick GC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956823; Chang TLY, 2003, J VIROL, V77, P6777, DOI 10.1128/JVI.77.12.6777-6784.2003; CORDERO OJ, 1992, BIOCHEM INT, V28, P1117; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; ESCHENFELDT WH, 1986, P NATL ACAD SCI USA, V83, P9403, DOI 10.1073/pnas.83.24.9403; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Nunez NG, 2012, CANCER RES, V72, P592, DOI 10.1158/0008-5472.CAN-11-0534; GOODALL GJ, 1986, P NATL ACAD SCI USA, V83, P8926, DOI 10.1073/pnas.83.23.8926; Halder SK, 2012, J NEUROCHEM, V123, P262, DOI 10.1111/j.1471-4159.2012.07897.x; HARITOS AA, 1984, P NATL ACAD SCI-BIOL, V81, P1008, DOI 10.1073/pnas.81.4.1008; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Ioannou K, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-43; Karachaliou CE, 2015, INT J PHARMACEUT, V486, P1, DOI 10.1016/j.ijpharm.2015.03.031; Kusmartsev S, 2006, CANCER METAST REV, V25, P323, DOI 10.1007/s10555-006-9002-6; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; MANROW RE, 1993, J MOL BIOL, V234, P281, DOI 10.1006/jmbi.1993.1583; MANROW RE, 1992, GENOMICS, V13, P319, DOI 10.1016/0888-7543(92)90248-Q; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Mosoian A, 2006, J VIROL, V80, P9200, DOI 10.1128/JVI.00589-06; Mosoian A, 2011, FUTURE MED CHEM, V3, P1199, DOI [10.4155/fmc.11.72, 10.4155/FMC.11.72]; Mosoian A, 2010, P NATL ACAD SCI USA, V107, P10178, DOI 10.1073/pnas.0914870107; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Omotuyi O, 2015, EXPERT OPIN BIOL TH, V15, pS223, DOI 10.1517/14712598.2015.1005597; Pejaver V, 2014, PROTEIN SCI, V23, P1077, DOI 10.1002/pro.2494; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Romani L, 2004, BLOOD, V103, P4232, DOI 10.1182/blood-2003-11-4036; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rubtsov Iu P, 1995, Mol Biol (Mosk), V29, P1320; Rubtsov Y, 1996, FEBS LETT, V397, P215, DOI 10.1016/S0014-5793(96)01171-4; Rubtsov YP, 1997, FEBS LETT, V413, P135, DOI 10.1016/S0014-5793(97)00824-7; Salaun B, 2007, CLIN CANCER RES, V13, P4565, DOI 10.1158/1078-0432.CCR-07-0274; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Skopeliti M, 2007, PROTEOMICS, V7, P1814, DOI 10.1002/pmic.200600870; Song SX, 2009, VACCINE, V27, P1111, DOI 10.1016/j.vaccine.2008.11.095; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Teixeira A, 2014, J INFECT DIS, DOI [10.1093/infdis/jiu643PMID:25404520, DOI 10.1093/INFDIS/JIU643PMID:25404520]; Tsai SY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003848; Uversky VN, 2013, CURR PHARM DESIGN, V19, P4191, DOI 10.2174/1381612811319230005; Uversky VN, 1999, BIOCHEMISTRY-US, V38, P15009, DOI 10.1021/bi990752+; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Xie, 1998, Genome Inform Ser Workshop Genome Inform, V9, P193; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Yi SL, 2008, PROTEIN EXPRES PURIF, V57, P1, DOI 10.1016/j.pep.2007.09.005	54	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156486	10.1371/journal.pone.0156486	http://dx.doi.org/10.1371/journal.pone.0156486			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310139	Green Submitted, gold, Green Published			2022-12-26	WOS:000378029800006
J	Prins, MR; van der Wurff, P; Meijer, OG; Bruijn, SM; van Dieen, JH				Prins, Maarten R.; van der Wurff, Peter; Meijer, Onno G.; Bruijn, Sjoerd M.; van Dieen, Jaap H.			Mechanical Perturbations of the Walking Surface Reveal Unaltered Axial Trunk Stiffness in Chronic Low Back Pain Patients	PLOS ONE			English	Article							PELVIS-THORAX COORDINATION; TRANSVERSE PLANE; GAIT; ROTATIONS; PEOPLE; SPEED	Introduction Patients with chronic low back pain (CLBP) often demonstrate altered timing of thorax rotations in the transverse plane during gait. Increased axial trunk stiffness has been claimed to cause this movement pattern. Objectives The objective of this study was to assess whether axial trunk stiffness is increased in gait in CLBP patients. Methods 15 CLBP patients and 15 healthy controls walked on a treadmill that imposed rotational perturbations in the transverse plane. The effect of these perturbations on transverse pelvis, thorax and trunk (thorax relative to pelvis) rotations was evaluated in terms of residual rotations, i.e., the deviation of these movements from the unperturbed patterns. In view of the heterogeneity of the CLBP group, we additionally performed a subgroup comparison between seven patients and seven controls with maximal between-group contrast for timing of thorax rotations. Results Rotations of the walking surface had a clear effect on transverse pelvis, thorax and trunk rotations in all groups. No significant between-group differences on residual transverse pelvis, thorax and trunk rotations were observed. Conclusion Axial trunk stiffness in gait does not appear to be increased in CLBP. Altered timing of thorax rotations in CLBP does not seem to be a result of increased axial trunk stiffness.	[Prins, Maarten R.; van der Wurff, Peter] Mil Rehabil Ctr Aardenburg, Res & Dev, Doorn, Netherlands; [Prins, Maarten R.; Meijer, Onno G.; Bruijn, Sjoerd M.; van Dieen, Jaap H.] Vrije Univ Amsterdam, Fac Behav & Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Prins, Maarten R.; van der Wurff, Peter] HU Univ Appl Sci Utrecht, Dept Phys Therapy, Utrecht, Netherlands; [Meijer, Onno G.; Bruijn, Sjoerd M.] Fujian Med Univ, Orthopaed Biomech Lab, Quanzhou, Fujian, Peoples R China	Vrije Universiteit Amsterdam; Fujian Medical University	Prins, MR (corresponding author), Mil Rehabil Ctr Aardenburg, Res & Dev, Doorn, Netherlands.; Prins, MR (corresponding author), Vrije Univ Amsterdam, Fac Behav & Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.; Prins, MR (corresponding author), HU Univ Appl Sci Utrecht, Dept Phys Therapy, Utrecht, Netherlands.	MR.Prins@MRCDoorn.nl	Bruijn, S.M./AAE-7446-2019; van Dieen, Jaap/B-3937-2013; Prins, Maarten/E-7963-2018	Bruijn, S.M./0000-0003-0290-2131; van Dieen, Jaap/0000-0002-7719-5585; Prins, Maarten/0000-0003-3593-202X	Netherlands Organization for Scientific Research (NWO) [451-12-041]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Sjoerd M. Bruijn was supported by a grant from the Netherlands Organization for Scientific Research (NWO #451-12-041).	Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Brown SH, 2007, EXPLORING GEOMETRIC; Bruening DA, 2015, GAIT POSTURE, V41, P540, DOI 10.1016/j.gaitpost.2014.12.011; Bruijn SM, 2008, GAIT POSTURE, V27, P455, DOI 10.1016/j.gaitpost.2007.05.017; Freddolini M, 2014, J ELECTROMYOGR KINES, V24, P947, DOI 10.1016/j.jelekin.2014.09.009; Ghamkhar L, 2015, PM&R, V7, P519, DOI 10.1016/j.pmrj.2015.01.013; Huang YP, 2011, EUR SPINE J, V20, P491, DOI 10.1007/s00586-010-1639-8; Kubo M, 2006, J BIOMECH, V39, P750, DOI 10.1016/j.jbiomech.2004.12.024; Lamoth CJC, 2006, EUR SPINE J, V15, P23, DOI 10.1007/s00586-004-0825-y; Lamoth CJC, 2006, GAIT POSTURE, V23, P230, DOI 10.1016/j.gaitpost.2005.02.006; Lamoth CJC, 2002, GAIT POSTURE, V16, P101, DOI 10.1016/S0966-6362(01)00146-1; Lamoth CJC, 2002, SPINE, V27, pE92, DOI 10.1097/00007632-200202150-00016; Lamoth CJC, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-13; Lee PJ, 2006, J ELECTROMYOGR KINES, V16, P51, DOI 10.1016/j.jelekin.2005.06.006; Pataky TC, 2013, J BIOMECH, V46, P2394, DOI 10.1016/j.jbiomech.2013.07.031; Seay JF, 2011, SPINE, V36, pE1070, DOI 10.1097/BRS.0b013e3182015f7c; Selles RW, 2001, CLIN BIOMECH, V16, P175, DOI 10.1016/S0268-0033(00)00080-2; van den Hoorn W, 2012, J BIOMECH, V45, P342, DOI 10.1016/j.jbiomech.2011.10.024; van der Hulst M, 2010, J ELECTROMYOGR KINES, V20, P31, DOI 10.1016/j.jelekin.2009.03.009; Weerdesteyn V, 2004, HUM MOVEMENT SCI, V23, P351, DOI 10.1016/j.humov.2004.08.011; Wu WH, 2014, HUM MOVEMENT SCI, V33, P194, DOI 10.1016/j.humov.2013.09.002; Wu WH, 2002, CLIN BIOMECH, V17, P678, DOI 10.1016/S0268-0033(02)00109-2	22	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157253	10.1371/journal.pone.0157253	http://dx.doi.org/10.1371/journal.pone.0157253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310528	Green Published, gold, Green Submitted			2022-12-26	WOS:000378029800048
J	Tashiro, H; Takahashi, K; Hayashi, S; Kato, G; Kurata, K; Kimura, S; Sueoka-Aragane, N				Tashiro, Hiroki; Takahashi, Koichiro; Hayashi, Shinichiro; Kato, Go; Kurata, Keigo; Kimura, Shinya; Sueoka-Aragane, Naoko			Interleukin-33 from Monocytes Recruited to the Lung Contributes to House Dust Mite-Induced Airway Inflammation in a Mouse Model	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; DENDRITIC CELLS; LYMPHOID-CELLS; SEVERE ASTHMA; IL-33; CYTOKINES; IMMUNITY; DISEASE; HETEROGENEITY; PHAGOCYTOSIS	Background Interleukin-33 (IL-33) activates group 2 innate lymphoid cells (ILC2), resulting in T-helper-2 inflammation in bronchial asthma. Airway epithelial cells were reported as sources of IL-33 during apoptosis and necrosis. However, IL-33 is known to be from sources other than airway epithelial cells such as leukocytes, and the mechanisms of IL-33 production and release are not fully understood. The aim of this study was to clarify the role of IL-33 production by monocytes in airway inflammation. Methods BALB/c mice were sensitized and challenged with a house dust mite (HDM) preparation. Airway inflammation was assessed by quantifying inflammatory cells in bronchoalveolar lavage (BAL) fluid, and IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) levels in lung. Immunohistochemistry for IL-33 in lung sections was also performed. Ly6c, CD11b, and CD11c expression was examined by flow cytometry. Clodronate liposomes were used in the HDM-airway inflammation model to deplete circulating monocytes. Results The IL-33, but not IL-25 or TSLP, level in lung homogenates was markedly increased in HDM mice compared to control mice. IL-33-positive cells in the lungs were identified using immunohistochemistry and were increased in areas surrounding bronchi and vasculature. Furthermore, IL- 33 levels were increased in mononuclear cells derived from lungs of HDM mice compared to controls. The expression of Ly6c in mononuclear cells was significantly higher in HDM mice than in controls. Treatment with clodronate liposomes led to inhibition of not only inflammatory cells in BAL fluid, airway hyper reactivity and Th2 cytokines in lung, but also IL-33 in lung. Conclusion IL-33 from monocytes recruited to the lung may contribute to the pathogenesis of HDM-induced airway inflammation.	[Tashiro, Hiroki; Takahashi, Koichiro; Hayashi, Shinichiro; Kato, Go; Kimura, Shinya; Sueoka-Aragane, Naoko] Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga 840, Japan; [Kurata, Keigo] Inst Tokyo Environm Allergy, Tokyo, Japan	Saga University	Takahashi, K (corresponding author), Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga 840, Japan.	takahak@cc.saga-u.ac.jp						Barros MHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080908; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chen LL, 2013, AM J PHYSIOL-LUNG C, V305, pL702, DOI 10.1152/ajplung.00194.2013; Donnelly LE, 2012, CHEST, V141, P1055, DOI 10.1378/chest.11-2348; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Guo Z, 2014, J ASTHMA, V51, P863, DOI 10.3109/02770903.2014.921196; Hsu CL, 2012, J IMMUNOL, V189, P3421, DOI 10.4049/jimmunol.1201224; Huynh MLN, 2005, AM J RESP CRIT CARE, V172, P972, DOI 10.1164/rccm.200501-035OC; Kamijo S, 2013, J IMMUNOL, V190, P4489, DOI 10.4049/jimmunol.1201212; Kato G, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0039-y; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Li JJ, 2010, J IMMUNOL, V185, P4401, DOI 10.4049/jimmunol.1001039; Llop-Guevara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088714; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Martinez-Martinez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079176; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Pappas K, 2013, CYTOKINE, V64, P613, DOI 10.1016/j.cyto.2013.09.010; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Saglani S, 2013, J ALLERGY CLIN IMMUN, V132, P676, DOI 10.1016/j.jaci.2013.04.012; Sasaki O, 2013, J IMMUNOL, V191, P2879, DOI 10.4049/jimmunol.1300460; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Takahashi K, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-33; Tattersfield AE, 2002, LANCET, V360, P1313, DOI 10.1016/S0140-6736(02)11312-2; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yanagawa Y, 2011, BRAIN BEHAV IMMUN, V25, P1427, DOI 10.1016/j.bbi.2011.04.012; Yang M, 2012, J LEUKOCYTE BIOL, V91, P557, DOI 10.1189/jlb.0711357; Zaslona Z, 2014, J IMMUNOL, V193, P4245, DOI 10.4049/jimmunol.1400580	44	28	29	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157571	10.1371/journal.pone.0157571	http://dx.doi.org/10.1371/journal.pone.0157571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310495	Green Submitted, Green Published, gold			2022-12-26	WOS:000378029800100
J	Neves, JV; Caldas, C; Ramos, MF; Rodrigues, PNS				Neves, Joao V.; Caldas, Carolina; Ramos, Miguel F.; Rodrigues, Pedro N. S.			Hepcidin-Dependent Regulation of Erythropoiesis during Anemia in a Teleost Fish, Dicentrarchus labrax	PLOS ONE			English	Article							IRON-METABOLISM; TRANSCRIPTION FACTORS; MITOCHONDRIAL HEME; PEPTIDE HEPCIDIN; EXPRESSION; GENE; OVERLOAD; LIVER; BMP6; INFLAMMATION	Anemia is a common disorder, characterized by abnormally low levels of red blood cells or hemoglobin. The mechanisms of anemia development and response have been thoroughly studied in mammals, but little is known in other vertebrates, particularly teleost fish. In this study, different degrees of anemia were induced in healthy European sea bass specimens (Dicentrarchus labrax) and at pre-determined time points hematological parameters, liver iron content and the expression of genes involved in iron homeostasis and hematopoiesis, with particular attention on hepcidins, were evaluated. The experimental anemia prompted a decrease in hamp1 expression in all tested organs, in accordance to an increased need for iron absorption and mobilization, with slight increases in hamp2 in the kidney and intestine. The liver was clearly the major organ involved in iron homeostasis, decreasing its iron content and showing a gene expression profile consistent with an increased iron release and mobilization. Although both the spleen and head kidney are involved in erythropoiesis, the spleen was found to assume a more preponderant role in the recovery of erythrocyte levels. The intestine was also involved in the response to anemia, through the increase of iron transporting genes. Administration of Hamp1 or Hamp2 mature peptides showed that only Hamp1 affects hematological parameters and liver iron content. In conclusion, the molecular mechanisms of response to anemia present in sea bass are similar to the ones described for mammals, with these results indicating that the two hepcidin types from teleosts assume different roles during anemia.	[Neves, Joao V.; Caldas, Carolina; Ramos, Miguel F.; Rodrigues, Pedro N. S.] Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Neves, Joao V.; Caldas, Carolina; Ramos, Miguel F.; Rodrigues, Pedro N. S.] Univ Porto, IBMC, Iron & Innate Immun, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Rodrigues, Pedro N. S.] Univ Porto, ICBAS, Rua Campo Alegre 823, P-4100 Porto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto	Neves, JV (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Porto, Portugal.; Neves, JV (corresponding author), Univ Porto, IBMC, Iron & Innate Immun, Rua Campo Alegre 823, P-4100 Porto, Portugal.	jneves@ibmc.up.pt	Neves, Jessika M. M./F-9215-2017; Mott, Tamí/I-5317-2012; Caldas, Carlos/U-7250-2019; Rodrigues, Pedro/B-3228-2008; Pereira, Ricardo J/K-7451-2017	Neves, Jessika M. M./0000-0003-3983-5171; Mott, Tamí/0000-0002-5896-4780; Caldas, Carlos/0000-0003-3547-1489; Rodrigues, Pedro/0000-0002-3799-1544; Pereira, Ricardo J/0000-0002-8076-4822; Caldas, Carolina/0000-0003-3967-6211; Lima, Sergio Maia Queiroz/0000-0001-9365-4879; Neves, Joao/0000-0003-1993-0999	FEDER-Fundo Europeu de Desenvolvimento Regional funds through COMPETE - Operational Programme for Competitiveness and Internationalization (POCI), Portugal; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao [POCI-01-0145-FEDER-007274, FCOMP-01-0124-FEDER-029339 (PTDC/MAR-BIO/3204/2012)]; FCT [SFRH/BPD/86380/2012]	FEDER-Fundo Europeu de Desenvolvimento Regional funds through COMPETE - Operational Programme for Competitiveness and Internationalization (POCI), Portugal; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by FEDER-Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020, and by Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the projects "Institute for Research and Innovation in Health Sciences" (POCI-01-0145-FEDER-007274) and FCOMP-01-0124-FEDER-029339 (PTDC/MAR-BIO/3204/2012). JVN is supported by FCT under the grant SFRH/BPD/86380/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisen P, 1999, CURR OPIN CHEM BIOL, V3, P200, DOI 10.1016/S1367-5931(99)80033-7; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Andrews NC, 2004, J CLIN INVEST, V113, P1251, DOI 10.1172/JCI200421441; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arndt S, 2010, GASTROENTEROLOGY, V138, P372, DOI 10.1053/j.gastro.2009.09.048; Barnes AC, 2011, FISH SHELLFISH IMMUN, V31, P350, DOI 10.1016/j.fsi.2011.05.027; Boldt DH, 1999, AM J MED SCI, V318, P207, DOI 10.1097/00000441-199910000-00001; Bury N, 2003, COMP BIOCHEM PHYS C, V135, P97, DOI 10.1016/S1532-0456(03)00021-8; Bury NR, 2001, J EXP BIOL, V204, P3779; CATTON WT, 1951, BLOOD, V6, P39, DOI 10.1182/blood.V6.1.39.39; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Cho YS, 2009, DEV COMP IMMUNOL, V33, P46, DOI 10.1016/j.dci.2008.07.009; Clark SF, 2008, NUTR CLIN PRACT, V23, P128, DOI 10.1177/0884533608314536; Conrad ME, 1999, AM J MED SCI, V318, P213, DOI 10.1097/00000441-199910000-00002; Darshan D, 2009, BIOMETALS, V22, P77, DOI 10.1007/s10534-008-9187-y; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; ESTEBAN MA, 1989, ARCH HISTOL CYTOL, V52, P407, DOI 10.1679/aohc.52.407; Fleming MD, 2012, J CLIN INVEST, V122, P4328, DOI 10.1172/JCI66607; Ganz T, 2005, BEST PRACT RES CL HA, V18, P171, DOI 10.1016/j.beha.2004.08.020; Ganz T, 2004, CURR OPIN HEMATOL, V11, P251, DOI 10.1097/00062752-200407000-00004; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hilton KB, 2008, GENE, V415, P40, DOI 10.1016/j.gene.2008.02.016; Hu XY, 2007, COMP IMMUNOL MICROB, V30, P55, DOI 10.1016/j.cimid.2006.10.004; Huang H, 2009, BLOOD, V113, P3593, DOI 10.1182/blood-2008-08-173641; Imagawa S, 1997, BLOOD, V89, P1430, DOI 10.1182/blood.V89.4.1430; Ingley E, 2004, IUBMB LIFE, V56, P177, DOI 10.1080/15216540410001703956; Kautz L, 2011, HAEMATOL-HEMATOL J, V96, P199, DOI 10.3324/haematol.2010.031963; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nam YK, 2011, FISH SHELLFISH IMMUN, V31, P1251, DOI 10.1016/j.fsi.2011.09.007; Neves JV, 2011, FISH SHELLFISH IMMUN, V31, P1154, DOI 10.1016/j.fsi.2011.10.006; Neves JV, 2015, J IMMUNOL, V195, P2696, DOI 10.4049/jimmunol.1501153; Neves JV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-106; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2002, BLOOD CELL MOL DIS, V29, P327, DOI 10.1006/bcmd.2002.0573; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pereiro R, 2012, FISH SHELLFISH IMMUN, V32, P879, DOI 10.1016/j.fsi.2012.02.016; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; Rodrigues PNS, 2006, DEV COMP IMMUNOL, V30, P1156, DOI 10.1016/j.dci.2006.02.005; Saboor Muhammad, 2011, J Ayub Med Coll Abbottabad, V23, P115; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Torrance J.D., 1980, METHODS HEMATOLOGY, P104; Viatte L, 2009, BIOCHIMIE, V91, P1223, DOI 10.1016/j.biochi.2009.06.012; Weiss G, 2009, BBA-GEN SUBJECTS, V1790, P682, DOI 10.1016/j.bbagen.2008.08.006; Wessling-Resnick M, 1999, CRIT REV BIOCHEM MOL, V34, P285, DOI 10.1080/10409239991209318; Worthen CA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00034; Zhou JG, 2011, FISH SHELLFISH IMMUN, V30, P559, DOI 10.1016/j.fsi.2010.11.021	50	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153940	10.1371/journal.pone.0153940	http://dx.doi.org/10.1371/journal.pone.0153940			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27309356	Green Published, gold, Green Submitted			2022-12-26	WOS:000374898500102
J	Neves, JMM; Lima, SMQ; Mendes, LF; Torres, RA; Pereira, RJ; Mott, T				Neves, Jessika M. M.; Lima, Sergio M. Q.; Mendes, Liana F.; Torres, Rodrigo A.; Pereira, Ricardo J.; Mott, Tami			Population Structure of the Rockpool Blenny Entomacrodus vomerinus Shows Source-Sink Dynamics among Ecoregions in the Tropical Southwestern Atlantic	PLOS ONE			English	Article							REEF FISH; LARVAL DISPERSAL; PHYLOGEOGRAPHY; BIOGEOGRAPHY; NEUTRALITY; TELEOSTEI; MIGRATION; PATTERNS; GENETICS; COASTAL	The Tropical Southwestern Atlantic is characterized by prominent ecosystems with large-scale oceanographic complexity. Yet, the evolutionary processes underlying genetic differentiation and connectivity in this region remain largely unknown. Entomacrodus vomerinus (Valenciennes, 1836) is a demersal fish with planktonic larvae endemic to this marine province, inhabiting shallow tidal pools in continental and oceanic reef environments. We evaluated the population structure, genetic diversity and gene flow of E. vomerinus using mitochondrial data (CYTB and COI) and nuclear (rhodopsin, RHO) DNA sequences. We sampled a total of 85 individuals, comprising 46 from three oceanic archipelagos with varying distance from the coast (Sao Pedro and Sao Paulo-SS, Fernando de Noronha-FE and Rocas Atoll-RA) and 39 from two localities in northeastern Brazilian coast (Rio Grande do Norte-RN and Bahia-BA). Multilocus analysis revealed the presence of three Evolutionarily Significant Units-ESUs (SS, FE+RA, and RN+BA), which are in accordance with distinct marine ecoregions. Coalescent analyses showed that the central ESU has a larger effective population size than the other two, suggesting strong asymmetries in the genetic diversity across the species range. Moreover, they showed that gene flow is highly asymmetric, suggesting a source-sink dynamics from the central ESU into the remaining ones, in agreement with oceanic currents. Together, these results provide insights in the evolutionary mechanisms facilitating diversification in this marine province.	[Neves, Jessika M. M.; Mott, Tami] Univ Fed Alagoas, Setor Biodiversidade, Lab Diversidade Mol, Maceio, Alagoas, Brazil; [Lima, Sergio M. Q.] Univ Fed Rio Grande do Norte, Dept Bot & Zool, Lab Ictiol Sistemat & Evolut, BR-59072970 Natal, RN, Brazil; [Mendes, Liana F.] Univ Fed Rio Grande do Norte, Dept Ecol, Lab Oceano, BR-59072970 Natal, RN, Brazil; [Torres, Rodrigo A.] Univ Fed Pernambuco, Dept Zool, Lab Genom Evolutiva & Ambiental, Recife, PE, Brazil; [Pereira, Ricardo J.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark	Universidade Federal de Alagoas; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal de Pernambuco; University of Copenhagen	Neves, JMM (corresponding author), Univ Fed Alagoas, Setor Biodiversidade, Lab Diversidade Mol, Maceio, Alagoas, Brazil.	neves.jmm@gmail.com	Neves, Jessika M. M./F-9215-2017; Mott, Tamí/I-5317-2012; Caldas, Carlos/U-7250-2019; Rodrigues, Pedro/B-3228-2008; Pereira, Ricardo J/K-7451-2017	Neves, Jessika M. M./0000-0003-3983-5171; Mott, Tamí/0000-0002-5896-4780; Caldas, Carlos/0000-0003-3547-1489; Rodrigues, Pedro/0000-0002-3799-1544; Pereira, Ricardo J/0000-0002-8076-4822; Caldas, Carolina/0000-0003-3967-6211; Lima, Sergio Maia Queiroz/0000-0001-9365-4879; Neves, Joao/0000-0003-1993-0999	Fundacao Universitaria de Desenvolvimento de Extensao e Pesquisa (Fundepes); Financiadora de Estudos e Projetos (FINEP) [1312/10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [301208/2012-3]; European Union's Horizon research and innovation program under the Marie Sklodowska-Curie (MSCA) [658706]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao Universitaria de Desenvolvimento de Extensao e Pesquisa (Fundepes); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Union's Horizon research and innovation program under the Marie Sklodowska-Curie (MSCA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Support was provided by Fundacao Universitaria de Desenvolvimento de Extensao e Pesquisa (Fundepes - http://www.fundepes.br/) and Financiadora de Estudos e Projetos (FINEP - http://www.finep.gov.br/) grant #1312/10 (TM); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - http://www.cnpq.br/) grant #301208/2012-3 (RAT); and the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie (MSCA - http://ec.europa.eu/research/mariecurieactions/index_en.htm) grant #658706 (RJP). Scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - http://www.capes.gov.br/) (JMMN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Baldwin CC, 2009, ZOOTAXA, P1; Barroso R, 2010, MAR BIOL, V157, P69, DOI 10.1007/s00227-009-1296-9; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Cruzan MB, 2000, TRENDS ECOL EVOL, V15, P491, DOI 10.1016/S0169-5347(00)01998-4; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; EDWARDS A, 1983, J BIOGEOGR, V10, P65, DOI 10.2307/2844583; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feitoza Bertran M., 2003, Aqua (Miradolo Terme), V7, P61; Fitzpatrick BM, 2009, MOL ECOL, V18, P3961, DOI 10.1111/j.1365-294X.2009.04314.x; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Francisco SM, 2011, J EXP MAR BIOL ECOL, V403, P14, DOI 10.1016/j.jembe.2011.03.020; Fu YX, 1997, GENETICS, V147, P915; Gaither MR, 2015, MOL ECOL, V24, P1543, DOI 10.1111/mec.13129; Gama-Maia DJ, 2016, J MAR BIOL ASSOC UK, V96, P1677, DOI 10.1017/S0025315415002052; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedgecock D, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.30; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Jacobina UP, 2014, HELGOLAND MAR RES, V68, P17, DOI 10.1007/s10152-013-0365-0; Joyeux JC, 2001, J BIOGEOGR, V28, P831, DOI 10.1046/j.1365-2699.2001.00602.x; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Leao Zelinda M. A. N., 2000, Marine Pollution Bulletin, V41, P112, DOI 10.1016/S0025-326X(00)00105-3; Leao ZMAN, 2005, MAR POLLUT BULL, V51, P599, DOI 10.1016/j.marpolbul.2005.04.024; Leigh JW, POPART POPULATION AN; Macedo-Soares LCP, 2012, MAR ECOL PROG SER, V444, P207, DOI 10.3354/meps09436; Macieira RM, 2015, ENVIRON BIOL FISH, V98, P385, DOI 10.1007/s10641-014-0269-0; Mai ACG, 2014, ESTUAR COAST SHELF S, V149, P80, DOI 10.1016/j.ecss.2014.07.013; Medeiros Paulo R., 2007, Pan-American Journal of Aquatic Sciences, V2, P288; Mendes LF, 2000, THESIS; Mendes LD, 2006, REV BRAS ZOOL, V23, P817, DOI 10.1590/S0101-81752006000300029; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Motoki A, 2009, REM-REV ESC MINAS, V62, P331, DOI 10.1590/S0370-44672009000300011; Muss A, 2001, EVOLUTION, V55, P561, DOI 10.1554/0014-3820(2001)055[0561:POOTRO]2.0.CO;2; Nanninga GB, 2014, MOL ECOL, V23, P591, DOI 10.1111/mec.12623; Nielsen R, 2001, GENETICS, V158, P885; Paiva Maria Isabel G., 2015, Pan-American Journal of Aquatic Sciences, V10, P19; Pinheiro HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118180; Pringle JM, 2001, P NATL ACAD SCI USA, V108, P15288; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rangel Carlos A., 2010, Revista Brasileira de Zoociencias, V12, P17; Rangel CA, 2009, ZOOTAXA, P51, DOI 10.11646/zootaxa.2006.1.4; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Rodriguez-Rey GT, 2016, J EXP MAR BIOL ECOL, V474, P204, DOI 10.1016/j.jembe.2015.10.016; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Sacramento LA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/264270; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; SMITH MF, 1993, BIOL J LINN SOC, V50, P149, DOI 10.1111/j.1095-8312.1993.tb00924.x; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stephens M, 2004, DOCUMENTATION PHASE, P35; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Ward Robert D, 2012, Methods Mol Biol, V858, P423, DOI 10.1007/978-1-61779-591-6_21; Wares JP, 2001, EVOLUTION, V55, P295; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Williams JT, 2014, ENTOMACRODUS VOMERIN, DOI [10.2305/IUCN.UK.2014-3.RLTS.T185176A1776911.en, DOI 10.2305/IUCN.UK.2014-3.RLTS.T185176A1776911.EN]	65	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157472	10.1371/journal.pone.0157472	http://dx.doi.org/10.1371/journal.pone.0157472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309356	Green Submitted, gold, Green Published			2022-12-26	WOS:000378029800079
